@Article{20161,
author  = {Velasquez, T. and Mackey, G. and Lusk, J. and Kyle, U. and Fontenot, T. and Marshall, P. and Shekerdemian, L. and Coss-Bu, J. and Nishigaki, A. and Yatabe, T. and Tamura, T. and Yamashita, K. and Yokoyama, M. and Ruiz-Rodriguez, J. and Encina, B. and Belmonte, R. and Troncoso, I. and Tormos, P. and Riveiro, M. and Baena, J. and Sanchez, A. and Ba√±eras, J. and Cord√≥n, J. and Duran, N. and Ruiz, A. and Caballero, J. and Nuvials, X. and Riera, J. and Serra, J. and Rutten, A. and van, I. and Der, K. and Van, L. and Kovacikova, L. and Skrak, P. and Zahorec, M. and Kyle, U. and Akcan-Arikan, A. and Silva, J. and Mackey, G. and Lusk, J. and Goldsworthy, M. and Shekerdemian, L. and Coss-Bu, J. and Wood, D. and Harrison, D. and Parslow, R. and Davis, P. and Pappachan, J. and Goodwin, S. and Ramnarayan, P. and Chernyshuk, S. and Yemets, H. and Zhovnir, V. and Pulitano‚Äô, S. and De, R. and Mancino, A. and Villa, G. and Tosi, F. and Franchi, P. and Conti, G. and Patel, B. and Khine, H. and Shah, A. and Sung, D. and Singer, L. and Haghbin, S. and Inaloo, S. and Serati, Z. and Idei, M. and Nomura, T. and Yamamoto, N. and Sakai, Y. and Yoshida, T. and Matsuda, Y. and Yamaguchi, Y. and Takaki, S. and Yamaguchi, O. and Goto, T. and Longani, N. and Medar, S. and Abdel-Aal, I. and El, A. and Mohammed, H. and Mohamed, A. and Parry, S. and Knight, L. and Denehy, L. and De, M. and Baldwin, C. and Sani, D. and Kayambu, G. and da, S. and Phongpagdi, P. and Puthucheary, Z. and Granger, C. and Rydingsward, J. and Horkan, C. and Christopher, K. and McWilliams, D. and Jones, C. and Reeves, E. and Atkins, G. and Snelson, C. and Aitken, L. and Rattray, J. and Kenardy, J. and Hull, A. and Ullman, A. and Le, B. and Mitchell, M. and Davis, C. and Macfarlane, B. and Azevedo, J. and Rocha, L. and De, F. and Cavalheiro, A. and Lucinio, N. and Lobato, M. and Ebeling, G. and Kraegpoeth, A. and Laerkner, E. and De, B. and White, C. and Gregory, S. and Forni, L. and Flowers, E. and Curtis, A. and Wood, C. and Siu, K. and Venkatesan, K. and Muhammad, J. and Ng, L. and Seet, E. and Baptista, N. and Escoval, A. and Tomas, E. and Agrawal, R. and Mathew, R. and Varma, A. and Dima, E. and Charitidou, E. and Perivolioti, E. and Pratikaki, M. and Vrettou, C. and Giannopoulos, A. and Zakynthinos, S. and Routsi, C. and Atchade, E. and Houz√©, S. and Jean-Baptiste, S. and Thabut, G. and Gen√®ve, C. and Tanaka, S. and Lortat-Jacob, B. and Augustin, P. and Desmard, M. and Montravers, P. and de, M. and Barbadillo, S. and Alejandro, R. and √?lvarez-Lerma, F. and Vall√©s, J. and Catal√°n, R. and Palencia, E. and Jare√±o, A. and Granada, R. and Ignacio, M. and Cui, N. and Liu, D. and Wang, H. and Su, L. and Qiu, H. and Li, R. and Jaffal, K. and Rouz√©, A. and Poissy, J. and Sendid, B. and Nseir, S. and Paramythiotou, E. and Rizos, M. and Frantzeskaki, F. and Antoniadou, A. and Vourli, S. and Zerva, L. and Armaganidis, A. and Riera, J. and Gottlieb, J. and Greer, M. and Wiesner, O. and Mart√≠nez, M. and Acu√±a, M. and Rello, J. and Welte, T. and Atchade, E. and Mignot, T. and Houz√©, S. and Jean-Baptiste, S. and Thabut, G. and Lortat-Jacob, B. and Tanaka, S. and Augustin, P. and Desmard, M. and Montravers, P. and Soussi, S. and Dudoignon, E. and Ferry, A. and Chaussard, M. and Benyamina, M. and Alanio, A. and Touratier, S. and Chaouat, M. and Lafaurie, M. and Mimoun, M. and Mebazaa, A. and Legrand, M. and Sheils, M. and Patel, C. and Mohankumar, L. and Akhtar, N. and Noriega, S. and Aldana, N. and Le√≥n, J. and Baquero, J. and Bernal, F. and Ahmadnia, E. and Hadley, J. and Millar, M. and Hall, D. and Hewitt, H. and Yasuda, H. and Sanui, M. and Komuro, T. and Kawano, S. and Andoh, K. and Yamamoto, H. and Noda, E. and Hatakeyama, J. and Saitou, N. and Okamoto, H. and Kobayashi, A. and Takei, T. and Matsukubo, S. and Rotzel, H. and L√°zaro, A. and Prada, D. and Gimillo, M. and Barinas, O. and Cortes, M. and Franco, J. and Roca, J. and Carratal√°, A. and Gon√ßalves, B. and Turon, R. and Mendes, A. and Miranda, F. and Mata, P. and Cavalcanti, D. and Melo, N. and Lacerda, P. and Kurtz, P. and Righy, C. and Rosario, L. and Lesmes, S. and Romero, J. and Herrera, A. and Pertuz, E. and S√°nchez, M. and Sanz, E. and Hualde, J. and Hern√°ndez, A. and Irazabal, J. and Spatenkova, V. and Bradac, O. and Suchomel, P. and Urli, T. and Lazzeri, E. and Aspide, R. and Zanello, M. and Perez-Borrero, L. and Garcia-Alvarez, J. and Arias-Verdu, M. and Aguilar-Alonso, E. and Rivera-Fernandez, R. and Mora-Ordo√±ez, J. and De, L. and Castillo-Lorente, E. and Guerrero-Lopez, F. and Lesmes, S. and Rosario, L. and Pertuz, E. and Hern√°ndez, A. and Romero, J. and S√°nchez, M. and Herrera, A. and Ram√≠rez, J. and Sanz, E. and Hualde, J. and Le√≥n, J. and Navarro-Guillam√≥n, L. and Cordovilla-Guardia, S. and Iglesias-Santiago, A. and Guerrero-L√≥pez, F. and Fern√°ndez-Mond√©jar, E. and Vidal, A. and Perez, M. and Juez, A. and Arias, N. and Colino, L. and Perez, J. and P√©rez, H. and Calpe, P. and Alcala, M. and Robaglia, D. and Perez, C. and Lan, S. and Cunha, M. and Moreira, T. and Santos, F. and Lafuente, E. and Fernandes, M. and Silva, J. and Rosario, L. and Lesmes, S. and Herrera, A. and Romero, J. and Pertuz, E. and S√°nchez, M. and Sanz, E. and Echeverr√≠a, J. and Hern√°ndez, A. and Hualde, J. and Podlepich, V. and Sokolova, E. and Alexandrova, E. and Lapteva, K. and Kurtz, P. and Shuinotsuka, C. and Rabello, L. and Vianna, G. and Reis, A. and Cairus, C. and Salluh, J. and Bozza, F. and Torres, J. and Araujo, N. and Garc√≠a-Olivares, P. and Keough, E. and Dalorzo, M. and Tang, L. and De, S. and D√≠az, M. and Marcos-Zambrano, L. and Guerrero, J. and Gomez, S. and Lopez, G. and Cuellar, A. and Nieto, O. and Gonzalez, J. and Bhasin, D. and Rai, S. and Singh, H. and Gupta, O. and Bhattal, M. and Sampley, S. and Sekhri, K. and Nandha, R. and Aliaga, F. and Olivares, F. and Appiani, F. and Farias, P. and Alberto, F. and Hern√°ndez, A. and Pons, S. and Sonneville, R. and Bouadma, L. and Neuville, M. and Mariotte, E. and Radjou, A. and Lebut, J. and Chemam, S. and Voiriot, G. and Dilly, M. and Mourvillier, B. and Dorent, R. and Nataf, P. and Wolff, M. and Timsit, J. and Ediboglu, O. and Ataman, S. and Ozkarakas, H. and Kirakli, C. and Vakalos, A. and Avramidis, V. and Obukhova, O. and Kurmukov, I. and Kashiya, S. and Golovnya, E. and Baikova, V. and Ageeva, T. and Haritydi, T. and Kulaga, E. and Rios-Toro, J. and Perez-Borrero, L. and Aguilar-Alonso, E. and Arias-Verdu, M. and Garcia-Alvarez, J. and Lopez-Caler, C. and De, L. and Rodriguez-Fernandez, S. and Sanchez-Or√©zzoli, M. and Martin-Gallardo, F. and Nikhilesh, J. and Joshi, V. and Villarreal, E. and Ruiz, J. and Gordon, M. and Quinza, A. and Gimenez, J. and Pi√±ol, M. and Castellanos, A. and Ramirez, P. and Jeon, Y. and Jeong, W. and Kim, M. and Jeong, I. and Ahn, M. and Ahn, J. and Han, S. and Choi, J. and Song, Y. and Kim, J. and Ku, N. and Shah, H. and Kellner, F. and Rezai, F. and Mistry, N. and Yodice, P. and Ovnanian, V. and Fless, K. and Handler, E. and Alejos, R. and Romeu, J. and Ant√≥n, D. and Quinart, A. and Mart√≠, A. and Llaurado-Serra, M. and Lobo-Civico, A. and Ventura-Rosado, A. and Pi√±ol-Tena, A. and Pi-Guerrero, M. and Pa√±os-Espinosa, C. and Peralvo-Bernat, M. and Marine-Vidal, J. and Gonzalez-Engroba, R. and Montesinos-Cerro, N. and Treso-Geira, M. and Valeiras-Valero, A. and Martinez-Reyes, L. and Sandiumenge, A. and Jimenez-Herrera, M. and Helyar, S. and Riozzi, P. and Noon, A. and Hallows, G. and Cotton, H. and Keep, J. and Hopkins, P. and Taggu, A. and Renuka, S. and Sampath, S. and Rood, P. and Frenzel, T. and Verhage, R. and Bonn, M. and Pickkers, P. and van, d. and van, d. and Corradi, F. and Melnyk, L. and Moggia, F. and Pienovi, R. and Adriano, G. and Brusasco, C. and Mariotti, L. and Lattuada, M. and Bloomer, M. and Coombs, M. and Ranse, K. and Endacott, R. and Maertens, B. and Blot, K. and Blot, S. and Amerongen, M. and van, d. and Twisk, J. and Girbes, A. and Spijkstra, J. and Riozzi, P. and Helyar, S. and Cotton, H. and Hallows, G. and Noon, A. and Bell, C. and Peters, K. and Feehan, A. and Keep, J. and Hopkins, P. and Churchill, K. and Hawkins, K. and Brook, R. and Paver, N. and Endacott, R. and Maistry, N. and van, W. and Rouw, N. and van, G. and Evelein-Brugman, S. and Taggu, A. and Krishna, B. and Sampath, S. and Putzu, A. and Fang, M. and Berto, M. and Belletti, A. and Cassina, T. and Cabrini, L. and Mistry, M. and Alhamdi, Y. and Welters, I. and Abrams, S. and Toh, C. and Han, H. and Gil, E. and Lee, D. and Park, C. and Winder-Rhodes, S. and Lotay, R. and Doyle, J. and Ke, M. and Huang, W. and Chiang, C. and Hung, W. and Cheng, C. and Lin, K. and Lin, S. and Chiou, K. and Wann, S. and Shu, C. and Kang, P. and Mar, G. and Liu, C. and Dub√≥, S. and Aquevedo, A. and Jibaja, M. and Berrutti, D. and Labra, C. and Lagos, R. and Garc√≠a, M. and Ramirez, V. and Tobar, M. and Picoita, F. and Pel√°ez, C. and Carpio, D. and Alegr√≠a, L. and Hidalgo, C. and Godoy, K. and Bakker, J. and Hern√°ndez, G. and Sadamoto, Y. and Katabami, K. and Wada, T. and Ono, Y. and Maekawa, K. and Hayakawa, M. and Sawamura, A. and Gando, S. and Marin-Mateos, H. and Perez-Vela, J. and Garcia-Gigorro, R. and Peiretti, M. and Lopez-Gude, M. and Chacon-Alves, S. and Renes-Carre√±o, E. and Montejo-Gonz√°lez, J. and Parlevliet, K. and Touw, H. and Beerepoot, M. and Boer, C. and Elbers, P. and Tuinman, P. and Abdelmonem, S. and Helmy, T. and El, S. and Ghazal, S. and Akhlagh, S. and Masjedi, M. and Hozhabri, K. and Kamali, E. and Z√Ωkov√°, I. and Paldusov√°, B. and Sedl√°k, P. and Morman, D. and Youn, A. and Ohta, Y. and Sakuma, M. and Bates, D. and Morimoto, T. and Su, P. and Chang, W. and Lin, W. and Chen, C. and Facchin, F. and Zarantonello, F. and Panciera, G. and De, C. and Venrdramin, A. and Ballin, A. and Tonetti, T. and Persona, P. and Ori, C. and Del, S. and Rossi, S. and Vergani, G. and Cressoni, M. and Chiumello, D. and Chiurazzi, C. and Brioni, M. and Algieri, I. and Tonetti, T. and Guanziroli, M. and Colombo, A. and Tomic, I. and Colombo, A. and Crimella, F. and Carlesso, E. and Gasparovic, V. and Gattinoni, L. and Neto, A. and Schmidt, M. and Pham, T. and Combes, A. and de, A. and Pelosi, P. and Schultz, M. and Katira, B. and Engelberts, D. and Giesinger, R. and Ackerley, C. and Yoshida, T. and Zabini, D. and Otulakowski, G. and Post, M. and Kuebler, W. and McNamara, P. and Kavanagh, B. and Pirracchio, R. and Rigon, M. and Carone, M. and Chevret, S. and Annane, D. and Eladawy, S. and El-Hamamsy, M. and Bazan, N. and Elgendy, M. and De, P. and Vallecoccia, M. and Cutuli, S. and Di, G. and Pennisi, M. and Conti, G. and Antonelli, M. and Andreis, D. and Khaliq, W. and Singer, M. and Hartmann, J. and Harm, S. and Carmona, S. and Almudevar, P. and Abell√°n, A. and Ramos, J. and P√©rez, L. and Valbuena, B. and Sanz, N. and Sim√≥n, I. and Arrigo, M. and Feliot, E. and Deye, N. and Cariou, A. and Guidet, B. and Jaber, S. and Leone, M. and Resche-Rigon, M. and Baron, A. and Legrand, M. and Gayat, E. and Mebazaa, A. and Balik, M. and Kolnikova, I. and Maly, M. and Waldauf, P. and Tavazzi, G. and Kristof, J. and Herpain, A. and Su, F. and Post, E. and Taccone, F. and Vincent, J. and Creteur, J. and Lee, C. and Hatib, F. and Jian, Z. and Buddi, S. and Cannesson, M. and Filekoviƒá, S. and Turel, M. and Knafelj, R. and Gorjup, V. and Staniƒá, R. and Gradi≈°ek, P. and Ceroviƒá, O. and Mirkoviƒá, T. and Noƒ?, M. and Tirkkonen, J. and Hellevuo, H. and Olkkola, K. and Hoppu, S. and Lin, K. and Hung, W. and Chiang, C. and Huang, W. and Juan, W. and Lin, S. and Cheng, C. and Lin, P. and Fong, K. and Hou, D. and Kang, P. and Wann, S. and Chen, Y. and Mar, G. and Liu, C. and Paul, M. and Bougouin, W. and Geri, G. and Dumas, F. and Champigneulle, B. and Legriel, S. and Charpentier, J. and Mira, J. and Sandroni, C. and Cariou, A. and Zimmerman, J. and Sullivan, E. and Noursadeghi, M. and Fox, B. and Sampson, D. and McHugh, L. and Yager, T. and Cermelli, S. and Seldon, T. and Bhide, S. and Brandon, R. and Brandon, R. and Zwaag, J. and Beunders, R. and Pickkers, P. and Kox, M. and Gul, F. and Arslantas, M. and Genc, D. and Zibandah, N. and Topcu, L. and Akkoc, T. and Cinel, I. and Greco, E. and Lauretta, M. and Andreis, D. and Singer, M. and Garcia, I. and Cordero, M. and Martin, A. and Pall√°s, T. and Montero, J. and Rey, J. and Malo, L. and Montoya, A. and Martinez, A. and Ayala, L. and Zepeda, E. and Granillo, J. and Sanchez, J. and Alejo, G. and Cabrera, A. and Montenegro, A. and Pham, T. and Beduneau, G. and Schortgen, F. and Piquilloud, L. and Zogheib, E. and Jonas, M. and Grelon, F. and Runge, I. and Terzi, N. and Grang√©, S. and Barberet, G. and Guitard, P. and Frat, J. and Constan, A. and Chr√©tien, J. and Mancebo, J. and Mercat, A. and Richard, J. and Brochard, L. and Soilemezi, E. and Koco, E. and Savvidou, S. and Nouris, C. and Matamis, D. and Di, M. and Spadaro, S. and Volta, C. and Mariani, M. and Colaprico, A. and Antonio, C. and Bruno, F. and Grasso, S. and Rodriguez, A. and Mart√≠n-Loeches, I. and D√≠az, E. and Masclans, J. and Gordo, F. and Sol√©-Viol√°n, J. and Bod√≠, M. and Avil√©s-Jurado, F. and Trefler, S. and Magret, M. and Reyes, L. and Mar√≠n-Corral, J. and Yebenes, J. and Esteban, A. and Anzueto, A. and Aliberti, S. and Restrepo, M. and Larsson, J. and Redfors, B. and Ricksten, S. and Haines, R. and Powell-Tuck, J. and Leonard, H. and Ostermann, M. and Berthelsen, R. and Itenov, T. and Perner, A. and Jensen, J. and Ibsen, M. and Jensen, A. and Bestle, M. and Bucknall, T. and Dixon, J. and Boa, F. and MacPhee, I. and Philips, B. and Doyle, J. and Saadat, F. and Samuels, T. and Huddart, S. and McCormick, B. and DeBrunnar, R. and Preece, J. and Swart, M. and Peden, C. and Richardson, S. and Forni, L. and Kalfon, P. and Baumstarck, K. and Estagnasie, P. and Geantot, M. and Berric, A. and Simon, G. and Floccard, B. and Signouret, T. and Boucekine, M. and Fromentin, M. and Nyunga, M. and Sossou, A. and Venot, M. and Robert, R. and Follin, A. and Renault, A. and Garrouste, M. and Collange, O. and Levrat, Q. and Villard, I. and Th√©venin, D. and Pottecher, J. and Patrigeon, R. and Revel, N. and Vigne, C. and Mimoz, O. and Auquier, P. and Pawar, S. and Jacques, T. and Deshpande, K. and Pusapati, R. and Wood, B. and Pulham, R. and Wray, J. and Brown, K. and Pierce, C. and Nadel, S. and Ramnarayan, P. and Azevedo, J. and Montenegro, W. and Rodrigues, D. and Sousa, S. and Araujo, V. and Leitao, A. and Prazeres, P. and Mendonca, A. and Paula, M. and Das, N. and Loudet, C. and Busico, M. and Vazquez, D. and Villalba, D. and Lischinsky, A. and Veronesi, M. and Emmerich, M. and Descotte, E. and Juliarena, A. and Bisso, M. and Grando, M. and Tapia, A. and Camargo, M. and Ulla, D. and Corzo, L. and dos, S. and Ramos, A. and Doglia, J. and Estenssoro, E. and Carbonara, M. and Magnoni, S. and Donald, C. and Shimony, J. and Conte, V. and Triulzi, F. and Stretti, F. and Macr√¨, M. and Snyder, A. and Stocchetti, N. and Brody, D. and Podlepich, V. and Shimanskiy, V. and Savin, I. and Lapteva, K. and Chumaev, A. and Tjepkema-Cloostermans, M. and Hofmeijer, J. and Beishuizen, A. and Hom, H. and Blans, M. and van, P. and Longhi, L. and Frigeni, B. and Curinga, M. and Mingone, D. and Beretta, S. and Patruno, A. and Gandini, L. and Vargiolu, A. and Ferri, F. and Ceriani, R. and Rottoli, M. and Lorini, L. and Citerio, G. and Pifferi, S. and Battistini, M. and Cordolcini, V. and Agarossi, A. and Di, R. and Ortolano, F. and Stocchetti, N. and Lourido, C. and Cabrera, J. and Santana, J. and Alzola, L. and del, R. and P√©rez, H. and Torrent, R. and Eslami, S. and Dalhuisen, A. and Fiks, T. and Schultz, M. and Hanna, A. and Spronk, P. and Wood, M. and Maslove, D. and Muscedere, J. and Scott, S. and Saha, T. and Hamilton, A. and Petsikas, D. and Payne, D. and Boyd, J. and Puthucheary, Z. and McNelly, A. and Rawal, J. and Connolly, B. and McPhail, M. and Sidhu, P. and Rowlerson, A. and Moxham, J. and Harridge, S. and Hart, N. and Montgomery, H. and Jovaisa, T. and Thomas, B. and Gupta, D. and Wijayatilake, D. and Shum, H. and King, H. and Chan, K. and Tang, K. and Yan, W. and Arias, C. and Latorre, J. and De, L. and Garrido, E. and Feijoo, A. and Gancedo, C. and Tofi√±o, A. and Rodr√≠guez, F. and Gemmell, L. and Campbell, R. and Doherty, P. and MacKay, A. and Singh, N. and Vitaller, S. and Nagib, H. and Prieto, J. and Del, A. and Zayas, B. and Gomez, C. and Tirumala, S. and Pasha, S. and Kumari, B. and Martinez-Lopez, P. and Puerto-Morl√°n, A. and Nuevo-Ortega, P. and Pujol, L. and Dolset, R. and Gonz√°lez, B. and Riera, S. and √?lvarez, J. and Quintana, S. and Mart√≠nez, L. and Algarte, R. and S√°nchez, B. and Trenado, J. and Tomas, E. and Brock, N. and Viegas, E. and Filipe, E. and Cottle, D. and Traynor, T. and Mart√≠nez, M. and M√°rquez, M. and G√≥mez, L. and Mart√≠nez, N. and Mu√±oz, J. and Bellver, B. and Varea, M. and Llorente, M. and Calvo, C. and Hillier, S. and Faulds, M. and Hendra, H. and Lawrence, N. and Maekawa, K. and Hayakawa, M. and Ono, Y. and Kodate, A. and Sadamoto, Y. and Tominaga, N. and Mizugaki, A. and Murakami, H. and Yoshida, T. and Katabami, K. and Wada, T. and Sawamura, A. and Gando, S. and Silva, S. and Kerhuel, L. and Malagurski, B. and Citerio, G. and Chabanne, R. and Laureys, S. and Puybasset, L. and Nobile, L. and Pognuz, E. and Rossetti, A. and Verginella, F. and Gaspard, N. and Creteur, J. and Ben-Hamouda, N. and Oddo, M. and Taccone, F. and Ono, Y. and Hayakawa, M. and Iijima, H. and Maekawa, K. and Kodate, A. and Sadamoto, Y. and Mizugaki, A. and Murakami, H. and Katabami, K. and Wada, T. and Sawamura, A. and Gando, S. and Kodate, A. and Katabami, K. and Wada, T. and Ono, Y. and Maekawa, K. and Hayakawa, M. and Sawamura, A. and Gando, S. and Andersen, L. and Raymond, T. and Berg, R. and Nadkarni, V. and Grossestreuer, A. and Kurth, T. and Donnino, M. and Kr√ºger, A. and Ostadal, P. and Janotka, M. and Vondrakova, D. and Kongpolprom, N. and Cholkraisuwat, J. and Pekkarinen, P. and Ristagno, G. and Masson, S. and Latini, R. and Bendel, S. and Ala-Kokko, T. and Varpula, T. and Vaahersalo, J. and Hoppu, S. and Tiainen, M. and Mion, M. and Plebani, M. and Pettil√§, V. and Skrifvars, M. and Son, Y. and Kim, K. and Suh, G. and Kwon, W. and Ko, J. and Park, M. and Cavicchi, F. and Iesu, E. and Nobile, L. and Vincent, J. and Creteur, J. and Taccone, F. and Tanaka, H. and Otani, N. and Ode, S. and Ishimatsu, S. and Mart√≠nez, L. and Algarte, R. and S√°nchez, B. and Romero, I. and Mart√≠nez, F. and Quintana, S. and Trenado, J. and Vondrakova, D. and Ostadal, P. and Kruger, A. and Janotka, M. and Malek, F. and Neuzil, P. and Yeh, Y. and Chen, Y. and Wang, C. and Huang, C. and Chao, A. and Lee, C. and Lai, C. and Chan, W. and Cheng, Y. and Sun, W. and Kaese, S. and Horstmann, C. and Lebiedz, P. and Mourad, M. and Gaudard, P. and Eliet, J. and Zeroual, N. and Colson, P. and Ostadal, P. and Mlcek, M. and Hrachovina, M. and Kruger, A. and Vondrakova, D. and Janotka, M. and Mates, M. and Hala, P. and Kittnar, O. and Neuzil, P. and Jacky, A. and Rudiger, A. and Spahn, D. and Bettex, D. and Kara, A. and Akin, S. and Dos, r. and Struijs, A. and Caliskan, K. and van, T. and Dubois, E. and de, W. and Zijlstra, F. and Gommers, D. and Ince, C. and Marca, L. and Xini, A. and Mongkolpun, W. and Cordeiro, C. and Leite, R. and Lheureux, O. and Bader, A. and Rincon, L. and Santacruz, C. and Preiser, J. and Chao, A. and Chao, A. and Chen, Y. and Kim, W. and Ahn, C. and Cho, Y. and Lim, T. and Oh, J. and Choi, K. and Jang, B. and Ha, J. and Mecklenburg, A. and Stamm, J. and Soeffker, G. and Kubik, M. and Sydow, K. and Reichenspurner, H. and Kluge, S. and Braune, S. and Bergantino, B. and Ruberto, F. and Magnanimi, E. and Privato, E. and Zullino, V. and Bruno, K. and Pugliese, F. and Sales, G. and Girotto, V. and Vittone, F. and Brazzi, L. and Fritz, C. and Kimmoun, A. and Vanhuyse, F. and Trifan, B. and Orlowski, S. and Albuisson, E. and Tran, N. and Levy, B. and Chhor, V. and Joachim, J. and Follin, A. and Champigneulle, B. and Chatelon, J. and Fave, G. and Mantz, J. and Pirracchio, R. and Diaz, D. and Villanova, M. and Aguirregabyria, M. and Andrade, G. and L√≥pez, L. and Palencia, E. and John, G. and Cowan, R. and Hart, R. and Lake, K. and Litchfield, K. and Song, J. and Lee, Y. and Cho, Y. and Choi, S. and Vermeir, P. and Vandijck, D. and Blot, S. and Mariman, A. and Verhaeghe, R. and Deveugele, M. and Vogelaers, D. and Chok, L. and Bachli, E. and Bettex, D. and Cottini, S. and Keller, E. and Maggiorini, M. and Schuepbach, R. and Fiks, T. and Stiphout, C. and Grevelink, M. and Vaneker, I. and Ruijter, A. and Buise, M. and Spronk, P. and Tena, S. and Barrachina, L. and Portillo, J. and Aznar, G. and Campos, L. and Sell√©s, M. and Tom√°s, M. and Muncharaz, A. and Skinner, L. and Monsalvo, S. and Olavarria, E. and St√ºmpfle, R. and Na, S. and Park, J. and Chung, C. and Park, C. and Suh, G. and Yang, J. and Witter, T. and Brousseau, C. and Butler, M. and Erdogan, M. and Dougall, P. and Green, R. and Abbott, T. and Torrance, H. and Cron, N. and Vaid, N. and Emmanuel, J. and Siddiqui, S. and Prabu, N. and Chaudhari, H. and Patil, V. and Divatia, J. and Solanki, S. and Kulkarni, A. and Gutierrez, L. and Bader, A. and Brasseur, A. and Lheureux, O. and Vincent, J. and Creteur, J. and Taccone, F. and Hempel, D. and Stauffert, N. and Recker, F. and Schr√∂der, T. and Reusch, S. and Schleifer, J. and Breitkreutz, R. and Sj√∂vall, F. and Perner, A. and M√∏ller, M. and Moraes, R. and Borges, F. and Guillen, J. and Zabaletta, W. and Ruiz-Ramos, J. and Ramirez, P. and Marqu√©s-Mi√±ana, M. and Villarreal, E. and Gordon, M. and Sosa, M. and Concha, P. and Castellanos, A. and Menendez, R. and Ram√≠rez, C. and Santana, M. and Balc√°zar, L. and Escalada, S. and Viera, M. and V√°zquez, C. and D√≠az, J. and Campelo, F. and Monroy, N. and Santana, P. and Santana, S. and Guti√©rrez-Pizarraya, A. and Garnacho-Montero, J. and Martin, C. and Baumstarck, K. and Leone, M. and Mart√≠n-Loeches, I. and Pirracchio, R. and Legrand, M. and Mainardi, J. and Mantz, J. and Cholley, B. and Hubbard, A. and Frontera, P. and Vega, L. and Miguelena, P. and Us√≥n, M. and L√≥pez, A. and Clemente, E. and Iba√±es, P. and Aguilar, A. and Palomar, M. and Olaechea, P. and Uriona, S. and Vallverdu, M. and Catalan, M. and Nuvials, X. and Aragon, C. and Lerma, F. and Jeon, Y. and Jeong, W. and Kim, M. and Jeong, I. and Ahn, M. and Ahn, J. and Han, S. and Choi, J. and Song, Y. and Kim, J. and Ku, N. and Bassi, G. and Xiol, E. and Senussi, T. and Idone, F. and Motos, A. and Chiurazzi, C. and Travierso, C. and Fern√°ndez-Barat, L. and Amaro, R. and Hua, Y. and Ranzani, O. and Bobi, Q. and Rigol, M. and Torres, A. and Fern√°ndez, I. and Soler, E. and de, V. and Pastor, E. and Hernandis, V. and Ros, M. and Rubio, R. and Torner, M. and Brugger, S. and Eroles, A. and Moles, S. and Cabello, J. and Schoenenberger, J. and Casals, X. and Vidal, M. and Garrido, B. and Martinez, M. and Mirabella, L. and Cotoia, A. and Tullo, L. and Stella, A. and Di, B. and Di, G. and Dambrosio, M. and Cinnella, G. and Rosario, L. and Lesmes, S. and Romero, J. and Herrera, A. and Pertuz, E. and S√°nchez, M. and Sanz, E. and Hualde, J. and Hern√°ndez, A. and Ramirez, J. and Takahashi, H. and Kazutoshi, F. and Okada, Y. and Oobayashi, W. and Naito, T. and Baidya, D. and Maitra, S. and Anand, R. and Ray, B. and Arora, M. and Ruffini, C. and Rota, L. and Corona, A. and Sesana, G. and Ravasi, S. and Catena, E. and Naumann, D. and Mellis, C. and Husheer, S. and Bishop, J. and Midwinter, M. and Hutchings, S. and Corradi, F. and Brusasco, C. and Manca, T. and Ramelli, A. and Lattuada, M. and Nicolini, F. and Gherli, T. and Vezzani, A. and Young, A. and Carmona, A. and Santiago, A. and Guillamon, L. and Delgado, M. and Delgado-Amaya, M. and Curiel-Balsera, E. and Rivera-Romero, L. and Castillo-Lorente, E. and Carrero-G√≥mez, F. and Aguayo-DeHoyos, E. and Healey, A. and Cameron, C. and Jiao, L. and St√ºmpfle, R. and P√©rez, A. and Martin, S. and del, M. and Toval, S. and Rico, J. and Aldecoa, C. and Oguzhan, K. and Demirkiran, O. and Kirman, M. and Bozbay, S. and Kosuk, M. and Asyralyyeva, G. and Dilek, M. and Duzgun, M. and Telli, S. and Aydin, M. and Yilmazer, F. and Hodgson, L. and Dimitrov, B. and Stubbs, C. and Forni, L. and Venn, R. and Vedage, D. and Shawaf, S. and Naran, P. and Sirisena, N. and Kinnear, J. and Dimitrov, B. and Hodgson, L. and Stubbs, C. and Forni, L. and Venn, R. and Londo√±o, J. and Cardenas, C. and Gin√©s, A. and Gubianas, C. and S√°nchez, E. and Sirvent, J. and Panafidina, V. and Shlyk, I. and Ilyina, V. and Judickas, S. and Kezyte, G. and Urbanaviciute, I. and Serpytis, M. and Gaizauskas, E. and Sipylaite, J. and Sprung, C. and Munteanu, G. and Morales, R. and Kasdan, H. and Volker, T. and Reiter, A. and Cohen, Y. and Himmel, Y. and Meissonnier, J. and Banderas-Bravo, M. and G√≥mez-Jim√©nez, C. and Garc√≠a-Mart√≠nez, M. and Mart√≠nez-Carmona, J. and Fern√°ndez-Ortega, J. and O‚ÄòDwyer, M. and Starczewska, M. and Wilks, M. and Vincent, J. and Torsvik, M. and Gustad, L. and Bangstad, I. and Vinje, L. and Dam√•s, J. and Sollig√•rd, E. and Mehl, A. and Tsunoda, M. and Kang, M. and Saito, M. and Saito, N. and Akizuki, N. and Namiki, M. and Takeda, M. and Yuzawa, J. and Yaguchi, A. and Frantzeskaki, F. and Tsirigotis, P. and Chondropoulos, S. and Paramythiotou, E. and Theodorakopoulou, M. and Stamouli, M. and Gkirkas, K. and Dimopoulou, I. and Makiko, S. and Tsunoda, M. and Kang, M. and Yuzawa, J. and Akiduki, N. and Namiki, M. and Takeda, M. and Yaguchi, A. and Preau, S. and Ambler, M. and Sigurta, A. and Saeed, S. and Singer, M. and Jochmans, S. and Chelly, J. and Vong, L. and Sy, O. and Serbource-Goguel, J. and Rolin, N. and Weyer, C. and Abdallah, R. and Adrie, C. and Vinsonneau, C. and Monchi, M. and Mayr, U. and Huber, W. and Karsten, E. and Lahmer, T. and Thies, P. and Henschel, B. and Fischer, G. and Schmid, R. and Ediboglu, O. and Ataman, S. and Naz, I. and Yaman, G. and Kirakli, C. and Su, P. and Kou, P. and Lin, W. and Chen, C. and Lozano, J. and S√°nchez, P. and Francioni, J. and Ferr√≥n, F. and Sim√≥n, J. and Riad, Z. and Mezidi, M. and Aublanc, M. and Perinel, S. and Lissonde, F. and Louf-Durier, A. and Yonis, H. and Tapponnier, R. and Richard, J. and Louis, B. and Gu√©rin, C. and Mezidi, M. and Yonis, H. and Aublanc, M. and Lissonde, F. and Louf-Durier, A. and Perinel, S. and Tapponnier, R. and Richard, J. and Gu√©rin, C. and Marmanidou, K. and Oikonomou, M. and Nouris, C. and Loizou, C. and Soilemezi, E. and Matamis, D. and Somhorst, P. and Gommers, D. and Hayashi, K. and Hirayama, T. and Yumoto, T. and Tsukahara, K. and Iida, A. and Nosaka, N. and Sato, K. and Ugawa, T. and Nakao, A. and Ujike, Y. and Hirohata, S. and Mojoli, F. and Torriglia, F. and Giannantonio, M. and Orlando, A. and Bianzina, S. and Tavazzi, G. and Mongodi, S. and Pozzi, M. and Iotti, G. and Braschi, A. and Jansen, D. and Gadgil, S. and Doorduin, J. and Roesthuis, L. and van, d. and Heunks, L. and Chen, G. and Sun, X. and He, X. and Yang, Y. and Shi, Z. and Xu, M. and Zhou, J. and Pereira, S. and Tucci, M. and Tonelotto, B. and Simoes, C. and Morais, C. and Pompeo, M. and Kay, F. and Amato, M. and Vieira, J. and Suzuki, S. and Mihara, Y. and Hikasa, Y. and Okahara, S. and Morimatsu, H. and Kwon, H. and Moon, Y. and Lee, S. and Jung, K. and Shin, W. and Jun, I. and Song, J. and Hwang, G. and Lee, S. and Moon, Y. and Kwon, H. and Jung, K. and Shin, W. and Jun, I. and Song, J. and Hwang, G. and Ramelli, A. and Manca, T. and Corradi, F. and Brusasco, C. and Nicolini, F. and Gherli, T. and Brianti, R. and Fanzaghi, P. and Vezzani, A. and Tudor, B. and Klaus, D. and Lebherz-Eichinger, D. and Lechner, C. and Schwarz, C. and Bodingbauer, M. and Seemann, R. and Kaczirek, K. and Fleischmann, E. and Roth, G. and Krenn, C. and Malyshev, A. and Sergey, S. and Yamaguchi, Y. and Nomura, T. and Yoshitake, E. and Idei, M. and Yoshida, T. and Takaki, S. and Yamaguchi, O. and Kaneko, M. and Goto, T. and Tenc√©, N. and Zaien, I. and Wolf, M. and Trouiller, P. and Jacobs, F. and Kelly, J. and Veigas, P. and Hollands, S. and Min, A. and Rizoli, S. and Robles, C. and de, O. and Tarabrin, O. and Gavrychenko, D. and Mazurenko, G. and Tarabrin, P. and Garcia, I. and Martin, A. and Mendez, M. and orden, V. and Noval, R. and McCue, C. and Gemmell, L. and MacKay, A. and Luj√°n, J. and Villa, P. and Llorente, B. and Molina, R. and Alc√°zar, L. and Juanas, C. and Rogero, S. and Pascual, T. and Cambronero, J. and Almud√©var, P. and Dom√≠nguez, J. and Carmona, S. and Casta√±eda, D. and Abell√°n, A. and Lucendo, A. and P√©rez, L. and Rivas, R. and Sanz, N. and Ramos, J. and Villamizar, P. and Javadpour, S. and Kalani, N. and Amininejad, T. and Jamali, S. and Sobhanian, S. and Laurent, A. and Bonnet, M. and Rigal, R. and Aslanian, P. and Hebert, P. and Capellier, G. and Contreras, M. and Mej√≠as, C. and Ruiz, F. and Lombardo, M. and Perez, J. and de, H. and Estella, A. and Viciana, R. and Fontai√±a, L. and Rico, T. and Madue√±o, V. and Recuerda, M. and Fern√°ndez, L. and Sandiumenge, A. and Bonet, S. and Mazo, C. and Rubiera, M. and Ruiz-Rodr√≠guez, J. and Gracia, R. and Espinel, E. and Pont, T. and Kotsopoulos, A. and Jansen, N. and Abdo, W. and Gopcevic, A. and Gavranovic, Z. and Vucic, M. and Glogoski, M. and Penavic, L. and Horvat, A. and Martin-Villen, L. and Egea-Guerero, J. and Revuelto-Rey, J. and Aldabo-Pallas, T. and Correa-Chamorro, E. and Gallego-Corpa, A. and Granados, P. and Faivre, V. and Wildenberg, L. and Huot, B. and Lukaszewicz, A. and Simsir, M. and Mengelle, C. and Payen, D. and Sanz, N. and Valbuena, B. and de, l. and Almudena, P. and P√©rez, L. and Carmona, S. and Abell√°n, A. and Sim√≥n, I. and Mu√±oz, J. and Ramos, J. and Carmona, S. and Almudevar, P. and Abellan, A. and Lucendo, M. and Perez, L. and Dominguez, J. and Rivas, R. and Villamizar, P. and Wee, S. and Ong, C. and Lau, Y. and Wong, Y. and Banderas-Bravo, M. and Olea-Jim√©nez, V. and Mora-Ord√≥√±ez, J. and G√≥mez-Jim√©nez, C. and Mu√±oz-Mu√±oz, J. and Vallejo-B√°ez, J. and Daga-Ruiz, D. and Lebr√≥n-Gallardo, M. and Rialp, G. and Raurich, J. and Mor√°n, I. and Mart√≠n, M. and Heras, G. and Mas, A. and Vallverd√∫, I. and Hraiech, S. and Bourenne, J. and Guervilly, C. and Forel, J. and Adda, M. and Sylla, P. and Mouaci, A. and Gainnier, M. and Papazian, L. and Bauer, P. and Kumbamu, A. and Wilson, M. and Pannu, J. and Egginton, J. and Kashyap, R. and Gajic, O. and Yoshihiro, S. and Sakuraya, M. and Hayakawa, M. and Hirata, A. and Kawamura, N. and Tsutui, T. and Yoshida, K. and Hashimoto, Y. and Chang, C. and Hu, H. and Chiu, L. and Hung, C. and Li, S. and Kao, K. and Sibley, S. and Drover, J. and D‚ÄôArsigny, C. and Parker, C. and Howes, D. and Moffatt, S. and Erb, J. and Ilan, R. and Messenger, D. and Ball, I. and Boyd, J. and Harrison, M. and Ridi, S. and Muscedere, J. and Andrade, A. and Costa, R. and Souza, V. and Gonzalez, V. and Amorim, V. and Rolla, F. and Filho, C. and Miranda, R. and Atchasiri, S. and Buranavanich, P. and Wathanawatthu, T. and Suwanpasu, S. and Bureau, C. and Rolland-Debord, C. and Poitou, T. and Clavel, M. and Perbet, S. and Terzi, N. and Kouatchet, A. and Similowski, T. and Demoule, A. and Diaz, P. and Nunes, J. and Esc√≥rcio, S. and Silva, G. and Chaves, S. and Jardim, M. and C√¢mara, M. and Fernandes, N. and Duarte, R. and Jardim, J. and Pereira, C. and N√≥brega, J. and Chen, C. and Lai, C. and Cheng, K. and Chou, W. and Lee, S. and Cha, Y. and Lee, W. and Onodera, M. and Nakataki, E. and Oto, J. and Imanaka, H. and Nishimura, M. and Khadjibaev, A. and Sabirov, D. and Rosstalnaya, A. and Akalaev, R. and Parpibaev, F. and Antonucci, E. and Rossini, P. and Gandolfi, S. and Montini, E. and Orlando, S. and van, N. and Karachi, F. and Hanekom, S. and Andrade, A. and Pereira, U. and Filho, C. and Costa, R. and Parkin, M. and Moore, M. and Andrade, A. and Costa, R. and Carvalho, K. and Filho, C. and Min, H. and Kim, H. and Lee, D. and Choi, Y. and Lee, E. and Song, I. and Kim, D. and E, Y. and Kim, J. and Park, J. and Cho, Y. and Lee, J. and Suh, J. and Jo, Y. and Kim, K. and Lee, Y. and Ferrero-Calleja, J. and Merino-Vega, D. and Gonz√°lez-Jim√©nez, A. and Sigcha, M. and Hern√°ndez-Tejedor, A. and Martin-Vivas, A. and Gab√°n-D√≠ez, √. and Luna, R. and De, l. and Temprano-G√≥mez, I. and Afonso-Rivero, D. and Pellin-Ari√±o, J. and Algora-Weber, A. and Fumis, R. and Ferraz, A. and Junior, J. and Kirca, H. and Cakin, O. and Unal, M. and Mutlu, H. and Ramazanoglu, A. and Cengiz, M. and Nicolini, E. and Pelisson, F. and Nunes, R. and da, S. and Carreira, M. and Bellissimo-Rodrigues, F. and Ferez, M. and Basile-Filho, A. and Chao, H. and Chen, C. and Chen, L. and Hravnak, M. and Clermont, G. and Pinsky, M. and Dubrawski, A. and Varas, J. and Montero, R. and S√°nchez-Elvira, L. and D√≠az, P. and Delgado, C. and Ruiz, B. and Guerrero, A. and Galache, J. and Sherif, H. and Hassanin, H. and El, H. and Samy, W. and Ly, H. and David, H. and Burtin, P. and Charpentier, C. and Barral, M. and Courant, P. and Fournel, E. and Gaide-Chevronnay, L. and Durand, M. and Albaladejo, P. and Payen, J. and Chavanon, O. and Ortiz, A. and Pozzebon, S. and Lheureux, O. and Brasseur, A. and Vincent, J. and Creteur, J. and Taccone, F. and Fumagalli, F. and Scala, S. and Affatato, R. and De, M. and Zani, D. and Novelli, D. and Marra, C. and Luciani, A. and De, Z. and Luini, M. and Letizia, T. and Pravettoni, D. and Staszewsky, L. and Masson, S. and Belloli, A. and Di, G. and Scanziani, E. and Latini, R. and Ristagno, G. and Kye, Y. and Suh, G. and Kwon, W. and Kim, K. and Yu, K. and Babini, G. and Ristagno, G. and Grassi, L. and Fumagalli, F. and Bendel, S. and De, M. and Affatato, R. and Masson, S. and Latini, R. and Scanziani, E. and Reinikainen, M. and Skrifvars, M. and Kappler, F. and Blobner, M. and Schaller, S. and Roasio, A. and Costanzo, E. and Cardellino, S. and Iesu, E. and Cavicchi, F. and Fontana, V. and Nobile, L. and Vincent, J. and Creteur, J. and Taccone, F. and Park, M. and You, K. and Suh, G. and Kwon, W. and Ko, S. and Kim, K. and Xini, A. and Marca, L. and Lheureux, O. and Brasseur, A. and Vincent, J. and Creteur, J. and Taccone, F. and Beane, A. and Thilakasiri, M. and De, S. and Stephens, T. and Sigera, C. and Athapattu, P. and Jayasinghe, S. and Padeniya, A. and Haniffa, R. and Santiago, A. and S√°ez, V. and Ruiz-Ruano, R. and Gonz√°lez, A. and Kunze-Szikszay, N. and Wand, S. and Klapsing, P. and Wetz, A. and Heyne, T. and Schwerdtfeger, K. and Troeltzsch, M. and Bauer, M. and Quintel, M. and Moerer, O. and Cook, D. and Rutherford, W. and Scales, D. and Adhikari, N. and Cuthbertson, B. and Suzuki, T. and Takei, T. and Fushimi, K. and Iwamoto, M. and Nakagawa, S. and Mendsaikhan, N. and Begzjav, T. and Lundeg, G. and D√ºnser, M. and Romero, D. and Cabrera, J. and Santana, J. and Padilla, Y. and P√©rez, H. and Torrent, R. and Kleinpell, R. and Chouris, I. and Radu, V. and Stougianni, M. and Lavrentieva, A. and Lagonidis, D. and Price, R. and Day, A. and Arora, N. and Henderson, M. and Hickey, S. and Costa, M. and Carvalho, J. and Gomes, A. and Mergulh√£o, P. and Chan, K. and Shum, H. and Yan, W. and Maghsoudi, B. and Tabei, S. and Masjedi, M. and Sabetian, G. and Tabatabaei, H. and Akbarzadeh, A. and Saigal, S. and Pakhare, A. and Joshi, R. and Pattnaik, S. and Ray, B. and Rousseau, A. and Michel, L. and Bawin, M. and Cavalier, E. and Reginster, J. and Damas, P. and Bruyere, O. and Zhou, J. and Cauwenberghs, H. and De, B. and Neels, H. and Deblier, I. and Berghmans, J. and Himpe, D. and Barea-Mendoza, J. and Portillo, I. and Fern√°ndez, M. and Gigorro, R. and Vela, J. and Mateos, H. and Alves, S. and Varas, G. and Rodriguez-Biendicho, A. and Carre√±o, E. and Gonz√°lez, J. and Yang, J. and Chiang, C. and Hung, W. and Huang, W. and Cheng, C. and Lin, K. and Lin, S. and Chiou, K. and Wann, S. and Lin, K. and Kang, P. and Mar, G. and Liu, C. and Zhou, J. and Choi, Y. and Yoon, S. and Gordillo-Brenes, A. and Fernandez-Zamora, M. and Perez-Borrero, L. and Arias-Verdu, M. and Aguilar-Alonso, E. and Herruzo-Aviles, A. and Garcia-Delgado, M. and Hinojosa-Perez, R. and Curiel-Balsera, E. and Rivera-Fernandez, R. and Lesmes, S. and Rosario, L. and Hern√°ndez, A. and Herrera, A. and Sanz, E. and S√°nchez, M. and Hualde, J. and Pascual, O. and Le√≥n, J. and Irazabal, J. and P√©rez, A. and Fern√°ndez, P. and Amor, L. and Albaiceta, G. and Lesmes, S. and Rosario, L. and Hern√°ndez, A. and Sanz, E. and S√°nchez, M. and Calvo, S. and Herrera, A. and Hualde, J. and Pascual, O. and Le√≥n, J. and Corona, A. and Ruffini, C. and Spazzadeschi, A. and Marrazzo, F. and Gandola, A. and Sciurti, R. and Savi, C. and Catena, E. and Ke, M. and Cheng, C. and Huang, W. and Chiang, C. and Hung, W. and Lin, K. and Lin, S. and Wann, S. and Chiou, K. and Tseng, C. and Kang, P. and Mar, G. and Liu, C. and Bertini, P. and De, S. and Guarracino, F. and Bertini, P. and Baldassarri, R. and Guarracino, F. and Buitinck, S. and van, d. and Oto, J. and Nakataki, E. and Tsunano, Y. and Izawa, M. and Tane, N. and Onodera, M. and Nishimura, M. and Ghosh, S. and Gupta, A. and De, G. and Mazza, E. and Limuti, R. and Prosperi, M. and Bissenova, N. and Yergaliyeva, A. and Talan, L. and Yƒ±lmaz, G. and G√ºven, G. and Yoruk, F. and Altƒ±ntas, N. and Mukherjee, D. and Agarwal, L. and Mandal, K. and Palomar, M. and Balsera, B. and Vallverdu, M. and Martinez, M. and Garcia, M. and Castellana, D. and Lopez, R. and Barcenilla, F. and Kaminsky, G. and Carre√±o, R. and Escrib√°, A. and Fuentes, M. and G√°lvez, V. and Del, O. and Nieto, B. and Vaquerizo, C. and Alvarez, J. and De, l. and Torres, E. and Bogossian, E. and Nouer, S. and Salgado, D. and Brugger, S. and Jim√©nez, G. and Torner, M. and Vidal, M. and Garrido, B. and Casals, X. and Gaite, F. and Cabello, J. and Mart√≠nez, M. and Doganci, M. and Izdes, S. and Besevli, S. and Alkan, A. and Kayaaslan, B. and Ram√≠rez, C. and Balc√°zar, L. and Santana, M. and Viera, M. and Escalada, S. and V√°zquez, C. and Penichet, S. and Campelo, F. and L√≥pez, M. and Santana, P. and Santana, S. and Repess√©, X. and Artiguenave, M. and Paktoris-Papine, S. and Espinasse, F. and Dinh, A. and El, S. and Charron, C. and G√©ri, G. and Vieillard-Baron, A. and Marmanidou, K. and Oikonomou, M. and Nouris, C. and Dimitroulakis, K. and Soilemezi, E. and Matamis, D. and Ferr√©, A. and Guillot, M. and Teboul, J. and Lichtenstein, D. and M√©zi√®re, G. and Richard, C. and Monnet, X. and Pham, T. and Beduneau, G. and Schortgen, F. and Piquilloud, L. and Zogheib, E. and Jonas, M. and Grelon, F. and Runge, I. and Terzi, N. and Grang√©, S. and Barberet, G. and Guitard, P. and Frat, J. and Constan, A. and Chr√©tien, J. and Mancebo, J. and Mercat, A. and Richard, J. and Brochard, L. and Prƒ´dƒ?ne, S. and Sabeƒº≈Üikovs, O. and Mojoli, F. and Orlando, A. and Bianchi, I. and Torriglia, F. and Bianzina, S. and Pozzi, M. and Iotti, G. and Braschi, A. and Beduneau, G. and Pham, T. and Schortgen, F. and Piquilloud, L. and Zogheib, E. and Jonas, M. and Grelon, F. and Runge, I. and Terzi, N. and Grang√©, S. and Barberet, G. and Guitard, P. and Frat, J. and Constan, A. and Chr√©tien, J. and Mancebo, J. and Mercat, A. and Richard, J. and Brochard, L. and Kondili, E. and Psarologakis, C. and Kokkini, S. and Amargianitakis, V. and Babalis, D. and Chytas, A. and Chouvarda, I. and Vaporidi, K. and Georgopoulos, D. and Trapp, O. and Kalenka, A. and Mojoli, F. and Orlando, A. and Bianchi, I. and Torriglia, F. and Bianzina, S. and Pozzi, M. and Iotti, G. and Braschi, A. and Lozano, J. and S√°nchez, P. and Francioni, J. and Ferr√≥n, F. and Sim√≥n, J. and Spadaro, S. and Karbing, D. and Gioia, A. and Moro, F. and Corte, F. and Mauri, T. and Volta, C. and Rees, S. and Petrova, M. and Mohan, R. and Butrov, A. and Beeharry, S. and Vatsik, M. and Sakieva, F. and Gobert, F. and Yonis, H. and Tapponnier, R. and Fernandez, R. and Labaune, M. and Burle, J. and Barbier, J. and Vincent, B. and Cleyet, M. and Richard, J. and Gu√©rin, C. and Shinotsuka, C. and Creteur, J. and Taccone, F. and T√∂rnblom, S. and Nisula, S. and Vaara, S. and Poukkanen, M. and Andersson, S. and Pettil√§, V. and Pesonen, E. and Xie, Z. and Liao, X. and Kang, Y. and Zhang, J. and Kubota, K. and Egi, M. and Mizobuchi, S. and Hegazy, S. and El-Keraie, A. and El, S. and El, H. and Rodrigues, N. and Pereira, M. and Godinho, I. and Gameiro, J. and Neves, M. and Gouveia, J. and e, S. and Lopes, J. and Mckinlay, J. and Kostalas, M. and Kooner, G. and Dudas, G. and Horton, A. and Kerr, C. and Karanjia, N. and Creagh-Brown, B. and Forni, L. and Yamazaki, A. and Ganuza, M. and Molina, J. and Martinez, F. and Freile, M. and Fernandez, N. and Travieso, P. and Bandert, A. and Frithiof, R. and Lipcsey, M. and Smekal, D. and Schlaepfer, P. and Durovray, J. and Plouhinec, V. and Chiappa, C. and Bellomo, R. and Schneider, A. and Mitchell, S. and Durrant, J. and Street, H. and Dunthorne, E. and Shears, J. and Caballero, C. and Hutchison, R. and Schwarze, S. and Ghabina, S. and Thompson, E. and Prowle, J. and Kirwan, C. and Gonzalez, C. and Pinto, J. and Orozco, V. and Pati√±o, J. and Garcia, P. and Contreras, K. and Rodriguez, P. and Echeverri, J.},
title  = {ESICM LIVES 2016: part three: Milan, Italy. 1‚Äì5 October 2016.},
journal  = {Intensive Care Medicine Experimental},
volume  = {4},
number  = {Suppl 1},
pages  = {},
year  = {2016},
abstract  = {},
address  = {Texas Children‚Äôs Hospital, Clinical Nutriiton, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine, Nankoku, Japan Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine, Nankoku, Japan Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine, Nankoku, Japan Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine, Nankoku, Japan Kochi Medical School, Department of Anesthesiology and Intensive Care Medicine, Nankoku, Japan Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Anesthesia & Reanimation Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Neurocritical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Neurocritical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Coronary Care Unit, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Sagrat Cor University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain Vall d‚Äô Hebron University Hospital, Critical Care Department, Barcelona, Spain St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands St Elisabeth Twee Steden Hospital, ICU, Tilburg, Netherlands National Institute of Cardiovascular Diseases, PCICU, Bratislava, Slovakia National Institute of Cardiovascular Diseases, Bratislava, Slovakia National Institute of Cardiovascular Diseases, Pediatric Cardiac Intensive Care Unit, Bratislava, Slovakia Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Texas Children‚Äôs Hospital, Intensive Care, Houston, USA Bristol Royal Hospital for Children, Paediatric Intensive Care Unit, Bristol, UK Intensive Care National Audit & Research Centre (ICNARC), London, UK University of Leeds, Leeds, UK Bristol Royal Hospital for Children, Paediatric Intensive Care Unit, Bristol, UK Southampton University Hospitals NHS Trust, Southampton, UK Bristol Royal Hospital for Children, Paediatric Intensive Care Unit, Bristol, UK Great Ormond Street Hospital, London, UK UCCC, ICU, Kyiv, Ukraine UCCC, ICU, Kyiv, Ukraine UCCC, ICU, Kyiv, Ukraine Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy International Renal Research Institute of Vicenza (IRRIV), Department of Nephrology, Dialysis and Transplantation, Vicenza, Italy Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy Catholic University, Department of Anesthesia and Intensive Care, Rome, Italy The Children‚Äôs Hospital at Montefiore, Pediatric Critical Care, Bronx, USA The Children‚Äôs Hospital at Montefiore, Bronx, USA The Children‚Äôs Hospital at Montefiore, Bronx, USA The Children‚Äôs Hospital at Montefiore, Bronx, USA The Children‚Äôs Hospital at Montefiore, Bronx, USA Shiraz University of Medical Sciences, Pediatric intensive Care, Shiraz, Islamic  Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Department of Anesthesiology, Yokohama, Japan Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Intensive Care Unit, Yokohama, Japan Yokohama City University Hospital, Department of Anesthesiology, Yokohama, Japan The Children‚Äôs Hospital at Montefiore, Pediatric Critical Care, Bronx, USA The Children‚Äôs Hospital at Montefiore, Pediatric Critical Care, Bronx, USA Cairo University/Kasr Alainy Medical School, Anesthesia, Pain and Surgical ICU, Cairo, Egypt Cairo University/Kasr Alainy Medical School, Cairo, Egypt Cairo University/Kasr Alainy Medical School, Cairo, Egypt Cairo University/Kasr Alainy Medical School, Cairo, Egypt The University of Melbourne, Department of Physiotherapy, Melbourne, Australia Royal Melbourne Hospital, Department of Physiotherapy, Melbourne, Australia The University of Melbourne, Department of Physiotherapy, Melbourne, Australia Peter MacCallum Cancer Centre, Department of Physiotherapy, Melbourne, Australia Flinders Medical Centre, Department of Physiotherapy, Adelaide, Australia National University Hospital, Department of Rehabilitation, Singapore, Singapore National University Hospital, Department of Rehabilitation, Singapore, Singapore Escola Superior da Saude, Health Sciences Program, Brasilia, Brazil The University of Melbourne, Department of Physiotherapy, Melbourne, Australia University College London Hospitals, Division of Critical Care, London, UK The University of Melbourne, Department of Physiotherapy, Melbourne, Australia Brigham and Women‚Äôs Hospital, Department of Rehabilitation, Boston, USA Brigham and Women‚Äôs Hospital, Department of Medicine, Boston, USA Brigham and Women‚Äôs Hospital, Renal Division, Boston, USA Queen Elizabeth Hospital NHS FT, Birmingham, UK Queen Elizabeth Hospital NHS FT, Birmingham, UK Queen Elizabeth Hospital NHS FT, Birmingham, UK Queen Elizabeth Hospital NHS FT, Birmingham, UK Queen Elizabeth Hospital NHS FT, Birmingham, UK City University London, School of Health Sciences, London, UK University of Dundee, Dundee, UK University of Queensland, Brisbane, Australia NHS Tayside, Dundee, UK Griffith University, NHMRC Centre of Research Excellence in Nursing, Menzies Health Institute Queensland, Brisbane, Australia University of Queensland, Brisbane, Australia Griffith University, NHMRC Centre of Research Excellence in Nursing, Menzies Health Institute Queensland, Brisbane, Australia Princess Alexandra Hospital, Intensive Care Unit, Brisbane, Australia Griffith University, NHMRC Centre of Research Excellence in Nursing, Menzies Health Institute Queensland, Brisbane, Australia Hospital Israelita Albert Einstein, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, S√£o Paulo, Brazil Odense University Hospital, Anesthesiology and Intensive Care Medicine, Odense, Denmark Odense University Hospital, Anesthesiology and Intensive Care Medicine, Odense, Denmark Odense University Hospital, University of Southern Denmark, Odense, Denmark Royal Brompton and Harefield NHS Foundation Trust, Rehabilitation and Therapies,  London, UK Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK Royal Surrey County Hospital, Guildford, UK Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK Guys and St Thomas NHS Foundation Trust, London, UK Guys and St Thomas NHS Foundation Trust, London, UK Guys and St Thomas NHS Foundation Trust, London, UK Khoo Teck Puat Hospital, Rehabilitation Services, Singapore, Singapore Khoo Teck Puat Hospital, Anaesthesia & Surgical Intensive Care, Singapore, Singapore Khoo Teck Puat Hospital, Rehabilitation Services, Singapore, Singapore Khoo Teck Puat Hospital, Rehabilitation Services, Singapore, Singapore Khoo Teck Puat Hospital, Anaesthesia & Surgical Intensive Care, Singapore, Singapore Clinica Sagrada Esperan√ßa, Luanda, Angola Escola Nacional de Saude Publica/UNL, Lisboa, Portugal Clinica Sagrada Esperan√ßa, Luanda, Angola Fortis Escorts Heart Institute, Critical Care Medicine, New Delhi, India Fortis Escorts Heart Institute, Critical Care Medicine, New Delhi, India Fortis Escorts Heart Institute, Critical Care Medicine, New Delhi, India University of Athens, Medical School, Evangelismos Hospital, Athens, Greece National Technical University of Athens, Athens, Greece Evangelismos Hospital, Athens, Greece Evangelismos Hospital, Athens, Greece Evangelismos Hospital, Athens, Greece Evangelismos Hospital, Athens, Greece Evangelismos Hospital, Athens, Greece Evangelismos Hospital, Athens, Greece Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hospital Universitari M√∫tua de Terrassa, Intensive Care Department, Terrassa, Spain Hospital General de Catalunya, Intensive Care Department, Sant Cugat del Vall√©s,  Spain Hospital Universitari de Tarragona Joan XXIII, Intensive Care Department, Tarragona, Spain Hospital del Mar, Intensive Care Department, Barcelona, Spain Hospital Parc Taul√≠, Intensive Care Department, Sabadell, Spain Hospital General de Vic, Intensive Care Department, Vic, Spain Hospital Infanta Leonor, Intensive Care Department, Madrid, Spain Hospital del SAS de Jerez, Intensive Care Department, Jerez de la Frontera, Spain Hospital de Bellvitge, Intensive Care Department, Barcelona, Spain St James‚Äôs University Hospital, Dublin, Ireland Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China Peking Union Medical College Hospital, Critical Care Medicine, Beijing, China Nanjing Zhongda Hospital, Southeast University School of Medicine, Critical Care  Medicine, Nanjing, China Peking University First Hospital, Peking University, Research Center for Medical  Mycology, Beijing, China Lille University Hospital, ICU, Lille, France Lille University Hospital, ICU, Lille, France Lille University Hospital, ICU, Lille, France Lille University Hospital, Mycology and Parasitology Lab, Lille, France Lille University Hospital, ICU, Lille, France Attikon University Hospital, Athens, Greece Attikon University Hospital, Athens, Greece Attikon University Hospital, Athens, Greece Attikon University Hospital, Athens, Greece Attikon University Hospital, Athens, Greece Attikon University Hospital, Athens, Greece Attikon University Hospital, Athens, Greece Vall d‚ÄôHebron University Hospital, Critical Care, Barcelona, Spain Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany Vall d‚ÄôHebron University Hospital, Critical Care, Barcelona, Spain Vall d‚ÄôHebron University Hospital, Critical Care, Barcelona, Spain Vall d‚ÄôHebron University Hospital, Critical Care, Barcelona, Spain Hannover Medical School, Department of Respiratory Medicine, Hannover, Germany Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France Hopital Bichat Claude Bernard, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and SMUR and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and SMUR and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and SMUR and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and SMUR and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and SMUR and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Mycology Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Pharmacy Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Plastic Surgery and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Infectious Diseases, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Plastic Surgery and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and SMUR and Burn Unit, Paris, France AP-HP, GH St-Louis-Lariboisi√®re, Department of Anesthesiology and Critical Care and SMUR and Burn Unit, Paris, France Dudley Group of Hospitals NHS Foundation Trust, Anaesthetics, Dudley, UK Dudley Group of Hospitals NHS Foundation Trust, Anaesthetics, Dudley, UK Dudley Group of Hospitals NHS Foundation Trust, Microbiology, Dudley, UK Dudley Group of Hospitals NHS Foundation Trust, Anaesthetics, Dudley, UK Hospital Sim√≥n Bol√≠var, Burn ICU, Bogot√°, Colombia Hospital Sim√≥n Bol√≠var, Burn ICU, Bogot√°, Colombia Hospital Sim√≥n Bol√≠var, Burn ICU, Bogot√°, Colombia Hospital Sim√≥n Bol√≠var, Burn ICU, Bogot√°, Colombia Hospital Sim√≥n Bol√≠var, Burn ICU, Bogot√°, Colombia Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London,  UK Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London,  UK Royal London Hospital, Barts Health NHS Trust, Microbiology Department, London, UK Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London,  UK Adult Critical Care Unit, Royal London Hospital, Barts Health NHS Trust, London,  UK Japanese Red Cross Musashino Hospital, Emergency And Critical Care Medicine, Tokyo, Japan Saitama Medical Center, Jichi Medical University, Department of Anesthesiology and Critical Care Medicine, Saitama, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Japanese Society of Education for Physicians and Trainees in Intensive Care, Tokyo, Japan Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Hospital Clinic Universitari Valencia, Valencia, Spain Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Paulo Niemeyer State Brain Institute, Rio de Janeiro, Brazil Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurology, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Regional Hospital, Neurocenter, Neurointensive Care Unit, Liberec, Czech Republic Military University Hospital and First Medical School, Charles University, Department of Neurosurgery, Prague, Czech Republic Regional Hospital, Neurocenter, Department of Neurosurgery, Liberec, Czech Republic IRCCS Istituto delle Scienze Neurologiche, Anesthesia and Intensive Care, Bellaria Hospital, Bologna, Italy University of Bologna, Bologna, Italy IRCCS Istituto delle Scienze Neurologiche, Anesthesia and Intensive Care, Bellaria Hospital, Bologna, Italy IRCCS Istituto delle Scienze Neurologiche, Anesthesia and Intensive Care, Bellaria Hospital, Bologna, Italy Hospital Serrania, Ronda, Spain Hospital Serrania, Ronda, Spain Hospital Regional, Intensive Care, Malaga, Spain Hospital Infanta Margarita, Intensive Care, Cabra, Spain Hospital Serrania, Ronda, Spain Hospital Regional, Intensive Care, Malaga, Spain Hospital Infanta Margarita, Intensive Care, Cabra, Spain Hospital Neurotraumatologico, Jaen, Spain Hospital Virgen de las Nieves, Intensive Care, Granada, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Neurology, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Hospital Rey Juan Carlos, M√≥stoles, Spain Hospital Rey Juan Carlos, M√≥stoles, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan, Province of China Centro Hospitalar T√¢mega e Sousa, Intensive Care, Penafiel, Portugal Centro Hospitalar T√¢mega e Sousa, Intensive Care, Penafiel, Portugal Centro Hospitalar T√¢mega e Sousa, Intensive Care, Penafiel, Portugal Centro Hospitalar T√¢mega e Sousa, Intensive Care, Penafiel, Portugal Centro Hospitalar T√¢mega e Sousa, Intensive Care, Penafiel, Portugal Centro Hospitalar T√¢mega e Sousa, Intensive Care, Penafiel, Portugal Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurology, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Burdenko Neurosurgery Institute, Moscow, Russian Federation Burdenko Neurosurgery Institute, Moscow, Russian Federation Burdenko Neurosurgery Institute, Moscow, Russian Federation Burdenko Neurosurgery Institute, Moscow, Russian Federation Fiocruz, Rio de Janeiro, Brazil D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Gregorio Mara√±on, Microbiology, Madrid, Spain Hospital Gregorio Mara√±on, Intensive Care Unit, Madrid, Spain Hospital Juarez de M√©xico, ICU, Mexico City, Mexico Hospital Juarez de M√©xico, ICU, Mexico City, Mexico Hospital Juarez de M√©xico, ICU, Mexico City, Mexico Hospital Juarez de M√©xico, ICU, Mexico City, Mexico Hospital Juarez de M√©xico, ICU, Mexico City, Mexico Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine, Mohali, India Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine, Mohali, India Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine, Mohali, India Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine, Mohali, India Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine, Mohali, India Max Superspeciality Hospital, Critical Care, Pulmonary and Sleep Medicine, Mohali, India Dr. H.S.J Institute of Dental Sciences, Pharmacology, Chandigarh, India Dr. H.S.J Institute of Dental Sciences, Pharmacology, Chandigarh, India Instituto Nacional del T√≥rax, Fellow Respiratory Medicine, Santiago, Chile Hospital Militar de Santiago, Intensive Care, Santiago, Chile Hospital Militar de Santiago, Intensive Care, Santiago, Chile Hospital Militar de Santiago, Intensive Care, Santiago, Chile Hospital Militar de Santiago, Intensive Care, Santiago, Chile Hospital Militar de Santiago, Intensive Care, Santiago, Chile Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Anaesthesiology, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Cardiovascular surgery, Paris, France Bichat University Hospital, Cardiovascular surgery, Paris, France Bichat University Hospital, Medical ICU, Paris, France Bichat University Hospital, Medical ICU, Paris, France Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Xanthi General Hospital, ICU, Xanthi, Greece Xanthi General Hospital, ICU, Xanthi, Greece N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Express Laboratory, Moscow, Russian  Federation N.N. Blokhin Russian Cancer Research Center, Express Laboratory, Moscow, Russian  Federation N.N. Blokhin Russian Cancer Research Center, Biochemical Laboratory, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Biochemical Laboratory, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Microbiology Department, Moscow, Russian Federation Hospital Serrania, Ronda, Spain Hospital Serrania, Ronda, Spain Hospital Infanta Margarita, Intensive Care, Cabra, Spain Hospital Regional, Intensive Care, Malaga, Spain Hospital Serrania, Ronda, Spain Hospital Regional, Intensive Care, Malaga, Spain Hospital Infanta Margarita, Intensive Care, Cabra, Spain Hospital Serrania, Ronda, Spain Hospital Serrania, Ronda, Spain Hospital Serrania, Ronda, Spain CHL Hospitals, Dept of Critical Care Services, Indore, India Shalby Hospital, Dept of Critical Care Services, Indore, India Hospital la Fe, Intensive Care Unit, Valencia, Spain Hospital la Fe, Valencia, Spain Hospital la Fe, Valencia, Spain Hospital la Fe, Valencia, Spain Hospital la Fe, Valencia, Spain Hospital la Fe, Valencia, Spain Hospital la Fe, Valencia, Spain Hospital la Fe, Valencia, Spain Yonsei Wonju University College of Medicine, Department of Internal Medicine, Wonju, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Saint Barnabas Medical Center, Department of Medicine, Livingston, USA Saint Barnabas Medical Center, Department of Medicine, Livingston, USA Saint Barnabas Medical Center, Department of Medicine, Livingston, USA Saint Barnabas Medical Center, Department of Medicine, Livingston, USA Saint Barnabas Medical Center, Department of Medicine, Livingston, USA Saint Barnabas Medical Center, Department of Medicine, Livingston, USA Saint Barnabas Medical Center, Department of Medicine, Livingston, USA Saint Barnabas Medical Center, Department of Medicine, Livingston, USA CHU Bordeaux, Bordeaux, France Hospital Cl√≠nic, Barcelona, Spain CHU Bordeaux, Bordeaux, France CHU Bordeaux, Bordeaux, France Hospital Cl√≠nic, Barcelona, Spain Rovira i Virgili University, Nursing Department, Tarragona, Spain Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain Verge de la Cinta University Hospital, Intensive Care Unit, Tortosa, Spain Hospital de Sant Joan Desp√≠ Moiss√®s Broggi, Intensive Care Unit, Barcelona, Spain Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain Joan XXIII University Hospital, Intensive Care Unit, Tarragona, Spain University Hospital Vall d‚ÄôHebron, Medical Transplant Coordination Department, Barcelona, Spain Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain Verge de la Cinta University Hospital, Intensive Care Unit, Tortosa, Spain Hospital de Sant Joan Desp√≠ Moiss√®s Broggi, Intensive Care Unit, Barcelona, Spain Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain University Hospital Vall d‚ÄôHebron, Medical Transplant Coordination Department, Barcelona, Spain Rovira i Virgili University, Nursing Department, Tarragona, Spain King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK St. Johns Medical College Hospital, Critical Care Medicine, Bangalore, India St. Johns Medical College Hospital, Bangalore, India St. Johns Medical College Hospital, Bangalore, India Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands Radboud University Nijmegen Medical Centre, Intensive Care, Nijmegen, Netherlands Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Deakin University, School of Nursing and Midwifery, Melbourne, Australia Victoria University, Wellington, Graduate School of Nursing Midwifery and Health, Wellington, New Zealand University of Canberra, Faculty of Health, Canberra, Australia Royal Devon and Exeter Hospital, Royal Devon and Exeter Clinical School, Exeter,  UK Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium Ghent University, Dept. of Internal Medicine, Ghent, Belgium VU University Medical Center, Intensive Care, Amsterdam, Netherlands VU University Medical Center, Intensive Care, Amsterdam, Netherlands VU University Medical Center, Epidemiology and Biostatistics, Amsterdam, Netherlands VU University Medical Center, Intensive Care, Amsterdam, Netherlands VU University Medical Center, Intensive Care, Amsterdam, Netherlands King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, Audit Team, King‚Äôs Critical Care, London, UK King‚Äôs College Hospital, Audit Team, King‚Äôs Critical Care, London, UK King‚Äôs College Hospital, Audit Team, King‚Äôs Critical Care, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK King‚Äôs College Hospital, ACET Research Team, London, UK Royal Devon and Exeter Hospital, ICU, Exeter, UK Royal Devon and Exeter Hospital, ICU, Exeter, UK Royal Devon and Exeter Hospital, ICU, Exeter, UK Royal Devon and Exeter Hospital, ICU, Exeter, UK Plymouth University/Royal Devon and exeter Hospital Clinical School, Exeter, UK Royal Brompton and Harefield NHS Foundation Trust, Rehabilitation and Therapies,  London, UK Senior ICU Nurse Quality and Safety VU University Medical Center, Amsterdam, Netherlands Senior ICU Nurse Quality and Safety VU University Medical Center, Amsterdam, Netherlands ICU Nursing, VU University Medical Center, Amsterdam, Netherlands VU University Medical Center, Amsterdam, Netherlands St. Johns Medical College Hospital, Critical Care Medicine, Bangalore, India St. Johns Medical College Hospital, Bangalore, India St. Johns Medical College, Bangalore, India Fondazione Cardiocentro Ticino, Cardiac Anesthesia and Intensive Care, Lugano, Switzerland IRCCS San Raffaele Scientific Institute, Department of Anesthesia and Intensive Care, Milan, Italy Fondazione Cardiocentro Ticino, Cardiac Anesthesia and Intensive Care, Lugano, Switzerland IRCCS San Raffaele Scientific Institute, Department of Anesthesia and Intensive Care, Milan, Italy Fondazione Cardiocentro Ticino, Cardiac Anesthesia and Intensive Care, Lugano, Switzerland IRCCS San Raffaele Scientific Institute, Department of Anesthesia and Intensive Care, Milan, Italy University of Liverpool, Institute of Ageing and Chronic Disease, Liverpool, UK University of Liverpool, Institute of Infection and Global Health, Liverpool, UK University of Liverpool, Institute of Infection and Global Health, Liverpool, UK University of Liverpool, Institute of Infection and Global Health, Liverpool, UK University of Liverpool, Institute of Infection and Global Health, Liverpool, UK Samsung Medical Center, Surgery, Seoul, Republic of Korea Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea Samsung Medical Center, Surgery, Seoul, Republic of Korea Royal Surrey County Hospital NHS Foundation Trust, Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative Research Group (SPACER), Guildford, UK Royal Surrey County Hospital NHS Foundation Trust, Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative Research Group (SPACER), Guildford, UK Royal Surrey County Hospital NHS Foundation Trust, Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative Research Group (SPACER), Guildford, UK Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Universidad de Concepci√≥n, Facultad de Medicina, Departamento de Kinesiolog√≠a, Concepcion, Chile Hospital Dr. S√≥tero del R√≠o, Unidad de Pacientes Cr√≠ticos, Santiago, Chile Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador Universidad de la Rep√∫blica, Hospital de Cl√≠nicas, Centro de Terapia Intensiva, Montevideo, Uruguay Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de Medicina Intensiva, Santiago, Chile Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de Medicina Intensiva, Santiago, Chile Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador Hospital Eugenio Espejo, Unidad de Cuidados Intensivos, Quito, Ecuador Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de Medicina Intensiva, Santiago, Chile Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de Medicina Intensiva, Santiago, Chile Hospital Guillermo Grant Benavente, Concepcion, Chile Hospital Guillermo Grant Benavente, Concepcion, Chile Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de Medicina Intensiva, Santiago, Chile Pontificia Universidad Catolica de Chile, Facultad de Medicina, Departamento de Medicina Intensiva, Santiago, Chile Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Graduate School of Medicine, Emergency and Critical Care Medicine, Sapporo, Japan Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain Hospital 12 de Octubre, Medicina Intensiva, Madrid, Spain VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands VU University Medical Center Amsterdam, Anaesthesiology, Amsterdam, Netherlands VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands VU University Medical Center Amsterdam, Anaesthesiology, Amsterdam, Netherlands VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands VU University Medical Center, Intensive Care Medicine, Amsterdam, Netherlands University of Alexandria, Critical Care, Alexandria, Egypt University of Alexandria, Critical Care, Alexandria, Egypt Medical Research Institute, Biomedical Informatics & Medical Statistics, Alexandria, Egypt University of Alexandria, Critical Care, Alexandria, Egypt Shiraz University of Medical Sciences, Anesthesia and Intensive Care Department,  Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Anesthesia and Intensive Care Department,  Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Anesthesia and Intensive Care Department,  Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec,  Czech Republic Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec,  Czech Republic Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec,  Czech Republic Regional Hospital Liberec, Department of Anesthesia and intensive Care, Liberec,  Czech Republic Chungnam National University Hospital, Anesthesiology and Pain Medicine, Daejon,  Republic of Korea Hyogo College of Medicine, General Internal Medicine, Nishinomiya, Japan Hyogo College of Medicine, Clinical Epidemiology, Nishinomiya, Japan Brigham and Women‚Äôs Hospital, General Internal Medicine, Boston, USA Hyogo College of Medicine, Clinical Epidemiology, Nishinomiya, Japan National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China University of Padova, Department of Medicine (DIMED), Padova, Italy University of Padova, Department of Medicine (DIMED), Padova, Italy University of Padova, Department of Medicine (DIMED), Padova, Italy University of Padova, Department of Medicine (DIMED), Padova, Italy University of Padova, Department of Medicine (DIMED), Padova, Italy University of Padova, Department of Medicine (DIMED), Padova, Italy University of Padova, Department of Medicine (DIMED), Padova, Italy Azienda Ospedaliera di Padova, Emergency Department, Padova, Italy University of Padova, Department of Medicine (DIMED), Padova, Italy University of Toronto, Interdepartmental Division of Critical Care Medicine, Toronto, Canada Azienda Ospedaliera di Padova, Emergency Department, Padova, Italy Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Policlinico Di Milano, Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Milano, Italy Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine, Goettingen, Germany Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Policlinico Di Milano, Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Milano, Italy Univesity of Zagreb, Department of Intensive Care Medicine, Rebro, Croatia Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Universit√† degli Studi di Milano, Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Milano, Italy Univesity of Zagreb, Department of Intensive Care Medicine, Rebro, Croatia Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine, Goettingen, Germany Hospital Israelita Albert Einstein, Critical Care Medicine, S√£o Paulo, Brazil Australian and New Zealand Intensive Care Research Centre, School of Public Health, Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Australia Groupe Hospitalier Henri Mondor; Assistance Publique-H√¥pitaux de Paris, Service de R√©animation M√©dicale, Cr√©teil, France Institute of Cardiometabolism and Nutrition (iCAN); H√¥pital de la Piti√©-Salp√™tri√®re, Assistance Publique-H√¥pitaux de Paris, Medical-Surgical Intensive Care Unit, Paris, France University Hospital Carl Gustav Carus, Technische Universit√§t Dresden, 21Pulmonary Engineering Group, Department of Anesthesiology and Intensive Care Medicine, Dresden, Germany IRCCS San Martino IST, University of Genoa, Surgical Sciences and Integrated Diagnostics, Genoa, Italy Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada Hospital for Sick Children, University of Toronto, Neonatal Medicine, Toronto, Canada Hospital for Sick Children, Division of Electron Microscopy, Toronto, Canada Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Hospital for Sick Children, University of Toronto, Neonatal Medicine, Toronto, Canada Hospital for Sick Children, Physiology and Experimental Medicine, Toronto, Canada Hopital Europeen Georges Pompidou, Anesthesiology and Intensive Care Medicine, Paris, France Universit√© Paris Diderot, Paris, France University of Washington, Seattle, USA Universit√© Paris Diderot, Paris, France Universit√© de Versailles Saint-Quentin-en-Yvelines, Garches, France Faculty of Pharmacy-Ain Shams University, Cairo, Egypt Faculty of Pharmacy-Ain Shams University, Cairo, Egypt Critical Care Medicine Department Cairo University Hospitals, Cairo, Egypt Faculty of Medicine - Ain Shams University, Cairo, Egypt Sacro Cuore Catholic University, A. Gemelli Hospital, Department of Anesthesiology and Intensive Care, Rome, Italy Sacro Cuore Catholic University, A. Gemelli Hospital, Department of Anesthesiology and Intensive Care, Rome, Italy Sacro Cuore Catholic University, A. Gemelli Hospital, Department of Anesthesiology and Intensive Care, Rome, Italy Sacro Cuore Catholic University, A. Gemelli Hospital, Department of Anesthesiology and Intensive Care, Rome, Italy Sacro Cuore Catholic University, A. Gemelli Hospital, Department of Anesthesiology and Intensive Care, Rome, Italy Sacro Cuore Catholic University, A. Gemelli Hospital, Department of Anesthesiology and Intensive Care, Rome, Italy Sacro Cuore Catholic University, A. Gemelli Hospital, Department of Anesthesiology and Intensive Care, Rome, Italy Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Danube University, Department for Health Sciences and Biomedicine, Krems, Austria Danube University, Department for Health Sciences and Biomedicine, Krems, Austria Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain Hospital Universtario Puerta de Hierro Majadahonda, Intensive Care Unit, Madrid,  Spain AP-HP, Saint Louis and Lariboisi√®re University Hospitals, Department of Anesthesiology and Critical Care Medicine, Paris, France AP-HP, Saint Louis and Lariboisi√®re University Hospitals, Department of Anesthesiology and Critical Care Medicine, Paris, France AP-HP, Saint Louis and Lariboisi√®re University Hospitals, Department of Anesthesiology and Critical Care Medicine, Paris, France AP-HP, H√¥pital Cochin, Medical Intensive Care Unit, Paris, France AP-HP, H√¥pital Saint-Antoine, Medical Intensive Care Unit, Paris, France Saint-Eloi University Hospital, Department of Anesthesiology and Critical Care Medicine, Montpellier, France AP-HM, H√¥pital Nord, Department of Anesthesiology and Critical Care Medicine, Marseille, France AP-HP, Saint Louis University Hospital, Biostatistics and Clinical Epidemiology Research Unit Department, Paris, France AP-HP, H√¥pital Ambroise Par√©, Department of Anesthesiology and Critical Care Medicine, Paris, France AP-HP, Saint Louis and Lariboisi√®re University Hospitals, Department of Anesthesiology and Critical Care Medicine, Paris, France AP-HP, Saint Louis and Lariboisi√®re University Hospitals, Department of Anesthesiology and Critical Care Medicine, Paris, France AP-HP, Saint Louis and Lariboisi√®re University Hospitals, Department of Anesthesiology and Critical Care Medicine, Paris, France 1st Medical Faculty, Charles University, Prague, Czech Republic 1st Medical Faculty, Charles University, Prague, Czech Republic 1st Medical Faculty, Charles University, Prague, Czech Republic 3rd Medical Faculty, Charles University, Prague, Czech Republic University of Pavia, Pavia, Italy 1st Medical Faculty, Charles University, Prague, Czech Republic Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care Unit, Bruxelles, Belgium Experimental Laboratory of Intensive Care, Universit√© Libre de Bruxelles, Bruxelles, Belgium Experimental Laboratory of Intensive Care, Universit√© Libre de Bruxelles, Bruxelles, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care Unit, Bruxelles, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care Unit, Bruxelles, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care Unit, Bruxelles, Belgium Edwards Lifesciences, Critical Care, Irvine, USA Edwards Lifesciences, Critical Care, Irvine, USA Edwards Lifesciences, Critical Care, Irvine, USA Edwards Lifesciences, Critical Care, Irvine, USA University of California Los Angeles, Anesthesiology, Los Angeles, USA University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical Intensive Therapy, Ljubljana, Slovenia University Medical Center Ljubljana, Department of Pulmonary Diseases and Allergy, Ljubljana, Slovenia University Medical Center Ljubljana, Center for Intensive Internal Medicin, Ljubljana, Slovenia University Medical Center Ljubljana, Center for Intensive Internal Medicin, Ljubljana, Slovenia University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical Intensive Therapy, Ljubljana, Slovenia University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical Intensive Therapy, Ljubljana, Slovenia University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical Intensive Therapy, Ljubljana, Slovenia University Medical Centre Ljubljana, Department of Anaesthesiology and Surgical Intensive Therapy, Ljubljana, Slovenia University Medical Center Ljubljana, Center for Intensive Internal Medicin, Ljubljana, Slovenia Sein√§joki Central Hospital, Department of Anaesthesiology and Intensive Care Medicine, Sein√§joki, Finland Tampere University Hospital, Department of Emergency Medicine, Tampere, Finland Helsinki University Hospital, Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, Helsinki, Finland Tampere University Hospital, Department of Intensive Care Medicine, Tampere, Finland Kaohsiung Veterans General Hospital, Department of Critical Care Medicine, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Critical Care Medicine, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Critical Care Medicine, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Critical Care Medicine, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Emergency, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Internal Medicine, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular division, Kaohsiung City, Taiwan, Province of China ICU Cochin Hospital, Paris, France ICU Cochin Hospital, Paris, France ICU Cochin Hospital, Paris, France Emergency Department, Cochin Hospital, Paris, France ICU Cochin Hospital, Paris, France ICU Mignot Hospital, Versailles, France ICU Cochin Hospital, Paris, France ICU Cochin Hospital, Paris, France Anesthesiology and Intensive Care, Catholic University School of Medicine, Rome,  Italy ICU Cochin Hospital, Paris, France University of Washington School of Medicine, Seattle Children‚Äôs Hospital, Pediatric Critical Care Medicine, Seattle, USA University of Washington School of Medicine, Seattle Children‚Äôs Hospital, Pediatric Critical Care Medicine, Seattle, USA University College London, Faculty of Medical Sciences, Division of Infection & Immunity, London, UK Immunexpress, Seattle, USA Immunexpress, Seattle, USA Immunexpress, Seattle, USA Immunexpress, Seattle, USA Immunexpress, Seattle, USA Immunexpress, Seattle, USA Immunexpress, Seattle, USA Immunexpress, Seattle, USA Immunexpress, Seattle, USA Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care Research, Nijmegen, Netherlands Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey Marmara University, Pediatric Immunology, Istanbul, Turkey Marmara University, Pediatric Immunology, Istanbul, Turkey Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey Marmara University, Pediatric Immunology, Istanbul, Turkey Marmara University, Anaesthesiology and Reanimation, Istanbul, Turkey Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Hospital Virgen del Rocio, Sevilla, Spain Hospital Virgen del Rocio, Sevilla, Spain Hospital Virgen del Rocio, Sevilla, Spain Hospital Virgen del Rocio, Sevilla, Spain Hospital Virgen del Rocio, Sevilla, Spain Hospital Virgen del Rocio, Sevilla, Spain Hospital Virgen del Rocio, Sevilla, Spain ABC Medical Center, Critical Care Unit, Mexico, Mexico ABC Medical Center, Mexico, Mexico ABC Medical Center, Mexico, Mexico ABC Medical Center, Mexico, Mexico ABC Medical Center, Mexico, Mexico ABC Medical Center, Mexico, Mexico ABC Medical Center, Mexico, Mexico ABC Medical Center, Mexico, Mexico ABC Medical Center, Mexico, Mexico H√¥pital Tenon, APHP, Medical and Surgical ICU, Paris, France Rouen University Hospital, Medical Intensive Care, Rouen, France CHU Henri Mondor, Medical ICU, Cr√©teil, France University Hospital of Lausanne, Intensive Care and Burn Unit, Lausanne, Switzerland CHU d‚ÄôAmiens, Cardiothoracic and Vascular ICU, Amiens, France CHU Hotel Dieu, Medical ICU, Nantes, France Hospital Le Mans, Intensive Care Unit, Le Mans, France CHR d‚ÄôOrleans, Medical ICU, Orleans, France CHU Grenoble Alpes, Medical ICU, Grenoble, France Universit√© Grenoble-Alpes, Inserm U1042, Grenoble, France CHR de Mulhouse, Medical ICU, Mulhouse, France Rouen University Hospital, Surgical Intensive Care, Rouen, France CHU de Poitiers, Medical ICU, Poitiers, France CHU Henri Mondor and ReVA Network, Medical ICU, Cr√©teil, France CHU d‚ÄôAngers, Clinical Research Institute, Angers, France Hospital de Sant Pau, Servei de Medicina Intensiva, Barcelona, Spain CHU d‚ÄôAngers, Medical ICU, Angers, France Annecy Genevois General Hospital, Annecy, France University of Toronto Saint Michael‚Äôs Hospital and Keenan Research Centre, Interdepartmental Division of Critical Care, Toronto, Canada ‚ÄòPapageorgiou‚Äô General Hospital, ICU, Thessaloniki, Greece ‚ÄòPapageorgiou‚Äô General Hospital, ICU, Thessaloniki, Greece ‚ÄòPapageorgiou‚Äô General Hospital, ICU, Thessaloniki, Greece ‚ÄòPapageorgiou‚Äô General Hospital, ICU, Thessaloniki, Greece ‚ÄòPapageorgiou‚Äô General Hospital, ICU, Thessaloniki, Greece Dipartimento dell‚ÄòEmergenza e dei Trapianti d‚ÄòOrgano, Universit√† degli Studi ‚ÄúAldo Moro‚Ä?, Bari, Italy Ferrara University, Ferrara, Italy Ferrara University, Ferrara, Italy Dipartimento dell‚ÄòEmergenza e dei Trapianti d‚ÄòOrgano, Universit√† degli Studi ‚ÄúAldo Moro‚Ä?, Bari, Italy Dipartimento dell‚ÄòEmergenza e dei Trapianti d‚ÄòOrgano, Universit√† degli Studi ‚ÄúAldo Moro‚Ä?, Bari, Italy Dipartimento dell‚ÄòEmergenza e dei Trapianti d‚ÄòOrgano, Universit√† degli Studi ‚ÄúAldo Moro‚Ä?, Bari, Italy Dipartimento dell‚ÄòEmergenza e dei Trapianti d‚ÄòOrgano, Universit√† degli Studi ‚ÄúAldo Moro‚Ä?, Bari, Italy Dipartimento dell‚ÄòEmergenza e dei Trapianti d‚ÄòOrgano, Universit√† degli Studi ‚ÄúAldo Moro‚Ä?, Bari, Italy Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain St James‚Äôs University Hospital. Trinity Center for Health Sciences, Anaesthesia and Critical Care, Dublin, Ireland Hospital Parc Tauli, Critical Care Medicine, Sabadell, Spain Hospital del Mar/CIBERES/UPF, Critical Care Medicine, Barcelona, Spain Hospital del Henares, Critical Care Medicine, Madrid, Spain Hospital Dr. Negr√≠n, Critical Care Medicine, Las Palmas de Gran Canaria, Spain Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain Universitat Rovira i Virgili/IISPV, Tarragona, Spain Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain Hospital Universitari Joan XXIII, Critical Care Medicine, Tarragona, Spain UT Heatlh Science Center at San Antonio and South Texas Veterans Health Care System, Pulmonary Disease and Critical Care, San Antonio, USA Hospital del Mar/CIBERES/UPF, Critical Care Medicine, Barcelona, Spain Hospital de Matar√≥, Critical Care Medicine, Matar√≥, Spain Hospital de Getafe, Critical Care Medicine, Madrid, Spain UT Heatlh Science Center at San Antonio and South Texas Veterans Health Care System, Pulmonary Disease and Critical Care, San Antonio, USA University of Milan - Biocca San Genaro Hospital, School of Medicine and Surgery, Monza, Italy UT Heatlh Science Center at San Antonio and South Texas Veterans Health Care System, Pulmonary Disease and Critical Care, San Antonio, USA University of Gothenburg, Department of Anesthesia and Intensive Care, Sahlgrenska University Hospital, G√∂teborg, Sweden University of Gothenburg, Department of Cardiothoracic Anesthesia and Intensive Care, Sahlgrenska University Hospital, G√∂teborg, Sweden University of Gothenburg, Department of Anesthesia and Intensive Care, Sahlgrenska University Hospital, G√∂teborg, Sweden Guy‚Äôs & St Thomas Hospital, London, UK Guy‚Äôs & St Thomas Hospital, London, UK Guy‚Äôs & St Thomas Hospital, London, UK Guy‚Äôs & St Thomas Hospital, London, UK Nordsj√¶llands Hospital, Dept. of Anaesthesiology and Intensive Care, Hiller√∏d, Denmark Nordsj√¶llands Hospital, Dept. of Anaesthesiology and Intensive Care, Hiller√∏d, Denmark Rigshospitalet, Copenhagen University Hospital, Dept. of intensive Care, Copenhagen, Denmark Rigshospitalet, Copenhagen University Hospital, CHIP & PERSIMUNE, Dept. of Infectious Diseases, Copenhagen, Denmark Nordsj√¶llands Hospital, Dept. of Anaesthesiology and Intensive Care, Hiller√∏d, Denmark University of Copenhagen, Dept. of Biostatistics, Copenhagen, Denmark Nordsj√¶llands Hospital, Dept. of Anaesthesiology and Intensive Care, Hiller√∏d, Denmark St George‚Äôs, University of London, London, UK St Georges NHS Foundation Trust, General Intensive Care, London, UK St Georges NHS Foundation Trust, Clinical Blood Sciences, London, UK St George‚Äôs, University of London, Renal Medicine, London, UK St George‚Äôs, University of London, General Intensive Care, London, UK Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative Research Group (SPACER), Guildford, UK Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative Research Group (SPACER), Guildford, UK Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative Research Group (SPACER), Guildford, UK Department of Anaesthesia, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK Royal Devon and Exeter Hospital, Exeter, UK Royal Devon and Exeter Hospital, Exeter, UK Royal Devon and Exeter Hospital, Exeter, UK South Devon Healthcare NHS Foundation Trust, Torquay, UK Department of Anaesthesia and Intensive Care, Royal United Hospital Bath NHS Trust, Bath, UK Department of Surgery, Royal United Hospital Bath NHS Trust, Bath, UK Department of Intensive Care Medicine and Surrey Peri-Operative Anaesthesia and Critical Care Collaborative Research Group (SPACER), Guildford, UK CH Chartres, R√©animation, Chartres, France Aix-Marseille Universit√©, Unit√© de Recherche EA 3279, Marseille, France Clinique Ambroise Par√©, R√©animation, Neuilly/Seine, France CHU Dijon Bourgogne, Anesth√©sie R√©animation, Dijon, France CHI Toulon/La Seyne sur Mer, R√©animation Polyvalente, Toulon, France CH Troyes, R√©animation, Troyes, France CHU Edouard Herriot, Hospices Civils de Lyon, R√©animation Polyvalente, Lyon, France H√¥pital Europ√©en de Marseille, R√©animation, Marseille, France Aix-Marseille Universit√©, Unit√© de Recherche EA 3279, Marseille, France CHU Cochin, AP-HP, R√©animation Chirurgicale, Paris, France CH Victor Provo, R√©animation Polyvalente, Roubaix, France CH Emile Roux, R√©animation, Le Puy-en-Velay, France CHU Saint-Louis, R√©animation M√©dicale, Paris, France CHU La Mil√©trie, R√©animation M√©dicale, Poitiers, France H√¥pital Europ√©en Georges Pompidou, AP-HP, R√©animation Chirugicale, Paris, France CHU Brest, R√©animation M√©dicale, Brest, France Groupe Hospitalier Paris Saint-Joseph, M√©decine Intensive et R√©animation, Paris,  France CHU Strasbourg, H√¥pital Civil, R√©animation Chirugicale Polyvalente, Strasbourg, France Groupe Hospitalier de La Rochelle - R√© - Aunis, R√©animation, La Rochelle, France CHU Beaujon, AP-HP, Anesth√©sie R√©animation, Clichy, France CH Lens, R√©animation, Lens, France CHU Strasbourg, H√¥pital Hautepierre, R√©animation Chirugicale, Strasbourg, France CH Auxerre, R√©animation, Auxerre, France CHU Nice, H√¥pital Pasteur, R√©animation M√©dico-Chirurgicale, Nice, France CHU H√¥pital Nord, AP-HM, R√©animation Chirugicale, Marseille, France CHU La Mil√©trie, R√©animation Chirugicale, Poitiers, France Aix-Marseille Universit√©, Unit√© de Recherche EA 3279, Marseille, France St George Hospital, Intensive Care, Sydney, Australia St George Hospital, Sydney, Australia St George Hospital, Sydney, Australia St George Hospital, Sydney, Australia St George Hospital, Sydney, Australia Great Ormond Street Hospital, Critical Care and Cardiorespiratory Division, London, UK Great Ormond Street Hospital, Critical Care and Cardiorespiratory Division, London, UK Great Ormond Street Hospital, Critical Care and Cardiorespiratory Division, London, UK Great Ormond Street Hospital, Paediatric Intensive Care Unit, London, UK St Mary‚Äôs Hospital and Charing Cross Hospital Imperial College NHS trust, Paediatric Intensive Care Unit, London, UK Great Ormond Street Hospital, Children‚Äôs Acute Transport Service, London, UK Hospital Sao Domingos, ICU, Sao Luis, Brazil Hospital Sao Domingos, ICU, Sao Luis, Brazil Hospital Sao Domingos, Sao Luis, Brazil Hospital Sao Domingos, ICU, Sao Luis, Brazil Hospital Sao Domingos, ICU, Sao Luis, Brazil Hospital Sao Domingos, ICU, Sao Luis, Brazil Hospital Sao Domingos, ICU, Sao Luis, Brazil Hospital Sao Domingos, ICU, Sao Luis, Brazil Hospital Sao Domingos, Sao Luis, Brazil HIGA Gral San Martin, La Plata, Argentina HIGA Gral San Martin, La Plata, Argentina Hospital de Trauma F Abete, Municipio Islas Malvinas, Argentina Sanatorio Anchorena, Buenos Aires, Argentina Hospital Municipal Chivilcoy, Chivilcoy, Argentina Instituto De Neurolog√≠a Cognitiva-INECO, Buenos Aires, Argentina Instituto Fleni, Escobar, Argentina Sanatorio G√ºemes, Buenos Aires, Argentina Hospital Brit√°nico de Buenos Aires, Buenos Aires, Argentina Hospital Austral, Pilar, Argentina Hospital San Antonio, Gualeguay, Argentina Clinica Bazterrica, Buenos Aires, Argentina Hospital Domingo Funes, Santa Maria de Punilla, Argentina Hospital San Luis, San Luis, Argentina HIGA San Jos√©, Pergamino, Argentina Hospital Artemides Zatti, Viedma, Argentina Hospital de Gastroenterologia Udaondo, Buenos Aires, Argentina Sanatorio Parque, Rosario, Argentina Hospital Dr. Carlos Mac√≠as, Mar de Aj√≥, Argentina HIGA San Jos√©, Pergamino, Argentina Fondazione IRCCS C√† Granda-Ospedale Maggiore Policlinico, Department of Anaesthesiology and Intensive Care, Milan, Italy Fondazione IRCCS C√† Granda-Ospedale Maggiore Policlinico, Department of Anaesthesiology and Intensive Care, Milano, Italy University of Washington School of Medicine, Department of Neurological Surgery,  Seattle, USA Washington University, Mallinckrodt Institute of Radiology, St. Louis, USA Fondazione IRCCS C√† Granda-Ospedale Maggiore Policlinico, Department of Anaesthesiology and Intensive Care, Milano, Italy Fondazione IRCCS C√† Granda-Ospedale Maggiore Policlinico, Department of Neuroradiology, Milano, Italy Milan University, Milano, Italy Milan University, Milano, Italy Washington University, Mallinckrodt Institute of Radiology, St. Louis, USA Fondazione IRCCS C√† Granda-Ospedale Maggiore Policlinico, Department of Anaesthesiology and Intensive Care, Milano, Italy Washington University, Department of Neurology, St. Louis, USA Burdenko Neurosurgery Institute, Moscow, Russian Federation Burdenko Neurosurgery Institute, Moscow, Russian Federation Burdenko Neurosurgery Institute, Moscow, Russian Federation Burdenko Neurosurgery Institute, Moscow, Russian Federation Burdenko Neurosurgery Institute, Moscow, Russian Federation Medisch Spectrum Twente, Clinical Neurophysiology and Neurology, Enschede, Netherlands Rijnstate Hospital, Neurology, Arnhem, Netherlands Medisch Spectrum Twente, Intensive Care Medicine, Enschede, Netherlands Medisch Spectrum Twente, Intensive Care Medicine, Enschede, Netherlands Rijnstate Hospital, Intensive Care Medicine, Arnhem, Netherlands Medisch Spectrum Twente, Clinical Neurophysiology and Neurology, Enschede, Netherlands Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical Care Medicine, Bergamo, Italy Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Neurology, Bergamo, Italy University of Milan, Milano, Italy University of Milan - Bicocca, Monza, Italy Ospedale San Gerardo, Neurology, Monza, Italy Ospedale San Gerardo, Anesthesia and Critical Care Medicine, Monza, Italy Ospedale San Gerardo, Anesthesia and Critical Care Medicine, Monza, Italy Ospedale San Gerardo, Anesthesia and Critical Care Medicine, Monza, Italy Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical Care Medicine, Bergamo, Italy Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical Care Medicine, Bergamo, Italy Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Neurology, Bergamo, Italy Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Anesthesia and Critical Care Medicine, Bergamo, Italy University of Milan - Bicocca, Monza, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Neuroscience Intensive Care Unit, Milan, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Neuroscience Intensive Care Unit, Milan, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Neuroscience Intensive Care Unit, Milan, Italy Universit√† degli Studi di Milano, Milan, Italy Universit√† degli Studi di Milano, Milan, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Neuroscience Intensive Care Unit, Milan, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Neuroscience Intensive Care Unit, Milan, Italy Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Department of Economy, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Department of Economy, University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Academic Medical Center, University of Amsterdam, Medical Informatics, Amsterdam, Netherlands Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care Medicine, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Medical Informatics, Amsterdam, Netherlands Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands Queen‚Äôs University, Centre for Neuroscience Studies, Kingston, Canada Queen‚Äôs University, Medicine and Critical Care, Kingston, Canada Queen‚Äôs University, Medicine and Critical Care, Kingston, Canada Queen‚Äôs University, Centre for Neuroscience Studies, Kingston, Canada Queen‚Äôs University, Anaesthesia and Perioperative Medicine, Kingston, Canada Queen‚Äôs University, Surgery, Kingston, Canada Queen‚Äôs University, Surgery, Kingston, Canada Queen‚Äôs University, Surgery, Kingston, Canada Queen‚Äôs University, Centre for Neuroscience Studies, Kingston, Canada University College London Hospitals NHS Foundation Trust, Division of Critical Care, London, UK University College London Hospitals, NIHR Biomedical Research Centre, London, UK UCL/University College London Hospitals NHS Foundation Trust, Institute of Sport, Exercise and Health, London, UK Guy‚Äôs & St Thomas‚Äô NHS Foundation Trust and King‚Äôs College London, NIHR Biomedical Research Centre, London, UK St Mary‚Äôs Hospital and Imperial College London, Hepatology & Gastroenterology, London, UK Kings College Hospital NHS Foundation Trust, Department of Radiology, London, UK Kings College London, Centre of Human and Aerospace Physiological Sciences, London, UK King‚Äôs College London, Department of Asthma, Allergy and Lung Biology, London, UK Kings College London, Centre of Human and Aerospace Physiological Sciences, London, UK Guy‚Äôs & St Thomas‚Äô NHS Foundation Trust, Lane Fox Clinical Respiratory Physiology Research Centre, London, UK University College London Hospitals, NIHR Biomedical Research Centre, London, UK Queen‚Äôs Hospital, Critical Care Department, Romford, UK Queen‚Äôs Hospital, Critical Care Department, Romford, UK Queen‚Äôs Hospital, Pharmacy Service, Romford, UK Queen‚Äôs Hospital, Critical Care Department, Romford, UK Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Tuen Mun Hospital, Hong Kong, Hong Kong China Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Hospital Universitario La Paz, Madrid, Spain Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Royal Berkshire Hospital, Critical Care Unit, Reading, UK Hospital Costa del Sol Marbella, Malaga, Spain Hospital Costa del Sol Marbella, Malaga, Spain Hospital Costa del Sol Marbella, Malaga, Spain Hospital Costa del Sol Marbella, Malaga, Spain Hospital Costa del Sol Marbella, Malaga, Spain Hospital Costa del Sol Marbella, Malaga, Spain NRI Medical College and Hospital, Department of Critical Care, Guntur, India NRI Medical College and Hospital, Department of Critical Care, Guntur, India NRI Medical College and Hospital, Department of Critical Care, Guntur, India Hospital Universitario Virgen de la Victoria, Malaga, Spain Hospital Universitario Virgen de la Victoria, Malaga, Spain Hospital Universitario Virgen de la Victoria, Malaga, Spain Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain Hospital Universitari Mutua Terrassa, Intensive Care Medicine, Terrassa, Spain Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Clinica Sagrada Esperan√ßa, Luanda, Angola Clinica Sagrada Esperan√ßa, Luanda, Angola Clinica Sagrada Esperan√ßa, Luanda, Angola Clinica Sagrada Esperan√ßa, Luanda, Angola Lancashire Teaching Hospitals Trust, Critical Care, Preston, UK Lancashire Teaching Hospitals Trust, Critical Care, Preston, UK Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Fundaci√≥n Jim√©nez D√≠az, Madrid, Spain Broomfield Hospital, Intensive Care Unit, Chelmsford, UK Broomfield Hospital, Intensive Care Unit, Chelmsford, UK Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Japan Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Japan University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France University Teaching Hospital of Purpan, Critical Care Medicine, Toulouse, France INSERM 1214, Toulouse NeuroImaging Center (TONIC), Toulouse, France School of Medicine and Surgery, University Milano Bicocca and Hospital San Gerardo, Department of Anaesthesiology and Critical Care, Monza, Italy University Teaching Hospital of Purpan, Toulouse, France University Hospital of Clermont-Ferrand, Critical Care Unit, Clermont-Ferrand, France University Hospital and University of Li√®ge, Cyclotron Research Center and Department of Neurology, Li√®ge, Belgium Groupe Hospitalier Piti√©-Salp√©tri√®re, APHP, Critical Care and Anaesthesiology Department, Paris, France H√¥pital Erasme, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Ospedali Riuniti, Department of Perioperative Medicine, Trieste, Italy CHUV, Department of Neurology, Lausanne, Switzerland Hopital Erasme, Universit√© Libre de Bruxelles, Department of Neurology, Brussels, Belgium CHUV, Department of Neurology, Lausanne, Switzerland CHUV, Department of Intensive Care, Lausanne, Switzerland Ospedali Riuniti, Department of Perioperative Medicine, Trieste, Italy Hokkaido University Hospital, Emergency and Critical Care Medicine, Sapporo, Japan Hokkaido University Hospital, Emergency and Critical Care Medicine, Sapporo, Japan Ospedali Riuniti, Department of Perioperative Medicine, Trieste, Italy Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Graduate School of Medicine, Division of Acute and Critical Care Medicine, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Hokkaido University Hospital, Clinical Research and Medical Innovation Center, Sapporo, Japan Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Aarhus University Hospital, Anesthesiology, Aarhus, Denmark Beth Israel Deaconess Medical Center, Harvard Medical School, Emergency Medicine, Boston, USA The Children‚Äôs Hospital of Philadelphia, Philadelphia, USA University of Pennsylvania, Philadelphia, USA University of Pennsylvania, Philadelphia, USA Institute of Public Health, Charit√© - Universit√§tsmedizin Berlin, Berlin, Germany Beth Israel Deaconess Medical Center, Harvard Medical School, Critical Care, Boston, USA Medical City Children‚Äôs Hospital, Dallas, USA Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand Chulalongkorn University, Pulmonary and Critical Care Medicine, Bangkok, Thailand King Chulalongkorn Memmorial Hospital, Bangkok, Thailand Chulalongkorn University, Medicine, Bangkok, Thailand IRCCS - Istituto di Ricerche Farmacologiche ‚ÄòMario Negri‚Äô, Department of Cardiovascular Research, Milan, Italy Kuopio University Hospital, Division of Intensive Care Medicine, Kuopio, Finland Kuopio University Hospital, Division of Intensive Care Medicine, Kuopio, Finland Kuopio University Hospital, Division of Intensive Care Medicine, Kuopio, Finland Oulu University Hospital, Medical Research Center Oulu, Department of Anaesthesiology, University of Oulu and Division of Intensive Care Medicine, Oulu, Finland Tampere University Hospital, Department of Intensive Care, Tampere, Finland IRCCS - Istituto di Ricerche Farmacologiche ‚ÄòMario Negri‚Äô, Department of Cardiovascular Research, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄòMario Negri‚Äô, Department of Cardiovascular Research, Milan, Italy Helsinki University Hospital, Department of Neurology, Helsinki, Finland University-Hospital of Padova, Department of Laboratory Medicine, Padova, Italy Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea IRCCS - Istituto di Ricerche Farmacologiche ‚ÄòMario Negri‚Äô, Department of Cardiovascular Research, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄòMario Negri‚Äô, Department of Cardiovascular Research, Milan, Italy Universit√© Libre de Bruxelles - Erasme University Hospital, Department of Intensive Care, Bruxelles, Belgium Universit√© Libre de Bruxelles - Erasme University Hospital, Department of Intensive Care, Bruxelles, Belgium Universit√© Libre de Bruxelles - Erasme University Hospital, Department of Intensive Care, Bruxelles, Belgium Universit√© Libre de Bruxelles - Erasme University Hospital, Department of Intensive Care, Bruxelles, Belgium Universit√© Libre de Bruxelles - Erasme University Hospital, Department of Intensive Care, Bruxelles, Belgium Universit√© Libre de Bruxelles - Erasme University Hospital, Department of Intensive Care, Bruxelles, Belgium St Luke‚Äôs International Hospital, Emergency, Tokyo, Japan St Luke‚Äôs International Hospital, Emergency, Tokyo, Japan St Luke‚Äôs International Hospital, Emergency, Tokyo, Japan St Luke‚Äôs International Hospital, Emergency, Tokyo, Japan St Luke‚Äôs International Hospital, Emergency, Tokyo, Japan St Luke‚Äôs International Hospital, Emergency, Tokyo, Japan St Luke‚Äôs International Hospital, Tokyo, Japan Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Hospital Universitari Mutua Terrassa, Critical Care Department, Terrassa, Spain Hospital Universitari Mutua Terrassa, Terrassa, Spain Hospital Universitari Mutua Terrassa, Terrassa, Spain Hospital Universitari Mutua Terrassa, Terrassa, Spain Na Homolce Hospital, Prague, Czech Republic Hospital Universitari Mutua Terrassa, Terrassa, Spain Hospital Universitari Mutua Terrassa, Terrassa, Spain Hospital Universitari Mutua Terrassa, Terrassa, Spain National Taiwan University Hospital, Department of Anesthesiology, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Anesthesiology, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Anesthesiology, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Anesthesiology, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Anesthesiology, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Anesthesiology, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan, Province of China Far Eastern Memorial Hospital, Department of Anesthesiology, New Taipei, Taiwan,  Province of China Far Eastern Memorial Hospital, Department of Anesthesiology, New Taipei, Taiwan,  Province of China National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan, Province of China Far Eastern Memorial Hospital, Department of Anesthesiology, New Taipei, Taiwan,  Province of China Division of Electrophysiology, Department of Cardiovascular Medicine, University  of M√ºnster, M√ºnster, Germany National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan, Province of China National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan, Province of China Division of Cardiology, Department of Cardiovascular Medicine, University of M√ºnster, M√ºnster, Germany CHU Montpellier, Montpellier, France CHU Montpellier, Montpellier, France Na Homolce Hospital, Prague, Czech Republic Na Homolce Hospital, Prague, Czech Republic Na Homolce Hospital, Prague, Czech Republic Na Homolce Hospital, Prague, Czech Republic Na Homolce Hospital, Prague, Czech Republic Charles University in Prague, Prague, Czech Republic Cantonal Hospital Winterthur, Winterthur, Switzerland Cantonal Hospital Winterthur, Winterthur, Switzerland Charles University in Prague, Prague, Czech Republic Charles University in Prague, Prague, Czech Republic Charles University in Prague, Prague, Czech Republic Charles University in Prague, Prague, Czech Republic Charles University in Prague, Prague, Czech Republic Cantonal Hospital Winterthur, Winterthur, Switzerland Charles University in Prague, Prague, Czech Republic University Hospital Zurich, Institute for Anaesthesiology, Cardio-surgical Intensive Care Unit, Zurich, Switzerland Erasmus Medical Center, Rotterdam, Netherlands Erasmus Medical Center, Rotterdam, Netherlands Erasmus Medical Center, Rotterdam, Netherlands University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium University Hospital Erasme, Universit√© Libre de Bruxelles, Critical Care, Brussels, Belgium Texas Children‚Äôs Hospital, Clinical Nutriiton, Houston, USA National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China National Taiwan University Hospital, Taipei, Taiwan, Province of China Chang Gung Memorial Hospital, Linkou, Taoyaun Taiwan, Province of China National Taiwan University Hospital, Department of Surgery, Taipei, Taiwan, Province of China Hallym University, Emergency Medicine, Seoul, Republic of Korea Hanyang University, Emergency Medicine, Seoul, Republic of Korea Hanyang University, Neurosurgery, Seoul, Republic of Korea Hanyang University, Emergency Medicine, Seoul, Republic of Korea Hanyang University, Neurosurgery, Seoul, Republic of Korea Hanyang University, Neurosurgery, Seoul, Republic of Korea Kyung Hee University, Preventive Medicine, Seoul, Republic of Korea University Medical Center Hamburg-Eppendorf, Intensive Care Medicine, Hamburg, Germany Hanyang University, Emergency Medicine, Seoul, Republic of Korea University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology, Hamburg, Germany University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology, Hamburg, Germany University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology, Hamburg, Germany University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology, Hamburg, Germany University Heart Center Hamburg-Eppendorf, Cardiovascular Surgery, Hamburg, Germany St. Franziskus Hospital M√ºnster, Pneumology and Intensive Care Medicine, M√ºnster, Germany University Heart Center Hamburg-Eppendorf, General and Interventional Cardiology, Hamburg, Germany Universit√† La Sapienza di Roma, UOD Terapia Intensiva nei Trapianti d‚ÄôOrgano, Policlinico Umberto I, Roma, Italy University of Turin, Dept. of Surgical Sciences, Turin, Italy University of Turin, Dept. of Surgical Sciences, Turin, Italy University of Turin, Dept. of Surgical Sciences, Turin, Italy University of Turin, Dept. of Surgical Sciences, Turin, Italy University of Turin, Dept. of Surgical Sciences, Turin, Italy University of Turin, Dept. of Surgical Sciences, Turin, Italy University of Turin, Dept. of Surgical Sciences, Turin, Italy Citt√† della Salute e della Scienza Hospital, Dept. of Anesthesiology, Turin, Italy Citt√† della Salute e della Scienza Hospital, Dept. of Anesthesiology, Turin, Italy INSERM, U1116, Vandoeuvre-les-Nancy, France Citt√† della Salute e della Scienza Hospital, Dept. of Anesthesiology, Turin, Italy Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France Ecole de Chirurgie de Nancy, Vandoeuvre les Nancy, France CHU de Nancy, Plateforme d‚ÄôAide √† la Recherche Clinique, Vandoeuvre-les-Nancy, France Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France Hopital Europeen Georges Pompidou, Paris, France CHU de Nancy, Plateforme d‚ÄôAide √† la Recherche Clinique, Vandoeuvre-les-Nancy, France Ecole de Chirurgie de Nancy, Vandoeuvre-les-Nancy, France Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK Glasgow Royal Infirmary, Anaesthesia, Glasgow, UK Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Ghent University Hospital, General Internal Medicin, Gent, Belgium Ghent University Hospital, General Internal Medicin, Gent, Belgium Ghent University Hospital, General Internal Medicin, Gent, Belgium Ghent University Hospital, General Internal Medicin, Gent, Belgium Ghent University, Public Health, Gent, Belgium Ghent University, Internal Medicin, Gent, Belgium Ghent University, General Internal Medicine, Gent, Belgium Ghent University, Family Medicine and Primary Health Care, Gent, Belgium Ghent University, Internal Medicin, Gent, Belgium Ghent University Hospital, Internal Medicine, Gent, Belgium University Hospital Zurich, University Zurich, Z√ºrich, Switzerland Hospital Uster, Department of Internal Medicine, Uster, Switzerland University Hospital Zurich, University Zurich, Heart and Vascular Surgical Intensive Care Unit, Zurich, Switzerland University Hospital Zurich, University Zurich, Surgical Intensive Care Unit, Zurich, Switzerland University Hospital Zurich, University Zurich, Neurosurgical Intensive Care Unit, Zurich, Switzerland University Hospital Zurich, University Zurich, Medical Intensive Care Unit, Zurich, Switzerland University Hospital Zurich, University Zurich, Surgical Intensive Care Unit, Z√ºrich, Switzerland Gelre Hospitals Apeldoorn, Intensive Care Medicine, Apeldoorn, Netherlands Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands Catharina Hospital, Intensive Care Medicine, Eindhoven, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care Medicine, Amsterdam, Netherlands Gelre Hospitals Apeldoorn, Physiotherapy, Apeldoorn, Netherlands Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, General Intensive Care Unit, London, UK Imperial College Healthcare NHS Trust, Haematology, London, UK Samsung Medical Center, Seoul, Republic of Korea Samsung Medical Center, Seoul, Republic of Korea Imperial College Healthcare NHS Trust, Haematology, London, UK Dalhousie University, Critical Care Medicine, Halifax, Canada Dalhousie University, Critical Care Medicine, Halifax, Canada Dalhousie University, Critical Care Medicine, Halifax, Canada Dalhousie University, Critical Care Medicine, Halifax, Canada Dalhousie University, Critical Care Medicine, Halifax, Canada Dalhousie University, Critical Care Medicine, Halifax, Canada Dalhousie University, Anesthesiology, Pain Management and Perioperative Medicine, Halifax, Canada Dalhousie University, Emergency Medicine, Halifax, Canada Dalhousie University, Anesthesiology, Pain Management and Perioperative Medicine, Halifax, Canada Queen Mary University of London, William Harvey Research Institute, London, UK Dalhousie University, Respiratory Therapy, Halifax, Canada Dalhousie University, Anesthesiology, Pain Management and Perioperative Medicine, Halifax, Canada London School of Economics, London, UK London School of Economics, London, UK Northwick Park Hospital, London, UK Barts Health NHS Trust, London, UK Tata Memorial Hospital, Anaesthesia, Critical Care and Pain, Mumbai, India Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico Insituto Mexicano del Seguro Social, Internal Medicine, Celaya, Mexico University of Frankfurt, Frankfurt, Germany University Bonn, Bonn, Germany Hospital Frankfurt Hoechst, Frankfurt, Germany KfH Bad Soden, Bad Soden, Germany Ultrasound Network in Acute and Critical Care, Frankfurt, Germany Hospital Frankfurt Hoechst, Frankfurt, Germany Rigshospitalet, Copenhagen University Hospital, Intensive Care Unit 4131, Copenhagen, Denmark Lund University, Dep. of Clinical Sciences, Lund, Sweden Lund University, Dep. of Clinical Sciences, Lund, Sweden Lund University, Dep. of Clinical Sciences, Lund, Sweden Hospital Femina Grupo Hopsitalar Concei√ß√£o, Intensive Care, Porto Alegre, Brazil Hospital Universitari i Polit√®cnic la Fe, Intensive Care Unit, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Intensive Care Unit, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Intensive Care Unit, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pharmacy, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pharmacy, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pneumology, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pharmacy, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pharmacy, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pharmacy, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pharmacy, Valencia, Spain Hospital Universitari i Polit√®cnic la Fe, Pharmacy, Valencia, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Intensive Care Unit, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain University of Las Palmas de Gran Canaria, Mathematics and Informatics Deparment,  Las Palmas de Gran Canaria, Spain Hospital Virgen del Rocio, Seville, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain Hospital Virgen Macarena, Seville, Spain Aix Marseille Universit√©, Assistance Publique-H√¥pitaux de Marseille, H√¥pital Nord, Service d‚ÄôAnesth√©sie et de R√©animation, Marseille, France EA 3279 Research Unit, Aix Marseille University & Assistance Publique-H√¥pitaux de Marseille, Marseille, France Department of Clinical Medicine, Trinity College, Wellcome Trust-HRB Clinical Research Facility, St James Hospital, Dublin, Ireland EA 3279 Research Unit, Aix Marseille University & Assistance Publique-H√¥pitaux de Marseille, Marseille, France Hopital Europeen Georges Pompidou, Anesthesiology and Intensive Care Medicine, Paris, France University of California Berkeley, Biostatistics, Berkeley, USA Hopital Europeen Georges Pompidou, Paris, France University of California Berkeley, Berkeley, USA Hospital Universitario Miguel Servet, ICU, Zaragoza, Spain Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain Hospital de Barbastro, Barbastro, Spain Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain Hospital de Barbastro, Barbastro, Spain HU Arnau de Vilanova, Lleida, Spain Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain Hospital Universitario Miguel Servet, Microbiology, Zaragoza, Spain H Galdakao, Bilbao, Spain HU Vall d‚ÄôHebron, Barcelona, Spain HU Doce de Octubre, Madrid, Spain H Galdakao, Bilbao, Spain HU Malaga, Malaga, Spain H Galdakao, Bilbao, Spain Parc de Salut Mar. IMIM (Mar Medical Research Institut), Barcelona, Spain Yonsei Wonju University College of Medicine, Department of Internal Medicine, Wonju, Republic of Korea Yonsei University College of Medicine, Department of Internal Medicine, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea Yonsei University College of Medicine, AIDS Research Institute, Seoul, Republic of Korea University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia medico-chirurgica e dei trapianti, Milano, Italy Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy University of Milan, Fisiopatologia Medico-Chirurgica e dei Trapianti, Milano, Italy Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain University of Murcia, Faculty of Veterinary, Murcia, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain Hospital Virgen de la Arrixaca, Pharmacy, El Palmar, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Institut de Recerca Biom√©dica de Lleida, Lleida, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurology, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Juntendo University School of Medicine, General Medicine, Tokyo, Japan Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Complejo Hospitalario de Navarra, Neurosurgery, Pamplona, Navarra Spain Niijima, Tokyo National Health Insurance Clinic, Tokyo, Japan Niijima, Tokyo National Health Insurance Clinic, Tokyo, Japan Tokyo Metropolitan Government, Emergency Medical Services and Disaster Response Section, Tokyo, Japan All India Institute of Medical Sciences, Anesthesiology Critical Care and Pain Medicine, New Delhi, India Niijima, Tokyo National Health Insurance Clinic, Tokyo, Japan ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, UK NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, UK ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy Kings College Hospital, London, UK Heartfelt Technologies Ltd, Cambridge, UK Ente Ospedaliero Ospedali Galliera, Anestesia e Rianimazione, Genova, Italy Kings College Hospital, London, UK Kings College Hospital, London, UK Heartfelt Technologies Ltd, Cambridge, UK Azienda Ospedaliero-Universitaria di Parma, Dipartimento Cardio-Nefro-Polmonare,  UO di Cardiochirurgia, Parma, Italy Azienda Ospedaliero-Universitaria di Parma, Dipartimento Cardio-Nefro-Polmonare,  UO di Cardiochirurgia, Parma, Italy Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK Azienda Ospedaliero-Universitaria di Parma, Dipartimento Cardio-Nefro-Polmonare,  UO di Cardiochirurgia, Parma, Italy Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK Royal Brompton and Harefield Trust, Speech and Language Therapy, London, UK Complejo Hospitalario de Granada, Intensive Care Unit, Granada, Spain Hospital Regional M√°laga, M√°laga, Spain Hospital Regional M√°laga, M√°laga, Spain Hospital Regional M√°laga, M√°laga, Spain Hospital Regional M√°laga, M√°laga, Spain Complejo Hospitalario de Ja√©n, Jaen, Spain Complejo Hospitalario de Ja√©n, Jaen, Spain Complejo Hospitalario de Ja√©n, Jaen, Spain Hospital Puerta del Mar, Cadiz, Spain Hospital Virgen de las Nieves, Granada, Spain Hammersmith Hospital, Imperial College Healthcare NHS Trust, Department of Surgery and Cancer, London, UK Hospital Rio Hortega, Valladolid, Spain Hospital Rio Hortega, Valladolid, Spain Hospital Rio Hortega, Valladolid, Spain Hospital Rio Hortega, Valladolid, Spain Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive Care, Istanbul, Turkey Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive Care, Istanbul, Turkey Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive Care, Istanbul, Turkey Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive Care, Istanbul, Turkey Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive Care, Istanbul, Turkey Istanbul University Cerrahpasa Medical Faculty, Anesthesiology and Intensive Care, Istanbul, Turkey University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK Western Sussex Hospitals NHS FT, Worthing, UK Western Sussex Hospitals NHS FT, Worthing, UK Royal Surrey County Hospital, Intensive Care, Guildford, UK University of Surrey, Guildford, UK University of Brighton, Brighton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK University of Southampton, Faculty of Medicine, Southampton, UK Western Sussex Hospitals NHS FT, Worthing, UK Western Sussex Hospitals NHS FT, Worthing, UK Royal Surrey County Hospital, Intensive Care, Guildford, UK University of Surrey, Guildford, UK University of Brighton, Brighton, UK Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain Pavlov First Saint-Petersburg State Medical University, Anesthesiology and Intensive Care, Saint-Petersburg, Russian Federation Dr Josep Trueta University Hospital, Clinical laboratory, Girona, Spain Saint-Petersburg I. I. Dzhanelidze Research institute of Emergency Medicine, Saint-Petersburg, Russian Federation Saint-Petersburg I. I. Dzhanelidze Research institute of Emergency Medicine, Saint-Petersburg, Russian Federation Vilnius University, Clinic of Anaesthesiology and Intensive Care, Vilnius, Lithuania Vilnius University, Faculty of Medicine, Vilnius, Lithuania Hadassah Hebrew University Medical Center, Jerusalem, Israel Hadassah Hebrew University Medical Center, Jerusalem, Israel Vilnius University, Faculty of Medicine, Vilnius, Lithuania Vilnius University, Faculty of Medicine, Vilnius, Lithuania Vilnius University, Faculty of Medicine, Vilnius, Lithuania LeukoDx, Jerusalem, Israel LeukoDx, Jerusalem, Israel LeukoDx, Jerusalem, Israel Regional University Hospital in M√°laga, Intensive Care Medicine, M√°laga, Spain Regional University Hospital in M√°laga, Intensive Care Medicine, M√°laga, Spain Regional University Hospital in M√°laga, Intensive Care Medicine, M√°laga, Spain Regional University Hospital in M√°laga, Intensive Care Medicine, M√°laga, Spain Regional University Hospital in M√°laga, Intensive Care Medicine, M√°laga, Spain Regional University Hospital in M√°laga, Intensive Care Medicine, M√°laga, Spain Queen Mary University of London, William Harvey Research Institute, London, UK Queen Mary University of London, William Harvey Research Institute, London, UK Queen Mary University of London, William Harvey Research Institute, London, UK Queen Mary University of London, William Harvey Research Institute, London, UK Queen Mary University of London, William Harvey Research Institute, London, UK The Royal London Hospital, Adult Critical Care Unit, London, UK Queen Mary University of London, London, UK Erasme University Hospital, Universit√© Libre de Bruxelles, Brussels, Belgium Nord University, Faculty of Health Science, Levanger, Norway Nord-Tr√∏ndelag Hospital Trust, Levanger Hospital, Internal Medicine, Levanger, Norway Norwegian University of Technology and Science (NTNU), Department of Neuroscience (INM), Trondheim, Norway Norwegian University of Technology and Science (NTNU), Department of Neuroscience (INM), Trondheim, Norway Norwegian University of Technology and Science (NTNU), Department of Neuroscience (INM), Trondheim, Norway Norwegian University of technology and Science (NTNU), Centre of Molecular Inflammation Research, Department of Cancer Research and Molecular Medicine, Trondheim, Norway St Olavs University Hospital, Clinic of Anesthesia and Intensive Care, Trondheim, Norway Nord-Tr√∏ndelag Hospital Trust, Levanger Hospital, Internal Medicine, Levanger, Norway Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Critical Care, Athens, Greece Attikon University Hospital, 2nd Department of Internal Medicine, Athens, Greece National and Kapodistrian University of Athens, Department of Experimental Physiology, Athens, Greece National and Kapodistrian University of Athens, Department of Experimental Physiology, Athens, Greece Attikon University Hospital, 2nd Department of Internal Medicine, Athens, Greece Attikon University Hospital, 2nd Department of Internal Medicine, Athens, Greece National and Kapodistrian University of Athens, Department of Experimental Physiology, Athens, Greece National and Kapodistrian University of Athens, Department of Experimental Physiology, Athens, Greece Tokyo Women‚Äôs Medical University, Tokyo, Japan University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK Lille Univ Hospital, Lille, France Lille Univ Hospital, Lille, France Lille Univ Hospital, Lille, France Lille Univ Hospital, Lille, France Lille Univ Hospital, Lille, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Melun Hospital, Clinical Research Unit, Melun, France Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University Hospital, Department of Internal Medicine, Tainan, Taiwan, Province of China National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan, Province of China National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan, Province of China National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan, Province of China National Cheng Kung University, Medical Device Innovation Center, Tainan, Taiwan, Province of China Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Hospital of Manises, Intensive Care Unit, Valencia, Spain Complejo Hospitalario de Ja√©n, Intensive Care Unit, Ja√©n, Spain R√©animation M√©dicale, H√¥pital de la Croix-Rousse, Lyon, France Hospital of Manises, Intensive Care Unit, Valencia, Spain IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France IMRB, INSERM 955, Cr√©teil, France H√¥pital de la Croix-Rousse, R√©animation M√©dicale, Lyon, France IMRB, INSERM 955, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France INSERM 955, Equipe 13, Cr√©teil, France Cyprus University of Technology, Department of Electrical Engineering, Computer Engineering and Informatics, Limassol, Cyprus Cyprus University of Technology, Department of Electrical Engineering, Computer Engineering and Informatics, Limassol, Cyprus Cyprus University of Technology, Department of Electrical Engineering, Computer Engineering and Informatics, Limassol, Cyprus Erasmus Medical Center, Intensive Care Adults, Rotterdam, Netherlands Cyprus University of Technology, Department of Electrical Engineering, Computer Engineering and Informatics, Limassol, Cyprus Cyprus University of Technology, Department of Electrical Engineering, Computer Engineering and Informatics, Limassol, Cyprus Okayama University Hospital, Department of Clinical Engineering, Okayama City, Japan Okayama University Hospital, Department of Clinical Engineering, Okayama City, Japan Okayama University Hospital, Advanced Emergency and Critical Care Center, Okayama City, Japan Okayama University Hospital, Advanced Emergency and Critical Care Center, Okayama City, Japan Kawasaki Medical School, Department of Acute Care & Primary Care Medicine, Kurashiki City, Japan Kawasaki Medical School, Department of Acute Care & Primary Care Medicine, Kurashiki City, Japan Kawasaki Medical School, Department of Acute Care & Primary Care Medicine, Kurashiki City, Japan Kawasaki Medical School, Department of Acute Care & Primary Care Medicine, Kurashiki City, Japan Kawasaki Medical School, Department of Acute Care & Primary Care Medicine, Kurashiki City, Japan Kawasaki Medical School, Department of Acute Care & Primary Care Medicine, Kurashiki City, Japan Kawasaki Medical School, Department of Acute Care & Primary Care Medicine, Kurashiki City, Japan Okayama University, Department of Medical Technology Graduate School of Health Sciences, Okayama City, Japan Fondazione IRCCS Policlinico S. Matteo, Anesthesia and Intensive Care, University of Pavia, Pavie, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy Radboudumc, Intensive Care, Nijmegen, Netherlands University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy University of Chieti, School of residency in Anesthesia, Intensive Care and Pain  Therapy, Chieti, Italy Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care Medicine, Beijing, China Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care Medicine, Beijing, China Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care Medicine, Beijing, China Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care Medicine, Beijing, China Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care Medicine, Beijing, China Beijing Tiantan Hospital, Capital Medical University, Department of Critical Care Medicine, Beijing, China University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Anesthesia,  Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Anesthesia,  Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Anesthesia,  Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Anesthesia,  Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Anesthesia,  Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Anesthesia,  Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Anesthesia,  Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Pulmonary and Critical Care, Sao Paulo, Brazil Hospital Sirio Libanes, Anesthesia, Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Radiology, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Pulmonary and Critical Care, Sao Paulo, Brazil Hospital Sirio Libanes, Anesthesia, Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Pulmonary and Critical Care, Sao Paulo, Brazil Okayama University Hospital, Department of Intensive Care, Okayama, Japan Hospital Sirio Libanes, Anesthesia, Critical Care and Pain, Sao Paulo, Brazil University of Sao Paulo, Faculty of Medicine, Hospital das Cl√≠nicas, Pulmonary and Critical Care, Sao Paulo, Brazil Okayama University Medical School, Department of Anesthesiology and Resuscitology, Okayama, Japan Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea Asan Medical Center, University of Ulsan College of Medicine, Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Seoul,  Republic of Korea University Hospital of Parma, Parma, Italy University Hospital of Parma, Parma, Italy University Hospital of Parma, Parma, Italy University Hospital of Parma, Parma, Italy University Hospital of Parma, Parma, Italy University Hospital of Parma, Parma, Italy University Hospital of Parma, Parma, Italy University Hospital of Parma, Parma, Italy E.O. Ospedali Galliera, Genoa, Italy E.O. Ospedali Galliera, Genoa, Italy Medical University of Vienna, Department of Anesthesiology, General Intensive Care and Pain Medicine, Vienna, Austria Medical University of Vienna, Department of Anesthesiology, General Intensive Care and Pain Medicine, Vienna, Austria E.O. Ospedali Galliera, Genoa, Italy E.O. Ospedali Galliera, Genoa, Italy E.O. Ospedali Galliera, Genoa, Italy E.O. Ospedali Galliera, Genoa, Italy E.O. Ospedali Galliera, Genoa, Italy Medical University of Vienna, Department of Surgery/Div. of General Surgery, Vienna, Austria Medical University of Vienna, Department of Surgery/Div. of General Surgery, Vienna, Austria Medical University of Vienna, Department of Surgery/Div. of General Surgery, Vienna, Austria Medical University of Vienna, Department of Surgery/Div. of General Surgery, Vienna, Austria Medical University of Vienna, Department of Cranio-, Maxillofacial and Oral Surgery, Vienna, Austria Medical University of Vienna, Department of Cranio-, Maxillofacial and Oral Surgery, Vienna, Austria Pirogov Russian National Research Medical University, Anesthesiology and Intensive Care Medicine, Moscow, Russian Federation Medical University of Vienna, Department of Cranio-, Maxillofacial and Oral Surgery, Vienna, Austria Medical University of Vienna, Department of Surgery/Div. of General Surgery, Vienna, Austria Medical University of Vienna, Department of Surgery/Div. of General Surgery, Vienna, Austria Medical University of Vienna, Department of Surgery/Div. of General Surgery, Vienna, Austria Yokohama City University Graduate school of Medicine, Department of Anesthesiology and Critical Care, Yokohama, Japan Yokohama City University Graduate school of Medicine, Department of Anesthesiology and Critical Care, Yokohama, Japan Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan CHU Antoine B√©cl√®re APHP, Intensive Care Unit, Clamart, France Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan CHU Antoine B√©cl√®re APHP, Intensive Care Unit, Clamart, France Yamato Municipal Hospital, Department of Anesthesia, Yamato, Japan CHU Antoine B√©cl√®re APHP, Department of Hematology, Clamart, France CHU Antoine B√©cl√®re APHP, Department of Hematology, Clamart, France University Hospitals Birmingham NHS Trust, Critical Care, Birmingham, UK CHU Antoine B√©cl√®re APHP, Department of Hematology, Clamart, France CHU Antoine B√©cl√®re APHP, Department of Hematology, Clamart, France University of Toronto, Toronto, Canada Royal College of Surgeons in Ireland, Dublin, Ireland Royal College of Surgeons in Ireland, Dublin, Ireland St Michael‚Äôs Hospital, Toronto, Canada Royal College of Surgeons in Ireland, Dublin, Ireland Odessa National Medical University, Anesthesiology and Intensive Care, Odessa, Ukraine Odessa National Medical University, Anesthesiology and Intensive Care, Odessa, Ukraine Odessa National Medical University, Odessa, Ukraine Odessa National Medical University, Odessa, Ukraine Odessa National Medical University, Odessa, Ukraine Hospital Virgen del Rocio, Sevilla, Spain Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK Royal Alexandra Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Hospital Universitario Pr√≠ncipe de Asturias, Intensive Care Unit, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Intensive Care Unit, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Hematology, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Madrid, Spain Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Madrid, Spain Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran University of Franche-Comt√©, Laboratory of Psychology EA 3188, Besan√ßon, France University of Franche-Comt√©, Laboratory of Psychology EA 3188, Besan√ßon, France University of Franche-Comt√©, Laboratory of Psychology EA 3188, Besan√ßon, France University of Franche-Comt√©, Laboratory of Psychology EA 3188, Besan√ßon, France University of Franche-Comt√©, Laboratory of Psychology EA 3188, Besan√ßon, France CR CHUM, Montreal, Canada CR CHUM, Montreal, Canada CHRU Minjoz, Besan√ßon, France CHRU Minjoz, Besan√ßon, France CHRU Minjoz, Besan√ßon, France Complejo Hospitalario de Granada, Granada, Spain Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Intensive Care Unit, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Jerez de la Frontera, Spain University Hospital Vall d‚ÄôHebron, Transplant Coordination, Barcelona, Spain Hospital del SAS de Jerez, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Jerez de la Frontera, Spain Hospital del SAS de Jerez, Jerez de la Frontera, Spain University Hospital Vall d‚ÄôHebron, Stroke Unit, Neurology, Barcelona, Spain University Hospital Vall d‚ÄôHebron, Barcelona, Spain St Elisabeth Twee Steden Hospital, Intensive Care Medicine, Tilburg, Netherlands University Hospital Vall d‚ÄôHebron, Barcelona, Spain St Elisabeth Twee Steden Hospital, Intensive Care Medicine, Tilburg, Netherlands St Elisabeth Twee Steden Hospital, Intensive Care Medicine, Tilburg, Netherlands University Hospital Vall d‚ÄôHebron, Stroke Unit, Neurology, Barcelona, Spain University Hospital Vall d‚ÄôHebron, Stroke Unit, Neurology, Barcelona, Spain The Dutch Transplant Foundation, Leiden, Netherlands Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Clinical Hospital Center Sestre Milosrdnice, Anaesthesiology and Intensive Care,  Zagreb, Croatia Hospital Universitario Virgen del Rocio, Coordinaci√≥n de Trasplantes, Seville, Spain Hospital Universitario Virgen del Rocio, Coordinaci√≥n de Trasplantes, Seville, Spain Hospital Universitario Virgen del Rocio, Coordinaci√≥n de Trasplantes, Seville, Spain Hospital Universitario Virgen del Rocio, Coordinaci√≥n de Trasplantes, Seville, Spain Hospital Universitario Virgen del Rocio, Coordinaci√≥n de Trasplantes, Seville, Spain Hospital Universitario Virgen del Rocio, Coordinaci√≥n de Trasplantes, Seville, Spain Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain Universit√© Paris Diderot, Sorbonne Paris Cit√©, INSERM UMR1160, Paris, France Hospital Universitario Juan XXII, Critical Care, Tarragona, Spain Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain Hospital Universitario Virgen del Rocio, Critical Care, Seville, Spain APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France APHP, Lariboisiere University Hospital, Surgical ICU, Paris, France Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Puerta de Hierro Hospital, Intensive Care Unit, Majadahonda, Spain Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Anaesthesiology, Pain and Intensive Care, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Regional University Hospital in M√°laga, Intensive Care Medicine, M√°laga, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hosiptal Son Ll√†tzer, Intensive Care Department, Palma de Mallorca, Spain Hospital Son Espases, Intensive Care Department, Palma de Mallorca, Spain Hospital de la Santa Creu i Sant Pau, Intensive Care Department, Barcelona, Spain Hospital Torrej√≥n de Ardoz, Intensive Care Department, Madrid, Spain Hospital Infanta Leonor, Intensive Care Department, Madrid, Spain Hospital de Sant Joan Desp√≠ Moiss√®s Broggi, Intensive Care Department, Sant Joan  Desp√≠, Spain Hospital Sant Joan de D√©u, Intensive Care Department, Reus, Spain APHM, CHU Nord, Medical ICU, Marseilles, France APHM, CHU Timone, Medical ICU, Marseilles, France Mayo Clinic, Pulmonary and Critical Care, Rochester, USA APHM, CHU Timone, Medical ICU, Marseilles, France APHM, CHU Timone, Medical ICU, Marseilles, France APHM, CHU Timone, Medical ICU, Marseilles, France APHM, CHU Timone, Medical ICU, Marseilles, France APHM, CHU Timone, Medical ICU, Marseilles, France Mayo Clinic, Pulmonary and Critical Care, Rochester, USA APHM, CHU Timone, Medical ICU, Marseilles, France Mayo Clinic, Center for the Science of Health Care Delivery, Rochester, USA Mayo Clinic, Mayo Foundation for Medical Education and Research, Rochester, USA Mayo Clinic, Center for the Science of Health Care Delivery, Rochester, USA Mayo Clinic, Anesthesia Clinical Research, Rochester, USA Mayo Clinic, Mayo Foundation for Medical Education and Research, Rochester, USA JA Hiroshima General Hospital, Pharmaceutical Department, Hatsukaiti-shi, Hiroshima Japan Mayo Clinic, Center for the Science of Health Care Delivery, Rochester, USA JA Hiroshima General Hospital, Division of Emergency and Critical Care Medicine,  Hatsukaiti-shi, Hiroshima Japan Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Hokkaido Japan Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Hokkaido Japan Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Hokkaido Japan Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Hokkaido Japan Hokkaido University Hospital, Emergency and Critical Care Center, Sapporo, Hokkaido Japan JA Hiroshima General Hospital, Division of Emergency and Critical Care Medicine,  Hatsukaiti-shi, Hiroshima Japan Chang Gung Memorial Hospital, Linkou, Taoyuan City, Taiwan, Province of China Queen‚Äôs University, Critical Care Medicine, Kingston, Canada Queen‚Äôs University, Critical Care Medicine, Kingston, Canada Queen‚Äôs University, Critical Care Medicine, Kingston, Canada Queen‚Äôs University, Critical Care Medicine, Kingston, Canada Queen‚Äôs University, Critical Care Medicine, Kingston, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada Hospital Municipal Moyses Deutsch, ICU, S√£o Paulo, Brazil University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada University of Western Ontario, Critical Care Medicine, London, Canada Hospital Municipal Moyses Deutsch, Quality Sector, S√£o Paulo, Brazil Hospital Municipal Moyses Deutsch, Quality Sector, S√£o Paulo, Brazil Hospital Municipal Moyses Deutsch, Quality Sector, S√£o Paulo, Brazil Hospital Municipal Moyses Deutsch, Quality Sector, S√£o Paulo, Brazil Hospital Municipal Moyses Deutsch, Quality Sector, S√£o Paulo, Brazil Hospital Municipal Moyses Deutsch, Quality Sector, S√£o Paulo, Brazil Hospital Municipal Moyses Deutsch, Quality Sector, S√£o Paulo, Brazil KCMH, Nursing Department, Bangkok, Thailand Universit√© Pierre et Marie Curie, UMR_S 1158 and H√¥pital Piti√©-Salp√™tri√®re, Respiratory Division and Medical ICU, Paris, France Universit√© Pierre et Marie Curie, UMR_S 1158 and H√¥pital Piti√©-Salp√™tri√®re, Respiratory Division and Medical ICU, Paris, France Universit√© Pierre et Marie Curie, UMR_S 1158 and H√¥pital Piti√©-Salp√™tri√®re, Respiratory Division and Medical ICU, Paris, France Universit√© Pierre et Marie Curie, UMR_S 1158 and H√¥pital Piti√©-Salp√™tri√®re, Respiratory Division and Medical ICU, Paris, France H√¥pital Dupuytren, Limoges, France H√¥pital Dupuytren, Limoges, France H√¥pital Dupuytren, Limoges, France CHU de Clermont-Ferrand and Universit√© d‚ÄôAuvergne, Clermont-Ferrand, France Universit√© Grenoble-Alpes and CHU Grenoble Alpes, Grenoble, France CHU d‚ÄôAngers, Angers, France Hospital Dr. N√©lio Mendon√ßa, Servi√ßo de Medicina Intensiva, Funchal, Portugal H√¥pital Dupuytren, Limoges, France H√¥pital Dupuytren, Limoges, France Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chia Nan University of Pharmacy and Science, Recreation and Health-Care Management, Tainan, Taiwan, Province of China Chi-Mei Medical Center, Intensive Care Medicine, Tainan, Taiwan, Province of China Chi Mei Medical Center, Internal Medicine, Tainan, Taiwan, Province of China Chi-Mei Medical Center, Tainan, Taiwan, Province of China Chi-Mei Medical Center, Intensive Care Medicine, Tainan, Taiwan, Province of China Yonsei University Wonju College of Medicine, Emergency Medicine, Wonju, Republic  of Korea Tokushima University Graduate School, Critical Care and Emergency Medicine, Tokushima, Japan Yonsei University Wonju College of Medicine, Emergency Medicine, Wonju, Republic  of Korea Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan Uzbekistan Research Center of Emergency Medicine, Tashkent, Uzbekistan Takarazuka City Hospital, Intensive Care Unit, Takarazuka, Japan Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan Guglielmo da Saliceto Hospital, Intermediate Care Unit, Piacenza, Italy Guglielmo da Saliceto Hospital, Intermediate Care Unit, Piacenza, Italy Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan Tashkent Institute of Postgraduate Medical Education, Tashkent, Uzbekistan Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy Stellenbosch University, Stellenbsoch, South Africa Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy Guglielmo da Saliceto Hospital, Local Health Care Unit, Piacenza, Italy University of the Western Cape, Cape Town, South Africa University of the Western Cape, Cape Town, South Africa Hospital Municipal Moyses Deutsch, ICU, Sao Paulo, Brazil St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK Hospital Municipal Moyses Deutsch, ICU, S√£o Paulo, Brazil Hospital Municipal Moyses Deutsch, ICU, S√£o Paulo, Brazil Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Critical Care Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Anesthesiology, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Republic of Korea Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital S√≠rio-Liban√™s, Intensive Care Unit, S√£o Paulo, Brazil Hospital Geral do Grajau, Intensive Care Unit, Sao Paulo, Brazil Hospital S√≠rio Libanes, Intensive Care Unit, S√£o Paulo, Brazil Akdeniz University, Antalya, Turkey Ribeir√£o Preto Medical School, University of S√£o Paulo, Division of Intensive Care, Department of Surgery and Anatomy, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Division of Intensive Care, Department of Surgery and Anatomy, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Division of Intensive Care, Department of Surgery and Anatomy, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Division of Intensive Care, Department of Surgery and Anatomy, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Division of Intensive Care, Department of Surgery and Anatomy, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Division of Intensive Care, Department of Surgery and Anatomy, Ribeir√£o Preto, Brazil Intensive Care Unit of S√£o Francisco Hospital, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Social Medicine Department, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Social Medicine Department, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Social Medicine Department, Ribeir√£o Preto, Brazil Ribeir√£o Preto Medical School, University of S√£o Paulo, Social Medicine Department, Ribeir√£o Preto, Brazil Chi Mei Medical Center, Intensive Care Medicine, Tainan, Taiwan, Province of China Ribeir√£o Preto Medical School, University of S√£o Paulo, Social Medicine Department, Ribeir√£o Preto, Brazil Intensive Care Unit of S√£o Francisco Hospital, Ribeir√£o Preto, Brazil Carnegie Mellon University, Robotics Institute, Pittsburgh, USA Carnegie Mellon University, Robotics Institute, Pittsburgh, USA University of Pittsburgh, School of Nursing, Pittsburgh, USA University of Pittsburgh, Department of Critical Care Medicine, School of Medicine, Pittsburgh, USA Hospital Universitario Pr√≠ncipe de Asturias, Alcal√° de Henares, Madrid Spain Hospital Universitario Pr√≠ncipe de Asturias, Alcal√° de Henares, Madrid Spain University of Pittsburgh, School of Nursing, Pittsburgh, USA Cairo University, Critical Care Medicine, Cairo, Egypt Cairo University, Critical Care Medicine, Cairo, Egypt Cairo University, Critical Care Medicine, Cairo, Egypt Cairo University, Critical Care Medicine, Cairo, Egypt Cairo University, Critical Care Medicine, Cairo, Egypt Cairo University, Critical Care Medicine, Cairo, Egypt Cairo University, Critical Care Medicine, Cairo, Egypt Cairo University, Critical Care Medicine, Cairo, Egypt Clinique du Mill√©naire, H√©rault, Montpellier, France Clinique du Mill√©naire, H√©rault, Montpellier, France Clinique du Mill√©naire, H√©rault, Montpellier, France Clinique du Mill√©naire, H√©rault, Montpellier, France Clinique du Mill√©naire, Montpellier, France CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France CHU Grenoble, Anesthesiology and Intensive Care, Grenoble, France CHU Grenoble, Cardiac Surgery, Grenoble, France CHU Grenoble, Cardiac Surgery, Grenoble, France CHU Grenoble, Cardiac Surgery, Grenoble, France CHU Grenoble, Cardiac Surgery, Grenoble, France CHU Grenoble, Cardiac Surgery, Grenoble, France Erasme University Hospital, Universit√© Libre de Bruxelles, Department of Intensive Care, Brussels, Belgium IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy University of Milan, Milan, Italy University of Milan, Milan, Italy University of Milan, Milan, Italy Istituto Zooprofilattico Sperimentale della Lombardia e dell‚ÄôEmilia, Lodi, Italy Istituto Zooprofilattico Sperimentale della Lombardia e dell‚ÄôEmilia, Lodi, Italy University of Milan, Milan, Italy University of Milan, Milan, Italy University of Milan, Milan, Italy Sacco Hospital, Milan, Italy Sacco Hospital, Milan, Italy VHS Medical Center, Emergency Medicine, Seoul, Republic of Korea Istituto Zooprofilattico Sperimentale della Lombardia e dell‚ÄôEmilia, Lodi, Italy University of Milan, Milan, Italy University of Milan, Milan, Italy Istituto Zooprofilattico Sperimentale della Lombardia e dell‚ÄôEmilia, Lodi, Italy Istituto Zooprofilattico Sperimentale della Lombardia e dell‚ÄôEmilia, Lodi, Italy Istituto Zooprofilattico Sperimentale della Lombardia e dell‚ÄôEmilia, Lodi, Italy University of Milan, Milan, Italy University of Milan, Milan, Italy Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy IRCCS - Istituto di Ricerche Farmacologiche ‚ÄúMario Negri‚Ä?, Milan, Italy Texas Children‚Äôs Hospital, Clinical Nutriiton, Houston, USA Kuopio University Hospital, Kuopio, Finland Kuopio University Hospital, Kuopio, Finland Kuopio University Hospital, Kuopio, Finland University of Milan, Milan, Italy North Karelia Central Hospital, Karelia, Finland Kuopio University Hospital, Kuopio, Finland Kuopio University Hospital, Kuopio, Finland Kuopio University Hospital, Kuopio, Finland North Karelia Central Hospital, Karelia, Finland Helsinki University Hospital, Helsinki, Finland Technische Universit√§t M√ºnchen, Klinik f√ºr Anaesthesiologie, Munich, Germany Cardinal Massaia Hospital, Anesthesia and Intensive Care Unit, Asti, Italy Cardinal Massaia Hospital, Anesthesia and Intensive Care Unit, Asti, Italy Cardinal Massaia Hospital, Anesthesia and Intensive Care Unit, Asti, Italy ULB Universit√© Libre de Bruxelles, Department of Intensive Care, Erasme University Hospital, Bruxelles, Belgium ULB Universit√© Libre de Bruxelles, Department of Intensive Care, Erasme University Hospital, Bruxelles, Belgium ULB Universit√© Libre de Bruxelles, Department of Intensive Care, Erasme University Hospital, Bruxelles, Belgium Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University Hospital, Emergency Medicine, Seoul, Republic of Korea Seoul National University, Neurology, Seoul, Republic of Korea Seoul National University, Neurology, Seoul, Republic of Korea Seoul National University, Neurology, Seoul, Republic of Korea Seoul National University, Neurology, Seoul, Republic of Korea Erasme Hospital, Brussels, Belgium Seoul National University, Neurology, Seoul, Republic of Korea Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri Lanka Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri Lanka Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri Lanka Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri Lanka Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri Lanka Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri Lanka Network for Improving Critical Care Systems and Training (NICST), Colombo, Sri Lanka National Intensive Care Surveillance, Quality Secretariat Building, Castle Street Hospital for Women, Colombo, Sri Lanka National Intensive Care Surveillance, Quality Secretariat Building, Castle Street Hospital for Women, Colombo, Sri Lanka National Intensive Care Surveillance, Quality Secretariat Building, Castle Street Hospital for Women, Colombo, Sri Lanka National Intensive Care Surveillance, Quality Secretariat Building, Castle Street Hospital for Women, Colombo, Sri Lanka National Intensive Care Surveillance, Quality Secretariat Building, Castle Street Hospital for Women, Colombo, Sri Lanka Royal London Hospital, Barts Health, Adult Critical Care Unit, London, UK Royal London Hospital, Barts Health, Adult Critical Care Unit, London, UK Lady Ridgeway Hospital for Children, Colombo, Sri Lanka Royal London Hospital, Barts Health, Adult Critical Care Unit, London, UK University Medical Centre G√∂ttingen, Department for Anaesthesiology, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Anaesthesiology, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Anaesthesiology, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Anaesthesiology, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany Sunnybrook Health Sciences Centre, Critical Care, Toronto, Canada University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany University Medical Centre G√∂ttingen, Department for Oral and Maxillofacial Surgery, G√∂ttingen, Germany Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical Care Medicine, Yokohama, Japan Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical Care Medicine, Yokohama, Japan Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical Care Medicine, Yokohama, Japan Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical Care Medicine, Yokohama, Japan Yokohama City Minato Red Cross Hospital, Department of Emergency and Critical Care Medicine, Yokohama, Japan Tokyo Medical and Dental University, Health Policy and Informatics Section, Department of Health Policy, Tokyo, Japan Tokyo Medical and Dental University, Health Policy and Informatics Section, Department of Health Policy, Tokyo, Japan Center for Cancer Control and Information Services, Division of Health Services Research, Tokyo, Japan National Center for Child Health and Development, Department of Critical Care, Tokyo, Japan Intermed Hospital, Intensive Care Department, Ulaanbaatar, Mongolia Health Sciences University of Mongolia, Division of Emergency Medicine and Anaesthesia, Ulaanbaatar, Mongolia Health Sciences University of Mongolia, Division of Emergency Medicine and Anaesthesia, Ulaanbaatar, Mongolia University Hospital Salzburg and Paracelsus Private Medical University, Department of Anesthesiology, Perioperative and General Intensive Care Medicine,  Salzburg, Austria Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Rush University Medical Center, Chicago, USA Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Department of Economy. University of Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Giannitsa General Hospital, Intensive Care Unit, Giannitsa, Greece G. Papanikolaou Hospital, A‚Äô Intensive Care Unit, Thessaloniki, Greece G. Papanikolaou Hospital, A‚Äô Intensive Care Unit, Thessaloniki, Greece G. Papanikolaou Hospital, A‚Äô Intensive Care Unit, Thessaloniki, Greece Heart of England NHS Foundation Trust, Birmingham, UK G. Papanikolaou Hospital, A‚Äô Intensive Care Unit, Thessaloniki, Greece Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Unit, Glasgow, UK Golden Jubilee National Hospital, Department of Anaesthesia, Clydebank, UK Centro Hospitalar de S.Jo√£o, Porto, Portugal University of Porto, Porto, Portugal Centro Hospitalar de S√£o Jo√£o/University of Porto, Porto, Portugal University of Porto, Porto, Portugal Tuen Mun Hospital, Anaesthesia & Intensive Care, Hong Kong, Hong Kong, China Pamela Youde Nethersole Eastern Hospital, Intensive Care, Hong Kong, Hong Kong China Shiraz University of Medical Sciences, Shiraz, Iran, Shiraz Anesthesiology and Critical Care Research Center, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Iran, Shiraz Anesthesiology and Critical Care Research Center, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz Anesthesiology and Critical Care Research Center, Shiraz, Islamic Republic of Iran Department of Epidemiology, School of Public Health - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz Anesthesiology and Critical Care Research Center, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz Anesthesiology and Critical Care Research Center, Shiraz, Islamic Republic of Iran Student Research Committee - Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran AIIMS Bhopal, Department of Trauma & Emergency, Bhopal, India AIIMS Bhopal, Community and Family Medicine, Bhopal, India AIIMS Bhopal, Medicine, Bhopal, India Apollo Hospitals, Critical Care Unit, Bhubaneswar, India Apollo Hospitals, Bhubaneswar, India University Hospital of Li√®ge, General Intensive Care Unit and Burn Centre, Li√®ge, Belgium University of Li√®ge, Li√®ge, Belgium University Hospital of Li√®ge, Clinical Chemistry Department, Li√®ge, Belgium University Hospital of Li√®ge, Clinical Chemistry Department, Li√®ge, Belgium University of Li√®ge, Department of Public Health, Epidemiology and Health Economics, Li√®ge, Belgium Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China University of Li√®ge, Li√®ge, Belgium Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China ZNA Middelheim General Hospital, Department of Anaesthesiology, Antwerp, Belgium University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium ZNA Middelheim General Hospital, Department of Cardiac Surgery, Antwerp, Belgium Hospital 12 de Octubre, Cardiac Intensive Care Unit, Critical Care Department, Madrid, Spain University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium University of Antwerp, Department of Pharmaceutic Sciences, Antwerp, Belgium Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Fooyin University, Department of Physical Therapy, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China Sir Run Run Shaw Hospital, Intensive Care Medicine, Hanghzou, China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Pusan National University Yangsan Hospital, Anesthesia and Pain Medicine, Yangsan-si, Republic of Korea Korea University Anam Hospital, Anaesthesiology and Pain Medicine, Seoul, Republic of Korea Hospital Puerta del Mar, Cadiz, Spain Hospital Regional, Intensive Care, Malaga, Spain Hospital Serrania, Ronda, Spain Hospital Regional, Intensive Care, M√°laga, Spain Hospital Infanta Margarita, Intensive Care, Cabra, Spain Hospital Virgen del Rocio, Intensive Care, Sevilla, Spain Hospital Virgen de las Nieves, Intensive Care, Granada, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Hospital Virgen de las Nieves, Intensive Care, Granada, Spain Hospital Serrania, Ronda, Spain Hospital Regional, Intensive Care, M√°laga, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 1, Oviedo, Spain Hospital Universitario Central de Asturias, ICU 3, Oviedo, Spain Hospital Universitario Central de Asturias, Oviedo, Spain Complejo Hospitalario de Navarra, Intensive Care Medicine, Pamplona, Spain Hospital Universitario Central de Asturias, ICU 3, Oviedo, Spain ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy ASST Sacco Fatebenefratelli, Milano, Italy Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Critical Care Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Cardiovascular Division, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung City, Taiwan, Province of China University Hospital of Pisa, Department of Anaesthesia and Critical Care Medicine, Cardiothoracic and Vascular Anaesthesia, Pisa, Italy Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung City, Taiwan, Province of China Kaohsiung Veterans General Hospital, Department of Medical Education and Research, Kaohsiung City, Taiwan, Province of China University of Pisa, Scuola di Specializzazione in Malattie del l‚ÄôApparato Cardiovascolare, Pisa, Italy University Hospital of Pisa, Department of Anaesthesia and Critical Care Medicine, Cardiothoracic and Vascular Anaesthesia, Pisa, Italy University of Pisa, Scuola di Specializzazione in Malattie del l‚ÄôApparato Cardiovascolare, Pisa, Italy OLVG Hospital, Department of Intensive Care, Amsterdam, Netherlands OLVG Hospital, Department of Intensive Care, Amsterdam, Netherlands OLVG Hospital, Department of Intensive Care, Amsterdam, Netherlands Tilburg University; TIAS School for Business and Society, Tilburg, Netherlands Tilburg University; TIAS School for Business and Society, Tilburg, Netherlands Tokushima University Graduate School, Emergency and Critical Care Medicine, Tokushima, Japan Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India Tokushima University Graduate School, Emergency and Critical Care Medicine, Tokushima, Japan Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India Fortis Escorts Hospital, Critical Care Medicine, Faridabad, India Fortis Escorts Hospital, Microbiology, Faridabad, India Niguarda Ca Granda Hospital, Anesthesia CCM 2, Milan, Italy Niguarda Ca Granda Hospital, Milan, Italy National Scientific Medical Research Center, Clinical Microbiology, Astana, Kazakhstan National Scientific Medical Research Center, Clinical Microbiology, Astana, Kazakhstan National Scientific Medical Research Center, Clinical Microbiology, Astana, Kazakhstan Ankara University Faculty of Medicine, Department of Internal Medicine Division of Intensive Care, Ankara, Turkey Ankara University Faculty of Medicine, Department of Internal Medicine Division of Intensive Care, Ankara, Turkey Ankara University Faculty of Medicine, Clinical Microbiology and Infection Disease, Ankara, Turkey Woodlands Multispeciality Hospital, Clinical Microbiology Dept, Kolkata, India Ankara University Faculty of Medicine, Clinical Microbiology and Infection Disease, Ankara, Turkey Woodlands Multispeciality Hospital, Clinical Microbiology Dept, Kolkata, India Ankara University Faculty of Medicine, Clinical Microbiology and Infection Disease, Ankara, Turkey Woodlands Multispeciality Hospital, Nephrology Dept, Kolkata, India Cure Clinic Nursing Home, Kolkata, India HU Arnau de Vilanova, Lleida, Spain IRBLL, Lleida, Spain IRBLL, Lleida, Spain IRBLL, Lleida, Spain Hospital Universitario de Fuenlabrada, Intensive Care Unit, Madrid, Spain IRBLL, Lleida, Spain IRBLL, Lleida, Spain IRBLL, Lleida, Spain IRBLL, Lleida, Spain Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, ICU, Rio de Janeiro, Brazil Universidade Federal do Rio de Janeiro, Infectious Diseases, Rio de Janeiro, Brazil Hospital Universitario Arnau de Vilanova, Lleida, Spain Universidade Federal do Rio de Janeiro, Infectious Diseases, Rio de Janeiro, Brazil Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Anesthesiology and Reanimation, Ankara, Turkey Yildirim Beyazit University, Biostatistics and Medical Informatics, Ankara, Turkey Yildirim Beyazit University, Biostatistics and Medical Informatics, Ankara, Turkey Yildirim Beyazit University, Biostatistics and Medical Informatics, Ankara, Turkey Yildirim Beyazit University, Infectious Diseases and Microbiology, Ankara, Turkey University Hospital of Gran Canaria Dr. Negr√≠n, Intensive Care Unit, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain University Hospital of Gran Canaria Dr. Negr√≠n, Microbiology Department, Las Palmas de Gran Canaria, Spain Hospital of Getafe, Intensive Care Unit, Madrid, Spain University of Las Palmas de Gran Canaria, Mathematics and Informatcs Deparment, Las Palmas de Gran Canaria, Spain Intensive Care Unit, Ambroise Par√© University Hospital, Assistance Publique, H√¥pitaux de Paris, Boulogne-Billancourt, France University Hospital of Gran Canaria Dr. Negr√≠n, Pharmacy Department, Las Palmas de Gran Canaria, Spain Infection control Unit, Ambroise Par√© University Hospital, Assistance Publique, H√¥pitaux de Paris, Boulogne-Billancourt, France Infection control Unit, Ambroise Par√© University Hospital, Assistance Publique, H√¥pitaux de Paris, Boulogne-Billancourt, France Infection control Unit, Ambroise Par√© University Hospital, Assistance Publique, H√¥pitaux de Paris, Boulogne-Billancourt, France Infectious Diseases Unit, Ambroise Par√© University Hospital, Assistance Publique, H√¥pitaux de Paris, Boulogne-Billancourt, France Microbiology Unit, Section Biology Pathology and Health Products, Ambroise Par√© University Hospital, Assistance Publique, H√¥pitaux de Paris, Boulogne-Billancourt, France Intensive Care Unit, Ambroise Par√© University Hospital, Assistance publique, H√¥pitaux de Paris, Boulogne-Billancourt, France Intensive Care Unit, Ambroise Par√© University Hospital, Assistance Publique - H√¥pitaux de Paris, Boulogne-Billancourt, France Rescu, Li Ka Shing Institute at St Michael‚Äòs Hospital, Toronto, Canada University of Versailles Saint-Quentin en Yvelines, Faculty of Medicine Paris Ile-de-France Ouest, Saint-Quentin en Yvelines, France H√¥pital de Bic√™tre, H√¥pitaux universitaires Paris-Sud, Universit√© Paris-Sud, Service de r√©animation m√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux universitaires Paris-Sud, Universit√© Paris-Sud, Service de r√©animation m√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux universitaires Paris-Sud, Universit√© Paris-Sud, Service de r√©animation m√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux universitaires Paris-Sud, Universit√© Paris-Sud, Service de r√©animation m√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux universitaires Paris-Sud, Universit√© Paris-Sud, Service de r√©animation m√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux universitaires Paris-Sud, Universit√© Paris-Sud, Service de r√©animation m√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital Ambroise Par√©, H√¥pitaux universitaires Paris-Ile-de-France-Ouest, Universit√© de Versailles Saint Quentin en Yvelines, Service de r√©animation polyvalente, Boulogne-Billancourt, France H√¥pital Ambroise Par√©, H√¥pitaux universitaires Paris-Ile-de-France-Ouest, Universit√© de Versailles Saint Quentin en Yvelines, Service de r√©animation polyvalente, Boulogne-Billancourt, France H√¥pital Ambroise Par√©, H√¥pitaux universitaires Paris-Ile-de-France-Ouest, Universit√© de Versailles Saint Quentin en Yvelines, Service de r√©animation polyvalente, Boulogne-Billancourt, France Centre hospitalier de Sens, Service de r√©animation polyvalente, Sens, France CHU Tenon, APHP, Medical and Surgical ICU, Paris, France H√¥pital Ambroise Par√©, H√¥pitaux universitaires Paris-Ile-de-France-Ouest, Universit√© de Versailles Saint Quentin en Yvelines, Service de r√©animation polyvalente, Boulogne-Billancourt, France H√¥pital Ambroise Par√©, H√¥pitaux universitaires Paris-Ile-de-France-Ouest, Universit√© de Versailles Saint Quentin en Yvelines, Service de r√©animation polyvalente, Boulogne-Billancourt, France University of Toronto, Interdepartmental Division of Critical Care, Toronto, Canada Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France University Hospital of Lausanne, Intensive Care and Burn Unit, Lausanne, Switzerland CHU d‚ÄôAmiens, Cardiothoracic and Vascular ICU, Amiens, France Universit√© Jules Verne, Picardie, INSERM U1088 - CURS, Amiens, France Hospital Le Mans, Intensive Care Unit, Le Mans, France CHR d‚ÄôOrleans, Medical ICU, Orleans, France CHU Grenoble Alpes, Medical ICU, Grenoble, France Universit√© Grenoble-Alpes, Inserm U1042, Grenoble, France Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France Rouen University Hospital, Surgical Intensive Care, Rouen, France CHU de Poitiers, Medical ICU, Poitiers, France Universit√© de Poitiers, INSERM, CIC- 1402, √âquipe 5 ALIVE, Poitiers, France CHU d‚ÄôAngers, Clinical Research Institute, Angers, France Hospital de Sant Pau, Servei de Medicina Intensiva, Barcelona, Spain CHU d‚ÄôAngers, Medical ICU, Angers, France Annecy Genevois General Hospital, Annecy, France Saint Michael‚Äôs Hospital and Keenan Research Centre, Interdepartmental Division of Critical Care, Toronto, Canada Rƒ´ga Stradi≈Ü≈° University, Faculty of Continuing Education, Residency Section, Riga, Latvia Rƒ´ga Stradi≈Ü≈° University, Department of Anaesthesiology & Intensive Care, Riga, Latvia Pauls Stradins Clinical University Hospital, Department of Intensive Care, Riga,  Latvia Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, Medical Intensive Care, Rouen, France Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France University of Toronto, Interdepartmental Division of Critical Care, Toronto, Canada University Hospital of Lausanne, Intensive Care and Burn Unit, Lausanne, Switzerland CHU d‚ÄôAmiens, Cardiothoracic and Vascular ICU, Amiens, France Universit√© Jules Verne, Picardie, INSERM U1088 - CURS, Amiens, France Hospital Le Mans, Intensive Care Unit, Le Mans, France CHR d‚ÄôOrleans, Medical ICU, Orleans, France CHU Grenoble Alpes, Medical ICU, Grenoble, France Universit√© Grenoble-Alpes, Inserm U1042, Grenoble, France Rouen University Hospital, UPRES EA3830 IRIB, Rouen, France Rouen University Hospital, Surgical Intensive Care, Rouen, France CHU de Poitiers, Medical ICU, Poitiers, France Universit√© de Poitiers, INSERM, CIC- 1402, √âquipe 5 ALIVE, Poitiers, France CHU d‚ÄôAngers, Clinical Research Institute, Angers, France Hospital de Sant Pau, Servei de Medicina Intensiva, Barcelona, Spain CHU d‚ÄôAngers, Medical ICU, Angers, France Annecy Genevois General Hospital, Annecy, France Saint Michael‚Äôs Hospital and Keenan Research Centre, Interdepartmental Division of Critical Care, Toronto, Canada University of Crete, School of Medicine, Intensive Care, Heraklio, Crete Greece University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece General Hospital of Larissa, Intensive Care, Larissa, Greece General Hospital of Larissa, Intensive Care, Larissa, Greece General Hospital of Larissa, Intensive Care, Larissa, Greece University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece Asklepios Schlossberg Klinik, Early Neurological Rehabilitation, Bad K√∂nig, Germany Asklepios Schlossberg Klinik, Early Neurological Rehabilitation, Bad K√∂nig, Germany University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece University Hospital of Heraklio, Intensive Care, Heraklio, Crete Greece University Heidelberg, Anaesthesiology and Intensiv Care Medicine, Heppenheim, Germany Fondazione IRCCS Policlinico S. Matteo, Anesthesia and Intensive Care, University of Pavia, Pavie, Italy Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Quir√≥n de M√°laga, Intensive Care Unit, M√°laga, Spain Hospital Universitario Reina Sof√≠a, Intensive Care Unit, C√≥rdoba, Spain Hospital de Manises, Valencia, Spain Complejo Hospitalario de Ja√©n, Ja√©n, Spain University of Ferrara/Intensive Care Unit, Morphology, Surgery and Experimental Medicine, Ferrara, Italy Hospital de Manises, Valencia, Spain Aalborg University, Respiratory and Critical Care group (rcare) Center for Model-based Medical Decision Support (MMDS) Department of Health Science and Technology, Aalborg, Denmark University of Milan, Department of Anesthesia, Critical Care and Emergency Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Aalborg University, Respiratory and Critical Care group (rcare) Center for Model-based Medical Decision Support (MMDS) Department of Health Science and Technology, Aalborg, Denmark Aalborg University, Respiratory and Critical Care group (rcare) Center for Model-based Medical Decision Support (MMDS) Department of Health Science and Technology, Aalborg, Denmark Aalborg University, Respiratory and Critical Care group (rcare) Center for Model-based Medical Decision Support (MMDS) Department of Health Science and Technology, Aalborg, Denmark Peoples‚Äô Friendship University of Russia, Anesthesiology & Intensive Care, Moscow, Russian Federation Aalborg University, Respiratory and Critical Care group (rcare) Center for Model-based Medical Decision Support (MMDS) Department of Health Science and Technology, Aalborg, Denmark University of Milan, Department of Anesthesia, Critical Care and Emergency Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Hospices Civils de Lyon, H√¥pital de la Croix Rousse, Service de Reanimation M√©dicale, Lyon, France Hospices Civils de Lyon, H√¥pital de la Croix Rousse, Service de Reanimation M√©dicale, Lyon, France Hospices Civils de Lyon, H√¥pital de la Croix Rousse, Service de Reanimation M√©dicale, Lyon, France Hospices Civils de Lyon, H√¥pital de la Croix Rousse, Service de Reanimation M√©dicale, Lyon, France Hospices Civils de Lyon, H√¥pital de la Croix Rousse, Service de Reanimation M√©dicale, Lyon, France Hospices Civils de Lyon, H√¥pital de la Croix Rousse, Service de Reanimation M√©dicale, Lyon, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France Universit√© de Lyon, Universit√© Claude Bernard Lyon 1, Villeurbanne, France University of Helsinki and Helsinki University Hospital, Helsinki, Finland University of Helsinki and Helsinki University Hospital, Helsinki, Finland University of Helsinki and Helsinki University Hospital, Helsinki, Finland Lapland Central Hospital, Rovaniemi, Finland Lapland Central Hospital, Rovaniemi, Finland Lapland Central Hospital, Rovaniemi, Finland West China Hospital, Sichuan University, Department of Critical Care Medicine, Chengdu, China Lapland Central Hospital, Rovaniemi, Finland Lapland Central Hospital, Rovaniemi, Finland Lapland Central Hospital, Rovaniemi, Finland Kobe University Hospital, Anesthesiology, Kobe, Japan Kobe University Hospital, Anesthesiology, Kobe, Japan Kobe University Hospital, Anesthesiology, Kobe, Japan Kobe University Hospital, Anesthesiology, Kobe, Japan Alexandria University, Critical Care Medicine, Alexandria, Egypt Alexandria University, Critical Care Medicine, Alexandria, Egypt Alexandria University, Critical Care Medicine, Alexandria, Egypt Alexandria University, Internal Medicine-Nephrology Unit, Alexandria, Egypt Alexandria University, Clinical and Chemical Pathology, Alexandria, Egypt Centro Hospitalar Lisboa Norte, Nephrology and Renal Transplantation, Lisbon, Portugal Alexandria University, Internal Medicine-Nephrology Unit, Alexandria, Egypt Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK Centro Hospitalar Lisboa Norte, Intensive Care Medicine, Lisbon, Portugal University of Surrey, Guildford, UK University of Surrey, Guildford, UK University of Surrey, Guildford, UK University of Surrey, Guildford, UK Aomori Jekeikai Hospiyal, Clinical Engineer, Aomori, Japan Aomori Jekeikai Hospiyal, Clinical Engineer, Aomori, Japan University of Semmelweis, Budapest, Hungary University of Surrey, Guildford, UK University of Surrey, Guildford, UK Clinica Universidad de Navarra, Anesthesia and Critical Care Unit, Pamplona, Spain Clinica Universidad de Navarra, Nephrology, Pamplona, Spain Clinica Universidad de Navarra, Nephrology, Pamplona, Spain Clinica Universidad de Navarra, Nephrology, Pamplona, Spain Clinica Universidad de Navarra, Nephrology, Pamplona, Spain Uppsala University, Surgical Sciencies, Uppsala, Sweden Clinica Universidad de Navarra, Nephrology, Pamplona, Spain Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne, Switzerland Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne, Switzerland Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne, Switzerland Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne, Switzerland Centre Hospitalier Universitaire Vaudois, Anaesthesiology Department, Lausanne, Switzerland Centre Hospitalier Universitaire Vaudois, Anaesthesiology Department, Lausanne, Switzerland Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne, Switzerland Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne, Switzerland Royal Brompton and Harefield NHS Foundation Trust, London, UK Centre Hospitalier Universitaire Vaudois, Adult Intensive Care Unit, Lausanne, Switzerland Barts Health NHS Trust, Adult Critical Care, London, UK Barts Health NHS Trust, Adult Critical Care, London, UK Barts Health NHS Trust, Adult Critical Care, London, UK Barts Health NHS Trust, Adult Critical Care, London, UK Barts Health NHS Trust, Adult Critical Care, London, UK Barts Health NHS Trust, Adult Critical Care, London, UK Nikisso Medical, London, UK Nikisso Medical, London, UK Nikisso Medical, London, UK Hospital Universitario San Ignacio, Internal Medicine, Nephrology, Bogota, Colombia Nikisso Medical, London, UK Nikisso Medical, London, UK Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia Pontificia Universidad Javeriana, Internal Medicine, Bogota, Colombia Hospital Militar Central, Nephrology, Bogota, Colombia Hospital Militar Central, Nephrology, Bogota, Colombia Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia Pontificia Universidad Javeriana, Nefrology, Bogota, Colombia},
note  = {Intensive Care Med Exp. 2016 Sep 29;4(Suppl 1):. doi:10.1186/s40635-016-0100-7.}
}

@Article{20152,
author  = {},
title  = {Poster Session II Tuesday, December 8, 2015.},
journal  = {Neuropsychopharmacology},
volume  = {40},
number  = {Suppl 1},
pages  = {S272-442},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1038/npp.2015.326.}
}

@Article{20153,
author  = {},
title  = {Poster Session I Monday, December 7, 2015.},
journal  = {Neuropsychopharmacology},
volume  = {40},
number  = {Suppl 1},
pages  = {S106-271},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1038/npp.2015.325.}
}

@Article{4,
author  = {Proulx, M. and Gwinnutt, J. and Dell‚ÄôErba, S. and Levy-Tzedek, S. and de, S. and Brown, D.},
title  = {‚Äúvisual‚Ä?¬†control of action with sensory¬†substitution.},
journal  = {Restorative Neurology and Neuroscience},
volume  = {34},
number  = {1},
pages  = {29-44},
year  = {},
abstract  = {Vision is the dominant sense for perception-for-action in humans and other higher primates. Advances in sight restoration now utilize the other intact senses to provide information that is normally sensed visually through sensory substitution to replace missing visual information. Sensory substitution devices translate visual information from a sensor, such as a camera or ultrasound device, into a format that the auditory or tactile systems can detect and process, so the visually impaired can see through hearing or touch. Online control of action is essential for many daily tasks such as pointing, grasping and navigating, and adapting to a sensory substitution device successfully requires extensive learning. Here we review the research on sensory substitution for vision restoration in the context of providing the means of online control for action in the blind or blindfolded. It appears that the use of sensory substitution devices utilizes the neural visual system; this suggests the hypothesis that sensory substitution draws on the same underlying mechanisms as unimpaired visual control of action. Here we review the current state of the art for sensory substitution approaches to object recognition, localization, and navigation, and the potential these approaches have for revealing a metamodal behavioral and neural basis for the online control of action.},
address  = {Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK Cognition, Aging and Rehabilitation Lab, Recanati School for Community Health Professions, Department of Physical Therapy & Zlotowski Center for Neuroscience,  Ben Gurion University of the Negev, Beer-Sheva, Israel Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK Crossmodal Cognition Lab, Department of Psychology, University of Bath, Bath, UK},
note  = {Restor Neurol Neurosci. ;34(1):29-44. doi:10.3233/RNN-150541.}
}

@Article{20155,
author  = {},
title  = {UEG Week 2015 Poster Presentations.},
journal  = {United European Gastroenterology Journal},
volume  = {3},
number  = {5 Suppl},
pages  = {146-687},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1177/2050640615601623.}
}

@Article{20156,
author  = {Shull, P. and Damian, D.},
title  = {review.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {12},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Sensory impairments decrease quality of life and can slow or hinder rehabilitation. Small, computationally powerful electronics have enabled the recent development of wearable systems aimed to improve function for individuals  with sensory impairments. The purpose of this review is to synthesize current haptic wearable research for clinical applications involving sensory impairments. We define haptic wearables as untethered, ungrounded body worn devices that interact with skin directly or through clothing and can be used in natural environments outside a laboratory. Results of this review are categorized by degree of sensory impairment. Total impairment, such as in an amputee, blind, or  deaf individual, involves haptics acting as sensory replacement; partial impairment, as is common in rehabilitation, involves haptics as sensory augmentation; and no impairment involves haptics as trainer. This review found that wearable haptic devices improved function for a variety of clinical applications including: rehabilitation, prosthetics, vestibular loss, osteoarthritis, vision loss and hearing loss. Future haptic wearables development should focus on clinical needs, intuitive and multimodal haptic displays, low energy demands, and biomechanical compliance for long-term usage.},
address  = {State Key Laboratory of Mechanical System and Vibration, School of Mechanical Engineering, Shanghai Jiao Tong University, Room 930, Mechanical Engineering Bld, 800 Dong Chuan Road, Shanghai, 200240 China Boston Children‚Äôs Hospital, Harvard University, 330 Longwood Avenue, Boston, Massachusetts 02115 USA},
note  = {J Neuroeng Rehabil. 2015 Jul 20;12:. doi:10.1186/s12984-015-0055-z.}
}

@Article{20157,
author  = {},
title  = {Medicine.},
journal  = {Journal of General Internal Medicine},
volume  = {30},
number  = {Suppl 2},
pages  = {45-551},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11606-015-3271-0.}
}

@Article{20158,
author  = {},
title  = {Abstracts for the 15th International Congress on Schizophrenia Research (ICOSR).},
journal  = {Schizophrenia Bulletin},
volume  = {41},
number  = {Suppl 1},
pages  = {S1-S341},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1093/schbul/sbv010.}
}

@Article{20149,
author  = {},
title  = {Poster Session III Wednesday, December 10, 2014.},
journal  = {Neuropsychopharmacology},
volume  = {39},
number  = {Suppl 1},
pages  = {S473-647},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1038/npp.2014.282.}
}

@Article{201410,
author  = {},
title  = {Poster Session II Tuesday, December 09, 2014.},
journal  = {Neuropsychopharmacology},
volume  = {39},
number  = {Suppl 1},
pages  = {S291-472},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1038/npp.2014.281.}
}

@Article{201411,
author  = {Gori, M. and Vercillo, T. and Sandini, G. and Burr, D.},
title  = {Tactile feedback improves auditory spatial localization.},
journal  = {Frontiers in Psychology},
volume  = {5},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Our recent studies suggest that congenitally blind adults have severely impaired  thresholds in an auditory spatial bisection task, pointing to the importance of vision in constructing complex auditory spatial maps (Gori et al., 2014). To explore strategies that may improve the auditory spatial sense in visually impaired people, we investigated the impact of tactile feedback on spatial auditory localization in 48 blindfolded sighted subjects. We measured auditory spatial bisection thresholds before and after training, either with tactile feedback, verbal feedback, or no feedback. Audio thresholds were first measured with a spatial bisection task: subjects judged whether the second sound of a three sound sequence was spatially closer to the first or the third sound. The tactile feedback group underwent two audio-tactile feedback sessions of 100 trials, where each auditory trial was followed by the same spatial sequence played on the subject‚Äôs forearm; auditory spatial bisection thresholds were evaluated after each session. In the verbal feedback condition, the positions of  the sounds were verbally reported to the subject after each feedback trial. The no feedback group did the same sequence of trials, with no feedback. Performance  improved significantly only after audio-tactile feedback. The results suggest that direct tactile feedback interacts with the auditory spatial localization system, possibly by a process of cross-sensory recalibration. Control tests with  the subject rotated suggested that this effect occurs only when the tactile and acoustic sequences are spatially congruent. Our results suggest that the tactile  system can be used to recalibrate the auditory sense of space. These results encourage the possibility of designing rehabilitation programs to help blind persons establish a robust auditory sense of space, through training with the tactile modality.},
address  = {Robotics Brain and Cognitive Sciences Department, Istituto Italiano di TecnologiaGenoa, Italy Robotics Brain and Cognitive Sciences Department, Istituto Italiano di TecnologiaGenoa, Italy Robotics Brain and Cognitive Sciences Department, Istituto Italiano di TecnologiaGenoa, Italy Department of Neuroscience, Psychology, Pharmacology and Child Health, University of FlorenceFlorence, Italy},
note  = {Front Psychol. 2014 Oct 20;5:. doi:10.3389/fpsyg.2014.01121.}
}

@Article{201412,
author  = {},
title  = {UEG Week 2014 Poster Presentations.},
journal  = {United European Gastroenterology Journal},
volume  = {2},
number  = {1 Suppl},
pages  = {A132-605},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1177/2050640614548980.}
}

@Article{201413,
author  = {},
title  = {ACTRIMS-ECTRIMS MSBoston 2014: Poster Sessions 2.},
journal  = {Multiple Sclerosis (Houndmills, Basingstoke, England)},
volume  = {20},
number  = {1 Suppl},
pages  = {285-496},
year  = {2014},
abstract  = {},
address  = {},
note  = {Mult Scler. 2014 Sep;20(1 Suppl):285-496. doi:10.1177/1352458514547846.}
}

@Article{201414,
author  = {},
title  = {Session 1.},
journal  = {Multiple Sclerosis (Houndmills, Basingstoke, England)},
volume  = {20},
number  = {1 Suppl},
pages  = {67-284},
year  = {2014},
abstract  = {},
address  = {},
note  = {Mult Scler. 2014 Sep;20(1 Suppl):67-284. doi:10.1177/1352458514546077.}
}

@Article{201415,
author  = {},
title  = {ACTS Abstracts.},
journal  = {Clinical and Translational Science},
volume  = {7},
number  = {3},
pages  = {202-76},
year  = {2014},
abstract  = {},
address  = {},
note  = {Clin Transl Sci. 2014 Jun;7(3):202-76. Epub 2014 Jun 10 doi:10.1111/cts.12171.}
}

@Article{201416,
author  = {},
title  = {Medicine.},
journal  = {Journal of General Internal Medicine},
volume  = {29},
number  = {Suppl 1},
pages  = {1-545},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11606-014-2834-9.}
}

@Article{201317,
author  = {},
title  = {UEG Week 2013 Poster Presentations.},
journal  = {United European Gastroenterology Journal},
volume  = {1},
number  = {1 Suppl},
pages  = {A135-587},
year  = {2013},
abstract  = {},
address  = {},
note  = {doi:10.1177/2050640613502900.}
}

@Article{201318,
author  = {},
title  = {Medicine.},
journal  = {Journal of General Internal Medicine},
volume  = {28},
number  = {Suppl 1},
pages  = {1-489},
year  = {2013},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11606-013-2436-y.}
}

@Article{201219,
author  = {Lahav, O. and Schloerb, D. and Kumar, S. and Srinivasan, M.},
title  = {A Virtual Environment for People Who Are Blind ‚Äì A Usability Study.},
journal  = {Journal of assistive technologies},
volume  = {6},
number  = {1},
pages  = {},
year  = {2012},
abstract  = {For most people who are blind, exploring an unknown environment can be unpleasant, uncomfortable, and unsafe. Over the past years, the use of virtual reality as a learning and rehabilitation tool for people with disabilities has been on the rise. This research is based on the hypothesis that the supply of appropriate perceptual and conceptual information through compensatory sensorial  channels may assist people who are blind with anticipatory exploration. In this research we developed and tested the BlindAid system, which allows the user to explore a virtual environment. The two main goals of the research were: (a) evaluation of different modalities (haptic and audio) and navigation tools, and (b) evaluation of spatial cognitive mapping employed by people who are blind. Our research included four participants who are totally blind. The preliminary findings confirm that the system enabled participants to develop comprehensive cognitive maps by exploring the virtual environment.},
address  = {Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of  Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of  Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of  Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA Laboratory for Human and Machine Haptics (The Touch Lab), Research Laboratory of  Electronics, Massachusetts Institute of Technology, Cambridge, MA, USA},
note  = {J Assist Technol. 2012;6(1):. doi:10.1108/17549451211214346.}
}

@Article{201120,
author  = {},
title  = {Abstracts for the 13th International Congress on Schizophrenia Research (ICOSR).},
journal  = {Schizophrenia Bulletin},
volume  = {37},
number  = {Suppl 1},
pages  = {1-327},
year  = {2011},
abstract  = {},
address  = {},
note  = {Schizophr Bull. 2011 Mar;37(Suppl 1):1-327. doi:10.1093/schbul/sbq173.}
}

@Article{201721,
author  = {Hong, K. and Khan, M.},
title  = {and Increased Number of Commands: A Review.},
journal  = {Frontiers in Neurorobotics},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {In this article, non-invasive hybrid brain‚Äìcomputer interface (hBCI) technologies for improving classification accuracy and increasing the number of commands are reviewed. Hybridization combining more than two modalities is a new trend in brain imaging and prosthesis control. Electroencephalography (EEG), due to its easy use and fast temporal resolution, is most widely utilized in combination with other brain/non-brain signal acquisition modalities, for instance, functional near infrared spectroscopy (fNIRS), electromyography (EMG), electrooculography (EOG), and eye tracker. Three main purposes of hybridization are to increase the number of control commands, improve classification accuracy and reduce the signal detection time. Currently, such combinations of EEG‚Äâ+‚ÄâfNIRS and EEG‚Äâ+‚ÄâEOG are most commonly employed. Four principal components (i.e., hardware, paradigm, classifiers, and features) relevant to accuracy improvement are discussed. In the case of brain signals, motor imagination/movement tasks are combined with cognitive tasks to increase active brain‚Äìcomputer interface (BCI) accuracy. Active and reactive tasks sometimes are combined: motor imagination with steady-state evoked visual potentials (SSVEP) and motor imagination with P300. In the case of reactive tasks, SSVEP is most widely combined with P300 to increase the number of commands. Passive BCIs, however, are rare. After discussing the hardware and strategies involved in the development of hBCI, the second part examines the approaches used to increase the number of control commands and to enhance classification accuracy. The future prospects and the extension of hBCI in real-time applications for daily life scenarios are provided.},
address  = {School of Mechanical Engineering, Pusan National University, Busan, South Korea School of Mechanical Engineering, Pusan National University, Busan, South Korea},
note  = {Front Neurorobot. 2017 Jul 24;11:. doi:10.3389/fnbot.2017.00035.}
}

@Article{201722,
author  = {Ee, C. and Thuraisingam, S. and Pirotta, M. and French, S. and Xue, C. and Teede, H. and Kristoffersen, A. and Sirois, F. and Stub, T. and Engler, J. and Joos, S. and G√ºthlin, C. and Felenda, J. and Beckmann, C. and Stintzing, F. and Evans, R. and Bronfort, G. and Keefe, D. and Taberko, A. and Hanson, L. and Haley, A. and Ma, H. and Jolton, J. and Yarosh, L. and Keefe, F. and Nam, J. and Evans, R. and Ojala, L. and Kreitzer, M. and Hanson, L. and Fink, C. and Kraft, K. and Flower, A. and Lewith, G. and Harman, K. and Stuart, B. and Bishop, F. and Frawley, J. and F√ºleki, L. and Kiss, E. and Vancsik, T. and Krenacs, T. and Funabashi, M. and Pohlman, K. and Mior, S. and Thiel, H. and Hill, M. and Cassidy, D. and Westaway, M. and Yager, J. and Hurwitz, E. and Kawchuk, G. and O‚ÄôBeirne, M. and Vohra, S. and Gaboury, I. and Morin, C. and Gaertner, K. and Torchetti, L. and Frei-Erb, M. and Kundi, M. and Frass, M. and Gallo, E. and Maggini, V. and Comite, M. and Sofi, F. and Baccetti, S. and Vannacci, A. and Di, S. and Monechi, M. and Gori, L. and Rossi, E. and Firenzuoli, F. and Mediati, R. and Ballerini, G. and Gardiner, P. and Lestoquoy, A. and Negash, L. and Stillman, S. and Shah, P. and Liebschutz, J. and Adelstein, P. and Farrell-Riley, C. and Brackup, I. and Penti, B. and Saper, R. and Sampedro, I. and Carvajal, G. and Gleiss, A. and Gross, M. and Brendlin, D. and R√∂ttger, J. and Stritter, W. and Seifert, G. and Grzanna, N. and Stange, R. and Guendling, P. and Gu, W. and Lu, Y. and Wang, J. and Zhang, C. and Bai, H. and He, Y. and Zhang, X. and Zhang, Z. and Wang, D. and Meng, F. and Hagel, A. and Albrecht, H. and Vollbracht, C. and Dauth, W. and Hagel, W. and Vitali, F. and Ganzleben, I. and Schultis, H. and Konturek, P. and Stein, J. and Neurath, M. and Raithel, M. and Hagel, A. and Vollbracht, C. and Raithel, M. and Konturek, P. and Krick, B. and Haller, H. and Klose, P. and Dobos, G. and K√ºmmel, S. and Cramer, H. and Haller, H. and Saha, F. and Kowoll, A. and Ebner, B. and Berger, B. and Dobos, G. and Choi, K. and He, L. and Wang, H. and He, X. and Gu, C. and Zhang, Y. and Zhao, L. and Tong, X. and He, L. and Wang, H. and He, X. and Gu, C. and Zhang, Y. and Zhao, L. and Tong, X. and He, L. and Wang, H. and He, X. and Gu, C. and Zhang, Y. and Zhao, L. and Tong, X. and Ho, R. and Chung, V. and Wu, X. and Wong, C. and Wu, J. and Wong, S. and Lau, A. and Sit, R. and Wong, W. and Holmes, M. and Bishop, F. and Calman, L. and Holmes, M. and Bishop, F. and Lewith, G. and Newell, D. and Field, J. and Htut, W. and Han, D. and Choi, D. and Choi, S. and Kim, H. and Hwang, J. and Huang, C. and Jang, B. and Chen, F. and Ko, S. and Huang, W. and Jin, D. and Lian, F. and Jang, S. and Kim, K. and Lee, E. and Sun, S. and Go, H. and Ko, Y. and Park, S. and Jang, B. and Shin, Y. and Ko, S. and Janik, H. and Greiffenhagen, N. and Bolte, J. and Kraft, K. and Jaworski, M. and Adamus, M. and Dobrzynska, A. and Jeitler, M. and Jaspers, J. and von, S. and Koch, B. and Michalsen, A. and Steckhan, N. and Kessler, C. and Jin, D. and Huang, W. and Pang, B. and Lian, F. and Jong, M. and Baars, E. and Glockmann, A. and Hamre, H. and Kainuma, M. and Murakami, A. and Kubota, T. and Kobayashi, D. and Sumoto, Y. and Furusyo, N. and Ando, S. and Shimazoe, T. and Kelber, O. and Verjee, S. and Gorgus, E. and Schrenk, D. and Kemper, K. and Hill, E. and Kemper, K. and Rao, N. and Gascon, G. and Mahan, J. and Kienle, G. and Dietrich, J. and Schmoor, C. and Huber, R. and Kim, W. and Han, D. and Ahmed, M. and He, L. and Hwang, J. and Kiss, E. and Vancsik, T. and Meggyeshazi, N. and Kovago, C. and Krenacs, T. and Klaus, A. and Zerm, R. and Pranga, D. and Ostermann, T. and Reif, M. and von, L. and Brinkhaus, B. and Kr√∂z, M. and Klaus, A. and Zerm, R. and Pranga, D. and Recchia, D. and Ostermann, T. and Reif, M. and von, L. and Brinkhaus, B. and Kr√∂z, M. and Klein-Laansma, C. and Jong, M. and von, H. and Jansen, J. and van, W. and Jong, M. and Ko, Y. and Sun, S. and Go, H. and Jeon, C. and Song, Y. and Ko, S. and Koch, A. and Rabsilber, S. and Lauche, R. and K√ºmmel, S. and Dobos, G. and Langhorst, J. and Cramer, H. and Koch, A. and Trifunovic-Koenig, M. and Klose, P. and Cramer, H. and Dobos, G. and Langhorst, J. and Koster, E. and Baars, E. and Delnoij, D. and Kroll, L. and Weiss, K. and Kubo, A. and Hendlish, S. and Altschuler, A. and Connolly, N. and Avins, A. and Lauche, R. and Recchia, D. and Cramer, H. and Wardle, J. and Lee, D. and Sibbritt, D. and Adams, J. and Ostermann, T. and Lauche, R. and Sibbritt, D. and Park, C. and Mishra, G. and Adams, J. and Cramer, H. and Lechner, J. and Lee, I. and Chae, Y. and Lee, J. and Cho, S. and Choi, Y. and Lee, J. and Ryu, H. and Yoon, S. and Oh, H. and Hyun, L. and Kim, J. and Yoon, S. and Lee, J. and Shin, S. and Jang, M. and M√ºller, I. and Park, S. and Lestoquoy, A. and Laird, L. and Negash, L. and Mitchell, S. and Gardiner, P. and Li, X. and Wang, Y. and Zhen, J. and Yu, H. and Liu, T. and Gu, X. and Liu, H. and Ma, W. and Zhang, C. and Shang, X. and Bai, Y. and Meng, F. and Liu, W. and Rooney, C. and Smith, A. and Lopes, S. and Demarzo, M. and do, P. and Lorenz, P. and Gr√ºndemann, C. and Heinrich, M. and Garcia-K√§ufer, M. and Grunewald, F. and Messerschmidt, S. and Herrick, A. and Gruber, K. and Beckmann, C. and Kn√∂dler, M. and Huber, R. and Steinborn, C. and Stintzing, F. and Lu, T. and Wang, L. and Wu, D. and Luberto, C. and Hall, D. and Chad-Friedman, E. and Lechner, S. and Park, E. and Luberto, C. and Park, E. and Goodman, J. and Luer, S. and Heri, M. and von, A. and Frei-Erb, M. and Ma, W. and Meng, F. and Maggini, V. and Gallo, E. and Landini, I. and Lapucci, A. and Nobili, S. and Mini, E. and Firenzuoli, F. and McDermott, C. and Lewith, G. and Richards, S. and Cox, D. and Frossell, S. and Leydon, G. and Eyles, C. and Raphael, H. and Rogers, R. and Selby, M. and Adler, C. and Allam, J. and Meng, F. and Gu, W. and Zhang, C. and Bai, H. and Zhang, Z. and Wang, D. and Bu, X. and Zhang, H. and Zhang, J. and Liu, H. and Mikolasek, M. and Berg, J. and Witt, C. and Barth, J. and Miskulin, I. and Lalic, Z. and Miskulin, M. and Dumic, A. and Sebo, D. and Vcev, A. and Mohammed, N. and Han, D. and Ahmed, M. and Choi, S. and Im, H. and Hwang, J. and Mukherjee, A. and Kandhare, A. and Bodhankar, S. and Mukherjee, A. and Kandhare, A. and Thakurdesai, P. and Bodhankar, S. and Munk, N. and Evans, E. and Froman, A. and Kline, M. and Bair, M. and Musial, F. and Kristoffersen, A. and Alr√¶k, T. and Hamre, H. and Stub, T. and Bj√∂rkman, L. and F√∏nneb√∏, V. and Pang, B. and Lian, F. and Ni, Q. and Tong, X. and Li, X. and Liu, W. and Feng, S. and Zhao, X. and Zheng, Y. and Zhao, X. and Lin, Y. and Pang, B. and Lian, F. and Tong, X. and Zhao, T. and Zhao, X. and Phd, H. and Zhang, C. and Pang, B. and Liu, F. and Tong, X. and Zhao, L. and Zhao, X. and Ye, R. and Gu, C. and Pang, B. and Ni, Q. and Tong, X. and Lian, F. and Zhao, X. and Jin, D. and Zhao, X. and Zheng, Y. and Lin, Y. and Peng, W. and Lauche, R. and Sibbritt, D. and Adams, J. and Peng, W. and Wardle, J. and Cramer, H. and Mishra, G. and Lauche, R. and Pohlman, K. and Mior, S. and Funabashi, M. and De, C. and El-Bayoumi, M. and Haig, B. and Kelly, K. and Wade, D. and O‚ÄôBeirne, M. and Vohra, S. and Portalupi, E. and Gobo, G. and Bellavita, L. and Guglielmetti, C. and Raak, C. and Teuber, M. and Molsberger, F. and von, R. and Reichelt, U. and Schwanebeck, U. and Zeil, S. and Vogelberg, C. and Veintimilla, D. and Vollbracht, C. and Mery, G. and Villavicencio, M. and Moran, S. and Sachse, C. and G√ºndlin, P. and Stange, R. and Sahebkarkhorasani, M. and Azizi, H. and Schumann, D. and Lauche, R. and Sundberg, T. and Leach, M. and Cramer, H. and Seca, S. and Greten, H. and Selliah, S. and Shakya, A. and Han, D. and Kim, H. and Choi, D. and Im, H. and Choi, S. and Sherbakova, A. and Ulrich-Merzenich, G. and Kelber, O. and Abdel-Aziz, H. and Sibinga, E. and Webb, L. and Ellen, J. and Skrautvol, K. and N√•den, D. and Song, R. and Grabowska, W. and Osypiuk, K. and Diaz, G. and Bonato, P. and Park, M. and Hausdorff, J. and Fox, M. and Sudarsky, L. and Tarsy, D. and Novakowski, J. and Macklin, E. and Wayne, P. and Song, R. and Hwang, I. and Ahn, S. and Lee, M. and Wayne, P. and Sohn, M. and Sorokin, O. and Steckhan, N. and Heydeck, D. and Borchert, A. and Hohmann, C. and K√ºhn, H. and Michalsen, A. and Kessler, C. and Steckhan, N. and Hohmann, C. and Cramer, H. and Michalsen, A. and Dobos, G. and von, S. and Kirschbaum, C. and Stalder, T. and St√∂ckigt, B. and Teut, M. and Suhr, R. and Sulmann, D. and Brinkhaus, B. and Streeter, C. and Gerbarg, P. and Silveri, M. and Brown, R. and Jensen, J. and Stritter, W. and Rutert, B. and Eggert, A. and L√§ngler, A. and Seifert, G. and Holmberg, C. and Sun, J. and Deng, X. and Li, W. and Wen, B. and Robinson, N. and Liu, J. and Sung, H. and Yang, N. and Go, H. and Shin, S. and Jung, H. and Kim, Y. and Jung, W. and Park, T. and Suzuki, K. and Ito, T. and Uchida, S. and Kamohara, S. and Ono, N. and Takamura, M. and Yokochi, A. and Maruyama, K. and Tapia, P. and Thabaut, K. and Brinkhaus, B. and St√∂ckigt, B. and Thronicke, A. and Kr√∂z, M. and Steele, M. and Matthes, H. and Herbstreit, C. and Schad, F. and Tian, J. and Lian, F. and Yang, L. and Tong, X. and Tian, T. and Zhang, H. and Tian, X. and Wang, C. and Chai, Q. and Zhang, L. and Xia, R. and Huang, N. and Fei, Y. and Liu, J. and Trent, N. and Miraglia, M. and Dusek, J. and Pasalis, E. and Khalsa, S. and Trifunovic-K√∂nig, M. and Klose, P. and Cramer, H. and Lauche, R. and Koch, A. and Dobos, G. and Langhorst, J. and Uebelacker, L. and Tremont, G. and Gillette, L. and Epstein-Lubow, G. and Strong, D. and Abrantes, A. and Tyrka, A. and Tran, T. and Gaudiano, B. and Miller, I. and Ullmann, G. and Ullmann, G. and Li, Y. and Vaidya, S. and Marathe, V. and Vale, A. and Motta, J. and Donad√£o, F. and Valente, A. and Valente, L. and Ghelman, R. and Vesovic, D. and Jevdic, D. and Jevdic, A. and Jevdic, K. and Djacic, M. and Letic, D. and Bozic, D. and Markovic, M. and Dunjic, S. and Vesovic, D. and Jevdic, D. and Jevdic, A. and Jevdic, K. and Djacic, M. and Letic, D. and Bozic, D. and Markovic, M. and Ruscuklic, G. and Baksa, D. and Dunjic, S. and Vesovic, D. and Jevdic, D. and Jevdic, A. and Jevdic, K. and Djacic, M. and Letic, D. and Bozic, D. and Markovic, M. and Ruscuklic, G. and Baksa, D. and Dunjic, S. and Vesovic, D. and Jevdic, D. and Jevdic, A. and Jevdic, K. and Djacic, M. and Letic, D. and Bozic, D. and Markovic, M. and Ruscuklic, G. and Baksa, D. and Dunjic, S. and Vesovic, D. and Jevdic, D. and Jevdic, A. and Jevdic, K. and Djacic, M. and Letic, D. and Bozic, D. and Markovic, M. and Vrca, K. and Dunjic, S. and Vincent, A. and Wahner-Roedler, D. and Whipple, M. and Vogelius, M. and Vollbracht, C. and Friesecke, I. and G√ºndling, P. and Wahner-Roedler, D. and Mahapatra, S. and Hynes, R. and Van, R. and Looker, S. and Ghosh, A. and Bauer, B. and Cutshall, S. and Walach, H. and Flores, A. and Walach, H. and Ofner, M. and Kastner, A. and Schwarzl, G. and Schwameder, H. and Alexander, N. and Strutzenberger, G. and Wang, J. and Lu, Y. and Gu, W. and Zhang, C. and Bu, X. and Zhang, H. and Zhang, J. and He, Y. and Zhang, X. and Meng, F. and Wang, S. and Yu, H. and Shi, J. and Hao, Y. and Liu, T. and Wu, J. and Qiu, Z. and Gu, X. and Wang, Y. and Lou, C. and Watts, S. and Wayne, P. and Osypiuk, K. and Vergara-Diaz, G. and Bonato, P. and Gow, B. and Hausdorff, J. and Miranda, J. and Sudarsky, L. and Tarsy, D. and Fox, M. and Macklin, E. and Wode, K. and Bergqvist, J. and Bernhardsson, B. and Nordberg, J. and Kienle, G. and Sharp, L. and Henriksson, R. and Woo, Y. and Hyun, M. and Wu, H. and Wang, T. and Zhao, Y. and Wei, Y. and Tian, L. and He, L. and Wang, X. and Wu, R. and Feng, S. and Han, M. and Caldwell, P. and Liu, S. and Zhang, J. and Liu, J. and Xia, R. and Chai, Q. and Fei, Y. and Guo, Z. and Wang, C. and Liu, Z. and Li, X. and Zhang, Y. and Liu, J. and Yang, I. and Lincha, V. and Ahn, S. and Lee, D. and Shin, H. and Yang, L. and Sibbritt, D. and Peng, W. and Adams, J. and Yang, N. and Sung, H. and Shin, S. and Go, H. and Jung, H. and Kim, Y. and Park, T. and Yap, A. and Kwan, Y. and Tan, C. and Ibrahim, S. and Ang, S. and Yayi, A. and Han, D. and Im, H. and Hwang, J. and Choi, S. and Yoo, J. and Yoo, H. and Jang, S. and Lee, H. and Youssef, A. and Ezzat, S. and Motaal, A. and El-Askary, H. and Yu, X. and Cui, Y. and Zhang, Y. and Lian, F. and Yun, Y. and Ko, Y. and Ahn, J. and Jang, B. and Kim, K. and Ko, S. and Choi, I. and Zerm, R. and Glinz, A. and Pranga, D. and Berger, B. and ten, B. and Reif, M. and B√ºssing, A. and Gutenbrunner, C. and Kr√∂z, M. and Zerm, R. and Helbrecht, B. and Pranga, D. and Brinkhaus, B. and Michalsen, A. and Kr√∂z, M. and Zhang, H. and Fang, T. and Wang, J. and Zhang, C. and He, Y. and Zhang, X. and Zhang, Z. and Wang, D. and Meng, F. and Zhang, J. and Zhang, C. and Bai, H. and Shen, Z. and Ma, W. and Liu, H. and Bai, Y. and Shang, X. and Meng, F. and Zhang, R. and Wu, F. and Li, M. and Xuan, X. and Shen, X. and Ren, K. and Berman, B. and Zhen, J. and Li, X. and Gu, X. and Yu, H. and Zheng, Z. and Wan, Y. and Wang, Y. and Ma, X. and Dong, F. and Liu, T. and Zhen, J. and Li, X. and Gu, X. and Yu, H. and Zheng, Z. and Wan, Y. and Wang, Y. and Ma, X. and Dong, F. and Liu, T. and Zick, S. and Harris, R. and Bae, G. and Kwon, J. and Lee, H. and Nam, J. and Lee, S. and Lee, D. and Han, J. and Yun, Y. and Lee, J. and Park, H. and Park, S. and Bocci, C. and Ivaldi, G. and Vietti, I. and Meaglia, I. and Guffi, M. and Ruggiero, R. and Gualea, M. and Longa, E. and Bonucci, M. and Croke, S. and Rodriguez, L. and Caracuel-Mart√≠nez, J. and Fajardo-Rodr√≠guez, M. and Ariza-Garc√≠a, A. and la, F. and Arroyo-Morales, M. and Estrems, M. and G√≥mez, V. and Estrems, M. and Sabater, M. and Ferreri, R. and Bernardini, S. and Pulcri, R. and Cracolici, F. and Rinaldi, M. and Porciani, C. and Firenzuoli, F. and Baccetti, S. and Di, S. and Monechi, M. and Gallo, E. and Maggini, V. and Gori, L. and Rossi, E. and Fisher, P. and Hughes, J. and Mendoza, A. and MacPherson, H. and Witt, C. and Filshie, J. and Lewith, G. and Di, F. and Bernardini, A. and Messe, M. and Primitivo, V. and Iasella, P. and Ghelman, R. and Taminato, M. and Alcantara, J. and De, O. and Rodrigues, D. and Mumme, J. and Sunakozawa, O. and Filho, V. and Seifert, G. and Goldenberg, J. and Day, A. and Sasagawa, M. and Ward, L. and Cooley, K. and Gunnarsdottir, T. and Hjaltadottir, I. and Hajimonfarednejad, M. and Hannan, N. and Hellsing, R. and Wode, K. and Nordberg, J. and Nordberg, J. and Andermo, S. and Arman, M. and von, H. and Torrielo, P. and Vilar√≥, C. and Cabrera, F. and Huber, R. and Hui, H. and Ziea, E. and Tsui, D. and Hsieh, J. and Lam, C. and Chan, E. and Jensen, M. and Battalio, S. and Chan, J. and Edwards, K. and Gertz, K. and Day, M. and Sherlin, L. and Ehde, D. and Kim, K. and Jang, S. and Jang, B. and Go, H. and Park, S. and Ko, S. and Kraft, K. and Janik, H. and B√∂rner, A. and Lee, J. and Lee, B. and Chang, G. and Menassa, A. and Motoo, Y. and M√ºller, J. and Rabini, S. and Vinson, B. and Kelber, O. and Storr, M. and Kraft, K. and Niemeijer, M. and Baars, E. and Hoekman, J. and Ruijssenaaars, W. and Njoku, F. and Klose, P. and Brinkhaus, B. and Michalsen, A. and Dobos, G. and Cramer, H. and Norheim, A. and Alr√¶k, T. and Okumus, F. and Oncu-Celik, H.},
title  = {May 2017.},
journal  = {BMC Complementary and Alternative Medicine},
volume  = {17},
number  = {Suppl 1},
pages  = {},
year  = {2017},
abstract  = {},
address  = {0000 0004 1936 834Xgrid.1013.3National Institute of Complementary Medicine, Western Sydney University, Sydney, Australia 0000 0001 2179 088Xgrid.1008.9Department of General Practice, University of Melbourne, Melbourne, Australia 0000 0001 2179 088Xgrid.1008.9Department of General Practice, University of Melbourne, Melbourne, Australia 0000 0004 1936 8331grid.410356.5School of Rehabilitation Therapy, Queens University, Ontario, Canada 0000 0001 2163 3550grid.1017.7School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia 0000 0004 1936 7857grid.1002.3School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia 0000000122595234grid.10919.30NAFKAM, UiT, The Arctic University of Norway, Troms√∏, 9019 Norway 0000 0004 1936 9262grid.11835.3eDepartment of Psychology, University of Sheffield, Sheffield, S1 1HD UK 0000000122595234grid.10919.30Department of Community Medicine, UiT The Arctic University of Norway, Troms√∏, 9019 Norway 0000 0004 1936 9721grid.7839.5Institue of General Practice, Goethe University Frankfurt, Frankfurt, 60590 Germany 0000 0001 2190 1447grid.10392.39Department of General Practice, University of T√ºbingen, T√ºbingen, Germany 0000 0004 1936 9721grid.7839.5Institue of General Practice, Goethe University Frankfurt, Frankfurt, 60590 Germany Med.-pharm. Information/Klinische Forschung, WALA Heilmittel GmbH, Bad Boll/ Eckw√§lden, 73087 Germany Med.-pharm. Information/Klinische Forschung, WALA Heilmittel GmbH, Bad Boll/ Eckw√§lden, 73087 Germany Ressortleitung Wissenschaft, WALA Heilmittel GmbH, Bad Boll/Eckw√§lden, 73087 Germany 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA grid.454628.9Minneapolis College of Art and Design, Minneapolis, MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA grid.454628.9Minneapolis College of Art and Design, Minneapolis, MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnesota, Minneapolis, 55455 MN USA Caring Bridge, Minneapolis, MN USA 0000000419368657grid.17635.36University of Minnesota, Minneapolis, 55455 MN USA 0000000419368657grid.17635.36University of Minnesota, Minneapolis, 55455 MN USA Phytomedicines Supply and Development Center, Innovation & Development, Bayer Consumer Health Steigerwald Arzneimittelwerk GmbH, Darmstadt, 68526 Germany 0000000121858338grid.10493.3fUniversity Medicine of Rostock, Rostock, 18055 Germany 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of Southampton, Southampton, UK 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of Southampton, Southampton, UK 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of Southampton, Southampton, UK 0000 0004 1936 9297grid.5491.9Primary Care and Population Sciences, University of Southampton, Southampton, UK 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton, UK 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0004 0473 5995grid.418591.0Canadian Memorial Chiropractic College, Toronto,  Canada 0000 0004 0489 9631grid.417783.eAnglo-European College of Chiropractic, Bournemouth, UK 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada 0000 0001 2157 2938grid.17063.33University of Toronto, Toronto, Canada 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 2188 0957grid.410445.0University of Hawaii at Manoa, Honolulu, Hawai‚ÄôI  USA grid.17089.37University of Alberta, Edmonton, Canada 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0000 9064 6198grid.86715.3dFamily Medicine, Universite de Sherbrooke, Sherbrooke, J1H 5N4 Canada 0000 0000 9064 6198grid.86715.3dFamily Medicine, Universite de Sherbrooke, Sherbrooke, J1H 5N4 Canada 0000 0001 0726 5157grid.5734.5Institute for Complementary Medicine, University of Bern, Bern, 3008 Switzerland 0000 0001 0726 5157grid.5734.5Institute for Complementary Medicine, University of Bern, Bern, 3008 Switzerland 0000 0001 0726 5157grid.5734.5Institute for Complementary Medicine, University of Bern, Bern, 3008 Switzerland 0000 0000 9259 8492grid.22937.3dInstitute of Environmental Health, Medical University of Vienna, Vienna, 1090 Austria 0000 0000 9259 8492grid.22937.3dDepartment of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, 1090 Austria 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy 0000 0004 1759 9494grid.24704.35Center for Integrative Medicine, Careggi Universtary Hospital, Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy 0000 0004 1759 9494grid.24704.35Center for Integrative Medicine, Careggi Universtary Hospital, Florence, Italy Tuscan Network of Integrative Medicine, Region of Tuscany, Florence, Italy 0000 0004 1759 9494grid.24704.35Center for Integrative Medicine, Careggi Universtary Hospital, Florence, Italy 0000 0004 1759 9494grid.24704.35Cure Palliative e Terapia Del Dolore, Careggi Universitary Hospital, Florence, Italy 0000 0004 1759 9494grid.24704.35Cure Palliative e Terapia Del Dolore, Careggi Universitary Hospital, Florence, Italy 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA grid.475621.3Codman Square Health Center, Dorchester, MA USA grid.475621.3Codman Square Health Center, Dorchester, MA USA grid.475621.3Dothouse Health Center, Dorchester, MA USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 MA USA ENERGIMED, Barcelona, 08007 Spain ENERGIMED, Barcelona, 08007 Spain 0000 0000 9259 8492grid.22937.3dCenter for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, 1090 Austria 0000 0001 2218 4662grid.6363.0AG f√ºr Integrative Medizin in der P√§diatrischen Onkologie, Charit√© Universit√§tsmedizin, Berlin, 13353 Germany 0000 0001 2218 4662grid.6363.0AG f√ºr Integrative Medizin in der P√§diatrischen Onkologie, Charit√© Universit√§tsmedizin, Berlin, 13353 Germany 0000 0001 2218 4662grid.6363.0AG f√ºr Integrative Medizin in der P√§diatrischen Onkologie, Charit√© Universit√§tsmedizin, Berlin, 13353 Germany 0000 0001 2218 4662grid.6363.0AG f√ºr Integrative Medizin in der P√§diatrischen Onkologie, Charit√© Universit√§tsmedizin, Berlin, 13353 Germany 0000 0001 2218 4662grid.6363.0AG f√ºr Integrative Medizin in der P√§diatrischen Onkologie, Charit√© Universit√§tsmedizin, Berlin, 13353 Germany 0000 0004 0593 1824grid.440934.eComplementary Medicine, Hochschule Fresenius, M√ºnchen, 80798 Germany 0000 0004 0415 8446grid.473656.5Naturheilkunde, Immanuel-Krankenhaus, Berlin, 14109 Germany 0000 0004 0593 1824grid.440934.eComplementary Medicine, Hochschule Fresenius, M√ºnchen, 80798 Germany grid.459365.8Beijing Hospital of Traditional Chinese Medicine, Rheumatism, Beijing, China grid.464481.bEmergency Department, Xiyuan Hospital, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatism, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Nephrology, Beijing, China Rehabilitation Department, Xiluoyuan Community Health Service Centre, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatism, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatism, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatism, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatism, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatism, Beijing, China 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany Pascoe Naturmedizin, Gie√üen, 35394 Germany Institute of Employment Research, Nuremberg, Germany 0000 0004 0380 0396grid.416464.5Martha Maria, Nuremberg, Germany 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany 0000 0004 0572 0285grid.461810.aSynlab, Weiden, Germany Thuringia Clinic, Saalfeld, Germany Department of Nutritional Medicine, Sachsenhausen, Germany 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany Pascoe Naturmedizin, Gie√üen, 35394 Germany 0000 0001 2107 3311grid.5330.5University of Erlangen, Erlangen, 91054 Germany Thuringia Clinic, Saalfeld, Germany Pascoe Naturmedizin, Gie√üen, 35394 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Breast Unit, Kliniken Essen-Mitte, Essen, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0000 9024 6397grid.412581.bDepartment of Health, Institute for Integrative Medicine, Witten/Herdecke University, Herdecke, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Acadamy of Chinese Medicine Sciences, Beijing, China 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The  Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The  Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The  Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The  Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1937 0482grid.10784.3aHong Kong Institute of Integrative Medicine, The  Chinese University of Hong Kong, Hong Kong, 852 Hong Kong 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton, SO17 1BJ UK 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton, SO17 1BJ UK 0000 0004 1936 9297grid.5491.9Faculty of Health Sciences, University of Southampton, Southampton, SO17 1BJ UK 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton, SO17 1BJ UK 0000 0004 1936 9297grid.5491.9Psychology, University of Southampton, Southampton, SO17 1BJ UK 0000 0004 1936 9297grid.5491.9Primary Medical Care, University of Southampton, Southampton, SO16 5ST UK 0000 0004 0489 9631grid.417783.eAnglo-European College of Chiropractic, Bournemouth, BH5 2DF UK Back2Health, Southsea, PO4 0DW UK 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 133-791 South Korea 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, 02447 South Korea 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, 02447 South Korea 0000 0004 0604 5314grid.278247.cTaipei Veterans General Hospital, Taipei, Taiwan 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul, 02447 South Korea grid.464297.aDepartment of Endocrinology, Guang‚Äôanmen Hospital China Academy of Chinese Medical Sciences, Beijing, 100053 China grid.464297.aDepartment of Endocrinology, Guang‚Äôanmen Hospital China Academy of Chinese Medical Sciences, Beijing, 100053 China grid.464297.aDepartment of Endocrinology, Guang‚Äôanmen Hospital China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea 0000 0004 0533 2258grid.412417.5Sangji University Korean Medicine Hospital, Wonju, South Korea 0000 0004 0533 259Xgrid.443977.aSemyung University, Jecheon, South Korea 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea 0000 0001 0523 5122grid.411948.1Daejeon University, Daejeon, South Korea 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea 0000 0001 2171 7818grid.289247.2Kyung Hee University, Seoul, 02447 South Korea 0000000121858338grid.10493.3fComplementary Medicine, University of Medicine Rostock, Rostock, 18057 Germany 0000000121858338grid.10493.3fComplementary Medicine, University of Medicine Rostock, Rostock, 18057 Germany Strandklinik Boltenhagen, Boltenhagen, Germany 0000000121858338grid.10493.3fComplementary Medicine, University of Medicine Rostock, Rostock, 18057 Germany 0000000113287408grid.13339.3bDepartment of Medical Psychology, Medical University of Warsaw, Warsaw, 02-091 Poland 0000000113287408grid.13339.3bDepartment of Medical Psychology, Medical University of Warsaw, Warsaw, 02-091 Poland 0000000113287408grid.13339.3bDepartment of Medical Psychology, Medical University of Warsaw, Warsaw, 02-091 Poland Department of Internal and Complementary Medicine, Immanuel Hospital Berlin, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Charit√© - University Medical Center, Berlin, 10117  Germany Department of Internal and Complementary Medicine, Immanuel Hospital Berlin, Berlin, 14109 Germany Department of Internal and Complementary Medicine, Immanuel Hospital Berlin, Berlin, 14109 Germany Department of Internal and Complementary Medicine, Immanuel Hospital Berlin, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Charit√© - University Medical Center, Berlin, 10117  Germany Department of Internal and Complementary Medicine, Immanuel Hospital Berlin, Berlin, 14109 Germany 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fGuang An Men Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China Louis Bolk Institute, Driebergen, 3972LA Netherlands Louis Bolk Institute, Driebergen, 3972LA Netherlands IFAEMM at the Witten/Herdecke University, Freiburg, Germany IFAEMM at the Witten/Herdecke University, Freiburg, Germany 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan 0000 0001 2242 4849grid.177174.3Department of General Internal Medicine, Kyushu University, Fukuoka, Japan 0000 0004 0404 8415grid.411248.aSleep Apnea Center, Kyushu University Hospital, Fukuoka, Japan 0000 0001 2242 4849grid.177174.3Community Medicine Education Unit, Graduate School Of Medical Science, Kyushu University, Fukuoka, 812-8582 Japan Innovation & Development, Phytomedicines Supply and development Center, Steigerwald Arzneimittelwerk GmbH, Bayer Consumer Health, Darmstadt, 64295 Germany 0000 0001 2155 0333grid.7645.0Food Chemistry and Toxicology, University of Kaiserslautern, Kaiserslautern, 67663 Germany 0000 0001 2155 0333grid.7645.0Food Chemistry and Toxicology, University of Kaiserslautern, Kaiserslautern, 67663 Germany 0000 0001 2155 0333grid.7645.0Food Chemistry and Toxicology, University of Kaiserslautern, Kaiserslautern, 67663 Germany OSU, Blacklick, 43004 OH USA OSU, Blacklick, 43004 OH USA OSU, Blacklick, 43004 OH USA 0000 0001 2285 7943grid.261331.4College of Medicine, OSU, Columbus, 43210 OH USA OSU, Blacklick, 43004 OH USA OSU, Blacklick, 43004 OH USA 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, Medical Center ‚Äì University of Freiburg, Freiburg, 79106 Germany 0000 0004 0386 9924grid.32224.35Massachusetts General Hospital, Boston, MA USA 0000 0000 9428 7911grid.7708.8Clinical Trials Unit Freiburg, Medical Center ‚Äì University of Freiburg, Freiburg, Germany 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, Medical Center ‚Äì University of Freiburg, Freiburg, 79106 Germany 0000 0001 1364 9317grid.49606.3dGraduate School of Public Policy, Hanyang University, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary 0000 0001 1015 7851grid.129553.9Department of Pharmacology and Toxicology, Szent  Istvan University Faculty of Veterinary Science, Budapest, 1078 Hungary 0000 0001 0942 9821grid.11804.3c1st Department of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, 1085 Hungary Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany 0000 0000 9024 6397grid.412581.bIntegrative Medicine, Witten/Herdecke University, Witten/Herdecke, Germany Society for Clinical Research, Berlin, Germany Research Institute Havelh√∂he, Berlin, 14089 Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University, Berlin, 10117 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany 0000 0000 9024 6397grid.412581.bIntegrative Medicine, Witten/Herdecke University, Witten/Herdecke, Germany 0000 0000 9024 6397grid.412581.bIntegrative Medicine, Witten/Herdecke University, Witten/Herdecke, Germany Society for Clinical Research, Berlin, Germany Research Institute Havelh√∂he, Berlin, 14089 Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University, Berlin, Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands 0000 0001 1530 0805grid.29050.3eNursing, Mid-Sweden University, Sundsvall, Sweden Naturopathy and Integrative Medicine, Department of Gynaecological Endocrinology  and Reproductive Medicine, University Women‚Äôs Hospital Heidelberg, Heidelberg, Germany Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands Health Care and Nutrition, Louis Bolk Institute, Driebergen, 3972LA Netherlands 0000 0001 2171 7818grid.289247.2Preventive Medicine, Kyung Hee University, Seoul, 02447 South Korea 0000 0004 0533 2258grid.412417.5Korean Internal Medicine, Sangji University, Wonju, South Korea 0000 0004 0533 259Xgrid.443977.aKorean Internal Medicine, Semyung University, Jecheon, South Korea 0000 0004 0647 2973grid.256155.0Korean Internal Medicine, Gachon University, Seongnam, South Korea 0000 0004 0647 2973grid.256155.0Rehabilitation Medicine, Gachon University, Seongnam, South Korea 0000 0001 2171 7818grid.289247.2Preventive Medicine, Kyung Hee University, Seoul, 02447 South Korea 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany grid.459714.aDepartment of Gynecology, Malteser Hospital St. Anna, Duisburg, Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Interdisclipinary Breast Cancer Center, Kliniken  Essen-Mitte, Essen, Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany 0000 0001 0006 4176grid.461714.1Department of Internal and Integrative Medicine,  Kliniken Essen-Mitte, Essen, 45276 Germany grid.449761.9University of Applied Sciences Leiden, Leiden, 2333CK Netherlands grid.449761.9University of Applied Sciences Leiden, Leiden, 2333CK Netherlands 0000 0001 0943 3265grid.12295.3dScientific Centre for Transformation in Care and  Welfare (Tranzo), Tilburg University, Leiden, Netherlands 0000 0001 2108 9006grid.7307.3Sport sciences, University of Augsburg, Augsburg, 86135 Germany 0000 0001 2108 9006grid.7307.3Sport sciences, University of Augsburg, Augsburg, 86135 Germany 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland, CA 94612 USA 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland, CA 94612 USA 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland, CA 94612 USA 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland, CA 94612 USA 0000 0000 9957 7758grid.280062.eDivision of Research, Kaiser Permanente, Oakland, CA 94612 USA 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0000 9024 6397grid.412581.bDepartment of Psychology and Psychotherapy, University of Witten/Herdecke, Witten, Germany 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 8606grid.26790.3aDepartment of Public Health Sciences, University  of Miami, Miami, FL USA 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0000 9024 6397grid.412581.bDepartment of Psychology and Psychotherapy, University of Witten/Herdecke, Witten, Germany 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0001 0860 4915grid.63054.34Department of Psychology, University of Connecticut, Storrs, CT USA 0000 0000 9320 7537grid.1003.2School of Public Health, University of Queensland,  Herston, QLD Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), University of Technology Sydney, Ultimo, 2007 Australia Praxisklinik M√ºnchen, Munich, 81547 Germany 0000 0001 0196 8249grid.411544.1Abt. Innere Medizin VI - Psychosomatische Medizin und Psychotherapie, Universit√§tsklinikum T√ºbingen, T√ºbingen, 72076 Germany Acupuncture & Meridian Science Research Center, Seoul, 130-701 South Korea 0000 0001 2171 7818grid.289247.2Kyung Hee University, College of Korean Medicine, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Clinical Korean Medicine, Kyung Hee University, Graduate School, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Clinical Korean Medicine, Kyung Hee University, Graduate School, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean Internal Medicine, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean Internal Medicine, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean Internal Medicine, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean Internal Medicine, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean Internal Medicine, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean Internal Medicine, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Korean Internal Medicine, Seoul, South Korea 0000 0000 8653 1507grid.412301.5Cardiovascular Engineering, Helmholtz Institute of RWTH Aachen University & Hospital, Aachen, 52074 Germany 0000 0004 0533 2258grid.412417.5Oriental biomedical engineering, Sangji University, Wonju, 26339 South Korea 0000 0004 0533 2258grid.412417.5Oriental biomedical engineering, Sangji University, Wonju, 26339 South Korea 0000 0000 8653 1507grid.412301.5Cardiovascular Engineering, Helmholtz Institute of RWTH Aachen University & Hospital, Aachen, 52074 Germany 0000 0000 8653 1507grid.412301.5Cardiovascular Engineering, Helmholtz Institute of RWTH Aachen University & Hospital, Aachen, 52074 Germany 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 USA 0000 0004 0367 5222grid.475010.7Boston University School of Medicine, Boston, USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 USA 0000 0004 0367 5222grid.475010.7Boston University School of Medicine, Boston, USA 0000 0001 2183 6745grid.239424.aFamily Medicine, Boston University Medical Center, Boston, 02118 USA 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang  Hospital, Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang  Hospital, Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang  Hospital, Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang  Hospital, Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang  Hospital, Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine Dong Fang  Hospital, Chinese Medicine, Beijing, China 0000 0000 8550 1509grid.418737.eEdward Via College of Osteopathic Medicine, Auburn, AL USA 0000 0001 2299 3507grid.16753.36Northwestern University, Evanston, IL USA 0000 0001 2297 8753grid.252546.2Auburn University, Auburn, AL USA 0000 0004 1937 0722grid.11899.38Internal Medicine-General Internal Medicine and Semiology, University of S√£o Paulo-School of Medicine, S√£o Paulo, 01218011 Brazil 0000 0001 0514 7202grid.411249.bPublic Health, Brazilian Center for Mindfulness and Health Promotion ‚Äì UNIFESP, S√£o Paulo, 04753-060 Brazil 0000 0004 1937 0722grid.11899.38Internal Medicine-General Internal Medicine and Semiology, University of S√£o Paulo-School of Medicine, S√£o Paulo, 01218011 Brazil Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, University Medical  Center, Freiburg, 79106 Germany Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, University Medical  Center, Freiburg, 79106 Germany 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, University Medical  Center, Freiburg, 79106 Germany Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany Department of Pharmacology and Clinical Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany Department of Pharmacology and Clinical Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany Department of Pharmacology and Clinical Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, University Medical  Center, Freiburg, 79106 Germany 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, University Medical  Center, Freiburg, 79106 Germany Department of Analytical Development and Research, Wala Heilmittel GmbH, Bad Boll/Eckwaelden, 73087 Germany 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China 0000 0004 1757 641Xgrid.440665.5The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China 0000 0004 0386 9924grid.32224.35Harvard Medical School/ Massachusetts General Hospital, Boston, 02114 MA USA 0000 0004 0386 9924grid.32224.35Harvard Medical School/ Massachusetts General Hospital, Boston, 02114 MA USA 0000 0004 0386 9924grid.32224.35Benson-Henry Institute for Mind-Body Medicine, Massachusetts General Hospital, Boston, MA USA 0000 0004 1936 8606grid.26790.3aUniversity of Miami, Miami, FL USA 0000 0004 0386 9924grid.32224.35Harvard Medical School/ Massachusetts General Hospital, Boston, 02114 MA USA 0000 0004 0386 9924grid.32224.35Harvard Medical School/Massachusetts General Hospital, Boston, 02114 MA USA 0000 0004 0386 9924grid.32224.35Harvard Medical School/Massachusetts General Hospital, Boston, 02114 MA USA 0000 0004 0386 9924grid.32224.35Harvard Medical School/Massachusetts General Hospital, Boston, 02114 MA USA grid.412353.2Division of Pediatric Hematology/Oncology, University Children‚Äôs Hospital, Bern, Switzerland 0000 0001 0726 5157grid.5734.5Institute of Complementary Medicine, University, Bern, Switzerland 0000 0001 0726 5157grid.5734.5Institute of Complementary Medicine, University, Bern, Switzerland 0000 0001 0726 5157grid.5734.5Institute of Complementary Medicine, University, Bern, Switzerland Dongfang Hospital of Beijing University of Traditional Medicine, Clinical, Beijing, China Dongfang Hospital of Beijing University of Traditional Medicine, Clinical, Beijing, China 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Health Sciences, University of Florence, viale Pieraccini 6, 50139 Florence, Italy 0000 0004 1757 2304grid.8404.8Department of Experimental and Clinical Medicine, University of Florence, Florence, viale Pieraccini 6, 50139 Florence, Italy Referring Center for Phytotherapy, Centre for Integrative Medicine - Careggi, Universitary Hospital, 50139 Florence, Italy 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of  Southampton, Southampton, SO16 5ST UK 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of  Southampton, Southampton, SO16 5ST UK 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK Rebuilding Your Life Project, Oxford, UK 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of  Southampton, Southampton, SO16 5ST UK 0000 0004 1936 9297grid.5491.9Primary Care and Population Science, University of  Southampton, Southampton, SO16 5ST UK Rebuilding Your Life Project, Oxford, UK Oxfordshire CFS/ME Service, Oxford, UK 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK 0000 0000 8761 3918grid.266218.9University of Cumbria, Carlisle, UK 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China grid.459365.8Department of Rheumatology, Beijing Hospital of Traditional Chinese  Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Nephrology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China Department of Traditional Chinese Medicine, Xiluoyuan Community Health Service Center of Fengtai Distict, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland 0000 0004 0478 9977grid.412004.3Institute for Complementary and Integrative Medicine, UniversityHospital Zurich, Zurich, 8091 Switzerland 0000 0001 1015 399Xgrid.412680.9Institute for Integrative Medicine, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, 31000 Croatia APIPHARMA Ltd., Zagreb, Croatia 0000 0001 1015 399Xgrid.412680.9Institute for Integrative Medicine, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, 31000 Croatia 0000 0001 1015 399Xgrid.412680.9Department of Internal Medicine, Family Medicine  and Medical History, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia 0000 0001 1015 399Xgrid.412680.9Institute for Integrative Medicine, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, 31000 Croatia 0000 0001 1015 399Xgrid.412680.9Department of Internal Medicine, Family Medicine  and Medical History, Faculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 1364 9317grid.49606.3dHanyang University, College of Medicine, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, Seoul, South Korea 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of Pharmacy, BVDU, Pune, India 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of Pharmacy, BVDU, Pune, India 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of Pharmacy, BVDU, Pune, India 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of Pharmacy, BVDU, Pune, India 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of Pharmacy, BVDU, Pune, India Indus Biotech Private Limited, Pune, India 0000 0004 0503 0903grid.411681.bDepartment of Pharmacology, Poona College of Pharmacy, BVDU, Pune, India 0000 0001 2287 3919grid.257413.6Health Sciences, Indiana University School of Health and Rehabilitation Sciences, Indianapolis, 46202 IN USA 0000 0001 2287 3919grid.257413.6Health Sciences, Indiana University School of Health and Rehabilitation Sciences, Indianapolis, 46202 IN USA 0000 0000 9681 3540grid.280828.8Roudebush VA Medical Center, Indianapolis, IN USA 0000 0000 9681 3540grid.280828.8Roudebush VA Medical Center, Indianapolis, IN USA 0000 0001 2287 3919grid.257413.6Health Sciences, Indiana University School of Health and Rehabilitation Sciences, Indianapolis, 46202 IN USA 0000000122595234grid.10919.30Department of Community Medicine, National Research  Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University of Norway, UiT, Troms√∏, 9037 Norway 0000000122595234grid.10919.30Department of Community Medicine, National Research  Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University of Norway, UiT, Troms√∏, 9037 Norway 0000 0004 1936 834Xgrid.1013.3National Institute of Complementary Medicine, Western Sydney University, Sydney, Australia 0000 0000 9024 6397grid.412581.bInstitute for Applied Epistemology and Medical Methodology, University of Witten-Herdecke, Herdecke, Germany 0000000122595234grid.10919.30Department of Community Medicine, National Research  Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University of Norway, UiT, Troms√∏, 9037 Norway Dental Biomaterials Adverse Reaction Unit, Uni Health, Uni Research, Bergen, Norway 0000000122595234grid.10919.30Department of Community Medicine, National Research  Center in Complementary and Alternative Medicine, NAFKAM, The Arctic University of Norway, UiT, Troms√∏, 9037 Norway 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fInstitute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 1799 2712grid.412635.7Endocrinology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China grid.464481.bDigestion, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China Obesity Research Center, Beijing Wuguanda Biological Technology co., LTD., Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0001 1431 9176grid.24695.3cTraditional Chinese Medicine, Centre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, Beijing, China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 0632 3409grid.410318.fDepartment of Endocrinology, Guang anmen Hospital of China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia 0000 0001 2187 5445grid.5718.bFaculty of Medicine, University of Duisburg-Essen,  Essen, Germany 0000 0000 9320 7537grid.1003.2School of Public Health, University of Queensland,  Brisbane, Australia 0000 0004 1936 7611grid.117476.2Faculty of Health, University of Technology Sydney, Sydney, 2007 Australia grid.17089.37University of Alberta, Edmonton, T6G 2C8 Canada 0000 0004 0473 5995grid.418591.0Canadian Memorial Chiropractic College, Toronto,  Canada grid.17089.37University of Alberta, Edmonton, T6G 2C8 Canada 0000 0000 9130 6822grid.25055.37Memorial University of Newfoundland, St. John‚Äôs,  Canada New Brunswick Chiropractors‚Äô Association, Fredericton, Canada Ontario Chiropractic Association, Toronto, Canada Ontario Chiropractic Association, Toronto, Canada Newfoundland & Labrador Chiropractic Association, St. John‚Äôs, Canada 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada grid.17089.37University of Alberta, Edmonton, T6G 2C8 Canada ARESMA, Milano, Italy 0000 0004 1757 2822grid.4708.bDepartment of Philosophy, University of Milano, Milano, Italy ARESMA, Milano, Italy 0000 0004 1757 2822grid.4708.bDepartment of Economics, Management and Quantitative Methods, University of Milano, DEMM, Milano, Italy 0000 0000 9024 6397grid.412581.bInstitute for Integrative Medicine, Witten/Herdecke University, Herdecke, 58313 Germany H:G - Hochschule f√ºr Gesundheit und Sport GmbH, Berlin, 10367 Germany H:G - Hochschule f√ºr Gesundheit und Sport GmbH, Berlin, 10367 Germany grid.37828.36Institute of Family Medicine, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, 23570 Germany 0000 0001 2111 7257grid.4488.0Technische Universit√§t Dresden, Medizinische Fakult√§t Carl Gustav Carus, Dresden, Germany Koordinierungszentrum f√ºr klinische Studien, Dresden, Germany 0000 0001 1091 2917grid.412282.fUniversit√§tsklinikum Carl Gustav Carus, Klinik und Poliklinik f√ºr Kinder- und Jugendmedizin, Dresden, Germany 0000 0001 1091 2917grid.412282.fUniversit√§tsklinikum Carl Gustav Carus, Klinik und Poliklinik f√ºr Kinder- und Jugendmedizin, Dresden, Germany Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador Pascoe Naturmedizin, Gie√üen, 35394 Germany Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador Clinical Nutrition and Dietetics, SOLCA Cancer Hospital, Guayaquil, 000 Ecuador Department of Natural Medicine, Immanuel Krankenhaus Berlin-Wannsee, Berlin, 14109 Germany 0000 0004 0593 1824grid.440934.eNaturheilkunde und Komplement√§re Medizin, Hochschule Fresenius, Idstein (Taunus), Germany Department of Natural Medicine, Immanuel Krankenhaus Berlin-Wannsee, Berlin, 14109 Germany Iranian Traditional Medicine, Mashhad Medical University, Mashhad, 9172314 Islamic Republic of Iran 0000 0001 2198 6209grid.411583.aDepartment of Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, 9135913556 Islamic Republic of Iran 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), Faculty of Health, University of Technology Sydney, Sydney, New South Wales Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), Faculty of Health, University of Technology Sydney, Sydney, New South Wales Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), Faculty of Health, University of Technology Sydney, Sydney, New South Wales Australia 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, 45276 Germany Chinese Medicine, Heidelberg School of Chinese Medicine, Heidelberg, Germany 0000 0001 1503 7226grid.5808.5Traditional Chinese Medicine, Institute of Biomedical Sciences Abel Salazar, University of Porto, Porto, Portugal 0000 0004 1937 0650grid.7400.3Department of Systematic and Evolutionary Botany, University of Zurich, Z√ºrich, 8008 Switzerland 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, 04763 South Korea 0000 0001 1364 9317grid.49606.3dHealthcare Administration, Hanyang University, Seoul, 133-791 South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, Seoul, South Korea 0000 0001 2240 3300grid.10388.32Medizinische Klinik III, UKB, Friedrich Wilhelms-Universit√§t Bonn, Bonn, 53127 Germany 0000 0001 2240 3300grid.10388.32Medizinische Klinik III, UKB, Friedrich Wilhelms-Universit√§t Bonn, Bonn, 53127 Germany Phytomeidines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH, Bayer Consumer Health, Darmstadt, 64295 Germany Bayer Consumer Health, Medicial Affairs, Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany 0000 0001 2171 9311grid.21107.35Pediatrics, Johns Hopkins School of Medicine, Baltimore, 21224 MD USA 0000 0001 2171 9311grid.21107.35Mental Health, Johns Hopkins School of Public Health, Baltimore, MD USA 0000 0001 2171 9311grid.21107.35Johns Hopkins School of Public Health, Baltimore, MD USA 0000 0000 9151 4445grid.412414.6Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences, Oslo, 0130 Norway 0000 0000 9151 4445grid.412414.6Faculty of Health Sciences, Oslo and Akershus University College of Applied Sciences, Oslo, 0130 Norway 0000 0001 0722 6377grid.254230.2Department of Nursing, Chungnam National University, Daejeon, 301747 South Korea 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard Medical School and Brigham and Women‚Äôs Hospital, Boston, MA 02215 USA 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard Medical School and Brigham and Women‚Äôs Hospital, Boston, MA 02215 USA 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Harvard Medical  School, Boston, MA USA 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Harvard Medical  School, Boston, MA USA Nursing, Woosong College, Daejeon, South Korea 0000 0004 1937 0546grid.12136.37Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv-Yafo, Israel 000000041936754Xgrid.38142.3cNeurology, Harvard Medical School, Boston, MA USA 0000 0004 0378 8294grid.62560.37Neurology, Brigham and Women‚Äôs Hospital, Boston,  MA USA 000000041936754Xgrid.38142.3cNeurology, Harvard Medical School, Boston, MA USA 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard Medical School and Brigham and Women‚Äôs Hospital, Boston, MA 02215 USA 0000 0004 0386 9924grid.32224.35Massachusetts General Hospital, Boston, MA USA 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, Harvard Medical School and Brigham and Women‚Äôs Hospital, Boston, MA 02215 USA 0000 0001 0722 6377grid.254230.2Department of Nursing, Chungnam National University, Daejeon, 301747 South Korea 0000 0004 0647 2279grid.411665.1Chungnam National University Hospital, Daejeon, South Korea 0000 0001 0722 6377grid.254230.2Department of Nursing, Chungnam National University, Daejeon, 301747 South Korea 0000 0001 2293 5761grid.257409.dKinesiology, Recreation and Sport, Indiana State  University, Terre Haute, IN USA 000000041936754Xgrid.38142.3cHarvard Medical School, Boston, MA 02215 USA 0000 0004 0647 2279grid.411665.1Chungnam National University Hospital, Daejeon, South Korea National Ayurvedic Medical Association of Russia, Novosibirsk, 630108 Russian Federation Clinical Naturopathy, Charit√© Institute of Social Medicine, Epidemiologiy and Health Economics, Berlin, 14109 Germany Charit√© Institute of Biochemistry, Berlin, 10117 Germany Charit√© Institute of Biochemistry, Berlin, 10117 Germany Clinical Naturopathy, Charit√© Institute of Social Medicine, Epidemiologiy and Health Economics, Berlin, 14109 Germany Charit√© Institute of Biochemistry, Berlin, 10117 Germany Clinical Naturopathy, Charit√© Institute of Social Medicine, Epidemiologiy and Health Economics, Berlin, 14109 Germany Clinical Naturopathy, Charit√© Institute of Social Medicine, Epidemiologiy and Health Economics, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute of Social medicine, Epidemiologiy and Health Economics, Charit√© University Hospital, Berlin, 14109 Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, 10117 Germany 0000 0004 1936 7558grid.189504.1Psychiatry, Boston University School of Mediicine, Boston, 02118 MA USA 0000 0001 0728 151Xgrid.260917.bPsychiatry, New York Medical College, Valhalla, 10955 NY USA 0000 0004 1936 7558grid.189504.1Psychiatry, Boston University School of Mediicine, Boston, 02118 MA USA Psychiatry, Columbia College of Surgeon, New York, NY USA 000000041936754Xgrid.38142.3cPsychiatry, Harvard University, Belmont, CA USA 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and  Hematology, Charit√© Universit√§tsmedizin Berlin, Berlin, 13353 Germany 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and  Hematology, Charit√© Universit√§tsmedizin Berlin, Berlin, 13353 Germany 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and  Hematology, Charit√© Universit√§tsmedizin Berlin, Berlin, 13353 Germany 0000 0000 9024 6397grid.412581.bInstitute for Integrative Medicine, Gemeinschaftskrankenhaus Herdecke, Witten/Herdecke University, Witten/Herdecke, Germany 0000 0001 2218 4662grid.6363.0Department of Pediatrics, Division of Oncology and  Hematology, Charit√© Universit√§tsmedizin Berlin, Berlin, 13353 Germany 0000 0001 2218 4662grid.6363.0Institute of Public Health, Charit√© Universit√§tsmedizin Berlin, Berlin, Germany 0000 0001 1431 9176grid.24695.3cCenter for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0004 1759 3543grid.411858.1Guangxi university of Chinese Medicine Affiliated Hospital, Guangxi, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0004 1759 3543grid.411858.1Guangxi university of Chinese Medicine Affiliated Hospital, Guangxi, China 0000 0001 2112 2291grid.4756.0Faculty of Health and Social Care, London South Bank University, London, UK 0000 0001 1431 9176grid.24695.3cCenter for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, 100029 China Institute for Integrative Medicine, Catholic Kwandong University International St. Mary‚Äôs Hospital, Incheon, South Korea Institute for Integrative Medicine, Catholic Kwandong University International St. Mary‚Äôs Hospital, Incheon, South Korea 0000 0004 0533 259Xgrid.443977.aInternal Medicine, Semyung University, Chungju, South Korea 0000 0004 0533 259Xgrid.443977.aInternal Medicine, Semyung University, Jecheon, South Korea 0000 0001 0098 1097grid.453028.8Korean Medicine, Korea Health Industry Development Institute, Osong, South Korea 0000 0004 0533 259Xgrid.443977.aInternal Medicine, Semyung University, Chungju, South Korea 0000 0001 2171 7818grid.289247.2Internal Medicine, Kyunghee University, Seoul, South Korea Institute for Integrative Medicine, Catholic Kwandong University International St. Mary‚Äôs Hospital, Incheon, South Korea MOA Health Science Foundation, President, Tokyo, Japan 0000 0004 0373 3971grid.136593.bOsaka University School of Medicine, Integrative  Medicine, Osaka, Japan MOA Health Science Foundation, Tokyo, Japan Japan Society of Integrative Medicine, Tokyo, Japan Japan Society of Integrative Medicine, Tokyo, Japan 0000 0004 1769 2015grid.412075.5Kampo medicine outpatient clinic, Mie University  Hospital, Tsu, 24201 Japan 0000 0004 1769 2015grid.412075.5Pain Clinic, Mie University Hospital, Tsu, 24201  Japan 0000 0004 1769 2015grid.412075.5Kampo medicine outpatient clinic, Mie University  Hospital, Tsu, 24201 Japan Department of Family Medicine, School of Medicine, Pontifica Cniversidad Cat√≥lica de Chile, Santiago, 8330077 Chile 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© - Universit√§tsmedizin Berlin, Berlin, Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Hospital Havelh√∂he, Berlin, Germany Hospital Havelh√∂he, Berlin, Germany Research Institute Havelh√∂he, Berlin, 14089 Germany grid.464297.aGuang‚Äôanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053 China grid.464297.aGuang‚Äôanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053 China grid.256883.2Hebei Medical University Pharmaceutical Research Institute, Shijiazhuang, 050017 China grid.464297.aGuang‚Äôanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, The Preclinical medicine Institute, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, The Preclinical medicine Institute, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0004 0632 3409grid.410318.fAcupuncture, Xiyuan Hospital CACMS, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0004 0378 8294grid.62560.37Brigham and Women‚Äôs Hospital, Medicine, Boston, MA USA Kripalu Center for Yoga & Health, Stockbridge, MA USA 0000 0000 8739 9261grid.413636.5Allina Health, Minneapolis, MN USA Kripalu Center for Yoga & Health, Stockbridge, MA USA 0000 0004 0378 8294grid.62560.37Brigham and Women‚Äôs Hospital, Medicine, Boston, MA USA 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Centre of Integrative Gastroenterology, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Centre of Integrative Gastroenterology, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2187 5445grid.5718.bDepartment of Internal and Integrative Medicine, Centre of Integrative Gastroenterology, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital, Providence, 02906 RL USA 0000 0004 1936 9094grid.40263.33Brown University, Providence, RL USA Independent Yoga Consultant, Providence, RL USA 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital, Providence, 02906 RL USA 0000 0001 2107 4242grid.266100.3UCSD, San Diego, CA USA 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital, Providence, 02906 RL USA 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital, Providence, 02906 RL USA 0000 0001 0557 9478grid.240588.3Rhode Island Hospital, Providence, RL USA 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital, Providence, 02906 RL USA 0000 0000 8593 9332grid.273271.2Psychosocial Research, Butler Hospital, Providence, 02906 RL USA 0000 0000 9560 654Xgrid.56061.34Social and Behavioral Sciences, School of Public  Health, University of Memphis, Memphis, 38152 TN USA 0000 0000 9560 654Xgrid.56061.34Social and Behavioral Sciences, University of Memphis, School of Public Health, Memphis, 38152 TN USA 0000 0000 9560 654Xgrid.56061.34Exercise, Sport and Movement Science, University  of Memphis, School of Health Studies, Memphis, TN USA Health Solutions, Pune, India Health Solutions, Pune, India Clinic, Vila Velha, 29102010 Brazil Clinic, Vila Velha, 29102010 Brazil Clinic, Vila Velha, 29102010 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-03 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-03 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-03 Brazil VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia Private Practice ‚ÄúAstrocit‚Ä?, Vrsac, Serbia Private Practice ‚ÄúDr Jevdic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Health care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Center for Integrative Procedures and Supplements ‚ÄúDr Dunjic‚Ä?, Belgrade, Serbia VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia Private Practice ‚ÄúAstrocit‚Ä?, Vrsac, Serbia Private Practice ‚ÄúDr Jevdic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia ‚ÄúPlanet Zdravja‚Ä?, Ljubljana, Slovenia ‚ÄúPlanet Zdravja‚Ä?, Ljubljana, Slovenia Center for Integrative Procedures and Supplements ‚ÄúDr Dunjic‚Ä?, Belgrade, Serbia VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia Private Practice ‚ÄúAstrocit‚Ä?, Vrsac, Serbia Private Practice ‚ÄúDr Jevdic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia ‚ÄúPlanet Zdravja‚Ä?, Ljubljana, Slovenia ‚ÄúPlanet Zdravja‚Ä?, Ljubljana, Slovenia Center for Integrative Procedures and Supplements ‚ÄúDr Dunjic‚Ä?, Belgrade, Serbia VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia Private Practice ‚ÄúAstrocit‚Ä?, Vrsac, Serbia Private Practice ‚ÄúDr Jevdic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia ‚ÄúPlanet Zdravja‚Ä?, Ljubljana, Slovenia ‚ÄúPlanet Zdravja‚Ä?, Ljubljana, Slovenia Center for Integrative Procedures and Supplements ‚ÄúDr Dunjic‚Ä?, Belgrade, Serbia VISAN - Sanitary Medical School of Applied Sciences, Belgrade, 11000 Serbia Private Practice ‚ÄúAstrocit‚Ä?, Vrsac, Serbia Private Practice ‚ÄúDr Jevdic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Special Neuropsychiatric Hospital ‚ÄúDr S. Bakalovic‚Ä?, Vrsac, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia Health Care Center ‚Äú1. Oktobar‚Ä?, Plandiste, Serbia ‚ÄúPlanet Zdravja‚Ä?, Sarajevo, Bosnia and Herzegovina Center for Integrative Procedures and Supplements ‚ÄúDr Dunjic‚Ä?, Belgrade, Serbia 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, 55905 NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, 55905 NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, 55905 NY USA 0000 0001 0674 042Xgrid.5254.6Institute of Public Health, University of Copenhagen, Copenhagen, 1353 Denmark Naturopathy & Complementary Medicine, Carl Remigius Medical School, Idstein, 65510 Germany Naturopathy & Complementary Medicine, Carl Remigius Medical School, Idstein, 65510 Germany Naturopathy & Complementary Medicine, Carl Remigius Medical School, Idstein, 65510 Germany 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, General Internal Medicine, Rochester, NY USA 0000 0001 2205 0971grid.22254.33Pediatric Gastroenterology, Poznan Medical University, Poznan, 60-572 Poland 0000 0004 1936 7988grid.4305.2Department of Psychology, University of Edinburgh,  Edinburgh, UK 0000 0001 2205 0971grid.22254.33Pediatric Gastroenterology, Poznan Medical University, Poznan, 60-572 Poland 0000 0000 8988 2476grid.11598.34Institute of Pathophysiology, Medical University  Graz, Graz, Austria 0000 0001 1941 5140grid.9970.7Department of Traumatology, University of Linz, Linz, Austria 0000 0001 1941 5140grid.9970.7Department of Radiology, University of Linz, Linz,  Austria 0000000110156330grid.7039.dSports Science, University of Salzburg, Salzburg, Austria 0000000110156330grid.7039.dSports Science, University of Salzburg, Salzburg, Austria 0000000110156330grid.7039.dSports Science, University of Salzburg, Salzburg, Austria 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0004 0632 3409grid.410318.fEmergency Department, Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, China grid.459365.8Department of Rheumatology, Beijing Hospital of Traditional Chinese  Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Nephrology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDepartment of Rheumatology, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China grid.445029.eNatural Biotechnology, Nanhua University, Dalin, 622 Taiwan grid.445029.eNatural Biotechnology, Nanhua University, Dalin, 622 Taiwan 0000 0004 1936 9297grid.5491.9Primary Care, University of Southampton, Southhampton, SO16 5ST UK 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, BWH/HMS, Boston, MA USA 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, BWH/HMS, Boston, MA USA 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA USA 000000041936754Xgrid.38142.3cPhysical Medicine & Rehabilitation, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA USA 0000 0004 0378 8294grid.62560.37Osher Center for Integrative Medicine, BWH/HMS, Boston, MA USA 0000 0004 1937 0546grid.12136.37Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 0000 0004 0451 8771grid.416228.bSpaulding Rehabilitation Hospital, Physical Medicine & Rehabilitation, Boston, MA USA 0000 0004 0378 8294grid.62560.37Neurology, Brigham and Women‚Äôs Hospital, Boston,  MA USA 0000 0000 9011 8547grid.239395.7Beth Israel Deaconess Medical Center, Boston, MA  USA 0000 0000 9011 8547grid.239395.7Laboratory of Brain Network Imaging and Modulation, Beth Israel Deaconess Medical Center, Boston, MA USA 0000 0004 0386 9924grid.32224.35Massachusetts General Hospital, Boston, MA USA Regional Cancer Center Stockholm Gotland, Stockholm, Sweden 0000 0004 0623 9776grid.440104.5St G√∂rans Hospital, Stockholm, Sweden 0000 0004 1937 0626grid.4714.6Karolinska Institutet, Stockholm, Sweden Regional Cancer Center Stockholm Gotland, Stockholm, Sweden 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, Institute for Environmental Health Sciences and Hospital Infection Control, Medical Center ‚Äì University of Freiburg, Freiburg, Germany Regional Cancer Center Stockholm Gotland, Stockholm, Sweden Regional Cancer Center Stockholm Gotland, Stockholm, Sweden 0000 0001 0671 5021grid.255168.dPreventive Medicine, College of Korean Medicine,  Dongguk University Graduate School, Seoul, South Korea 0000 0001 0671 5021grid.255168.dPreventive medicine, College of Korean Medicine,  Dongguk University, Gyeongju-si, South Korea 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM Diagnostics, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM Diagnostics, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM Diagnostics, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM Diagnostics, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM Diagnostics, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM Diagnostics, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, TCM Diagnostics, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0004 1936 834Xgrid.1013.3The Children‚Äôs Hospital at Westmead and Discipline  of Paediatrics and Child Health, University of Sydney, Sydney, Australia grid.464297.aGuang‚Äôanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China 0000 0004 1936 8972grid.25879.31Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, USA 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China Journal of Traditional Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  China grid.464481.bDepartment of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China China Association of Traditional Chinese Medicine, Beijing, China Beijing Kawin Technology Share-holding CO., Ltd, Beijing, China 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine, Physiology, Gyeongju-si, South Korea 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine, Physiology, Gyeongju-si, South Korea 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine, Anatomy, Gyeongju-si, South Korea 0000 0001 0671 5021grid.255168.dDongguk University, Division of Bioscience, Gyeongju-si, South Korea 0000 0001 0671 5021grid.255168.dDongguk University College of Korean Medicine, Physiology, Gyeongju-si, South Korea 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007 Australia 0000 0004 1936 7611grid.117476.2University of Technology Sydney, Ultimo, 2007 Australia Catholic Kwandong University Int St.Mary‚Äôs Hospital, Integrative Medicine, Incheon, South Korea 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University, Korean Internal Medicine, Chungju, South Korea 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University, Korean Internal Medicine, Jecheon, South Korea 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University, Korean Internal Medicine, Chungju, South Korea 0000 0001 0098 1097grid.453028.8Korea Health Industry Development Institute, Korean Medicine, Osong, South Korea 0000 0004 0533 259Xgrid.443977.aCollege of Korean Medicine, Semyung University, Korean Internal Medicine, Chungju, South Korea Catholic Kwandong University Int St.Mary‚Äôs hospital, Incheon, South Korea 0000 0004 0385 0924grid.428397.3Duke-NUS Medical School, Singapore, Singapore 0000 0004 0385 0924grid.428397.3Duke-NUS Medical School, Singapore, Singapore 0000 0001 2180 6431grid.4280.eNational University of Singapore, Singapore, Singapore OneHeartBeat Percussions, Singapore, Singapore 0000 0000 8958 3388grid.414963.dKK Women‚Äôs and Children‚Äôs Hospital, Singapore, Singapore 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, South Korea 0000 0001 1364 9317grid.49606.3dGlobal Health and Development, Hanyang University, College of Medicine, Seoul, South Korea 0000 0001 0523 5122grid.411948.1Daejeon University, Obstetrics and Gynecology, Daejeon, South Korea 0000 0001 0523 5122grid.411948.1Daejeon University, Daejeon, South Korea 0000 0001 0523 5122grid.411948.1Daejeon University, Obstetrics and Gynecology, Daejeon, South Korea 0000 0004 0647 2973grid.256155.0Gachon University, College of Korean Medicine, Seongnam, South Korea Heliopolis University for Sustainable Development, Medicinal Plants, Nasr City, Egypt 0000 0004 0639 9286grid.7776.1Cairo University, Medicinal Plants, Cairo, Egypt 0000 0004 0639 9286grid.7776.1Cairo University, Medicinal Plants, Cairo, Egypt 0000 0004 0639 9286grid.7776.1Cairo University, Medicinal Plants, Cairo, Egypt grid.464297.aGuang‚Äôanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China grid.464297.aGuang‚Äôanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  China grid.464297.aGuang‚Äôanmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung  Hee University Hospital at Gangdong, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate School, Kyung Hee University, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung  Hee University Hospital at Gangdong, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate School, Kyung Hee University, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Dermatology of Korean Medicine, Kyung Hee University, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate School, Kyung Hee University, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung  Hee University Hospital at Gangdong, Seoul, South Korea FIH-Berlin, Berlin, Germany FIH-Berlin, Berlin, Germany FIH-Berlin, Berlin, Germany 0000 0000 9024 6397grid.412581.bInstitute for Integrative Medicine, University Witten/Herdecke, Witten, Germany 0000 0000 9529 9877grid.10423.34Hannover Medical School, Clinic for Rehabilitative Medicine, Hannover, Germany Society for Clinical Research, Berlin, Germany Internal Medicine, Gemeinschaftskrankenhaus Havelh√∂ne, Berlin, Germany Society for Clinical Research, Berlin, Germany FIH-Berlin, Berlin, Germany FIH-Berlin, Berlin, Germany FIH-Berlin, Berlin, Germany FIH-Berlin, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany FIH-Berlin, Berlin, Germany 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatology, Beijing, China Community Health Service Center of Yangsong Town, Traditional Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Nephrology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Rheumatology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Beijing China, Rheumatology, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Beijing China, Rheumatology, Beijing, China Xiluoyuan Community Health Service Center, Fengtai District, Beijing, China, Traditional Chinese Medicin, Beijing, China Jingzhou Central Hospital of Hubei Province, China, Hubei, China Jingzhou Central Hospital of Hubei Province, China, Hubei, China Jingzhou Central Hospital of Hubei Province, China, Hubei, China Jingzhou Central Hospital of Hubei Province, China, Hubei, China Jingzhou Central Hospital of Hubei Province, China, Hubei, China Jingzhou Central Hospital of Hubei Province, China, Hubei, China Center for Integrative Medicine, University of Maryland, Baltimore, MD USA 0000 0001 2372 7462grid.412540.6Shanghai University of Traditional Chinese Medicine, Shanghai, China 0000 0001 2372 7462grid.412540.6Shanghai University of Traditional Chinese Medicine, Shanghai, China Center for Integrative Medicine, University of Maryland, Baltimore, MD USA 0000 0001 2372 7462grid.412540.6Shanghai University of Traditional Chinese Medicine, Shanghai, China Department of Neural and Pain Sciences, Dental School, University of Maryland, Baltimore, MD USA Center for Integrative Medicine, University of Maryland, Baltimore, MD USA 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000 0001 1431 9176grid.24695.3cSchool of Basic Medical, Beijing University of Chinese Medicine, Beijing, 100029 China 0000000086837370grid.214458.eFamily Medicine, University of Michigan, Ann Arbor,  MI 48105 USA 0000000086837370grid.214458.eFamily Medicine, University of Michigan, Ann Arbor,  MI 48105 USA 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine Hospital, Internal Medicine, Yangsan-si, South Korea 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine Hospital, Internal Medicine, Yangsan-si, South Korea 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine Hospital, Internal Medicine, Yangsan-si, South Korea 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University  Yangsan Hospital, Yangsan, South Korea 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University  Yangsan Hospital, Yangsan, South Korea 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University  Yangsan Hospital, Yangsan, South Korea 0000 0004 0442 9883grid.412591.aDepartment of Urology, Pusan National University  Yangsan Hospital, Yangsan, South Korea 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine Hospital, Internal Medicine, Yangsan-si, South Korea 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine Hospital, Internal Medicine, Yangsan-si, South Korea 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine Hospital, Internal Medicine, Yangsan-si, South Korea 0000 0001 0719 8572grid.262229.fPusan National University Korean Medicine Hospital, Internal Medicine, Yangsan-si, South Korea S. Maugeri Fondation, Pavia, 27100 Italy S. Maugeri Fondation, Pavia, 27100 Italy S. Maugeri Fondation, Pavia, 27100 Italy S. Maugeri Fondation, Pavia, 27100 Italy S. Maugeri Fondation, Pavia, 27100 Italy S. Maugeri Fondation, Pavia, 27100 Italy S. Maugeri Fondation, Pavia, 27100 Italy S. Maugeri Fondation, Pavia, 27100 Italy S. Feliciano Hospital, Outpatient Oncology, Rome, Italy 0000 0004 1936 8403grid.9909.9School of Heathcare, University of Leeds Alumnus, Rochdale, OL12 7RX UK Nursing, Faculty of Health Sciences/University of Granada, Granada, 18971 Spain Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service, Granada, Spain Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service, Granada, Spain Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service, Granada, Spain Physiotherapy Unit, University Hospital San Cecilio/Health Andalusian Service, Granada, Spain Nursing, Faculty of Health Sciences/University of Granada, Granada, 18971 Spain Fundaci√≥ S√†nitaria de Mollet, Surgery, Barcelona, Spain 0000 0004 1767 5311grid.459594.0Hospital de Viladecans, Barcelona, Spain Fundaci√≥ S√†nitaria de Mollet, Surgery, Barcelona, Spain 0000 0004 1764 9746grid.413293.eHospital Royo Villanova, Zaragoza, Spain Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest Toscana, Grosseto, 58100 Italy Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest Toscana, Grosseto, 58100 Italy Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest Toscana, Grosseto, 58100 Italy Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest Toscana, Grosseto, 58100 Italy Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest Toscana, Grosseto, 58100 Italy Hospital Centre of Integrated Medicine, Hospital of Pitigliano ASL Sudest Toscana, Grosseto, 58100 Italy 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, Italy Tuscan Network of Integrative Medicine, Florence, Italy Tuscan Network of Integrative Medicine, Florence, Italy 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy 0000 0004 1759 9494grid.24704.35Referring Centre for Phytotherapy, Center for Integrative Medicine, Careggi Universitary Hospital, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, Italy grid.439673.cRoyal London Hospital for Integrated Medicine, UCLH NHS Trust, London, WC1N 3HR UK grid.439673.cRoyal London Hospital for Integrated Medicine, UCLH NHS Trust, London, WC1N 3HR UK 0000 0004 0612 2754grid.439749.4UCH Cancer Clinical Trials Unit, London, UK 0000 0004 1936 9668grid.5685.eUniversity of York, York, UK 0000 0004 0478 9977grid.412004.3University Hospital Zurich, Zurich, Switzerland 0000 0004 0417 0461grid.424926.fRoyal Marsden Hospital, London, UK 0000 0004 1936 9297grid.5491.9University of Southampton, Southampton, UK IOMED, Lecce, Italy IOMED, Lecce, Italy IOMED, Lecce, Italy IOMED, Lecce, Italy IOMED, Lecce, Italy 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0004 1937 0722grid.11899.38Instituto do Tratamento do C√¢ncer Infantil ‚Äì Department of Pediatric Oncology, Faculdade de Medicina da Universidade de S√£o Paulo, Sao Paulo, 05410-030 Brazil 0000 0001 2218 4662grid.6363.0Department of Pediatric Oncology, Charit√© University Medicine, Berlin, Germany 0000 0004 0415 7072grid.252865.eBastyr University, Kenmore, WA 98028-4966 USA 0000 0004 0415 7072grid.252865.eBastyr University, Kenmore, WA 98028-4966 USA 0000 0004 0415 7072grid.252865.eBastyr University, Kenmore, WA 98028-4966 USA 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine, University of Technology, Sydney, Australia 0000 0004 1936 7611grid.117476.2Australian Research Centre in Complementary and Integrative Medicine, University of Technology, Sydney, Australia 0000 0004 0640 0021grid.14013.37Faculty of Nursing, University of Iceland, Reykjavik, 105 Iceland 0000 0004 0640 0021grid.14013.37Faculty of Nursing, University of Iceland, Reykjavik, 105 Iceland 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz, 71747637 Islamic Republic of Iran Alchemy Health & Wellbeing, Miami, 4220 Australia Regional Cancer Center Stockholm/Gotland, Stockholm, SE-102 39 Sweden Regional Cancer Center Stockholm/Gotland, Stockholm, SE-102 39 Sweden 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences & Society, Karolinska Institutet, Huddinge, SE-14183 Sweden 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences & Society, Karolinska Institute, Huddinge, SE-14183 Sweden 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences & Society, Karolinska Institute, Huddinge, SE-14183 Sweden 0000 0004 1937 0626grid.4714.6Department of Neurobiology, Caring Sciences & Society, Karolinska Institute, Huddinge, SE-14183 Sweden grid.413361.2Hospital San Juan de Dios, Internal Medicine, Santiago de Chile, Chile grid.413361.2Hospital San Juan de Dios, Internal Medicine, Santiago de Chile, Chile grid.413361.2Hospital San Juan de Dios, Internal Medicine, Santiago de Chile, Chile Centro de Estudios e Investigaci√≥n Terap√©utica, Santiago de Chile, Chile 0000 0000 9428 7911grid.7708.8Center for Complementary Medicine, University Medical Center Freiburg, Freiburg, 79106 Germany 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000000122986657grid.34477.33University of Washington, Seattle, WA USA 0000000122986657grid.34477.33University of Washington, Seattle, WA USA 0000000122986657grid.34477.33University of Washington, Seattle, WA USA 0000000122986657grid.34477.33University of Washington, Seattle, WA USA 0000000122986657grid.34477.33University of Washington, Seattle, WA USA 0000 0000 9320 7537grid.1003.2University of Queensland, Brisbane, Australia 0000 0004 0384 0646grid.419438.3Southwest College of Naturopathic Medicine, Tempe, AZ USA 0000000122986657grid.34477.33University of Washington, Seattle, WA USA Management Policy, National Development Institute of Korean Medicine, Gyeongsan-si, 38540 South Korea Management Policy, National Development Institute of Korean Medicine, Gyeongsan-si, 38540 South Korea Management Policy, National Development Institute of Korean Medicine, Gyeongsan-si, 38540 South Korea Management Policy, National Development Institute of Korean Medicine, Gyeongsan-si, 38540 South Korea Management Policy, National Development Institute of Korean Medicine, Gyeongsan-si, 38540 South Korea Management Policy, National Development Institute of Korean Medicine, Gyeongsan-si, 38540 South Korea Naturopathy, University of Medicine, Rostock, 18057 Germany Naturopathy, University of Medicine, Rostock, 18057 Germany Urology, University of Medicine, Rostock, 18057 Germany 0000 0001 0357 1464grid.411231.4Pediatrics of Korean Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Pediatrics of Korean Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea 0000 0001 0357 1464grid.411231.4Pediatrics of Korean Medicine, Kyung Hee University Hospital at Gangdong, Seoul, South Korea Mental Health, CMI (Clinica Medicina Integrativa), Madrid, 28015 Spain 0000 0001 0265 5359grid.411998.cDepartment of Medical Oncology, Kanazawa Medical  University, Uchinada, Ishikawa 920-0293 Japan Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH,  Bayer Consumer Health, Darmstadt, 64295 Germany 0000 0004 1936 9756grid.10253.35Department of Medical Cell Biology, Philipps-University Marburg, Marburg, Germany Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH,  Bayer Consumer Health, Darmstadt, 64295 Germany Phytomedicines Supply and Development Center, Steigerwald Arzneimittelwerk GmbH,  Bayer Consumer Health, Darmstadt, 64295 Germany Center for Endoscopy Starnberg, Starnberg, Germany Naturopathy, Center for Internal Medicine, University of Medicine, Rostock, Germany 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK Netherlands 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK Netherlands 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK Netherlands 0000000120346234grid.5477.1University of Applied Sciences, Leiden, 2333CK Netherlands 0000 0001 0668 7243grid.266093.8Irvine School of Medicine, Irvine, University of  California, Irvine, CA USA 0000 0001 2187 5445grid.5718.bInternal Medicine and Integrative Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2187 5445grid.5718.bInternal Medicine and Integrative Medicine, University of Duisburg-Essen, Essen, Germany 0000 0001 2187 5445grid.5718.bInternal Medicine and Integrative Medicine, University of Duisburg-Essen, Essen, Germany 0000000122595234grid.10919.30National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Sciences, The Arctic University of Troms√∏, Troms√∏, 9037 Norway 0000000122595234grid.10919.30National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, Faculty of Health Sciences, The Arctic University of Troms√∏, Troms√∏, 9037 Norway 0000 0004 0471 9346grid.411781.aDepartment of Midwifery, Istanbul Medipol University, Istanbul, 34083 Turkey Delivery Room, Istanbul Bahcelievler Public Hospital, Istanbul, 34180 Turkey},
note  = {doi:10.1186/s12906-017-1783-3.}
}

@Article{201623,
author  = {Bos, L. and Schouten, L. and van, V. and Wiewel, M. and Ong, D. and Cremer, O. and Artigas, A. and Martin-Loeches, I. and Hoogendijk, A. and van, d. and Horn, J. and Juffermans, N. and Schultz, M. and de, P. and Pham, T. and Carteaux, G. and Dessap, A. and Brun-Buisson, C. and Fan, E. and Bellani, G. and Laffey, J. and Mercat, A. and Brochard, L. and Maitre, B. and Howells, P. and Thickett, D. and Knox, C. and Park, D. and Gao, F. and Tucker, O. and Whitehouse, T. and McAuley, D. and Perkins, G. and Pham, T. and Laffey, J. and Bellani, G. and Fan, E. and Pisani, L. and Roozeman, J. and Simonis, F. and Giangregorio, A. and Schouten, L. and Van, d. and Horn, J. and Neto, A. and Festic, E. and Dondorp, A. and Grasso, S. and Bos, L. and Schultz, M. and Koster-Brouwer, M. and Verboom, D. and Scicluna, B. and van, d. and Frencken, J. and Schultz, M. and van, d. and Bonten, M. and Cremer, O. and Ko, J. and Kim, K. and Suh, G. and Kwon, W. and Kim, K. and Shin, J. and Ranzani, O. and Prina, E. and Menendez, R. and Ceccato, A. and Mendez, R. and Cilloniz, C. and Gabarrus, A. and Ferrer, M. and Torres, A. and Urbano, A. and Zhang, L. and Swigon, D. and Pike, F. and Parker, R. and Clermont, G. and Scheer, C. and Kuhn, S. and Modler, A. and Vollmer, M. and Fuchs, C. and Hahnenkamp, K. and Rehberg, S. and Gr√ºndling, M. and Taggu, A. and Darang, N. and √ñveges, N. and L√°szl√≥, I. and T√°nczos, K. and N√©meth, M. and Leb√°k, G. and Tudor, B. and √ârces, D. and Kaszaki, J. and Huber, W. and Tr√°sy, D. and Moln√°r, Z. and Ferrara, G. and Edul, V. and Canales, H. and Martins, E. and Canull√°n, C. and Murias, G. and Pozo, M. and Eguillor, J. and Buscetti, M. and Ince, C. and Dubin, A. and Aya, H. and Rhodes, A. and Fletcher, N. and Grounds, R. and Cecconi, M. and Jacquet-Lagr√®ze, M. and Riche, M. and Schweizer, R. and Portran, P. and Fornier, W. and Lilot, M. and Neidecker, J. and Fellahi, J. and Escoresca-Ortega, A. and Guti√©rrez-Pizarraya, A. and Charris-Castro, L. and Corcia-Palomo, Y. and Fernandez-Delgado, E. and Garnacho-Montero, J. and Roger, C. and Muller, L. and Elotmani, L. and Lipman, J. and Lefrant, J. and Roberts, J. and Mu√±oz-Berm√∫dez, R. and Samper, M. and Climent, C. and Vasco, F. and Sara, V. and Luque, S. and Campillo, N. and Cerrato, S. and Masclans, J. and Alvarez-Lerma, F. and Brugger, S. and Jimenez, G. and Torner, M. and Cabello, J. and Garrido, B. and Casals, X. and Gaite, F. and Vidal, M. and Mart√≠nez, M. and Gusarov, V. and Shilkin, D. and Dementienko, M. and Nesterova, E. and Lashenkova, N. and Kuzovlev, A. and Zamyatin, M. and Demoule, A. and Carreira, S. and Lavault, S. and Palancca, O. and Morawiec, E. and Mayaux, J. and Arnulf, I. and Similowski, T. and Rasmussen, B. and Maltesen, R. and Hanifa, M. and Pedersen, S. and Kristensen, S. and Wimmer, R. and Panigada, M. and Bassi, G. and Ranzani, O. and Kolobow, T. and Zanella, A. and Cressoni, M. and Berra, L. and Parrini, V. and Kandil, H. and Salati, G. and Livigni, S. and Amatu, A. and Andreotti, A. and Tagliaferri, F. and Moise, G. and Mercurio, G. and Costa, A. and Vezzani, A. and Lindau, S. and Babel, J. and Cavana, M. and Consonni, D. and Pesenti, A. and Gattinoni, L. and Torres, A. and Mansouri, P. and Zand, F. and Zahed, L. and Dehghanrad, F. and Bahrani, M. and Ghorbani, M. and Cambiaghi, B. and Moerer, O. and Mauri, T. and Kunze-Szikszay, N. and Ritter, C. and Pesenti, A. and Quintel, M. and Vilander, L. and Kaunisto, M. and Vaara, S. and Pettil√§, V. and Mulier, J. and Rozemeijer, S. and Spoelstra-de, M. and Elbers, P. and Tuinman, P. and de, W. and Oudemans-van, S. and Liberatore, A. and Souza, R. and Martins, A. and Vieira, J. and Koh, I. and Mart√≠nez, M. and S√°nchez, R. and Gasc√≥n, L. and Mulero, M. and Freire, A. and Mu√±oz, A. and Acebes, S. and Mart√≠nez, √. and Aliaga, S. and Para, L. and Pay√°, J. and Mulero, F. and Guerci, P. and Ince, Y. and Heeman, P. and Ergin, B. and Ince, C. and Uz, Z. and Massey, M. and Ince, Y. and Papatella, R. and Bulent, E. and Guerci, P. and Toraman, F. and Ince, C. and Longbottom, E. and Torrance, H. and Owen, H. and Hinds, C. and Pearse, R. and O‚ÄôDywer, M. and Trogrlic, Z. and van, d. and Lingsma, H. and Ponssen, H. and Schoonderbeek, J. and Schreiner, F. and Verbrugge, S. and Duran, S. and van, A. and Bakker, J. and Gommers, D. and Ista, E. and Krajƒ?ov√°, A. and Waldauf, P. and Du≈°ka, F. and Shah, A. and Roy, N. and McKechnie, S. and Doree, C. and Fisher, S. and Stanworth, S. and Jensen, J. and Overgaard, D. and Bestle, M. and Christensen, D. and Egerod, I. and Pivkina, A. and Gusarov, V. and Zhivotneva, I. and Pasko, N. and Zamyatin, M. and Jensen, J. and Egerod, I. and Bestle, M. and Christensen, D. and Alklit, A. and Hansen, R. and Knudsen, H. and Grode, L. and Overgaard, D. and Hravnak, M. and Chen, L. and Dubrawski, A. and Clermont, G. and Pinsky, M. and Parry, S. and Knight, L. and Connolly, B. and Baldwin, C. and Puthucheary, Z. and Denehy, L. and Hart, N. and Morris, P. and Mortimore, J. and Granger, C. and Jensen, H. and Piers, R. and Van, d. and Malmgren, J. and Metaxa, V. and Reyners, A. and Darmon, M. and Rusinova, K. and Talmor, D. and Meert, A. and Cancelliere, L. and Zubek, L. and Maia, P. and Michalsen, A. and Decruyenaere, J. and Kompanje, E. and Vanheule, S. and Azoulay, E. and Vansteelandt, S. and Benoit, D. and Van, d. and Piers, R. and Jensen, H. and Malmgren, J. and Metaxa, V. and Reyners, A. and Darmon, M. and Rusinova, K. and Talmor, D. and Meert, A. and Cancelliere, L. and Zubek, L. and Maia, P. and Michalsen, A. and Decruyenaere, J. and Kompanje, E. and Vanheule, S. and Azoulay, E. and Vansteelandt, S. and Benoit, D. and Ryan, C. and Dawson, D. and Ball, J. and Noone, K. and Aisling, B. and Prudden, S. and Ntantana, A. and Matamis, D. and Savvidou, S. and Giannakou, M. and Gouva, M. and Nakos, G. and Koulouras, V. and Aron, J. and Lumley, G. and Milliken, D. and Dhadwal, K. and McGrath, B. and Lynch, S. and Bovento, B. and Sharpe, G. and Grainger, E. and Pieri-Davies, S. and Wallace, S. and McGrath, B. and Lynch, S. and Bovento, B. and Grainger, E. and Pieri-Davies, S. and Sharpe, G. and Wallace, S. and Jung, M. and Cho, J. and Park, H. and Suh, G. and Kousha, O. and Paddle, J. and Gripenberg, L. and Rehal, M. and Wernerman, J. and Rooyackers, O. and de, G. and Choo, W. and Spoelstra-de, M. and Swart, E. and Oudemans-van, S. and Talan, L. and G√ºven, G. and Altƒ±ntas, N. and Padar, M. and Uusvel, G. and Starkopf, L. and Starkopf, J. and Blaser, A. and Kalaiselvan, M. and Arunkumar, A. and Renuka, M. and Shivkumar, R. and Volbeda, M. and ten, K. and Hoekstra, M. and van, d. and Nijsten, M. and Komaromi, A. and Rooyackers, O. and Wernerman, J. and Norberg, √. and Smedberg, M. and Mori, M. and Pettersson, L. and Norberg, √. and Rooyackers, O. and Wernerman, J. and Theodorakopoulou, M. and Christodoulopoulou, T. and Diamantakis, A. and Frantzeskaki, F. and Kontogiorgi, M. and Chrysanthopoulou, E. and Lygnos, M. and Diakaki, C. and Armaganidis, A. and Gundogan, K. and Dogan, E. and Coskun, R. and Muhtaroglu, S. and Sungur, M. and Ziegler, T. and Guven, M. and Kleyman, A. and Khaliq, W. and Andreas, D. and Singer, M. and Meierhans, R. and Schuepbach, R. and De, B. and Zand, F. and Sabetian, G. and Nikandish, R. and Hagar, F. and Masjedi, M. and Maghsudi, B. and Vazin, A. and Ghorbani, M. and Asadpour, E. and Kao, K. and Chiu, L. and Hung, C. and Chang, C. and Li, S. and Hu, H. and El, M. and Ali, M. and Rageb, D. and Helmy, M. and Marin-Corral, J. and Vil√†, C. and Masclans, J. and V√†zquez, A. and Mart√≠n-Loeches, I. and D√≠az, E. and Y√©benes, J. and Rodriguez, A. and √?lvarez-Lerma, F. and Varga, N. and Cortina-Guti√©rrez, A. and Dono, L. and Mart√≠nez-Mart√≠nez, M. and Maldonado, C. and Papiol, E. and P√©rez-Carrasco, M. and Ferrer, R. and Nweze, K. and Morton, B. and Welters, I. and Houard, M. and Voisin, B. and Ledoux, G. and Six, S. and Jaillette, E. and Nseir, S. and Romdhani, S. and Bouneb, R. and Loghmari, D. and Aicha, N. and Ayachi, J. and Meddeb, K. and Chouch√®ne, I. and Khedher, A. and Boussarsar, M. and Chan, K. and Yu, W. and Marin-Corral, J. and Vil√†, C. and Masclans, J. and Nolla, J. and Vidaur, L. and Bonastre, J. and Suberbiola, B. and Guerrero, J. and Rodriguez, A. and Coll, N. and Jim√©nez, G. and Brugger, S. and Calero, J. and Garrido, B. and Garc√≠a, M. and Mart√≠nez, M. and Vidal, M. and de, l. and Vendrell, E. and Palomera, E. and G√ºell, E. and Y√©benes, J. and Serra-Prat, M. and Bermejo-Mart√≠n, J. and Almirall, J. and Tomas, E. and Escoval, A. and Froe, F. and Pereira, M. and Velez, N. and Viegas, E. and Filipe, E. and Groves, C. and Reay, M. and Chiu, L. and Hu, H. and Hung, C. and Chang, C. and Li, S. and Kao, K. and Ballin, A. and Facchin, F. and Sartori, G. and Zarantonello, F. and Campello, E. and Radu, C. and Rossi, S. and Ori, C. and Simioni, P. and Umei, N. and Shingo, I. and Santos, A. and Candeias, C. and Moniz, I. and Mar√ßal, R. and e, S. and Ribeiro, J. and Georger, J. and Ponthus, J. and Tchir, M. and Amilien, V. and Ayoub, M. and Barsam, E. and Martucci, G. and Panarello, G. and Tuzzolino, F. and Capitanio, G. and Ferrazza, V. and Carollo, T. and Giovanni, L. and Arcadipane, A. and S√°nchez, M. and Gonz√°lez-Gay, M. and D√≠az, F. and L√≥pez, M. and Zogheib, E. and Villeret, L. and Nader, J. and Bernasinski, M. and Besserve, P. and Caus, T. and Dupont, H. and Morimont, P. and Habran, S. and Hubert, R. and Desaive, T. and Blaffart, F. and Janssen, N. and Guiot, J. and Pironet, A. and Dauby, P. and Lambermont, B. and Zarantonello, F. and Ballin, A. and Facchin, F. and Sartori, G. and Campello, E. and Pettenuzzo, T. and Citton, G. and Rossi, S. and Simioni, P. and Ori, C. and Kirakli, C. and Ediboglu, O. and Ataman, S. and Yarici, M. and Tuksavul, F. and Keating, S. and Gibson, A. and Gilles, M. and Dunn, M. and Price, G. and Young, N. and Remeta, P. and Bishop, P. and Zamora, M. and Mu√±oz-Bono, J. and Curiel-Balsera, E. and Aguilar-Alonso, E. and Hinojosa, R. and Gordillo-Brenes, A. and Arboleda-S√°nchez, J. and Skorniakov, I. and Vikulova, D. and Whiteley, C. and Shaikh, O. and Jones, A. and Ostermann, M. and Forni, L. and Scott, M. and Sahatjian, J. and Linde-Zwirble, W. and Hansell, D. and Laoveeravat, P. and Srisawat, N. and Kongwibulwut, M. and Peerapornrattana, S. and Suwachittanont, N. and Wirotwan, T. and Chatkaew, P. and Saeyub, P. and Latthaprecha, K. and Tiranathanagul, K. and Eiam-ong, S. and Kellum, J. and Berthelsen, R. and Perner, A. and Jensen, A. and Jensen, J. and Bestle, M. and Gebhard, D. and Price, J. and Kennedy, C. and Akcan-Arikan, A. and Liberatore, A. and Souza, R. and Martins, A. and Vieira, J. and Kang, Y. and Nakamae, M. and Koh, I. and Hamed, K. and Khaled, M. and Soliman, R. and Mokhtar, M. and Seller-P√©rez, G. and Arias-Verd√∫, D. and Llopar-Valdor, E. and De-Di√≥s-Chac√≥n, I. and Quesada-Garc√≠a, G. and Herrera-Gutierrez, M. and Hafes, R. and Carroll, G. and Doherty, P. and Wright, C. and Vera, I. and Ralston, M. and Gemmell, M. and MacKay, A. and Black, E. and Wright, C. and Docking, R. and Appleton, R. and Ralston, M. and Gemmell, L. and Appleton, R. and Wright, C. and Docking, R. and Black, E. and Mackay, A. and Rozemeijer, S. and Mulier, J. and R√∂ttgering, J. and Elbers, P. and Spoelstra-de, M. and Tuinman, P. and de, W. and Oudemans-van, S. and Mejeni, N. and Nsiala, J. and Kilembe, A. and Akilimali, P. and Thomas, G. and Egerod, I. and Andersson, A. and Fagerdahl, A. and Knudsen, V. and Meddeb, K. and Cheikh, A. and Hamdaoui, Y. and Ayachi, J. and Guiga, A. and Fraj, N. and Romdhani, S. and Sma, N. and Bouneb, R. and Chouchene, I. and Khedher, A. and Bouafia, N. and Boussarsar, M. and Amirian, A. and Ziaian, B. and Masjedi, M. and Fleischmann, C. and Thomas-Rueddel, D. and Schettler, A. and Schwarzkopf, D. and Stacke, A. and Reinhart, K. and Filipe, E. and Escoval, A. and Martins, A. and Sousa, P. and Velez, N. and Viegas, E. and Tomas, E. and Snell, G. and Matsa, R. and Paary, T. and Kalaiselvan, M. and Cavalheiro, A. and Rocha, L. and Vallone, C. and Tonilo, A. and Lobato, M. and Malheiro, D. and Sussumo, G. and Lucino, N. and Zand, F. and Rosenthal, V. and Masjedi, M. and Sabetian, G. and Maghsudi, B. and Ghorbani, M. and Dashti, A. and Yousefipour, A. and Goodall, J. and Williamson, M. and Tant, E. and Thomas, N. and Balci, C. and Gonen, C. and Haftacƒ±, E. and Gurarda, H. and Karaca, E. and Paldusov√°, B. and Z√Ωkov√°, I. and ≈†√≠mov√°, D. and Houston, S. and D‚ÄôAntona, L. and Lloyd, J. and Garnelo-Rey, V. and Sosic, M. and Sotosek-Tokmazic, V. and Kuharic, J. and Antoncic, I. and Dunatov, S. and Sustic, A. and Chong, C. and Sim, M. and Lyovarin, T. and D√≠az, F. and Gald√≥, S. and Garach, M. and Romero, O. and Bail√≥n, A. and Pinel, A. and Colmenero, M. and Gritsan, A. and Gazenkampf, A. and Korchagin, E. and Dovbish, N. and Lee, R. and Lim, M. and Chong, C. and Lim, B. and See, J. and Assis, R. and Filipe, F. and Lopes, N. and Pessoa, L. and Pereira, T. and Catorze, N. and Aydogan, M. and Aldasoro, C. and Marchio, P. and Jorda, A. and Mauricio, M. and Guerra-Ojeda, S. and Gimeno-Raga, M. and Colque-Cano, M. and Bertomeu-Artecero, A. and Aldasoro, M. and Valles, S. and Tonon, D. and Triglia, T. and Martin, J. and Alessi, M. and Bruder, N. and Garrigue, P. and Velly, L. and Spina, S. and Scaravilli, V. and Marzorati, C. and Colombo, E. and Savo, D. and Vargiolu, A. and Cavenaghi, G. and Citerio, G. and Andrade, A. and Bulgarelli, P. and Araujo, J. and Gonzalez, V. and Souza, V. and Costa, A. and Massant, C. and Filho, C. and Morbeck, R. and Burgo, L. and van, G. and van, E. and Leijte, G. and Koeneman, B. and Kox, M. and Pickkers, P. and Garc√≠a-de, l. and de, l. and Fern√°ndez-Porcel, A. and Rueda-Molina, C. and Nuevo-Ortega, P. and Tsvetanova-Spasova, T. and C√°mara-Sola, E. and Garc√≠a-Alc√°ntara, A. and Salido-D√≠az, L. and Liao, X. and Feng, T. and Zhang, J. and Cao, X. and Wu, Q. and Xie, Z. and Li, H. and Kang, Y. and Winkler, M. and Nierhaus, A. and Mudersbach, E. and Bauer, A. and Robbe, L. and Zahrte, C. and Schwedhelm, E. and Kluge, S. and Z√∂llner, C. and Morton, B. and Mitsi, E. and Pennington, S. and Reine, J. and Wright, A. and Parker, R. and Welters, I. and Blakey, J. and Rajam, G. and Ades, E. and Ferreira, D. and Wang, D. and Kadioglu, A. and Gordon, S. and Koch, R. and Kox, M. and Rahamat-Langedoen, J. and Schloesser, J. and de, J. and Pickkers, P. and Bringue, J. and Guillamat-Prats, R. and Torrents, E. and Martinez, M. and Camprub√≠-Rimblas, M. and Artigas, A. and Blanch, L. and Park, S. and Park, Y. and Song, D. and Shrestha, S. and Park, S. and Koh, Y. and Park, M. and Hong, C. and Lesur, O. and Coquerel, D. and Sainsily, X. and Cote, J. and S√∂llradl, T. and Murza, A. and Dumont, L. and Dumaine, R. and Grandbois, M. and Sarret, P. and Marsault, E. and Salvail, D. and Auger-Messier, M. and Chagnon, F. and Lauretta, M. and Greco, E. and Dyson, A. and Singer, M. and Preau, S. and Ambler, M. and Sigurta, A. and Saeed, S. and Singer, M. and Sarƒ±ca, L. and Zibandeh, N. and Genc, D. and Gul, F. and Akkoc, T. and Kombak, E. and Cinel, L. and Akkoc, T. and Cinel, I. and Pollen, S. and Arulkumaran, N. and Singer, M. and Torrance, H. and Longbottom, E. and Warnes, G. and Hinds, C. and Pennington, D. and Brohi, K. and O‚ÄôDwyer, M. and Kim, H. and Na, S. and Kim, J. and Chang, Y. and Chao, A. and Shih, P. and Lee, C. and Yeh, Y. and Chen, L. and Adriaanse, M. and Trogrlic, Z. and Ista, E. and Lingsma, H. and Rietdijk, W. and Ponssen, H. and Schoonderbeek, J. and Schreiner, F. and Verbrugge, S. and Duran, S. and Gommers, D. and van, d. and Funcke, S. and Sauerlaender, S. and Saugel, B. and Pinnschmidt, H. and Reuter, D. and Nitzschke, R. and Perbet, S. and Biboulet, C. and Lenoire, A. and Bourdeaux, D. and Pereira, B. and Plaud, B. and Bazin, J. and Sautou, V. and Mebazaa, A. and Constantin, J. and Legrand, M. and Boyko, Y. and Jennum, P. and Nikolic, M. and Oerding, H. and Holst, R. and Toft, P. and Nedergaard, H. and Haberlandt, T. and Jensen, H. and Toft, P. and Park, S. and Kim, S. and Cho, Y. and Lim, Y. and Chan, A. and Tang, S. and Nunes, S. and Forsberg, S. and Blomqvist, H. and Berggren, L. and S√∂rberg, M. and Sarapohja, T. and Wickerts, C. and Hofhuis, J. and Rose, L. and Blackwood, B. and Akerman, E. and Mcgaughey, J. and Egerod, I. and Fossum, M. and Foss, H. and Georgiou, E. and Graff, H. and Kalafati, M. and Sperlinga, R. and Schafer, A. and Wojnicka, A. and Spronk, P. and Zand, F. and Khalili, F. and Afshari, R. and Sabetian, G. and Masjedi, M. and Maghsudi, B. and Khodaei, H. and Javadpour, S. and Petramfar, P. and Nasimi, S. and Vazin, A. and Ziaian, B. and Tabei, H. and Gunther, A. and Hansen, J. and Sackey, P. and Storm, H. and Bernhardsson, J. and Sundin, √. and Bj√§rt√•, A. and Bienert, A. and Smuszkiewicz, P. and Wiczling, P. and Przybylowski, K. and Borsuk, A. and Trojanowska, I. and Matysiak, J. and Kokot, Z. and Paterska, M. and Grzeskowiak, E. and Messina, A. and Bonicolini, E. and Colombo, D. and Moro, G. and Romagnoli, S. and De, G. and Corte, F. and Romano, S. and Silversides, J. and Major, E. and Mann, E. and Ferguson, A. and Mcauley, D. and Marshall, J. and Blackwood, B. and Fan, E. and Diaz-Rodriguez, J. and Silva-Medina, R. and Gomez-Sandoval, E. and Gomez-Gonzalez, N. and Soriano-Orozco, R. and Gonzalez-Carrillo, P. and Hern√°ndez-Flores, M. and Pilarczyk, K. and Lubarksi, J. and Wendt, D. and Dusse, F. and G√ºnter, J. and Huschens, B. and Demircioglu, E. and Jakob, H. and Palmaccio, A. and Dell‚ÄôAnna, A. and Grieco, D. and Torrini, F. and Iaquaniello, C. and Bongiovanni, F. and Antonelli, M. and Toscani, L. and Antonakaki, D. and Bastoni, D. and Aya, H. and Rhodes, A. and Cecconi, M. and Jozwiak, M. and Depret, F. and Teboul, J. and Alphonsine, J. and Lai, C. and Richard, C. and Monnet, X. and L√°szl√≥, I. and Demeter, G. and √ñveges, N. and T√°nczos, K. and N√©meth, M. and Tr√°sy, D. and Kertmegi, I. and √ârces, D. and Tudor, B. and Kaszaki, J. and Moln√°r, Z. and Hasanin, A. and Lotfy, A. and El-adawy, A. and Nassar, H. and Mahmoud, S. and Abougabal, A. and Mukhtar, A. and Quinty, F. and Habchi, S. and Luzi, A. and Antok, E. and Hernandez, G. and Lara, B. and Enberg, L. and Ortega, M. and Leon, P. and Kripper, C. and Aguilera, P. and Kattan, E. and Bakker, J. and Huber, W. and Lehmann, M. and Sakka, S. and Bein, B. and Schmid, R. and Preti, J. and Creteur, J. and Herpain, A. and Marc, J. and Zogheib, E. and Trojette, F. and Bar, S. and Kontar, L. and Titeca, D. and Richecoeur, J. and Gelee, B. and Verrier, N. and Mercier, R. and Lorne, E. and Maizel, J. and Dupont, H. and Slama, M. and Abdelfattah, M. and Eladawy, A. and Elsayed, M. and Mukhtar, A. and Montenegro, A. and Zepeda, E. and Granillo, J. and S√°nchez, J. and Alejo, G. and Cabrera, A. and Montoya, A. and Lee, C. and Hatib, F. and Cannesson, M. and Theerawit, P. and Morasert, T. and Sutherasan, Y. and Zani, G. and Mescolini, S. and Diamanti, M. and Righetti, R. and Scaramuzza, A. and Papetti, M. and Terenzoni, M. and Gecele, C. and Fusari, M. and Hakim, K. and Chaari, A. and Ismail, M. and Elsaka, A. and Mahmoud, T. and Bousselmi, K. and Kauts, V. and Casey, W. and Hutchings, S. and Naumann, D. and Wendon, J. and Watts, S. and Kirkman, E. and Jian, Z. and Buddi, S. and Lee, C. and Settels, J. and Hatib, F. and Pinsky, M. and Bertini, P. and Guarracino, F. and Trepte, C. and Richter, P. and Haas, S. and Eichhorn, V. and Kubitz, J. and Reuter, D. and Soliman, M. and Hamimy, W. and Fouad, A. and Mukhtar, A. and Charlton, M. and Tonks, L. and Mclelland, L. and Coats, T. and Thompson, J. and Sims, M. and Williams, D. and Roushdy, D. and Soliman, R. and Nahas, R. and Arafa, M. and Hung, W. and Chiang, C. and Huang, W. and Lin, K. and Lin, S. and Cheng, C. and Kang, P. and Wann, S. and Mar, G. and Liu, C. and Carranza, M. and Fernandez, H. and Roman, J. and Lucena, F. and Garcia, A. and Vazquez, A. and Serrano, A. and Moreira, L. and Vidal-Perez, R. and Herranz, U. and Acuna, J. and Gil, C. and Allut, J. and Sedes, P. and Lopez, C. and Paz, E. and Rodriguez, C. and Gonzalez-Juanatey, J. and Vallejo-Baez, A. and de, l. and Nuevo-Ortega, P. and Fern√°ndez-Porcel, A. and C√°mara-Sola, E. and Tsvetanova-Spasova, T. and Rueda-Molina, C. and Salido-D√≠az, L. and Garc√≠a-Alc√°ntara, A. and Aron, J. and Marharaj, R. and Gervasio, K. and Bottiroli, M. and Mondino, M. and De, C. and Calini, A. and Montrasio, E. and Milazzo, F. and Gagliardone, M. and Vallejo-B√°ez, A. and de, l. and Nuevo-Ortega, P. and Fern√°ndez-Porcel, A. and C√°mara-Sola, E. and Tsvetanova-Spasova, T. and Rueda-Molina, C. and Salido-D√≠az, L. and Garc√≠a-Alc√°ntara, A. and Moreira, L. and Vidal-Perez, R. and Anido, U. and Gil, C. and Acuna, J. and Sedes, P. and Lopez, C. and Paz, E. and Allut, J. and Rodriguez, C. and Gonzalez-Juanatey, J. and Hamdaoui, Y. and Khedher, A. and Cheikh-Bouhlel, M. and Ayachi, J. and Meddeb, K. and Sma, N. and Fraj, N. and Aicha, N. and Romdhani, S. and Bouneb, R. and Chouchene, I. and Boussarsar, M. and Dela, C. and Bernardo, J. and Galfo, F. and Dyson, A. and Singer, M. and Marino, A. and Dyson, A. and Singer, M. and Chao, C. and Hou, P. and Huang, W. and Hung, C. and Chiang, C. and Hung, W. and Lin, K. and Lin, S. and Liou, Y. and Hung, S. and Lin, Y. and Cheng, C. and Kuo, F. and Chiou, K. and Chen, C. and Yan, L. and Liu, C. and Wang, H. and Kang, P. and Chen, H. and Ho, C. and Mar, G. and Liu, C. and Grewal, S. and Gopal, S. and Corbett, C. and Wilson, A. and Capps, J. and Ayoub, W. and Lomas, A. and Ghani, S. and Moore, J. and Atkinson, D. and Sharman, M. and Swinnen, W. and Pauwels, J. and Mignolet, K. and Pannier, E. and Koch, A. and Sarens, T. and Temmerman, W. and Elmenshawy, A. and Fayed, A. and Elboriuny, M. and Hamdy, E. and Zakaria, E. and Falk, A. and Petosic, A. and Olafsen, K. and W√∏ien, H. and Flaatten, H. and Sunde, K. and Agra, J. and Cabrera, J. and Santana, J. and Alzola, L. and P√©rez, H. and Pires, T. and Calder√≥n, H. and Pereira, A. and Castro, S. and Granja, C. and Norkiene, I. and Urbanaviciute, I. and Kezyte, G. and Ringaitiene, D. and Jovaisa, T. and Vogel, G. and Johansson, U. and Sandgren, A. and Svensen, C. and Joelsson-Alm, E. and Leite, M. and Murbach, L. and Osaku, E. and Costa, C. and Pelenz, M. and Neitzke, N. and Moraes, M. and Jaskowiak, J. and Silva, M. and Zaponi, R. and Abentroth, L. and Ogasawara, S. and Jorge, A. and Duarte, P. and Murbach, L. and Leite, M. and Osaku, E. and Barreto, J. and Duarte, S. and Taba, S. and Miglioranza, D. and Gund, D. and Lordani, C. and Costa, C. and Ogasawara, S. and Jorge, A. and Duarte, P. and Vollmer, H. and Gager, M. and Waldmann, C. and Mazzeo, A. and Tesio, R. and Filippini, C. and Vallero, M. and Giolitti, C. and Caccia, S. and Medugno, M. and Tenaglia, T. and Rosato, R. and Mastromauro, I. and Brazzi, L. and Terragni, P. and Urbino, R. and Fanelli, V. and Ranieri, V. and Mascia, L. and Ballantyne, J. and Paton, L. and Mackay, A. and Perez-Teran, P. and Roca, O. and Ruiz-Rodriguez, J. and Zapatero, A. and Serra, J. and Masclans, J. and Bianzina, S. and Cornara, P. and Rodi, G. and Tavazzi, G. and Pozzi, M. and Iotti, G. and Mojoli, F. and Braschi, A. and Vishnu, A. and Buche, D. and Pande, R. and Moolenaar, D. and Bakhshi-Raiez, F. and Dongelmans, D. and de, K. and de, L. and Fern√°ndez, I. and Ba√±o, D. and Moreno, J. and Rubio, R. and Scott, J. and Phelan, D. and Morely, D. and O‚ÄôFlynn, J. and Stapleton, P. and Lynch, M. and Marsh, B. and Carton, E. and O‚ÄôLoughlin, C. and Cheng, K. and Sung, M. and Elghonemi, M. and Saleh, M. and Meyhoff, T. and Krag, M. and Hjortrup, P. and Perner, A. and M√∏ller, M. and √ñhman, T. and Sigmundsson, T. and Redondo, E. and Hallb√§ck, M. and Suarez-Sipmann, F. and Bj√∂rne, H. and Sander, C. and Cressoni, M. and Chiumello, D. and Chiurazzi, C. and Brioni, M. and Algieri, I. and Guanziroli, M. and Vergani, G. and Tonetti, T. and Tomic, I. and Colombo, A. and Crimella, F. and Carlesso, E. and Colombo, A. and Gasparovic, V. and Gattinoni, L. and El-Sherif, R. and Al-Basser, M. and Raafat, A. and El-Sherif, A. and Simonis, F. and Schouten, L. and Cremer, O. and Ong, D. and Amoruso, G. and Cinnella, G. and Schultz, M. and Bos, L. and Huber, W. and Schmidle, P. and Findeisen, M. and Hoppmann, P. and Jaitner, J. and Brettner, F. and Schmid, R. and Lahmer, T. and Festic, E. and Rajagopalan, G. and Bansal, V. and Frank, R. and Hinds, R. and Levitt, J. and Siddiqui, S. and Gilbert, J. and Sim, K. and Wang, C. and Hu, H. and Li, I. and Tang, W. and Kao, K. and Persona, P. and De, C. and Franco, M. and Facchin, F. and Ori, C. and Rossi, S. and Goffi, A. and Li, S. and Hu, H. and Chiu, L. and Hung, C. and Chang, C. and Kao, K. and Ruiz, B. and Varas, J. and Montero, R. and Delgado, C. and Navarrete, O. and Mezquita, M. and Peces, E. and Nakamura, M. and Hajjar, L. and Galas, F. and Ortiz, T. and Amato, M. and Bitker, L. and Costes, N. and Le, B. and Lavenne, F. and Mojgan, D. and Richard, J. and Chiurazzi, C. and Cressoni, M. and Massari, D. and Guanziroli, M. and Vergani, G. and Gotti, M. and Brioni, M. and Algieri, I. and Cadringher, P. and Tonetti, T. and Chiumello, D. and Gattinoni, L. and Zerman, A. and T√ºrkoƒülu, M. and Arƒ±k, G. and Yƒ±ldƒ±rƒ±m, F. and G√ºll√º, Z. and Kara, I. and Boyacƒ±, N. and Aydoƒüan, B. and Gaygƒ±sƒ±z, √. and G√∂nderen, K. and Aygencel, G. and Aydoƒüdu, M. and √úlger, Z. and G√ºrsel, G. and Riera, J. and Toral, C. and Mazo, C. and Mart√≠nez, M. and Baldir√†, J. and Lagunes, L. and Roman, A. and Deu, M. and Rello, J. and Levine, D. and Mohus, R. and Askim, √. and Paulsen, J. and Mehl, A. and Dewan, A. and Dam√•s, J. and Sollig√•rd, E. and √Ösvold, B. and Paulsen, J. and Askim, √. and Mohus, R. and Mehl, A. and DeWan, A. and Sollig√•rd, E. and Dam√•s, J. and √Ösvold, B. and Aktepe, O. and Kara, A. and Yeter, H. and Topeli, A. and Norrenberg, M. and Devroey, M. and Khader, H. and Preiser, J. and Tang, Z. and Qiu, C. and Tong, L. and Cai, C. and Theodorakopoulou, M. and Diamantakis, A. and Kontogiorgi, M. and Chrysanthopoulou, E. and Christodoulopoulou, T. and Frantzeskaki, F. and Lygnos, M. and Apostolopoulou, O. and Armaganidis, A. and Moon, J. and Park, M. and Kwon, I. and Chon, G. and Ahn, J. and Kwon, S. and Chang, Y. and Lee, J. and Yoon, S. and Lee, J. and Kostalas, M. and Mckinlay, J. and Kooner, G. and Dudas, G. and Horton, A. and Kerr, C. and Karanjia, N. and Creagh-Brown, B. and Altintas, N. and Izdes, S. and Keremoglu, O. and Alkan, A. and Neselioglu, S. and Erel, O. and Tardif, N. and Gustafsson, T. and Rooyackers, O. and MacEachern, K. and Traille, M. and Bromberg, I. and Lapinsky, S. and Moore, M. and Tang, Z. and Cai, C. and Tong, L. and Garc√≠a-Garmendia, J. and Villarrasa-Clemente, F. and Maroto-Monserrat, F. and Rufo-Tejeiro, O. and Jorge-Amigo, V. and S√°nchez-Santamar√≠a, M. and Col√≥n-Pallar√©s, C. and Barrero-Almod√≥var, A. and Gallego-Lara, S. and Anthon, C. and M√ºller, R. and Haase, N. and M√∏ller, K. and Hjortrup, P. and Wetterslev, J. and Perner, A. and Nakanishi, M. and Kuriyama, A. and Fukuoka, T. and Abd, e. and Elsaid, h. and Moktar, A. and Eladawy, A. and Elazizy, H. and Hakim, K. and Chaari, A. and Elbahr, M. and Ismail, M. and Mahmoud, T. and Kauts, V. and Bousselmi, K. and Khalil, E. and Casey, W. and Zaky, S. and Rizk, A. and Elghonemi, M. and Ahmed, R. and Vieira, J. and Souza, R. and Liberatore, A. and Koh, I. and Ospina-Tasc√≥n, G. and Marin, A. and Echeverry, G. and Bermudez, W. and Madri√±an-Navia, H. and Valencia, J. and Qui√±onez, E. and Marulanda, A. and Arango-D√°vila, C. and Bruhn, A. and Hernandez, G. and De, B. and Cortes, D. and Su, F. and Vincent, J. and Creteur, J. and Tullo, L. and Mirabella, L. and Di, M. and Cinnella, G. and Dambrosio, M. and Lujan, C. and irigoyen, J. and Cartanya, f. and Garc√≠a, R. and Mukhtar, A. and Ahmed, M. and El, A. and Hasanin, A. and Ayman, E. and Salem, M. and Eladawy, A. and Fathy, S. and Nassar, H. and Zaghlol, A. and Arzapalo, M. and Vals√∏, √. and Sunde, K. and Rust√∏en, T. and Schou-Bredal, I. and Skogstad, L. and T√∏ien, K. and Padilla, C. and Palmeiro, Y. and Egbaria, W. and Kigli, R. and Maertens, B. and Blot, K. and Blot, S. and Santana-Santos, E. and dos, S. and Ferretti-Rebustini, R. and dos, S. and Verardino, R. and Bortolotto, L. and Doyle, A. and Naldrett, I. and Tillman, J. and Price, S. and Shrestha, S. and Pearson, P. and Greaves, J. and Goodall, D. and Berry, A. and Richardson, A. and Odundo, G. and Omengo, P. and Obonyo, P. and Chanzu, N. and Kleinpell, R. and Sarris, S. and Nedved, P. and Heitschmidt, M. and Ben-Ghezala, H. and Snouda, S. and Djobbi, S. and Ben-Ghezala, H. and Snouda, S. and Rose, L. and Adhikari, N. and Leasa, D. and Fergusson, D. and Mckim, D. and Weblin, J. and Tucker, O. and McWilliams, D. and Doesburg, F. and Cnossen, F. and Dieperink, W. and Bult, W. and Nijsten, M. and Galvez-Blanco, G. and Zepeda, E. and Guzman, C. and S√°nchez, J. and Granillo, J. and Stroud, J. and Thomson, R. and Llaurado-Serra, M. and Lobo-Civico, A. and Pi-Guerrero, M. and Blanco-Sanchez, I. and Pi√±ol-Tena, A. and Pa√±os-Espinosa, C. and Alabart-Segura, Y. and Coloma-Gomez, B. and Fernandez-Blanco, A. and Braga-Dias, F. and Treso-Geira, M. and Valeiras-Valero, A. and Martinez-Reyes, L. and Sandiumenge, A. and Jimenez-Herrera, M. and Prada, R. and Ju√°rez, P. and Argando√±a, R. and D√≠az, J. and Ramirez, C. and Saavedra, P. and Santana, S. and Obukhova, O. and Kashiya, S. and Kurmukov, I. and Pronina, A. and Simeone, P. and Puybasset, L. and Auzias, G. and Coulon, O. and Lesimple, B. and Torkomian, G. and Velly, L. and Bienert, A. and Bartkowska-Sniatkowska, A. and Wiczling, P. and Szerkus, O. and Siluk, D. and Bartkowiak-Wieczorek, J. and Rosada-Kurasinska, J. and Warzybok, J. and Borsuk, A. and Kaliszan, R. and Grzeskowiak, E. and Caballero, C. and Roberts, S. and Isgro, G. and Hall, D. and Guillaume, G. and Passouant, O. and Dumas, F. and Bougouin, W. and Champigneulle, B. and Arnaout, M. and Chelly, J. and Chiche, J. and Varenne, O. and Mira, J. and Marijon, E. and Cariou, A. and Beerepoot, M. and Touw, H. and Parlevliet, K. and Boer, C. and Elbers, P. and Tuinman, P. and Reina, √. and Palomo, Y. and Berm√∫dez, R. and Vill√©n, L. and Garc√≠a, I. and Izurieta, J. and Bernal, J. and Jim√©nez, F. and Cota-Delgado, F. and de, l. and Fern√°ndez-Porcel, A. and Nuevo-Ortega, P. and C√°mara-Sola, E. and Tsvetanova-Spasova, T. and Rueda-Molina, C. and Salido-D√≠az, L. and Garc√≠a-Alc√°ntara, A. and Kaneko, T. and Tanaka, H. and Kamikawa, M. and Karashima, R. and Iwashita, S. and Irie, H. and Kasaoka, S. and Arola, O. and Laitio, R. and Saraste, A. and Airaksinen, J. and Pietil√§, M. and Hynninen, M. and Wennervirta, J. and B√§cklund, M. and Ylikoski, E. and Silvasti, P. and Nukarinen, E. and Gr√∂nlund, J. and Harjola, V. and Niiranen, J. and Korpi, K. and Varpula, M. and Roine, R. and Laitio, T. and Salah, S. and Hassen, B. and Fehmi, A. and Kim, S. and Hsu, Y. and Barea-Mendoza, J. and Garc√≠a-Fuentes, C. and Castillo-Jaramillo, M. and Dominguez-Aguado, H. and Viejo-Moreno, R. and Terceros-Almanza, L. and Azn√°rez, S. and Mudarra-Reche, C. and Xu, W. and Chico-Fern√°ndez, M. and Montejo-Gonz√°lez, J. and Crewdson, K. and Thomas, M. and Merghani, M. and Fenner, L. and Morgan, P. and Lockey, D. and van, L. and Oomen, B. and Binnekade, J. and Dongelmans, D. and de, H. and Juffermans, N. and Vroom, M. and Algarte, R. and Mart√≠nez, L. and S√°nchez, B. and Romero, I. and Mart√≠nez, F. and Quintana, S. and Trenado, J. and Sheikh, O. and Pogson, D. and Clinton, R. and Riccio, F. and Gemmell, L. and MacKay, A. and Arthur, A. and Young, L. and Sinclair, A. and Markopoulou, D. and Venetsanou, K. and Filippou, L. and Salla, E. and Stratouli, S. and Alamanos, I. and Guirgis, A. and Rodriguez, R. and Lorente, M. and Guarasa, I. and Ukere, A. and Meisner, S. and Greiwe, G. and Opitz, B. and Benten, D. and Nashan, B. and Fischer, L. and Trepte, C. and Reuter, D. and Haas, S. and Behem, C. and Tavazzi, G. and Ana, B. and Vazir, A. and Gibson, D. and Price, S. and Masjedi, M. and Hadavi, M. and alam, M. and Sasani, M. and Parenti, N. and Agrusta, F. and Palazzi, C. and Pifferi, B. and Sganzerla, R. and Tagliazucchi, F. and Luciani, A. and M√∂ller, M. and M√ºller-Engelmann, J. and Montag, G. and Adams, P. and Lange, C. and Neuzner, J. and Gradaus, R. and Wodack, K. and Th√ºrk, F. and Waldmann, A. and Gr√§ssler, M. and Nishimoto, S. and B√∂hm, S. and Kaniusas, E. and Reuter, D. and Trepte, C. and Sigmundsson, T. and √ñhman, T. and Redondo, E. and Hallb√§ck, M. and Wallin, M. and Sipman, F. and Oldner, A. and Sander, C. and Bj√∂rne, H. and Colinas, L. and Hernandez, G. and Vicho, R. and Serna, M. and Cuena, R. and Canabal, A. and Chaari, A. and Hakim, K. and Etman, M. and El, B. and El, S. and Bousselmi, K. and Arali, A. and Kauts, V. and Casey, W. and Bond, O. and De, S. and Iesu, E. and Franchi, F. and Vincent, J. and Creteur, J. and Scolletta, S. and Taccone, F. and Marutyan, Z. and Hamidova, L. and Shakotko, A. and Movsisyan, V. and Uysupova, I. and Evdokimov, A. and Petrikov, S. and Gonen, C. and Haftacƒ±, E. and Balci, C. and Calvo, F. and Bejarano, N. and Baladron, V. and Villazala, R. and Redondo, J. and Padilla, D. and Villarejo, P. and Akcan-Arikan, A. and Kennedy, C. and Arzapalo, M. and Gomez-Gonzalez, C. and Mas-Font, S. and Puppo-Moreno, A. and Herrera-Gutierrez, M. and Garcia-Garcia, M. and Aldunate-Calvo, S. and Plata-Menchaca, E. and P√©rez-Fern√°ndez, X. and Estruch, M. and Betbese-Roig, A. and Campos, P. and Lora, M. and Gaibor, N. and Medina, R. and Sanguino, V. and Casanova, E. and Riera, J. and Kritmetapak, K. and Peerapornratana, S. and Kittiskulnam, P. and Dissayabutra, T. and Tiranathanagul, K. and Susantithapong, P. and Praditpornsilpa, K. and Tungsanga, K. and Eiam-Ong, S. and Srisawat, N. and Winkelmann, T. and Busch, T. and Meixensberger, J. and Bercker, S. and Cabeza, E. and S√°nchez, M. and Gim√©nez, N. and Mel√≥n, C. and de, L. and Esta√±, P. and Bernal, M. and de, L. and Ergin, B. and Guerci, P. and Specht, P. and Ince, Y. and Ince, C. and Balik, M. and Zakharchenko, M. and Los, F. and Brodska, H. and de, T. and Augustin, P. and Desmard, M. and Montravers, P. and Stapel, S. and de, B. and Oudemans, H. and Hollinger, A. and Schweingruber, T. and Jockers, F. and Dickenmann, M. and Siegemund, M. and Runciman, N. and Ralston, M. and Appleton, R. and Mauri, T. and Alban, L. and Turrini, C. and Sasso, T. and Langer, T. and Panigada, M. and Taccone, P. and Carlesso, E. and Marenghi, C. and Grasselli, G. and Pesenti, A. and Wibart, P. and Reginault, T. and Garcia, M. and Barbrel, B. and Benard, A. and Bader, C. and Vargas, F. and Bui, H. and Hilbert, G. and Sim√≥n, J. and S√°nchez, P. and Ferr√≥n, F. and de, A. and Marin, J. and Antonia, V. and Ruano, L. and Monica, M. and Ferrer, R. and Masclans, J. and Roca, O. and Hong, G. and Kim, D. and Kim, Y. and Park, J. and Jee, Y. and xiang, Z. and Jia-xing, W. and dan, W. and long, N. and Yu, W. and Yan, Z. and Cheng, X. and Kobayashi, T. and Onodera, Y. and Akimoto, R. and Sugiura, A. and Suzuki, H. and Iwabuchi, M. and Nakane, M. and Kawamae, K. and Sanchez, P. and Rodriguez, M. and Delgado, M. and S√°nchez, V. and G√≥mez, A. and Sim√≥n, J. and Beuret, P. and Fortes, C. and Lauer, M. and Reboul, M. and Chakarian, J. and Fabre, X. and Philippon-Jouve, B. and Devillez, S. and Clerc, M. and Rittayamai, N. and Sklar, M. and Dres, M. and Rauseo, M. and Campbell, C. and West, B. and Tullis, D. and Brochard, L. and Onodera, Y. and Akimoto, R. and Suzuki, H. and Okada, M. and Nakane, M. and Kawamae, K. and Ahmad, N. and Wood, M. and Glossop, A. and Lucas, J. and Ortiz, A. and Alonso, D. and De, P. and Gonz√°lez, L. and Costa, R. and Spinazzola, G. and Pizza, A. and Ferrone, G. and Rossi, M. and Antonelli, M. and Conti, G. and Ribeiro, H. and Alves, J. and Sousa, M. and Reis, P. and Socolovsky, C. and Cauley, R. and Frankel, J. and Beam, A. and Olaniran, K. and Gibbons, F. and Christopher, K. and Pennington, J. and Zolfaghari, P. and King, H. and Kong, H. and Shum, H. and Yan, W. and Kaymak, C. and Okumus, N. and Sari, A. and Erdogdu, B. and Aksun, S. and Basar, H. and Ozcan, A. and Ozcan, N. and Oztuna, D. and Malmgren, J. and Lundin, S. and Tor√©n, K. and Eckerstr√∂m, M. and Wallin, A. and Waldenstr√∂m, A. and Riccio, F. and Pogson, D. and Antonio, A. and Leivas, A. and Kenji, F. and James, E. and Morgan, P. and Carroll, G. and Gemmell, L. and MacKay, A. and Wright, C. and Ballantyne, J. and Jonnada, S. and Gerrard, C. and Jones, N. and Salciccioli, J. and Marshall, D. and Komorowski, M. and Hartley, A. and Sykes, M. and Goodson, R. and Shalhoub, J. and Villanueva, J. and Garda, R. and Lago, A. and Ruiz, E. and Vaquero, R. and Rodr√≠guez, C. and P√©rez, E. and Hilasque, C. and Oliva, I. and Sirgo, G. and Martin, M. and Olona, M. and Gilavert, M. and Bod√≠, M. and Ebm, C. and Aggarwal, G. and Huddart, S. and Quiney, N. and Cecconi, M. and Fernandes, S. and Silva, J. and Gouveia, J. and Silva, D. and Marques, R. and Bento, H. and Alvarez, A. and Silva, Z. and Diaz, D. and Mart√≠nez, M. and Herrejon, E. and de, l. and Gonzalo, G. and Lopez, M. and de, G. and Matilla, C. and Chueca, P. and Longares, M. and Abril, R. and Aguilar, A. and de, M. and Fern√°ndez, R. and Labor√≠as, P. and Castellanos, M. and Labor√≠as, M. and Cho, J. and Kim, J. and Park, J. and Woo, S. and West, T. and Powell, E. and Rimmer, A. and Orford, C. and Jones, N. and Williams, J. and Matilla, C. and de, G. and Chueca, P. and Abril, R. and Longares, M. and Aguilar, A. and de, M. and Bourne, R. and Shulman, R. and Tomlin, M. and Mills, G. and Borthwick, M. and Berry, W. and Huertas, D. and Manzano, F. and Villagr√°n-Ram√≠rez, F. and Ruiz-Perea, A. and Rodr√≠guez-Mej√≠as, C. and Santiago-Ruiz, F. and Colmenero-Ruiz, M. and K√∂nig, C. and Matt, B. and Kortgen, A. and Hartog, C. and Wong, A. and Balan, C. and Barker, G. and Srisawat, N. and Peerapornratana, S. and Laoveeravat, P. and Tachaboon, S. and Eiam-ong, S. and Paratz, J. and Kayambu, G. and Boots, R. and Arzapalo, M. and Vlasenko, R. and Gromova, E. and Loginov, S. and Kiselevskiy, M. and Dolgikova, Y. and Tang, K. and Chau, C. and Lam, K. and Gil, E. and Suh, G. and Park, C. and Park, J. and Chung, C. and Lee, C. and Chao, A. and Shih, P. and Chang, Y. and Lai, C. and Hsu, Y. and Yeh, Y. and Cheng, Y. and Colella, V. and Zarrillo, N. and D‚ÄôAmico, M. and Forfori, F. and Pezza, B. and Laddomada, T. and Beltramelli, V. and Pizzaballa, M. and Doronzio, A. and Balicco, B. and Kiers, D. and van, d. and Gerretsen, J. and de, M. and el, M. and Rongen, G. and Gomes, M. and Kox, M. and Pickkers, P. and Riksen, N. and Kashiwagi, Y. and Okada, M. and Hayashi, K. and Inagaki, Y. and Fujita, S. and Nakamae, M. and Kang, Y. and Souza, R. and Liberatore, A. and Koh, I. and Blet, A. and Sadoune, M. and Lemari√©, J. and Bihry, N. and Bern, R. and Polidano, E. and Merval, R. and Launay, J. and L√©vy, B. and Samuel, J. and Mebazaa, A. and Hartmann, J. and Harm, S. and Weber, V.},
title  = {ESICM LIVES 2016: part one: Milan, Italy. 1-5 October 2016.},
journal  = {Intensive Care Medicine Experimental},
volume  = {4},
number  = {Suppl 1},
pages  = {},
year  = {2016},
abstract  = {},
address  = {Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands UMCU, Utrecht, Netherlands UMCU, Utrecht, Netherlands Autonomous University of Barcelona, Barcelona, Spain Hospital S√£o Francisco Xavier, Lisbon, Portugal Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands CHU Henri Mondor, Medical ICU, Cr√©teil, France H√¥pital Tenon, APHP, Medical and Surgical ICU, Paris, France CHU Henri Mondor, Medical ICU, Cr√©teil, France CHU Henri Mondor, Medical ICU, Cr√©teil, France CHU Henri Mondor, Medical ICU, Cr√©teil, France University Health Network, University of Toronto, Critical Care Medicine, Toronto, Canada University of Milan - Bicocca, Health Sciences, School of Medicine and Surgery, Monza, Italy St Michael‚Äôs Hospital, University of Toronto, Anesthesia, Toronto, Canada CHU d‚ÄôAngers, Medical ICU, Angers, France Interdepartmental Division of Critical Care, University of Toronto Saint Michael‚Äôs Hospital and Keenan Research Centre, Toronto, Canada CHU Henri Mondor, Medical ICU, Cr√©teil, France University of Birmingham, Institute for Inflammation and Ageing, Birmingham, UK University of Birmingham, Institute for Inflammation and Ageing, Birmingham, UK University of Sheffield, Mathematics and Statistics Help Centre, Sheffield, UK Heart of England NHS Foundation Trust, Intensive Care Medicine, Birmingham, UK University of Birmingham, Institute for Inflammation and Ageing, Birmingham, UK Department of Surgery, University Hospitals Birmingham NHS Trust, Birmingham, UK University Hospitals Birmingham NHS Trust, Anaesthesia and Critical Care Medicine, Birmingham, UK Queen‚Äôs University of Belfast, Wellcome-Wolfson Institute for Experimental Medicine, Belfast, UK Heart of England NHS Foundation Trust, Intensive Care Medicine, Birmingham, UK St Michael‚Äôs Hospital, University of Toronto, Critical Care, Toronto, Canada St Michael‚Äôs Hospital, University of Toronto, Anesthesia, Toronto, Canada University of Milan-Bicocca, Health Sciences, School of Medicine and Surgery, Monza, Italy University Health Network, University of Toronto, Critical Care Medicine, Toronto, Canada Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Mayo Clinic, Jacksonville, USA Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands University of Bari ‚ÄòAldo Moro‚Äô, Bari, Italy Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands Academic Medical Center, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, Netherlands University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Center for Experimental and Molecular Medicine, Amsterdam, Netherlands University Medical Center Utrecht, Julius Center for Health Sciences and Primary  Care, Utrecht, Netherlands University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands Seoul National University Hospital, Seoul, Republic of Korea Seoul National University Hospital, Seoul, Republic of Korea Seoul National University Hospital, Seoul, Republic of Korea Seoul National University Hospital, Seoul, Republic of Korea Department of Emergency Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea Department of Emergency Medicine, Seoul National University Boramae Hospital, Seoul, Republic of Korea Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D‚Äôinvestigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D‚Äôinvestigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain Pneumology Department, ISS/Hospital Universitario y Politecnico La Fe, CIBER Enfermedades Respiratorias (CIBERES), Valencia, Spain Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D‚Äôinvestigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain Pneumology Department, ISS/Hospital Universitario y Politecnico La Fe, CIBER Enfermedades Respiratorias (CIBERES), Valencia, Spain Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D‚Äôinvestigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D‚Äôinvestigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D‚Äôinvestigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D‚Äôinvestigacions August Pi I Sunyer (IDIBAPS), Barcelona, Spain Department of Mathematics, University of Pittsburgh, Pittsburgh, USA Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, USA Department of Mathematics, University of Pittsburgh, Pittsburgh, USA University of Pittsburgh, Biostatistics, Pittsburgh, USA Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, USA Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, USA Department of Anesthesiology, University of Greifswald, Greifswald, Germany Department of Anesthesiology, University of Greifswald, Greifswald, Germany University of Greifswald, Greifswald, Germany University of Greifswald, Institute of Bioinfomatics, University Medicine Greifswald, Greifswald, Germany Department of Anesthesiology, University of Greifswald, Greifswald, Germany Department of Anesthesiology, University of Greifswald, Greifswald, Germany Department of Anesthesiology, University of Greifswald, Greifswald, Germany Department of Anesthesiology, University of Greifswald, Greifswald, Germany St. Johns Medical College, Bangalore, India Yashoda Hospials, Secundrabad, India University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy,  Szeged, Hungary University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy,  Szeged, Hungary University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy,  Szeged, Hungary University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy,  Szeged, Hungary University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy,  Szeged, Hungary Medical University of Vienna, Anaesthesiology and General Intensive Care Medicine, Vienna, Austria University of Szeged Faculty of Medicine, Surgical Research, Szeged, Hungary University of Szeged Faculty of Medicine, Surgical Research, Szeged, Hungary Technische Universit√§t M√ºnchen, Gastroenterology, Munich, Germany University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy,  Szeged, Hungary University of Szeged Faculty of Medicine, Anaesthesiology and Intensive Therapy,  Szeged, Hungary Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina Academic Medical Center, University of Amsterdam, Translational Physiology, Amsterdam, Netherlands Facultad de Ciencias M√©dicas, Universidad Nacional de La Plata, C√°tedra de Farmacolog√≠a Aplicada, La Plata, Argentina St George‚Äôs University Hospitals NHS Foundation Trust, Adult Critical Care Directorate, London, UK St George‚Äôs University Hospitals NHS Foundation Trust, Adult Critical Care Directorate, London, UK St George‚Äôs University Hospitals NHS Foundation Trust, Adult Critical Care Directorate, London, UK St George‚Äôs University Hospitals NHS Foundation Trust, Adult Critical Care Directorate, London, UK St George‚Äôs University Hospitals NHS Foundation Trust, Adult Critical Care Directorate, London, UK H√¥pital Louis Pradel, Anesth√©sie R√©animation, Bron, France H√¥pital Louis Pradel, Anesth√©sie R√©animation, Bron, France H√¥pital Louis Pradel, Anesth√©sie R√©animation, Bron, France H√¥pital Louis Pradel, Anesth√©sie R√©animation, Bron, France H√¥pital Louis Pradel, Anesth√©sie R√©animation, Bron, France H√¥pital Femme M√®re Enfant, Lyon, France H√¥pital Louis Pradel, Anesth√©sie R√©animation, Bron, France H√¥pital Louis Pradel, Anesth√©sie R√©animation, Bron, France Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain Intensive Care Unit, Hospital Virgen del Rocio, Sevilla, Spain Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes  University Hospital, Nimes, France Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes  University Hospital, Nimes, France Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes  University Hospital, Nimes, France University of Queensland, Burns Trauma Critical Care Research Centre, Brisbane, Australia Department of Anaesthesiology, Critical Care, Pain and Emergency Medicine, Nimes  University Hospital, Nimes, France University of Queensland, Burns Trauma Critical Care Research Centre, Brisbane, Australia Hospital del Mar-IMIM, Critical Care, Barcelona, Spain Hospital del Mar-IMIM, Critical Care, Barcelona, Spain Hospital del Mar-IMIM, Critical Care, Barcelona, Spain Hospital del Mar-IMIM, Critical Care, Barcelona, Spain Hospital del Mar-IMIM, Critical Care, Barcelona, Spain Hospital del Mar, Pharmacy, Barcelona, Spain Hospital del Mar, Pharmacy, Barcelona, Spain Hospital del Mar, Pharmacy, Barcelona, Spain Hospital del Mar-IMIM, Critical Care, Barcelona, Spain Hospital del Mar-IMIM, Critical Care, Barcelona, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Microbiology Laboratory, Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Pitie-Salpetriere Hospital and Pierre and Marie Curie University, Paris, France Department of Anaesthesia and Intensive Care Medicine, Aalborg University Hospital, Aalborg, Denmark Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Department of Clinical Medicine, Aalborg University, Aalborg, Denmark Department of Chemistry and Bioscience, Section of Biotechnology, Aalborg University, Aalborg, Denmark Policlinico Di Milano, Milan, Italy Hospital Clinic, Barcelona, Spain Hospital Clinic, Barcelona, Spain National Institutes of Health, Bethesda, USA Policlinico Di Milano, Milan, Italy Policlinico Di Milano, Milan, Italy Massachusetts General Hospital, Boston, USA Ospedale Nuovo del Mugello, Borgo San Lorenzo (FI), Italy Gruppo Ospedaliero San Donato, San Donato M.se, Italy Arcispedale S. Maria Nuova, Reggio Emilia, Italy Ospedale San Giovanni Bosco, Torino, Italy Policlinico San Matteo, Pavia, Italy Policlinico di Modena, Modena, Italy Azienda Ospedaliero - Universitaria di Parma, Parma, Italy Ospedale Citt√† di Sesto San Giovanni, Sesto San Giovanni, Italy Policlinico Gemelli, Roma, Italy Azienda Ospedaliero-Universitaria di Parma, Parma, Italy Azienda Ospedaliero-Universitaria di Parma, Parma, Italy University Hospital Frankfurt, Frankfurt, Germany University Hospital Center Zagreb, Zagreb, Croatia Ospedale Santa Chiara, Trento, Italy Policlinico Di Milano, Milan, Italy Policlinico Di Milano, Milan, Italy University of G√∂ttingen, G√∂ttingen, Germany Hospital Clinic, Barcelona, Spain School of Nursing, Shiraz University of Medical Science, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Anesthesiology and Critical Care Research  Center, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran University of Milan - Bicocca, Monza, Italy University of Goettingen, Goettingen, Germany Fondazione IRCCS Ospedale Maggiore Policlinico, Anesthesia and Critical Care, Milan, Italy University of Goettingen, Goettingen, Germany University of Goettingen, Goettingen, Germany University of Milan, Milan, Italy University of Goettingen, Goettingen, Germany University of Helsinki and Helsinki University Hospital, Intensive Care Medicine, Helsinki, Finland Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland University of Helsinki and Helsinki University Hospital, Intensive Care Medicine, Helsinki, Finland University of Helsinki and Helsinki University Hospital, Intensive Care Medicine, Helsinki, Finland VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands VU Medical Centre, Intensive Care Adults, Amsterdam, Netherlands Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Universidade Federal de S√£o Paulo, Morphology and Genetics, S√£o Paulo, Brazil Biological Institute of S√£o Paulo, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, An√°lisis Cl√≠nicos, Cartagena, Spain Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, Cartagena, Spain Hospita Santa Luc√≠a, Intensive Care, Cartagena, Spain Hospital Santa Luc√≠a, Intensive Care, Cartagena, Spain Department of Physiology, School of Medicine Murcia, Murcia, Spain Department of Translational Physiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Department of Translational Physiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Department of Medical Technical Innovation & Development (MIO), Academic Medical  Center, University of Amsterdam, Amsterdam, Netherlands Department of Translational Physiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Department of Translational Physiology, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands Academic Medical Centre Amsterdam, Translational Physiology, Amsterdam, Netherlands Department of Energency Medicine, Harvard Medical School, Boston, USA Academic Medical Center, University of Amsterdam, Transaltional Physiology, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Transaltional Physiology, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Transaltional Physiology, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Transaltional Physiology, Amsterdam, Netherlands Department of Cardio-thoracic Surgery, Acibadem University, Istanbul, Turkey Academic Medical Center, University of Amsterdam, Transaltional Physiology, Amsterdam, Netherlands Queen Mary University of London, WHRI, Translational Medicine and Therapeutics, London, UK Queen Mary University of London, WHRI, Translational Medicine and Therapeutics, London, UK Queen Mary University of London, WHRI, Translational Medicine and Therapeutics, London, UK Queen Mary University of London, WHRI, Translational Medicine and Therapeutics, London, UK Queen Mary University of London, WHRI, Translational Medicine and Therapeutics, London, UK Queen Mary University of London, WHRI, Translational Medicine and Therapeutics, London, UK Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands Department of Public Health, Erasmus Medical Centre, Rotterdam, Netherlands Department of Intensive Care, Albert Schweitzer Hospital, Dordrecht, Netherlands Department of Intensive Care, Ikazia Hospital, Rotterdam, Netherlands Department of Intensive Care, IJsselland Hospital, Rotterdam, Netherlands Department of Intensive Care, Sint Franciscus Gasthuis, Rotterdam, Netherlands Department of Intensive Care, Maasstad Hospital, Rotterdam, Netherlands KU Leuven, Academic Centre for Nursing and Midwifery, Leuven, Belgium Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands Department of Pediatric Surgery, Intensive Care Unit, Erasmus Medical Center - Sophia Children‚Äôs Hospital, Rotterdam, Netherlands Third Faculty of Medicine, Charles University in Prague, Laboratory for Metabolism and Bioenergetics, Prague, Czech Republic Department of Anaesthesiology and Intensive Care, Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic Third Faculty of Medicine, Charles University in Prague, Laboratory for Metabolism and Bioenergetics, Prague, Czech Republic Nuffield Division of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK University of Oxford, Weatherall Institute of Molecular Medicine, Oxford, UK Nuffield Division of Anaesthetics, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Oxford University Hospitals NHS Foundation Trust, Systematic Review Initiative NHS Blood & Transplant, Oxford, UK Oxford University Hospitals NHS Foundation Trust, Systematic Review Initiative NHS Blood & Transplant, Oxford, UK Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Department of Anesthesiology, Nordsj√¶llands Hospital, University of Copenhagen, Hiller√∏d, Denmark Department of Nursing, Metropolitan University, Copenhagen, Denmark Department of Anesthesiology, Nordsj√¶llands Hospital, University of Copenhagen, Hiller√∏d, Denmark Department of Anesthesiology, Nordsj√¶llands Hospital, University of Copenhagen, Hiller√∏d, Denmark Department of Neuroanesthesiology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Anestesiology and Intensive Care,  Moscow, Russian Federation N.I. Pirogov National Medical Surgical Center, Moscow, Russian Federation Department of Anesthesiology, Nordsj√¶llands Hospital, University of Copenhagen, Hiller√∏d, Denmark University of Copenhagen, Health & Medical Sciences, Copenhagen, Denmark Department of Anesthesiology, Nordsj√¶llands Hospital, University of Copenhagen, Hiller√∏d, Denmark Department of Anesthesiology, Nordsj√¶llands Hospital, University of Copenhagen, Hiller√∏d, Denmark Department of Psychology, University of Southern Denmark, Odense, Denmark Department of Anesthesiology, Nordsj√¶llands Hospital, University of Copenhagen, Hiller√∏d, Denmark Department of Anesthesiology, Herlev Hospital, University of Copenhagen, Herlev,  Denmark Department of Anesthesiology, Hospital of Horsens, Horsens, Denmark Department of Nursing, Metropolitan University, Copenhagen, Denmark University of Pittsburgh, School of Nursing, Pittsburgh, USA Carnegie Mellon University, Robotics Institute, Auton Lab, Pittsburgh, USA Carnegie Mellon University, Robotics Institute, Auton Lab, Pittsburgh, USA University of Pittsburgh, Critical Care Medicine, Pittsburgh, Pennsylvania USA University of Pittsburgh, Critical Care Medicine, Pittsburgh, Pennsylvania USA Department of Physiotherapy, The University of Melbourne, Melbourne, Australia Department of Physiotherapy, Royal Melbourne Hospital, Melbourne, Australia Guy‚Äôs and St Thomas‚Äô NHS Foundation Trust and Kings College, London, UK University of South Australia, Member of the International Centre for Allied Health Evidence (iCAHE) and the Sansom Institute, Adelaide, Australia Division of Respiratory and Critical Care, National University Hospital, Singapore, Singapore Department of Physiotherapy, The University of Melbourne, Melbourne, Australia Guy‚Äôs and St Thomas‚Äô NHS Foundation Trust and Kings College, London, UK Division of Critical Care and Pulmonology, University of Kentucky, Kentucky, USA Guy‚Äôs & St Thomas‚Äô NHS Foundation Trust, Lane Fox Respiratory Unit, London, UK Department of Physiotherapy, The University of Melbourne, Melbourne, Australia Department of Anaesthesiology and Intensive Care, Lillebaelt Hospital, Vejle and  Kolding, Denmark Department of Geriatrics, Ghent University Hospital, Gent, Belgium Department of Intensive Care, Ghent University Hospital, Gent, Belgium Department of Anaesthesiology and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden King‚Äôs College Hospital, Critical Care and Major Trauma, London, UK Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands Saint-Etienne University Hospital and Jacques Lisfranc Medical School, Saint-Etienne, France Department of Anaesthesia and Intensive Care Medicine, General University Hospital, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA Institut Jules Bordet, ULB, Service des soins Intensifs et Ergences Oncologiques, Bruxelles, Belgium Dipartimento Emergenza Urgenza Anestesia e Rianimazione, Ospedale Maggiore della  Carit√† Novara, Novara, Italy Semmelweis University, Budapest, Hungary Intensive Care Department, Hospital S.Ant√≥nio, Porto, Portugal Department of Anesthesiology and Critical Care, Tettnang Hospital, Tettnang, Germany Department of Intensive Care, Ghent University Hospital, Gent, Belgium Department of Intensive Care, Erasmus Hospital, Rotterdam, Netherlands Department of Psychoanalysis and Clinical Consulting, Ghent University, Gent, Belgium H√¥pital Saint Louis, Service de Reanimation M√©dicale, Paris, France Department of Applied Mathematics and Computer Science and Statistics, Ghent University, Gent, Belgium Department of Intensive Care, Ghent University Hospital, Gent, Belgium Department of Intensive Care, Ghent University Hospital, Gent, Belgium Department of Geriatrics, Ghent University Hospital, Gent, Belgium Department of Anaestesiology and Intensive Care, Lillebaelt Hospital, Veijle and  Kolding, Denmark Department of Anaesthesiology and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden King‚Äôs College Hospital, Critical Care and Major Trauma, London, UK Department of Internal Medicine, University of Groningen, University Medical Center Groningen, Groningen, Netherlands Saint-Etienne University Hospital and Jacques Lisfranc Medical School, Saint-Etienne, France Department of Anaesthesia and Intensive Care, General University Hospital, 1st Faculty of Medicine, Charles University in Prague, Prague, Czech Republic Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, USA Institut Jules Bordet, ULB, Service des Soins Intensifs et Urgences Oncologiques, Bruxelles, Belgium Dipartimento Emergenza Urgenza Anestesia e Rianimazione, Ospedale maggiore della  carit√† Novara, Novara, Italy Semmelweis University, Budapest, Hungary Department of Intensive Care, Hospital S. Ant√≥nio, Porto, Portugal Department of Anesthesiology and Critical Care, Tettnang Hospital, Tettnang, Germany Department of Intensive Care, Ghent University Hospital, Gent, Belgium Department of Intensive Care, Erasmus Hospital, Rotterdam, Netherlands Department of Psychoanalysis and Clinical Consulting, Ghent University, Gent, Belgium Hopital Saint Louis, Service de Reanimation M√©dicale, Paris, France Department of Applied Mathematics and Computer Science and Statistics, Ghent University, Gent, Belgium Department of Intensive Care, Ghent University Hospital, Gent, Belgium St Georges NHS Foundation Trust, General Intensive Care, London, UK St Georges NHS Foundation Trust, General Intensive Care, London, UK St Georges NHS Foundation Trust, General Intensive Care, London, UK St Georges NHS Foundation Trust, General Intensive Care, London, UK St Georges NHS Foundation Trust, General Intensive Care, London, UK St Georges NHS Foundation Trust, General Intensive Care, London, UK Papageorgiou General Hospital, ICU, Thessaloniki, Greece Papageorgiou General Hospital, ICU, Thessaloniki, Greece Papageorgiou General Hospital, ICU, Thessaloniki, Greece AHEPA University Hospital, ICU, Thessaloniki, Greece Technological Educational Institutes of Ipeirus, Ioannina, Greece University Hospital of Ioannina, ICU, Ioannina, Greece University Hospital of Ioannina, ICU, Ioannina, Greece Royal Free Hospital, Intensive Care Unit, London, UK Royal Free Hospital, Intensive Care Unit, London, UK Royal Free Hospital, Intensive Care Unit, London, UK Royal Free Hospital, Intensive Care Unit, London, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK University Hospital South Manchester, Manchester, UK Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Department of Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea Royal Cornwall Hospital, Intensive Care Unit, Truro, UK Royal Cornwall Hospital, Intensive Care Unit, Truro, UK Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Department of Intensive Care, VU University Medical Center, Amsterdam, Netherlands Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center, Amsterdam, Netherlands Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center, Amsterdam, Netherlands Department of Internal Medicine Division of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey Department of Internal Medicine Division of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey Department of Internal Medicine Division of Intensive Care, Ankara University Faculty of Medicine, Ankara, Turkey Department of Anaesthesiology and Intensive Care, Tartu University Hospital, Tartu, Estonia Department of Anaesthesiology and Intensive Care, Tartu University Hospital, Tartu, Estonia University of Copenhagen, Faculty of Health and Medical Sciences, Section of Biostatistics, Institute of Public Health, Copenhagen, Denmark Department of Anaesthesiology and Intensive Care, Tartu University Hospital, Tartu, Estonia Department of Anaesthesiology and Intensive Care, University of Tartu, Tartu, Estonia Department of Critical Care Medicine, Sri Ramachandra University, Chennai, India Department of Critical Care Medicine, Sri Ramachandra University, Chennai, India Department of Anesthesiology, Sri Ramachandra University, Chennai, India Department of Critical Care Medicine, Sri Ramachandra University, Chennai, India Department of Intensive Care, University Medical Center Groningen, University of  Groningen, Groningen, Netherlands Department of Intensive Care, University Medical Center Groningen, University of  Groningen, Groningen, Netherlands Department of Intensive Care, University Medical Center Groningen, University of  Groningen, Groningen, Netherlands Departments of Intensive Care and Anesthesiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands Department of Intensive Care, University Medical Center Groningen, University of  Groningen, Groningen, Netherlands Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Karolinska University Hospital Huddinge, Stockholm, Sweden Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Erciyes University, Intensive Care Unit, Kayseri, Turkey Internal Medicine Department, Erciyes University, Kayseri, Turkey Erciyes University, Intensive Care Unit, Kayseri, Turkey Clinical Biochemistry Department, Erciyes University, Kayseri, Turkey Erciyes University, Intensive Care Unit, Kayseri, Turkey Department of Medicine, Division of Endocrinology, Metabolism and Lipids, Emory University, Atlanta, USA Erciyes University, Intensive Care Unit, Kayseri, Turkey University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University Hospital Zurich, University Zurich, Surgical Intensive Care Unit, Zurich, Switzerland University Hospital Zurich, University Zurich, Surgical Intensive Care Unit, Zurich, Switzerland Royal Brompton and Harefield NHS Foundation Trust, London, UK Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Trauma Research Center, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Chang Gung Memorial Hospital, Thoacic Medicine, Kwei-Shan, Taoyuan, Taiwan, Province of China Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Critical Care Department, Faculty of Medicine - Beni Suef University, Cairo, Egypt Critical Care Department, Faculty of Medicine - Beni Suef University, Cairo, Egypt Critical Care Department, Faculty of Medicine - Cairo University, Cairo, Egypt Critical Care Department, Faculty of Medicine - Beni Suef University, Cairo, Egypt Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Department of Anesthesia and Critical Care, Multidisciplinary Intensive Care Research Organization (MICRO). St James‚Äôs; University Hospital. Trinity Center for Health Sciences, Dublin, Ireland Critical Care Department, Hospital Parc Tauli, Sabadell, Spain Critical Care Department, Hospital de Matar√≥, Matar√≥, Spain Critical Care Department, University Hospital Joan XXIII - IISPV-URV, Tarragona,  Spain Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain Hospital Universitari Vall d‚ÄôHebron, Critical Care, Barcelona, Spain University of Liverpool, Institute of Infection and Global Health, Liverpool, UK Royal Liverpool University Hospital, Intensive Care Unit, Liverpool, UK Royal Liverpool University Hospital, Intensive Care Unit, Liverpool, UK Lille University Hospital, ICU, Lille, France Lille University Hospital, ICU, Lille, France Lille University Hospital, ICU, Lille, France Lille University Hospital, ICU, Lille, France Lille University Hospital, ICU, Lille, France Lille University Hospital, ICU, Lille, France Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Chi Mei Medical Center, Tainan, Taiwan, Province of China Chi Mei Medical Center, Tainan, Taiwan, Province of China Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Critical Care Department, Hospital Parc de Salut Mar - GREPAC, IMIM, Barcelona, Spain Pompeu Fabra University (UPF) - CEXS, Barcelona, Spain Critical care Department, Hospital de Donosti, San Sebastian, Spain Critical care Department, Hospital la Fe, Valencia, Spain Critical care Department, Hospital de Valdecillas, Santander, Spain Critical care Department, Hospital Gregorio Mara√±on, Madrid, Spain CIBERES. Instituto de Salud Carlos III, Madrid, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Hospital Universitari Arnau de Vilanova, Lleida, Spain Consorci Sanitari del Maresme, Intensive Care Unit, Matar√≥, Spain Consorci Sanitari del Maresme, Intensive Care Unit, Matar√≥, Spain Consorci Sanitari del Maresme, Investigation Unit, Matar√≥, Spain Consorci Sanitari del Maresme, Intensive Care Unit, Matar√≥, Spain Consorci Sanitari del Maresme, Intensive Care Unit, Matar√≥, Spain Consorci Sanitari del Maresme, Investigation Unit, Matar√≥, Spain Hospital Cl√≠nico Universitario de Valladolid, Unidad de Investigaci√≥n M√©dica en Infecci√≥n e Immunidad, Valladolid, Spain Consorci Sanitari del Maresme, Intensive Care Unit, Matar√≥, Spain Clinica Sagrada Esperan√ßa, ICU, Luanda, Angola Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal Clinica Sagrada Esperan√ßa, Infectiology, Luanda, Angola Clinica Sagrada Esperan√ßa, Luanda, Angola Clinica Sagrada Esperan√ßa, Luanda, Angola Clinica Sagrada Esperan√ßa, ICU, Luanda, Angola University Hospital, UHCW NHS Trust, General Critical Care, Coventry, UK Department of Anaesthetics and Intensive Care, Dudley Group of Hospitals NHS Foundation Trust, Dudley, UK Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua, Italy Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua, Italy Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua, Italy Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua, Italy Department of Medicine, University of Padua, Thrombotic and Hemorrhagic Diseases  Unit, Padua, Italy Department of Medicine, University of Padua, Thrombotic and Hemorrhagic Diseases  Unit, Padua, Italy Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua, Italy Department of Medicine-DIMED, Azienda Ospedaliera di Padova, UOC Anesthesia and Intensive Care Unit, Padua, Italy Department of Medicine, University of Padua, Thrombotic and Hemorrhagic Diseases  Unit, Padua, Italy Nippon Medical School Hospital, Tokyo, Japan Nippon Medical School Hospital, Tokyo, Japan Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon, Portugal Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon, Portugal Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon, Portugal Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon, Portugal Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon, Portugal Intensive Care Department, University Hospital of Santa Maria, CHLN, Lisbon, Portugal Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint Georges, France Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint Georges, France Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint Georges, France Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint Georges, France Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint Georges, France Centre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Reanimation Polyvalente - Surveillance Continue, Villeneuve Saint Georges, France Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, Palermo, Italy Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, Palermo, Italy IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies,  Statistics, Research Office, Palermo, Italy Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, Palermo, Italy Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, Palermo, Italy Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, Palermo, Italy Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, Palermo, Italy Department of Anesthesia and Intensive Care, IRCCS-ISMETT Mediterranean Institute for Transplantation and Advanced Therapies, Palermo, Italy Hospital Universitario Marqu√©s de Valdecilla, Intensive Care Unit, Santander, Spain Hospital Universitario Marqu√©s de Valdecilla, Rheumathology Service, Santander, Spain Universidad de Cantabria, Preventive Medicine and Public Health, Santander, Spain Hospital Universitario Marqu√©s de Valdecilla, Intensive Care Unit, Santander, Spain CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens,  France CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens,  France CHU Amiens - Picardie, Cardiac Surgery, Amiens, France CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens,  France CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens,  France Universit√© de Picardie Jules Verne, CURS, Amiens, France CHU Amiens - Picardie, Cardio Thoracic and Vascular Intensive Care Unit, Amiens,  France University Hospital of Li√®ge, Medical and Coronary Intensive Care, Liege, Belgium University of Li√®ge, GIGA Research, Li√®ge, Belgium University of Li√®ge, GIGA Research, Li√®ge, Belgium University of Li√®ge, GIGA Research, Li√®ge, Belgium University Hospital of Li√®ge, Perfusion School, Liege, Belgium University of Li√®ge, GIGA Research, Li√®ge, Belgium University Hospital of Li√®ge, Medical and Coronary Intensive Care, Liege, Belgium University of Li√®ge, GIGA Research, Li√®ge, Belgium University of Li√®ge, GIGA Research, Li√®ge, Belgium University Hospital of Li√®ge, Medical and Coronary Intensive Care, Liege, Belgium Department of Medicine (DIMED), University of Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Emergency Department, Azienda Ospedaliera di Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Department of Medicine (DIMED), University of Padova, Padova, Italy Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Dr. Suat Seren Chest Diseases and Surgery Training Hospital, Intensive Care Unit, Izmir, Turkey Royal Infirmary of Edinburgh, Ward 118, Edinburgh, UK Royal Infirmary of Edinburgh, Edinburgh, UK Royal Infirmary of Edinburgh, Edinburgh, UK Royal Infirmary of Edinburgh, Edinburgh, UK Royal Infirmary of Edinburgh, Edinburgh, UK Royal Infirmary of Edinburgh, Edinburgh, UK PAH Harlow, Intensive Care, Harlow, UK Colchester NHSFT, Intensive Care, Colchester, UK Hospital Regional M√°laga, Intensive Care, M√°laga, Spain Hospital Regional M√°laga, Intensive Care, M√°laga, Spain Hospital Regional M√°laga, Intensive Care, M√°laga, Spain Hospital Infanta Margarita, Intensive Care, Cabra, Spain Hospital Virgen del Rocio, Intensive Care, Sevilla, Spain Hospital Puerta del Mar, Intensive Care, C√°diz, Spain Hospital Regional M√°laga, M√°laga, Spain Guy‚Äôs & St Thomas‚Äô NHS Foundation Trust, London, UK Sverdlovsk Regional Clinical Hospital 1, Ekaterinburg, Russian Federation Guy‚Äôs & St Thomas‚Äô NHS Foundation Trust, London, UK Guy‚Äôs & St Thomas‚Äô NHS Foundation Trust, London, UK Guy‚Äôs & St Thomas‚Äô NHS Foundation Trust, London, UK Guys and St Thomas‚Äô NHS Foundation Trust, London, UK Royal Surrey County Hospital, Guildford, UK Royal Surrey County Hospital, ICU and SPACeR research group, Guildford, UK Cheetah Medical, Inc., Director of Clinical Operations, Newton Center, USA Health Economics Trexin, Chief Data Scientist, Chicago, USA Cheetah Medical, Inc., Chief Physician Executive, Newton Center, USA Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Excellence Center for Critical Care Nephrology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Anesthesiology, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross and Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand Department of Critical Care Medicine, Center for Critical Care Nephrology, CRISMA Center, University of Pittsburgh School of Medicine, Pittsburgh, USA Department of Anaesthesiology and Intensive Care, Nordsj√¶llands Hospital, Hiller√∏d, Denmark Department of Intensive Care, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Department of Biostatistics, University of Copenhagen, Copenhagen, Denmark Department of Infectious Diseases, Rigshospitalet, Copenhagen University Hospital, CHIP & PERSIMUNE, Copenhagen, Denmark Department of Anaesthesiology and Intensive Care, Nordsj√¶llands Hospital, Hiller√∏d, Denmark University of Texas Health Science Center San Antonio, Pediatric Critical Care Medicine, San Antonio, USA Baylor College of Medicine, Pediatric Cardiology, Houston, USA Baylor College of Medicine, Pediatric Critical Care Medicine, Houston, USA Baylor College of Medicine, Pediatric Critical Care Medicine, Houston, USA Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Morphology and Genetics, S√£o Paulo, Brazil Biological Institute of S√£o Paulo, Sao Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt Faculty of Medicine, Cairo University, Critical Care Medicine, Cairo, Egypt Complejo Universitario Carlos Haya, M√°laga, Spain Complejo Universitario Carlos Haya, M√°laga, Spain Hospital Parc Tauli, Sabadell, Spain Hospital Son Llatzer, Palma de Mallorca, Spain Complejo Universitario Carlos Haya, M√°laga, Spain Complejo Universitario Carlos Haya, M√°laga, Spain University of Glasgow, Glasgow, UK Queen Elizabeth Hospital, Critical Care, Glasgow, UK Queen Elizabeth Hospital, Critical Care, Glasgow, UK Queen Elizabeth Hospital, Critical Care, Glasgow, UK Centro Universitario de La Costa, Puerto Vallarta, Jalisco Mexico Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK Queen Elizabeth University Hospital, Intensive Care Unit, Glasgow, UK Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands Department of Intensive Care, VU University Medical Center Amsterdam, Adults, Amsterdam, Netherlands University of Kinshasa, Anaesthesiology and Intensive Care, Kinshasa, Democratic  Republic of the Congo University of Kinshasa, Anaesthesiology and Intensive Care, Kinshasa, Democratic  Republic of the Congo University of Kinshasa, Anaesthesiology and Intensive Care, Kinshasa, Democratic  Republic of the Congo University of Kinshasa, Public Heath, Kinshasa, Democratic Republic of the Congo H√¥pital Nord, Reanimation, Marseille, France Rigshospitalet, Copenhagen University Hospital, Neurointensive Care Unit, Copenhagen, Denmark University of Gothenburg, The Sahlgrenska Academy, Gothenburg, Sweden Karolinska Institute, Stockholm, Sweden Rigshospitalet, Copenhagen University Hospital, Intensive Care Unit, Copenhagen,  Denmark Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Hospital Hygiene Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Internal Medicine Department, Farhat Hached University Hospital, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Hospital Hygiene Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Clinica Sagrada Esperan√ßa, ICU, Luanda, Angola Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal Clinica Sagrada Esperan√ßa, Luanda, Angola Escola Nacional de Saude Publica/ UNL, Lisboa, Portugal Clinica Sagrada Esperan√ßa, Luanda, Angola Clinica Sagrada Esperan√ßa, Luanda, Angola Clinica Sagrada Esperan√ßa, Luanda, Angola Royal Stoke University Hospital, Critical Care, Stoke-on-Trent, UK Royal Stoke University Hospital, Critical Care, Stoke-on-Trent, UK Apollo Hospitals, Intensive Care Medicine, Bangalore, India SRI Ramachindra University, Intensive Care Medicine, Chennai, India Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Hospital Israelita Albert Einstein, ICU, S√£o Paulo, Brazil Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran International Nosocomial Infection Control Consortium, Buenos Aires, Argentina Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz HIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Salford Royal NHS Foundation Trust, Critical Care, Salford, UK Salford Royal NHS Foundation Trust, Manchester, UK Salford Royal NHS Foundation Trust, Manchester, UK Salford Royal NHS Foundation Trust, Manchester, UK Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey Department of Anesthesia and Intensive Care, Regional Hospital Liberec, Liberec,  Czech Republic Department of Anesthesia and Intensive Care, Regional Hospital Liberec, Liberec,  Czech Republic Regional Hospital Liberec, Neurocentre, Liberec, Czech Republic St Mary‚Äôs Hospital, Adult Intensive Care Unit, London, UK St Mary‚Äôs Hospital, Adult Intensive Care Unit, London, UK St Mary‚Äôs Hospital, Adult Intensive Care Unit, London, UK St Mary‚Äôs Hospital, Adult Intensive Care Unit, London, UK Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Faculty  of Medicine, University of Rijeka, Rijeka, Croatia Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Faculty  of Medicine, University of Rijeka, Rijeka, Croatia Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia Department of Neurology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia Department of Anesthesiology, Reanimatology and Intensive Care Medicine, Faculty  of Medicine, University of Rijeka, Rijeka, Croatia Tan Tock Seng Hospital, National Healthcare Group (Singapore), Singapore, Singapore National University of Singapore, Singapore, Singapore National University of Singapore, Singapore, Singapore Hospital Universitario San Cecilio, Granada, Spain Hospital Universitario San Cecilio, Granada, Spain Hospital Universitario San Cecilio, Granada, Spain Hospital Universitario San Cecilio, Granada, Spain Hospital Universitario San Cecilio, Granada, Spain Hospital Universitario San Cecilio, Granada, Spain Hospital Universitario San Cecilio, Granada, Spain Krasnoyarsk State Medical University, Krasnoyarsk Regional Hospital, Anaesthesiology and Intensive Care, Krasnoyarsk, Russian Federation Krasnoyarsk State Medical University, Krasnoyarsk Regional Hospital, Anaesthesiology and Intensive Care, Krasnoyarsk, Russian Federation Krasnoyarsk Regional Hospital, Krasnoyarsk, Russian Federation Krasnoyarsk Clinical Regional Hospital, Anaesthesiology and Intensive Care, Krasnoyarsk, Russian Federation Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Tan Tock Seng Hospital, National Healthcare Group, Singapore, Singapore Centro Hospitalar do M√©dio Tejo, Unidade de Cuidados Intensivos Polivalente, Abrantes, Portugal Hospital de Santa Maria/CHLN, Lisboa, Portugal Centro Hospitalar do M√©dio Tejo, Abrantes, Portugal Centro Hospitalar do M√©dio Tejo, Abrantes, Portugal Centro Hospitalar do M√©dio Tejo, Abrantes, Portugal Centro Hospitalar do M√©dio Tejo, Abrantes, Portugal Inonu University, Intensive Care, Malatya, Turkey University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain University of Valencia/School of Medicine, Valencia, Spain Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille, France Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille, France University School of Medicine, NORT Laboratory, INSERM 1062 INRA 1260, Marseille, France APHM, CHU Timone, Laboratoire NORT INSERM U 1062 INRA U 1260, Marseille, France Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille, France APHM, CHU Timone, Vascular Research Center of Marseille INSERM UMRS 1076, CERIMED, Marseille, France Department of Anaesthesiology & Intensive Care, APHM, CHU Timone, Marseille, France University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy Department of Emergency and Intensive Care, San Gerardo Hospital, Neurointensive  Care, Monza, Italy Department of Emergency and Intensive Care, San Gerardo Hospital, Neurointensive  Care, Monza, Italy Department of Emergency and Intensive Care, San Gerardo Hospital, Neurointensive  Care, Monza, Italy Department of Otolaryngology, San Gerardo Hospital, Monza, Italy University of Milan - Bicocca, School of Medicine and Surgery, Milan, Italy Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil Hospital Israelita Albert Einstein, Neurology/Telemedicine, Sao Paulo, Brazil Hospital Israelita Albert Einstein, Neurology/Telemedicine, Sao Paulo, Brazil Hospital municipal Moyses Deutsch, ICU, Sao Paulo, Brazil Hospital Israelita Albert Einstein, Telemedicine, Sao Paulo, Brazil Hospital municipal Moyses Deutsch, Telemedicine, Sao Paulo, Brazil Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Radboud University Medical Center, Anesthesiology, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Clinical Chemistry Department, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain West China Hospital of Sichuan University, Chengdu, China West China Second Hospital of Sichuan University, Chengdu, China West China Hospital of Sichuan University, Chengdu, China West China Hospital of Sichuan University, Chengdu, China West China Second Hospital of Sichuan University, Chengdu, China West China Hospital of Sichuan University, Chengdu, China West China Second Hospital of Sichuan University, Chengdu, China West China Hospital of Sichuan University, Chengdu, China Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Institute of Clinical Pharmacology and Toxicology, Hamburg, Germany Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Institute of Clinical Pharmacology and Toxicology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Institute of Clinical Pharmacology and Toxicology, Hamburg, Germany Department of Anaesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Aintree University Hospital NHS Foundation Trust, Critical Care, Liverpool, UK University of Liverpool, Institute of Ageing and Chronic Disease, Liverpool, UK Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Centers for Disease Control, Bacterial Infection, Atlanta, USA Centers for Disease Control, Bacterial Infection, Atlanta, USA Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK University of Liverpool, Institute of Infection & Global Health, Liverpool, UK Liverpool School of Tropical Medicine, Clinical Sciences, Liverpool, UK Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Radboud University Medical Center, Virology, Nijmegen, Netherlands NIZO, Ede, Netherlands Radboud University Medical Center, Pediatrics, Nijmegen, Netherlands Radboud University Medical Center, Intensive Care, Nijmegen, Netherlands Fundaci√≥ Parc Taul√≠, Sabadell, Spain CIBERES, Grup 33, Sabadell, Spain Corporaci√≥ Sanit√†ria i Universitaria Parc Taul√≠, Critical Care Center, Sabadell,  Spain Corporaci√≥ Sanit√†ria i Universitaria Parc Taul√≠, Critical Care Center, Sabadell,  Spain Fundaci√≥ Parc Taul√≠, Sabadell, Spain CIBERES, Grup 33, Sabadell, Spain Fundaci√≥ Parc Taul√≠, Sabadell, Spain Kyung Hee University/Kyung Hee Medical Center, Pulmonary and Critical Care Medicine, Seoul, Republic of Korea Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Seoul, Republic of Korea Department of Pharmacology, College of Medicine, Hallym University, Chuncheon, Republic of Korea Department of Pharmacology, College of Medicine, Hallym University, Chuncheon, Republic of Korea Kyung Hee University/Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea University of Ulsan College of Medicine/ Asan Medical Center, Seoul, Republic of  Korea Kyung Hee University/Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea Department of Physiology College of Medicine, Kyungpook National University, Daegue, Republic of Korea Sherbrooke, ICU/Medicine, Sherbrooke, Canada Sherbrooke, ICU/Medicine, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada IPS Therapeutic Inc, Sherbrooke, Canada Sherbrooke, Pharmacology/Physiology, Sherbrooke, Canada Sherbrooke, ICU/Medicine, Sherbrooke, Canada Division of Medicine, Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK Bloomsbury Institute of Intensive Care Medicine, University College London, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK University College London, Faculty of Medical Sciences, London, UK Marmara University, Anesthesiology and Reanimation, Istanbul, Turkey Marmara University, Pediatric Immunology and Alergy, Istanbul, Turkey Marmara University, Pediatric Immunology and Alergy, Istanbul, Turkey Marmara University, Anesthesiology and Reanimation, Istanbul, Turkey Tubitak Arastƒ±rma Merkezi, Gen Engineering, Istanbul, Turkey Marmara University, Pathology, Istanbul, Turkey Marmara University, Pathology, Istanbul, Turkey Marmara University, Pediatric Immunology and Alergy, Istanbul, Turkey Marmara University, Anesthesiology and Reanimation, Istanbul, Turkey UCL, Bloomsbury Institute of Intensive Care Medicine, London, UK UCL, Bloomsbury Institute of Intensive Care Medicine, London, UK UCL, Bloomsbury Institute of Intensive Care Medicine, London, UK Barts Health NHS Trust, London, UK Barts Health NHS Trust, London, UK The Bizard Institute, Barts & the London School of Medicine & Dentistry, London,  UK Barts Health NHS Trust, London, UK The Bizard Institute, Barts & the London School of Medicine & Dentistry, London,  UK Barts Health NHS Trust, London, UK Barts Health NHS Trust, London, UK Yonsei University College of Medicine, Anesthesiology, Seoul, Republic of Korea Yonsei University College of Medicine, Anesthesiology, Seoul, Republic of Korea Yonsei University College of Medicine, Anesthesiology, Seoul, Republic of Korea National Yang-Ming University, Institute of Emergency and Critical Care Medicine, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China National Yang-Ming University, Institute of Emergency and Critical Care Medicine, Taipei, Taiwan, Province of China Department of Intensive Care, Bravis Hospital, Roosendaal, Netherlands Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands Department of Pediatric Surgery, Intensive Care Unit, Erasmus MC-Sophia Children‚Äôs Hospital, University Medical Center, Rotterdam, Netherlands Department of Public Health, Erasmus Medical Centre, Rotterdam, Netherlands Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands Department of Intensive Care, Albert Schweitzer Hospital, Dordrecht, Netherlands Department of Intensive Care, Ikazia Hospital, Rotterdam, Netherlands Department of Intensive Care, IJsselland Hospital, Rotterdam, Netherlands Department of Intensive Care, Sint Franciscus Gasthuis, Rotterdam, Netherlands Department of Intensive Care, Maasstad Hospital, Rotterdam, Netherlands Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands Department of Intensive Care, Erasmus Medical Center, Rotterdam, Netherlands University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and Intensive Care Medicine, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and Intensive Care Medicine, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and Intensive Care Medicine, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Institute of Medical Biometry and Epidemiology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and Intensive Care Medicine, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Center of Anesthesiology and Intensive Care Medicine, Hamburg, Germany University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France Saint-Louis Hospital, APHP, Burn ICU, Paris, France University Hospital Clermont-Ferrand, Pharmacy, Clermont-Ferrand, France University Hospital Clermont-Ferrand, Biostatistics, Clermont-Ferrand, France Saint-Louis Hospital, APHP, Burn ICU, Paris, France University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France University Hospital Clermont-Ferrand, Pharmacy, Clermont-Ferrand, France Saint-Louis Hospital, APHP, Burn ICU, Paris, France University Hospital Clermont-Ferrand, ICU, Clermont-Ferrand, France Saint-Louis Hospital, APHP, Burn ICU, Paris, France Odense University Hospital, University of Southern Denmark, Anaesthesiology and Intensive Therapy, Odense, Denmark Danish Center for Sleep Medicine, University of Copenhagen, Copenhagen, Denmark Danish Center for Sleep Medicine, University of Copenhagen, Copenhagen, Denmark University of Southern Denmark, Vejle, Denmark University of Southern Denmark, Odense, Denmark Odense University Hospital, University of Southern Denmark, Anaesthesiology and Intensive Therapy, Odense, Denmark University of Southern Denmark, Odense, Denmark Lillebaelt Hospital, Kolding, Denmark University of Southern Denmark, Odense, Denmark University of Southern Denmark, Odense, Denmark Sheikh Khalifa Specialty Hospital, Anesthesiology, Rak, United Arab Emirates Department of Pulmonology, Sheikh Khalifa Specialty Hospital, Rak, United Arab Emirates Seoul National University Bundang Hospital, Seongnam, Republic of Korea Department of Pharmacy, National University of Singapore, Singapore, Singapore Department of Pharmacy, National University of Singapore, Singapore, Singapore Department of Pharmacy, National University Hospital, Singapore, Singapore Department of Anesthesiology and Intensive Care, Danderyd Hospital, Stockholm, Sweden Department of Anesthesiology and Intensive Care, Norrt√§lje Hospital, Norrt√§lje, Sweden Department of Anesthesiology and Intensive Care, Karolinska University Hospital,  Stockholm, Sweden Department of Anesthesiology and Intensive Care, √ñrebro University Hospital, √ñrebro, Sweden Orion Pharma, Stockholm, Sweden Orion Pharma, Espoo, Finland Department of Anesthesiology and Intensive Care, Danderyd Hospital, Stockholm, Sweden Gelre Hospitals Apeldoorn, Intensive Care, Apeldoorn, Netherlands University of Toronto, Toronto, Canada University Belfast, Belfast, UK Clinc of Intensive Care, Malmo, Sweden Queens University Belfast, Belfast, UK University of Copenhagen, Copenhagen, Denmark University of Agdar, Grimstad, Norway Univeristy of Agdar, Grimstad, Norway Division of Intensive Care, Cyprus, Cyprus University of Copenhagen, Copenhagen, Denmark University of Athens, Athens, Greece University Cattolica del Sacro Cuore, Turino, Italy Division of Intensive Care, ·Öü, Germany University Warminsko-Mazwski, Olsztyn, Poland Gelre Hospitals Apeldoorn, Intensive Care, Apeldoorn, Netherlands Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Department of Drug Abuse Control, Shiraz University of Medical Sciences, Shiraz,  Islamic Republic of Iran Trauma Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Department of Neurosurgery, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Department of Critical Care Nursing, Jahrom University of Medical Sciences, Jahrom, Islamic Republic of Iran Department of Neurology, Shiraz University Of Medical Sciences, Shiraz, Islamic Republic of Iran Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Karolinska University Hospital, Stockholm, Sweden University of Oslo, Oslo, Norway Karolinska University Hospital, Stockholm, Sweden University of Oslo, Oslo, Norway Mitt Universitetet, √ñstersund, Sweden Mitt Universitetet, √ñstersund, Sweden Mitt Universitetet, √ñstersund, Sweden Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Medical University of Gdansk, Gdansk, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Medical University of Gdansk, Gdansk, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland AOU Maggiore della Carit√†, Novara, Italy Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy AOU Maggiore della Carit√†, Novara, Italy AOU Maggiore della Carit√†, Novara, Italy Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy Azienda Ospedaliero-Universitaria Careggi, Novara, Italy Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy Belfast Health and Social Care Trust, Critical Care, Belfast, UK Belfast Health and Social Care Trust, Critical Care, Belfast, UK Belfast Health and Social Care Trust, Critical Care, Belfast, UK Southern Health and Social Care Trust, Anaesthetics and Intensive Care, Craigavon, UK Belfast Health and Social Care Trust, Critical Care, Belfast, UK University of Toronto, Critical Care Medicine, Toronto, Canada Queen‚Äôs University of Belfast, Centre for Experimental Medicine, Belfast, UK University of Toronto, Critical Care Medicine, Toronto, Canada Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico Instituto Mexicano del Seguro Social, Radiology Unit, Leon, Mexico Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico Instituto Mexicano del Seguro Social, Intensive Care Unit, Leon, Mexico Department for Intensive Care Medicine, Imland Klinik Rendsburg, Rendsburg, Germany Department for Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany Department for Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany Department for Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany Department for Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany Department for Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany Department for Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany Department for Thoracic and Cardiovascular Surgery, University Hospital Essen, Essen, Germany Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine, Roma, Italy Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine, Roma, Italy Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine, Roma, Italy Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine, Roma, Italy Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine, Roma, Italy Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine, Roma, Italy Policlinico Universitario A. Gemelli, Anesthesia and Intensive Care Medicine, Roma, Italy St George‚Äôs University Hospital, London, UK St George‚Äôs University Hospital, London, UK St George‚Äôs University Hospital, London, UK St George‚Äôs University Hospital, London, UK St George‚Äôs University Hospital, London, UK St George‚Äôs University Hospital, London, UK H√¥pital de Bic√™tre, H√¥pitaux Universitaires Paris-Sud, Universit√© Paris-Sud, Service de R√©animation M√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux Universitaires Paris-Sud, Universit√© Paris-Sud, Service de R√©animation M√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux Universitaires Paris-Sud, Universit√© Paris-Sud, Service de R√©animation M√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux Universitaires Paris-Sud, Universit√© Paris-Sud, Service de R√©animation M√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux Universitaires Paris-Sud, Universit√© Paris-Sud, Service de R√©animation M√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux Universitaires Paris-Sud, Universit√© Paris-Sud, Service de R√©animation M√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France H√¥pital de Bic√™tre, H√¥pitaux Universitaires Paris-Sud, Universit√© Paris-Sud, Service de R√©animation M√©dicale, Inserm UMR_S999, Le Kremlin Bic√™tre, France Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary University of Szeged, Institute of Surgical Research, Szeged, Hungary University of Szeged, Institute of Surgical Research, Szeged, Hungary Department of Anaesthesiology and General Intensive Care Medicine, Medical University of Vienna, Vienna, Austria University of Szeged, Institute of Surgical Research, Szeged, Hungary Department of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt Department of Anesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt University of la Reunion, Intensive Care Unit, Saint Pierre de la Reunion, France University of la Reunion, Neurocritical Care Unit, Saint Pierre de la Reunion, France Anesthesiology Department, University of la Reunion, Saint Pierre de la Reunion,  France University of la Reunion, Intensive Care Unit, Saint Pierre de la Reunion, France Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile, Facultad de Medicina, Santiago, Chile Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia, Facultad de Medicina, Santiago, Chile Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia, Facultad de Medicina, Santiago, Chile Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile, Facultad de Medicina, Santiago, Chile Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile, Facultad de Medicina, Santiago, Chile Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia, Facultad de Medicina, Santiago, Chile Pontificia Universidad Catolica de Chile, Programa de Medicina de Urgencia, Facultad de Medicina, Santiago, Chile Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile, Facultad de Medicina, Santiago, Chile Departamento de Medicina Intensiva, Pontificia Universidad Catolica de Chile, Facultad de Medicina, Santiago, Chile Technische Universit√§t M√ºnchen, II. Medizinische Klinik, Munich, Germany Technische Universit√§t M√ºnchen, II. Medizinische Klinik, Munich, Germany Klinikum K√∂ln-Merheim, Cologne, Germany Asklepios Klinik St. Georg, Hamburg, Ghana Technische Universit√§t M√ºnchen, II. Medizinische Klinik, Munich, Germany Universit√© Libre de Bruxelles, Brussels, Belgium Universit√© Libre de Bruxelles, Brussels, Belgium Universit√© Libre de Bruxelles, Brussels, Belgium Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France CH Beauvais, Beauvais, France CH Beauvais, Beauvais, France CH Beauvais, Beauvais, France CH Beauvais, Beauvais, France Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France Univ. Hospital of Amiens, Amiens, France Cairo University, Cairo, Egypt Kasr Alainy Medical School, Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt ABC Medical Center, Critical Medicine, Mexico City, Mexico ABC Medical Center, Critical Medicine, Mexico City, Mexico ABC Medical Center, Critical Medicine, Mexico City, Mexico ABC Medical Center, Critical Medicine, Mexico City, Mexico ABC Medical Center, Critical Medicine, Mexico City, Mexico ABC Medical Center, Critical Medicine, Mexico City, Mexico ABC Medical Center, Critical Medicine, Mexico City, Mexico Edwards Lifesciences, Critical Care, Irvine, USA Edwards Lifesciences, Critical Care, Irvine, USA University of California Los Angeles, Anesthesiology, Los Angeles, USA Ramathibodi Hospital, Mahidol University, Medicine, Bangkok, Thailand Ramathibodi Hospital, Mahidol University, Medicine, Bangkok, Thailand Ramathibodi Hospital, Mahidol University, Medicine, Bangkok, Thailand Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy Santa Maria delle Croci Hospital, Anesthesia and Intensive Care, Ravenna, Italy King Hamad University Hospital, Intensive Care, Muharraq, Bahrain King Hamad University Hospital, Intensive Care, Muharraq, Bahrain King Hamad University Hospital, Intensive Care, Muharraq, Bahrain King Hamad University Hospital, Intensive Care, Muharraq, Bahrain King Hamad University Hospital, Intensive Care, Muharraq, Bahrain King Hamad University Hospital, Intensive Care, Muharraq, Bahrain King Hamad University Hospital, Intensive Care, Muharraq, Bahrain King Hamad University Hospital, Intensive Care, Muharraq, Bahrain Kings College Hospital, London, UK NIHR Surgical Reconstruction and Microbiology Research Centre, Birmingham, UK Kings College Hospital, London, UK Defence Science and Technology Laboratory, Salisbury, UK Defence Science and Technology Laboratory, Salisbury, UK Edwards Lifesciences, Irvine, USA Edwards Lifesciences, Irvine, USA Edwards Lifesciences, Irvine, USA Edwards Lifesciences, Amsterdam, Netherlands Edwards Lifesciences, Irvine, USA Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, USA Department of Anaesthesia and Critical Care Medicine, Cardiothoracic and Vascular Anaesthesia, University Hospital of Pisa, Pisa, Italy Department of Anaesthesia and Critical Care Medicine, Cardiothoracic and Vascular Anaesthesia, University Hospital of Pisa, Pisa, Italy University Medical Center Hamburg-Eppendorf, Hamburg, Germany Klinikum Harlaching, M√ºnchen, Germany University Medical Center Hamburg-Eppendorf, Hamburg, Germany Dalhousie University, Halifax, Canada University Medical Center Hamburg-Eppendorf, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Hamburg, Germany Cairo University, Anaesthesia, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt University Hospitals of Leicester NHS Trust, Anaesthesia, Critical Care and Pain, Leicester, UK University of Leicester, Leicester, UK University Hospitals of Leicester NHS Trust, Emergency Medicine Academic Group, Leicester, UK University Hospitals of Leicester NHS Trust, Emergency Medicine Academic Group, Leicester, UK University Hospitals of Leicester NHS Trust, Anaesthesia, Critical Care and Pain, Leicester, UK University of Leicester, Leicester, UK Ysbyty Glan Clwyd, Critical Care, Bodelwyddan, UK Critical Care Department, Faculty of Medicine, Cairo University, Cairo, Egypt Critical Care Department, Faculty of Medicine, Cairo University, Cairo, Egypt Critical Care Department, Cairo University, Cairo, Egypt Critical Care Department, Cairo University, Cairo, Egypt Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Hospital Universitario V. de Valme, Medicina Intensiva, Sevilla, Spain Hospital Universitario V. de Valme, Sevilla, Spain Hospital Universitario V. de Valme, Sevilla, Spain Hospital Universitario V. de Valme, Sevilla, Spain Hospital Universitario V. de Valme, Sevilla, Spain Hospital Universitario V. de Valme, Sevilla, Spain Hospital Universitario V. de Valme, Sevilla, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Kings College Hospital, Intensive Care Unit, London, UK Kings College Hospital, Intensive Care Unit, London, UK Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Anesthesia and Critical Care Medicine, Cardiothoracic Department ‚ÄòA. De Gasperis‚Äô, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Intensive Care, Santiago de Compostela, Spain Complexo Hospitalario Universitario de Santiago de Compostela, Cardiology, Santiago de Compostela, Spain Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Cardiology Department, Farhat Hached University Hospital, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Farhat Hached University Hospital, Medical Intensive Care Unit, Sousse, Tunisia Makati Medical Center, Internal Medicine, Makati, Philippines Makati Medical Center, Internal Medicine, Makati, Philippines University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK University College London, Bloomsbury Institute of Intensive Care Medicine, London, UK Emergency Department, Taipei Medical University Hospital, Taipei, Taiwan, Province of China Harvard Medical School, Boston, USA Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Critical Care Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province of China Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province of China Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province of China Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Kaohsiung City Government, Fire Bureau, Kaohsiung City, Taiwan, Province of China Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province of China Cardiovascular Division, Kaohsiung Veterans General Hospital, Kaohsiung City, Taiwan, Province of China Department of Health, Kaohsiung City Government, Kaohsiung City, Taiwan, Province of China New Cross Hospital, Integrated Critical Care Unit, Wolverhamptom, UK New Cross Hospital, Integrated Critical Care Unit, Wolverhamptom, UK New Cross Hospital, Critical Care Services, Research and Audit Office, Wolverhamptom, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK Central Manchester Foundation NHS Trust, Adult Critical Care, Manchester, UK az Sint-Blasius, Dendermonde, Belgium az Sint-Blasius, Dendermonde, Belgium az Sint-Blasius, Dendermonde, Belgium az Sint-Blasius, Dendermonde, Belgium az Sint-Blasius, Dendermonde, Belgium az Sint-Blasius, Dendermonde, Belgium az Sint-Blasius, Dendermonde, Belgium Alexandria University, Critical Care Medicine, Alexandria, Egypt Alexandria University, Critical Care Medicine, Alexandria, Egypt Alexandria University, Critical Care Medicine, Alexandria, Egypt Alexandria University, Critical Care Medicine, Alexandria, Egypt Alexandria University, Critical Care Medicine, Alexandria, Egypt Karolinska University Hospital, CIVA, Stockholm, Sweden Oslo University Hospital, General Intensive Care Unit - Ullev√•l, Oslo, Norway Department of Anaesthesiology, Oslo University Hospital, Oslo, Norway Oslo University Hospital, General Intensive Care Unit 1 -Rikshospitalet, Oslo, Norway Haukeland University Hospital, General Intensive Care Unit, Bergen, Norway Department of Anaesthesiology, Oslo University Hospital, Oslo, Norway Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Department of Economy. University of Las Palmas de Gran Canaria, Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Department of Economy. University of Las Palmas de Gran Canaria, Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain Hospital Insular Las Palmas GC, Las Palmas de Gran Canaria, Spain University of Algarve, Departmant of Biomedical Sciences and Medicine, Faro, Portugal Emergency and Intensive Care Departmant, Centro Hospitalar do Algarve, Hospital de Faro, Faro, Portugal Centro Hospitalar do Algarve, Hospital de Faro, Faro, Portugal Emergency and Intensive Care Departmant, Centro Hospitalar do Algarve, Hospital de Faro, Faro, Portugal University of Algarve, Departmant of Biomedical Sciences and Medicine, Faro, Portugal Vilnius University, Clinic of Anaesthesiology and Intensive care, Vilnius, Lithuania Vilnius University, Faculty of Medicine, Vilnius, Lithuania Vilnius University, Faculty of Medicine, Vilnius, Lithuania Vilnius University, Clinic of Anaesthesiology and Intensive care, Vilnius, Lithuania Lithuanian University of Health Sciences, Clinic of Anaesthesiology, Kaunas, Lithuania Department of Clinical Science and Education, Karolinska Institutet, S√∂dersjukhuset, Stockholm, Sweden Department of Clinical Science and Education, Karolinska Institutet, S√∂dersjukhuset, Stockholm, Sweden Linnaeus University, Kalmar/V√§xj√∂, Sweden Department of Clinical Science and Education, Karolinska Institutet, S√∂dersjukhuset, Stockholm, Sweden Department of Clinical Science and Education, Karolinska Institutet, S√∂dersjukhuset, Stockholm, Sweden Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Western Parana State University Hospital, Cascavel, Brazil Royal Berkshire Hospital, Intensive Care Unit, Reading, UK Royal Berkshire Hospital, Intensive Care Unit, Reading, UK Royal Berkshire Hospital, Intensive Care Unit, Reading, UK University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Psychology, Torino, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy University of Turin, Anesthesia and Intensive Care, Turin, Italy Sapienza University of Rome, Anesthesia and Intensive Care, Rome, Italy Sapienza University of Rome, Scienze e Biotecnologie Medico Chirurgiche, Rome, Italy Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Medicine, Glasgow,  UK Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Medicine, Glasgow,  UK Queen Elizabeth University Hospital, NHS GG&C, Intensive Care Medicine, Glasgow,  UK Hospital del Mar/CIBERES/UPF, Intensive Care, Barcelona, Spain Vall d‚ÄôHebr√≥n University Hospital, Intensive Care, Barcelona, Spain Vall d‚ÄôHebr√≥n University Hospital, Intensive Care, Barcelona, Spain Hospital del Mar/CIBERES/UPF, Intensive Care, Barcelona, Spain Vall d‚ÄôHebr√≥n University Hospital, Intensive Care, Barcelona, Spain Hospital del Mar/CIBERES/UPF, Intensive Care, Barcelona, Spain Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Anesthesia and Intensive Care, Fondazione IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy Blkapoor Super Speciality Hospital, BLK Centre for Critical Care, New Delhi, India Blkapoor Super Speciality Hospital, BLK Centre for Critical Care, New Delhi, India Blkapoor Super Speciality Hospital, BLK Centre for Critical Care, New Delhi, India University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands University Medical Center Utrecht, Intensive Care, Utrecht, Netherlands Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain Hospital Virgen de la Arrixaca, ICU, El Palmar, Spain Mater Misericordiae University Hospital, ICU, Dublin, Ireland Mater Misericordiae University Hospital, Dublin, Ireland Mater Misericordiae University Hospital, Dublin, Ireland Mater Misericordiae University Hospital, Dublin, Ireland Mater Misericordiae University Hospital, Microbiology, Dublin, Ireland Mater Misericordiae University Hospital, Microbiology, Dublin, Ireland Mater Misericordiae University Hospital, ICU, Dublin, Ireland Mater Misericordiae University Hospital, ICU, Dublin, Ireland Mater Misericordiae University Hospital, ICU, Dublin, Ireland Chi Mei Medical Center, Internal Medicine, Tainan, Taiwan, Province of China Chi Mei Medical Center, Internal Medicine, Tainan, Taiwan, Province of China Critical Care Medicine Department, Kasr Alainy Medical School, Cairo University,  Cairo, Egypt Critical Care Medicine Department, Kasr Alainy Medical School, Cairo University,  Cairo, Egypt Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen, Denmark Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen, Denmark Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen, Denmark Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen, Denmark Department of Intensive Care 4131, Copenhagen University Hospital, Copenhagen, Denmark Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Intensive Care Medicine, Hospital de Navarra, Pamplona, Spain Maquet Critical Care AB, Solna, Sweden Department of Surgical Sciences, Uppsala University, Hedenstierna Laboratory, Uppsala, Sweden Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Policlinico Di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine, Goettingen, Germany Department of Intensive Care Medicine, University of Zagreb, Rebro, Croatia Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Policlinico Di Milano, Milano, Italy Department of Intensive Care Medicine, University of Zagreb, Rebro, Croatia Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine, Goettingen, Germany Critical Care Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, Egypt Critical Care Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, Egypt Physiotherapy Department, Cairo University, Cairo, Egypt Critical Care Department, Kasr Al-Aini Hospitals, Cairo University, Cairo, Egypt Academic Medical Center, Amsterdam, Netherlands Academic Medical Center, Amsterdam, Netherlands University Medical Center Utrecht, Utrecht, Netherlands University Medical Center Utrecht, Utrecht, Netherlands University of Foggia, Foggia, Italy University of Foggia, Foggia, Italy Academic Medical Center, Amsterdam, Netherlands Academic Medical Center, Amsterdam, Netherlands Technische Universit√§t M√ºnchen, II. Medizinische Klinik, Munich, Germany Technische Universit√§t M√ºnchen, II. Medizinische Klinik, Munich, Germany St√§dtisches Klinikum M√ºnchen Harlaching, Munich, Germany Technische Universit√§t M√ºnchen, I. Medizinische Klinik, Munich, Germany Technische Universit√§t M√ºnchen, I. Medizinische Klinik, Munich, Germany Krankenhaus Barmherzige Br√ºder, Munich, Germany Technische Universit√§t M√ºnchen, II. Medizinische Klinik, Munich, Germany Technische Universit√§t M√ºnchen, II. Medizinische Klinik, Munich, Germany Mayo Clinic, Jacksonville, FL USA Mayo Clinic, Rochester, NY USA Mayo Clinic, Jacksonville, FL USA Mayo Clinic, Jacksonville, FL USA Mayo Clinic, Rochester, NY USA Stanford University, Stanford, CA USA Khoo Teck Puat Hospital, Singapore, Singapore Department of Critical Care, Whiston Hospital, Liverpool, UK Department of Critical Care, Whiston Hospital, Liverpool, UK Chang Gung University, School of Nursing, College of Medicine, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Department of Nursing, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, Province of China Chang Gung University, School of Nursing, College of Medicine, Taoyuan, Taiwan, Province of China Department of Respiratory Therapy, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Emergency Department, Azienda Ospedaliera di Padova, Padova, Italy Medicine Department, University of Padova, Padova, Italy Medicine Department, University of Padova, Padova, Italy Medicine Department, University of Padova, Padova, Italy Medicine Department, University of Padova, Padova, Italy Emergency Department, Azienda Ospedaliera di Padova, Padova, Italy Toronto Western Hospital MSNICU, Toronto, Canada Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Division of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China Hospital Universitario Pr√≠ncipe de Asturias, Intensive Care Unit, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Intensive Care Unit, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Intensive Care Unit, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Intensive Care Unit, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Pneumology, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Pneumology, Madrid, Spain Hospital Universitario Pr√≠ncipe de Asturias, Pneumology, Madrid, Spain Pulmonology Division, Hospital das Cl√≠nicas da Faculdade de Medicina da Universidade de S√£o Paulo, Heart Institute, S√£o Paulo, Brazil Cardiology Division, Hospital das Cl√≠nicas da Faculdade de Medicina da Universidade de S√£o Paulo, Heart Institute, S√£o Paulo, Brazil Anesthesiology Division, Hospital das Cl√≠nicas da Faculdade de Medicina da Universidade de S√£o Paulo, Heart Institute, S√£o Paulo, Brazil Pulmonology Division, Hospital das Cl√≠nicas da Faculdade de Medicina da Universidade de S√£o Paulo, Heart Institute, S√£o Paulo, Brazil Pulmonology Division, Hospital das Cl√≠nicas da Faculdade de Medicina da Universidade de S√£o Paulo, Heart Institute, S√£o Paulo, Brazil Hospices Civils de Lyon, H√¥pital de la Croix-Rousse - Service de r√©animation m√©dicale, Lyon, France CERMEP, Bron, France CERMEP, Bron, France CERMEP, Bron, France Hospices Civils de Lyon, H√¥pital de la Croix-Rousse - Service d‚Äôanatomopathologie, Lyon, France Hospices Civils de Lyon, H√¥pital de la Croix-Rousse - Service de r√©animation m√©dicale, Lyon, France Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti, Universit√† degli Studi di Milano, Milano, Italy Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine, Goettingen, Germany Dipartimento di Anestesia, Rianimazione, Urgenza ed Emergenza, Policlinico Di Milano, Milano, Italy Georg-August-University Goettingen, Anesthesiology and Intensive Care Medicine, Goettingen, Germany Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Geriatrics, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Department of Geriatrics, Gazi University Faculty of Medicine, Ankara, Turkey Department of Critical Care Medicine, Gazi University Faculty of Medicine, Ankara, Turkey Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain CIBERES, Instituto de Salud Carlos III, Madrid, Spain Vall d‚ÄôHebr√≥n University Hospital, Thoracic Surgery, Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX USA Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Centre of Molecular Inflammation Research, Trondheim, Norway Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT USA Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway Norwegian University of Science and Technology, Centre of Molecular Inflammation  Research, Trondheim, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway Norwegian University of Science and Technology, Institute of Cancer Research and  Molecular Medicine, Trondheim, Norway Yale University School of Public Health, New Haven, CT USA Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway Norwegian University of Science and Technology, Centre of Molecular Inflammation  Research, Trondheim, Norway Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway Hacettepe University, Ankara, Turkey Hacettepe University, Ankara, Turkey Hacettepe University, Ankara, Turkey Hacettepe University, Ankara, Turkey Erasme, Brussels, Belgium Erasme Hospital, ICU, Brussels, Belgium Erasme Hospital, ICU, Brussels, Belgium Erasme Hospital, ICU, Brussels, Belgium The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Attikon University Hospital, ICU, Athens, Greece Department of Internal Medicine, Chungnam National University Hospital, Daejeon,  Republic of Korea Department of Internal Medicine, Chungnam National University Hospital, Daejeon,  Republic of Korea Chungnam National University Hospital, Clinical Trials Center, Daejeon, Republic  of Korea Department of Internal Medicine, Cheongju St. Mary‚Äôs Hospital, Cheongju, Republic of Korea Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea Department of Internal Medicine, Konyang University Hospital, Daejeon, Republic of Korea Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Republic of Korea Department of Internal Medicine, Konkuk University Chungju Hospital, Chungju, Republic of Korea Department of Internal Medicine, Konkuk University Chungju Hospital, Chungju, Republic of Korea Department of Internal Medicine, Chungnam National University Hospital, Daejeon,  Republic of Korea Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK Royal Surrey County Hospital, Guildford, UK Royal Surrey County Hospital, Guildford, UK University of Surrey, Guildford, UK Royal Surrey County Hospital, ICU and SPACeR Research Group, Guildford, UK Department of Internal Medicine, Ankara University Faculty of Medicine, Intensive Care, Ankara, Turkey Department of Anesthesiology and Reanimation, Yƒ±ldƒ±rƒ±m Beyazƒ±t University, Medical Faculty, Ankara, Turkey Department of Anesthesiology and Reanimation, Yƒ±ldƒ±rƒ±m Beyazƒ±t University, Medical Faculty, Ankara, Turkey Department of Biostatistics and Medical Informatics, Yƒ±ldƒ±rƒ±m Beyazƒ±t University, Ankara, Turkey Department of Biochemistry, Yƒ±ldƒ±rƒ±m Beyazƒ±t University, Medical Faculty, Ankara, Turkey Department of Biochemistry, Yƒ±ldƒ±rƒ±m Beyazƒ±t University, Medical Faculty, Ankara, Turkey Karolinska University Hospital / Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital / Karolinska Institutet, Stockholm, Sweden Karolinska University Hospital / Karolinska Institutet, Stockholm, Sweden Mount Sinai Hospital, Toronto, Canada Mount Sinai Hospital, Toronto, Canada Mount Sinai Hospital, Toronto, Canada Mount Sinai Hospital, Toronto, Canada St Georges NHS Foundation Trust, Critical Care Directorate, London, UK The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Hospital San Juan de Dios del Aljarafe, Intensive Care Unit, Bormujos, Sevilla Spain Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark Copenhagen University Hospital - Rigshospitalet, Center of Inflammation and Metabolism, Copenhagen, Denmark Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark Copenhagen University Hospital - Rigshospitalet, Centre for Clinical Intervention Research - Copenhagen Trial Unit, Copenhagen, Denmark Department of Intensive Care, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark Department of Emergency Medicine, Kurashiki Central Hospital, Kurashiki, Japan Department of General Medicine, Kurashiki Central Hospital, Kurashiki, Japan Department of General Medicine, Kurashiki Central Hospital, Kurashiki, Japan Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt Cairo University/Kasr Alainy Medical School, Anethesia, Cairo, Egypt Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Intensive Care Department, King Hamad University Hospital, Muharraq, Bahrain Cairo University, Critical Care, Cairo, Egypt Cairo University, Critical Care, Cairo, Egypt Cairo University, Critical Care, Cairo, Egypt Cairo University, Critical Care, Cairo, Egypt Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Morphology and Genetics, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Department of Intensive Care Medicine, Fundaci√≥n Valle del Lili - Universidad ICESI, Cali, Colombia Departamento de Medicina Intensiva, Pontificia Universidad Cat√≥lica de Chile, Facultad de Medicina, Santiago, Chile Departamento de Medicina Intensiva, Pontificia Universidad Cat√≥lica de Chile, Facultad de Medicina, Santiago, Chile Department of Intensive Care Medicine, CHIREC Hospitals, Universit√© Libre de Bruxelles (ULB), Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care, Brussels, Belgium Erasme University Hospital, Universit√© Libre de Bruxelles, Intensive Care, Brussels, Belgium University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy University of Foggia, Anaesthesia and Intensive Care, Foggia, Italy Joan XXIII University Hospital, Tarragona, Spain Joan XXIII University Hospital, Tarragona, Spain Joan XXIII University Hospital, Tarragona, Spain Joan XXIII University Hospital, Tarragona, Spain Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University Medical School, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt Cairo University, Cairo, Egypt SSA UADY, M√©rida, Mexico Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway Divison of Cancer, Oslo University Hospital, Oslo, Norway Division of Medicine, Oslo University Hospital, Oslo, Norway Division on Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway Hospital Clinico UC - CHRISTUS, Unidad de Paciente Critico, Santiago, Chile Universidad de los Andes, Santiago, Chile Tal Hashomer Hospital, General ICU, Umm el Fahem, Israel Tel Aviv University, Ramat Gan, Israel Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium Ghent University, Faculty of Medicine and Health Sciences, Ghent, Belgium Department of Internal Medicine, Ghent University, Ghent, Belgium Heart Institute (InCor) do Hospital das Cl√≠nicas da Faculdades de Medicina da Universidade de S√£o Paulo, Nursing Coordination, S√£o Paulo, Brazil Instituto Israelita de Ensino e Pesquisa Albert Einstein, School of Nursing, S√£o  Paulo, Brazil Nursing School of University of S√£o Paulo, S√£o Paulo, Brazil Heart Institute (InCor) do Hospital das Cl√≠nicas da Faculdades de Medicina da Universidade de S√£o Paulo, Nursing Coordination, S√£o Paulo, Brazil Heart Institute (InCor) do Hospital das Cl√≠nicas da Faculdades de Medicina da Universidade de S√£o Paulo, Nursing Coordination, S√£o Paulo, Brazil Hypertension Department, Heart Institute (InCor) do Hospital das Cl√≠nicas da Faculdades de Medicina da Universidade de S√£o Paulo, S√£o Paulo, Brazil The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK The Royal Brompton and Harefield NHS Foundation Trust, Critical Care, London, UK Frimley Health NHS Foundation Trust, ICU, Frimley, UK The Royal College of Nursing Critical Care and Inflight Nursing Forum, London, UK Northumbria University, Newcastle, UK Northumbria University, Newcastle, UK UKCCNA, Manchester, UK BACCN, Newcastle, UK Gertrude‚Äôs Children‚Äôs Hospital, Nairobi, Kenya Gertrude‚Äôs Children‚Äôs Hospital, Nairobi, Kenya Gertrude‚Äôs Children‚Äôs Hospital, Nairobi, Kenya Gertrude‚Äôs Children‚Äôs Hospital, Nairobi, Kenya Rush University Medical Center, Chicago, USA Rush University Medical Center, Chicago, USA Rush University Medical Center, Chicago, USA Rush University Medical Center, Chicago, USA Teaching Department of Emergency and Critical Care Medicine, University of Tunis  El Manar, Zaghouan, Tunisia Teaching Department of Emergency and Critical Care Medicine, University of Tunis  El Manar, Zaghouan, Tunisia Teaching Department of Emergency and Critical Care Medicine, University of Tunis  El Manar, Zaghouan, Tunisia Teaching Department of Emergency and Critical Care Medicine, University of Tunis  El Manar, Zaghouan, Tunisia Teaching Department of Emergency and Critical Care Medicine, University of Tunis  El Manar, Zaghouan, Tunisia University of Toronto, Toronto, Canada Sunnybrook Health Sciences Centre, Toronto, Canada London Health Sciences Centre, London, Canada Ottawa Hospital Research Institute, Ottawa, Canada Ottawa Hospital, Ottawa, Canada University Hospitals Birmingham NHS Foundation Trust, Physiotherapy, Birmingham,  UK University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK University Hospitals Birmingham NHS Foundation Trust, Physiotherapy, Birmingham,  UK Department of Critical Care, University Medical Center Groningen, Groningen, Netherlands University of Groningen, Artificial Intelligence, Groningen, Netherlands Department of Critical Care, University Medical Center Groningen, Groningen, Netherlands University Medical Center Groningen, Hospital Pharmacy, Groningen, Netherlands Department of Critical Care, University Medical Center Groningen, Groningen, Netherlands ABC Medical Center, Intensive Care Unit, Mexico City, Mexico ABC Medical Center, Intensive Care Unit, Mexico City, Mexico ABC Medical Center, Intensive Care Unit, Mexico City, Mexico ABC Medical Center, Intensive Care Unit, Mexico City, Mexico ABC Medical Center, Intensive Care Unit, Mexico City, Mexico St Georges NHS Foundation Trust, Cardiothoracic Intensive Care, London, UK St Georges NHS Trust, London, UK Nursing Department, Rovira i Virgili University, Tarragona, Spain Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain Hospital de Sant Joan Desp√≠ Moiss√®s Broggi, Intensive Care Unit, Barcelona, Spain Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain Verge de la Cinta University Hospital, Intensive Care Unit, Tortosa, Spain Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain Joan XXIII University Hospital, Intensive Care Unit, Tarragona, Spain Joan XXIII University Hospital, Intensive Care Unit, Tarragona, Spain Dr Josep Trueta University Hospital, Intensive Care Unit, Girona, Spain Quiron Salud-Hospital General de Catalunya, Intensive Care Unit, Barcelona, Spain Verge de la Cinta University Hospital, Intensive Care Unit, Tarragona, Spain Hospital de Sant Joan Desp√≠ Moiss√®s Broggi, Intensive Care Unit, Barcelona, Spain Sant Pau I Santa Tecla University Hospital, Intensive Care Unit, Tarragona, Spain Vall d‚ÄôHebr√≥n University Hospital, Barcelona, Spain Nursing Department, Rovira i Virgili University, Tarragona, Spain Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain Hospital Universitario de Gran Canaria Dr Negrin, Las Palmas de Gran Canaria, Spain N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian Federation N.N. Blokhin Russian Cancer Research Center, Medical ICU, Moscow, Russian Federation Department of Anaesthesiology and Critical Care Medicine, Aix Marseille University, CHU Timone, Marseille, France CHU Piti√©-Salp√™tri√®re, Neurosurgical Intensive Care Unit, Paris, France Aix-Marseille University / CNRS, Institut des Neurosciences de la Timone, UMR7289, Marseille, France Aix-Marseille University / CNRS, Institut des Neurosciences de la Timone, UMR7289, Marseille, France CHU Piti√©-Salp√™tri√®re, Neurosurgical Intensive Care Unit, Paris, France CHU Piti√©-Salp√™tri√®re, Neurosurgical Intensive Care Unit, Paris, France Department of Anaesthesiology and Critical Care Medicine, Aix Marseille University, CHU Timone, Marseille, France Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Medical University of Gdansk, Gdansk, Poland Medical University of Gdansk, Gdansk, Poland Medical University of Gdansk, Gdansk, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Medical University of Gdansk, Gdansk, Poland Medical University of Gdansk, Gdansk, Poland Poznan Unversity of Medical Sciences, Poznan, Poland Royal Brompton and Harefield NHS Foundation Trust, London, UK Royal Brompton and Harefield NHS Foundation Trust, London, UK Royal Brompton and Harefield NHS Foundation Trust, London, UK Royal Brompton and Harefield NHS Foundation Trust, London, UK Cochin Hospital, Medical Intensive Care Unit, Paris, France Cochin Hospital, Medical Intensive Care Unit, Paris, France Paris Descartes University, Paris, France Cochin Hospital, Medical Intensive Care Unit, Paris, France Cochin Hospital, Medical Intensive Care Unit, Paris, France Cochin Hospital, Medical Intensive Care Unit, Paris, France Intensive Care Unit of Melun Hospital, Melun, France Cochin Hospital, Medical Intensive Care Unit, Paris, France Paris Descartes University, Paris, France Cochin Hospital, Medical Intensive Care Unit, Paris, France Paris Descartes University, Paris, France Cochin Hospital, Medical Intensive Care Unit, Paris, France VU University Medical Center Amsterdam, Intensive Care, Amsterdam, Netherlands VU University Medical Center Amsterdam, Amsterdam, Netherlands VU University Medical Center Amsterdam, Amsterdam, Netherlands VU University Medical Center Amsterdam, Amsterdam, Netherlands VU University Medical Center Amsterdam, Amsterdam, Netherlands VU University Medical Center Amsterdam, Amsterdam, Netherlands Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Hospital Universitario Virgen del Roc√≠o, Sevilla, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Department of Intensive Care Unit, University Hospital Virgen de la Victoria / IBIMA, M√°laga, Spain Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan Emergency and General Medicine, Kumamoto University Hospital, Kumamoto, Japan Division of Perioperative Services, Intensive Care Medicine and Pain Management,  Turku University, Turku University Hospital, Turku, Finland Division of Perioperative Services, Intensive Care Medicine and Pain Management,  Turku University, Turku University Hospital, Turku, Finland Turku University, Turku University Hospital, Heart Center, Turku, Finland Turku University, Turku University Hospital, Heart Center, Turku, Finland Turku University, Turku University Hospital, Heart Center, Turku, Finland Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University, Helsinki University Hospital, Helsinki, Finland Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University, Helsinki University Hospital, Helsinki, Finland Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University, Helsinki University Hospital, Helsinki, Finland Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University, Helsinki University Hospital, Helsinki, Finland Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University, Helsinki University Hospital, Helsinki, Finland Division of Intensive Care Medicine, Department of Anaesthesiology, Intensive Care and Pain Medicine, Helsinki University, Helsinki University Hospital, Helsinki, Finland Division of Perioperative Services, Intensive Care Medicine and Pain Management,  Turku University, Turku University Hospital, Turku, Finland Department of Emergency Medicine and Services, Helsinki University, Helsinki University Hospital, Helsinki, Finland Department of Cardiology, Helsinki University, Helsinki University Hospital, Helsinki, Finland Department of Cardiology, Helsinki University, Helsinki University Hospital, Helsinki, Finland Department of Cardiology, Helsinki University, Helsinki University Hospital, Helsinki, Finland Division of Clinical Neurosciences, Turku University, Turku University Hospital,  Turku, Finland Division of Perioperative Services, Intensive Care Medicine and Pain Management,  Turku University, Turku University Hospital, Turku, Finland Regional Hospital of Zaghouan, Zaghouan, Tunisia Regional Hospital of Zaghouan, Zaghouan, Tunisia Regional Hospital of Zaghouan, Zaghouan, Tunisia Catholic University of Korea, Seoul, Republic of Korea National Taiwan University Hospital, Anesthesiology, Taipei, Taiwan, Province of  China Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Bethesda, Maryland USA Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain Critical Care Department, Hospital 12 de Octubre, Trauma ICU, Madrid, Spain North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK North Bristol NHS Trust, Anaesthetics and Intensive Care Medicine, Bristol, UK Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Clinical Research Unit, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Intensive Care, Amsterdam, Netherlands Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain Hospital Universitari Mutua Terrassa, Terrassa, Spain Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain Critical Care Department, Hospital Universitari Mutua Terrassa, Terrassa, Spain Queen Alexandra Hospital, Critical Care, Portsmouth, UK Queen Alexandra Hospital, Critical Care, Portsmouth, UK Queen Alexandra Hospital, Critical Care, Portsmouth, UK Queen Alexandra Hospital, Critical Care, Portsmouth, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Golden Jubilee National Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Golden Jubilee National Hospital, Anaesthetics and Intensive Care, Glasgow, UK KAT Hospital, B ICU and Research Center, Kifisia, Greece KAT Hospital, B ICU and Research Center, Kifisia, Greece KAT Hospital, B ICU and Research Center, Kifisia, Greece KAT Hospital, B ICU and Research Center, Kifisia, Greece KAT Hospital, B ICU and Research Center, Kifisia, Greece KAT Hospital, B ICU and Research Center, Kifisia, Greece Khoula Hospital, ICU, Muscat, Oman Carlos Haya Hospital, ICU, Mal√°ga, Spain Carlos Haya Hospital, M√°laga, Spain Carlos Haya Hospital, ICU, Mal√°ga, Spain University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Internal Medicine, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Internal Medicine, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Hepatobiliary Surgery and Visceral Transplantation, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Hepatobiliary Surgery and Visceral Transplantation, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany University Medical Center Hamburg-Eppendorf, Anesthesiology, Hamburg, Germany University of Pavia, Anaesthesia, Intensive Care and Pain Therapy, Pavia, Italy Cardiology Department, Universitat Aut√≤noma de Barcelona, Barcelona, Spain Cardiology Department, Royal Brompton and Harefield NHS Foundation Trust, London, UK Cardiology Department, Royal Brompton and Harefield NHS Foundation Trust, London, UK Royal Brompton and Harefield NHS Foundation Trust, London, UK Anesthesia and Intensive Care Department, Shiraz University of Medical Sciences,  Shiraz, Islamic Republic of Iran Anesthesia and Intensive Care Department, Shiraz University of Medical Sciences,  Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran Shiraz University of Medical Sciences, Radiology, Shiraz, Islamic Republic of Iran University of Modena, Bologna, Italy University of Modena, Modena, Italy University of Modena, Modena, Italy University of Modena, Modena, Italy University of Modena, Modena, Italy University of Modena, Modena, Italy University of Modena, Modena, Italy Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany Klinikum Kassel, Cardiology and Intensive Care, Kassel, Germany Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Vienna University of Technology, Institute of Electrodynamics, Microwave and Circuit Engineering, Vienna, Austria Swisstom AG, Landquart, Switzerland Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Swisstom AG, Landquart, Switzerland Vienna University of Technology, Institute of Electrodynamics, Microwave and Circuit Engineering, Vienna, Austria Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Anesthesiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Intensive Care Medicine, Hospital de Navarra, Pamplona, Spain Maquet Critical Care, Stockholm, Sweden Maquet Critical Care, Stockholm, Sweden Department of Surgical Sciences, Hedenstierna Laboratory, Uppsala, Sweden Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Department of Anaesthesiology, Surgical Services and Intensive Care Medicine, Karolinska University Hospital, Stockholm, Sweden Hospital Virgen de la Salud, SESCAM, Intensive Care Medicine, Toledo, Spain Hospital Virgen de la Salud, SESCAM, Intensive Care Medicine, Toledo, Spain Hospital Quironsalud Palmaplanas, Intensive Care Medicine, Palma de Mallorca, Spain Hospital Marina Salud Denia, Intensive Care Medicine, Murcia, Spain Hospital Virgen de la Salud, SESCAM, Research Unit, Medical Council, Toledo, Spain Hospital Virgen de la Salud, SESCAM, Intensive Care Medicine, Toledo, Spain King Hamad University Hospital, Intensive Care, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain King Hamad University Hospital, Muharaq, Bahrain Department of Intensive Care, Hopital Erasme, Universit√© Libre de Bruxelles, Brussels, Belgium Department of Intensive Care, Hopital Erasme, Universit√© Libre de Bruxelles, Brussels, Belgium Department of Intensive Care, Hopital Erasme, Universit√© Libre de Bruxelles, Brussels, Belgium Department of Medical Biotechnologies, University of Siena, Anesthesia and Intensive Care Unit, Siena, Italy Department of Intensive Care, Hopital Erasme, Universit√© Libre de Bruxelles, Brussels, Belgium Department of Intensive Care, Hopital Erasme, Universit√© Libre de Bruxelles, Brussels, Belgium Department of Medical Biotechnologies, University of Siena, Anesthesia and Intensive Care Unit, Siena, Italy Department of Intensive Care, Hopital Erasme, Universit√© Libre de Bruxelles, Brussels, Belgium N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russian Federation N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russian Federation N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russian Federation N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russian Federation N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russian Federation N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russian Federation N.V. Sklifosovsky Research Institute of Emergency Medicine of the Moscow Healthcare Department, Moscow, Russian Federation Kocaeli Derince Training Hospital, Intensive Care, Kocaeli, Turkey Kocaeli Derince Education and Research Hospital, Kocaeli, Turkey Kocaeli Derince Training Hospital, Intensive Care, Kocaeli, Turkey Facultad de Medicina Ciudad Real, Hospital General Universitario de Ciudad Real,  Anestesiologia y Reanimacion, Ciudad Real, Spain Facultad de Medicina Ciudad Real, Hospital General Universitario Ciudad Real, Cuidados Criticos Pediatricos, Ciudad Real, Spain Hospital General Universitario Ciudad Real, Anestesiologia y Reanimacion, Ciudad  Real, Spain Hospital General Universitario Ciudad Real, Anestesiologia y Reanimacion, Ciudad  Real, Spain Hospital General Universitario Ciudad Real, Anestesiologia y Reanimacion, Ciudad  Real, Spain Facultad de Medicina Ciudad Real, Hospital General Universitario Ciudad Real, Cirug√≠a Hepatobiliar, Ciudad Real, Spain Facultad de Medicina Ciudad Real, Hospital General Universitario Ciudad Real, Cirug√≠a Hepatobiliar, Ciudad Real, Spain Baylor College of Medicine, Pediatric Critical Care, Houston, TX USA Baylor College of Medicine, Pediatric Critical Care, Houston, TX USA SSA UADY, M√©rida, Mexico Hospital U.V. Roc√≠o, Seville, Spain Hospital General Universitario de Castellon, Castellon, Spain Hospital U.V. Roc√≠o, Seville, Spain H Carlos Haya, Malaga, Spain Hospital de Sagunto, Valencia, Spain Complejo Hospitalario de Navarra, Pamplona, Spain Instituto Nacional de Ciencias M√©dicas y Nutrici√≥n Salvador Zubir√°n, Critical Care, M√©xico, Mexico Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Hospital de la Santa Creu i Sant Pau, Institut de Recerca Cardiovascular, Barcelona, Spain Hospital de la Santa Creu i Sant Pau, Critical Care, Barcelona, Spain Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Hospital Universitari de Bellvitge, Critical Care, L‚ÄôHospitalet, Spain Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Biochemistry, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand Department of Medicine, Division of Nephrology, Chulalongkorn University, Bangkok, Thailand University Hospital Leipzig, Anesthesia and Intensive Care, Leipzig, Germany University Hospital Leipzig, Anesthesia and Intensive Care, Leipzig, Germany University Hospital Leipzig, Neurosurgery, Leipzig, Germany University Hospital Leipzig, Anesthesia and Intensive Care, Leipzig, Germany Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Hospital Universitario La Paz, Medicina Intensiva, Madrid, Spain Academic Medical Center, University of Amsterdam, Translational Physiology, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Translational Physiology, Amsterdam, Netherlands Erasmus Medical Center, Experimental Anesthesiology, Roterdam, Netherlands Academic Medical Center, University of Amsterdam, Translational Physiology, Amsterdam, Netherlands Academic Medical Center, University of Amsterdam, Translational Physiology, Amsterdam, Netherlands 1st Medical Faculty, Charles University, Prague, Czech Republic 1st Medical Faculty, Charles University, Prague, Czech Republic 1st Medical Faculty, Charles University, Prague, Czech Republic 1st Medical Faculty, Charles University, Prague, Czech Republic Hopital Bichat Claude Bernard, Anaesthesiology and Surgical Critical Care, Paris, France Hopital Bichat Claude Bernard, Anaesthesiology and Surgical Critical Care, Paris, France Centre Hospitalier Sud Francilien, Critical Care Medecine, Corbeil-Essonnes, France Hopital Bichat Claude Bernard, Anaesthesiology and Surgical Critical Care, Paris, France VU University Medical Center, Intensive Care, Amsterdam, Netherlands VU University Medical Center, Intensive Care, Amsterdam, Netherlands VU University Medical Center, Intensive Care, Amsterdam, Netherlands University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care, Basel, Switzerland University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care, Basel, Switzerland University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care, Basel, Switzerland University Hospital Basel, Nephrology & Transplant Immunology, Basel, Switzerland University Hospital Basel, Anaesthesia & Intensive Care: Surgical Intensive Care, Basel, Switzerland Queen Elizabeth University Hospital, NHS GG&C, Glasgow, UK Queen Elizabeth University Hospital, NHS GG&C, Glasgow, UK Queen Elizabeth University Hospital, NHS GG&C, Glasgow, UK Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy Fondazione IRCCS Ca‚Äô Granda Ospedale Maggiore Policlinico, Milano, Italy CHU Bordeaux, R√©animation M√©dicale, Bordeaux, France CHU Bordeaux, R√©animation M√©dicale, Bordeaux, France CHU Bordeaux, R√©animation M√©dicale, Bordeaux, France CHU Bordeaux, R√©animation M√©dicale, Bordeaux, France CHU Bordeaux, Unit√© d‚Äô√âpidemiologie Clinique, Bordeaux, France CHU Bordeaux, Unit√© d‚Äô√âpidemiologie Clinique, Bordeaux, France CHU Bordeaux, R√©animation M√©dicale, Bordeaux, France CHU Bordeaux, R√©animation M√©dicale, Bordeaux, France CHU Bordeaux, R√©animation M√©dicale, Bordeaux, France Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Complejo Hospitalario de Ja√©n, Intensive Care Unit, Ja√©n, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Parc de Salut Mar. IMIM (Mar Medical Research Institut), Barcelona, Spain Critical Care Department, Parc de Salut Mar. IMIM (Mar Medical Research Institut), Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Joan XXIII University Hospital, Tarragona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Critical Care Department, Parc de Salut Mar. IMIM (Mar Medical Research Institut), Barcelona, Spain Critical Care Department, Vall d‚ÄôHebron University Hospital, Barcelona, Spain Department of Internal Medicine, Dankook University Hospital, Dankook University  College of Medicine, Cheonan, Republic of Korea Department of Internal Medicine, Dankook University Hospital, Dankook University  College of Medicine, Cheonan, Republic of Korea Department of Internal Medicine, Dankook University Hospital, Dankook University  College of Medicine, Cheonan, Republic of Korea Department of Internal Medicine, Dankook University Hospital, Dankook University  College of Medicine, Cheonan, Republic of Korea Department of Internal Medicine, Dankook University Hospital, Dankook University  College of Medicine, Cheonan, Republic of Korea 309th Hospital PLA, Beijing, China 309th Hospital PLA, Beijing, China 309th Hospital PLA, Beijing, China 309th Hospital PLA, Beijing, China 309th Hospital PLA, Beijing, China 309th Hospital PLA, Beijing, China 309th Hospital PLA, Beijing, China Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Yamagata University Faculty of Medicine, Anaesthesiology and Critical Care Medicine, Yamagata, Japan Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Hospital Universitario Reina Sofia, Intensive Care Unit, C√≥rdoba, Spain Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Centre Hospitalier, Intensive Care Unit, Roanne, France Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Division of Respirology, St. Michael‚Äôs Hospital, Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael‚Äôs Hospital,  Toronto, Canada Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata, Japan Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata, Japan Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata, Japan Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata, Japan Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata, Japan Department of Anesthesiology, Faculty of Medicine, Yamagata University, Yamagata, Japan Northern General Hospital, Sheffield Teaching Hospital NHS Trust, Anaesthesia and Critical Care, Sheffield, UK Northern General Hospital, Sheffield Teaching Hospital NHS Trust, Anaesthesia and Critical Care, Sheffield, UK Northern General Hospital, Sheffield Teaching Hospital NHS Trust, Anaesthesia and Critical Care, Sheffield, UK Hospital Universitario Ram√≥n y Cajal, Unidad de Cuidados Intensivos, Madrid, Spain Hospital Universitario Ram√≥n y Cajal, Unidad de Cuidados Intensivos, Madrid, Spain Hospital Universitario Ram√≥n y Cajal, Unidad de Cuidados Intensivos, Madrid, Spain Hospital Universitario Ram√≥n y Cajal, Unidad de Cuidados Intensivos, Madrid, Spain Hospital Universitario Ram√≥n y Cajal, Unidad de Cuidados Intensivos, Madrid, Spain Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome, Italy Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome, Italy Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome, Italy Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome, Italy Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome, Italy Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome, Italy Department of Anesthesia and Intensive Care, Catholic University of Rome, Rome, Italy Centro Hospitalar de Entre o Douro e Vouga, Servi√ßo de Medicina Intensiva Polivalente, Santa Maria da Feira, Portugal Centro Hospitalar de Entre o Douro e Vouga, Servi√ßo de Medicina Intensiva Polivalente, Santa Maria da Feira, Portugal Centro Hospitalar de Entre o Douro e Vouga, Servi√ßo de Medicina Intensiva Polivalente, Santa Maria da Feira, Portugal Centro Hospitalar de Entre o Douro e Vouga, Servi√ßo de Medicina Intensiva Polivalente, Santa Maria da Feira, Portugal Department of Medicine, Massachusetts General Hospital, Boston, MA USA Department of Surgery, Massachusetts General Hospital, Boston, MA USA Spaulding Rehabilitation Hospital, Physical Medicine & Rehabilitation, Boston, MA USA Harvard Medical School, Biomedical Informatics, Boston, MA USA Massachusetts General Hospital, Renal Division, Boston, MA USA Massachusetts General Hospital, Pulmonary and Critical Care Medicine, Boston, MA  USA Brigham and Women‚Äôs Hospital, Renal Division, Boston, MA USA Barts Health NHS Trust, Adult Critical Care Unit, London, UK Barts Health NHS Trust, Adult Critical Care Unit, London, UK Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Department of Intensive Care, Pamela Youde Nethersole Eastern Hospital, Hong Kong, Hong Kong China Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training and Research Hospital, Intensive Care Unit, Ankara, Turkey Ministry of Health, Departmant of Health Services, Ankara, Turkey Ministry of Health, Departmant of Health Services, Ankara, Turkey Ministry of Health, Departmant of Health Services, Ankara, Turkey Ministry of Health, Departmant of Health Services, Ankara, Turkey Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training and Research Hospital, Intensive Care Unit, Ankara, Turkey Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training and Research Hospital, Intensive Care Unit, Ankara, Turkey Anesthesiology and Reanimation Department, Ministry of Health, Ankara Training and Research Hospital, Intensive Care Unit, Ankara, Turkey Medical Biostatistics Department, University of Ankara, Faculty of Medicine, Ankara, Turkey Department of Anaesthesiology and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden Department of Anaesthesiology and Intensive Care, Sahlgrenska University Hospital, Gothenburg, Sweden University of Gothenburg, Gothenburg, Sweden University of Gothenburg, Gothenburg, Sweden University of Gothenburg, Gothenburg, Sweden University of Gothenburg, Gothenburg, Sweden Queen Alexandra Hospital, Critical Care, Portsmouth, UK Queen Alexandra Hospital, Critical Care, Portsmouth, UK Hospital de Cl√≠nicas de Porto Alegre, Porto Alegre, Brazil Hospital de Cl√≠nicas de Porto Alegre, Porto Alegre, Brazil Hospital de Cl√≠nicas de Porto Alegre, Porto Alegre, Brazil East Surrey Hospital, Intensive Care, Redhill, UK East Surrey Hospital, Intensive Care, Redhill, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK Queen Elizabeth University Hospital, Anaesthetics and Intensive Care, Glasgow, UK University of Cambridge, Gonville & Caius College, Cambridge, UK Papworth Hospital, Papworth Everard, UK Papworth Hospital, Papworth Everard, UK Imperial College London, London, UK Imperial College London, London, UK Imperial College London, London, UK Imperial College London, London, UK Imperial College London, London, UK Imperial College London, London, UK Imperial College London, London, UK Hospital Cl√≠nico Universitario de Santiago de Compostela, Critical Care Unit, Santiago de Compostela, Spain Hospital Cl√≠nico Universitario de Santiago de Compostela, Critical Care Unit, Santiago de Compostela, Spain Hospital Cl√≠nico Universitario de Santiago de Compostela, Critical Care Unit, Santiago de Compostela, Spain Hospital Cl√≠nico Universitario de Santiago de Compostela, Critical Care Unit, Santiago de Compostela, Spain Hospital Cl√≠nico Universitario de Santiago de Compostela, Critical Care Unit, Santiago de Compostela, Spain Hospital Cl√≠nico Universitario de Santiago de Compostela, Critical Care Unit, Santiago de Compostela, Spain Hospital Cl√≠nico Universitario de Santiago de Compostela, Abdominal Transplant Unit, Santiago de Compostela, Spain St. George‚Äôs Healthcare Trust, Neuro ICU, London, UK Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain Hospital Universitario de Torrej√≥n, Intensive Care Unit, Madrid, Spain Department of Preventive Medicine, Hospital Universitari Joan XXIII, Tarragona, Spain Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain Hospital Universitari Joan XXIII, Intensive Care Unit, Tarragona, Spain WPK Hopsital, Vienna, Austria Royal Surrey County Hospital, Guildford, UK Royal Surrey County Hospital, Guildford, UK Royal Surrey County Hospital, Guildford, UK St. George‚Äôs Healthcare Trust, London, UK Hospital de Santa Maria/CHLN, Servi√ßo de Medicina Intensiva, Lisboa, Portugal Hospital de Santa Maria/CHLN, Servi√ßo de Medicina Intensiva, Lisboa, Portugal Hospital de Santa Maria/CHLN, Servi√ßo de Medicina Intensiva, Lisboa, Portugal Hospital de Santa Maria/CHLN, Servi√ßo de Medicina Intensiva, Lisboa, Portugal Hospital de Santa Maria/CHLN, Servi√ßo de Medicina Intensiva, Lisboa, Portugal Hospital de Santa Maria/CHLN, Lisboa, Portugal Hospital de Santa Maria/CHLN, Servi√ßo de Medicina Intensiva, Lisboa, Portugal Hospital de Santa Maria/CHLN, Servi√ßo de Medicina Intensiva, Lisboa, Portugal Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Infanta Leonor, Intensive Care Unit, Madrid, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Comarcal Santa Ana, UCI, Motril, Spain Hospital Comarcal Santa Ana, Motril, Spain Hospital Comarcal Santa Ana, Motril, Spain Hospital Comarcal Santa Ana, Motril, Spain Inha University Hospital, Pulmonary and Critical Care, Incheon, Republic of Korea Inha University Hospital, Pulmonary and Critical Care, Incheon, Republic of Korea Inha University Hospital, Pulmonary and Critical Care, Incheon, Republic of Korea Inha University, Internal Medicine, Incheon, Republic of Korea University Hospital of Wales, Anaesthetics, Cardiff, UK Royal Gwent Hospital, Newport, UK Royal Gwent Hospital, Newport, UK Royal Gwent Hospital, Newport, UK Royal Gwent Hospital, Newport, UK Royal Gwent Hospital, Newport, UK Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Hospital Universitario Miguel Servet, Medicina Intensiva, Zaragoza, Spain Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK University College London Hospitals NHS Foundation Trust, London, UK Southampton University Hospitals NHS Trust, Southampton, UK Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK Oxford University Hospitals NHS Foundation Trust, Oxford, UK Guy‚Äôs and St Thomas‚Äô NHS Foundation Trust, London, UK Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Complejo Hospitalario de Granada, Granada, Spain Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Department of Anesthesiology and Intensive Care Medicine, Jena University Hospital, Jena, Germany Oxford University Hospitals NHS Trust, OCCULAR Group, Adult Intensive Care Unit,  Oxford, UK Oxford University Hospitals NHS Trust, OCCULAR Group, Adult Intensive Care Unit,  Oxford, UK Oxford University Hospitals NHS Trust, OCCULAR Group, Adult Intensive Care Unit,  Oxford, UK Chulalongkorn university, Medicine, Bangkok, Thailand Chulalongkorn university, Medicine, Bangkok, Thailand Chulalongkorn university, Medicine, Bangkok, Thailand Chulalongkorn university, Medicine, Bangkok, Thailand Chulalongkorn university, Medicine, Bangkok, Thailand University of Queensland, Brisbane, Australia University of Queensland, Brisbane, Australia University of Queensland, Brisbane, Australia SSA UADY, M√©rida, Mexico NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation Moscow Botkin Clinic, Moscow, Russian Federation NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation NN Blokhin Russisn Cancer Research Center, Moscow, Russian Federation North District Hospital, Hong Kong, Hong Kong China North District Hospital, Hong Kong, Hong Kong China North District Hospital, Hong Kong, Hong Kong China Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea Samsung Medical Center, Critical Care Medicine, Seoul, Republic of Korea Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Nursing, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Department of Anesthesiology, National Taiwan University Hospital, Taipei, Taiwan, Province of China Ospedale Sant‚ÄôAnna e San Sebastiano, U.O. di Anestesia e Rianimazione, Caserta, Italy Ospedale Sant‚ÄôAnna e San Sebastiano, U.O. di Anestesia e Rianimazione, Caserta, Italy Ospedale S. Maria delle Grazie - ASL Napoli 2 Nord, U.O. di Anestesia e Rianimazione, Pozzuoli, Italy AOUP Universit√† degli Studi di Pisa, IV U.O. di Anestesia e Rianimazione, Pisa, Italy Ospedale Sant‚ÄôAnna e San Sebastiano, U.O. di Anestesia e Rianimazione, Caserta, Italy San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy San Marco Hospital, Anesthesia and Intensive Care, Zingonia, Italy Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Pharmacology and Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Pharmacology and Toxicology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Cardiology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Internal Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands Department of Anesthesiology, Asahikawa Medical University, Asahikawa City, Hokkaido Japan Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City, Hokkaido Japan Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City, Hokkaido Japan Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City, Hokkaido Japan Department of Emergency Medicine, Asahikawa Medical University, Asahikawa City, Hokkaido Japan Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Morphology and Genetics, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Federal University of S√£o Paulo, Surgery, S√£o Paulo, Brazil Inserm, UMR-S 942, Paris, France Inserm, UMR-S 942, Paris, France CHU Nancy, H√¥pital Central, Medical Intensive Care Unit, Nancy, France AP-HP, Cardiology, Paris, France Inserm, UMR-S 942, Paris, France Inserm, UMR-S 942, Paris, France Inserm, UMR-S 942, Paris, France AP-HP, Biochemistry and Molecular Biology, Paris, France CHU Nancy, H√¥pital Brabois, Medical Intensive Care Unit, Nancy, France Inserm, UMR-S 942, Paris, France Inserm, UMR-S 942, Paris, France Danube University Krems, Center for Biomedical Technology, Krems, Austria Danube University Krems, Center for Biomedical Technology, Krems, Austria Danube University Krems, Center for Biomedical Technology, Krems, Austria},
note  = {Intensive Care Med Exp. 2016 Sep 29;4(Suppl 1):. doi:10.1186/s40635-016-0098-x.}
}

@Article{201624,
author  = {},
title  = {Anaheim, California, July 23-27, 2016.},
journal  = {American Journal of Pharmaceutical Education},
volume  = {80},
number  = {5},
pages  = {},
year  = {2016},
abstract  = {},
address  = {},
note  = {Am J Pharm Educ. 2016 Jun 25;80(5):. doi:10.5688/ajpe805S2.}
}

@Article{201625,
author  = {Jaillette, E. and Girault, C. and Brunin, G. and Zerimech, F. and Chiche, A. and Broucqsault-Dedrie, C. and Fayolle, C. and Minacori, F. and Alves, I. and Barrailler, S. and Robriquet, L. and Delaporte, E. and Thellier, D. and Delcourte, C. and Duhamel, A. and Nseir, S. and Valette, X. and Desmeulles, I. and Savary, B. and Masson, R. and Seguin, A. and Daubin, C. and Sauneuf, B. and Verrier, P. and Pottier, V. and Orabona, M. and Samba, D. and Viquesnel, G. and Lermuzeaux, M. and Hazera, P. and Hanouz, J. and Parienti, J. and Du, C. and Demoule, A. and Clavel, M. and Rolland-Debord, C. and Perbet, S. and Terzi, N. and Kouatchet, A. and Wallet, F. and Roze, H. and Vargas, F. and Gu√©rin, C. and Dellamonica, J. and Jaber, S. and Similowski, T. and Quenot, J. and Binquet, C. and Vinsonneau, C. and Barbar, S. and Vinault, S. and Deckert, V. and Lemaire, S. and Hssain, A. and Bruy√®re, R. and Souweine, B. and Lagrost, L. and Adrie, C. and Jung, B. and Daurat, A. and De, J. and Chanques, G. and Mahul, M. and Monnin, M. and Molinari, N. and Lheureux, O. and Trepo, E. and Hites, M. and Cotton, F. and Wolff, F. and Surin, R. and Cr√©teur, J. and Vincent, J. and Gustot, T. and Jacobs, F. and Taccone, F. and Neuville, M. and Timsit, J. and El-Helali, N. and Le, M. and Magalhaes, E. and Radjou, A. and Smonig, R. and Soubirou, J. and Voiriot, G. and Sonneville, R. and Bouadma, L. and Mourvillier, B. and G√©lisse, E. and Brasseur, A. and Roisin, S. and De, B. and Van, R. and Carlier, E. and Piagnerelli, M. and Vanhaeverbeek, M. and Danguy, C. and Biston, P. and Au, S. and Begot, E. and Dalmay, F. and Repess√©, X. and Prat, G. and Bouferrache, K. and Slama, M. and Vieillard-Baron, A. and Monnet, X. and Marik, P. and Teboul, J. and Jozwiak, M. and Richard, C. and Chauvet, J. and El-Dash, S. and Delastre, O. and Bouffandeau, B. and Jusserand, D. and Michot, J. and Bauer, F. and Brazier, F. and Mercado, P. and Kontar, L. and Titeca, D. and De, C. and Bacari-Risal, G. and Riviere, A. and Maizel, J. and Guillot, C. and Le, R. and Lampin, M. and Sadik, A. and Botte, A. and Leteurtre, S. and Collins, A. and Kempeneers, C. and Cajgfinger, N. and Ohlmann, C. and Pouyau, R. and Subtil, F. and Baudin, F. and Massenavette, B. and Javouhey, E. and Milesi, C. and Essouri, S. and Liet, J. and Afanetti, M. and Durand, S. and Durand, P. and Roze, J. and Dupont, D. and Cambonie, G. and Soyer, B. and Rusca, M. and Lukaszewicz, A. and Crassard, I. and Guichard, J. and Bresson, D. and de, l. and Cantier, M. and Sabben, C. and Louedec, L. and Delbosc, S. and Journ√©, C. and Ou, P. and Klein, I. and Chau, F. and Lefort, A. and Desilles, J. and Michel, J. and Mazighi, M. and Salem, O. and Demeret, S. and Bolgert, F. and Sharshar, T. and Grabli, D. and Arib, S. and Crippa, I. and Soummer, A. and Engrand, N. and Guedin, P. and Aldea, S. and Cerf, C. and Desailly, V. and Pasquier, P. and Brun, P. and Roux, D. and Latournerie, G. and Kasprzyk, L. and Grosjean, V. and Latreche, A. and Habert, P. and Huot, S. and Jobin, T. and Tesni√®re, A. and Dreyfuss, D. and Ricard, J. and Mignon, A. and Gaudry, S. and Laithier, F. and Kimmoun, A. and Chouihed, T. and Albizzati, S. and Camenzind, E. and Vanhuyse, F. and Levy, B. and Cour, M. and Venet, F. and Hernu, R. and Demaret, J. and Monneret, G. and Argaud, L. and Dumas, F. and Lamhaut, L. and Rosencher, J. and P√®ne, F. and Varenne, O. and Carli, P. and Jouven, X. and Spaulding, C. and Cariou, A. and Geri, G. and Bonnetain, F. and Marijon, E. and Empana, J. and Mirouse, A. and Resche-Rigon, M. and Mayaux, J. and Rabbat, A. and Meert, A. and Benoit, D. and Bruneel, F. and Azoulay, E. and Dupuis, C. and Schwebel, C. and Ruckly, S. and Goldgran-Toledano, D. and Marcotte, G. and Lafarge, A. and Pichereau, C. and Theodose, I. and Scotto, M. and Kemlin, D. and Ghrenassia, E. and Schlemmer, B. and Vimpere, D. and Galicier, L. and Contou, D. and Gu√©rot, E. and Grimaldi, D. and Ricome, S. and Maury, E. and Plantef√®ve, G. and Dessap, A. and Brun-Buisson, C. and de, P. and Dub√©, B. and Delemazure, J. and Dres, M. and Rousseau, L. and Drouot, X. and Diaz, V. and Rebollar, Y. and Frat, J. and Thille, A. and Aissa, D. and Coquet, P. and Ruiz, J. and Ferre, F. and Hoarau, L. and Riu-Poulenc, B. and Bataille, B. and Silva, S. and Baudel, J. and Big√©, N. and Tahiri, J. and Dub√©e, V. and Guidet, B. and Ait-Oufella, H. and Jinglun, L. and Shen, F. and Monnet, X. and Bailly, S. and Leroy, O. and Montravers, P. and Constantin, J. and Dupont, H. and Guillemot, D. and Lortholary, O. and Perrigault, P. and Gangneux, J. and Razazi, K. and Mekontso-Dessap, A. and Jansen, C. and Lecronier, M. and Sandrine, V. and Mira, J. and Blein, S. and Marin, N. and Rousseau, C. and Charpentier, J. and Pachot, A. and Hraiech, S. and Bordes, J. and De, L. and M√®ge, J. and Forel, J. and Guervilly, C. and Adda, M. and Raoult, D. and Papazian, L. and Kentish-Barnes, N. and Cohen-Solal, Z. and Kentish-Barnes, N. and Souppart, V. and Kerhuel, L. and Haubertin, C. and Exbrayat, I. and Rozi√®res, E. and Argain, A. and Suc, A. and Vignes, M. and Cougot, P. and Fourcade, O. and Brunel, E. and Messika, J. and Tubach, F. and Dubief, E. and Pasquet, B. and Guillo, S. and Pierron, C. and Grimaud, M. and Farnoux, C. and Maillard, A. and Decav√®le, M. and Prodanovic, H. and Idbaih, A. and Alentorn, A. and Delattre, J. and De, M. and Brule, N. and Conrad, M. and Dailler, F. and Navellou, J. and Alves, M. and Tonnelier, J. and Ruckly, S. and Picard, G. and Rogemond, V. and Honnorat, J. and Marzorati, C. and Lebert, C. and Perez, P. and Citerio, G. and Legriel, S. and Tripon, S. and Mallet, M. and Rudler, M. and Imbert-Bismut, F. and Thabut, D. and Canet, E. and Faguer, S. and Moreau, A. and Barbier, F. and Merceron, S. and Guitton, C. and Labadie, F. and Lemiale, V. and Faucher, E. and Klouche, K. and Chevret, S. and Ragot, S. and Coudroy, R. and Boulain, T. and Jamet, A. and Mercat, A. and Brochard, L. and Roux, A. and Lemiale, V. and Franchineau, G. and Brechot, N. and Lebreton, G. and Hekimian, G. and Nieszkowska, A. and Leprince, P. and Trouillet, J. and Combes, A. and Schmidt, M. and Barrot, L. and Piton, G. and Bailey, M. and Panwar, R. and Belin, N. and Belon, F. and Patry, C. and Grandperrin, M. and Chaignat, C. and Labro, G. and Vivet, B. and Capellier, G. and Daix, T. and Gu√©rin, E. and Tavernier, E. and Mercier, E. and Gissot, V. and Vallejo, C. and Fran√ßois, B. and Ravry, C. and Pichon, N. and Chapellas, C. and Fedou, A. and Galy, A. and Ploy, M. and Barraud, O. and Vignon, P. and Thooft, A. and Conotte, R. and Colet, J. and Le, D. and Tarazona, V. and Brumpt, C. and Moins-Teisserenc, H. and Uhel, F. and Azzaoui, I. and Gregoire, M. and Pangault, C. and Dulong, J. and Cynober, L. and Roussel, M. and Le, T. and Tarte, K. and Demiselle, J. and Auchabie, J. and Dequin, P. and Chudeau, N. and Fourrier, F. and Grange, S. and Piquilloud, L. and Lautrette, A. and Boyer, S. and Letheulle, J. and Lerolle, N. and Truche, A. and Clec‚Äôh, C. and Zaoui, P. and Laurent, V. and Toledano, D. and Ragey, S. and Gros, A. and Dumenil, A. and Jamali, S. and Darmon, M. and Chouraqui, M. and Dewitte, A. and Chastel, B. and Carles, P. and Fleureau, C. and Joannes-Boyau, O. and Ouattara, A. and Joseph, A. and Garrouste-Orgeas, M. and Max, A. and Lerin, T. and Gr√©goire, C. and Kloeckner, M. and Bruel, C. and Brochon, S. and Philippart, F. and Pichot, E. and Simons, C. and Flint, A. and Aubron, C. and Bellomo, R. and Pilcher, D. and Cheng, A. and Hegarty, C. and Martinelli, A. and Howden, B. and Reade, M. and Mcquilten, Z. and Bretonni√®re, C. and Villers, D. and Soares, M. and Gonzalez, F. and Vincent, F. and Fauch√©, C. and Gay, S. and Skowron, O. and Levrat, A. and Dorez, D. and Decav√®le, M. and Foucrier, A. and Pease, S. and Gauss, T. and Paugam, C. and Gorham, J. and Ameye, L. and Paesmans, M. and Berghmans, T. and Sculier, J. and Meert, A. and Deras, P. and Martinez, O. and Latry, P. and Capdevila, X. and Charbit, J. and Jaubert, J. and Etiennar, C. and Ginoux, L. and Sebbah, J. and Haouache, H. and Dhonneur, G. and Cheikh, C. and Moussaid, I. and Ghazaoui, O. and Belkadi, K. and El, Y. and Salmi, S. and Pajot, L. and Zuber, B. and Darmon, M. and Bedos, J. and Dupont, B. and Eug√®ne, A. and Galateau-Sall√©, F. and Michard, B. and Lebas, B. and Boivin, A. and Guillot, M. and Harlay, M. and Janssen-Langenstein, R. and Schenck, M. and Ellero, B. and Woehl-Jaegle, M. and Besch, C. and Castelain, V. and Bachellier, P. and Schneider, F. and Camus, C. and Saliba, F. and Goubaux, B. and Bonadona, A. and Lavayssiere, L. and Quinart, A. and Barbot, O. and Dharancy, S. and Delafosse, B. and Barraud, H. and Galbois, A. and Veber, B. and Cayot, S. and Souche, B. and Locher, C. and Roux, O. and Figorilli, F. and Putignano, A. and Houssel, P. and Francoz, C. and Weiss, E. and Agarwal, B. and Jalan, R. and Durand, F. and Ghezala, H. and Daoudi, R. and Kaddour, M. and Ghadhoune, H. and Rachedi, E. and Guissouma, J. and Ben, S. and Azzeza, W. and Brahmi, H. and Elghord, H. and Kada, A. and Chikh, R. and Slimani, R. and a, B. and Regaieg, K. and Kamilia, C. and Baccouche, N. and Turki, O. and Chaari, A. and Ben, H. and Bouaziz, M. and Medhioub, F. and Zekri, M. and Rgieg, K. and Bhimada, C. and Mounir, B. and Cheikh, C. and Lang, E. and Welschbillig, S. and Perrin, M. and Devys, J. and Benbernou, S. and Mokhtari-Djebli, H. and Ilies, S. and Bouyacoub, K. and Azza, A. and Zogheib, E. and Nader, J. and Villeret, L. and Guilbart, M. and Besserve, P. and Caus, T. and Mastroianni, C. and Santi, F. and H√©kimian, G. and Pascal, L. and Chastre, J. and Perrier, V. and Deniau, B. and Klasen, F. and Ponthus, J. and Ngasseu, P. and Amilien, V. and Barsam, E. and Lehericey, P. and Tchir, M. and Georger, J. and Puech, B. and Vandroux, D. and Roussiaux, A. and Belcour, D. and Ferdynus, C. and Martinet, O. and Jabot, J. and Fresco, M. and Demeilliers-Pfister, G. and Merle, V. and Brunel, V. and Dureuil, B. and Leydier, S. and Clerc-Urmes, I. and Lemarie, J. and Maigrat, C. and Cravoisy-Popovic, A. and Barraud, D. and Nace, L. and Gibot, S. and Agrinier, N. and Bollaert, P. and Daban, J. and Boutonnet, M. and Dumas, G. and Falzone, E. and Jault, P. and Lenoir, B. and Makunza, J. and Mejeni, N. and Mazaud, A. and B√©ague, S. and Rousselle, A. and Durocher, A. and Perez, P. and Grinea, A. and Bedoui, N. and Stoian, A. and Baboi, L. and Gobert, F. and Yonis, H. and Tapponier, R. and Bruyneel, A. and Bonus, T. and Cuvelier, G. and Machayeckhi, S. and Olieuz, S. and Legrand, A. and Feki, F. and Jamoussi, A. and Merhebene, T. and Braham, E. and Ghariani, A. and Mezni, F. and Slim, L. and Khelil, J. and Besbes, M. and Marchalot, A. and Beduneau, G. and Carpentier, D. and Besnier, E. and Gastaldi, G. and Abily, J. and Beuzelin, M. and Nay, M. and Mankikian, J. and Herv√©, V. and Soulie, M. and Cronier, P. and Kantor, E. and Federici, L. and Gilbert, M. and Mezhari, I. and Choukroun, G. and Marque, S. and Coppere, Z. and Fulgencio, J. and Blayau, C. and Pham, T. and Djibre, M. and Reffienna, M. and Lefort, S. and Debue, A. and Daviaud, F. and Cabon, S. and Addou, Z. and Douah, A. and Moussati, M. and Belhabiche, K. and Aouffen, N. and Soulier, S. and Mauriat, P. and Tafer, N. and Mortamet, G. and Amaddeo, A. and Khirani, S. and Fauroux, B. and Khanes, G. and Liutko, O. and Bidnenko, S. and Doye, E. and Voirin, N. and Maucort-Boulch, D. and Kolev-Descamp, K. and Aouane, I. and Essid, A. and Hammami, W. and Haegy, I. and Bataille, J. and Bergounioux, J. and Morin, L. and Ray, S. and Maclaren, G. and Nadel, S. and Kneyber, M. and Peters, M. and Jansen, K. and De, L. and Wilson, C. and Schlapbach, L. and Tissi√®res, P. and Girard, A. and Savajols, E. and Burguet, A. and Semama, D. and Litzler-Renault, S. and Fredj, H. and Hassouna, M. and Hechmi, Y. and Cherif, M. and Zouheir, J. and Dernane, A. and Bouakkaz, F. and Taleb, L. and Zeddine, M. and Lyazidi, A. and Richard, J. and Mouhsen, A. and Harmouchi, M. and Rattal, M. and Huck, M. and Leclerc, T. and Donat, N. and Cirodde, A. and Schaal, J. and Masson, Y. and Hoffmann, C. and Cerland, L. and Valentino, R. and Chabartier, C. and Villain-Coquet, L. and Ferge, J. and Brouste, Y. and Mehdaoui, H. and Louriz, M. and Madani, N. and Amlaiky, F. and Dendane, T. and Abidi, K. and Zekraoui, A. and Zeggwagh, A. and Abouqal, R. and Brahim, A. and Ferhi, F. and Bouslama, M. and Benjazia, K. and Zeineb, A. and Mahassen, D. and Cadiet, J. and Ferron, M. and Prat, V. and Erraud, A. and Aillerie, V. and Mevel, M. and Grabherr, A. and Chatham, J. and Gauthier, C. and Lauzier, B. and Rozec, B. and Joffre, J. and Loyer, X. and Lavillegrand, J. and Zeboudj, L. and Laurans, L. and Esposito, B. and Tedgui, A. and Mallat, Z. and Wei, C. and Kattani, N. and Louis, H. and Orlowski, S. and Tharaux, P. and Burban, M. and Meyer, G. and Olland, A. and Yver, B. and Toti, F. and Schini-Kerth, V. and Monnier, A. and Leborgne, P. and Meziani, F. and Clavier, T. and Paulus, M. and Castel, H. and Richard, V. and Pons, S. and Skurnik, D. and Six, S. and Jaffal, K. and Vigneron, C. and Large, A. and Bador, J. and Aho, S. and Prin, S. and Touil, Y. and Ayed, S. and Ali, H. and Tilouch, N. and Mateur, H. and Talik, I. and Gharbi, R. and Hassen, M. and Elatrous, S. and Patry, I. and Bertrand, X. and Zahar, J. and Essaied, W. and Wolkewitz, M. and Soued, M. and Cook, F. and Lobo, D. and Mounier, R. and Emirian, A. and Decousser, J. and Slaoui, M. and Benslama, A. and Valance, D. and Allou, N. and Allyn, J. and Jean-Bart, E. and Bel., F. and Morey, F. and Sedillot, N. and Biard, L. and Galliot, R. and Zunarelli, R. and Gauzere, B. and Cartier, J. and Jouve, T. and Hilleret, M. and Hamidfar-Roy, R. and Ara-Somohano, C. and Minet, C. and Pourcelet, A. and Hougardy, J. and Defrance, P. and De, L. and Boyer, A. and Gruson, D. and Clouzeau, B. and Hajjam, N. and Nasri, H. and Doghri, H. and Mongardon, N. and Levesque, E. and Bastide, M. and Richecoeur, J. and Frenoy, E. and Lemaire, C. and Schortgen, F. and Preau, S. and Ehooman, F. and Montlahuc, C. and Bardon, J. and Postel-Vinay, N. and Lafi, M. and Jacobs, F. and Prat, D. and Le, M. and Moneger, G. and Demars, N. and Trouiller, P. and Tenc√©, N. and Zaien, I. and Wolf, M. and Allardet-Servent, J. and Lebsir, M. and Dubroca, C. and Portugal, M. and Castanier, M. and Signouret, T. and Soundaravelou, R. and Lepidi, A. and Halfon, P. and Seghboyan, J. and Gamblin, C. and Benturquia, N. and Roussel, O. and Chevillard, L. and Risede, P. and Callebert, J. and Khelfa, M. and Blel, Y. and Thabet, H. and Brahmi, N. and Amamou, M. and Le, L. and Baud, F. and Le, B. and Vivien, B. and Soufir, L. and Carli, P. and Le, L. and Essafi, F. and Foudhaili, N. and Slimen, A. and Jabla, R. and Hammed, H. and Marzouk, M. and Boujelbene, N. and Dachraoui, F. and Hachani, A. and Abdallah, S. and Lakhal, H. and Ghribi, C. and Ali, I. and Abdellaoui, I. and Ouanes-Besbes, L. and Abroug, F. and Demiri, S. and Lorut, C. and Van, L. and Lefebvre, A. and Alifano, M. and Reignard, J. and Samama, M. and Dusser, D. and Roche, N. and R√©miniac, F. and Landel, C. and Gensburger, S. and Bocar, T. and Mordier, L. and Philippe, M. and Le, P. and Vecellio, L. and Ehrmann, S. and Poiroux, L. and Thevoz, D. and Simons, J. and Roeseler, J. and Loiez, A. and G√©rard, S. and Dousse, N. and L‚Äôhotellier, S. and Baumgarten, E. and Borschneck, S. and Kharcha, F. and Ghander, C. and Tresallet, C. and Puymirat, E. and Fagon, J. and Aegerter, P. and Diehl, J. and Hauw-Berlemont, C. and Chatellier, G. and Danchin, N. and Aissaoui, N. and Aissat, N. and Bernard, R. and Amour, J. and Bougl√©, A. and Vidal, C. and Nima, D. and Shaida, V. and Dorget, A. and Br√©chot, N. and Toufiki, R. and Mouaffak, Y. and Adib, A. and Amine, M. and Moumine, S. and Jonard, M. and Ducloy-Bouthors, A. and Bouju, P. and Barbarot, N. and Gacouin, A. and Fillatre, P. and Grillet, G. and Goepp, A. and Clairet, A. and Limat, S. and Cornette, C. and Fatnassi, A. and Romdhani, C. and Sammoud, W. and Labbene, I. and Ferjani, M. and Taibi, H. and Elatiqi, I. and Iraqui, A. and Cherkab, R. and Haddad, W. and Elkettani, C. and Barrou, L. and Cave, F. and Lerolle, N. and Doutrellot, P. and Vaysse, B. and Inan, M. and Khelfoun, K. and Nasserallah, M. and Maizel, J. and Legrand-Monteil, C. and Tasseel-Ponche, S. and Kowalski, B. and Guaguere, A. and Boulle-Geronimi, C. and Masse, J. and Vanbaelinghem, C. and Herbecq, P. and Mokline, A. and Draief, S. and Gharsallah, L. and Rahmani, I. and Gasri, B. and Tlaili, S. and Hammouda, R. and Messadi, A. and Michel, P. and Gel√©e, B. and Fadel, F. and Thuong, M. and Ait-Aoudia, S. and Laddi, S. and Sahraoui, M. and Muller, M. and Faucher, A. and Hermann, B. and Berlemont, C. and Arnaout, M. and Busson, J. and Dhumeaux, J. and Ericher, N. and Lucas, P. and Dumas, M. and Chapelle, C. and Philippon-Jouve, B. and Morel, J. and Beuret, P. and Bureau, C. and Poitou, T. and Coudroy, R. and Petua, P. and Ghezala, H. and Prades, A. and Basty, M. and Monet, C. and Mounet, B. and Futier, E. and Leroux, A. and Oudinot, X. and Laurent, M. and Ouanes, I. and Jochmans, S. and Alphonsine, J. and Van, V. and Rolin, N. and Sy, O. and Serbource-Goguel, J. and Ellrodt, O. and Monchi, M. and Bahloul, M. and Olfa, T. and Chokri, B. and Chelly, H. and Trichot, A. and Colin, G. and Vinatier, I. and Bachoumas, K. and Lacherade, J. and Fiancette, M. and Joret, A. and Yehia, A. and Henry-Laguarrigue, M. and Martin-Lef√®vre, L. and Razazi, K. and Surenaud, M. and Bedet, A. and Seemann, A. and H√ºe, S. and Clere-Jehl, R. and Charles, A. and Geny, B. and Bilbault, P. and Bourcier, S. and Lejour, G. and Bourcier, S. and Bo√™lle, P. and Safaa, N. and Paulus, S. and Flamens, C. and Neidecker, J. and Rambaud, J. and Allioux, C. and Guedj, R. and Guellec, I. and Guilbert, J. and Leger, P. and Demoulin, M. and Durandy, A. and Jean, S. and Carbajal, R. and Morand, A. and Zieleskiewicz, L. and Brissaud, O. and Le, B. and Meresse, Z. and Panuel, M. and Thomachot, L. and Leone, M. and Michel, F. and Deho‚Äô, A. and Sadozai, L. and Dauger, S. and Prot-Labarthe, S. and Genuini, M. and Florence, M. and Treluyer, J. and Renolleau, S. and Chalavon, E. and Dessein, R. and Grandbastien, B. and Pesin, S. and Dubos, F. and Leteurtre, S. and Puel, M. and Szulc, M. and Philippe, A. and Severac, F. and Astruc, D. and Kuhn, P. and Desprez, P. and Aoul, N. and Colomb, B. and Petion, A. and Queudet, L. and Remy, S. and Youssef, M. and Roumeliotis, N. and Dong, C. and Pettersen, G. and Crevier, L. and Emeriaud, G. and Naudin, J. and Abdallah, L. and Ganier, M. and Frannais, K. and Douglas, D. and Flusin, C. and Brossier, D. and Eltaani, R. and Sauthier, M. and Guillois, B. and Rambaud, J. and Larroquet, M. and Amblard, A. and Lode, N. and Casadevall, I. and Kessous, K. and Walti, H. and Poir√©, C. and Chen, H. and Megarbane, B. and M‚Äôrad, A. and Habacha, S. and Chatbri, B. and M‚Äôrad, A. and Masniere, C. and Megarbane, B. and M‚Äôrad, A. and Souissi, S. and Ghord, H. and Kouraichi, N. and Brahmi, N. and Marhb√®ne, T. and Mejri, I. and Lakhdar, D. and Merhabane, T. and la, M. and Charlotte, O. and Wegelius, H. and Landelle, C. and Schrenzel, J. and Kaiser, L. and Pugin, J. and Belhadj, H. and Chanareille, P. and Ladureau, A. and Sanna, A. and Rolle, A. and Pons, B. and Piednoir, P. and Ardisson, F. and Martino, F. and Bernos, T. and Elkoun, K. and Elain, E. and Lawson, R. and Resh-Rigon, M. and Belorgey, S. and Thiery, G. and Berlemont, C. and Pricopi, C. and Barthes, F. and Doddie, T. and Nsiala, M. and Situakibanza, N. and Amisi, B. and Kazadi, M. and Kilembe, M. and Clement, C. and Lamontagne, F. and Boyer, V. and Naimo, S. and Raulais, R. and Genevois, E. and Bouchoud, L. and Boroli, F. and Abidi, N. and Abbas, M. and Harbarth, S. and Pugin, J. and Charles, P. and Dereux, C. and De, G. and Morisse, E. and France, J. and Gasser, D. and Badia, P. and Picard, W. and Corne, P. and De, B. and Seguin, S. and Blasco, A. and Ledur, V. and Jonquet, O. and Sophie, P. and Artiguenave, M. and Sayed, F. and Espinasse, F. and Dinh, A. and Charron, C. and Lebas, B. and Hatsch, S. and Maestraggi, Q. and Dureau, A. and Faitot, F. and Margetis, D. and Bouvet, O. and Chevret, D. and Denamur, E. and Simonet, J. and Vest, P. and Peigne, V. and Couffin, S. and Cheikh, B. and Khedher, A. and Meddeb, K. and Azouzi, A. and Hamdaoui, Y. and Ayachi, J. and Brahim, W. and Bouneb, R. and Boussarsar, M. and Florens, N. and Var√©on, J. and Malatray, A. and Argaud, L. and Dupland, P. and Vergier, R. and Issaurat, P. and Estagnasi√©, P. and Squara, P. and Brusset, A. and G√©nin, V. and Jendoubi, A. and Jlassi, R. and Hamrouni, B. and Marzougui, Y. and Kouka, J. and Ghedira, S. and Houissa, M. and Dhifaoui, K. and Hajjej, Z. and Oziel, J. and Dinh, A. and Neulier, C. and Amara, M. and Nebot, N. and Troch√©, G. and Breton, N. and Cavelot, S. and Pangon, B. and Merrer, J. and Labaste, F. and Conil, J. and Grossac, J. and Ruiz, S. and Grare, M. and Minville, V. and Georges, B. and Van, D. and Karoubi, P. and Huang, C. and Carbonne, H. and Amarsy, R. and Mateo, J. and Von, E. and Vercheval, C. and Damas, P. and Bouguerra, C. and Naas, N. and Muller, J. and Schaeffer, M. and Loc, P. and Deboscker, S. and Harley, M. and Lavigne, T. and Brunet, J. and Canoville, B. and Lellouche, F. and L‚Äôher, E. and Bouchard, P. and Delorme, M. and Elfaramawy, T. and Gosselin, B. and Guegan, S. and Michotte, J. and Staderini, E. and Dugernier, J. and Rusu, R. and Liistro, G. and Reychler, G. and Delorme, M. and Simon, M. and Essoukaki, E. and Duprez, F. and Michotte, J. and Contal, O. and Trabelsi, B. and Hajjej, Z. and Garsallah, H. and Hajjej, Z. and Harira, K. and Rafat, C. and Mariotte, E. and Le, J. and Roy, P. and Michallet, M. and Zerbib, Y. and Baudin, F. and Blot, F. and Bornstain, C. and Gelinotte, S. and Rigaud, J. and Tamion, F. and Bouteloup, M. and Darmon, M. and Nouira, H. and Boisram√©-Helms, J. and Degirmenci, S. and Kummerlen, C. and Delile, E. and Thi√©baut, P. and Do, R. and Coquerel, D. and Nevi√®re, R. and Ichou, L. and Carbonell, N. and Rautou, P. and Nousbaum, J. and Renou, C. and Anty, R. and Landraud, L. and Ait-Oufella, H. and Coudroy, R. and Lecron, J. and Helary, M. and Paillot, J. and Pili-Floury, S. and Khedher, S. and Maoui, A. and Ezzamouri, A. and Salem, M. and Kerdjana, L. and Dumitrescu, M. and Mimoz, O. and Debaene, B. and Migeot, V. and Dahyot-Fizelier, C. and Khedher, S. and maoui, A. and Champigneulle, B. and Zafrani, L. and Lascarrou, J. and Lissonde, F. and Le, T. and Reignier, J. and Platon, L. and Lambert, J. and Lagier, D. and Brun, J. and Sannini, A. and Chow-Chine, L. and Bisbal, M. and Faucher, M. and Mokart, D. and la, M. and Virgnie, L. and Gaudet, A. and Parmentier-Decrucq, E. and De, F. and Dubucquoi, S. and Lassalle, P. and Mathieu, D. and Richard, J. and Tapponnier, R. and Quintin, L. and Pichot, C. and Petitjeans, F. and Guillon, A. and Jouan, Y. and Breah, D. and Gueugnon, F. and Dalloneau, E. and Baranek, T. and Henry, C. and Morello, E. and Renauld, J. and Pichavant, M. and Gosset, P. and Courty, Y. and Diot, P. and Si-Tahar, M. and Tadi√©, J. and Vuillard, C. and La, C. and Ponsin, P. and Boddaert, G. and Grand, B. and Baudoin, Y. and Bonnet, S. and Snouda, S. and Abbes, M. and Benchiekh, I. and Cheikh, C. and Sedghiani, I. and Maaroufi, N. and Belayachi, J. and Debono, L. and Auvet, A. and Nadal-Desbarats, L. and Tankovic, J. and Dahoumane, R. and Oufella, H. and Offenstadt, G. and Filali, A. and Faure, E. and Van, G. and Nigeon, O. and Bazus, H. and Mallat, J. and Thevenin, D. and Lempereur-Legros, S. and Ledoux, D. and Nys, M. and Hajjej, Z. and Messika, J. and Clermont, O. and Aubry, A. and Fernandes, R. and Venot, M. and Bailly, S. and Garnaud, C. and Cornet, M. and Pavese, P. and Foroni, L. and Boisset, S. and le, M. and Ouanes, I. and Abid, M. and Ezzouine, H. and Edith, C. and Sztrymf, B. and Brunot, V. and Serre, J. and Landreau, L. and Boussarsar, M. and Ouanes, I. and Jean-Michel, V. and Couturaud, F. and Moore, E. and Egreteau, P. and Boles, J. and Herbrecht, J. and Kaeuffer, C. and Meyer, A. and Mokline, A. and Arfi, K. and Lesage, F. and S√©guret, S. and Dupic, L. and De, S. and Baptiste, A. and Georges, H. and Delannoy, P. and Devos, P. and Albarracin, D. and Ducousso-Lacaze, A. and Dufour, J. and Cabasson, S. and Veinstein, A. and Chatellier, D. and Robert, R. and Ha, V. and Lau, N. and Mimoun, L. and Forceville, X. and Maamar, A. and Chevalier, S. and Botoc, V. and Rouleau, S. and Desachy, A. and Calvat, S. and Lafon, C. and Cracco, C. and Van, G. and Temime, J. and Molmy, P. and Gasan, G. and B√©ranger, A. and Chappuy, H. and Bertrand, P. and Beurton, A. and Bodet-Contentin, L. and Boisram√©-Helms, J. and Danin, P. and Dubois, E. and Karaca, Y. and Mora, P. and Vodovar, D. and Desbrosses, Y. and Chauchet, A. and Daguindau, E. and Deconinck, E. and Chermak, A. and Baron, M. and Calvet, L. and Sapin, A. and Pereira, B. and Vettoretti, L. and Lacroix, J. and Clayton, L. and Sabri, E. and Bardiaux, L. and Tiberghien, P. and Hebert, P. and Lenglin√©, E. and Venot, M. and Soci√©, G. and Borcoman, E. and Rusinova, K. and Del, G. and Mercier, M. and Hamel, J. and Raveau, T. and Moles, M. and Clavert, A. and Hunault-Berger, M. and Ifrah, N. and Schmidt-Tanguy, A. and Carreira, S. and Lavault, S. and Pallanca, O. and Morawiec, E. and Arnulf, I. and D‚Äôhumi√®res, T. and Carri√©, C. and Gisbert-Mora, C. and Bonnardel, E. and Biais, M. and Hilbert, G. and Bureau, C. and Joannon, T. and Marincamp, A. and Chiche, J. and Ferre, A. and Lichtenstein, D. and Meziere, G. and Dres, M. and Gonzalez, C. and Vignon, P. and Hamzaoui, O. and Geffriaud, T. and Leleu, F. and Maizel, J. and Boissier, F. and Cuquemelle, E. and Lim, P. and Amara, R. and Boussarsar, M. and L√©ger, J. and Jacob, C. and Bouferache, K. and Vignon, P. and Ragot, C. and Corradi, L. and Maizel, J. and Maurice, L. and Julliand, S. and Deho, A. and Le, B. and Jacquot, A. and Valla, F. and Letois, F. and Salvadori, A. and Ottonello, G. and Blanot, S. and Montmayeur, J. and Orliaguet, G. and Tarmiz, K. and Habas, F. and Baleine, J. and Lebouhellec, J. and Combes, C. and Chomton, M. and Jouvet, P. and Ranchin, B. and Macher, M. and Gaillot, T. and Bahloul, M. and Moine, M. and Ageron, F. and Jannel, C. and Debillon, T. and Wroblewski, I. and Duprey, M. and Jarlier, V. and Luyt, C. and Bailly, S. and Longval, T. and Schnell, D. and Padoin, C. and Cohen, Y. and Mokline, A. and Gaies, E. and Triki, S. and Klouz, A. and Moussa, M. and Desrumaux, F. and May, F. and Perrin, M. and Nguyen, J. and Tiercelet, K. and Fournier, J. and Cherin, M. and Kitzis, M. and Misset, B. and Mathien, C. and Poidevin, A. and Donatti, L. and Mootien, J. and Pinto, L. and Egard, M. and Bodur, G. and Barberet, G. and Ionescu, C. and Ganster, F. and Guiot, P. and Kuteifan, K. and Mpela, A. and Chelly, J. and Gu√©rin, L. and Persichini, R. and Hullin, T. and Deye, N. and Aubertein, P. and Paul, M. and Bougouin, W. and Sandroni, C. and Passouant, O. and Geri, G. and Llitjos, J. and Chenevier-Gobeaux, C. and Batteux, F. and Llitjos, J. and Drouet, L. and Voicu, S. and Henry, P. and Dillinger, J. and Bougouin, W. and Resiere, D. and Dessoy, A. and Soyer, B. and Faivre, V. and Damoisel, C. and Soyer, B. and Stiel, L. and Galoisy, A. and Mauvieux, L. and Zobairi, F. and Angles-Cano, E. and Stiel, L. and Piau, C. and Tadi√©, J. and Daix, T. and Jeannet, R. and Feuillard, J. and Jolly, L. and Boufenzer, A. and Carrasco, K. and Derive, M. and Gibot, S. and Merdji, H. and Belaidouni, N. and Toubiana, J. and L‚ÄôHermitte, Y. and Woimant, F. and Oppenheim, C. and Couvreur, C. and Dolveck, F. and Devriese, M. and Dupeyrat, S. and Ray, P. and Lefevre, G. and Fartoukh, M. and Roothaer, N. and Carpentier, A. and Vaniet, F. and Maisonneuve, A. and Wiel, E. and Canu, S. and Hammad, E. and Antonini, F. and Poirier, M. and Vigne, C. and Haddam, M. and Alingrin, J. and Dangers, L. and Mangiapan, G. and Huet, I. and Dhalluin, X. and Bautin, N. and Quiot, J. and De, V. and Chenivesse, C. and Tarmiz, K. and Medhioub, F. and Smaoui, M. and Cheikh, C. and El, A. and Weiss, N. and Mochel, F. and Galanaud, D. and Puybasset, L. and Lodey, M. and Guiller, E. and Weiss, N. and Silva, S. and Vuillaume, C. and De, P. and Demonet, J. and Sinnah, F. and Dalloz, M. and D‚Äôortho, M. and Rouvel-Tallec, A. and Couret, D. and Catan, A. and Nativel, B. and Planesse, C. and Diotel, N. and Meilhac, O. and Roy-Gash, F. and Lebard, C. and Larbi, A. and Gaudin, V. and Bonnin, F. and Sultan, O. and Hoc, C. and Mathieu, E. and Lapergue, B. and Bourdain, F. and Caron, M. and Parrot, A. and Labbe, V. and Hafiani, E. and Quesnel, C. and Genay, S. and D√©caudin, B. and Ethgen, S. and Odou, P. and Lebuffe, G. and Gaudry, S. and Aubron, C. and Mcquilte, Z. and Garrouste-Orgeas, M. and Soufir, L. and Allaouchiche, B. and Verdi√®re, B. and Nyunga, M. and Banaias, N. and Colling, D. and Kauv, M. and Blondeau, E. and Ouanes, I. and Auclin, E. and Haw-Berlemont, C. and Taieb, J. and Oudard, S. and Morissette, G. and Kechaou, W. and Litalien, C. and Merouani, A. and Phan, V. and Bouchard, J. and Starck, J. and Briand, N. and Sachs, P. and Angoulvant, F. and Sommet, J. and Holvoet, L. and Benkerrou, M. and Dreyfus, L. and Bordet, F. and Touzet, S. and Denis, A. and Le, C. and Ch√©ron, G. and Nabbout, R. and Patteau, G. and Heilbronner, C. and Hubert, P. and Oualha, M. and Aoul, N. and Crulli, B. and Toledano, B. and Poirier, N. and Vobecky, S. and Khouadja, H. and Robert, R. and Vinet, M. and Vinclair, C. and Boisram√©-Helms, J. and Beloncle, F. and Radermacher, P. and Asfar, P. and Coupez, E. and Boh√©, J. and Shinotsuka, C. and Caironi, P. and Villois, P. and Fontana, V. and Creteur, J. and Pourcine, F. and Vong, L. and Weyer, C. and Akando, B. and Abdallah, R. and Wetzstein, M. and Maizel, J. and Antier, N. and Serroukh, Y. and Boudjeltia, K. and Joosten, A. and Rousseau, A. and Delabranche, X. and Grunebaum, L. and Delabranche, X. and Mootien, Y. and Gaci, R. and Garric, J. and Delbove, A. and Darreau, C. and Dargent, A. and Soudry-Faure, A. and De, C. and Demondion, P. and Blanchard, J. and Chocron, S. and Meneveau, N. and Corsi, F. and Meynieu, P. and Repusseau, B. and Germain, A. and Baudry, G. and Hierle, L. and Besch, G. and Thomas, G. and Cassir, N. and Dizier, S. and Roch, A. and Trebbia, G. and Govindaradjou, K. and Devaquet, J. and Picard, C. and Parquin, F. and Leguen, M. and Felten, M. and Sage, E. and Chapelier, A. and Decav√®le, M. and Duruisseaux, M. and Fleury, J. and Antoine, M. and Carette, M. and Wislez, M. and Givel, C. and De, M. and De, K. and Tandjaoui-Lambiotte, Y. and Freynet, O. and Kimmoun, A. and Baux, E. and Das, V. and Talec, P. and Anguel, N. and Louis, G. and Girerd, N. and Tallon, P. and Hadchouel-Duverg√©, A. and Salvi, N. and Cairet, P. and Delacourt, C. and Blandine, B. and Beraud, L. and Coppere, Z. and Lamaziere, A. and Lionnet, F. and Fartoukh, M. and Lehingue, S. and D‚Äôjourno, X. and Jean-Marie, F. and Thibault, R. and Makhlouf, A. and Mulliez, A. and Gonzalez, C. and Dadet, S. and Kekstas, G. and Preiser, J. and Rotovnik, K. and Rozalen, I. and Kupczyk, K. and Krznaric, Z. and Cano, N. and Pichard, C. and Le, R. and Jotterand, C. and Rooze, S. and Moullet, C. and Henin, A. and Ettori, F. and Zemmour, C. and Boher, J. and Arnaout, M. and Feltry, A. and Ben, S. and Audibert, J. and Conia, A. and Gontier, O. and Hamrouni, M. and Lherm, T. and Ouchenir, A. and R√©tif, J. and Proudhom, A. and Lagardere, C. and Tissot, S. and Kalfon, P. and Sacre, L. and Villa, A. and Khadija, A. and Garnier, R. and Baud, F. and Baud, F. and Vasset, B. and Heinzelman, A. and Baud, F. and Jouffroy, R. and Durand, E. and Compagnon, P. and Maaroufi, N. and M‚Äôrad, A. and Jebri, A. and Ghezala, H. and Legout, C. and Baud, F. and Castot-Villepelet, A. and Valade, S. and Lesieur, O. and Delmas, B. and Visseaux, B. and Cohen, J. and Nguyen, L. and Morbieu, C. and Burdet, C. and Lescure, F. and Armand-Lefevre, L. and Yazdanpanah, Y. and Houhou-Fidouh, N. and Cazaux, M. and Goff, J. and Meignin, V. and Boutboul, D. and Rispail, P. and Brunot, V. and Besnard, N. and Ceballos, P. and Stoclin, A. and Rotolo, F. and Wartelle, M. and Hicheri, Y. and Maillet, S. and Chachaty, E. and Pignon, J. and Venot, M. and Delorme, M. and Bialais, E. and Julie, D. and Paoloni, L. and Wittebolle, X. and Hickmann, C. and Castanares-Zapatero, D. and Tordeur, A. and Colmant, L. and Wittebole, X. and Tirone, G. and Laterre, P. and Ducroux, L. and Kemlin, C. and Moulton, E. and Rosso, C. and Le, N. and Mongodi, S. and Bouhemad, B. and Rodrigues, J. and Botteau, C. and Duprez, F. and Waroquier, F. and Christiaens, K. and Vantrimpont, F. and Duprez, F. and Elkhawand, C. and Vermeesh, F.},
title  = {French Intensive Care Society, International congress ‚Äì R√©animation 2016.},
journal  = {Annals of Intensive Care},
volume  = {6},
number  = {Suppl 1},
pages  = {},
year  = {2016},
abstract  = {PHYSICIANS ABSTRACTSO1 Impact of tracheal cuff shape on microaspiration of gastric contents in intubated critically ill patients: a multicenter randomized controlled study (BEST CUFF)Emmanuelle Jaillette, Christophe Girault, Guillaume Brunin, Farid Zerimech, Arnaud Chiche, C√©line Broucqsault-Dedrie, Cyril Fayolle,  Franck Minacori, Isabelle Alves, Stephanie Barrailler, Laurent Robriquet, Fabienne Tamion, Emmanuel Delaporte, Damien Thellier, Claire Delcourte, Alain Duhamel, Saad NseirO2 Bicarbonate versus saline for contrast-induced acute kidney injury prevention in critically ill patientsXavier Valette, Isabelle Desmeulles,  Benoit Savary, Romain Masson, Am√©lie Seguin, C√©dric Daubin, Bertrand Sauneuf, Jennifer Brunet, Pierre Verrier, V√©ronique Pottier, Marie Orabona, D√©sir√© Samba,  G√©rald Viquesnel, Mathilde Lermuzeaux, Pascal Hazera, Jean-Luc Hanouz, Jean-Jacques Parienti, Damien Du CheyronO3 Neurally adjusted ventilatory assist in the early phase of weaning from mechanical ventilation: a multicenter randomized studyAlexandre Demoule, Marc Clavel, Camille Rolland-Debord, S√©bastien Perbet, Nicolas Terzi, Achille Kouatchet, Florent Wallet, Hadrien Roze, Fr√©d√©ric  Vargas, Claude Gu√©rin, Jean Dellamonica, Samir Jaber, Thomas SimilowskiO4 Very high volume hemofiltration with the Cascade system in septic shock patientsJean-Pierre Quenot, Christine Binquet, Christophe Vinsonneau, Saber-Davide Barbar, Sandrine Vinault,, Val√©rie Deckert, Stephanie Lemaire, Ali Ait Hssain, R√©mi Bruy√®re, Bertrand Souweine, Laurent Lagrost, Christophe AdrieO5  Effect of rapid response systems on hospital mortality, a prospective interventional study and systematic reviewBoris Jung, Aurelien Daurat, Audrey De  Jong, G√©rald Chanques, Martin Mahul,, Marion Monnin, Nicolas Molinari, Samir JaberO6 Beta-lactams serum concentrations in critically ill cirrhotic patients: a matched control studyOlivier Lheureux, Eric Trepo, Maya Hites, Frederic Cotton, Fleur Wolff, Rudy Surin, Jacques Cr√©teur, Jean-Louis Vincent, Thierry Gustot, Frederique Jacobs, Fabio Silvio TacconeO7 Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: Risk factors and side effectsMathilde Neuville, Jean-Fran√ßois Timsit, Najoua El-Helali, Alban Le Monnier, Eric Magalhaes, Aguila Radjou, Roland Smonig, Jean-Fran√ßois Soubirou, Guillaume Voiriot, Romain Sonneville, Lila Bouadma, Bruno MourvillierO8 Amikacin  peak concentrations in patients receiving extracorporeal membrane oxygenation (ECMO) support: a case‚Äìcontrol studyElodie G√©lisse, Mathilde Neuville, Etienne De Montmollin, Guillaume Voiriot, Jean-Fran√ßois Soubirou, Roland Smonig, Aguila Radjou, Eric Magalhaes, Lila Bouadma, Bruno Mourvillier, Jean-Fran√ßois Timsit, Romain SonnevilleO9 A high aminoglycoside regimen associated with renal replacement therapy for the treatment of multi-drug-resistant pathogensAlexandre  Brasseur, Maya Hites, Sandrine Roisin, Frederic Cotton, Jean-Louis Vincent, Daniel De Backer, Frederique Jacobs, Fabio Silvio TacconeO10 Optimization of administration of vancomycin in septic patients: a prospective randomized studyValerie Van Ruychevelt, Eric Carlier, Michael Piagnerelli, Michel Vanhaeverbeek, Christine Danguy, Patrick BistonO11 Impact of elevated intra-abdominal pressure on the ability of dynamic parameters to predict fluid responsivenessSiu-Ming Au, Emmanuelle Begot, Fran√ßois Dalmay, Xavier Repess√©, Gwenael Prat, Koceila Bouferrache, Michel Slama, Philippe Vignon, Antoine Vieillard-BaronO12 Passive leg raising for predicting fluid responsiveness: a systematic review and meta-analysisXavier Monnet, Paul Marik, Jean-Louis TeboulO13 Predicting volume responsiveness by using combined end-expiratory and end-inspiratory occlusion tests with echocardiographyMathieu Jozwiak, Jean-Louis  Teboul, Christian Richard, Xavier MonnetO14 Early dynamic left intraventricular obstruction is associated with hypovolemia and hight mortality in septic shock patientsJean-Louis Chauvet, Shari El-Dash, Olivier Delastre, Bernard Bouffandeau, Dominique Jusserand, Jean-Baptiste Michot, Fabrice Bauer, Julien Maizel, Michel SlamaO15 Predictive factors for poor hemodynamic tolerance to fluid removal in ICU: the DepleRea studyFran√ßois Brazier, Pablo Mercado, Loay Kontar, Dimitri Titeca, Bertand De Cagny, Gaelle Bacari-Risal, Antoine Riviere, Michel Slama, Julien MaizelO16 High-flow nasal cannula: first-line treatment of noninvasive ventilation for infants with bronchiolitis. Applicability and risk factors for failureCamille Guillot, Claire Le Reun, Marie Lampin, Ahmed Sadik, Astrid Botte,  Alain Duhamel, St√©phane LeteurtreO17 Is high-flow nasal cannula better than nasal continuous positive airway pressure for bronchiolitis management in pediatric intensive care unit?Aur√©lie Collins, C√©line Kempeneers, Nathalie CajgfingerO18 Interest and risk of high-flow cannula during acute hypoxemic pneumonia in children: a retrospective studyCamille Ohlmann, Robin Pouyau, Fabien Subtil, Florent Baudin, Bruno Massenavette, Etienne JavouheyO19 Interest of high-flow nasal cannula (HFNC) versus nasal continuous positive airway pressure (nCPAP) during the initial management of severe bronchiolitis in infants: a multicenter randomized controlled trialChristophe Milesi, Sandrine Essouri, Robin Pouyau,, Jean-Michel Liet, Mickael Afanetti, Julien Baleine, Sabine Durand, Philippe Durand, Etienne Javouhey, Jean Christophe Roze, Didier Dupont, Gilles CambonieO20 Outcome of severe cerebral venous thrombosis in intensive care unit: a cohort studyBenjamin Soyer, Marco Rusca, Anne-Claire Lukaszewicz, Isabelle Crassard, Jean-Pierre Guichard, Damien Bresson, Didier Payen de la GaranderieO21 Brain lesion spectrum characterization in an experimental model of infective endocarditisMarie Cantier, Candice Sabben, Liliane Louedec, Sandrine Delbosc, Cl√©ment Journ√©, Phalla Ou, Isabelle Klein, Fran√ßoise Chau, Agnes Lefort, Jean-Philippe Desilles, Jean-Baptiste Michel, Romain Sonneville, Mika√´l MazighiO22 Outcome of patients with Parkinson‚Äôs disease admitted in intensive care unitOmar Ben Hadj Salem, Sophie Demeret, Alexandre Demoule, Thomas Similowski, Francis Bolgert, Tarek Sharshar, David GrabliO23 Cerebrospinal fluid  glucose and lactate concentrations after subarachnoid hemorrhageSafa Arib, Ilaria Alice Crippa, Jacques Cr√©teur, Jean-Louis Vincent, Fabio Silvio TacconeO24 Spontaneous angionegative subarachnoidal hemorrhage: neurological outcome based on a retrospective study of 68 patientsAlexis Soummer, Nicolas Engrand, Pierre Guedin, Gr√©goire Trebbia, Sorin Aldea, Charles CerfO25 Serious game evaluation of a one-hour training basic life support session for secondary school students: new tools for future bystandersVictoire Desailly, Pierre Pasquier, Patrick Brun, Damien Roux, Jonathan Messika, Gwendoline Latournerie, Laetitia Kasprzyk, Vincent Grosjean, Amine Latreche, Pierre Habert, Stephane Huot, Timon Jobin, Antoine Tesni√®re, Didier Dreyfuss, Jean-Damien Ricard, Alexandre Mignon, St√©phane GaudryO26 Refractory out-of-hospital refractory cardiac arrest treated by veno-arterial extracorporeal membrane oxygenation. A retrospective single-center  experience from 2012 to 2015. CARECMO program (Cardiac ARrest Extra Corporeal Membrane Oxygenation)Fran√ßois-Xavier Laithier, Antoine Kimmoun, Tahar Chouihed, St√©phane Albizzati, Edoardo Camenzind, Fabrice Vanhuyse, Bruno LevyO27 Decreased  monocyte HLA-DR expression after out-of-hospital cardiac arrestMartin Cour, Fabienne Venet, Romain Hernu, Julie Demaret, Guillaume Monneret, Laurent ArgaudO28 Is emergent PCI associated with a clinical benefit in post-cardiac arrest patients without ST-segment elevation pattern? Insights from the PROCAT II registryFlorence Dumas, Wulfran Bougouin, Guillaume Geri, Lionel Lamhaut, Julien  Rosencher, Fr√©d√©ric P√®ne, Jean-Daniel Chiche, Olivier Varenne, Pierre Carli, Xavier Jouven, Jean-Paul Mira, Christian Spaulding, Alain CariouO29 Predictors of long-term quality of life after cardiac arrest: insights from the Parisian registryGuillaume Geri, Florence Dumas, Franck Bonnetain,, Wulfran Bougouin, Benoit Champigneulle, Michel Arnaout, Pierre Carli, Eloi Marijon, Olivier Varenne, Jean-Paul Mira, Jean Philippe Empana, Alain CariouO30 Red blood cell transfusions in early resuscitation of severe sepsis and septic shock in patients with hematological malignanciesAdrien Mirouse, Matthieu Resche-Rigon, Virginie Lemiale, Djamel Mokart, Fran√ßois Vincent, Julien Mayaux, Antoine Rabbat, Martine  Nyunga, Anne Pascale Meert, Dominique Benoit, Achille Kouatchet, Micha√´l Darmon,  Fabrice Bruneel, Elie Azoulay, Fr√©d√©ric P√®neO31 Causal effect of transfusion on mortality and other adverse events among critically ill septic patients: an observational study with a marginal structural modelClaire Dupuis, Micha√´l Darmon, Carole Schwebel, Elie Azoulay, Romain Sonneville, Lila Bouadma, Roland Smonig, Yves Cohen, St√©phane Ruckly, Christophe Adrie, Dany Goldgran-Toledano, S√©bastien Bailly, Guillaume Marcotte, Ma√Øt√© Garrouste-Orgeas, Jean-Fran√ßois TimsitO32 Autoimmune hemolytic anemia in the intensive care unitAntoine Lafarge,  Claire Pichereau, Sandrine Valade, Marion Venot, Akli Chermak, Igor Theodose, Marion Scotto, Delphine Kemlin, Claire Givel, Le√Øla Mourtada, Etienne Ghrenassia, Emmanuel Canet, Virginie Lemiale, Beno√Æt Schlemmer, Elie Azoulay, Eric MariotteO33 Pre-ICU location, lead time bias and outcomes in patients with thrombotic microangiopathiesDamien Vimpere, Sandrine Valade, Marion Venot, Claire Pichereau, Akli Chermak, Virginie Lemiale, Emmanuel Canet, Lionel Galicier, Elie  Azoulay, Eric MariotteO34 Septic shocks with no early etiological diagnosis: a multicenter prospective cohort study (the shock 24 study)Damien Contou, Damien Roux, Sebastien Jochmans, Remi Coudroy, Emmanuel Gu√©rot, David Grimaldi, Sylvie Ricome, Eric Maury, Ga√´tan Plantef√®ve, Julien Mayaux, Armand Mekontso Dessap, Christian Brun-Buisson, Nicolas de ProstO35 Respective contribution of diaphragm  and limbs muscles weakness on weaning from mechanical ventilation outcomeAlexandre Demoule, Bruno-Pierre Dub√©, Julien Mayaux, Julie Delemazure, Thomas Similowski, Martin DresO36 Impact of sleep quality on the duration of weaning from mechanical ventilationLudivine Rousseau, Xavier Drouot, V√©ronique Diaz, Yohann Rebollar, Jean-Pierre Frat, Remi Coudroy, Ren√© Robert, Arnaud, W Thille, Groupe ALIVEO37 Integrative ultrasound assessment of lung, cardiac and diaphragm function during a successful weaning trial predicts postextubation distressDalinda Ait Aissa, Pierre Coquet, Jean Ruiz, Fabrice Ferre, Lucille Hoarau, B√©atrice Riu-Poulenc, Benoit Bataille, Stein SilvaO38 ETCO2 improved outcome prediction of mechanical ventilation weaningJean-Luc Baudel, Simon Bourcier, Claire Pichereau, Na√Øke Big√©, Jalel Tahiri, Vincent Dub√©e, Bertrand Guidet, Eric Maury, Hafid Ait-OufellaO39 Characteristics of 150 cases of weaning-induced pulmonary oedema and effects of diureticsLiu Jinglun, Feng Shen,  Jean-Louis Teboul, Christian Richard, Xavier MonnetO40 Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasisS√©bastien Bailly, Olivier Leroy, Philippe Montravers, Jean-Michel Constantin, Herv√© Dupont, Didier Guillemot, Olivier Lortholary, Jean-Paul Mira, Pierre-Fran√ßois Perrigault, Jean-Pierre Gangneux, Elie Azoulay, Jean-Fran√ßois TimsitO41 Intensive care acquired pneumonia due to extended-spectrum Œ≤-lactamase-producing Enterobacteriaceae (ESBL-PE) among patients with prior colonization: Frequency, risk factors and prognosisKeyvan Razazi, Armand Mekontso-Dessap, Chloe Jansen, Nicolas de Prost, Christian Brun-BuissonO42 Epidemiology, characteristics and outcomes of septic critically ill patients after the removal of a totally implantable venous-access portsMarie  Lecronier, Valade Sandrine, Na√Øke Big√©, Nicolas de Prost, Damien Roux, Jean-Damien Ricard, Eric Maury, Julien Mayaux, Elie Azoulay, Alexandre Demoule, Martin DresO43 Genetic risk of Pseudomonas aeruginosa ventilator-associated pneumonia: the EXTENSE studyJean-Paul Mira, Sophie Blein, Nathalie Marin, Christophe Rousseau, Julien Charpentier, Jean-Daniel Chiche, Alexandre PachotO44  Cytomegalovirus reactivation enhances the virulence of a Staphylococcus aureus pneumonia in a mouse modelSami Hraiech, Julien Bordes, Samuel Lehingue, Lamballerie Xavier De, Jean-Louis M√®ge, Jean-Marie Forel, Christophe Guervilly, M√©lanie Adda, Didier Raoult, Laurent PapazianO45 Families looking back: meaning-making after a decision to accept or refuse organ donation. A qualitative approachNancy Kentish-Barnes, Zo√© Cohen-Solal, Elie AzoulayO46 The letter of condolence at the heart of family centered care. A qualitative approach of relatives‚Äô experienceNancy Kentish-Barnes, Zo√© Cohen-Solal, Virginie Souppart, Elie AzoulayO47 Use of a children information booklet to support young relatives  visiting a critically ill adult: impact on ICU practicesLionel Kerhuel, Carole Haubertin, Isabelle Exbrayat, Elodie Rozi√®res, Audrey Argain, Agn√®s Suc, Michel Vignes, Pierre Cougot, B√©atrice Riu-Poulenc, Stein Silva, Olivier Fourcade, Elodie BrunelO48 Withdrawal of life-support therapies reporting in ICU randomized controlled trial: Let us move to a transparent reporting‚Äîa systematic reviewJonathan Messika, St√©phane Gaudry, Florence Tubach, Emeline Dubief, Blandine Pasquet, Sylvie Guillo, Didier Dreyfuss, Jean-Damien RicardO49 Gasp during children end-of-life: healthcare providers‚Äô feelings and knowledgeCharlotte Pierron, Marion Grimaud, Caroline Farnoux, Am√©lie MaillardO50  Prognosis of malignant primary brain tumors in intensive care unitMaxens Decav√®le, Nicolas Weiss, H√©l√®ne Prodanovic, Julien Mayaux, Ahmed Idbaih, Agusti Alentorn, Jean-Yves Delattre, Thomas Similowski, Alexandre DemouleO51 Impact of early immunomodulating treatment on outcome of adult patients with anti-N-methyl-d-aspartate receptor encephalitis requiring intensive care: a multicentre study with prospective long-term follow-upEtienne De Montmollin, Sophie Demeret, Noelle Brule, Marie Conrad, Fr√©d√©ric Dailler, Nicolas Lerolle, Jean-Christophe Navellou, Carole Schwebel, Mikael Alves, Martin Cour, Nicolas Engrand, Jean-Marie Tonnelier, Stephane Ruckly, G√©raldine Picard, V√©ronique Rogemond, Jean-Fran√ßois Timsit, J√©r√¥me Honnorat, Romain Sonneville, ENCEPHALITICA study groupO52 Determinants of outcome in critically ill patients with hematological malignancy and central neurological failure: data from the TRIAL OH studyChiara Marzorati, Virginie Lemiale, Djamel Mokart, Fr√©d√©ric P√®ne, Achille Kouatchet, Julien Mayaux, Fran√ßois Vincent, Martine Nyunga, Fabrice Bruneel, Antoine Rabbat, Christine Lebert, Pierre Perez, Dominique Benoit, Giuseppe Citerio, Elie Azoulay, St√©phane LegrielO53 Ammonemia predicts severity and outcome in cirrhotic patients with hepatic encephalopathy in ICUSimona Tripon, Maxime Mallet, Marika Rudler, Francoise Imbert-Bismut, Dominique Thabut, Nicolas  WeissO54 Acute varicella zoster encephalitis admitted to the ICU: a case series of 47 patientsEmmanuel Canet, Adrien Mirouse, Romain Sonneville, Laurent Argaud,  Stanislas Faguer, Keyvan Razazi, Claude Gu√©rin, Pierre Perez, Anne-Sophie Moreau, Claire Pichereau, Fran√ßois Barbier, Sybille Merceron, Am√©lie Seguin, Julien Mayaux, Guillaume Geri, Christophe Guitton, Francois Labadie, Elie AzoulayO55 High-flow nasal cannula for acute respiratory failure in immunocompromised patientsVirginie Lemiale, Matthieu Resche-Rigon, Djamel Mokart, Fr√©d√©ric P√®ne, Etienne Faucher, Christophe Guitton, Antoine Rabbat, Christophe Girault, Achille  Kouatchet, Fran√ßois Vincent, Fabrice Bruneel, Martine Nyunga, Am√©lie Seguin, Kada Klouche, Sylvie Chevret, Elie Azoulay, Groupe de Recherche en Reanimation Respiratoire du patient d‚ÄôOnc-h√©matologieO56 High-flow oxygen therapy through a nasal cannula in immunocompromised patients with acute hypoxemic respiratory failureJean-Pierre Frat, St√©phanie Ragot, Christophe Girault, Remi Coudroy, Ren√©  Robert, Jean-Michel Constantin, Gwenael Prat, Thierry Boulain, Ang√©line Jamet,, Alain Mercat, Laurent Brochard, Arnaud, W. ThilleO57 Prospective validations of the PASTEIL score to assess the clinical pretest probability of Pneumocystis jirovecii pneumonia (PjP) in patients with hematologic malignancies (HMs) and acute respiratory failure (ARF)Elie Azoulay, Sylvie Chevret, Antoine Roux, Etienne Faucher, Fran√ßois Vincent, Antoine Rabbat, Achille Kouatchet, Fr√©d√©ric P√®ne, Julien Mayaux, Pierre Perez, Martine Nyunga, Christophe Guitton, Fabrice Bruneel, Kada Klouche, Djamel Mokart, Virginie LemialeO58 Bedside contribution of electrical impedance tomography (EIT) to set mechanical ventilation for severe acute respiratory distress syndrome (ARDS) on extracorporeal membrane oxygenation (ECMO)Guillaume Franchineau, Nicolas Brechot, Guillaume Lebreton, Guillaume Hekimian, Ania Nieszkowska, Charles-Edouard Luyt, Pascal Leprince, Jean Louis Trouillet, Alain Combes, Matthieu SchmidtO59 Liberal oxygenation versus restrictive oxygenation in ICU patients: effects on proinflammatory cytokines, sRAGE and organ dysfunctions - results of an ancillary studyLo√Øc Barrot, Ga√´l Piton, Michael Bailey, Rakshit Panwar, Nicolas Belin, Fran√ßois Belon,, Cyrille Patry, Jean-Christophe Navellou, Mathilde Grandperrin, Claire Chaignat, Guylaine  Labro, B√©reng√®re Vivet, Gilles CapellierO60 Immature granulocyte level at the acute phase of sepsis, a potential prognostic marker of clinical deterioration. The Septiflux 2 multicenter trialThomas Daix, Estelle Gu√©rin, Elsa Tavernier, Emmanuelle Mercier, Val√©rie Gissot, Christine Vallejo, Jean-Paul Mira, Christophe Guitton, Bruno Fran√ßois, Septiflux trial GroupO61 Analysis of microbiome and resistome using next-generation sequencing in urine samples from patients with sepsis, severe sepsis or septic shockC√©line Ravry, Bruno Fran√ßois, Emmanuelle Begot, Nicolas Pichon, Catherine Chapellas, Anne-Laure Fedou, Antoine Galy, Marie-C√©cile Ploy, Olivier Barraud, Philippe VignonO62 Patients metabolomic profiles at intensive care admissionAurelie Thooft, Raphael Conotte, Jean-Marie Colet, Patrick Biston, Michael PiagnerelliO63 Lymphocyte phenotype during severe  sepsis and septic shockMatthieu Le Dorze, Virginie Tarazona,, Caren Brumpt,, H√©l√®ne Moins-Teisserenc,, Anne-Claire Lukaszewicz, Didier Payen de la GaranderieO64 Myeloid-derived suppressor cells expressing arginase-1 and IDO play a major role in immune dysfunction during septic shockFabrice Uhel, Imane Azzaoui,, Murielle Gregoire, C√©line Pangault, Jo√´lle Dulong,, Luc Cynober,, Jean-Marc Tadi√©, Mika√´l Roussel,, Yves Le Tulzo, Karin TarteO65 Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis admitted to the intensive care  unit: a multicenter studyJulien Demiselle,, Johann Auchabie,, Julie Boisram√©-Helms, Pierre Fran√ßois Dequin, Damien Du Cheyron, Micha√´l Darmon, Nicolas Chudeau, Guillaume Geri, Ren√© Robert, Fran√ßois Fourrier, Steven Grange, Christophe Guitton, Lise Piquilloud, Alexandre Lautrette, Sonia Boyer, Emmanuel Gu√©rot, Julien Letheulle, Nicolas LerolleO66 Continuous renal replacement therapy versus intermittent hemodialysis: impact on mortality and renal recoveryAnne Sophie Truche, Micha√´l Darmon, S√©bastien Bailly, Christophe Clec‚Äôh, Claire Dupuis, Benoit Misset, Elie Azoulay, Carole Schwebel, Lila Bouadma, Christophe Adrie, Guillaume Marcotte, Philippe Zaoui, Virginie Laurent, Dany Goldgran Toledano, Romain Sonneville, Bertrand Souweine, Jean-Fran√ßois TimsitO67 Hospital  survival and need of renal replacement therapy with respect to AKI duration in critically ill patients: results of a multicenter cohort studySophie Perinel Ragey, Anne Sophie Truche, Bertrand Souweine, S√©bastien Bailly, Elie Azoulay, Lila Bouadma, Christophe Clec‚Äôh, Ma√Øt√© Garrouste-Orgeas, Antoine Gros, Carole Schwebel, Christophe Adrie, Anne Sylvie Dumenil, Laurent Argaud, Samir Jamali, Dany Goldgran Toledano, Guillaume Marcotte, Micha√´l Darmon, Jean-Fran√ßois Timsit, For the OUTCOMEREA study groupO68 Early versus delayed initiation of renal replacement therapy in septic acute kidney injury: a retrospective studyMikhael Chouraqui, Antoine Dewitte, Brigitte Chastel, Pauline Carles, Catherine Fleureau, Olivier Joannes-Boyau, Alexandre OuattaraO69 Renal recovery after severe acute kidney injury in critically ill myeloma patientsAdrien Joseph, Marion Venot, Sandrine Valade, Eric Mariotte, Claire Pichereau, Akli Chermak, Virginie Lemiale, Elie Azoulay, Emmanuel CanetO70 Impact of proactive nurse participation in ICU family conferences: a Mixed-Method StudyMa√Øt√© Garrouste-Orgeas, Adeline Max, Talia Lerin, Charles Gr√©goire, Stephane Ruckly, Martin Kloeckner, C√©dric Bruel, Sandie Brochon, Francois Philippart, Emmanuelle Pichot, Clara Simons, Jean-Fran√ßois Timsit, Benoit MissetO71 Duration of platelet storage and outcome of critically ill patientsAndrew Flint, C√©cile Aubron, Michael Bailey, Rinaldo Bellomo, David Pilcher, Allen Cheng, Colin Hegarty, Anthony Martinelli, Benjamin  Howden, Michael Reade, Zoe McquiltenO72 REA-C-SUR safety culture in intensive care in France: is there a link with morbi-mortality conferences?C√©dric Bretonni√®re, Daniel Villers, Christophe Guitton, Groupe RMM, Qualit√© et S√©curit√©  des Soins - CBPR-CFARO73 Survival of critically ill solid cancer patients: results of a retrospective multicentre studyM Soares, Virginie Lemiale, Djamel Mokart, Fr√©d√©ric Gonzalez, Fabrice Bruneel, Yves Cohen, Elie Azoulay, Micha√´l Darmon, Fran√ßois Vincent, for the GrrrOH: Groupe de recherche en r√©animation respiratoire en Onco-H√©matologie (Group for Research in Respiratory Intensive Care Onco-Hematology)O74 Encouraging results of the French controlled donation after circulatory death Maastricht category III ProgramCl√©mence Fauch√©, Michel Muller, Samuel Gay, Olivier Skowron, Albrice Levrat, Didier DorezO75 Clinical significance of cardiac troponin I release in severe trauma patientsMaxens Decav√®le, Arnaud Foucrier, Sebastian Pease, Tobias Gauss, Catherine PaugamO76 The modified Glasgow prognostic score is helpful in screening lung cancer patient at  risk of hospitalization at the emergency departmentJulie Gorham, Lieveke Ameye, Marianne Paesmans, Thierry Berghmans, Jean-Paul Sculier, Anne-Pascale MeertO77 Relationship between body mass index classes and massive transfusion needs in trauma patients and predictive performance of the TASH score in obese and non-obese populations: a retrospective study on 910 trauma patientsAudrey De Jong, Pauline Deras, Orianne Martinez, Pascal Latry, Samir Jaber, Xavier Capdevila, Jonathan CharbitO78 The Eschmann stylet as first tracheal access tool  during emergency difficult tracheal intubation: An initial simulation trial followed by a clinical studyJaubert J., Celia Etiennar, Lucie Ginoux, Jean-Luc Sebbah, Hakim Haouache, Gilles DhonneurO79 Maternal mortality risk factors for eclampsiaChaigar Mohammed Cheikh, I. Moussaid, O. Ghazaoui, Kamal Belkadi, S. El  Youssoufi, S. SalmiO80 Use of aminoglycosides in cirrhotic patients admitted in intensive care for severe sepsis or septic shock: short- and intermediate-term impact on renal function and mortalityLaure Pajot, Benjamin Zuber, Carole Schwebel, Romain Sonneville, Benoit Misset, Michael Darmon, Guillaume Marcotte, Anne Sophie Truche, Dany Goldgran-Toledano, Bertrand Souweine, Samir Jamali, Stephane Ruckly, Elie Azoulay, Christophe Clec‚Äôh, Jean Pierre Bedos, Jean-Fran√ßois Timsit, OutcomeR√©aO81 Diagnostic yield and therapeutic impact of liver biopsy in the intensive care unitBertrand Sauneuf, Benoit Dupont, Axelle Eug√®ne, Jean-Luc Hanouz, Fran√ßoise Galateau-Sall√©, Nicolas TerziO82 Critically ill patients requiring liver transplantation: a 7-year monocentric retrospective  experienceBaptiste Michard, Benjamin Lebas, Alexandra Boivin, Max Guillot, Jean-Etienne Herbrecht, Marie-Line Harlay, Ralf Janssen-Langenstein, Maleka Schenck, Bernard Ellero, Marie-Lorraine Woehl-Jaegle, Camille Besch, Vincent Castelain, Philippe Bachellier, Francis SchneiderO83 Hospital survival and access to liver transplantation of MARS-treated patients in France, 2004‚Äì2008: a retrospective multicenter study (RETROMARS)Christophe Camus, Fawzi Saliba, Bernard Goubaux, Agn√®s Bonadona, Laurence Lavayssiere, Catherine Paugam, Alice Quinart, Olivier Barbot, Sebastien Dharancy, Bertrand Delafosse, Nicolas Pichon,  Helene Barraud, Arnaud Galbois, Benoit Veber, Sophie Cayot, Bruno Souche, Clara Locher, RETROMARS Study GroupOlivier Roux, Francesco Figorilli, Antonella Putignano, Pauline Houssel, Claire Francoz, Emmanuel Weiss, Catherine Paugam, Banwari Agarwal, Rajiv Jalan, Fran√ßois DurandP1 Severe brain injuries: epidemiology and outcome in a Tunisian medical intensive care unitHassen Ben Ghezala, Salah Snouda, Rebeh Daoudi, Moez KaddourP2 Stroke prognosis in the ICU of the regional hospital of Bizerte and withhold and withdrawal treatment decisionsHatem Ghadhoune, E. Rachedi, J. Guissouma, A. Ben Slimene, W. Azzeza, H. Brahmi, H. ElghordP3 Brain death predictive factors for traumatic brain injuryAhmed Youssef Kada, Radia Chikh, Roza Slimani, Kheireddine.a BouyoucefP4 Guillain‚ÄìBarr√© syndrome in intensive care unit: epidemiology and prognostic factors: analysis of 30 patientsKais Regaieg, Chtara Kamilia, Najeh Baccouch, Olfa Turki, Anis Chaari, Hmida Chokri Ben, Mabrouk Bahloul, Mounir BouazizP5 Eclampsia: epidemiological and clinical study about 194 casesFatma Kaaniche Medhioub, Najeh Baccouch, Manel Zekri, Kais Rgieg, Chokri Bhimada, Bouaziz MounirP6 Neuroimagery in eclampsia and preclampsiaChaigar Mohammed Cheikh, I. Moussaid, Kamal Belkadi, O. Ghazaoui, S. El Youssoufi, S. SalmiP7 Interest of brain oxygen tension measurement (PbrO2) in the diagnosis of cerebral vasospasm after aneurismal subarachnoid hemorrhageElodie Lang, Stephane Welschbillig, Fabian Roy-Gash, Nicolas EngrandP8 Noninvasive ventilation: an alternative to the intubation during myasthenic crisisMathilde Perrin, Fabian Roy-Gash, Stephane Welschbillig, Jean-Michel DevysP9 Interest of the transcranial Doppler ultrasound in the management of severe traumatic brain injurySoumia Benbernou, Houria Mokhtari-Djebli, Sofiane Ilies, Khalida Bouyacoub, Abdelkader AzzaP10 VV-ECMO on  ARDS: toward a lower anticoagulation ratio?Elie Zogheib, Joseph Nader, L√©onie Villeret, Mathieu Guilbart, Patricia Besserve, Thierry Caus, Herv√© DupontP11 Inter-hospital transportation of patients implanted with veno-venous ECMO: Experience of the Piti√©-Salp√™tri√®re mobile ECMO teamNicolas Brechot, Ciro Mastroianni, Matthieu Schmidt, Francesca Santi, Guillaume Lebreton, Charles-Edouard Luyt, Jean Louis Trouillet, Ania Nieszkowska, Guillaume H√©kimian, Leprince Pascal, Jean Chastre, Alain CombesP12 Evolution of tidal volume and compliance under pressure-controlled mode during the first 24 hours of ECMO ARDS  patients transported to a referral centerHadrien Roze, Benjamin Repusseau, Jean-Christophe Richard, Virginie Perrier, Alexandre OuattaraP13 Extracorporeal dioxide carbon removal (ECCO2R), a French national surveyBenjamin Deniau, Jean-Damien Ricard, Jonathan Messika, Didier Dreyfuss, St√©phane GaudryP14 Levels  of microparticles in acute respiratory distress syndrome with veno-venous extra-corporeal membrane oxygenationChristophe Guervilly, Fanny Klasen, Sami Hraiech, Jean-Marie Forel, Laurent PapazianP15 In patients under extracorporeal CO2 removal therapy (ECCO2R) for ARDS can we do prone position? Efficiency, stability and safety of the maneuverJean Pierre Ponthus, Polysie Ngasseu, Virginie Amilien, Elise Barsam, Pierre Lehericey, Martial Tchir, Jean Francois GeorgerP16 Feasibility of the implementation of a technique of extra-corporeal CO2 removal (ECCO2R) in an intensive care unit which does not use ECMO and its real utilizationVirginie Amilien, Jean Pierre Ponthus, Polysie Ngasseu, Martial Tchir, Elise Barsam, Pierre Lehericey, Jean Francois GeorgerP17 Six-hour daily session of high-frequency oscillatory ventilation in moderate-to-severe ARDS: impact on the end-expiratory lung volume, compliance and oxygenationB√©r√©nice Puech, David Vandroux, Arnaud Roussiaux, Dominique Belcour, Cyril Ferdynus, Olivier Martinet, Julien JabotP18 Can we optimize prescription of laboratory tests in surgical intensive care unit (ICU)? Study of appropriateness of careMarion Fresco, Ga√´lle Demeilliers-Pfister, V√©ronique Merle, Val√©ry Brunel, Benoit Veber, Bertrand DureuilP19 Impact of the implementation of guidelines for  laboratory testing in an intensive care unitS√©bastien Leydier, Isabelle Clerc-Urmes, J√©r√©mie Lemarie, Charles-Henri Maigrat, Marie Conrad, Aur√©lie Cravoisy-Popovic, Damien Barraud, Lionel Nace, S√©bastien Gibot, Nelly Agrinier, Pierre-Edouard BollaertP20 Identifying useless precaution to reduce costs in ICUVincent Peigne, Jean-Louis Daban, Mathieu Boutonnet, Guillaume Dumas, Elisabeth Falzone, Patrick Jault, Bernard LenoirP21 The ICU of the teaching hospital of KinshasaJoseph Nsiala Makunza, Nathalie MejeniP22 Security culture and risk management in intensive care units: risk cartography in a French intensive care unitAm√©lie Mazaud, S√©bastien B√©ague, Anne-Flore Rousselle, Alain DurocherP23 Acquiring messages of medical articles according to the reading style: the BIBLIOFLASH multicenter studyRomain Sonneville, Benjamin Sztrymf, Emmanuel Canet, for the BIBLIOFLASH study groupP24 ICU portrayal in social media  channelsPauline Perez, Alexandra Grinea, Nicolas WeissP25 The burnout syndrome in a Tunisian intensive care unit: what is the truth?Hassen Ben Ghezala, Naoures Bedoui, Salah Snouda, Rebeh Daoudi, Moez KaddourP26 Resistance of endotracheal tubes measured after extubation in ICU patientsAlina Stoian, Loredana Baboi, Florent Gobert, Hodane Yonis, Romain Tapponier, Jean-Christophe Richard, Claude Gu√©rinP27 Length of endotracheal tube, humidification system and airway resistance: an experimental bench studyFr√©d√©ric Duprez, Arnaud Bruyneel, Thierry  Bonus, Gr√©gory Cuvelier, Sharam Machayeckhi, Sandra Olieuz, Alexandre LegrandP28  Diagnosis contribution and safety of bronchoalveolar lavage in intensive care unitFatma Feki, Amira Jamoussi, Takoua Merhebene, Emna Braham, Asma Ghariani, Faouzi El Mezni, Leila Slim, Jalila Ben Khelil, Mohamed BesbesP29 Impact of fiberoptic bronchoscopy performed under noninvasive ventilation on the outcome of critically ill patients: a cohort study over 11¬†yearsAntoine Marchalot, Christophe Girault, Gaetan Beduneau, Doroth√©e Carpentier, Steven Grange, Emmanuel Besnier, Gioia Gastaldi, Julien Abily, Marion Beuzelin, Fabienne TamionP30 New single-use flexible bronchoscope dedicated for the invasive mechanical ventilation: a proof of conceptMai-Anh Nay, Adrien Auvet, Julie Mankikian, Virginie Herv√©, Antoine GuillonP31 Incidence of and risk factors for difficult intubation in ICUMarie Soulie, Pierrick Cronier, Elie Kantor, Laura Federici, Marion Gilbert, Ilham Mezhari, G√©rald Choukroun, Sophie MarqueP32 Endotracheal self-extubation in the intensive care unit: a two-year observational studyZ. Coppere, Maxens Decav√®le, Jean-Pierre Fulgencio, Clarisse Blayau, Tai Pham, Muriel Fartoukh, Michel DjibreP33 Criteria to assess extubation readiness and prediction of successful weaningMatthieu Reffienna, Michel Arnaout, S√©bastien Lefort, Anne-Sophie Debue, Fabrice Daviaud, Sarah Cabon, Fr√©d√©ric P√®ne, Julien Charpentier, Alain Cariou, Jean-Paul Mira, Jean-Daniel Chiche, Working Group on Mechanical VentilationP34 Domestic accidents during school holidays in childrenNabil Tabet Aoul, Zakaria Addou, Ali Douah, Mohamed Moussati, Kamel Belhabiche, Nabil AouffenP35 Pediatric ARDS: interest of prone positioning and NAVA ventilation during veno-venous ECMOSylvie Soulier, Philippe Mauriat, Nadir Tafer, Alexandre OuattaraP36 Esogastric pressure measurement as a guide for noninvasive ventilation in unexplained hypercapnic respiratory failure in infantsGuillaume Mortamet, Alessandro Amaddeo, Sonia Khirani, Brigitte FaurouxP37 Experience Of Antibacterial Treatment Of Bone And Joint Sepsis Of Young ChildrenGennadiy Khanes, Olga Liutko, Svitlana BidnenkoP38 Comparison of toxic and septic shocks in childrenSolenn Remy, Emilie Doye, Nicolas Voirin, Delphine Maucort-Boulch, Karine Kolev-Descamp, Guillaume Monneret, Etienne JavouheyP39 Pediatric carbon monoxide poisoning in the Ile-de-France Region, Link between HbCO level and clinical presentationImane El Aouane, Aben Essid, Wallid Hammami,  Isabelle Haegy, Jacques Bataille, Jean BergouniouxP40 Refractory septic shock in  children: an ESPNIC definitionLuc Morin, Samiran Ray, Graeme Maclaren, Etienne Javouhey, Simon Nadel, Martin Kneyber, Mark Peters, Koos Jansen, Daniele De Luca, Clare Wilson, Luregn Schlapbach, Pierre Tissi√®res, The infection, inflammation and sepsis section of the ESPNICP41 Impact of the Leonetti law on end-of-life practices in a French NICU and PICU, from January 2011 to December 2014Anne-Claire Girard, Elodie Savajols, Antoine Burguet, Denis Semama, Stephanie Litzler-RenaultP42 Mortality risk factors for anticoagulant-related bleedingInes  Sedghiani, Hana Fredj, Malek Hassouna, Youssef Zied El Hechmi, Mohamed Ali Cherif, Jerbi ZouheirP43 Management of the polytrauma in the emergency department of CHUOranHouria Mokhtari-Djebli, Soumia Benbernou, Ahmed Dernane, Fouad Bouakkaz, Khalida Bouyacoub, Abdelkader AzzaP44 Realization of a feedback system  of respiratory parameters during CPRLhoucine Ben Taleb, Elmaati Essoukaki, A Zeddine Mouhsen, Aissam Lyazidi, Jean-Christophe Marie Richard, Ahmed Mouhsen, Mohammed Harmouchi, Mourad RattalP45 Burns from French military operations: a 14-year retrospective observational analysisMatthias Huck, Thomas Leclerc, Nicolas Donat, Audrey Cirodde, Jean-Vivien Schaal, Yannick Masson, Cl√©ment HoffmannP46 Drowning in Martinique‚Äîcharacteristics and infectious complicationsDabor Resiere, Laura Cerland, Ruddy Valentino, C Chabartier, Laurent Villain-Coquet, Jean-Louis Ferge, Y Brouste, Bruno Megarbane, Hossein MehdaouiP47 Prevalence, characteristics, and associated factors to physician‚Äôs conflicts in Emergency Department: A multicentric Moroccan studyJihane Belayachi, Maha Louriz, Naoufal Madani, Fatiha Amlaiky, Tarek Dendane, Khalid Abidi, Aicha Zekraoui, Amine Ali Zeggwagh, Redouane AbouqalP48 Serious peripartum complications needing  admission in obstetrical ICU: retrospective study about 127 casesAffra Brahim, Fehmi Ferhi, Hosni Khouadja, Mohamed Amine Bouslama, Khalil Tarmiz, Khaled BenjaziaP49 Epidemiology of suicide in emergency departmentNeila Maaroufi, Abid Zeineb, Dhaouadi MahassenP50 Beneficial cardiovascular effects of O-GlcNAc stimulation in early phase of septic shockJulien Cadiet, Marine Ferron, Valentine Prat, Angelique Erraud, Virginie Aillerie, Mathieu Mevel, Amandine Grabherr, John C. Chatham, Chantal Gauthier, Benjamin Lauzier, Bertrand RozecP51 MiR-21 deficiency increases mortality during experimental septic shockJeremie Joffre, Xavier Loyer, Jean-R√©mi Lavillegrand, Lynda Zeboudj, Ludivine Laurans, Bruno Esposito, Alain Tedgui, Ziad Mallat, Hafid Ait-OufellaP52 Isolated heart rate reduction by ivabradine does not improve cardiac and vascular function in experimental septic shockChaojie Wei, Narimane Al Kattani, Huguette Louis, Sophie Orlowski, Bruno Levy, Antoine KimmounP53 Exploration and modulation of the EGF-R  during experimental septic shockJean-R√©mi Lavillegrand, Lynda Zeboudj, Jeremie Joffre,, Ludivine Laurans,, Bruno Esposito, Alain Tedgui, Pierre-Louis Tharaux, Hafid Ait-OufellaP54 An intravenous omega-3 bolus at reperfusion time improves shock and vascular dysfunction in a myocardial ischemia‚Äìreperfusion rat modelM√©lanie Burban, Gr√©gory Meyer, Anne Olland, Blandine Yver, Florence Toti, Val√©rie Schini-Kerth, Alexandra Monnier, Alexandra Boivin, Pierrick Leborgne, Ferhat Meziani, Julie Boisram√©-HelmsP55 Impact of urantide antagonist of urotensinergic system on myocardial function during a murine model of septic shockEmmanuel Besnier, Thomas Clavier, Mulder Paulus, H√©l√®ne Castel, Vincent Richard, Fabienne TamionP56 Association of dexamethasone and antibodies to poly-Œ≤(1,6)-n-acetyl-glucosamine in prevention and treatment of neonatal bacterial meningitis: an experimental studySt√©phanie Pons, Bruno Mourvillier, David SkurnikP57 Hyperoxemia as a risk factor for ventilator-associated pneumoniaSophie Six, Karim Jaffal, Saad NseirP59 Significance of prior digestive  colonisation with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with ventilator-associated pneumoniaR√©mi Bruy√®re, Clara Vigneron, Audrey Large, Julien Bador, Serge Aho, Sebastien Prin, Jean-Pierre Quenot, Pierre-Emmanuel CharlesP60 Lower respiratory tract colonization in mechanically ventilated patients: Incidence, risk factors and impact on prognosisYosr Touil, Soufia Ayed, Habiba Sik Ali, Najla Tilouch, Houda Mateur, I Talik, Rim Gharbi, Mohamed Fekih Hassen, Souheil ElatrousP61 Epidemiology of ventilator-associated pneumonia in the ICU among patients already hospitalized: early- versus late-onset pneumoniaMathilde Grandperrin, Isabelle Patry, Xavier Bertrand, Jean-Christophe Navellou, Ga√´l Piton, Gilles CapellierP62 Systematic review of inclusion/exclusion criteria, judgment criteria and statistical hypothesis in randomized controlled trials assessing the efficacy of antimicrobials for hospital-acquired and ventilator-associated pneumonia treatmentEmmanuel Weiss, Jean-Ralph Zahar, Christophe Adrie, Wafa Essaied, Martin Wolkewitz, Jean-Fran√ßois TimsitP63 Gram stain identification resulting from blindly inserted telescoping plugged catheter material. Does it contribute to diagnosis and treatment of ventilator-associated pneumonia?Micka√´l Soued, Fabrice Cook, David Lobo, Roman Mounier, Aur√©lie Emirian, Jean Winoc Decousser, Gilles DhonneurP64 Colistin in nosocomial pneumonia in intensive careHanane Ezzouine, Mohamed Toufik Slaoui, Abdellatif BenslamaP65 Bedside tissue perfusion evaluation predicts intradialytic hemodynamic instability in critically ill patientsNa√Øke Big√©, Claire Pichereau, Jean-R√©mi Lavillegrand, Arnaud Galbois, Mikael Alves, Jean-Luc Baudel, Simon Bourcier, Vincent Dub√©e, Jalel Tahiri, Eric Maury, Bertrand Guidet, Hafid Ait-OufellaP66 Evaluation of electrolytes and acid‚Äìbase disorders in patients undergoing citrate-based anticoagulation for continuous renal replacement therapy in intensive care unitBenjamin Delmas, Olivier Joannes-Boyau, Antoine Dewitte, Julien Jabot, Doroth√©e Valance, Nicolas Allou, J√©r√¥me Allyn, Catherine Fleureau,, Alexandre OuattaraP67 Continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a cost study impact of replacement fluids consumptionsElodie Jean-Bart, Floriane Bel., Fabienne Morey, R√©mi Bruy√®re, Nicholas SedillotP68 Acute kidney injury in patients receiving liposomal amphotericin B in an intensive care unit: register of 104 patients from 2008 to 2014Marion Venot, Lucie Biard, Sylvie Chevret, Sandrine Valade, Eric Mariotte, Claire Pichereau, Virginie Lemiale, Elie Azoulay, Emmanuel CanetP69 Regional citrate-based anticoagulation for dummies in continuous venovenous hemofiltration: does it work?Doroth√©e Valance, Richard Galliot, Romain Zunarelli, David Vandroux, Cyril Ferdynus, Bernard-Alex Gauzere, Olivier Martinet, Julien JabotP70 Incidence of and risk factors for acute kidney injury in early postoperative liver transplantation according to AKIN classificationJean-Charles  Cartier, Thomas Jouve, Marie-No√´lle Hilleret, Rebecca Hamidfar-Roy, Claire Ara-Somohano, Cl√©mence Minet, Agn√®s Bonadona, Carole SchwebelP71 Metabolic acidosis uncompensated by kidney in septic patients: a predictive factor for acute kidney injury?Aline Pourcelet, Jean-Michel Hougardy, Pierre Defrance, Patrick Biston, Michael PiagnerelliP72 Blood volume monitoring is useful to predict intradialytic hypotension during intermittent hemodialysisLouis De Laforcade, Alexandre Boyer, Didier Gruson, Benjamin ClouzeauP73 Risk factors for  occurrence of acute kidney injury in diabetic ketoacidosisNajah Hajjam, Ines Sedghiani, Houda Nasri, Hamdi Doghri, Youssef Zied El Hechmi, Mohamed Ali Cherif, Jerbi ZouheirP74 Face-to-face tracheal intubation with the video laryngoscope Airtraq in the sitting patients: a report of 3-year experience in patients after  failed conventional tracheal intubation techniqueGilles Dhonneur, Nicolas Mongardon, Eric Levesque, Hakim HaouacheP75 Ultrasound-guided central venous access technique among French intensivistsMarie-Ana√Øs Bastide, Jack Richecoeur, Eric Frenoy, Christian Lemaire, Bertrand Sauneuf, Fabienne Tamion, Saad Nseir, Damien Du Cheyron, Herv√© Dupont, Julien Maizel, BoReal Study GroupP76 Ultrasound-guided venous catheter insertion. What do French intensivists really do?Hafid Ait-Oufella, Eric Maury, Julien Maizel, Fr√©d√©rique Schortgen, C√©cile Aubron, Christophe Clec‚Äôh, Christophe Guitton, Kada Klouche, Nicolas Lerolle, Fr√©d√©ric P√®ne, Sebastien Preau, Carole Schwebel, Nicolas Terzi, Fr√©d√©ric Vargas,  Vincent CastelainP77 Can we trust new connected devices recording heart rate and  oxygen saturation? A concordance assessment in intensive care unitFranck Ehooman, Yacine Tandjaoui-Lambiotte, Claire Montlahuc, Guillaume Van Der Meersch, Johanna  Oziel, Jean Bardon, Matthieu Resche-Rigon, Nicolas Postel-Vinay, Yves CohenP78 Hemoglobin monitoring with HemoCue¬©, spectrophotometry and blood cells analyzer:  comparison of agreement, completion time and costsMehdi Lafi, Fr√©d√©ric Jacobs, Dominique Prat, Matthieu Le Meur, Olfa Hamzaoui, Anne Sylvie Dumenil, Guy Moneger, Nad√®ge Demars, Pierre Trouiller, Benjamin SztrymfP79 Activated partial thromboplastin time and anti-Xa measurements in heparin monitoring among critical care patientsNo√©mie Tenc√©, In√®s Zaien, Martine Wolf, Pierre Trouiller, Fr√©d√©ric JacobsP80 Agreement between the Point-Of-Care Siemens RAPIDPoint¬Æ 500 Blood gas system and central laboratory measurement of hemoglobin, hematocrit, glucose and  electrolytes in ICU patientsJ√©r√¥me Allardet-Servent, Melissa Lebsir, Christian Dubroca, Mireille Portugal, Matthias Castanier, Thomas Signouret, Guillemette Thomas, Rettinavelou Soundaravelou, Anne Lepidi, Philippe Halfon, Jean-Marie SeghboyanP81 Clinical features and prognosis of pesticide poisoningNeila Maaroufi, Dhaouadi Mahassen, Abid ZeinebP82 Variability of neurobehavioral toxicity of naphyrone, a new synthetic cathinone, according to its acute or binge administrationCamille Gamblin, Nadia Benturquia, Olivier Roussel, Lucie Chevillard, Patricia Risede, Jacques Callebert, Bruno MegarbaneP83 Acute acenocoumarin poisoning: an epidemiological and clinical studyA. M‚Äôrad, Hana Fredj, Messaouda Khelfa, Youssef Blel, H. Thabet, Nozha Brahmi, M. AmamouP84 Death by deliberate self-poisoning in Sfax, Tunisia: Victims characteristics and  toxic substance profileYoussef¬†Nouma, Wiem¬†Ben Amar, Sami¬†Bardaa, Karama¬†Regaieg, Kaouthar¬†Jammeli, Mabrouk¬†Bahloul, Zouheir¬†Hammami, Maatoug¬†SamirP85 Adverse drug reactions (ADRs) collected by medical-staffed ambulances: pilot studyA. Lillo-Le  Lou√´t, F. Baud, C. Le Beller, B. Vivien, L. Soufir, P. Carli and H. Le Lou√´tP86 Prognostic value of plasma concentration of acebutolol in acute poisoningA. M‚Äôrad, Youssef Blel, Fatma Essafi, Nasreddine Foudhaili, Abdelaziz Ben Slimen, Nozha Brahmi, M. AmamouP87 Baseline pharmacologic treatment for patients admitted in ICU for AECOPD: trends in use and conformity to the GOLD guidelinesIslem Ouanes, Rami Jabla, Hedia Hammed, Mahdi Marzouk, Nesrine Boujelbene, Fahmi Dachraoui, Asma Hachani, Saousen Ben Abdallah, Hend Ben Lakhal, Chaima Ghribi, Imen Ben Ali, Imen Abdellaoui, Lamia Ouanes-Besbes, Fekri AbrougP88 Blood eosinophils levels and acute exacerbations of COPDIslem Ouanes, Asma Hachani, Lamia Ouanes-Besbes, Saousen Ben Abdallah, Rami Jabla, Hedia Hammed, Mahdi Marzouk, Hend Ben Lakhal, Imen Ben Ali, Imen Abdellaoui, Chaima Ghribi, Fahmi Dachraoui, Fekri AbrougP89 POFE: postoperative outcomes of chronic obstructive pulmonary disease (COPD) frequent exacerbators after pulmonary resection‚Äîa pilot  studySuela Demiri, Christine Lorut, Van Lang, Daniel Luu, Antoine Rabbat, Aur√©lie Lefebvre, Marco Alifano, Jean-Francois Reignard, Marc Samama, Daniel Dusser, Nicolas RocheP90 Optimal delivery of salbutamol with a pressurized metered-dose inhaler within a high-flow nasal therapy circuitFran√ßois R√©miniac, Cassandre Landel, Samuel Gensburger, Thomas Bocar, Lydiane Mordier, Marion Philippe, D√©borah Le Pennec, Laurent Vecellio, Stephan EhrmannP91 Differences in perceptions between the various healthcare professionals working at the bedside of the risks related to the rehabilitation proceduresLaurent Poiroux, David Thevoz, Julien Simons, Cheryl Hickmann, Jean Roeseler, Anth√©a Loiez, St√©phanie G√©rard, Nicolas Dousse, Tai Pham, Nicolas Terzi, Lise PiquilloudP92 Early rehabilitation in critically ill patients: a prospective multicenter assessment of real-life practiceLorraine Ducroux, Sylvie L‚Äôhotellier, Elodie Baumgarten, St√©phanie Borschneck, Francis Schneider, Vincent CastelainP93 Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock: report of nine casesGuillaume H√©kimian, Nicolas Brechot, Matthieu Schmidt, Fatima Kharcha,  C√©cile Ghander, Guillaume Lebreton, Christophe Tresallet, Jean Louis Trouillet, Pascal Leprince, Alain Combes, Charles-Edouard LuytP94 Mortality related to cardiogenic shock in critically ill patients in France, 1997‚Äì2012Etienne Puymirat, Jean-Yves Fagon, Philippe Aegerter, Florence Boissier, Jean-Luc Diehl,  Caroline Hauw-Berlemont, Bertrand Guidet, Gilles Chatellier, Nicolas Danchin, Nadia AissaouiP95 Benefits of extracorporeal life support (ECLS) in elderly patients with postcardiotomy refractory cardiogenic shockNadia Aissat, R. Bernard, Guillaume Lebreton, Dimitri Margetis, Julien Amour, Pascal Leprince, Adrien Bougl√©P96 Heart transplantation versus ventricular assist device: which therapy for patients with refractory cardiogenic shock?Charles Vidal, Guillaume Lebreton, Djavidi Nima, Varnous Shaida, Adrien Bougl√©, Pascal Leprince, Julien AmourP97 Refractory cardiogenic shock in immunocompromised patients rescued by veno-arterial extracorporeal membrane oxygenationAmandine Dorget, Nicolas Br√©chot, Guillaume Lebreton, Guillaume Hekimian, Ania Nieszkowska, Charles-Edouard Luyt, Pascal Leprince, Jean Louis Trouillet, Alain Combes, Matthieu SchmidtP98 Which index severity to use in obstetric medium? (Comparison  of 4 scores)Rabi Toufiki, Youssef Mouaffak, Ahmed Rhassan El Adib, M. AmineP99 Maternal mortality in obstetric department of UH IBN ROCHD, Casablanca, MoroccoKamal Belkadi, I. Moussaid, Chaigar Mohammed Cheikh, S. Moumine, S. El Youssoufi, S. SalmiP100 Disseminated intravascular coagulation in pregnant women: evaluation of a new scoreMarie Jonard, Anne Sophie Ducloy-Bouthors, Fran√ßois FourrierP101 Validity of severity scores in critically ill obstetric patientsFatma Kaaniche Medhioub, Anis Chaari, Olfa Turki, Kais Rgieg, Mabrouk Bahloul, Hmida Chokri Ben, Bouaziz MounirP102 Evaluation of a neuromuscular blockade with benzylisoquinoliniums: a comparison of a train of four with a clinical assessmentPierre Bouju, Nicolas Barbarot, Arnaud Gacouin, Fabrice Uhel,  Julien Letheulle, Pierre Fillatre, Guillaume Grillet, Ang√©lique Goepp, Jean-Marc  Tadi√©, Yves Le TulzoP103 The use of enteral route for drug administration in the  ICU is dimly rationalAnne-Laure Clairet, Gilles Capellier, Samuel Limat, Christian Cornette, Ga√´l PitonP104 Microcirculatory effects of norepinephrine in  septic shock: a muscle microdialysis studyAmira Fatnassi, Zied Hajjej, Chiheb Romdhani, Walid Sammoud, Iheb Labbene, Mustapha FerjaniP105 Administration of drugs per os by stomach tube for enteral feeding in surgical ICUHind Taibi, Ijlal Elatiqi, A Iraqui, Rachid Cherkab, Wafae Haddad, Chafik Elkettani, Lahoucine BarrouP106 Implementation of an intensive care follow-up clinicFabien Cave, Alain Mercat, Nicolas LerolleP107 Needs assessment of adults post-intensive care rehabilitation department in Amiens University HospitalGaelle Bacari-Risal, Pierre Louis Doutrellot, Benoit Vaysse, M. Inan, K. Khelfoun, M. Nasserallah, Julien Maizel, C. Legrand-Monteil, S. Tasseel-PoncheP108 Factors of degradation on independence and quality of life at 3 and 6¬†months after stay in intensive care unitBenjamin Kowalski, Anne Guaguere, Claire Boulle-GeronimiP109 Octavie: Epidemiological study of mortality and autonomy 3 and 6¬†months after ICU stay for very elderly patientsJuliette Masse, Cl√©ment Vanbaelinghem, Patrick HerbecqP110 Analysis of burn injuries in the elderlyAmel Mokline, Syrine Draief, Lazhari Gharsallah, Imen Rahmani, Bahija Gasri, Sofiene Tlaili, Rym Hammouda, Amen Allah  MessadiP111 ICU admission criteria for patients 85¬†years and olderPhilippe Michel, Bruno Gel√©e, Fouad Fadel, Marie ThuongP112 Facteurs pronostiques chez les patients √¢g√©s admis en r√©animation m√©dicale. Prognostic factors in elderly patients admitted in medical intensive careSandra Ait-Aoudia, Salima Laddi, Mohamed-Mohcen SahraouiP113 Uncontrolled donation after circulatory determination of death: 42¬†months of experience in a general hospitalCl√©mence Fauch√©, Samuel Gay, Michel Muller, Anna Faucher, Olivier Skowron, Albrice Levrat, Didier DorezP114 Epidemiology of long stays in ICUBertrand Hermann, Caroline Hauw Berlemont, Alexandra Monnier, Florence Boissier, Nadia Aissaoui, Jean-Yves Fagon, Jean-Luc Diehl, Emmanuel Gu√©rotP115 Are daily sedation stops safe in a medical ICU?Michel Arnaout, Julien Charpentier, Benoit Champigneulle, Julie Busson, Anne-Sophie Debue, Julie Dhumeaux, Guillaume Geri, Wulfran Bougouin, Nicole Ericher, S√©bastien Lefort, Pierre Lucas, Alain Cariou, Jean-Paul Mira, Fr√©d√©ric P√®ne, Jean-Daniel Chiche, Groupe de travail sur la ventilationP116 Delay in awakening after stopping continuous sedation in critically ill patients: incidence, risk factors and impact on ventilator weaningMagalie Dumas, Celine Chapelle, Benedicte Philippon-Jouve, Jerome Morel, Pascal BeuretP117 Risk factors and prognosis impact of decreased patient‚Äìventilator synchrony in mechanically ventilated patients‚Äîa prospective studyC√¥me Bureau, Camille Rolland-Debord, Tymoth√©e Poitou, Marc Clavel, S√©bastien Perbet, Nicolas Terzi, Achille Kouatchet, Thomas Similowski, Alexandre Demoule, Universit√© Paris 6‚ÄîPierre et Marie Curie and Institut National pour la Sant√© et la Recherche M√©dicale, UMRS1158, ParisP118 High-flow oxygen therapy through a nasal cannula versus noninvasive ventilation versus in immunocompromised patients with acute respiratory failureRemi Coudroy,  Ang√©line Jamet, Philippe Petua, Ren√© Robert, Jean-Pierre Frat, Arnaud, W. ThilleP119 The use of dexmedetomidine in patients with noninvasive ventilation: a preliminary studyHassen Ben Ghezala, Salah Snouda, Rebeh Daoudi, Moez KaddourP120 Comparison of tolerance of 4 interfaces for preventive noninvasive ventilation after abdominal surgery in intensive care units assessed by patients and caregiversAudrey De Jong, Albert Prades, Marion Monnin, Martin Mahul, Marion Basty, Cl√©ment Monet, Benjamin Mounet, Emmanuel Futier, G√©rald Chanques, Samir JaberP121 Dexmedetomidine, new approach in sedation analgesia: a prospective and  observational study of mechanically ventilated patients in adults intensive care  units in a university hospital during the first year of useAudrey Leroux, Xavier  Oudinot, Ga√´lle Demeilliers-Pfister, Marc LaurentP122 Pain, confusion, and agitation associated with noninvasive ventilationNesrine Boujelbene, Rami Jabla,  Fahmi Dachraoui, Islem Ouanes, Saousen Ben Abdallah, Mahdi Marzouk, Asma Hachani, Hedia Hammed, Hend Ben Lakhal, Imen Ben Ali, Chaima Ghribi, Imen Abdellaoui, Lamia Ouanes-Besbes, Fekri AbrougP123 Impact of metformin on prognosis of ICU patientsSebastien Jochmans, Jean-Emmanuel Alphonsine, Ly Van Vong, Nathalie Rolin, Oumar Sy, Jean Serbource-Goguel, Jonathan Chelly, Olivier Ellrodt, Mehran  Monchi, Christophe VinsonneauP124 Serum cholinesterase activity in the diagnosis  of septic shock due to bacterial infections: a new specific biomarker of sepsisMabrouk Bahloul, Turki Olfa, Najeh Baccouche, Kais Regaieg, Chtara Kamilia, Benhamida Chokri, Hedi Chelly, Mounir BouazizP125 Is hyperoxaemia a rare event during septic shock patients management?Am√©lie Trichot, Gwenha√´l Colin, Jean-Baptiste Lascarrou, Isabelle Vinatier, Konstantinos Bachoumas, Jean-Claude Lacherade, Maud Fiancette, Aur√©lie Joret, Aihem Yehia, Christine Lebert, Matthieu Henry-Laguarrigue, Laurent Martin-Lef√®vreP126 Myocardial depressant factor during human septic shock: screening of twenty-three cytokines and chemokinesKeyvan Razazi, Florence Boissier, Mathieu Surenaud, Alexandre Bedet, Nicolas de Prost, Aurelien Seemann, Christian Brun-Buisson, Sophie H√ºe, Armand Mekontso-DessapP127  Plasma of septic shock patients modifies in vitro mitochondrial respiration of human PBMC as well as lymphocytes and monocytes cell linesRapha√´l Clere-Jehl, Julie Boisram√©-Helms, Anne-Laure Charles, Pierrick Leborgne, Xavier Delabranche,  Bernard Geny, Ferhat Meziani, Pascal BilbaultP128 Assessment of skin endothelial  functions during severe infectionsSimon Bourcier, Claire Pichereau, Vincent Dub√©e, Gabriel Lejour, Jean-Luc Baudel, Arnaud Galbois, Jalel Tahiri, Na√Øke Big√©, Eric Maury, Bertrand Guidet, Hafid Ait-OufellaP129 Toe-to-Room temperature gradient correlates with tissue perfusion and predicts outcome during septic shockSimon Bourcier, Claire Pichereau, Pierre Yves Bo√™lle, Nemlaghi Safaa, Vincent Dub√©e, Gabriel Lejour, Jean-Luc Baudel, Arnaud Galbois, Jean-R√©mi Lavillegrand, Na√Øke Big√©, Jalel Tahiri, Eric Maury, Bertrand Guidet, Hafid Ait-OufellaP130 Determination of HLA-DR expression on monocytes in heart recipients and clinical outcome correlationSylvie Paulus, Claire Flamens, Guillaume Monneret, Julie Demaret, Jean NeideckerP131 Nosocomial infections in neonates under ECMOJerome Rambaud, Cecile Allioux, Romain Guedj, Isabelle Guellec, Julia Guilbert, Pierre-Louis Leger, Maryne Demoulin, Am√©lie Durandy, Sandrine Jean, Ricardo CarbajalP132 Point-of-care ultrasound in pediatric and neonatal intensive care units: prospective, observational transversal studyAur√©lie Morand, Laurent Zieleskiewicz, Olivier Brissaud, St√©phane Le Bel, Mickael Afanetti, Zo√© Meresse, Astrid Botte, Michel Panuel, Laurent Thomachot, Jean-Michel Constantin, Marc Leone, Fabrice MichelP133 Use of continuous infusion of clonidine for sedation in critically ill children: indications, efficacy and side effectsAnna Deho‚Äô, La√Øly Sadozai, St√©phane Dauger, Sonia Prot-LabartheP134 Pharmacokinetic analysis of continuous infusion vancomycin therapy in critically  ill childrenMathieu Genuini, Mehdi Oualha, Moulin Florence, Jean-Marc Treluyer, Fabrice Lesage, Sylvain RenolleauP135 Incidence of central venous catheter-associated bacteraemia in a paediatric intensive care unitEmmanuelle Chalavon, Claire Le Reun, Rodrigue Dessein, Bruno Grandbastien, Alain Duhamel, Sarah Pesin, Fran√ßois Dubos, St√©phane LeteurtreEmmanuelle Chalavon, Claire Le Reun, Rodrigue Dessein, Bruno Grandbastien, Alain Duhamel, Sarah Pesin, Fran√ßois  Dubos, St√©phane LeteurtreP136 Outcome at 2¬†months at the infectious level of the  pediatric central venous catheters: prospective evaluation of the guidelines optimization impactMarie-Aude Puel, Marie Szulc, Anais Philippe, Fran√ßois Severac, Dominique Astruc, Pierre Kuhn, Philippe DesprezMarie-Aude Puel, Marie Szulc, Anais Philippe, Fran√ßois Severac, Dominique Astruc, Pierre Kuhn, Philippe  DesprezP137 Ten years of intensive care in children hospital in Oran, AlgeriaNabil Tabet Aoul, zakaria addou, Ali Douah, Mohamed Moussati, Kamel Belhabiche, Nabil AouffenNabil Tabet Aoul, zakaria addou, Ali Douah, Mohamed Moussati, Kamel Belhabiche, Nabil AouffenP138 High-frequency percussive ventilation during neonatal transportation: a pilot studyBeno√Æt Colomb, Karine Kolev-Descamp, Anne Marie Petion, Laurent Queudet, Elodie Savajols, Stephanie Litzler-Renault, Denis SemamaP139 Lymphopenia after severe infectious shock in children: association with severity and risk for nosocomial infectionEmilie Doye, Solenn Remy, Nicolas Voirin, Delphine Maucort-Boulch, Karine Kolev-Descamp, Guillaume Monneret, Etienne JavouheyP140 Importance of troponin evaluation in scorpion envenomation in pediatric intensive care unitMouaffak YoussefP141 Hyperosmolar therapy in pediatric traumatic brain injury: a retrospective studyNadia Roumeliotis, Christian Dong, Geraldine Pettersen, Louis Crevier, Guillaume EmeriaudP142 Cerebral sinovenous thrombosis in children: report of seven casesMouaffak YoussefP143 Optimising nurse confidence and skill acquisition in paediatric continuous renal replacement therapy (pCRRT) through a training programme: result of the first-year experience in a tertiary care centreJ√©r√¥me Naudin, Laetitia Abdallah, Marion Ganier, Karine Frannais, Dylia Douglas, Cecile  Flusin, Anna Deho‚Äô, St√©phane DaugerP144 From high-quality electronic database to  the new concept of perpetual patient. Preliminary resultsDavid Brossier, Redha Eltaani, Micha√´l Sauthier, Guillaume Emeriaud, Bernard Guillois, Philippe JouvetP145 Transportation of children on extracorporeal membrane oxygenation: 1-year experience of a tertiary referral center in the Paris regionJerome Rambaud, Pierre-Louis Leger, Michelle Larroquet, Alain Amblard, Noella Lode, Julia Guilbert, Sandrine Jean, Isabelle Guellec, Isabelle Casadevall, Katia Kessous, Herv√© Walti, Ricardo CarbajalP146 Acute neurotoxicity of bath salts combining 3,4-methylenedioxypyrovalerone and mephedrone in the ratChristophe Poir√©, Nadia Benturquia, Olivier Roussel, Lucie Chevillard, Patricia Risede, Jacques Callebert, Huixiong Chen, Bruno MegarbaneP147 Acute organophosphate poisoning: what about pralidoxime use?A. M‚Äôrad, Sahar Habacha, Bassem Chatbri, Youssef Blel, H Thabet, Nozha Brahmi, M. AmamouP148 Acute nifedipine poisoning: clinical and prognosis aspectsA. M‚Äôrad, Fatma Essafi, Nasreddine Foudhaili, Youssef Blel, H. Thabet, Nozha Brahmi, M. AmamouP149 Acute behavioral toxicity and addictive liability of the new synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV) in the ratCyril Masniere, Nadia Benturquia, Olivier Roussel, Lucie Chevillard, Patricia Risede, Jacques Callebert, Bruno MegarbaneP150 Clinical and therapeutic characteristics of metformin poisoningA. M‚Äôrad, Messaouda Khelfa, Hana Fredj, Youssef Blel, H. Thabet, Nozha Brahmi, M. AmamouP151 Calcium channel blockers poisoningSamar Souissi, Hatem El Ghord, N. Kouraichi, N. Brahmi, H. Thabet, M. AmamouP152 Characteristics and outcomes in patients with community-acquired pneumonia admitted to intensive care unitTakoua  Marhb√®ne, Islam Mejri, Amira Jamoussi, Douha Lakhdar, Asma Ghariani, Leila Slim,  Jalila Ben Khelil, Mohamed BesbesP153 Comparison of characteristics and outcomes  of pneumococcal community-acquired pneumonia versus other pathogensTakoua T. Merhabane, H√©la Maamouri, Amira Jamoussi, Asma Ghariani, Leila Slim, Jalila Ben Khelil, Mohamed BesbesP154 Outcome of L. pneumophila pneumonia and risk factors for ICU admissionOestreicher Charlotte, Helena Wegelius, Caroline Landelle, Jacques Schrenzel, Laurent Kaiser, J√©r√¥me PuginP155 The descending necrotizing mediastinitis: report of 60 casesHind BelhadjP156 Characteristics, mortality risk factors and therapeutic approach of ARDS in patients with severe leptospirosis in Reunion IslandPaul Chanareille, Julien Jabot, Benjamin Delmas, Arnaud Roussiaux,  Cyril Ferdynus, Bernard-Alex Gauzere, Olivier Martinet, David VandrouxP157 Characterization of organ dysfunction in severe leptospirosisAd√©lie Ladureau, Alice Sanna, Am√©lie Rolle, Bertrand Pons, Pascale Piednoir, Fanny Ardisson, Fr√©d√©ric Martino, Thomas Bernos, Khalid Elkoun, Elie Elain, Roland Lawson, Matthieu Resh-Rigon, Sophie Belorgey, Guillaume ThieryP158 Report of experience:  management of a pre-XDR and XDR-TB population hospitalized in a medical ICUCaroline Hauw Berlemont, Cyprian Pricopi, Florence Boissier, Alexandra Monnier, Fran√ßoise Barthes, Jean-Luc Diehl, Jean-Yves Fagon, Emmanuel Gu√©rotP159  Benefit of magnesium sulfate for tetanus management in adults: case of the provincial general referral hospital of KinshasaThansya Doddie, Mj Nsiala, Nh Situakibanza, Be Amisi, Mj Kazadi, Ma KilembeP160 Ebola fever outbreak: questioning the delivery of careChristophe Clement, Fran√ßois LamontagneP161 Marked decrease in the incidence of ventilator-associated pneumonia using a bundle of care containing selective oropharyngeal decontaminationBoyer, Val√©rie Nocquet, Caroline Landelle, S√©bastien Naimo, Ronan Raulais, Emilie Genevois, Lucie Bouchoud, Filippo Boroli, Nour Abidi, Mohamed Abbas, Stefan Harbarth, J√©r√¥me PuginP162 Ventilator-associated pneumonia prevention by oral care improvement: a before‚Äìafter studyPierre-Emmanuel Charles, Caroline Dereux, Audrey Large, R√©mi Bruy√®re, Sebastien Prin, Julien Bador, Jean-Pierre QuenotP163 Impact  of a multifaceted bundle ventilator-associated pneumonia prevention program in a  secondary care medical‚Äìsurgical intensive care unitStanislas De Guillebon, Eloise Morisse, Julie France, Deborah Gasser, Philippe Badia, Walter PicardP164 Daily chlorhexidine bathing in a medical intensive care unit: effects on healthcare-associated infections and on acquisition of multidrug-resistant bacteriaP. Corne, Nicolas Molinari, I. De Boulastel, S. Seguin, A. Blasco, V. Ledur, Olivier Jonquet, Kada KloucheP165 Impact of twin bedrooms intensive care unit on the epidemiology of extended-spectrum beta-lactamase-producing enterobacteriaceaePaktoris-Papine Sophie, Margaux Artiguenave, Faten El Sayed, Florence Espinasse, Aur√©lien Dinh, Cyril Charron, Xavier Repess√©, Antoine Vieillard-BaronP166 Prophylactic confinement after liver transplant: a necessity  or a useless precaution?Benjamin Lebas, Sophie Hatsch, Quentin Maestraggi, Anne-Florence Dureau, Vincent Castelain, Bernard Ellero, Fran√ßois Faitot, Max Guillot, Francis SchneiderP167 Proteomic response and adaptation mechanisms of E. coli 536 to overcome the inhibitory effect of cranberry proanthocyanidinsDimitri  Margetis, Odile Bouvet, Didier Chevret, Didier Dreyfuss, Erick Denamur, Jean-Damien RicardP168 Is daily measurement of CRP useful to detect earlier ventilator-associated pneumonia?Justine Simonet, Mathieu Boutonnet, Jean-Louis Daban, Elisabeth Falzone, Guillaume Dumas, Philippe Vest, Vincent PeigneP169 Clinical and biological features of healthcare-associated coagulase-negative Staphylococci meningitis: results of a retrospective studySeverine Couffin, David Lobo, Gilles Dhonneur, Roman MounierP170 Prognostic value of electrocardiographic abnormalities in patients with acute pulmonary embolismM. Cheikh Bouhlel, Ahmed Khedher, Kaoula Meddeb, A. Azouzi, Y. Hamdaoui, Jihene Ayachi, W. Brahim, Rania Bouneb, Mohamed BoussarsarP171 Does mean arterial pressure alarm improve the time spent within blood pressure target range in septic shock? A before and after studyNans Florens, Martin Cour, Julie Var√©on, Arnaud Malatray, Romain Hernu, Laurent ArgaudP172 Respiratory change of pulse pressure is not indicative of preload reserve in cardiac surgery patientsPierre Dupland, Thomas D‚Äôhumi√®res, Romain Vergier, Pauline Issaurat, Philippe Estagnasi√©, Pierre Squara, Alain BrussetP173 Importance of diastolic arterial pressure to optimize pulse pressure  variation performances for patients receiving norepinephrineVincent G√©nin, David  Vandroux, Cyril Ferdynus, Arnaud Roussiaux, J√©r√¥me Allyn, Nicolas Allou, Olivier  Martinet, Julien JabotP174 Multi-parameter monitoring for tissue perfusion in septic shock: correlations between macrohemodynamic and metabolic parameters: Preliminary resultsAli Jendoubi, Rifka Jlassi, Bassem Hamrouni, Yahia Marzougui,  Jihen Kouka, Salma Ghedira, Mohamed HouissaP175 Correlation between changes in levels of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) and weight before and after dialysisKaouther Dhifaoui, Zied Hajjej, Walid Sammoud, Iheb Labbene, Mustapha FerjaniP176 Impact of colonization with multidrug-resistant bacteria on  the outcome of patients with hematological malignancies admitted to the intensive care medicineJohanna Oziel, Carole Schwebel, Elie Azoulay, Micha√´l Darmon, Bertrand Souweine, Lila Bouadma, Guillaume Marcotte, Christophe Clec‚Äôh, Yves Cohen, Outcomerea Study GroupP177 ICU moving followed by a drop of imipenem-resistant Pseudomonas aeruginosaAlexy Tran Dinh, Caroline Neulier, Marl√®ne Amara, Nicaise Nebot, Gilles Troch√©, Nelly Breton, Benjamin Zuber, S√©bastien Cavelot, B√©atrice Pangon, Jean Pierre Bedos, Jacques Merrer, David GrimaldiP178 Risk factors of carbapenem resistance acquisition in intensive care  unitFran√ßois Labaste, Jean-Marie Conil, Julia Grossac, St√©phanie Ruiz, Marion Grare, Olivier Fourcade, Vincent Minville, Bernard GeorgesP179 Risk factors for subsequent infection among patients with extended-spectrum beta-lactamase-producing enterobacteriaceae colonization: a retrospective studyGuillaume Van Der Meersch, Johanna Oziel, Yacine Tandjaoui-Lambiotte, Fr√©d√©ric Gonzalez, Philippe Karoubi, Christophe Huang, Christophe Clec‚Äôh, Yves CohenP180 Is rectal colonisation predictive of extended-spectrum Œ≤-lactamase-producing enterobacteriaceae presence in respiratory samples performed in the intensive care unit?Helene Carbonne, Matthieu Le Dorze, Rishma Amarsy, Joaquim Mateo, Didier Payen de la GaranderieP181 Antibiotic therapy in intensive care unit patients: appraisal of medical attitude related to therapy appropriateness, severity of infection and outcomeSophie Leloup Von Edelsberg, Christelle Vercheval, Monique Nys, Pierre DamasP182 Epidemiology and associated factors of ICU-acquired infections in critically ill patients: a prospective cohort studyZied Hajjej, Chaker Bouguerra, Noura Naas, Walid Sammoud, Iheb Labbene, Mustapha FerjaniP183 The impact of nosocomial infection acquired in intensive care units on mortality and length of stay until hospital discharge: a  retrospective, monocentric, 10-year studyJoris Muller, Fran√ßois Severac, Mickael  Schaeffer, Pierre Tran Ba Loc, St√©phanie Deboscker, Maleka Schenck, Marie-Line Harley, Ralf Janssen-Langenstein, Jean-Etienne Herbrecht, Benjamin Lebas, Max Guillot, Vincent Castelain, Francis Schneider, Thierry LavigneP184 Incidence and  prognosis of catheter-associated urinary tract infections in intensive care unit: the IPRIUS studyJennifer Brunet, Bertrand Canoville, C√©dric Daubin, Am√©lie Seguin, Nicolas Terzi, Xavier Valette, Pierre Verrier, Damien Du CheyronP185 Automatic tube compensation during mechanical ventilation in ICU patients. Meta-analysis of trials on weaning outcome and physiologic effectsAlina Stoian, Claude Gu√©rinP186 Automated oxygen titration during high-flow oxygen therapy. Evaluation of the feasibility in healthy subjectsFran√ßois Lellouche, Erwan L‚Äôher, Pierre Alexandre Bouchard, Mathieu Delorme, Tamer Elfaramawy, Benoit GosselinP187 Accuracy of ventilators for intermediate care to deliver tidal volume. A bench studyClaude Gu√©rin, Loredana Baboi, Sarah Guegan, Fabien SubtilP188 Efficiency of ventilators for intermediate care to deliver adequate FIO2. A bench studyClaude Gu√©rin, Loredana Baboi, Fabien Subtil, Sarah GueganP189 In vitro comparison of inspiratory-synchronized and continuous nebulization modes during noninvasive ventilation: analysis of inhaled and lost dosesJean-Bernard Michotte, Enrico Staderini, Jonathan Dugernier, Rares Rusu, Jean Roeseler, Giuseppe Liistro, Gregory ReychlerP190 Short-term physiological effects of nasal high flow in patients with respiratory distress. Impact of flow rates on the work of breathingMathieu Delorme, Pierre Alexandre Bouchard, Mathieu Simon, Fran√ßois LelloucheP191 Design and implementation of an active artificial lungElmaati Essoukaki, Lhoucine Ben Taleb, Mohammed Harmouchi, Mourad Rattal, Ahmed Mouhsen,  Jean-Christophe Marie Richard, A Zeddine Mouhsen, Aissam LyazidiP192 Assessment of the accuracy of ventilator simulation softwaresFr√©d√©ric Duprez, Jean Bernard Michotte, Olivier Contal, Thierry Bonus, Sandra Olieuz, Gr√©gory Cuvelier, Sharam  MachayeckhiP193 Outcome and early prognostic factors in neutropenic patients admitted to the intensive care unitBecem Trabelsi, Zied Hajjej, Walid Sammoud, Hedi Garsallah, Mustapha FerjaniP194 Blood loss and transfusion practice in medical surgical intensive care unit: 1-year studyWalid Sammoud, Zied Hajjej, Khaoula Harira, Hedi Garsallah, Mustapha FerjaniP195 Atypical hemolytic and uremic syndrome in critically ill adult patientsElie Azoulay, Akli Chermak, C√©dric Rafat, Claire Pichereau, Emmanuel Canet, Virginie Lemiale, Valade Sandrine, Marion Venot, Beno√Æt Schlemmer, Eric MariotteP196 Outcome of critically ill patients after allogeneic hematopoietic stem cell transplantation: comparison of cord blood cells with others cells as hematopoietic stem cells sourceCaroline  Le Jeune, Florent Wallet, Pascal Roy, Laurent Argaud, Mauricette MichalletP197 Outcome of patients with organ failures related to solid malignancies and receiving chemotherapy in the intensive care unitYoann Zerbib, Julien Maizel, Na√Øke Big√©, Benoit Misset, Nicolas de Prost, Virginie Lemiale, Sylvie Ricome, Fran√ßois Baudin, Muriel Fartoukh, Fr√©d√©ric Jacobs, Fran√ßois Blot, Matthieu Schmidt, Antoine Rabbat, Julien Mayaux, Fr√©d√©ric Gonzalez, Caroline Bornstain, Elie Azoulay, Fr√©d√©ric P√®neP198 Characteristics and outcomes of patients with hematological malignancies (HMs) admitted to the intensive care unitSt√©phanie Gelinotte, Doroth√©e Carpentier, Steven Grange, Julien Abily, Marion Beuzelin, Emmanuel Besnier, Gioia Gastaldi, Gaetan Beduneau, Jean-Philippe Rigaud, Christophe Girault, Fabienne TamionP199 Influence of neutropenia on mortality of  critically ill cancer patients: Results of a systematic review and meta-analysis  of available evidencesMarie Bouteloup, Sophie Perinel Ragey, Elie Azoulay, Djamel Mokart, Micha√´l Darmon, Groupe de Recherche en R√©animation Respiratoire et Onco-Hematologique (GRRROH)P200 Thrombotic Microangiopathy (TMA) Syndromes in the ICU: experience of a Tunisian ICUJihene Ayachi, Ahmed Khedher, Kaoula Meddeb, A.  Azouzi, Y Hamdaoui, H. Nouira, Rania Bouneb, Mohamed BoussarsarP201 ‚ÄúImmunonutrition‚Ä? failed to improve septic shock-induced vascular dysfunction in  a rat modelJulie Boisram√©-Helms, Gr√©gory Meyer, Su Degirmenci, M√©lanie Burban, Val√©rie Schini-Kerth, Alexandra Boivin, Rapha√´l Clere-Jehl, Alexandra Monnier, Christine Kummerlen, Ferhat MezianiP202 PTP1B gene deletion improves glucose metabolism and limits cardiovascular dysfunction in experimental septic shockEug√©nie Delile, Pierre-Alain Thi√©baut, Jean-Claude Do Rego, David Coquerel,  R√©mi Nevi√®re, Vincent Richard, Fabienne TamionP203 Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitisLaure Ichou, Nicolas Carbonell, Pierre-Emmanuel Rautou, Ludivine Laurans, Simon Bourcier, Claire Pichereau, Jean-Luc Baudel, Jean-Baptiste Nousbaum, Christophe Renou, Rodolphe Anty, Jacques Tankovic, Eric Maury, Bertrand Guidet, Luce Landraud, Hafid Ait-OufellaP204 Modulation of inflammatory response related to severe peritonitis by polymyxin-B  hemoperfusionRemi Coudroy, Jean-Claude Lecron, Didier Payen de la Garanderie, Ren√© Robert, ABDOMIX GroupP205 Descriptive study of ultrasonographic data inside  a surgical intensive care unit for cholestasis diagnosis: dechorea studyMichael Helary, Jonathan Paillot, Sebastien Pili-FlouryP206 In-hospital mortality and predictive risk factors for patients with cirrhosisSana Khedher, Amira Maoui, Asma Ezzamouri, Mohamed SalemP207 CONSTIPREA: evaluation of the management of constipation in intensive care‚ÄîNational Survey of French intensivitsLamia Kerdjana, Mihaela Dumitrescu, Olivier Mimoz, Bertrand Debaene, Virginie Migeot, Claire Dahyot-FizelierP208 Corrosive ingestion in adults: endoscopic findings and agents involvedSana Khedher, Asma Ezzamouri, Amira Maoui, Mohamed Salem, Amira A. MaouiP209 Hypoxic hepatitis after out-of-hospital cardiac arrest: incidence, determinants and prognosisBenoit Champigneulle, Guillaume Geri, Wulfran Bougouin, Florence Dumas, Michel Arnaout, Lara Zafrani, Fr√©d√©ric P√®ne, Julien Charpentier,  Jean-Paul Mira, Alain CariouP210 Aspiration pneumonitis in comatose patients treated with invasive mechanical ventilation. The SPIRE prospective surveyJean-Baptiste Lascarrou, Floriane Lissonde, Aur√©lie Le Thuaut, Konstantinos Bachoumas, Gwenha√´l Colin, Matthieu Henry-Laguarrigue, Maud Fiancette, Jean-Claude Lacherade, Christine Lebert, Isabelle Vinatier, Aihem Yehia, Aur√©lie  Joret, Laurent Martin-Lef√®vre, Jean ReignierP211 Ventilator-associated pneumonia  (VAP) in cancer patients: impact of 1-year survivalLaura Platon, Jer√¥me Lambert,  David Lagier, Jeanpaul Brun, Antoine Sannini, Laurent Chow-Chine, Magali Bisbal,  Marion Faucher, Djamel MokartP212 High-resolution computed tomography (HRCT) patterns in patients with pneumocystis pneumoniaLe√Øla Mourtada, Lemiale Virgnie,  Claire Givel, Valade Sandrine, Claire Pichereau, Emmanuel Canet, Eric Mariotte, Elie AzoulayP213 Plasma endocan predicts the occurrence of acute respiratory distress syndrome (ARDS) in severe sepsis and septic shock patientsAlexandre Gaudet, Erika Parmentier-Decrucq, Nathalie De Freitas Caires, Sylvain Dubucquoi,  Philippe Lassalle, Daniel MathieuP214 Comparison of 3 diagnostic methods to identify fluid responsiveness during prone position in ARDSJean-Christophe Richard, Hodane Yonis, Florent Gobert, Romain Tapponnier, Claude Gu√©rinP215 Low pressure support-high PEEP for early severe acute respiratory distress syndrome:  a retrospective analysisLuc Quintin, C. Pichot, F. PetitjeansP216 Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defenceAntoine Guillon, Youenn Jouan, Daborah Breah, Fabien Gueugnon, Emilie Dalloneau, Thomas Baranek, Clemence Henry, Eric Morello, Jc Renauld, M Pichavant, Philippe Gosset, Y Courty, Patrice Diot, Mustapha Si-TaharP217 Impaired phagocytosis of apoptotic neutrophils in human ARDS: beneficial effects of metforminFabrice Uhel, Murielle Gregoire, Arnaud Gacouin, Yves Le Tulzo, Karin Tarte, Jean-Marc Tadi√©P218 What are the deteP219 Emergency thoracotomy: development and results in a military trauma centerrminants of needle aspiration  success in primary spontaneous pneumothorax?Constance Vuillard, Jean-Damien Ricard, B√©atrice La Combe, St√©phane Gaudry, Didier Dreyfuss, Jonathan MessikaP219 Emergency thoracotomy: development and results in a military trauma centerPauline Ponsin, Jean-Louis Daban, Guillaume Boddaert, Bertrand Grand, Vincent Peigne, Yohan Baudoin, Mathieu Boutonnet, Patrick Jault, St√©phane BonnetP220 Management of isthmic aortic rupture in polytraumatized patients in ICU: a report of 12 casesChtara Kamilia, Kais Regaieg, Olfa Turki, Najeh Baccouch, Anis Chaari, Hmida Chokri Ben, Mabrouk Bahloul, Mounir BouazizP221 NT-proBNP levels and echocardiography findings in the etiologic diagnosis of acute dyspneaSalah Snouda, Hassen Ben Ghezala, Mohamed Fehmi Abbes, Rebeh Daoudi, Moez Kaddour, Imen BenchiekhP222 Cardiac decompensation in peripartumKamal Belkadi, I. Moussaid, Chaigar Mohammed Cheikh, S. El Youssoufi, S. SalmiP223 Peripheral intravenous catheter-related complications in an emergency wardInes Sedghiani, Hana Fredj, Hamdi Doghri, Youssef Zied El Hechmi, Mohamed Ali Cherif, Jerbi ZouheirP224 Burnout in the emergency roomNeila Maaroufi, Abid ZeinebP225 Prevalence, and characteristics of elderly patient admitted in a Moroccan Medical Unit for the Acute CareJihane Belayachi, Leila Debono, Naoufal Madani, Fatiha Amlaiky, Tarek Dendane, Khalid Abidi, Aicha Zekraoui, Amine Ali Zeggwagh, Redouane AbouqalP226 Metabolic phenotyping in bronchoalveolar lavage fluids distinguishes influenza and pneumococcal pneumoniaAdrien Auvet, Antoine Guillon, Lydie Nadal-Desbarats, Thomas Baranek, Eric Morello, Fran√ßois R√©miniac, Mustapha Si-TaharP227 Microbiological documentation of pneumonia in the ICU by per-bronchoscopic bronchial aspiration (PBA) is very similar to that obtained by bronchoalveolar lavage (BAL)Jean-Luc Baudel, Jacques Tankovic, Redouane Dahoumane, Arnaud Galbois, Hafid Ait Oufella, Georges Offenstadt, Eric Maury, Bertrand GuidetP228 Compliance with the H3 bundle of the 2012 surviving sepsis campaign according to  the chain of care of septic patients: the sepsis CHOC studyAmel Filali, Emmanuel  Faure, Nicolas Van Grunderbeeck, Olivier Nigeon, Juliette Masse, H Bazus, Jihad Mallat, Didier TheveninP229 CRP ratio as a predictive tool for mortality in ICU septic patientsSophie Lempereur-Legros, Didier Ledoux, Monique Nys, Pierre DamasP230 Candidemia in ICU: Epidemiology and prognostic factorsZied Hajjej, Walid Sammoud, Becem Trabelsi, Iheb Labbene, Mustapha FerjaniP231 Extracorporeal  membrane oxygenation cannula-associated infections: implication of virulent Escherichia coli phylogroupsJonathan Messika, Olivier Clermont, Matthieu Schmidt, Alexandra Aubry, Romain Fernandes, Erick Denamur, Alain Combes, Jean-Damien RicardP232 Is diabetes mellitus a risk factor for intensive care unit-acquired infections in intensive care unit patients with hematologic malignancies?Marion Venot, Sylvie Chevret, Djamel Mokart, Fr√©d√©ric P√®ne, Virginie Lemiale, Achille Kouatchet, Julien Mayaux, Fran√ßois Vincent, Martine Nyunga, Fabrice Bruneel, Elie AzoulayP233 Should we need aerobic‚Äìanaerobic or specific blood culture bottles for diagnosing candidemia in ICU patients?S√©bastien Bailly, Jean-Fran√ßois Timsit, C√©cile Garnaud, Muriel Cornet, Patricia Pavese, Rebecca Hamidfar-Roy, Luc Foroni, Sandrine Boisset, Carole Schwebel, Dani√®le MaubonP234 Invasive Candida infection  in a Tunisian ICU: an observational cohort studyIslem Ouanes, Maha Abid, Hend Ben Lakhal, Saousen Ben Abdallah, Fahmi Dachraoui, Hedia Hammed, Rami Jabla, Asma Hachani, Mahdi Marzouk, Imen Abdellaoui, Chaima Ghribi, Imen Ben Ali, Lamia Ouanes-Besbes, Fekri AbrougP235 Causes of admission in medical intensive care of  patients suffering from severe psychiatric disordersHanane Ezzouine, Constant Aniolo Edith, Abdellatif BenslamaP236 Unplanned extubation in critical care: still to learn from local surveyFr√©d√©ric Jacobs, Dominique Prat, Matthieu Le Meur, Olfa Hamzaoui, Anne Sylvie Dumenil, Guy Moneger, Nad√®ge Demars, Pierre Trouiller, Benjamin SztrymfP237 Mortality associated with nights and weekends admission to intensive care unit (ICU): results of a 9-year cohort study (2006‚Äì2014)Vincent Brunot, Jean-Emmanuel Serre, P. Corne, Nicolas Molinari, L. Landreau, Olivier Jonquet, Kada KloucheP238 Determinants and outcomes associated  with decisions to deny admission in a Tunisian ICURania Bouneb, Kaoula Meddeb, Y. Hamdaoui, H Nouira, A. Azouzi, Jihene Ayachi, Ahmed Khedher, Mohamed BoussarsarP239 Characteristics and outcomes of patients not admitted to ICUNesrine Boujelbene, Rami Jabla, Fahmi Dachraoui, Islem Ouanes, Mahdi Marzouk,  Hedia Hammed, Asma Hachani, Hend Ben Lakhal, Chaima Ghribi, Imen Abdellaoui, Imen Ben Ali, Saousen Ben Abdallah, Lamia Ouanes-Besbes, Fekri AbrougP240 Long-term outcomes of critically ill patients with severe acute kidney injury requiring renal replacement therapyVanessa Jean-Michel, Francis Couturaud, Elizabeth Moore, Pierre-Yves Egreteau, Jean-Michel Boles, C√©cile AubronP241 Nowadays, SAPSII better predicts 1-year mortality than hospital mortalityJean-Etienne Herbrecht, Max Guillot, Quentin Maestraggi, Charlotte Kaeuffer, Ralf Janssen-Langenstein, Sylvie L‚Äôhotellier, Sophie Hatsch, Benjamin Lebas, Alexandra Boivin, Maleka Schenck, Marie-Line Harlay, Anne Meyer, Vincent Castelain, Francis SchneiderP242  Impact of diabetes on burn injury: preliminary results from retrospective studyAmel Mokline, Imen Rahmani, Khaouther Ben Arfi, Lazhari Gharsallah, Sofiene  Tlaili, Bahija Gasri, Rym Hammouda, Amen Allah MessadiP243 Withdrawal or withholding of life-sustaining treatments decisions: Is there a risk of excessive influence of medical imaging?Fabrice Lesage, Sylvie S√©guret, Laurent Dupic, Laure De Saint Blanquat, Sylvain RenolleauP244 Withholding and withdrawal of life-sustaining treatments in intensive care unit patients: predisposing factors  and implementationAnne-Sophie Baptiste, Hugues Georges, Pierre-Yves Delannoy, Patrick Devos, Olivier LeroyP245 Advanced directives in an old patient with suicide attempt: analysis of ICU physicians perceptionDolores Albarracin, A. Ducousso-Lacaze, Ang√©line Jamet,, Julien Dufour, S√©verin Cabasson, Anne Veinstein, Delphine Chatellier, Jean-Pierre Frat, Ren√© RobertP246 Having the talk about advance directives in the daily practice: Is a stay in an intensive care unit a good opportunity?Vivien Hong Tuan Ha, Nicolas Lau, Lucie Mimoun, Xavier ForcevilleP247 Long-term outcome of patients who have withheld life support in intensive careAdel Maamar, St√©phanie Chevalier, Vlad Botoc, Yves Le TulzoP248 Epidemiology of refusals in a polyvalent intensive care unit ad outcome of refused patientsStephane Rouleau, David Schnell, Arnaud Desachy, Sylvie Calvat, Philippe Petua, Charles Lafon, Christophe CraccoP249 Ten critical sentences you have already heard in the Intensive Care Unit and the Emergency Department, their real meanings and consequencesNicolas Van Grunderbeeck, J. Temime, Perrine Molmy, Stephanie Barrailler, G. Gasan, Olivier Nigeon, Didier TheveninP250 Communication with the parents: a challenge in the pediatric intensive care unitAgathe B√©ranger, Charlotte Pierron, Laure De Saint Blanquat, Sandrine Jean, H√©l√®ne ChappuyP251 End of life in the intensive care unit: between practice and knowledgePierre-Marie Bertrand, Alexandra Beurton, Laetitia Bodet-Contentin, Julie Boisram√©-Helms, Pierre-√©Ric Danin, Elsa Dubois, Elodie G√©lisse, Yasemin Karaca, Pierre Mora, Nicolas de Prost, Damien Roux, Alexis Soummer, Dominique Vodovar, Committee of young intensivists of the French Society for Intensive Care Medicine (FICS)S1 The HICU Score (Hematologic Intensive Care Unit Score): a new prognostic score for predicting 30-day and 1-year mortality of patients with hematologic malignancies admitted in ICUYohan Desbrosses, Guylaine Labro, Ga√´l Piton, Adrien Chauchet, Etienne Daguindau, Fran√ßois Blot, Eric Deconinck, Gilles  CapellierS2 Patients with multiple myeloma in the ICU: trends of use and outcomes over timeAkli Chermak, Adrien Joseph, Virginie Lemiale, Claire Pichereau, Marinne Baron, Emmanuel Canet, Eric Mariotte, Micha√´l Darmon, Elie AzoulayS3 Impact of bone marrow aspiration on the management of adult critically ill patientsLaure Calvet, Anne Fran√ßoise Sapin, Bruno Pereira, Alexandre Lautrette, Bertrand SouweineS4 Red blood cells transfusion in ICU: descriptive analysis of French cohort from ‚ÄúAge BLood Evaluation‚Ä? clinical trialLucie Vettoretti, Sebastien Pili-Floury, Ga√´l Piton, Jacques Lacroix, Lucy Clayton, Elham Sabri, Laurent Bardiaux, Pierre Tiberghien, Paul Hebert, Gilles Capellier, ABLE French InvestigatorsS5 Graft-versus-host disease trajectories and mortality in critically ill allogeneic stem cell recipientsClaire Pichereau, Etienne Lenglin√©, Anne-Sophie Moreau, Eric Mariotte, Marion Venot, Sandrine Valade, Akli Chermak, Virginie Lemiale, Emmanuel Canet, G√©rard Soci√©, Beno√Æt Schlemmer, Elie AzoulayS6  Outcome of 544 patients with solid cancer in the intensive care unit: the Oncor√©a studyEdith Borcoman, Virginie Lemiale, Eric Mariotte, Claire Pichereau, Emmanuel  Canet, Adrien Joseph, Akli Chermak, Sandrine Valade, Marion Venot, Beno√Æt Schlemmer, Elie AzoulayS7 Assessing the process of ICU admission refusal in critically ill patients with hematological malignanciesKaterina Rusinova, Virginie Lemiale, Matthieu Resche-Rigon, Djamel Mokart, Antoine Rabbat, Fr√©d√©ric  P√®ne, Achille Kouatchet, Fabrice Bruneel, Julien Mayaux, Fran√ßois Vincent, Pierre Perez, Martine Nyunga, Elie Azoulay, Groupe de Recherche en R√©animation Respiratoire en Onco-H√©matologieS8 Neurologic and hepatic failures at ICU admission are associated with worst prognosis for patients with lymphomasAur√©lien Sutra Del Galy, Achille Kouatchet, M√©lanie Mercier, Jean-Fran√ßois Hamel, Tommy Raveau, Marie-Pierre Moles, Aline Clavert, Mathilde Hunault-Berger, Alain Mercat, Norbert Ifrah, Aline Schmidt-TanguyS9 Impact of earplugs and eye mask on sleep in critically ill patients: a prospective randomized polysomnographic studyAlexandre Demoule, Serge Carreira, Sophie Lavault, Olivier Pallanca, Elise Morawiec, Julien Mayaux, Isabelle Arnulf, Thomas SimilowskiS10 Diaphragmatic paralysis after adult cardiac surgery: incidence and predicting factorsThomas D‚Äôhumi√®res, Pierre Dupland, Pauline Issaurat, Romain Vergier, Philippe Estagnasi√©, Alain Brusset, Pierre SquaraS11 Ultrasound evaluation of diaphragmatic dysfunction: prognostic marker of ICU weaning failureC√©dric Carri√©, Chlo√© Gisbert-Mora, Eline Bonnardel,  Matthieu Biais, Fr√©d√©ric Vargas, Gilles HilbertS12 A prospective multicentric study to evaluate the impact of breathing variability on clinical outcomes in mechanically ventilated patientsC√¥me Bureau, Camille Rolland-Debord, Tymoth√©e Poitou, Marc Clavel, S√©bastien Perbet, Nicolas Terzi, Achille Kouatchet, Thomas Similowski, Alexandre Demoule, Universit√© Paris 6 ‚ÄîPierre et Marie Curie and Institut National pour la Sant√© et la Recherche M√©dicale, UMRS1158, ParisS13 Nurse-driven sedation protocol with sedation vacation and incidence of unplanned  extubationsPierre Lucas, Julien Charpentier, Michel Arnaout, Thomas Joannon,, S√©bastien Lefort, Aude Marincamp, Anne-Sophie Debue, Matthieu Reffienna, Fr√©d√©ric P√®ne, Jean-Paul Mira, Alain Cariou, Jean-Daniel Chiche, Working Group on Mechanical VentilationS14 Lung ultrasound enables to detect weaning-induced cardiogenic pulmonary oedemaAlexis Ferre, Max Guillot, Jean-Louis Teboul, Daniel  Lichtenstein, Gilbert Meziere, Christian Richard, Xavier MonnetS15 Pleural effusion during the weaning from mechanical ventilation: prevalence and impactDamien Roux, Tai Pham, Alexandra Beurton, Muriel Fartoukh, Jean-Damien Ricard, Alexandre Demoule, Martin DresS16 Prognostic impact of left ventricular diastolic dysfunction in patients with septic shockC√©line Gonzalez, Fran√ßois Dalmay, Emmanuelle Begot, Nicolas Pichon, Bruno Fran√ßois, Anne-Laure Fedou, Catherine Chapellas, Antoine Galy, Philippe VignonS17 Norepinephrine exerts an inotropic effect at the early phase of human septic shockOlfa Hamzaoui, Mathieu Jozwiak, Thomas Geffriaud, Benjamin Sztrymf, Dominique Prat, Fr√©d√©ric Jacobs, Xavier Monnet, Pierre Trouiller, Christian Richard, Jean-Louis TeboulS18 Effect of high PEEP after recruitment maneuver on right ventricular function in ARDS: Is it good for the lung and for the heart?Shari El-Dash, Loay Kontar, Fran√ßois Leleu, Bertand De Cagny, Fran√ßois Brazier, Dimitri Titeca, Gaelle Bacari-Risal, Julien Maizel, Michel SlamaS19 Myocardial dysfunction during septic shock: prevalence, prognosis and role of loading conditionsFlorence Boissier, Keyvan Razazi, Aurelien Seemann, Arnaud, W Thille, Nicolas de Prost, Elise Cuquemelle,,  Filippo Boroli,, Alexandre Bedet, Pascal Lim, Christian Brun-Buisson, Armand Mekontso DessapS20 Echocardiography for the critically ill: 1-year experience of  a noninvasive intensive care unitW Brahim, R Amara, A Azouzi, Ahmed Khedher, Jihene Ayachi, Rania Bouneb, Y Hamdaoui, Kaoula Meddeb, Mohamed BoussarsarS21 Echocardiographic indices to predict fluid responsiveness in ventilated patients  with circulatory failure: which threshold for which aim?Emmanuelle Begot, Xavier  Repess√©, Julie L√©ger, Gwenael Prat, Cyril Charron, Pierre-Yves Egreteau, Christophe Jacob, Koceila Bouferache, Loay Kontar, Julien Maizel, Michel Slama, Antoine Vieillard-Baron, Philippe VignonS22 Effects of norepinephrine on the right ventricle assessed by transthoracic echocardiography in the ICUClaire Ragot, Laure Corradi, Fr√©d√©ric VargasS23 Effect of recruitment maneuver on left ventricular systolic strainPablo Mercado, Julien Maizel, Loay Kontar, Bertand De  Cagny, Fran√ßois Brazier, Dimitri Titeca, Gaelle Bacari-Risal, Antoine Riviere, Shari El-Dash, Michel SlamaS24 Management of diabetic ketoacidosis in two pediatric intensive care units: comparison of two care protocolsLaure Maurice, St√©phane Dauger, S Julliand, Anna Deho, Fleur Le BourgeoisS25 NUTRI-REAPED: Nutritional status on admission to the pediatric intensive care unit‚Äîa French multicentric studyAurelien Jacquot, Frederic Valla, B√©n√©dicte Gaillard-Le Roux, Flavie Letois, Gilles Cambonie, NutriSIPS26 Apnea test in children for brain death diagnosis: efficacy and complicationsAlexandre Salvadori, Gaia Ottonello, St√©phane Blanot, Juliette Montmayeur, Gilles OrliaguetS27 Interest of the ultrasound in the central venous catheterization in children poses in intensive care unitFehmi Ferhi, Hosni Khouadja, Mohamed Amine Bouslama, Affra Brahim, Khalil Tarmiz, Khaled BenjaziaS28 Supraclavicular approach to the innominate vein in pediatric intensive care unit: interest in the prevention of thrombosis and catheter-related blood stream infectionFlora Habas, Julien Baleine, Julia Lebouhellec, Christophe Milesi, Clementine Combes, Gilles CambonieS29 EPURE Study: Preliminary results on the organization of pediatric acute dialysis in 2 French-speaking countriesMaryline Chomton, Philippe Jouvet, Bruno Ranchin, Marie  Alice Macher, Th√©ophile Gaillot, EPURE Study GroupS30 Hyperglycemia in severe scorpion envenomed children: incidence and impact outcomeMabrouk Bahloul, Najeh Baccouche, Kais Regaieg, Turki Olfa, Chtara Kamilia, Benhamida Chokri, Hedi Chelly, Mounir BouazizS31 Prehospital care and initial hospital care of pediatric patients with severe trauma hospitalized in the ICU at Grenoble University Hospital, data from the ‚ÄúTRENAU‚Ä? trauma-systemMurielle Moine, Fran√ßois Xavier Ageron, Claire Jannel, Thierry Debillon, Isabelle WroblewskiS32 Ventilator-associated pneumonia due to multi- or extensively drug-resistant Pseudomonas aeruginosa: comparison with susceptible strainsMatthieu Duprey, Nicolas Br√©chot, Alexandra Aubry, Guillaume Hekimian, Matthieu Schmidt, Ania Nieszkowska, Jean Louis Trouillet, Vincent Jarlier, Alain Combes, Jean Chastre, Charles-Edouard LuytS33 Can we predict a secondary documented infection in patients empirically treated for an invasive candidiasis?S√©bastien Bailly, Olivier Leroy, Jean-Paul Mira, Herv√© Dupont, Jean-Pierre Gangneux, Philippe Montravers, Jean-Michel Constantin, Didier Guillemot, Olivier Lortholary, Pierre-Fran√ßois Perrigault, Elie Azoulay, Jean-Fran√ßois TimsitS34 Should aminoglycosides be administered to hematological patients with septic shock? Data from the Groupe de Recherche respiratoire en R√©animation Onco-H√©matologique (Grrr-OH)Thomas Longval, Sylvie Chevret, Fabrice Bruneel, Djamel Mokart, Fr√©d√©ric P√®ne, Julien Mayaux, Achille Kouatchet, Martine Nyunga, Antoine Rabbat, Pierre Perez, Christine Lebert, Dominique Benoit, Fran√ßois Vincent, Virginie Lemiale, Elie AzoulayS35 Is de-escalation of antimicrobial therapy safe in hematology patients?David Schnell, Claire Montlahuc, Matthieu Resche-Rigon, Achille Kouatchet, Jean-Ralph Zahar, Micha√´l Darmon, Fr√©d√©ric P√®ne, Virginie Lemiale, Antoine Rabbat, Fran√ßois Vincent, Fabrice Bruneel, Djamel Mokart, Elie AzoulayS36 Pharmacokinetics and absolute bioavailability of voriconazole administered through a nasogastric tube with continuous enteral feeding to critically ill ventilated patientsPhilippe Karoubi, Christophe Huang, Antoine Rabbat, Johanna Oziel, Guillaume Van Der Meersch, Yacine Tandjaoui-Lambiotte, Fr√©d√©ric Gonzalez,  Christophe Clec‚Äôh, Christophe Padoin, Yves CohenS37 Which optimal daily dose for  linezolid in burn patients?Amel Mokline, Lazhari Gharsallah, Imen Rahmani, Emna Gaies, Sofiene Tlaili, Bahija Gasri, Rym Hammouda, Sameh Triki, Anis Klouz, Amen  Allah MessadiS38 Predictive factors of sub-therapeutic peak concentration after a single dose of amikacin in postoperative cardiovascular critically ill patientsMouhamed Moussa, Flavie DesrumauxS39 Supra-therapeutic serum levels and toxicity of beta-lactam antibiotics in septic ICU patients requiring replacement  therapy for acute renal failure: a single-center cohort studyFaten May, Marion Perrin, Najoua El-Helali, Jean-Claude Nguyen, Kelly Tiercelet, Stephane Ruckly, Julien Fournier, M√©lanie Cherin, C√©dric Bruel, Francois Philippart, Ma√Øt√© Garrouste-Orgeas, Marie Dominique Kitzis, Alban Le Monnier, Jean-Fran√ßois Timsit, Benoit MissetS40 Post-cardiac arrest syndrome: lessons from a monocentric retrospective studyCyrille Mathien, Antoine Poidevin, Luis Donatti, Joy Mootien,  Luis Pinto, Mathieu Egard, Gokhan Bodur, Guillaume Barberet, Carmen Ionescu, Frederique Ganster, Philippe Guiot, Khaldoun KuteifanS41 Out-of-hospital cardiac  arrest (OHCA) score for prediction of outcome of in-hospital cardiac arrest: results of the OSPICA pilot studyAlain Mpela, Jonathan Chelly, Jennifer Brunet, St√©phane Legriel, Laurent Gu√©rin, Romain Persichini, Alexis Soummer, Bertrand Sauneuf, Tai Pham, Thomas Hullin, Nicolas Deye, Pierre Aubertein, Mehran MonchiS42 Delayed awakening after cardiac arrest: causes and outcome in the Parisian registryMarine Paul, Wulfran Bougouin, Guillaume Geri, Florence Dumas, Benoit Champigneulle, St√©phane Legriel, Julien Charpentier, Jean-Paul Mira, Claudio Sandroni, Alain CariouS43 Incidence and characteristics of sudden unexplained cardiac death: insights from the Parisian registryOlivier Passouant,  Guillaume Geri, Florence Dumas, Wulfran Bougouin, Benoit Champigneulle, Michel Arnaout, Jonathan Chelly, Jean-Daniel Chiche, Olivier Varenne, Jean-Paul Mira, Alain CariouS44 Supranormal oxygen tension is not associated with an impaired redox balance in patients resuscitated from cardiac arrestJean-Fran√ßois Llitjos,  Camille Chenevier-Gobeaux, Julien Charpentier, Florence Dumas, Guillaume Geri, Wulfran Bougouin, Benoit Champigneulle, Michel Arnaout, Jean-Paul Mira, Fr√©d√©ric  P√®ne, Frederic Batteux, Alain CariouS45 Impaired biological response to aspirin in comatose patients resuscitated from out-of-hospital cardiac arrestJean-Fran√ßois Llitjos, Ludovic Drouet, Sebastian Voicu, Nicolas Deye, Bruno Megarbane, Patrick Henry, Jean-Guillaume DillingerS46 Gender differences in coronary reperfusion after cardiac arrestWulfran Bougouin, Florence Dumas, Eloi Marijon, Guillaume Geri, Benoit Champigneulle, Jean-Daniel Chiche, Olivier Varenne, Christian Spaulding, Jean-Paul Mira, Xavier Jouven, Alain CariouS47 Prognostic factors of out-of-hospital cardiac arrests in Martinique: prospective  study over a period of 29¬†months, about 385 casesDabor Resiere, A. L. Dessoy, Ruddy Valentino, C. Chabartier, Laurent Villain-Coquet, Jean-Louis Ferge, Y. Brouste, Bruno Megarbane, Hossein MehdaouiS48 Incubation of immune cells in septic plasma: effect on glucose utilization and on phenotypic expression on monocytes, polymorphonuclears and lymphocytesBenjamin Soyer, Val√©rie Faivre, Charles Damoisel, Anne-Claire Lukaszewicz, Didier Payen de la GaranderieS49 Ex vivo effects of hyperglycemia on phenotype and production of reactive oxygen species by the NADPH oxidase of human immune cells in acute inflammatory responseBenjamin Soyer, Val√©rie Faivre, Charles Damoisel, Anne-Claire Lukaszewicz, Didier Payen de la GaranderieS52 HMGB1 induces neutrophils dysfunction after septic shockFabrice Uhel, Murielle Gregoire, Arnaud Gacouin, Caroline Piau, Yves Le Tulzo, Karin Tarte, Jean-Marc Tadi√©S53 Rapid mobilization  of myeloid-derived suppressor cells during sepsis and relation with clinical courseThomas Daix, Robin Jeannet, Emmanuelle Begot, Nicolas Pichon, Anne-Laure Fedou, Estelle Gu√©rin, Philippe Vignon, Jean Feuillard, Bruno Fran√ßoisS54 Targeted endothelial TREM-1 deletion protects mice during septic shockLucie Jolly, Amir Boufenzer, J√©r√©mie Lemarie, Kevin Carrasco, Marc Derive, Sebastien GibotS55 Polymicrobial sepsis inhibits tumor growth in cancer miceHamid Merdji, Jean-Fran√ßois Llitjos, Christophe Rousseau, Nadia Belaidouni, Julie Toubiana, Jean-Paul Mira, Jean-Daniel Chiche, Fr√©d√©ric P√®neS56 Telestroke implementation in the biggest French region (12 millions inhabitants): the project ORTIFYann L‚ÄôHermitte, France Woimant, Catherine Oppenheim, Christophe Couvreur, Fran√ßois DolveckS57 Free haemoglobin concentration in patients with sickle cell disease referred to the emergency room: Is it useful?Pierre Mora, Magali Devriese, Sophie Dupeyrat, Patrick Ray, Guillaume Lefevre, Muriel FartoukhS58 Evaluation of the prescription and use of antibiotics in an emergency department of a general hospital by Gyssens MethodNicolas Roothaer, Am√©lie Carpentier, Fabien Vaniet, Antoine Maisonneuve, Eric WielS59 High dosages of norepinephrine in trauma patientsS√©bastien Canu, Emmanuelle Hammad, Francois Antonini, Marion Poirier, Laurent Zieleskiewicz, Coralie Vigne, Malik Haddam, Julie Alingrin, Marc LeoneS60 Bleeding risk of pleural procedures in patients taking antiplatelet therapy: a multicentric prospective studyLaurence Dangers, Gilles Mangiapan, Mikael Alves, Na√Øke Big√©, Jonathan Messika, Elise Morawiec, Mathilde Neuville, Christophe Cracco, Gaetan Beduneau, Nicolas Terzi, Isabelle Huet, Xavier Dhalluin, Nathalie  Bautin, Jean Jacques Quiot, Corinne Appere De Vecchi, Thomas Similowski, C√©cile ChenivesseS61 Interest of the association fibrinogen/tranexamic acid in the management of severe postpartum hemorrhageKhalil Tarmiz, Fehmi Ferhi, Hosni Khouadja, Affra Brahim, Mohamed Amine Bouslama, Khaled BenjaziaS62 HELLP syndrome in ICU: epidemiological, clinical and prognostic study about 112 casesFatma Kaaniche Medhioub, Kais Rgieg, Olfa Turki, Mariem Smaoui, Anis Chaari, Benhamida  Chokri, Mabrouk Bahloul, Bouaziz MounirS63 Neurological complications in eclampsiaChaigar Mohammed Cheikh, I. Moussaid, Kamal Belkadi, E. El Alami, S. El  Youssoufi, S. SalmiS64 Brain water contain is dependent on plasmatic ammonemia levels in hyperammoniemic encephalopathy, a quantitative CT scan studyNicolas Weiss, Fanny Mochel, Damien Galanaud, Louis Puybasset, Dominique Thabut, Brain Liver Piti√©-Salp√™tri√®re Study Group (BLIPS), Paris, FranceS65 Sodium phenylbutyrate administration to avoid neurological worsening in hepatic encephalopathy patients in ICUSimona Tripon, Marion Lodey, Elsa Guiller, Maxime Mallet, Marika Rudler, Dominique Thabut, Nicolas Weiss, Brain Liver Piti√©-Salp√™tri√®re Study Group (BLIPS), Paris, FranceS66 Disruption of posteromedial large-scale neural communication predicts recovery from comaStein Silva, B√©atrice Riu-Poulenc, Jean Ruiz, Corine Vuillaume, Francesco De Pasquale,  Jean Francois DemonetS67 Loss of sleep elements on continuous EEG monitoring is associated with mortality in patients with cardiogenic shock requiring veno-arterial extra-corporeal membrane oxygenation (ECMO)Fabrice Sinnah, Marie Amelie Dalloz, Eric Magalhaes, Mathilde Neuville, Roland Smonig, Aguila Radjou, Bruno Mourvillier, Lila Bouadma, Jean-Fran√ßois Timsit, Marie Pia D‚Äôortho, Anny Rouvel-Tallec, Romain SonnevilleS68 Protective effects of high-density lipoprotein therapy in a mouse model of ischemic stroke hemorrhagic transformation due to acute hyperglycemiaDavid Couret, Aur√©lie Catan, Brice Nativel, Cynthia Planesse, Nicolas Diotel, Olivier MeilhacS69 Glucocorticoids as  a ‚Äúrescue therapy‚Ä? for delayed intracranial hypertension after acute brain injury: a retrospective studyFabian Roy-Gash, Stephane Welschbillig, Elodie Lang, Christophe Lebard, Nicolas EngrandS70 Organ donation: early talks (ET) to relatives before occurence of brain deathAnne-Gaelle Si Larbi, Virginie Gaudin, France Bonnin, Oceane Sultan,, Alexis Soummer, Gr√©goire Trebbia, Cecile Hoc, Emmanuel Mathieu, Bertrand Lapergue, Frederic Bourdain, Charles CerfS71 Remifentanil target-controlled infusion for procedures generating pain or discomfort in the ICU: feasibility, safety and tolerance evaluationMargot Caron,  Antoine Parrot, Maxens Decav√®le, Clarisse Blayau, Jean-Pierre Fulgencio, Vincent  Labbe, Michel Djibre, El Mahdi Hafiani, Christophe Quesnel, Muriel Fartoukh, Tai  PhamS72 Minimizing dead-volume infusion devices leads to a reduction in hypoglycaemia in surgery patients admitted to a perioperative intensive care unitStephanie Genay, Bertrand D√©caudin, Sabine Ethgen, Pascal Odou, Gilles LebuffeS73 Patient-important outcomes in randomized controlled trials in critically ill patientsSt√©phane Gaudry, Jonathan Messika, Jean-Damien Ricard, Blandine Pasquet, Sylvie Guillo, Emeline Dubief, Didier Dreyfuss, Florence TubachS74 Epidemiology of platelets transfusion in critically ill patientsC√©cile  Aubron, Andrew Flint, Michael Bailey, Rinaldo Bellomo, David Pilcher, Allen Cheng, Colin Hegarty, Anthony Martinelli, Benjamin Howden, Michael Reade, Zoe McquiltenS75 Outcome of selected nonagenarians admitted in ICUs: a multicenter study from the Outcomerea research groupMa√Øt√© Garrouste-Orgeas, Stephane Ruckly,  Francois Philippart, Anne Sylvie Dumenil, Dany Goldgran Toledano, Samir Jamali, Carole Schwebel, Lilia Soufir, Christophe Clec‚Äôh, Micha√´l Darmon, Bernard Allaouchiche, Laurent Argaud, Bruno Verdi√®re, Muriel Fartoukh, M√©lanie Cherin, Elie Azoulay, Jean-Fran√ßois TimsitS76 A systematic follow-up consultation guarantee quality of care in intensive care unitMartine Nyunga, No√©mie Banaias, Cl√©ment Vanbaelinghem, C√©line Broucqsault-Dedrie, Delphine Colling, Marie Kauv, Erik Blondeau, Patrick HerbecqS77 Change in functional autonomy following ICU stayIslem Ouanes, Mahdi Marzouk, Lamia Ouanes-Besbes, Rami Jabla, Chaima Ghribi,  Nesrine Boujelbene, Asma Hachani, Saousen Ben Abdallah, Hedia Hammed, Hend Ben Lakhal, Imen Ben Ali, Imen Abdellaoui, Fahmi Dachraoui, Fekri AbrougS78 Outcome of Intensive Care Unit (ICU) elderly patients admitted with solid tumorEdouard Auclin, Emmanuel Gu√©rot, Caroline Haw-Berlemont, Julien Taieb, St√©phane Oudard, Jean-Luc Diehl, Jean-Yves Fagon, Nadia AissaouiS79 Risks factors for mortality in critically ill children with acute kidney injury requiring renal replacement therapyGenevieve Morissette, Wassim Kechaou, Catherine Litalien, A√Øcha Merouani,  V√©ronique Phan, Jos√©e Bouchard, Philippe JouvetS80 Epinephrine use in pediatric septic shock: a retrospective, single-center study on 117 patientsJulie Starck, Mehdi Oualha, Nelly Briand, Jean-Marc Treluyer, Sylvain Renolleau, Laurent DupicS81 Sickle cell disease in pediatric intensive care unit: a five-year retrospective monocentric study of 74 patientsPhilippe Sachs, S Julliand, Fran√ßois Angoulvant, Julie Sommet, L Holvoet, M Benkerrou, St√©phane DaugerS82 Implementation and evaluation of a paediatric nurse-driven sedation protocol in a PICUL√©lia Dreyfus, Fabienne Bordet, Sandrine Touzet, Ang√©lique Denis, Etienne JavouheyS83 Diagnostic evaluation and management of new-onset seizures and seizures with known epilepsy in children: a retrospective and comparative analysisJulien Le Coz, G√©rard Ch√©ron, Rima Nabbout, Geraldine Patteau, Claire Heilbronner, Philippe Hubert, Sylvain Renolleau, Mehdi OualhaS84 MRI sedation in  children in pediatric hospital in Oran, AlgeriaNabil Tabet Aoul, zakaria addou, Ali Douah, Mohamed Moussati, Kamel Belhabiche, Nabil AouffenS85 Neurally adjusted ventilatory assist in pediatric patients following cardiac surgery: feasibility in clinical practice and impact on ventilation pressuresBenjamin Crulli, Baruch Toledano, Nancy Poirier, Suzanne Vobecky, Guillaume EmeriaudS86 Percutaneous central venous cannulation: a Seldinger technique versus an ultrasound guidance technique in a pediatric intensive care unitFehmi Ferhi, Hosni Khouadja, Mohamed  Amine Bouslama, Affra Brahim, Khalil Tarmiz, Khaled BenjaziaS87 Effect of remote  ischemic preconditioning on renal resistive index in healthy volunteersRen√© Robert, M. Vinet, Ang√©line Jamet, Remi Coudroy, Arnaud W. ThilleS88 Peak concentration of high-dose AMIKACIN does not affect renal recovery at day 90: a retrospective study of 93 patients in a single medical Intensive Care UnitCamille Vinclair, Romain Sonneville, Bruno Mourvillier, Mathilde Neuville, Roland Smonig, Eric Magalhaes, Guillaume Voiriot, Aguila Radjou, Jean-Fran√ßois Soubirou, Stephane Ruckly, Lila Bouadma, Jean-Fran√ßois TimsitS89 Resuscitating chronic hypertensive patient with a high mean arterial pressure target during septic shock protects against acute renal failureJulie Boisram√©-Helms, Ferhat Meziani, Jean-Fran√ßois Hamel, Fran√ßois Beloncle, Jean-Louis Teboul, Peter Radermacher, Pierre AsfarS90 Guidewire exchange vs new-site placement for temporary dialysis catheters insertion in ICU patients: Is there a greater risk of colonization or dysfunction?Elisabeth Coupez, Jean-Fran√ßois Timsit, Stephane Ruckly, Carole Schwebel, Didier Gruson, Emmanuel Canet, Kada Klouche, Laurent Argaud, Julien Boh√©, Ma√Øt√© Garrouste-Orgeas, Fran√ßois Vincent, Sophie Cayot, Micha√´l Darmon, Alexandre Boyer, Elie Azoulay, Lila Bouadma, Alexandre Lautrette, Bertrand SouweineS92 Assessment of chloride levels on renal function after cardiac arrestCl√°udia Righy Shinotsuka, Pietro Caironi, Paola Villois, Vito Fontana, Jean-Louis Vincent, Jacques Creteur, Fabio Silvio TacconeS93 Sustained low-efficiency dialysis with regional citrate anticoagulation is safe for patients with acute liver failure or cirrhosisFranck Pourcine, Ly Vong, Jonathan  Chelly, Sebastien Jochmans, Oumar Sy, Olivier Ellrodt, Nathalie Rolin, Jean-Emmanuel Alphonsine,, Claire Marie Weyer, Jean Serbource-Goguel, Benoit Akando, Razach Abdallah, Mehran Monchi, Christophe VinsonneauS94 The new biomarker Nephrocheck‚Ñ¢ can discriminate the population of septic shock patients with an AKIN 1 or 2 acute renal failure who will not progress toward the AKIN 3 levelMorgane Wetzstein, Loay Kontar, Dimitri Titeca, Fran√ßois Brazier, Bertand De Cagny, Gaelle Bacari-Risal, Antoine Riviere, Michel Slama, Julien MaizelS95 Is thrombocytopenia an early prognostic marker in septic shock?Nadiejda Antier, Christine Binquet, Sandrine Vinault, Ferhat Meziani, Julie Boisram√©-Helms, Jean-Pierre QuenotS96 Assessment of fibrinolysis in critically ill patientsYasmina Serroukh, Karim Zouaoui Boudjeltia, Anne Joosten, Alexandre Rousseau, Patrick Biston, Michael PiagnerelliS97 Early detection of disseminated  intravascular coagulation during septic shock: a multicentre prospective studyXavier Delabranche, Jean-Pierre Quenot, Thierry Lavigne, Emmanuelle Mercier, Bruno Fran√ßois, Fran√ßois Severac, L√©lia Grunebaum, Laure Stiel, Florence Toti, Ferhat Meziani, Julie Boisram√©-Helms, CRICS NetworkS98 Activation or dysregulation of coagulation during septic shock: How to stratify patients in 2016?Xavier Delabranche, Thierry Lavigne, Laure Stiel, Julie Boisram√©-Helms, Achille Kouatchet, Maleka Schenck, L√©lia Grunebaum, Yoganaden Mootien, Nicolas Lerolle, Ferhat MezianiS99 Associated factors to early high blood pressure after  weaning vasopressors during septic shockRostane Gaci, Jean-Romain Garric, Damien  Barraud, Marie Conrad, Aur√©lie Cravoisy-Popovic, J√©r√©mie Lemarie, Charles-Henri Maigrat, Pierre-Edouard Bollaert, S√©bastien GibotS100 Impact of endotracheal intubation on septic shock outcome: a post hoc analysis of the SEPSISPAM trialAgathe Delbove, C√©dric Darreau, Nicolas Lerolle, Pierre Asfar, CNER DESC r√©animation grand ouestS101 Corporal Contention at the Onset of Septic shock (COCOONs): study protocol and preliminary results of a phase II trialAuguste Dargent, Audrey Large, Agn√®s Soudry-Faure, Sebastien Prin, Pierre-Emmanuel Charles, Jean-Pierre Quenot, COCOONs Study GroupS102 Veno-arterial ECMO for refractory cardiogenic shock following cardiac arrestMarc Pineton De Chambrun, Nicolas Br√©chot, Guillaume Hekimian, Guillaume Lebreton, Matthieu Schmidt, Pierre Demondion, Ania Nieszkowska, Jean Louis Trouillet, Pascal Leprince, Jean Chastre, Alain Combes, Charles-Edouard LuytS103 Outcome of patients with pulmonary embolism treated by extra-corporeal life support (ECLS)Jean-Christophe Blanchard, Fran√ßois Belon, Sydney Chocron, Nicolas Meneveau, Lo√Øc Barrot, Nicolas Belin, B√©reng√®re Vivet, Guylaine Labro, Jean-Christophe Navellou, Cyrille Patry, Ga√´l Piton, Gilles CapellierS104 Acute massive pulmonary embolism rescued by veno-arterial extracorporeal membrane oxygenationFilippo Corsi, Guillaume Lebreton, Nicolas Br√©chot, Guillaume H√©kimian, Ania Nieszkowska, Charles-Edouard  Luyt, Pascal Leprince, Jean Louis Trouillet, Alain Combes, Matthieu SchmidtS105 Outcome of patient recused for extracorporeal membrane oxygenation for ARDSPierre-Emmanuel Meynieu, Benjamin Repusseau, Virginie Perrier, Arnaud Germain, Antoine Dewitte, Hadrien Roze, Alexandre OuattaraS106 Refractory electrical storm rescued by venoarterial extracorporeal membrane oxygenationGuillaume Baudry, Guillaume Lebreton, Guillaume Hekimian, Nicolas Brechot, Ania Nieszkowska, Charles-Edouard Luyt, Jean Louis Trouillet, Pascal Leprince, Alain Combes, Matthieu SchmidtS107 Incidence and determinants of severe bleeding among patients with extra-corporeal membrane oxygenation (ECMO)Lucie Hierle, Fran√ßois Belon, Guillaume Besch, Sebastien Pili-Floury, Lo√Øc Barrot, B√©reng√®re Vivet, Guylaine Labro, Jean-Christophe Navellou, Cyrille Patry, Nicolas Belin, Ga√´l Piton, Gilles CapellierS108 Venovenous extracorporeal membranous oxygenation device-related infections and colonizationsGuillemette Thomas, Jean-Marie Forel, Nadim Cassir, Sami Hraiech, Christophe Guervilly, Fanny Klasen, M√©lanie Adda, St√©phanie Dizier, Antoine Roch, Laurent PapazianS109 High emergency lung transplant for end-stage cystic fibrosis: ECMO as a bridge to transplant for patients with temporary contraindicationsGr√©goire Trebbia, Kiruba Govindaradjou,  Alexis Soummer, J√©r√¥me Devaquet, Cl√©ment Picard, Antoine Roux, Fran√ßois Parquin,  Elise Cuquemelle, Morgan Leguen, Marie-Louise Felten, Edouard Sage, Alain Chapelier, Charles CerfS110 Malignant acute respiratory distress syndrome in diffuse lepidic adenocarcinoma (DLA): diagnosis and current issuesMaxens Decav√®le, Antoine Parrot, Michael Duruisseaux, Jocelyne Fleury, Martine Antoine,  Marie-France Carette, Marie Wislez, Muriel FartoukhS111 Acute respiratory failure from pulmonary leukemic infiltrates: diagnosis contribution of high-resolution computed tomography (HRCT)Claire Givel, Virginie Lemiale, Constance De Margerie-Mellon, Etienne Lenglin√©, Le√Øla Mourtada, Fran√ßois Vincent, Akli Chermak, Eric De Kerviler, Elie AzoulayS112 Characteristics and outcome of patients with interstitial lung disease admitted to the intensive care unit over  a 15-year periodYacine Tandjaoui-Lambiotte, Fr√©d√©ric Gonzalez, Olivia Freynet, Guillaume Van Der Meersch, Johanna Oziel, Christophe Huang, Philippe Karoubi, Christophe Clec‚Äôh, Yves CohenS113 Outcome of patients admitted in intensive care  unit for acute manifestation of small vessel vasculitisAntoine Kimmoun, Elisabeth Baux, Vincent Das, Nicolas Terzi, Patrice Talec, Stephan Ehrmann, Guillaume Geri, Steven Grange, Nadia Anguel, Alexandre Demoule, Anne-Sophie Moreau, Elie Azoulay, Jean-Pierre Quenot, Julie Boisram√©-Helms, Guillaume Louis, Romain Sonneville, Nicolas Girerd, Bruno LevyS114 A monocenter retrospective study of predictive factors of prolonged intensive care unit hospitalization after a whole lung lavage procedure for patients with pulmonary alveolar proteinosisPauline Tallon,  Alice Hadchouel-Duverg√©, Nad√®ge Salvi, Pascale Cairet, Jean-Marc Treluyer, Mehdi  Oualha, Fabrice Lesage, Laure De Saint Blanquat, Sylvain Renolleau, Christophe Delacourt, Laurent DupicS115 Free fatty acids plasma profile during acute chest syndrome in adult patients with sickle cell disease: a pilot studyBlandine Lefebvre Blandine, Guillaume Lefevre, Laurence Beraud, Pierre Mora, Zo√© Coppere,  Antonin Lamaziere, Fran√ßois Lionnet, Muriel FartoukhS116 Extravascular lung water and lung ultrasound to predict severe primary graft dysfunction following lung transplantationSamuel Lehingue, Christophe Guervilly, St√©phanie Dizier, Laurent Zieleskiewicz, Xavier D‚Äôjourno, Guillemette Thomas, Fanny Klasen, M√©lanie Adda, Antoine Roch, Forel Jean-Marie, Marc Leone, Laurent PapazianS117 Results of the international multicentric prospective observational study Phase Angle Project: phase angle measured by bioimpedance analysis at intensive care unit (ICU) admission predicts 28-day survivalRonan Thibault, Anne-Marie Makhlouf, Aur√©lien Mulliez, Cristina Gonzalez, Sylvain Dadet, Gintautas Kekstas, Jean-Charles Preiser, Kozjek Nada Rotovnik, Isabel Ceniceros Rozalen, Kinga Kupczyk, Zeljko Krznaric, Fabienne Tamion, No√´l Cano, Claude Pichard, Phase angle project InvestigatorsS118 Nutrireaped: a survey of physician nutrition practices and knowledge in French-speaking pediatric intensive care unitsB√©n√©dicte Gaillard-Le  Roux, Aurelien Jacquot, Corinne Jotterand, Shancy Rooze, Clemence Moullet, Flavie Letois, Frederic VallaS119 A computerized tool increases compliance to caloric and protein targets and may lower mortality in neutropenic hematologic patients in the ICU: the NUTCHOCO study: NUTritionnal Care in Hematologic Oncologic patients and Critical OutcomeAur√©lia Henin, Florence Ettori, Christophe Zemmour,  Laurent Chow-Chine, Jeanpaul Brun, Antoine Sannini, Magali Bisbal, Marion Faucher, Jean Marie Boher, Djamel MokartS120 Systemic evaluation of intakes in patients receiving noninvasive ventilation: the STARVE studyMichel Arnaout, Aude  Marincamp, Matthieu Reffienna, Anne-Sophie Debue, Pierre Lucas, Audrey Feltry, Julien Charpentier, Benoit Champigneulle, Wulfran Bougouin, Guillaume Geri, Fr√©d√©ric P√®ne, Jean-Paul Mira, Alain Cariou, Jean-Daniel Chiche, Groupe de travail sur la ventilationS121 Computerized glucose control in the ICUSalah Adel  Ben, Juliette Audibert, Alexandre Conia, Olivier Gontier, Mouldi Hamrouni, Thierry Lherm, Abdelkader Ouchenir, J√©r√¥me R√©tif, Alain Proudhom, Chantal Lagardere, St√©phane Tissot, Pierre KalfonS122 Toxicodynetics in mono-intoxications with oxazepam and nordiazepam: an approach to a better understanding of drug‚Äìdrug interactionLynn Sacre, Antoine Villa, Alaywa Khadija,  Robert Garnier, Frederic BaudS123 Rapid triage of victims suspected of a chemical attack: a one-page sheet allowing identifying the toxidrome: the doctors without  borders (MSF) experienceFrederic Baud, Robert Garnier, Brigitte Vasset, Annette HeinzelmanS124 Low sensitivity of toxicological analysis in daily practice of acute poisonings: an endless rupture in spite of modern technologyFrederic Baud,  Alaywa Khadija, Romain Jouffroy, Lionel LamhautS125 Context of the request and interest of toxicological screening in a medical intensive care unitElsa D√©marest Durand, Fabienne Tamion, Christophe Girault, Gaetan Beduneau, Doroth√©e Carpentier, Patricia Compagnon, Steven GrangeS126 Acute poisoning in emergency departmentNeila Maaroufi, Dhaouadi MahassenS127 Management of poising: Are there  differences between specialised and non-specialised emergencies?A M‚Äôrad, Alia Jebri, Youssef Blel, Hend Ben Lakhal, Messaouda Khelfa, Nozha Brahmi, H ThabetS128 Jusquiame poisoning: report of a family intoxicationHassen Ben Ghezala, Salah Snouda, Rebeh Daoudi, Moez KaddourS129 Morbi-mortality of poisoning episodes in Paris region: a test for a multisource surveillance systemC√©line Legout, Robert Garnier, Antoine Villa, Frederic Baud, Philippe Aegerter, Anne Castot-VillepeletS130 Atypical pneumonia in the ICU: a retrospective multicentric studySandrine Valade, Virginie Lemiale, Laurent Argaud, Fr√©d√©ric P√®ne, Laurent Papazian, Fabrice Bruneel, Am√©lie Seguin, Achille  Kouatchet, Johanna Oziel, Olivier Lesieur, Florence Boissier, Bruno Megarbane, Na√Øke Big√©, Noelle Brule, Anne-Sophie Moreau, Alexandre Lautrette, Elie AzoulayS131 Severe leptospirosis: analysis of mortality and organ failures in 134 patients hospitalized in intensive care unitBenjamin Delmas, Julien Jabot, Paul Chanareille, J√©r√¥me Allyn, Nicolas Allou, Cyril Ferdynus, Bernard-Alex Gauzere, Olivier Martinet, David VandrouxS132 In severe pneumonia, respiratory viruses are not passengers but pathogensGuillaume Voiriot, Benoit Visseaux, Johana Cohen, Liem Binh Luong Nguyen, Mathilde Neuville, Caroline Morbieu, Charles Burdet, Aguila Radjou, Fran√ßois-Xavier Lescure, Roland Smonig, Laurence Armand-Lefevre, Bruno Mourvillier, Yazdan Yazdanpanah, Jean-Fran√ßois Soubirou, Stephane Ruckly, Nadira Houhou-Fidouh, Jean-Fran√ßois TimsitS133 Critical care management of patients with HHV8-associated disordersMarine Cazaux, Claire Pichereau, Marion Venot, Sandrine Valade, Virginie Lemiale, Akli Chermak, Emmanuel Canet, Le Goff J√©r√¥me, Veronique Meignin, David Boutboul, Lionel Galicier, Elie Azoulay, Eric MariotteS134 Emerging moulds in critically ill patients: epidemiological trends,  clinical features and ICU outcomeLaura Platon, Philippe Rispail, Vincent Brunot,  N. Besnard, Patrice Ceballos, Kada KloucheS135 Intensive care unit-associated bloodstream infection and ventilator-associated pneumonia in critically ill cancer patients: a 12-year retrospective studyAnnabelle Stoclin, Federico Rotolo, Muriel Wartelle, Yosr Hicheri, Sylvia Maillet, Elisabeth Chachaty, Jean-Pierre Pignon, Fran√ßois BlotS136 Is diabetes mellitus a risk factor for intensive care unit-acquired infections?Marion Venot, Stephane Ruckly, Christophe Clec‚Äôh, Micha√´l Darmon, Bernard Allaouchiche, Dany Goldgran Toledano, Ma√Øt√© Garrouste-Orgeas, Christophe Adrie, Jean-Fran√ßois Timsit, Elie AzoulayPHYSIOTHERAPISTS ABSTRACTSO85 Short-term physiological effects of nasal high-flow in healthy subjects. Impact of flow rates on the work of breathingMathieu Delorme, Pierre Alexandre Bouchard, Mathieu Simon, Fran√ßois LelloucheO86 High-flow therapy allows a decreased workload of accessory respiratory musclesEmilie Bialais, Dupuis Julie, Laura Paoloni, Gregory Reychler, Xavier WittebolleO87 Patient perception and feasibility of early mobilization in  the critically illCheryl Hickmann, Diego Castanares-Zapatero, Emilie Bialais, Jonathan Dugernier, Antoine Tordeur, Lise Colmant, Xavier Wittebole, Giuseppe Tirone, Jean Roeseler, Pierre-Fran√ßois LaterreP252 Early rehabilitation in critically ill patients: a prospective multicenter assessment of real-life practiceLorraine Ducroux, Sylvie L‚Äôhotellier, Elodie Baumgarten, St√©phanie Borschneck, Francis Schneider, Vincent CastelainP253 Motor imagery and functional magnetic resonance imagingClaire Kemlin, Eric Moulton, Charlotte RossoP254 Thoracic ultrasound: potential new tool for physiotherapists in respiratory management‚Äîa narrative reviewAymeric Le Neindre, Silvia Mongodi, Francois Philippart, B√©a√Ød BouhemadP255 In vitro comparison of a vibrating-mesh nebulizer  operating in expiratory synchronized and inspiratory nebulization modes during noninvasive ventilationJoana Rodrigues, Caroline Botteau, Jonathan Dugernier, Giuseppe Liistro, Gregory Reychler, Jean-Bernard MichotteP256 Evaluation of a new system of oxygen administration: the Wenoll systemFr√©d√©ric Duprez, Fran√ßois Waroquier, Karel Christiaens, Gr√©gory Cuvelier, Frank Vantrimpont, Sharam MachayeckhiP257 Evaluation of three portable oxyconcentrators in high altitudeFr√©d√©ric Duprez, Fran√ßois Waroquier, Karel Christiaens, Gr√©gory Cuvelier, Charbel Elkhawand, Frank Vantrimpont, Sharam Machayeckhi, Frank Vermeesh},
address  = {Centre de r√©animation, Centre Hospitalier R√©gional Universitaire de Lille (CHRU), Lille, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France Reanimation, Hospital Center De Boulogne-Sur-Mer, Boulogne-sur-Mer, France Laboratoire de biochimie et biologie mol√©culaire, C.h.r.u. Lille, Lille, France R√©animation, Centre Hospitalier de Tourcoing, Tourcoing, France R√©animation, H√¥pital Victor Provo, Roubaix, France Reanimation, Hospital Center De Dunkerque, Dunkerque, France Reanimation, Hospital Saint Philibert, Lille, France Reanimation, Hospital Center De Valenciennes, Valenciennes, France Reanimation, C.H. de Lens, Lens, France Centre de r√©animation, Centre Hospitalier R√©gional Universitaire de Lille (CHRU), Lille, France Reanimation, Hospital Center De Boulogne-Sur-Mer, Boulogne-sur-Mer, France R√©animation, Centre Hospitalier de Tourcoing, Tourcoing, France Centre de r√©animation, Centre Hospitalier R√©gional Universitaire de Lille (CHRU), Lille, France Clinique de sant√© publique, plateforme d‚Äôaide m√©thodologique, C.h.r.u. Lille, Lille, France Centre de r√©animation, Centre Hospitalier R√©gional Universitaire de Lille (CHRU), Lille, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation polyvalente, C.H. M√©morial France - Etats-Unis (Saint-L√¥), Saint-L√¥,  France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation polyvalente, C.H. M√©morial France - Etats-Unis (Saint-L√¥), Saint-L√¥,  France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France Unit√© de biostatistique et de recherche clinique, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France Service de r√©animation adultes, C.H.U. Estaing, Clermont-Ferrand, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation m√©dicale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France R√©animation m√©dicale et chirurgicale, CHU Lyon Sud, Lyon, France Service d‚Äôanesth√©sie r√©animation 2, unit√© r√©animation thoracique greffe, CHU de Bordeaux, Bordeaux, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation m√©dicale, Centre Hospitalier Universitaire Archet, Nice, France DAR B, H√¥pital Saint Eloi, Montpellier, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation m√©dicale, CHU Dijon, Dijon, France Centre d‚Äôinvestigation clinique, Chu Dijon, Dijon, France R√©animation polyvalente, Centre Hospitalier Marc Jacquet, Melun, France 30, Chru De N√Æmes, N√Æmes, France Centre d‚Äôinvestigation clinique, Chu Dijon, Dijon, France 21, Facult√© de m√©decine, Dijon, France 21, Facult√© de m√©decine, Dijon, France R√©animation m√©dicale, CHU Gabriel-Montpied, Clermont-Ferrand, France R√©animation m√©dicale, CHU Dijon, Dijon, France R√©animation m√©dicale, CHU Gabriel-Montpied, Clermont-Ferrand, France 21, Facult√© de m√©decine, Dijon, France Physiologie, H√¥pital Cochin, Paris, France DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France D√©partement de l‚Äôinformation m√©dicale, H√¥pital La Colombi√®re, Montpellier, France Service de soins intensifs, Hospital Erasme, Brussel, Belgium Service de gastroent√©rologie, Hospital Erasme, Brussel, Belgium Service de maladies infectieuses, Hospital Erasme, Brussel, Belgium Service de biochimie m√©dicale, Hospital Erasme, Brussel, Belgium Service de biochimie m√©dicale, Hospital Erasme, Brussel, Belgium Service de maladies infectieuses, Hospital Erasme, Brussel, Belgium Service de soins intensifs, Hospital Erasme, Brussel, Belgium Service de soins intensifs, Hospital Erasme, Brussel, Belgium Service de gastroent√©rologie, Hospital Erasme, Brussel, Belgium Service de maladies infectieuses, Hospital Erasme, Brussel, Belgium Service de soins intensifs, Hospital Erasme, Brussel, Belgium R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France Service de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard-APHP, Paris, France Unit√© de microbiologie clinique et dosages des anti-infectieux, Groupe hospitalier Paris Saint-Joseph, Paris, France Unit√© de microbiologie clinique et dosages des anti-infectieux, Groupe hospitalier Paris Saint-Joseph, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France Unit√© de r√©animation robert debr√©, CHU Reims, Reims, France Soins Intensifs, H√¥pital Erasme, Brussels, Belgium Service de microbiologie clinique, Hospital Erasme, Brussel, Belgium Soins intensifs, Hospital Erasme, Brussels, Belgium Intensive Care Unit, H√¥pital Civil Marie Curie, Charleroi, Belgium Intensive Care Unit, H√¥pital Civil Marie Curie, Charleroi, Belgium Intensive Care Unit, H√¥pital Civil Marie Curie, Charleroi, Belgium Internal medicine, Hospital Andr√© V√©sale, Montigny-le-Tilleul, Belgium Pharmacy, Hospital Andr√© V√©sale, Montigny-le-Tilleul, Belgium Intensive Care Unit, H√¥pital Civil Marie Curie, Charleroi, Belgium Icu, Hospital Ambroise Par√©, Boulogne-Billancourt, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France R√©animation Polyvalente, CHU Limoges, Limoges, France R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France R√©animation m√©dicale, CHRU de Brest, Brest, France Icu, Hospital Foch, Suresnes, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France Service de r√©animation m√©dicale, inserm umr_s 999, H√¥pital de Bic√™tre, Universit√© Paris-Sud, Facult√© de M√©decine, Universit√© Paris-Saclay, Le Kremlin-Bic√™tre, France Department of Medicine, Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, USA Service de r√©animation m√©dicale, inserm umr_s 999, H√¥pital de Bic√™tre, Universit√© Paris-Sud, Facult√© de M√©decine, Universit√© Paris-Saclay, Le Kremlin-Bic√™tre, France Service de r√©animation m√©dicale, H√¥pital de Bic√™tre, Facult√© de m√©decine Paris-Sud, universit√© Paris-Sud, Le Kremlin-Bic√™tre, France Service de r√©animation m√©dicale, H√¥pital de Bic√™tre, Facult√© de m√©decine Paris-Sud, universit√© Paris-Sud, Le Kremlin-Bic√™tre, France R√©animation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil, Elbeuf, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil, Elbeuf, France R√©animation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil, Elbeuf, France R√©animation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil, Elbeuf, France R√©animation Polyvalente - USC, Centre Hospitalier Elbeuf Louviers Val de Reuil, Elbeuf, France Cardiology, Chu De Rouen, Rouen, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation et surveillance continue p√©diatriques, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France R√©animation et surveillance continue p√©diatriques, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France R√©animation et surveillance continue p√©diatriques, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France R√©animation et surveillance continue p√©diatriques, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France R√©animation et surveillance continue p√©diatriques, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France R√©animation et surveillance continue p√©diatriques, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France Pediatric departement, CHR de la Citadelle, Li√®ge, Belgium Pediatric respirology departement, CHR de la Citadelle, Li√®ge, Belgium Pediatric intensive care unit, CHR de la Citadelle, Li√®ge, Belgium R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France Service de biostatistiques, Hospices Civils de Lyon, Lyon, France R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France R√©animation p√©diatrique, H√¥pital Arnaud-de-Villeneuve, Montpellier, France Service de r√©animation p√©diatrique, CHU de Bic√™tre, Le Kremlin-Bic√™tre, France R√©animation p√©diatrique, CHU de Nantes, Nantes, France R√©animation p√©diatrique, H√¥pitaux P√©diatrique CHU-Lenval, Nice, France R√©animation p√©diatrique, H√¥pital Arnaud-de-Villeneuve, Montpellier, France Service de r√©animation p√©diatrique, CHU de Bic√™tre, Le Kremlin-Bic√™tre, France R√©animation p√©diatrique, CHU de Nantes, Nantes, France R√©animation p√©diatrique, H√¥pitaux P√©diatrique CHU-Lenval, Nice, France R√©animation p√©diatrique, H√¥pital Arnaud-de-Villeneuve, Montpellier, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France Neurologie, CHU Lariboisi√®re, Paris, France Neuroradiologie, CHU Lariboisi√®re, Paris, France Neurochirurgie, CHU Lariboisi√®re, Paris, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1137, infection, antimicrobiens, mod√©lisation, evolution, H√¥pital Bichat-Claude Bernard, Paris, France Service de m√©decine interne, Hospital Beaujon, Clichy, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Inserm u1148, laboratory for vascular translational science, H√¥pital Bichat-Claude Bernard, Paris, France Service de r√©animation m√©dicale, Cochin, Paris, France Service de r√©animation neurologique, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation neurologique, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation, H√¥pital Raymond-Poincar√©, Garches, France F√©deration des maladies du syst√®me nerveux, Piti√©-Salp√™tri√®re Hospital, Paris, France Service de soins intensifs, Hospital Erasme, Brussels, Belgium Service de soins intensifs, Hospital Erasme, Brussels, Belgium R√©animation, Hospital Foch, Suresnes, France D√©partement d‚Äôanesth√©sie-r√©animation, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France Neuroradiology, Hospital Foch, Suresnes, France Neurosurgery, Hospital Foch, Suresnes, France R√©animation, Hospital Foch, Suresnes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Giga la vie, Institut des Hauts de Seine, Nanterre, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Laboratoire ilumens, Universist√© Ren√© Descartes - Paris V, Paris, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Laboratoire ilumens, Universist√© Ren√© Descartes - Paris V, Paris, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France R√©animation m√©dicale brabois, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France R√©animation m√©dicale brabois, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France Sau-samu-smur, C.H.U. de Nancy, Nancy, France Sau-samu-smur, C.H.U. de Nancy, Nancy, France Cardiologie, C.H.U. de Nancy, Nancy, France Chirurgie cardiaque, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France R√©animation m√©dicale brabois, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France Laboratoire d‚Äôimmunologie, H√¥pital √âdouard Herriot, Lyon, France R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France Laboratoire d‚Äôimmunologie, H√¥pital √âdouard Herriot, Lyon, France Laboratoire d‚Äôimmunologie, H√¥pital √âdouard Herriot, Lyon, France R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France Emergency department, Cochin hospital-APHP, Paris, France R√©animation adulte, H√¥pital Necker - Enfants Malades, Paris, France Cardiologie, H√¥pital Cochin-Port Royal, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Cardiologie, H√¥pital Cochin, Paris, France R√©animation adulte - samu, H√¥pital Necker - Enfants Malades, Paris, France Cardiologie, H√¥pital Europ√©en Georges-Pompidou, Paris, France Cardiologie, H√¥pital Europ√©en Georges-Pompidou, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Unit√© de m√©thodologie et de qualit√© de vie en canc√©rologie, CHRU de Besan√ßon, Boulevard Alexandre Fleming, Besan√ßon, France Cardiologie, H√¥pital Europ√©en Georges-Pompidou, Rue Leblanc, Paris, France Inserm u970, Paris Centre de recherche Cardio-vasculaire, Paris, France R√©animation m√©dicale, h√¥pital Cochin, Assistance Publique - H√¥pitaux de Paris, Paris, France Biostatistiques, H√¥pital Saint-Louis, Paris, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation pneumologique, H√¥pital Cochin, Paris, France R√©animation, Institut Jules Bordet, Brussels, Belgium R√©animation polyvalente, Hopital universitaire, Gand, Belgium R√©animation m√©dico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France R√©animation m√©dicale, CHU Bichat, Paris, France 38, C.H.U de Grenoble C.H.U, La Tronche, France Umr 1137, Inserm iame, Paris, France R√©animation, CH gonesse, Gonesse, France Reanimation medicale, Assistance Publique H√¥pitaux de Paris, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France Immuno-h√©matologie, Assistance Publique H√¥pitaux de Paris, Paris, France Medical Intensive Care Unit, Hospital Henri Mondor, Cr√©teil, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France Service de r√©animation polyvalente, Centre Hospitalier de Versailles, Le Chesnay, France Service de r√©animation polyvalente, Centre hospitalier intercommunal Robert Ballanger, Aulnay-sous-Bois, France R√©animation M√©dicale, H√¥pital Saint-Antoine, AP-HP, Paris, France R√©animation polyvalente, C.H. Victor Dupouy (Argenteuil), Argenteuil, France R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France Neurophysiologie et explorations fonctionnelles, Chu De Poitiers, Poitiers, France Neurophysiologie et explorations fonctionnelles, Chu De Poitiers, Poitiers, France Neurophysiologie et explorations fonctionnelles, Chu De Poitiers, Poitiers, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France R√©animation, Centre Hospitalier Universitaire Toulouse, Toulouse, France Critical care unit, CHR, Narbonne, France R√©animation, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France R√©animation, Centre Hospitalier Universitaire Toulouse, Toulouse, France R√©animation, Centre Hospitalier Universitaire Toulouse, Toulouse, France R√©animation, Centre Hospitalier Universitaire Toulouse, Toulouse, France Critical care unit, CHR, Narbonne, France Critical care unit/inserm u825, University Teaching Hospital of Purpan, Toulouse, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France Service de r√©animation m√©dicale, inserm umr_s 999, H√¥pital de Bic√™tre, Universit√© Paris-Sud, Facult√© de M√©decine, Universit√© Paris-Saclay, Le Kremlin-Bic√™tre, France Service de r√©animation m√©dicale, inserm umr_s 999, H√¥pital de Bic√™tre, Universit√© Paris-Sud, Facult√© de M√©decine, Universit√© Paris-Saclay, Le Kremlin-Bic√™tre, France Service de r√©animation m√©dicale, inserm umr_s 999, H√¥pital de Bic√™tre, Universit√© Paris-Sud, Facult√© de M√©decine, Universit√© Paris-Saclay, Le Kremlin-Bic√™tre, France Descid - team 5, INSERM U1137, Paris, France R√©animation, Centre Hospitalier de Tourcoing, Tourcoing, France Anesth√©sie et soins intensifs, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation adulte, C.H.U. Estaing, Clermont-Ferrand, France R√©animation cardio thoracique et vasculaire, CHU Amiens-Picardie, Amiens, France Umr 1181, Biostatistics, Biomathematics, Pharmacoepidemiology and Infectious Diseases, Inserm, Paris, France Necker Pasteur Center for Infectious Diseases, Hospital Necker, Paris, France R√©animation m√©dicale et chirurgicale, C.H.U. De Montpellier, Prades-le-Lez, France Mycologie, Hospital Center University De Rennes, Rennes, France R√©animation m√©dicale, Hospital Henri Mondor, Cr√©teil, France R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France Cepi, Hospital Henri Mondor, Cr√©teil, France Service de pneumologie et r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re - APHP, Paris, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Biostatistics/Bioinformatics, Biom√©rieux, Marcy-l‚Äô√âtoile, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Unit√© 1016, institut National de la Sant√© et de la Recherche M√©dicale, 22 rue m√©chain, 75014 Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Recherche diagnostique, Biomerieux, Rue Censier, Paris, France R√©animation DRIS, H√¥pital Nord APHM, Marseille, France Anesth√©sie, H√¥pital d‚Äôinstruction des Arm√©es Sainte-Anne, Toulon, France Unite des virus emergents umr190 ‚Äúemergence des pathologies virales‚Ä? faculte de medecine, 27, Aix-Marseille Universit√©, Marseille, France Ihu m√©diterran√©e infection, urmite cnrs ird inserm umr 7278, Aix-Marseille Universit√©, Marseille, France R√©animation d√©tresses respiratoires et infections s√©v√®res (DRIS), H√¥pital Nord APHM, Marseille, France R√©animation d√©tresses respiratoires et infections s√©v√®res (DRIS), H√¥pital Nord APHM, Marseille, France R√©animation d√©tresses respiratoires et infections s√©v√®res (DRIS), H√¥pital Nord APHM, Marseille, France Ihu m√©diterran√©e infection, urmite cnrs ird inserm umr 7278, Aix-Marseille Universit√©, Marseille, France R√©animation d√©tresses respiratoires et infections s√©v√®res, H√¥pital Nord APHM, Marseille, France R√©animation m√©dicale, Assistance Publique H√¥pitaux de Paris, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, Assistance Publique H√¥pitaux de Paris, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, Assistance Publique H√¥pitaux de Paris, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France Pain Management and Palliative Care Unit - Children Hospital, CHU Toulouse, Toulouse, France Child and Adolescent Psychiatry Unit - La Grave Hospital, CHU Toulouse, Toulouse, France Critical Care Unit - Rangueil Hospital, CHU Toulouse, Toulouse, France Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France Critical care unit - purpan hospital, CHU Toulouse, Toulouse, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France D√©partement d‚Äôepid√©miologie et recherche clinique, Unit√© de Recherche Clinique Paris Nord, Paris, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France D√©partement d‚Äôepid√©miologie et recherche clinique, Unit√© de Recherche Clinique Paris Nord, Paris, France D√©partement d‚Äôepid√©miologie et recherche clinique, Unit√© de Recherche Clinique Paris Nord, Paris, France R√©animation et surveillance continue p√©diatriques, Hospital Robert-Debr√©, Paris,  France R√©animation et surveillance continue m√©dicochirurgicales p√©diatriques, H√¥pital Necker Enfants-Malades, Paris, France R√©animation n√©onatale et n√©onatalogie, H√¥pital Robert-Debr√©, Paris, France R√©animation et m√©decine n√©onatales, H√¥pital Cochin-Port-royal, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France Service de pneumologie et r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Service de neurologie mazarin 2, Piti√©-Salp√™tri√®re Hospital, Paris, France Service de neurologie mazarin 2, Piti√©-Salp√™tri√®re Hospital, Paris, France Service de neurologie mazarin 2, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation, C.H. G√©n√©ral Saint Denis h√¥pital Delafontaine, Saint-Denis, France R√©animation m√©dicale, CHU, Nantes, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation neurologique, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France R√©animation m√©dicale, CHU Brest, Brest, France R√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France Centre national de reference des syndromes neurologiques paran√©oplasiques, H√¥pital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre national de reference des syndromes neurologiques paran√©oplasiques, H√¥pital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Centre national de reference des syndromes neurologiques paran√©oplasiques, H√¥pital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Bron, France Anaesthesiology and Critical Care Department, San Gerardo Hospital, Monza, Italy R√©animation, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation polyvalente, C.H.U. de Nancy, Nancy, France Anaesthesiology and Critical Care Department, San Gerardo Hospital, Monza, Italy R√©animation m√©dico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay, France Brain-Liver Piti√©-Salp√™tri√®re Study Group (BLIPS), Soins Intensifs d‚ÄôH√©patologie, Piti√©-Salp√™tri√®re Hospital, Paris, France Brain-Liver Piti√©-Salp√™tri√®re Study Group (BLIPS), Soins Intensifs d‚ÄôH√©patologie, Piti√©-Salp√™tri√®re Hospital, Paris, France Brain-Liver Piti√©-Salp√™tri√®re Study Group (BLIPS), Soins Intensifs d‚ÄôH√©patologie, Piti√©-Salp√™tri√®re Hospital, Paris, France D√©partement de biochimie, H√¥pital Piti√©-Salp√™tri√®re, Paris, France Brain-Liver Piti√©-Salp√™tri√®re Study Group (BLIPS), Soins Intensifs d‚ÄôH√©patologie, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France D√©partement de n√©phrologie et transplantation d‚Äôorganes, Hopital Rangueil, Toulouse, France R√©animation M√©dicale, H√¥pital Saint-Louis, Assistance Publique H√¥pitaux de Paris, Paris, France Loiret, H√¥pital R√©gional Orl√©ans La Source, Orl√©ans, France R√©animation m√©dico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay, France R√©animation m√©dicale, C.H.U. H√¥tel Dieu, Nantes, France Service de r√©animation polyvalente, H√¥pitaux de Saint-Nazaire, Saint-Nazaire, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France Service de r√©animation, CHU Lapeyronie, Montpellier, France Service de biostatistique et information m√©dicale, H√¥pital Saint-Louis, Paris, France D√©partement de Biostatistiques et d‚ÄôEpid√©miologie, CHU de Poitiers, Poitiers, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France R√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France Service de r√©animation m√©dicale et m√©decine hyperbare, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Interdepartmental Division of Critical Care- University of Toronto, Hospital St.  Michael and Keenan Research Center, Toronto, Canada 92151, Hospital Foch, Suresnes, France Medical ICU, H√¥pital Saint Louis, Paris, France Paris, Piti√©-Salp√™tri√®re Hospital, Paris, France Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, Piti√©-Salp√™tri√®re Hospital, Paris, France Cardiac and Thoracic Surgery, iCAN, Institute of Cardiometabolism and Nutrition,  Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Medical Intensive Care Unit, iCAN, Institute of Cardiometabolism and Nutrition, Piti√©-Salp√™tri√®re Hospital, Paris, France Service de r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, Paris, France Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Service de r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, Paris, France Service de r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, Paris, France Service de pneumologie et r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation m√©dicale, CHRU de Besan√ßon, Besan√ßon, France Depm, Monash University, ANZIC-RC, Melbourne, Australia Depm, Monash University, ANZIC-RC, Melbourne, Australia R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation m√©dicale, CHRU de Besan√ßon, Besan√ßon, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France Inserm cic 1435/medical-surgical icu, Chu Limoges, Limoges, France Hematology Laboratory/umr cnrs 7276, Chu Limoges, Limoges, France Inserm cic 1415, Chru H√¥pitaux De Tours, Tours, France Medical icu, Chru H√¥pitaux De Tours, Tours, France Emergency Department/Inserm cic 1415, Chru H√¥pitaux De Tours, Tours, France Emergency Department, Chu Limoges, Limoges, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France Service de R√©animation Polyvalente/Inserm UMR-S 1092/Facult√© de M√©decine, Centre  Hospitalier Universitaire de Limoges, Limoges, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France Inserm UMR-S 1092/Facult√© de M√©decine/Laboratoire de Bact√©riologie, Centre Hospitalier Universitaire de Limoges, Limoges, France Inserm UMR-S 1092/Facult√© de M√©decine/Laboratoire de Bact√©riologie, Centre Hospitalier Universitaire de Limoges, Limoges, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France R√©animation polyvalente, C.H.U. De Charleroi, Charleroi, Belgium Laboratoire de biologie humaine et toxicologie, Universit√© de Mons - Campus Plaine de Nimy, Mons, Belgium Laboratoire de biologie humaine et toxicologie, Universit√© de Mons - Campus Plaine de Nimy, Mons, Belgium Anesthesiology and critical care, Hospital Lariboisi√®re, Paris, France Anesthesiology and critical care, Hospital Lariboisi√®re, Paris, France Hematology, Hospital Lariboisi√®re, Paris, France Immunology, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France P√¥le biologie, Centre Hospitalier Universitaire de Rennes, Rennes, France Biosit and inserm u917, faculte de medecine, universite rennes i, Centre Hospitalier Universitaire de Rennes, Rennes, France Inserm u917, Facult√© de M√©decine de Rennes - Universit√© Rennes 1, Rennes, France Inserm u917, Facult√© de M√©decine de Rennes - Universit√© Rennes 1, Rennes, France Service de biochimie, AP-HP, H√¥pital Cochin, Paris, France Inserm u917, Facult√© de M√©decine de Rennes - Universit√© Rennes 1, Rennes, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France Biosit and inserm u917, faculte de medecine, universite rennes i, Centre Hospitalier Universitaire de Rennes, Rennes, France Service de n√©phrologie et transplantation r√©nale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France D√©partement de r√©animation m√©dicale et m√©decine hyperbare, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France R√©animation polyvalente, CHRU H√¥pitaux de Tours, Tours, France Centre hospitalier universitaire d‚Äôangers, Service de R√©animation M√©dicale et M√©decine Hyperbare, Angers, France R√©animation, Centre de r√©animation, Lille, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France Service de m√©decine intensive adulte et centre des br√ªl√©s, CHUV | Centre hospitalier universitaire vaudois, Lausanne, Switzerland R√©animation m√©dicale, CHU Gabriel-Montpied, Clermont-Ferrand, France Service de r√©animation m√©dicale, CHU Nice, Nice, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France R√©animation m√©dicale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Umr 1137 iame equipe 5 descid, Universit√© Paris Diderot, Paris, France R√©animation medico-chirurgicale, Hopital avicenne, Bobigny, France Nephrologie, C.H.U Grenoble, La Tronche, France R√©animation m√©dicale, Hospital Center De Versailles, Le Chesnay, France R√©animation polyvalente, Centre Hospitalier G√©n√©ral, Gonesse, France R√©animation G, CHU H√¥pital Nord, Saint-Priest-en-Jarez, France R√©animation m√©dico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay, France R√©animation chirurgicale, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation m√©dicale, Centre Hospitalier Sud Essonne, Dourdan, France R√©animation M√©dicale, CHU Saint-Etienne - H√¥pital Nord, Saint-√âtienne, France R√©animation polyvalente, service d‚Äôanesth√©sie-r√©animation 2, CHU de Bordeaux, Maison du Haut L√©v√®que, Avenue de Magellan, Pessac, France R√©animation polyvalente, service d‚Äôanesth√©sie-r√©animation 2, CHU de Bordeaux, Maison du Haut L√©v√®que, Avenue de Magellan, Pessac, France R√©animation polyvalente, service d‚Äôanesth√©sie-r√©animation 2, CHU de Bordeaux, Maison du Haut L√©v√®que, Avenue de Magellan, Pessac, France R√©animation polyvalente, service d‚Äôanesth√©sie-r√©animation 2, CHU de Bordeaux, Maison du Haut L√©v√®que, Avenue de Magellan, Pessac, France R√©animation polyvalente, service d‚Äôanesth√©sie-r√©animation 2, CHU de Bordeaux, Maison du Haut L√©v√®que, Avenue de Magellan, Pessac, France R√©animation polyvalente, service d‚Äôanesth√©sie-r√©animation 2, CHU de Bordeaux, Maison du Haut L√©v√®que, Avenue de Magellan, Pessac, France R√©animation polyvalente, service d‚Äôanesth√©sie r√©animation 2, CHU de Bordeaux, Bordeaux, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation, Fondation Hopital Saint Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France Ile de France, Hospital Group Paris Saint-Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France R√©animation, H√¥pital Paris Saint-Joseph, Paris, France R√©animation, Groupe Hospitalier Paris Saint-Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France R√©animation, H√¥pital Paris Saint-Joseph, Paris, France Depm, Monash University, ANZIC-RC, Melbourne, Australia R√©animation m√©dicale, CHRU de Brest, La Cavale Blanche, Brest, France Depm, Monash University, ANZIC-RC, Melbourne, Australia Intensive Care Unit, Alfred Hospital, Melbourne, Australia Depm, Monash University, Melbourne, Australia The Transfusion Service, Austin Hospital, Heidelberg, Australia The Transfusion Service, Austin Hospital, Heidelberg, Australia Infectious Diseases Department, Austin Hospital, Heidelberg, Australia Infectious Diseases Department, Austin Hospital, Heidelberg, Australia Depm, Transfusion Research Unit, Monash University, Melbourne, Australia R√©animation m√©dicale polyvalente, C.H.U. H√¥tel Dieu, Nantes, France R√©animation m√©dicale polyvalente, C.H.U. H√¥tel Dieu, Nantes, France Post-graduation Program, D‚ÄôOr Institute for Research and Education, Rio de Janeiro, Brazil R√©animation m√©dico-chirurgicale, H√¥pital Avicenne, Bobigny, France R√©animation m√©dico-chirurgicale, GHIC Le Raincy-Montfermeil, Montfermeil, France Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy, France Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy, France Haute savoie, Department of Urology, Hospital Center Annecy Genevois, Metz-Tessy, France Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy, France Haute savoie, Organ Procurement Coordination, Hospital Center Annecy Genevois, Metz-Tessy, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France Unit√© de r√©animation chirurgicale polyvalente, service d‚Äôanesth√©sie r√©animation,  Hospital Beaujon, Clichy, France Unit√© de r√©animation chirurgicale polyvalente, service d‚Äôanesth√©sie r√©animation,  Hospital Beaujon, Clichy, France Unit√© de r√©animation chirurgicale polyvalente, service d‚Äôanesth√©sie r√©animation,  Hospital Beaujon, Clichy, France Unit√© de r√©animation chirurgicale polyvalente, service d‚Äôanesth√©sie r√©animation,  Hospital Beaujon, Clichy, France Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium Data Centre, Institute Jules Bordet, Brussels, Belgium Data Centre, Institute Jules Bordet, Brussels, Belgium Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium Intensive Care and Thoracic Oncology, Institute Jules Bordet, Brussels, Belgium Dar a centre r√©gional d‚Äôaccueil des polytraumatis√©s, Hospital Lapeyronie, Montpellier Cedex 5, France Dar a centre r√©gional d‚Äôaccueil des polytraumatis√©s, Hospital Lapeyronie, Montpellier Cedex 5, France Inserm u1046, Hospital Lapeyronie, Montpellier Cedex 5, France Dar a centre r√©gional d‚Äôaccueil des polytraumatis√©s, Hospital Lapeyronie, Montpellier Cedex 5, France Dar a centre r√©gional d‚Äôaccueil des polytraumatis√©s, Hospital Lapeyronie, Montpellier Cedex 5, France Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Cr√©teil, France Prehospital Emergency Medicine Unit (smur 95), Centre Hospitalier, Gonesse, France Prehospital Emergency Medicine Unit (smur 95), Centre Hospitalier, Gonesse, France Prehospital Emergency Medicine Unit (smur 95), Centre Hospitalier, Gonesse, France Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Cr√©teil, France Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Cr√©teil, France Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco R√©animation m√©dico-chirurgicale, Hospital Center De Versailles, Le Chesnay, France R√©animation m√©dico-chirurgicale, Hospital Center De Versailles, Le Chesnay, France R√©animation m√©dicale, CHU Bichat, Paris, France R√©animation m√©dico-chirurgicale, Hospital Center De Versailles, Le Chesnay, France D√©partement d‚Äôh√©pato-gastroent√©rologie et nutrition, C.H.U de Caen, Caen, France Laboratoire d‚Äôanatomie pathologique, C.H.U de Caen, Caen, France Laboratoire d‚Äôanatomie pathologique, C.H.U de Caen, Caen, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, inserm umr_s 999, H√¥pital de Bic√™tre, Universit√© Paris-Sud, Facult√© de M√©decine, Universit√© Paris-Saclay, Le Kremlin-Bic√™tre, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de chirurgie h√©pato-biliaire et transplantation, H√¥pital de Hautepierre,  H√¥pitaux Universitaires de Strasbourg, Strasbourg, France Service de chirurgie h√©pato-biliaire et transplantation, H√¥pital de Hautepierre,  H√¥pitaux Universitaires de Strasbourg, Strasbourg, France Service de chirurgie h√©pato-biliaire et transplantation, H√¥pital de Hautepierre,  H√¥pitaux Universitaires de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de chirurgie h√©pato-biliaire et transplantation, H√¥pital de Hautepierre,  H√¥pitaux Universitaires de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France 35033, Hospital Center University De Rennes, Rennes, France Villejuif, Hospital University Paul Brousse, Villejuif, France 06000, CHU Nice, Nice, France R√©animation m√©dicale, C.H.U. Grenoble, La Tronche, France 31000, CHU Rangueil, Toulouse, France 33000, CHU, Bordeaux, France 25000, CHU, Besan√ßon, France 59000, CHRU Huriez, Lille, France 69000, Hospices Civils de Lyon, Lyon, France 54000, H√©patogastroent√©rologie, CHU Nancy, Nancy, France R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France Reanimation chirurgicale, Centre Hospitalier Universitaire Rouen, Rouen, France 63000, CHU, Clermont-Ferrand, France 34000, CHU Saint-Eloi, Montpellier, France 35000, CIC Pontchaillou, Rennes, France Hepatology and Liver Intensive Care Unit, H√¥pital Beaujon, Clichy, France UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United Kingdom UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United Kingdom Hepatology and Liver Intensive Care Unit, Hospital Beaujon, Clichy, France Hepatology and Liver Intensive Care Unit, Hospital Beaujon, Clichy, France D√©partement d‚Äôanesth√©sie-r√©animation, H√¥pital Beaujon, Boulevard du G√©n√©ral Leclerc, Clichy, France Intensive Care Unit, Royal Free Hospital, London, United Kingdom UCL Institute for Liver and Digestive Health, Royal Free Hospital, London, United Kingdom Service d‚Äôh√©patologie, H√¥pital Beaujon, Clichy, France Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan, Tunisia Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan, Tunisia Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan, Tunisia Service de r√©animation m√©dicale, H√¥pital universitaire de Bizerte, Bizerte, Tunisia Service de r√©animation m√©dicale, H√¥pital universitaire de Bizerte, Bizerte, Tunisia Service de r√©animation m√©dicale, H√¥pital universitaire de Bizerte, Bizerte, Tunisia Service de r√©animation m√©dicale, H√¥pital universitaire de Bizerte, Bizerte, Tunisia Service de r√©animation m√©dicale, H√¥pital universitaire de Bizerte, Bizerte, Tunisia Service de r√©animation m√©dicale, H√¥pital universitaire de Bizerte, Bizerte, Tunisia Service de r√©animation m√©dicale, H√¥pital universitaire de Bizerte, Bizerte, Tunisia Neurosurgery, CHU de Blida, Blida, Algeria Neurosurgery, CHU de Blida, Blida, Algeria Neurosurgery, CHU de Blida, Blida, Algeria Neurosurgery, CHU de Blida, Blida, Algeria R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia ICU, CHU Habib Bourguiba, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia ICU, CHU Habib Bourguiba, Sfax, Tunisia Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia R√©animation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco D√©partement d‚Äôanesth√©sie - r√©animation, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France D√©partement d‚Äôanesth√©sie - r√©animation, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France 75019, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France 75019, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France Urgences Medicales Chuoran, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria Urgences Medicales Chuoran, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria Urgences Medicales Chuoran, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria Urgences Medicales, Chu Oran, Oran, Algeria Urgences Medicales, Chu Oran, Oran, Algeria R√©animation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France Chirurgie cardiaque, CHU Amiens-Picardie, Salouel, France R√©animation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France R√©animation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France R√©animation cardio thoracique et vasculaire, CHU Amiens-Picardie, Salouel, France Chirurgie cardiaque, CHU Amiens-Picardie, Salouel, France Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Service de r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, Paris, France Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Service de r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, Paris, France R√©animation polyvalente, service d‚Äôanesth√©sie r√©animation 2, CHU de Bordeaux, Bordeaux, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France R√©animation d√©tresses respiratoires et infections s√©v√®res, H√¥pital Nord APHM, Marseille, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint Georges, Lucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France Unit√© de soutien m√©thodologique, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France Reanimation chirurgicale, Centre Hospitalier Universitaire Rouen, Rouen, France Reanimation chirurgicale, Centre Hospitalier Universitaire Rouen, Rouen, France D√©partement d‚Äô√©pid√©miologie et de sant√© publique, Centre Hospitalier Universitaire Rouen, Rouen, France Institut de biologie clinique, Centre Hospitalier Universitaire Rouen, Rouen, France Anesth√©sie, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France Epid√©miologie et evaluation clinique, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France Epid√©miologie et evaluation clinique, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France D√©partement d‚ÄôAnesth√©sie-R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France D√©partement d‚ÄôAnesth√©sie-R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Anesth√©sie-R√©animation, H√¥pital Priv√© d‚ÄôAthis-Mons - Site Caron, Athis-Mons, France Anesth√©sie-r√©animation, Clinique universitaire de Kinshasa, Kinshasa, Democratic  Republic of the Congo Service d‚Äôanesth√©sie r√©animation, H√¥pital √âdouard Herriot, Lyon, France R√©animation polyvalente adulte, Hospital Center De Dunkerque, Dunkerque, France Cellule de management de la qualit√© et de la gestion du risque, Hospital Center De Dunkerque, Dunkerque, France R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille,  France Unit√© de r√©animation neurologique, f√©deration de neurologie 1, pole des maladies  du systeme nerv, Groupe Hospitalier Piti√©-Salp√™tri√®re Charles Foix, Assistance Publique ‚Äì H√¥pitaux de Paris, Paris, France Unit√© de r√©animation neurologique, f√©deration de neurologie 1, pole des maladies  du systeme nerv, Groupe Hospitalier Piti√©-Salp√™tri√®re Charles Foix, Assistance Publique ‚Äì H√¥pitaux de Paris, Paris, France Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan, Tunisia R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France Nursing School, Condorcet, Mons, Belgium ICU, C.H. Epicura, Hornu, Belgium Laboratoire de l‚Äôeffort et du mouvement, Condorcet, Tournai, Belgium ICU, C.H. Epicura, Hornu, Belgium ICU, C.H. Epicura, Hornu, Belgium Physiologie et pharmacologie, Universit√© de Mons - Campus Plaine de Nimy, Mons, Belgium Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Pathology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Microbiology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Pathology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Microbiology, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Respiratory ICU, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia Seine-Maritime, CHU Charles Nicolle Rouen, Rouen, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France R√©animation polyvalente, CHRU H√¥pitaux de Tours, Tours, France Inserm u1100, centre d‚Äô√©tude des pathologies respiratoires, Universit√© Fran√ßois Rabelais, Tours, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation P√©diatrique de Canastel d‚Äôoran, Departement de medecine d‚ÄôOran Algerie, Oran, Algeria Anesth√©sie R√©animation P√©diatrique, Etablissement Hospitalier Sp√©cialis√© en P√©diatrie Canastel, Oran, Algeria Anesth√©sie R√©animation P√©diatrique, Etablissement Hospitalier Sp√©cialis√© en P√©diatrie Canastel, Oran, Algeria Anesth√©sie R√©animation P√©diatrique, Etablissement Hospitalier Sp√©cialis√© en P√©diatrie Canastel, Oran, Algeria Anesth√©sie R√©animation P√©diatrique, Etablissement Hospitalier Sp√©cialis√© en P√©diatrie Canastel, Oran, Algeria Sar 2, H√¥pital Haut-L√©v√®que, Pessac, France Sar 2, unit√© cardiopathies cong√©nitales, H√¥pital Haut-L√©v√®que, Pessac, France Sar 2, unit√© cardiopathies cong√©nitales, H√¥pital Haut-L√©v√®que, Pessac, France R√©animation m√©dico-chirurgicale p√©diatrique, H√¥pital Necker, Rue de S√®vres, Paris, France Pediatric Non Invasive Ventilation and Sleep Unit, H√¥pital Necker, Rue de S√®vres, Paris, France Pediatric Non Invasive Ventilation and Sleep Unit, H√¥pital Necker, Rue de S√®vres, Paris, France Pediatric Non Invasive Ventilation and Sleep Unit, H√¥pital Necker, Rue de S√®vres, Paris, France Neonatal Surgery, National Ukrainian Pediatric Hospital OkhMatDyt, Kyiv, Ukraine Microbiology and Chemotherapy, Research Inctitute of Orthopedics of Medical Sciences of Ukraine, Kyiv, Ukraine Microbiology and Chemotherapy, Research Inctitute of Orthopedics of Medical Sciences of Ukraine, Kyiv, Ukraine 69, H√¥pital Femme M√®re Enfant, Bron, France Cnrs umr 5558, Hospices Civils de Lyon, Lyon, France Cnrs umr 5558, Hospices Civils de Lyon, Lyon, France R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron, France 92380, Hopital Raymond Poincare - Medecine Phys, Garches, France 92380, Hopital Raymond Poincare - Medecine Phys, Garches, France 92380, Hopital Raymond Poincare - Medecine Phys, Boulevard Raymond Poincar√©, Garches, France 92380, Hopital Raymond Poincare - Medecine Phys, Garches, France 92380, Hopital Raymond Poincare - Medecine Phys, Boulevard Raymond Poincar√©, Garches, France Unit√© de r√©animation p√©diatrique, Hopital Raymond Poincare - Medecine Phys, Garches, France R√©animation et surveillance continue p√©diatriques, CHU Kremlin Bic√™tre, Le Kremlin Bic√™tre, France Pediatric intensive care unit, Great Ormond Street Hospital, London, United Kingdom Pediatric Intensive Care Unit, The Royal Children‚Äôs Hospital, Parkville, Australia Pediatric Intensive Care Unit, Saint Mary‚Äôs Hospital, London, United Kingdom Pediatric Intensive Care Unit, Beatrix Children‚Äôs Hospital, Groningen, Netherlands Pediatric intensive care unit, Great Ormond Street Hospital, London, United Kingdom Pediatric Intensive Care Unit, Wihelmina Children‚Äôs Hospital, Utrecht, Netherlands Neonatal Intensive Care Unit, Hospital Antoine B√©cl√®re, Clamart, France Pediatric Intensive Care Unit, Saint Mary‚Äôs Hospital, London, United Kingdom Pediatric Intensive Care Unit, Royal Children Hospital, Brisbane, Australia R√©animation et surveillance continue p√©diatriques, CHU Kremlin Bic√™tre, Le Kremlin Bic√™tre, France C√¥te d‚Äôor, C.H. Chalon sur Sa√¥ne William Morey, Chalon-sur-Sa√¥ne, France P√©diatrie 2, Chu Dijon, Dijon, France P√©diatrie 2, Chu Dijon, Dijon, France P√©diatrie 2, Chu Dijon, Dijon, France R√©animation p√©diatrique polyvalente, Chu Dijon, Dijon, France Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia UMC, Hospital Center and University D‚Äôoran, Oran, Algeria Urgences Medicales Chuoran, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria Laboratoire rayonnement-mati√®re et instrumentation, Universit√© hassan 1er, Facult√© des Sciences et Techniques, Settat, Morocco Laboratoire rayonnement-mati√®re et instrumentation, Universit√© hassan 1er, Facult√© des Sciences et Techniques, Settat, Morocco Institut sup√©rieur des sciences de la sant√©-laboratoire rayonnement-mati√®re et instrumentation, Universit√© hassan 1er, Settat, Morocco Emergency and Intensive Care Department, General Hospital of Annecy, Annecy, France Laboratoire d‚Äôing√©nierie, management industriel et innovation, Facult√© des Sciences et Techniques, Settat, Morocco Laboratoire rayonnement-mati√®re et instrumentation, Universit√© hassan 1er, Facult√© des Sciences et Techniques, Settat, Morocco Institut sup√©rieur des sciences de la sant√©-laboratoire rayonnement-mati√®re et instrumentation, Universit√© hassan 1er, Settat, Morocco Centre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Centre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Centre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Centre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Centre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Centre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Centre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Service de r√©animation m√©dico-chirurgicale, CHU de Fort de France, Fort-de-France, France Service de r√©animation m√©dico-chirurgicale, CHU de Fort de France, Fort-de-France, France Service de r√©animation m√©dico-chirurgicale, CHU de Fort de France, Fort-de-France, France Samu 972, CHU de Fort de France, Fort-de-France, France Service de r√©animation m√©dico-chirurgicale, CHU de Fort de France, Fort-de-France, France Samu 972, CHU de Fort de France, Fort-de-France, France Service de r√©animation m√©dico-chirurgicale, CHU de Fort de France, Fort-de-France, France Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco Service de r√©animation m√©dicale et de toxicologie clinique- chu ibn sina-universite mohamed v, Hopital Ibn Sina, Rabat, Morocco Service de r√©animation m√©dicale et de toxicologie clinique- chu ibn sina-universite mohamed v, Hopital Ibn Sina, Rabat, Morocco Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco Service de r√©animation m√©dicale et de toxicologie clinique- chu ibn sina-universite mohamed v, Hopital Ibn Sina, Rabat, Morocco Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia Emergency, General Hospital, Tunis, Tunisia Tunisia, General Hospital, Tunis, Tunisia Department of Anesthesiology and Intensive Care Unit, Centre hospitalier universitaire de Nantes, Nantes, France L‚Äôinstitut du thorax, INSERM UMR 1087, Nantes, France L‚Äôinstitut du thorax, INSERM UMR 1087, Nantes, France L‚Äôinstitut du thorax, INSERM UMR 1087, Nantes, France L‚Äôinstitut du thorax, INSERM UMR 1087, Nantes, France Atlantic Gene Therapies, INSERM UMR 1089, Nantes, France L‚Äôinstitut du thorax, INSERM UMR 1087, Nantes, France Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, United States of America L‚Äôinstitut du thorax, INSERM UMR 1087, Nantes, France L‚Äôinstitut du thorax, INSERM UMR 1087, Nantes, France R√©animation CTCV Transplantation thoracique, CHU de Nantes - H√¥pital Nord Laennec, Saint-Herblain, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France U970, Inserm, Paris, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France U970, Inserm, Paris, France U970, Inserm, Paris, France U970, Inserm, Paris, France U970, Inserm, Paris, France U970, Inserm, Paris, France Inserm u1116, Universit√© de Lorraine, Vand≈ìuvre-l√®s-Nancy, France Inserm u1116, Universit√© de Lorraine, Vand≈ìuvre-l√®s-Nancy, France Dcac, Inserm, Vand≈ìuvre-l√®s-Nancy, France Service de biochimie, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France U970, Inserm, Paris, France Umr7213, Strasbourg University, Strasbourg, France Ea 4278, Universit√© d‚ÄôAvignon, Avignon, France Chirurgie thoracique, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France Ea7293, Strasbourg University, Strasbourg, France Umr7213, Strasbourg University, Strasbourg, France Umr7213, Strasbourg University, Strasbourg, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France Service d‚Äôaccueil des urgences, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France P√¥le R√©animations Anesth√©sie SAMU, Hospital Center University Rouen, Rouen, France U1096, Inserm, Rouen, France U982, Inserm, Mont-Saint-Aignan, France U1096, Inserm, Rouen, France Division of Infectious Diseases, Brigham and Women‚Äôs Hospital, Boston, United States of America Division of Infectious Diseases, Brigham and Women‚Äôs Hospital, Boston, United States of America Centre de r√©animation, Centre Hospitalier R√©gional Universitaire de Lille (CHRU), Lille, France Centre de r√©animation, Centre Hospitalier R√©gional Universitaire de Lille (CHRU), Lille, France R√©animation m√©dicale, CHU Dijon, Dijon, France R√©animation m√©dicale, CHU Dijon, Dijon, France 21000, Chu Dijon, Dijon, France Service d‚Äôepidemiologie et d‚Äôhygi√®ne hospitali√®re, Chu Dijon, Dijon, France R√©animation m√©dicale, CHU Dijon, Dijon, France R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation m√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia Bact√©riologie, CHRU de Besan√ßon, Besan√ßon, France Hygi√®ne hospitali√®re, Centre Hospitalier R√©gional Universitaire de Besan√ßon, Besan√ßon, France Unit√© de pr√©vention et de lutte contre les infections nosocomiales, C.H.U. d‚ÄôAngers, Rue Larrey, Angers, France Umr 1137 iame, Universit√© Paris Diderot, Paris, France Biostatistics, Biostatistical Institute, Freiburg, Germany Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Cr√©teil, France Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Cr√©teil, France Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Cr√©teil, France Anesthesia and Intensive Care Medicine, Hospital Henri Mondor, Cr√©teil, France Microbiology, Hospital Henri Mondor, Cr√©teil, France Microbiology, Hospital Henri Mondor, Cr√©teil, France Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn Rushd-Casablanca, Casablanca, Morocco Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn Rushd-Casablanca, Casablanca, Morocco R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France Pharmacy, Hospital Center Fleyriat, Bourg-en-Bresse, France Pharmacy, Hospital Center Fleyriat, Bourg-en-Bresse, France Pharmacy, Hospital Center Fleyriat, Bourg-en-Bresse, France Intensive care unit, Hospital Center Fleyriat, Bourg-en-Bresse, France Service de biostatistique et information m√©dicale, H√¥pital Saint-Louis, Paris, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation m√©dicale, C.H.U de Grenoble, La Tronche, France N√©phrologie, h√©modialyse, transplantation r√©nale, C.H.U de Grenoble, La Tronche,  France H√©pato-gastro-ent√©rologie, C.H.U de Grenoble, La Tronche, France R√©animation m√©dicale, C.H.U., La Tronche, France R√©animation m√©dicale, C.H.U de Grenoble, La Tronche, France R√©animation m√©dicale, C.H.U. Grenoble, Grenoble, France Nephrology, Hospital Erasme, Brussels, Belgium Nephrology, Hospital Erasme, Brussels, Belgium Intensive care, Hospital Civil Charleroi, Charleroi, Belgium C.H. Lyon Sud, Pierre-B√©nite, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Cr√©teil, France Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Cr√©teil, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation polyvalente, C.H. de Beauvais, Beauvais, France R√©animation polyvalente, Hospital Center General Du Havre, Le Havre, France R√©animation polyvalente, Hospital Center De Roubaix, Roubaix, France R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille,  France R√©animation m√©dico-chirurgicale, H√¥pital Avicenne, Bobigny, France Service de biostatistique et information m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation chirurgicale, H√¥pital Henri Mondor, Cr√©teil, France Unit√© d‚Äôhypertension art√©rielle, H√¥pital Europ√©en Georges Pompidou, Paris, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France Service d‚Äôh√©matologie biologique, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation, H√¥pital Europ√©en Marseille, Marseille, France Laboratoire europ√©en, Laboratoire d‚Äôanalyses de Biologie M√©dicale Alphabio, Marseille, France Laboratoire europ√©en, Laboratoire d‚Äôanalyses de Biologie M√©dicale Alphabio, Marseille, France Laboratoire europ√©en, Laboratoire d‚Äôanalyses de Biologie M√©dicale Alphabio, Marseille, France R√©animation, H√¥pital Europ√©en Marseille, Marseille, France R√©animation, H√¥pital Europ√©en Marseille, Marseille, France R√©animation, H√¥pital Europ√©en Marseille, Marseille, France R√©animation, H√¥pital Europ√©en Marseille, Marseille, France Laboratoire europ√©en, Laboratoire d‚Äôanalyses de Biologie M√©dicale Alphabio, Marseille, France R√©animation, H√¥pital Europ√©en Marseille, Marseille, France Inserm u1144, Universit√© Paris Descartes, Paris, France Inserm u1144, Universit√© Paris Descartes, Paris, France Inserm u1144, Universit√© Paris Descartes, Paris, France Inserm u1144, Universit√© Paris Descartes, Paris, France Inserm u1144, Universit√© Paris Descartes, Paris, France Inserm u1144, Universit√© Paris Descartes, Paris, France Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Emergency, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Centre R√©gional de Pharmacovigilance (CRPV), H√¥pital Europ√©en Georges Pompidou, Paris, France SAMU de Paris, H√¥pital Necker EM, Paris, France Centre R√©gional de Pharmacovigilance (CRPV), H√¥pital Europ√©en Georges Pompidou, Paris, France SAMU de Paris, H√¥pital Necker EM, Paris, France R√©animation, Groupe hospitalier Saint-Joseph, Paris, France SAMU de Paris, H√¥pital Necker EM, Paris, France CRPV H√¥pital Henri Mondor, AP-HP, Paris, France Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia H√¥pital Cochin, Paris, France R√©animation pneumologique, H√¥pital Cochin, Paris, France Anesth√©sie r√©animation, H√¥pital Cochin, Paris, France R√©animation pneumologique, H√¥pital Cochin, Paris, France Chirurgie thoracique, H√¥pital Cochin, Paris, France Chirurgie thoracique, H√¥pital Cochin, Paris, France Anesth√©sie r√©animation, H√¥pital Cochin, Paris, France R√©animation pneumologique, H√¥pital Cochin, Paris, France R√©animation pneumologique, H√¥pital Cochin, Paris, France Anesth√©sie-r√©animation, CHRU H√¥pitaux De Tours, Tours, France Inserm u1100, a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√©  Fran√ßois Rabelais, Tours, France Inserm u1100, a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√©  Fran√ßois Rabelais, Tours, France Inserm u1100, a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√©  Fran√ßois Rabelais, Tours, France Inserm u1100, a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√©  Fran√ßois Rabelais, Tours, France Inserm u1100, a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√©  Fran√ßois Rabelais, Tours, France Inserm u1100, a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√©  Fran√ßois Rabelais, Tours, France Inserm u1100, a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√©  Fran√ßois Rabelais, Tours, France R√©animation polyvalente, CHRU H√¥pitaux de Tours, Tours, France D√©partement de r√©animation m√©dicale et m√©decine hyperbare, CHU d‚ÄôAngers, Angers,  France Service de physioth√©rapie cardio-respiratoire, CHUV, Lausanne, Switzerland Service de physioth√©rapie cardio-respiratoire, CHUV, Lausanne, Switzerland Service des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium D√©partement de r√©animation m√©dicale et de m√©decine hyperbare, C.H.U. d‚ÄôAngers, Angers, France Service de physioth√©rapie, H√¥pital neuch√¢telois, Neuch√¢tel, Switzerland Service de soins intensifs, H√¥pitaux Universitaires de Gen√®ve, Gen√®ve, Switzerland R√©animation m√©dicale, H√¥pitaux Universitaires de Strasbourg (H√¥pital de Hautepierre), Strasbourg, France 67000, Cabinet lib√©ral de masso kin√©sith√©rapie, Strasbourg, France Hautepierre r√©animation m√©dicale, C.H.R.U. H√¥pitaux Universitaires Strasbourg, Strasbourg, France Endocrinologie, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Endocrinologie, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Chirurgie Digestive, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Cardiology, H√¥pital Europ√©en Georges-Pompidou, Paris, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France URC, Hospital Ambroise Par√©, Boulogne-Billancourt, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France Unit√© de recherche clinique, Hopital Europeen Georges-Pompidou, Paris, France Cardiologie, H√¥pital Europ√©en Georges-Pompidou, Paris, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France Ile de France, Piti√©-Salp√™tri√®re Hospita, ICAN, Paris, France Ile de France, Piti√©-Salp√™tri√®re Hospita, ICAN, Paris, France Dar, Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Ile de France, Piti√©-Salp√™tri√®re Hospita, ICAN, Paris, France R√©animation chirurgicale cardio-vasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France R√©animation chirurgicale cardio-vasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Service de chirurgie cardio-vasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Medical Intensive Care Unit, iCAN, Institute of Cardiometobalism and Nutrition, Groupe Hospitalier Piti√©‚ÄìSalp√™tri√®re, Paris, France Medical Intensive Care Unit, iCAN, Institute of Cardiometobalism and Nutrition, Groupe Hospitalier Piti√©‚ÄìSalp√™tri√®re, Paris, France Service Anaesthesia and Intensive Care Hospital Mother ‚Äì Child, CHU Marrakech, Marrakech, Morocco Service Anaesthesia and Intensive Care Hospital Mother ‚Äì Child, CHU Marrakech, Marrakech, Morocco Service Anaesthesia and Intensive Care Hospital Mother ‚Äì Child, CHU Marrakech, Marrakech, Morocco Clinical Laboratory of Epidemiology, CHU Marrakech, Marrakech, Morocco Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Nord, Centre de r√©animation, Lille, France Anesth√©sie obst√©tricale, Hospital Jeanne De Flandre, Lille, France Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France Service de r√©animation polyvalente, Centre hospitalier, Saint Brieuc, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France Service de r√©animation polyvalente, Centre hospitalier, Saint Brieuc, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France P√¥le pharmaceutique, CHU de Besan√ßon, Besan√ßon, France P√¥le pharmaceutique, CHU de Besan√ßon, Besan√ßon, France Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Anesth√©sie R√©animation, Chu Ibn Rochd, Casablanca, Morocco Anesth√©sie R√©animation, Chu Ibn Rochd, Casablanca, Morocco Anesth√©sie r√©animation, CHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie R√©animation, Chu Ibn Rochd, Casablanca, Morocco Anesth√©sie R√©animation, Chu Ibn Rochd, Casablanca, Morocco Anesth√©sie R√©animation, Chu Ibn Rochd, Casablanca, Morocco Anesth√©sie R√©animation, Chu Ibn Rochd, Casablanca, Morocco R√©animation m√©dicale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France R√©animation m√©dicale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France M√©decine physique et r√©adaptation neurologique et ufr de m√©decine upjv, p√¥le sant√©, Centre Hospitalier Universitaire, Amiens, France Service d‚Äôinformation m√©dicale, service d‚Äô√©pid√©miologie, Centre Hospitalier Universitaire, Amiens, France Soins Service, Service d‚Äôhospitalisation √† domicile, Rivery, France Service des urgences, C.H. Compi√®gne-Noyon, Compi√®gne, France D√©partement de m√©decine g√©n√©rale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France M√©decine physique et r√©adaptation plateau technique et unit√© mobile de mpr, Centre Hospitalier Universitaire, Amiens, France M√©decine physique et r√©adaptation neurologique et ufr de m√©decine upjv, p√¥le sant√©, Centre Hospitalier Universitaire, Amiens, France Reanimation, Centre Hospitalier de Douai, Douai, France R√©animation polyvalente, Hospital Center De Douai, Douai, France R√©animation polyvalente, H√¥pital de Douai, Douai, France P√¥le de r√©animation h√¥pital roger salengro, C.H.R.U. Lille, Lille, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia R√©animation m√©dico-chirurgicale, CH Ren√© Dubos, Pontoise, France R√©animation polyvalente, C.H. de Beauvais, Beauvais, France R√©animation m√©dico-chirurgicale, CH Ren√© Dubos, Pontoise, France R√©animation m√©dico-chirurgicale, CH Ren√© Dubos, Pontoise, France R√©animation medicale, Hopital central de l‚Äôarmee (HCA), Alger, Algeria R√©animation medicale, Hopital central de l‚Äôarmee (HCA), Alger, Algeria R√©animation medicale, Hopital central de l‚Äôarmee (HCA), Alger, Algeria Haute savoie, Intensive Care Unit, Hospital Center Annecy Genevois, Metz-Tessy, France Coordination des dons d‚Äôorgane et de tissus, Hospital Center Annecy Genevois, Metz-Tessy, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation polyvalente urgences, Centre Hospitalier Universitaire, Saint-Priest-en-Jarez, France Unit√© de recherche clinique innovation et pharmacologie, Centre Hospitalier Universitaire, Saint-Priest-en-Jarez, France R√©animation polyvalente, Centre Hospitalier, Roanne, France R√©animation polyvalente, Centre Hospitalier Universitaire, Saint-Priest-en-Jarez, France R√©animation polyvalente, Centre Hospitalier, Roanne, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France Paris, Pierre and Marie Curie University, Paris, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan, Tunisia DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France DAR B, H√¥pital Saint Eloi, Montpellier, France Dar, CHU Estaing, Clermont-Ferrand, France Pharmacy, CHU - H√¥pitaux de Rouen, Rouen, France Pharmacy, CHU - H√¥pitaux de Rouen, Rouen, France Pharmacy, CHU - H√¥pitaux de Rouen, Rouen, France R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia ICU, CHU Habib Bourguiba, Sfax, Tunisia R√©animation polyvalente, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation polyvalente, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation polyvalente, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation polyvalente, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation polyvalente, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France R√©animation m√©dicale, Hospital Henri Mondor, Cr√©teil, France Inserm u955, H√¥pital Henri Mondor, Cr√©teil, France R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France Laboratoire d‚Äôimmunologie, H√¥pital Henri Mondor, Cr√©teil, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France Laboratoire de physiologie, Facult√© de M√©decine, Equipe d‚Äôaccueil 3072, Strasbourg, France Laboratoire de physiologie, Facult√© de M√©decine, Equipe d‚Äôaccueil 3072, Strasbourg, France Service d‚Äôaccueil des urgences, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France Service de sant√© publique, H√¥pital Saint-Antoine, Paris, France R√©animation polyvalente, Hospital Center Private Claude Galien, Quincy-sous-S√©nart, France Anesth√©sie-r√©animation, Hopital Louis Pradel, Bron, France Anesth√©sie-r√©animation, Hopital Louis Pradel, Bron, France Anesth√©sie-r√©animation, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France Urgences p√©diatriques, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France R√©animation n√©onatale et p√©diatrique, H√¥pital Trousseau, Paris, France Anesth√©sie-r√©animation p√©diatrique, Hospital Nord, Marseille, France Bouches du rh√¥ne, H√¥pital Nord, Chemin des Bourrely, Marseille, France Service de r√©animation p√©diatrique et n√©onatale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Anesth√©sie-r√©animation p√©diatrique, Hospital Timone, Marseille, France Anesth√©sie-r√©animation, Hospital Nord, Marseille, France Imagerie m√©dicale, H√¥pital Nord, Marseille, France Anesth√©sie-R√©animation P√©diatrique, H√¥pital Nord, Marseille, France D√©partement d‚Äôanesth√©sie r√©animation, H√¥pital Nord, Chemin des Bourrely, Marseille, France Anesth√©sie-R√©animation P√©diatrique, H√¥pital Nord, Marseille, France Service de r√©animation et surveillance continue p√®diatriques, Hospital Robert-Debr√©, Paris, France D√©partement de pharmacie, Hospital Robert-Debr√©, Paris, France Service de r√©animation et surveillance continue p√®diatriques, Hospital Robert-Debr√©, Paris, France D√©partement de pharmacie, Hospital Robert-Debr√©, Paris, France Hospital Necker, Paris, France R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France Centre d‚Äôinvestigation clinique, Institut Imagine, Paris, France R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France R√©animation p√©diatrique, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France Center for infection and immunity, CHRU de Lille, Lille, France Department of epidemiology and public health, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France Department of epidemiology and public health, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France Pediatric Emergency Unit and Infectious Diseases, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France R√©animation p√©diatrique, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France R√©animation n√©onatale, CHU de Strasbourg, Strasbourg, France P√©diatrie, CHU de Strasbourg, Strasbourg, France P√©diatrie, CHU de Strasbourg, Strasbourg, France Laboratoire de biostatistique et d‚Äôinformatique m√©dicale, CHU de Strasbourg, Strasbourg, France R√©animation n√©onatale, CHU de Strasbourg, Strasbourg, France R√©animation n√©onatale, CHU de Strasbourg, Strasbourg, France R√©animation p√©diatrique, CHU de Strasbourg, Strasbourg, France R√©animation p√©diatrique canastel, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria R√©animation p√©diatrique polyvalente, Chu Dijon, Dijon, France Smur p√©diatrique, CHU Dijon, Dijon, France Smur p√©diatrique, CHU Dijon, Dijon, France R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron, France Service Anaesthesia and Intensive Care Hospital Mother ‚Äì Child, CHU Marrakech, Marrakech, Morocco Soins intensifs p√©diatriques, CHU Sainte Justine, Montr√©al, Canada Centre de recherche, CHU Sainte-Justine, Montr√©al, Canada Soins intensifs p√©diatriques, CHU Sainte Justine, Montr√©al, Canada Neurochirurgie, CHU Sainte-Justine, Montr√©al, Canada Soins intensifs p√©diatriques, CHU Sainte Justine, Montr√©al, Canada R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada Unit√© de recherche clinique appliqu√©e, CHU Sainte-Justine, Montr√©al, Canada Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada N√©onatalogie, CHU, Caen, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France Chirugie p√©diatrique, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France Smur p√©diatrique, Robert Debr√©, Paris, France Smur p√©diatrique, Robert Debr√©, Paris, France Smur p√©diatrique, Robert Debr√©, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France Inserm u1144, Universit√© Paris Descartes, Paris, France CNRS umr8601, Universit√© Paris Descartes, Paris, France Service de R√©animation M√©dicale et Toxicologique, CHU Lariboisi√®re, Paris, France Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Inserm u1144, Universit√© Paris Descartes, Paris, France Service de R√©animation M√©dicale et Toxicologique, CHU Lariboisi√®re, Paris, France Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Service de r√©animation, Centre d‚Äôassistance m√©dicale-urgente, Tunis, Tunisia \, Centre d‚Äôassistance m√©dicale urgente, Tunis, Tunisia Service de r√©animation, Centre d‚Äôassistance m√©dicale-urgente, Tunis, Tunisia Service de r√©animation m√©dicale, Centre d‚Äôassistance m√©dicale-urgente, Tunis, Tunisia R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia R√©animation respiratoire, H√¥pital Abderrahmen Mami de pneumo-phtisiologie, Ariana, Tunisia R√©animation m√©dicale, Hospital Abderrahmen Mami De Pneumo-Phtisiologie, Ariana, Tunisia R√©animation respiratoire, H√¥pital Abderrahmen Mami de pneumo-phtisiologie, Ariana, Tunisia Service de r√©animation m√©dicale, Centre d‚Äôassistance m√©dicale-urgente, Tunis, Tunisia Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Infection Control Programme, University Hospitals of Geneva, Geneva, Switzerland Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Reanimation -anesthesie, CHU Mohamed VI, Marrakesh, Morocco R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France D√©partement de biostatistiques, H√¥pital Saint Louis, Paris, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France Centre de r√©animation, Centre Hospitalier R√©gional Universitaire de Lille (CHRU), Lille, France D√©partement de biostatistiques, H√¥pital Saint Louis, Paris, France R√©animation, Centre Hospitalier G√©n√©ral de Saint-Denis, Saint-Denis, France R√©animation - Grands brul√©s, CHU Pointe √† Pitre - Abymes, Pointe √† Pitre, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France Chirurgie Thoracique, Hopital Europeen Georges-Pompidou, Paris, France Chirurgie Thoracique, Hopital Europeen Georges-Pompidou, Paris, France Anesth√©sie-r√©animation, Cliniques universitaires de Kinshasa, Kinshasa, Democratic Republic of the Congo Anaesthesiology ‚ÄìReanimation, Cliniques Universitaires, Kinshasa, Democratic Republic of the Congo Internal Medicine, Tropical Medicine, Infectious and Parasitic Diseases, University of Kinshasa, Kinshasa, Democratic Republic of the Congo Anaesthesiology ‚ÄìReanimation, Cliniques Universitaires, Kinshasa, Democratic Republic of the Congo Anaesthesiology-Reanimation, Provincial General Referral Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo Anaesthesiology ‚ÄìReanimation, Cliniques Universitaires, Kinshasa, Democratic Republic of the Congo RMC, Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France Intensive Care Unit, Universit√© de Sherbrooke, Sherbrooke, Canada Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Pharmacy, University Hospitals of Geneva, Geneva, Switzerland R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France Intensive Care, University Hospitals of Geneva, Geneva, Switzerland Infectious Diseases, University Hospitals of Geneva, Geneva, Switzerland Infection Control Programme, University Hospitals of Geneva, Geneva, Switzerland Intensive Care, University Hospitals of Geneva, Geneva, Switzerland R√©animation m√©dicale, CHU Dijon, Dijon, France 21000, Chu Dijon, Dijon, France CHU de BORDEAUX, Bordeaux, France Pyren√©es-atlantiques, Hospital Fran√ßois Mitterrand, Pau, France Pyren√©es-atlantiques, Hospital Fran√ßois Mitterrand, Pau, France Pyren√©es-atlantiques, Hospital Fran√ßois Mitterrand, Pau, France Pyren√©es-atlantiques, Hospital Fran√ßois Mitterrand, Pau, France Pyren√©es-atlantiques, Hospital Fran√ßois Mitterrand, Pau, France R√©animation m√©dicale, H√¥pital Lapeyronie, Montpellier, France R√©animation m√©dicale, H√¥pital Lapeyronie, Montpellier, France R√©animation m√©dicale, H√¥pital Lapeyronie, Montpellier, France Unit√© d‚Äôhygi√®ne hospitali√®re et de pr√©vention, H√¥pital Lapeyronie, Montpellier, France Direction des achats et des approvisionnements, Centre Andr√© Benech, Montpellier, France R√©animation m√©dicale, H√¥pital Lapeyronie, Montpellier, France R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France Service de microbiologie, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France Equipe op√©rationnelle d‚Äôhygi√®ne hospitali√®re, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France Equipe op√©rationnelle d‚Äôhygi√®ne hospitali√®re, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France Service de chirurgie h√©pato-biliaire et transplantation, H√¥pital de Hautepierre,  H√¥pitaux Universitaires de Strasbourg, Strasbourg, France Ile de France, Piti√©-Salp√™tri√®re Hospita, ICAN, Paris, France Iame - inserm umr1137, Universit√© Paris Diderot, Paris, France 78, I.N.R.A ((Institut National de Recherche Agronomique)), Jouy-en-Josas, France Iame inserm umr1137, Universit√© Paris Diderot, Paris, France R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Biochimie, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France R√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Surgical Intensive Care, Hospital Henri Mondor, Cr√©teil, France R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France Reanimation, Clinical Ambroise Par√©, Neuilly-sur-Seine, France ICU, Clinical Ambroise Par√©, Neuilly-sur-Seine, France ICU, Clinical Ambroise Par√©, Neuilly-sur-Seine, France Reanimation, Clinical Ambroise Par√©, Neuilly-sur-Seine, France Reanimation, Clinical Ambroise Par√©, Neuilly-sur-Seine, France Reanimation, Clinical Ambroise Par√©, Neuilly-sur-Seine, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia Anesthesia and Intensive Care, Charles Nicolle Teaching Hospital, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia R√©animation pneumologique et soins intensifs respiratoires, H√¥pital Cochin, Paris, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France 78150, Hospital Center De Versailles, Le Chesnay, France R√©animation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean Poulhes, Toulouse, France R√©animation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean Poulhes, Toulouse, France R√©animation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean Poulhes, Toulouse, France R√©animation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean Poulhes, Toulouse, France Service de bact√©riologie, Hospital Center University Toulouse - Casselardit Ancely, Toulouse, France R√©animation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean Poulhes, Toulouse, France R√©animation polyvalente, CHU Toulouse Rangueil, Avenue du Professeur Jean Poulhes, Toulouse, France R√©animation pneumologique et soins intensifs respiratoires, H√¥pital Cochin, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Avicenne, Bobigny, France R√©animation m√©dico-chirurgicale, H√¥pital Avicenne, Bobigny, France Hospital Lariboisi√®re, Paris, France Equipe op√©rationnelle d‚Äôhygi√®ne, Hospital Lariboisi√®re, Paris, France Anesthesiology and critical care, Hospital Lariboisi√®re, Paris, France Intensive Care, CHU Sart-Tilman, Li√®ge, Belgium Clinical Pharmacy, CHU Sart-Tilman, Li√®ge, Belgium Intensive Care, CHU Sart-Tilman, Li√®ge, Belgium Department of Preventive Medicine, Military Hospital of Tunis, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Infection Control Unit, Strasbourg University Hospital, Strasbourg, France Public Health Service, Strasbourg University Hospital, Strasbourg, France Public Health Service, Strasbourg University Hospital, Strasbourg, France Infection Control Unit, Strasbourg University Hospital, Strasbourg, France Medical Intensive Care Unit, Strasbourg University Hospital, Strasbourg, France Infection Control Unit, Strasbourg University Hospital, Strasbourg, France R√©animation chirurgicale, Centre Hospitalier Universitaire de Caen (CHU), Caen, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen, Caen, France Centre de recherche de l‚Äôiucpq, Institut Universitaire de Cardiologie et de Pneumologie de Qu√©bec, Qu√©bec, Canada R√©animation m√©dicale, CHRU de Brest, Brest, France Centre de recherche de l‚Äôiucpq, Institut Universitaire de Cardiologie et de Pneumologie de Qu√©bec, Qu√©bec, Canada 33, H√¥pital Haut-L√©v√™que, Avenue Magellan, Pessac, France D√©partement de g√©nie √©lectrique et informatique de l‚Äôuniversit√© laval, Universit√© Laval, Qu√©bec, Canada D√©partement de g√©nie √©lectrique et informatique de l‚Äôuniversit√© laval, Universit√© Laval, Qu√©bec, Canada Stagiaire 5√®me ann√©e, ProG‚ÄôHEI, Lille, France Haute √©cole de sant√© vaud, University of Applied Sciences and Arts Western Switzerland (HES-SO), Lausanne, Switzerland Haute √©cole d‚Äôing√©nierie et de gestion du canton de vaud, University of Applied Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Haute √©cole d‚Äôing√©nierie et de gestion du canton de vaud, University of Applied Sciences and Arts Western Switzerland, Yverdon-les-Bains, Switzerland Service de pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium Service de pneumologie, Cliniques Universitaires Saint-Luc, Brussels, Belgium 33, H√¥pital Haut-L√©v√™que, Avenue Magellan, Pessac, France Centre de recherche de l‚Äôiucpq, Institut Universitaire de Cardiologie et de Pneumologie de Qu√©bec, Qu√©bec, Canada Laboratoire rayonnement-mati√®re et instrumentation, Universit√© hassan 1er, Facult√© des Sciences et Techniques, Settat, Morocco ICU, C.H. Epicura, Hornu, Belgium Physiotherapy, Haute √âcole de Sant√© Vaud, Lausanne, Switzerland Physiotherapy, Haute √âcole de Sant√© Vaud, Lausanne, Switzerland Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunisia, Tunis, Tunisia Service de r√©animation m√©dico-chirurgicale, H√¥pital Louis-Mourier - APHP, Colombes, France Service de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard-APHP, Paris, France Hematology, CHU Lyon Sud, Lyon, France Biostatistics, Hospices Civils de Lyon, Lyon, France Hematology, CHU Lyon Sud, Lyon, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation chirurgicale, Cochin Port-Royal, Paris, France R√©animation m√©dicale, Institut Gustave Roussy, Villejuif, France R√©animation polyvalente, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil,  Montfermeil, France Reanimation Polyvalente, Centre Hospitalier de Dieppe, Dieppe, France Reanimation Polyvalente, Centre Hospitalier de Dieppe, Dieppe, France R√©animation M√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation m√©dicale, Hospital Center Valence, Valence, France R√©animation M√©dicale, CHU Saint-Etienne - H√¥pital Nord, Saint-√âtienne, France R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France Umr7213, Strasbourg University, Strasbourg, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France Inserm u1096, Universit√© de rouen, Rouen, France Inserm u1096, Universit√© de rouen, Rouen, France Scac-irib, Universit√© de Rouen, Rouen, France Inserm u1096, Universit√© de rouen, Rouen, France Inserm u995 equipe 4, Universit√© Lille 2, Lille, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France Service d‚Äôh√©patologie, H√¥pital Saint-Antoine, Paris, France Service d‚Äôh√©patologie, Hospital Beaujon, Clichy, France Service d‚Äôh√©pato-gastro-ent√©rologie, CHRU de Brest H√¥pital Morvan, Brest, France Service d‚Äôh√©pato-gastro-ent√©rologie, CH, Hy√®res, France Service d‚Äôhepato-gastro-enterologie, CHU Nice, Nice, France Service de microbiologie, CHU Nice, Nice, France Service de reanimation, H√¥pital Saint-Antoine, Paris, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France Litec ea4331, Chu De Poitiers, Poitiers, France Anesth√©sie-R√©animation, Hospital Jean Minjoz, Besan√ßon, France Reanimation chirurgicale, Hospital Jean Minjoz, Besan√ßon, France R√©animation chirurgicale, CHU de Besan√ßon, Besan√ßon, France Digestif USI, EPS Charles Nicolle, Bardo, Tunisia Digestif USI, EPS Charles Nicolle, Bardo, Tunisia Digestif USI, EPS Charles Nicoles, Tunis, Tunisia Digestif USI, EPS Charles Nicoles, Tunis, Tunisia R√©animation m√©dicale, CHU Lariboisi√®re, Paris, France Service d‚Äô√©pid√©miologie clinique, CHU de Poitiers, Poitiers, France R√©animation chirurgicale, CHU de Poitiers, Poitiers, France D√©partement d‚Äôanesth√©sie-r√©animation, CHU de Poitiers, Poitiers, France Service d‚Äô√©pid√©miologie clinique, CHU de Poitiers, Poitiers, France R√©animation neuro-chirurgicale, CHU de Poitiers, Poitiers, France Digestif USI, EPS Charles Nicolle, Bardo, Tunisia Digestif USI, EPS Charles Nicolles, Tunis, Tunisia R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation polyvalente, Centre Hospitalier D√©partemental - site de La Roche-sur-Yon, La Roche-sur-Yon, France D√©partement d‚Äôanesth√©sie, CHU de Nantes, Nantes Cedex 1, France Biostatistiques, C.H.U. H√¥tel Dieu, Nantes, France R√©animation m√©dicale, C.H.U de Nantes, Nantes, France R√©animation m√©dicale, CHU lapeyronie, Montpellier, France Sbim, H√¥pital Saint-Louis, Paris, France H√¥pital la timone (Marseille), CHU La Timone (Marseille), Marseille, France Reanimation, Institute Paoli-Calmettes, Marseille, France Reanimation, Institute Paoli-Calmettes, Marseille, France R√©animation, Institute Paoli-Calmettes, Marseille, France Reanimation, Institute Paoli-Calmettes, Marseille, France Reanimation, Institute Paoli-Calmettes, Marseille, France R√©animation, Institut Paoli-Calmettes, Marseille, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France P√¥le de r√©animation, h√¥pital salengro, Centre Hospitalier R√©gional Universitaire  de Lille, Lille, France P√¥le de r√©animation, h√¥pital salengro, Centre Hospitalier R√©gional Universitaire  de Lille, Lille, France Lunginnov, Institut Pasteur de Lille, Lille, France Institut d‚Äôimmunologie, Centre de biologie-pathologie g√©n√©tique, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France Inserm u1019 e13, Institut Pasteur de Lille, Lille, France P√¥le de r√©animation, h√¥pital salengro, Centre Hospitalier R√©gional Universitaire  de Lille, Lille, France R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France Physiology, CNRS, Lyon-Villeurbanne, France Physiology, U Lyon1, Lyon, France Critical Care, Hospital Instruction Armed Desgenettes, Lyon, France R√©animation polyvalente, CHRU H√¥pitaux de Tours, Tours, France R√©animation polyvalente - u1100 centre d‚Äôetude des pathologies respiratoires, CHRU H√¥pitaux de Tours, Tours, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France Universit√© catholique de Louvain, De Duve institute, Brussels, Belgium Institut pasteur de lille, Centre for infection and immunity, Lille, France Institut pasteur de lille, Centre for infection and immunity, Lille, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France Pneumologie, CHRU H√¥pitaux de Tours, Tours, France Inserm u1100, Centre d‚Äô√©tude des pathologies respiratoires, Tours, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Chirurgie thoracique et vasculaire, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Avenue Henri Barbusse, Clamart, France Chirurgie thoracique et vasculaire, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Avenue Henri Barbusse, Clamart, France Chirurgie visc√©rale, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Avenue Henri Barbusse, Clamart, France Chirurgie visc√©rale, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Avenue Henri Barbusse, Clamart, France Teaching Department of Emergency and Intensive Care, Regional hospital of Zaghouan, Zaghouan, Tunisia Cardiology, Regional hospital of Zaghouan, Zaghouan, Tunisia Teaching Department of Emergency and Intensive Care, Regional hospital of Zaghouan, Zaghouan, Tunisia Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Emergency and Intensive Care Department, Hopital Habib Thameur, Tunis, Tunisia General Hospital, Tunis, Tunisia Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco Medical Emergency Department, Ibn Sina University Hospital, Rabat, Morocco R√©animation polyvalente, CHRU H√¥pitaux de Tours, Tours, France INSERM U930 √©quipe 2, Universit√© fran√ßois Rabelais, Tours, France Bact√©riologie, H√¥pital Saint-Antoine, Paris, France Bact√©riologie, H√¥pital Saint-Antoine, Paris, France R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France Maladies Infectieuses, C.H.R.U. Lille, Lille, France Groupe de recherche translationnelle relation h√¥te-pathog√®ne, Universite Lille 2  - Droit et Sant√©, Lille, France R√©animation Polyvalente & USC, Centre Hospitalier de Lens, Lens, France Service d‚Äôaccueil des urgences & usc, Centre Hospitalier de Lens, Lens, France Maladies Infectieuses, Centre Hospitalier de Lens, Lens, France R√©animation Polyvalente & USC, Centre Hospitalier de Lens, Lens, France R√©animation Polyvalente & USC, Centre Hospitalier de Lens, Lens, France ICU, CHR Verviers, Verviers, Belgium Soins intensifs g√©n√©raux, CHU Sart-Tilman, Li√®ge, Belgium Soins intensifs g√©n√©raux, CHU Sart-Tilman, Li√®ge, Belgium Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France Iame, umr 1137, INSERM, Univ Paris Diderot, Sorbonne Paris Cit√©, Paris, France Service de microbiologie, Inserm u1135, Immunity and Infectious Diseases Center,  H√¥pital de la Piti√©-salp√©tri√®re, Sorbonne Universit√©s, UPMC Univ Paris 06, Paris, France Iame, umr 1137, INSERM, Univ Paris Diderot, Sorbonne Paris Cit√©, Paris, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France Equipe 11, Institut Albert Bonniot - Inserm U823, La Tronche, France Laboratoire de parasitologie-mycologie, C.H.U., La Tronche, France Laboratoire de parasitologie-mycologie m√©dicale, C.H.U. Grenoble, La Tronche, France Maladies infectieuses, C.H.U., La Tronche, France Pharmacie, C.H.U. Grenoble, La Tronche, France Laboiratoire bact√©riologie-hygi√®ne, C.H.U., La Tronche, France Parasitologie-mycologie m√©dicale, C.H.U. Grenoble, La Tronche, France R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn Rushd-Casablanca, Casablanca, Morocco Anesthesiology and Intensive Care Department, University Teaching Hospital Ibn Rushd-Casablanca, Casablanca, Morocco R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France R√©animation m√©dicale, CHU lapeyronie, Montpellier, France N√©phrologie, Chu lapeyronie, Montpellier, France R√©animation m√©dicale, CHU lapeyronie, Montpellier, France R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation m√©dicale, CHRU de Brest site La Cavale Blanche - Universit√© de Bretagne Occidentale, Brest, France D√©partement de m√©decine interne et pneumologie, ea 3878, cic inserm 1412, ifr 148, CHRU de Brest site La Cavale Blanche - Universit√© de Bretagne Occidentale, Brest, France Department of Epidemiology Preventive Medicine, Monash University, Melbourne, Australia R√©animation, Centre Hospitalier des Pays de Morlaix, Morlaix, France R√©animation m√©dicale, CHRU de Brest site La Cavale Blanche - Universit√© de Bretagne Occidentale, Brest, France Service de r√©animation m√©dicale, H√¥pital de Hautepierre, H√¥pitaux Universitaires  de Strasbourg, Strasbourg, France R√©animation m√©dicale, H√¥pitaux Universitaires de Strasbourg (H√¥pital de Hautepierre), Strasbourg, France R√©animation m√©dicale, H√¥pitaux Universitaires de Strasbourg (H√¥pital de Hautepierre), Strasbourg, France Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia R√©animation et surveillance continue p√©diatriques, CHU Necker-Enfants Malades, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Necker-Enfants Malades, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Necker-Enfants Malades, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Necker-Enfants Malades, Paris, France Hospital Center De Tourcoing, Tourcoing, France R√©animation, Centre Hospitalier de Tourcoing, Tourcoing, France R√©animation, Centre Hospitalier de Tourcoing, Tourcoing, France Laboratoire de biostatistiques, Maison r√©gionale de la recherche clinique, Lille, France Departement de psychologie ea 4050 caps, Universit√© de Poitiers, Poitiers, France Departement de psychologie ea 4050 caps, Universit√© de Poitiers, Poitiers, France Service de r√©animation m√©dicale, Chu De Poitiers, Poitiers, France Service de r√©animation, Centre Hospitalier La Rochelle, La Rochelle, France Service de r√©animation m√©dicale, Chu De Poitiers, Poitiers, France Service de r√©animation m√©dicale, Chu De Poitiers, Poitiers, France R√©animation m√©dicale, Chu De Poitiers, Poitiers, France Intensive Care Unit, Hospital Center De Meaux, Meaux, France R√©animation, H√¥pital de Meaux, Meaux, France R√©animation, H√¥pital de Meaux, Meaux, France R√©animation, H√¥pital de Meaux, Meaux, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France R√©animation polyvalente, C.H. de Saint Malo, Saint-Malo, France R√©animation polyvalente, C.H. de Saint Malo, Saint-Malo, France Service de r√©animation polyvalente, CH D‚ÄôAngoul√™me, Angoul√™me, France Service de r√©animation polyvalente, CH D‚ÄôAngoul√™me, Angoul√™me, France Service de r√©animation polyvalente, CH D‚ÄôAngoul√™me, Angoul√™me, France Service de r√©animation polyvalente, CH D‚ÄôAngoul√™me, Angoul√™me, France Service de r√©animation polyvalente, CH D‚ÄôAngoul√™me, Angoul√™me, France R√©animation Polyvalente & USC, C.H. de Lens, Lens, France R√©animation Polyvalente & USC, C.H. de Lens, Lens, France R√©animation Polyvalente & USC, C.H. de Lens, Lens, France R√©animation Polyvalente & USC, C.H. de Lens, Lens, France Laboratoire d‚Äô√©thique m√©dicale, Universit√© Paris Descartes, Paris, France Urgences p√©diatriques, H√¥pital Trousseau, Paris, France Service de r√©animation m√©dico-chirurgicale, Centre Hospitalier, Cannes, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation polyvalente, CHRU H√¥pitaux de Tours, Tours, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France R√©animation chirurgicale, H√¥pital l‚ÄôArchet 2, Nice, France Sau-samu-smur, C.H.U. de Nancy, Nancy, France Service de r√©animation p√©diatrique, CHRU de Lille - H√¥pital Jeanne de Flandre, Lille, France Service de r√©animation m√©dicale, CHU Cochin - Saint-Vincent de Paul - Site Cochin, Paris, France R√©animation M√©dicale et Toxicologique, H√¥pital Lariboisi√®re, Paris, France H√©matologie, CHRU de Besan√ßon, Besan√ßon, France H√©matologie, CHRU de Besan√ßon, Besan√ßon, France H√©matologie, CHRU de Besan√ßon, Besan√ßon, France H√©matologie, CHRU de Besan√ßon, Besan√ßon, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France Immuno Hematologie, H√¥pital Saint-Louis, Paris, France R√©animation m√©dicale, CHU Gabriel-Montpied, Clermont-Ferrand, France Laboratoire d‚Äôh√©matologie, CHU Estaing, Clermont-Ferrand, France Department of clinical research and innovation (DRCI), CHU Clermont-Ferrand, Clermont-Ferrand, France R√©animation m√©dicale, CHRU de Besan√ßon, Besan√ßon, France Urgences et soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada Clinical Research, CHU Sainte-Justine, Montr√©al, Canada Centre for Practice-Changing Research, Hospital Research Institute, Ottawa, Canada Distribution, Etablissement Fran√ßais du Sang, Besan√ßon, France Direction de la recherche, Etablissement Fran√ßais du Sang, Saint-Denis, France Hospital Research Institute, Ottawa, Canada H√©matologie, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France H√©matologie-greffe de moelle, H√¥pital Saint Louis, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France Department of Anesthesiology and Intensive Care, First Faculty of Medicine Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic Maladies du sang, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Maladies du sang, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France D√©partement de r√©animation m√©dicale et de m√©decine hyperbare, C.H.U. d‚ÄôAngers, Angers, France Service de r√©animation m√©dicale et m√©decine hyperbare, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Maladies du sang, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Maladies du sang, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Maladies du sang, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Maladies du sang, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Maladies du sang, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France Anesthesia and Intensice Care Unit, Hospital Saint-Camille, Bry-sur-Marne, France Sleep disorder unit, Piti√©-Salp√™tri√®re Hospital, Paris, France Sleep disorder unit, Piti√©-Salp√™tri√®re Hospital, Paris, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France Sleep disorder unit, Piti√©-Salp√™tri√®re Hospital, Paris, France ICU, Clinical Ambroise Par√©, Neuilly-sur-Seine, France R√©animation des urgences, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France 33, Hospital Pellegrin, Bordeaux, France R√©animation des urgences, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France R√©animation des urgences, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Service de r√©animation m√©dicale, inserm umr_s 999, H√¥pital de Bic√™tre, Universit√© Paris-Sud, Facult√© de M√©decine, Universit√© Paris-Saclay, Le Kremlin-Bic√™tre, France Service de r√©animation m√©dicale, AP-HP, H√¥pital Ambroise-Par√©, Boulogne-Billancourt, France Service de r√©animation polyvalente, Centre hospitalier de Sens, Sens, France Intensive Care and Respiratory Division, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation Polyvalente, CHU Limoges, Limoges, France Service de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges,  Limoges, France R√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France Service de r√©animation m√©dicale, H√¥pital de Bic√™tre, Facult√© de m√©decine Paris-Sud, universit√© Paris-Sud, Le Kremlin-Bic√™tre, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France 92151, Hospital Foch, Suresnes, France Cardiologie, H√¥pital Henri Mondor, Cr√©teil, France R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia Inserm cic 1415, C.H. R√©gional Universitaire de TOURS, Tours, France R√©animation m√©dicale, CHRU de Brest, Brest, France R√©animation polyvalente, H√¥pital Foch, Suresnes, France Inserm cic 1435/medical-surgical icu/umr 1092, Medecine University, Chu Limoges,  Limoges, France 33, Hopital Robert Boulin, Libourne, France 974, Hopital Felix Guyon, Saint-Denis, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France Hospital Robert-Debr√©, Paris, France Reanimation Pediatrique, Hospital Robert-Debr√©, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France R√©animation et surveillance continue p√©diatriques, H√¥pital Robert Debr√©, Paris, France R√©animation p√©diatrique, CHU de Montpellier - H√¥pital Arnaud de Villeneuve, Montpellier, France R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France Inserm cic 1411, CHU de Montpellier, Montpellier, France HIA B√©gin, Paris, France Intensive Care, Fondazione IRCCS - Policlinico San Matteo, Pavia, Italy R√©animation neurochirurgicale p√©diatrique, Hospital Necker, Paris, France R√©animation neurochirurgicale p√©diatrique, Hospital Necker, Paris, France R√©animation neurochirurgicale p√©diatrique, Hospital Necker, Paris, France Sousse Centre, Chu Farhat Hached, Sousse, Tunisia R√©animation p√©diatrique, H√¥pital Arnaud-de-Villeneuve, Montpellier, France R√©animation p√©diatrique, H√¥pital Arnaud-de-Villeneuve, Montpellier, France R√©animation p√©diatrique, H√¥pital Arnaud-de-Villeneuve, Montpellier, France R√©animation p√©diatrique, H√¥pital Arnaud-de-Villeneuve, Montpellier, France Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada P√©diatrie, CHU Lyon, Lyon, France P√©diatrie, CHU Robert Debr√©, Paris, France P√©diatrie, Hospital Center University De Rennes, Rennes, France R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia Reanimation Pediatrique, C.H.U., La Tronche, France P√¥le SAU - SAMU 74 - R√©animation, CHANGE, Annecy, France Reanimation Pediatrique, C.H.U., La Tronche, France Reanimation Pediatrique, C.H.U., La Tronche, France Reanimation Pediatrique, C.H.U., La Tronche, France Service de R√©animation M√©dicale, Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de microbiologie, Inserm u1135, Immunity and Infectious Diseases Center,  H√¥pital de la Piti√©-salp√©tri√®re, Sorbonne Universit√©s, UPMC Univ Paris 06, Paris, France Service de R√©animation M√©dicale, Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Descid - team 5, INSERM U1137 - IAME, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France Service de r√©animation polyvalente, CH D‚ÄôAngoul√™me, Angoul√™me, France Service Pharmacie, Laboratoire de contr√¥le, Hopital Avicenne, Bobigny, France R√©animation m√©dico-chirugicale, H√¥pital Avicenne, Universit√© Paris 13, Bobigny, France Intensive Burn Care Department, Burn and Trauma Center, Tunis, Tunisia Laboratory of pharmacology, Charles Nicolle Hospital, Tunis, Tunisia Laboratory of pharmacology, Charles Nicolle Hospital, Tunis, Tunisia Laboratory of pharmacology, Charles Nicolle Hospital, Tunis, Tunisia Nord, C.H.R.U. Lille, Lille, France Nord, C.H.R.U. Lille, Lille, France R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia Biostatistics, CHU, Grenoble, France Microbiologie, Groupe Hospitalier Paris Saint-Joseph, Paris, France R√©animation polyvalente, Hospital Group Paris Saint-Joseph, Paris, France R√©animation polyvalente, Hospital Group Paris Saint-Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France Microbiologie clinique, Groupe Hospitalier Paris-Saint-Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France 68, Hospital Center De Mulhouse, Mulhouse, France 68, Hospital Center De Mulhouse, Mulhouse, France 68, Hospital Center De Mulhouse, Mulhouse, France 68, Hospital Center De Mulhouse, Mulhouse, France R√©animation m√©dicale, Centre Hospitalier de Mulhouse, Mulhouse, France R√©animation m√©dicale, Centre Hospitalier de Mulhouse, Mulhouse, France R√©animation m√©dicale, Centre Hospitalier de Mulhouse, Mulhouse, France R√©animation m√©dicale, Centre Hospitalier de Mulhouse, Mulhouse, France R√©animation m√©dicale, Centre Hospitalier de Mulhouse, Mulhouse, France R√©animation m√©dicale, Centre Hospitalier de Mulhouse, Mulhouse, France 68, Hospital Center De Mulhouse, Mulhouse, France R√©animation m√©dicale, Centre Hospitalier de Mulhouse, Mulhouse, France M√©decine intensive, Centre Hospitalier Marc Jacquet, Melun, France M√©decine intensive, Centre Hospitalier Marc Jacquet, Melun, France R√©animation, Hospital Ambroise Par√©, Boulogne-Billancourt, France R√©animation m√©dicale, Hospital Bic√™tre, Le Kremlin-Bic√™tre, France R√©animation, Centre Hospitalier d‚ÄôEtampes, √âtampes, France R√©animation M√©dicale et Toxicologique, H√¥pital Lariboisi√®re, Paris, France M√©decine intensive, Centre Hospitalier Marc Jacquet, Melun, France R√©animation m√©dicale, Cochin Port-Royal, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Department of Anaesthesiology and Intensive Care, Catholic University School of Medicine, Rome, Italy R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Biology, Cochin Port-Royal, Paris, France Biology, Cochin Port-Royal, Paris, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Department of Angio-Hematology, Hospital Lariboisi√®re, Paris, France Intensive Care Unit, Hospital Lariboisi√®re, Paris, France Cardiology, Hospital Lariboisi√®re, Paris, France Cardiology, Hospital Lariboisi√®re, Paris, France Cochin Hospital, Paris, France Service de r√©animation m√©dico-chirurgicale, CHU de Fort de France, Fort-de-France, France Service de r√©animation m√©dico-chirurgicale, CHU de Fort de France, Fort-de-France, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France R√©animation chirurgicale, CHU Lariboisi√®re, Paris, France R√©animation M√©dicale NHC, CHU de Strasbourg, Strasbourg, France Laboratoire d‚Äôh√©matologie, CHU de Strasbourg, Strasbourg, France Laboratoire d‚Äôh√©matologie, CHU de Strasbourg, Strasbourg, France Ea7293, Strasbourg University, Strasbourg, France Inserm umr_s1140 ‚Äúinnovative therapies in haemostasis‚Ä?, Inserm, Paris, France R√©animation M√©dicale NHC, CHU de Strasbourg, Strasbourg, France Service de bact√©riologie et hygi√®ne hospitali√®re, Centre Hospitalier Universitaire de Rennes, Rennes, France R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France Inserm cic 1435/medical-surgical icu, Chu Limoges, Limoges, France UMR CNRS 7276, Medecine University, Chu Limoges, Limoges, France Hematology Laboratory/umr cnrs 7276, Medecine university, Chu Limoges, Limoges, France Inserm u1116, Facult√© de M√©decine, Vand≈ìuvre-l√®s-Nancy, France Inotrem, Nancy, France Inserm u1116, Facult√© de M√©decine, Vand≈ìuvre-l√®s-Nancy, France Inotrem, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France Departement d‚Äôanesth√©sie-r√©animation, CHU de Reims, Reims, France U1016, 22 rue m√©chain, 75014, Paris, Institut National de la Sant√© et de la Recherche M√©dicale, Paris, France U1016, 22 rue m√©chain, 75014, Paris, Institut National de la Sant√© et de la Recherche M√©dicale, Paris, France F√©d√©ration des urgences, h√¥pital marc jacquet melun, GCSdSISIF, Paris, Melun, France H√¥pital lariboisi√®re Paris, Agence r√©gionnale de Sant√©, Paris, France Neuroradiologie, C.H. Sainte Anne, Paris, France GCSdSISIF, Paris, France F√©d√©ration des urgences, h√¥pital marc jacquet melun, GCSdSISIF, Paris, Melun, France Service de biochimie et hormonologie, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France Service d‚Äôacceuil des urgences, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France Service de biochimie et hormonologie, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 59, Hospital Center De Valenciennes, Valenciennes, France 59, Hospital Center De Valenciennes, Valenciennes, France 59, Hospital Center De Valenciennes, Valenciennes, France 59, Hospital Center De Valenciennes, Valenciennes, France Nord, P√¥le de l‚ÄôUrgence-SAMU du Nord- CHRU de Lille, Lille, France 13015, Hospital Nord, Marseille, France 13015, Hospital Nord, Marseille, France 13015, Hospital Nord, Marseille, France 13015, Hospital Nord, Marseille, France 13015, Hospital Nord, Marseille, France 13015, Hospital Nord, Marseille, France Service de r√©animation polyvalente, H√¥pital Nord, Chemin des Bourrely, Marseille, France Service de pneumologie et r√©animation m√©dicale, Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de pneumologie et pathologies professionnelles, Centre Hospitalier Intercommunal de Cr√©teil, Cr√©teil, France Service de pneumologie, Centre hospitalier universitaire de Toulouse, Toulouse, France Clinique des maladies respiratoires, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France Service de pneumologie et allergologie, Centre hospitalier de Roubaix, Roubaix, France D√©partement de m√©decine interne et de pneumologie, Centre Hospitalier R√©gional Universitaire de Brest, Brest, France Service de pneumologie, Centre Hospitalier Victor Dupouy, Argenteuil, France Service de pneumologie et r√©animation m√©dicale, Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia Facult√© de m√©decine de Sfax, Sfax, Tunisia R√©animation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Anesthesie reanimation, CHU Ibn Rochd Casa, Casablanca, Morocco Unit√© de r√©animation neurologique, H√¥pital Piti√©-Salp√™tri√®re, Paris, France Unit√© neurom√©tabolique, Piti√©-Salp√™tri√®re Hospital, Paris, France Neuroradiologie, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation neurochirurgicale, Piti√©-Salp√™tri√®re Hospital, Paris, France Pharmacology, Piti√©-Salp√™tri√®re Hospital, Paris, France Pharmacology, Piti√©-Salp√™tri√®re Hospital, Paris, France Unit√© de r√©animation neurologique, H√¥pital Piti√©-Salp√™tri√®re, Paris, France Critical care unit/inserm u825, University Teaching Hospital of Purpan, Toulouse, France R√©animation, Centre Hospitalier Universitaire Toulouse, Toulouse, France Neuroscience and Neuroimaging, Santa Lucia, Roma, Italy Applied Neurosciences, Leeanards Memory Centera, Lausanne, Switzerland Service de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard, Paris, France D√©partement de physiologie, H√¥pital Bichat Claude Bernard, Paris, France D√©partement de physiologie, H√¥pital Bichat Claude Bernard, Paris, France D√©partement de physiologie, H√¥pital Bichat Claude Bernard, Paris, France Neurocritical Care Unit, CHU de la R√©union, Groupe Hospitalier Sud R√©union, Saint-Pierre, R√©union, France Inserm, UMR 1188 Diab√®te ath√©rothrombose Th√©rapies R√©union Oc√©an Indien (D√©TROI), Sainte Clotilde, R√©union, France Inserm, UMR 1188 Diab√®te ath√©rothrombose Th√©rapies R√©union Oc√©an Indien (D√©TROI), Sainte Clotilde, R√©union, France Inserm, UMR 1188 Diab√®te ath√©rothrombose Th√©rapies R√©union Oc√©an Indien (D√©TROI), Sainte Clotilde, R√©union, France Inserm, UMR 1188 Diab√®te ath√©rothrombose Th√©rapies R√©union Oc√©an Indien (D√©TROI), Sainte Clotilde, R√©union, France Inserm, UMR 1188 Diab√®te ath√©rothrombose Th√©rapies R√©union Oc√©an Indien (D√©TROI), Sainte Clotilde, R√©union, France D√©partement d‚Äôanesth√©sie - r√©animation, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France Intensive Care Unit, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France R√©animation, Hospital Foch, Suresnes, France Coordination hospitali√®re, Hospital Foch, Suresnes, France Coordination hospitali√®re, Hospital Foch, Suresnes, France R√©animation, Hospital Foch, Suresnes, France Sau, Hospital Foch, Suresnes, France Sau, Hospital Foch, Suresnes, France Neurologie, Hospital Foch, Suresnes, France Neurologie, Hospital Foch, Suresnes, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France Pharmacy Institute, C.H.R.U. Lille, Lille, France Pharmacy Institute, C.H.R.U. Lille, Lille, France Anaesthesia and Resuscitation Department, C.H.R.U. Lille, Lille, France Pharmacy Institute, C.H.R.U. Lille, Lille, France Anaesthesia and Resuscitation Department, C.H.R.U. Lille, Lille, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, Colombes, France R√©animation m√©dicale, CHRU de Brest, Brest, France Depm, Transfusion Research Unit, Monash University, Melbourne, Australia R√©animation, Fondation Hopital Saint Joseph, Paris, France R√©animation polyvalente, Groupe Hospitalier Paris-Saint-Joseph, Paris, France R√©animation, H√¥pital civil de Lyon, Lyon, France R√©animation, Centre Hospitalier G√©n√©ral de Saint-Denis, Saint-Denis, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France R√©animation Polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia Oncologie m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France R√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France Oncologie digestive, Hopital Europeen Georges-Pompidou, Paris, France Oncologie m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France Pediatric Critical Care, CHU Sainte-Justine, Montr√©al, Canada Pediatric Critical Care, CHU Sainte-Justine, Montr√©al, Canada Pediatric Critical Care, CHU Sainte-Justine, Montr√©al, Canada Pediatric Nephrology, CHU Sainte-Justine, Montr√©al, Canada Pediatric Nephrology, CHU Sainte-Justine, Montr√©al, Canada Nephrology, Sacr√©-Coeur Hospital, Montr√©al, Canada R√©animation et Surveillance Continue M√©dico Chirurgicale, H√¥pital Necker - Enfants Malades, Paris, France Centre d‚Äôinvestigation clinique, Institut Imagine, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France Urgences p√©diatriques, CHU Necker-Enfants Malades, Paris, France R√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France Centre drepanocytose, Hospital Robert-Debr√©, Paris, France Centre drepanocytose, Hospital Robert-Debr√©, Paris, France R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France R√©animation p√©diatrique hfme, Hospices civils de Lyon, Lyon, France P√¥le information m√©dicale √©valuation recherche, Hospices Civils de Lyon, Lyon, France P√¥le information m√©dicale √©valuation recherche, Hospices Civils de Lyon, Lyon, France Urgences p√©diatriques, Hospital Robert-Debr√©, Paris, France Urgences p√©diatriques, Hospital Necker - Enfants Malades, Paris, France Neurologie p√©diatrique, Hospital Necker - Enfants Malades, Paris, France Urgences p√©diatriques, Hospital Necker - Enfants Malades, Paris, France R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France R√©animation p√©diatrique canastel, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada Chirurgie cardiaque p√©diatrique, CHU Sainte-Justine, Montr√©al, Canada Chirurgie cardiaque p√©diatrique, CHU Sainte-Justine, Montr√©al, Canada Anesthesia and Intensive Care, Chu Farhat Hached, Sousse, Tunisia Service de r√©animation m√©dicale, Chu De Poitiers, Poitiers, France Service de r√©animation m√©dicale, Chu De Poitiers, Poitiers, France Pyr√©n√©es-atlantiques, Hospital Center De La C√¥te Basque, Bayonne, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France D√©partement de r√©animation m√©dicale et de m√©decine hyperbare, C.H.U. d‚ÄôAngers, Angers, France Institut f√ºr an√§sthesiologische pathophysiologie und verfahrensentwicklung, Universit√§tsklinikum Ulm, Ulm, Germany R√©animation, C.H.U. d‚ÄôAngers, Angers, France CHU Gabriel-Montpied, Clermont-Ferrand, France Service de r√©animation, CHU Lyon Sud, Lyon, France Service de soins intensifs, Hospital Erasme, Brussels, Belgium Dipartimento di fisiopatologia medico-chirurgica e dei trapianti, University of Milan, Milano, Italy Service de soins intensifs, Hospital Erasme, Brussels, Belgium Service de soins intensifs, Hospital Erasme, Brussels, Belgium Service de soins intensifs, Hospital Erasme, Brussels, Belgium Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France R√©animation, Ch Al√®s c√©vennes, Al√®s, France Intensive Care Unit, C.H.U. De Charleroi, Charleroi, Belgium Laboratoire de m√©decine exp√©rimentale - universit√© libre de Brussels, C.H.U. De Charleroi, Charleroi, Belgium Intensive Care Unit, C.H.U. De Charleroi, Charleroi, Belgium Laboratoire de m√©decine exp√©rimentale - universit√© libre de Brussels, C.H.U. De Charleroi, Charleroi, Belgium R√©animation M√©dicale NHC, CHU de Strasbourg, Strasbourg, France Laboratoire d‚Äôh√©matologie et h√©mostase, CHU de Strasbourg, Strasbourg, France R√©animation M√©dicale NHC, CHU de Strasbourg, Strasbourg, France R√©animation m√©dicale, Hospital Center De Mulhouse, Mulhouse, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France R√©animation M√©dicale, H√¥pital Central, C.H.U. de Nancy, Nancy, France D√©partement de soins intensifs de pneumologie, Centre hospitalier universitaire de Nantes, Nantes, France D√©partement de r√©animation m√©dicale et de m√©decine hyperbare, C.H.U. d‚ÄôAngers, Angers, France CHU Dijon, Dijon, France Direction de la recherche clinique et de l‚Äôinnovation, CHU Dijon, Dijon, France Service de r√©animation m√©dicale, Groupe Hospitalier La Piti√©-Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, APHP, Paris, France Service de chirurgie thoracique et cardiovasculaire, Groupe Hospitalier La Piti√©  Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, APHP, Paris, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France Chirurgie cardiaque, CHU de Besan√ßon, Besan√ßon, France Cardiologie, C.H. R√©gional Universitaire de Besan√ßon, Besan√ßon, France Dipartimento di anestesia e rianimazione, Policlinico Universitario A. Gemelli, Universit√† Cattolica Del Sacro Cuore, Rome, Italy R√©animation polyvalente, service d‚Äôanesth√©sie r√©animation 2, CHU de Bordeaux, Bordeaux, France R√©animation polyvalente, service d‚Äôanesth√©sie r√©animation 2, CHU de Bordeaux, Bordeaux, France R√©animation polyvalente, service d‚Äôanesth√©sie r√©animation 2, CHU de Bordeaux, Bordeaux, France Service de R√©animation M√©dicale, Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France R√©animation M√©dicale, CHU de Besan√ßon, Besan√ßon, France R√©animation chirurgicale, CHU de Besan√ßon, Besan√ßon, France R√©animation d√©tresses respiratoires et infections s√©v√®res, H√¥pital Nord APHM, Marseille, France Unit√© de recherche sur les maladies infectieuses tropicales et √©mergentes, H√¥pital Nord APHM, Marseille, France R√©animation d√©tresses respiratoires et infections s√©v√®res, H√¥pital Nord APHM, Marseille, France R√©animation DRIS, H√¥pital Nord APHM, Marseille, France R√©animation, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France 92151, Hospital Foch, Suresnes, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France Service de pneumologie, C.H.U de Grenoble C.H.U, La Tronche, France D√©partement d‚Äôanatomie et cytologie pathologiques, H√¥pital Tenon, Paris, France D√©partement d‚Äôanatomie et cytologie pathologiques, H√¥pital Tenon, Paris, France Service de radiologie, H√¥pital Tenon, Paris, France Service de pneumologie, H√¥pital Tenon, Paris, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France Radiologie, Saint Louis, Paris, France Radiologie, Hopital Saint Louis, Paris, France R√©animation pneumologique et soins intensifs respiratoires, H√¥pital Cochin, Paris, France Pneumologie, H√¥pital Avicenne, Bobigny, France R√©animation m√©dicale brabois, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France R√©animation m√©dicale brabois, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France R√©animation polyvalente adulte, Centre Hospitalier Intercommunal Andr√© Gr√©goire,  Montreuil, France R√©animation m√©dicale, C.H.U. d‚ÄôAngers, Angers, France R√©animation m√©dicale, CHU de Bic√™tre, Le Kremlin Bic√™tre, France R√©animation polyvalente, H√¥pital de Mercy, Ars Laquenexy, France Cardiologie - Centre d‚Äôinvestigation clinique pierre Drouin, Centre Hospitalier Universitaire de Nancy, Vand≈ìuvre-l√®s-Nancy, France Hospital Necker, Paris, France Pneumologie, Hospital Necker, Paris, France Anesth√©sie, Hospital Necker, Paris, France Anesth√©sie, Hospital Necker, Paris, France Pneumologie, Hospital Necker, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France Service de biochimie et hormonologie, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France Service de spectrom√©trie de masse, Facult√© de M√©decine Saint Antoine, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France Service de m√©decine interne, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Sorbonne Universit√©s, UPMC Universit√© Paris 06, Paris, France Bouches du rh√¥ne, H√¥pital Nord, Chemin des Bourrely, Marseille, France Bouches du rh√¥ne, H√¥pital Nord, Chemin des Bourrely, Marseille, France R√©animation des d√©tresses respiratoires et des infections s√©v√®res, Hospital Nord, Marseille, France Service d‚ÄôEndocrinologie, Diab√©tologie, Nutrition, Hospital Center University De  Rennes, Rennes, France Nutrition Unit, Geneva University Hospital, Geneva, Switzerland Drci, CHU Gabriel-Montpied, Clermont-Ferrand, France Nutrition, Universit√© de Pelotas, Pelotas, Brazil Service de nutrition clinique, CHU Gabriel-Montpied, Clermont-Ferrand, France Department of ICU, Vilnius University Hospital, Vilnius, Lithuania Service de R√©animation M√©dico-Chirurgicale, H√¥pital Erasme, Bruxelles, Belgium Department of Clinical Nutrition, Institute of Oncology, Ljubljana, Slovenia Department of ICU, Clinic USP Palmaplanas, Palma, Spain Department of ICU, Bydgoszcz Hospital, Bydgoszcz, Poland Departement of Internal Medicine, Univ. Hospital Center Zagreb, Zagreb, Croatia Service de nutrition clinique, CHU Gabriel-Montpied, Clermont-Ferrand, France Nutrition Unit, Geneva University Hospital, Geneva, Switzerland Pediatric Intensive Care Unit, C.H.U de Nantes, Nantes, France Pediatric Intensive Care Unit, University of Lausanne, Lausanne, Switzerland Pediatric Intensive Care Unit, Brussels University Hospital, Brussels, Belgium Pediatric Intensive Care Unit, University of Lausanne, Lausanne, Switzerland Anesthesie r√©animation, Hospital Timone, Marseille, France Bouches du rh√¥ne, Institute Paoli-Calmettes, Marseille, France Statistics, Institute Paoli-Calmettes, Marseille, France Statistics, Institute Paoli-Calmettes, Marseille, France R√©animation M√©dicale, H√¥pital Cochin, Paris, France Equipe mobile de nutrition, H√¥pital Cochin, Paris, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France R√©animation Polyvalente, H√¥pitaux de Chartres, Chartres, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France Information Technology, GE Healthcare IT France & BeNeLux, Lyon, France Information Technology, GE Healthcare IT France & BeNeLux, Lyon, France Information Technology, GE Healthcare IT France & BeNeLux, Lyon, France R√©animation polyvalente, C.H. de Chartres, Le Coudray, France H√¥pital Fernand Widal, Centre Antipoison et de Toxicovigilance de Paris, Paris, France H√¥pital Fernand Widal, Centre Antipoison et de Toxicovigilance de Paris, Paris, France Samu de Paris centre antipoison de paris umr-8536, Hospital Necker, Paris, France H√¥pital Fernand Widal, Centre Antipoison et de Toxicovigilance de Paris, Paris, France 75014, SAMU de Paris R√©animation polyvalente, Paris, France 75014, SAMU de Paris R√©animation polyvalente, Paris, France 2, rue saint sabin 75012 Paris, M√©decins Sans Fronti√®res, Paris, France 2, rue saint-sabin 75012, M√©decins Sans Fronti√®res, Paris, France 75014, SAMU de Paris R√©animation polyvalente, Paris, France R√©animation adulte, H√¥pital Necker - Enfants Malades, Paris, France 76, Chu Rouen, Rouen, France 76, Centre Hospitalier Universitaire Rouen, Rouen, France General Hospital, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Teaching Department of Emergency and Intensive Care, Hospital Zaghouan, Zaghouan, Tunisia Agence r√©gionale de sant√© ile-de-france, Cellule de l‚ÄôInVS en r√©gions (Cire) √éle-de-France et Champagne-Ardenne, Paris, France 75014, SAMU de Paris R√©animation polyvalente, Paris, France D√©partement des vigilances, Agence r√©gionale de sant√© (ARS) Ile-de-France, Paris, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France R√©animation, Centre Hospitalier la Rochelle, La Rochelle, France R√©animation Polyvalente, CHU La R√©union, Saint-Denis, France Service de virologie, H√¥pital Bichat-Claude Bernard, Paris, France Service de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard-APHP, Paris, France Service de maladies infectieuses et tropicales, H√¥pital Bichat-Claude Bernard, Paris, France Service de maladies infectieuses et tropicales, H√¥pital Bichat-Claude Bernard, Paris, France Service de maladies infectieuses et tropicales, H√¥pital Bichat-Claude Bernard, Paris, France Service de maladies infectieuses et tropicales, H√¥pital Bichat-Claude Bernard, Paris, France Service de microbiologie, H√¥pital Bichat-Claude Bernard, Paris, France Service de maladies infectieuses et tropicales, H√¥pital Bichat-Claude Bernard, Paris, France Service de virologie, H√¥pital Bichat-Claude Bernard, Paris, France R√©animation m√©dicale, H√¥pital Saint Louis, Paris, France Virology, H√¥pital Saint Louis, Paris, France Anatomopathology, H√¥pital Saint Louis, Paris, France Immuno-h√©matologie, Assistance Publique H√¥pitaux de Paris, Paris, France Mycologie, Hospital Arnaud-De-Villeneuve, Montpellier, France R√©animation m√©dicale, H√¥pital Lapeyronie, Montpellier, France R√©animation m√©dicale, H√¥pital Lapeyronie, Montpellier, France H√©matologie, CHRU H√¥pital Saint Eloi, Montpellier, France R√©animation-USCM, Gustave Roussy, Villejuif, France Service de biostatistique et d‚Äô√©pid√©miologie, inserm u1018, cesp, Universit√© paris-sud, Gustave Roussy, Villejuif, France Direction du syst√®me d‚Äôinformation, Gustave Roussy, Villejuif, France Service de r√©animation m√©dico-chirurgicale, Gustave Roussy, Villejuif, France Service d‚Äôinformation m√©dicale, Gustave Roussy, Villejuif, France Service de microbiologie m√©dicale, Gustave Roussy, Villejuif, France Service de biostatistique et d‚Äôepidemiologie, inserm u1018, cesp, Universit√© paris-sud, Gustave Roussy, Villejuif, France R√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France 33, H√¥pital Haut-L√©v√™que, Avenue Magellan, Pessac, France Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Sevice des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium Sevice des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium Sevice des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium Service des soins intensifs, Cliniques Universitaires Saint-Luc, Brussels, Belgium Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Intensive Care Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium Hautepierre r√©animation m√©dicale, C.H.R.U. H√¥pitaux Universitaires Strasbourg, Strasbourg, France Service de m√©decine physique et r√©adaptation, H√¥pital Piti√©-Salp√™tri√®re, Paris, France Institut du cerveau et de la moelle, H√¥pital Piti√©-Salp√™tri√®re, Paris, France Service des urgences c√©r√©bro-vasculaires, H√¥pital Piti√©-Salp√™tri√®re, Paris, France Intensive care unit and department of critical care medicine, Groupe Hospitalier  Paris Saint-Joseph, Paris, France Department of anesthesia and intensive care, Fondazione IRCCS Policlinico S Matteo, Pavie, Italy Department of anesthesia and surgical intensive care unit, CHU Dijon, Dijon, France Haute √©cole de sant√© vaud, University of Applied Sciences and Arts Western Switzerland (HES-SO), Lausanne, Switzerland Haute √©cole de sant√© vaud, University of Applied Sciences and Arts Western Switzerland (HES-SO), Lausanne, Switzerland ICU, C.H. Epicura, Hornu, Belgium Emergency unit, C.H. Epicura, Hornu, Belgium Emergency unit, C.H. Epicura, Hornu, Belgium Emergency unit, C.H. Epicura, Hornu, Belgium ICU, C.H. Epicura, Hornu, Belgium Pneumology, C.H. Epicura, Hornu, Belgium Emergency unit, C.H. Epicura, Hornu, Belgium},
note  = {Ann Intensive Care. 2016 Jun 17;6(Suppl 1):. doi:10.1186/s13613-016-0114-z.}
}

@Article{201626,
author  = {Vercillo, T. and Burr, D. and Gori, M.},
title  = {Congenitally Blind Children.},
journal  = {Developmental psychology},
volume  = {52},
number  = {6},
pages  = {847-53},
year  = {2016},
abstract  = {A recent study has shown that congenitally blind adults, who have never had visual experience, are impaired on an auditory spatial bisection task (Gori, Sandini, Martinoli, & Burr, 2014). In this study we investigated how thresholds for auditory spatial bisection and auditory discrimination develop with age in sighted and congenitally blind children (9 to 14 years old). Children performed 2 spatial tasks (minimum audible angle and space bisection) and 1 temporal task (temporal bisection). There was no impairment in the temporal task for blind children but, like adults, they showed severely compromised thresholds for spatial bisection. Interestingly, the blind children also showed lower precision  in judging minimum audible angle. These results confirm the adult study and go on to suggest that even simpler auditory spatial tasks are compromised in children,  and that this capacity recovers over time.},
address  = {Department of Psychology, University of Nevada Department of Neuroscience, University of Florence and CNR Institute of Neuroscience, Pisa, Italy U-VIP Unit for Visually Impaired People, Fondazione Istituto Italiano di Tecnologia, Genoa, Italy},
note  = {Dev Psychol. 2016 Jun;52(6):847-53. doi:10.1037/dev0000103.}
}

@Article{201527,
author  = {Martinez-Sala, A. and Losilla, F. and S√°nchez-Aarnoutse, J. and Garc√≠a-Haro, J.},
title  = {Impaired People.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {15},
number  = {12},
pages  = {32168-87},
year  = {2015},
abstract  = {Indoor navigation is a challenging task for visually impaired people. Although there are guidance systems available for such purposes, they have some drawbacks  that hamper their direct application in real-life situations. These systems are either too complex, inaccurate, or require very special conditions (i.e., rare in everyday life) to operate. In this regard, Ultra-Wideband (UWB) technology has been shown to be effective for indoor positioning, providing a high level of accuracy and low installation complexity. This paper presents SUGAR, an indoor navigation system for visually impaired people which uses UWB for positioning, a  spatial database of the environment for pathfinding through the application of the A* algorithm, and a guidance module. The interaction with the user takes place using acoustic signals and voice commands played through headphones. The suitability of the system for indoor navigation has been verified by means of a functional and usable prototype through a field test with a blind person. In addition, other tests have been conducted in order to show the accuracy of different relevant parts of the system.},
address  = {},
note  = {Sensors (Basel). 2015 Dec 21;15(12):32168-87. doi:10.3390/s151229912.}
}

@Article{201528,
author  = {},
title  = {Panels, Mini-Panels and Study Groups Monday, December 7, 2015.},
journal  = {Neuropsychopharmacology},
volume  = {40},
number  = {Suppl 1},
pages  = {S1-S105},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1038/npp.2015.324.}
}

@Article{201529,
author  = {},
title  = {UEG Week 2015 Oral Presentations.},
journal  = {United European Gastroenterology Journal},
volume  = {3},
number  = {5 Suppl},
pages  = {1-145},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1177/2050640615601611.}
}

@Article{201530,
author  = {},
title  = {Harbor, Maryland, July 11-15, 2015.},
journal  = {American Journal of Pharmaceutical Education},
volume  = {79},
number  = {5},
pages  = {},
year  = {2015},
abstract  = {},
address  = {},
note  = {Am J Pharm Educ. 2015 Jun 25;79(5):. doi:10.5688/ajpe795S4.}
}

@Article{201531,
author  = {},
title  = {ACTS Abstracts.},
journal  = {Clinical and Translational Science},
volume  = {8},
number  = {3},
pages  = {178-258},
year  = {2015},
abstract  = {},
address  = {},
note  = {Clin Transl Sci. 2015 Jun;8(3):178-258. Epub 2015 Jun 15 doi:10.1111/cts.12290.}
}

@Article{201532,
author  = {},
title  = {2015 ACVIM Forum Research Abstract Program.},
journal  = {Journal of Veterinary Internal Medicine},
volume  = {29},
number  = {4},
pages  = {1122-256},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1111/jvim.12609.}
}

@Article{201433,
author  = {Wollman, I. and Fritz, C. and Poitevineau, J. and McAdams, S.},
title  = {Evaluation.},
journal  = {PLoS ONE},
volume  = {9},
number  = {12},
pages  = {},
year  = {2014},
abstract  = {The role of auditory and tactile modalities involved in violin playing and evaluation was investigated in an experiment employing a blind violin evaluation  task under different conditions: i) normal playing conditions, ii) playing with auditory masking, and iii) playing with vibrotactile masking. Under each condition, 20 violinists evaluated five violins according to criteria related to  violin playing and sound characteristics and rated their overall quality and relative preference. Results show that both auditory and vibrotactile feedback are important in the violinists‚Äô evaluations but that their relative importance depends on the violinist, the violin and the type of evaluation (different criteria ratings or preference). In this way, the overall quality ratings were found to be accurately predicted by the rating criteria, which also proved to be  perceptually relevant to violinists, but were poorly correlated with the preference ratings; this suggests that the two types of ratings (overall quality  vs preference) may stem from different decision-making strategies. Furthermore, the experimental design confirmed that violinists agree more on the importance of criteria in their overall evaluation than on their actual ratings for different violins. In particular, greater agreement was found on the importance of criteria related to the sound of the violin. Nevertheless, this study reveals that there are fundamental differences in the way players interpret and evaluate each criterion, which may explain why correlating physical properties with perceptual  properties has been challenging so far in the field of musical acoustics.},
address  = {Sorbonne Universit√©s, UPMC University Paris 06/CNRS, UMR 7190, Institut Jean le Rond, d'Alembert, F-75015, Paris, France Sorbonne Universit√©s, UPMC University Paris 06/CNRS, UMR 7190, Institut Jean le Rond, d'Alembert, F-75015, Paris, France Sorbonne Universit√©s, UPMC University Paris 06/CNRS, UMR 7190, Institut Jean le Rond, d'Alembert, F-75015, Paris, France Schulich School of Music, McGill University, 555 Sherbrooke Street West, Montreal, Quebec, H3A 1E3, Canada},
note  = {PLoS One. 2014 Dec 4;9(12):. doi:10.1371/journal.pone.0112552.}
}

@Article{201434,
author  = {},
title  = {Poster Session I Monday, December 08, 2014.},
journal  = {Neuropsychopharmacology},
volume  = {39},
number  = {Suppl 1},
pages  = {S112-290},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1038/npp.2014.280.}
}

@Article{201435,
author  = {},
title  = {Panel, Mini-panel, and Study Group.},
journal  = {Neuropsychopharmacology},
volume  = {39},
number  = {Suppl 1},
pages  = {S1-S111},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1038/npp.2014.279.}
}

@Article{201436,
author  = {Honeine, J. and Schieppati, M.},
title  = {subjects balancing under static and dynamic conditions.},
journal  = {Frontiers in Systems Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Maintaining equilibrium is basically a sensorimotor integration task. The central nervous system (CNS) continually and selectively weights and rapidly integrates sensory inputs from multiple sources, and coordinates multiple outputs. The weighting process is based on the availability and accuracy of afferent signals at a given instant, on the time-period required to process each input, and possibly on the plasticity of the relevant pathways. The likelihood that sensory  inflow changes while balancing under static or dynamic conditions is high, because subjects can pass from a dark to a well-lit environment or from a tactile-guided stabilization to loss of haptic inflow. This review article presents recent data on the temporal events accompanying sensory transition, on which basic information is fragmentary. The processing time from sensory shift to reaching a new steady state includes the time to (a) subtract or integrate sensory inputs; (b) move from allocentric to egocentric reference or vice versa;  and (c) adjust the calibration of motor activity in time and amplitude to the new sensory set. We present examples of processes of integration of posture-stabilizing information, and of the respective sensorimotor time-intervals while allowing or occluding vision or adding or subtracting tactile information. These intervals are short, in the order of 1‚Äì2 s for different postural conditions, modalities and deliberate or passive shift. They are just longer for haptic than visual shift, just shorter on withdrawal than on  addition of stabilizing input, and on deliberate than unexpected mode. The delays are the shortest (for haptic shift) in blind subjects. Since automatic balance stabilization may be vulnerable to sensory-integration delays and to interference from concurrent cognitive tasks in patients with sensorimotor problems, insight into the processing time for balance control represents a critical step in the design of new balance- and locomotion training devices.},
address  = {Department of Public Health, Experimental and Forensic Medicine, University of PaviaPavia, Italy Department of Public Health, Experimental and Forensic Medicine, University of PaviaPavia, Italy},
note  = {Front Syst Neurosci. 2014 Oct 06;8:. doi:10.3389/fnsys.2014.00190.}
}

@Article{201337,
author  = {Legge, G. and Beckmann, P. and Tjan, B. and Havey, G. and Kramer, K. and Rolkosky, D. and Gage, R. and Chen, M. and Puchakayala, S. and Rangarajan, A.},
title  = {Indoor Navigation by People with Visual Impairment Using a Digital Sign System.},
journal  = {PLoS ONE},
volume  = {8},
number  = {10},
pages  = {},
year  = {2013},
abstract  = {There is a need for adaptive technology to enhance indoor wayfinding by visually-impaired people. To address this need, we have developed and tested a Digital Sign System. The hardware and software consist of digitally-encoded signs widely distributed throughout a building, a handheld sign-reader based on an infrared camera, image-processing software, and a talking digital map running on  a mobile device. Four groups of subjects‚Äîblind, low vision, blindfolded sighted,  and normally sighted controls‚Äîwere evaluated on three navigation tasks. The results demonstrate that the technology can be used reliably in retrieving information from the signs during active mobility, in finding nearby points of interest, and following routes in a building from a starting location to a destination. The visually impaired subjects accurately and independently completed the navigation tasks, but took substantially longer than normally sighted controls. This fully functional prototype system demonstrates the feasibility of technology enabling independent indoor navigation by people with visual impairment.},
address  = {Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin Cities, Minnesota, United States of America University of St. Thomas, St. Paul, Minnesota, United States of America University of Southern California, Los Angeles, California, United States of America Advanced Medical Electronics Corporation (AME), Maple Grove, Minnesota, United States of America Advanced Medical Electronics Corporation (AME), Maple Grove, Minnesota, United States of America Advanced Medical Electronics Corporation (AME), Maple Grove, Minnesota, United States of America Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin Cities, Minnesota, United States of America Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin Cities, Minnesota, United States of America Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin Cities, Minnesota, United States of America Minnesota laboratory for Low-Vision Research, University of Minnesota, Twin Cities, Minnesota, United States of America},
note  = {PLoS One. 2013 Oct 8;8(10):. doi:10.1371/journal.pone.0076783.}
}

@Article{201338,
author  = {},
title  = {IL, July 13-17, 2013.},
journal  = {American Journal of Pharmaceutical Education},
volume  = {77},
number  = {5},
pages  = {},
year  = {2013},
abstract  = {},
address  = {},
note  = {Am J Pharm Educ. 2013 Jun 12;77(5):. doi:10.5688/ajpe775109.}
}

@Article{201139,
author  = {},
title  = {Antonio, TX, July 9-13, 2011.},
journal  = {American Journal of Pharmaceutical Education},
volume  = {75},
number  = {5},
pages  = {},
year  = {2011},
abstract  = {},
address  = {},
note  = {Am J Pharm Educ. 2011 Jun 10;75(5):. doi:10.5688/ajpe755105.}
}

@Article{201140,
author  = {},
title  = {ECR 2011 Book of Abstracts - B - Scientific Sessions.},
journal  = {Insights into Imaging},
volume  = {2},
number  = {Suppl 1},
pages  = {135-324},
year  = {2011},
abstract  = {},
address  = {},
note  = {Insights Imaging. 2011 Mar 1;2(Suppl 1):135-324. doi:10.1007/s13244-011-0077-4.}
}

@Article{201741,
author  = {Budimirovic, D. and Berry-Kravis, E. and Erickson, C. and Hall, S. and Hessl, D. and Reiss, A. and King, M. and Abbeduto, L. and Kaufmann, W.},
title  = {syndrome.},
journal  = {Journal of Neurodevelopmental Disorders},
volume  = {9},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Objective: Fragile X syndrome (FXS) has been the neurodevelopmental disorder with the most active translation of preclinical breakthroughs into clinical trials. This process has led to a critical assessment of outcome measures, which resulted in a comprehensive review published in 2013. Nevertheless, the disappointing outcome of several recent phase III drug trials in FXS, and parallel efforts at evaluating behavioral endpoints for trials in autism spectrum disorder (ASD), has emphasized the need for re-assessing outcome measures and revising recommendations for FXS. Methods: After performing an extensive database search (PubMed, Food and Drug Administration (FDA)/National Institutes of Health (NIH)‚Äôs www.ClinicalTrials.gov, etc.) to determine progress since 2013, members of the Working Groups who published the 2013 Report evaluated the available outcome measures for FXS and related neurodevelopmental disorders using the COSMIN grading system of levels of evidence. The latter has also been applied to a British survey of endpoints for ASD. In addition, we also generated an informal classification of outcome measures for use in FXS intervention studies as instruments appropriate to detect shorter- or longer-term changes. Results: To date, a total of 22 double-blind controlled clinical trials in FXS have been identified through www.ClinicalTrials.gov and an extensive literature search. The vast majority of these FDA/NIH-registered clinical trials has been completed between 2008 and 2015 and has targeted the core excitatory/inhibitory imbalance present in FXS and other neurodevelopmental disorders. Limited data exist on reliability and validity for most tools used to measure cognitive, behavioral, and other problems in FXS in these trials and other studies. Overall, evidence for most tools supports a moderate tool quality grading. Data on sensitivity to treatment, currently under evaluation, could improve ratings for some cognitive and behavioral tools. Some progress has also been made at identifying promising biomarkers, mainly on blood-based and neurophysiological measures. Conclusion: Despite the tangible progress in implementing clinical trials in FXS, the increasing data on measurement properties of endpoints, and the ongoing process of new tool development, the vast majority of outcome measures are at the moderate quality level with limited information on reliability, validity, and sensitivity to treatment. This situation is not unique to FXS, since reviews of endpoints for ASD have arrived at similar conclusions. These findings, in conjunction with the predominance of parent-based measures particularly in the behavioral domain, indicate that endpoint development in FXS needs to continue with an emphasis on more objective measures (observational, direct testing, biomarkers) that reflect meaningful improvements in quality of life. A major continuous challenge is the development of measurement tools concurrently with testing drug safety and efficacy in clinical trials.},
address  = {0000 0001 2171 9311grid.21107.35Departments of Psychiatry and Behavioral Sciences, Kennedy Krieger Institute and Child Psychiatry, Johns Hopkins University School of Medicine, 716 N. Broadway, Baltimore, MD 21205 USA 0000 0001 0705 3621grid.240684.cDepartments of Pediatrics, Neurological Sciences, Biochemistry, Rush University Medical Center, 1725 West Harrison, Suite 718, Chicago, IL 60612 USA 0000 0001 2179 9593grid.24827.3bDivision of Child and Adolescent Psychiatry, Cincinnati Children‚Äôs Hospital Medical Center and the University of Cincinnati College of Medicine, 3333 Burnet Avenue MLC 4002, Cincinnati, OH 45229 USA 0000000419368956grid.168010.eDivision of Interdisciplinary Brain Sciences, Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Road, Stanford, CA 94305 USA 0000 0000 9752 8549grid.413079.8MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, 2825 50th Street, Sacramento, CA 95817 USA 0000000419368956grid.168010.eDivision of Interdisciplinary Brain Sciences, Departments of Psychiatry and Behavioral Sciences, Radiology and Pediatrics, Stanford University, 401 Quarry Road, Stanford, CA 94305 USA grid.476963.9Autism & Developmental Medicine Institute, Geisinger Health System,  Present address: Novartis Pharmaceuticals Corporation, US Medical, One Health Plaza, East Hanover, NJ 07936 USA 0000 0000 9752 8549grid.413079.8MIND Institute and Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, 2825 50th Street, Sacramento, CA 95817 USA 0000 0000 8571 0933grid.418307.9Center for Translational Research, Greenwood Genetic Center, 113 Gregor Mendel Circle, Greenwood, SC 29646 USA},
note  = {J Neurodev Disord. 2017 Jun 12;9:. doi:10.1186/s11689-017-9193-x.}
}

@Article{201742,
author  = {Fowlkes, B. and Ghanouni, P. and Sanghvi, N. and Coussios, C. and Lyon, P. and Gray, M. and Mannaris, C. and Victor, M. and Stride, E. and Cleveland, R. and Carlisle, R. and Wu, F. and Middleton, M. and Gleeson, F. and Aubry, J. and Pauly, K. and Moonen, C. and Vortman, J. and Ghanouni, P. and Sharabi, S. and Daniels, D. and Last, D. and Guez, D. and Levy, Y. and Volovick, A. and Grinfeld, J. and Rachmilevich, I. and Amar, T. and Zibly, Z. and Mardor, Y. and Harnof, S. and Plaksin, M. and Weissler, Y. and Shoham, S. and Kimmel, E. and Naor, O. and Farah, N. and Shoham, S. and Paeng, D. and Xu, Z. and Snell, J. and Quigg, A. and Eames, M. and Jin, C. and Everstine, A. and Sheehan, J. and Lopes, B. and Kassell, N. and Looi, T. and Khokhlova, V. and Mougenot, C. and Hynynen, K. and Drake, J. and Slayton, M. and Amodei, R. and Compton, K. and McNelly, A. and Latt, D. and Slayton, M. and Amodei, R. and Compton, K. and Kearney, J. and Melodelima, D. and Dupre, A. and Chen, Y. and Perol, D. and Vincenot, J. and Chapelon, J. and Rivoire, M. and Guo, W. and Ren, G. and Shen, G. and Neidrauer, M. and Zubkov, L. and Weingarten, M. and Margolis, D. and Lewin, P. and McDannold, N. and Sutton, J. and Vykhodtseva, N. and Livingstone, M. and Kobus, T. and Zhang, Y. and Vykhodtseva, N. and McDannold, N. and Schwartz, M. and Huang, Y. and Lipsman, N. and Jain, J. and Chapman, M. and Sankar, T. and Lozano, A. and Hynynen, K. and Schwartz, M. and Yeung, R. and Huang, Y. and Lipsman, N. and Jain, J. and Chapman, M. and Lozano, A. and Hynynen, K. and Damianou, C. and Papadopoulos, N. and Volovick, A. and Grinfeld, J. and Levy, Y. and Brokman, O. and Zadicario, E. and Brenner, O. and Castel, D. and Wu, S. and Grondin, J. and Zheng, W. and Heidmann, M. and Karakatsani, M. and S√°nchez, C. and Ferrera, V. and Konofagou, E. and Damianou, C. and Yiannakou, M. and Cho, H. and Lee, H. and Han, M. and Choi, J. and Lee, T. and Ahn, S. and Chang, Y. and Park, J. and Ellens, N. and Partanen, A. and Farahani, K. and Airan, R. and Carpentier, A. and Canney, M. and Vignot, A. and Lafon, C. and Chapelon, J. and Delattre, J. and Idbaih, A. and Od√©en, H. and Bolster, B. and Jeong, E. and Parker, D. and Gaur, P. and Feng, X. and Fielden, S. and Meyer, C. and Werner, B. and Grissom, W. and Marx, M. and Ghanouni, P. and Pauly, K. and Weber, H. and Taviani, V. and Pauly, K. and Ghanouni, P. and Hargreaves, B. and Tanaka, J. and Kikuchi, K. and Ishijima, A. and Azuma, T. and Minamihata, K. and Yamaguchi, S. and Nagamune, T. and Sakuma, I. and Takagi, S. and Santin, M. and Marsac, L. and Maimbourg, G. and Monfort, M. and Larrat, B. and Fran√ßois, C. and Leh√©ricy, S. and Tanter, M. and Aubry, J. and Karakatsani, M. and Samiotaki, G. and Wang, S. and Acosta, C. and Feinberg, E. and Konofagou, E. and Kovacs, Z. and Tu, T. and Papadakis, G. and Reid, W. and Hammoud, D. and Frank, J. and Kovacs, Z. and Kim, S. and Jikaria, N. and Bresler, M. and Qureshi, F. and Frank, J. and Xia, J. and Tsui, P. and Liu, H. and Plata, J. and Fielden, S. and Sveinsson, B. and Hargreaves, B. and Meyer, C. and Pauly, K. and Plata, J. and Salgaonkar, V. and Adams, M. and Diederich, C. and Ozhinsky, E. and Bucknor, M. and Rieke, V. and Partanen, A. and Mikhail, A. and Severance, L. and Negussie, A. and Wood, B. and de, G. and Schubert, G. and Moonen, C. and Ries, M. and Poorman, M. and Dockery, M. and Chaplin, V. and Dudzinski, S. and Spears, R. and Caskey, C. and Giorgio, T. and Grissom, W. and Costa, M. and Papaevangelou, E. and Shah, A. and Rivens, I. and Box, C. and Bamber, J. and ter, H. and Burks, S. and Nagle, M. and Nguyen, B. and Bresler, M. and Frank, J. and Burks, S. and Nagle, M. and Nguyen, B. and Bresler, M. and Kim, S. and Milo, B. and Frank, J. and Le, N. and Song, S. and Zhou, K. and Nabi, G. and Huang, Z. and Ben-Ezra, S. and Rosen, S. and Mihcin, S. and Strehlow, J. and Karakitsios, I. and Le, N. and Schwenke, M. and Demedts, D. and Prentice, P. and Haase, S. and Preusser, T. and Melzer, A. and Mestas, J. and Chettab, K. and Gomez, G. and Dumontet, C. and Werle, B. and Lafon, C. and Marquet, F. and Bour, P. and Vaillant, F. and Amraoui, S. and Dubois, R. and Ritter, P. and Ha√Øssaguerre, M. and Hocini, M. and Bernus, O. and Quesson, B. and Livneh, A. and Kimmel, E. and Adam, D. and Robin, J. and Arnal, B. and Fink, M. and Tanter, M. and Pernot, M. and Khokhlova, T. and Schade, G. and Wang, Y. and Kreider, W. and Simon, J. and Starr, F. and Karzova, M. and Maxwell, A. and Bailey, M. and Khokhlova, V. and Lundt, J. and Allen, S. and Sukovich, J. and Hall, T. and Xu, Z. and Schade, G. and Wang, Y. and Khokhlova, T. and May, P. and Lin, D. and Bailey, M. and Khokhlova, V. and Constans, C. and Deffieux, T. and Tanter, M. and Aubry, J. and Park, E. and Ahn, Y. and Kang, S. and Park, D. and Lee, J. and Vidal-Jove, J. and Perich, E. and Ruiz, A. and Jaen, A. and Eres, N. and del, C. and Myers, R. and Kwan, J. and Coviello, C. and Rowe, C. and Crake, C. and Finn, S. and Jackson, E. and Carlisle, R. and Coussios, C. and Pouliopoulos, A. and Li, C. and Tinguely, M. and Tang, M. and Garbin, V. and Choi, J. and Lyon, P. and Mannaris, C. and Gray, M. and Folkes, L. and Stratford, M. and Carlisle, R. and Wu, F. and Middleton, M. and Gleeson, F. and Coussios, C. and Nwokeoha, S. and Carlisle, R. and Cleveland, R. and Wang, Y. and Khokhlova, T. and Li, T. and Farr, N. and D‚ÄôAndrea, S. and Starr, F. and Gravelle, K. and Chen, H. and Partanen, A. and Lee, D. and Hwang, J. and Tardoski, S. and Ngo, J. and Gineyts, E. and Roux, J. and Cl√©zardin, P. and Melodelima, D. and Conti, A. and Magnin, R. and Gerstenmayer, M. and Lux, F. and Tillement, O. and M√©riaux, S. and Penna, S. and Romani, G. and Dumont, E. and Larrat, B. and Sun, T. and Power, C. and Zhang, Y. and Sutton, J. and Miller, E. and McDannold, N. and Sapozhnikov, O. and Tsysar, S. and Yuldashev, P. and Khokhlova, V. and Svet, V. and Kreider, W. and Li, D. and Pellegrino, A. and Petrinic, N. and Siviour, C. and Jerusalem, A. and Cleveland, R. and Yuldashev, P. and Karzova, M. and Cunitz, B. and Dunmire, B. and Kreider, W. and Sapozhnikov, O. and Bailey, M. and Khokhlova, V. and Inserra, C. and Guedra, M. and Mauger, C. and Gilles, B. and Solovchuk, M. and Sheu, T. and Thiriet, M. and Zhou, Y. and Neufeld, E. and Baumgartner, C. and Payne, D. and Kyriakou, A. and Kuster, N. and Xiao, X. and McLeod, H. and Melzer, A. and Dillon, C. and Rieke, V. and Ghanouni, P. and Parker, D. and Payne, A. and Khokhova, V. and Yuldashev, P. and Sinilshchikov, I. and Andriyakhina, Y. and Khokhlova, T. and Kreider, W. and Maxwell, A. and Sapozhnikov, O. and Partanen, A. and Rybyanets, A. and Shvetsova, N. and Berkovich, A. and Shvetsov, I. and Sapozhnikov, O. and Khokhlova, V. and Shaw, C. and Rivens, I. and Civale, J. and Giussani, D. and ter, H. and Lees, C. and Bour, P. and Marquet, F. and Ozenne, V. and Toupin, S. and Quesson, B. and Dumont, E. and Ozhinsky, E. and Salgaonkar, V. and Diederich, C. and Rieke, V. and Kaye, E. and Monette, S. and Maybody, M. and Srimathveeravalli, G. and Solomon, S. and Gulati, A. and Preusser, T. and Haase, S. and Bezzi, M. and Jenne, J. and Lango, T. and Levy, Y. and M√ºller, M. and Sat, G. and Tanner, C. and Zangos, S. and G√ºnther, M. and Melzer, A. and Lafon, C. and Dinh, A. and Niaf, E. and Bratan, F. and Guillen, N. and Souchon, R. and Lartizien, C. and Crouzet, S. and Rouviere, O. and Chapelon, J. and Han, Y. and Wang, S. and Konofagou, E. and Payen, T. and Palermo, C. and Sastra, S. and Chen, H. and Han, Y. and Olive, K. and Konofagou, E. and van, B. and de, G. and Mougenot, C. and van, d. and Moonen, C. and Ries, M. and Gerstenmayer, M. and Magnin, R. and Fellah, B. and Le, B. and Larrat, B. and Gerstenmayer, M. and Magnin, R. and M√©riaux, S. and Le, B. and Larrat, B. and Allen, S. and Hernandez-Garcia, L. and Cain, C. and Hall, T. and Lyka, E. and Elbes, D. and Coviello, C. and Cleveland, R. and Coussios, C. and Zhou, K. and Le, N. and Li, C. and Huang, Z. and Tamano, S. and Jimbo, H. and Azuma, T. and Yoshizawa, S. and Fujiwara, K. and Itani, K. and Umemura, S. and Damianou, C. and Yiannakou, M. and Ellens, N. and Partanen, A. and Stoianovici, D. and Farahani, K. and Zaini, Z. and Takagi, R. and Yoshizawa, S. and Umemura, S. and Zong, S. and Shen, G. and Watkins, R. and Pascal-Tenorio, A. and Adams, M. and Plata, J. and Salgaonkar, V. and Jones, P. and Butts-Pauly, K. and Diederich, C. and Bouley, D. and Rybyanets, A. and Ren, G. and Guo, W. and Shen, G. and Chen, Y. and Lin, C. and Hsieh, H. and Wei, K. and Liu, H. and Garnier, C. and Renault, G. and Farr, N. and Partanen, A. and Negussie, A. and Mikhail, A. and Seifabadi, R. and Wilson, E. and Eranki, A. and Kim, P. and Wood, B. and L√ºbke, D. and Jenne, J. and Huber, P. and G√ºnther, M. and L√ºbke, D. and Georgii, J. and Schwenke, M. and Dresky, C. and Haller, J. and G√ºnther, M. and Preusser, T. and Jenne, J. and Eranki, A. and Farr, N. and Partanen, A. and Yarmolenko, P. and Negussie, A. and Sharma, K. and Celik, H. and Wood, B. and Kim, P. and Li, G. and Qiu, W. and Zheng, H. and Tsai, M. and Chu, P. and Liu, H. and Webb, T. and Vyas, U. and Pauly, K. and Walker, M. and Zhong, J. and Looi, T. and Waspe, A. and Drake, J. and Hodaie, M. and Yang, F. and Huang, S. and Zur, Y. and Volovick, A. and Assif, B. and Aurup, C. and Kamimura, H. and Wang, S. and Chen, H. and Acosta, C. and Carneiro, A. and Konofagou, E. and Volovick, A. and Grinfeld, J. and Castel, D. and Rothl√ºbbers, S. and Schwaab, J. and Tanner, C. and Mihcin, S. and Houston, G. and G√ºnther, M. and Jenne, J. and Ozhinsky, E. and Bucknor, M. and Rieke, V. and Azhari, H. and Weiss, N. and Sosna, J. and Goldberg, S. and Barrere, V. and Melodelima, D. and Jang, K. and Burks, S. and Kovacs, Z. and Tu, T. and Lewis, B. and Kim, S. and Nagle, M. and Jikaria, N. and Frank, J. and Zhou, Y. and Wang, X. and Ahn, Y. and Park, E. and Park, D. and Kang, S. and Lee, J. and Suomi, V. and Konofagou, E. and Edwards, D. and Cleveland, R. and Larrabee, Z. and Eames, M. and Hananel, A. and Aubry, J. and Rafaely, B. and Volovick, A. and Grinfeld, J. and Kimmel, E. and Debbiny, R. and Dekel, C. and Assa, M. and Kimmel, E. and Menikou, G. and Damianou, C. and Mouratidis, P. and Rivens, I. and ter, H. and Pineda-Pardo, J. and de, P. and Martinez, R. and Hernandez, F. and Casas, S. and Oliver, C. and Pastor, P. and Vela, L. and Obeso, J. and Greillier, P. and Zorgani, A. and Souchon, R. and Melodelima, D. and Catheline, S. and Lafon, C. and Solovov, V. and Vozdvizhenskiy, M. and Orlov, A. and Wu, C. and Sun, M. and Shih, T. and Chen, W. and Prieur, F. and Pillon, A. and Mestas, J. and Cartron, V. and Cebe, P. and Chansard, N. and Lafond, M. and Lafon, C. and Inserra, C. and Seya, P. and Chen, W. and Bera, J. and Boissenot, T. and Larrat, B. and Fattal, E. and Bordat, A. and Chacun, H. and Guetin, C. and Tsapis, N. and Maruyama, K. and Unga, J. and Suzuki, R. and Fant, C. and Lafond, M. and Rogez, B. and Ngo, J. and Lafon, C. and Mestas, J. and Afadzi, M. and Myhre, O. and Vea, S. and Bj√∏rk√∏y, A. and Yemane, P. and van, W. and Berg, S. and Hansen, R. and Angelsen, B. and Davies, C.},
title  = {Israel. 14-18 March, 2016.},
journal  = {Journal of Therapeutic Ultrasound},
volume  = {5},
number  = {Suppl 1},
pages  = {},
year  = {2017},
abstract  = {},
address  = {0000000086837370grid.214458.eBasic Radiological Sciences Division, Department of  Radiology, University of Michigan, Ann Arbor, Michigan USA 0000000419368956grid.168010.eStanford School of Medicine, Stanford, California USA grid.421488.3SonaCare Medical, Indianapolis, Indiana USA 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 0488 9484grid.415719.fHIFU Unit, Churchill Hospital, Oxford, UK 0000 0004 1936 8948grid.4991.5Department of Oncology, University of Oxford, Oxford, UK 0000 0004 0488 9484grid.415719.fDepartment of Radiology, Churchill Hospital, Oxford, UK Institut Langevin, Paris, France 0000000419368956grid.168010.eStanford School of Medicine, Stanford, California USA 0000000090126352grid.7692.aCenter for Imaging Sciences, Imaging Division, University Medical Center, Utrecht, The Netherlands grid.435375.3InSighTec, Haifa, Israel 0000000419368956grid.168010.eStanford School of Medicine, Stanford, California USA 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel grid.435375.3InSighTec, Haifa, Israel grid.435375.3InSighTec, Haifa, Israel grid.435375.3InSighTec, Haifa, Israel grid.435375.3InSighTec, Haifa, Israel grid.435375.3InSighTec, Haifa, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat-Gan, Israel 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie Nanotechnology Institute, Technion ‚Äì Israel Institute of Technology, Haifa, Israel 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie Nanotechnology Institute, Technion ‚Äì Israel Institute of Technology, Haifa, Israel 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie Nanotechnology Institute, Technion ‚Äì Israel Institute of Technology, Haifa, Israel 0000000121102151grid.6451.6Faculty of Biomedical Engineering & Russell Berrie Nanotechnology Institute, Technion ‚Äì Israel Institute of Technology, Haifa, Israel 0000 0004 1937 0538grid.9619.7ELSC Center for Brain Sciences, Hebrew University,  Jerusalem, Israel 0000 0004 1937 0503grid.22098.31Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel 0000000121102151grid.6451.6Biomedical Engineering, Technion- Israel Institute of  Technology, Haifa, Israel grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA 0000 0000 9136 933Xgrid.27755.32Neurosurgery, University of Virginia, Charlottesville, Virginia USA grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA 0000 0001 0725 5207grid.411277.6Ocean System Engineering, Jeju National University, Jeju, Republic of Korea 0000 0000 9136 933Xgrid.27755.32Biology, University of Virginia, Charlottesville, Virginia USA 0000 0000 9136 933Xgrid.27755.32Neurosurgery, University of Virginia, Charlottesville, Virginia USA 0000 0000 9136 933Xgrid.27755.32Pathology, University of Virginia, Charlottesville, Virginia USA grid.428670.fFocused Ultrasound Foundation, Charlottesville, Virginia USA 0000 0004 0473 9646grid.42327.30Hospital for Sick Children, Toronto, Ontario Canada 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA Philips Healthcare, Markham, Ontario Canada grid.17063.33Sunnybrook Research Institute, Toronto, Ontario Canada 0000 0004 0473 9646grid.42327.30Hospital for Sick Children, Toronto, Ontario Canada Guided Therapy Systems, LLC, Mesa, Arizona USA Guided Therapy Systems, LLC, Mesa, Arizona USA Guided Therapy Systems, LLC, Mesa, Arizona USA 0000 0001 2168 186Xgrid.134563.6School of Medicine, University of Arizona, Tucson, Arizona USA 0000 0001 2168 186Xgrid.134563.6School of Medicine, University of Arizona, Tucson, Arizona USA Guided Therapy Systems, Mesa, Arizona USA Guided Therapy Systems, Mesa, Arizona USA Guided Therapy Systems, Mesa, Arizona USA The CORE Institute, Phoenix, Arizona USA LabTAU - U1032, INSERM, Lyon, France 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France LabTAU - U1032, INSERM, Lyon, France LabTAU - U1032, INSERM, Lyon, France 0000 0001 0200 3174grid.418116.bCentre Leon Berard, Lyon, France Department of Oral Maxillofacial and Head Neck Oncology, Shanghai 9th People‚Äôs Hospital, Shanghai, China Department of Oral Maxillofacial and Head Neck Oncology, Shanghai 9th People‚Äôs Hospital, Shanghai, China Department of Oral Maxillofacial and Head Neck Oncology, Shanghai 9th People‚Äôs Hospital, Shanghai, China 0000 0001 2181 3113grid.166341.7The School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania USA 0000 0001 2181 3113grid.166341.7The School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania USA 0000 0001 2181 3113grid.166341.7Department of Surgery, College of Medicine, Drexel University, Philadelphia, Pennsylvania USA 0000 0004 1936 8972grid.25879.31Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania USA 0000 0001 2181 3113grid.166341.7The School of Biomedical Engineering, Science and Health Systems, Drexel University, Philadelphia, Pennsylvania USA 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women‚Äôs Hospital, Boston,  Massachusetts USA 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women‚Äôs Hospital, Boston,  Massachusetts USA 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women‚Äôs Hospital, Boston,  Massachusetts USA 000000041936754Xgrid.38142.3cNeurobiology, Harvard Medical School, Boston, Massachusetts USA 0000 0004 0444 9382grid.10417.33Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, Netherlands 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women‚Äôs Hospital, Boston,  Massachusetts USA 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women‚Äôs Hospital, Boston,  Massachusetts USA 0000 0004 0378 8294grid.62560.37Radiology, Brigham and Women‚Äôs Hospital, Boston,  Massachusetts USA grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada grid.17089.37Surgery (Neurosurgery), University of Alberta, Edmonton, Alberta Canada grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada grid.17063.33Surgery (Neurosurgery), University of Toronto, Toronto, Ontario Canada 0000 0000 9743 1587grid.413104.3Sunnybrook Health Sciences Centre, Toronto, Ontario Canada 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus 0000 0004 1936 8497grid.28577.3fCity University, London, UK grid.435375.3INSIGHTEC, Tirat Carmel, Israel grid.435375.3INSIGHTEC, Tirat Carmel, Israel grid.435375.3INSIGHTEC, Tirat Carmel, Israel grid.435375.3INSIGHTEC, Tirat Carmel, Israel grid.435375.3INSIGHTEC, Tirat Carmel, Israel 0000 0004 0604 7563grid.13992.30Weizmann Institute, Rehovot, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat Gan, Israel 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fNeuroscience, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea 0000 0001 0661 1556grid.258803.4Kyungpook National University, Daegu, Republic of Korea Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea 0000 0001 0661 1556grid.258803.4Kyungpook National University, Daegu, Republic of Korea Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore, Maryland USA 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore, Maryland USA 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore, Maryland USA 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore, Maryland USA 0000 0001 2150 9058grid.411439.aAssistance Publique Hopitaux de Paris, Hopital de la Pitie Salpetriere, Department of Neurosurgery, Paris, France CarThera, Lyon, France CarThera, Lyon, France INSERM, U1032, LabTau, Lyon, France INSERM, U1032, LabTau, Lyon, France 0000 0001 2149 7878grid.410511.0Universite Paris, UPMC, Paris, France 0000 0001 2150 9058grid.411439.aAssistance Publique Hopitaux de Paris, Hopital de la Pitie Salpetriere, Department of Neuro-Oncology, Paris, France Siemens Healthcare, Salt Lake City, Utah USA Siemens Healthcare, Salt Lake City, Utah USA 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, Utah USA 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, Utah USA 0000 0001 2264 7217grid.152326.1Vanderbilt University, Nashville, Tennessee USA 0000 0000 9136 933Xgrid.27755.32University of Virginia, Charlottesville, Virginia USA 0000 0000 9136 933Xgrid.27755.32University of Virginia, Charlottesville, Virginia USA 0000 0000 9136 933Xgrid.27755.32University of Virginia, Charlottesville, Virginia USA 0000 0001 0726 4330grid.412341.1University Children‚Äôs Hospital, Zurich, Switzerland 0000 0001 2264 7217grid.152326.1Vanderbilt University, Nashville, Tennessee USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan 0000 0001 2151 536Xgrid.26999.3dThe University of Tokyo, Tokyo, Japan Centre de NeuroImagerie de Recherche - CENIR, Paris, France Supersonic Imagine, Aix-en-Provence, France 0000 0001 2217 0017grid.7452.4Institut Langevin, Universit√© Denis Diderot, Paris, France Inserm U 1127, CNRS UMR 7225, Sorbonne Universit√©s, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle √©pini√®re, ICM, Paris, France 0000 0001 2112 9282grid.4444.0Institut Langevin, CNRS, Paris, France Inserm U 1127, CNRS UMR 7225, Sorbonne Universit√©s, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle √©pini√®re, ICM, Paris, France Centre de NeuroImagerie de Recherche - CENIR, Paris, France 0000000121866389grid.7429.8Institut Langevin, INSERM, Paris, France 0000 0001 2112 9282grid.4444.0Institut Langevin, CNRS, Paris, France 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000000419368729grid.21729.3fBiological Sciences, Columbia University, New York,  New York USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, New York USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dCenter for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland  USA 0000 0001 2297 5165grid.94365.3dCenter for Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland  USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institute of Health, Bethesda, Maryland USA grid.145695.aDepartment of Electrical Engineering, Chang Gung University, Taoyuan, Taiwan grid.145695.aDepartment of Medical Imaging and Radiological Sciences, Chang Gung  University, Taoyuan, Taiwan grid.145695.aDepartment of Electrical Engineering, Chang Gung University, Taoyuan, Taiwan 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000 0000 9136 933Xgrid.27755.32Bioengineering, University of Virginia, Charlottesville, Virginia USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000 0000 9136 933Xgrid.27755.32Bioengineering, University of Virginia, Charlottesville, Virginia USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, California USA 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San  Francisco, San Francisco, California USA 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San  Francisco, San Francisco, California USA 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San  Francisco, San Francisco, California USA 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California USA 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California USA 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California USA Clinical Science MR Therapy, Philips, Andover, Massachusetts USA 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Center for Interventional Oncology, Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland USA 0000000090126352grid.7692.aImaging Division, University Medical Center, Utrecht,  Netherlands Philips Healthcare, Vantaa, Finland 0000000090126352grid.7692.aImaging Division, University Medical Center, Utrecht,  Netherlands 0000000090126352grid.7692.aImaging Division, University Medical Center, Utrecht,  Netherlands 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University, Nashville, Tennessee USA 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University, Nashville, Tennessee USA 0000 0001 2264 7217grid.152326.1Chemical and Physical Biology, Vanderbilt University, Nashville, Tennessee USA 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University, Nashville, Tennessee USA 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University, Nashville, Tennessee USA 0000 0001 2264 7217grid.152326.1Radiology, Vanderbilt University, Nashville, Tennessee USA 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University, Nashville, Tennessee USA 0000 0001 2264 7217grid.152326.1Biomedical Engineering, Vanderbilt University, Nashville, Tennessee USA The Institute of Cancer Research, Department of Physics, Sutton, UK The Institute of Cancer Research, Department of Physics, Sutton, UK The Institute of Cancer Research, Department of Physics, Sutton, UK The Institute of Cancer Research, Department of Physics, Sutton, UK The Institute of Cancer Research, Department of Physics, Sutton, UK The Institute of Cancer Research, Department of Physics, Sutton, UK The Institute of Cancer Research, Department of Physics, Sutton, UK 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0001 2194 5650grid.410305.3Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, Maryland USA 0000 0004 0397 2876grid.8241.fMechanical Engineering, University of Dundee, Dundee, Angus UK 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000 0004 0397 2876grid.8241.fMechanical Engineering, University of Dundee, Dundee, Angus UK 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK 0000 0004 0397 2876grid.8241.fMechanical Engineering, University of Dundee, Dundee, Angus UK Action-Physics, Pardes-Hanna, Israel CByond ltd., Nesher, Israel School of Medicine, IMSaT, Dundee, UK 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany School of Medicine, IMSaT, Dundee, UK School of Medicine, IMSaT, Dundee, UK 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany School of Medicine, IMSaT, Dundee, UK 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany 0000 0000 9261 3939grid.4561.6Fraunhofer, Mevis, Bremen Germany School of Medicine, IMSaT, Dundee, UK U1032, INSERM, Lyon, Rhone-Alpes France 0000 0001 2172 4233grid.25697.3fUniversit√© de lyon, Lyon, Rhone-Alpes France Bioaster, Lyon, Rhone-Alpes France U1052, INSERM, Lyon, Rhone-Alpes France Bioaster, Lyon, Rhone-Alpes France U1032, INSERM, Lyon, Rhone-Alpes France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France IHU Institut de Rythmologie et de Mod√©lisation Cardiaque, Bordeaux, France 0000000121102151grid.6451.6Department of Biomedical Engineering, Technion-Israel  Institute of Technology, Haifa, Israel 0000000121102151grid.6451.6Department of Biomedical Engineering, Technion-Israel  Institute of Technology, Haifa, Israel 0000000121102151grid.6451.6Department of Biomedical Engineering, Technion-Israel  Institute of Technology, Haifa, Israel 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587,  INSERM U979, Universit√© Paris Diderot, Paris, France 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587,  INSERM U979, Universit√© Paris Diderot, Paris, France 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587,  INSERM U979, Universit√© Paris Diderot, Paris, France 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587,  INSERM U979, Universit√© Paris Diderot, Paris, France 0000 0001 2217 0017grid.7452.4Institut Langevin, ESPCI ParisTech, CNRS UMR 7587,  INSERM U979, Universit√© Paris Diderot, Paris, France 0000000122986657grid.34477.33Department of Medicine, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Department of Urology, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Applied Physics Laboratory, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Applied Physics Laboratory, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Applied Physics Laboratory, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Applied Physics Laboratory, University of Washington, Seattle, Washington USA 0000 0001 2342 9668grid.14476.30Physics Department, M.V. Lomonosov Moscow State University, Moscow, Russian Federation 0000000122986657grid.34477.33Department of Urology, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Applied Physics Laboratory, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Applied Physics Laboratory, University of Washington, Seattle, Washington USA 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, Michigan USA 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, Michigan USA 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, Michigan USA 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, Michigan USA 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, Michigan USA 0000000122986657grid.34477.33Urology, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Appied Physics Lab, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Medicine, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Urology, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Urology, University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33Appied Physics Lab, University of Washington, Seattle, Washington USA 0000 0001 2342 9668grid.14476.30Physics, M.V. Lomonosov Moscow State University,  Moscow, Russian Federation 0000 0001 2217 0017grid.7452.4Institut Langevin, Universit√© Paris Diderot, Paris, France 0000000121866389grid.7429.8Institut Langevin, INSERM, Paris, France 0000000121866389grid.7429.8Institut Langevin, INSERM, Paris, France 0000 0001 2112 9282grid.4444.0Institut Langevin, CNRS, Paris, France 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea Surgical Oncology, HIFU Unit, Hospital Universitari Mutua Terrassa (HUMT), Barcelona, Spain Interventional Oncology Unit, Institut Khuab, Barcelona, Spain Surgical Oncology, HIFU Unit, Hospital Universitari Mutua Terrassa (HUMT), Barcelona, Spain Research Unit, Hospital Universitari Mutua Terrassa (HUMT), Barcelona, Spain Interventional Oncology Unit, Institut Khuab, Barcelona, Spain Medical Direction Department, Hospital Universitari Mutua Terrassa (HUMT), Barcelona, Spain 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK OxSonics Ltd, Oxford, UK OxSonics Ltd, Oxford, UK OxSonics Ltd, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK OxSonics Ltd, Oxford, UK OxSonics Ltd, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK 0000 0001 2113 8111grid.7445.2Chemical Engineering, Imperial College London, London, UK 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK 0000 0001 2113 8111grid.7445.2Chemical Engineering, Imperial College London, London, UK 0000 0001 2113 8111grid.7445.2Bioengineering, Imperial College London, London, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0001 0440 1440grid.410556.3University of Oxford & Oxford University Hospitals NHS Foundation Trust, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Institute of Biomedical Engineering, University of  Oxford, Oxford, UK 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA Philips, Bethesda, Maryland USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA 0000000122986657grid.34477.33University of Washington, Seattle, Washington USA LabTAU - U1032, INSERM, Lyon, France LabTAU - U1032, INSERM, Lyon, France Lyos - U1033, INSERM, Lyon, France Lyos - U1033, INSERM, Lyon, France Lyos - U1033, INSERM, Lyon, France LabTAU - U1032, INSERM, Lyon, France CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France 0000 0001 2150 7757grid.7849.2Universit√© Lyon 1, Lyon, France 0000 0001 2150 7757grid.7849.2Universit√© Lyon 1, Lyon, France CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France 0000 0001 2181 4941grid.412451.7Department of Neuroscience, G. D‚ÄôAnnunzio University, Chieti, Italy 0000 0001 2181 4941grid.412451.7Department of Neuroscience, G. D‚ÄôAnnunzio University, Chieti, Italy Image Guided Therapy, Pessac, France CEA/DSV/I2BM/NeuroSpin, Gif sur Yvette, France 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, Massachusetts USA 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, Massachusetts USA 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, Massachusetts USA 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, Massachusetts USA 0000 0004 1936 7531grid.429997.8Department of Electrical and Computer Engineering, Tufts University, Medford, Massachusetts USA 0000 0004 0378 8294grid.62560.37Department of Radiology, Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, Massachusetts USA 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation N.N. Andreyev Acoustics Institute, Moscow, Russian Federation 0000000122986657grid.34477.33Center for Industrial and Medical Ultrasound, Applied Physics Laboratory, University of Washington, Seattle, WA USA 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5Department of Engineering Science, University of Oxford, Oxford, UK 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of Washington, Seattle, WA USA 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of Washington, Seattle, WA USA 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of Washington, Seattle, WA USA 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation 0000000122986657grid.34477.33CIMU, Applied Physics Laboratory, University of Washington, Seattle, WA USA 0000 0001 2342 9668grid.14476.30Physics Faculty, Moscow State University, Moscow, Russian Federation LabTAU Inserm U1032, Lyon, France LabTAU Inserm U1032, Lyon, France 0000 0004 1765 5089grid.15399.37INSA de Lyon, Villeurbanne, France LabTAU Inserm U1032, Lyon, France 0000000406229172grid.59784.37Institutes of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Taiwan 0000 0004 0546 0241grid.19188.39National Taiwan University, Taipei, Taiwan 0000 0001 1955 3500grid.5805.8Sorbonne Universities, UPMC Univ Paris 06, Paris, France 0000 0001 2224 0361grid.59025.3bNanyang Technological University, Singapore, Singapore grid.443853.dIT‚ÄôIS Foundation for Research on Information Technologies in Society, Zurich, Switzerland grid.443853.dIT‚ÄôIS Foundation for Research on Information Technologies in Society, Zurich, Switzerland grid.443853.dIT‚ÄôIS Foundation for Research on Information Technologies in Society, Zurich, Switzerland grid.443853.dIT‚ÄôIS Foundation for Research on Information Technologies in Society, Zurich, Switzerland grid.443853.dIT‚ÄôIS Foundation for Research on Information Technologies in Society, Zurich, Switzerland Institute for Medical Science and Technology, Dundee, UK 0000 0000 9009 9462grid.416266.1Ninewells Hospital, Dundee, UK Institute for Medical Science and Technology, Dundee, UK 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, UT USA 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA USA 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, CA USA 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, UT USA 0000 0001 2193 0096grid.223827.eRadiology, University of Utah, Salt Lake City, UT USA 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State University, Moscow, Russian Federation 0000000122986657grid.34477.33Department of Gastroenterology, School of Medicine,  University of Washington, Seattle, WA USA 0000000122986657grid.34477.33Center for Industrial and Medical Ultrasound, University of Washington, Seattle, WA USA 0000000122986657grid.34477.33Department of Urology, School of Medicine, University of Washington, Seattle, WA USA 0000 0001 2342 9668grid.14476.30Physics Faculty, M.V. Lomonosov Moscow State University, Moscow, Russian Federation Clinical Science MR Therapy, Philips, Andover, MA USA 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don, Russian Federation 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don, Russian Federation Saint Petersburg Polytechnical University, Saint Petersburg, Russian Federation 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don, Russian Federation 0000 0001 2342 9668grid.14476.30Moscow State University, Moscow, Russian Federation 0000 0001 2342 9668grid.14476.30Moscow State University, Moscow, Russian Federation 0000000121885934grid.5335.0Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK 0000 0001 1271 4623grid.18886.3fJoint Department of Physics, The Institute of Cancer Research, London, UK 0000 0001 1271 4623grid.18886.3fJoint Department of Physics, The Institute of Cancer Research, London, UK 0000000121885934grid.5335.0Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK 0000 0001 1271 4623grid.18886.3fJoint Department of Physics, The Institute of Cancer Research, London, UK 0000 0001 2113 8111grid.7445.2Institute of Developmental and Reproductive Biology, Imperial College London, UK, London, UK IHU-Liryc, Pessac, France IHU-Liryc, Pessac, France IHU-Liryc, Pessac, France IHU-Liryc, Pessac, France IHU-Liryc, Pessac, France Image Guided Therapy, Pessac, France 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA USA 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San  Francisco, San Francisco, CA USA 0000 0001 2297 6811grid.266102.1Radiation Oncology, University of California San  Francisco, San Francisco, CA USA 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA USA 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York, NY USA 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York, NY USA 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York, NY USA 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York, NY USA 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York, NY USA 0000 0001 2171 9952grid.51462.34Memorial Sloan Kettering Cancer Center, New York, NY USA 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany grid.7841.aUniversita Degli Studi Di Roma La Sapienza, Rome, Italy grid.436006.7Mediri GmbH, Heidelberg, Germany 0000 0004 0448 3150grid.4319.fStiftelsen SINTEF, Trondheim, Norway grid.435375.3InSightec, Haifa, Israel grid.435349.cIBSmm, Brno, Czech Republic GE Medical Systems, Haifa, Israel 0000 0001 2156 2780grid.5801.cETH, Zurich, Switzerland 0000 0004 1936 9721grid.7839.5Johann Wolfgang Goethe University, Frankfurt, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0397 2876grid.8241.fIMSat, University of Dundee, Dundee, UK LabTAU, INSERM, Lyon, France LabTAU, INSERM, Lyon, France 0000 0004 0638 0358grid.462859.4CREATIS, Lyon, France 0000 0001 2163 3825grid.413852.9Hospices Civils de Lyon, Lyon, France EDAP-TMS, Vaux-en-Velin, France LabTAU, INSERM, Lyon, France 0000 0004 0638 0358grid.462859.4CREATIS, Lyon, France 0000 0001 2163 3825grid.413852.9Hospices Civils de Lyon, Lyon, France LabTAU, INSERM, Lyon, France LabTAU, INSERM, Lyon, France 0000000419368729grid.21729.3fDepartment of Biomedical Engineering, Columbia University, New York, NY USA 0000000419368729grid.21729.3fDepartment of Biomedical Engineering, Columbia University, New York, NY USA 0000000419368729grid.21729.3fDepartment of Biomedical Engineering, Columbia University, New York, NY USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, NY USA 0000000419368729grid.21729.3fHerbert Irving Comprehensive, Cancer Center, Columbia University, New York, NY USA 0000000419368729grid.21729.3fHerbert Irving Comprehensive, Cancer Center, Columbia University, New York, NY USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, NY USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, NY USA 0000000419368729grid.21729.3fHerbert Irving Comprehensive, Cancer Center, Columbia University, New York, NY USA 0000000419368729grid.21729.3fBiomedical Engineering, Columbia University, New York, NY USA 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht, Utrecht, Netherlands 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht, Utrecht, Netherlands Philips, Ontario, Ontario, Canada 0000000090126352grid.7692.aRadiology, University Medical Center Utrecht, Utrecht, Netherlands 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht, Utrecht, Netherlands 0000000090126352grid.7692.aImaging Department, University Medical Center Utrecht, Utrecht, Netherlands grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif-sur-Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France grid.457334.2NeuroSpin, CEA Saclay, Gif sur Yvette, France 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, MI USA 0000000086837370grid.214458.eFMRI Lab, University of Michigan, Ann Arbor, MI USA 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, MI USA 0000000086837370grid.214458.eBiomedical Engineering, University of Michigan, Ann  Arbor, MI USA 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford,  UK 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford,  UK 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford,  UK 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford,  UK 0000 0004 1936 8948grid.4991.5Engineering Science, University of Oxford, Oxford,  UK 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK 0000 0004 0397 2876grid.8241.fUniversity of Dundee, Dundee, UK 0000 0001 2248 6943grid.69566.3aGraduate School of Engineering, Tohoku University, Sendai, Miyagi Japan 0000 0001 2248 6943grid.69566.3aGraduate School of Engineering, Tohoku University, Sendai, Miyagi Japan 0000 0001 2151 536Xgrid.26999.3dDepartment of Mechanical Engineering, The University of Tokyo, Bunkyo, Tokyo Japan 0000 0001 2248 6943grid.69566.3aGraduate School of Engineering, Tohoku University, Sendai, Miyagi Japan Hitachi Aloka Medical, Ltd., Kokubunji, Tokyo Japan Hitachi Aloka Medical, Ltd., Kokubunji, Tokyo Japan 0000 0001 2248 6943grid.69566.3aGraduate School of Biomedical Engineering, Tohoku University, Sendai, Miyagi Japan 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore, MD USA 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore, MD USA 0000 0001 2171 9311grid.21107.35Urology, Johns Hopkins University, Baltimore, MD  USA 0000 0001 2171 9311grid.21107.35Radiology, Johns Hopkins University, Baltimore, MD USA 0000 0001 2248 6943grid.69566.3aBiomedical Engineering, Tohoku University, Sendai, Japan 0000 0001 2248 6943grid.69566.3aCommunication Engineering, Tohoku University, Sendai, Japan 0000 0001 2248 6943grid.69566.3aCommunication Engineering, Tohoku University, Sendai, Japan 0000 0001 2248 6943grid.69566.3aBiomedical Engineering, Tohoku University, Sendai, Japan 0000 0004 0368 8293grid.16821.3cSchool of Biomedical Engineering, Shanghai Jiao Tong University, Biomedical Instrument Institute, Shanghai, China 0000 0004 0368 8293grid.16821.3cShanghai Jiao Tong University, Med-X Research Institute, Shanghai, China 0000000419368956grid.168010.eRadiology, Stanford University, Stanford, CA USA 0000000419368956grid.168010.eComparative Medicine, Stanford University, Palo Alto, CA USA 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San Francisco, CA USA 0000 0004 0450 875Xgrid.414123.1Radiology, Stanford University, Palo Alto, CA USA 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San Francisco, CA USA 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San Francisco, CA USA 0000 0004 0450 875Xgrid.414123.1Radiology, Stanford University, Palo Alto, CA USA 0000 0001 2297 6811grid.266102.1Thermal Therapy Research Group, UCSF, San Francisco, CA USA 0000 0004 0450 875Xgrid.414123.1Comparative Medicine, Stanford University, Palo Alto, CA USA 0000 0001 2172 8170grid.182798.dSouthern Federal University, Rostov on Don, Russian Federation 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China 0000 0004 0368 8293grid.16821.3cShangai Jiao Tong University, Shanghai, China grid.145695.aChang Gung University, Taoyuan, Taiwan grid.145695.aChang Gung University, Taoyuan, Taiwan grid.145695.aChang Gung University, Taoyuan, Taiwan grid.145695.aChang Gung University, Taoyuan, Taiwan 0000 0001 2217 0017grid.7452.4Universit√© Paris 7, Paris, France 0000 0004 0643 431Xgrid.462098.1Institut Cochin, Paris, France 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA Clinical Science MR Therapy, Philips, Andover, MA USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA grid.239560.bChildren‚Äôs National Medical Center, Washington, DC USA grid.239560.bChildren‚Äôs National Medical Center, Washington, DC USA grid.239560.bChildren‚Äôs National Medical Center, Washington, DC USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD, USA 0000 0004 0496 8246grid.428590.2MRI Physics, Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2MRI Physics, Fraunhofer MEVIS, Bremen, Germany 0000 0004 0492 0584grid.7497.dDeutsches Krebsforschungszentrum, Heidelberg, Germany 0000 0004 0496 8246grid.428590.2MRI Physics, Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0001 2186 1887grid.4764.1PTB Braunschweig, Braunschweig, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany grid.239560.bChildren‚Äôs National Medical Center, Washington, DC USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA Clinical Science MR Therapy, Philips, Andover, MA USA grid.239560.bChildren‚Äôs National Medical Center, Washington, DC USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA grid.239560.bChildren‚Äôs National Medical Center, Washington, DC USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dNational Institutes of Health, Bethesda, MD USA grid.239560.bChildren‚Äôs National Medical Center, Washington, DC USA 0000 0001 0483 7922grid.458489.cShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China 0000 0001 0483 7922grid.458489.cShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China 0000 0001 0483 7922grid.458489.cShenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China grid.145695.aDepartment of Electrical Engineering, Chang Gung University, Taoyuan, Taiwan grid.145695.aDepartment of Electrical Engineering, Chang Gung University, Taoyuan, Taiwan grid.145695.aDepartment of Electrical Engineering, Chang Gung University, Taoyuan, Taiwan 0000 0004 0450 875Xgrid.414123.1Electrical Engineering, Stanford University, Palo Alto, CA USA 0000 0004 0450 875Xgrid.414123.1Radiology, Stanford University, Palo Alto, CA USA 0000 0004 0450 875Xgrid.414123.1Electrical Engineering, Stanford University, Palo Alto, CA USA grid.17063.33Institute of Medical Science, University of Toronto, Toronto, Ontario Canada 0000 0004 0474 0428grid.231844.8Krembil Research Institute, University Health Network, Toronto, Ontario Canada 0000 0004 0473 9646grid.42327.30Centre for Image Guided Innovation and Therapeutic Intervention, Hospital for Sick Children, Toronto, Ontario Canada 0000 0004 0473 9646grid.42327.30Centre for Image Guided Innovation and Therapeutic Intervention, Hospital for Sick Children, Toronto, Ontario Canada 0000 0004 0473 9646grid.42327.30Centre for Image Guided Innovation and Therapeutic Intervention, Hospital for Sick Children, Toronto, Ontario Canada 0000 0004 0474 0428grid.231844.8Krembil Research Institute, University Health Network, Toronto, Ontario Canada 0000 0001 0425 5914grid.260770.4Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan 0000 0001 0425 5914grid.260770.4Department of Biomedical Imaging and Radiological Sciences, National Yang-Ming University, Taipei, Taiwan General Electric, Tirat Carmel, Israel grid.435375.3InSighTec, Tirat Carmel, Israel grid.435375.3InSighTec, Tirat Carmel, Israel 0000000419368729grid.21729.3fColumbia University, New York, NY USA 0000 0004 1937 0722grid.11899.38Universidade de S√£o Paulo, S√£o Paulo, Brasil 0000000419368729grid.21729.3fColumbia University, New York, NY USA 0000000419368729grid.21729.3fColumbia University, New York, NY USA 0000000419368729grid.21729.3fColumbia University, New York, NY USA 0000 0004 1937 0722grid.11899.38Universidade de S√£o Paulo, S√£o Paulo, Brasil 0000000419368729grid.21729.3fColumbia University, New York, NY USA grid.435375.3InSighTec, Tirat Carmel, Israel grid.435375.3InSighTec, Tirat Carmel, Israel 0000 0001 2107 2845grid.413795.dSheba Medical Center, Ramat Gan, Israel grid.436006.7mediri GmbH, Heidelberg, Germany grid.436006.7mediri GmbH, Heidelberg, Germany 0000 0001 2156 2780grid.5801.cETH Z√ºrich, Z√ºrich, Switzerland IMSAT, Dundee, UK IMSAT, Dundee, UK 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0004 0496 8246grid.428590.2Fraunhofer MEVIS, Bremen, Germany 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA USA 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA USA 0000 0001 2297 6811grid.266102.1Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, CA USA 0000000121102151grid.6451.6Biomedical Engineering, Technion, IIT, Haifa, Israel 0000000121102151grid.6451.6Biomedical Engineering, Technion, IIT, Haifa, Israel 0000 0001 2221 2926grid.17788.31Department of Radiology, Hadassah, Hebrew University, Medical Center, Jerusalem, Israel 0000 0001 2221 2926grid.17788.31Department of Radiology, Hadassah, Hebrew University, Medical Center, Jerusalem, Israel 0000 0004 0450 6033grid.462394.eInserm, Lyon, France 0000 0004 0450 6033grid.462394.eInserm, Lyon, France 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dFrank Laboratory, Radiology and Imaging Sciences, National Institutes of Health, Bethesda, MD USA 0000 0001 2224 0361grid.59025.3bNanyang Technological University, Singapore, Singapore 0000 0001 2224 0361grid.59025.3bNanyang Technological University, Singapore, Singapore 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0001 0302 820Xgrid.412484.fRadiology, Seoul National University Hospital, Seoul, Republic of Korea 0000 0004 1936 8948grid.4991.5University of Oxford, Oxford, UK 0000000419368729grid.21729.3fColumbia University, New York City, NY USA 0000 0004 1936 8948grid.4991.5University of Oxford, Oxford, UK 0000 0004 1936 8948grid.4991.5University of Oxford, Oxford, UK grid.428670.fFocused Ultrasound Foundation, Charlottesville, VA USA grid.428670.fFocused Ultrasound Foundation, Charlottesville, VA USA grid.428670.fFocused Ultrasound Foundation, Charlottesville, VA USA Institut Langevin, Paris, France 0000 0004 1937 0511grid.7489.2Department of Electrical and Computer Engineering,  Ben-Gurion University of the Negev, Beer-Sheva, Israel grid.435375.3InSighTec, Tirat Carmel, Israel grid.435375.3InSighTec, Tirat Carmel, Israel 0000000121102151grid.6451.6Biomedical Engineering, Technion ‚Äì Israel Institute of Technology, Haifa, Israel 0000000121102151grid.6451.6Biomedical Engineering, Technion ‚Äì Israel Institute of Technology, Haifa, Israel Biomedical Engineering, Technion, Haifa, Israel Biomedical Engineering, Technion, Haifa, Israel Biomedical Engineering, Technion, Haifa, Israel 0000 0004 1936 8497grid.28577.3fCity University, London, UK 0000 0000 9995 3899grid.15810.3dCyprus University of Technology, Limassol, Cyprus 0000 0001 1271 4623grid.18886.3fRadiotherapy and Imaging, The Institute of Cancer Research, Sutton, London, Surrey UK 0000 0001 1271 4623grid.18886.3fRadiotherapy and Imaging, The Institute of Cancer Research, Sutton, London, Surrey UK 0000 0001 1271 4623grid.18886.3fRadiotherapy and Imaging, The Institute of Cancer Research, Sutton, London, Surrey UK HM CINAC. Hospital Puerta del Sur, M√≥stoles, Spain HM CINAC. Hospital Puerta del Sur, M√≥stoles, Spain HM CINAC. Hospital Puerta del Sur, M√≥stoles, Spain HM CINAC. Hospital Puerta del Sur, M√≥stoles, Spain Hospital Puerta del Sur, M√≥stoles, Spain Hospital Puerta del Sur, M√≥stoles, Spain Hospital Puerta del Sur, M√≥stoles, Spain HM CINAC. Hospital Puerta del Sur, M√≥stoles, Spain HM CINAC. Hospital Puerta del Sur, M√≥stoles, Spain LabTau - U1032, INSERM, Lyon, France LabTau - U1032, INSERM, Lyon, France LabTau - U1032, INSERM, Lyon, France LabTau - U1032, INSERM, Lyon, France LabTau - U1032, INSERM, Lyon, France LabTau - U1032, INSERM, Lyon, France Samara Oncology Center, Samara, Russian Federation Samara Oncology Center, Samara, Russian Federation Samara Oncology Center, Samara, Russian Federation 0000 0004 0572 7815grid.412094.aPhysical Medicine & Rehabilitation, National Taiwan University Hospital, Taipei, Taiwan 0000 0004 0572 7815grid.412094.aPhysical Medicine & Rehabilitation, National Taiwan University Hospital, Taipei, Taiwan 0000 0004 0572 7815grid.412094.aMedical Imaging, National Taiwan University Hospital, Taipei, Taiwan 0000 0004 0572 7815grid.412094.aPhysical Medicine & Rehabilitation, National Taiwan University Hospital, Taipei, Taiwan 0000 0004 1936 8921grid.5510.1University of Oslo, Oslo, Norway Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre Fabre, Toulouse, France U1032, LabTau, INSERM, Lyon, France Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre Fabre, Toulouse, France Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre Fabre, Toulouse, France Centre de Recherche en Oncologie Experimentale, Institut de Recherche Pierre Fabre, Toulouse, France U1032, LabTau, INSERM, Lyon, France U1032, LabTau, INSERM, Lyon, France LabTAU Inserm U1032, Lyon, France Laboratoire de M√©canique et d‚ÄôAcoustique CNRS - UPR 7051, Marseille, France 0000 0004 0572 7815grid.412094.aNational Taiwan University Hospital, Taipei, Taiwan LabTAU Inserm U1032, Lyon, France Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Universit√© Paris Sacla, Ch√¢tenay-Malabry, France CEA, Neurospin, Saclay, France Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Universit√© Paris Sacla, Ch√¢tenay-Malabry, France Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Universit√© Paris Sacla, Ch√¢tenay-Malabry, France Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Universit√© Paris Sacla, Ch√¢tenay-Malabry, France Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Universit√© Paris Sacla, Ch√¢tenay-Malabry, France Institut Galien Paris-Sud, CNRS, Univ. Paris-Sud, Universit√© Paris Sacla, Ch√¢tenay-Malabry, France 0000 0000 9239 9995grid.264706.1Department of DDS Research, Teikyo University, Tokyo, Japan 0000 0000 9239 9995grid.264706.1Department of DDS Research, Teikyo University, Tokyo, Japan 0000 0000 9239 9995grid.264706.1Department of DDS Research, Teikyo University, Tokyo, Japan LabTAU, INSERM U1032, Lyon, France LabTAU, INSERM U1032, Lyon, France LabTAU, INSERM U1032, Lyon, France LabTAU, INSERM U1032, Lyon, France LabTAU, INSERM U1032, Lyon, France LabTAU, INSERM U1032, Lyon, France Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway Circulation and Medical Imaging, Norwegian Univeristy of Science and Techonlogy,  Trondhiem, Norway Circulation and Medical Imaging, Norwegian Univeristy of Science and Techonlogy,  Trondhiem, Norway Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway SINTEF Technology and Society, Trondhiem, Norway SINTEF Technology and Society, Trondhiem, Norway Circulation and Medical Imaging, Norwegian Univeristy of Science and Techonlogy,  Trondhiem, Norway Physics, Norwegian Univeristy of Science and Techonlogy, Trondhiem, Norway},
note  = {J Ther Ultrasound. 2017 Mar 17;5(Suppl 1):. doi:10.1186/s40349-016-0079-2.}
}

@Article{201643,
author  = {Mocanu, B. and Tapu, R. and Zaharia, T.},
title  = {Detection and Recognition.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {11},
pages  = {},
year  = {2016},
abstract  = {In the most recent report published by the World Health Organization concerning people with visual disabilities it is highlighted that by the year 2020, worldwide, the number of completely blind people will reach 75 million, while the number of visually impaired (VI) people will rise to 250 million. Within this context, the development of dedicated electronic travel aid (ETA) systems, able to increase the safe displacement of VI people in indoor/outdoor spaces, while providing additional cognition of the environment becomes of outmost importance.  This paper introduces a novel wearable assistive device designed to facilitate the autonomous navigation of blind and VI people in highly dynamic urban scenes.  The system exploits two independent sources of information: ultrasonic sensors and the video camera embedded in a regular smartphone. The underlying methodology exploits computer vision and machine learning techniques and makes it possible to identify accurately both static and highly dynamic objects existent in a scene, regardless on their location, size or shape. In addition, the proposed system is  able to acquire information about the environment, semantically interpret it and  alert users about possible dangerous situations through acoustic feedback. To determine the performance of the proposed methodology we have performed an extensive objective and subjective experimental evaluation with the help of 21 VI subjects from two blind associations. The users pointed out that our prototype is highly helpful in increasing the mobility, while being friendly and easy to learn.},
address  = {ARTEMIS Department, Institut Mines-T√©l√©com/T√©l√©com SudParis, UMR CNRS MAP5 8145,  9 rue Charles Fourier, √âvry 91000, France; bogdan.mocanu@telecom-sudparis.eu (B.M.); titus.zaharia@telecom-sudparis.eu (T.Z.) ARTEMIS Department, Institut Mines-T√©l√©com/T√©l√©com SudParis, UMR CNRS MAP5 8145,  9 rue Charles Fourier, √âvry 91000, France; bogdan.mocanu@telecom-sudparis.eu (B.M.); titus.zaharia@telecom-sudparis.eu (T.Z.) ARTEMIS Department, Institut Mines-T√©l√©com/T√©l√©com SudParis, UMR CNRS MAP5 8145,  9 rue Charles Fourier, √âvry 91000, France; bogdan.mocanu@telecom-sudparis.eu (B.M.); titus.zaharia@telecom-sudparis.eu (T.Z.)},
note  = {Sensors (Basel). 2016 Oct 28;16(11):. doi:10.3390/s16111807.}
}

@Article{201544,
author  = {Bamidis, P. and Fissler, P. and Papageorgiou, S. and Zilidou, V. and Konstantinidis, E. and Billis, A. and Romanopoulou, E. and Karagianni, M. and Beratis, I. and Tsapanou, A. and Tsilikopoulou, G. and Grigoriadou, E. and Ladas, A. and Kyrillidou, A. and Tsolaki, A. and Frantzidis, C. and Sidiropoulos, E. and Siountas, A. and Matsi, S. and Papatriantafyllou, J. and Margioti, E. and Nika, A. and Schlee, W. and Elbert, T. and Tsolaki, M. and Vivas, A. and Kolassa, I.},
title  = {training dosage and severity of neurocognitive disorder.},
journal  = {Frontiers in Aging Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Physical as well as cognitive training interventions improve specific cognitive functions but effects barely generalize on global cognition. Combined physical and cognitive training may overcome this shortcoming as physical training may facilitate the neuroplastic potential which, in turn, may be guided by cognitive  training. This study aimed at investigating the benefits of combined training on  global cognition while assessing the effect of training dosage and exploring the  role of several potential effect modifiers. In this multi-center study, 322 older adults with or without neurocognitive disorders (NCDs) were allocated to a computerized, game-based, combined physical and cognitive training group (n = 237) or a passive control group (n = 85). Training group participants were allocated to different training dosages ranging from 24 to 110 potential sessions. In a pre-post-test design, global cognition was assessed by averaging standardized performance in working memory, episodic memory and executive function tests. The intervention group increased in global cognition compared to  the control group, p = 0.002, Cohen‚Äôs d = 0.31. Exploratory analysis revealed a trend for less benefits in participants with more severe NCD, p = 0.08 (cognitively healthy: d = 0.54; mild cognitive impairment: d = 0.19; dementia: d  = 0.04). In participants without dementia, we found a dose-response effect of the potential number and of the completed number of training sessions on global cognition, p = 0.008 and p = 0.04, respectively. The results indicate that combined physical and cognitive training improves global cognition in a dose-responsive manner but these benefits may be less pronounced in older adults  with more severe NCD. The long-lasting impact of combined training on the incidence and trajectory of NCDs in relation to its severity should be assessed in future long-term trials.},
address  = {Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Institute of Psychology and Pedagogy, Clinical and Biological Psychology, Ulm University, UlmGermany Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Laboratory of Medical Physics, Faculty of Health Sciences, Medical School, Aristotle University of ThessalonikiThessaloniki, Greece Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Behavioral Neurology and Neuropsychology Unit, 1st and 2nd Department of Neurology, Medical School, National Kapodistrian University of AthensAthens, Greece Department of Psychiatry and Psychotherapy, University of RegensburgRegensburg, Germany Clinical Psychology and Clinical Neuropsychology, University of KonstanzKonstanz, Germany Greek Association of Alzheimer‚Äôs Disease and Related Disorders, ThessalonikiGreece Cognitive Psychology and Neuropsychology Lab, Department of Psychology, City College, The University of Sheffield International Faculty, ThessalonikiGreece Institute of Psychology and Pedagogy, Clinical and Biological Psychology, Ulm University, UlmGermany},
note  = {Front Aging Neurosci. 2015 Aug 07;7:. doi:10.3389/fnagi.2015.00152.}
}

@Article{201545,
author  = {Nozawa, T. and Taki, Y. and Kanno, A. and Akimoto, Y. and Ihara, M. and Yokoyama, R. and Kotozaki, Y. and Nouchi, R. and Sekiguchi, A. and Takeuchi, H. and Miyauchi, C. and Ogawa, T. and Goto, T. and Sunda, T. and Shimizu, T. and Tozuka, E. and Hirose, S. and Nanbu, T. and Kawashima, R.},
title  = {Structure, and Driving Safety in Senior Daily Drivers: A Pilot Study.},
journal  = {Behavioural Neurology},
volume  = {2015},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Background. Increasing proportion of the elderly in the driving population raises the importance of assuring their safety. We explored the effects of three different types of cognitive training on the cognitive function, brain structure, and driving safety of the elderly. Methods. Thirty-seven healthy elderly daily drivers were randomly assigned to one of three training groups: Group V trained in a vehicle with a newly developed onboard cognitive training program, Group P trained with a similar program but on a personal computer, and Group C trained to solve a crossword puzzle. Before and after the 8-week training period, they underwent neuropsychological tests, structural brain magnetic resonance imaging,  and driving safety tests. Results. For cognitive function, only Group V showed significant improvements in processing speed and working memory. For driving safety, Group V showed significant improvements both in the driving aptitude test and in the on-road evaluations. Group P showed no significant improvements in either test, and Group C showed significant improvements in the driving aptitude  but not in the on-road evaluations. Conclusion. The results support the effectiveness of the onboard training program in enhancing the elderly's abilities to drive safely and the potential advantages of a multimodal training approach.},
address  = {Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Division of Medical Neuroimage Analysis, Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai 980-8575, Japan Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan Research Division 2, Mobility Services Laboratory, Nissan Motor Co., Ltd., Kanagawa 243-0123, Japan Research Division 2, Mobility Services Laboratory, Nissan Motor Co., Ltd., Kanagawa 243-0123, Japan CAE and Testing Division 1, Vehicle Test and Measurement Technology Development,  Nissan Motor Co., Ltd., Kanagawa 243-0192, Japan Research Division 2, Mobility Services Laboratory, Nissan Motor Co., Ltd., Kanagawa 243-0123, Japan Research Division 2, Prototype and Test Department, Nissan Motor Co., Ltd., Kanagawa 243-0123, Japan Smart Ageing International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai 980-8575, Japan},
note  = {Behav Neurol. 2015;2015:. Epub 2015 Jun 16 doi:10.1155/2015/525901.}
}

@Article{201546,
author  = {Coskun, V. and Ozdenizci, B. and Ok, K.},
title  = {The Survey on Near Field Communication.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {15},
number  = {6},
pages  = {13348-405},
year  = {2015},
abstract  = {Near Field Communication (NFC) is an emerging short-range wireless communication  technology that offers great and varied promise in services such as payment, ticketing, gaming, crowd sourcing, voting, navigation, and many others. NFC technology enables the integration of services from a wide range of applications  into one single smartphone. NFC technology has emerged recently, and consequently not much academic data are available yet, although the number of academic research studies carried out in the past two years has already surpassed the total number of the prior works combined. This paper presents the concept of NFC  technology in a holistic approach from different perspectives, including hardware improvement and optimization, communication essentials and standards, applications, secure elements, privacy and security, usability analysis, and ecosystem and business issues. Further research opportunities in terms of the academic and business points of view are also explored and discussed at the end of each section. This comprehensive survey will be a valuable guide for researchers and academicians, as well as for business in the NFC technology and ecosystem.},
address  = {},
note  = {Sensors (Basel). 2015 Jun 05;15(6):13348-405. doi:10.3390/s150613348.}
}

@Article{201447,
author  = {},
title  = {38th Annual Meeting of the European Thyroid Association.},
journal  = {European Thyroid Journal},
volume  = {3},
number  = {Suppl 1},
pages  = {73-226},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1159/000365244.}
}

@Article{201448,
author  = {Di, P. and Maravita, A. and Zollo, L. and Guglielmelli, E. and Di, L.},
title  = {Augmentation-related brain plasticity.},
journal  = {Frontiers in Systems Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Today, the anthropomorphism of the tools and the development of neural interfaces require reconsidering the concept of human-tools interaction in the framework of  human augmentation. This review analyses the plastic process that the brain undergoes when it comes into contact with augmenting artificial sensors and effectors and, on the other hand, the changes that the use of external augmenting devices produces in the brain. Hitherto, few studies investigated the neural correlates of augmentation, but clues on it can be borrowed from logically-related paradigms: sensorimotor training, cognitive enhancement, cross-modal plasticity, sensorimotor functional substitution, use and embodiment  of tools. Augmentation modifies function and structure of a number of areas, i.e., primary sensory cortices shape their receptive fields to become sensitive to novel inputs. Motor areas adapt the neuroprosthesis representation firing-rate to refine kinematics. As for normal motor outputs, the learning process recruits  motor and premotor cortices and the acquisition of proficiency decreases attentional recruitment, focuses the activity on sensorimotor areas and increases the basal ganglia drive on the cortex. Augmentation deeply relies on the frontoparietal network. In particular, premotor cortex is involved in learning the control of an external effector and owns the tool motor representation, while the intraparietal sulcus extracts its visual features. In these areas, multisensory integration neurons enlarge their receptive fields to embody supernumerary limbs. For operating an anthropomorphic neuroprosthesis, the mirror system is required to understand the meaning of the action, the cerebellum for the formation of its internal model and the insula for its interoception. In conclusion, anthropomorphic sensorized devices can provide the critical sensory afferences to evolve the exploitation of tools through their embodiment, reshaping the body representation and the sense of the self.},
address  = {Institute of Neurology and Fondazione Alberto Sordi - Research Institute for Ageing, Campus Bio Medico University of RomeRome, Italy Department of Psycology, Universit√† di Milano-BicoccaMilano, Italy Laboratory of Biomedical Robotics and Biomicrosystems CIR - Centre for Integrated Research, Campus Bio Medico University of RomeRome, Italy Laboratory of Biomedical Robotics and Biomicrosystems CIR - Centre for Integrated Research, Campus Bio Medico University of RomeRome, Italy Institute of Neurology and Fondazione Alberto Sordi - Research Institute for Ageing, Campus Bio Medico University of RomeRome, Italy},
note  = {Front Syst Neurosci. 2014 Jun 11;8:. doi:10.3389/fnsys.2014.00109.}
}

@Article{201449,
author  = {Connors, E. and Chrastil, E. and S√°nchez, J. and Merabet, L.},
title  = {comparison of directed instruction vs. video game based learning approaches.},
journal  = {Frontiers in Human Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {For profoundly blind individuals, navigating in an unfamiliar building can represent a significant challenge. We investigated the use of an audio-based, virtual environment called Audio-based Environment Simulator (AbES) that can be explored for the purposes of learning the layout of an unfamiliar, complex indoor environment. Furthermore, we compared two modes of interaction with AbES. In one  group, blind participants implicitly learned the layout of a target environment while playing an exploratory, goal-directed video game. By comparison, a second group was explicitly taught the same layout following a standard route and instructions provided by a sighted facilitator. As a control, a third group interacted with AbES while playing an exploratory, goal-directed video game however, the explored environment did not correspond to the target layout. Following interaction with AbES, a series of route navigation tasks were carried  out in the virtual and physical building represented in the training environment  to assess the transfer of acquired spatial information. We found that participants from both modes of interaction were able to transfer the spatial knowledge gained as indexed by their successful route navigation performance. This transfer was not apparent in the control participants. Most notably, the game-based learning strategy was also associated with enhanced performance when participants were required to find alternate routes and short cuts within the target building suggesting that a ludic-based training approach may provide for a more flexible mental representation of the environment. Furthermore, outcome comparisons between early and late blind individuals suggested that greater prior visual experience did not have a significant effect on overall navigation performance following training. Finally, performance did not appear to be associated with other factors of interest such as age, gender, and verbal memory  recall. We conclude that the highly interactive and immersive exploration of the  virtual environment greatly engages a blind user to develop skills akin to positive near transfer of learning. Learning through a game play strategy appears to confer certain behavioral advantages with respect to how spatial information is acquired and ultimately manipulated for navigation.},
address  = {The Laboratory for Visual Neuroplasticity, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical SchoolBoston, MA, USA Department of Psychology, Center for Memory and Brain, Boston UniversityBoston, MA, USA Department of Computer Science, Center for Advanced Research in Education, University of ChileSantiago, Chile The Laboratory for Visual Neuroplasticity, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical SchoolBoston, MA, USA},
note  = {Front Hum Neurosci. 2014 May 01;8:. doi:10.3389/fnhum.2014.00223.}
}

@Article{201350,
author  = {},
title  = {Oral and Posters, June 8.},
journal  = {European Journal of Psychotraumatology},
volume  = {4},
number  = {},
pages  = {},
year  = {2013},
abstract  = {},
address  = {},
note  = {Eur J Psychotraumatol. 2013 Jun 04;4:. doi:10.3402/ejpt.v4i0.21127.}
}

@Article{201351,
author  = {},
title  = {Oral and Posters, June 7.},
journal  = {European Journal of Psychotraumatology},
volume  = {4},
number  = {},
pages  = {},
year  = {2013},
abstract  = {},
address  = {},
note  = {Eur J Psychotraumatol. 2013 Jun 04;4:. doi:10.3402/ejpt.v4i0.21098.}
}

@Article{201352,
author  = {Ommaya, A. and Adams, K. and Allman, R. and Collins, E. and Cooper, R. and Dixon, C. and Fishman, P. and Henry, J. and Kardon, R. and Kerns, R. and Kupersmith, J. and Lo, A. and Macko, R. and McArdle, R. and McGlinchey, R. and McNeil, M. and O‚ÄôToole, T. and Peckham, P. and Tuszynski, M. and Waxman, S. and Wittenberg, G.},
title  = {Opportunities in rehabilitation research.},
journal  = {Journal of rehabilitation research and development},
volume  = {50},
number  = {6},
pages  = {vii-xxxii},
year  = {2013},
abstract  = {},
address  = {VA Office of Research and Development, Washington, DC Mental Health Service, VA Ann Arbor Healthcare System, Ann Arbor, MI; and Department of Psychiatry, University of Michigan, Ann Arbor, MI Geriatric Research, Education, and Clinical Center (GRECC) and Division of Gerontology and Geriatrics, Birmingham VA Medical Center (VAMC), Birmingham, AL;  and Division of Gerontology, Geriatrics, and Palliative Medicine, Department of Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL Research and Development Service, Edward Hines, Jr. VA Hospital, Hines, IL; and College of Nursing, University of Illinois at Chicago, Chicago, IL Human Engineering Research Laboratories, VA Pittsburgh Healthcare System, Pittsburgh, PA GRECC, VA Pittsburgh Healthcare System, Pittsburg, PA; and University of Pittsburgh, Pittsburgh, PA Neurology Service, Baltimore VAMC, Baltimore, MD; and Department of Neurology, University of Maryland School of Medicine, Baltimore, MD National Center for Rehabilitative Auditory Research, Portland VAMC, Portland, OR; and Department of Otolaryngology, Head and Neck Surgery, Oregon Health & Science University, Portland, OR Division of Neuro-ophthalmology and VA Research Center for the Prevention and Treatment of Visual Loss, Iowa City VA Health Care System, Iowa City, IA; and University of Iowa, Iowa City, IA Pain Research, Informatics, Multi-Morbidity, and Education Center, VA Connecticut Healthcare System, New Haven, CT; and Departments of Psychiatry, Neurology, and Psychology, Yale University, New Haven, CT VA Office of Research and Development, Washington, DC Providence VAMC, Providence, RI; and Departments of Neurology and Public Health,  Division of Biology and Medicine, Brown University, Providence, RI Rehabilitation Research and Development (RR&D) Center of Excellence and GRECC, Baltimore VAMC, Baltimore, MD; and Departments of Neurology, Medicine, and Physical Therapy and Rehabilitation Science, University of Maryland School of Medicine, Baltimore, MD Bay Pines VA Healthcare System, Bay Pines, FL; and Department of Communication Sciences and Disorders, College of Behavioral and Community Disorders, University of South Florida, Tampa, FL GRECC and Translational Research Center for TBI and Stress Disorders, VA Boston Healthcare System, Boston, MA; and Department of Psychiatry, Harvard Medical School, Boston, MA GRECC, VA Pittsburgh Healthcare System, Pittsburg, PA; and Department of Communication Science and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA Providence VAMC, Providence, RI; and Alpert Medical School, Brown University, Providence, RI Cleveland Functional Electrical Stimulation Center, Louis Stokes Cleveland VAMC,  Cleveland, OH; and Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH VA San Diego Healthcare System, San Diego, CA; and Department of Neurosciences, University of California, San Diego, La Jolla, CA Center of Excellence for Restoration of Nervous System Function, VA Connecticut Healthcare System, New Haven, CT; and Yale School of Medicine, New Haven, CT GRECC, Baltimore VAMC, Baltimore, MD; and Department of Neurology, University of  Maryland School of Medicine, Baltimore, MD},
note  = {J Rehabil Res Dev. 2013;50(6):vii-xxxii. doi:10.1682/JRRD.2012.09.0167.}
}

@Article{201353,
author  = {S√°nchez, J. and Espinoza, M. and de, B. and Merabet, L.},
title  = {gaming.},
journal  = {Conference. Creativity & Cognition Conference},
volume  = {2013},
number  = {},
pages  = {353-6},
year  = {2013},
abstract  = {In this work we present the results of the cognitive impact evaluation regarding  the use of Audiopolis, an audio and/or haptic-based videogame. The software has been designed, developed and evaluated for the purpose of developing orientation  and mobility (O&M) skills in blind users. The videogame was evaluated through cognitive tasks performed by a sample of 12 learners. The results demonstrated that the use of Audiopolis had a positive impact on the development and use of O&M skills in school-aged blind learners.},
address  = {Department of Computer Science and Center for Advanced Research in Education (CARE), University Of Chile Santiago, Chile, jsanchez@dcc.uchile.cl Department of Computer Science and Center for Advanced Research in Education (CARE), University Of Chile Santiago, Chile, maespino@dcc.uchile.cl Faculty of Informatics, Pontifical Catholic University of Rio Grande do Sul Rio Grande do Sul, Brazil, marcia.campos@pucrs.br Dept. Ophthalmology Massachusetts Eye and Ear Infirmary, Harvard Medical School Boston, MA, USA, lotfi_merabet@meei.harvard.edu},
note  = {Creat Cognit. 2013;2013:353-6. doi:10.1145/2466627.2466673.}
}

@Article{201254,
author  = {Rodr√≠guez, A. and Yebes, J. and Alcantarilla, P. and Bergasa, L. and Almaz√°n, J. and Cela, A.},
title  = {Acoustic Feedback.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {12},
number  = {12},
pages  = {17476-96},
year  = {2012},
abstract  = {The aim of this article is focused on the design of an obstacle detection system  for assisting visually impaired people. A dense disparity map is computed from the images of a stereo camera carried by the user. By using the dense disparity map, potential obstacles can be detected in 3D in indoor and outdoor scenarios. A ground plane estimation algorithm based on RANSAC plus filtering techniques allows the robust detection of the ground in every frame. A polar grid representation is proposed to account for the potential obstacles in the scene. The design is completed with acoustic feedback to assist visually impaired users  while approaching obstacles. Beep sounds with different frequencies and repetitions inform the user about the presence of obstacles. Audio bone conducting technology is employed to play these sounds without interrupting the visually impaired user from hearing other important sounds from its local environment. A user study participated by four visually impaired volunteers supports the proposed system.},
address  = {Department of Electronics, University of Alcal√°, Alcal√° de Henares, 28871 Madrid, Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es  (L.M.B.); javier.almazan@depeca.uah.es (J.A.) Department of Electronics, University of Alcal√°, Alcal√° de Henares, 28871 Madrid, Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es  (L.M.B.); javier.almazan@depeca.uah.es (J.A.) ISIT UMR 6284 CNRS, Universit√© d‚ÄôAuvergne, 63001 Clermont-Ferrand, France; E-Mail: pablofdezalc@gmail.com Department of Electronics, University of Alcal√°, Alcal√° de Henares, 28871 Madrid, Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es  (L.M.B.); javier.almazan@depeca.uah.es (J.A.) Department of Electronics, University of Alcal√°, Alcal√° de Henares, 28871 Madrid, Spain; E-Mails: alberto.rodrguezfernndez@gmail.com (A.R.); bergasa@depeca.uah.es  (L.M.B.); javier.almazan@depeca.uah.es (J.A.) Department of Automation and Industrial Control, National Polytechnic, EC170135 Quito, Ecuador; E-Mail: andres_cela@yahoo.com},
note  = {Sensors (Basel). 2012 Dec 17;12(12):17476-96. doi:10.3390/s121217476.}
}

@Article{201255,
author  = {},
title  = {ECR 2012 Book of Abstracts - B - Scientific Sessions.},
journal  = {Insights into Imaging},
volume  = {3},
number  = {Suppl 1},
pages  = {135-363},
year  = {2012},
abstract  = {},
address  = {},
note  = {Insights Imaging. 2012 Mar 21;3(Suppl 1):135-363. doi:10.1007/s13244-012-0158-z.}
}

@Article{201056,
author  = {},
title  = {Seattle, Washington, July 10-14, 2010.},
journal  = {American Journal of Pharmaceutical Education},
volume  = {74},
number  = {5},
pages  = {},
year  = {2010},
abstract  = {},
address  = {},
note  = {Am J Pharm Educ. 2010 Jun 15;74(5):.}
}

@Article{201057,
author  = {},
title  = {B - Scientific Sessions.},
journal  = {Insights into Imaging},
volume  = {1},
number  = {Suppl 1},
pages  = {127-322},
year  = {2010},
abstract  = {},
address  = {},
note  = {Insights Imaging. 2010 Mar 9;1(Suppl 1):127-322. doi:10.1007/s13244-010-0011-1.}
}

@Article{200958,
author  = {COUGHLAN, J. and MANDUCHI, R.},
title  = {AND VISUALLY IMPAIRED USERS.},
journal  = {languages, algorithms},
volume  = {18},
number  = {3},
pages  = {379-97},
year  = {2009},
abstract  = {We describe a wayfinding system for blind and visually impaired persons that uses a camera phone to determine the user's location with respect to color markers, posted at locations of interest (such as offices), which are automatically detected by the phone. The color marker signs are specially designed to be detected in real time in cluttered environments using computer vision software running on the phone; a novel segmentation algorithm quickly locates the borders  of the color marker in each image, which allows the system to calculate how far the marker is from the phone. We present a model of how the user's scanning strategy (i.e. how he/she pans the phone left and right to find color markers) affects the system's ability to detect color markers given the limitations imposed by motion blur, which is always a possibility whenever a camera is in motion. Finally, we describe experiments with our system tested by blind and visually impaired volunteers, demonstrating their ability to reliably use the system to find locations designated by color markers in a variety of indoor and outdoor environments, and elucidating which search strategies were most effective for users.},
address  = {The Smith-Kettlewell Eye Research Institute San Francisco, California 94115, USA  coughlan@ski.org Department of Computer Engineering, University of California Santa Cruz, California, 95064 manduchi@soe.ucsc.edu},
note  = {Int J Artif Intell Tools. 2009 Jun 1;18(3):379-97. doi:10.1142/S0218213009000196.}
}

@Article{200759,
author  = {},
title  = {Medicine.},
journal  = {Journal of General Internal Medicine},
volume  = {22},
number  = {Suppl 1},
pages  = {1-276},
year  = {2007},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11606-007-0176-6.}
}

@Article{200360,
author  = {},
title  = {Abstracts of the 12th Annual Meeting of Israel Society for Neuroscience.},
journal  = {Neural Plasticity},
volume  = {10},
number  = {3},
pages  = {179-241},
year  = {2003},
abstract  = {},
address  = {},
note  = {Neural Plast. 2003;10(3):179-241. doi:10.1155/NP.2003.179.}
}

@Article{201761,
author  = {Bagheri, A. and Liu, X. and Tassone, C. and Thometz, J. and Chaloupka, A. and Tarima, S. and Cohen, L. and Simic, M. and Dennis, S. and Refshauge, K. and Pappas, E. and Parent, E. and Pietrosanu, M. and Redford, E. and Schmidt, S. and Hill, D. and Moreau, M. and Hedden, D. and Adeeb, S. and Lou, E. and Brink, R. and Schl√∂sser, T. and Colo, D. and Vincken, K. and van, S. and Hui, S. and Chu, W. and Cheng, J. and Castelein, R. and Kechagias, V. and Grivas, T. and Vlasis, K. and Michas, K. and Grivas, T. and Kechagias, V. and Vlasis, K. and Michas, K. and Tam, E. and Yu, F. and Hung, V. and Shi, L. and Qin, L. and Ng, B. and Chu, W. and Griffith, J. and Cheng, J. and Lam, T. and Xue, C. and Shi, L. and Hui, S. and Lam, T. and Ng, B. and Cheng, J. and Chu, W. and Hui, S. and Pialasse, J. and Wong, J. and Lam, T. and Ng, B. and Cheng, J. and Chu, W. and Vo, Q. and Le, L. and Lou, E. and Zheng, R. and Hill, D. and Moreau, M. and Hedden, D. and Mahood, J. and Southon, S. and Lou, E. and Brignol, A. and Cheriet, F. and Miron, M. and Laporte, C. and Qiu, Y. and Liu, H. and Liu, Z. and Zhu, Z. and Qian, B. and Liu, X. and Rizza, R. and Thometz, J. and Rosol, D. and Tassone, C. and Tarima, S. and North, P. and Zaina, F. and Pesenti, F. and Negrini, S. and Persani, L. and Capodaglio, P. and Polli, N. and Yip, B. and Yu, F. and Hung, V. and Lam, T. and Qin, L. and Ng, B. and Cheng, J. and Zhang, J. and Lee, W. and Chen, H. and Tam, E. and Man, G. and Lam, T. and Ng, B. and Qiu, Y. and Cheng, J. and Liu, H. and Liu, Z. and Zhu, Z. and Qian, B. and Qiu, Y. and Harasymczuk, P. and Andrusiewicz, M. and Janusz, P. and Biecek, P. and Kotwicki, T. and Kotwicka, M. and Lee, J. and Shin, J. and Goh, T. and Son, S. and Chen, H. and Lee, W. and Zhang, J. and Tam, E. and Man, G. and Lam, T. and Ng, B. and Qiu, Y. and Cheng, J. and Schwartz, M. and Gilday, S. and Bylski-Austrow, D. and Glos, D. and Schultz, L. and O‚ÄôHara, S. and Jain, V. and Sturm, P. and Wang, X. and Crandall, D. and Parent, S. and Larson, N. and Labelle, H. and Aubin, C. and Fard, N. and Southon, S. and Moreau, M. and Hedden, D. and Duke, K. and Southon, S. and Lukenchuk, L. and Kerslake, M. and Huynh, G. and Chorney, J. and Tsui, B. and Tobert, D. and Bakarania, P. and Berdishevsky, H. and Grimes, K. and Matsumoto, H. and Hyman, J. and Roye, B. and Roye, D. and Vitale, M. and Black, J. and Bradley, M. and Drake, S. and Glynn, D. and Maude, E. and Berdishevsky, H. and Lindgren, A. and Bakarania, P. and Grimes, K. and Matsumoto, H. and Feinberg, N. and Bloom, Z. and Roye, D. and Vitale, M. and Dupuis, S. and Fortin, C. and Caouette, C. and Aubin, C. and Gur, G. and Yakut, Y. and Jevtiƒá, N. and Schreiber, S. and Hennes, A. and Pantoviƒá, M. and de, M. and Barral, F. and Pourret, S. and de, M. and Barral, F. and Pourret, S. and Aulisa, A. and Guzzanti, V. and Galli, M. and Falciglia, F. and Aulisa, L. and Bernard, J. and Deceuninck, J. and Berthonnaud, E. and Rougelot, A. and Pickering, M. and Chaleat-Valayer, E. and Webb, R. and Bettany-Saltikov, J. and Neil, B. and Zaina, F. and Poggio, M. and Donzelli, S. and Lusini, M. and Minnella, S. and Negrini, S. and de, M. and Barral, F. and Hoang, A. and Mao, S. and Shi, B. and Qian, B. and Zhu, Z. and Sun, X. and Qiu, Y. and Cobetto, N. and Aubin, C. and Parent, S. and Barch, S. and Turgeon, I. and Labelle, H. and Raihan, H. and Kumar, D. and Khasnabis, C. and Equbal, A. and Chakraborty, A. and Biswas, A. and Gur, G. and Dilek, B. and Ayhan, C. and Simsek, E. and Aras, O. and Aksoy, S. and Yakut, Y. and Lou, E. and Hill, D. and Zheng, R. and Donauer, A. and Tilburn, M. and Raso, J. and Morau, M. and Hedden, D. and Chen, H. and Man-Sang, W. and Cohen, L. and Kobayashi, S. and Simic, M. and Dennis, S. and Refshauge, K. and Pappas, E. and Aslanzadeh, F. and Parent, E. and MacIntosh, B. and Maragkoudakis, E. and Grivas, T. and Gelalis, I. and Mazioti, C. and Tsilimidos, G. and Burwell, R. and Zheng, Y. and Wu, X. and Dang, Y. and Sun, N. and Yang, Y. and Wang, T. and He, C. and Wong, M. and Donzelli, S. and Martinez, G. and Negrini, A. and Zaina, F. and Negrini, S. and Matsumoto, H. and Feinberg, N. and Shirley, M. and Swindell, H. and Bloom, Z. and Roye, D. and Akbarnia, B. and Garg, S. and Sanders, J. and Skaggs, D. and Smith, J. and Vitale, M. and Rizza, R. and Liu, X. and Thometz, J. and Lou, E. and Hill, D. and Donauer, A. and Tilburn, M. and Hedden, D. and Moreau, M. and Healy, A. and Farmer, S. and Chockalingam, N. and Aulisa, A. and Guzzanti, V. and Galli, M. and Pizzetti, P. and Aulisa, L. and Maruyama, T. and Kobayashi, Y. and Nakao, Y. and Liu, H. and Qian, B. and Qiu, Y. and Mao, S. and Wang, B. and Yu, Y. and Zhu, Z. and Berdishevsky, H. and Lindgren, A. and Bakarania, P. and Grimes, K. and Makhni, M. and Shillingford, J. and Vitale, M. and Black, J. and Maude, E. and Turland, A. and Glynn, D. and Caronni, A. and Scium√®, L. and Donzelli, S. and Zaina, F. and Negrini, S. and Schreiber, S. and Parent, E. and Moez, E. and Hedden, D. and Hill, D. and Moreau, M. and Lou, E. and Watkins, E. and Southon, S. and Parent, E. and Schreiber, S. and Moez, E. and Sloan, P. and Hedden, D. and Moreau, M. and Hill, D. and Southon, S. and Watkins, E. and Parent, E. and Ghaneei, M. and Adeeb, S. and Schreiber, S. and Moreau, M. and Hedden, D. and Hill, D. and Southon, S. and Karavidas, N. and Dritsa, D. and Bettany-Saltikov, J. and Hanchard, N. and Kim, D. and Kim, J. and Sbihli, A. and Parent, E. and Levey, L. and Holowka, M. and Davis, L. and Dolan, L. and Weinstein, S. and Larson, J. and Meyer, M. and Boody, B. and Sarwark, J. and Schreiber, S. and Parent, E. and Hedden, D. and Hill, D. and Thometz, J. and Liu, X. and Rizza, R. and Tassone, C. and Liu, X. and Gundlach, B. and Tarima, S. and Grant, A. and Kalyan, R. and Hekal, W. and Honeyman, C. and Cook, T. and Murray, S. and Pitruzzella, M. and Donzelli, S. and Zaina, F. and Negrini, S. and de, M. and Barral, F. and Pourret, S. and de, M. and Barral, F. and Pourret, S. and Grimes, K. and Feinberg, N. and Hope, J. and Berdishevsky, H. and Bakarania, P. and Matsumoto, H. and Swindell, H. and Yoshimachi, J. and Roye, D. and Vitale, M. and Touchette, J. and St-Jean, A. and Brousseau, D. and Marcotte, L. and Th√©roux, J. and Doucet, C. and Lin, Y. and Wong, M. and MacMahon, J. and MacMahon, E. and Boyette, J. and Stikeleather, L. and Lebel, A. and Lebel, V. and Pancholi-Parekh, C. and Stolze, L. and Selthafner, M. and Hong, K. and Liu, X. and Thometz, J. and Tassone, C. and Morrison, P. and Hanke, T. and Knott, P. and Krumdick, N. and Chockalingam, N. and Shannon, T. and Davenhill, R. and Needham, R. and Jasani, V. and Ahmed, E. and St-Jean, A. and Touchette, J. and Drake, S. and Brousseau, D. and Marcotte, L. and Th√©roux, J. and Doucet, C. and Aulisa, A. and Guzzanti, V. and Gordano, M. and Mastantuoni, G. and Aulisa, L. and Chandrinos, M. and Grivas, T. and Kechagias, V. and G≈Çowka, P. and Gawe≈Ç, D. and Kasprzak, B. and Nowak, M. and Morzy≈Ñski, M. and Kotwicki, T. and Deceuninck, J. and Bernard, J. and Lecante, C. and Berthonnaud, E. and Fortin, C. and Aubin-Fournier, J. and Bettany-Saltikov, J. and Parent, E. and Feldman, D. and Bernard, J. and Liu, Z. and Zhang, W. and Hu, Z. and Zhu, W. and Jin, M. and Han, X. and Qiu, Y. and Cheng, J. and Zhu, Z. and Liu, Z. and Guo, J. and Wu, T. and Qian, B. and Zhu, Z. and Zhu, F. and Jiang, J. and Qiu, Y. and Han, X. and Liu, Z. and Liu, H. and Qiu, Y. and Guo, J. and Yan, H. and Sun, X. and Cheng, J. and Zhu, Z. and Di, F. and Zaina, F. and Pitruzzella, M. and Donzelli, S. and Negrini, S. and Needham, R. and Chatzistergos, P. and Chockalingam, N. and Brink, R. and Schl√∂sser, T. and Colo, D. and Vincken, K. and van, S. and Hui, S. and Chu, W. and Cheng, J. and Castelein, R. and Bylski-Austrow, D. and Glos, D. and Jain, V. and Reynolds, J. and Sturm, P. and Wall, E. and Igoumenou, V. and Megaloikonomos, P. and Tsiavos, K. and Panagopoulos, G. and Mavrogenis, A. and Grivas, T. and Soultanis, K. and Papagelopoulos, P. and Fard, N. and Duke, K. and Chan, A. and Parent, E. and Lou, E. and Lee, J. and Shin, J. and Goh, T. and Son, S. and Kobayashi, S. and Togawa, D. and Hasegawa, T. and Yamato, Y. and Oe, S. and Banno, T. and Mihara, Y. and Matsuyama, Y.},
title  = {‚Äì SOSORT-IRSSD 2016 meeting: Banff, Canada. 25-28 May 2016.},
journal  = {Scoliosis and Spinal Disorders},
volume  = {12},
number  = {Suppl 1},
pages  = {},
year  = {2017},
abstract  = {},
address  = {0000 0001 2111 8460grid.30760.32Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI USA Department of Orthopaedic Surgery, Milwaukee, WI USA Department of Orthopaedic Surgery, Milwaukee, WI USA Department of Orthopaedic Surgery, Milwaukee, WI USA Department of Orthopaedic Surgery, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI USA 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrcht, The Netherlands 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrcht, The Netherlands 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrcht, The Netherlands 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong  SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong  SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong  SAR 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrcht, The Netherlands Private practice, Athens, Greece grid.459305.eDepartment of Orthopaedics and Traumatology, Tzaneio General Hospital of Piraeus, Piraeus, Greece 0000 0001 2155 0800grid.5216.0Department of Anatomy, Medical School, University of Athens, Athens, Greece Kimi Health Center, Kimi, Greece grid.459305.eDepartment of Orthopaedics and Traumatology, Tzaneio General Hospital of Piraeus, Piraeus, Greece Private Practice, Athens, Greece 0000 0001 2155 0800grid.5216.0Department of Anatomy, Medical School, University of Athens, Athens, Greece Kimi Health Center, Kimi, Greece 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin,, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aBone Quality and Health Centre, Department of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong  SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong  SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Medicine & Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopedics & Traumatology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Imaging and Interventional Radiology, The Chinese University of Hong Kong, Shatin, Hong Kong SAR grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 2222 4302grid.459234.d√âcole de technologie sup√©rieure, Montr√©al, Canada Polytechnique Montr√©al, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montr√©al, Qu√©bec Canada 0000 0001 2222 4302grid.459234.d√âcole de technologie sup√©rieure, Montr√©al, Canada 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6The Department of Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI USA 0000 0001 0706 8057grid.260064.6Department of Mechanical Engineering, Milwaukee School of Engineering, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Department of Pathology, Children‚Äôs Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI USA grid.419440.cISICO, Milan, Italy 0000 0004 1757 9530grid.418224.9Division of Endocrine & Metabolic Disease, Istituto Auxologico Italiano, Milan, Italy 0000 0001 1090 9021grid.418563.dDon Gnocchi Foundation, Brescia, Italy 0000 0004 1757 9530grid.418224.9Division of Endocrine & Metabolic Disease, Istituto Auxologico Italiano, Milan, Italy 0000 0004 1757 9530grid.418224.9Rehabilitation Department, Istituto Auxologico Italiano, Verbania, Italy 0000 0004 1757 9530grid.418224.9Division of Endocrine & Metabolic Disease, Istituto Auxologico Italiano, Milan, Italy 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Faculty of Medicine, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong SAR 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong Joint Scoliosis Research Center of the Chinese University of Hong Kong and Nanjing University, Nanjing and Hong Kong, People‚Äôs Republic of China 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0001 2205 0971grid.22254.33Department of Pediatric Orthopedics and Traumatology, University of Medical Sciences Poznan, Poznan, Poland 0000 0001 2205 0971grid.22254.33Department of Cell Biology, University of Medical Sciences Poznan, Poznan, Poland 0000 0001 2205 0971grid.22254.33Department of Pediatric Orthopedics and Traumatology, University of Medical Sciences Poznan, Poznan, Poland 0000 0004 1937 1290grid.12847.38Department of Medical Statistics, University of Warsaw, Warsaw, Poland 0000 0001 2205 0971grid.22254.33Department of Pediatric Orthopedics and Traumatology, University of Medical Sciences Poznan, Poznan, Poland 0000 0001 2205 0971grid.22254.33Department of Cell Biology, University of Medical Sciences Poznan, Poznan, Poland 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong Joint Scoliosis Research Center of the Chinese University of Hong Kong and Nanjing University, Nanjing and Hong Kong, People‚Äôs Republic of China 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, The  Chinese University of Hong Kong, Shatin, NT Hong Kong 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA Polytechnique Montr√©al, Montr√©al, Canada Sonoran Spine Center and Research Foundation, Phoenix, AZ USA 0000 0001 2173 6322grid.411418.9Sainte-Justine University Hospital Center, Montr√©al, Canada 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, MN USA 0000 0001 2173 6322grid.411418.9Sainte-Justine University Hospital Center, Montr√©al, Canada Polytechnique Montr√©al, Montr√©al, Canada grid.17089.37Department of Mechanical Engineering, University of Alberta, Edmonton, Canada 0000 0004 0459 7625grid.241114.3Alberta Health Services, University of Alberta Hospital, Edmonton, Canada grid.17089.37Division of Orthopaedic Surgery, University of Alberta, Edmonton, Canada grid.17089.37Division of Orthopaedic Surgery, University of Alberta, Edmonton, Canada grid.17089.37Department of Mechanical Engineering, University of Alberta, Edmonton, Canada 0000 0004 0633 3703grid.416656.6Stollery Children‚Äôs Hospital, Edmonton, Alberta Canada 0000 0004 0633 3703grid.416656.6Stollery Children‚Äôs Hospital, Edmonton, Alberta Canada 0000 0004 0633 3703grid.416656.6Stollery Children‚Äôs Hospital, Edmonton, Alberta Canada 0000 0004 0633 3703grid.416656.6Stollery Children‚Äôs Hospital, Edmonton, Alberta Canada 0000 0001 0351 6983grid.414870.eIWK Health Centre, Halifax, Nova Scotia Canada 0000 0004 0633 3703grid.416656.6Stollery Children‚Äôs Hospital, Edmonton, Alberta Canada 000000041936754Xgrid.38142.3cHarvard Medical School, Boston, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, USA Scoliosis SOS, London, UK Scoliosis SOS, London, UK 0000 0001 2169 5989grid.252381.fArkansas State University, Jonesboro, AR USA Independant, York, UK Scoliosis SOS, London, UK 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA Polytechnique Montr√©al, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montr√©al, Canada Polytechnique Montr√©al, Montr√©al, Canada Polytechnique Montr√©al, Montr√©al, Canada 0000 0001 2342 7339grid.14442.37Hacettepe University, Ankara, Turkey 0000 0001 2342 7339grid.14442.37Hacettepe University, Ankara, Turkey 0000 0001 2149 743Xgrid.10822.39University of Novi Sad, Faculty of Sport and Physical Education, Novi Sad, Serbia grid.17089.37Department of Pediatrics, University of Alberta, Edmonton, Canada MVZ Bad Sobernheim GmbH, Bad Sobernheim, Germany 0000 0001 2149 743Xgrid.10822.39University of Novi Sad, Faculty of Sport and Physical Education, Novi Sad, Serbia Clinique du parc, Lyon, France Lecante Group, Lyon, France Lecante Group, Lyon, France Clinique du Parc, Lyon, France Lecante Group, Lyon, France Lecante Group, Lyon, France U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital ‚ÄúAgostino Gemelli‚Ä?, Catholic University of the Sacred Heart School of Medicine, Rome, 00168 Italy U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital ‚ÄúAgostino Gemelli‚Ä?, Catholic University of the Sacred Heart School of Medicine, Rome, 00168 Italy Croix Rouge fran√ßaise-CMCR des Massues, Lyon, France 0000 0001 2150 7757grid.7849.2Laboratoire de physiologie de l‚Äôexercice, Universit√© de Lyon, Saint √âtienne, France Croix Rouge fran√ßaise-CMCR des Massues, Lyon, France Croix Rouge fran√ßaise-CMCR des Massues, Lyon, France Croix Rouge fran√ßaise-CMCR des Massues, Lyon, France Croix Rouge fran√ßaise-CMCR des Massues, Lyon, France Teesside University/Peacocks Medical Group, Newcastle, UK 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK grid.419440.cISICO, Milan, Italy grid.419440.cISICO, Milan, Italy grid.419440.cISICO, Milan, Italy grid.419440.cISICO, Milan, Italy grid.419440.cISICO, Milan, Italy 0000 0001 1090 9021grid.418563.dDon Gnocchi Foundation, Brescia, Italy Clinique du parc, Lyon, France Lecante group, Lyon, France Lecante group, Lyon, France 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Polytechnique Montr√©al, Montr√©al, Canada Polytechnique Montr√©al, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montr√©al, Canada 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences & National Institute for the Orthopaedically Handicapped, Kolkata, India 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences & National Institute for the Orthopaedically Handicapped, Kolkata, India 0000000121633745grid.3575.4World Health Organization, Geneva, Switzerland 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences & National Institute for the Orthopaedically Handicapped, Kolkata, India 0000 0001 2157 0617grid.39953.35Indian Statistical Institute, Kolkata, India 0000 0004 1799 577Xgrid.418546.aThe West Bengal University of Health Sciences & National Institute for the Orthopaedically Handicapped, Kolkata, India 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey School of Physical Therapy and Rehabilitation, Dokuzeylul University, Izmir, Turkey 0000 0004 0595 6407grid.412109.fDepartment of Physiotherapy and Rehabilitation, School of Health Sciences, Dumlupinar University, Kutahya, Turkey 0000 0001 2342 7339grid.14442.37Department of Audiology, Voice and Speech Disorders, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey 0000 0001 2342 7339grid.14442.37Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hacettepe University, Ankara, Turkey grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia 0000 0004 1936 834Xgrid.1013.3The University of Sydney, Sydney, Australia grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0004 1936 7697grid.22072.35University of Calgary, Calgary, Canada Private Practice, Athens, Greece grid.459305.e‚ÄúTzaneio‚Ä? General Hospital of Piraeus, Piraeus, Greece 0000 0004 0622 9754grid.411740.7University Hospital of Ioannina, Ioannina, Greece grid.459305.e‚ÄúTzaneio‚Ä? General Hospital of Piraeus, Piraeus, Greece grid.459305.e‚ÄúTzaneio‚Ä? General Hospital of Piraeus, Piraeus, Greece 0000 0001 0440 1889grid.240404.6Nottingham University Hospitals Trust, Nottingham, UK 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi, Jiangsu China 0000 0004 1799 0784grid.412676.0Department of Gastroenterology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu China Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi, Jiangsu China Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi, Jiangsu China Department of Rehabilitation Medicine, Wuxi Rehabilitation Hospital, Wuxi, Jiangsu China 0000 0004 1770 1022grid.412901.fDepartment of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan China 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000 0004 0383 2910grid.286440.cRady Children‚Äôs Hospital, San Diego, CA USA 0000 0001 0690 7621grid.413957.dChildren‚Äôs Hospital Colorado, Aurora, CO USA 0000 0004 1936 9174grid.16416.34University of Rochester, Rochester, NY USA 0000 0001 2153 6013grid.239546.fChildren‚Äôs Hospital of Los Angeles, Los Angeles,  CA USA 0000 0001 2193 0096grid.223827.eUniversity of Utah, Salt Lake City, UT USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA Growing Spine Foundation, San Diego, CA USA Children‚Äôs Spine Foundation, Valley Forge, PA USA 0000 0001 0706 8057grid.260064.6Department of Mechanical Engineering, Milwaukee School of Engineering, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Department of Orthopaedic Surgery, Medical College of Wisconsin, Milwaukee, WI USA grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, UK 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, UK 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, UK U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital ‚ÄúAgostino Gemelli‚Ä?, Catholic University of the Sacred Heart School of Medicine, Rome, 00168 Italy Independent practitioner, Rome, Italy 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital ‚ÄúAgostino Gemelli‚Ä?, Catholic University of the Sacred Heart School of Medicine, Rome, 00168 Italy Saitama Prefectural Rehabilitation Center, Ageo, Japan 0000 0001 2216 2631grid.410802.fSaitama Medical Center, Saitama Medical University, Moroyama, Japan 0000 0001 2216 2631grid.410802.fSaitama Medical Center, Saitama Medical University, Moroyama, Japan 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA Scoliosis SOS, London, UK Scoliosis SOS, London, UK Scoliosis SOS, London, UK Independant, York, UK Department of Neurorehabilitation Sciences, Casa di Cura del Policlinico, Milan,  Italy 0000 0004 1757 2822grid.4708.bUniversity of Milan, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 0693 8815grid.413574.0Alberta Health Services, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada Scoliosis Spine Laser Centre, Athens, Greece 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK Seoul Hyun Rehabilitation Hospital, Seoul, Korea Seoul Hyun Rehabilitation Hospital, Seoul, Korea Spine Academy Physical Therapy, PLLC, Lexington, MA USA grid.17089.37University of Alberta, Edmonton, Canada 0000 0004 0371 6071grid.428158.2Children‚Äôs Healthcare of Atlanta, Atlanta, GA USA 0000 0004 0371 6071grid.428158.2Children‚Äôs Healthcare of Atlanta, Atlanta, GA USA 0000 0004 0371 6071grid.428158.2Children‚Äôs Healthcare of Atlanta, Atlanta, GA USA 0000 0004 1936 8294grid.214572.7University of Iowa, Iowa City, IA USA 0000 0004 1936 8294grid.214572.7University of Iowa, Iowa City, IA USA 0000 0004 1936 8294grid.214572.7University of Iowa, Iowa City, IA USA 0000 0001 2299 3507grid.16753.36Northwestern University, Chicago, IL USA 0000 0001 2299 3507grid.16753.36Northwestern University, Chicago, IL USA 0000 0001 2299 3507grid.16753.36Northwestern University, Chicago, IL USA 0000 0004 0388 2248grid.413808.6Ann & Robert H. Lurie Children‚Äôs Hospital of Chicago, Chicago, IL USA grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada Children‚Äôs Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI USA Children‚Äôs Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, WI USA 0000 0001 0706 8057grid.260064.6Milwaukee School of Engineering, Milwaukee, WI USA 0000 0001 0568 442Xgrid.414086.fDeptartment of Orthopaedic Surgery, Children‚Äôs Hospital of Wisconsin, Milwaukee, WI USA 0000 0001 0568 442Xgrid.414086.fDeptartment of Orthopaedic Surgery, Children‚Äôs Hospital of Wisconsin, Milwaukee, WI USA 0000 0001 2111 8460grid.30760.32Medical College of Wisconsin, Milwaukee, WI USA 0000 0004 1936 8438grid.266539.dDivision of Biostatistics, Institute for Health and Society Education, University of Kentucky, Lexignton, KY USA The Spine Corporation, Millennium House, Foxwood Road, Chesterfield, S41 9RF UK James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK The Spine Corporation, Millennium House, Foxwood Road, Chesterfield, S41 9RF UK James Cook University Hospitals, Marton Road, Middlesbrough, TS4 3BW UK grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy grid.419440.cISICO Italian Scientific Spine Institute, Milan, Italy Clinique du Parc, Lyon, France Lecante Group, Lyon, France Lecante Group, Lyon, France Clinique du Parc, Lyon, France Lecante Group, Lyon, France Lecante Group, Lyon, France 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000000419368729grid.21729.3fColumbia University Medical Center/Morgan Stanley Children‚Äôs Hospital, New York, NY USA 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada Private Practice, Montr√©al, Canada 0000 0001 2292 3357grid.14848.31Faculty of Medecine, University of Montreal, Montreal, Qu√©bec Canada 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China 0000 0004 1764 6123grid.16890.36Interdisciplinary Division of Biomedical Engineering, The Hong Kong Polytechnic University, Hong Kong, China Moyarta 2, LLC, The Plains, VA USA Moyarta 2, LLC, The Plains, VA USA Moyarta 2, LLC, The Plains, VA USA National Scoliosis Center, Fairfax, VA USA Ottawa & District Physiotherapy Clinic and Scoliosis Physiotherapy and Posture Centre, Ottawa, Canada Saba University School of Medicine, Devens, MA USA Pediatric Rehabilitation New York (PRNY), Totowa, NJ USA Stolze Therapies, Denver, CO USA 0000 0001 0568 442Xgrid.414086.fDepartment of Physical Therapy, Children‚Äôs Hospital of Wisconsin, Milwaukee, USA 0000 0001 0568 442Xgrid.414086.fDepartment of Physical Therapy, Children‚Äôs Hospital of Wisconsin, Milwaukee, USA Department of Orthopaedic Surgery, Children‚Äôs Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, USA Department of Orthopaedic Surgery, Children‚Äôs Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, USA Department of Orthopaedic Surgery, Children‚Äôs Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, USA Morrison Physical Therapy, Lake Forest, Illinois USA grid.260024.2Midwestern University, Downers Grove, Illinois USA 0000 0004 0388 7807grid.262641.5Rosalind Franklin University, North Chicago, Illinois USA grid.260024.2Midwestern University, Downers Grove, Illinois USA 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, ST4 2DF UK 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, ST4 2DF UK 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, ST4 2DF UK 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, ST4 2DF UK 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, ST4 2DF UK 0000000106863366grid.19873.34Faculty of Health Sciences, Staffordshire University, Stoke-on-Trent, ST4 2DF UK 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada 0000 0001 2169 5989grid.252381.fArkansas State University, Jonesboro, AR USA 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada Private Practice, Montr√©al, Canada 0000 0001 2292 3357grid.14848.31Faculty of Medecine, University of Montreal, Montreal, Qu√©bec Canada 0000 0001 2197 8284grid.265703.5Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®res, Qu√©bec Canada U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy U.O.C. of Orthopedics and Traumatology, Children‚Äôs Hospital Bambino Ges√π, Institute of Scientific Research, P.zza S. Onofrio 4, Rome, 00165 Italy 0000 0004 1760 4193grid.411075.6Department of Orthopedics, University Hospital ‚ÄúAgostino Gemelli‚Ä?, Catholic University of the Sacred Heart School of Medicine, Rome, 00168 Italy grid.459305.eDepartment of Orthopaedics and Traumatology, ‚ÄúTzaneio‚Ä? General Hospital of Piraeus, Piraeus, Greece grid.459305.eDepartment of Orthopaedics and Traumatology, ‚ÄúTzaneio‚Ä? General Hospital of Piraeus, Piraeus, Greece Orthopaedic Surgeon, Athens, Greece 0000 0001 2205 0971grid.22254.33Spine Disorders and Pediatric Orthopedics Department, University of Medical Sciences, Poznan, Poland Division of Virtual Engineering, University of Technology, Poznan, Poland 0000 0001 2205 0971grid.22254.33Department of Biophysics, University of Medical Sciences, Poznan, Poland Division of Virtual Engineering, University of Technology, Poznan, Poland Division of Virtual Engineering, University of Technology, Poznan, Poland 0000 0001 2205 0971grid.22254.33Spine Disorders and Pediatric Orthopedics Department, University of Medical Sciences, Poznan, Poland 0000 0001 2158 1682grid.6279.aLaboratoire de Physiologie de l‚ÄôExercice (EA4338),  Universit√© Jean Monnet, Saint-Etienne, France Centre des Massues-Croix Rouge Fran√ßaise, 92 rue Edmond Locard, 69005 Lyon, France Ets Lecante, 125 rue Bataille, 69008 Lyon, France 0000 0001 2158 1682grid.6279.aLaboratoire de Physiologie de l‚ÄôExercice (EA4338),  Universit√© Jean Monnet, Saint-Etienne, France 0000 0001 2292 3357grid.14848.31Universit√© de Montr√©al, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2325 1783grid.26597.3fTeesside University, Middlesbrough, UK grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 2292 3357grid.14848.31Universit√© de Montr√©al, Montr√©al, Canada Centre M√©dico-Chirurgical des Massues, Lyon, France Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Joint Scoliosis Research Center of the Chinese University of Hong Kong and Nanjing University, Hong Kong, China Department of Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China 0000 0004 1800 1685grid.428392.6Spine Surgery, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China The Joint Scoliosis Research Center of Nanjing University and the Chinese University of Hong Kong, Nanjing, China Spine Surgery, Drum Tower Hospital of Nanjing University Medical School, Nanjing, China grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy grid.419440.cISICO (Italian Scientific Spine Institute), Milan, Italy 0000000417571846grid.7637.5Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy 0000000106863366grid.19873.34Staffordshire University, Stoke-on-Trent, UK 0000000106863366grid.19873.34Staffordshire University, Stoke-on-Trent, UK 0000000106863366grid.19873.34Staffordshire University, Stoke-on-Trent, UK 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrecht, The Netherlands 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrecht, The Netherlands 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrecht, The Netherlands 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands 0000000090126352grid.7692.aImage Sciences Institute, University Medical Center Utrecht, Utrecht, The Netherlands 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China 0000 0004 1937 0482grid.10784.3aDepartment of Imaging & Interventional Radiology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China 0000 0004 1937 0482grid.10784.3aDepartment of Orthopaedics and Traumatology, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, China 0000000090126352grid.7692.aDepartment of Orthopaedic Surgery, University Medical  Center Utrecht, Utrecht, The Netherlands 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA SpineForm LLC, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0000 9025 8099grid.239573.9Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH USA 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University Medical School, ATTIKON University Hospital, Athens, Greece 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University Medical School, ATTIKON University Hospital, Athens, Greece 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University Medical School, ATTIKON University Hospital, Athens, Greece 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University Medical School, ATTIKON University Hospital, Athens, Greece 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University Medical School, ATTIKON University Hospital, Athens, Greece Department of Trauma and Orthopaedics ‚ÄúTzaneion‚Ä? General Hospital of Piraeus, Piraeus, Greece 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University Medical School, ATTIKON University Hospital, Athens, Greece 0000 0001 2155 0800grid.5216.0First Department of Orthopaedics, Athens University Medical School, ATTIKON University Hospital, Athens, Greece grid.17089.37Department of Mechanical Engineering, University of Alberta, Edmonton, Canada grid.17089.37Department of Mechanical Engineering, University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada grid.17089.37University of Alberta, Edmonton, Canada 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0001 0719 8572grid.262229.fPusan National University School of Medicine, Busan, South Korea 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan 0000 0004 1762 0759grid.411951.9Hamamatsu University School of Medicine, Hamamatsu, Japan},
note  = {Scoliosis Spinal Disord. 2017 May 30;12(Suppl 1):. doi:10.1186/s13013-017-0124-0.}
}

@Article{201762,
author  = {Bougouin, W. and Marijon, E. and Planquette, B. and Karam, N. and Dumas, F. and Celermajer, D. and Jost, D. and Lamhaut, L. and Beganton, F. and Cariou, A. and Meyer, G. and Jouven, X. and Bureau, C. and Charpentier, J. and Salem, O. and Guillemet, L. and Arnaout, M. and Ferre, A. and Geri, G. and Mongardon, N. and P√®ne, F. and Chiche, J. and Mira, J. and Labro, G. and Belon, F. and Luu, V. and Chenet, J. and Besch, G. and Puyraveau, M. and Piton, G. and Capellier, G. and Martin, M. and Lascarrou, J. and Le, T. and Lacherade, J. and Martin-Lef√®vre, L. and Fiancette, M. and Vinatier, I. and Lebert, C. and Bachoumas, K. and Yehia, A. and Henry-Laguarrigue, M. and Colin, G. and Reignier, J. and Privat, E. and Escutnaire, J. and Dumont, C. and Baert, V. and Vilhelm, C. and Hubert, H. and Robert-Edan, V. and Lakhal, K. and Quartin, A. and Hobbs, B. and Cely, C. and Bell, C. and Pham, T. and Schein, R. and Geng, Y. and Ng, C. and Ehrmann, S. and Gandonni√®re, C. and Boisram√©-Helms, J. and Le, T. and De, B. and Mercier, E. and Mankikian, J. and Bretagnol, A. and Meziani, F. and Halimi, J. and Le, G. and Gaudry, S. and Hajage, D. and Tubach, F. and Pons, B. and Boulet, E. and Boyer, A. and Chevrel, G. and Lerolle, N. and Carpentier, D. and de, P. and Lautrette, A. and Mayaux, J. and Nseir, S. and Ricard, J. and Dreyfuss, D. and Robert, R. and Garzotto, F. and Kipnis, E. and Tetta, C. and Ronco, C. and Schnell, D. and Aurelie, B. and Reynaud, M. and Clec‚Äôh, C. and Benyamina, M. and Vincent, F. and Mariat, C. and Bornstain, C. and Rouleau, S. and Leroy, C. and Cohen, Y. and Morel, J. and Legrand, M. and Terreaux, J. and Darmon, M. and Cantier, M. and Morisot, A. and Gu√©rot, E. and Canet, E. and De, M. and Voiriot, G. and Neuville, M. and Timsit, J. and Sonneville, R. and Fayssoil, A. and Stojkovic, T. and Behin, A. and Ogna, A. and Lofaso, F. and Laforet, P. and Wahbi, K. and Prigent, H. and Duboc, D. and Orlikowski, D. and Eymard, B. and Annane, D. and Le, G. and Cholet, C. and Br√©chot, N. and Hekimian, G. and Besset, S. and Lebreton, G. and Nieszkowska, A. and Trouillet, J. and Leprince, P. and Combes, A. and Luyt, C. and Griton, M. and Sesay, M. and De, P. and Bienvenu, T. and Biais, M. and Nouette-Gaulain, K. and Fossat, G. and Baudin, F. and Coulanges, C. and Bobet, S. and Dupont, A. and Courtes, L. and Benzekri, D. and Kamel, T. and Muller, G. and Bercault, N. and Barbier, F. and Runge, I. and Skarzynski, M. and Mathonnet, A. and Boulain, T. and Jouan, Y. and Teixera, N. and Hassen-Khodja, C. and Guillon, A. and Gaborit, C. and Grammatico-Guillon, L. and Rebi√®re, C. and Azoulay, E. and Misset, B. and Ruckly, S. and Garrouste-Orgeas, M. and Kentish-Barnes, N. and Duranteau, J. and Thuong, M. and Joseph, L. and Renault, A. and Lesieur, O. and Larbi, A. and Viquesnel, G. and Zuber, B. and Marque, S. and Kandelman, S. and Pichon, N. and Floccard, B. and Galon, M. and Chevret, S. and Kentish-Barnes, N. and Seegers, V. and Legriel, S. and Jaber, S. and Lefrant, J. and Reuter, D. and Guisset, O. and Cracco, C. and Seguin, A. and Durand-Gasselin, J. and Thirion, M. and Cohen-Solal, Z. and Foulgoc, H. and Rogier, J. and Delobbe, E. and Schortgen, F. and Asfar, P. and Julie, B. and Grimaldi, D. and Fabien, G. and Anguel, N. and Sigismond, L. and Matthieu, H. and Gonzalez, F. and Fran√ßois, L. and Guitton, C. and Schenck, M. and Jean-Marc, D. and Radermacher, P. and Kentish-Barnes, N. and Makunza, J. and Nathalie, M. and Pierre, A. and Adolphe, K. and Mahieu, R. and Reydel, T. and Jamet, A. and Chudeau, N. and Huntzinger, J. and Grange, S. and Courte, A. and Lemarie, J. and Gibot, S. and Champey, J. and Dellamonica, J. and Du, C. and Contou, D. and Tadi√©, J. and Cour, M. and Beduneau, G. and Marchalot, A. and Gu√©rin, L. and Jochmans, S. and Terzi, N. and Preau, S. and Brun-Buisson, C. and Dessap, A. and Vedrenne-Cloquet, M. and Breinig, S. and Jung, C. and Brussieux, M. and Marcoux, M. and Durrmeyer, X. and Blond√©, R. and Angoulvant, F. and Grasset, J. and Naudin, J. and Dauger, S. and Remy, S. and Kolev-Descamp, K. and Demaret, J. and Monneret, G. and Javouhey, E. and Chomton, M. and Sauthier, M. and Vallieres, E. and Jouvet, P. and Geslain, G. and Guellec, I. and Rambaud, J. and Schmidt, M. and Schellongowski, P. and Dorget, A. and Patroniti, N. and Taccone, F. and Miranda, D. and Reuter, J. and Prodanovic, H. and Pierrot, M. and Balik, M. and Park, S. and Gu√©rin, C. and Papazian, L. and Jean, R. and Ayzac, L. and Loundou, A. and Forel, J. and Mezidi, M. and Aublanc, M. and Perinel-Ragey, S. and Lissonde, F. and Louf-Durier, A. and Tapponnier, R. and Yonis, H. and Coudroy, R. and Frat, J. and Boissier, F. and Thille, A. and Richard, F. and Le, G. and Fahri, J. and Kouatchet, A. and Bodet-Contentin, L. and Garot, D. and Le, P. and Vecellio, L. and Tavernier, E. and Dequin, P. and Messika, J. and Martin, Y. and Maquigneau, N. and Puechberty, C. and Stoclin, A. and Villard, S. and Dechanet, A. and De, J. and Monnin, M. and Girard, M. and Chanques, G. and Molinari, N. and Decav√®le, M. and Campion, S. and Ainsouya, R. and Ni√©rat, M. and Raux, M. and Similowski, T. and Demoule, A. and Razazi, K. and Tchir, M. and May, F. and Carteaux, G. and Pauline, R. and Marc, A. and Bedos, J. and Mehrsa, K. and Mauger-Briche, C. and Mijon, F. and Trouiller, P. and Sztrymf, B. and Cretallaz, P. and Mermillod-Blondin, R. and Savary, D. and Sedghiani, I. and Doghri, H. and Jendoubi, A. and Hamdi, D. and Cherif, M. and Hechmi, Y. and Zouheir, J. and Persico, N. and Maltese, F. and Ferrigno, C. and Bablon, A. and Marmillot, C. and Roch, A. and Sedghiani, I. and Papin, G. and Gainnier, M. and Argaud, L. and Christophe, A. and Souweine, B. and Goldgran-Toledano, D. and Marcotte, G. and Dumenil, A. and Carole, S. and Cecchini, J. and Tuffet, S. and Fartoukh, M. and Roux, D. and Thyrault, M. and Armand, M. and Chauveau, S. and Wesner, N. and Monnier-Cholley, L. and Big√©, N. and Ait-Oufella, H. and Guidet, B. and Dub√©e, V. and Labroca, P. and Lemari√©, J. and Chiesa, G. and Laroyenne, I. and Borrini, L. and Klotz, R. and Sy, Q. and Cristina, M. and Paysant, J. and Fill√¢tre, P. and Gacouin, A. and Revest, M. and Tattevin, P. and Flecher, E. and Le, T. and Jamme, M. and Daviaud, F. and Marin, N. and Thy, M. and Duceau, B. and Ardisson, F. and Sandrine, V. and Venot, M. and Schlemmer, B. and Zafrani, L. and Pons, S. and Styfalova, L. and Bouadma, L. and Radjou, A. and Lebut, J. and Mourvillier, B. and Dorent, R. and Dilly, M. and Nataf, P. and Wolff, M. and Le, G. and Bourcier, S. and Tandjaoui-Lambiotte, Y. and Das, V. and Alves, M. and Big√©, N. and Kamilia, C. and Rania, A. and Baccouch, N. and Turki, O. and Ben, H. and Bahloul, M. and Bouaziz, M. and Dupuis, C. and Perozziello, A. and Letheulle, J. and Valette, M. and Herrmann-Storck, C. and Crosby, L. and Elkoun, K. and Madeux, B. and Martino, F. and Migueres, H. and Piednoir, P. and Posch, M. and Thiery, G. and Huynh-Ky, M. and Bouchard, P. and Sarrazin, J. and Lellouche, F. and Nay, M. and Lortat-Jacob, B. and Rozec, B. and Colnot, M. and Belin, N. and Barrot, L. and Navellou, J. and Patry, C. and Chaignat, C. and Claveau, M. and Claude, F. and Aubron, C. and Mcquilten, Z. and Bailey, M. and Board, J. and Buhr, H. and Cartwright, B. and Dennis, M. and Forrest, P. and Hodgson, C. and Mcilroy, D. and Murphy, D. and Murray, L. and Pellegrino, V. and Pilcher, D. and Sheldrake, J. and Tran, H. and Vallance, S. and Cooper, J. and Bombled, C. and Vidal, C. and Margetis, D. and Amour, J. and Coart, D. and Dubois, J. and Van, H. and Mesotten, D. and Bailly, S. and Lucet, J. and Lepape, A. and L‚Äôh√©riteau, F. and Aup√©e, M. and Bervas, C. and Boussat, S. and Berger-Carbonne, A. and Machut, A. and Savey, A. and Tudesq, J. and Valade, S. and Galicier, L. and De, B. and Munoz-Bongrand, N. and Mignard, X. and Biard, L. and Mokart, D. and Nyunga, M. and Bruneel, F. and Rabbat, A. and Perez, P. and Meert, A. and Benoit, D. and Mariotte, E. and Ehooman, F. and Hamidfar-Roy, R. and Hourmant, Y. and Mailloux, A. and Beurton, A. and Teboul, J. and Girroto, V. and Laura, G. and Richard, C. and Monnet, X. and Dub√©e, V. and Merdji, H. and Dang, J. and Preda, G. and Baudel, J. and Desnos, C. and Zeitouni, M. and Belaroussi, I. and Parrot, A. and Blayau, C. and Fulgencio, J. and Quesnel, C. and Labbe, V. and De, C. and Beloncle, F. and Merceron, S. and Fedun, Y. and Lecomte, B. and Devaquet, J. and Puidupin, M. and Verdi√®re, B. and Amoura, Z. and Vuillard, C. and Xavier, J. and Bourlier, D. and David, A. and Caroline, S. and David, M. and Gerald, S. and Olivier, S. and Humbert, M. and Laurent, S. and Dujardin, O. and Bougl√©, A. and Ait, H. and Salem, J. and El-Helali, N. and Coppere, Z. and Gibelin, A. and Taconet, C. and Djibre, M. and Maamar, A. and Colobert, E. and Fillatre, P. and Uhel, F. and Camus, C. and Moraly, J. and Dahoumane, R. and Maury, E. and Tan, B. and Emmanuel, V. and Pauline, M. and Laurence, P. and Philippe, P. and Zahar, J. and Catherine, H. and Christian, P. and Karim, A. and Mounia, H. and Laura, T. and Rasoldier, V. and Mager, G. and Eraldi, J. and Gelinotte, S. and Bougerol, F. and Dehay, J. and Rigaud, J. and Declercq, P. and Michel, J. and Aissa, N. and Henard, S. and Guerci, P. and Latar, I. and Levy, B. and Girerd, N. and Kimmoun, A. and Abdallah, S. and Nakaa, S. and Hraiech, K. and Braiek, D. and Adhieb, A. and M‚Äôghirbi, A. and Ousji, A. and Hammouda, Z. and Abroug, F. and Sellami, W. and Hajjej, Z. and Samoud, W. and Labbene, I. and Ferjani, M. and Medhioub, F. and Allela, R. and Algia, N. and Cherif, S. and Attia, D. and Herinjatovo, A. and Francois, X. and Bouhouri, M. and Slaoui, M. and Soufi, A. and Khaleq, K. and Hamoudi, D. and Nsiri, A. and Harrar, R. and Maury, E. and Goursaud, S. and Gauberti, M. and Labeyrie, P. and Gaberel, T. and Agin, V. and Maubert, E. and Vivien, D. and Gakuba, C. and Armel, A. and Abdou, R. and Kalouch, S. and Yaqini, K. and Chlilek, A. and Sellami, W. and Yedder, S. and Tonnelier, A. and Herv√©, F. and Halley, G. and Frances, J. and Moriconi, M. and Saoli, M. and Garnero, A. and Demory, D. and Arnal, J. and Canoville, B. and Daubin, C. and Brunet, J. and Ghezala, H. and Snouda, S. and Ben, C. and Kaddour, M. and Ouanes, I. and Marzouk, M. and Haniez, F. and Jaillet, H. and Maas, H. and Andrivet, P. and Darn√©, C. and Viau, F. and Ghezala, H. and Ouanes, I. and Dangers, L. and Montlahuc, C. and Perbet, S. and Ouanes, I. and Hamouda, Z. and Nakee, S. and Ouanes-Besbes, L. and Meddeb, K. and Khedher, A. and Sma, N. and Ayachi, J. and Khelfa, M. and Fraj, N. and Lakhal, H. and Hammed, H. and Boukadida, R. and Hafsa, H. and Chouchene, I. and Boussarsar, M. and Ben, B. and Ouanes-Besbes, L. and Benatti, K. and Dafir, A. and Aissaoui, W. and Elallame, W. and Haddad, W. and Cherkab, R. and Elkettani, C. and Barrou, L. and Hamou, Z. and Repess√©, X. and Charron, C. and Aubry, A. and Paternot, A. and Maizel, J. and Slama, M. and Vieillard-Baron, A. and Trifi, A. and Abdellatif, S. and Fatnassi, M. and Daly, F. and Nasri, R. and Ismail, K. and Lakhal, S. and Bazalgette, F. and Daurat, A. and Roger, C. and Muller, L. and Doyen, D. and Plattier, R. and Robert, A. and Hyvernat, H. and Bernardin, G. and Jozwiak, M. and Gimenez, J. and Mercado, P. and Depret, F. and Tilouch, N. and Mater, H. and Habiba, B. and Jaoued, O. and Gharbi, R. and Hassen, M. and Elatrous, S. and Pasquier, P. and Vuillemin, Q. and Schaal, J. and Martinez, T. and Duron, S. and Trousselard, M. and Schwartzbrod, P. and Baugnon, T. and Dupic, L. and Gout, C. and De, S. and S√©guret, S. and Le, F. and Orliaguet, G. and Hubert, P. and Big√©, N. and Leblanc, G. and Briand, R. and Brousse, L. and Brunet, V. and Chatelain, L. and Prat, D. and Jacobs, F. and Demars, N. and Hamzaoui, O. and Moneger, G. and Sztrymf, B. and Duburcq-Gury, E. and Satre-Buisson, L. and Duburcq, T. and Poissy, J. and Robriquet, L. and Jourdain, M. and S√©cheresse, T. and Miquet, M. and Simond, A. and Usseglio, P. and Hamdaoui, Y. and Boussarsar, M. and Desailly, V. and Brun, P. and Iglesias, P. and Huet, J. and Masseran, C. and Claudon, A. and Ebeyer, C. and Truong, T. and Tesni√®re, A. and Mignon, A. and Gaudry, S. and Resiere, D. and Valentino, R. and Fabre, J. and Roze, B. and Ferge, J. and Charbatier, C. and Marie, S. and Scholsser, M. and Aitsatou, S. and Raad, M. and Cabie, A. and Mehdaoui, H. and Cousin, C. and Rousseau, C. and Llitjos, J. and Alby-Laurent, F. and Toubiana, J. and Belaidouni, N. and Cherruault, M. and Tamburini, J. and Bouscary, D. and Fert, S. and Delile, E. and Besnier, E. and Coquerel, D. and Nevi√®re, R. and Richard, V. and Tamion, F. and Wei, C. and Louis, H. and Margaux, S. and Eliane, A. and Sophie, O. and Kimmoun, A. and Riad, Z. and Coroir, M. and R√©my, B. and Camille, B. and Joffre, J. and Aegerter, P. and Ilic, D. and Ginet, M. and Pignard, C. and Nguyen, P. and Mourey, G. and Samain, E. and Pili-Floury, S. and Jouffroy, R. and Nicolas, C. and Alvarez, J. and Tomasso, M. and Philippe, P. and Raphalen, J. and Fr√©d√©ric, J. and Vivien, B. and Pierre, C. and Baud, F. and Fredj, H. and Blel, Y. and Brahmi, N. and Ghezala, H. and Hanak, A. and Malissin, I. and Poupon, J. and Risede, P. and Chevillard, L. and Megarbane, B. and Barghouth, M. and M‚Äôrad, A. and Hmida, M. and Thabet, H. and Liang, H. and Callebert, J. and Lagard, C. and Megarbane, B. and Habacha, S. and Chatbri, B. and Camillerapp, C. and Labat, L. and Soichot, M. and Gar√ßon, P. and Goury, A. and Kerdjana, L. and Voicu, S. and Deye, N. and Megarbane, B. and Armel, A. and Anas, B. and Othman, M. and Moumine, S. and Kalouch, S. and Yakini, K. and Chlilek, A. and Hajji, A. and Louati, A. and Khaldi, A. and Borgi, A. and Ghali, N. and Bouziri, A. and Menif, K. and Ben, J. and Armel, A. and Brochon, J. and Dumitrescu, M. and Th√©venot, S. and Saulnier, J. and Husseini, K. and Laland, C. and Cremniter, J. and Bousseau, A. and Castel, O. and Br√©maud-Csizmadia, C. and Diss, M. and Portefaix, A. and Berthiller, J. and Gillet, Y. and Aoul, N. and Douah, A. and Addou, Z. and Youbi, H. and Moussati, M. and Belhabiche, K. and Mir, S. and Abada, S. and Amel, Z. and Aouffen, N. and Bouzit, Z. and Grati, A. and Dhonneur, G. and Boussarsar, M. and Lau, N. and Mezhari, I. and Roucaud, N. and Le, M. and Paulet, R. and Coudray, J. and Ghomari, W. and Boumlik, R. and Peigne, V. and Daban, J. and Boutonnet, M. and Lenoir, B. and Yassine, H. and Mohamed, C. and Khalid, A. and Ihssan, M. and Said, E. and Said, S. and Jazia, A. and Fatima, J. and Wafa, S. and Maha, B. and Khaoula, B. and Sami, T. and Abdallah, T. and Medhioub, F. and Rollet-Cohen, V. and Sachs, P. and Merchaoui, Z. and Renolleau, S. and Oualha, M. and Eloi, M. and Jean, S. and Demoulin, M. and Valentin, C. and Guilbert, J. and Walti, H. and Carbajal, R. and Leger, P. and Karaca-Altintas, Y. and Botte, A. and Labreuche, J. and Drumez, E. and Devos, P. and Bour, F. and Leclerc, F. and Ahmed, A. and khaled, M. and Louati, A. and Aida, B. and Ammar, K. and Narjess, G. and Ahmed, H. and Asma, B. and Jaballah, N. and Leger, P. and Pansiot, J. and Besson, V. and Palmier, B. and Baud, O. and Cauli, B. and Charriaut-Marlangue, C. and Mansuy, A. and Michel, F. and Le, B. and Boubnova, J. and Ughetto, F. and Ovaert, C. and Fouilloux, V. and Paut, O. and Jacquet-Lagr√®ze, M. and Tiebergien, N. and Hanna, N. and Evain, J. and Baudin, F. and Courtil-Teyssedre, S. and Bompard, D. and Lilot, M. and Chardonal, L. and Fellahi, J. and Claverie, C. and Pouessel, G. and Dorkenoo, A. and Renaudin, J. and Eb, M. and Deschildre, A. and Leteurtre, S. and Yassine, H. and Kamal, B. and Adil, O. and Ouafa, A. and Mouhamed, M. and Rachid, C. and Lahoucine, B. and Dachraoui, F. and Nakkaa, S. and Zaineb, H. and Mlika, D. and Gloulou, O. and Boussarsar, M. and Zelmat, S. and Batouche, D. and Chaffi, B. and Mazour, F. and Benatta, N. and Fathallah, I. and Aloui, R. and Zoubli, A. and Kouraichi, N. and Fathallah, I. and Kouraichi, N. and Salem, S. and Vicaut, E. and Megarbane, B. and Ambroise, D. and Loriot, A. and Bourgogne, E. and Megarbane, B. and Ghadhoune, H. and Jihene, G. and Trabelsi, I. and Allouche, H. and Brahmi, H. and Samet, M. and Ghord, H. and Lebeau, R. and Laplanche, J. and Benturquia, N. and Megarbane, B. and Blel, Y. and M‚Äôrad, A. and Essafi, F. and Benabderrahim, A. and Jouffroy, R. and Resiere, D. and Sanchez, B. and Inamo, J. and Megarbane, B. and Batouche, D. and Zerhouni, A. and Tabeliouna, K. and Negadi, A. and Mentouri, Z. and Le, G. and Hanouz, J. and Normand, H. and Khoury, A. and Sall, F. and De, L. and Pugin, A. and Pazart, L. and Vidal, C. and Leroux, F. and Khoury, A. and L‚ÄôHer, E. and Marjanovic, N. and Khoury, A. and Desmettre, T. and Lambert, C. and Ragey, S. and Baboi, L. and Bazin, J. and Koffel, C. and Dhonneur, G. and Bouzit, Z. and Bradai, L. and Ayed, I. and Aissa, F. and Haouache, H. and Marechal, Y. and Biston, P. and Piagnerelli, M. and Bortolotti, P. and Colling, D. and Colas, V. and Voisin, B. and Dewavrin, F. and Onimus, T. and Girardie, P. and Saulnier, F. and Urbina, T. and Nguyen, Y. and Druoton, A. and Soudant, M. and Barraud, D. and Conrad, M. and Cravoisy-Popovic, A. and Nace, L. and Bollaert, P. and Martin, R. and Bitker, L. and Richard, J. and Brossier, D. and Goyer, I. and Marquis, C. and Lampin, M. and Duhamel, A. and B√©hal, H. and Dhaoui, T. and Godeffroy, V. and Devouge, E. and Evrard, D. and Delepoulle, F. and Racoussot, S. and Grandbastien, B. and Lampin, M. and Heilbronner, C. and Roy, E. and Masson, A. and Hadchouel-Duverg√©, A. and Rigourd, V. and Delacroix, E. and Wroblewski, I. and Pin, I. and Ego, A. and Payen, V. and Debillon, T. and Millet, A. and Denot, J. and Berthelot, V. and Thueux, E. and Reymond, M. and De, L. and Amblard, A. and Leger, P. and Aoul, N. and Lemiale, V. and Oziel, J. and Brule, N. and Moreau, A. and Marhb√®ne, T. and Sellami, S. and Jamoussi, A. and Ayed, S. and Mhiri, E. and Slim, L. and Khelil, J. and Besbes, M. and Chawki, S. and Hamdi, A. and Ciroldi, M. and Cottereau, A. and Obadia, E. and Zerbib, Y. and Andrejak, C. and Ricome, S. and Dupont, H. and Baudin, F. and Dureau, P. and Tanguy, A. and Arbelot, C. and Ben, H. and Charfeddine, A. and Granger, B. and Laporte, L. and Hermetet, C. and Regaieg, K. and Khemakhem, R. and Chelly, H. and Cheikh, C. and Mountij, H. and Rghioui, K. and Haddad, W. and Cherkab, R. and Barrou, H. and Naima, A. and bennani, O. and Regaieg, K. and Douib, A. and Samet, A. and Cungi, P. and Nguyen, C. and Cotte, J. and D‚Äôaranda, E. and Meaudre, E. and Avaro, J. and Slaoui, M. and Mokline, A. and Rahmani, I. and Laajili, A. and Amri, H. and Gharsallah, L. and Gasri, B. and Tlaili, S. and Hammouda, R. and Messadi, A.},
title  = {Congress.},
journal  = {Annals of Intensive Care},
volume  = {7},
number  = {Suppl 1},
pages  = {},
year  = {2017},
abstract  = {},
address  = {grid.414093.bCardiologie, H√¥pital Europ√©en Georges-Pompidou, Rue Leblanc, Paris,  France grid.414093.bCardiologie, H√¥pital Europ√©en Georges-Pompidou, Rue Leblanc, Paris,  France grid.414093.bUsip, Hopital Europeen Georges-Pompidou, Paris, France grid.414093.bCardiologie, H√¥pital Europ√©en Georges-Pompidou, Rue Leblanc, Paris,  France 0000 0001 0274 3893grid.411784.fService d‚Äôaccueil des urgences, H√¥pital Cochin, Paris, France 0000 0004 1936 834Xgrid.1013.3Cardiology, Sydney Medical School, Sydney, Australia Bspp, B.s.p.p., Paris, France 0000 0004 0593 9113grid.412134.1R√©animation adulte, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0495 1460grid.462416.3Paris descartes, Inserm U970, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France grid.414093.bService de Pneumologie et Soins Intensifs, Hopital Europeen Georges-Pompidou, Paris, France grid.414093.bCardiologie, H√¥pital Europ√©en Georges-Pompidou, Rue Leblanc, Paris,  France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8Centre de m√©thodologie clinique, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8D√©partement d‚Äôanesth√©sie et de r√©animation, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8R√©animation chirurgicale, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Centre de m√©thodologie clinique, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Clinical Research Unit, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France Intensive Care, District Hospital Center, La Roche-Sur-Yon, France grid.31151.37Medical Intensive Care Unit, University Hospital Center, Nantes, France 0000 0004 0471 8845grid.410463.4R√©animation p√©diatrique, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France French National Out-of-Hospital Cardiac Arrest Registry (r√©ac), Lille, France Public Health Department, Universit√© Lille 2 ‚Äì Facult√© de M√©decine Henri Warembourg, Loos, France French National Out-of-Hospital Cardiac Arrest Registry (r√©ac), Lille, France 0000 0001 2097 7060grid.16780.38Public Health Department, Universit√© Lille 2 ‚Äì Facult√© de M√©decine Henri Warembourg, Lille, France 0000 0001 2097 7060grid.16780.38Public Health Department, Universit√© Lille 2 ‚Äì Facult√© de M√©decine Henri Warembourg, Lille, France 0000 0004 0472 0371grid.277151.7Service de r√©animation chirurgicale, H√¥pital Guillaume et Ren√© La√´nnec, CHU de Nantes, Nantes, France 0000 0004 0472 0371grid.277151.7Service de r√©animation chirurgicale, H√¥pital Guillaume et Ren√© La√´nnec, CHU de Nantes, Nantes, France 0000 0004 1936 8606grid.26790.3aDivision of pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Miami School of Medicine, Miami, USA 0000 0001 2291 4776grid.240145.6Department of Biostatistics, University of Texas  M.D. Anderson Cancer Center, Houston, TX USA 0000 0000 9206 2401grid.267308.8Division of Pediatric Nephrology and Hypertension, University of Texas Health Science Center-Houston, Houston, TX USA 0000 0000 9206 2401grid.267308.8Division of Pediatric Nephrology and Hypertension, University of Texas Health Science Center-Houston, Houston, TX USA 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0004 1936 8606grid.26790.3aDivision of pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of Miami School of Medicine, Miami, USA 0000 0001 2291 4776grid.240145.6Research Medical Library, University of Texas M.D. Anderson Cancer Center, Houston, TX USA 0000 0001 2291 4776grid.240145.6Department of Radiology, University of Texas M.D. Anderson Cancer Center, Houston, TX USA R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France Biochimie et biologie mol√©culaire, CHRU H√¥pitaux de Tours, Tours, France Biochimie et biologie mol√©culaire, CHRU H√¥pitaux de Tours, Tours, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France R√©animation m√©dicale, Nouvel H√¥pital Civil, CHU Strasbourg, Strasbourg, France N√©phrologie, transplantation r√©nale et h√©modialyse, CHRU H√¥pitaux de Tours, Tours, France Biochimie et biologie mol√©culaire, CHRU H√¥pitaux de Tours, Tours, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France 0000 0001 0273 556Xgrid.414205.6D√©partement d‚Äô√©pid√©miologie et de recherche clinique, H√¥pital Louis-Mourier - APHP, Colombes, France D√©partement d‚Äôepid√©miologie et recherche clinique, Unit√© de Recherche Clinique Paris Nord, Paris, France R√©animation - Grands Brul√©s, CHU Pointe √† Pitre - Abymes, Pointe a Pitre, France Val d‚Äôoise, H√¥pital Ren√© Dubos, Pontoise, France 0000 0004 0593 7118grid.42399.35R√©animation m√©dicale, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France Essonnes, C.H. Sud Francilien, Corbeil-Essonnes, France 0000 0004 0472 0283grid.411147.6R√©animation m√©dicale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France R√©animation m√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France 0000 0004 0639 4151grid.411163.0R√©animation m√©dicale, CHU Gabriel-Montpied, Clermont-Ferrand, France 0000 0001 2150 9058grid.411439.aService de pneumologie et r√©animation m√©dicale, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0004 0471 8845grid.410463.4Centre de R√©animation, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France Service de R√©animation M√©dico-Chirurgicale, CHU Louis Mourier, Colombes, France 0000 0001 2217 0017grid.7452.4Inserm, iame, umr 1137, Universit√© Paris Diderot, Sorbonne Paris Cit√©, Paris, France Service de R√©animation m√©dicaleCHU de Poitiers, Poitiers, France 0000 0004 1758 2035grid.416303.3International Renal Research Institute of Vicenza, San Bortolo Hospital, Vicenza, Italy 0000 0004 0471 8845grid.410463.4R√©animation chirurgicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France grid.415062.4Research Extracorporeal Therapies, Fresenius Medical Care, Bad Homburg Vor Der H√∂he, Germany 0000 0004 1758 2035grid.416303.3International Renal Research Institute of Vicenza, San Bortolo Hospital, Vicenza, Italy Service de reanimation, Service de R√©animation polyvalente, Angoul√™me, France D√©partement de sant√© publique, Institut de Canc√©rologie de la Loire Lucien Neuwirth, Saint-Priest-En-Jarez, France R√©animation polyvalente b, Hospital Center University De Saint-√âtienne, Saint-Priest-En-Jarez, France 0000 0000 8715 2621grid.413780.9R√©animation medico-chirurgicale, H√¥pital Avicenne, Bobigny, France 0000 0001 2300 6614grid.413328.fAnesth√©sie r√©animation et traitement chirurgical  des grands br√ªl√©s, APHP - Hopital Saint-Louis, Paris, France 0000 0000 8620 9964grid.420138.cR√©animation polyvalente, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France 0000 0004 1765 1491grid.412954.fN√©phrologie, Centre Hospitalier Universitaire de  Saint-√âtienne, Saint-√âtienne, France 0000 0000 8620 9964grid.420138.cR√©animation polyvalente, Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France Service de r√©animation, Hospital Center D‚Äôangoul√™me, Angoul√™me, France 0000 0004 0639 4151grid.411163.0R√©animation m√©dicale, CHU Gabriel-Montpied, Clermont-Ferrand, France 0000 0000 8715 2621grid.413780.9R√©animation medico-chirurgicale, H√¥pital Avicenne, Bobigny, France R√©animation polyvalente b, Hospital Center University De Saint-√âtienne, Saint-Priest-En-Jarez, France 0000 0001 2300 6614grid.413328.fAnesth√©sie r√©animation et traitement chirurgical  des grands br√ªl√©s, APHP - Hopital Saint-Louis, Paris, France 0000 0004 1765 1491grid.412954.fR√©animation m√©dicale, CHU Saint-Etienne - H√¥pital Nord, Saint-√âtienne, France 0000 0004 1765 1491grid.412954.fR√©animation m√©dicale, CHU Saint-Etienne - H√¥pital Nord, Saint-√âtienne, France 0000 0000 8588 831Xgrid.411119.dService de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard-APHP, Paris, France Centre m√©moire, clinique rainier iii, Hospital Center Princesse Grace, Monaco, Monaco grid.414093.bR√©animation m√©dicale, Hopital Europeen Georges-Pompidou, Paris, France 0000 0001 2300 6614grid.413328.fService de r√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0004 0443 544Xgrid.413961.8R√©animation, C.H. G√©n√©ral Saint Denis h√¥pital Delafontaine, Saint-Denis, France 0000 0001 2259 4338grid.413483.9Service de r√©animation m√©dicale, H√¥pital Tenon (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dService de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard-APHP, Paris, France 0000 0000 8588 831Xgrid.411119.dService de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dService de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard-APHP, Paris, France Neurologie et reanimation polyvalente, Institute De Myologie et CHU Raymond Poincar√©, Garches, France Neurologie, Institute De Myologie, Paris, France Neurologie, Institute De Myologie, Paris, France R√©animation polyvalente et pole ventilation √† domicile, CHU Raymond Poincare, Garches, France grid.414291.bService d‚Äôexplorations fonctionnelles respiratoires, H√¥pital Raymond-Poincar√© (AP-HP), Garches, France Neurologie, Institute De Myologie, Paris, France Neurologie, Institute De Myologie, Paris, France grid.414291.bService d‚Äôexplorations fonctionnelles respiratoires, H√¥pital Raymond-Poincar√© (AP-HP), Garches, France 0000 0001 0274 3893grid.411784.fCardiologie, H√¥pital Cochin, Paris, France R√©animation polyvalente et pole ventilation √† domicile, CHU Raymond Poincare, Garches, France Neurologie, Institute De Myologie, Paris, France grid.414291.bR√©animation m√©dico-chirurgicale, H√¥pital Raymond-Poincar√©, Garches,  France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Service de r√©animation m√©dicaleGroupe Hospitalier Piti√© Salp√™tri√®re, Paris, France Neuro ICUCHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France Neuro ICUCHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France Neuro ICUCHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France Neuro ICUCHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France Neuro ICUCHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France Neuro ICUCHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France Service de pneumologie, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France Service de r√©animation chirurgicale, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans,  France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France Service des urgences, CHRU H√¥pitaux de Tours, Tours, France Service d‚Äôinformation m√©dicale, √©pid√©miologie et √©conomie de la sant√©, CHRU H√¥pitaux de Tours, Tours, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France Service d‚Äôinformation m√©dicale, √©pid√©miologie et √©conomie de la sant√©, CHRU H√¥pitaux de Tours, Tours, France Service d‚Äôinformation m√©dicale, √©pid√©miologie et √©conomie de la sant√©, CHRU H√¥pitaux de Tours, Tours, France 0000 0001 0274 7763grid.414363.7R√©animation, Fondation Hopital Saint Joseph, Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France R√©animation m√©dicale, Hospital Center University, Rouen, France Statistics Department, Outcomerea research group, Paris, France 0000 0001 0274 7763grid.414363.7R√©animation, Fondation Hopital Saint Joseph, Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, Assistance Publique H√¥pitaux de Paris, H√¥pital Saint Louis, Paris, France 0000 0001 2181 7253grid.413784.dR√©animation chirurgicale, H√¥pital Bic√™tre, Le Kremlin-Bic√™tre, France Val d‚Äôoise, CH Ren√© Dubos, Pontoise, France 0000 0001 2181 7253grid.413784.dR√©animation chirurgicale, H√¥pital Bic√™tre, Le Kremlin-Bic√™tre, France 0000 0004 0472 3249grid.411169.aR√©animation m√©dicale, CHU Brest, Brest, France R√©animation, Centre Hospitalier la Rochelle, La Rochelle, France Hospital Foch, 92151 Suresnes, France R√©animation chirurgicale, C.H.U de Caen, Caen, France Intensive Care Unit, Hospital Center De Versailles, Le Chesnay, France ICU, C.H. Sud Francilien, Corbeil-Essonnes, France 0000 0000 8595 4540grid.411599.1Anesth√©sie r√©animation, H√¥pital Beaujon (AP-HP),  Clichy, France 0000 0001 1486 4131grid.411178.aService de r√©animation polyvalente, Centre Hospitalier Universitaire de Limoges, Limoges, France 0000 0001 2198 4166grid.412180.eD√©partement anesth√©sie-r√©animation, H√¥pital √âdouard Herriot, Lyon, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, AP-HP, H√¥pital Saint Louis, Paris, France 0000 0001 2300 6614grid.413328.fService de biostatistique et information m√©dicale, H√¥pital Saint-Louis, Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, Assistance Publique H√¥pitaux de Paris, H√¥pital Saint Louis, Paris, France Umr 669, Inserm, Paris, France 0000 0001 2177 7052grid.418080.5R√©animation, Centre Hospitalier de Versailles, Le Chesnay, France grid.414352.5DAR B, H√¥pital Saint Eloi, Montpellier, France 0000 0004 0593 8241grid.411165.6R√©animation chirurgicale, Hopital Car√©meau, N√Æmes, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France 0000 0004 0593 7118grid.42399.35R√©animation m√©dicale-h√¥pital saint-andr√©, Centre  Hospitalier Universitaire de Bordeaux, Bordeaux, France Service de reanimation, Service de R√©animation polyvalente, Angoul√™me, France 0000 0004 0472 0160grid.411149.8R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen, Caen, France R√©animation, H√¥pital Sainte-Musse, Toulon, France 0000 0004 0639 3263grid.414474.6Val d‚Äôoise, Centre Hospitalier Victor Dupouy (Argenteuil), Argenteuil, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, Assistance Publique H√¥pitaux de Paris, H√¥pital Saint Louis, Paris, France 0000 0004 0593 7118grid.42399.3533, CHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France 0000 0004 0593 7118grid.42399.3533, CHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France 0000 0004 0593 7118grid.42399.3533, CHU ‚Äì H√¥pitaux de Bordeaux, Bordeaux, France 0000 0001 2292 1474grid.412116.1R√©animation m√©dicale, H√¥pital Henri-Mondor (AP-HP), Cr√©teil Cedex, France R√©animation, C.H.U. d‚ÄôAngers, Angers, France R√©animation m√©dicale, Nouvel H√¥pital Civil, H√¥pitaux Universitaires de Strasbourg, Strasbourg, France 0000 0001 2177 7052grid.418080.5Service de r√©animation polyvalente, Centre Hospitalier de Versailles, Le Chesnay, France R√©animation, C.H. ‚Äì Le Mans, Le Mans, France 0000 0001 2181 7253grid.413784.dR√©animation m√©dicale, CHU de Bic√™tre, Le Kremlin  Bic√™tre, France R√©animation chirurgicale, C.H.U. d‚ÄôAngers, Angers, France R√©animation polyvalente, Hospital Center Departmental De Vend√©e, La Roche-Sur-Yon, France 0000 0000 8715 2621grid.413780.9R√©animation medico-chirurgicale, H√¥pital Avicenne, Bobigny, France R√©animation, C.H. de Saint Brieuc, Saint-Brieuc, France R√©animation m√©dicale, C.H.U. H√¥tel Dieu, Nantes, France 0000 0001 2177 138Xgrid.412220.7R√©animation m√©dicale, C.H.R.U. H√¥pitaux Universitaires Strasbourg, Strasbourg, France R√©animation, C.H. Chalon sur Sa√¥ne William Morey, Chalon-Sur-Sa√¥ne, France grid.410712.1Institut f√ºr an√§sthesiologische pathophysiologie und verfahrensentwicklung, Universit√§tsklinikum Ulm, Ulm, Germany 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, Assistance Publique H√¥pitaux de Paris, H√¥pital Saint Louis, Paris, France 0000 0000 9927 0991grid.9783.5Anesth√©sie-R√©animation, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of the Congo 0000 0000 9927 0991grid.9783.5Anesth√©sie-R√©animation, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of the Congo Statistics, School of Public Health, Kinshasa, Democratic Republic of the Congo 0000 0000 9927 0991grid.9783.5Anesth√©th√©sie-r√©animation, Cliniqes Universitaires  de Kinshasa, Kinshasa, Democratic Republic of the Congo 0000 0004 0472 0283grid.411147.6R√©animation m√©dicale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France 0000 0004 0472 0283grid.411147.6R√©animation m√©dicale, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France R√©animation m√©dicaleCHU de Poitiers, Poitiers, France R√©animation m√©dico-chirurgicale, C.H. - Le Mans, Le Mans, France grid.440367.2R√©animation m√©dicale, Centre hospitalier Bretagne Atlantique, Vannes, France R√©animation m√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France R√©animation polyvalente, Centre Hospitalier Yves le Foll, Saint-Brieuc, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France R√©animation m√©dicale, C.H.U. Grenoble, Grenoble, France 0000 0001 2322 4179grid.410528.aR√©animation m√©dicale, Centre Hospitalier Universitaire Archet, Nice, France 0000 0004 0472 0160grid.411149.8R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen, Caen, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2175 0984grid.411154.4R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France 0000 0001 2163 3825grid.413852.9R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France R√©animation m√©dicale, Centre Hospitalier Universitaire Rouen, Rouen, France Service de r√©animation m√©dicale, Centre Hospitalier de Dieppe, Dieppe, France 0000 0000 9982 5352grid.413756.2R√©animation m√©dicale, H√¥pital Ambroise Par√© (AP-HP), Boulogne-Billancourt, France Service de R√©animation, Centre Hospitalier Marc Jacquet, Melun, France Service de r√©animation m√©dicale, Clinique de R√©animation M√©dicale, Grenoble, France 0000 0004 0471 8845grid.410463.4R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France Service de r√©animation n√©onatale, C.H. Intercommunal Cr√©teil, Cr√©teil, France Service de r√©animation n√©onatale et p√©diatrique, Hospital Center University Toulouse - Casselardit Ancely, Toulouse, France Centre de recherche clinique, C.H. Intercommunal Cr√©teil, Cr√©teil, France Centre de recherche clinique, C.H. Intercommunal Cr√©teil, Cr√©teil, France Service de r√©animation n√©onatale et p√©diatrique, Hospital Center University Toulouse - Casselardit Ancely, Toulouse, France Service de r√©animation n√©onatale, C.H. Intercommunal Cr√©teil, Cr√©teil, France Mayotte, CHM, Mamoudzou, France Urgences p√©diatriquesCHU Necker-Enfants Malades, Paris, France Iriseo, Iriseo - 3D Supports multim√©dia Interactifs, Saint-Victurnien, France 0000 0004 0472 3476grid.139510.fR√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France 0000 0004 0472 3476grid.139510.fR√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France grid.414103.3R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron/Lyon, France grid.414103.3R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron/Lyon, France 0000 0001 2163 3825grid.413852.9Laboratoire d‚Äôimmunologie cellulaire, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France 0000 0001 2163 3825grid.413852.9Laboratoire d‚Äôimmunologie cellulaire, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France grid.414103.3R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron/Lyon, France 0000 0001 2173 6322grid.411418.9Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9Microbiology Department, CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada 0000 0004 1937 0589grid.413235.2H√¥pital Robert-Debr√© (AP-HP), Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France Service de r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France Unit 13i2, Department of Medicine I/intensive care, Vienna, Austria Service de r√©animation m√©dicale, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France 0000 0004 1756 8604grid.415025.7Anestesia e raiamizione, Ospedale San Gerardo, Monza, Italy 0000 0000 8571 829Xgrid.412157.4Service de Soins Intensifs, H√¥pital Erasme, Brussels, Belgium 000000040459992Xgrid.5645.2Intensive Care, Erasmus University Medical Center, Rotterdam, Netherlands 0000 0000 8588 831Xgrid.411119.dService de r√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard-APHP, Paris, France 0000 0001 2150 9058grid.411439.aUnit√© de r√©animation et de surveillance continueservice de pneumologie et r√©animation m√©dicale, Piti√©-Salp√™tri√®re Hospital, Paris, France Service de r√©animation medicale, Hopital Universitaire d‚ÄôAngers, Angers, France 0000 0000 9100 9940grid.411798.2Department of Anaesthesia and Intensive Care, General University Hospital in Prague, Prague, Czech Republic 0000 0000 9834 782Xgrid.411945.cPulmonaryallergy and Critical Care, Hallym University Sacred Heart Hospital, Seoul, Republic of Korea 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 1773 6284grid.414244.3Service de r√©animation-d√©tresses respiratoires et infections s√©v√®res, H√¥pital Nord, Marseille, France 0000 0004 0472 0371grid.277151.7R√©animation m√©dicale, CHU H√¥tel-Dieu Nantes, Nantes, France C-clin, H√¥pital Henry Gabrielle, Saint-Genis-Laval, France 0000 0001 2176 4817grid.5399.6Unit√© de recherche de sant√© publique, Facult√© de M√©decine secteur Timone (Aix-Marseille Universit√©), Marseille, France R√©animation m√©dicale, Hospital Nord, Marseille, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation m√©dicaleCHU de Poitiers, Poitiers, France R√©animation m√©dicaleCHU de Poitiers, Poitiers, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France R√©animation m√©dicaleCHU de Poitiers, Poitiers, France 0000 0004 0472 0283grid.411147.6Service de r√©animation m√©dicale et m√©decine hyperbare, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France 0000 0004 0472 0283grid.411147.6D√©partement de biologie des agents infectieux et  pharmaco-toxicologie, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France 0000 0004 0472 0283grid.411147.6Service des maladies du sang, Centre Hospitalier  Universitaire d‚ÄôAngers, Angers, France 0000 0004 0472 0283grid.411147.6Service de r√©animation m√©dicale et m√©decine hyperbare, Centre Hospitalier Universitaire d‚ÄôAngers, Angers, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France 0000 0001 2182 6141grid.12366.30CEPR (Inserm U1100/EA 6305), a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√© Fran√ßois Rabelais, Tours, France 0000 0001 2182 6141grid.12366.30CEPR (Inserm U1100/EA 6305), a√©rosolth√©rapie et biom√©dicaments √† vis√©e respiratoire, Universit√© Fran√ßois Rabelais, Tours, France Inserm cic 1415, CHRU H√¥pitaux de Tours, Tours, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France 0000 0001 0273 556Xgrid.414205.6R√©animation m√©dico-chirurgicale, H√¥pital Louis-Mourier - APHP, Colombes, France R√©animation, Centre Hospitalier D√©partemental ‚Äì site de La Roche-sur-Yon, La Roche-Sur-Yon, France R√©animation-uscm, Gustave Roussy, Villejuif, France R√©animation-uscm, Gustave Roussy, Villejuif, France 0000 0001 0273 556Xgrid.414205.6R√©animation m√©dico-chirurgicale, H√¥pital Louis-Mourier - APHP, Colombes, France 0000 0000 8588 831Xgrid.411119.dUnit√© de recherche clinique, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France grid.414352.5DAR B, H√¥pital Saint Eloi, Montpellier, France grid.414352.5DAR B, H√¥pital Saint Eloi, Montpellier, France grid.414352.5DAR B, H√¥pital Saint Eloi, Montpellier, France grid.414352.5DAR B, H√¥pital Saint Eloi, Montpellier, France Dim, H√¥pital La Colombi√®re, Montpellier, France 0000 0001 2150 9058grid.411439.aService de pneumologie et r√©animation m√©dicale, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2150 9058grid.411439.aInserm umr_s 1158 ‚Äúneurophysiologie respiratoire  exp√©rimentale et clinique‚Ä?, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2150 9058grid.411439.aInserm umr_s 1158 ‚Äúneurophysiologie respiratoire  exp√©rimentale et clinique‚Ä?, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2150 9058grid.411439.aInserm umr_s 1158 ‚Äúneurophysiologie respiratoire  exp√©rimentale et clinique‚Ä?, Piti√©-Salp√™tri√®re Hospital, Paris, France D√©partement d‚Äôanesth√©sie-r√©animation et umr_s 1158, H√¥pital Universitaire Piti√©-Salp√™tri√®re, Paris, France 0000 0001 2150 9058grid.411439.aService de pneumologie et r√©animation m√©dicale, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2150 9058grid.411439.aService de pneumologie et r√©animation m√©dicale, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France R√©animation polyvalente - surveillance continue, Ctre Hospitalier Intercommunal de Villeneuve Saint GeorgesLucie et Raymond AUBRAC, Villeneuve-Saint-Georges, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aService d‚Äôaccueil des urgences, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0001 2177 7052grid.418080.5R√©animation m√©dico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay, France 0000 0001 2177 7052grid.418080.5Service d‚Äôaccueil des urgences, Centre Hospitalier de Versailles, Le Chesnay, France Service d‚Äôaccueil des urgences, C.H. Intercommunal de Meulan-Les Mureaux, Meulan-En-Yvelines, France R√©animation polyvalente, C.H. Intercommunal de Meulan-Les Mureaux, Meulan-En-Yvelines, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France P√¥le sau - samu 74 - smur - r√©animation, C.H. Annecy Genevois, Metz-Tessy, France P√¥le sau - samu 74 - smur - r√©animation, C.H. Annecy Genevois, Metz-Tessy, France P√¥le sau - samu 74 - smur - r√©animation, C.H. Annecy Genevois, Metz-Tessy, France Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia 0000 0004 1773 6284grid.414244.3Service d‚Äôaccueil des urgences adultes, H√¥pital Nord APHM, Marseille, France 0000 0004 1773 6284grid.414244.3R√©animation DRIS, H√¥pital Nord APHM, Marseille, France 0000 0004 1773 6284grid.414244.3Service d‚Äôaccueil des urgences adultes, H√¥pital Nord APHM, Marseille, France 0000 0004 1773 6284grid.414244.3Service d‚Äôaccueil des urgences adultes, H√¥pital Nord APHM, Marseille, France 0000 0004 1773 6284grid.414244.3Service d‚Äôaccueil des urgences adultes, H√¥pital Nord APHM, Marseille, France 0000 0004 1773 6284grid.414244.3R√©animation DRIS, H√¥pital Nord APHM, Marseille, France Emergency and Intensive Care Department, h√¥pital habib thameur, Tunis, Tunisia 0000 0001 2217 0017grid.7452.4INSERM U1137 √©quipe 5, Universit√© Paris Diderot, 75018 Paris, France grid.411266.6R√©animation des urgences m√©dicales, H√¥pital de la Timone, Marseille, France 0000 0001 2163 3825grid.413852.9R√©animation M√©dicale, Hospices Civils de Lyon - Groupement Hospitalier Edouard Herriot, Lyon, France 0000 0001 0274 3893grid.411784.fH√¥pital Cochin, 75014 Paris, France 0000 0004 0639 4151grid.411163.0R√©animation m√©dicale, CHU Gabriel-Montpied, Clermont-Ferrand, France R√©animation polyvalente, Centre Hospitalier G√©n√©ral, Gonesse, France 0000 0001 2175 4109grid.50550.35Reanimation medicale, Assistance Publique H√¥pitaux de Paris, Paris, France 0000 0000 9454 4367grid.413738.aR√©animation chirurgicale, H√¥pital Antoine B√©cl√®re, Clamart, France 38, C.H.U de Grenoble, C.H.U, La Tronche, La Tronche, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 0273 556Xgrid.414205.6R√©animation m√©dico-chirurgicale, H√¥pital Louis-Mourier - APHP, Colombes, France ICU, C.H. de Longjumeau, Longjumeau, France 0000 0001 2292 1474grid.412116.1R√©animation m√©dicale, H√¥pital Henri-Mondor (AP-HP), Cr√©teil Cedex, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3Radiologie, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France Service de r√©√©ducation et d‚Äôappareillage, Institut Robert Merle d‚ÄôAubign√©, Valenton, France Service de m√©decine physique et de r√©adaptation, Centre Medico-Chirurgical de Readaptation des Massues, Lyon, France 0000 0004 1795 3756grid.414028.bService de m√©decine physique et de r√©adaptation,  H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Service de m√©decine physique et de r√©adaptation, Centre de m√©decine physique et de r√©adaptation de la tour de Gassies, Brugge, France Service de m√©decine physique et de r√©adaptation, H√¥pital la renaissance sanitaire, Villiers-Saint-Denis, France Service de m√©decine physique et de r√©adaptation, P√¥le Saint H√©lier, Rennes, France 0000 0001 0071 9523grid.418570.fCentre louis pierquin, Institut R√©gional de M√©decine Physique et de R√©adaptation, Nancy, France 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France 0000 0001 2175 0984grid.411154.4Service de chirurgie thoracique, cardiaque et vasculaire, Centre Hospitalier Universitaire, Rennes, France 0000 0001 2175 0984grid.411154.4Service de maladies infectieuses et r√©animation m√©dicale, Centre Hospitalier Universitaire, Rennes, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dR√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France ICUREsearch, Paris, France 0000 0000 8588 831Xgrid.411119.dR√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dR√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dR√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dR√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dCardiologie, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dAnesth√©sie r√©animation chirurgie cardio-vasculaire, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dChirurgie cardiaque et vasculaire, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0000 8588 831Xgrid.411119.dR√©animation m√©dicale et infectieuse, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0000 8715 2621grid.413780.993, H√¥pital Avicenne, Bobigny, France R√©animation polyvalente adulte, Centre Hospitalier Intercommunal Andr√© Gr√©goire,  Montreuil, France R√©animation m√©dicale, C.H. Intercommunal Poissy/Saint-Germain-en-Laye, Poissy Cedex, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia grid.413497.cR√©animation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0000 8588 831Xgrid.411119.dR√©animation m√©dicale, CHU BICHAT, Paris, France 0000 0001 2217 0017grid.7452.4Umr 1137, Facult√© de M√©decine Xavier Bichat, Paris, France Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Virology, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe Intensive care unit, Hospital Center Regional University, Pointe-a-Pitre, Guadeloupe 0000 0000 8521 1798grid.421142.0Centre de recherche de l‚Äôiucpq, Institut Universitaire de Cardiologie et de Pneumologie de Qu√©bec, Qu√©bec, Canada 0000 0000 8521 1798grid.421142.0Centre de recherche de l‚Äôiucpq, Institut Universitaire de Cardiologie et de Pneumologie de Qu√©bec, Qu√©bec, Canada 0000 0000 8521 1798grid.421142.0Centre de recherche de l‚Äôiucpq, Institut Universitaire de Cardiologie et de Pneumologie de Qu√©bec, Qu√©bec, Canada 0000 0000 8521 1798grid.421142.0Centre de recherche de l‚Äôiucpq, Institut Universitaire de Cardiologie et de Pneumologie de Qu√©bec, Qu√©bec, Canada 0000 0004 1792 201Xgrid.413932.eR√©animation m√©dicale polyvalente, H√¥pital de La Source, CHR Orl√©ans, Orl√©ans, France 0000 0000 8588 831Xgrid.411119.dR√©animation chirurgicale polyvalente, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France R√©animation CTCV Transplantation thoracique, CHU de Nantes - H√¥pital Nord Laennec, Saint-Herblain, France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France R√©animation m√©dicaleBd Tanguy Prigent, Brest, France 0000 0004 1936 7857grid.1002.3DEPM, Transfusion Research Unit, Monash University, Melbourne, Australia 0000 0004 1936 7857grid.1002.3DEPM, Monash University, ANZIC-RC, Melbourne, Australia 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne, Australia 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred Hospital, Sydney, Australia 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred Hospital, Sydney, Australia 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred Hospital, Camperdown, Australia 0000 0004 0385 0051grid.413249.9Intensive Care Unit, Royal Prince Alfred Hospital, Sydney, Australia 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne, Australia 0000 0004 0432 511Xgrid.1623.6Anesthesiology, Alfred Hospital, Prahran, Australia 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne, Australia 0000 0004 1936 7857grid.1002.3DEPM, Monash University, ANZIC-RC, Melbourne, Australia 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne, Australia 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne, Australia 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne, Australia 0000 0004 0432 511Xgrid.1623.6Haematology, Alfred Hospital, Prahran, Australia 0000 0004 0432 511Xgrid.1623.6Intensive Care Unit, Alfred Hospital, Melbourne, Australia 0000 0004 1936 7857grid.1002.3DEPM, Monash University, ANZIC-RC, Melbourne, Australia 0000 0001 1955 3500grid.5805.8D√©partement d‚Äôanesth√©sie et de r√©animation, UMRS INSERM 1166, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0001 1955 3500grid.5805.8D√©partement d‚Äôanesth√©sie et de r√©animation, UMRS INSERM 1166, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0001 1955 3500grid.5805.8D√©partement d‚Äôanesth√©sie et de r√©animation, UMRS INSERM 1166, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0001 1955 3500grid.5805.8D√©partement d‚Äôanesth√©sie et de r√©animation, UMRS INSERM 1166, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0004 0626 3338grid.410569.fIntensive care medicine, UZ Leuven, Louvain, Belgium 0000 0004 0578 1096grid.414977.8Anesthesia & Intensive Care, Jessa Ziekenhuis, Campus Virga Jesse, Hasselt, Belgium 0000 0004 0626 3338grid.410569.fIntensive care medicine, UZ Leuven, Louvain, Belgium 0000 0004 0612 7379grid.470040.7Anaesthesiology & Intensive Care, Ziekenhuis Oost-Limburg a.v., Genk, Belgium 0000000121866389grid.7429.8Iame team 5, INSERM UMR 1137, Paris, France 0000 0000 8588 831Xgrid.411119.dHygi√®ne hospitali√®re, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France 0000 0001 2163 3825grid.413852.9R√©animation, Hospices Civils De Lyon, Lyon, France 0000 0000 8588 831Xgrid.411119.dM√©decine interne, H√¥pital Bichat-Claude Bernard (AP-HP), Paris, France Hygi√®ne hospitali√®re, C.H.U de Rennes, Rennes, France 0000 0004 0593 7118grid.42399.35Pharmacie, CHU - H√¥pitaux de Bordeaux, Bordeaux,  France R√©animation, CHRU Nancy, Nancy, France grid.418199.cDGOS, Minist√®re des Affaires sociales et de la Sant√©, Paris, France 0000 0001 2163 3825grid.413852.9Cclin sud est, Hospices Civils De Lyon, Lyon, France 0000 0001 2163 3825grid.413852.9Cclin, Hospices Civils De Lyon, Lyon, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France 0000 0001 2300 6614grid.413328.fImmuno-h√©matologie, H√¥pital Saint-Louis (AP-HP),  Paris, France 0000 0001 2300 6614grid.413328.fRadiologie, H√¥pital Saint-Louis, Paris, France 0000 0001 2300 6614grid.413328.fChirurgie visc√©rale, H√¥pital Saint-Louis, Paris,  France 0000 0001 2300 6614grid.413328.fReanimation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0001 2175 4109grid.50550.35Sbim, Assistance Publique H√¥pitaux de Paris, Paris, France 0000 0004 0598 4440grid.418443.eR√©animation, Institut Paoli-Calmettes, Marseille, France R√©animation polyvalente, Centre Hospitalier de Roubaix, Roubaix, France 0000 0001 2177 7052grid.418080.5R√©animation m√©dico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay, France 0000 0001 0274 3893grid.411784.fR√©animation pneumologique, H√¥pital Cochin, Paris, France R√©animation polyvalente, C.H.U. de Nancy, Nancy, France 0000 0001 0684 291Xgrid.418119.4R√©animation, Institut Jules Bordet, Brussels, Belgium 0000 0004 0626 3303grid.410566.0R√©animation polyvalente, Hopital universitaire, Gand, Belgium 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France R√©animation m√©dicale, C.H.U., La Tronche, La Tronche, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis, Paris, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0004 1937 1100grid.412370.3Service de R√©animation M√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3Service de R√©animation M√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3Service de R√©animation M√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon -APHP, Paris, France 0000 0001 2175 4109grid.50550.35Service de r√©animation m√©dicale, Groupe Hospitalier La Piti√©-Salp√™tri√®re, Institut de Cardiom√©tabolisme et Nutrition, Assistance Publique H√¥pitaux de Paris, Paris, France D√©partement de r√©animation m√©dicale et de m√©decine hyperbare, C.H.U. d‚ÄôAngers, Angers, France 0000 0001 2177 7052grid.418080.5Service de r√©animation m√©dico-chirurgicale, Centre Hospitalier de Versailles, Le Chesnay, France grid.440367.2Service de r√©animation polyvalente, Centre Hospitalier Bretagne Atlantique, Vannes, France Service de r√©animation polyvalente, Centre Hospitalier Notre-Dame de la Mis√©ricorde, Ajaccio, France Service de r√©animation polyvalente, Hospital Foch, Suresnes, France 0000 0000 8943 5457grid.414010.0Service de r√©animation polyvalente, H√¥pital d‚Äôinstruction des arm√©es Desgenettes, Lyon, France Service de r√©animation polyvalente, Centre Hospitalier G√©n√©ral de Saint-Denis, Saint-Denis, France 0000 0001 2175 4109grid.50550.35Service de m√©decine interne, Groupe Hospitalier La Piti√©-Salp√™tri√®re, Institut IE3M, Assistance Publique H√¥pitaux de Paris, Paris, France 0000 0001 2181 7253grid.413784.dH√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dVal de marne, H√¥pital Bic√™tre (AP-HP), Le Kremlin-Bic√™tre, France 0000 0001 1955 3500grid.5805.8D√©partement d‚Äôanesth√©sie et de r√©animation, UMRS INSERM 1166, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0001 1955 3500grid.5805.8D√©partement d‚Äôanesth√©sie et de r√©animation, UMRS INSERM 1166, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0001 1955 3500grid.5805.8D√©partement d‚Äôanesth√©sie et de r√©animation, UMRS INSERM 1166, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0001 1955 3500grid.5805.8Centre d‚Äôinvestigation clinique paris est 1421, d√©partement de pharmacologie, H√¥pital Universitaire La Piti√©-Salp√™tri√®re, Universit√© Pierre et Marie Curie, IHU ICAN, Paris, France 0000 0001 0274 7763grid.414363.7Unit√© de microbiologie clinique et dosages des anti-infectieux, Groupe hospitalier Paris Saint-Joseph, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon -APHP, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon -APHP, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon -APHP, Paris, France 0000 0001 2259 4338grid.413483.9R√©animation m√©dico-chirurgicale, H√¥pital Tenon -APHP, Paris, France 0000 0001 2175 0984grid.411154.4R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France 0000 0001 2175 0984grid.411154.4R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France 0000 0001 2175 0984grid.411154.4R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France 0000 0001 2175 0984grid.411154.4R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France 0000 0001 2175 0984grid.411154.4R√©animation m√©dicale, Centre Hospitalier Universitaire de Rennes, Rennes, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3Microbiologie, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation M√©dicale, H√¥pital Saint-Antoine, AP-HP, Paris, France R√©animation Polyvalente, H√¥pital Saint Joseph Saint Luc, Lyon, France R√©animation Polyvalente, H√¥pital Saint Joseph Saint Luc, Lyon, France Pharmacie, H√¥pital Saint Joseph Saint Luc, Lyon, France Biologie, H√¥pital Saint Joseph Saint Luc, Lyon, France D√©partement d‚Äôinformation m√©dicale, H√¥pital Saint Joseph Saint Luc, Lyon, France 0000 0004 0472 0283grid.411147.6Unit√© de pr√©vention et lutte contre les infections nosocomiales (uplin), CHU Angers, Angers, France 0000 0001 2163 3825grid.413852.9Hygi√®ne hospitali√®re, Hospices Civils de Lyon, Lyon, France R√©animation Polyvalente, H√¥pital Saint Joseph Saint Luc, Lyon, France 0000 0001 2185 090Xgrid.36823.3cLaboratoire mesurs, Conservatoire National des Arts et M√©tiers, Paris, France 0000 0001 2185 090Xgrid.36823.3cLaboratoire mesurs, Conservatoire National des Arts et M√©tiers, Paris, France 0000 0001 2185 090Xgrid.36823.3cLaboratoire mesurs, Conservatoire National des Arts et M√©tiers, Paris, France R√©animation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France Microbiologie, Centre Hospitalier de Dieppe, Dieppe, France R√©animation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France R√©animation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France R√©animation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France R√©animation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France R√©animation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France R√©animation polyvalente, Centre Hospitalier de Dieppe, Dieppe, France Service de r√©animation m√©dicale brabois, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy, France Service de microbiologie, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy, France Service de maladie infectieuse et tropicale, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy,  France Service de r√©animation chirurgicale brabois, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy,  France Centre d‚Äôinvestigation clinique pierre drouin, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy, France Service de r√©animation m√©dicale brabois, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy, France Cardiologie - centre d‚Äôinvestigation clinique pierre drouin, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation M√©dicale Brabois, Centre Hospitalier  Universitaire de Nancy, Vand≈ìuvre-L√®s-Nancy, France grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia 0000 0001 2323 5644grid.412124.0Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0Hopital r√©gional mahres, Facult√© de m√©decine de Sfax, Sfax, Tunisia Intensive Care, hopital r√©gional Gafsa, Sfax, Tunisia Intensive Care, hopital r√©gional mahres, Sfax, Tunisia URGENCES, Centre Hospitalier G√©n√©ral de Longjumeau, Longjumeau, France URGENCES, Centre Hospitalier G√©n√©ral de Longjumeau, Longjumeau, France Samu, C.H. Sud Francilien, Corbeil-Essonnes, France 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France Calvados, P√¥le Anesth√©sie-R√©animation C.H.U de Caen, Caen, France Calvados, INSERM U919, Cyceron, Caen, France Calvados, INSERM U919, Cyceron, Caen, France Calvados, Neurochirurgie, C.H.U de Caen, Caen, France Calvados, INSERM U919, Cyceron, Caen, France Calvados, INSERM U919, Cyceron, Caen, France Calvados, INSERM U919, Cyceron, Caen, France Calvados, P√¥le Anesth√©sie-R√©animation C.H.U de Caen, Caen, France Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Service de r√©animation p√©diatriqueChu Ibn Rochd, Casablanca, Morocco Service de r√©animation p√©diatriqueChu Ibn Rochd, Casablanca, Morocco Service de r√©animation p√©diatriqueChu Ibn Rochd, Casablanca, Morocco grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia grid.415617.0Department of Critical Care Medicine and Anesthesiology, Military Hospital of Tunis, Tunis, Tunisia FinistereC.H. de Cornouaille, Quimper, France FinistereC.H. de Cornouaille, Quimper, France FinistereC.H. de Cornouaille, Quimper, France FinistereC.H. de Cornouaille, Quimper, France FinistereC.H. de Cornouaille, Quimper, France VAR, Hospital Sainte Musse, Toulon, France VAR, Hospital Sainte Musse, Toulon, France R√©animation polyvalente, H√¥pital Sainte-Musse, Toulon, France R√©animation polyvalente, H√¥pital Sainte-Musse, Toulon, France 0000 0004 0472 0160grid.411149.8R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen, Caen, France 0000 0004 0472 0160grid.411149.8R√©animation m√©dicale, Centre Hospitalier Universitaire de Caen, Caen, France 0000 0004 0472 0160grid.411149.8Anesth√©sie, Centre Hospitalier Universitaire de Caen, Caen, France 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Avenue du Mar√©chal de Lattre de Tassigny, Cr√©teil, France R√©animation M√©dicale, Hopital regional zaghouan, facult√© de m√©decine de Tunis, Zaghouan, Tunisia Teaching Department of Emergency and Intensive Care, Regional Hospital of Zaghouan, Zaghouan, Tunisia R√©animation M√©dicale, Hopital regional zaghouan, facult√© de m√©decine de Tunis, Zaghouan, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia 91, C.H. Bligny, Briis-Sous-Forges, France 91, C.H. Bligny, Briis-Sous-Forges, France 91, C.H. Bligny, Briis-Sous-Forges, France 91, C.H. Bligny, Briis-Sous-Forges, France 91, C.H. Bligny, Briis-Sous-Forges, France 91, C.H. Bligny, Briis-Sous-Forges, France R√©animation M√©dicale, Teaching Department of Emergency and Intensive Care, Hospital of Zaghouan, Zaghouan, Tunisia grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia Service de pneumologie et r√©animation m√©dicale, Groupe Hospitalier Piti√© Salp√™tri√®re, Paris, France 0000 0001 2300 6614grid.413328.fDepartment of Informatics and Biostatistics, Saint Louis Hospital, Paris, France Service de r√©animation adultes, C.H.U. Estaing, Clermont-Ferrand, France grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, Research laboratory n¬∞ lr14es05, Faculty of medicine, CHU Farhat Hached, Sousse, Tunisia R√©animation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco 0000 0001 2181 7253grid.413784.dR√©animation m√©dicale, CHU de Bic√™tre, Le Kremlin  Bic√™tre, France 0000 0000 9982 5352grid.413756.2R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France 0000 0000 9982 5352grid.413756.2R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France 0000 0000 9982 5352grid.413756.2R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France 0000 0000 9982 5352grid.413756.2R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France 0000 0004 0593 702Xgrid.134996.0R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France 0000 0004 0593 702Xgrid.134996.0R√©animation m√©dicale, Centre Hospitalier Universitaire, Amiens, France 0000 0000 9982 5352grid.413756.2R√©animation m√©dico-chirurgicale, Assistance Publique - H√¥pitaux de Paris, H√¥pital Ambroise Par√©, Boulogne-Billancourt, France R√©animation m√©dicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis,  Tunisia R√©animation m√©dicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis,  Tunisia R√©animation m√©dicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis,  Tunisia R√©animation m√©dicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis,  Tunisia R√©animation m√©dicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis,  Tunisia R√©animation m√©dicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis,  Tunisia R√©animation m√©dicale, Centre hospitalier universitaire la Rabta de Tunis, Tunis,  Tunisia R√©animation, Chru De N√Æmes, N√Æmes, France R√©animation, Chru De N√Æmes, N√Æmes, France R√©animation, Chru De N√Æmes, N√Æmes, France R√©animation, Chru De N√Æmes, N√Æmes, France R√©animation m√©dicale, CHU H√¥pital l‚ÄôArchet 1, Route Saint-Antoine de Ginesti√®re,  Nice, France R√©animation m√©dicale, CHU H√¥pital l‚ÄôArchet 1, Route Saint-Antoine de Ginesti√®re,  Nice, France R√©animation m√©dicale, H√¥pitaux de l‚ÄôArchet 1 et 2, Nice, France R√©animation m√©dicale, CHU H√¥pital l‚ÄôArchet 1, Route Saint-Antoine de Ginesti√®re,  Nice, France grid.413770.6Service de r√©animation, H√¥pital l‚ÄôArchet 2, Nice, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France 0000 0001 2181 7253grid.413784.dService de r√©animation m√©dicale, INSERM UMRS_999, universit√© paris-sud, H√¥pital de bic√™tre, h√¥pitaux universitaires paris-sud, Assistance publique ‚Äì H√¥pitaux de Paris, Le Kremlin-Bic√™tre, France R√©animation M√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation M√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation M√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation M√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation M√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation M√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia R√©animation M√©dicale, EPS Taher Sfar Mahdia, Mahdia, Tunisia 0000 0004 1795 3756grid.414028.bService de r√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Antenne m√©dicale, Centre m√©dical des arm√©es, Besan√ßon, France 0000 0004 1795 3756grid.414028.bCentre de traitement des br√ªl√©s, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France 0000 0004 1795 3756grid.414028.bService de r√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Unit√© de recherche, Centre d‚Äô√©pid√©miologie et de sant√© publique des arm√©es, Marseille, France grid.418221.cD√©partement de neurosciences et contraintes op√©rationnelles, Institut de Recherche Biom√©dicale des Arm√©es, Br√©tigny-Sur-Orge, France Antenne m√©dicale, Centre m√©dical des arm√©es, Besan√ßon, France 0000 0004 0593 9113grid.412134.1R√©animation neurochirurgicale p√©diatrique, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation neurochirurgicale p√©diatrique, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation neurochirurgicale p√©diatrique, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation neurochirurgicale p√©diatrique, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, Hospital Antoine B√©cl√®re, Clamart, France 0000 0000 9454 4367grid.413738.aR√©animation polyvalente, H√¥pital Antoine B√©cl√®re, Clamart, France P√¥le de r√©animation, h√¥pital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret, Lille, France P√¥le de r√©animation, h√¥pital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret, Lille, France P√¥le de r√©animation, h√¥pital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret, Lille, France P√¥le de r√©animation, h√¥pital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret, Lille, France P√¥le de r√©animation, h√¥pital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret, Lille, France P√¥le de r√©animation, h√¥pital salengro, C.H.R.U. - Lille, Avenue Oscar Lambret, Lille, France 73, Centre hospitalier M√©tropole Savoie, Chamb√©ry, France 73, Centre hospitalier M√©tropole Savoie, Chamb√©ry, France 73, Centre hospitalier M√©tropole Savoie, Chamb√©ry, France 73, Centre hospitalier M√©tropole Savoie, Chamb√©ry, France grid.412791.8R√©animation m√©dicale, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, Research laboratory n¬∞ lr14es05, Faculty of medicine, CHU Farhat Hached, Sousse, Tunisia Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France Giga la vis, Institut des Hauts de Seine, Nanterre, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France 0000 0001 0274 3893grid.411784.fService de pneumologie et r√©animation, H√¥pital Cochin, Paris, France 0000 0001 2188 0914grid.10992.33Laboratoire ilumens, Universist√© Ren√© Descartes - Paris V, Paris, France Service de r√©animation m√©dico-chirurgicale, CHU Louis Mourier, Colombes, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France Cardiology Department, University Hospital of Martinique, Fort-De-France, France Infectious and Tropical Diseases Department, University Hospital of Martinique, Fort-De-France, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France Department of Neurology, University Hospital of Martinique, Fort-De-France, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France Infectious and Tropical Diseases Department, University Hospital of Martinique, Fort-De-France, France Intensive Care Unit, University Hospital of Martinique, Fort-De-France, France 0000 0001 0274 3893grid.411784.fMedical Intensive Care, H√¥pital Cochin, Paris, France 0000000121866389grid.7429.8Unit√© 1016, 22 rue m√©chain, Institut National de la Sant√© et de la Recherche M√©dicale, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000000121866389grid.7429.8U1016, Institut National de la Sant√© et de la Recherche M√©dicale, 22 rue m√©chain, Paris, France 0000000121866389grid.7429.8U1016, Institut National de la Sant√© et de la Recherche M√©dicale, 22 rue m√©chain, Paris, France 0000000121866389grid.7429.8U1016, Institut National de la Sant√© et de la Recherche M√©dicale, 22 rue m√©chain, Paris, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fHaematology, H√¥pital Cochin, Paris, France 0000 0001 0274 3893grid.411784.fHaematology, H√¥pital Cochin, Paris, France 0000 0001 2108 3034grid.10400.35INSERM U1096, Universit√© de rouen, Rouen, France 0000 0001 2108 3034grid.10400.35INSERM U1096, Universit√© de rouen, Rouen, France P√¥le R√©animations Anesth√©sie SAMU, Hospital Center University Rouen, Rouen, France U1096, INSERM, Rouen, France 0000 0001 2097 7060grid.16780.38Inserm u995 equipe 4, Universit√© Lille 2, Lille,  France U1096, INSERM, Rouen, France R√©animation m√©dicale, Hospital Center University Rouen, Rouen, France 0000 0001 2194 6418grid.29172.3fU1116, Facult√© de M√©decine de Nancy, Vand≈ìuvre-L√®s-Nancy, France 0000 0001 2194 6418grid.29172.3fU1116, Facult√© de M√©decine de Nancy, Vand≈ìuvre-L√®s-Nancy, France 0000 0001 2194 6418grid.29172.3fU1116, Facult√© de M√©decine de Nancy, Vand≈ìuvre-L√®s-Nancy, France Unit√© espri-biobase, CHRU Nancy, Vand≈ìuvre-L√®s-Nancy, France Service de biochimie, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy, France Service de r√©animation m√©dicale brabois, CHRU de Nancy, Vand≈ìuvre-L√®s-Nancy, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France R√©animation chirurgicale cardiovasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France R√©animation chirurgicale cardiovasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France R√©animation chirurgicale cardiovasculaire et thoracique, Groupe Hospitalier Piti√©-Salp√™tri√®re, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France URC, Hospital Ambroise Par√©, Boulogne-Billancourt, France 0000 0004 0638 9213grid.411158.8R√©animation chirurgicale, CHU Jean Minjoz, Besan√ßon, France 0000 0004 0638 9213grid.411158.8R√©animation chirurgicale, CHU Jean Minjoz, Besan√ßon, France 0000 0004 0638 9213grid.411158.8R√©animation chirurgicale, CHU Jean Minjoz, Besan√ßon, France 0000 0004 1937 0589grid.413235.2Laboratoire d‚Äôh√©matologie, Hopital Robert Debr√©,  Reims, France Laboratoire d‚Äôh√©mostase, cytologie et plateforme de biomonitoring, EFS Bourgogne  Franche-Comt√©, Besancon, France 0000 0004 0638 9213grid.411158.8R√©animation chirurgicale, CHU Jean Minjoz, Besan√ßon, France 0000 0004 0638 9213grid.411158.8R√©animation chirurgicale, CHU Jean Minjoz, Besan√ßon, France Anesth√©sie R√©animation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France Service de pharmacologie toxicologie, APHP - Hopital Raymond Poincar√©, Paris, France 0000 0001 2175 4109grid.50550.35Assistance Publique H√¥pitaux de Paris, Paris, France Anesth√©sie R√©animation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France Anesth√©sie R√©animation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1Service de r√©animation adulte, H√¥pital Necker, Assistance Publique H√¥pitaux de Paris, Paris, France Anesth√©sie R√©animation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation adulte - samu, H√¥pital Necker - Enfants Malades, Paris, France Anesth√©sie R√©animation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France SAMU de ParisR√©animation polyvalente, 75014 Paris, France Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia 0000 0001 2292 1474grid.412116.1R√©animation M√©dicale, H√¥pital Henri Mondor, Avenue du Mar√©chal de Lattre de Tassigny, Cr√©teil, France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Laboratory of Toxicology, Lariboisi√®re Hospital,  Paris, France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Emergency, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France Departement of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Departement of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0000 9725 279Xgrid.411296.9Laboratory of Toxicology, Lariboisi√®re Hospital,  Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10, universit√© tunis el manar, Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Peadiatric Intensive Care Unit, Children Hospital of Tunis, Tunis, Tunisia Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Laboratory of Bacteriology, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Infection Prevention Team, Chu de poitiers, Poitiers, France 0000 0000 9336 4276grid.411162.1Neonatal and Paediatric Intensive Care, Chu de poitiers, Poitiers, France grid.414103.3PEDIATRIE, H√¥pital Femme M√®re Enfant, Bron, France grid.414103.3R√©animation P√©diatrique, Groupement Hospitalier Est-H√¥pital Femme M√®re Enfant, Bron, France 0000 0001 2163 3825grid.413852.9P√¥le information m√©dicale evaluation recherche, equipe d‚Äôaccueil 4129, hospices civils de Lyon, Lyon, France grid.414103.3R√©animation P√©diatrique, Groupement Hospitalier Est-H√¥pital Femme M√®re Enfant, Bron, France R√©animation p√©diatrique canastel, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria Anesth√©sie r√©animation p√©diatrique, Etablissement hospitalier sp√©cialis√© en p√©diatrie Canastel, Oran, Algeria R√©animation p√©diatrique de Canastel d‚Äôoran, Departement de medecine d‚ÄôOran Algerie, Oran, Algeria Anesth√©sie r√©animation p√©diatrique, Etablissement hospitalier sp√©cialis√© en p√©diatrie Canastel, Oran, Algeria Anesth√©sie r√©animation p√©diatrique, Etablissement hospitalier sp√©cialis√© en p√©diatrie Canastel, Oran, Algeria Anesth√©sie r√©animation p√©diatrique, Etablissement hospitalier sp√©cialis√© en p√©diatrie Canastel, Oran, Algeria R√©animation p√©diatrique canastel, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria R√©animation p√©diatrique canastel, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria R√©animation p√©diatrique, EHS CANASTEL, Oran, Algeria Anesth√©sie r√©animation p√©diatrique, Etablissement hospitalier sp√©cialis√© en p√©diatrie Canastel, Oran, Algeria 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France grid.412791.8R√©animation m√©dicale, Research laboratory n¬∞ lr14es05, Faculty of medicine, CHU Farhat Hached, Sousse, Tunisia ICU, C.H. des Deux Vall√©es - site Longjumeau, Longjumeau, France ICU, C.H. des Deux Vall√©es - site Longjumeau, Longjumeau, France ICU, C.H. des Deux Vall√©es - site Longjumeau, Longjumeau, France ICU, C.H. des Deux Vall√©es - site Longjumeau, Longjumeau, France ICU, C.H. des Deux Vall√©es - site Longjumeau, Longjumeau, France ICU, C.H. des Deux Vall√©es - site Longjumeau, Longjumeau, France Anesth√©sie-R√©animatiion, CHU Abdelkader Hassani, Sidi Bel Abb√®s, Algeria Urgences m√©dico-chirurgicales, CHU Abdelkader Hassani, Sidi Bel Abb√®s, Algeria 0000 0004 0639 3482grid.418064.fR√©animation, Centre hospitalier M√©tropole Savoie, Chamb√©ry, France 0000 0004 1795 3756grid.414028.bR√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France 0000 0004 1795 3756grid.414028.bR√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France 0000 0004 1795 3756grid.414028.bD√©partement d‚Äôanesth√©sie-r√©animation, H√¥pital d‚ÄôInstruction des Arm√©es Percy, Clamart, France Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia 0000 0001 2323 5644grid.412124.0Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0004 0593 9113grid.412134.1R√©animation et surveillance continue p√©diatriques, H√¥pital Necker, Rue de S√®vres, Paris, France 0000 0004 0472 3476grid.139510.fR√©animation et surveillance continue p√©diatriques, CHU Robert Debr√©, Paris, France R√©animation n√©onatale et p√©diatrique, CHU Kremlin-bic√™tre, Le Kremlin-Bic√™tre, France 0000 0004 0593 9113grid.412134.1R√©animation p√©diatrique polyvalente, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation et surveillance continue m√©dico-chirurgicales, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 1937 0589grid.413235.2Unit√© u1141, INSERM-H√¥pital Robert Debr√©, Paris,  France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France 0000 0004 0471 8845grid.410463.4Pediatric Intensive Care Unit, CHU Lille, 59000 Lille, France 0000 0004 0471 8845grid.410463.4Pediatric Intensive Care Unit, CHU Lille, 59000 Lille, France 0000 0004 0471 8845grid.410463.4Department of Biostatistics, CHU Lille, 59000 Lille, France 0000 0004 0471 8845grid.410463.4Department of Biostatistics, CHU Lille, 59000 Lille, France 0000 0004 0471 8845grid.410463.4Department of Biostatistics, CHU Lille, 59000 Lille, France Physioflow, Manatec Biomedical, 78300 Poissy, France 0000 0004 0471 8845grid.410463.4R√©animation p√©diatrique, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia Unit√© de recherche ur12sp10. universit√© tunis el manar, Service de r√©animation p√©diatrique polyvalente, H√¥pital d‚Äôenfants B√©chir Hamza de Tunis, Tunis, Tunisia R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France 0000 0004 1937 0589grid.413235.2Inserm u1141, H√¥pital Robert Debr√©, Paris, France 0000 0001 2188 0914grid.10992.33Pharmacologie de la circulation c√©r√©brale, INSERM EA4475, Facult√© de Pharmacie, University Paris Descartes, Paris, France 0000 0001 2188 0914grid.10992.33Pharmacologie de la circulation c√©r√©brale, INSERM EA4475, Facult√© de Pharmacie, University Paris Descartes, Paris, France 0000 0004 1937 0589grid.413235.2Inserm u1141, H√¥pital Robert Debr√©, Paris, France 0000 0001 1955 3500grid.5805.8Inserm nps, Universit√© UPMC, Paris, France 0000 0004 1937 0589grid.413235.2Inserm u1141, H√¥pital Robert Debr√©, Paris, France grid.411266.6Anesth√©sie-r√©animation p√©diatrique, Hopital de la Timone, Marseille, France grid.411266.6Anesth√©sie-r√©animation p√©diatrique, Hopital de la Timone, Marseille, France grid.411266.6Anesth√©sie-r√©animation p√©diatrique, Hopital de la Timone, Marseille, France grid.411266.6Centre de r√©f√©rence des hernies diaphragmatiques, H√¥pital de la Timone, Marseille, France grid.411266.6Anesth√©sie-r√©animation p√©diatrique, Hopital de la Timone, Marseille, France grid.411266.6Cardiologie p√©diatrique, H√¥pital de la Timone, Marseille, France grid.411266.6Chirurgie cardiaque p√©diatrique, H√¥pital de la Timone, Marseille, France grid.411266.6Anesth√©sie-r√©animation p√©diatrique, Hopital de la Timone, Marseille, France grid.413858.3Anesth√©sie r√©animation, H√¥pital Louis Pradel, Bron, France grid.413858.3Anesth√©sie r√©animation, H√¥pital Louis Pradel, Bron, France grid.413858.3Anesth√©sie r√©animation, H√¥pital Louis Pradel, Bron, France grid.414103.3R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron, France grid.414103.3R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron, France grid.414103.3R√©animation p√©diatrique, H√¥pital Femme M√®re Enfant, Bron, France grid.413858.3Anesth√©sie r√©animation, H√¥pital Louis Pradel, Bron, France grid.414103.3Anesth√©sie, H√¥pital Femme M√®re Enfant, Bron, France grid.413858.3Anesth√©sie r√©animation, H√¥pital Louis Pradel, Bron, France grid.413858.3Anesth√©sie r√©animation, H√¥pital Louis Pradel, Bron, France 0000 0004 0471 8845grid.410463.4R√©animation p√©diatrique, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France P√©diatrie, Centre Hospitalier de Roubaix, Roubaix, France 0000 0004 0471 8845grid.410463.4R√©animation p√©diatrique, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France Department of allergology, Emile Durkheim Hospital, √âpinal, France Department of epidemiology (cepidc), National Mortality Center, Le Kremlin-Bic√™tre, France 0000 0004 0471 8845grid.410463.4Pediatric Pulmonology and Allergy Department, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France 0000 0004 0471 8845grid.410463.4R√©animation p√©diatrique, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco grid.420157.5R√©animation polyvalente, CHU Fattouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia R√©animation Polyvalente, CHU Fatouma Bourguiba, Monastir, Tunisia grid.412791.8Pharmacy Department, CHU Farhat Hached, Sousse, Tunisia grid.412791.8Pharmacy Department, CHU Farhat Hached, Sousse, Tunisia grid.412791.8R√©animation m√©dicale, Research laboratory n¬∞ lr14es05, Faculty of medicine, CHU Farhat Hached, Sousse, Tunisia Anesth√©sie r√©animation chirurgicale, EHU 1er Novembre, Oran, Algeria R√©animation p√©diatrique, Centre Hospitalier et Universitaire d‚ÄôOran, Oran, Algeria Service de gyn√©co-obst√©trique, EHS 1er Novembre, Oran, Algeria Anesthesie-r√©animation chirurgicale, EHS 1ER NOVEMBRE, Oran, Algeria Cardiologie, Centre Hospitalier et Universitaire d‚ÄôOran, Oran, Algeria Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia Intensive Care Unit, Regional Hospital of Ben Arous, Tunis, Tunisia 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Biostatistics, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France grid.414093.bLaboratory of Biochemistry, HEGP, Paris, France 0000 0000 9725 279Xgrid.411296.9Laboratory of Toxicology, Lariboisi√®re Hospital,  Paris, France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France 0000000122959819grid.12574.35R√©animation m√©dicale bizerte, Facult√© de m√©decine de Tunis, Bizerte, Tunisia 0000000122959819grid.12574.35R√©animation m√©dicale bizerte, Facult√© de m√©decine de Tunis, Bizerte, Tunisia 0000000122959819grid.12574.35R√©animation m√©dicale bizerte, Facult√© de m√©decine de Tunis, Bizerte, Tunisia 0000000122959819grid.12574.35R√©animation m√©dicale bizerte, Facult√© de m√©decine de Tunis, Bizerte, Tunisia 0000000122959819grid.12574.35R√©animation m√©dicale bizerte, Facult√© de m√©decine de Tunis, Bizerte, Tunisia 0000000122959819grid.12574.35R√©animation m√©dicale bizerte, Facult√© de m√©decine de Tunis, Bizerte, Tunisia 0000000122959819grid.12574.35R√©animation m√©dicale bizerte, Facult√© de m√©decine de Tunis, Bizerte, Tunisia 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0001 2188 0914grid.10992.33Inserm u1144, Paris-Descartes University, Paris,  France 0000 0000 9725 279Xgrid.411296.9Department of Medical and Toxicological Critical  Care, Lariboisi√®re Hospital, Paris, France Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Department of Intensive Care and Toxicology, Centre d‚ÄôAssistance M√©dicale Urgente, Tunis, Tunisia Anesth√©sie R√©animation SAMUAPHP - CHRU Necker Enfants Malades, Paris, France Centre Hospitalier Universitaire de Fort de France, Fort-De-France, Martinique France Centre Hospitalier Universitaire de Fort de France, Fort-De-France, Martinique France Centre Hospitalier Universitaire de Fort de France, Fort-De-France, Martinique France 0000 0000 9725 279Xgrid.411296.9Service de R√©animation M√©dicale et Toxicologique, CHU Lariboisi√®re, Paris, France R√©animation p√©diatrique, Centre Hospitalier et Universitaire d‚ÄôOran, Oran, Algeria Reanimation, EHS CANASTEL, Oran, Algeria R√©animation p√©diatrique, Centre Hospitalier et Universitaire d‚ÄôOran, Oran, Algeria R√©animation p√©diatrique, Centre Hospitalier et Universitaire d‚ÄôOran, Oran, Algeria R√©animation p√©diatrique, Centre Hospitalier et Universitaire d‚ÄôOran, Oran, Algeria 0000 0004 0472 0160grid.411149.8Service d‚Äôanesth√©sie r√©animation, Centre Hospitalier Universitaire de Caen, Caen, France 0000 0004 0472 0160grid.411149.8Service d‚Äôanesth√©sie r√©animation, Centre Hospitalier Universitaire de Caen, Caen, France 0000 0004 0472 0160grid.411149.8Service d‚Äôexplorations fonctionnelles respiratoire, Centre Hospitalier Universitaire de Caen, Caen, France 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Inserm cic 1431, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, H√¥pital jean Minjoz, Besan√ßon, France grid.411766.3R√©animation m√©dicale, CHRU de Brest, Brest, France 0000 0000 9336 4276grid.411162.1Urgences, CHU de Poitiers, Poitiers, France 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, CHU de Besan√ßon, Besan√ßon, France 0000 0004 0638 9213grid.411158.8R√©animation m√©dicale, CHU de Besan√ßon, Besan√ßon,  France 0000 0004 0638 9213grid.411158.8Emergency Medicine and Critical Care, CHU de Besan√ßon, Besan√ßon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 0639 4151grid.411163.0CHU Gabriel-Montpied, Clermont-Ferrand, France Anesthesia and Intensive Care Medicine, Centre Hospitalier Louis Pradel, Lyon, France 0000 0004 1799 3934grid.411388.7Anesthesia and Intensive Care Medicine, CHU Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 2292 1474grid.412116.1Service d‚ÄôAnesth√©sie et des R√©animations Chirurgicales, H√¥pital Henri Mondor, Cr√©teil, France 0000 0001 0124 3248grid.413871.8Reanimation polyvalente, H√¥pital Civil Marie Curie, Charleroi, Belgium 0000 0001 0124 3248grid.413871.8Reanimation polyvalente, H√¥pital Civil Marie Curie, Charleroi, Belgium 0000 0001 0124 3248grid.413871.8Reanimation polyvalente, H√¥pital Civil Marie Curie, Charleroi, Belgium 0000 0004 0471 8845grid.410463.4R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France 0000 0004 0471 8845grid.410463.4R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France 0000 0004 0594 4203grid.418063.8R√©animation Polyvalente, Centre Hospitalier De Valenciennes, Valenciennes, France 0000 0004 0471 8845grid.410463.4R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France 0000 0004 0594 4203grid.418063.8R√©animation Polyvalente, Centre Hospitalier De Valenciennes, Valenciennes, France 0000 0004 0471 8845grid.410463.4R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France 0000 0004 0471 8845grid.410463.4R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France 0000 0004 0471 8845grid.410463.4R√©animation m√©dicale, Centre Hospitalier R√©gional Universitaire de Lille, Lille, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1937 1100grid.412370.3R√©animation m√©dicale, H√¥pital Saint-Antoine, Paris, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France Cic 1433 √©pid√©miologie et clinique, C.H.U. de Nancy, Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France 0000 0004 1765 1301grid.410527.5R√©animation m√©dicale, H√¥pital Central, C.H.U. de  Nancy, Nancy, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0004 4685 6736grid.413306.3R√©animation m√©dicale, H√¥pital de la Croix-Rousse, Lyon, France 0000 0001 2173 6322grid.411418.9Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada 0000 0001 2173 6322grid.411418.9Soins intensifs p√©diatriques, CHU Sainte-Justine, Montr√©al, Canada 0000 0004 0471 8845grid.410463.4R√©animation p√©diatrique, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France 0000 0004 0471 8845grid.410463.4Sant√© publique:√©pid√©miologie et qualit√© des soinsservice de biostatistiques, CHRU de Lille, Lille, France 0000 0004 0471 8845grid.410463.4Biostatistiques, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France P√©diatrie, C.H. de Cambrai, Cambrai, France P√©diatrie, C.H. de Lens, Lens, France P√©diatrie, C.H. d ‚ÄòArras, Arras, France P√©diatrie, C.H. de Boulogne-sur-Mer, Boulogne-Sur-Mer, France P√©diatrie, C.H. de Dunkerque, Dunkirk, France P√©diatrie, C.H. de Douai, Douai, France 0000 0004 0471 8845grid.410463.4Sant√© publique:√©pid√©miologie et qualit√© des soinsservice de gestion du risque infectieux, CHRU de Lille, Lille, France 0000 0004 0471 8845grid.410463.4R√©animation p√©diatrique, C.H. R√©gional Universitaire de Lille (CHRU de Lille), Lille, France 0000 0004 0593 9113grid.412134.1Service de r√©animation et surveillance continue m√©dico-chirurgicale p√©diatrique, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1Service de p√©diatrie g√©n√©rale, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1Service de r√©animation et surveillance continue m√©dico-chirurgicale p√©diatrique, H√¥pital Necker - Enfants Malades, Paris, France 0000 0004 0593 9113grid.412134.1Pneumology, Hospital Necker, Paris, France 0000 0004 0593 9113grid.412134.1R√©animation n√©onatale, H√¥pital Necker - Enfants Malades, Paris, France Is√®re, H√¥pital couple enfant, Grenoble, France Reanimation pediatrique, C.h.u., La Tronche, La Tronche, France Is√®re, H√¥pital couple enfant, Grenoble, France Is√®re, H√¥pital couple enfant, Grenoble, France Is√®re, H√¥pital couple enfant, Grenoble, France Reanimation pediatrique, C.h.u., La Tronche, La Tronche, France Is√®re, H√¥pital couple enfant, Grenoble, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique et n√©onatale, Hopital pour enfants Trousseau, Paris, France R√©animation p√©diatrique canastel, Facult√© de m√©decine d‚ÄôOran, Oran, Algeria 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France 0000 0000 8715 2621grid.413780.9R√©animation medico-chirurgicale, H√¥pital Avicenne, Bobigny, France 0000 0004 0472 0371grid.277151.7R√©animation m√©dicale, CHU, Nantes, France 0000 0001 2300 6614grid.413328.fR√©animation m√©dicale, H√¥pital Saint-Louis (AP-HP), Paris, France grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3Microbiologie Laboratory, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3Microbiologie Laboratory, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia grid.413207.3R√©animation m√©dicale, H√¥pital Abderrahmen Mami, Ariana, Tunisia R√©animation polyvalente adulte, Centre Hospitalier Intercommunal Andr√© Gr√©goire,  Montreuil, France R√©animation polyvalente adulte, Centre Hospitalier Intercommunal Andr√© Gr√©goire,  Montreuil, France R√©animation polyvalente adulte, Centre Hospitalier Intercommunal Andr√© Gr√©goire,  Montreuil, France R√©animation polyvalente adulte, Centre Hospitalier Intercommunal Andr√© Gr√©goire,  Montreuil, France R√©animation polyvalente adulte, Centre Hospitalier Intercommunal Andr√© Gr√©goire,  Montreuil, France 0000 0001 0274 3893grid.411784.fR√©animation m√©dicale, H√¥pital Cochin, Paris, France 0000 0004 0593 702Xgrid.134996.0Service de R√©animation Pneumologique, CHU Amiens  - H√¥pital Sud, Amiens, France Service de r√©animation polyvalente, Centre hospitalier intercommunal Robert Ballanger, Aulnay-Sous-Bois, France R√©animation cardio thoracique et vasculaire, CHU Amiens-Picardie, Amiens, France R√©animation chirurgicale, Cochin Port-Royal, Paris, France 0000 0001 1955 3500grid.5805.8Service d‚Äôanesth√©sie et de r√©animation, Institut de cardiologiepiti√© salpetri√®re hospital, Facult√© de M√©decine Pierre et Marie Curie, Paris, France 0000 0001 2150 9058grid.411439.aD√©partement de biostatistiques, sant√© publique et information m√©dicale, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2150 9058grid.411439.aR√©animation chirurgicale polyvalente, H√¥pital de  la Piti√©-Salp√™tri√®re, Paris, France 0000 0001 2150 9058grid.411439.aService d‚Äôanesth√©sie et de r√©animation, institut  de cardiologie, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2150 9058grid.411439.aService d‚Äôanesth√©sie et de r√©animation, institut  de cardiologie, Piti√©-Salp√™tri√®re Hospital, Paris, France 0000 0001 2150 9058grid.411439.aD√©partement de biostatistiques, sant√© publique et information m√©dicale, Piti√©-Salp√™tri√®re Hospital, Paris, France R√©animation polyvalenteCHRU H√¥pitaux de Tours, Tours, France Service d‚Äôinformation m√©dicaled‚Äô√©pid√©miologie et d‚Äô√©conomie de la sant√©, CHRU H√¥pitaux de Tours, Tours, France grid.413497.cICU, CHU Habib Bourguiba, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco Anesth√©sie r√©animationCHU Ibn Rochd Casa, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Medical Informatics Laboratory, Chu Ibn Rochd, Casablanca, Morocco 0000 0004 0647 7037grid.414346.0Medical Informatics Laboratory, Chu Ibn Rochd, Casablanca, Morocco grid.413497.cICU, CHU Habib Bourguiba, Sfax, Tunisia 0000 0001 2323 5644grid.412124.0R√©animation polyvalente, Facult√© de m√©decine de Sfax, Sfax, Tunisia grid.413497.cR√©animation polyvalente, CHU Habib Bourguiba, Sfax, Tunisia 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, H√¥pital d‚ÄôInstruction des Arm√©es Sainte-Anne, Toulon, France 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, H√¥pital d‚ÄôInstruction des Arm√©es Sainte-Anne, Toulon, France 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, H√¥pital d‚ÄôInstruction des Arm√©es Sainte-Anne, Toulon, France 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, H√¥pital d‚ÄôInstruction des Arm√©es Sainte-Anne, Toulon, France 0000 0000 9759 428Xgrid.414039.bIntensive Care Unit and Anesthesiology, H√¥pital d‚ÄôInstruction des Arm√©es Sainte-Anne, Toulon, France 0000 0000 9759 428Xgrid.414039.bThoracic Surgery Department, H√¥pital d‚ÄôInstruction des Arm√©es Sainte-Anne, Toulon, France 0000 0004 0647 7037grid.414346.0Reanimation des urgences chirurgicale, Chu Ibn Rochd, Casablanca, Morocco Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia Burn Care Department, Trauma and Burn Center, Tunis, Tunisia},
note  = {Ann Intensive Care. 2017 Jan 10;7(Suppl 1):. doi:10.1186/s13613-016-0223-8.}
}

@Article{201663,
author  = {Zaaroor, M. and Sinai, A. and Goldsher, D. and Eran, A. and Nassar, M. and Schlesinger, I. and Parker, J. and Ravikumar, V. and Ghanouni, P. and Stein, S. and Halpern, C. and Krishna, V. and Hargrove, A. and Agrawal, P. and Changizi, B. and Bourekas, E. and Knopp, M. and Rezai, A. and Mead, B. and Kim, N. and Mastorakos, P. and Suk, J. and Miller, W. and Klibanov, A. and Hanes, J. and Price, R. and Wang, S. and Olumolade, O. and Kugelman, T. and Jackson-Lewis, V. and Karakatsani, M. and Han, Y. and Przedborski, S. and Konofagou, E. and Hynynen, K. and Aubert, I. and Leinenga, G. and Nisbet, R. and Hatch, R. and Van, d. and Evans, H. and G√∂tz, J. and G√∂tz, J. and Nisbet, R. and Van, d. and Evans, H. and Leinenga, G. and Fishman, P. and Yarowsky, P. and Frenkel, V. and Wei-Bin, S. and Nguyen, B. and Sanchez, C. and Acosta, C. and Chen, C. and Wu, S. and Karakatsani, M. and Konofagou, E. and Aryal, M. and Papademetriou, I. and Zhang, Y. and Power, C. and McDannold, N. and Porter, T. and Kovacs, Z. and Kim, S. and Jikaria, N. and Qureshi, F. and Bresler, M. and Frank, J. and Od√©en, H. and Chiou, G. and Snell, J. and Todd, N. and Madore, B. and Parker, D. and Pauly, K. and Marx, M. and Ghanouni, P. and Jonathan, S. and Grissom, W. and Arvanitis, C. and McDannold, N. and Clement, G. and Parker, D. and de, B. and Od√©en, H. and Payne, A. and Christensen, D. and Maimbourg, G. and Santin, M. and Houdouin, A. and Lehericy, S. and Tanter, M. and Aubry, J. and Pauly, K. and Federau, C. and Werner, B. and Halpern, C. and Ghanouni, P. and Paeng, D. and Xu, Z. and Snell, J. and Quigg, A. and Eames, M. and Jin, C. and Everstine, A. and Sheehan, J. and Lopes, M. and Kassell, N. and Snell, J. and Quigg, A. and Drake, J. and Price, K. and Lustgarten, L. and Sin, V. and Mougenot, C. and Donner, E. and Tam, E. and Hodaie, M. and Waspe, A. and Looi, T. and Pichardo, S. and Lee, W. and Chung, Y. and Jung, Y. and Song, I. and Yoo, S. and Lee, W. and Kim, H. and Jung, Y. and Chung, Y. and Song, I. and Lee, J. and Yoo, S. and Caskey, C. and Zinke, W. and Cosman, J. and Shuman, J. and Schall, J. and Aurup, C. and Wang, S. and Chen, H. and Acosta, C. and Konofagou, E. and Kamimura, H. and Carneiro, A. and Todd, N. and Sun, T. and Zhang, Y. and Power, C. and Nazai, N. and Patz, S. and Livingstone, M. and McDannold, N. and Mainprize, T. and Huang, Y. and Alkins, R. and Chapman, M. and Perry, J. and Lipsman, N. and Bethune, A. and Sahgal, A. and Trudeau, M. and Hynynen, K. and Liu, H. and Hsu, P. and Wei, K. and Sun, T. and Power, C. and Zhang, Y. and Sutton, J. and Alexander, P. and Aryal, M. and Miller, E. and McDannold, N. and Kobus, T. and Zhang, Y. and McDannold, N. and Carpentier, A. and Canney, M. and Vignot, A. and Beccaria, K. and Leclercq, D. and Lafon, C. and Chapelon, J. and Hoang-Xuan, K. and Delattre, J. and Idbaih, A. and Xu, Z. and Moore, D. and Xu, A. and Schmitt, P. and Snell, J. and Foley, J. and Eames, M. and Sheehan, J. and Kassell, N. and Sukovich, J. and Cain, C. and Xu, Z. and Pandey, A. and Snell, J. and Chaudhary, N. and Camelo-Piragua, S. and Allen, S. and Paeng, D. and Cannata, J. and Teofilovic, D. and Bertolina, J. and Kassell, N. and Hall, T. and Xu, Z. and Wu, S. and Karakatsani, M. and Grondin, J. and Sanchez, C. and Ferrera, V. and Konofagou, E. and ter, H. and Mouratidis, P. and Repasky, E. and Timbie, K. and Badr, L. and Campbell, B. and McMichael, J. and Buckner, A. and Prince, J. and Stevens, A. and Bullock, T. and Price, R. and Skalina, K. and Guha, C. and Orsi, F. and Bonomo, G. and Vigna, P. and Mauri, G. and Varano, G. and Schade, G. and Wang, Y. and Pillarisetty, V. and Hwang, J. and Khokhlova, V. and Bailey, M. and Khokhlova, T. and Khokhlova, V. and Sinilshchikov, I. and Yuldashev, P. and Andriyakhina, Y. and Kreider, W. and Maxwell, A. and Khokhlova, T. and Sapozhnikov, O. and Partanen, A. and Lundt, J. and Allen, S. and Sukovich, J. and Hall, T. and Cain, C. and Xu, Z. and Preusser, T. and Haase, S. and Bezzi, M. and Jenne, J. and Lang√∏, T. and Midiri, M. and Mueller, M. and Sat, G. and Tanner, C. and Zangos, S. and Guenther, M. and Melzer, A. and Menciassi, A. and Tognarelli, S. and Cafarelli, A. and Diodato, A. and Ciuti, G. and Rothluebbers, S. and Schwaab, J. and Strehlow, J. and Mihcin, S. and Tanner, C. and Tretbar, S. and Preusser, T. and Guenther, M. and Jenne, J. and Payen, T. and Palermo, C. and Sastra, S. and Chen, H. and Han, Y. and Olive, K. and Konofagou, E. and Adams, M. and Salgaonkar, V. and Scott, S. and Sommer, G. and Diederich, C. and Vidal-Jove, J. and Perich, E. and Ruiz, A. and Velat, M. and Melodelima, D. and Dupre, A. and Vincenot, J. and Yao, C. and Perol, D. and Rivoire, M. and Tucci, S. and Mahakian, L. and Fite, B. and Ingham, E. and Tam, S. and Hwang, C. and Tuveson, D. and Ferrara, K. and Scionti, S. and Chen, L. and Cvetkovic, D. and Chen, X. and Gupta, R. and Wang, B. and Ma, C. and Bader, K. and Haworth, K. and Maxwell, A. and Holland, C. and Sanghvi, N. and Carlson, R. and Chen, W. and Chaussy, C. and Thueroff, S. and Cesana, C. and Bellorofonte, C. and Wang, Q. and Wang, H. and Wang, S. and Zhang, J. and Bazzocchi, A. and Napoli, A. and Staruch, R. and Bing, C. and Shaikh, S. and Nofiele, J. and Szczepanski, D. and Staruch, M. and Williams, N. and Laetsch, T. and Chopra, R. and Ghanouni, P. and Rosenberg, J. and Bitton, R. and Napoli, A. and LeBlang, S. and Meyer, J. and Hurwitz, M. and Pauly, K. and Partanen, A. and Yarmolenko, P. and Partanen, A. and Celik, H. and Eranki, A. and Beskin, V. and Santos, D. and Patel, J. and Oetgen, M. and Kim, A. and Kim, P. and Sharma, K. and Chisholm, A. and Drake, J. and Aleman, D. and Waspe, A. and Looi, T. and Pichardo, S. and Napoli, A. and Bazzocchi, A. and Scipione, R. and Temple, M. and Waspe, A. and Amaral, J. and Huang, Y. and Endre, R. and Lamberti-Pasculli, M. and de, R. and Campbell, F. and Stimec, J. and Gupta, S. and Singh, M. and Mougenot, C. and Hopyan, S. and Hynynen, K. and Czarnota, G. and Drake, J. and Brenin, D. and Rochman, C. and Kovatcheva, R. and Vlahov, J. and Zaletel, K. and Stoinov, J. and Han, Y. and Wang, S. and Konofagou, E. and Bucknor, M. and Rieke, V. and Shim, J. and Staruch, R. and Koral, K. and Chopra, R. and Laetsch, T. and Lang, B. and Wong, C. and Lam, H. and Kovatcheva, R. and Vlahov, J. and Zaletel, K. and Stoinov, J. and Shinkov, A. and Hu, J. and Sharma, K. and Zhang, X. and Macoskey, J. and Ives, K. and Owens, G. and Gurm, H. and Shi, J. and Pizzuto, M. and Cain, C. and Xu, Z. and Payne, A. and Dillon, C. and Christofferson, I. and Hilas, E. and Shea, J. and Greillier, P. and Ankou, B. and Bessi√®re, F. and Zorgani, A. and Pioche, M. and Kwiecinski, W. and Magat, J. and Melot-Dusseau, S. and Lacoste, R. and Quesson, B. and Pernot, M. and Catheline, S. and Chevalier, P. and Lafon, C. and Marquet, F. and Bour, P. and Vaillant, F. and Amraoui, S. and Dubois, R. and Ritter, P. and Ha√Øssaguerre, M. and Hocini, M. and Bernus, O. and Quesson, B. and Tebebi, P. and Burks, S. and Kim, S. and Milo, B. and Frank, J. and Gertner, M. and Zhang, J. and Wong, A. and Fite, B. and Liu, Y. and Kheirolomoom, A. and Seo, J. and Watson, K. and Mahakian, L. and Tam, S. and Zhang, H. and Foiret, J. and Borowsky, A. and Ferrara, K. and Xu, D. and Melzer, A. and Thanou, M. and Centelles, M. and Wright, M. and Amrahli, M. and So, P. and Gedroyc, W. and Centelles, M. and Wright, M. and Gedroyc, W. and Thanou, M. and Kneepkens, E. and Heijman, E. and Keupp, J. and Weiss, S. and Nicolay, K. and Gr√ºll, H. and Fite, B. and Wong, A. and Liu, Y. and Kheirolomoom, A. and Mahakian, L. and Tam, S. and Foiret, J. and Ferrara, K. and Burks, S. and Nagle, M. and Kim, S. and Milo, B. and Frank, J. and Sapozhnikov, O. and Nikolaeva, A. and Terzi, M. and Tsysar, S. and Maxwell, A. and Cunitz, B. and Bailey, M. and Mourad, P. and Downs, M. and Yang, G. and Wang, Q. and Konofagou, E. and Burks, S. and Nagle, M. and Nguyen, B. and Bresler, M. and Kim, S. and Milo, B. and Frank, J. and Burks, S. and Nagle, M. and Kim, S. and Milo, B. and Frank, J. and Chen, J. and Farry, J. and Dixon, A. and Du, Z. and Dhanaliwala, A. and Hossack, J. and Klibanov, A. and Ranjan, A. and Maples, D. and Chopra, R. and Bing, C. and Staruch, R. and Wardlow, R. and Staruch, M. and Malayer, J. and Ramachandran, A. and Nofiele, J. and Namba, H. and Kawasaki, M. and Izumi, M. and Kiyasu, K. and Takemasa, R. and Ikeuchi, M. and Ushida, T. and Crake, C. and Papademetriou, I. and Zhang, Y. and Porter, T. and McDannold, N. and Kothapalli, S. and Leighton, W. and Wang, Z. and Partanen, A. and Gach, H. and Straube, W. and Altman, M. and Chen, H. and Kim, Y. and Lim, H. and Rhim, H. and Kim, Y. and Lim, H. and Rhim, H. and van, B. and Braat, M. and Moonen, C. and van, d. and Ries, M. and Marrocchio, C. and Dababou, S. and Bitton, R. and Pauly, K. and Ghanouni, P. and Lee, J. and Lee, J. and Chung, H. and Kang, S. and Kang, K. and Son, K. and Zhang, D. and Adams, M. and Salgaonkar, V. and Plata, J. and Jones, P. and Pascal-Tenorio, A. and Bouley, D. and Sommer, G. and Pauly, K. and Diederich, C. and Bond, A. and Dallapiazza, R. and Huss, D. and Warren, A. and Sperling, S. and Gwinn, R. and Shah, B. and Elias, W. and Curley, C. and Zhang, Y. and Negron, K. and Miller, W. and Klibanov, A. and Abounader, R. and Suk, J. and Hanes, J. and Price, R. and Karakatsani, M. and Samiotaki, G. and Wang, S. and Kugelman, T. and Acosta, C. and Konofagou, E. and Kovacs, Z. and Tu, T. and Papadakis, G. and Hammoud, D. and Frank, J. and Silvestrini, M. and Wolfram, F. and G√ºllmar, D. and Reichenbach, J. and Hofmann, D. and B√∂ttcher, J. and Schubert, H. and Lesser, T. and Almquist, S. and Parker, D. and Christensen, D. and Camarena, F. and Jim√©nez-Gamb√≠n, S. and Jim√©nez, N. and Konofagou, E. and Chang, J. and Chaplin, V. and Griesenauer, R. and Miga, M. and Caskey, C. and Ellens, N. and Airan, R. and Quinones-Hinojosa, A. and Farahani, K. and Partanen, A. and Feng, X. and Fielden, S. and Zhao, L. and Miller, W. and Wintermark, M. and Pauly, K. and Meyer, C. and Guo, S. and Lu, X. and Zhuo, J. and Xu, S. and Gullapalli, R. and Gandhi, D. and Jin, C. and Brokman, O. and Eames, M. and Snell, J. and Paeng, D. and Baek, H. and Kim, H. and Leung, S. and Webb, T. and Pauly, K. and McDannold, N. and Zhang, Y. and Vykhodtseva, N. and Nguyen, T. and Sukovich, J. and Hall, T. and Xu, Z. and Cain, C. and Park, C. and Park, S. and Jung, N. and Kim, M. and Chang, W. and Jung, H. and Chang, J. and Pichardo, S. and Hynynen, K. and Plaksin, M. and Weissler, Y. and Shoham, S. and Kimmel, E. and Quigg, A. and Snell, J. and Paeng, D. and Eames, M. and Sapozhnikov, O. and Rosnitskiy, P. and Khokhlova, V. and Shoham, S. and Krupa, S. and Hazan, E. and Naor, O. and Levy, Y. and Maimon, N. and Brosh, I. and Kimmel, E. and Kahn, I. and Sukovich, J. and Xu, Z. and Hall, T. and Allen, S. and Cain, C. and Cahill, J. and Sun, T. and Zhang, Y. and Power, C. and Livingstone, M. and McDannold, N. and Todd, N. and Colas, E. and Wydra, A. and Waspe, A. and Looi, T. and Maev, R. and Pichardo, S. and Drake, J. and Aly, A. and Sun, T. and Zhang, Y. and Sesenoglu-Laird, O. and Padegimas, L. and Cooper, M. and McDannold, N. and Waszczak, B. and Tehrani, S. and Miller, W. and Slingluff, C. and Larner, J. and Andarawewa, K. and Bucknor, M. and Ozhinsky, E. and Shah, R. and Krug, R. and Rieke, V. and Deckers, R. and Linn, S. and Suelmann, B. and Braat, M. and Witkamp, A. and Vaessen, P. and van, D. and Bartels, L. and Bos, C. and van, d. and Borys, N. and Storm, G. and Van, d. and Moonen, C. and Farr, N. and Alnazeer, M. and Yarmolenko, P. and Katti, P. and Partanen, A. and Eranki, A. and Kim, P. and Wood, B. and Farrer, A. and Almquist, S. and Dillon, C. and Parker, D. and Christensen, D. and Payne, A. and Ferrer, C. and Bartels, L. and de, S. and van, S. and Moonen, C. and Bos, C. and Liu, Y. and Liu, J. and Fite, B. and Foiret, J. and Leach, J. and Ferrara, K. and Gupta, R. and Cvetkovic, D. and Ma, C. and Chen, L. and Haase, S. and Zidowitz, S. and Melzer, A. and Preusser, T. and Lee, H. and Hsu, F. and Kuo, C. and Jeng, S. and Chen, T. and Yang, N. and Chiou, J. and Jeng, S. and Kao, Y. and Pan, C. and Wu, J. and Chen, T. and Hsu, F. and Lee, H. and Chiou, J. and Hsu, F. and Tsai, Y. and Lee, H. and Chiou, J. and Johnson, S. and Parker, D. and Payne, A. and Li, D. and He, Y. and Mihcin, S. and Karakitsios, I. and Strehlow, J. and Schwenke, M. and Haase, S. and Demedts, D. and Levy, Y. and Preusser, T. and Melzer, A. and Mihcin, S. and Rothluebbers, S. and Karakitsios, I. and Xiao, X. and Strehlow, J. and Demedts, D. and Cavin, I. and Sat, G. and Preusser, T. and Melzer, A. and Minalga, E. and Payne, A. and Merrill, R. and Parker, D. and Hadley, R. and Ramaekers, P. and Ries, M. and Moonen, C. and de, G. and Shahriari, K. and Parvizi, M. and Asadnia, K. and Chamanara, M. and Kamrava, S. and Chabok, H. and Schwenke, M. and Strehlow, J. and Demedts, D. and Tanner, C. and Rothluebbers, S. and Preusser, T. and Strehlow, J. and Stein, R. and Demedts, D. and Schwenke, M. and Rothluebbers, S. and Preusser, T. and Demedts, D. and Haase, S. and Muller, S. and Strehlow, J. and Lang√∏, T. and Preusser, T. and Tan, J. and Zachiu, C. and Ramaekers, P. and Moonen, C. and Ries, M. and Wolfram, F. and G√ºllmar, D. and Schubert, H. and Lesser, T. and Erasmus, H. and Colas, E. and Waspe, A. and Mougenot, C. and Looi, T. and Van, A. and Benson, L. and Drake, J. and Jang, K. and Tu, T. and Jikaria, N. and Nagle, M. and Angstadt, M. and Lewis, B. and Qureshi, F. and Burks, S. and Frank, J. and McLean, H. and Payne, A. and Hoogenboom, M. and Eikelenboom, D. and den, B. and Wesseling, P. and Heerschap, A. and F√ºtterer, J. and Adema, G. and Wang, K. and Zhang, Y. and Zhong, P. and Xiao, X. and Joy, J. and McLeod, H. and Melzer, A. and Bing, C. and Staruch, R. and Nofiele, J. and Szczepanski, D. and Staruch, M. and Laetsch, T. and Chopra, R. and Bing, C. and Staruch, R. and Yarmolenko, P. and Celik, H. and Nofiele, J. and Szczepanski, D. and Kim, P. and Kim, H. and Lewis, M. and Chopra, R. and Shah, R. and Ozhinsky, E. and Rieke, V. and Bucknor, M. and Diederich, C. and Salgaonkar, V. and Jones, P. and Adams, M. and Ozilgen, A. and Zahos, P. and Coughlin, D. and Tang, X. and Lotz, J. and Jedruszczuk, K. and Gulati, A. and Solomon, S. and Kaye, E. and Fielden, S. and Mugler, J. and Miller, W. and Pauly, K. and Meyer, C. and Barbato, G. and Scoarughi, G. and Corso, C. and Gorgone, A. and Migliore, I. and Larrabee, Z. and Hananel, A. and Eames, M. and Aubry, J. and Eranki, A. and Farr, N. and Partanen, A. and Sharma, K. and Yarmolenko, P. and Wood, B. and Kim, P. and Farr, N. and Kothapalli, S. and Eranki, A. and Negussie, A. and Wilson, E. and Seifabadi, R. and Kim, P. and Chen, H. and Wood, B. and Partanen, A. and Moon, H. and Kang, J. and Sim, C. and Chang, J. and Kim, H. and Lee, H. and Sasaki, N. and Takiguchi, M. and Sebeke, L. and Luo, X. and de, J. and Heemels, M. and Heijman, E. and Gr√ºll, H. and Strehlow, J. and Schwenke, M. and Demedts, D. and Preusser, T. and McLeod, H. and Abraham, C. and Pichardo, S. and Curiel, L. and Ramaekers, P. and de, G. and Berriet, R. and Moonen, C. and Ries, M. and Dillon, C. and Jan√°t-Amsbury, M. and Payne, A. and Corea, J. and Ye, P. and Arias, A. and Pauly, K. and Lustig, M. and Svedin, B. and Payne, A. and Parker, D.},
title  = {August- 1 September 2016.},
journal  = {Journal of Therapeutic Ultrasound},
volume  = {4},
number  = {Suppl 1},
pages  = {1-113},
year  = {2016},
abstract  = {},
address  = {Rambam Health Care Campus, Haifa, Israel Rambam Health Care Campus, Haifa, Israel Rambam Health Care Campus, Haifa, Israel Rambam Health Care Campus, Haifa, Israel Rambam Health Care Campus, Haifa, Israel Rambam Health Care Campus, Haifa, Israel Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA University of Pennsylvania, Philadelphia, PA USA Stanford University, Stanford, CA USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA University of Virginia, Charlottesville, VA USA Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD USA Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD USA Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD USA University of Virginia, Charlottesville, VA USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Sunnybrook Health Sciences Centre, Toronto, ON Canada Sunnybrook Research Institute, Toronto, ON Canada Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, St Lucia, QLD Australia The University of Queensland, Brisbane (St Lucia Campus), QLD Australia Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, St Lucia, QLD Australia University of Leuven, Leuven, Belgium The University of Queensland, Brisbane (St Lucia Campus), QLD Australia The University of Queensland, Brisbane (St Lucia Campus), QLD Australia The University of Queensland, Brisbane (St Lucia Campus), QLD Australia The University of Queensland, Brisbane (St Lucia Campus), QLD Australia The University of Queensland, Brisbane (St Lucia Campus), QLD Australia The University of Queensland, Brisbane (St Lucia Campus), QLD Australia Clem Jones Centre for Ageing Dementia Research, Queensland Brain Institute, The University of Queensland, St Lucia, QLD Australia University of Maryland School of Medicine/Baltimore VAMC, Baltimore, MD USA Research & Development Service, VA Maryland Healthcare System and University of Maryland School of Medicine, Baltimore, MD USA University of Maryland School of Medicine, Baltimore, MD USA University of Maryland School of Medicine, Baltimore, MD USA University of Maryland School of Medicine, Baltimore, MD USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Brigham and Women‚Äôs Hospital, Boston, MA USA Boston University, Boston, MA USA Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Rambam Health Care Campus, Haifa, Israel Boston University, Boston, MA USA National Institutes of Health, Bethesda, MD USA National Institutes of Health, Bethesda, MD USA National Institutes of Health, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA University of Utah, Salt Lake City, UT USA Brigham and Women‚Äôs Hospital, Boston, MA USA Focused Ultrasound Foundation, Charlottesville, VA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA University of Utah, Salt Lake City, UT USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Vanderbilt University, Nashville, TN USA Vanderbilt University, Nashville, TN USA Georgia Institute of Technology, Atlanta, GA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Cleveland Clinic, Cleveland, OH USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Paris, France CENIR, ICM, CNRS U7225, INSERM U975, Paris, France Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Paris, France CENIR, ICM, CNRS U7225, INSERM U975, Paris, France Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Paris, France Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Paris, France Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA University Children‚Äôs Hospital Zurich, Zurich, Switzerland Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Hospital for Sick Children, Toronto, ON Canada Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada Philips Healthcare Canada, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Toronto Western Hospital, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada Thunder Bay Regional Research Institute, Thunder Bay, ON Canada Brigham and Women‚Äôs Hospital, Boston, MA USA Incheon St. Mary‚Äôs Hospital, The Catholic University of Korea, Incheon, Republic  of Korea Incheon St. Mary‚Äôs Hospital, The Catholic University of Korea, Incheon, Republic  of Korea Incheon St. Mary‚Äôs Hospital, The Catholic University of Korea, Incheon, Republic  of Korea Brigham and Women‚Äôs Hospital, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Department of Brain and Cognitive Engineering, Korea University, Seoul, Republic  of Korea Incheon St. Mary‚Äôs Hospital, The Catholic University of Korea, Incheon, Republic  of Korea Incheon St. Mary‚Äôs Hospital, The Catholic University of Korea, Incheon, Republic  of Korea Incheon St. Mary‚Äôs Hospital, The Catholic University of Korea, Incheon, Republic  of Korea Department of Brain and Cognitive Engineering, Korea University, Seoul, Republic  of Korea Brigham and Women‚Äôs Hospital, Boston, MA USA Vanderbilt University, Nashville, TN USA Vanderbilt University, Nashville, TN USA Vanderbilt University, Nashville, TN USA Vanderbilt University, Nashville, TN USA Vanderbilt University, Nashville, TN USA Columbia University, New York, NY USA Columbia University, New York, NY USA Washington University in St. Louis, St. Louis, MO USA Washington University in St. Louis, St. Louis, MO USA Washington University in St. Louis, St. Louis, MO USA Universidade de Sao Paolo, Sao Paulo, Brazil Universidade de Sao Paolo, Sao Paulo, Brazil Brigham and Women‚Äôs Hospital, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Boston University, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Sunnybrook Health Sciences Centre, Toronto, ON Canada Physical Sciences Platform, Sunnybrook Research Institute, Toronto, ON Canada University of Toronto, Toronto, ON Canada University of Toronto, Toronto, ON Canada Sunnybrook Research Institute, Toronto, ON Canada Sunnybrook Health Sciences Centre, Toronto, ON Canada Sunnybrook Health Sciences Centre, Toronto, ON Canada Sunnybrook Research Institute, Toronto, ON Canada Sunnybrook Research Institute, Toronto, ON Canada Sunnybrook Health Sciences Centre, Toronto, ON Canada Chang Gung University, Taoyuan, Taiwan Chang Gung University, Taoyuan, Taiwan Chang Gung Memorial Hospital, Taoyuan, Taiwan Brigham and Women‚Äôs Hospital, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Tufts University, Medford, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Radboud University Medical Center, Nijmegen, Netherlands Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Hopital de la Piti√©-Salp√™tri√®re, Assistance Publique Hopitaux de Paris, Paris, France CarThera, Denver, CO USA CarThera, Lyon, France Hopital de la Piti√©-Salp√™tri√®re, Assistance Publique Hopitaux de Paris, Paris, France Hopital de la Piti√©-Salp√™tri√®re, Assistance Publique Hopitaux de Paris, Paris, France University of Virginia, Charlottesville, VA USA INSERM Unit 1032, Lyon, France Institut du Cerveau et de la Moelle √©pini√®re, ICM, Paris, France Hopital de la Piti√©-Salp√™tri√®re, Assistance Publique Hopitaux de Paris, Paris, France Hopital de la Piti√©-Salp√™tri√®re, Assistance Publique Hopitaux de Paris, Paris, France University of Virginia, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia Health System, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Virginia, Charlottesville, VA USA University of Michigan, Ann Arbor, MI USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA Jeju National University, Jeju, Republic of Korea HistoSonics, Inc., Ann Arbor, MI USA HistoSonics, Inc., Ann Arbor, MI USA HistoSonics, Inc., Ann Arbor, MI USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA The Institute of Cancer Research, Sutton, Surrey, UK The Institute of Cancer Research, Sutton, Surrey, UK Roswell Park Cancer Institute, Buffalo, NY USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Albert Einstein College of Medicine, Bronx, NY USA Montefiore Medical Center, Bronx, NY USA Istituto Europeo di Oncologia, Milan, Italy Istituto Europeo di Oncologia, Milan, Italy Istituto Europeo di Oncologia, Milan, Italy Istituto Europeo di Oncologia, Milan, Italy University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA M.V. Lomonosov Moscow State University, Moscow, Russian Federation M.V. Lomonosov Moscow State University, Moscow, Russian Federation M.V. Lomonosov Moscow State University, Moscow, Russian Federation University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA Philips, Bethesda, MD USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Universita Degli Studi Di Roma La Sapienza, Rome, Italy mediri GmbH, Heidelberg, Baden-W√ºrttemberg Germany Stiftelsen SINTEF, Trondheim, Norway University of Palermo, Palermo, Italy IBSmm Engineering spol. s r.o., Brno, Czech Republic GE Medical Systems Israel Ltd, Tirat Carmel, Israel ETH Zurich, Computer Vision Laboratory, Zurich, Switzerland Johann Wolfgang Goethe-Universit√§t, Frankfurt, Germany Fraunhofer MEVIS, Bremen, Germany University of Dundee, Dundee, UK Scuola Superiore Sant‚ÄôAnna - The BioRobotics Institute, Pontedera, Italy Scuola Superiore Sant‚ÄôAnna - The BioRobotics Institute, Pontedera, Italy Scuola Superiore Sant‚ÄôAnna - The BioRobotics Institute, Pontedera, Italy Scuola Superiore Sant‚ÄôAnna - The BioRobotics Institute, Pontedera, Italy Scuola Superiore Sant‚ÄôAnna - The BioRobotics Institute, Pontedera, Italy Fraunhofer MEVIS, Bremen, Germany mediri GmbH, Heidelberg, Baden-W√ºrttemberg Germany Fraunhofer MEVIS, Bremen, Germany University of Dundee - TRANS-FUSIMO, Dundee, Scotland UK ETH Zurich, Computer Vision Laboratory, Zurich, Switzerland Fraunhofer IBMT, St. Ingbert, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Washington University in St. Louis, St. Louis, MO USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA UCSF Thermal Therapy Research Group, San Francisco, CA USA University of California Sunnyvale, Sunnyvale, CA USA University of California Sunnyvale, Sunnyvale, CA USA Stanford University, Stanford, CA USA University of California San Francisco, San Francisco, CA USA Hospital University Mutua Terrassa, Barcelona, Spain Institut Khuab Barcelona, Barcelona, Spain Institut Khuab Barcelona, Barcelona, Spain Institut Khuab Barcelona, Barcelona, Spain LabTAU - INSERM U1032, Lyon, France Centre Leon Berard, Lyon, France LabTAU - INSERM U1032, Lyon, France Centre Leon Berard, Lyon, France Centre Leon Berard, Lyon, France Centre Leon Berard, Lyon, France University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA Cold Spring Harbor Laboratory, Cold Spring Harbor, NY USA Cold Spring Harbor Laboratory, Cold Spring Harbor, NY USA University of California Davis, Davis, CA USA Scionti Prostate Center, Sarasota, FL USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA University of Cincinnati, Cincinnati, OH USA University of Cincinnati, Cincinnati, OH USA University of Washington, Seattle, WA USA University of Cincinnati, Cincinnati, OH USA SonaCare Medical, LLC, Indianapolis, IN USA SonaCare Medical, LLC, Indianapolis, IN USA Ulthera, Inc., Mesa, AZ USA Caritas Hospital St. Josef, University of Regensburg, Strasslach-Dingharting, Germany Klinikum Muenchen Harlaching, Munich, Germany Clinica Columbus, Milan, Italy Clinica Columbus, Milan, Italy Shanghai First People‚Äôs Hospital, Shanghai, China Shanghai Cancer Center, Shanghai, China Shanghai Huashan Hospital, Shanghai, China The ‚ÄúRizzoli‚Ä? Orthopaedic Institute, Bologna, Italy Policlinico Umberto I, University of Rome ‚Äì La Sapienza, Rome, Italy Philips Research, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Oklahoma Health Sciences Center, Oklahoma City, OK USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA University of Rome, Rome, Italy Focused Ultrasound Foundation, Charlottesville, VA USA Fox Chase Cancer Center, Philadelphia, PA USA Jefferson University Hospitals, Philadelphia, PA USA Stanford University, Stanford, CA USA Philips, Bethesda, MD USA Sheikh Zayed Institute for Pediatric Surgical Innovation, Children‚Äôs National Health System, Washington, DC USA Sheikh Zayed Institute for Pediatric Surgical Innovation, Children‚Äôs National Health System, Washington, DC USA Sheikh Zayed Institute for Pediatric Surgical Innovation, Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA University of Toronto, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada University of Toronto, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada Thunder Bay Regional Research Institute, Thunder Bay, ON Canada Policlinico Umberto I, University of Rome ‚Äì La Sapienza, Rome, Italy The ‚ÄúRizzoli‚Ä? Orthopaedic Institute, Bologna, Italy University of Rome ‚Äì La Sapienza, Rome, Italy Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Sunnybrook Health Sciences Center, Toronto, ON Canada Sunnybrook Health Sciences Center, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Philips Healthcare Canada, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Sunnybrook Health Sciences Center, Toronto, ON Canada Sunnybrook Health Sciences Center, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University Hospital of Endocrinology, Sofia, Bulgaria University Hospital of Endocrinology, Sofia, Bulgaria University Medical Centre Ljubljana, Ljubljana, Slovenia University Hospital of Endocrinology, Sofia, Bulgaria Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA Children‚Äôs Health, Decatur, GA USA Philips Research, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Hong Kong, Hong Kong, Hong Kong SAR University of Hong Kong, Hong Kong, Hong Kong SAR Theraclion Asia Pacific Limited, Hong Kong, Hong Kong SAR University Medical Centre Ljubljana, Ljubljana, Slovenia University Hospital of Endocrinology, Sofia, Bulgaria University Medical Centre Ljubljana, Ljubljana, Slovenia University Hospital of Endocrinology, Sofia, Bulgaria Medical University Sofia, Clinical Center of Endocrinology, Sofia, Bulgaria Weill Cornell Medicine, New York, NY USA Children‚Äôs National Health System, Washington, DC USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA INSERM / Universit√© de Lyon, Lyon, France Hospices Civils de Lyon, Lyon, France Hospices Civils de Lyon, Lyon, France INSERM / Universit√© de Lyon, Lyon, France Hospices Civils de Lyon, Lyon, France Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Paris, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France Station de Primatologie-UPS846-CNRS, Rousset sur Arc, France Station de Primatologie-UPS846-CNRS, Rousset sur Arc, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Paris, France INSERM / Universit√© de Lyon, Lyon, France Hospices Civils de Lyon, Lyon, France University of Virginia, Charlottesville, Virginia, United States and INSERM Unit  1032, Lyon, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France IHU Liryc, Electrophysiology and Heart Modeling Institute, Pessac-Bordeaux, France National Institutes of Health, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA Kona Medical, Inc., Bellevue, WA USA Kona Medical, Inc., Bellevue, WA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA Chongqing Changlin Science & Technology Ltd., Chongqing, China University of Dundee, Dundee, UK King‚Äôs College London, London, UK King‚Äôs College London, London, UK King‚Äôs College London, London, UK King‚Äôs College London, London, UK King‚Äôs College London, London, UK Imperial College Healthcare London, London, UK King‚Äôs College London, London, UK King‚Äôs College London, London, UK Imperial College Healthcare London, London, UK King‚Äôs College London, London, UK Eindhoven University of Technology, Eindhoven, Netherlands Philips Research, Eindhoven, Netherlands Philips Research, Hamburg, Germany Philips Research, Hamburg, Germany Eindhoven University of Technology, Eindhoven, Netherlands Philips Research, Eindhoven, Netherlands University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA University of Washington, Seattle, WA USA Moscow State University, Moscow, Russian Federation Moscow State University, Moscow, Russian Federation Moscow State University, Moscow, Russian Federation University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Oklahoma State University, Stillwater, OK USA Oklahoma State University, Stillwater, OK USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA Philips Research, Dallas, TX USA Oklahoma State University, Stillwater, OK USA University of Oklahoma Health Sciences Center, Oklahoma City, OK USA Oklahoma State University, Stillwater, OK USA Oklahoma State University, Stillwater, OK USA University of Texas Southwestern Medical Center, Dallas, TX USA Kochi University, Kochi Medical School, Nankoku, Kochi Japan Kochi University, Kochi Medical School, Nankoku, Kochi Japan Kochi University, Kochi Medical School, Nankoku, Kochi Japan Kochi University, Kochi Medical School, Nankoku, Kochi Japan Kochi University, Kochi Medical School, Nankoku, Kochi Japan Kochi University, Kochi Medical School, Nankoku, Kochi Japan Multidisciplinary Pain Center, School of Medicine, Aichi Medical University, Nagakute, Aichi Japan Brigham and Women‚Äôs Hospital, Boston, MA USA Boston University, Boston, MA USA Harvard Medical School, Boston, MA USA Boston University, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Washington University in Saint Louis, Saint Louis, MO USA Washington University in Saint Louis, Saint Louis, MO USA Washington University in Saint Louis, Saint Louis, MO USA Philips, Bethesda, MD USA Washington University in Saint Louis, Saint Louis, MO USA Washington University in Saint Louis, Saint Louis, MO USA Washington University in Saint Louis, Saint Louis, MO USA Washington University in Saint Louis, Saint Louis, MO USA Samsung Medical Center, Seoul, Republic of Korea Samsung Medical Center, Seoul, Republic of Korea Samsung Medical Center, Seoul, Republic of Korea Samsung Medical Center, Seoul, Republic of Korea Samsung Medical Center, Seoul, Republic of Korea Samsung Medical Center, Seoul, Republic of Korea University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University of Rome ‚Äì La Sapienza, Rome, Italy University of Rome ‚Äì La Sapienza, Rome, Italy Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Seoul National University Hospital, Seoul, Republic of Korea Seoul National University Hospital, Seoul, Republic of Korea Seoul National University Hospital, Seoul, Republic of Korea Seoul National University Hospital, Seoul, Republic of Korea Alpinion Medical Systems, Seoul, Republic of Korea Alpinion Medical Systems, Seoul, Republic of Korea The First Affiliated Hospital of Harbin Medical University, Harbin, China University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA Stanford University, Stanford, CA USA University of California San Francisco, San Francisco, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA University of California San Francisco, San Francisco, CA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Swedish Neuroscience Institute, Seattle, WA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Johns Hopkins University, Baltimore, MD USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD USA Center for Nanomedicine/Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD USA University of Virginia, Charlottesville, VA USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA Columbia University, New York, NY USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA University of California Davis, Davis, CA USA SRH Wald-Klinikum Gera / Clinic of Thoracic Surgery, Gera, Germany Institute of Diagnostic and Interventional Radiology, University Hospital - Friedrich Schiller University, Jena, Germany Institute of Diagnostic and Interventional Radiology, University Hospital - Friedrich Schiller University, Jena, Germany SRH Wald-Klinikum Gera, Gera, Germany SRH Wald-Klinikum Gera, Gera, Germany Institute of Animal Experimentation, Friedrich Schiller University, Jena, Germany SRH Wald-Klinikum Gera, Gera, Germany University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA Universitat Polit√®cnica de Val√®ncia, Gandia, Spain Universitat Polit√®cnica de Val√®ncia, Gandia, Spain LUNAM Universite. Universit√© du Maine, Le Mans, Spain Columbia University, New York, NY USA YUMC Severance Hospital, Seoul, Republic of Korea Vanderbilt University Institute of Imaging Science, Nashville, TN USA Vanderbilt University, Nashville, TN USA Vanderbilt University, Nashville, TN USA Vanderbilt University, Nashville, TN USA Johns Hopkins University, Baltimore, MD USA Stanford University, Stanford, CA USA Johns Hopkins University, Baltimore, MD USA National Cancer Institute, Bethesda, MD USA Philips, Bethesda, MD USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Stanford University, Stanford, CA USA University of Virginia, Charlottesville, VA USA University of Maryland Baltimore, Baltimore, MD USA University of Maryland Baltimore, Baltimore, MD USA University of Maryland Baltimore, Baltimore, MD USA University of Maryland Baltimore, Baltimore, MD USA University of Maryland Baltimore, Baltimore, MD USA University of Maryland Baltimore, Baltimore, MD USA Focused Ultrasound Foundation, Charlottesville, VA USA InSightec Ltd, Tirat Carmel, Israel Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Korea Institute of Science and Technology, Seoul, Republic of Korea Korea Institute of Science and Technology, Seoul, Republic of Korea Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Stanford University, Stanford, CA USA Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA USA Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA Severance Hospital, Yonsei University, Seoul, Republic of Korea Severance Hospital, Yonsei University, Seoul, Republic of Korea Severance Hospital, Yonsei University, Seoul, Republic of Korea Severance Hospital, Yonsei University, Seoul, Republic of Korea Severance Hospital, Yonsei University, Seoul, Republic of Korea Severance Hospital, Yonsei University, Seoul, Republic of Korea YUMC Severance Hospital, Seoul, Republic of Korea Thunder Bay Regional Research Institute, Thunder Bay, ON Canada Sunnybrook Health Sciences Centre, Toronto, ON Canada Technion ‚Äì Israel Institute of Technology, Haifa, Israel Technion ‚Äì Israel Institute of Technology, Haifa, Israel Technion ‚Äì Israel Institute of Technology, Haifa, Israel Technion ‚Äì Israel Institute of Technology, Haifa, Israel Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA Focused Ultrasound Foundation, Charlottesville, VA USA University of Washington, Seattle, WA USA Moscow State University, Moscow, Russian Federation University of Washington, Seattle, WA USA InSightec Ltd, Tirat Carmel, Israel Technion - Israel Institute of Technology, Haifa, Israel Technion - Israel Institute of Technology, Haifa, Israel Technion - Israel Institute of Technology, Haifa, Israel InSightec Ltd, Tirat Carmel, Israel InSightec Ltd, Tirat Carmel, Israel Technion - Israel Institute of Technology, Haifa, Israel Technion - Israel Institute of Technology, Haifa, Israel Technion - Israel Institute of Technology, Haifa, Israel University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA Georgia Institute of Technology, Atlanta, GA USA Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA USA Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA USA Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA USA Brigham and Women‚Äôs Hospital, Boston, MA USA Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada The Institute for Diagnostic Imaging Research, Windsor, ON Canada Hospital for Sick Children, Toronto, ON Canada Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada The Institute for Diagnostic Imaging Research, Windsor, ON Canada Thunder Bay Regional Research Institute, Thunder Bay, ON Canada Hospital for Sick Children, Toronto, ON Canada Northeastern University, Boston, MA USA Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA USA Harvard Medical School, Boston, MA USA Coprenicus Therapeutics, Inc., Cleveland, OH USA Coprenicus Therapeutics, Inc., Cleveland, OH USA Coprenicus Therapeutics, Inc., Cleveland, OH USA Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA USA Northeastern University, Boston, MA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands Celsion Corporation, Lawrenceville, NJ USA Utrecht University, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands National Institutes of Health, Bethesda, MD USA National Institutes of Health, Bethesda, MD USA The Sheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC USA National Institutes of Health, Bethesda, MD USA Philips, Bethesda, MD USA Children‚Äôs National Health System, Washington, DC USA Children‚Äôs National Health System, Washington, DC USA National Institutes of Health, Bethesda, MD USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA University of California Davis, Davis, CA USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA Fox Chase Cancer Center, Philadelphia, PA USA Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany University of Dundee, Dundee, UK Fraunhofer MEVIS, Bremen, Germany Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan Taipei Medical University Healthcare System, Taipei, Taiwan University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA Shanghai A&S Science Technology Development Co., LTD., Shanghai, China Shanghai A&S Science Technology Development Co., LTD., Shanghai, China IMSAT, Dundee, UK University of Dundee, Dundee, UK Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany InSightec Ltd, Tirat Carmel, Israel Fraunhofer MEVIS, Bremen, Germany University of Dundee, Dundee, UK IMSAT, Dundee, UK Fraunhofer MEVIS, Bremen, Germany University of Dundee, Dundee, UK University of Dundee - FUTURA, Dundee, UK Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany NHS, Dundee, UK GE Medical Systems Israel Ltd., Tirat Carmel, Israel Fraunhofer MEVIS, Bremen, Germany University of Dundee, Dundee, UK University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands Islamic Azad University, Science and Research Branch, Tehran, Iran Islamic Azad University, Science and Research Branch, Tehran, Iran Islamic Azad University, Science and Research Branch, Tehran, Iran Islamic Azad University, Science and Research Branch, Tehran, Iran Iran University of Medical Sciences, Tehran, Iran University of Southern California Los Angeles, Los Angeles, CA USA Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany ETH Zurich, Computer Vision Laboratory, Zurich, Switzerland Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Fraunhofer MEVIS, Bremen, Germany Stiftelsen SINTEF, Trondheim, Norway Fraunhofer MEVIS, Bremen, Germany Stiftelsen SINTEF, Trondheim, Norway Fraunhofer MEVIS, Bremen, Germany University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands SRH Wald-Klinikum Gera, Gera, Germany Institute of Diagnostic and Interventional Radiology, Friedrich Schiller University, Jena, Germany Institute of Animal Experimentation, Friedrich Schiller University, Jena, Germany SRH Wald-Klinikum Gera, Gera, Germany University of Rome ‚Äì La Sapienza, Rome, Italy Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Philips Healthcare Canada, Toronto, ON Canada Centre for Image Guided Innovation and Therapeutic Intervention, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada Hospital for Sick Children, Toronto, ON Canada National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA National Institutes of Health Clinical Center, Bethesda, MD USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA Radboud University Medical Center, Nijmegen, Netherlands Radboud University Medical Center, Nijmegen, Netherlands Radboud University Medical Center, Nijmegen, Netherlands Radboud University Medical Center, Nijmegen, Netherlands Radboud University Medical Center, Nijmegen, Netherlands Radboud University Medical Center, Nijmegen, Netherlands Radboud University Medical Center, Nijmegen, Netherlands Virginia Tech, Blacksburg, VA USA Duke University, Durham, NC USA Duke University, Durham, NC USA University of Dundee - FUTURA, Dundee, UK University of Dundee, Dundee, UK University of Dundee, Dundee, UK University of Dundee, Dundee, UK University of Texas Southwestern Medical Center, Dallas, TX USA Philips Research, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Oklahoma Health Sciences Center, Oklahoma City, OK USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA Philips Research, Dallas, TX USA Philips Research, Dallas, TX USA Sheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA Children‚Äôs National Health System, Washington, DC USA Texas Scottish Rite Hospital for Children, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of Texas Southwestern Medical Center, Dallas, TX USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, Sunnyvale, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, Napa, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA University of California San Francisco, San Francisco, CA USA Memorial Sloan-Kettering Cancer Center, New York, NY USA Memorial Sloan-Kettering Cancer Center, New York, NY USA Memorial Sloan-Kettering Cancer Center, New York, NY USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Stanford University, Stanford, CA USA University of Virginia, Charlottesville, VA USA Promedica Bioelectronics SRL, Rome, Italy Promedica Bioelectronics SRL, Rome, Italy Promedica Bioelectronics SRL, Rome, Italy Promedica Bioelectronics SRL, Rome, Italy Promedica Bioelectronics SRL, Rome, Italy University of Virginia, Charlottesville, VA USA FUS Mobile Inc., Alpharetta, GA USA University of Virginia, Charlottesville, VA USA Institut Langevin Ondes et Images, ESPCI ParisTech, CNRS UMR 7587, INSERM U979, Paris, France Children‚Äôs National Health System, Washington, DC USA National Institutes of Health, Bethesda, MD USA Philips, Bethesda, MD USA Children‚Äôs National Health System, Washington, DC USA The Sheikh Zayed Institute for Pediatric Surgical Innovation, Washington, DC USA National Institutes of Health, Bethesda, MD USA Children‚Äôs National Health System, Washington, DC USA National Institutes of Health, Bethesda, MD USA Washington University in Saint Louis, Saint Louis, MO USA Children‚Äôs National Health System, Washington, DC USA National Institutes of Health, Bethesda, MD USA Children‚Äôs National Health System, Washington, DC USA National Institutes of Health, Bethesda, MD USA Children‚Äôs National Health System, Washington, DC USA Washington University in Saint Louis, Saint Louis, MO USA National Institutes of Health, Bethesda, MD USA Philips, Bethesda, MD USA Seoul National University Bundang Hospital, Seongnam, Republic of Korea Sogang University, Seoul, Republic of Korea Sogang University, Seoul, Republic of Korea Sogang University, Seoul, Republic of Korea Sogang University, Seoul, Republic of Korea Seoul National University Bundang Hospital, Seongnam, Republic of Korea Hokkaido University, Sapporo, Hokkaido Japan Hokkaido University, Sapporo, Hokkaido Japan Uniklinik Koeln, Cologne, Germany Eindhoven University of Technology, Eindhoven, Netherlands Eindhoven University of Technology, Eindhoven, Netherlands Eindhoven University of Technology, Eindhoven, Netherlands Philips Research, Eindhoven, Netherlands Eindhoven University of Technology, Eindhoven, Netherlands Fraunhofer MEVIS, Bremen, Germany Philips Research, Eindhoven, Netherlands Philips Research, Eindhoven, Netherlands Philips Research, Eindhoven, Netherlands Univerisity of Dundee, Dundee, UK Thunder Bay Regional Research Institute, Thunder Bay, ON Canada Thunder Bay Regional Research Institute, Thunder Bay, ON Canada Thunder Bay Regional Research Institute, Thunder Bay, ON Canada University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands IMASONIC SAS, Voray sur l‚ÄôOgnon, France University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University Medical Center ‚Äì Utrecht, Utrecht, Netherlands University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of California Berkeley, Berkeley, CA USA University of California Berkeley, Berkeley, CA USA University of California Berkeley, Berkeley, CA USA Stanford University, Stanford, CA USA University of California Berkeley, Berkeley, CA USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA University of Utah, Salt Lake City, UT USA},
note  = {J Ther Ultrasound. 2016 Nov 21;4(Suppl 1):1-113. doi:10.1186/s40349-016-0076-5.}
}

@Article{201664,
author  = {Teo, W. and Muthalib, M. and Yamin, S. and Hendy, A. and Bramstedt, K. and Kotsopoulos, E. and Perrey, S. and Ayaz, H.},
title  = {Literature.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {In the last decade, virtual reality (VR) training has been used extensively in video games and military training to provide a sense of realism and environmental interaction to its users. More recently, VR training has been explored as a possible adjunct therapy for people with motor and mental health dysfunctions. The concept underlying VR therapy as a treatment for motor and cognitive dysfunction is to improve neuroplasticity of the brain by engaging users in multisensory training. In this review, we discuss the theoretical framework underlying the use of VR as a therapeutic intervention for neurorehabilitation and provide evidence for its use in treating motor and mental disorders such as cerebral palsy, Parkinson‚Äôs disease, stroke, schizophrenia, anxiety disorders, and other related clinical areas. While this review provides some insights into the efficacy of VR in clinical rehabilitation and its complimentary use with neuroimaging (e.g., fNIRS and EEG) and neuromodulation (e.g., tDCS and rTMS), more research is needed to understand how different clinical conditions are affected by VR therapies (e.g., stimulus presentation, interactivity, control and types of VR). Future studies should consider large, longitudinal randomized controlled trials to determine the true potential of VR therapies in various clinical populations.},
address  = {Institute for Physical Activity and Nutrition (IPAN), Deakin University, BurwoodVIC, Australia EuroMov, University of MontpellierMontpellier, France Liminal Pty Ltd., MelbourneVIC, Australia School of Exercise and Nutrition Sciences, Deakin University, BurwoodVIC, Australia Liminal Pty Ltd., MelbourneVIC, Australia Liminal Pty Ltd., MelbourneVIC, Australia EuroMov, University of MontpellierMontpellier, France School of Biomedical Engineering, Science and Health Systems, Drexel University,  PhiladelphiaPA, USA},
note  = {Front Hum Neurosci. 2016 Jun 24;10:. doi:10.3389/fnhum.2016.00284.}
}

@Article{201665,
author  = {Iorfino, F. and Hickie, I. and Lee, R. and Lagopoulos, J. and Hermens, D.},
title  = {and anxiety disorders: a systematic review.},
journal  = {BMC Psychiatry},
volume  = {16},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Mood and anxiety disorders are leading causes of disability and mortality, due largely to their onset during adolescence and young adulthood and  broader impact on functioning. Key factors that are associated with disability and these disorders in young people are social and economic participation (e.g. education, employment), physical health, suicide and self-harm behaviours, and alcohol and substance use. A better understanding of the objective markers (i.e.  neurobiological parameters) associated with these factors is important for the development of effective early interventions that reduce the impact of disability and illness persistence. Methods: We systematically reviewed the literature for neurobiological parameters (i.e. neuropsychology, neuroimaging, sleep-wake and circadian biology, neurophysiology and metabolic measures) associated with functional domains in young people (12 to 30 years) with mood and/or anxiety disorders. Results: Of the one hundred and thirty-four studies selected, 7.6¬†% investigated social and economic participation, 2.1¬†% physical health, 15.3¬†% suicide and self-harm behaviours, 6.9¬†% alcohol and substance use, whereas the majority (68.1¬†%) focussed on clinical syndrome. Conclusions: Despite the predominance of studies that solely examine the clinical syndrome of young people the literature also provides evidence of distinct associations among objective measures (indexing various aspects of brain circuitry) and other functional domains. We suggest that a shift in focus towards characterising the mechanisms that underlie and/or mediate multiple functional domains will optimise personalised interventions and improve illness trajectories.},
address  = {Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet Street, Camperdown, NSW 2050 Australia Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet Street, Camperdown, NSW 2050 Australia Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet Street, Camperdown, NSW 2050 Australia Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet Street, Camperdown, NSW 2050 Australia Clinical Research Unit, Brain and Mind Centre, University of Sydney, 94 Mallet Street, Camperdown, NSW 2050 Australia},
note  = {BMC Psychiatry. 2016 May 23;16:. doi:10.1186/s12888-016-0852-3.}
}

@Article{201666,
author  = {Abraham, J. and Golubnitschaja, O. and Akhmetov, I. and Andrews, R. and Quintana, L. and Andrews, R. and Baban, B. and Liu, J. and Qin, X. and Wang, T. and Mozaffari, M. and Bati, V. and Meleshko, T. and Levchuk, O. and Boyko, N. and Bauer, J. and Boerner, E. and Podbielska, H. and Bomba, A. and Petrov, V. and Drobnych, V. and Bubnov, R. and Bykova, O. and Boyko, N. and Brunner-La, R. and Fleischhacker, L. and Golubnitschaja, O. and Heemskerk, F. and Helms, T. and Jaarsma, T. and Kinkorov√°, J. and Ramaekers, J. and Ruff, P. and Schnur, I. and Vanoli, E. and Verdu, J. and Brunner-La, R. and Bubnov, R. and Grabovetskyi, S. and Mykhalchenko, O. and Tymoshok, N. and Shcherbakov, O. and Semeniv, I. and Spivak, M. and Bubnov, R. and Ostapenko, T. and Bubnov, R. and Kobyliak, N. and Zholobak, N. and Spivak, M. and Cauchi, J. and Cherepakhin, D. and Bakay, M. and Borovikov, A. and Suchkov, S. and Cie≈õlik, B. and Migasiewicz, A. and Podbielska, M. and Pelleter, M. and Giemza, A. and Podbielska, H. and Cirak, S. and Del, R. and Bordi, P. and Citi, V. and Palombi, M. and Pinto, C. and Tiseo, M. and Danesi, R. and Einhorn, L. and Fazekas, J. and Muhr, M. and Schoos, A. and Panakova, L. and Herrmann, I. and Manzano-Szalai, K. and Oida, K. and Fiebiger, E. and Singer, J. and Jensen-Jarolim, E. and Elnar, A. and Ouamara, N. and Boyko, N. and Coumoul, X. and Antignac, J. and Le, B. and Eppe, G. and Renaut, J. and Bonn, T. and Guignard, C. and Ferrante, M. and Chiusano, M. and Cuzzocrea, S. and O‚ÄôKeeffe, G. and Cryan, J. and Bisson, M. and Barakat, A. and Hmamouchi, I. and Zawia, N. and Kanthasamy, A. and Kisby, G. and Alves, R. and P√©rez, O. and Burgard, K. and Spencer, P. and Bomba, N. and Haranta, M. and Zaitseva, N. and May, I. and Grojean, S. and Body-Malapel, M. and Harari, F. and Harari, R. and Yeghiazaryan, K. and Golubnitschaja, O. and Calabrese, V. and Nemos, C. and Soulimani, R. and Evsevyeva, M. and Mishenko, E. and Kumukova, Z. and Chudnovsky, E. and Smirnova, T. and Evsevyeva, M. and Ivanova, L. and Eremin, M. and Rostovtseva, M. and Evsevyeva, M. and Eremin, M. and Koshel, V. and Sergeeva, O. and Konovalova, N. and Girotra, S. and Golubnitschaja, O. and Golubnitschaja, O. and Debald, M. and Kuhn, W. and Yeghiazaryan, K. and Bubnov, R. and Goncharenko, V. and Lushchyk, U. and Grech, G. and Konieczka, K. and Golubnitschaja, O. and Erwich, J. and Costigliola, V. and Yeghiazaryan, K. and Gembruch, U. and Goncharenko, V. and Beniuk, V. and Kalenska, O. and Bubnov, R. and Goncharenko, V. and Beniuk, V. and Bubnov, R. and Melnychuk, O. and Gorbacheva, I. and Orekhova, L. and Tachalov, V. and Grechanyk, O. and Abdullaiev, R. and Bubnov, R. and Hagan, S. and Martin, E. and Pearce, I. and Oliver, K. and Haytac, C. and Salimov, F. and Yoksul, S. and Kunin, A. and Moiseeva, N. and Herrera-Imbroda, B. and del, R. and Lara, M. and Angulo, A. and Machuca, S. and Herrera-Imbroda, B. and del, R. and Lara, M. and Ionescu, J. and Isamulaeva, A. and Kunin, A. and Magomedov, S. and Isamulaeva, A. and Josifova, T. and Kapalla, M. and Kub√°≈à, J. and Golubnitschaja, O. and Costigliola, V. and Costigliola, V. and Kapalla, M. and Kub√°≈à, J. and Golubnitschaja, O. and Kent, A. and Fisher, T. and Dias, T. and Kinkorov√°, J. and Topolƒ?an, O. and Kohl, M. and Kunin, A. and Moiseeva, N. and Kurchenko, A. and Beniuk, V. and Goncharenko, V. and Bubnov, R. and Boyko, N. and Strokan, A. and Kzhyshkowska, J. and Gudima, A. and Stankevich, K. and Filimonov, V. and Kl√ºter, H. and Mamontova, E. and Tverdokhlebov, S. and Lushchyk, U. and Novytskyy, V. and Babii, I. and Lushchyk, N. and Riabets, L. and Legka, I. and Marcus-Kalish, M. and Mitelpunkt, A. and Galili, T. and Shachar, N. and Benjamini, Y. and Migasiewicz, A. and Pelleter, M. and Bauer, J. and Dere≈Ñ, E. and Podbielska, H. and Moiseeva, N. and Kunin, A. and Kunin, D. and Moiseeva, N. and Ippolitov, Y. and Kunin, D. and Morozov, A. and Chirkova, N. and Aliev, N. and Mozaffari, M. and Liu, J. and Baban, B. and Mozaffari, M. and Liu, J. and Abdelsayed, R. and Shi, X. and Baban, B. and Nov√°k, J. and ≈†tork, M. and Zeman, V. and Oosterhuis, W. and Theodorsson, E. and Orekhova, L. and Kudryavtseva, T. and Isaeva, E. and Tachalov, V. and Loboda, E. and Pazzagli, M. and Malentacchi, F. and Mancini, I. and Brandslund, I. and Vermeersch, P. and Schwab, M. and Marc, J. and van, S. and Siest, G. and Theodorsson, E. and Di, R. and Pleva, M. and Juhar, J. and Pleva, M. and Juhar, J. and Pol√≠vka, j. and Jank≈Ø, F. and Pe≈°ta, M. and Dole≈æal, J. and Kr√°l√≠ƒ?kov√°, M. and Pol√≠vka, J. and Pol√≠vka, J. and Luke≈°ov√°, A. and M√ºllerov√°, N. and ≈†evƒ?√≠k, P. and Rohan, V. and Richter, K. and Miloseva, L. and Niklewski, G. and Richter, K. and Acker, J. and Niklewski, G. and Safonicheva, O. and Costigliola, V. and Safonicheva, O. and Sautin, M. and Sinelnikova, J. and Suchkov, S. and Secer, S. and von, B. and Shapira, N. and Shcherbakov, A. and Kunin, A. and Moiseeva, N. and Shumilovich, B. and Lipkind, Z. and Vorobieva, Y. and Kunin, D. and Sudareva, A. and Smokovski, I. and Milenkovic, T. and Sol√≠s-Herrera, A. and Arias-Esparza, M. and Suchkov, S. and Sridhar, K. and Golubnitschaja, O. and Studneva, M. and Song, S. and Creeden, J. and –úandrik, –. and Suchkov, S. and Theodorsson, E. and Tofail, S. and Topolƒ?an, O. and Kinkorov√°, J. and Fiala, O. and Karl√≠kov√°, M. and Svobodov√°, ≈. and Kuƒ?era, R. and Fuchsov√°, R. and T≈ôe≈°ka, V. and ≈†im√°nek, V. and Pecen, L. and ≈†oupal, J. and Svaƒ?ina, ≈. and Tretyak, E. and Studneva, M. and Suchkov, S. and Trovato, F. and Martines, G. and Brischetto, D. and Catalano, D. and Musumeci, G. and Trovato, G. and Tsangaris, G. and Anagnostopoulos, A. and Tsangaris, G. and Anagnostopoulos, A. and Verd√∫, J. and Guti√©rrez, G. and Rovira, J. and Martinez, M. and Fleischhacker, L. and Green, D. and Garson, A. and Tamburini, E. and Cuomo, S. and Martinez-Leon, J. and Abrisqueta, T. and Brunner-La, R. and Jaarsma, T. and Arredondo, T. and Vera, C. and Fico, G. and Golubnitschaja, O. and Arribas, F. and Onderco, M. and Vara, I. and Verd√∫, J. and Sambo, F. and Di, C. and Cobelli, C. and Facchinetti, A. and Fico, G. and Bellazzi, R. and Sacchi, L. and Dagliati, A. and Segnani, D. and Tibollo, V. and Ottaviano, M. and Gabriel, R. and Groop, L. and Postma, J. and Martinez, A. and Hakaste, L. and Tuomi, T. and Zarkogianni, K. and Volchek, I. and Pototskaya, N. and Petrov, A. and Volchek, I. and Pototskaya, N. and Petrov, A. and Voog-Oras, √. and Jagur, O. and Leibur, E. and Niibo, P. and Jagom√§gi, T. and Nguyen, M. and Pruunsild, C. and Piikov, D. and Saag, M. and Wang, W. and Wang, W. and Weinh√§usel, A. and Pulverer, W. and Wielscher, M. and Hofner, M. and Noehammer, C. and Soldo, R. and Hettegger, P. and Gyurjan, I. and Kulovics, R. and Sch√∂nthaler, S. and Beikircher, G. and Kriegner, A. and Pabinger, S. and Vierlinger, K. and Y√ºzba≈üƒ±oƒülu, A. and √ñzg√º√ß, M.},
title  = {EPMA-World Congress 2015: Bonn, Germany. 3-5 September 2015.},
journal  = {The EPMA Journal},
volume  = {7},
number  = {Suppl 1},
pages  = {},
year  = {2016},
abstract  = {A1 Predictive and prognostic biomarker panel for targeted application of radioembolisation improving individual outcomes in hepatocellular carcinomaJella-Andrea Abraham, Olga GolubnitschajaA2 Integrated market access approach amplifying value of ‚ÄúRx-CDx‚Ä?Ildar AkhmetovA3 Disaster response: an opportunity to improve global healthcareRussell J. Andrews, Leonidas QuintanaA4 USA PPPM: proscriptive, profligate, profiteering medicine-good for 1¬†% wealthy, not for 99¬†% unhealthyRussell J. AndrewsA5 The role of IDO in a murine model of gingivitis: predictive and therapeutic potentialsBabak Baban, Jun Yao Liu, Xu Qin, Tailing Wang, Mahmood S. MozaffariA6 Specific diets for personalised treatment of diabetes type 2Viktoriia V. Bati, Tamara V. Meleshko, Olga B. Levchuk, Nadiya V. BoykoA7 Towards personalized physiotherapeutic approachJoanna  Bauer, Ewa Boerner, Halina PodbielskaA8 Cells, animal, SHIME and in silico models for detection and verification of specific biomarkers of non-communicable chronic diseasesAlojz Bomba, Viktor O. Petrov, Volodymyr G. Drobnych, Rostyslav V. Bubnov, Oksana M. Bykova, Nadiya V. BoykoA9 INTERACT-chronic care model: Self-treatment by patients with decision support e-Health solutionHans-Peter Brunner-La Rocca, Lutz Fleischhacker, Olga Golubnitschaja, Frank Heemskerk, Thomas Helms, Tiny Jaarsma, Judita Kinkorova, Jan Ramaekers, Peter Ruff, Ivana Schnur, Emilio Vanoli, Jose VerduA10 PPPM in cardiovascular medicine in 2015Hans-Peter Brunner-La RoccaA11 Magnetic resonance imaging of nanoparticles in mice, potential for theranostic and contrast media development ‚Äì pilot resultsRostyslav V. Bubnov, Sergiy A. Grabovetskyi, Olena M. Mykhalchenko, Natalia O. Tymoshok, Oleksandr B. Shcherbakov, Igor P. Semeniv, Mykola Y. SpivakA12 Ultrasound diagnosis for diabetic neuropathy - comparative studyRostyslav V. Bubnov, Tetyana V. OstapenkoA13 Ultrasound for stratification patients with diabetic foot ulcers for prevention and personalized treatment - pilot resultsRostyslav V. Bubnov, Nazarii M. Kobyliak, Nadiya M. Zholobak, Mykola Ya. SpivakA14 Project ImaGenX ‚Äì designing and executing a questionnaire on environment and lifestyle risk of breast cancerJohn Paul CauchiA15 Genomics ‚Äì a new structural brand of predictive, preventive and personalized medicine or the new driver as well?Dmitrii Cherepakhin, Marina Bakay, Artem Borovikov, Sergey SuchkovA16 Survey of questionnaires for evaluation of the quality of life in various medical fieldsBarbara Cie≈õlik, Agnieszka Migasiewicz, Maria-Luiza Podbielska, Markus Pelleter, Agnieszka Giemza, Halina PodbielskaA17 Personalized  molecular treatment for muscular dystrophiesSebahattin CirakA18 Secondary mutations in circulating tumour DNA for acquired drug resistance in patients with advanced ALK‚Äâ+‚ÄâNSCLCMarzia Del Re, Paola Bordi, Valentina Citi, Marta Palombi, Carmine Pinto, Marcello Tiseo, Romano DanesiA19 Recombinant species-specific FcŒµRI alpha proteins for diagnosis of IgE-mediated allergies in dogs, cats and horsesLukas Einhorn, Judit Fazekas, Martina Muhr, Alexandra Schoos, Lucia Panakova, Ina Herrmann, Krisztina Manzano-Szalai, Kumiko Oida, Edda Fiebiger, Josef Singer, Erika Jensen-JarolimA20 Global methodology for developmental neurotoxicity testing in humans and animals early and chronically exposed to chemical contaminantsArpin√© A. Elnar, Nadia Ouamara, Nadiya Boyko, Xavier Coumoul, Jean-Philippe Antignac, Bruno Le Bizec, Gauthier Eppe, Jenny Renaut, Torsten Bonn, C√©dric Guignard, Margherita Ferrante, Maria Liusa Chiusano, Salvatore Cuzzocrea, Gerard O'Keeffe, John Cryan, Michelle Bisson, Amina Barakat, Ihsane Hmamouchi, Nasser Zawia, Anumantha Kanthasamy, Glen E. Kisby, Rui Alves, Oscar Villaca√±as P√©rez, Kim Burgard, Peter Spencer, Norbert Bomba, Martin Haranta, Nina Zaitseva, Irina May, St√©phanie Grojean, Mathilde Body-Malapel, Florencia Harari, Raul Harari, Kristina Yeghiazaryan, Olga Golubnitschaja, Vittorio Calabrese, Christophe Nemos, Rachid SoulimaniA21 Mental indicators at young people with attributes hypertension and pre-hypertensionMaria E. Evsevyeva, Elena A. Mishenko, Zurida V. Kumukova, Evgeniy V. Chudnovsky, Tatyana A. SmirnovaA22 On the approaches to the early diagnosis of stress-induced hypertension in young employees of State law enforcement agenciesMaria E. Evsevyeva, Ludmila V. Ivanova, Michail V. Eremin, Maria V. RostovtsevaA23 –°entral aortic pressure and indexes of augmentation in young persons in view of risk factorsMaria E. Evsevyeva, Michail V. Eremin, Vladimir I. Koshel, Oksana V. Sergeeva, Nadesgda M. KonovalovaA24 Breast cancer prediction and prevention: Are  reliable biomarkers in horizon?Shantanu Girotra, Olga GolubnitschajaA25 Flammer Syndrome and potential formation of pre-metastatic niches: A multi-centred study  on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic diseaseOlga Golubnitschaja, Manuel Debald, Walther Kuhn, Kristina Yeghiazaryan, Rostyslav V. Bubnov, Vadym M. Goncharenko, Ulyana Lushchyk, Godfrey Grech, Katarzyna KonieczkaA26 Innovative tools for prenatal diagnostics and monitoring: improving individual pregnancy outcomes and health-economy in EUOlga Golubnitschaja, Jan Jaap Erwich, Vincenzo Costigliola, Kristina Yeghiazaryan, Ulrich GembruchA27 Immunohistochemical assessment of APUD cells in endometriosisVadym M. Goncharenko, Vasyl O. Beniuk, Olga V. Kalenska, Rostyslav V. BubnovA28 Updating personalized management algorithm of endometrial hyperplasia in pre-menopause womenVadym M. Goncharenko,  Vasyl O. Beniuk, Rostyslav V. Bubnov, Olga MelnychukA29 The personified treatment approach of polimorbid patients with periodontal inflammatory diseasesIrina A. Gorbacheva, Lyudmila Y. Orekhova, Vadim V. TachalovA30 Ukrainian experience in hybrid war ‚Äì the challenge to update algorithms for personalized care and early prevention of different military injuriesOlena I. Grechanyk, Rizvan Ya. Abdullaiev, Rostyslav V. BubnovA31 Tear fluid biomarkers: a comparison of tear fluid sampling and storage protocolsSuzanne Hagan, Eilidh Martin, Ian Pearce, Katherine OliverA32 The correlation of dietary habits with gingival problems during menstruationCenk Haytac, Fariz Salimov, Servin Yoksul, Anatoly A. Kunin, Natalia S. MoiseevaA33 Genomic medicine in a contemporary Spanish population of prostate cancer: our experienceBernardo Herrera-Imbroda, Sergio del R√≠o-Gonz√°lez, Maria Fernanda Lara, Antonia Angulo, Francisco Javier Machuca Santa-CruzA34 Challenges, opportunities and collaborations for personalized medicine applicability in uro-oncological diseaseBernardo Herrera-Imbroda, Sergio del R√≠o-Gonz√°lez, Maria Fernanda LaraA35 Metabolic hallmarks of cancer as targets for a personalized therapyJohn IonescuA36 Influence of genetic polymorphism as a predictor of the development of periodontal disease in patients with gastric ulcer and 12 duodenal ulcerAlfiya Z. Isamulaeva, Anatoly A. Kunin, Shamil Sh. Magomedov, Aida I. IsamulaevaA37 Challenges in diabetic macular edemaTatjana JosifovaA38 Overview of the EPMA strategies in laboratory medicine relevant for PPPMMarko Kapalla, Juraj Kub√°≈à, Olga Golubnitschaja, Vincenzo CostigliolaA39 EPMA initiative for effective organization of medical travel: European concepts and criteriaVincenzo Costigliola, Marko Kapalla, Juraj Kub√°≈à, Olga GolubnitschajaA40  Design and innovation in e-textiles: implications for PPPMAnthony Kent, Tom Fisher, Tilak DiasA41 Biobank in Pilsen as a member of national node BBMRI_CZJudita Kinkorov√°, Ond≈ôej Topolƒ?anA42 Big data in personalized medicine: hype and hopeMatthias KohlA43 The 3P approach as the platform of the European Dentistry Department (DPPPD)Anatoly A. Kunin, Natalia S. MoiseevaA44 The endometrium cytokine patterns for predictive diagnosis of proliferation severity  and cancer preventionAndrii I. Kurchenko, Vasyl A. Beniuk, Vadym M. Goncharenko,  Rostyslav V. Bubnov, Nadiya V. Boyko, Andriy M. StrokanA45 A monocyte-based in-vitro system for testing individual responses to the implanted material: future for personalized implant constructionJulia Kzhyshkowska, Alexandru Gudima, Ksenia S. Stankevich, Victor D. Filimonov4, Harald Kl√ºter, Evgeniya M. Mamontova, Sergei I. TverdokhlebovA46 Prediction and prevention of adverse health effects by meteorological factors: Biomarker patterns and creation of a device for self-monitoring and integrated careUlyana B. Lushchyk, Viktor V. Novytskyy, Igor  P. Babii, Nadiya G. Lushchyk, Lyudmyla S. Riabets, Ivanna I. LegkaA47 Targeting "disease signatures" towards personalized healthcareMira Marcus-Kalish, Alexis Mitelpunkt, Tal Galili, Neta Shachar, Yoav BenjaminiA48 Influence of the skin imperfection on the personal quality of life and possible tools for objective diagnosisAgnieszka Migasiewicz, Markus Pelleter, Joanna Bauer, Ewelina Dere≈Ñ, Halina PodbielskaA49 The new direction in caries prevention based on the ultrastructure of dental hard tissues and filling materialsNatalia S. Moiseeva, Anatoly A. Kunin, Dmitry A. KuninA50 The use of LED radiation in prevention of dental diseasesNatalia S. Moiseeva, Yury A. Ippolitov, Dmitry A. Kunin, Alexei N. Morozov, Natalia V. Chirkova, Nakhid T. AlievA51 Status of endothelial progenitor cells in diabetic nephropathy: predictive and preventive potentialsMahmood S. Mozaffari, Jun Yao Liu, Babak BabanA52 The status of glucocorticoid-induced leucine zipper protein in salivary gland in Sj√∂gren‚Äôs syndrome: predictive and personalized treatment potentialsMahmood S. Mozaffari, Jun Yao Liu, Rafik Abdelsayed, Xing-Ming Shi, Babak BabanA53 Maximal aerobic capacity - important quality marker of healthJaroslav Nov√°k, Milan ≈†tork, V√°clav ZemanA54 The EMPOWER  project: laboratory medicine and Horizon 2020Wytze P. Oosterhuis, Elvar TheodorssonA55 Personality profile manifestations in patient‚Äôs attitude to oral care and adherence to doctor‚Äôs prescriptionsLyudmila Y. Orekhova, Tatyana V. Kudryavtseva, Elena R. Isaeva, Vadim V. Tachalov, Ekaterina S. LobodaA56 Results  of an European survey on personalized medicine addressed to directions of laboratory medicineMario Pazzagli, Francesca Malentacchi, Irene Mancini, Ivan Brandslund, Pieter Vermeersch, Matthias Schwab, Janja Marc, Ron H.N. van Schaik,  Gerard Siest, Elvar Theodorsson, Chiara Di RestaA57 MCI or early dementia predictive speech based diagnosis techniquesMatus Pleva, Jozef JuharA58 Personalized speech based mobile application for eHealthMatus Pleva, Jozef JuharA59 Circulating tumor cell-free DNA as the biomarker in the management of cancer patientsJi≈ô√≠ Pol√≠vka jr., Filip Jank≈Ø, Martin Pe≈°ta, Jan Dole≈æal, Milena Kr√°l√≠ƒ?kov√°, Ji≈ô√≠ Pol√≠vkaA60 Complex stroke care ‚Äì educational programme in Stroke Centre University Hospital PlzenJi≈ô√≠ Pol√≠vka, Alena Luke≈°ov√°, Nina M√ºllerov√°, Petr ≈†evƒ?√≠k, Vladim√≠r RohanA61 Sleep apnea and sleep fragmentation contribute to  brain agingKneginja Richter, Lence Miloseva, G√ºnter NiklewskiA62 Personalised approach for sleep disturbances in shift workersKneginja Richter, Jens Acker, Guenter NiklewskiA63 Medical travel and innovative PPPM clusters: new concept of  integrationOlga Safonicheva, Vincenzo CostigliolaA64 Medical travel and women healthOlga SafonichevaA65 Continuity of generations in the training of specialists in the field of reconstructive microsurgeryMaxim Sautin, Janna Sinelnikova, Sergey SuchkovA66 Telemonitoring of stroke patients ‚Äì empirical evidence of individual risk management results from an observational study in GermanySong√ºl Secer, Stephan von BandemerA67 Women‚Äôs increasing breast cancer risk with n-6 fatty acid intake explained by estrogen-fatty acid interactive effect on DNA damage: implications for gender-specific nutrition within personalized medicineNiva ShapiraA68 Cytobacterioscopy of the gingival crevicular fluid as a method for preventive diagnosis of periodontal diseasesAleksandr Shcherbakov, Anatoly A. Kunin, Natalia S. MoiseevaA69 Use of specially treated composites in dentistry to avoid violations of aestheticsBogdan R. Shumilovich, Zhanna Lipkind, Yulia Vorobieva, Dmitry A. Kunin, Anastasiia V. SudarevaA70 National eHealth system ‚Äì platform for preventive, predictive and personalized diabetes careIvica Smokovski, Tatjana MilenkovicA72 The common energy levels of Prof. Szent-Gy√∂rgyi, the intrinsic chemistry of melanin, and the muscle physiopathology. Implications in the context of Preventive, Predictive, and Personalized MedicineArturo Sol√≠s-Herrera, Mar√≠a del Carmen Arias-Esparza, Sergey SuchkovA73 Plurality and individuality of hepatocellular carcinoma: PPPM perspectivesKrishna Chander Sridhar, Olga GolubnitschajaA74 Strategic aspects of  higher medical education reforms to secure newer educational platforms for getting biopharma professionals maturesMaria Studneva, Sihong Song, James Creeden, –úark –úandrik, Sergey SuchkovA75 Overview of the strategies and activities of the European Federation of Clinical Chemistry and Laboratory Medicine, (EFLM)Elvar Theodorsson, EFLMA76 New spectroscopic techniques for point of care label free diagnosticsSyed A. M. TofailA77 Tumor markers for personalized medicine and oncology - the role of Laboratory MedicineOnd≈ôej Topolƒ?an, Judita Kinkorov√°, Ond≈ôej Fiala, Marie Karl√≠kov√°, ≈†√°rka Svobodov√°, Radek Kuƒ?era, Radka Fuchsov√°, Vladislav T≈ôe≈°ka, V√°clav ≈†im√°nek, Ladislav Pecen, Jan ≈†oupal, ≈†tƒõp√°n Svaƒ?ina2A78 Modern medical terminology (MMT) as a driver of the global educational reformsEvgeniya Tretyak, Maria Studneva, Sergey SuchkovA79 Juvenile hypertension; the relevance of novel predictive, preventive and personalized assessment of its determinantsFrancesca M. Trovato, G. Fabio Martines, Daniela Brischetto, Daniela Catalano, Giuseppe Musumeci, Guglielmo M. TrovatoA80 Proteomarkers BiotechGeorge Th. Tsangaris, Athanasios K. AnagnostopoulosA81 Proteomics and mass spectrometry based non-invasive prenatal testing of fetal health and pregnancy complicationsGeorge Th. Tsangaris, Athanasios K. AnagnostopoulosA82 Integrated Ecosystem for an Integrated Care model for Heart Failure (HF) patients including related comorbidities (ZENITH)Jos√© Verd√∫, German  Guti√©rrez, Jordi Rovira, Marta Martinez, Lutz Fleischhacker, Donna Green, Arthur  Garson, Elena Tamburini, Stefano Cuomo, Juan Martinez-Leon, Teresa Abrisqueta, Hans-Peter Brunner-La Rocca, Tiny Jaarsma, Teresa Arredondo, Cecilia Vera, Giuseppe Fico, Olga Golubnitschaja, Fernando Arribas, Martina Onderco, Isabel Vara, on behalf of ZENITH consortiumA83 Predictive, preventive and personalized medicine in diabetes onset and complication (MOSAIC project)Jos√© Verd√∫, Francesco Sambo, Barbara Di Camillo, Claudio Cobelli, Andrea Facchinetti, Giuseppe Fico, Riccardo Bellazzi, Lucia Sacchi, Arianna Dagliati, Daniele Segnani, Valentina Tibollo, Manuel Ottaviano, Rafael Gabriel, Leif Groop, Jacqueline Postma, Antonio Martinez, Liisa Hakaste, Tiinamaija Tuomi, Konstantia Zarkogianni, on behalf of MOSAIC consortiumA84 Possibilities for personalized therapy of diabetes using in  vitro screening of insulin and oral hypoglycemic agentsIgor Volchek, Nina Pototskaya, Andrey PetrovA85 The innovative technology for personalized therapy of human diseases based on in vitro drug screeningIgor Volchek, Nadezhda Pototskaya, Andrey PetrovA86 Bone destruction and temporomandibular joint: predictive markers, pathogenetic aspects and quality of life√úlle Voog-Oras, Oksana Jagur, Edvitar Leibur, Priit Niibo, Triin Jagom√§gi, Minh Son Nguyen, Chris Pruunsild, Dagmar Piikov, Mare SaagA87 Sub-optimal health management ‚Äì global vision for concepts in medical travelWei WangA88 Sub-optimal health management: synergic PPPM-TCAM approachWei WangA89 Innovative technologies for minimal invasive diagnosticsAndreas Weinh√§usel, Walter Pulverer, Matthias Wielscher, Manuela Hofner, Christa Noehammer, Regina Soldo, Peter Hettegger, Istvan Gyurjan, Ronald Kulovics, Silvia Sch√∂nthaler, Gabriel Beikircher, Albert Kriegner, Stephan Pabinger, Klemens VierlingerA90 Rare disease diobanks for personalized medicineAy≈üe Y√ºzba≈üƒ±oƒülu, Meral √ñzg√º√ß, Member of EuroBioBank - European Network of DNA, Cell and Tissue Banks for Rare Diseases},
address  = {Department of Radiology, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn,  Germany Department of Radiology, University of Bonn, Sigmund-Freud-Str. 25, 53105, Bonn,  Germany Market Access at Unicorn, P.O.B. 91, Zhytomyr, 10020 Ukraine Nanotechnology & Smart Systems, NASA Ames Research Center, Moffett Field, CA USA Department of Neurosurgery, Valparaiso University Medical School, Valparaiso, Chile Nanotechnology & Smart Systems, NASA Ames Research Center, Moffett Field, CA USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Research, Developing and Training Centre of Molecular Microbiology and Mucosal Immunology, Uzhhorod National University, Uzhhorod, Ukraine Research, Developing and Training Centre of Molecular Microbiology and Mucosal Immunology, Uzhhorod National University, Uzhhorod, Ukraine Research, Developing and Training Centre of Molecular Microbiology and Mucosal Immunology, Uzhhorod National University, Uzhhorod, Ukraine Research, Developing and Training Centre of Molecular Microbiology and Mucosal Immunology, Uzhhorod National University, Uzhhorod, Ukraine Department of Biomedical Engineering, Wroclaw University of Technology, Wroclaw,  Poland Faculty of Physiotherapy, Wroc≈Çaw University School of Physical Education, Wroclaw, Poland Department of Biomedical Engineering, Wroclaw University of Technology, Wroclaw,  Poland Pavol Jozef ≈†af√°rik University, Ko≈°ice, Slovakia Uzhhorod National University, Uzhhorod, Ukraine Uzhhorod National University, Uzhhorod, Ukraine Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department, The Centre of Ultrasound Diagnostics and Interventional Sonography, Kyiv, Ukraine Association ‚ÄúHealth and Wealth‚Ä?, Kyiv, Ukraine Cassovia Life Science, Kysuck√© Nov√© Mesto, Slovakia Maastricht University Medical Centre, Maastricht, The Netherlands Fleischhacker GmbH, Schwerte, Germany The European Association for Predictive, Preventive and Personalised Medicine, Brussels, Belgium RIMS bvba, Overijse, Belgium German Foundation For the Chronically Ill, F√ºrth, Germany Link√∂ping University, Norrk√∂ping, Sweden Medical Faculty Pilsen, Pilsen, Czech Republic Sananet Care BV, Sittard, The Netherlands Exploris AG, Z√ºrich, Switzerland sense.ly, San Francisco, USA Mulimedica SPA, Milano, Italy Medtronic Iberica SA, Madrid, Spain Maastricht University Medical Centre, Maastricht, The Netherlands Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Zabolotny Str., 21, Kyiv, 03680 Ukraine Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Zabolotny Str., 21, Kyiv, 03680 Ukraine Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Zabolotny Str., 21, Kyiv, 03680 Ukraine Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 154, Zabolotny st., Kyiv, 03680 Ukraine Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 154, Zabolotny st., Kyiv, 03680 Ukraine Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Zabolotny Str., 21, Kyiv, 03680 Ukraine Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, 154, Zabolotny st., Kyiv, 03680 Ukraine Centre of Ultrasound Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department,  Zabolotny Str., 21, Kyiv, 03680 Ukraine Endocrinology centre, Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Zabolotny Str., 21, Kyiv, 03680 Ukraine Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine Bogomolets National Medical University, T. Shevchenko boulevard, 13, Kyiv, 01601  Ukraine Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine Department of Physiology and Biochemistry, University of Malta, Msida, Malta First Moscow State Medical University, Moscow, Russia The Children‚Äôs Hospital of Philadelphia, Philadelphia, USA First Moscow State Medical University, Moscow, Russia First Moscow State Medical University, Moscow, Russia Faculty of Physiotherapy, Wroclaw University School of Physical Education, Wroclaw, Poland Faculty of Physiotherapy, Wroclaw University School of Physical Education, Wroclaw, Poland Inwestasekur, Wroclaw, Poland VIANESSE AG, Research and Development, Engelberg, Switzerland VIANESSE AG, Research and Development, Engelberg, Switzerland Faculty of Physiotherapy, Wroclaw University School of Physical Education, Wroclaw, Poland Center for Molecular Medicine, University Hospital Cologne, Cologne, Germany Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Medical Oncology Unit, University Hospital of Parma, Parma, Italy Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Medical Oncology Unit, University Hospital of Parma, Parma, Italy Medical Oncology Unit, University Hospital of Parma, Parma, Italy Clinical Pharmacology and Pharmacogenetics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria Division of Gastroenterology and Nutrition, Boston Children‚Äôs Hospital and Department of Pediatrics, Harvard Medical School, Boston, USA Comparative Immunology and Oncology, Institute for Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria Comparative Medicine, Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University Vienna and University Vienna, Vienna, Austria Universit√© de Lorraine, Metz, France CHR Metz-Thionville, P√¥le m√®re-enfant, Metz, France Cassovia Life Sciences, Research and Innovation, Ko≈°ice, Slovakia Universit√© Paris Descartes, Paris, France Ecole Nationale V√©t√©rinaire, Agroalimentaire et de l‚ÄôAlimentation, Nantes, France Ecole Nationale V√©t√©rinaire, Agroalimentaire et de l‚ÄôAlimentation, Nantes, France Universit√© de Li√®ge, Li√®ge, Belgium Luxembourg Institute of Sciences and Technology, Belvaux, Luxembourg Luxembourg Institute of Sciences and Technology, Belvaux, Luxembourg Luxembourg Institute of Sciences and Technology, Belvaux, Luxembourg University of Catania, Catania, Italy University Federico II of Naples, Naples, Italy University of Messina, Messina, Italy University College Cork, Cork, Ireland University College Cork, Cork, Ireland Institut National de l‚ÄôEnvironnement Industriel et des Risques, Paris, France University Hospital, Rabat, Morocco University Hospital, Rabat, Morocco University of Rhodes Island, Rhodes Island, USA Iowa State University, Ames, IA USA Western University of Health Sciences, Oregon, USA Biomedical Research Institute of Lleida, Lleida, Catalunya Spain CEO - Owner at Intelligent Pharma, Barcelona, Spain Laboratoires R√©unis, Luxembourg, Luxembourg Oregon Health & Science University, Oregon, USA PAMIDA International, Kysuck√© Nov√© Mesto, Slovakia PAMIDA International, Kysuck√© Nov√© Mesto, Slovakia University of Perm, Perm, Russia University of Perm, Perm, Russia European Drug Development Hub, Nancy, France Universit√© de Lille II Droit et Sant√©, Lille, France Institute for Production and Work Environment Development, Quito, Ecuador Institute for Production and Work Environment Development, Quito, Ecuador European Association for Predictive and Personalised Medicine, Brussels, Belgium European Association for Predictive and Personalised Medicine, Brussels, Belgium University of Catania, Catania, Italy Universit√© de Lorraine, Metz, France Universit√© de Lorraine, Metz, France Stavropol State Medical University, Stavropol, Russia Stavropol State Medical University, Stavropol, Russia Stavropol State Medical University, Stavropol, Russia Stavropol State Medical University, Stavropol, Russia Stavropol State Medical University, Stavropol, Russia Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Stavropol State Medical University, Stavropol, Russian Federation Department of Radiology, University of Bonn, Bonn, Germany Department of Radiology, University of Bonn, Bonn, Germany Breast Cancer Research Centre, University of Bonn, Bonn, Germany Breast Cancer Research Centre, University of Bonn, Bonn, Germany Breast Cancer Research Centre, University of Bonn, Bonn, Germany Breast Cancer Research Centre, University of Bonn, Bonn, Germany Clinical hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Kyiv, Ukraine Clinical hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Kyiv, Ukraine Clinical hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Kyiv, Ukraine University of Malta, Msida, Malta Department of Ophthalmology, University of Basel, Basel, Switzerland Department of Radiology, University of Bonn, Bonn, Germany University Medical Center Groningen, Groningen, The Netherlands European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium Department of Radiology, University of Bonn, Bonn, Germany Department of Gynaecology and Obstetrics, University of Bonn, Bonn, Germany Clinical Hospital ‚ÄòPheophania‚Äô of State Affairs Department, Zabolotny str., 21, Kyiv, 03680 Ukraine Bogomolets National Medical University, Kyiv, 01601 Ukraine Clinical Hospital ‚ÄòPheophania‚Äô of State Affairs Department, Zabolotny str., 21, Kyiv, 03680 Ukraine Clinical Hospital ‚ÄòPheophania‚Äô of State Affairs Department, Zabolotny str., 21, Kyiv, 03680 Ukraine Bogomolets National Medical University, Kyiv, 01601 Ukraine Bogomolets National Medical University, Kyiv, 01601 Ukraine Clinical Hospital ‚ÄòPheophania‚Äô of State Affairs Department, Zabolotny str., 21, Kyiv, 03680 Ukraine Bogomolets National Medical University, Kyiv, 01601 Ukraine St. Petersburg Periodontal Center ‚ÄúPAKS‚Ä?, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia St. Petersburg Periodontal Center ‚ÄúPAKS‚Ä?, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia St. Petersburg Periodontal Center ‚ÄúPAKS‚Ä?, Pavlov First Saint Petersburg State Medical University, Saint Petersburg, Russia Main Ukrainian Military Clinical Hospital #17 in Kyiv, Gospitalna str., 18, Kyiv, Ukraine Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine Clinical Hospital ‚ÄúPheophania‚Ä? of State Affairs Department, Zabolotny Str., 21, Kyiv, 03680 Ukraine Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland UK Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland UK Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland UK Vision Sciences, School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland UK Cukurova University, Faculty of Dentistry, Adana, Turkey Cukurova University, Faculty of Dentistry, Adana, Turkey Cukurova University, Faculty of Dentistry, Adana, Turkey Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Intercenter Urology Unit, Virgen de la Victoria University Hospital, M√°laga, Spain Intercenter Urology Unit, Virgen de la Victoria University Hospital, M√°laga, Spain Intercenter Urology Unit, Virgen de la Victoria University Hospital, M√°laga, Spain Myriad Genetics Espa√±a S.L.U, Madrid, Spain Intercenter Urology Unit, Virgen de la Victoria University Hospital, M√°laga, Spain Intercenter Urology Unit, Virgen de la Victoria University Hospital, M√°laga, Spain Intercenter Urology Unit, Virgen de la Victoria University Hospital, M√°laga, Spain Intercenter Urology Unit, Virgen de la Victoria University Hospital, M√°laga, Spain Spezialklinik Neukirchen, Neukirchen beim Heiligen Blut, Germany Department of Therapeutic Dentistry Medical University ‚ÄúAstrakhan State Medical Academy‚Ä? Russian Ministry of Health, 121 Bakinskaya St., Astrakhan, 414000 Russia Faculty of Dentistry Medical University ‚ÄúVoronezh State Medical Academy‚Ä? of the Ministry of Health of the Russian Federation n.a. N.N. Burdenko, Institute of Dentistry at VGMA n.a. N.N. Burdenko, 14 pr. Revolyutsii, Voronezh, 394000 Russia Department of Therapeutic Stomatology, Medical University ‚ÄúAstrakhan State Medical University‚Ä? the Ministry of Health of Russia, 121 Bakinskaya St., Astrakhan, 414000 Russia Faculty of Dentistry Medical University ‚ÄúAstrakhan State Medical Academy‚Ä?, the Ministry of Health of Russia, Russia, 121 Bakinskaya St., Astrakhan, 414000 Russia Augenzentrum Fankhauser, Bern, Switzerland European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium European Association for Predictive, Preventive and Personalised Medicine (EPMA), Brussels, Belgium School of Art and Design, Nottingham Trent University, Nottingham, UK School of Art and Design, Nottingham Trent University, Nottingham, UK School of Art and Design, Nottingham Trent University, Nottingham, UK Faculty Hospital in Pilsen, Charles University Medical Faculty in Pilsen, Pilsen, Czech Republic Faculty Hospital in Pilsen, Charles University Medical Faculty in Pilsen, Pilsen, Czech Republic Department of Medical and Life Sciences, Furtwangen University, Villingen-Schwenningen, Germany Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Bogomolets National Medical University, Kyiv, 01601 Ukraine Bogomolets National Medical University, Kyiv, 01601 Ukraine Bogomolets National Medical University, Kyiv, 01601 Ukraine Clinical Hospital ‚ÄòPheophania‚Äô of State Affairs Department, Zabolotny str., 21, Kyiv, 03680 Ukraine Zabolotny Institute of Microbiology and Virology, National Academy of Sciences of Ukraine, Zabolotny Str., 154, Kyiv, 03680 Ukraine Clinical Hospital ‚ÄòPheophania‚Äô of State Affairs Department, Zabolotny str., 21, Kyiv, 03680 Ukraine Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany National Research Tomsk Polytechnic University, Tomsk, Russia Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany National Research Tomsk Polytechnic University, Tomsk, Russia National Research Tomsk Polytechnic University, Tomsk, Russia Istyna-Veritas Research Center, Kyiv, Ukraine Institute of Mathematics of NAS of Ukraine, Kyiv, Ukraine Clinic of Healthy Vessels, Kyiv, Ukraine Medical center ‚ÄúUkrainian medical innovations‚Ä?, Ternopil, Ukraine Veritas IT Med Center for Innovative Medical Technologies, 4 Williams Str., Kyiv, 03191 Ukraine Specialized clinic ‚ÄúVessels, brain, neurorehabilitation‚Ä?, Muscat, Oman Department of Statistics and Operations Research, the Sackler Faculty of Exact Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel Department of Statistics and Operations Research, the Sackler Faculty of Exact Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel Department of Statistics and Operations Research, the Sackler Faculty of Exact Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel Department of Statistics and Operations Research, the Sackler Faculty of Exact Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel Department of Statistics and Operations Research, the Sackler Faculty of Exact Sciences, the Sagol School of Neurosciences, Tel Aviv University, Tel Aviv, Israel Wroclaw University School of Physical Education, Faculty of Physiotherapy, Wroclaw, Poland VIANESSE AG, Research and Development, Engelberg, Switzerland Wroclaw University of Technology, Department of Biomedical Engineering, Wroclaw,  Poland Wroclaw University of Technology, Department of Biomedical Engineering, Wroclaw,  Poland Wroclaw University School of Physical Education, Faculty of Physiotherapy, Wroclaw, Poland Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Department of Oral Biology, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Department of Oral Biology, College of Dental Medicine, Georgia Regents University, Augusta, Georgia 30912 USA Institute of Sports Medicine, Medical Faculty of Charles University, Plze≈à, Czech Republic Faculty of Applied Electronics, Western-Bohemian University, Plze≈à, Czech Republic Institute of Sports Medicine, Medical Faculty of Charles University, Plze≈à, Czech Republic Atrium-Orbis, Department of Clinical Chemistry and Haematology, Heerlen, The Netherlands Department of Clinical Chemistry, University Hospital, SE-581 85 Link√∂ping, Sweden Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia General and Clinical Psychology Department, Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia Therapeutic Dentistry Department, Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation, Saint Petersburg, Russia Department of Clinical and Experimental Biomedical Sciences, University of Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy Department of Clinical and Experimental Biomedical Sciences, University of Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy Department of Clinical and Experimental Biomedical Sciences, University of Florence, Viale G. Pieraccini, 6, 50139 Florence, Italy Department of Biochemistry Faculty of Health Sciences, University of Southern Denmark, Vejle Hospital, Vejle, Denmark Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven,  Belgium Department of Clinical Pharmacology, University Hospital Tuebingen, Tuebingen, Germany Department of Clinical Biochemistry, Faculty of Pharmacy, University of Ljubljana, Ljubljana, Slovenia Department of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, The Netherlands University of Lorraine, UMR ISERM U1122; IGE-PCV, Genetique Cardiovasculaire, Nancy, France Division of Microbiology and Molecular Medicine, Department of Clinical, Experimental Medicine, Faculty of Health Sciences, Link√∂ping University, Link√∂ping, Sweden Genomic Unit for the Diagnosis of Human Pathologies, Vita-Salute San Raffaele University, Milan, Italy Department of Electronics and Multimedia Communications, Faculty of Electrical Engineering and Informatics, Technical university of Kosice, Letn√° 9, Ko≈°ice, Slovakia Department of Electronics and Multimedia Communications, Faculty of Electrical Engineering and Informatics, Technical university of Kosice, Letn√° 9, Ko≈°ice, Slovakia Department of Electronics and Multimedia Communications, Faculty of Electrical Engineering and Informatics, Technical university of Kosice, Letn√° 9, Ko≈°ice, Slovakia Department of Electronics and Multimedia Communications, Faculty of Electrical Engineering and Informatics, Technical university of Kosice, Letn√° 9, Ko≈°ice, Slovakia Department of Histology and Embryology in Plzen, Charles University in Prague, Plzen, Czech Republic Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USA Department of Biology, Faculty of Medicine in Plzen, Charles University in Prague and Faculty Hospital Plzen, Plzen, Czech Republic Department of Surgery, Faculty of Medicine in Plzen, Charles University in Prague and Faculty Hospital Plzen, Plzen, Czech Republic Department of Histology and Embryology in Plzen, Charles University in Prague, Plzen, Czech Republic Department of Neurology, Faculty of Medicine in Plzen, Charles University in Prague and Faculty Hospital Plzen, Plzen, Czech Republic University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in Prague, Department of Neurology, Plzen, Czech Republic University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in Prague, Department of Neurology, Plzen, Czech Republic University Hospital Plzen, Department of Quality Assessment, Plzen, Czech Republic University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in Prague, Department of Neurology, Plzen, Czech Republic University Hospital Plzen and Faculty of Medicine in Plzen, Charles University in Prague, Department of Neurology, Plzen, Czech Republic University Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical University, Nuremberg, Germany Faculty for Medical Sciences, University Goce Delcev, Stip, Macedonia University Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical University, Nuremberg, Germany Univesity Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical University, Nuremberg, Germany Clinic for Sleep Medicine, Bad Zurzcach, Schwitzerland Univesity Clinic for Psychiatry and Psychotherapy, Paracelsus Private Medical University, Nuremberg, Germany First Moscow State Medical University named by Sechenov, Moscow, Russia European Association for Predictive, Preventive and Personalised Medicine, Brussels, Belgium First Moscow State Medical University by I.M. Sechenov, Moscow, Russia European Clinic of Sports Traumatology and Orthopaedics, Moscow, Russia A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia A.I.Evdokimov Moscow State University of Medicine & Dentistry, Moscow, Russia Westdeutsches Zentrum f√ºr angewandte Telemedizin, Duisburg, Germany Institute for Work and Technology, Gelsenkirchen, Germany Institute for Nutrition Research, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh N.N. Burdenko State Medical University, Voronezh, Russia Voronezh State Medical University named after N.N. Burdenko, Postgraduate Dentistry Department, Voronezh, Russia Voronezh State Medical University named after N.N. Burdenko, Postgraduate Dentistry Department, Voronezh, Russia Voronezh State Medical University named after N.N. Burdenko, Postgraduate Dentistry Department, Voronezh, Russia Voronezh State Medical University named after N.N. Burdenko, Postgraduate Dentistry Department, Voronezh, Russia Voronezh State Medical University named after N.N. Burdenko, Postgraduate Dentistry Department, Voronezh, Russia National Diabetes Committee and University Clinic of Emergency Internal Medicine  and Toxicology, Skopje, Republic of Macedonia National Diabetes Committee and University Clinic of Endocrinology, Diabetes and  Metabolic Disorders, Skopje, Republic of Macedonia Human Photosynthesis Study Center, Av. Aguascalientes Norte 607, Pulgas Pandas Sur, Aguascalientes M√©xico Human Photosynthesis Study Center, Av. Aguascalientes Norte 607, Pulgas Pandas Sur, Aguascalientes M√©xico I.M. Sechenov Firts Moscow State Medical University and A.I. Konstantinov Moscow  State Medical & Dental University, Moscow, Russia Department of Radiology, Univeristy of Bonn, Bonn, Germany Department of Radiology, Univeristy of Bonn, Bonn, Germany I.M. Sechenov First Moscow State Medical University (PMGMU), Moscow, Russia Department of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL USA Roche Diagnostics Ltd., Rotkreuz, Switzerland, and Roche Diagnostics Division, Basel, Switzerland I.M. Sechenov First Moscow State Medical University (PMGMU), Moscow, Russia I.M. Sechenov First Moscow State Medical University (PMGMU), Moscow, Russia IKE/Klinisk kemi, Lab1, Hus 420, Plan 11, Universitetssjukhuset, SE-581 85, Link√∂ping, Sweden Department of Physics and Energy, and Materials and Surface Science Institute (MSSI), University of Limerick, ·Öü, Ireland Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic Faculty Hospital in Pilsen and Faculty of Medice in Pilsen, Charles University Prague, Pilsen, Czech Republic General Faculty Hospital and 1st Faculty of Medice in Prague, Charles University  Prague, Prague, Czech Republic General Faculty Hospital and 1st Faculty of Medice in Prague, Charles University  Prague, Prague, Czech Republic Clinical Hospital 86, Federal Medical Biological Agency of Russia, Moscow, Russia I.M. Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, Moscow, 119991 Russia I.M. Sechenov First Moscow State Medical University, Trubetskaya Str. 8-2, Moscow, 119991 Russia Department of Clinical and Experimental Medicine, University Hospital of Catania, Catania, Italy Department of Clinical and Experimental Medicine, University Hospital of Catania, Catania, Italy Department of Clinical and Experimental Medicine, University Hospital of Catania, Catania, Italy Department of Clinical and Experimental Medicine, University Hospital of Catania, Catania, Italy Department of Bio-Medical Sciences, Human Anatomy and Histology Section, School of Medicine, University of Catania, Catania, Italy Department of Clinical and Experimental Medicine, University Hospital of Catania, Catania, Italy Proteomarkers Biotech P.C., Athens, Greece Proteomarkers Biotech P.C., Athens, Greece Proteomarkers Biotech P.C., Athens, Greece Proteomarkers Biotech P.C., Athens, Greece Medtronic Iberica S.A., Madrid, Spain Medtronic Iberica S.A., Madrid, Spain Telefonica, Madrid, Spain Telefonica, Madrid, Spain Fleischhacker, Schwerte, Germany Grand-Aides, Houston, Texas USA Grand-Aides, Houston, Texas USA I+ SRL, Firenze, Italy I+ SRL, Firenze, Italy Hospital G.U. Valencia, Valencia, Spain Hospital G.U. Valencia, Valencia, Spain Maastricht U. Medical Centre, Maastricht, The Netherlands Linkopings Universitet, Linkopings, Sweden Universidad Politecnica de Madrid, Madrid, Spain Universidad Politecnica de Madrid, Madrid, Spain Universidad Politecnica de Madrid, Madrid, Spain European Association for Predictive, Preventive and Personalised Medicine, Brussels, Belgium Hospital U. 12 de Octubre, Madrid, Spain Elsevier, Amsterdam, The Netherlands Elsevier, Amsterdam, The Netherlands Medtronic Iberica S.A., Madrid, Spain Universita Degli Studi di Padova, Padova, Italy Universita Degli Studi di Padova, Padova, Italy Universita Degli Studi di Padova, Padova, Italy Universita Degli Studi di Padova, Padova, Italy Universidad Politecnica de Madrid, Madrid, Spain Universita Degli Studi di Pavia, Pavia, Italy Universita Degli Studi di Pavia, Pavia, Italy Universita Degli Studi di Pavia, Pavia, Italy Fondazione Salvatore Maugeri Clinica del Lavoro e Della Riabilitazione, Pavia, Italy Fondazione Salvatore Maugeri Clinica del Lavoro e Della Riabilitazione, Pavia, Italy Asociacion Espanola para el desarrollo de La Epidemiologia Clinica, Madrid, Spain Asociacion Espanola para el desarrollo de La Epidemiologia Clinica, Madrid, Spain Lunds Universitet, Lund, Sweden Lunds Universitet, Lund, Sweden Soluciones Tecnologicas para la Salud y el Bienestar (TSB), Valencia, Spain Samfundet Folkhalsan I Svenska Finland RF, Helsingfors, Finland Samfundet Folkhalsan I Svenska Finland RF, Helsingfors, Finland National Technical University of Athens, Athens, Greece DiscoveryMed Ltd, St. Petersburg, Russia Belarus State Medical University, Minsk, Belarus DiscoveryMed Ltd, St. Petersburg, Russia DiscoveryMed Ltd, St. Petersburg, Russia Belarus State Medical University, Minsk, Belarus DiscoveryMed Ltd, St. Petersburg, Russia University of Tartu, Department of Stomatology, Tartu, Estonia Clinic of Dentistry, Department of Maxillofacial Surgery, Tartu, Estonia University of Tartu, Department of Internal Medicine, Tartu, Estonia University of Tartu, Department of Stomatology, Tartu, Estonia University of Tartu, Department of Stomatology, Tartu, Estonia University of Tartu, Department of Stomatology, Tartu, Estonia University of Tartu, Department of Pediatrics, Tartu, Estonia University of Tartu, Department of Stomatology, Tartu, Estonia University of Tartu, Department of Stomatology, Tartu, Estonia School of Medical Science, Edith Cowan University, Perth, Australia School of Medical Science, Edith Cowan University, Perth, Australia Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Molecular Diagnostics, AIT- Austrian Institute of Technology GmbH, Vienna, Austria Hacettepe University Center for Biobanking and Genomics, DNA/Cell Bank for Rare Diseases, Ankara, Turkey Hacettepe University Center for Biobanking and Genomics, DNA/Cell Bank for Rare Diseases, Ankara, Turkey},
note  = {EPMA J. 2016 May 9;7(Suppl 1):. doi:10.1186/s13167-016-0054-6.}
}

@Article{201667,
author  = {Nichols, D.},
title  = {Psychedelics.},
journal  = {Pharmacological Reviews},
volume  = {68},
number  = {2},
pages  = {264-355},
year  = {2016},
abstract  = {Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are  generally considered physiologically safe and do not lead to dependence or addiction. Their origin predates written history, and they were employed by early cultures in many sociocultural and ritual contexts. After the virtually contemporaneous discovery of (5R,8R)-(+)-lysergic acid-N,N-diethylamide (LSD)-25  and the identification of serotonin in the brain, early research focused intensively on the possibility that LSD and other psychedelics had a serotonergic basis for their action. Today there is a consensus that psychedelics are agonists or partial agonists at brain serotonin 5-hydroxytryptamine 2A receptors, with particular importance on those expressed on apical dendrites of neocortical pyramidal cells in layer V. Several useful rodent models have been developed over the years to help unravel the neurochemical correlates of serotonin 5-hydroxytryptamine 2A receptor activation in the brain, and a variety of imaging techniques have been employed to identify key brain areas that are directly affected by psychedelics. Recent and exciting developments in the field have occurred in clinical research, where several double-blind placebo-controlled phase 2 studies of psilocybin-assisted psychotherapy in patients with cancer-related psychosocial distress have demonstrated unprecedented positive relief of anxiety and depression. Two small pilot studies of psilocybin-assisted  psychotherapy also have shown positive benefit in treating both alcohol and nicotine addiction. Recently, blood oxygen level‚Äìdependent functional magnetic resonance imaging and magnetoencephalography have been employed for in vivo brain imaging in humans after administration of a psychedelic, and results indicate that intravenously administered psilocybin and LSD produce decreases in oscillatory power in areas of the brain‚Äôs default mode network.},
address  = {},
note  = {Pharmacol Rev. 2016 Apr;68(2):264-355. Epub 2016 Apr doi:10.1124/pr.115.011478.}
}

@Article{201668,
author  = {Garc√≠a-Betances, R. and Cabrera-Umpi√©rrez, M. and Ottaviano, M. and Pastorino, M. and Arredondo, M.},
title  = {People with Aging- and Disability-Derived Functional Impairments.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {2},
pages  = {},
year  = {2016},
abstract  = {Despite the speedy evolution of Information and Computer Technology (ICT), and the growing recognition of the importance of the concept of universal design in all domains of daily living, mainstream ICT-based product designers and developers still work without any truly structured tools, guidance or support to  effectively adapt their products and services to users‚Äô real needs. This paper presents the approach used to define and evaluate parametric cognitive models that describe interaction and usage of ICT by people with aging- and disability-derived functional impairments. A multisensorial training platform was used to train, based on real user measurements in real conditions, the virtual parameterized user models that act as subjects of the test-bed during all stages  of simulated disabilities-friendly ICT-based products design. An analytical study was carried out to identify the relevant cognitive functions involved, together with their corresponding parameters as related to aging- and disability-derived functional impairments. Evaluation of the final cognitive virtual user models in  a real application has confirmed that the use of these models produce concrete valuable benefits to the design and testing process of accessible ICT-based applications and services. Parameterization of cognitive virtual user models allows incorporating cognitive and perceptual aspects during the design process.},
address  = {},
note  = {Sensors (Basel). 2016 Feb 22;16(2):. doi:10.3390/s16020266.}
}

@Article{201669,
author  = {Woods, A. and Antal, A. and Bikson, M. and Boggio, P. and Brunoni, A. and Celnik, P. and Cohen, L. and Fregni, F. and Herrmann, C. and Kappenman, E. and Knotkova, H. and Liebetanz, D. and Miniussi, C. and Miranda, P. and Paulus, W. and Priori, A. and Reato, D. and Stagg, C. and Wenderoth, N. and Nitsche, M.},
title  = {A technical guide to tDCS, and related non-invasive brain stimulation tools.},
journal  = {Clinical Neurophysiology},
volume  = {127},
number  = {2},
pages  = {1031-48},
year  = {2016},
abstract  = {Transcranial electrical stimulation (tES), including transcranial direct and alternating current stimulation (tDCS, tACS) are non-invasive brain stimulation techniques increasingly used for modulation of central nervous system excitability in humans. Here we address methodological issues required for tES application. This review covers technical aspects of tES, as well as applications like exploration of brain physiology, modelling approaches, tES in cognitive neurosciences, and interventional approaches. It aims to help the reader to appropriately design and conduct studies involving these brain stimulation techniques, understand limitations and avoid shortcomings, which might hamper the scientific rigor and potential applications in the clinical domain.},
address  = {Center for Cognitive Aging and Memory, Institute on Aging, McKnight Brain Institute, Department of Aging and Geriatric Research, Department of Neuroscience, University of Florida, Gainesville, FL, USA University Medical Center, Dept. Clinical Neurophysiology, Georg-August-University, Goettingen, Germany Department of Biomedical Engineering, The City College of New York, USA Social and Cognitive Neuroscience Laboratory and Developmental Disorders Program, Center for Health and Biological Science, Mackenzie Presbyterian University, S√£o  Paulo, SP, Brazil Service of Interdisciplinary Neuromodulation, Department and Institute of Psychiatry, University of S√£o Paulo, S√£o Paulo, Brazil Department of Physical Medicine and Rehabilitation, Johns Hopkins Medical Institution, Baltimore, MD, USA Human Cortical Physiology and Neurorehabilitation Section, National Institute of  Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA Laboratory of Neuromodulation, Center for Clinical Research Learning, Department  of Physical Medicine and Rehabilitation, Harvard University, USA Experimental Psychology Lab, Center of excellence Hearing4all, Department for Psychology, Faculty for Medicine and Health Sciences, Carl von Ossietzky Universit√§t, Ammerl√§nder Heerstr, Oldenburg, Germany Center for Mind & Brain and Department of Psychology, University of California, Davis, Davis, CA, USA MJHS Institute for Innovation in Palliative Care, New York, NY, USA University Medical Center, Dept. Clinical Neurophysiology, Georg-August-University, Goettingen, Germany Neuroscience Section, Department of Clinical and Experimental Sciences, University of Brescia & Cognitive Neuroscience Section, IRCCS Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy Institute of Biophysics and Biomedical Engineering (IBEB), Faculdade de Ci√™ncias, Universidade de Lisboa, Lisbon, Portugal University Medical Center, Dept. Clinical Neurophysiology, Georg-August-University, Goettingen, Germany Direttore Clinica Neurologica III, Universit√† degli Studi di Milano, Ospedale San Paolo, Milan, Italy Department of Biomedical Engineering, The City College of New York, USA Centre for Functional MRI of the Brain (FMRIB) Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Oxford Centre for Human Brain Activity (OHBA), Department of Psychiatry, University of Oxford, Oxford, UK Neural Control of Movement Lab, Dept. Health Sciences and Technology, ETH Z√ºrich, Switzerland University Medical Center, Dept. Clinical Neurophysiology, Georg-August-University, Goettingen, Germany},
note  = {doi:10.1016/j.clinph.2015.11.012.}
}

@Article{201570,
author  = {},
title  = {Wasting, Paris, France, 4-6 December 2015.},
journal  = {Journal of Cachexia, Sarcopenia and Muscle},
volume  = {6},
number  = {4},
pages  = {398-509},
year  = {2015},
abstract  = {},
address  = {},
note  = {doi:10.1002/jcsm.12087.}
}

@Article{201571,
author  = {DiPietro, J. and Costigan, K. and Voegtline, K.},
title  = {Studies in Fetal Behavior: Revisited, Renewed, and Reimagined.},
journal  = {Monographs of the Society for Research in Child Development},
volume  = {80},
number  = {3},
pages  = {vii-vii94},
year  = {2015},
abstract  = {Among the earliest volumes of this Monograph series was a report by Lester Sontag and colleagues, of the esteemed Fels Institute, on the heart rate of the human fetus as an expression of the developing nervous system. Here, some 75 years later, we commemorate this work and provide historical and contemporary context on knowledge regarding fetal development, as well as results from our own research. These are based on synchronized monitoring of maternal and fetal parameters assessed between 24 and 36 weeks gestation on 740 maternal-fetal pairs compiled from eight separate longitudinal studies, which commenced in the early 1990s. Data include maternal heart rate, respiratory sinus arrhythmia, and electrodermal activity and fetal heart rate, motor activity, and their integration. Hierarchical linear modeling of developmental trajectories reveals that the fetus develops in predictable ways consistent with advancing parasympathetic regulation. Findings also include: within-fetus stability (i.e.,  preservation of rank ordering over time) for heart rate, motor, and coupling measures; a transitional period of decelerating development near 30 weeks gestation; sex differences in fetal heart rate measures but not in most fetal motor activity measures; modest correspondence in fetal neurodevelopment among siblings as compared to unrelated fetuses; and deviations from normative fetal development in fetuses affected by intrauterine growth restriction and other conditions. Maternal parameters also change during this period of gestation and there is evidence that fetal sex and individual variation in fetal neurobehavior  influence maternal physiological processes and the local intrauterine context. Results are discussed within the framework of neuromaturation, the emergence of individual differences, and the bidirectional nature of the maternal-fetal relationship. We pose a number of open questions for future research. Although the human fetus remains just out of reach, new technologies portend an era of accelerated discovery of the earliest period of development.},
address  = {Johns Hopkins Bloomberg School of Public Health The Johns Hopkins Hospital Johns Hopkins Bloomberg School of Public Health},
note  = {Monogr Soc Res Child Dev. 2015 Sep;80(3):vii-vii94. doi:10.1111/mono.v80.3.}
}

@Article{201572,
author  = {},
title  = {Arizona.},
journal  = {Journal of the American Association for Laboratory Animal Science : JAALAS},
volume  = {54},
number  = {5},
pages  = {568-668},
year  = {2015},
abstract  = {},
address  = {},
note  = {J Am Assoc Lab Anim Sci. 2015 Sep;54(5):568-668. Epub 2015 Sep}
}

@Article{201473,
author  = {},
title  = {UEG Week 2014 Oral Presentations.},
journal  = {United European Gastroenterology Journal},
volume  = {2},
number  = {1 Suppl},
pages  = {A1-A131},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1177/2050640614548974.}
}

@Article{201474,
author  = {Gatica-Rojas, V. and M√©ndez-Rebolledo, G.},
title  = {brain of patients with neurological diseases.},
journal  = {Neural Regeneration Research},
volume  = {9},
number  = {8},
pages  = {888-96},
year  = {2014},
abstract  = {Two key characteristics of all virtual reality applications are interaction and immersion. Systemic interaction is achieved through a variety of multisensory channels (hearing, sight, touch, and smell), permitting the user to interact with the virtual world in real time. Immersion is the degree to which a person can feel wrapped in the virtual world through a defined interface. Virtual reality interface devices such as the Nintendo¬Æ Wii and its peripheral nunchuks-balance board, head mounted displays and joystick allow interaction and immersion in unreal environments created from computer software. Virtual environments are highly interactive, generating great activation of visual, vestibular and proprioceptive systems during the execution of a video game. In addition, they are entertaining and safe for the user. Recently, incorporating therapeutic purposes in virtual reality interface devices has allowed them to be used for the rehabilitation of neurological patients, e.g., balance training in older adults and dynamic stability in healthy participants. The improvements observed in neurological diseases (chronic stroke and cerebral palsy) have been shown by changes in the reorganization of neural networks in patients‚Äô brain, along with better hand function and other skills, contributing to their quality of life. The data generated by such studies could substantially contribute to physical rehabilitation strategies.},
address  = {Laboratory of Human Motor Control, Faculty of Health Sciences, University of Talca, Talca, Chile Laboratory of Human Motor Control, School of Kinesiology, Faculty of Health Sciences, University of Talca, Talca, Chile},
note  = {Neural Regen Res. 2014 Apr 15;9(8):888-96. doi:10.4103/1673-5374.131612.}
}

@Article{201475,
author  = {},
title  = {Treatments for DiabetesVienna, Austria, February 5‚Äì8, 2014.},
journal  = {Diabetes Technology & Therapeutics},
volume  = {16},
number  = {Suppl 1},
pages  = {A-1-A-162},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1089/dia.2014.1515.}
}

@Article{201376,
author  = {},
title  = {Translational Science 2013 Abstracts.},
journal  = {Clinical and Translational Science},
volume  = {6},
number  = {2},
pages  = {103-64},
year  = {2013},
abstract  = {},
address  = {},
note  = {Clin Transl Sci. 2013 Apr;6(2):103-64. Epub 2013 Apr 18 doi:10.1111/cts.12047.}
}

@Article{201277,
author  = {Lewald, J. and Tegenthoff, M. and Peters, S. and Hausmann, M.},
title  = {Passive Auditory Stimulation Improves Vision in Hemianopia.},
journal  = {PLoS ONE},
volume  = {7},
number  = {5},
pages  = {},
year  = {2012},
abstract  = {Techniques employed in rehabilitation of visual field disorders such as hemianopia are usually based on either visual or audio-visual stimulation and patients have to perform a training task. Here we present results from a completely different, novel approach that was based on passive unimodal auditory  stimulation. Ten patients with either left or right-sided pure hemianopia (without neglect) received one hour of unilateral passive auditory stimulation on either their anopic or their intact side by application of repetitive trains of sound pulses emitted simultaneously via two loudspeakers. Immediately before and  after passive auditory stimulation as well as after a period of recovery, patients completed a simple visual task requiring detection of light flashes presented along the horizontal plane in total darkness. The results showed that one-time passive auditory stimulation on the side of the blind, but not of the intact, hemifield of patients with hemianopia induced an improvement in visual detections by almost 100% within 30 min after passive auditory stimulation. This  enhancement in performance was reversible and was reduced to baseline 1.5 h later. A non-significant trend of a shift of the visual field border toward the blind hemifield was obtained after passive auditory stimulation. These results are compatible with the view that passive auditory stimulation elicited some activation of the residual visual pathways, which are known to be multisensory and may also be sensitive to unimodal auditory stimuli as were used here.Trial Registration: DRKS00003577},
address  = {Department of Cognitive Psychology, Faculty of Psychology, Ruhr University Bochum, Bochum, Germany Department of Neurology, BG-Kliniken Bergmannsheil, Ruhr University Bochum, Bochum, Germany Department of Radiology, BG-Kliniken Bergmannsheil, Ruhr University Bochum, Bochum, Germany Department of Psychology, University of Durham, Durham, United Kingdom},
note  = {PLoS One. 2012 May 29;7(5):. doi:10.1371/journal.pone.0031603.}
}

@Article{201278,
author  = {K√§rcher, S. and Fenzlaff, S. and Hartmann, D. and Nagel, S. and K√∂nig, P.},
title  = {Sensory Augmentation for the Blind.},
journal  = {Frontiers in Human Neuroscience},
volume  = {6},
number  = {},
pages  = {},
year  = {2012},
abstract  = {Common navigational aids used by blind travelers during large-scale navigation divert attention away from important cues of the immediate environment (i.e., approaching vehicles). Sensory augmentation devices, relying on principles similar to those at work in sensory substitution, can potentially bypass the bottleneck of attention through sub-cognitive implementation of a set of rules coupling motor actions with sensory stimulation. We provide a late blind subject  with a vibrotactile belt that continually signals the direction of magnetic north. The subject completed a set of behavioral tests before and after an extended training period. The tests were complemented by questionnaires and interviews. This newly supplied information improved performance on different time scales. In a pointing task we demonstrate an instant improvement of performance based on the signal provided by the device. Furthermore, the signal was helpful in relevant daily tasks, often complicated for the blind, such as keeping a direction over longer distances or taking shortcuts in familiar environments. A homing task with an additional attentional load demonstrated a significant improvement after training. The subject found the directional information highly expedient for the adjustment of his inner maps of familiar environments and describes an increase in his feeling of security when exploring  unfamiliar environments with the belt. The results give evidence for a firm integration of the newly supplied signals into the behavior of this late blind subject with better navigational performance and more courageous behavior in unfamiliar environments. Most importantly, the complementary information provided by the belt lead to a positive emotional impact with enhanced feeling of security. The present experimental approach demonstrates the positive potential of sensory augmentation devices for the help of handicapped people.},
address  = {Neurobiopsychology, Institute of Cognitive Science, University Osnabr√ºckOsnabr√ºck, Germany Neurobiopsychology, Institute of Cognitive Science, University Osnabr√ºckOsnabr√ºck, Germany Neurobiopsychology, Institute of Cognitive Science, University Osnabr√ºckOsnabr√ºck, Germany Neurobiopsychology, Institute of Cognitive Science, University Osnabr√ºckOsnabr√ºck, Germany Neurobiopsychology, Institute of Cognitive Science, University Osnabr√ºckOsnabr√ºck, Germany},
note  = {Front Hum Neurosci. 2012 Mar 01;6:. doi:10.3389/fnhum.2012.00037.}
}

@Article{201079,
author  = {},
title  = {ACRT‚Ä?SCTS Scholar Abstracts.},
journal  = {Clinical and Translational Science},
volume  = {3},
number  = {2},
pages  = {S8-S55},
year  = {2010},
abstract  = {},
address  = {},
note  = {doi:10.1111/j.1752-8062.2010.00181_2.x.}
}

@Article{200580,
author  = {Loomis, J. and Marston, J. and Golledge, R. and Klatzky, R.},
title  = {Spatial Displays for Route Guidance.},
journal  = {Journal of visual impairment & blindness},
volume  = {99},
number  = {4},
pages  = {219-32},
year  = {2005},
abstract  = {This article reports on a study of route guidance using a navigation system that  receives location information from a Global Positioning System receiver. Fifteen  visually impaired participants traveled along 50-meter (about 164-foot) paths in  each of five conditions that were defined by the type of display interface used.  One of the virtual displays‚Äîvirtual speech‚Äîled to the shortest travel times and the highest subjective ratings, despite concerns about the use of headphones.},
address  = {Department of Psychology, University of California, Santa Barbara, CA 93106; loomis@psych.ucsb.edu. Department of Geography, University of California, Santa Barbara, CA 93106; marstonj@geog.ucsb.edu. Department of Geography, University of California, Santa Barbara, CA 93106; golledge@geog.ucsb.edu. Department of Psychology, Carnegie Mellon University, Baker Hall 342C, Pittsburgh, PA 15213; klatzky@andrew.cmu.edu.},
note  = {J Vis Impair Blind. 2005;99(4):219-32.}
}

@Article{201781,
author  = {Ortiz, M. and Schnabel, K. and Teut, M. and Rotter, G. and Binting, S. and Cree, M. and Lotz, F. and Suhr, R. and Brinkhaus, B. and Parvizi, M. and Handjani, F. and Zarshenas, M. and Moein, M. and Nimrouzi, M. and Hatam, G. and Hasanzadeh, J. and Hamidizadeh, N. and Parvizi, M. and Heydari, M. and Namazi, M. and Parvizi, Z. and Pasalar, M. and Mosaffa-Jahromi, M. and Bagheri-Lankarani, K. and Afsharypuor, S. and Tamaddon, A. and Ostovar, M. and Peloni, G. and Bolliger, I. and Faria, R. and Quadri, P. and Sanzeni, W. and Zemp, D. and Risvoll, H. and Giverhaug, T. and Halvorsen, K. and Waaseth, M. and Musial, F. and Rossi, E. and Baccetti, S. and Picchi, M. and Conti, T. and Firenzuoli, F. and Guido, C. and Bosco, F. and Guido, C. and Rossi, E. and Panozzo, M. and Picchi, M. and Cervino, C. and Nurra, L. and Rossi, E. and Picchi, M. and Firenzuoli, F. and Traversi, A. and Vuono, K. and Sabatini, F. and Bellandi, T. and Rutert, B. and Eggert, A. and Seifert, G. and Stritter, W. and Holmberg, C. and L√§ngler, A. and Salamonsen, A. and Wiesener, S. and Schad, F. and Steele, M. and Kr√∂z, M. and Matthes, H. and Herbstreit, C. and Thronicke, A. and Schlingensiepen, I. and von, S. and Schneider, R. and Waeber, L. and Vagedes, J. and Kaczala, G. and Pharisa, C. and Wildhaber, J. and Huber, B. and Sidorov, P. and Sovershaeva, E. and Sim√µes-W√ºst, A. and Nietlispach, A. and Mennet, M. and Schnelle, M. and von, M. and Wang, X. and Woo, H. and Lee, J. and Wu, Y. and Cho, Y. and Yun, Y. and Kim, H. and Jung, W. and Jang, B. and Ziea, E. and Hui, H. and Li, M. and Tsui, D. and Lam, C. and Hsieh, J. and Chan, E. and Balneaves, L. and Burnside, S. and Doyle, E. and Dorazio, S. and Chan, P. and Bhagra, A. and Chen, P. and Chung, V. and Wu, J. and Lin, Z. and Wong, W. and Wu, X. and Ho, R. and Wong, C. and Chan, L. and Ziea, E. and Elder, W. and Cardarelli, R. and Kaspar, C. and Kempenich, R. and Kopferschmitt, J. and Marinko, Z. and Damir, S. and Vcev, A. and Monezi, R. and Ruggerini, E. and Fuchigami, I. and Mazini, A. and Monezi, R. and Oliveira, M. and Papuga, P. and Schloss, J. and Steel, A. and Jacobsen, M. and Monezi, R. and Jacobsen, M. and Mangini, M. and Trapani, G. and Di, G. and Zanino, L. and Ciullo, L. and Lanaro, D. and Cerritelli, F. and Macr√¨, F. and Tsai, A. and Lin, C. and Wu, T. and D‚ÄôAlessandro, E. and Watts, S. and Zhang, Y. and Wu, X. and Li, X. and Fei, Y. and Liu, J. and Zhao, N. and Jia, L. and Yan, X. and Zhen, F. and Liu, Z. and Liu, J. and Ahn, J. and Yun, Y. and AlEidi, S. and Mohamed, A. and Al-Beda, A. and Abutalib, R. and Khalil, M. and Amri, H. and Badekila, S. and Behmanesh, E. and Mozaffarpour, S. and Behmanesh, E. and Mozaffarpour, S. and Behmanesh, E. and Shirooye, P. and Meybodi, R. and Mokaberinejad, R. and Tansaz, M. and Mozaffarpour, S. and Chung, V. and Wu, X. and Wu, J. and Daneshfard, B. and Hosseinkhani, A. and Tafazoli, V. and Jaladat, A. and Jaladat, A. and Sadeghi, H. and Jia, L. and Zhao, N. and Yan, X. and Zhou, L. and Zhao, M. and Li, W. and Liu, J. and Liu, Z. and Jia, L. and Zhao, N. and Yan, X. and Zhou, L. and Zhao, M. and Li, W. and Liu, J. and Liu, Z. and Larsen, A. and Salamonsen, A. and Kristoffersen, A. and Hamran, T. and Evjen, B. and Stub, T. and Li, M. and Cai, J. and Lu, T. and Yin, L. and Wu, D. and Wang, L. and Liew, S. and Liu, T. and Bai, C. and Zheng, Z. and Wan, Y. and Xu, J. and Wang, X. and Yu, H. and Gu, X. and Liu, Z. and Yan, X. and Jia, L. and Zhao, N. and Yang, G. and Liu, J. and Mozaffarpour, S. and Behmanesh, E. and Nimrouzi, M. and Tafazoli, V. and Daneshfard, B. and Ostrowski, D. and Fox, K. and Pasalar, M. and Tabatabei, F. and Amini, F. and Sathasivampillai, S. and Rajamanoharan, P. and Munday, M. and Heinrich, M. and Scherrer, Y. and Heinrich, M. and Szuter, C. and Amini, F. and Tabatabaei, F. and Tavakoli, A. and Tavakoli, F. and Pasalar, M. and rostami, M. and Torri, M. and Szuter, C. and Walach, H. and Warner, F. and Majumdar, A. and Serasingh, P. and Yan, X. and Jia, L. and Zhao, N. and Liu, Z. and Liu, J. and Zhao, N. and Zhen, F. and Jia, L. and Yan, X. and Liu, Z. and Liu, J. and Abbing, A. and Ponstein, A. and Baars, E. and Croke, S. and Hanser, S. and Heckel, V. and Kr√ºerke, D. and Sim√µes-W√ºst, A. and Weiss, S. and Metzner, S. and Lee, J. and Hyun, M. and Masetti, M. and Oepen, R. and Gruber, H. and Heusser, P. and Pelz, H. and Perlitz, V. and Ponstein, A. and Abbing, A. and Baars, E. and Robinson, N. and Ronan, P. and Mian, A. and Madge, S. and Lorenc, A. and Agent, P. and Carr, S. and Ronan, P. and Robinson, N. and Carr, S. and Mian, A. and Lorenc, A. and Agent, P. and Madge, S. and Winnubst, M. and Monezi, R. and Abolghasemi, J. and Heydari, M. and Baccetti, S. and Rossi, E. and Fedi, P. and Di, S. and Belvedere, K. and Baccetti, S. and Rossi, E. and Firenzuoli, F. and Di, S. and Belvedere, K. and Beaven, K. and Rose, A. and Florschutz, G. and Phil, N. and Parsons, H. and Stewart-Brown, S. and Burke, K. and Busch, M. and Heyning, F. and Smit, J. and Jeekel, H. and de, G. and Guido, P. and Barraza, N. and Balbarrey, Z. and Ribas, A. and Jimenez, B. and Iachino, C. and Quattrone, F. and Gaioli, M. and Dell‚ÄôOrso, M. and Villanueva, S. and Rocha, C. and Macchi, A. and Cai, J. and Chen, L. and Wu, D. and Wang, S. and Choi, E. and Go, N. and Lee, Y. and Dahal, G. and Frauenknecht, X. and Gerhardt, H. and Galanti, M. and Cerda, C. and Galanti, M. and Galanti, M. and Heckersdorf, D. and Jorquera, H. and Saldivia, M. and Jakubonienƒó, D. and McEwen, B. and Melo, F. and Fontana, F. and Valle, A. and Neres, M. and Mohagheghzadeh, A. and Zohalinezhad, M. and Njaradi, O. and Dunjic, M. and Njaradi, O. and Dunjic, M. and Ostrowski, D. and Fox, K. and Pokladnikova, J. and Selke-Krulichova, I. and Seo, J. and Jang, H. and Sim√µes-W√ºst, A. and Molt√≥-Puigmart√≠, C. and van, D. and Dagnelie, P. and Thijs, C. and Tihanyi, E. and Hegyi, G. and Zhang, Y. and Li, X. and Fei, Y. and Liu, J. and Zhang, Y. and Liu, J. and Tong, X.},
title  = {3-5 May 2017.},
journal  = {BMC Complementary and Alternative Medicine},
volume  = {17},
number  = {Suppl 1},
pages  = {},
year  = {2017},
abstract  = {},
address  = {0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0001 2218 4662grid.6363.0Institute for Social Medicine, Epidemiology and Health Economics, Charit√© University Hospital, Berlin, Germany 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0001 0745 1259grid.412573.6Molecular Dermatology Research Centre, Shiraz University of Medicine, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Medicinal Plants Processing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Basic Sciences in Infectious Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Department of Epidemiology, Shiraz University of  Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0001 0745 1259grid.412573.6Molecular Dermatology Research Centre, Shiraz University of Medicine, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Health Policy Research Center, Shiraz University  of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Health Policy Research Center, Shiraz University  of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Center for Nanotechnology in Drug Delivery, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic  Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850 Switzerland 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850 Switzerland 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850 Switzerland 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850 Switzerland 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850 Switzerland 0000 0004 0478 8536grid.477768.dOspedale Beata Vergine, Mendrisio, 6850 Switzerland NKS Kl√∏ver√•sen as, Bod√∏, 8076 Norway 0000 0004 4689 5540grid.412244.5RELIS North Norway, University Hospital North Norway, Troms√∏, 9037 Norway 0000000122595234grid.10919.30Department of Pharmacy, UiT The Arctic University of Norway, Troms√∏, Norway 0000000122595234grid.10919.30Department of Pharmacy, UiT The Arctic University of Norway, Troms√∏, Norway 0000000122595234grid.10919.30National Research Center in Complementary and Alternative Medicine (NAFKAM), Department of Community Medicine, The Arctic University of Norway UiT, Troms√∏, 9037 Norway Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative Medicine, Lucca, 55100 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative Medicine, Lucca, 55100 Italy Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative Medicine, Lucca, 55100 Italy Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative Medicine, Lucca, 55100 Italy Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative Medicine, Lucca, 55100 Italy Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative Medicine, Lucca, 55100 Italy Homeopatic Clinic ASL Tuscany North West Lucca, Tuscan network for Integrative Medicine, Florence, Italy Tuscany Network of Integrative Medicine, Florence, 50139 Italy Tuscany Network of Integrative Medicine, Florence, 50139 Italy Tuscany Network of Integrative Medicine, Florence, 50139 Italy Tuscany Network of Integrative Medicine, Florence, 50139 Italy Tuscany Network of Integrative Medicine, Florence, 50139 Italy Regional Centre for Clinical Risk Management, Tuscany Region, Florence, 50139 Italy 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charit√© University Hospital, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charit√© University Hospital, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charit√© University Hospital, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Pediatric Oncology, Charit√© University Hospital, Berlin, 10117 Germany 0000 0001 2218 4662grid.6363.0Institute of Public Health, Charit√© University Hospital, Berlin, 13353 Germany Institute for Integrative Medicine, Community Hospital Herdecke, Herdecke, Germany 0000000122595234grid.10919.30Department of Community Medicine, National Research  Center in Complementary and Alternative Medicine, UiT The Arctic University of Norway, Troms√∏, 9037 Norway 0000000122595234grid.10919.30Department of Community Medicine, National Research  Center in Complementary and Alternative Medicine, UiT The Arctic University of Norway, Troms√∏, 9037 Norway Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Hospital Havelh√∂he, Berlin, Germany Research Institute Havelh√∂he, Berlin, 14089 Germany Institut f√ºr wissenschaftliche Homoeopathie, Berlin, 13505 Germany Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland Filderklinik, ARCIM Institute, Filderstadt, Germany Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland Department of Pediatrics, Fribourg Hospital HFR, Fribourg, 1708 Switzerland 0000 0001 0339 7822grid.412254.4Mental Health, Northern State Medical University, Arkhangelsk, Russian Federation 0000 0001 0339 7822grid.412254.4Mental Health, Northern State Medical University, Arkhangelsk, Russian Federation 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich, 8091 Switzerland 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich, 8091 Switzerland Weleda AG, Arlesheim, 4144 Switzerland Weleda AG, Arlesheim, 4144 Switzerland 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich, 8091 Switzerland grid.464481.bXiyuan Hospital of China Academy of Chinese Medical Sciences, Oncology Department, Beijing, China 0000 0001 0357 1464grid.411231.4Department of Korean Gynecology, Kyung Hee University Hospital at Gangdong, Seoul, 05278 South Korea 0000 0001 0357 1464grid.411231.4Department of Korean Gynecology, Kyung Hee University Hospital at Gangdong, Seoul, 05278 South Korea 0000 0001 0376 205Xgrid.411304.3Chengdu University of Traditional Chinese Medicine, School of Acupuncture, Chengdu, China 0000 0000 9632 6718grid.19006.3eULCA, David Geffen School of Medicine, Center for East West Medicine, Los Angeles, CA USA 0000 0001 0357 1464grid.411231.4Department of Korean Medicine Dermatology, Kyung  Hee University Hospital at Gangdong, Seoul, 134-806 South Korea 0000 0001 2171 7818grid.289247.2Department of Biofunctional Medicine & Diagnostics, Kyung Hee University Korean Medicine Hospital, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Science in Korean Medicine, Graduate School, Kyung Hee University, Seoul, South Korea 0000 0001 2171 7818grid.289247.2Department of Preventive Medicine, Graduate School, Kyung Hee University, Seoul, South Korea 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1764 4320grid.414370.5Chinese Medicine Department, Hospital Authority,  Hong Kong, Hong Kong 0000 0004 1936 9609grid.21613.37College of Nursing, University of Manitoba, Winnipeg, R3T 2N2 Canada 0000 0004 0463 0093grid.460766.5The Scarborough Hospital, Toronto, Canada 0000 0004 0463 0093grid.460766.5The Scarborough Hospital, Toronto, Canada 0000 0004 0463 0093grid.460766.5The Scarborough Hospital, Toronto, Canada Leslie Dan Faculty of Pharmacy, Toronto, Canada 0000 0004 0459 167Xgrid.66875.3aMayo Clinic, Rochester, MN USA 0000 0004 0572 7372grid.413814.bChinese medicine, Changhua Christian Hospital, Changhua, 500 Taiwan 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong Institute of Integrative Medicine, Hong Kong, Hong Kong 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong Institute of Integrative Medicine, Hong Kong, Hong Kong 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong Institute of Integrative Medicine, Hong Kong, Hong Kong 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong Institute of Integrative Medicine, Hong Kong, Hong Kong 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong 0000 0004 1937 0482grid.10784.3aDepartment of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong Institute of Integrative Medicine, Hong Kong, Hong Kong 0000 0004 1937 0482grid.10784.3aThe Chinese University of Hong Kong, Hong Kong Institute of Integrative Medicine, Hong Kong, Hong Kong 0000 0004 1936 8438grid.266539.dUniversity of Kentucky, Lexington, KY USA 0000 0004 1936 8438grid.266539.dUniversity of Kentucky, Lexington, KY USA Simonton Cancer Center, Ulm, 89077 Germany AREMA, Strasbourg, 67000 France Unistra, Strasbourg, 67000 France Department of Integrative Medicine, Faculty of medicine Osijek, Osijek, 31000 Croatia Department of Integrative Medicine, Faculty of medicine Osijek, Osijek, 31000 Croatia Department of Integrative Medicine, Faculty of medicine Osijek, Osijek, 31000 Croatia 0000 0001 0514 7202grid.411249.bCampus Avan√ßado de Extens√£o Santo Amaro, UNIFESP, S√£o Paulo, 04753060 Brazil Setor Espiritualidade e Sa√∫de, Funda√ß√£o Mokiti Okada, S√£o Paulo, 04015-050 Brazil 0000 0001 2295 1681grid.456932.fReligious Studies, Methodist University of S√£o Paulo, S√£o Bernardo do Campo, 09641-000 Brazil 0000 0001 2163 588Xgrid.411247.5Departamento de Ci√™ncias Biol√≥gicas, Universidade Federal de S√£o Carlos, S√£o Carlos, 13565-905 Brazil 0000 0001 0514 7202grid.411249.bUNIFESP, S√£o Paulo, 04753060 Brazil 0000 0001 2163 588Xgrid.411247.5Departamento de Ci√™ncias Biol√≥gicas, Universidade Federal de S√£o Carlos, S√£o Carlos, 13565-905 Brazil Daofa, Komenda, 1218 Slovenia 0000 0000 9962 2299grid.459858.dOffice of Research, Endeavour College of Natural  Health, Fortitude Valley, 4006 Australia 0000 0000 9962 2299grid.459858.dOffice of Research, Endeavour College of Natural  Health, Fortitude Valley, 4006 Australia Curso T√©cnico em Massoterapia, Escola de Educa√ß√£o Profissional Cec√≠lia Meireles ‚Äì SEG, Porto Alegre, Brazil 0000 0001 0514 7202grid.411249.bUNIFESP, S√£o Paulo, 04753060 Brazil 0000 0004 0520 9866grid.464548.fFisioterapia, Centro Universit√°rio Metodista-IPA, Porto Alegre, 90420-004 Brazil Curso T√©cnico em Massoterapia, Escola de Educa√ß√£o Profissional Cec√≠lia Meireles ‚Äì SEG, Porto Alegre, Brazil SMB ITALIA, Sanremo, 18038 Italy SIOMI, Integrative Medicine School, Firenze, Italy SMB ITALIA, Sanremo, 18038 Italy Istituto Europeo di Medicina Osteopatica, Osteopathy School, Genova, Italy Istituto Europeo di Medicina Osteopatica, Osteopathy School, Genova, Italy COME Collaboration ONLUS, Fondazione per la Ricerca in Ambito Osteopatico, Vasto, Italy SIOMI, Integrative Medicine School, Firenze, Italy Acupuncture Centre of IOTHCFMSUP, S√£o Paulo, 05410001 Brazil 0000 0004 1937 0722grid.11899.38Acupuncture Centre of Orthopaedic and Traumatology Institute of Hospital das Clinicas, Medical School, S√£o Paulo University, S√£o Paulo, Brazil 0000 0004 1937 0722grid.11899.38Acupuncture Centre of Orthopaedic and Traumatology Institute of Hospital das Clinicas, Medical School, S√£o Paulo University, S√£o Paulo, Brazil 0000 0004 1937 0722grid.11899.38Acupuncture Centre of Orthopaedic and Traumatology Institute of Hospital das Clinicas, Medical School, S√£o Paulo University, S√£o Paulo, Brazil 0000 0004 1936 9297grid.5491.9Primary Care, University of Southampton, Southhampton, SO16 5ST United Kingdom 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China Changying Community Health Service Center, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Seoul, 05278 South Korea 0000 0001 0357 1464grid.411231.4Kyung Hee University Hospital at Gangdong, Seoul, 05278 South Korea National Center for Complementary and Alternative Medicine, Riyadh, Saudi Arabia 0000 0004 1773 5396grid.56302.32Family and Community Medicine Department, King Saud University, Riyadh, Saudi Arabia National Center for Complementary and Alternative Medicine, Riyadh, Saudi Arabia Orthopedic Surgery, King Fahad Hospital, Madinah, Saudi Arabia National Center for Complementary and Alternative Medicine, Riyadh, Saudi Arabia 0000 0001 2186 0438grid.411667.3Biochemistry and Cellular and Molecular Biology,  Georgetown University Medical Center, Washington, D.C, USA Ayurveda, Muniyal Institute of Ayurveda Medical Sciences, Manipal, 576104 India 0000 0001 0166 0922grid.411705.6School of Traditional Medicine and History of Medical Science Research Center, University of Medical Sciences, Babol, 47176477  Iran, Islamic Republic of 0000 0001 0166 0922grid.411705.6School of Traditional Medicine and History of Medical Science Research Center, University of Medical Sciences, Babol, 47176477  Iran, Islamic Republic of Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran, Islamic Republic of Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran, Islamic Republic of Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran, Islamic Republic of Traditional Medicine, Shahid eheshti University of Medical Science, Tehran, 1516745811 Iran, Islamic Republic of Traditional Medicine, Shahid eheshti University of Medical Science, Tehran, 1516745811 Iran, Islamic Republic of Traditional Medicine, Shahid eheshti University of Medical Science, Tehran, 1516745811 Iran, Islamic Republic of Traditional Medicine, Shahid eheshti University of Medical Science, Tehran, 1516745811 Iran, Islamic Republic of Traditional Medicine, University of Medical Science, Babol, 4717647745 Iran, Islamic Republic of 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong 0000 0004 1937 0482grid.10784.3aJockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong Hong Kong 0000 0000 8819 4698grid.412571.4Student Research Committee, Shiraz University of  Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cXiyuan hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDongzhimen hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cXiyuan hospital, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic University of Norway UiT, Troms√∏, 9037 Norway 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic University of Norway UiT, Troms√∏, 9037 Norway 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic University of Norway UiT, Troms√∏, 9037 Norway Department of Health and Care Sciences, The Artic University of Norway, Troms√∏, 9037 Norway Centre for Sami studies, The Actic University of Norway, Troms√∏, 9037 Norway 0000000122595234grid.10919.30Department of Community Medicine, NAFKAM, The Arctic University of Norway UiT, Troms√∏, 9037 Norway 0000 0000 8848 7685grid.411866.cGuangzhou University of Chinese Medicine, Guangzhou, 510000 China 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China 0000 0000 8848 7685grid.411866.cThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China 0000 0004 1757 641Xgrid.440665.5The Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, China 0000 0004 0366 8516grid.444452.7Cyberjaya University College of Medical Sciences, Cyberjaya, Malaysia 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Beijing,  100029 China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center for Evidence-based Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center for Evidence-based Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center for Evidence-based Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center for Evidence-based Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center for Evidence-based Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cBeijing University of Chinese Medicine, Center for Evidence-based Chinese Medicine, Beijing, China Traditional Medicine and Medical history Research Centre, University of Medical Science, Babol, Iran, Islamic Republic of Traditional Medicine and Medical history Research Centre, University of Medical Science, Babol, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of Office of Hawaiian Affairs, Honolulu, 96817 HI USA Office of Hawaiian Affairs, Honolulu, 96817 HI USA 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000000121901201grid.83440.3bSchool of Phramacy, University College London, London, WC1N 1AX United Kingdom Provincial Department of Indigenous Medicine, Trincomalee, Sri Lanka 0000000121901201grid.83440.3bSchool of Phramacy, University College London, London, WC1N 1AX United Kingdom 0000000121901201grid.83440.3bSchool of Phramacy, University College London, London, WC1N 1AX United Kingdom 0000 0004 1937 0642grid.6612.3Sustainability Research Group, University of Basel, Basel, 4051 Switzerland 0000 0001 2161 2573grid.4464.2Research Group ‚ÄòPharmacognosy and Phytotherapy‚Äô, Univ. London, School of Pharmacy, London, WC1N 1AX United Kingdom 0000 0004 0402 6152grid.266820.8Sociology, University of New Brunswick, Fredericton, E3B4H7 Canada 0000 0001 0745 1259grid.412573.6School of Medicine, Traditional Medicine, Shiraz, Iran, Islamic Republic of 0000 0001 0745 1259grid.412573.6School of Medicine, Traditional Medicine, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0004 0402 6152grid.266820.8Sociology, University of New Brunswick, Fredericton, E3B4H7 Canada 0000 0004 0402 6152grid.266820.8Sociology, University of New Brunswick, Fredericton, E3B4H7 Canada 0000 0001 2205 0971grid.22254.33Pediatric Gastroenterology, Poznan Medical University, Poznan, 60-572 Poland 0000 0001 0710 330Xgrid.15822.3cMiddlesex University, London, NW4 4BT United Kingdom 0000 0004 5903 394Xgrid.417907.cSHAS, St Mary‚Äôs University Twickenham, Twickenham, TW1 4SX United Kingdom 0000 0001 0710 330Xgrid.15822.3cMiddlesex University, London, NW4 4BT United Kingdom 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence-based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cDongfang Hospital, Beijing University of Chinese  Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cEvidence-based medicine center, Beijing University of Chinese Medicine, Beijing, China 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied sciences, Leiden, 2300 AJ Netherlands 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied sciences, Leiden, 2300 AJ Netherlands 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied sciences, Leiden, 2300 AJ Netherlands 0000 0004 1936 8403grid.9909.9School of Heathcare, University of Leeds Alumnus, Rochdale, OL12 7RX United Kingdom grid.427946.aMusic Therapy, Berklee College of Music, Boston, 02215 USA Klinik Arlesheim, Arlesheim, 4144 Switzerland Klinik Arlesheim, Arlesheim, 4144 Switzerland Klinik Arlesheim, Arlesheim, 4144 Switzerland Klinik √ñschelbronn, Niefern-√ñschelbronn, Germany 0000 0001 2108 9006grid.7307.3University of Augsburg, Augsburg, Germany 0000 0001 0671 5021grid.255168.dCollege of Korean Medicine, Dongguk University, Goyang, South Korea 0000 0001 0671 5021grid.255168.dPreventive Medicine, College of Korean Medicine,  Dongguk University, Gyeongju, South Korea 0000 0001 2149 6891grid.412529.9Psychology, Pontificia Universidade Cat√≥lica de Sao Paulo, Rio de Janeiro, 22430 Brazil grid.448722.fResearch Institute for Creative Arts Therapies (RIArT), Alanus University of Arts and Social Sciences, Alfter/Bonn, 53347 Germany grid.448722.fResearch Institute for Creative Arts Therapies (RIArT), Alanus University of Arts and Social Sciences, Alfter/Bonn, 53347 Germany 0000 0000 9024 6397grid.412581.bTheory of Medicine, Integrative and Anthroposophic Medicine, Witten/Herdecke University, Herdecke, 58313 Germany DGOM e.V./HGMB i.G, Buxtehude, 21614 Germany DGOM e.V./HGMB i.G, Buxtehude, 21614 Germany 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied sciences, Leiden, 2300 AJ Netherlands 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied sciences, Leiden, 2300 AJ Netherlands 0000000120346234grid.5477.1Anthroposphic Health Care, University of applied sciences, Leiden, 2300 AJ Netherlands 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London, United Kingdom 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London, United Kingdom 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London, United Kingdom 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London, United Kingdom 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0001 2112 2291grid.4756.0School of Health and Social Care, London South Bank University, London, SE1 0AA United Kingdom 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London, United Kingdom 0000 0004 0581 2008grid.451052.7Royal Brompton and Harefield NHS Trust, London, United Kingdom 0000 0001 0514 7202grid.411249.bUNIFESP, Sao Paulo, 04753-060 Brazil 0000 0001 0514 7202grid.411249.bUNIFESP, Sao Paulo, 04753-060 Brazil 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, 71348457 Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, 71348457 Iran, Islamic Republic of Centre of Acupuncture and Traditional Chinese Medicine, Tuscan network for Integrative Medicine, Florence, 50133 Italy Tuscan network for Integrative Medicine, Florence, 50139 Italy Tuscan network for Integrative Medicine, Florence, 50139 Italy Tuscan network for Integrative Medicine, Florence, 50139 Italy Health Directorate, Region of Tuscany, Florence, 50139 Italy Centre of Acupuncture and Traditional Chinese Medicine, Tuscan network for Integrative Medicine, Florence, 50133 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Tuscan Network of Integrative Medicine, Florence, 50139 Italy Health Directorate, Region of Tuscany, Florence, 50139 Italy Eurythm Therapy, Raphael Medical Centre, Hildenborough, United Kingdom Eurythm Therapy, Raphael Medical Centre, Hildenborough, United Kingdom Eurythm Therapy, Raphael Medical Centre, Hildenborough, United Kingdom 0000 0000 8809 1613grid.7372.1Warwick Medical School, University of Warwick, Coventry, CV4 7AL United Kingdom 0000 0000 8809 1613grid.7372.1Warwick Medical School, University of Warwick, Coventry, CV4 7AL United Kingdom 0000 0000 8809 1613grid.7372.1Warwick Medical School, University of Warwick, Coventry, CV4 7AL United Kingdom 0000 0001 2188 0957grid.410445.0Office of Public Health Studies, University of Hawaii, Honolulu, HI USA Van Praag Instituut, Utrecht, 3511 VH Netherlands STZ Association of Teaching Hospitals, Utrecht, Netherlands 0000000122931605grid.5590.9Internal Medicine, Radboud University Medical School,  Nijmegen, Netherlands 0000000092621349grid.6906.9Surgery, Erasmus University Medical School, Rotterdam, Netherlands Ministery of Health, Den Haag, Netherlands grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina grid.440480.cHospital de Pediatria Garrahan, Universidad Maimonides, Buenos Aires, 1245 Argentina 0000 0000 8848 7685grid.411866.cThe TCM Clinical Outcome Assessment Team, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China Science and Technology Division, State Administration of Traditional Chinese Medicine of the People of China, Beijing, 100027 China 0000 0000 8848 7685grid.411866.cThe TCM Clinical Outcome Assessment Team, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120 China Science and Technology Division, State Administration of Traditional Chinese Medicine of the People of China, Beijing, 100027 China ONBODYCLINIC, Seoul, South Korea ONBODYCLINIC, Seoul, South Korea ONBODYCLINIC, Seoul, South Korea Department of Ayurveda, Ministry of Health, Kathmandu, Nepal 0000 0001 0617 3250grid.419802.6Sozialstiftung Bamberg, Bamberg, 96049 Germany 0000 0001 0617 3250grid.419802.6Sozialstiftung Bamberg, Bamberg, 96049 Germany grid.415779.9Public Policies, Ministry of Health, Santiago, 8320000 Chile grid.415779.9Public Policies, Ministry of Health, Santiago, 8320000 Chile grid.415779.9Ministry of Health, Public Policies, Santiago, Chile grid.415779.9Public Policies, Ministry of Health, Santiago, Chile Department of Quality of Life and Labor Relations, Chilean Health Ministry, Santiago, Chile Chilean Health Service, Santiago, Chile Department of health explicit guarantees and High Complexity Networks, Chilean Health Ministry, Santiago, Chile Nat≈´raliosios terapijos centras, Vilnius, 08119 Lithuania 0000 0000 9962 2299grid.459858.dDepartment of Nutritional Medicine, Endeavour College of Natural Health, Sydney, 2000 Australia Pharmacy, UPIS, Bras√≠lia, 70390-12 Brazil Pharmacy, UPIS, Bras√≠lia, 70390-12 Brazil Natural Pet, Bras√≠lia, Brazil Pharmacy, UPIS, Bras√≠lia, 70390-12 Brazil 0000 0000 8819 4698grid.412571.4Museum, Archives and Cultural Studies of Norani Vesal, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Museum, Archives and Cultural Studies of Norani Vesal, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of 0000 0000 8819 4698grid.412571.4Museum, Archives and Cultural Studies of Norani Vesal, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic Republic of BDORT Center, Belgrade, 11000 Serbia BDORT Center, Belgrade, 11000 Serbia BDORT Center, Belgrade, 11000 Serbia BDORT Center, Belgrade, 11000 Serbia Office of Hawaiian Affairs, Honolulu, HI USA 0000 0004 1937 116Xgrid.4491.8Charles University, Hradec Kralove, 50005 Czech Republic 0000 0004 1937 116Xgrid.4491.8Charles University, Hradec Kralove, 50005 Czech Republic 0000 0004 1937 116Xgrid.4491.8Charles University, Hradec Kralove, 50005 Czech Republic 0000 0000 8749 5149grid.418980.cKorea Institute of Oriental Medicine, Daejeon, South Korea 0000 0004 0478 9977grid.412004.3Obstetrics, University Hospital Zurich, Zurich, Switzerland 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, Netherlands 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, Netherlands 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, Netherlands 0000 0001 0481 6099grid.5012.6Epidemiology,CAPHRI School for Public Health and Primary Care, Maastricht University, Maastricht, Netherlands 0000 0001 0663 9479grid.9679.1Faculty of Health Sciences, University of Pecs, Pecs, Hungary 0000 0001 0663 9479grid.9679.1Confucius Institute of TCM, University of Pecs, Pecs, Hungary 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0001 1431 9176grid.24695.3cCenter for Evidence Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China 0000 0004 0632 3409grid.410318.fChina Academy of Chinese Medical Sciences, Guang‚Äôanmen Hospital, Beijing, China},
note  = {doi:10.1186/s12906-017-1784-2.}
}

@Article{201782,
author  = {Torrado, J. and Gomez, J. and Montoro, G.},
title  = {Smartwatches for Monitoring and Interaction.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {17},
number  = {6},
pages  = {},
year  = {2017},
abstract  = {In this paper, we analyze the needs of individuals with Autism Spectrum Disorders (ASD) to have a pervasive, feasible and non-stigmatizing form of assistance in their emotional self-regulation, in order to ease certain behavioral issues that  undermine their mental health throughout their life. We argue the potential of recent widespread wearables, and more specifically smartwatches, to achieve this  goal. Then, a smartwatch system that implements a wide range of self-regulation strategies and infers outburst patterns from physiological signals and movement is presented, along with an authoring tool for smartphones that is to be used by  caregivers or family members to create and edit these strategies, in an adaptive  way. We conducted an intensive experiment with two individuals with ASD who showed varied, representative behavioral responses to their emotional dysregulation. Both users were able to employ effective, customized emotional self-regulation strategies by means of the system, recovering from the majority of mild stress episodes and temper tantrums experienced in the nine days of experiment in their classroom.},
address  = {},
note  = {Sensors (Basel). 2017 Jun 11;17(6):. doi:10.3390/s17061359.}
}

@Article{201783,
author  = {Enriquez-Geppert, S. and Huster, R. and Herrmann, C.},
title  = {Tutorial.},
journal  = {Frontiers in Human Neuroscience},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Neurofeedback is attracting renewed interest as a method to self-regulate one‚Äôs own brain activity to directly alter the underlying neural mechanisms of cognition and behavior. It not only promises new avenues as a method for cognitive enhancement in healthy subjects, but also as a therapeutic tool. In the current article, we present a review tutorial discussing key aspects relevant to  the development of electroencephalography (EEG) neurofeedback studies. In addition, the putative mechanisms underlying neurofeedback learning are considered. We highlight both aspects relevant for the practical application of neurofeedback as well as rather theoretical considerations related to the development of new generation protocols. Important characteristics regarding the  set-up of a neurofeedback protocol are outlined in a step-by-step way. All these  practical and theoretical considerations are illustrated based on a protocol and  results of a frontal-midline theta up-regulation training for the improvement of  executive functions. Not least, assessment criteria for the validation of neurofeedback studies as well as general guidelines for the evaluation of training efficacy are discussed.},
address  = {Department of Clinical and Developmental Neuropsychology, Faculty of Behavioural  and Social Sciences, University of GroningenGroningen, Netherlands Department of Psychology, Faculty of Social Sciences, University of OsloOslo, Norway Experimental Psychology Laboratory, Department of Psychology, Faculty VI Medical  and Health Sciences, University of OldenburgOldenburg, Germany},
note  = {Front Hum Neurosci. 2017 Feb 22;11:. doi:10.3389/fnhum.2017.00051.}
}

@Article{201684,
author  = {},
title  = {North Carolina.},
journal  = {Journal of the American Association for Laboratory Animal Science : JAALAS},
volume  = {55},
number  = {5},
pages  = {606-710},
year  = {2016},
abstract  = {},
address  = {},
note  = {J Am Assoc Lab Anim Sci. 2016 Sep;55(5):606-710. Epub 2016 Sep}
}

@Article{201685,
author  = {Lin, Q. and Han, Y.},
title  = {A Dual-Field Sensing Scheme for a Guidance System for the Blind.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {5},
pages  = {},
year  = {2016},
abstract  = {An electronic guidance system is very helpful in improving blind people‚Äôs perceptions in a local environment. In our previous work ‚ÄúLin, Q.; Han, Y. A Context-Aware-Based Audio Guidance System for Blind People Using a Multimodal Profile Model. Sensors 2014, 14, 18670‚Äì18700‚Ä?, a context-aware guidance system using a combination of a laser scanner and a camera was proposed. By using a near-field graphical model, the proposed system could interpret a near-field scene in very high resolution. In this paper, our work is extended by adding a far-field graphical model. The integration of the near-field and the far-field models constitutes a dual-field sensing scheme. In the near-field range, reliable inference of the ground and object status is obtained by fusing range data and image data using the near-field graphical model. In the far-field range, which only the camera can cover, the far-field graphical model is proposed to interpret far-field image data based on appearance and spatial prototypes built using the near-field interpreted data. The dual-field sensing scheme provides a solution for the guidance systems to optimise their scene interpretation capability using  simple sensor configurations. Experiments under various local conditions were conducted to show the efficiency of the proposed scheme in improving blind people‚Äôs perceptions in urban environments.},
address  = {Sports-IT Convergence Department, Soongsil University, 511, Sangdo-Dong, Dongjak-Gu, Seoul 156-743, Korea; linqing15@ssu.ac.kr Department of Smart Systems Software, Soongsil University, 511, Sangdo-Dong, Dongjak-Gu, Seoul 156-743, Korea},
note  = {Sensors (Basel). 2016 May 11;16(5):. doi:10.3390/s16050667.}
}

@Article{201586,
author  = {Bittner, A. and Wykstra, S. and Yoshinaga, P. and Li, T.},
title  = {Telerehabilitation for people with low vision.},
journal  = {The Cochrane database of systematic reviews},
volume  = {8},
number  = {},
pages  = {CD011019},
year  = {2015},
abstract  = {Background: Low vision affects over 300 million people worldwide and can compromise both activities of daily living and quality of life. Rehabilitative training and vision assistive equipment (VAE) may help, but some visually impaired people have limited resources to attend in-person visits at rehabilitation clinics. These people may be able to overcome barriers to care through remote, Internet-based consultation (i.e., telerehabilitation). Objectives: To compare the effects of telerehabilitation with face-to-face (e.g., in-office or inpatient) vision rehabilitation services for improving vision-related quality of life and reading speed in people with visual function loss due to any ocular condition. Secondary objectives are to evaluate compliance with scheduled rehabilitation sessions, abandonment rates for visual assistive equipment devices, and patient satisfaction ratings. Search methods: We searched  CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (2015 Issue 5), Ovid MEDLINE, Ovid MEDLINE In-Process and Other Non-Indexed Citations,  Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1980 to June 2015), EMBASE (January  1980 to June 2015), PubMed (1980 to June 2015), ClinicalTrials.gov (www.clinicaltrials.gov) and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any language restriction or study design filter in the electronic searches; however, we restricted the searches from 1980 onwards because the Internet was not introduced to the public until 1982. We last searched the electronic databases on 15 June 2015. Selection criteria: We planned to include randomized controlled trials (RCTs) or controlled clinical trials (CCTs) in which participants were diagnosed with low vision and were undergoing low vision rehabilitation using an Internet, web-based technology compared with an approach  based on in-person consultations. Data collection and analysis: Two authors independently screened titles and abstracts, and then full-text articles against  the eligibility criteria. We planned to have two authors independently abstract data from included studies. We resolved discrepancies by discussion. Main results: We did not find any study that met the inclusion criteria for this review and, hence, we did not conduct a quantitative analysis. As a part of the background, we discussed review articles on telemedicine for facilitating communication with elderly individuals or for providing remote ophthalmological care. Authors‚Äô conclusions: We did not find any evidence on whether the use of telerehabilitation is feasible or a potentially viable means to remotely deliver  rehabilitation services to individuals with low vision. Given the disease burden  and the growing interest in telemedicine, there is a need for future pilot studies and subsequent clinical trials to explore the potential for telerehabilitation as a platform for providing services to people with low vision.},
address  = {Nova Southeastern University, College of Optometry, Ft Lauderdale, Florida, USA. Innovations for Poverty Action, New Haven, Connecticut, USA. Southern California College of Optometry, Marshall B Ketchum University, Fullerton, California, USA. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA},
note  = {doi:10.1002/14651858.CD011019.pub2.}
}

@Article{201587,
author  = {Lonstein, J. and L√©vy, F. and Fleming, A.},
title  = {non-human and human mammals.},
journal  = {Hormones and behavior},
volume  = {73},
number  = {},
pages  = {156-85},
year  = {2015},
abstract  = {Maternal interactions with young occupy most of the reproductive period for female mammals and are absolutely essential for offspring survival and development. The hormonal, sensory, reward-related, emotional, cognitive and neurobiological regulators of maternal caregiving behaviors have been well studied in numerous subprimate mammalian species, and some of the importance of this body of work is thought to be its relevance for understanding similar controls in humans. We here review many of the important biopsychological influences on maternal behaviors in the two best studied non-human animals, laboratory rats and sheep, and directly examine how the conceptual framework established by some of the major discoveries in these animal ‚Äúmodels‚Ä? do or do not hold for our understanding of human mothering. We also explore some of the limits for extrapolating from non-human animals to humans. We conclude that there are many similarities between non-human and human mothers in the biological and psychological factors influencing their early maternal behavior and that many of  the differences are due to species-characteristic features related to the role of hormones, the relative importance of each sensory system, flexibility in what behaviors are exhibited, the presence or absence of language, and the complexity  of cortical function influencing the behavior.},
address  = {Neuroscience Program and Department of Psychology, 108 Giltner Hall, Michigan State University, East Lansing, MI 48824 USA, Lonstein@msu.edu Physiologie de la Reproduction et des Comportements, INRA-CNRS-Universit√© de Tours-Haras Nationaux, Nouzilly, 37380 France, Frederic.Levy@tours.inra.fr Fraser Mustard Institute for Human Development & Department of Psychology, University of Toronto at Mississauga, 3359 Mississauga Road, Mississauga, ON L5L  1C6 Canada, alison.fleming@utoronto.ca},
note  = {Horm Behav. 2015 Jul;73:156-85. Epub 2015 Jun 27 doi:10.1016/j.yhbeh.2015.06.011.}
}

@Article{201588,
author  = {},
title  = {2014 Diabetes Technology Meeting Abstracts.},
journal  = {Journal of Diabetes Science and Technology},
volume  = {9},
number  = {2},
pages  = {342-485},
year  = {2015},
abstract  = {},
address  = {},
note  = {J Diabetes Sci Technol. 2015 Mar 1;9(2):342-485. doi:10.1177/1932296815570777.}
}

@Article{201589,
author  = {Rand, K. and Creem-Regehr, S. and Thompson, W.},
title  = {attention and mobility monitoring.},
journal  = {Journal of experimental psychology. Human perception and performance},
volume  = {41},
number  = {3},
pages  = {649-64},
year  = {2015},
abstract  = {The ability to navigate without getting lost is an important aspect of quality of life. In five studies, we evaluated how spatial learning is affected by the increased demands of keeping oneself safe while walking with degraded vision (mobility monitoring). We proposed that safe low-vision mobility requires attentional resources, providing competition for those needed to learn a new environment. In Experiments 1 and 2 participants navigated along paths in a real-world indoor environment with simulated degraded vision or normal vision. Memory for object locations seen along the paths was better with normal compared  to degraded vision. With degraded vision, memory was better when participants were guided by an experimenter (low monitoring demands) versus unguided (high monitoring demands). In Experiments 3 and 4, participants walked while performing an auditory task. Auditory task performance was superior with normal compared to  degraded vision. With degraded vision, auditory task performance was better when  guided compared to unguided. In Experiment 5, participants performed both the spatial learning and auditory tasks under degraded vision. Results showed that attention mediates the relationship between mobility-monitoring demands and spatial learning. These studies suggest that more attention is required and spatial learning is impaired when navigating with degraded viewing.},
address  = {Department of Psychology, University of Utah Department of Psychology, University of Utah School of Computing, University of Utah},
note  = {doi:10.1037/xhp0000040.}
}

@Article{201490,
author  = {Maciejasz, P. and Eschweiler, J. and Gerlach-Hahn, K. and Jansen-Troy, A. and Leonhardt, S.},
title  = {A survey on robotic devices for upper limb rehabilitation.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {11},
number  = {},
pages  = {3},
year  = {2014},
abstract  = {The existing shortage of therapists and caregivers assisting physically disabled  individuals at home is expected to increase and become serious problem in the near future. The patient population needing physical rehabilitation of the upper  extremity is also constantly increasing. Robotic devices have the potential to address this problem as noted by the results of recent research studies. However, the availability of these devices in clinical settings is limited, leaving plenty of room for improvement. The purpose of this paper is to document a review of robotic devices for upper limb rehabilitation including those in developing phase in order to provide a comprehensive reference about existing solutions and facilitate the development of new and improved devices. In particular the following issues are discussed: application field, target group, type of assistance, mechanical design, control strategy and clinical evaluation. This paper also includes a comprehensive, tabulated comparison of technical solutions  implemented in various systems.},
address  = {DEMAR - LIRMM, INRIA, University of Montpellier 2, CNRS, Montpellier, 161 rue Ada, 34095 Montpellier, France Chair of Medical Engineering (mediTEC), Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstra√üe 20, 52074 Aachen, Germany Philips Chair of Medical Information Technology (MedIT), Helmholtz-Institute for  Biomedical Engineering, RWTH Aachen University, Pauwelsstra√üe 20, 52074 Aachen, Germany Chair of Medical Engineering (mediTEC), Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University, Pauwelsstra√üe 20, 52074 Aachen, Germany Philips Chair of Medical Information Technology (MedIT), Helmholtz-Institute for  Biomedical Engineering, RWTH Aachen University, Pauwelsstra√üe 20, 52074 Aachen, Germany},
note  = {J Neuroeng Rehabil. 2014 Jan 9;11:3. doi:10.1186/1743-0003-11-3.}
}

@Article{201391,
author  = {},
title  = {Acute Pain.},
journal  = {British Journal of Pain},
volume  = {7},
number  = {2 Suppl},
pages  = {5-76},
year  = {2013},
abstract  = {},
address  = {},
note  = {Br J Pain. 2013 Apr;7(2 Suppl):5-76. doi:10.1177/2049463713481587.}
}

@Article{201392,
author  = {Wang, R. and Korotchenko, A. and Clarke, L. and Ben, M. and Mihailidis, A.},
title  = {Prescriber Perspectives.},
journal  = {Journal of rehabilitation research and development},
volume  = {50},
number  = {9},
pages  = {1287-300},
year  = {2013},
abstract  = {Collision avoidance technology has the capacity to facilitate safer mobility among older power mobility users with physical, sensory and cognitive impairments, thus enabling independence for more potential users. However, little is known about consumers‚Äô perceptions of collision avoidance. This article draws  on interviews with 29 users, five caregivers, and 10 prescribers to examine views on the design and utilization of this technology. Data analysis identified three  themes: ‚Äúuseful situations or contexts‚Ä?, ‚Äútechnology design issues and real life  application‚Ä?, and ‚Äúappropriateness of collision avoidance technology for a variety of users‚Ä?. Findings support the ongoing development of collision avoidance for older adult users. The majority of participants were supportive of  the technology, and felt that it might benefit current power mobility users and users with visual impairments, but might be unsuitable for people with significant cognitive impairments. Some participants voiced concerns regarding the risk for injury with power mobility use and some identified situations where  collision avoidance might be beneficial (driving backwards, avoiding dynamic obstacles, negotiating outdoor barriers, and learning power mobility use). Design issues include the need for context awareness, reliability, and user interface specifications. Furthermore, user desire to maintain driving autonomy indicates the need to develop collaboratively-controlled systems. This research lays the groundwork for future development by identifying and illustrating consumer needs  for this technology.},
address  = {Intelligent Assistive Technology and Systems Lab, Toronto Rehabilitation Institute and University of Toronto School of Kinesiology, The University of British Columbia School of Kinesiology, The University of British Columbia Gerontology Research Centre, Simon Fraser University Intelligent Assistive Technology and Systems Lab, Toronto Rehabilitation Institute and University of Toronto},
note  = {J Rehabil Res Dev. 2013;50(9):1287-300. doi:10.1682/JRRD.2012.10.0181.}
}

@Article{201293,
author  = {Price, C.},
title  = {speech, spoken language and reading.},
journal  = {Neuroimage},
volume  = {62},
number  = {2},
pages  = {816-47},
year  = {2012},
abstract  = {The anatomy of language has been investigated with PET or fMRI for more than 20¬†years. Here I attempt to provide an overview of the brain areas associated with heard speech, speech production and reading. The conclusions of many hundreds of studies were considered, grouped according to the type of processing, and reported in the order that they were published. Many findings have been replicated time and time again leading to some consistent and undisputable conclusions. These are summarised in an anatomical model that indicates the location of the language areas and the most consistent functions that have been assigned to them. The implications for cognitive models of language processing are also considered. In particular, a distinction can be made between processes that are localized to specific structures (e.g. sensory and motor processing) and processes where specialisation arises in the distributed pattern of activation over many different areas that each participate in multiple functions. For example, phonological processing of heard speech is supported by the functional integration of auditory processing and articulation; and orthographic processing  is supported by the functional integration of visual processing, articulation and semantics. Future studies will undoubtedly be able to improve the spatial precision with which functional regions can be dissociated but the greatest challenge will be to understand how different brain regions interact with one another in their attempts to comprehend and produce language.},
address  = {},
note  = {Neuroimage. 2012 Aug 15;62(2):816-47. doi:10.1016/j.neuroimage.2012.04.062.}
}

@Article{201294,
author  = {Bouchard, S. and Bernier, F. and Boivin, √. and Morin, B. and Robillard, G.},
title  = {Effectiveness of Stress Management Skills in Soldiers.},
journal  = {PLoS ONE},
volume  = {7},
number  = {4},
pages  = {},
year  = {2012},
abstract  = {This study assessed the efficacy of using visual and auditory biofeedback while immersed in a tridimensional videogame to practice a stress management skill (tactical breathing). All 41 participants were soldiers who had previously received basic stress management training and first aid training in combat. On the first day, they received a 15-minute refresher briefing and were randomly assigned to either: (a) no additional stress management training (SMT) for three  days, or (b) 30-minute sessions (one per day for three days) of biofeedback-assisted SMT while immersed in a horror/first-person shooter game. The training was performed in a dark and enclosed environment using a 50-inch television with active stereoscopic display and loudspeakers. On the last day, all participants underwent a live simulated ambush with an improvised explosive device, where they had to provide first aid to a wounded soldier. Stress levels were measured with salivary cortisol collected when waking-up, before and after the live simulation. Stress was also measured with heart rate at baseline, during an apprehension phase, and during the live simulation. Repeated-measure ANOVAs and ANCOVAs confirmed that practicing SMT was effective in reducing stress. Results are discussed in terms of the advantages of the proposed program for military personnel and the need to practice SMT.},
address  = {Universit√© du Qu√©bec en Outaouais, Gatineau, Qu√©bec, Canada Defence Research and Development Canada ‚Äì ValCartier, Qu√©bec, Canada Defence Research and Development Canada ‚Äì ValCartier, Qu√©bec, Canada Clinique de Psychologie Cognitive, Qu√©bec, Canada Universit√© du Qu√©bec en Outaouais, Gatineau, Qu√©bec, Canada},
note  = {PLoS One. 2012 Apr 27;7(4):. doi:10.1371/journal.pone.0036169.}
}

@Article{201295,
author  = {},
title  = {translational science 2012 meeting abstracts.},
journal  = {Clinical and Translational Science},
volume  = {5},
number  = {2},
pages  = {141-210},
year  = {2012},
abstract  = {},
address  = {},
note  = {doi:10.1111/j.1752-8062.2012.00398.x.}
}

@Article{201296,
author  = {},
title  = {ECR 2012 Book of Abstracts - A - Postergraduate Educational Programme.},
journal  = {Insights into Imaging},
volume  = {3},
number  = {Suppl 1},
pages  = {1-134},
year  = {2012},
abstract  = {},
address  = {},
note  = {Insights Imaging. 2012 Mar 21;3(Suppl 1):1-134. doi:10.1007/s13244-012-0153-4.}
}

@Article{200997,
author  = {Tsai, P. and Kaufhold, J. and Blinder, P. and Friedman, B. and Drew, P. and Karten, H. and Lyden, P. and Kleinfeld, D.},
title  = {direct counting and colocalization of nuclei and vessels.},
journal  = {Neuroscience},
volume  = {29},
number  = {46},
pages  = {14553-70},
year  = {2009},
abstract  = {It is well known that the density of neurons varies within the adult brain. In neocortex, this includes variations in neuronal density between different lamina  as well as between different regions. Yet the concomitant variation of the microvessels is largely uncharted. Here we present automated histological, imaging, and analysis tools to simultaneously map the locations of all neuronal and non-neuronal nuclei and the centerlines and diameters of all blood vessels within thick slabs of neocortex from mice. Based on total inventory measurements  of different cortical regions (~ 107 cells vectorized across brains), these methods revealed: (1) In three dimensions, the mean distance of the center of neuronal somata to the closest microvessel was 14 Œºm. (2) Volume samples within lamina of a given region show that the density of microvessels does not match the strong laminar variation in neuronal density. This holds for both agranular and granular cortex. (3) Volume samples in successive radii from the midline to the ventral-lateral edge, where each volume summed the number of cells and microvessels from the pia to the white matter, show a significant correlation between neuronal and microvessel densities. These data show that while neuronal and vascular densities do not track each other on the 100 Œºm scale of cortical lamina, they do track each other on the 1 ‚Äì 10 mm scale of the cortical mantle. The absence of a disproportionate density of blood vessels in granular lamina is  argued to be consistent with the initial locus of functional brain imaging signals.},
address  = {Department of Physics, University of California, San Diego SAIC Intelligent Systems Division, Arlington, VA Department of Physics, University of California, San Diego Department of Pharmacology, University of California School of Medicine, San Diego Department of Physics, University of California, San Diego Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA Department of Physics, University of California, San Diego},
note  = {J Neurosci. 2009 Nov 18;29(46):14553-70. doi:10.1523/JNEUROSCI.3287-09.2009.}
}

@Article{200998,
author  = {},
title  = {Scientific Abstracts.},
journal  = {Journal of General Internal Medicine},
volume  = {24},
number  = {Suppl 1},
pages  = {1-380},
year  = {2009},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11606-009-0963-3.}
}

@Article{200999,
author  = {YOUNG, J. and POWELL, S. and RISBROUGH, V. and MARSTON, H. and GEYER, M.},
title  = {for research in schizophrenia.},
journal  = {Pharmacology & therapeutics},
volume  = {122},
number  = {2},
pages  = {150-202},
year  = {2009},
abstract  = {Cognitive deficits in schizophrenia are among the core symptoms of the disease, correlate with functional outcome, and are not well treated with current antipsychotic therapies. In order to bring together academic, industrial, and governmental bodies to address this great ‚Äòunmet therapeutic need‚Äô, the NIMH sponsored the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) initiative. Through careful factor analysis and consensus of expert opinion, MATRICS identified seven domains of cognition that are deficient in schizophrenia (attention/vigilance, working memory, reasoning and problem solving, processing speed, visual learning and memory, verbal learning and memory, and social cognition) and recommended a specific neuropsychological test battery to probe these domains. In order to move the field forward and outline an approach for translational research, there is a need for a ‚Äúpreclinical MATRICS‚Ä? to develop a rodent test battery that is appropriate for drug development. In this review, we outline such an approach and review current  rodent tasks that target these seven domains of cognition. The rodent tasks are discussed in terms of their validity for probing each cognitive domain as well as a brief overview of the pharmacology and manipulations relevant to schizophrenia  for each task.},
address  = {},
note  = {doi:10.1016/j.pharmthera.2009.02.004.}
}

@Article{2009100,
author  = {},
title  = {Abstracts for the 12th International Congress on Schizophrenia Research (ICOSR).},
journal  = {Schizophrenia Bulletin},
volume  = {35},
number  = {Suppl 1},
pages  = {1-377},
year  = {2009},
abstract  = {},
address  = {},
note  = {Schizophr Bull. 2009 Mar;35(Suppl 1):1-377. doi:10.1093/schbul/sbn173.}
}

@Article{2012101,
author  = {Nicolas-Alonso, L. and Gomez-Gil, J.},
title  = {Brain Computer Interfaces, a Review.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {12},
number  = {2},
pages  = {1211-79},
year  = {2012},
abstract  = {A brain-computer interface (BCI) is a hardware and software communications system that permits cerebral activity alone to control computers or external devices. The immediate goal of BCI research is to provide communications capabilities to severely disabled people who are totally paralyzed or ‚Äòlocked in‚Äô by neurological neuromuscular disorders, such as amyotrophic lateral sclerosis, brain stem stroke, or spinal cord injury. Here, we review the state-of-the-art of BCIs, looking at the different steps that form a standard BCI: signal acquisition, preprocessing or signal enhancement, feature extraction, classification and the control interface. We discuss their advantages, drawbacks, and latest advances, and we survey the numerous technologies reported in the scientific literature to  design each step of a BCI. First, the review examines the neuroimaging modalities used in the signal acquisition step, each of which monitors a different functional brain activity such as electrical, magnetic or metabolic activity. Second, the review discusses different electrophysiological control signals that  determine user intentions, which can be detected in brain activity. Third, the review includes some techniques used in the signal enhancement step to deal with  the artifacts in the control signals and improve the performance. Fourth, the review studies some mathematic algorithms used in the feature extraction and classification steps which translate the information in the control signals into  commands that operate a computer or other device. Finally, the review provides an overview of various BCI applications that control a range of devices.},
address  = {},
note  = {Sensors (Basel). 2012 Jan 31;12(2):1211-79. doi:10.3390/s120201211.}
}

@Article{2007102,
author  = {Krewski, D. and Yokel, R. and Nieboer, E. and Borchelt, D. and Cohen, J. and Harry, J. and Kacew, S. and Lindsay, J. and Mahfouz, A. and Rondeau, V.},
title  = {HYDROXIDE.},
journal  = {Journal of toxicology and environmental health. Part B, Critical reviews},
volume  = {10},
number  = {Suppl 1},
pages  = {1-269},
year  = {2007},
abstract  = {},
address  = {Department of Epidemiology and Community Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada College of Pharmacy and Graduate Center for Toxicology, University of Kentucky Medical Center, Kentucky, USA Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada and Institute of Community Medicine, University of Troms√∏, Norway SantaFe Health Alzheimer‚Äôs Disease Research Center, Department of Neuroscience, McKnight Brain Institute, University of Florida, USA Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, USA National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA McLaughlin Centre for Population Health Risk Assessment, Institute of Population  Health, University of Ottawa, Ottawa, Ontario, Canada Aging-Related Diseases Section, Surveillance Division, Public Health Agency of Canada, Ottawa, Ontario, Canada United States Environmental Protection Agency, Washington DC, USA INSERM E0338 (Biostatistic), Universit√© Victor Segalen Bordeaux 2, Bordeaux, France},
note  = {doi:10.1080/10937400701597766.}
}

@Article{2016103,
author  = {Fern√°ndez, A. and Usamentiaga, R. and Car√∫s, J. and Casado, R.},
title  = {Driver Distraction Using Visual-Based Sensors and Algorithms.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {11},
pages  = {},
year  = {2016},
abstract  = {Driver distraction, defined as the diversion of attention away from activities critical for safe driving toward a competing activity, is increasingly recognized as a significant source of injuries and fatalities on the roadway. Additionally,  the trend towards increasing the use of in-vehicle information systems is critical because they induce visual, biomechanical and cognitive distraction and  may affect driving performance in qualitatively different ways. Non-intrusive methods are strongly preferred for monitoring distraction, and vision-based systems have appeared to be attractive for both drivers and researchers. Biomechanical, visual and cognitive distractions are the most commonly detected types in video-based algorithms. Many distraction detection systems only use a single visual cue and therefore, they may be easily disturbed when occlusion or illumination changes appear. Moreover, the combination of these visual cues is a  key and challenging aspect in the development of robust distraction detection systems. These visual cues can be extracted mainly by using face monitoring systems but they should be completed with more visual cues (e.g., hands or body information) or even, distraction detection from specific actions (e.g., phone usage). Additionally, these algorithms should be included in an embedded device or system inside a car. This is not a trivial task and several requirements must  be taken into account: reliability, real-time performance, low cost, small size,  low power consumption, flexibility and short time-to-market. The key points for the development and implementation of sensors to carry out the detection of distraction will also be reviewed. This paper shows a review of the role of computer vision technology applied to the development of monitoring systems to detect distraction. Some key points considered as both future work and challenges ahead yet to be solved will also be addressed.},
address  = {Grupo TSK, Technological Scientific Park of Gij√≥n, 33203 Gij√≥n, Asturias, Spain;  juanluis.carus@grupotsk.com Department of Computer Science and Engineering, University of Oviedo, Campus de Viesques, 33204 Gij√≥n, Asturias, Spain; rusamentiaga@uniovi.es (R.U.); rcasado@lsi.uniovi.es (R.C.) Grupo TSK, Technological Scientific Park of Gij√≥n, 33203 Gij√≥n, Asturias, Spain;  juanluis.carus@grupotsk.com Department of Computer Science and Engineering, University of Oviedo, Campus de Viesques, 33204 Gij√≥n, Asturias, Spain; rusamentiaga@uniovi.es (R.U.); rcasado@lsi.uniovi.es (R.C.)},
note  = {Sensors (Basel). 2016 Oct 28;16(11):. doi:10.3390/s16111805.}
}

@Article{2015104,
author  = {Baumeister, D. and Tojo, L. and Tracy, D.},
title  = {Legal highs: staying on top of the flood of novel psychoactive substances.},
journal  = {Therapeutic Advances in Psychopharmacology},
volume  = {5},
number  = {2},
pages  = {97-132},
year  = {2015},
abstract  = {There has been growing clinical, public, and media awareness and concern about the availability and potential harmfulness of so-called ‚Äòlegal highs‚Äô, which are  more appropriately called new or novel psychoactive substances (NPS). A cat-and-mouse process has emerged wherein unknown chemists and laboratories are producing new, and as yet nonproscribed, compounds for human consumption; and as  soon as they are banned, which they inevitably are, slightly modified analogues are produced to circumvent new laws. This rapidly changing environment, 81 new substances were identified in 2013 alone, has led to confusion for clinicians, psychopharmacologists, and the public at large. Our difficulties in keeping up with the process has had a two-fold negative effect: the danger of ignoring what  is confusing; and the problem that some of the newer synthesized compounds appear ever more potent. This review aims to circumscribe a quick moving and growing field, and to categorize NPS into five major groups based upon their ‚Äòparent‚Äô compounds: stimulants similar to cocaine, amphetamines and ecstasy; cannabinoids; benzodiazepine based drugs; dissociatives similar to ketamine and phencyclidine (PCP); and those modelled after classic hallucinogens such as LSD and psilocybin. Pharmacodynamic actions, subjective and physical effects, harmfulness, risk of dependency and, where appropriate, putative clinical potentials are described for each class. Clinicians might encounter NPS in various ways: anecdotal reportage;  acute intoxication; as part of a substance misuse profile; and as a precipitant or perpetuating factor for longer-term physical and psychological ill health. Current data are overall limited, and much of our knowledge and treatment strategies are based upon those of the ‚Äòparent‚Äô compound. There is a critical need for more research in this field, and for professionals to make themselves more aware of this growing issue and how it might affect those we see clinically  and try to help: a brave new world of so-called ‚Äòpsychonauts‚Äô consuming NPS will  also need informed ‚Äòpsychotherapeutonauts‚Äô. The paper should serve as a primer for clinicians and interested readers, as well as provide a framework into which  to place the new substances that will inevitably be synthesized in the future.},
address  = {Department of Psychology, Institute of Psychiatry, King‚Äôs College, London, UK Stress, Psychiatry and Immunology Lab, Department of Psychological Medicine, Institute of Psychiatry, King's College, London, UK Consultant Psychiatrist and Associate Clinical Director, Oxleas NHS Foundation Trust, Princess Royal University Hospital, and Cognition, Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry, King‚Äôs College, London BR6 8NY, UK},
note  = {Ther Adv Psychopharmacol. 2015 Apr;5(2):97-132. doi:10.1177/2045125314559539.}
}

@Article{2008105,
author  = {},
title  = {APASL Seoul 2008 Meeting.},
journal  = {Hepatology International},
volume  = {2},
number  = {Suppl 3},
pages  = {213-552},
year  = {2008},
abstract  = {},
address  = {},
note  = {doi:10.1007/s12072-008-9101-2.}
}

@Article{2016106,
author  = {Haugen, B. and Alexander, E. and Bible, K. and Doherty, G. and Mandel, S. and Nikiforov, Y. and Pacini, F. and Randolph, G. and Sawka, A. and Schlumberger, M. and Schuff, K. and Sherman, S. and Sosa, J. and Steward, D. and Tuttle, R. and Wartofsky, L.},
title  = {Cancer.},
journal  = {Thyroid},
volume  = {26},
number  = {1},
pages  = {1-133},
year  = {2016},
abstract  = {Background: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for the management of these disorders were revised in 2009, significant scientific advances have occurred in the field. The  aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid nodules and differentiated thyroid cancer.Methods: The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including  electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles on adults were eligible for inclusion. The American College of Physicians Guideline  Grading System was used for critical appraisal of evidence and grading strength of recommendations for therapeutic interventions. We developed a similarly formatted system to appraise the quality of such studies and resultant recommendations. The guideline panel had complete editorial independence from the ATA. Competing interests of guideline task force members were regularly updated,  managed, and communicated to the ATA and task force members.Results: The revised  guidelines for the management of thyroid nodules include recommendations regarding initial evaluation, clinical and ultrasound criteria for fine-needle aspiration biopsy, interpretation of fine-needle aspiration biopsy results, use of molecular markers, and management of benign thyroid nodules. Recommendations regarding the initial management of thyroid cancer include those relating to screening for thyroid cancer, staging and risk assessment, surgical management, radioiodine remnant ablation and therapy, and thyrotropin suppression therapy using levothyroxine. Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, management of recurrent and metastatic disease, consideration for clinical trials and targeted therapy, as well as directions for future research.Conclusions: We have developed evidence-based recommendations to inform clinical decision-making  in the management of thyroid nodules and differentiated thyroid cancer. They represent, in our opinion, contemporary optimal care for patients with these disorders.},
address  = {University of Colorado School of Medicine, Aurora, Colorado. Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. The Mayo Clinic, Rochester, Minnesota. Boston Medical Center, Boston, Massachusetts. Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. The University of Siena, Siena, Italy. Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. University Health Network, University of Toronto, Toronto, Ontario, Canada. Institute Gustave Roussy and University Paris Sud, Villejuif, France. Oregon Health and Science University, Portland, Oregon. University of Texas M.D. Anderson Cancer Center, Houston, Texas. Duke University School of Medicine, Durham, North Carolina. University of Cincinnati Medical Center, Cincinnati, Ohio. Memorial Sloan Kettering Cancer Center, New York, New York. MedStar Washington Hospital Center, Washington, DC.},
note  = {Thyroid. 2016 Jan 01;26(1):1-133. doi:10.1089/thy.2015.0020.}
}

@Article{2017107,
author  = {DeSutter, D. and Stieff, M.},
title  = {for learning environments in science, technology, engineering, and mathematics.},
journal  = {Cognitive Research},
volume  = {2},
number  = {1},
pages  = {},
year  = {2017},
abstract  = {Spatial thinking is a vital component of the science, technology, engineering, and mathematics curriculum. However, to date, broad development of learning environments that target domain-specific spatial thinking is incomplete. The present article visits the problem of improving spatial thinking by first reviewing the evidence that the human mind is embodied: that cognition, memory, and knowledge representation maintain traces of sensorimotor impressions from acting and perceiving in a physical environment. In particular, we review the evidence that spatial cognition and the ways that humans perceive and conceive of space are embodied. We then propose a set of design principles to aid researchers, designers, and practitioners in creating and evaluating learning environments that align principled embodied actions to targets of spatial thinking in science, technology, engineering, and mathematics.},
address  = {0000 0001 2175 0319grid.185648.6Department of the Learning Sciences, University of Illinois-Chicago, Chicago, IL 60607 USA 0000 0001 2175 0319grid.185648.6Department of the Learning Sciences, University of Illinois-Chicago, Chicago, IL 60607 USA},
note  = {doi:10.1186/s41235-016-0039-y.}
}

@Article{2014108,
author  = {Lydon, D. and Wilson, S. and Child, A. and Geier, C.},
title  = {Adolescent Brain Maturation and Smoking: What We Know and Where We‚Äôre Headed.},
journal  = {Neuroscience and biobehavioral reviews},
volume  = {45},
number  = {},
pages  = {323-42},
year  = {2014},
abstract  = {Smoking is a leading cause of mortality and morbidity worldwide. Smoking initiation often occurs during adolescence. This paper reviews and synthesizes adolescent development and nicotine dependence literatures to provide an account  of adolescent smoking from onset to compulsive use. We extend neurobiological models of adolescent risk-taking, that focus on the interplay between incentive processing and cognitive control brain systems, through incorporating psychosocial and contextual factors specific to smoking, to suggest that adolescents are more vulnerable than adults to cigarette use generally, but that  individual differences exist placing some adolescents at increased risk for smoking. Upon smoking, adolescents are more likely to continue smoking due to the increased positive effects induced by nicotine during this period. Continued use  during adolescence, may be best understood as reflecting drug-related changes to  neural systems underlying incentive processing and cognitive control, resulting in decision-making that is biased towards continued smoking. Persistent changes following nicotine exposure that may underlie continued dependence are described. We highlight ways that interventions may benefit from a consideration of cognitive-neuroscience findings.},
address  = {Department of Human Development and Family Studies, College of Health and Human Development, The Pennsylvania State University, 315 Health and Human Development  ‚Äì East, University Park, PA 16802 Department of Psychology, The College of the Liberal Arts, The Pennsylvania State University, 311 Moore Building, University Park, PA 16802 Department of Human Development and Family Studies, College of Health and Human Development, The Pennsylvania State University, 315 Health and Human Development  ‚Äì East, University Park, PA 16802 Department of Human Development and Family Studies, College of Health and Human Development, The Pennsylvania State University, 315 Health and Human Development  ‚Äì East, University Park, PA 16802},
note  = {doi:10.1016/j.neubiorev.2014.07.003.}
}

@Article{2017109,
author  = {Hayes, J. and Kraemer, D.},
title  = {Grounded understanding of abstract concepts: The case of STEM learning.},
journal  = {Cognitive Research},
volume  = {2},
number  = {1},
pages  = {},
year  = {2017},
abstract  = {Characterizing the neural implementation of abstract conceptual representations has long been a contentious topic in cognitive science. At the heart of the debate is whether the ‚Äúsensorimotor‚Ä? machinery of the brain plays a central role  in representing concepts, or whether the involvement of these perceptual and motor regions is merely peripheral or epiphenomenal. The domain of science, technology, engineering, and mathematics (STEM) learning provides an important proving ground for sensorimotor (or grounded) theories of cognition, as concepts  in science and engineering courses are often taught through laboratory-based and  other hands-on methodologies. In this review of the literature, we examine evidence suggesting that sensorimotor processes strengthen learning associated with the abstract concepts central to STEM pedagogy. After considering how contemporary theories have defined abstraction in the context of semantic knowledge, we propose our own explanation for how body-centered information, as computed in sensorimotor brain regions and visuomotor association cortex, can form a useful foundation upon which to build an understanding of abstract scientific concepts, such as mechanical force. Drawing from theories in cognitive neuroscience, we then explore models elucidating the neural mechanisms involved in grounding intangible concepts, including Hebbian learning, predictive coding,  and neuronal recycling. Empirical data on STEM learning through hands-on instruction are considered in light of these neural models. We conclude the review by proposing three distinct ways in which the field of cognitive neuroscience can contribute to STEM learning by bolstering our understanding of how the brain instantiates abstract concepts in an embodied fashion.},
address  = {0000 0001 2179 2404grid.254880.3Department of Psychological and Brain Sciences, Dartmouth College, Moore Hall 3 Maynard St., Hanover, NH 03755 USA 0000 0001 2179 2404grid.254880.3Department of Education, Dartmouth College, 5 Maynard St., Hanover, NH 03755 USA},
note  = {Cogn Res. 2017;2(1):. Epub 2017 Jan 30 doi:10.1186/s41235-016-0046-z.}
}

@Article{2015110,
author  = {Marschark, M. and Spencer, L. and Durkin, A. and Borgna, G. and Convertino, C. and Machmer, E. and Kronenberger, W. and Trani, A.},
title  = {Understanding Language, Hearing Status, and Visual-Spatial Skills.},
journal  = {The Journal of Deaf Studies and Deaf Education},
volume  = {20},
number  = {4},
pages  = {310-30},
year  = {2015},
abstract  = {It is frequently assumed that deaf individuals have superior visual-spatial abilities relative to hearing peers and thus, in educational settings, they are often considered visual learners. There is some empirical evidence to support the former assumption, although it is inconsistent, and apparently none to support the latter. Three experiments examined visual-spatial and related cognitive abilities among deaf individuals who varied in their preferred language modality  and use of cochlear implants (CIs) and hearing individuals who varied in their sign language skills. Sign language and spoken language assessments accompanied tasks involving visual-spatial processing, working memory, nonverbal logical reasoning, and executive function. Results were consistent with other recent studies indicating no generalized visual-spatial advantage for deaf individuals and suggested that their performance in that domain may be linked to the strength of their preferred language skills regardless of modality. Hearing individuals performed more strongly than deaf individuals on several visual-spatial and self-reported executive functioning measures, regardless of sign language skills  or use of CIs. Findings are inconsistent with assumptions that deaf individuals are visual learners or are superior to hearing individuals across a broad range of visual-spatial tasks. Further, performance of deaf and hearing individuals on  the same visual-spatial tasks was associated with differing cognitive abilities,  suggesting that different cognitive processes may be involved in visual-spatial processing in these groups.},
address  = {Rochester Institute of Technology, New Mexico State University, Rochester Institute of Technology, Rochester Institute of Technology, Rochester Institute of Technology, Rochester Institute of Technology, Indiana University School of Medicine, and Georgia Institute of Technology},
note  = {doi:10.1093/deafed/env025.}
}

@Article{2013111,
author  = {Kunz, B. and Creem-Regehr, S. and Thompson, W.},
title  = {Locomotion? Investigations of Walking and Wheelchairs.},
journal  = {PLoS ONE},
volume  = {8},
number  = {2},
pages  = {},
year  = {2013},
abstract  = {The relationship between biomechanical action and perception of self-motion during walking is typically consistent and well-learned but also adaptable. This  perceptual-motor coupling can be recalibrated by creating a mismatch between the  visual information for self-motion and walking speed. Perceptual-motor recalibration of locomotion has been demonstrated through effects on subsequent walking without vision, showing that learned perceptual-motor coupling influences a dynamic representation of one's spatial position during walking. Our present studies test whether recalibration of wheelchair locomotion, a novel form of locomotion for typically walking individuals, similarly influences subsequent wheelchair locomotion. Furthermore, we test whether adaptation to the pairing of  visual information for self-motion during one form of locomotion transfers to a different locomotion modality. We find strong effects of perceptual-motor recalibration for matched locomotion modalities ‚Äì walking/walking and wheeling/wheeling. Transfer across incongruent locomotion modalities showed weak  recalibration effects. The results have implications both for theories of perceptual-motor calibration mechanisms and their effects on spatial orientation, as well as for practical applications in training and rehabilitation.},
address  = {Department of Psychology, University of Dayton, Dayton, Ohio, United States of America Department of Psychology, University of Utah, Salt Lake City, Utah, United States of America School of Computing, University of Utah, Salt Lake City, Utah, United States of America},
note  = {PLoS One. 2013 Feb 12;8(2):. doi:10.1371/journal.pone.0054446.}
}

@Article{2012112,
author  = {Bedny, M. and Pascual-Leone, A. and Dravida, S. and Saxe, R.},
title  = {plasticity in congenitally versus late blind adults.},
journal  = {Brain and language},
volume  = {122},
number  = {3},
pages  = {162-70},
year  = {2012},
abstract  = {Recent evidence suggests that blindness enables visual circuits to contribute to  language processing. We examined whether this dramatic functional plasticity has  a sensitive period. BOLD fMRI signal was measured in congenitally blind, late blind (blindness onset 9-years-old or later) and sighted participants while they  performed a sentence comprehension task. In a control condition, participants listened to backwards speech and made match/non-match to sample judgments. In both, congenitally and late blind participants BOLD signal increased in bilateral foveal-pericalcarine cortex during response preparation, irrespective of whether  the stimulus was a sentence or backwards speech. However, only in congenitally blind people left occipital areas (pericalcarine, extrastriate, fusiform and lateral) responded more to sentences than backwards speech. We conclude that age  of blindness onset constrains the non-visual functions of occipital cortex: while plasticity is present in both congenitally and late blind individuals, recruitment of visual circuits for language depends on blindness during childhood.},
address  = {Massachussetts Institute of Technology, Department of Brain and Cognitive Sciences, Cambridge MA, USA. Berenson-Allen Center for Noninvasive Brain Stimulation, Division of Cognitive Neurology, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Massachussetts Institute of Technology, Department of Brain and Cognitive Sciences, Cambridge MA, USA. Massachussetts Institute of Technology, Department of Brain and Cognitive Sciences, Cambridge MA, USA.},
note  = {doi:10.1016/j.bandl.2011.10.005.}
}

@Article{2013113,
author  = {},
title  = {ESPR 2013.},
journal  = {Pediatric Radiology},
volume  = {43},
number  = {Suppl 3},
pages  = {459-656},
year  = {2013},
abstract  = {},
address  = {},
note  = {doi:10.1007/s00247-013-2675-4.}
}

@Article{2016114,
author  = {Cassetta, B. and Goghari, V.},
title  = {a randomized controlled trial.},
journal  = {Trials},
volume  = {17},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: In most domains of cognition, individuals with schizophrenia are generally found to be one standard deviation below the mean of the controls. As a result, examining the impact of cognitive remediation in individuals with schizophrenia has been a burgeoning area of research. However, the state of the literature remains unclear as to which domains of cognition should be targeted to produce the most widespread and durable benefits for individuals with schizophrenia. One suggestion is that targeting lower-level cognitive processes that are important for higher-level and more complex aspects of cognition may produce the most widespread benefits in cognition and everyday functioning. Relatively few studies have examined the effects of working memory or processing  speed training in schizophrenia, as most studies examine broad-based remediation  programs. Thus, a need exists for targeted working memory and processing speed training studies to better understand the mechanisms of cognitive enhancement in patients. This study aims to 1) investigate near-transfer gains (that is, the transfer of learning to related contexts) associated with working memory and processing speed training in schizophrenia patients; 2) investigate far-transfer gains (that is, the transfer of learning to new contexts) associated with working memory and processing speed training (that is, gains in other neurocognitive domains and social cognition); and 3) investigate real-world gains associated with training (that is, gains in daily functioning). Methods/Design: A double-blind randomized controlled trial with a three parallel group design will  be conducted. A random sample of 81 patients with schizophrenia or schizoaffective disorder will be recruited through outpatient clinics at Foothills Hospital and community support programs in Calgary, Alberta. Participants will be randomly assigned using a computer-generated program in a 1:1:1 ratio to a working memory-training group, a processing speed-training group, or a no-training control group. Training will be completed at home for 30 minutes per day, 5 days per week, for a total of 10 weeks. Neurocognitive, social cognitive, and daily functioning measures will be administered both pre- and post-training to detect training-related gains. The primary outcome measures  will include working memory and processing speed (near-transfer measures), as well as fluid intelligence (far-transfer measure). Trial registration: Current controlled trials NCT02478827 (ClinicalTrials.gov, registered on 15 June 2015). Electronic supplementary material: The online version of this article (doi:10.1186/s13063-016-1188-5) contains supplementary material, which is available to authorized users.},
address  = {Clinical Neuroscience of Schizophrenia Laboratory, Administration Building, Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4 Canada Clinical Neuroscience of Schizophrenia Laboratory, Administration Building, Department of Psychology, University of Calgary, 2500 University Drive NW, Calgary, AB T2N 1N4 Canada},
note  = {Trials. 2016 Jan 26;17:. doi:10.1186/s13063-016-1188-5.}
}

@Article{2013115,
author  = {},
title  = {Editors‚Äô Introduction.},
journal  = {Neuro-Ophthalmology},
volume  = {37},
number  = {sup1},
pages  = {1-109},
year  = {2013},
abstract  = {},
address  = {},
note  = {Neuroophthalmology. 2013 Feb 26;37(sup1):1-109. doi:10.3109/01658107.2013.767119.}
}

@Article{2016116,
author  = {Mugge, W. and Kuling, I. and Brenner, E. and Smeets, J.},
title  = {Accuracy.},
journal  = {PLoS ONE},
volume  = {11},
number  = {3},
pages  = {},
year  = {2016},
abstract  = {Humans make both random and systematic errors when reproducing learned movements. Intuitive haptic guidance that assists one to make the movements reduces such errors. Our study examined whether any additional haptic information about the location of the target reduces errors in a position reproduction task, or whether the haptic guidance needs to be assistive to do so. Holding a haptic device, subjects made reaches to visible targets without time constraints. They did so in a no-guidance condition, and in guidance conditions in which the direction of the force with respect to the target differed, but the force scaled with the distance to the target in the same way. We examined whether guidance forces directed towards the target would reduce subjects‚Äô errors in reproducing a prior position  to the same extent as do forces rotated by 90 degrees or 180 degrees, as it might because the forces provide the same information in all three cases. Without vision of the arm, both the accuracy and precision were significantly better with guidance directed towards the target than in all other conditions. The errors with rotated guidance did not differ from those without guidance. Not surprisingly, the movements tended to be faster when guidance forces directed the reaches to the target. This study shows that haptic guidance significantly improved motor performance when using it was intuitive, while non-intuitively presented information did not lead to any improvements and seemed to be ignored even in our simple paradigm with static targets and no time constraints.},
address  = {MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU University, Amsterdam, Netherlands MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU University, Amsterdam, Netherlands MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU University, Amsterdam, Netherlands MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU University, Amsterdam, Netherlands},
note  = {PLoS One. 2016 Mar 16;11(3):. doi:10.1371/journal.pone.0150912.}
}

@Article{2016117,
author  = {Bustamante, V. and Montes, S. and Madrigal, M. and Burciaga, A. and Mart√≠nez, M. and Johnson, M.},
title  = {therapy gym.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {13},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Stroke rehabilitation in low- and middle-income countries, such as Mexico, is often hampered by lack of clinical resources and funding. To provide a cost-effective solution for comprehensive post-stroke rehabilitation that can alleviate the need for one-on-one physical or occupational therapy, in lower and  upper extremities, we proposed and implemented a technology-assisted rehabilitation gymnasium in Chihuahua, Mexico. The Gymnasium for Robotic Rehabilitation (Robot Gym) consisted of low- and high-tech systems for upper and  lower limb rehabilitation. Our hypothesis is that the Robot Gym can provide a cost- and labor-efficient alternative for post-stroke rehabilitation, while being more or as effective as traditional physical and occupational therapy approaches. Methods: A typical group of stroke patients was randomly allocated to an intervention (n‚Äâ=‚Äâ10) or a control group (n‚Äâ=‚Äâ10). The intervention group received rehabilitation using the devices in the Robot Gym, whereas the control group (n‚Äâ=‚Äâ10) received time-matched standard care. All of the study subjects were subjected to 24 two-hour therapy sessions over a period of 6 to 8 weeks. Several clinical assessments tests for upper and lower extremities were used to evaluate motor function pre- and post-intervention. A cost analysis was done to compare the cost effectiveness for both therapies. Results: No significant differences were observed when comparing the results of the pre-intervention Mini-mental, Brunnstrom Test, and Geriatric Depression Scale Test, showing that both groups were functionally similar prior to the intervention. Although, both training groups were functionally equivalent, they had a significant age difference. The results of all of the upper extremity tests showed an improvement in function in both groups with no statistically significant differences between  the groups. The Fugl-Meyer and the 10 Meters Walk lower extremity tests showed greater improvement in the intervention group compared to the control group. On the Time Up and Go Test, no statistically significant differences were observed pre- and post-intervention when comparing the control and the intervention groups. For the 6 Minute Walk Test, both groups presented a statistically significant difference pre- and post-intervention, showing progress in their performance. The robot gym therapy was more cost-effective than the traditional one-to-one therapy used during this study in that it enabled therapist to train up to 1.5 to 6 times more patients for the approximately same cost in the long term. Conclusions: The results of this study showed that the patients that received therapy using the Robot Gym had enhanced functionality in the upper extremity tests similar to patients in the control group. In the lower extremity  tests, the intervention patients showed more improvement than those subjected to  traditional therapy. These results support that the Robot Gym can be as effective as traditional therapy for stroke patients, presenting a more cost- and labor-efficient option for countries with scarce clinical resources and funding.  Trial registration: ISRCTN98578807.},
address  = {Orthopaedic and Rehabilitation Engineering Center (OREC), Marquette University, Milwaukee, WI USA Biomedical Engineering, ITESM, Campus Chihuahua, Chihuahua, Chihuahua Mexico Centro de Rehabilitacion y Educacion Especial, DIF, Chihuahua, Chihuahua Mexico Centro de Rehabilitacion y Educacion Especial, DIF, Chihuahua, Chihuahua Mexico Biomedical Engineering, ITESM, Campus Chihuahua, Chihuahua, Chihuahua Mexico Department of Physical Medicine and Rehabilitation, University of Pennsylvania, Philadelphia, PA USA},
note  = {J Neuroeng Rehabil. 2016 Sep 15;13:. doi:10.1186/s12984-016-0190-1.}
}

@Article{2011118,
author  = {},
title  = {ECR 2011 Book of Abstracts - A - Postgraduate Educational Programme.},
journal  = {Insights into Imaging},
volume  = {2},
number  = {Suppl 1},
pages  = {1-134},
year  = {2011},
abstract  = {},
address  = {},
note  = {Insights Imaging. 2011 Mar 1;2(Suppl 1):1-134. doi:10.1007/s13244-011-0078-3.}
}

@Article{2017119,
author  = {Zhao, H. and Qiao, L. and Fan, D. and Zhang, S. and Turel, O. and Li, Y. and Li, J. and Xue, G. and Chen, A. and He, Q.},
title  = {Stimulation (tDCS): Clinical Applications and Safety Concerns.},
journal  = {Frontiers in Psychology},
volume  = {8},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Transcranial direct current stimulation (tDCS) is a widely-used tool to induce neuroplasticity and modulate cortical function by applying weak direct current over the scalp. In this review, we first introduce the underlying mechanism of action, the brief history from discovery to clinical scientific research, electrode positioning and montages, and parameter setup of tDCS. Then, we review  tDCS application in clinical samples including people with drug addiction, major  depression disorder, Alzheimer's disease, as well as in children. This review covers the typical characteristics and the underlying neural mechanisms of tDCS treatment in such studies. This is followed by a discussion of safety, especially when the current intensity is increased or the stimulation duration is prolonged. Given such concerns, we provide detailed suggestions regarding safety procedures  for tDCS operation. Lastly, future research directions are discussed. They include foci on the development of multi-tech combination with tDCS such as with  TMS and fMRI; long-term behavioral and morphological changes; possible applications in other research domains, and more animal research to deepen the understanding of the biological and physiological mechanisms of tDCS stimulation.},
address  = {Faculty of Psychology, Southwest UniversityChongqing, China Faculty of Psychology, Southwest UniversityChongqing, China Faculty of Psychology, Southwest UniversityChongqing, China School of Education, Guangxi UniversityNanning, China Department of Information systems and Decision Sciences, College of Business and  Economics, California State University, FullertonFullerton, CA, USA Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of SciencesBeijing, China National Key Laboratory of Cognitive Neuroscience and Learning, IDG/McGovern Institute for Brain Research, Beijing Normal UniversityBeijing, China National Key Laboratory of Cognitive Neuroscience and Learning, IDG/McGovern Institute for Brain Research, Beijing Normal UniversityBeijing, China Faculty of Psychology, Southwest UniversityChongqing, China Faculty of Psychology, Southwest UniversityChongqing, China},
note  = {Front Psychol. 2017 May 10;8:. doi:10.3389/fpsyg.2017.00685.}
}

@Article{2016120,
author  = {Wallace, D. and Cooper, N. and Paulmann, S. and Fitzgerald, P. and Russo, R.},
title  = {Healthy Adults.},
journal  = {PLoS ONE},
volume  = {11},
number  = {2},
pages  = {},
year  = {2016},
abstract  = {Background: tDCS studies typically find that: lowest levels of comfort occur at stimulation-onset; young adult participants experience less comfort than older participants; and participants‚Äô blinding seems effective at low current strengths. At 2 mA conflicting results have been reported, questioning the effectiveness of blinding in sham-controlled paradigms using higher current strengths. Investigator blinding is rarely reported. Objective: Using a protocol  with 30 min of 2 mA stimulation we sought to: (a) investigate the level of perceived comfort in young and older adults, ranging in age from 19 to 29 years and 63 to 76 years, respectively; (b) test investigator and participant blinding; (c) assess comfort over a longer stimulation duration; (d) add to the literature  on protocols using 2 mA current strength. Methods: A two-session experiment was conducted where sham and active stimulation were administered to the frontal cortex at the F8/FP1 sites in a within-subjects manner. Levels of perceived comfort were measured, using a visual analogue scale, at the start and end of stimulation in young and older adults. Post-stimulation, participants and investigators judged whether or not active stimulation was used. Results: Comfort scores were lower at stimulation onset in both age groups. Older adults reported: (i) more comfort than young participants overall; (ii) comparable levels of comfort in sham and active stimulation; (iii) significantly more comfort than the young participants during active stimulation. Stimulation mode was correctly identified above chance in the second of the two sessions; 65% of all participants correctly identified the stimulation mode, resulting in a statistical trend. Similarly, the experimenter correctly identified stimulation mode significantly above chance, with 62% of all investigator judgements correct  across 120 judgements. Conclusions: Using 2 mA current strength over 30 minutes,  tDCS stimulation comfort is lower at stimulation onset in young and older adults  and, overall, lower for young participants. Investigators and participants may be able to identify active stimulation at above chance levels, although accuracy never exceeded 65% for either participants or the experimenter. Further research  into blinding efficacy is recommended.},
address  = {Department of Psychology and Centre for Brain Science, University of Essex, Colchester, Essex, United Kingdom Department of Psychology and Centre for Brain Science, University of Essex, Colchester, Essex, United Kingdom Department of Psychology and Centre for Brain Science, University of Essex, Colchester, Essex, United Kingdom Monash Alfred Psychiatry Research Centre, Monash University Central Clinical School and The Alfred, Monash University, Melbourne, Australia Department of Psychology and Centre for Brain Science, University of Essex, Colchester, Essex, United Kingdom},
note  = {PLoS One. 2016 Feb 22;11(2):. doi:10.1371/journal.pone.0149703.}
}

@Article{2011121,
author  = {Banerjee, S. and Snyder, A. and Molholm, S. and Foxe, J.},
title  = {control mechanisms?},
journal  = {The Journal of Neuroscience},
volume  = {31},
number  = {27},
pages  = {9923-32},
year  = {2011},
abstract  = {Oscillatory alpha-band activity (8‚Äì15 Hz) over parieto-occipital cortex in humans plays an important role in suppression of processing for inputs at to-be-ignored  regions of space, with increased alpha-band power observed over cortex contralateral to locations expected to contain distractors. It is unclear if similar processes operate during deployment of spatial attention in other sensory modalities. Evidence from lesion patients suggests that parietal regions house supramodal representations of space. The parietal lobes are prominent generators  of alpha-oscillations; raising the possibility that alpha is a neural signature of supramodal spatial attention. Further, when spatial attention is deployed within vision, processing of task-irrelevant auditory inputs at attended locations is also enhanced, pointing to automatic links between spatial deployments across senses. Here, we asked whether lateralized alpha-band activity is also evident in a purely auditory spatial-cueing task, and whether it had the  same underlying generator configuration as in a purely visuo-spatial task. If common to both sensory-systems, this would provide strong support for ‚Äúsupramodal‚Ä? attention theory. Alternately, alpha-band differences between auditory and visual tasks would support a sensory-specific account. Lateralized shifts in alpha-band activity were indeed observed during a purely auditory-spatial task. Crucially, there were clear differences in scalp topographies of this alpha-activity depending on the sensory system within which  spatial attention was deployed. Findings suggest that parietally-generated alpha-band mechanisms are central to attentional deployments across modalities but that they are invoked in a sensory-specific manner. The data support an interactivity account, whereby a supramodal system interacts with sensory-specific control systems during deployment of spatial attention.},
address  = {The Cognitive Neurophysiology Laboratory, Children's Evaluation and Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert  Einstein College of Medicine, Van Etten Building ‚Äì Wing 1C, 1225 Morris Park Avenue, Bronx, N.Y. 10461, USA The Cognitive Neurophysiology Laboratory, Children's Evaluation and Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert  Einstein College of Medicine, Van Etten Building ‚Äì Wing 1C, 1225 Morris Park Avenue, Bronx, N.Y. 10461, USA The Cognitive Neurophysiology Laboratory, Children's Evaluation and Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert  Einstein College of Medicine, Van Etten Building ‚Äì Wing 1C, 1225 Morris Park Avenue, Bronx, N.Y. 10461, USA The Cognitive Neurophysiology Laboratory, Children's Evaluation and Rehabilitation Center (CERC), Departments of Pediatrics and Neuroscience, Albert  Einstein College of Medicine, Van Etten Building ‚Äì Wing 1C, 1225 Morris Park Avenue, Bronx, N.Y. 10461, USA},
note  = {J Neurosci. 2011 Jul 6;31(27):9923-32. doi:10.1523/JNEUROSCI.4660-10.2011.}
}

@Article{2012122,
author  = {Dichter, G. and Damiano, C. and Allen, J.},
title  = {genetic syndromes: animal models and clinical findings.},
journal  = {Journal of Neurodevelopmental Disorders},
volume  = {4},
number  = {1},
pages  = {19},
year  = {2012},
abstract  = {This review summarizes evidence of dysregulated reward circuitry function in a range of neurodevelopmental and psychiatric disorders and genetic syndromes. First, the contribution of identifying a core mechanistic process across disparate disorders to disease classification is discussed, followed by a review  of the neurobiology of reward circuitry. We next consider preclinical animal models and clinical evidence of reward-pathway dysfunction in a range of disorders, including psychiatric disorders (i.e., substance-use disorders, affective disorders, eating disorders, and obsessive compulsive disorders), neurodevelopmental disorders (i.e., schizophrenia, attention-deficit/hyperactivity disorder, autism spectrum disorders, Tourette‚Äôs syndrome, conduct disorder/oppositional defiant disorder), and genetic syndromes  (i.e., Fragile X syndrome, Prader‚ÄìWilli syndrome, Williams syndrome, Angelman syndrome, and Rett syndrome). We also provide brief overviews of effective psychopharmacologic agents that have an effect on the dopamine system in these disorders. This review concludes with methodological considerations for future research designed to more clearly probe reward-circuitry dysfunction, with the ultimate goal of improved intervention strategies.},
address  = {Carolina Institute for Developmental Disabilities, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA Neuroscience Research Unit Pfizer Global Research and Development, Groton, CT 06340, USA},
note  = {J Neurodev Disord. 2012;4(1):19. Epub 2012 Jul 6 doi:10.1186/1866-1955-4-19.}
}

@Article{2014123,
author  = {Vato, A. and Szymanski, F. and Semprini, M. and Mussa-Ivaldi, F. and Panzeri, S.},
title  = {Force-Fields.},
journal  = {PLoS ONE},
volume  = {9},
number  = {3},
pages  = {},
year  = {2014},
abstract  = {We examine bidirectional brain-machine interfaces that control external devices in a closed loop by decoding motor cortical activity to command the device and by encoding the state of the device by delivering electrical stimuli to sensory areas. Although it is possible to design this artificial sensory-motor interaction while maintaining two independent channels of communication, here we  propose a rule that closes the loop between flows of sensory and motor information in a way that approximates a desired dynamical policy expressed as a  field of forces acting upon the controlled external device. We previously developed a first implementation of this approach based on linear decoding of neural activity recorded from the motor cortex into a set of forces (a force field) applied to a point mass, and on encoding of position of the point mass into patterns of electrical stimuli delivered to somatosensory areas. However, this previous algorithm had the limitation that it only worked in situations when the position-to-force map to be implemented is invertible. Here we overcome this  limitation by developing a new non-linear form of the bidirectional interface that can approximate a virtually unlimited family of continuous fields. The new algorithm bases both the encoding of position information and the decoding of motor cortical activity on an explicit map between spike trains and the state space of the device computed with Multi-Dimensional-Scaling. We present a detailed computational analysis of the performance of the interface and a validation of its robustness by using synthetic neural responses in a simulated sensory-motor loop.},
address  = {Department of Robotics, Brain and Cognitive Sciences, Istituto Italiano di Tecnologia, Genova, Italy Department of Robotics, Brain and Cognitive Sciences, Istituto Italiano di Tecnologia, Genova, Italy Department of Robotics, Brain and Cognitive Sciences, Istituto Italiano di Tecnologia, Genova, Italy Department of Physiology, Northwestern University, Chicago, Illinois, United States of America Center for Neuroscience and Cognitive Systems @UniTn, Istituto Italiano di Tecnologia, Rovereto, Italy},
note  = {PLoS One. 2014 Mar 13;9(3):. doi:10.1371/journal.pone.0091677.}
}

@Article{2016124,
author  = {Shivkumar, K. and Ajijola, O. and Anand, I. and Armour, J. and Chen, P. and Esler, M. and De, F. and Fishbein, M. and Goldberger, J. and Harper, R. and Joyner, M. and Khalsa, S. and Kumar, R. and Lane, R. and Mahajan, A. and Po, S. and Schwartz, P. and Somers, V. and Valderrabano, M. and Vaseghi, M. and Zipes, D.},
title  = {therapeutics.},
journal  = {The Journal of Physiology},
volume  = {594},
number  = {14},
pages  = {3911-54},
year  = {2016},
abstract  = {The autonomic nervous system regulates all aspects of normal cardiac function, and is recognized to play a critical role in the pathophysiology of many cardiovascular diseases. As such, the value of neuroscience‚Ä?based cardiovascular  therapeutics is increasingly evident. This White Paper reviews the current state  of understanding of human cardiac neuroanatomy, neurophysiology, pathophysiology  in specific disease conditions, autonomic testing, risk stratification, and neuromodulatory strategies to mitigate the progression of cardiovascular diseases.},
address  = {UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of ExcellenceLos AngelesCAUSA UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of ExcellenceLos AngelesCAUSA Department of CardiologyUniversity of Minnesota Medical SchoolMinneapolisMNUSA UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of ExcellenceLos AngelesCAUSA Krannert Institute of CardiologyIndiana University School of MedicineIndianapolisINUSA Baker IDI Heart and Diabetes InstituteMelbourneVictoriaAustralia Department of Molecular Medicine, University of PaviaPaviaItaly Department of Pathology and Laboratory MedicineDavid Geffen School of Medicine at UCLALos AngelesCaliforniaUSA Division of CardiologyUniversity of Miami Miller School of MedicineMiamiFLUSA Department of Neurobiology and the Brain Research InstituteUniversity of CaliforniaLos AngelesCAUSA Division of Cardiovascular DiseasesMayo Clinic and Mayo FoundationRochesterMNUSA Laureate Institute for Brain ResearchTulsaOKUSA Departments of Anesthesiology and Radiological SciencesDavid Geffen School of Medicine at UCLALos AngelesCAUSA Department of PsychiatryUniversity of Arizona College of MedicineTucsonAZUSA Department of AnesthesiaUCLALos AngelesCAUSA Heart Rhythm InstituteUniversity of Oklahoma Health Sciences CenterOklahoma CityOKUSA Center for Cardiac Arrhythmias of Genetic OriginIRCCS Instituto Auxologico Italianoc/o Centro Diagnostico e di Ricerrca San CarloMilanItaly Division of Cardiovascular DiseasesMayo Clinic and Mayo FoundationRochesterMNUSA Methodist DeBakey Heart and Vascular Center and Methodist Hospital Research InstituteHouston Methodist HospitalHoustonTXUSA UCLA Cardiac Arrhythmia Center and Neurocardiology Research Center of ExcellenceLos AngelesCAUSA Indiana University School of MedicineIndianapolisINUSA},
note  = {J Physiol. 2016 Jul 15;594(14):3911-54. Epub 2016 Jun 14 doi:10.1113/JP271870.}
}

@Article{2011125,
author  = {Silverberg, N. and Ryan, L. and Carrillo, M. and Sperling, R. and Petersen, R. and Posner, H. and Snyder, P. and Hilsabeck, R. and Gallagher, M. and Raber, J. and Rizzo, A. and Possin, K. and King, J. and Kaye, J. and Ott, B. and Albert, M. and Wagster, M. and Schinka, J. and Cullum, C. and Farias, S. and Balota, D. and Rao, S. and Loewenstein, D. and Budson, A. and Brandt, J. and Manly, J. and Barnes, L. and Strutt, A. and Gollan, T. and Ganguli, M. and Babcock, D. and Litvan, I. and Kramer, J. and Ferman, T.},
title  = {Assessment of cognition in early dementia.},
journal  = {Alzheimer's & dementia : the journal of the Alzheimer's Association},
volume  = {7},
number  = {3},
pages  = {e60-76},
year  = {2011},
abstract  = {Better tools for assessing cognitive impairment in the early stages of Alzheimer‚Äôs disease (AD) are required to enable diagnosis of the disease before substantial neurodegeneration has taken place and to allow detection of subtle changes in the early stages of progression of the disease. The National Institute on Aging and the Alzheimer‚Äôs Association convened a meeting to discuss state of the art methods for cognitive assessment, including computerized batteries, as well as new approaches in the pipeline. Speakers described research using novel tests of object recognition, spatial navigation, attentional control, semantic memory, semantic interference, prospective memory, false memory and executive function as among the tools that could provide earlier identification of individuals with AD. In addition to early detection, there is a need for assessments that reflect real-world situations in order to better assess functional disability. It is especially important to develop assessment tools that are useful in ethnically, culturally and linguistically diverse populations  as well as in individuals with neurodegenerative disease other than AD.},
address  = {Division of Neuroscience, National Institute on Aging, National Institutes of Health, Bethesda MD Division of Neuroscience, National Institute on Aging, National Institutes of Health, Bethesda MD Alzheimer‚Äôs Association, Chicago, IL Center for Alzheimer Research and Treatment, Department of Neurology, Brigham and Women‚Äôs Hospital, Massachusetts General Hospital, Harvard Medical School, Boston, MA Department of Neurology, Mayo Clinic, Rochester, MN Rhode Island Hospital and Department of Neurology, Alpert Medical School of Brown University, Providence, RI Department of Psychiatry, University of Texas Health Science Center at San Antonio and Psychology Service, South Texas Veterans Health Care System Department of Psychological and Brain Sciences, Johns Hopkins University, Baltimore, MD Department of Behavioral Neuroscience and Neurology and Division of Neuroscience, ONPRC, Oregon Health and Science University University of Southern California, Institute for Creative Technologies, Playa Vista, CA Department of Neurology, University of California, San Francisco, CA Division of Behavioral and Social Research, National Institute on Aging, National Institutes of Health, Bethesda MD Departments of Neurology and Biomedical Engineering, Layton Aging & Alzheimer‚Äôs Disease Center, Oregon Center for Aging & Technology, Oregon Health & Science University and Portland Veteran‚Äôs Affairs Medical Center, Portland, OR Department of Cognitive, Linguistic and Psychological Sciences, Brown University, Street, Providence, RI Department of Neurology, Johns Hopkins University School of Medicine, Baltimore,  MD Division of Neuroscience, National Institute on Aging, National Institutes of Health, Bethesda MD James A. Haley VA Medical Center and Department of Psychiatry, University of South Florida, Tampa, FL University of Texas Southwestern Medical Center at Dallas, TX Department of Neurology, University of California, Davis, Sacramento, California Department of Psychology, Washington University, St. Louis, Missouri Schey Center for Cognitive Neuroimaging, Neurological Institute, Cleveland Clinic, Cleveland, OH Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center, Miami Beach, FL Department of Neurology, Boston University Alzheimer‚Äôs Disease Center, Boston University School of Medicine, Bedford, MA and Center for Translational Cognitive Neuroscience, Geriatric Research Education Clinical Center, Edith Nourse Rogers Memorial Veterans Hospital, Bedford, MA Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD Taub Institute for Research on Alzheimer‚Äôs Disease and the Aging Brain, Columbia  University Medical Center, New York, NY Rush Alzheimer‚Äôs Disease Center, Department of Neurological Sciences, and Department of Behavioral Sciences, 4Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, IL Baylor College of Medicine, Houston, TX Department of Psychiatry, University of California, San Diego, CA Departments of Psychiatry and Neurology, School of Medicine, University of Pittsburgh; Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD Division of Movement Disorders, Department of Neurology, University of Louisville, Louisville, KY Department of Neurology, University of California, San Francisco, CA Department of Psychiatry and Psychology, Mayo Clinic, College of Medicine, Jacksonville, FL},
note  = {Alzheimers Dement. 2011 May 1;7(3):e60-76. doi:10.1016/j.jalz.2011.05.001.}
}

@Article{2009126,
author  = {Rodr√≠guez-Fornells, A. and Cunillera, T. and Mestres-Miss√©, A. and de, D.},
title  = {Neurophysiological mechanisms involved in language learning in adults.},
journal  = {Philosophical Transactions of the Royal Society B: Biological Sciences},
volume  = {364},
number  = {1536},
pages  = {3711-35},
year  = {2009},
abstract  = {Little is known about the brain mechanisms involved in word learning during infancy and in second language acquisition and about the way these new words become stable representations that sustain language processing. In several studies we have adopted the human simulation perspective, studying the effects of brain-lesions and combining different neuroimaging techniques such as event-related potentials and functional magnetic resonance imaging in order to examine the language learning (LL) process. In the present article, we review this evidence focusing on how different brain signatures relate to (i) the extraction of words from speech, (ii) the discovery of their embedded grammatical structure, and (iii) how meaning derived from verbal contexts can inform us about the cognitive mechanisms underlying the learning process. We compile these findings and frame them into an integrative neurophysiological model that tries to delineate the major neural networks that might be involved in the initial stages of LL. Finally, we propose that LL simulations can help us to understand natural language processing and how the recovery from language disorders in infants and adults can be accomplished.},
address  = {Instituci√≥ Catalana de Recerca i Estudis Avan√ßats (ICREA), Barcelona, Spain Department of Basic Psychology, Faculty of Psychology, University of Barcelona, 08035 Barcelona, Spain Max Planck Institute for Human Cognitive and Brain Sciences, 04103 Leipzig, Germany Instituci√≥ Catalana de Recerca i Estudis Avan√ßats (ICREA), Barcelona, Spain},
note  = {doi:10.1098/rstb.2009.0130.}
}

@Article{2015127,
author  = {Honeine, J. and Crisafulli, O. and Sozzi, S. and Schieppati, M.},
title  = {balance-stabilizing haptic and visual information.},
journal  = {Journal of Neurophysiology},
volume  = {114},
number  = {6},
pages  = {3097-110},
year  = {2015},
abstract  = {We investigated the integration time of haptic and visual input and their interaction during stance stabilization. Eleven subjects performed four tandem-stance conditions (60 trials each). Vision, touch, and both vision and touch were added and withdrawn. Furthermore, vision was replaced with touch and vice versa. Body sway, tibialis anterior, and peroneus longus activity were measured. Following addition or withdrawal of vision or touch, an integration time period elapsed before the earliest changes in sway were observed. Thereafter, sway varied exponentially to a new steady-state while reweighting occurred. Latencies of sway changes on sensory addition ranged from 0.6 to 1.5 s  across subjects, consistently longer for touch than vision, and were regularly preceded by changes in muscle activity. Addition of vision and touch simultaneously shortened the latencies with respect to vision or touch separately, suggesting cooperation between sensory modalities. Latencies following withdrawal of vision or touch or both simultaneously were shorter than  following addition. When vision was replaced with touch or vice versa, adding one modality did not interfere with the effect of withdrawal of the other, suggesting that integration of withdrawal and addition were performed in parallel. The time  course of the reweighting process to reach the new steady-state was also shorter  on withdrawal than addition. The effects of different sensory inputs on posture stabilization illustrate the operation of a time-consuming, possibly supraspinal  process that integrates and fuses modalities for accurate balance control. This study also shows the facilitatory interaction of visual and haptic inputs in integration and reweighting of stance-stabilizing inputs.},
address  = {Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy; and Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy; and Centro Studi Attivit√† Motorie (CSAM), Fondazione Salvatore Maugeri (IRCSS), Pavia, Italy Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy; and},
note  = {doi:10.1152/jn.00618.2015.}
}

@Article{2013128,
author  = {Wiener-Vacher, S. and Hamilton, D. and Wiener, S.},
title  = {Vestibular activity and cognitive development in children: perspectives.},
journal  = {Frontiers in Integrative Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Vestibular signals play an essential role in oculomotor and static and dynamic posturomotor functions. Increasing attention is now focusing on their impact on spatial and non-spatial cognitive functions. Movements of the head in space evoke vestibular signals that make important contributions during the development of brain representations of body parts relative to one another as well as representations of body orientation and position within the environment. A central nervous system pathway relays signals from the vestibular nuclei to the hippocampal system where this input is indispensable for neuronal responses selective for the position and orientation of the head in space. One aspect of the hippocampal systems‚Äô processing to create episodic and contextual memories is its role in spatial orientation and navigation behaviors that require processing  of relations between background cues. These are also impaired in adult patients with vestibular deficits. However little is known about the impact of vestibular  loss on cognitive development in children. This is investigated here with a particular emphasis upon the hypothetical mechanisms and potential impact of vestibular loss at critical ages on the development of respective spatial and non-spatial cognitive processes and their brain substrates.},
address  = {Vestibular and Oculomotor Evaluation Unit, Department of Otorhinolaryngology, Robert Debr√© Pediatric HospitalParis, France Department of Psychology, University of New MexicoAlbuquerque, NM, USA Laboratoire de Physiologie de la Perception et de l‚ÄôAction, UMR-7152, Centre National de la Recherche Scientifique - Coll√®ge de FranceParis, France},
note  = {Front Integr Neurosci. 2013 Dec 11;7:. doi:10.3389/fnint.2013.00092.}
}

@Article{2016129,
author  = {Ordikhani-Seyedlar, M. and Lebedev, M. and Sorensen, H. and Puthusserypady, S.},
title  = {Challenges.},
journal  = {Frontiers in Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {We have witnessed a rapid development of brain-computer interfaces (BCIs) linking the brain to external devices. BCIs can be utilized to treat neurological conditions and even to augment brain functions. BCIs offer a promising treatment  for mental disorders, including disorders of attention. Here we review the current state of the art and challenges of attention-based BCIs, with a focus on  visual attention. Attention-based BCIs utilize electroencephalograms (EEGs) or other recording techniques to generate neurofeedback, which patients use to improve their attention, a complex cognitive function. Although progress has been made in the studies of neural mechanisms of attention, extraction of attention-related neural signals needed for BCI operations is a difficult problem. To attain good BCI performance, it is important to select the features of neural activity that represent attentional signals. BCI decoding of attention-related activity may be hindered by the presence of different neural signals. Therefore, BCI accuracy can be improved by signal processing algorithms  that dissociate signals of interest from irrelevant activities. Notwithstanding recent progress, optimal processing of attentional neural signals remains a fundamental challenge for the development of efficient therapies for disorders of attention.},
address  = {Division of Biomedical Engineering, Department of Electrical Engineering, Technical University of DenmarkLyngby, Denmark Department of Neurobiology, Duke UniversityDurham, NC, USA Division of Biomedical Engineering, Department of Electrical Engineering, Technical University of DenmarkLyngby, Denmark Division of Biomedical Engineering, Department of Electrical Engineering, Technical University of DenmarkLyngby, Denmark},
note  = {Front Neurosci. 2016 Aug 03;10:. doi:10.3389/fnins.2016.00352.}
}

@Article{2013130,
author  = {Torres, E. and Brincker, M. and Isenhower, R. and Yanovich, P. and Stigler, K. and Nurnberger, J. and Metaxas, D. and Jos√©, J.},
title  = {Autism: the micro-movement perspective.},
journal  = {Frontiers in Integrative Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {The current assessment of behaviors in the inventories to diagnose autism spectrum disorders (ASD) focus on observation and discrete categorizations. Behaviors require movements, yet measurements of physical movements are seldom included. Their inclusion however, could provide an objective characterization of behavior to help unveil interactions between the peripheral and the central nervous systems (CNSs). Such interactions are critical for the development and maintenance of spontaneous autonomy, self-regulation, and voluntary control. At present, current approaches cannot deal with the heterogeneous, dynamic and stochastic nature of development. Accordingly, they leave no avenues for real time or longitudinal assessments of change in a coping system continuously adapting and developing compensatory mechanisms. We offer a new unifying statistical framework to reveal re-afferent kinesthetic features of the individual with ASD. The new methodology is based on the non-stationary stochastic patterns of minute fluctuations (micro-movements) inherent to our natural actions. Such patterns of behavioral variability provide re-entrant sensory feedback contributing to the autonomous regulation and coordination of the motor output. From an early age, this feedback supports centrally driven volitional control and fluid, flexible transitions between intentional and spontaneous behaviors. We show that in ASD there is a disruption in the maturation of this form of proprioception. Despite this disturbance, each individual has unique adaptive compensatory capabilities that we can unveil and exploit to evoke faster and more accurate decisions. Measuring the kinesthetic re-afference in tandem with stimuli variations we can detect changes in their micro-movements indicative of a more predictive and reliable kinesthetic percept. Our methods address the heterogeneity of ASD with a personalized approach grounded in the inherent sensory-motor abilities that the individual has already  developed.},
address  = {Psychology Department, Rutgers Center for Cognitive Science, Center for Computational Biomedicine Imaging and Modeling (Computer Science), Movement Disorders, Neurology, Rutgers University School of Medicine, Rutgers UniversityNew Brunswick, NJ, USA Philosophy Department, University of MassachusettsBoston, MA, USA Psychology Department, Rutgers UniversityPiscataway, NJ, USA Computer Science Department, Rutgers UniversityPiscataway, NJ, USA Department of Psychiatry, Indiana University School of Medicine, Indiana UniversityIndianapolis, IN, USA Department of Psychiatry, Christian Sarkine Autism Treatment Center, Riley Hospital for Children, Indiana University School of Medicine, Indiana UniversityIndianapolis, IN, USA Computer Science Department, Center for Computational Biomedicine Imaging and Modeling, Rutgers Center for Cognitive Science, Rutgers UniversityPiscataway, NJ, USA Physics Department Bloomington, Department of Cellular and Integrative Physiology, Indiana University School of Medicine, Indiana UniversityBloomington, IN, USA},
note  = {Front Integr Neurosci. 2013 Jul 24;7:. doi:10.3389/fnint.2013.00032.}
}

@Article{2014131,
author  = {Bashshur, R. and Shannon, G. and Smith, B. and Alverson, D. and Antoniotti, N. and Barsan, W. and Bashshur, N. and Brown, E. and Coye, M. and Doarn, C. and Ferguson, S. and Grigsby, J. and Krupinski, E. and Kvedar, J. and Linkous, J. and Merrell, R. and Nesbitt, T. and Poropatich, R. and Rheuban, K. and Sanders, J. and Watson, A. and Weinstein, R. and Yellowlees, P.},
title  = {Management.},
journal  = {Telemedicine Journal and e-Health},
volume  = {20},
number  = {9},
pages  = {769-800},
year  = {2014},
abstract  = {The telemedicine intervention in chronic disease management promises to involve patients in their own care, provides continuous monitoring by their healthcare providers, identifies early symptoms, and responds promptly to exacerbations in their illnesses. This review set out to establish the evidence from the available literature on the impact of telemedicine for the management of three chronic diseases: congestive heart failure, stroke, and chronic obstructive pulmonary disease. By design, the review focuses on a limited set of representative chronic diseases because of their current and increasing importance relative to their prevalence, associated morbidity, mortality, and cost. Furthermore, these three diseases are amenable to timely interventions and secondary prevention through telemonitoring. The preponderance of evidence from studies using rigorous research methods points to beneficial results from telemonitoring in its various  manifestations, albeit with a few exceptions. Generally, the benefits include reductions in use of service: hospital admissions/re-admissions, length of hospital stay, and emergency department visits typically declined. It is important that there often were reductions in mortality. Few studies reported neutral or mixed findings.},
address  = {E-Health Center, University of Michigan Health System, Ann Arbor, Michigan. Department of Geography, University of Kentucky, Lexington, Kentucky. E-Health Center, University of Michigan Health System, Ann Arbor, Michigan. University of New Mexico, Albuquerque, New Mexico. Marshfield Clinic, Marshfield, Wisconsin. University of Michigan Health System, Ann Arbor, Michigan. E-Health Center, University of Michigan Health System, Ann Arbor, Michigan. Ontario Telemedicine Network, Toronto, Ontario, Canada. University of California at Los Angeles, Los Angeles, California. Family and Community Medicine, University of Cincinnati, Cincinnati, Ohio. Alaska Native Tribal Health Consortium, Anchorage, Alaska. University of Colorado Denver, Denver, Colorado. University of Arizona, Tucson, Arizona. Partners Health Care, Harvard University, Cambridge, Massachusetts. American Telemedicine Association, Washington, D.C. Virginia Commonwealth University, Richmond, Virginia. University of California Davis, Sacramento, California. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. University of Virginia, Charlottesville, Virginia. The Global Telemedicine Group, McLean, Virginia. University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania. University of Arizona, Tucson, Arizona. University of California Davis, Sacramento, California.},
note  = {Telemed J E Health. 2014 Sep 01;20(9):769-800. doi:10.1089/tmj.2014.9981.}
}

@Article{2017132,
author  = {Danna, J. and Velay, J.},
title  = {Two Deafferented Subjects Learning to Write New Characters.},
journal  = {Frontiers in Neuroscience},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {The aim of this study was to evaluate the compensatory effects of real-time auditory feedback on two proprioceptively deafferented subjects. The real-time auditory feedback was based on a movement sonification approach, consisting of translating some movement variables into synthetic sounds to make them audible. The two deafferented subjects and 16 age-matched control participants were asked  to learn four new characters. The characters were learned under two different conditions, one without sonification and one with sonification, respecting a within-subject protocol. The results revealed that characters learned with sonification were reproduced more quickly and more fluently than characters learned without and that the effects of sonification were larger in deafferented  than in control subjects. Secondly, whereas control subjects were able to learn the characters without sounds the deafferented subjects were able to learn them only when they were trained with sonification. Thirdly, although the improvement  was still present in controls, the performance of deafferented subjects came back to the pre-test level 2 h after the training with sounds. Finally, the two deafferented subjects performed differently from each other, highlighting the importance of studying at least two subjects to better understand the loss of proprioception and its impact on motor control and learning. To conclude, movement sonification may compensate for a lack of proprioception, supporting the auditory-proprioception substitution hypothesis. However, sonification would act  as a ‚Äúsensory prosthesis‚Ä? helping deafferented subjects to better feel their movements, without permanently modifying their motor performance once the prosthesis is removed. Potential clinical applications for motor rehabilitation are numerous: people with a limb prosthesis, with a stroke, or with some peripheral nerve injury may potentially be interested.},
address  = {},
note  = {Front Neurosci. 2017 Mar 23;11:. doi:10.3389/fnins.2017.00137.}
}

@Article{2013133,
author  = {Brandmeyer, A. and Sadakata, M. and Spyrou, L. and McQueen, J. and Desain, P.},
title  = {monitoring and neurofeedback.},
journal  = {Frontiers in Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Multivariate pattern classification methods are increasingly applied to neuroimaging data in the context of both fundamental research and in brain-computer interfacing approaches. Such methods provide a framework for interpreting measurements made at the single-trial level with respect to a set of two or more distinct mental states. Here, we define an approach in which the output of a binary classifier trained on data from an auditory mismatch paradigm  can be used for online tracking of perception and as a neurofeedback signal. The  auditory mismatch paradigm is known to induce distinct perceptual states related  to the presentation of high- and low-probability stimuli, which are reflected in  event-related potential (ERP) components such as the mismatch negativity (MMN). The first part of this paper illustrates how pattern classification methods can be applied to data collected in an MMN paradigm, including discussion of the optimization of preprocessing steps, the interpretation of features and how the performance of these methods generalizes across individual participants and measurement sessions. We then go on to show that the output of these decoding methods can be used in online settings as a continuous index of single-trial brain activation underlying perceptual discrimination. We conclude by discussing  several potential domains of application, including neurofeedback, cognitive monitoring and passive brain-computer interfaces.},
address  = {Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour, Radboud University NijmegenNijmegen, Netherlands Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour, Radboud University NijmegenNijmegen, Netherlands Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour, Radboud University NijmegenNijmegen, Netherlands Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour, Radboud University NijmegenNijmegen, Netherlands Centre for Cognition, Donders Institute for Brain, Cognition and Behaviour, Radboud University NijmegenNijmegen, Netherlands},
note  = {Front Neurosci. 2013 Dec 30;7:. doi:10.3389/fnins.2013.00265.}
}

@Article{2015134,
author  = {Roosink, M. and Robitaille, N. and McFadyen, B. and H√©bert, L. and Jackson, P. and Bouyer, L. and Mercier, C.},
title  = {mirror: development and proof-of-concept.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {12},
number  = {1},
pages  = {},
year  = {2015},
abstract  = {Background: Virtual reality (VR) provides interactive multimodal sensory stimuli  and biofeedback, and can be a powerful tool for physical and cognitive rehabilitation. However, existing systems have generally not implemented realistic full-body avatars and/or a scaling of visual movement feedback. We developed a ‚Äúvirtual mirror‚Ä? that displays a realistic full-body avatar that responds to full-body movements in all movement planes in real-time, and that allows for the scaling of visual feedback on movements in real-time. The primary  objective of this proof-of-concept study was to assess the ability of healthy subjects to detect scaled feedback on trunk flexion movements. Methods: The ‚Äúvirtual mirror‚Ä? was developed by integrating motion capture, virtual reality and projection systems. A protocol was developed to provide both augmented and reduced feedback on trunk flexion movements while sitting and standing. The task  required reliance on both visual and proprioceptive feedback. The ability to detect scaled feedback was assessed in healthy subjects (n‚Äâ=‚Äâ10) using a two-alternative forced choice paradigm. Additionally, immersion in the VR environment and task adherence (flexion angles, velocity, and fluency) were assessed. Results: The ability to detect scaled feedback could be modelled using  a sigmoid curve with a high goodness of fit (R2 range 89-98%). The point of subjective equivalence was not significantly different from 0 (i.e. not shifted), indicating an unbiased perception. The just noticeable difference was 0.035‚Äâ¬±‚Äâ0.007, indicating that subjects were able to discriminate different scaling levels consistently. VR immersion was reported to be good, despite some perceived delays between movements and VR projections. Movement kinematic analysis confirmed task adherence. Conclusions: The new ‚Äúvirtual mirror‚Ä? extends  existing VR systems for motor and pain rehabilitation by enabling the use of realistic full-body avatars and scaled feedback. Proof-of-concept was demonstrated for the assessment of body perception during active movement in healthy controls. The next step will be to apply this system to assessment of body perception disturbances in patients with chronic pain.},
address  = {Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration Sociale (CIRRIS), 525 Boul Hamel, Qu√©bec, QC G1M 2S8 Canada Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration Sociale (CIRRIS), 525 Boul Hamel, Qu√©bec, QC G1M 2S8 Canada Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration Sociale (CIRRIS), 525 Boul Hamel, Qu√©bec, QC G1M 2S8 Canada Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration Sociale (CIRRIS), 525 Boul Hamel, Qu√©bec, QC G1M 2S8 Canada Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration Sociale (CIRRIS), 525 Boul Hamel, Qu√©bec, QC G1M 2S8 Canada Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration Sociale (CIRRIS), 525 Boul Hamel, Qu√©bec, QC G1M 2S8 Canada Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration Sociale (CIRRIS), 525 Boul Hamel, Qu√©bec, QC G1M 2S8 Canada},
note  = {J Neuroeng Rehabil. 2015 Jan 5;12(1):. doi:10.1186/1743-0003-12-2.}
}

@Article{2016135,
author  = {Johnson-Glenberg, M. and Megowan-Romanowicz, C. and Birchfield, D. and Savio-Ramos, C.},
title  = {Content: Centripetal Force.},
journal  = {Frontiers in Psychology},
volume  = {7},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Embodiment theory proposes that knowledge is grounded in sensorimotor systems, and that learning can be facilitated to the extent that lessons can be mapped to  these systems. This study with 109 college-age participants addresses two overarching questions: (a) how are immediate and delayed learning gains affected  by the degree to which a lesson is embodied, and (b) how do the affordances of three different educational platforms affect immediate and delayed learning? Six  50 min-long lessons on centripetal force were created. The first factor was the degree of embodiment with two levels: (1) low and (2) high. The second factor was platform with three levels: (1) a large scale ‚Äúmixed reality‚Ä? immersive environment containing both digital and hands-on components called SMALLab, (2) an interactive whiteboard system, and (3) a mouse-driven desktop computer. Pre-tests, post-tests, and 1-week follow-up (retention or delayed learning gains) tests were administered resulting in a 2 √ó 3 √ó 3 design. Two knowledge subtests were analyzed, one that relied on more declarative knowledge and one that relied  on more generative knowledge, e.g., hand-drawing vectors. Regardless of condition, participants made significant immediate learning gains from pre-test to post-test. There were no significant main effects or interactions due to platform or embodiment on immediate learning. However, from post-test to follow-up the level of embodiment interacted significantly with time, such that participants in the high embodiment conditions performed better on the subtest devoted to generative knowledge questions. We posit that better retention of certain types of knowledge can be seen over time when more embodiment is present  during the encoding phase. This sort of retention may not appear on more traditional factual/declarative tests. Educational technology designers should consider using more sensorimotor feedback and gestural congruency when designing  and opportunities for instructor professional development need to be provided as  well.},
address  = {Department of Psychology, Arizona State University, TempeAZ, USA American Modeling Teachers Association, SacramentoCA, USA SMALLab Learning, LLC, North HollywoodCA, USA Mary Lou Fulton Teachers College, Arizona State University, TempeAZ, USA},
note  = {Front Psychol. 2016 Nov 25;7:. doi:10.3389/fpsyg.2016.01819.}
}

@Article{2016136,
author  = {Adewole, D. and Serruya, M. and Harris, J. and Burrell, J. and Petrov, D. and Chen, H. and Wolf, J. and Cullen, D.},
title  = {The Evolution of Neuroprosthetic Interfaces.},
journal  = {Critical reviews in biomedical engineering},
volume  = {44},
number  = {1-2},
pages  = {123-52},
year  = {2016},
abstract  = {The ideal neuroprosthetic interface permits high-quality neural recording and stimulation of the nervous system while reliably providing clinical benefits over chronic periods. Although current technologies have made notable strides in this  direction, significant improvements must be made to better achieve these design goals and satisfy clinical needs. This article provides an overview of the state  of neuroprosthetic interfaces, starting with the design and placement of these interfaces before exploring the stimulation and recording platforms yielded from  contemporary research. Finally, we outline emerging research trends in an effort  to explore the potential next generation of neuroprosthetic interfaces.},
address  = {Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Department of Neurology, Jefferson University, Philadelphia, PA, USA Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA Center for Brain Injury and Repair, Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA},
note  = {doi:10.1615/CritRevBiomedEng.2016017198.}
}

@Article{2012137,
author  = {Manduchi, R. and Coughlan, J.},
title  = {(Computer) Vision without Sight.},
journal  = {Communications of the ACM},
volume  = {55},
number  = {1},
pages  = {96-104},
year  = {2012},
abstract  = {Computer vision holds great promise for helping persons with blindness or visual  impairments (VI) to interpret and explore the visual world. To this end, it is worthwhile to assess the situation critically by understanding the actual needs of the VI population and which of these needs might be addressed by computer vision. This article reviews the types of assistive technology application areas  that have already been developed for VI, and the possible roles that computer vision can play in facilitating these applications. We discuss how appropriate user interfaces are designed to translate the output of computer vision algorithms into information that the user can quickly and safely act upon, and how system-level characteristics affect the overall usability of an assistive technology. Finally, we conclude by highlighting a few novel and intriguing areas of application of computer vision to assistive technology.},
address  = {Department of Computer Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064 The Smith-Kettlewell Eye Research Institute, 2318 Fillmore Street, San Francisco, CA 94115},
note  = {Commun ACM. 2012 Jan;55(1):96-104. doi:10.1145/2063176.2063200.}
}

@Article{2015138,
author  = {Val-Laillet, D. and Aarts, E. and Weber, B. and Ferrari, M. and Quaresima, V. and Stoeckel, L. and Alonso-Alonso, M. and Audette, M. and Malbert, C. and Stice, E.},
title  = {and treat eating disorders and obesity.},
journal  = {NeuroImage : Clinical},
volume  = {8},
number  = {},
pages  = {1-31},
year  = {2015},
abstract  = {Functional, molecular and genetic neuroimaging has highlighted the existence of brain anomalies and neural vulnerability factors related to obesity and eating disorders such as binge eating or anorexia nervosa. In particular, decreased basal metabolism in the prefrontal cortex and striatum as well as dopaminergic alterations have been described in obese subjects, in parallel with increased activation of reward brain areas in response to palatable food cues. Elevated reward region responsivity may trigger food craving and predict future weight gain. This opens the way to prevention studies using functional and molecular neuroimaging to perform early diagnostics and to phenotype subjects at risk by exploring different neurobehavioral dimensions of the food choices and motivation processes. In the first part of this review, advantages and limitations of neuroimaging techniques, such as functional magnetic resonance imaging (fMRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), pharmacogenetic fMRI and functional near-infrared spectroscopy (fNIRS) will be discussed in the context of recent work dealing with eating behavior, with a particular focus on obesity. In the second part of the review, non-invasive strategies to modulate food-related brain processes and functions will be presented. At the leading edge of non-invasive brain-based technologies is real-time fMRI (rtfMRI) neurofeedback, which is a powerful tool to better understand the complexity of human brain‚Äìbehavior relationships. rtfMRI, alone or when combined with other techniques and tools such as EEG and cognitive therapy,  could be used to alter neural plasticity and learned behavior to optimize and/or  restore healthy cognition and eating behavior. Other promising non-invasive neuromodulation approaches being explored are repetitive transcranial magnetic stimulation (rTMS) and transcranial direct-current stimulation (tDCS). Converging evidence points at the value of these non-invasive neuromodulation strategies to  study basic mechanisms underlying eating behavior and to treat its disorders. Both of these approaches will be compared in light of recent work in this field,  while addressing technical and practical questions. The third part of this review will be dedicated to invasive neuromodulation strategies, such as vagus nerve stimulation (VNS) and deep brain stimulation (DBS). In combination with neuroimaging approaches, these techniques are promising experimental tools to unravel the intricate relationships between homeostatic and hedonic brain circuits. Their potential as additional therapeutic tools to combat pharmacorefractory morbid obesity or acute eating disorders will be discussed, in terms of technical challenges, applicability and ethics. In a general discussion, we will put the brain at the core of fundamental research, prevention and therapy in the context of obesity and eating disorders. First, we will discuss the possibility to identify new biological markers of brain functions. Second, we will highlight the potential of neuroimaging and neuromodulation in individualized medicine. Third, we will introduce the ethical questions that are  concomitant to the emergence of new neuromodulation therapies.},
address  = {INRA, UR1341 ADNC, France Radboud University, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands Department of Epileptology, University Hospital Bonn, Germany Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy Massachusetts General Hospital, Harvard Medical School, USA Beth Israel Deaconess Medical Center, Harvard Medical School, USA Old Dominion University, USA INRA, US1395 Ani-Scans, France Oregon Research Institute, USA},
note  = {Neuroimage Clin. 2015 Mar 24;8:1-31. doi:10.1016/j.nicl.2015.03.016.}
}

@Article{2015139,
author  = {Brouwer, A. and Zander, T. and van, E. and Korteling, J. and Bronkhorst, A.},
title  = {recommendations to avoid common pitfalls.},
journal  = {Frontiers in Neuroscience},
volume  = {9},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Estimating cognitive or affective state from neurophysiological signals and designing applications that make use of this information requires expertise in many disciplines such as neurophysiology, machine learning, experimental psychology, and human factors. This makes it difficult to perform research that is strong in all its aspects as well as to judge a study or application on its merits. On the occasion of the special topic ‚ÄúUsing neurophysiological signals that reflect cognitive or affective state‚Ä? we here summarize often occurring pitfalls and recommendations on how to avoid them, both for authors (researchers) and readers. They relate to defining the state of interest, the neurophysiological processes that are expected to be involved in the state of interest, confounding factors, inadvertently ‚Äúcheating‚Ä? with classification analyses, insight on what underlies successful state estimation, and finally, the added value of neurophysiological measures in the context of an application. We hope that this paper will support the community in producing high quality studies and well-validated, useful applications.},
address  = {Perceptual and Cognitive Systems, Netherlands Organisation for Applied Scientific Research TNOSoesterberg, Netherlands Team PhyPA, Biological Psychology and Neuroergonomics, Technical UniversityBerlin, Germany Perceptual and Cognitive Systems, Netherlands Organisation for Applied Scientific Research TNOSoesterberg, Netherlands Training Performance Innovations, Netherlands Organisation for Applied Scientific Research TNOSoesterberg, Netherlands Perceptual and Cognitive Systems, Netherlands Organisation for Applied Scientific Research TNOSoesterberg, Netherlands},
note  = {Front Neurosci. 2015 Apr 30;9:. doi:10.3389/fnins.2015.00136.}
}

@Article{2013140,
author  = {Mehta, R. and Parasuraman, R.},
title  = {Neuroergonomics: a review of applications to physical and cognitive work.},
journal  = {Frontiers in Human Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Neuroergonomics is an emerging science that is defined as the study of the human  brain in relation to performance at work and in everyday settings. This paper provides a critical review of the neuroergonomic approach to evaluating physical  and cognitive work, particularly in mobile settings. Neuroergonomics research employing mobile and immobile brain imaging techniques are discussed in the following areas of physical and cognitive work: (1) physical work parameters; (2) physical fatigue; (3) vigilance and mental fatigue; (4) training and neuroadaptive systems; and (5) assessment of concurrent physical and cognitive work. Finally, the integration of brain and body measurements in investigating workload and fatigue, in the context of mobile brain/body imaging (‚ÄúMoBI‚Ä?), is discussed.},
address  = {Department of Environmental and Occupational Health, School of Rural Public Healthy, Texas A&M University, College StationTX, USA Center of Excellence in Neuroergonomics, Technology, and Cognition, George Mason  UniversityFairfax, VA, USA},
note  = {Front Hum Neurosci. 2013 Dec 23;7:. doi:10.3389/fnhum.2013.00889.}
}

@Article{2016141,
author  = {Buonamici, F. and Carfagni, M. and Furferi, R. and Governi, L. and Volpe, Y.},
title  = {of Bas-Reliefs?},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {9},
pages  = {},
year  = {2016},
abstract  = {Nowadays, the creation of methodologies and tools for facilitating the 3D reproduction of artworks and, contextually, to make their exploration possible and more meaningful for blind users is becoming increasingly relevant in society. Accordingly, the creation of integrated systems including both tactile media (e.g., bas-reliefs) and interfaces capable of providing the users with an experience cognitively comparable to the one originally envisioned by the artist, may be considered the next step for enhancing artworks exploration. In light of this, the present work provides a description of a first-attempt system designed  to aid blind people (BP) in the tactile exploration of bas-reliefs. In detail, consistent hardware layout, comprising a hand-tracking system based on Kinect¬Æ sensor and an audio device, together with a number of methodologies, algorithms and information related to physical design are proposed. Moreover, according to experimental test on the developed system related to the device position, some design alternatives are suggested so as to discuss pros and cons.},
address  = {},
note  = {Sensors (Basel). 2016 Aug 24;16(9):. doi:10.3390/s16091361.}
}

@Article{2013142,
author  = {Torres, E. and Yanovich, P. and Metaxas, D.},
title  = {variability as a proxy to evoke centrally driven intentional acts.},
journal  = {Frontiers in Integrative Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Autism can be conceived as an adaptive biological response to an early unexpected developmental change. Under such conceptualization one could think of emerging biological compensatory mechanisms with unique manifestations in each individual. Within a large group of affected people this would result in a highly heterogeneous spectral disorder where it would be difficult to tap into the hidden potentials of any given individual. A pressing question is how to treat the disorder while harnessing the capabilities and predispositions that the individual has already developed. It would indeed be ideal to use such strengths  to accelerate the learning of self-sufficiency and independence, important as the person transitions into adulthood. In this report, we introduce a new concept for therapeutic interventions and basic research in autism. We use visuo-spatial and  auditory stimuli to help augment the physical reality of the child and sensory-substitute corrupted kinesthetic information quantified in his/her movement patterns to help the person develop volitional control over the hand motions. We develop a co-adaptive child-computer interface that closes the sensory-motor feedback loops by alerting the child of a cause-effect relationship between the statistics of his/her real-time hand movement patterns and those of external media states. By co-adapting the statistics of the media states and those of the child's real-time hand movements, we found that without any food/token reward the children naturally remained engaged in the task. Even in the absence of practice, the learning gains were retained, transferred and improved 2‚Äì4 weeks later. This new concept demonstrates that individuals with autism do have spontaneous sensory-motor adaptive capabilities. When led to their self-discovery, these patterns of spontaneous behavioral variability (SBV) morph  into more predictive and reliable intentional actions. These can unlock and enhance exploratory behavior and autonomy in the individual with autism spectrum  disorders (ASD).},
address  = {Rutgers University Psychology Department, Computational Biomedicine Imaging and Medicine Center, Rutgers University Center for Cognitive ScienceNew Brunswick, NJ, USA Rutgers University Computer Science Department, Rutgers University Center for Cognitive Science PiscatawayNJ, USA Rutgers University Computer Science Department, Computational Biomedicine Imaging and Medicine Center, Rutgers University Center for Cognitive SciencePiscataway, NJ, USA},
note  = {Front Integr Neurosci. 2013 Jul 24;7:. doi:10.3389/fnint.2013.00046.}
}

@Article{2015143,
author  = {Mayer, K. and Wyckoff, S. and Fallgatter, A. and Ehlis, A. and Strehl, U.},
title  = {controlled trial.},
journal  = {Trials},
volume  = {16},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Background: Neurofeedback has been applied effectively in various areas, especially in the treatment of children with attention-deficit/hyperactivity disorder (ADHD). This study protocol is designed to investigate the effect of slow cortical potential (SCP) feedback and a new form of neurofeedback using near-infrared spectroscopy (NIRS) on symptomatology and neurophysiological parameters in an adult ADHD population. A comparison of SCP and NIRS feedback therapy methods has not been previously conducted and may yield valuable findings about alternative treatments for adult ADHD. Methods/Design: The outcome of both  neurofeedback techniques will be assessed over 30 treatment sessions and after a  6-month follow-up period, and then will be compared to a nonspecific biofeedback  treatment. Furthermore, to investigate if treatment effects in this proof-of-principle study can be predicted by specific neurophysiological baseline parameters, regression models will be applied. Finally, a comparison with healthy controls will be conducted to evaluate deviant pretraining neurophysiological parameters, stability of assessment measures, and treatment outcome. Discussion:  To date, an investigation and comparison of SCP and NIRS feedback training to an  active control has not been conducted; therefore, we hope to gain valuable insights in effects and differences of these types of treatment for ADHD in adults. Trial registration: This study is registered with the German Registry of  Clinical Trials: DRKS00006767, date of registration: 8 October 2014.},
address  = {Institute for Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, Silcherstrasse 5, 72076 T√ºbingen, Germany Institute for Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, Silcherstrasse 5, 72076 T√ºbingen, Germany Department for Psychiatry and Psychotherapy, University of T√ºbingen, Osianderstr. 24, 72076 T√ºbingen, Germany Department for Psychiatry and Psychotherapy, University of T√ºbingen, Osianderstr. 24, 72076 T√ºbingen, Germany Institute for Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, Silcherstrasse 5, 72076 T√ºbingen, Germany},
note  = {Trials. 2015 Apr 18;16:. doi:10.1186/s13063-015-0683-4.}
}

@Article{2016144,
author  = {Krucoff, M. and Rahimpour, S. and Slutzky, M. and Edgerton, V. and Turner, D.},
title  = {Training, and Neurorehabilitation.},
journal  = {Frontiers in Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {After an initial period of recovery, human neurological injury has long been thought to be static. In order to improve quality of life for those suffering from stroke, spinal cord injury, or traumatic brain injury, researchers have been working to restore the nervous system and reduce neurological deficits through a  number of mechanisms. For example, neurobiologists have been identifying and manipulating components of the intra- and extracellular milieu to alter the regenerative potential of neurons, neuro-engineers have been producing brain-machine and neural interfaces that circumvent lesions to restore functionality, and neurorehabilitation experts have been developing new ways to revitalize the nervous system even in chronic disease. While each of these areas  holds promise, their individual paths to clinical relevance remain difficult. Nonetheless, these methods are now able to synergistically enhance recovery of native motor function to levels which were previously believed to be impossible.  Furthermore, such recovery can even persist after training, and for the first time there is evidence of functional axonal regrowth and rewiring in the central  nervous system of animal models. To attain this type of regeneration, rehabilitation paradigms that pair cortically-based intent with activation of affected circuits and positive neurofeedback appear to be required‚Äîa phenomenon which raises new and far reaching questions about the underlying relationship between conscious action and neural repair. For this reason, we argue that multi-modal therapy will be necessary to facilitate a truly robust recovery, and  that the success of investigational microscopic techniques may depend on their integration into macroscopic frameworks that include task-based neurorehabilitation. We further identify critical components of future neural repair strategies and explore the most updated knowledge, progress, and challenges in the fields of cellular neuronal repair, neural interfacing, and neurorehabilitation, all with the goal of better understanding neurological injury and how to improve recovery.},
address  = {Department of Neurosurgery, Duke University Medical CenterDurham, NC, USA Department of Neurosurgery, Duke University Medical CenterDurham, NC, USA Department of Physiology, Feinberg School of Medicine, Northwestern UniversityChicago, IL, USA Department of Integrative Biology and Physiology, University of California, Los AngelesLos Angeles, CA, USA Department of Neurosurgery, Duke University Medical CenterDurham, NC, USA},
note  = {Front Neurosci. 2016 Dec 27;10:. doi:10.3389/fnins.2016.00584.}
}

@Article{2014145,
author  = {Pikuleva, I. and Curcio, C.},
title  = {Cholesterol in the retina: the best is yet to come.},
journal  = {Progress in retinal and eye research},
volume  = {0},
number  = {},
pages  = {64-89},
year  = {2014},
abstract  = {Historically understudied, cholesterol in the retina is receiving more attention  now because of genetic studies showing that several cholesterol-related genes are risk factors for age-related macular degeneration (AMD) and because eye pathology studies showing high cholesterol content of drusen, aging Bruch's membrane, and newly found subretinal lesions. The challenge before us is determining how the cholesterol-AMD link is realized. Meeting this challenge will require an excellent understanding these genes‚Äô roles in retinal physiology and how chorioretinal cholesterol is maintained. In the first half of this review, we will succinctly summarize physico-chemical properties of cholesterol, its distribution in the human body, general principles of maintenance and metabolism, and differences in cholesterol handling in human and mouse that impact on experimental approaches. This information will provide a backdrop to the second part of the review focusing on unique aspects of chorioretinal cholesterol homeostasis, aging in Bruch's membrane, cholesterol in AMD lesions, a model for lesion biogenesis, a model for macular vulnerability based on vascular biology, and alignment of AMD-related genes and pathobiology using cholesterol and an atherosclerosis-like progression as unifying features. We conclude with recommendations for the most important research steps we can take towards delineating the cholesterol-AMD link.},
address  = {Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, Ohio 44106, United States Department of Ophthalmology, University of Alabama, Birmingham, AL 35294, United  States},
note  = {doi:10.1016/j.preteyeres.2014.03.002.}
}

@Article{2014146,
author  = {Castillejo, E. and Almeida, A. and L√≥pez-de-Ipi√±a, D. and Chen, L.},
title  = {Modeling Users, Context and Devices for Ambient Assisted Living Environments.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {14},
number  = {3},
pages  = {5354-91},
year  = {2014},
abstract  = {The participation of users within AAL environments is increasing thanks to the capabilities of the current wearable devices. Furthermore, the significance of considering user's preferences, context conditions and device's capabilities help smart environments to personalize services and resources for them. Being aware of different characteristics of the entities participating in these situations is vital for reaching the main goals of the corresponding systems efficiently. To collect different information from these entities, it is necessary to design several formal models which help designers to organize and give some meaning to the gathered data. In this paper, we analyze several literature solutions for modeling users, context and devices considering different approaches in the Ambient Assisted Living domain. Besides, we remark different ongoing standardization works in this area. We also discuss the used techniques, modeled  characteristics and the advantages and drawbacks of each approach to finally draw several conclusions about the reviewed works.},
address  = {Deusto Institute of Technology‚ÄîDeustoTech, University of Deusto, Avda. Universidades 24, Bilbao 48007, Spain; E-Mails: aitor.almeida@deusto.es (A.A.); dipina@deusto.es (D.L.-I.) Deusto Institute of Technology‚ÄîDeustoTech, University of Deusto, Avda. Universidades 24, Bilbao 48007, Spain; E-Mails: aitor.almeida@deusto.es (A.A.); dipina@deusto.es (D.L.-I.) Deusto Institute of Technology‚ÄîDeustoTech, University of Deusto, Avda. Universidades 24, Bilbao 48007, Spain; E-Mails: aitor.almeida@deusto.es (A.A.); dipina@deusto.es (D.L.-I.) School of Computer Science and Informatics, Faculty of Technology, De Montfort University, Gateway House, The Gateway, Leicester, LE1 9BH, UK; E-Mail: liming.chen@dmu.ac.uk},
note  = {Sensors (Basel). 2014 Mar 17;14(3):5354-91. doi:10.3390/s140305354.}
}

@Article{2010147,
author  = {Traynelis, S. and Wollmuth, L. and McBain, C. and Menniti, F. and Vance, K. and Ogden, K. and Hansen, K. and Yuan, H. and Myers, S. and Dingledine, R.},
title  = {Glutamate Receptor Ion Channels: Structure, Regulation, and Function.},
journal  = {Pharmacological Reviews},
volume  = {62},
number  = {3},
pages  = {405-96},
year  = {2010},
abstract  = {The mammalian ionotropic glutamate receptor family encodes 18 gene products that  coassemble to form ligand-gated ion channels containing an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore. Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells. These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system. Glutamate receptors are postulated to play important roles in numerous neurological diseases and have attracted intense scrutiny. The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel. In this review we discuss  International Union of Basic and Clinical Pharmacology glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacology, allosteric modulation, mechanisms of gating and permeation, roles in normal physiological function, as well as the potential therapeutic use of pharmacological agents acting at glutamate receptors.},
address  = {},
note  = {Pharmacol Rev. 2010 Sep;62(3):405-96. doi:10.1124/pr.109.002451.}
}

@Article{2012148,
author  = {Cherney, L. and van, V.},
title  = {Language Disorders.},
journal  = {Seminars in speech and language},
volume  = {33},
number  = {3},
pages  = {243-57},
year  = {2012},
abstract  = {Telerehabilitation (telererehab) offers cost effective services that potentially  can improve access to care for those with acquired neurologic communication disorders. However, regulatory issues including licensure, reimbursement, and threats to privacy and confidentiality hinder the routine implementation of telerehab services into the clinical setting. Despite these barriers, rapid technological advances and a growing body of research regarding the use of telerehab applications support its use. This article reviews the evidence related to acquired neurologic speech and language disorders in adults, focusing on studies that have been published since 2000. Research studies have used telerehab systems to assess and treat disorders including dysarthria, apraxia of speech, aphasia, and mild Alzheimer‚Äôs disease. They show that telerehab is a valid and reliable vehicle for delivering speech and language services. The studies represent a progression of technological advances in computing, Internet, and mobile technologies. They range on a continuum from working synchronously (in real-time) with a speech-language pathologist to working asynchronously (offline) with a stand-in virtual therapist. One such system that uses a virtual therapist  for the treatment of aphasia, the Web-ORLA‚Ñ¢ (Rehabilitation Institute of Chicago, Chicago, IL) system, is described in detail. Future directions for the advancement of telerehab for clinical practice are discussed.},
address  = {Center for Aphasia Research and Treatment, Rehabilitation Institute of Chicago, Chicago, IL Institute of Cognitive Science, University of Colorado Boulder, Boulder, CO},
note  = {doi:10.1055/s-0032-1320044.}
}

@Article{2014149,
author  = {Stoeckel, L. and Garrison, K. and Ghosh, S. and Wighton, P. and Hanlon, C. and Gilman, J. and Greer, S. and Turk-Browne, N. and deBettencourt, M. and Scheinost, D. and Craddock, C. and Thompson, T. and Calderon, V. and Bauer, C. and George, M. and Breiter, H. and Whitfield-Gabrieli, S. and Gabrieli, J. and LaConte, S. and Hirshberg, L. and Brewer, J. and Hampson, M. and Van, D. and Mackey, S. and Evins, A.},
title  = {development.},
journal  = {NeuroImage : Clinical},
volume  = {5},
number  = {},
pages  = {245-55},
year  = {2014},
abstract  = {While reducing the burden of brain disorders remains a top priority of organizations like the World Health Organization and National Institutes of Health, the development of novel, safe and effective treatments for brain disorders has been slow. In this paper, we describe the state of the science for  an emerging technology, real time functional magnetic resonance imaging (rtfMRI)  neurofeedback, in clinical neurotherapeutics. We review the scientific potential  of rtfMRI and outline research strategies to optimize the development and application of rtfMRI neurofeedback as a next generation therapeutic tool. We propose that rtfMRI can be used to address a broad range of clinical problems by  improving our understanding of brain‚Äìbehavior relationships in order to develop more specific and effective interventions for individuals with brain disorders. We focus on the use of rtfMRI neurofeedback as a clinical neurotherapeutic tool to drive plasticity in brain function, cognition, and behavior. Our overall goal  is for rtfMRI to advance personalized assessment and intervention approaches to enhance resilience and reduce morbidity by correcting maladaptive patterns of brain function in those with brain disorders.},
address  = {Massachusetts General Hospital, Department of Psychiatry, USA Yale University School of Medicine, Department of Psychiatry, USA McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA Athinoula A. Martinos Center, USA Department of Psychiatry, Medical University of South Carolina, USA Massachusetts General Hospital, Department of Psychiatry, USA Department of Neuroscience, University of California, Berkeley, USA Department of Psychology, Princeton University, USA Princeton Neuroscience Institute, Princeton University, USA Department of Diagnostic Radiology, Yale University School of Medicine, USA Child Mind Institute, USA McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA Massachusetts General Hospital, Department of Psychiatry, USA Universidad Nacional Autonoma de Mexico, Instituto de Neurobiologia, Mexico Department of Psychiatry, Medical University of South Carolina, USA Massachusetts General Hospital, Department of Psychiatry, USA McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA McGovern Institute for Brain Research, Massachusetts Institute of Technology, USA School of Biomedical Engineering and Sciences, Virginia Tech, USA Department of Psychiatry and Human Behavior, Alpert Medical School of Brown University, USA Yale University School of Medicine, Department of Psychiatry, USA Department of Diagnostic Radiology, Yale University School of Medicine, USA Athinoula A. Martinos Center, USA Department of Anesthesia, Stanford University School of Medicine, USA Massachusetts General Hospital, Department of Psychiatry, USA},
note  = {Neuroimage Clin. 2014 Jul 10;5:245-55. doi:10.1016/j.nicl.2014.07.002.}
}

@Article{2012150,
author  = {Blaak, E. and Antoine, J. and Benton, D. and Bj√∂rck, I. and Bozzetto, L. and Brouns, F. and Diamant, M. and Dye, L. and Hulshof, T. and Holst, J. and Lamport, D. and Laville, M. and Lawton, C. and Meheust, A. and Nilson, A. and Normand, S. and Rivellese, A. and Theis, S. and Torekov, S. and Vinoy, S.},
title  = {Impact of postprandial glycaemia on health and prevention of disease.},
journal  = {Obesity Reviews},
volume  = {13},
number  = {10},
pages  = {923-84},
year  = {2012},
abstract  = {Postprandial glucose, together with related hyperinsulinemia and lipidaemia, has  been implicated in the development of chronic metabolic diseases like obesity, type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). In this review, available evidence is discussed on postprandial glucose in relation to body weight control, the development of oxidative stress, T2DM, and CVD and in maintaining optimal exercise and cognitive performance. There is mechanistic evidence linking postprandial glycaemia or glycaemic variability to the development of these conditions or in the impairment in cognitive and exercise performance. Nevertheless, postprandial glycaemia is interrelated with many other (risk) factors as well as to fasting glucose. In many studies, meal-related glycaemic response is not sufficiently characterized, or the methodology with respect to the description of food or meal composition, or the duration of the measurement of postprandial glycaemia is limited. It is evident that more randomized controlled dietary intervention trials using effective low vs. high glucose response diets are necessary in order to draw more definite conclusions on the role of postprandial glycaemia in relation to health and disease. Also of  importance is the evaluation of the potential role of the time course of postprandial glycaemia.},
address  = {Department of Human Biology, School of Nutrition & Toxicology Research and Metabolism (NUTRIM), Maastricht UniversityMaastricht, the Netherlands Danone Research CenterPalaiseau, France Department of Psychology, University of SwanseaWales, UK Division of Applied Nutrition and Food Chemistry, Department of Food Technology,  Engineering and Nutrition, Lund UniversityLund, Sweden Department of Clinical and Experimental Medicine, University Federico IINaples, Italy Department of Human Biology, School of Nutrition & Toxicology Research and Metabolism (NUTRIM), Maastricht UniversityMaastricht, the Netherlands Diabetes Center, Department of Internal Medicine, VU University Medical CenterAmsterdam, the Netherlands Institute of Psychological Sciences, University of LeedsLeeds, UK Kellogg EuropeDen Bosch, the Netherlands Department of Biomedical Sciences and Novo Nordisk Foundation Centre of Basic Metabolic Research, University of CopenhagenCopenhagen, Denmark Institute of Psychological Sciences, University of LeedsLeeds, UK Centre de Recherche en Nutrition Humaine, Rh√¥ne-Alpes, Center for European Nutrition, Safety and Health, Centre Hospitalier Lyon SudLyon, France Institute of Psychological Sciences, University of LeedsLeeds, UK ILSI EuropeBrussels, Belgium Division of Applied Nutrition and Food Chemistry, Department of Food Technology,  Engineering and Nutrition, Lund UniversityLund, Sweden Centre de Recherche en Nutrition Humaine, Rh√¥ne-Alpes, Center for European Nutrition, Safety and Health, Centre Hospitalier Lyon SudLyon, France Department of Clinical and Experimental Medicine, University Federico IINaples, Italy S√ºdzucker/BENEO GroupObrigheim, Germany Department of Biomedical Sciences and Novo Nordisk Foundation Centre of Basic Metabolic Research, University of CopenhagenCopenhagen, Denmark Kraft Foods, R&D Centre, Nutrition DepartmentSaclay, France},
note  = {Obes Rev. 2012 Oct;13(10):923-84. doi:10.1111/j.1467-789X.2012.01011.x.}
}

@Article{2017151,
author  = {Ben-Moussa, M. and Rubo, M. and Debracque, C. and Lange, W.},
title  = {Virtual Reality and Augmented Reality.},
journal  = {Frontiers in Psychiatry},
volume  = {8},
number  = {},
pages  = {},
year  = {2017},
abstract  = {The present paper explores the benefits and the capabilities of various emerging  state-of-the-art interactive 3D and Internet of Things technologies and investigates how these technologies can be exploited to develop a more effective  technology supported exposure therapy solution for social anxiety disorder. ‚ÄúDJINNI‚Ä? is a conceptual design of an in vivo augmented reality (AR) exposure therapy mobile support system that exploits several capturing technologies and integrates the patient‚Äôs state and situation by vision-based, audio-based, and physiology-based analysis as well as by indoor/outdoor localization techniques. DJINNI also comprises an innovative virtual reality exposure therapy system that  is adaptive and customizable to the demands of the in vivo experience and therapeutic progress. DJINNI follows a gamification approach where rewards and achievements are utilized to motivate the patient to progress in her/his treatment. The current paper reviews the state of the art of technologies needed  for such a solution and recommends how these technologies could be integrated in  the development of an individually tailored and yet feasible and effective AR/virtual reality-based exposure therapy. Finally, the paper outlines how DJINNI could be part of classical cognitive behavioral treatment and how to validate such a setup.},
address  = {Information Science Institute, Computer Science Centre, University of Geneva, Geneva, Switzerland Experimental Clinical Psychology, Department of Psychology, University of W√ºrzburg, W√ºrzburg, Germany Neuroscience of Emotion and Affective Dynamics Lab, Swiss Center for Affective Sciences, Department of Psychology, University of Geneva, Geneva, Switzerland Department of Clinical Psychology, Behavioural Science Institute, Radboud University Nijmegen, Nijmegen, Netherlands},
note  = {Front Psychiatry. 2017 Apr 28;8:. doi:10.3389/fpsyt.2017.00026.}
}

@Article{2011152,
author  = {Schreuder, M. and Rost, T. and Tangermann, M.},
title  = {Listen, You are Writing! Speeding up Online Spelling with a Dynamic Auditory BCI.},
journal  = {Frontiers in Neuroscience},
volume  = {5},
number  = {},
pages  = {},
year  = {2011},
abstract  = {Representing an intuitive spelling interface for brain‚Äìcomputer interfaces (BCI)  in the auditory domain is not straight-forward. In consequence, all existing approaches based on event-related potentials (ERP) rely at least partially on a visual representation of the interface. This online study introduces an auditory  spelling interface that eliminates the necessity for such a visualization. In up  to two sessions, a group of healthy subjects (N‚Äâ=‚Äâ21) was asked to use a text entry application, utilizing the spatial cues of the AMUSE paradigm (Auditory Multi-class Spatial ERP). The speller relies on the auditory sense both for stimulation and the core feedback. Without prior BCI experience, 76% of the participants were able to write a full sentence during the first session. By exploiting the advantages of a newly introduced dynamic stopping method, a maximum writing speed of 1.41‚Äâchar/min (7.55‚Äâbits/min) could be reached during the second session (average: 0.94‚Äâchar/min, 5.26‚Äâbits/min). For the first time, the presented work shows that an auditory BCI can reach performances similar to state-of-the-art visual BCIs based on covert attention. These results represent an important step toward a purely auditory BCI.},
address  = {Machine Learning Laboratory, Berlin Institute of TechnologyBerlin, Germany Machine Learning Laboratory, Berlin Institute of TechnologyBerlin, Germany Machine Learning Laboratory, Berlin Institute of TechnologyBerlin, Germany},
note  = {Front Neurosci. 2011 Oct 14;5:. doi:10.3389/fnins.2011.00112.}
}

@Article{2016153,
author  = {Schiefer, M. and Tan, D. and Sidek, S. and Tyler, D.},
title  = {individuals with upper limb loss using a myoelectric prosthesis.},
journal  = {Journal of neural engineering},
volume  = {13},
number  = {1},
pages  = {016001},
year  = {2016},
abstract  = {Objective: Tactile feedback is critical to grip and object manipulation. Its absence results in reliance on visual and auditory cues. Our objective was to assess the effect of sensory feedback on task performance in individuals with limb loss. Approach: Stimulation of the peripheral nerves using implanted cuff electrodes provided two subjects with sensory feedback with intensity proportional to forces on the thumb, index, and middle fingers of their prosthetic hand during object manipulation. Both subjects perceived the sensation on their phantom hand at locations corresponding to the locations of the forces on the prosthetic hand. A bend sensor measured prosthetic hand span. Hand span modulated the intensity of sensory feedback perceived on the thenar eminence for  subject 1 and the middle finger for subject 2. We performed three functional tests with the blindfolded subjects. First, the subject tried to determine whether or not a wooden block had been placed in his prosthetic hand. Second, the subject had to locate and remove magnetic blocks from a metal table. Third, the subject performed the Southampton Hand Assessment Procedure (SHAP). We also measured the subject‚Äôs sense of embodiment with a survey and his self-confidence. Main results: Blindfolded performance with sensory feedback was similar to sighted performance in the wooden block and magnetic block tasks. Performance on  the SHAP, a measure of hand mechanical function and control, was similar with and without sensory feedback. An embodiment survey showed an improved sense of integration of the prosthesis in self body image with sensory feedback. Significance: Sensory feedback by peripheral nerve stimulation improved object discrimination and manipulation, embodiment, and confidence. With both forms of feedback, the blindfolded subjects tended toward results obtained with visual feedback.},
address  = {Case Western Reserve University, Cleveland, OH, USA Case Western Reserve University, Cleveland, OH, USA Case Western Reserve University, Cleveland, OH, USA Case Western Reserve University, Cleveland, OH, USA},
note  = {doi:10.1088/1741-2560/13/1/016001.}
}

@Article{2015154,
author  = {Hauger, S. and Schnakers, C. and Andersson, S. and Becker, F. and Moberget, T. and Giacino, J. and Schanke, A. and L√∏vstad, M.},
title  = {Conscious State.},
journal  = {Behavioural Neurology},
volume  = {2015},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Background. The diagnostic usefulness of electrophysiological methods in assessing disorders of consciousness (DoC) remains to be established on an individual patient level, and there is need to determine what constitutes robust  experimental paradigm to elicit electrophysiological indices of covert cognitive  capacity. Objectives. Two tasks encompassing active and passive conditions were explored in an event-related potentials (ERP) study. The task robustness was studied in healthy controls, and their utility to detect covert signs of command-following on an individual patient level was investigated in patients in  a minimally conscious state (MCS). Methods. Twenty healthy controls and 20 MCS patients participated. The active tasks included (1) listening for a change of pitch in the subject's own name (SON) and (2) counting SON, both contrasted to passive conditions. Midline ERPs are reported. Results. A larger P3 response was  detected in the counting task compared to active listening to pitch change in the healthy controls. On an individual level, the counting task revealed a higher rate of responders among both healthy subjects and MCS patients. Conclusion. ERP  paradigms involving actively counting SON represent a robust paradigm in probing  for volitional cognition in minimally conscious patients and add important diagnostic information in some patients.},
address  = {Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen, Norway Department of Psychology and Neurosurgery, University of California, Los Angeles, CA 90095-1563, USA Department of Psychology, University of Oslo, Postboks 1094 Blindern, 0317 Oslo,  Norway Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen, Norway Norwegian Centre for Mental Disorders Research (NORMENT), KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Postboks 4953 Nydalen, 0424 Oslo, Norway Department of Physical Medicine and Rehabilitation, Harvard Medical School and Spaulding Rehabilitation Hospital, 300 First Avenue, Charlestown, MA 02129, USA Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen, Norway Department of Research, Sunnaas Rehabilitation Hospital, 1450 Nesoddtangen, Norway},
note  = {Behav Neurol. 2015;2015:. Epub 2015 Oct 4 doi:10.1155/2015/145913.}
}

@Article{2016155,
author  = {Remsik, A. and Young, B. and Vermilyea, R. and Kiekoefer, L. and Abrams, J. and Elmore, S. and Schultz, P. and Nair, V. and Edwards, D. and Williams, J. and Prabhakaran, V.},
title  = {therapies for restoration of distal upper extremity motor function after stroke.},
journal  = {Expert review of medical devices},
volume  = {13},
number  = {5},
pages  = {445-54},
year  = {2016},
abstract  = {Stroke is a leading cause of acquired disability resulting in distal upper extremity functional motor impairment. Stroke mortality rates continue to decline with advances in healthcare and medical technology. This has led to an increased  demand for advanced, personalized rehabilitation. Survivors often experience some level of spontaneous recovery shortly after their stroke event; yet reach a functional plateau after which there is exiguous motor recovery. Nevertheless, studies have demonstrated the potential for recovery beyond this plateau. Non-traditional neurorehabilitation techniques, such as those incorporating the brain-computer interface (BCI), are being investigated for rehabilitation. BCIs may offer a gateway to the brain‚Äôs plasticity and revolutionize how humans interact with the world. Non-invasive BCIs work by closing the proprioceptive feedback loop with real-time, multi-sensory feedback allowing for volitional modulation of brain signals to assist hand function. BCI technology potentially promotes neuroplasticity and Hebbian-based motor recovery by rewarding cortical activity associated with sensory-motor rhythms through use with a variety of self-guided and assistive modalities.},
address  = {},
note  = {Expert Rev Med Devices. 2016 May;13(5):445-54. doi:10.1080/17434440.2016.1174572.}
}

@Article{2017156,
author  = {Bandelow, B. and Baldwin, D. and Abelli, M. and Bolea-Alamanac, B. and Bourin, M. and Chamberlain, S. and Cinosi, E. and Davies, S. and Domschke, K. and Fineberg, N. and Gr√ºnblatt, E. and Jarema, M. and Kim, Y. and Maron, E. and Masdrakis, V. and Mikova, O. and Nutt, D. and Pallanti, S. and Pini, S. and Str√∂hle, A. and Thibaut, F. and Vaghix, M. and Won, E. and Wedekind, D. and Wichniak, A. and Woolley, J. and Zwanzger, P. and Riederer, P.},
title  = {Part II: Neurochemistry, neurophysiology and neurocognition.},
journal  = {Federation of Societies of Biological Psychiatry},
volume  = {18},
number  = {3},
pages  = {162-214},
year  = {2017},
abstract  = {Objective: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders,  obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Methods: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network. Results: The present article (Part II) summarises findings on potential  biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic  factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics. Conclusions: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that  should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.},
address  = {Department of Psychiatry and Psychotherapy, University of G√∂ttingen, Germany Faculty of Medicine, University of Southampton, Southampton, UK Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy School of Social and Community Medicine, Academic Unit of Psychiatry, University  of Bristol, Bristol, UK Neurobiology of Anxiety and Mood Disorders, University of Nantes, Nantes, France Hertfordshire Partnership University NHS Foundation Trust and University of Hertfordshire, Parkway, UK Department of Neuroscience Imaging and Clinical Sciences, Gabriele D‚ÄôAnnunzio University, Chieti, Italy Centre for Addiction and Mental Health, Geriatric Psychiatry Division, University of Toronto, Toronto, Canada Department of Psychiatry Psychosomatics and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany Hertfordshire Partnership University NHS Foundation Trust and University of Hertfordshire, Parkway, UK Department of Psychiatry Psychosomatics and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa,  Poland Department of Psychiatry College of Medicine, Korea University, Seoul, Republic of Korea Department of Psychiatry, North Estonia Medical Centre, Tallinn, Estonia Athens University Medical School, First Department of Psychiatry, Eginition Hospital, Athens, Greece Foundation Biological Psychiatry, Sofia, Bulgaria Faculty of Medicine Department of Medicine, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, UK UC Davis Department of Psychiatry and Behavioural Sciences, Sacramento, CA, USA Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Pisa, Italy Department of Psychiatry and Psychotherapy, Campus Charit√© Mitte, Charit√© ‚Äì University Medica Center Berlin, Berlin, Germany Faculty of Medicine Paris Descartes, University Hospital Cochin, Paris, France Department of Psychology and Behavioural and Clinical Neuroscience Institute, University of Cambridge, UK Department of Psychiatry College of Medicine, Korea University, Seoul, Republic of Korea Department of Psychiatry and Psychotherapy, University of G√∂ttingen, Germany Third Department of Psychiatry, Institute of Psychiatry and Neurology, Warszawa,  Poland Faculty of Medicine, University of Southampton, Southampton, UK kbo-Inn-Salzach-Klinikum Wasserburg am Inn, Germany Department of Psychiatry Psychosomatics and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany},
note  = {doi:10.1080/15622975.2016.1190867.}
}

@Article{2012157,
author  = {Brown, N. and Rodger, S. and Ware, R. and Kimble, R. and Cuttle, L.},
title  = {trial.},
journal  = {Trials},
volume  = {13},
number  = {},
pages  = {238},
year  = {2012},
abstract  = {Background: The intense pain and anxiety triggered by burns and their associated  wound care procedures are well established in the literature. Non-pharmacological intervention is a critical component of total pain management protocols and is used as an adjunct to pharmacological analgesia. An example is virtual reality, which has been used effectively to dampen pain intensity and unpleasantness. Possible links or causal relationships between pain/anxiety/stress and burn wound healing have previously not been investigated. The purpose of this study is to investigate these relationships, specifically by determining if a newly developed multi-modal procedural preparation and distraction device (Ditto‚Ñ¢) used during acute burn wound care procedures will reduce the pain and anxiety of a child and  increase the rate of re-epithelialization. Methods/design: Children (4 to 12 years) with acute burn injuries presenting for their first dressing change will be randomly assigned to either the (1) Control group (standard distraction) or (2) Ditto‚Ñ¢ intervention group (receiving Ditto‚Ñ¢, procedural preparation and Ditto‚Ñ¢ distraction). It is intended that a minimum of 29 participants will be recruited for each treatment group. Repeated measures of pain intensity, anxiety, stress and healing will be taken at every dressing change until complete wound re-epithelialization. Further data collection will aid in determining patient satisfaction and cost effectiveness of the Ditto‚Ñ¢ intervention, as well as its effect on speed of wound re-epithelialization. Discussion: Results of this study  will provide data on whether the disease process can be altered by reducing stress, pain and anxiety in the context of acute burn wounds. Trial registration: ACTRN12611000913976},
address  = {Centre for Children‚Äôs Burns and Trauma Research, Queensland Children‚Äôs Medical Research Institute, University of Queensland, Royal Children‚Äôs Hospital, Brisbane, Queensland, Australia Division of Occupational Therapy, The University of Queensland, School of Health  & Rehabilitation Sciences, Brisbane, Queensland, Australia The University of Queensland, Queensland Children‚Äôs Medical Research Institute, Brisbane, Queensland, Australia Centre for Children‚Äôs Burns and Trauma Research, Queensland Children‚Äôs Medical Research Institute, University of Queensland, Royal Children‚Äôs Hospital, Brisbane, Queensland, Australia Centre for Children‚Äôs Burns and Trauma Research, Queensland Children‚Äôs Medical Research Institute, University of Queensland, Royal Children‚Äôs Hospital, Brisbane, Queensland, Australia},
note  = {Trials. 2012 Dec 12;13:238. doi:10.1186/1745-6215-13-238.}
}

@Article{2006158,
author  = {},
title  = {},
journal  = {Gut},
volume  = {55},
number  = {Suppl 2},
pages  = {A1-A119},
year  = {2006},
abstract  = {},
address  = {},
note  = {Gut. 2006 Apr;55(Suppl 2):A1-A119.}
}

@Article{2014159,
author  = {Mottolese, R. and Redout√©, J. and Costes, N. and Le, B. and Sirigu, A.},
title  = {Switching brain serotonin with oxytocin.},
journal  = {Proceedings of the National Academy of Sciences of the United States of America},
volume  = {111},
number  = {23},
pages  = {8637-42},
year  = {2014},
abstract  = {Serotonin (5-HT) and oxytocin (OXT) are two neuromodulators involved in human affect and sociality and in disorders like depression and autism. Here we show that these chemical messengers interact in areas of the human brain important for the regulation of emotion-based behavior. By highlighting the role of OXT in the  regulation of 5-HT signaling, our findings can lead to novel therapeutic strategies for mental disorders such as social anxiety, depression, and autism.},
address  = {Center for Cognitive Neuroscience, Unit√© Mixte de Recherche 5229, Centre National de la Recherche Scientifique, 69675 Bron, France; University Claude Bernard Lyon 1, 69609 Lyon, France; and Centre d'Etude et de Recherche Multimodal et Pluridisciplinaire Imagerie du Vivant, 69003 Lyon, France University Claude Bernard Lyon 1, 69609 Lyon, France; and Center for Cognitive Neuroscience, Unit√© Mixte de Recherche 5229, Centre National de la Recherche Scientifique, 69675 Bron, France;},
note  = {doi:10.1073/pnas.1319810111.}
}

@Article{2016160,
author  = {Leighton, T.},
title  = {to ultrasound in air?},
journal  = {Proceedings. Mathematical, Physical, and Engineering Sciences / The Royal Society},
volume  = {472},
number  = {2185},
pages  = {},
year  = {2016},
abstract  = {New measurements indicate that the public are being exposed, without their knowledge, to airborne ultrasound. Existing guidelines are insufficient for such  exposures; the vast majority refers to occupational exposure only (where workers  are aware of the exposure, can be monitored and can wear protection). Existing guidelines are based on an insufficient evidence base, most of which was collected over 40 years ago by researchers who themselves considered it insufficient to finalize guidelines, but which produced preliminary guidelines. This warning of inadequacy was lost as nations and organizations issued ‚Äònew‚Äô guidelines based on these early guidelines, and through such repetition generated a false impression of consensus. The evidence base is so slim that few reports have progressed far along the sequence from anecdote to case study, to formal scientific controlled trials and epidemiological studies. Early studies reported  hearing threshold shifts, nausea, headache, fatigue, migraine and tinnitus, but there is insufficient research on human subjects, and insufficient measurement of fields, to assess what health risk current occupational and public exposures might produce. Furthermore, the assumptions underpinning audiology and physical measurements at high frequencies must be questioned: simple extrapolation of approaches used at lower frequencies does not address current unknowns. Recommendations are provided.},
address  = {},
note  = {Proc Math Phys Eng Sci. 2016 Jan;472(2185):. doi:10.1098/rspa.2015.0624.}
}

@Article{2011161,
author  = {Lester, B. and Miller, R. and Hawes, K. and Salisbury, A. and Bigsby, R. and Sullivan, M. and Padbury, J.},
title  = {Infant Neurobehavioral Development.},
journal  = {Seminars in perinatology},
volume  = {35},
number  = {1},
pages  = {8-19},
year  = {2011},
abstract  = {The trend toward single-room neonatal intensive care units (NICUs) is increasing; however scientific evidence is, at this point, mostly anecdotal. This is a critical time to assess the impact of the single-room NICU on improving medical and neurobehavioral outcomes of the preterm infant. We have developed a theoretical model that may be useful in studying how the change from an open-bay  NICU to a single-room NICU could affect infant medical and neurobehavioral outcome. The model identifies mediating factors that are likely to accompany the  change to a single-room NICU. These mediating factors include family centered care, developmental care, parenting and family factors, staff behavior and attitudes, and medical practices. Medical outcomes that plan to be measured are sepsis, length of stay, gestational age at discharge, weight gain, illness severity, gestational age at enteral feeding, and necrotizing enterocolitis (NEC). Neurobehavioral outcomes include the NICU Network Neurobehavioral Scale (NNNS) scores, sleep state organization and sleep physiology, infant mother feeding interaction scores, and pain scores. Preliminary findings on the sample of 150 patients in the open-bay NICU showed a ‚Äúbaseline‚Ä? of effects of family centered care, developmental care, parent satisfaction, maternal depression, and  parenting stress on the neurobehavioral outcomes of the newborn. The single-room  NICU has the potential to improve the neurobehavioral status of the infant at discharge. Neurobehavioral assessment can assist with early detection and therefore preventative intervention to maximize developmental outcome. We also present an epigenetic model of the potential effects of maternal care on improving infant neurobehavioral status.},
address  = {Brown Center for the Study of Children at Risk, Providence, RI. Brown Center for the Study of Children at Risk, Providence, RI. Brown Center for the Study of Children at Risk, Providence, RI. Brown Center for the Study of Children at Risk, Providence, RI. Brown Center for the Study of Children at Risk, Providence, RI. Brown Center for the Study of Children at Risk, Providence, RI. Brown, Alpert Medical School, Providence, RI.},
note  = {Semin Perinatol. 2011 Feb;35(1):8-19. doi:10.1053/j.semperi.2010.10.003.}
}

@Article{2014162,
author  = {Hsu, N. and Novick, J. and Jaeggi, S.},
title  = {The development and malleability of executive control abilities.},
journal  = {Frontiers in Behavioral Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Executive control (EC) generally refers to the regulation of mental activity. It  plays a crucial role in complex cognition, and EC skills predict high-level abilities including language processing, memory, and problem solving, as well as  practically relevant outcomes such as scholastic achievement. EC develops relatively late in ontogeny, and many sub-groups of developmental populations demonstrate an exaggeratedly poor ability to control cognition even alongside the normal protracted growth of EC skills. Given the value of EC to human performance, researchers have sought means to improve it through targeted training; indeed, accumulating evidence suggests that regulatory processes are malleable through experience and practice. Nonetheless, there is a need to understand both whether specific populations might particularly benefit from training, and what cortical mechanisms engage during performance of the tasks used in the training protocols. This contribution has two parts: in Part I, we review EC development and intervention work in select populations. Although promising, the mixed results in this early field make it difficult to draw strong conclusions. To guide future studies, in Part II, we discuss training studies that have included a neuroimaging component ‚Äì a relatively new enterprise that also has not yet yielded a consistent pattern of results post-training, preventing broad conclusions. We therefore suggest that recent developments in neuroimaging (e.g., multivariate and connectivity approaches) may be useful to advance our understanding of the neural mechanisms underlying the malleability of EC and brain plasticity. In conjunction with behavioral data, these methods may further inform our understanding of the brain‚Äìbehavior relationship and the extent to which EC is dynamic and malleable, guiding the development of future, targeted interventions to promote executive functioning in both healthy and atypical populations.},
address  = {Center for Advanced Study of Language, University of MarylandCollege Park, MD, USA Center for Advanced Study of Language, University of MarylandCollege Park, MD, USA School of Education, University of California, IrvineIrvine, CA, USA},
note  = {Front Behav Neurosci. 2014 Jun 24;8:. doi:10.3389/fnbeh.2014.00221.}
}

@Article{2008163,
author  = {},
title  = {21st ESICM Annual Congress.},
journal  = {Intensive Care Medicine},
volume  = {34},
number  = {Suppl 1},
pages  = {93-180},
year  = {2008},
abstract  = {},
address  = {},
note  = {doi:10.1007/s00134-008-1241-2.}
}

@Article{2013164,
author  = {Roland, J. and Hacker, C. and Breshears, J. and Gaona, C. and Hogan, R. and Burton, H. and Corbetta, M. and Leuthardt, E.},
title  = {Approaches.},
journal  = {Frontiers in Human Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Recent advances in basic neuroscience research across a wide range of methodologies have contributed significantly to our understanding of human cortical electrophysiology and functional brain imaging. Translation of this research into clinical neurosurgery has opened doors for advanced mapping of functionality that previously was prohibitively difficult, if not impossible. Here we present the case of a unique individual with congenital blindness and medically refractory epilepsy who underwent neurosurgical treatment of her seizures. Pre-operative evaluation presented the challenge of accurately and robustly mapping the cerebral cortex for an individual with a high probability of significant cortical re-organization. Additionally, a blind individual has unique priorities in one‚Äôs ability to read Braille by touch and sense the environment primarily by sound than the non-vision impaired person. For these reasons we employed additional measures to map sensory, motor, speech, language, and auditory perception by employing a number of cortical electrophysiologic mapping  and functional magnetic resonance imaging methods. Our data show promising results in the application of these adjunctive methods in the pre-operative mapping of otherwise difficult to localize, and highly variable, functional cortical areas.},
address  = {Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA Department of Biomedical Engineering, Washington University, St. Louis, MO, USA Department of Neurological Surgery, School of Medicine, University of California  San Francisco, San Francisco, CA, USA Department of Biomedical Engineering, Washington University, St. Louis, MO, USA Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, MO, USA Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO, USA},
note  = {Front Hum Neurosci. 2013 Jul 31;7:. doi:10.3389/fnhum.2013.00431.}
}

@Article{2015165,
author  = {Angulo-Sherman, I. and Guti√©rrez, D.},
title  = {Improvement in Operating a Brain-Computer Interface.},
journal  = {Computational Intelligence and Neuroscience},
volume  = {2015},
number  = {},
pages  = {},
year  = {2015},
abstract  = {We study the relationship between electroencephalographic (EEG) coherence and accuracy in operating a brain-computer interface (BCI). In our case, the BCI is controlled through motor imagery. Hence, a number of volunteers were trained using different training paradigms: classical visual feedback, auditory stimulation, and functional electrical stimulation (FES). After each training session, the volunteers' accuracy in operating the BCI was assessed, and the event-related coherence (ErCoh) was calculated for all possible combinations of pairs of EEG sensors. After at least four training sessions, we searched for significant differences in accuracy and ErCoh using one-way analysis of variance  (ANOVA) and multiple comparison tests. Our results show that there exists a high  correlation between an increase in ErCoh and performance improvement, and this effect is mainly localized in the centrofrontal and centroparietal brain regions  for the case of our motor imagery task. This result has a direct implication with the development of new techniques to evaluate BCI performance and the process of  selecting a feedback modality that better enhances the volunteer's capacity to operate a BCI system.},
address  = {Centro de Investigaci√≥n y de Estudios Avanzados (CINVESTAV), Unidad Monterrey, 66600 Apodaca, NL, Mexico Centro de Investigaci√≥n y de Estudios Avanzados (CINVESTAV), Unidad Monterrey, 66600 Apodaca, NL, Mexico},
note  = {Comput Intell Neurosci. 2015;2015:. Epub 2015 Jul 28 doi:10.1155/2015/824175.}
}

@Article{2015166,
author  = {Auriat, A. and Neva, J. and Peters, S. and Ferris, J. and Boyd, L.},
title  = {Characterize Post-Stroke Neuroplasticity.},
journal  = {Frontiers in Neurology},
volume  = {6},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Following stroke, the brain undergoes various stages of recovery where the central nervous system can reorganize neural circuitry (neuroplasticity) both spontaneously and with the aid of behavioral rehabilitation and non-invasive brain stimulation. Multiple neuroimaging techniques can characterize common structural and functional stroke-related deficits, and importantly, help predict  recovery of function. Diffusion tensor imaging (DTI) typically reveals increased  overall diffusivity throughout the brain following stroke, and is capable of indexing the extent of white matter damage. Magnetic resonance spectroscopy (MRS) provides an index of metabolic changes in surviving neural tissue after stroke, serving as a marker of brain function. The neural correlates of altered brain activity after stroke have been demonstrated by abnormal activation of sensorimotor cortices during task performance, and at rest, using functional magnetic resonance imaging (fMRI). Electroencephalography (EEG) has been used to  characterize motor dysfunction in terms of increased cortical amplitude in the sensorimotor regions when performing upper limb movement, indicating abnormally increased cognitive effort and planning in individuals with stroke. Transcranial  magnetic stimulation (TMS) work reveals changes in ipsilesional and contralesional cortical excitability in the sensorimotor cortices. The severity of motor deficits indexed using TMS has been linked to the magnitude of activity  imbalance between the sensorimotor cortices. In this paper, we will provide a narrative review of data from studies utilizing DTI, MRS, fMRI, EEG, and brain stimulation techniques focusing on TMS and its combination with uni- and multimodal neuroimaging methods to assess recovery after stroke. Approaches that  delineate the best measures with which to predict or positively alter outcomes will be highlighted.},
address  = {Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada Graduate Program in Neuroscience, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada Department of Physical Therapy, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada},
note  = {Front Neurol. 2015 Oct 29;6:. doi:10.3389/fneur.2015.00226.}
}

@Article{2001167,
author  = {},
title  = {Abstracts of the Tenth Annual Meeting of the Israel Society for Neurosciences.},
journal  = {Neural Plasticity},
volume  = {8},
number  = {3},
pages  = {157-210},
year  = {2001},
abstract  = {},
address  = {},
note  = {Neural Plast. 2001;8(3):157-210. doi:10.1155/NP.2001.157.}
}

@Article{2010168,
author  = {Saposnik, G. and Teasell, R. and Mamdani, M. and Hall, J. and McIlroy, W. and Cheung, D. and Thorpe, K. and Cohen, L. and Bayley, M.},
title  = {Rehabilitation: A Pilot Randomized Clinical Trial and Proof of Principle.},
journal  = {Stroke; a journal of cerebral circulation},
volume  = {41},
number  = {7},
pages  = {1477-84},
year  = {2010},
abstract  = {Background and Purpose: Hemiparesis resulting in functional limitation of an upper extremity is common among stroke survivors. Although existing evidence suggests that increasing intensity of stroke rehabilitation therapy results in better motor recovery, limited evidence is available on the efficacy of virtual reality for stroke rehabilitation. Methods: In this pilot, randomized, single-blinded clinical trial with 2 parallel groups involving stroke patients within 2 months, we compared the feasibility, safety, and efficacy of virtual reality using the Nintendo Wii gaming system (VRWii) versus recreational therapy  (playing cards, bingo, or ‚ÄúJenga‚Ä?) among those receiving standard rehabilitation  to evaluate arm motor improvement. The primary feasibility outcome was the total  time receiving the intervention. The primary safety outcome was the proportion of patients experiencing intervention-related adverse events during the study period. Efficacy, a secondary outcome measure, was evaluated with the Wolf Motor  Function Test, Box and Block Test, and Stroke Impact Scale at 4 weeks after intervention. Results: Overall, 22 of 110 (20%) of screened patients were randomized. The mean age (range) was 61.3 (41 to 83) years. Two participants dropped out after a training session. The interventions were successfully delivered in 9 of 10 participants in the VRWii and 8 of 10 in the recreational therapy arm. The mean total session time was 388 minutes in the recreational therapy group compared with 364 minutes in the VRWii group (P=0.75). There were no serious adverse events in any group. Relative to the recreational therapy group, participants in the VRWii arm had a significant improvement in mean motor  function of 7 seconds (Wolf Motor Function Test, 7.4 seconds; 95% CI, ‚àí14.5, ‚àí0.2) after adjustment for age, baseline functional status (Wolf Motor Function Test), and stroke severity. Conclusions: VRWii gaming technology represents a safe, feasible, and potentially effective alternative to facilitate rehabilitation therapy and promote motor recovery after stroke.},
address  = {},
note  = {doi:10.1161/STROKEAHA.110.584979.}
}

@Article{2016169,
author  = {Ladouce, S. and Donaldson, D. and Dudchenko, P. and Ietswaart, M.},
title  = {Approach.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {There is a growing body of evidence that important aspects of human cognition have been marginalized, or overlooked, by traditional cognitive science. In particular, the use of laboratory-based experiments in which stimuli are artificial, and response options are fixed, inevitably results in findings that are less ecologically valid in relation to real-world behavior. In the present review we highlight the opportunities provided by a range of new mobile technologies that allow traditionally lab-bound measurements to now be collected  during natural interactions with the world. We begin by outlining the theoretical support that mobile approaches receive from the development of embodied accounts  of cognition, and we review the widening evidence that illustrates the importance of examining cognitive processes in their context. As we acknowledge, in practice, the development of mobile approaches brings with it fresh challenges, and will undoubtedly require innovation in paradigm design and analysis. If successful, however, the mobile cognition approach will offer novel insights in a range of areas, including understanding the cognitive processes underlying navigation through space and the role of attention during natural behavior. We argue that the development of real-world mobile cognition offers both increased ecological validity, and the opportunity to examine the interactions between perception, cognition and action‚Äîrather than examining each in isolation.},
address  = {},
note  = {Front Hum Neurosci. 2017 Jan 12;10:. doi:10.3389/fnhum.2016.00694.}
}

@Article{2016170,
author  = {Brabin, B. and Gies, S. and Owens, S. and Claeys, Y. and D‚ÄôAlessandro, U. and Tinto, H. and Brabin, L.},
title  = {supplementation trials.},
journal  = {Trials},
volume  = {17},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Periconceptional supplementation could extend the period over which maternal and  fetal nutrition is improved, but there are many challenges facing early-life intervention studies. Periconceptional trials differ from pregnancy supplementation trials, not only because of the very early or pre-gestational timing of nutrient exposure but also because they generate subsidiary information on participants who remain non-pregnant. The methodological challenges are more complex although, if well designed, they provide opportunities to evaluate concurrent hypotheses related to the health of non-pregnant women, especially nulliparous adolescents. This review examines the framework of published and ongoing randomised trial designs. Four cohorts typically arise from the periconceptional trial design ‚Äî two of which are non-pregnant and two are pregnant ‚Äî and this structure provides assessment options related to pre-pregnant, maternal, pregnancy and fetal outcomes. Conceptually the initial decision for single or micronutrient intervention is central ‚Äî as is the choice of dosage and content ‚Äî in order to establish a comparative framework across trials, improve standardisation, and facilitate interpretation of mechanistic hypotheses. Other trial features considered in the review include: measurement options for baseline and outcome assessments; adherence to long-term supplementation; sample size considerations in relation to duration of nutrient supplementation; cohort size for non-pregnant and pregnant cohorts as the latter  is influenced by parity selection; integrating qualitative studies and data management issues. Emphasis is given to low resource settings where high infection rates and the possibility of nutrient-infection interactions may require appropriate safety monitoring. The focus is on pragmatic issues that may  help investigators planning a periconceptional trial.},
address  = {Clinical Division, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L35QA UK Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium Northumbria Healthcare NHS Foundation Trust, North Shields, NE29 8NH UK Clinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium Medical Research Council Unit (MRC), Fajara, The Gambia Clinical Research Unit of Nanoro (URCN/IRSS), Nanoro, Burkina Faso Institute of Cancer Sciences, University of Manchester, Manchester, UK},
note  = {Trials. 2016 Jan 30;17:. doi:10.1186/s13063-015-1124-0.}
}

@Article{2016171,
author  = {Tomlinson, T. and Miller, L.},
title  = {Toward a Proprioceptive Neural Interface That Mimics Natural Cortical Activity.},
journal  = {Advances in experimental medicine and biology},
volume  = {957},
number  = {},
pages  = {367-88},
year  = {2016},
abstract  = {The dramatic advances in efferent neural interfaces over the past decade are remarkable, with cortical signals used to allow paralyzed patients to control the movement of a prosthetic limb or even their own hand. However, this success has thrown into relief, the relative lack of progress in our ability to restore somatosensation to these same patients. Somatosensation, including proprioception, the sense of limb position and movement, plays a crucial role in  even basic motor tasks like reaching and walking. Its loss results in crippling deficits. Historical work dating back decades and even centuries has demonstrated that modality-specific sensations can be elicited by activating the central nervous system electrically. Recent work has focused on the challenge of refining these sensations by stimulating the somatosensory cortex (S1) directly. Animals are able to detect particular patterns of stimulation and even associate those patterns with particular sensory cues. Most of this work has involved areas of the somatosensory cortex that mediate the sense of touch. Very little corresponding work has been done for proprioception. Here we describe the effort  to develop afferent neural interfaces through spatiotemporally precise intracortical microstimulation (ICMS). We review what is known of the cortical representation of proprioception, and describe recent work in our lab that demonstrates for the first time, that sensations like those of natural proprioception may be evoked by ICMS in S1. These preliminary findings are an important first step to the development of an afferent cortical interface to restore proprioception.},
address  = {Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E., Chicago Avenue, Chicago, IL 60611, USA Department of Physiology, Feinberg School of Medicine, Northwestern University, 303 E., Chicago Avenue, Chicago, IL 60611, USA Department of Physical Medicine and Rehabilitation, Northwestern University, 710  North, Lake Shore Drive, Chicago, IL, USA Department of Biomedical Engineering, Northwestern University, 2145 Sheridan Road, Evanston, IL 60208, USA},
note  = {Adv Exp Med Biol. 2016;957:367-88. doi:10.1007/978-3-319-47313-0_20.}
}

@Article{2016172,
author  = {Scofield, M. and Heinsbroek, J. and Gipson, C. and Kupchik, Y. and Spencer, S. and Smith, A. and Roberts-Wolfe, D. and Kalivas, P.},
title  = {Importance of Glutamate Homeostasis.},
journal  = {Pharmacological Reviews},
volume  = {68},
number  = {3},
pages  = {816-71},
year  = {2016},
abstract  = {The nucleus accumbens is a major input structure of the basal ganglia and integrates information from cortical and limbic structures to mediate goal-directed behaviors. Chronic exposure to several classes of drugs of abuse disrupts plasticity in this region, allowing drug-associated cues to engender a pathologic motivation for drug seeking. A number of alterations in glutamatergic  transmission occur within the nucleus accumbens after withdrawal from chronic drug exposure. These drug-induced neuroadaptations serve as the molecular basis for relapse vulnerability. In this review, we focus on the role that glutamate signal transduction in the nucleus accumbens plays in addiction-related behaviors. First, we explore the nucleus accumbens, including the cell types and  neuronal populations present as well as afferent and efferent connections. Next we discuss rodent models of addiction and assess the viability of these models for testing candidate pharmacotherapies for the prevention of relapse. Then we provide a review of the literature describing how synaptic plasticity in the accumbens is altered after exposure to drugs of abuse and withdrawal and also how pharmacological manipulation of glutamate systems in the accumbens can inhibit drug seeking in the laboratory setting. Finally, we examine results from clinical trials in which pharmacotherapies designed to manipulate glutamate systems have been effective in treating relapse in human patients. Further elucidation of how  drugs of abuse alter glutamatergic plasticity within the accumbens will be necessary for the development of new therapeutics for the treatment of addiction  across all classes of addictive substances.},
address  = {},
note  = {Pharmacol Rev. 2016 Jul;68(3):816-71. Epub 2016 Jul doi:10.1124/pr.116.012484.}
}

@Article{2014173,
author  = {Str√∏m, C. and Rasmussen, L. and Sieber, F.},
title  = {Should general anaesthesia be avoided in the elderly?},
journal  = {Anaesthesia},
volume  = {69},
number  = {Suppl 1},
pages  = {35-44},
year  = {2014},
abstract  = {Surgery and anaesthesia exert comparatively greater adverse effects on the elderly than on the younger brain, manifest by the higher prevalence of postoperative delirium and cognitive dysfunction. Postoperative delirium and cognitive dysfunction delay rehabilitation, and are associated with increases in  morbidity and mortality among elderly surgical patients. We review the aetiology  of postoperative delirium and cognitive dysfunction in the elderly with a particular focus on anaesthesia and sedation, discuss methods of diagnosing and monitoring postoperative cognitive decline, and describe the treatment strategies by which such decline may be prevented.},
address  = {Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Department of Anaesthesia, Centre of Head and Orthopaedics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark Anaesthesiology, Department of Anaesthesiology/Critical Care Medicine, The Johns  Hopkins Medical Institutions, Baltimore, Maryland, USA},
note  = {Anaesthesia. 2014 Jan;69(Suppl 1):35-44. doi:10.1111/anae.12493.}
}

@Article{2010174,
author  = {Wang, W. and Collinger, J. and Perez, M. and Tyler-Kabara, E. and Cohen, L. and Birbaumer, N. and Brose, S. and Schwartz, A. and Boninger, M. and Weber, D.},
title  = {Neuroplasticity.},
journal  = {Physical medicine and rehabilitation clinics of North America},
volume  = {21},
number  = {1},
pages  = {157-78},
year  = {2010},
abstract  = {},
address  = {Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA Human Cortical Physiology Section and Stroke Neurorehabilitation Section, National Institute of Neurological Disorders and Stroke (NINDS), NIH, Bethesda, MD, USA Institute of Medical Psychology and Behavioral Neurobiology, University of Tuebingen, Tuebingen, Germany Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA},
note  = {Phys Med Rehabil Clin N Am. 2010 Feb;21(1):157-78. doi:10.1016/j.pmr.2009.07.003.}
}

@Article{2008175,
author  = {Redish, A. and Jensen, S. and Johnson, A.},
title  = {A unified framework for addiction: Vulnerabilities in the decision process.},
journal  = {The Behavioral and brain sciences},
volume  = {31},
number  = {4},
pages  = {415-87},
year  = {2008},
abstract  = {The understanding of decision-making systems has come together in recent years to form a unified theory of decision-making in the mammalian brain as arising from multiple, interacting systems (a planning system, a habit system, and a situation-recognition system). This unified decision-making system has multiple potential access points through which it can be driven to make maladaptive choices, particularly choices that entail seeking of certain drugs or behaviors.  We identify 10 key vulnerabilities in the system: (1) moving away from homeostasis, (2) changing allostatic set points, (3) euphorigenic ‚Äúreward-like‚Ä? signals, (4) overvaluation in the planning system, (5) incorrect search of situation-action-outcome relationships, (6) misclassification of situations, (7)  overvaluation in the habit system, (8) a mismatch in the balance of the two decision systems, (9) over-fast discounting processes, and (10) changed learning  rates. These vulnerabilities provide a taxonomy of potential problems with decision-making systems. Although each vulnerability can drive an agent to return to the addictive choice, each vulnerability also implies a characteristic symptomology. Different drugs, different behaviors, and different individuals are likely to access different vulnerabilities. This has implications for an individual‚Äôs susceptibility to addiction and the transition to addiction, for the potential for relapse, and for the potential for treatment.},
address  = {Department of Neuroscience, University of Minnesota, Minneapolis, MN 55455, redish@umn.edu, http://umn.edu/~redish/ Graduate Program in Computer Science, University of Minnesota, Minneapolis, MN 55455, jens0491@umn.edu Graduate Program in Neuroscience and Center for Cognitive Sciences, University of Minnesota, Minneapolis, MN 55455, john5726@umn.edu},
note  = {Behav Brain Sci. 2008 Aug;31(4):415-87. doi:10.1017/S0140525X0800472X.}
}

@Article{2009176,
author  = {Bloom, H. and Ahmed, I. and Alessi, C. and Ancoli-Israel, S. and Buysse, D. and Kryger, M. and Phillips, B. and Thorpy, M. and Vitiello, M. and Zee, P.},
title  = {Disorders in Older Persons.},
journal  = {Journal of the American Geriatrics Society},
volume  = {57},
number  = {5},
pages  = {761-89},
year  = {2009},
abstract  = {},
address  = {International Longevity Center-USA and Brookdale Department of Geriatrics and Adult Development, Mount Sinai Medical School Albert Einstein College of Medicine UCLA David Geffen School of Medicine and GRECC, VA Greater Los Angeles Healthcare Systems University of California San Diego, School of Medicine and Veterans Affairs San Diego Healthcare System Neuroscience Clinical and Translational Center, University of Pittsburgh School of Medicine Gaylord Sleep Center, Gaylord Hospital National Sleep Foundation and University of Kentucky College of Medicine Albert Einstein College of Medicine, Sleep-Wake Disorders Center-Montefiore Medical Center NW Geriatric Education Center, University of Washington Sleep Disorders Center, Northwestern University},
note  = {J Am Geriatr Soc. 2009 May;57(5):761-89.}
}

@Article{2016177,
author  = {Atluri, S. and Frehlich, M. and Mei, Y. and Garcia, D. and Rogasch, N. and Wong, W. and Daskalakis, Z. and Farzan, F.},
title  = {Electrophysiological Signals during Transcranial Magnetic Stimulation.},
journal  = {Frontiers in Neural Circuits},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Concurrent recording of electroencephalography (EEG) during transcranial magnetic stimulation (TMS) is an emerging and powerful tool for studying brain health and  function. Despite a growing interest in adaptation of TMS-EEG across neuroscience disciplines, its widespread utility is limited by signal processing challenges. These challenges arise due to the nature of TMS and the sensitivity of EEG to artifacts that often mask TMS-evoked potentials (TEP)s. With an increase in the complexity of data processing methods and a growing interest in multi-site data integration, analysis of TMS-EEG data requires the development of a standardized  method to recover TEPs from various sources of artifacts. This article introduces TMSEEG, an open-source MATLAB application comprised of multiple algorithms organized to facilitate a step-by-step procedure for TMS-EEG signal processing. Using a modular design and interactive graphical user interface (GUI), this toolbox aims to streamline TMS-EEG signal processing for both novice and experienced users. Specifically, TMSEEG provides: (i) targeted removal of TMS-induced and general EEG artifacts; (ii) a step-by-step modular workflow with  flexibility to modify existing algorithms and add customized algorithms; (iii) a  comprehensive display and quantification of artifacts; (iv) quality control check points with visual feedback of TEPs throughout the data processing workflow; and  (v) capability to label and store a database of artifacts. In addition to these features, the software architecture of TMSEEG ensures minimal user effort in initial setup and configuration of parameters for each processing step. This is partly accomplished through a close integration with EEGLAB, a widely used open-source toolbox for EEG signal processing. In this article, we introduce TMSEEG, validate its features and demonstrate its application in extracting TEPs  across several single- and multi-pulse TMS protocols. As the first open-source GUI-based pipeline for TMS-EEG signal processing, this toolbox intends to promote the widespread utility and standardization of an emerging technology in brain research.},
address  = {Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada Brain and Mental Health Laboratory, School of Psychological Sciences and Monash Biomedical Imaging, Monash Institute of Cognitive and Clinical Neuroscience, Monash UniversityMelbourne, VIC, Australia Institute of Biomaterials and Biomedical Engineering, University of TorontoToronto, ON, Canada Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental HealthToronto, ON, Canada},
note  = {Front Neural Circuits. 2016 Oct 07;10:. doi:10.3389/fncir.2016.00078.}
}

@Article{2017178,
author  = {Blume, F. and Hudak, J. and Dresler, T. and Ehlis, A. and K√ºhnhausen, J. and Renner, T. and Gawrilow, C.},
title  = {controlled trial.},
journal  = {Trials},
volume  = {18},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Background: Children with attention-deficit/hyperactivity disorder (ADHD) suffer  from attention deficits, motor hyperactivity, and impulsive behaviour. These impairments are experienced at home, at school, and with friends. Functional imaging studies show that ADHD behaviour and impairments in executive functions (EFs) are mirrored by aberrant neurophysiological functioning. Moreover, several  studies show that ADHD behaviour, impairments in EFs, and a lack of self-control  contribute to poor school performance. Non-pharmacological interventions such as  neurofeedback training (NFT), for instance, aim at improving neurophysiological and neuropsychological functioning as well as behaviour. Consequently, NFT is expected to improve school performance, EFs, and self-control in children with ADHD. Generalization of acquired self-regulation skills from laboratory to real life is crucial for a transfer to everyday situations and is hypothesized to be facilitated via training using virtual reality (VR) environments. Consequently, experiencing NFT in VR is expected to yield greater effects than training in two  dimensions (2D). Methods/design: Ninety children with a clinical diagnosis of ADHD will be included in the study. Participants may be medicated or unmedicated. After random assignation to one of three conditions, all participants receive 15  training sessions of either near-infrared spectroscopy (NIRS)-based NFT in VR, NIRS-based NFT in 2D, or electromyogram-based biofeedback training in VR. ADHD symptoms, self-control, EF, health-related quality of life, school performance, and motor activity measured via parent, teacher, and child reports or objectively will be assessed before and after the intervention and at a 6 months follow-up. Furthermore, we are interested in parents‚Äô expectations about the training‚Äôs effects. Discussion: This is, to our knowledge, the first study investigating the efficacy of NFT for children with ADHD in a VR compared to a 2D environment. Furthermore, this study will contribute to the discussion about the efficacy and  specific and unspecific effects of NFTs in children with ADHD. In addition to commonly assessed variables such as ADHD symptoms, NIRS and behavioural data obtained in EF measures, health-related quality of life, and parents‚Äô expectations about the intervention‚Äôs effects, this study will investigate the effects on self-control, school performance, and motor activity. Trial registration: ClinicalTrials.gov, NCT02572180. Registered on 19 November 2015. Electronic supplementary material: The online version of this article (doi:10.1186/s13063-016-1769-3) contains supplementary material, which is available to authorized users.},
address  = {0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network, University of T√ºbingen, Gartenstrasse 29, 72074 T√ºbingen, Germany 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network, University of T√ºbingen, Gartenstrasse 29, 72074 T√ºbingen, Germany 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network, University of T√ºbingen, Gartenstrasse 29, 72074 T√ºbingen, Germany 0000 0001 2190 1447grid.10392.39Department of Psychiatry and Psychotherapy, University of T√ºbingen, Calwerstrasse 14, 72076 T√ºbingen, Germany 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network, University of T√ºbingen, Gartenstrasse 29, 72074 T√ºbingen, Germany 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network, University of T√ºbingen, Gartenstrasse 29, 72074 T√ºbingen, Germany 0000 0001 2190 1447grid.10392.39LEAD Graduate School & Research Network, University of T√ºbingen, Gartenstrasse 29, 72074 T√ºbingen, Germany},
note  = {Trials. 2017 Jan 24;18:. doi:10.1186/s13063-016-1769-3.}
}

@Article{2015179,
author  = {Buzs√°ki, G.},
title  = {planning.},
journal  = {Hippocampus},
volume  = {25},
number  = {10},
pages  = {1073-188},
year  = {2015},
abstract  = {Sharp wave ripples (SPW‚Ä?Rs) represent the most synchronous population pattern in  the mammalian brain. Their excitatory output affects a wide area of the cortex and several subcortical nuclei. SPW‚Ä?Rs occur during ‚Äúoff‚Ä?line‚Ä? states of the brain, associated with consummatory behaviors and non‚Ä?REM sleep, and are influenced by numerous neurotransmitters and neuromodulators. They arise from the excitatory recurrent system of the CA3 region and the SPW‚Ä?induced excitation brings about a fast network oscillation (ripple) in CA1. The spike content of SPW‚Ä?Rs is temporally and spatially coordinated by a consortium of interneurons to replay fragments of waking neuronal sequences in a compressed format. SPW‚Ä?Rs assist in transferring this compressed hippocampal representation to distributed  circuits to support memory consolidation; selective disruption of SPW‚Ä?Rs interferes with memory. Recently acquired and pre‚Ä?existing information are combined during SPW‚Ä?R replay to influence decisions, plan actions and, potentially, allow for creative thoughts. In addition to the widely studied contribution to memory, SPW‚Ä?Rs may also affect endocrine function via activation  of hypothalamic circuits. Alteration of the physiological mechanisms supporting SPW‚Ä?Rs leads to their pathological conversion, ‚Äúp‚Ä?ripples,‚Ä? which are a marker of epileptogenic tissue and can be observed in rodent models of schizophrenia and Alzheimer's Disease. Mechanisms for SPW‚Ä?R genesis and function are discussed in this review. ¬© 2015 The Authors Hippocampus Published by Wiley Periodicals, Inc.},
address  = {The Neuroscience Institute, School of Medicine and Center for Neural Science, New York UniversityNew YorkNew York},
note  = {Hippocampus. 2015 Oct;25(10):1073-188. Epub 2015 Sep 26 doi:10.1002/hipo.22488.}
}

@Article{2016180,
author  = {Al-Shargie, F. and Kiguchi, M. and Badruddin, N. and Dass, S. and Hani, A. and Tang, T.},
title  = {Mental stress assessment using simultaneous measurement of EEG and fNIRS.},
journal  = {Biomedical Optics Express},
volume  = {7},
number  = {10},
pages  = {3882-98},
year  = {2016},
abstract  = {Previous studies reported mental stress as one of the major contributing factors  leading to various diseases such as heart attack, depression and stroke. An accurate stress assessment method may thus be of importance to clinical intervention and disease prevention. We propose a joint independent component analysis (jICA) based approach to fuse simultaneous measurement of electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) on the prefrontal cortex (PFC) as a means of stress assessment. For the purpose of this study, stress was induced by using an established mental arithmetic task under time pressure with negative feedback. The induction of mental stress was confirmed by salivary alpha amylase test. Experiment results showed that the proposed fusion of EEG and fNIRS measurements improves the classification accuracy of mental stress by +3.4% compared to EEG alone and +11% compared to fNIRS alone. Similar improvements were also observed in sensitivity and specificity of proposed approach over unimodal EEG/fNIRS. Our study suggests that combination of EEG (frontal alpha rhythm) and fNIRS (concentration change of oxygenated hemoglobin) could be a potential means to assess mental stress objectively.},
address  = {Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research, Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar,  Perak, Malaysia Hitachi, Ltd., Research & Development Group, 350-0395, Japan Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research, Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar,  Perak, Malaysia Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research, Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar,  Perak, Malaysia Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research, Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar,  Perak, Malaysia Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research, Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar,  Perak, Malaysia},
note  = {Biomed Opt Express. 2016 Sep 06;7(10):3882-98. doi:10.1364/BOE.7.003882.}
}

@Article{2006181,
author  = {Paterson, S. and Heim, S. and Friedman, J. and Choudhury, N. and Benasich, A.},
title  = {cognition, language and social behaviour.},
journal  = {Neuroscience and biobehavioral reviews},
volume  = {30},
number  = {8},
pages  = {1087-105},
year  = {2006},
abstract  = {Recent advances in cognitive neuroscience have allowed us to begin investigating  the development of both structure and function in the infant brain. However, despite the rapid evolution of technology, surprisingly few studies have examined the intersection between brain and behaviour over the first years of life. Even fewer have done so in the context of a particular research question. This paper aims to provide an overview of four domains that have been studied using techniques amenable to elucidating the brain/behaviour interface: language, face  processing, object permanence, and joint attention, with particular emphasis on studies focusing on early development. The importance of the unique role of development and the interplay between structure and function is stressed throughout. It is hoped that this review will serve as a catalyst for further thinking about the substantial gaps in our understanding of the relationship between brain and behaviour across development. Further, our aim is to provide ideas about candidate brain areas that are likely to be implicated in particular  behaviours or cognitive domains.},
address  = {Child Study Center, Yale University School of Medicine, 230 South Frontage Rd, New Haven, CT 06520‚Äì7900, USA Department of Psychology, University of Konstanz, Germany Infancy Studies Laboratory, Center for Molecular and Behavioral Neuroscience, Rutgers University, Newark, NJ, USA Infancy Studies Laboratory, Center for Molecular and Behavioral Neuroscience, Rutgers University, Newark, NJ, USA Infancy Studies Laboratory, Center for Molecular and Behavioral Neuroscience, Rutgers University, Newark, NJ, USA},
note  = {doi:10.1016/j.neubiorev.2006.05.001.}
}

@Article{2008182,
author  = {},
title  = {21st ESICM Annual Congress.},
journal  = {Intensive Care Medicine},
volume  = {34},
number  = {Suppl 1},
pages  = {181-268},
year  = {2008},
abstract  = {},
address  = {},
note  = {doi:10.1007/s00134-008-1240-3.}
}

@Article{2010183,
author  = {Cameir√£o, M. and Badia, S. and Oller, E. and Verschure, P.},
title  = {methodology, design, psychometrics, usability and validation.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {7},
number  = {},
pages  = {48},
year  = {2010},
abstract  = {Background: Stroke is a frequent cause of adult disability that can lead to enduring impairments. However, given the life-long plasticity of the brain one could assume that recovery could be facilitated by the harnessing of mechanisms underlying neuronal reorganization. Currently it is not clear how this reorganization can be mobilized. Novel technology based neurorehabilitation techniques hold promise to address this issue. Here we describe a Virtual Reality (VR) based system, the Rehabilitation Gaming System (RGS) that is based on a number of hypotheses on the neuronal mechanisms underlying recovery, the structure of training and the role of individualization. We investigate the psychometrics of the RGS in stroke patients and healthy controls. Methods: We describe the key components of the RGS and the psychometrics of one rehabilitation scenario called Spheroids. We performed trials with 21 acute/subacute stroke patients and 20 healthy controls to study the effect of the training parameters on task performance. This allowed us to develop a Personalized Training Module (PTM) for online adjustment of task difficulty. In addition, we studied task transfer between physical and virtual environments. Finally, we assessed the usability and acceptance of the RGS as a rehabilitation  tool. Results: We show that the PTM implemented in RGS allows us to effectively adjust the difficulty and the parameters of the task to the user by capturing specific features of the movements of the arms. The results reported here also show a consistent transfer of movement kinematics between physical and virtual tasks. Moreover, our usability assessment shows that the RGS is highly accepted by stroke patients as a rehabilitation tool. Conclusions: We introduce a novel VR based paradigm for neurorehabilitation, RGS, which combines specific rehabilitative principles with a psychometric evaluation to provide a personalized and automated training. Our results show that the RGS effectively adjusts to the individual features of the user, allowing for an unsupervised deployment of individualized rehabilitation protocols.},
address  = {Laboratory of Synthetic Perceptive Emotive and Cognitive Systems (SPECS), Department of Technology, Universitat Pompeu Fabra, Edifici la Nau, Roc Boronat 138, 08018 Barcelona, Spain Laboratory of Synthetic Perceptive Emotive and Cognitive Systems (SPECS), Department of Technology, Universitat Pompeu Fabra, Edifici la Nau, Roc Boronat 138, 08018 Barcelona, Spain Servei de Medicina F√≠sica i Rehabilitaci√≥, Hospital de L'Esperan√ßa, Barcelona, Spain Laboratory of Synthetic Perceptive Emotive and Cognitive Systems (SPECS), Department of Technology, Universitat Pompeu Fabra, Edifici la Nau, Roc Boronat 138, 08018 Barcelona, Spain},
note  = {J Neuroeng Rehabil. 2010 Sep 22;7:48. doi:10.1186/1743-0003-7-48.}
}

@Article{2017184,
author  = {Iamsakul, K. and Pavlovcik, A. and Calderon, J. and Sanderson, L.},
title  = {PROJECT HEAVEN: Preoperative Training in Virtual Reality.},
journal  = {Surgical Neurology International},
volume  = {8},
number  = {},
pages  = {},
year  = {2017},
abstract  = {A cephalosomatic anastomosis (CSA; also called HEAVEN: head anastomosis venture)  has been proposed as an option for patients with neurological impairments, such as spinal cord injury (SCI), and terminal medical illnesses, for which medicine is currently powerless. Protocols to prepare a patient for life after CSA do not  currently exist. However, methods used in conventional neurorehabilitation can be used as a reference for developing preparatory training. Studies on virtual reality (VR) technologies have documented VR's ability to enhance rehabilitation  and improve the quality of recovery in patients with neurological disabilities. VR-augmented rehabilitation resulted in increased motivation towards performing functional training and improved the biopsychosocial state of patients. In addition, VR experiences coupled with haptic feedback promote neuroplasticity, resulting in the recovery of motor functions in neurologically-impaired individuals. To prepare the recipient psychologically for life after CSA, the development of VR experiences paired with haptic feedback is proposed. This proposal aims to innovate techniques in conventional neurorehabilitation to implement preoperative psychological training for the recipient of HEAVEN. Recipient's familiarity to body movements will prevent unexpected psychological reactions from occurring after the HEAVEN procedure.},
address  = {Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC,  Chicago, Illinois, USA Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC,  Chicago, Illinois, USA Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC,  Chicago, Illinois, USA Department of Biomedical Engineering, Inventum Bioengineering Technologies, LLC,  Chicago, Illinois, USA},
note  = {Surg Neurol Int. 2017 Apr 26;8:. doi:10.4103/sni.sni_371_16.}
}

@Article{2012185,
author  = {Farage, M. and Miller, K. and Ajayi, F. and Hutchins, D.},
title  = {Design Principles to Accommodate Older Adults.},
journal  = {Global Journal of Health Science},
volume  = {4},
number  = {2},
pages  = {2-25},
year  = {2012},
abstract  = {The global population is aging. In many industrial countries, almost one in five  people are over age 65. As people age, gradual changes ensue in vision, hearing,  balance, coordination, and memory. Products, communication materials, and the physical environment must be thoughtfully designed to meet the needs of people of all ages. This article summarizes normal changes in sensory function, mobility, balance, memory, and attention that occur with age. It presents practical guidelines that allow design professionals to accommodate these changes and better meet the needs of older adults. Designing for older adults is inclusive design: it accommodates a range of physical and cognitive abilities and promotes  simplicity, flexibility, and ease of use for people of any age.},
address  = {Feminine Care Innovation Center, The Procter & Gamble Company 6110 Center Hill Rd, Cincinnati, OH 45224, USA Tel: 513-634-5594 E-mail: farage.m@pg.com The Procter and Gamble Company, Cincinnati, OH USA E-mail: miller.kw@pg.com The Procter and Gamble Company, Cincinnati, OH USA E-mail: Ajayi.fo@pg.com Hutchins & Associates LLC, Cincinnati, OH USA E-mail: hutchinsda@fuse.net},
note  = {Glob J Health Sci. 2012 Mar;4(2):2-25. Epub 2012 Mar 01 doi:10.5539/gjhs.v4n2p2.}
}

@Article{2013186,
author  = {Malouin, F. and Jackson, P. and Richards, C.},
title  = {review.},
journal  = {Frontiers in Human Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Many clinical studies have investigated the use of mental practice (MP) through motor imagery (MI) to enhance functional recovery of patients with diverse physical disabilities. Although beneficial effects have been generally reported for training motor functions in persons with chronic stroke (e.g., reaching, writing, walking), attempts to integrate MP within rehabilitation programs have been met with mitigated results. These findings have stirred further questioning  about the value of MP in neurological rehabilitation. In fact, despite abundant systematic reviews, which customarily focused on the methodological merits of selected studies, several questions about factors underlying observed effects remain to be addressed. This review discusses these issues in an attempt to identify factors likely to hamper the integration of MP within rehabilitation programs. First, the rationale underlying the use of MP for training motor function is briefly reviewed. Second, three modes of MI delivery are proposed based on the analysis of the research protocols from 27 studies in persons with stroke and Parkinson's disease. Third, for each mode of MI delivery, a general description of MI training is provided. Fourth, the review discusses factors influencing MI training outcomes such as: the adherence to MI training, the amount of training and the interaction between physical and mental rehearsal; the use of relaxation, the selection of reliable, valid and sensitive outcome measures, the heterogeneity of the patient groups, the selection of patients and  the mental rehearsal procedures. To conclude, the review proposes a framework for integrating MP in rehabilitation programs and suggests research targets for steering the implementation of MP in the early stages of the rehabilitation process. The challenge has now shifted towards the demonstration that MI training can enhance the effects of regular therapy in persons with subacute stroke during the period of spontaneous recovery.},
address  = {D√©partement de R√©adaptation, Facult√© de M√©decine, Universit√© LavalQu√©bec, QC, Canada Centre Interdisciplinaire de Recherche en R√©adaptation et Int√©gration SocialeQu√©bec, QC, Canada D√©partement de R√©adaptation, Facult√© de M√©decine, Universit√© LavalQu√©bec, QC, Canada},
note  = {Front Hum Neurosci. 2013 Sep 19;7:. doi:10.3389/fnhum.2013.00576.}
}

@Article{2013187,
author  = {Gigler, K. and Blomeke, K. and Shatil, E. and Weintraub, S. and Reber, P.},
title  = {with older adults.},
journal  = {to serve the ageing society},
volume  = {12},
number  = {1},
pages  = {26-35},
year  = {2013},
abstract  = {Increased levels of cognitive activity may improve general cognitive function in  older adults and potentially increase cognitive reserve, protecting against the onset of dementia associated with syndromes like Alzheimer's disease. To test the efficacy of cognitive training administered online, 18 participants (11 cognitively healthy; 7 mild cognitive impairment) were recruited from a clinical  population of older adults to complete an online training intervention (CogniFit‚Ñ¢). Before and after training, participants completed a separate battery of assessment measures, including measures of quality of life and competency at everyday activities, as well as a series of tests assessing cognitive function. Participants generally adhered to the online training protocol and completed a computerized assessment battery pre- and post-training. However, participants with mild cognitive impairment (MCI) were somewhat less likely to adhere to the protocol, suggesting that more direct contact is needed with this population in intervention research. Furthermore, participants demonstrated significant improvement on a measure of working memory and also in processing speed across several assessments, though these data are tentative, as no control data exist. These results, along with the generally good adherence observed, suggest that online cognitive training is feasible for this population and a potentially valuable tool for the wider dissemination of cognitive training.},
address  = {Department of Psychology, Northwestern University, Evanston, IL, USA Department of Psychology, University of Notre Dame, South Bend, IN, USA CogniFit‚Ñ¢ Research, New York, NY, USA Department of Psychiatry and Behavioral Sciences, Cognitive Neurology and Alzheimer's Disease Center, Northwestern University, Evanston, IL, USA Department of Psychology, Northwestern University, Evanston, IL, USA},
note  = {Gerontechnology. 2013 Jan 1;12(1):26-35. doi:10.4017/gt.2013.12.1.007.00.}
}

@Article{2014188,
author  = {Sivan, M. and Gallagher, J. and Makower, S. and Keeling, D. and Bhakta, B. and O‚ÄôConnor, R. and Levesley, M.},
title  = {limb exercise after stroke: results of a feasibility study in home setting.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {11},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Background: Home-based robotic technologies may offer the possibility of self-directed upper limb exercise after stroke as a means of increasing the intensity of rehabilitation treatment. The current literature has a paucity of robotic devices that have been tested in a home environment. The aim of this research project was to evaluate a robotic device Home-based Computer Assisted Arm Rehabilitation (hCAAR) that can be used independently at home by stroke survivors with upper limb weakness. Methods: hCAAR device comprises of a joystick handle moved by the weak upper limb to perform tasks on the computer screen. The  device provides assistance to the movements depending on users ability. Nineteen  participants (stroke survivors with upper limb weakness) were recruited. Outcome  measures performed at baseline (A0), at end of 8-weeks of hCAAR use (A1) and 1 month after end of hCAAR use (A2) were: Optotrak kinematic variables, Fugl Meyer Upper Extremity motor subscale (FM-UE), Action Research Arm Test (ARAT), Medical Research Council (MRC) and Modified Ashworth Scale (MAS), Chedoke Arm and Hand Activity Inventory (CAHAI) and ABILHAND. Results: Two participants were unable to use hCAAR: one due to severe paresis and the other due to personal problems. The remaining 17 participants were able to use the device independently in their home setting. No serious adverse events were reported. The median usage  time was 433 minutes (IQR 250 ‚Äì 791 min). A statistically significant improvement was observed in the kinematic and clinical outcomes at A1. The median gain in the scores at A1 were by: movement time 19%, path length 15% and jerk 19%, FM-UE 1 point, total MAS 1.5 point, total MRC 2 points, ARAT 3 points, CAHAI 5.5 points and ABILHAND 3 points. Three participants showed clinically significant improvement in all the clinical outcomes. Conclusions: The hCAAR feasibility study is the first clinical study of its kind reported in the current literature; in this study, 17 participants used the robotic device independently for eight weeks in their own homes with minimal supervision from healthcare professionals.  Statistically significant improvements were observed in the kinematic and clinical outcomes in the study. Electronic supplementary material: The online version of this article (doi:10.1186/1743-0003-11-163) contains supplementary material, which is available to authorized users.},
address  = {Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1 3EX UK School of Mechanical Engineering, University of Leeds, Leeds, LS1 3EX UK Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1 3EX UK School of Mechanical Engineering, University of Leeds, Leeds, LS1 3EX UK Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1 3EX UK Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, LS1 3EX UK School of Mechanical Engineering, University of Leeds, Leeds, LS1 3EX UK},
note  = {J Neuroeng Rehabil. 2014 Dec 12;11:. doi:10.1186/1743-0003-11-163.}
}

@Article{2002189,
author  = {Seymour, N. and Gallagher, A. and Roman, S. and O‚ÄôBrien, M. and Bansal, V. and Andersen, D. and Satava, R.},
title  = {Randomized, Double-Blinded Study.},
journal  = {Annals of Surgery},
volume  = {236},
number  = {4},
pages  = {458-64},
year  = {2002},
abstract  = {Objective: To demonstrate that virtual reality (VR) training transfers technical  skills to the operating room (OR) environment. Summary Background Data: The use of VR surgical simulation to train skills and reduce error risk in the OR has never been demonstrated in a prospective, randomized, blinded study. Methods: Sixteen surgical residents (PGY 1‚Äì4) had baseline psychomotor abilities assessed, then were randomized to either VR training (MIST VR simulator diathermy task) until expert criterion levels established by experienced laparoscopists were achieved (n = 8), or control non-VR-trained (n = 8). All subjects performed laparoscopic cholecystectomy with an attending surgeon blinded to training status. Videotapes of gallbladder dissection were reviewed independently by two investigators blinded to subject identity and training, and scored for eight predefined errors for each procedure minute (interrater reliability of error assessment r > 0.80). Results: No differences in baseline assessments were found  between groups. Gallbladder dissection was 29% faster for VR-trained residents. Non-VR-trained residents were nine times more likely to transiently fail to make  progress (P < .007, Mann-Whitney test) and five times more likely to injure the gallbladder or burn nontarget tissue (chi-square = 4.27, P < .04). Mean errors were six times less likely to occur in the VR-trained group (1.19 vs. 7.38 errors per case;P < .008, Mann-Whitney test). Conclusions: The use of VR surgical simulation to reach specific target criteria significantly improved the OR performance of residents during laparoscopic cholecystectomy. This validation of  transfer of training skills from VR to OR sets the stage for more sophisticated uses of VR in assessment, training, error reduction, and certification of surgeons.},
address  = {From the *Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A., and the ‚Ä†Department of Psychology, Queens University, Belfast, Northern Ireland, U.K. From the *Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A., and the ‚Ä†Department of Psychology, Queens University, Belfast, Northern Ireland, U.K. From the *Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A., and the ‚Ä†Department of Psychology, Queens University, Belfast, Northern Ireland, U.K. From the *Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A., and the ‚Ä†Department of Psychology, Queens University, Belfast, Northern Ireland, U.K. From the *Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A., and the ‚Ä†Department of Psychology, Queens University, Belfast, Northern Ireland, U.K. From the *Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A., and the ‚Ä†Department of Psychology, Queens University, Belfast, Northern Ireland, U.K. From the *Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A., and the ‚Ä†Department of Psychology, Queens University, Belfast, Northern Ireland, U.K.},
note  = {Ann Surg. 2002 Oct;236(4):458-64.}
}

@Article{2016190,
author  = {Ager, C. and Reilley, M. and Nicholas, C. and Bartkowiak, T. and Jaiswal, A. and Curran, M. and Albershardt, T. and Bajaj, A. and Archer, J. and Reeves, R. and Ngo, L. and Berglund, P. and ter, M. and Denis, C. and Ghadially, H. and Arnoux, T. and Chanuc, F. and Fuseri, N. and Wilkinson, R. and Wagtmann, N. and Morel, Y. and Andre, P. and Atkins, M. and Carlino, M. and Ribas, A. and Thompson, J. and Choueiri, T. and Hodi, F. and Hwu, W. and McDermott, D. and Atkinson, V. and Cebon, J. and Fitzharris, B. and Jameson, M. and McNeil, C. and Hill, A. and Mangin, E. and Ahamadi, M. and van, V. and van, Z. and Ibrahim, N. and Long, G. and Gartrell, R. and Blake, Z. and Simoes, I. and Fu, Y. and Saito, T. and Qian, Y. and Lu, Y. and Saenger, Y. and Budhu, S. and De, H. and Zappasodi, R. and Schlunegger, K. and Freimark, B. and Hutchins, J. and Barker, C. and Wolchok, J. and Merghoub, T. and Burova, E. and Allbritton, O. and Hong, P. and Dai, J. and Pei, J. and Liu, M. and Kantrowitz, J. and Lai, V. and Poueymirou, W. and MacDonald, D. and Ioffe, E. and Mohrs, M. and Olson, W. and Thurston, G. and Capasso, C. and Frascaro, F. and Carpi, S. and T√§htinen, S. and Feola, S. and Fusciello, M. and Peltonen, K. and Martins, B. and Sj√∂berg, M. and Pesonen, S. and Ranki, T. and Kyruk, L. and Yl√∂sm√§ki, E. and Cerullo, V. and Cerignoli, F. and Xi, B. and Guenther, G. and Yu, N. and Muir, L. and Zhao, L. and Abassi, Y. and Cervera-Carrasc√≥n, V. and Siurala, M. and Santos, J. and Havunen, R. and Parviainen, S. and Hemminki, A. and Dalgleish, A. and Mudan, S. and DeBenedette, M. and Plachco, A. and Gamble, A. and Grogan, E. and Krisko, J. and Tcherepanova, I. and Nicolette, C. and Dhupkar, P. and Yu, L. and Kleinerman, E. and Gordon, N. and Grenga, I. and Lepone, L. and Gameiro, S. and Knudson, K. and Fantini, M. and Tsang, K. and Hodge, J. and Donahue, R. and Schlom, J. and Evans, E. and Bussler, H. and Mallow, C. and Reilly, C. and Torno, S. and Scrivens, M. and Foster, C. and Howell, A. and Balch, L. and Knapp, A. and Leonard, J. and Paris, M. and Fisher, T. and Hu-Lieskovan, S. and Ribas, A. and Smith, E. and Zauderer, M. and Fogler, W. and Franklin, M. and Thayer, M. and Saims, D. and Magnani, J. and Gong, J. and Gray, M. and Hutchins, J. and Freimark, B. and Fromm, G. and de, S. and Giffin, L. and Xu, X. and Rose, J. and Schreiber, T. and Fantini, M. and Gameiro, S. and Knudson, K. and Clavijo, P. and Allen, C. and Donahue, R. and Lepone, L. and Grenga, I. and Hodge, J. and Tsang, K. and Schlom, J. and Gray, M. and Gong, J. and Hutchins, J. and Freimark, B. and Grogan, J. and Manieri, N. and Chiang, E. and Caplazi, P. and Yadav, M. and Hagner, P. and Chiu, H. and Waldman, M. and Klippel, A. and Thakurta, A. and Pourdehnad, M. and Gandhi, A. and Henrich, I. and Quick, L. and Young, R. and Chou, M. and Hotson, A. and Willingham, S. and Ho, P. and Choy, C. and Laport, G. and McCaffery, I. and Miller, R. and Tipton, K. and Wong, K. and Singson, V. and Wong, C. and Chan, C. and Huang, Y. and Liu, S. and Richardson, J. and Kavanaugh, W. and West, J. and Irving, B. and Tipton, K. and Wong, K. and Singson, V. and Wong, C. and Chan, C. and Huang, Y. and Liu, S. and Richardson, J. and Kavanaugh, W. and West, J. and Irving, B. and Jaini, R. and Loya, M. and Eng, C. and Johnson, M. and Adjei, A. and Opyrchal, M. and Ramalingam, S. and Janne, P. and Dominguez, G. and Gabrilovich, D. and de, L. and Hasapidis, J. and Diede, S. and Ordentlich, P. and Cruickshank, S. and Meyers, M. and Hellmann, M. and Kalinski, P. and Zureikat, A. and Edwards, R. and Muthuswamy, R. and Obermajer, N. and Urban, J. and Butterfield, L. and Gooding, W. and Zeh, H. and Bartlett, D. and Zubkova, O. and Agapova, L. and Kapralova, M. and Krasovskaia, L. and Ovsepyan, A. and Lykov, M. and Eremeev, A. and Bokovanov, V. and Grigoryeva, O. and Karpov, A. and Ruchko, S. and Nicolette, C. and Shuster, A. and Khalil, D. and Campesato, L. and Li, Y. and Merghoub, T. and Wolchok, J. and Lazorchak, A. and Patterson, T. and Ding, Y. and Sasikumar, P. and Sudarshan, N. and Gowda, N. and Ramachandra, R. and Samiulla, D. and Giri, S. and Eswarappa, R. and Ramachandra, M. and Tuck, D. and Wyant, T. and Leshem, J. and Liu, X. and Bera, T. and Terabe, M. and Bossenmaier, B. and Niederfellner, G. and Reiter, Y. and Pastan, I. and Xia, L. and Xia, Y. and Hu, Y. and Wang, Y. and Bao, Y. and Dai, F. and Huang, S. and Hurt, E. and Hollingsworth, R. and Lum, L. and Chang, A. and Wicha, M. and Li, Q. and Mace, T. and Makhijani, N. and Talbert, E. and Young, G. and Guttridge, D. and Conwell, D. and Lesinski, G. and Gonzales, R. and Huffman, A. and Wang, X. and Reshef, R. and MacKinnon, A. and Chen, J. and Gross, M. and Marguier, G. and Shwonek, P. and Sotirovska, N. and Steggerda, S. and Parlati, F. and Makkouk, A. and Bennett, M. and Chen, J. and Emberley, E. and Gross, M. and Huang, T. and Li, W. and MacKinnon, A. and Marguier, G. and Neou, S. and Pan, A. and Zhang, J. and Zhang, W. and Parlati, F. and Marshall, N. and Marron, T. and Agudo, J. and Brown, B. and Brody, J. and McQuinn, C. and Mace, T. and Farren, M. and Komar, H. and Shakya, R. and Young, G. and Ludwug, T. and Lesinski, G. and Morillon, Y. and Hammond, S. and Schlom, J. and Greiner, J. and Nath, P. and Schwartz, A. and Maric, D. and Roberts, D. and Obermajer, N. and Bartlett, D. and Kalinski, P. and Naing, A. and Papadopoulos, K. and Autio, K. and Wong, D. and Patel, M. and Falchook, G. and Pant, S. and Ott, P. and Whiteside, M. and Patnaik, A. and Mumm, J. and Janku, F. and Chan, I. and Bauer, T. and Colen, R. and VanVlasselaer, P. and Brown, G. and Tannir, N. and Oft, M. and Infante, J. and Lipson, E. and Gopal, A. and Neelapu, S. and Armand, P. and Spurgeon, S. and Leonard, J. and Hodi, F. and Sanborn, R. and Melero, I. and Gajewski, T. and Maurer, M. and Perna, S. and Gutierrez, A. and Clynes, R. and Mitra, P. and Suryawanshi, S. and Gladstone, D. and Callahan, M. and Crooks, J. and Brown, S. and Gauthier, A. and de, B. and MacDonald, A. and Brunet, L. and Rothwell, W. and Bell, P. and Wilson, J. and Sato-Kaneko, F. and Yao, S. and Zhang, S. and Carson, D. and Guiducci, C. and Coffman, R. and Kitaura, K. and Matsutani, T. and Suzuki, R. and Hayashi, T. and Cohen, E. and Schaer, D. and Li, Y. and Dobkin, J. and Amatulli, M. and Hall, G. and Doman, T. and Manro, J. and Dorsey, F. and Sams, L. and Holmgaard, R. and Persaud, K. and Ludwig, D. and Surguladze, D. and Kauh, J. and Novosiadly, R. and Kalos, M. and Driscoll, K. and Pandha, H. and Ralph, C. and Harrington, K. and Curti, B. and Sanborn, R. and Akerley, W. and Gupta, S. and Melcher, A. and Mansfield, D. and Kaufman, D. and Schmidt, E. and Grose, M. and Davies, B. and Karpathy, R. and Shafren, D. and Shamalov, K. and Cohen, C. and Sharma, N. and Allison, J. and Shekarian, T. and Valsesia-Wittmann, S. and Caux, C. and Marabelle, A. and Slomovitz, B. and Moore, K. and Youssoufian, H. and Posner, M. and Tewary, P. and Brooks, A. and Xu, Y. and Wijeratne, K. and Gunatilaka, L. and Sayers, T. and Vasilakos, J. and Alston, T. and Dovedi, S. and Elvecrog, J. and Grigsby, I. and Herbst, R. and Johnson, K. and Moeckly, C. and Mullins, S. and Siebenaler, K. and SternJohn, J. and Tilahun, A. and Tomai, M. and Vogel, K. and Wilkinson, R. and Vietsch, E. and Wellstein, A. and Wythes, M. and Crosignani, S. and Tumang, J. and Alekar, S. and Bingham, P. and Cauwenberghs, S. and Chaplin, J. and Dalvie, D. and Denies, S. and De, M. and Feng, J. and Frederix, K. and Greasley, S. and Guo, J. and Hardwick, J. and Kaiser, S. and Jessen, K. and Kindt, E. and Letellier, M. and Li, W. and Maegley, K. and Marillier, R. and Miller, N. and Murray, B. and Pirson, R. and Preillon, J. and Rabolli, V. and Ray, C. and Ryan, K. and Scales, S. and Srirangam, J. and Solowiej, J. and Stewart, A. and Streiner, N. and Torti, V. and Tsaparikos, K. and Zheng, X. and Driessens, G. and Gomes, B. and Kraus, M. and Xu, C. and Zhang, Y. and Kradjian, G. and Qin, G. and Qi, J. and Xu, X. and Marelli, B. and Yu, H. and Guzman, W. and Tighe, R. and Salazar, R. and Lo, K. and English, J. and Radvanyi, L. and Lan, Y. and Zappasodi, R. and Budhu, S. and Hellmann, M. and Postow, M. and Senbabaoglu, Y. and Gasmi, B. and Zhong, H. and Li, Y. and Liu, C. and Hirschhorhn-Cymerman, D. and Wolchok, J. and Merghoub, T. and Zha, Y. and Malnassy, G. and Fulton, N. and Park, J. and Stock, W. and Nakamura, Y. and Gajewski, T. and Liu, H. and Ju, X. and Kosoff, R. and Ramos, K. and Coder, B. and Petit, R. and Princiotta, M. and Perry, K. and Zou, J. and Arina, A. and Fernandez, C. and Zheng, W. and Beckett, M. and Mauceri, H. and Fu, Y. and Weichselbaum, R. and DeBenedette, M. and Lewis, W. and Gamble, A. and Nicolette, C. and Han, Y. and Wu, Y. and Yang, C. and Huang, J. and Wu, D. and Li, J. and Liang, X. and Zhou, X. and Hou, J. and Hassan, R. and Jahan, T. and Antonia, S. and Kindler, H. and Alley, E. and Honarmand, S. and Liu, W. and Leong, M. and Whiting, C. and Nair, N. and Enstrom, A. and Lemmens, E. and Tsujikawa, T. and Kumar, S. and Coussens, L. and Murphy, A. and Brockstedt, D. and Koch, S. and Sebastian, M. and Weiss, C. and Fr√ºh, M. and Pless, M. and Cathomas, R. and Hilbe, W. and Pall, G. and Wehler, T. and Alt, J. and Bischoff, H. and Geissler, M. and Griesinger, F. and Kollmeier, J. and Papachristofilou, A. and Doener, F. and Fotin-Mleczek, M. and Hipp, M. and Hong, H. and Kallen, K. and Klinkhardt, U. and Stosnach, C. and Scheel, B. and Schroeder, A. and Seibel, T. and Gnad-Vogt, U. and Zippelius, A. and Park, H. and Ahn, Y. and Kim, T. and Kim, S. and Kim, S. and Lee, Y. and Keam, B. and Kim, D. and Heo, D. and Pilon-Thomas, S. and Weber, A. and Morse, J. and Kodumudi, K. and Liu, H. and Mullinax, J. and Sarnaik, A. and Pike, L. and Bang, A. and Ott, P. and Balboni, T. and Taylor, A. and Spektor, A. and Wilhite, T. and Krishnan, M. and Cagney, D. and Alexander, B. and Aizer, A. and Buchbinder, E. and Awad, M. and Ghandi, L. and Hodi, F. and Schoenfeld, J. and Schwartz, A. and Nath, P. and Lessey-Morillon, E. and Ridnour, L. and Roberts, D. and Segal, N. and Sharma, M. and Le, D. and Ott, P. and Ferris, R. and Zelenetz, A. and Neelapu, S. and Levy, R. and Lossos, I. and Jacobson, C. and Ramchandren, R. and Godwin, J. and Colevas, A. and Meier, R. and Krishnan, S. and Gu, X. and Neely, J. and Suryawanshi, S. and Timmerman, J. and Vanpouille-Box, C. and Formenti, S. and Demaria, S. and Wennerberg, E. and Mediero, A. and Cronstein, B. and Formenti, S. and Demaria, S. and Gustafson, M. and DiCostanzo, A. and Wheatley, C. and Kim, C. and Bornschlegl, S. and Gastineau, D. and Johnson, B. and Dietz, A. and MacDonald, C. and Bucsek, M. and Qiao, G. and Hylander, B. and Repasky, E. and Turbitt, W. and Xu, Y. and Mastro, A. and Rogers, C. and Withers, S. and Wang, Z. and Khuat, L. and Dunai, C. and Blazar, B. and Longo, D. and Rebhun, R. and Grossenbacher, S. and Monjazeb, A. and Murphy, W. and Rowlinson, S. and Agnello, G. and Alters, S. and Lowe, D. and Scharping, N. and Menk, A. and Whetstone, R. and Zeng, X. and Delgoffe, G. and Santos, P. and Menk, A. and Shi, J. and Delgoffe, G. and Butterfield, L. and Whetstone, R. and Menk, A. and Scharping, N. and Delgoffe, G. and Nagasaka, M. and Sukari, A. and Byrne-Steele, M. and Pan, W. and Hou, X. and Brown, B. and Eisenhower, M. and Han, J. and Collins, N. and Manguso, R. and Pope, H. and Shrestha, Y. and Boehm, J. and Haining, W. and Cron, K. and Sivan, A. and Aquino-Michaels, K. and Gajewski, T. and Orecchioni, M. and Bedognetti, D. and Hendrickx, W. and Fuoco, C. and Spada, F. and Sgarrella, F. and Cesareni, G. and Marincola, F. and Kostarelos, K. and Bianco, A. and Delogu, L. and Hendrickx, W. and Roelands, J. and Boughorbel, S. and Decock, J. and Presnell, S. and Wang, E. and Marincola, F. and Kuppen, P. and Ceccarelli, M. and Rinchai, D. and Chaussabel, D. and Miller, L. and Bedognetti, D. and Nguyen, A. and Sanborn, J. and Vaske, C. and Rabizadeh, S. and Niazi, K. and Benz, S. and Patel, S. and Restifo, N. and White, J. and Angiuoli, S. and Sausen, M. and Jones, S. and Sevdali, M. and Simmons, J. and Velculescu, V. and Diaz, L. and Zhang, T. and Sims, J. and Barton, S. and Gartrell, R. and Kadenhe-Chiweshe, A. and Dela, C. and Turk, A. and Lu, Y. and Mazzeo, C. and Kung, A. and Bruce, J. and Saenger, Y. and Yamashiro, D. and Connolly, E. and Baird, J. and Crittenden, M. and Friedman, D. and Xiao, H. and Leidner, R. and Bell, B. and Young, K. and Gough, M. and Bian, Z. and Kidder, K. and Liu, Y. and Curran, E. and Chen, X. and Corrales, L. and Kline, J. and Dunai, C. and Aguilar, E. and Khuat, L. and Murphy, W. and Guerriero, J. and Sotayo, A. and Ponichtera, H. and Pourzia, A. and Schad, S. and Carrasco, R. and Lazo, S. and Bronson, R. and Letai, A. and Kornbluth, R. and Gupta, S. and Termini, J. and Guirado, E. and Stone, G. and Meyer, C. and Helming, L. and Tumang, J. and Wilson, N. and Hofmeister, R. and Radvanyi, L. and Neubert, N. and Till√©, L. and Barras, D. and Soneson, C. and Baumgaertner, P. and Rimoldi, D. and Gfeller, D. and Delorenzi, M. and Fuertes, M. and Speiser, D. and Abraham, T. and Xiang, B. and Magee, M. and Waldman, S. and Snook, A. and Blogowski, W. and Zuba-Surma, E. and Budkowska, M. and Salata, D. and Dolegowska, B. and Starzynska, T. and Chan, L. and Somanchi, S. and McCulley, K. and Lee, D. and Buettner, N. and Shi, F. and Myers, P. and Curbishley, S. and Penny, S. and Steadman, L. and Millar, D. and Speers, E. and Ruth, N. and Wong, G. and Thimme, R. and Adams, D. and Cobbold, M. and Thomas, R. and Hendrickx, W. and Al-Muftah, M. and Decock, J. and Wong, M. and Morse, M. and McDermott, D. and Clark, J. and Kaufman, H. and Daniels, G. and Hua, H. and Rao, T. and Dutcher, J. and Kang, K. and Saunthararajah, Y. and Velcheti, V. and Kumar, V. and Anwar, F. and Verma, A. and Chheda, Z. and Kohanbash, G. and Sidney, J. and Okada, K. and Shrivastav, S. and Carrera, D. and Liu, S. and Jahan, N. and Mueller, S. and Pollack, I. and Carcaboso, A. and Sette, A. and Hou, Y. and Okada, H. and Field, J. and Zeng, W. and Shih, V. and Law, C. and Senter, P. and Gardai, S. and Okeley, N. and Penny, S. and Abelin, J. and Saeed, A. and Malaker, S. and Myers, P. and Shabanowitz, J. and Ward, S. and Hunt, D. and Cobbold, M. and Profusek, P. and Wood, L. and Shepard, D. and Grivas, P. and Kapp, K. and Volz, B. and Oswald, D. and Wittig, B. and Schmidt, M. and Sefrin, J. and Hillringhaus, L. and Lifke, V. and Lifke, A. and Skaletskaya, A. and Ponte, J. and Chittenden, T. and Setiady, Y. and Valsesia-Wittmann, S. and Sivado, E. and Thomas, V. and El, A. and Papot, S. and Dumontet, C. and Dyson, M. and McCafferty, J. and El, A. and Verma, A. and Kumar, V. and Bommareddy, P. and Kaufman, H. and Zloza, A. and Kohlhapp, F. and Silk, A. and Jhawar, S. and Paneque, T. and Bommareddy, P. and Kohlhapp, F. and Newman, J. and Beltran, P. and Zloza, A. and Kaufman, H. and Cao, F. and Hong, B. and Rodriguez-Cruz, T. and Song, X. and Gottschalk, S. and Calderon, H. and Illingworth, S. and Brown, A. and Fisher, K. and Seymour, L. and Champion, B. and Eriksson, E. and Wenthe, J. and Hellstr√∂m, A. and Paul-Wetterberg, G. and Loskog, A. and Eriksson, E. and Milenova, I. and Wenthe, J. and St√•hle, M. and Jarblad-Leja, J. and Ullenhag, G. and Dimberg, A. and Moreno, R. and Alemany, R. and Loskog, A. and Eriksson, E. and Milenova, I. and Moreno, R. and Alemany, R. and Loskog, A. and Jhawar, S. and Goyal, S. and Bommareddy, P. and Paneque, T. and Kaufman, H. and Zloza, A. and Kaufman, H. and Silk, A. and Mehnert, J. and Gabrail, N. and Bryan, J. and Medina, D. and Bommareddy, P. and Shafren, D. and Grose, M. and Zloza, A. and Mitchell, L. and Yagiz, K. and Lopez, F. and Mendoza, D. and Munday, A. and Gruber, H. and Jolly, D. and Fuhrmann, S. and Radoja, S. and Tan, W. and Pourchet, A. and Frey, A. and Mohr, I. and Mulvey, M. and Ranki, T. and Pesonen, S. and Capasso, C. and Yl√∂sm√§ki, E. and Cerullo, V. and Andtbacka, R. and Ross, M. and Agarwala, S. and Grossmann, K. and Taylor, M. and Vetto, J. and Neves, R. and Daud, A. and Khong, H. and Meek, S. and Ungerleider, R. and Welden, S. and Tanaka, M. and Williams, M. and Andtbacka, R. and Curti, B. and Hallmeyer, S. and Fox, B. and Feng, Z. and Paustian, C. and Bifulco, C. and Grose, M. and Shafren, D. and Zafar, S. and Parviainen, S. and Siurala, M. and Hemminki, O. and Havunen, R. and T√§htinen, S. and Bramante, S. and Vassilev, L. and Wang, H. and Lieber, A. and Hemmi, S. and de, G. and Kanerva, A. and Hemminki, A. and Ansari, T. and Sundararaman, S. and Roen, D. and Lehmann, P. and Bloom, A. and Bender, L. and Walters, I. and Terabe, M. and Berzofsky, J. and Chapelin, F. and Okada, H. and Ahrens, E. and DeFalco, J. and Harbell, M. and Manning-Bog, A. and Scholz, A. and Zhang, D. and Baia, G. and Tan, Y. and Sokolove, J. and Kim, D. and Williamson, K. and Chen, X. and Colrain, J. and Santo, G. and Nguyen, N. and Volkmuth, W. and Greenberg, N. and Robinson, W. and Emerling, D. and Drake, C. and Petrylak, D. and Antonarakis, E. and Kibel, A. and Chang, N. and Vu, T. and Campogan, D. and Haynes, H. and Trager, J. and Sheikh, N. and Quinn, D. and Kirk, P. and Addepalli, M. and Chang, T. and Zhang, P. and Konakova, M. and Hagihara, K. and Pai, S. and VanderVeen, L. and Obalapur, P. and Kuo, P. and Quach, P. and Fong, L. and Charych, D. and Zalevsky, J. and Langowski, J. and Addepalli, M. and Kirksey, Y. and Nutakki, R. and Kolarkar, S. and Pena, R. and Hoch, U. and Zalevsky, J. and Doberstein, S. and Charych, D. and Cha, J. and Mallon, Z. and Perez, M. and McDaniel, A. and Anand, S. and Uecker, D. and Nuccitelli, R. and McDaniel, A. and Anand, S. and Cha, J. and Uecker, D. and Nuccitelli, R. and Obermajer, N. and Urban, J. and Wieckowski, E. and Muthuswamy, R. and Ravindranathan, R. and Bartlett, D. and Kalinski, P. and Renrick, A. and Thounaojam, M. and Thomas, P. and Pellom, S. and Shanker, A. and Pellom, S. and Thounaojam, M. and Dudimah, D. and Brooks, A. and Sayers, T. and Shanker, A. and Su, Y. and Adamus, T. and Zhang, Q. and Nechaev, S. and Kortylewski, M. and Wei, S. and Allison, J. and Anderson, C. and Tang, C. and Schoenhals, J. and Tsouko, E. and Heymach, J. and de, G. and Chang, J. and Hess, K. and Diab, A. and Sharma, P. and Allison, J. and Naing, A. and Hong, D. and Welsh, J. and Albershardt, T. and Parsons, A. and Leleux, J. and Reeves, R. and ter, M. and Berglund, P. and Ascarateil, S. and Koziol, M. and Penny, S. and Malaker, S. and Steadman, L. and Myers, P. and Bai, D. and Shabanowitz, J. and Hunt, D. and Cobbold, M. and Dai, P. and Wang, W. and Yang, N. and Shuman, S. and Merghoub, T. and Wolchok, J. and Deng, L. and Dillon, P. and Petroni, G. and Brenin, D. and Bullock, K. and Olson, W. and Smolkin, M. and Smith, K. and Nail, C. and Slingluff, C. and Sharma, M. and Fa‚Äôak, F. and Janssen, L. and Khong, H. and Xiao, Z. and Hailemichael, Y. and Singh, M. and Vianden, C. and Diab, A. and Zalevsky, J. and Hoch, U. and Overwijk, W. and Facciabene, A. and Stefano, P. and Chongyung, F. and Rafail, S. and Hailemichael, Y. and Nielsen, M. and Fa‚Äôak, F. and Vanderslice, P. and Woodside, D. and Market, R. and Biediger, R. and Marathi, U. and Overwijk, W. and Hollevoet, K. and Geukens, N. and Declerck, P. and Joly, N. and McIntosh, L. and Paramithiotis, E. and Rizell, M. and Sternby, M. and Andersson, B. and Karlsson-Parra, A. and Kuai, R. and Ochyl, L. and Schwendeman, A. and Moon, J. and Deng, W. and Hudson, T. and Lemmens, E. and Hanson, B. and Rae, C. and Burrill, J. and Skoble, J. and Katibah, G. and Murphy, A. and deVries, M. and Brockstedt, D. and Leong, M. and Lauer, P. and Dubensky, T. and Whiting, C. and Chen, X. and Hu, Y. and Xia, Y. and Zhou, L. and Bao, Y. and Huang, S. and Ren, X. and Hurt, E. and Hollingsworth, R. and Chang, A. and Wicha, M. and Li, Q. and Aggarwal, C. and Mangrolia, D. and Cohen, R. and Weinstein, G. and Morrow, M. and Bauml, J. and Kraynyak, K. and Boyer, J. and Yan, J. and Lee, J. and Humeau, L. and Oyola, S. and Duff, S. and Weiner, D. and Yang, Z. and Bagarazzi, M. and McNeel, D. and Eickhoff, J. and Jeraj, R. and Staab, M. and Straus, J. and Rekoske, B. and Liu, G. and Melssen, M. and Petroni, G. and Grosh, W. and Varhegyi, N. and Bullock, K. and Smolkin, M. and Smith, K. and Galeassi, N. and Deacon, D. and Gaughan, E. and Slingluff, C. and Ghisoli, M. and Barve, M. and Mennel, R. and Wallraven, G. and Manning, L. and Senzer, N. and Nemunaitis, J. and Ogasawara, M. and Ota, S. and Peace, K. and Hale, D. and Vreeland, T. and Jackson, D. and Berry, J. and Trappey, A. and Herbert, G. and Clifton, G. and Hardin, M. and Toms, A. and Qiao, N. and Litton, J. and Peoples, G. and Mittendorf, E. and Ghamsari, L. and Flano, E. and Jacques, J. and Liu, B. and Havel, J. and Makarov, V. and Merghoub, T. and Wolchok, J. and Hellmann, M. and Chan, T. and Flechtner, J. and Stefano, P. and Facciabene, A. and Facciponte, J. and Ugel, S. and De, S. and Coukos, G. and Paris, S. and Pottier, A. and Levy, L. and Lu, B. and Cappuccini, F. and Pollock, E. and Bryant, R. and Hamdy, F. and Hill, A. and Redchenko, I. and Sultan, H. and Kumai, T. and Fesenkova, V. and Celis, E. and Tsang, K. and Fantini, M. and Fernando, I. and Palena, C. and David, J. and Hodge, J. and Gabitzsch, E. and Jones, F. and Gulley, J. and Schlom, J. and Herranz, M. and Rafail, S. and Ugel, S. and Facciponte, J. and Stefano, P. and Facciabene, A. and Wada, H. and Shimizu, A. and Osada, T. and Fukaya, S. and Sasaki, E. and Abolhalaj, M. and Askmyr, D. and Lundberg, K. and Albrekt, A. and Greiff, L. and Lindstedt, M. and Flies, D. and Higuchi, T. and Ornatowski, W. and Harris, J. and Adams, S. and Aguilera, T. and Rafat, M. and Castellini, L. and Shehade, H. and Kariolis, M. and Jang, D. and vonEbyen, R. and Graves, E. and Ellies, L. and Rankin, E. and Koong, A. and Giaccia, A. and Ajina, R. and Wang, S. and Smith, J. and Pierobon, M. and Jablonski, S. and Petricoin, E. and Weiner, L. and Sherry, L. and Waller, J. and Anderson, M. and Bigley, A. and Bernatchez, C. and Haymaker, C. and Tannir, N. and Kluger, H. and Tetzlaff, M. and Jackson, N. and Gergel, I. and Tagliaferri, M. and Zalevsky, J. and Hoch, U. and Hwu, P. and Snzol, M. and Hurwitz, M. and Diab, A. and Barberi, T. and Martin, A. and Suresh, R. and Barakat, D. and Harris-Bookman, S. and Drake, C. and Friedman, A. and Berkey, S. and Downs-Canner, S. and Delgoffe, G. and Edwards, R. and Curiel, T. and Odunsi, K. and Bartlett, D. and Obermajer, N. and Bruno, T. and Moore, B. and Squalls, O. and Ebner, P. and Waugh, K. and Mitchell, J. and Franklin, W. and Merrick, D. and McCarter, M. and Palmer, B. and Kern, J. and Vignali, D. and Slansky, J. and Chan, A. and Qiu, X. and Fraser, K. and Jonas, A. and Ottoson, N. and Gordon, K. and Kangas, T. and Leonardo, S. and Ertelt, K. and Walsh, R. and Uhlik, M. and Graff, J. and Bose, N. and Gupta, R. and Mandloi, N. and Paul, K. and Patil, A. and Sathian, R. and Mohan, A. and Manoharan, M. and Chaudhuri, A. and Chen, Y. and Lin, J. and Ye, Y. and Xu, C. and Chen, G. and Guo, Z. and Komarov, A. and Chenchik, A. and Makhanov, M. and Frangou, C. and Zheng, Y. and Coltharp, C. and Unfricht, D. and Dilworth, R. and Fridman, L. and Liu, L. and Rajopadhye, M. and Miller, P. and Concha-Benavente, F. and Bauman, J. and Trivedi, S. and Srivastava, R. and Ohr, J. and Heron, D. and Duvvuri, U. and Kim, S. and Gooding, W. and Ferris, R. and Torrey, H. and Mera, T. and Okubo, Y. and Vanamee, E. and Foster, R. and Faustman, D. and Gartrell, R. and Stack, E. and Lu, Y. and Izaki, D. and Beck, K. and Jia, D. and Armenta, P. and White-Stern, A. and Fu, Y. and Blake, Z. and Marks, D. and Kaufman, H. and Taback, B. and Horst, B. and Saenger, Y. and Glickman, L. and Kanne, D. and Gauthier, K. and Desbien, A. and Francica, B. and Katibah, G. and Corrales, L. and Leong, J. and Sung, L. and Metchette, K. and Kasibhatla, S. and Pferdekamper, A. and Zheng, L. and Cho, C. and Feng, Y. and McKenna, J. and Tallarico, J. and Bender, S. and Ndubaku, C. and McWhirter, S. and Drake, C. and Gajewski, T. and Dubensky, T. and Gugel, E. and Bell, C. and Munk, A. and Muniz, L. and Bhardwaj, N. and Zhao, F. and Evans, K. and Xiao, C. and Holtzhausen, A. and Hanks, B. and Scholler, N. and Yin, C. and Van, d. and Prantner, A. and Krejsa, C. and Smith, L. and Johnson, B. and Branstetter, D. and Stein, P. and Jaen, J. and Tan, J. and Chen, A. and Chen, Y. and Park, T. and Powers, J. and Sexton, H. and Xu, G. and Young, S. and Schindler, U. and Deng, W. and Klinke, D. and Komar, H. and Mace, T. and Serpa, G. and Elnaggar, O. and Conwell, D. and Hart, P. and Schmidt, C. and Dillhoff, M. and Jin, M. and Ostrowski, M. and Lesinski, G. and Koti, M. and Au, K. and Peterson, N. and Truesdell, P. and Reid-Schachter, G. and Graham, C. and Craig, A. and Francis, J. and Kotlan, B. and Balatoni, T. and Farkas, E. and Toth, L. and Ujhelyi, M. and Savolt, A. and Doleschall, Z. and Horvath, S. and Eles, K. and Olasz, J. and Csuka, O. and Kasler, M. and Liszkay, G. and Barnea, E. and Kumar, S. and Tsujikawa, T. and Blakely, C. and Flynn, P. and Goodman, R. and Bueno, R. and Sugarbaker, D. and Jablons, D. and Broaddus, V. and West, B. and Coussens, L. and Kunk, P. and Obeid, J. and Winters, K. and Pramoonjago, P. and Smolkin, M. and Stelow, E. and Bauer, T. and Slingluff, C. and Rahma, O. and Lamble, A. and Kosaka, Y. and Huang, F. and Saser, K. and Adams, H. and Tognon, C. and Laderas, T. and McWeeney, S. and Loriaux, M. and Tyner, J. and Druker, B. and Lind, E. and Liu, Z. and Lu, S. and Kane, L. and Ferris, R. and Liu, Z. and Shayan, G. and Lu, S. and Ferris, R. and Femel, J. and Tsujikawa, T. and Lane, R. and Booth, J. and Lund, A. and Melssen, M. and Rodriguez, A. and Slingluff, C. and Engelhard, V. and Metelli, A. and Wu, B. and Fugle, C. and Saleh, R. and Sun, S. and Wu, J. and Liu, B. and Li, Z. and Morris, Z. and Guy, E. and Heinze, C. and Kler, J. and Gressett, M. and Werner, L. and Gillies, S. and Korman, A. and Loibner, H. and Hank, J. and Rakhmilevich, A. and Harari, P. and Sondel, P. and Newman, J. and Zloza, A. and Huelsmann, E. and Broucek, J. and Kaufman, H. and Brech, D. and Straub, T. and Irmler, M. and Beckers, J. and Buettner, F. and Schaeffeler, E. and Schwab, M. and Noessner, E. and Anand, S. and McDaniel, A. and Cha, J. and Uecker, D. and Nuccitelli, R. and Ordentlich, P. and Wolfreys, A. and Da, C. and Silva, J. and Crosby, A. and Staelens, L. and Craggs, G. and Cauvin, A. and Mason, S. and Paterson, A. and Lake, A. and Armet, C. and O‚ÄôConnor, R. and Hill, J. and Normant, E. and Adam, A. and Biniszkiewicz, D. and Chappel, S. and Palombella, V. and Holland, P. and Powers, J. and Becker, A. and Chen, A. and Leleti, M. and Newcomb, E. and Sexton, H. and Schindler, U. and Tan, J. and Young, S. and Jaen, J. and Rapisuwon, S. and Radfar, A. and Gardner, K. and Gibney, G. and Atkins, M. and Rennier, K. and Crowder, R. and Wang, P. and Pachynski, R. and Carrero, R. and Rivas, S. and Beceren-Braun, F. and Anthony, S. and Schluns, K. and Sawant, D. and Chikina, M. and Yano, H. and Workman, C. and Vignali, D. and Salerno, E. and Bedognetti, D. and Mauldin, I. and Deacon, D. and Shea, S. and Pinczewski, J. and Obeid, J. and Coukos, G. and Wang, E. and Gajewski, T. and Marincola, F. and Slingluff, C. and Spranger, S. and Horton, B. and Gajewski, T. and Suzuki, A. and Leland, P. and Joshi, B. and Puri, R. and Sweis, R. and Bao, R. and Luke, J. and Gajewski, T. and Theodoraki, M. and Mogundo, F. and Edwards, R. and Kalinski, P. and Won, H. and Moreira, D. and Gao, C. and Zhao, X. and Duttagupta, P. and Jones, J. and D‚ÄôApuzzo, M. and Pal, S. and Kortylewski, M.},
title  = {Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016.},
journal  = {Journal for Immunotherapy of Cancer},
volume  = {4},
number  = {Suppl 1},
pages  = {107-221},
year  = {2016},
abstract  = {},
address  = {Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France MedImmune, Cambridge, England UK Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France MedImmune, Cambridge, England UK Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC USA Westmead and Blacktown Hospitals, Melanoma Institute Australia, and the University of Sydney, Westmead, New South Wales Australia University of California, Los Angeles, CA USA University of Washington, Seattle, WA USA Dana-Farber Cancer Institute/Brigham and Women‚Äôs Hospital, Harvard University, Boston, MA USA Dana-Farber Cancer Institute/Brigham and Women‚Äôs Hospital, Harvard University, Boston, MA USA University of Texas MD Anderson Cancer Center, Houston, TX USA Beth Israel Deaconess Medical Center, Boston, MA USA Gallipoli Medical Research Foundation, Greenslopes Private Hospital, and the University of Queensland, Greenslopes, Queensland Australia Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria Australia Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand Waikato Hospital Regional Cancer Centre, Hamilton, New Zealand Royal Prince Alfred Hospital, Melanoma Institute Australia, the University of Sydney, and Chris O‚ÄôBrien Lifehouse, Camperdown, New South Wales Australia Tasman Oncology Research, Southport Gold Coast, Queensland Australia Merck & Co., Inc., Kenilworth, NJ USA Merck & Co., Inc., Kenilworth, NJ USA Quantitative Solutions, A Certara Company, Oss, Netherlands Quantitative Solutions, A Certara Company, Oss, Netherlands Merck & Co., Inc., Kenilworth, NJ USA Melanoma Institute Australia, the University of Sydney, Mater Hospital, and Royal North Shore Hospital, Wollstonecraft, New South Wales Australia Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Institut d‚ÄôInvestigacions Biomediques August Pi i Sunyer, Barcelona, Catalonia Spain Columbia University Medical Center, New York, NY USA Icahn School of Medicine at Mount Sinai, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA New York Presbyterian/Columbia University Medical Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Peregrine Pharmaceuticals, Inc., Tustin, CA USA Peregrine Pharmaceuticals, Inc., Tustin, CA USA Peregrine Pharmaceuticals, Inc., Tustin, CA USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA Regeneron, Tarrytown, NY USA University of Helsinki, Helsinki, Uusimaa Finland University of Siena, Supersano (LE), Puglia Italy University of Pisa, Pisa, Toscana Italy University of Helsinki, Helsinki, Uusimaa Finland University of Napoli Federico II, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland PeptiCRAd Oy, Helsinki, Uusimaa Finland PeptiCRAd Oy, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland ACEA Biosciences Inc., San Diego, CA USA ACEA Biosciences Inc., San Diego, CA USA ACEA Biosciences Inc., San Diego, CA USA ACEA Biosciences Inc., San Diego, CA USA ACEA Biosciences Inc., San Diego, CA USA ACEA Biosciences Inc., San Diego, CA USA ACEA Biosciences Inc., San Diego, CA USA TILT Biotherapeutics, Helsinki, Uusimaa Finland TILT Biotherapeutics, Helsinki, Uusimaa Finland TILT Biotherapeutics, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland TILT Biotherapeutics, Helsinki, Uusimaa Finland TILT Biotherapeutics, Helsinki, Uusimaa Finland St George‚Äôs University of London, London, UK The Royal Marsden Hospital and Imperial College London, London, UK Argos Therapeutics Inc., Durham, NC USA Argos Therapeutics Inc., Durham, NC USA Argos Therapeutics Inc., Durham, NC USA Argos Therapeutics Inc., Durham, NC USA Argos Therapeutics Inc., Durham, NC USA Argos Therapeutics Inc., Durham, NC USA Argos Therapeutics Inc., Durham, NC USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA University of California, Los Angeles, CA USA University of California, Los Angeles, CA USA Vaccinex, Rochester, NY USA Vaccinex, Rochester, NY USA GlycoMimetics, Inc., Rockville, MD USA MI Bioresearch, Ann Arbor, MI USA MI Bioresearch, Ann Arbor, MI USA MI Bioresearch, Ann Arbor, MI USA GlycoMimetics, Inc., Rockville, MD USA Peregrine Pharmaceuticals, Tustin, CA USA Peregrine Pharmaceuticals, Tustin, CA USA Peregrine Pharmaceuticals, Tustin, CA USA Peregrine Pharmaceuticals, Tustin, CA USA Heat Biologics, Inc., Durham, NC USA Heat Biologics, Inc., Durham, NC USA Heat Biologics, Inc., Durham, NC USA Heat Biologics, Inc., Durham, NC USA Heat Biologics, Inc., Durham, NC USA Heat Biologics, Inc., Durham, NC USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD USA National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA Peregrine Pharmaceuticals, Tustin, CA USA Peregrine Pharmaceuticals, Tustin, CA USA Peregrine Pharmaceuticals, Tustin, CA USA Peregrine Pharmaceuticals, Tustin, CA USA Genentech, South San Francisco, CA USA Genentech, South San Francisco, CA USA Genentech, South San Francisco, CA USA Genentech, South San Francisco, CA USA Genentech, South San Francisco, CA USA Celgene Corporation, Summit, NJ USA Celgene Corporation, Summit, NJ USA Celgene Corporation, Summit, NJ USA Celgene Corporation, Summit, NJ USA Celgene Corporation, Summit, NJ USA Celgene Corporation, San Francisco, CA USA Celgene Corporation, Summit, NJ USA University of Pennsylvania, Philadelphia, PA USA Children‚Äôs Hospital of Pennsylvania, Philadelphia, PA USA Children‚Äôs Hospital of Pennsylvania, Philadelphia, PA USA Children‚Äôs Hospital of Pennsylvania, Philadelphia, PA USA Corvus Pharmaceuticals, Burlingame, CA USA Corvus Pharmaceuticals, Burlingame, CA USA Corvus Pharmaceuticals, Burlingame, CA USA Corvus Pharmaceuticals, Burlingame, CA USA Corvus Pharmaceuticals, Burlingame, CA USA Corvus Pharmaceuticals, Burlingame, CA USA Corvus Pharmaceuticals, Burlingame, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA CytomX Therapeutics, Inc, South San Francisco, CA USA Lerner Research Institute, Cleveland Clinic, Cleveland, OH USA Lerner Research Institute, Cleveland Clinic, Cleveland, OH USA Lerner Research Institute, Cleveland Clinic, Cleveland, OH USA Sarah Cannon Research Institute, Nashville, TN USA Mayo Clinic, Rochester, MN USA Roswell Park Cancer Institute, Buffalo, NY USA Emory University, Atlanta, GA USA Dana-Farber Cancer Institute, Boston, MA USA The Wistar Institute, Philadelphia, PA USA The Wistar Institute, Philadelphia, PA USA Syndax Pharmaceuticals, Inc, Waltham, MA USA Syndax Pharmaceuticals, Inc, Waltham, MA USA Merck Research Laboratories, North Wales, PA USA Syndax Pharmaceuticals, Inc, Waltham, MA USA Syndax Pharmaceuticals, Inc, Waltham, MA USA Syndax Pharmaceuticals, Inc, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA  USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC IBC Generium, Volginsky, Vladimir Russia LLC IBC Generium, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia LLC Cellthera Pharm, Volginsky, Vladimir Russia Argos Therapeutics Inc., Durham, NC USA LLC IBC Generium, Volginsky, Vladimir Russia Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Curis, Inc., Lexington, MA USA Curis, Inc., Lexington, MA USA Curis, Inc., Lexington, MA USA Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Aurigene Discovery Technologies Limited, Bangalore, Karnataka India Curis, Inc., Lexington, MA USA Curis, Inc., Lexington, MA USA National Cancer Institute, NIH, Bethesda, MD USA National Cancer Institute, NIH, Bethesda, MD USA National Cancer Institute, NIH, Bethesda, MD USA National Cancer Institute, NIH, Bethesda, MD USA Roche Pharmaceutical Research &Early Development, Discovery Oncology, Innovation  Center Penzberg, Roche Diagnostics GmbH, Penzberg, Germany Roche Pharmaceutical Research &Early Development, Discovery Oncology, Innovation  Center Penzberg, Roche Diagnostics GmbH, Penzberg, Germany Technion Institute, Haifa, Iceland National Cancer Institute, NIH, Bethesda, MD USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA The No.1 People‚Äôs Hospital of Hefei, Hefei, Anhui People‚Äôs Republic of China The No.1 People‚Äôs Hospital of Hefei, Hefei, Anhui People‚Äôs Republic of China The No.1 People‚Äôs Hospital of Hefei, Hefei, Anhui People‚Äôs Republic of China Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei People‚Äôs Republic of China MedImmune Inc, Gaithersburg, MD USA MedImmune Inc, Gaithersburg, MD USA University of Virginia Cancer Center, Charlottesville, VA USA University of Michigan, Ann Arbor, MI USA University of Michigan Medical School, Ann Arbor, MI USA University of Michigan Medical Center, Ann Arbor, MI USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY USA Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY USA Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY USA Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Calithera Biosciences, South San Francisco, CA USA Icahn School of Medicine at Mount Sinai, New York, NY USA Icahn School of Medicine at Mount Sinai, New York, NY USA Icahn School of Medicine at Mount Sinai, New York, NY USA Icahn School of Medicine at Mount Sinai, New York, NY USA Icahn School of Medicine at Mount Sinai, New York, NY USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National  Cancer Institute, Bethesda, MD USA MedImmune LLC, Gaithersburg, MD USA Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National  Cancer Institute, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National  Cancer Institute, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD USA National Cancer Institute, National Institutes of Health, Bethesda, MD USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA  USA University of Texas MD Anderson Cancer Center, Houston, TX USA South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX USA Memorial Sloan Kettering Cancer Center, New York, NY USA UCLA, Los Angeles, CA USA Sarah Cannon Research Institute/Florida Cancer Specialists, Sarasota, FL USA SCRI at HealthONE, Denver, CO USA Oklahoma University, Oklahoma City, OK USA Dana-Farber Cancer Institute, Boston, MA USA ARMO BioSciences, Redwood City, CA USA South Texas Accelerated Research Therapeutics, LLC, San Antonio, TX USA ARMO BioSciences, Redwood City, CA USA University of Texas MD Anderson Cancer Center, Houston, TX USA ARMO BioSciences, Redwood City, CA USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA ARMO BioSciences, Redwood City, CA USA ARMO BioSciences, Redwood City, CA USA University of Texas MD Anderson Cancer Center, Houston, TX USA ARMO BioSciences, Redwood City, CA USA Sarah Cannon Research Institute, Nashville, TN USA Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD USA Seattle Cancer Care Alliance, University of Washington, Seattle, WA USA University of Texas MD Anderson Cancer Center, Houston, TX USA Dana-Farber Cancer Institute, Harvard University, Boston, MA USA Center for Hematologic Malignancies, Oregon Health and Sciences University, Portland, OR USA New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY USA Dana-Farber Cancer Institute, Harvard University, Boston, MA USA Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR USA Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra Spain University of Chicago Medical Center, Chicago, IL USA Bristol-Myers Squibb, Princeton, NJ USA Bristol-Myers Squibb, Lawrence Township, NJ USA Memorial Sloan Kettering Cancer Center, New York, NY USA Bristol-Myers Squibb, Lawrence Township, NJ USA Bristol-Myers Squibb, Lawrence Township, NJ USA Bristol-Myers Squibb, Lawrence Township, NJ USA Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra Spain Memorial Sloan Kettering Cancer Center, New York, NY USA MCCIR, University of Manchester, Manchester, England UK MCCIR, University of Manchester, Manchester, England UK Oncodesign, Dijon, Bourgogne France Oncodesign, Dijon, Bourgogne France MCCIR, University of Manchester, Manchester, England UK Immodulon Therapeutics Ltd, Uxbridge, England UK University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA University of Pennsylvania Perelman School of Medicine, Philadelphia, PA USA Moores Cancer Center, University of California, San Diego, La Jolla, CA USA Moores Cancer Center, University of California, San Diego, La Jolla, CA USA Dynavax Technologies, Berkeley, CA USA Moores Cancer Center, University of California, San Diego, La Jolla, CA USA Dynavax Technologies, Berkeley, CA USA Dynavax Technologies, Berkeley, CA USA Repertoire Genesis Incorporation, Ibaraki, Osaka Japan Repertoire Genesis Incorporation, Ibaraki, Osaka Japan Repertoire Genesis Incorporation, Ibaraki, Osaka Japan Moores Cancer Center, University of California, San Diego, La Jolla, CA USA Moores Cancer Center, University of California, San Diego, La Jolla, CA USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, Indianapolis, IN USA Eli Lilly and Company, Indianapolis, IN USA Eli Lilly and Company, Indianapolis, IN USA Eli Lilly and Company, Indianapolis, IN USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, Bridgewater, NJ USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA Eli Lilly and Company, New York, NY USA University of Surrey, Guildford, England UK St James University Hospital, Leeds, England UK Institute for Cancer Research, London, England UK Providence Cancer Center, Portland, OR USA Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, Oregon USA Huntsman Cancer Institute, Salt Lake City, UT USA Huntsman Cancer Institute, Salt Lake City, UT USA Institute for Cancer Research, London, England UK Institute for Cancer Research, London, England UK Merck & Co., Inc., Kenilworth, NJ USA Merck & Co., Inc., Kenilworth, NJ USA Merck & Co., Inc., Kenilworth, NJ USA Viralytics Ltd., Sydney, New South Wales Australia Viralytics Ltd., Sydney, New South Wales Australia Viralytics Ltd., Sydney, New South Wales Australia Bar Ilan University, Ramat Gan, HaMerkaz, Iceland Bar Ilan University, Ramat Gan, HaMerkaz, Iceland University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Universit√© Claude Bernard Lyon 1, Centre Leon Berard, Lyon, Rhone-Alpes France Centre Leon Berard, Innovations in Immunotherapy Platform, Lyon, Rhone-Alpes France Universit√© Claude Bernard Lyon 1, Centre Leon Berard, Lyon, Rhone-Alpes France Institue Goustave Roussy, Universit√© Claude Bernard Lyon 1, Centre Leon Berard, Villejuif, Ile-de-France France Sylvester Comprehensive Cancer Center/University of Miami, Miami, FL USA Stephenson Oklahoma Cancer Center, Oklahoma City, OK USA Advaxis Immunotherapies, Princeton, NJ USA Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, New York, NY USA CIP, Center for Cancer Research, BSP, Leidos Biomed Research Inc, National Cancer Institute-Frederick, Frederick, MD USA CIP, Center for Cancer Research, Leidos Biomed Research Inc, National Cancer Institute-Frederick, Frederick, MD USA University of Arizona, Southwest Center for Natural Products Research and Commercialization, Tucson, AZ USA University of Arizona, Southwest Center for Natural Products Research and Commercialization, Tucson, AZ USA University of Arizona, Tucson, AZ USA CIP, Center for Cancer Research, BSP, Leidos Biomed Research Inc, National Cancer Institute-Frederick, Frederick, MD USA 3M Company, St. Paul, MN USA 3M Company, St. Paul, MN USA Medimmune, Cambridge, England UK 3M Company, St. Paul, MN USA 3M Company, St. Paul, MN USA Medimmune, Gaithersburg, MD USA 3M Company, St. Paul, MN USA 3M Company, St. Paul, MN USA Medimmune, Cambridge, England UK 3M Company, St. Paul, MN USA 3M Company, St. Paul, MN USA 3M Company, St. Paul, MN USA 3M Company, St. Paul, MN USA Medimmune, Cambridge, England UK Medimmune, Cambridge, England UK Georgetown University/Medical School/Lombardi Cancer Center, Washington, DC USA Georgetown University/Medical School/Lombardi Cancer Center, Washington, DC USA Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium iTeos, Rue Auguste Piccard 48, Brussels, Hoofdstedelijk Gewest Belgium iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA Pfizer, San Diego, CA USA iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium iTeos, 6041 Gosselies, Brussels, Hoofdstedelijk Gewest Belgium Pfizer, San Diego, CA USA EMD Serono, Belmont, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA EMD Serono, Billerica, MA USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA University of Chicago, OSRF-HIM, Chicago, IL USA University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA Section of Hematology/Oncology, University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA University of Chicago Medical Center, Chicago, IL USA University of Chicago Medical Center, Chicago, IL USA Advaxis Immunotherapies, Princeton, NJ USA Advaxis Immunotherapies, Princeton, NJ USA Advaxis Immunotherapies, Princeton, NJ USA Advaxis Immunotherapies, Princeton, NJ USA Advaxis Immunotherapies, Princeton, NJ USA Advaxis Immunotherapies, Princeton, NJ USA Advaxis Immunotherapies, Princeton, NJ USA Advaxis Immunotherapies, Princeton, NJ USA The University of Chicago, Chicago, IL USA The University of Chicago, Chicago, IL USA The University of Chicago, Chicago, IL USA The University of Chicago, Chicago, IL USA The University of Chicago, Chicago, IL USA UT Southwestern, Dallas, TX USA The University of Chicago, Chicago, IL USA Argos Therapeutics, Durham, NC USA Argos Therapeutics, Durham, NC USA Argos Therapeutics, Durham, NC USA Argos Therapeutics, Durham, NC USA R&D Department, HRYZ Biotech Co., Shenzhen, Guangdong People‚Äôs Republic of China Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Guangzhou, Guangdong People‚Äôs Republic of China Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Guangzhou, Guangdong People‚Äôs Republic of China Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Guangzhou, Guangdong People‚Äôs Republic of China HRYZ Biotech Co., Shenzhen, Guangdong People‚Äôs Republic of China HRYZ Biotech Co., Shenzhen, Guangdong People‚Äôs Republic of China R&D Department, HRYZ Biotech Co., Shenzhen, Guangdong People‚Äôs Republic of China HRYZ Biotech Co., Shenzhen, Guangdong People‚Äôs Republic of China Department of Infectious Diseases and Hepatology Unit, Nanfang Hospital, Guangzhou, Guangdong People‚Äôs Republic of China Thoracic and GI Oncology Branch, National Cancer Institute, Bethesda, MD USA Department of Medicine, Division of Hematology Oncology, UCSF, San Francisco, CA  USA H. Lee Moffitt Cancer Center, Tampa, FL USA Gastrointestinal Oncology and Mesothelioma Programs, Section of Hematology/Oncology, University of Chicago, Chicago, IL USA Penn Prebyterian Medical Center, University of Pennsylvania, Philadelphia, PA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA CureVac AG, Tubingen, Baden-Wurttemberg Germany University Hospital Frankfurt, Medical Clinic II, Goethe University, Frankfurt, Hessen Germany Klinikum Darmstadt GmbH, Darmstadt, Hessen Germany Kantonsspital St. Gallen, St. Gallen, Switzerland Kantonsspital Winterthur, Winterthur, Zurich Switzerland Kantonsspital Graub√ºnden, Chur, Graubunden Switzerland Wilhelminenspital Wien, Wien, Austria Fachkliniken Wangen, Wangen (Allg√§u), Baden-Wurttemberg Germany J. Gutenberg University Hospital Mainz, Mainz, Rheinland-Pfalz Germany J. Gutenberg University Hospital Mainz, Mainz, Rheinland-Pfalz Germany Thoraxklinik Heidelberg gGmbH, Heidelberg, Baden-Wurttemberg Germany Klinikum Esslingen GmbH, Esslingen, Baden-Wurttemberg Germany Pius Hospital Oldenburg, Oldenburg, Niedersachsen Germany Heckeshorn Lung Clinic, Berlin, Germany University Hospital Basel, Basel-Stadt, Switzerland CureVac AG, Tubingen, Baden-Wurttemberg Germany CureVac AG, Tubingen, Baden-Wurttemberg Germany CureVac AG, Tubingen, Baden-Wurttemberg Germany CureVac AG, Tubingen, Baden-Wurttemberg Germany CureVac AG, Tubingen, Baden-Wurttemberg Germany CureVac AG, Frankfurt am Main, Hessen Germany CureVac AG, Frankfurt am Main, Hessen Germany CureVac AG, Tubingen, Baden-Wurttemberg Germany CureVac AG, Frankfurt am Main, Hessen Germany CureVac AG, Frankfurt am Main, Hessen Germany CureVac AG, Frankfurt am Main, Hessen Germany University Hospital Basel, Basel-Stadt, Switzerland SNU Cancer Research Institute, Seoul, Republic of Korea SNU Cancer Research Institute, Seoul, Republic of Korea Seoul National University Hospital, SNU Cancer Research Institute, Seoul, Republic of Korea SNU Cancer Research Institute, Seoul, Republic of Korea SNU Cancer Research Institute, Seoul, Republic of Korea SNU Cancer Research Institute, Seoul, Republic of Korea Seoul National University Hospital, SNU Cancer Research Institute, Seoul, Republic of Korea Seoul National University Hospital, SNU Cancer Research Institute, Seoul, Republic of Korea Seoul National University Hospital, SNU Cancer Research Institute, Seoul, Republic of Korea H. Lee Moffitt Cancer Center, Tampa, FL USA H. Lee Moffitt Cancer Center, Tampa, FL USA H. Lee Moffitt Cancer Center, Tampa, FL USA H. Lee Moffitt Cancer Center, Tampa, FL USA H. Lee Moffitt Cancer Center, Tampa, FL USA H. Lee Moffitt Cancer Center, Tampa, FL USA H. Lee Moffitt Cancer Center, Tampa, FL USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Harvard Radiation Oncology Program, Boston, MA USA Dana-Farber Cancer Institute, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA Dana-Farber Cancer Institute, Harvard University, Boston, MA USA Brigham and Women‚Äôs/Dana-Farber Cancer Center, Harvard University, Boston, MA USA National Cancer Institute, Bethesda, MD USA National Cancer Institute, Bethesda, MD USA National Cancer Institute, Bethesda, MD USA National Cancer Institute, Frederick, MD USA Department of Pathology, National Cancer Institute, Bethesda, MD USA Memorial Sloan Kettering Cancer Center, New York, NY USA University of Chicago Medicine, Chicago, IL USA Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD USA Dana-Farber Cancer Institute, Boston, MA USA University of Pittsburgh, Pittsburgh, PA USA Memorial Sloan Kettering Cancer Center, New York, NY USA University of Texas MD Anderson Cancer Center, Houston, TX USA Stanford University School of Medicine, Stanford, CA USA University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL USA Dana-Farber Cancer Institute, Boston, MA USA Karmanos Cancer Institute, Detroit, MI USA Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR USA Stanford University School of Medicine, Stanford, CA USA Bristol-Myers Squibb, Princeton, NJ USA Bristol-Myers Squibb, Princeton, NJ USA Bristol-Myers Squibb, Princeton, NJ USA Bristol-Myers Squibb, Princeton, NJ USA Bristol-Myers Squibb, Princeton, NJ USA UCLA Medical Center, Los Angeles, CA USA Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA Weill Cornell Medical College, New York, NY USA New York University Langone Medical Center, New York, NY USA Weill Cornell Medical College, New York, NY USA Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA Department of Radiation Oncology, Weill Cornell Medicine, New York, NY USA Mayo Clinic, Rochester, MN USA Mayo Clinic, Rochester, MN USA Mayo Clinic, Rochester, MN USA Mayo Clinic, Rochester, MN USA Mayo Clinic, Rochester, MN USA Mayo Clinic, Rochester, MN USA Mayo Clinic, Rochester, MN USA Mayo Clinic, Rochester, MN USA Roswell Park Cancer Institute, Buffalo, NY USA Roswell Park Cancer Institute, Buffalo, NY USA Roswell Park Cancer Institute, Buffalo, NY USA Roswell Park Cancer Institute, Buffalo, NY USA Roswell Park Cancer Institute, Buffalo, NY USA Pennsylvania State University, University Park, PA USA Pennsylvania State University, University Park, PA USA Pennsylvania State University, University Park, PA USA Pennsylvania State University, University Park, PA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA University of Minnesota, Minneapolis, MN USA Dana-Farber Cancer Institute, Boston, MA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA Aeglea BioTherapeutics, Austin, TX USA Aeglea BioTherapeutics, Austin, TX USA Aeglea BioTherapeutics, Austin, TX USA Aeglea BioTherapeutics, Austin, TX USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh Cancer Institute, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA Karmanos Cancer Institute, Detroit, MI USA Karmanos Cancer Institute, Detroit, MI USA iRepertoire, Inc, Huntsville, AL USA iRepertoire, Inc, Huntsville, AL USA iRepertoire, Inc, Huntsville, AL USA iRepertoire, Inc, Huntsville, AL USA iRepertoire, Inc, Huntsville, AL USA iRepertoire, Inc, Huntsville, AL USA Dana-Farber Cancer Institute, Boston, MA USA Dana-Farber Cancer Institute, Boston, MA USA Dana-Farber Cancer Institute, Boston, MA USA Broad Institute, Cambridge, MA USA Broad Institute, Cambridge, MA USA Dana-Farber Cancer Institute, Boston, MA USA University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA University of Chicago Medical Center, Chicago, IL USA University of Sassari, Sassari, Sardegna Italy Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Bristol-Myers Squibb, Lawrence Township, NJ USA University of Roma Tor Vergata, Roma, Lazio Italy University of Sassari, Sassari, Sardegna Italy University of Roma Tor Vergata, Roma, Lazio Italy Research Branch, Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Faculty of Medical & Human Sciences, University of Manchester, Manchester, England UK CNRS, Institute de Biologie Mol√©culaire et Cellulaire, Strasbourg, Alsace France University of Sassari, Sassari, Sardegna Italy Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Qatar Biomedical Research Institute (QBRI), Doha, Ar Rayyan Qatar Benaroya Research Institute, Seattle, WA USA Qatar Computing Research Institute, Doha, Ad Dawhah Qatar Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Leiden University Medical Center, Leiden, Zuid-Holland Netherlands Qatar Computing Research Institute, Doha, Ad Dawhah Qatar Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Wake Forest School of Medicine, Winston-Salem, NC USA Sidra Medical and Research Center, Doha, Ad Dawhah Qatar NantOmics, San Jose, CA USA NantOmics, Santa Cruz, CA USA NantOmics, Santa Cruz, CA USA NantOmics, Santa Cruz, CA USA NantOmics, Santa Cruz, CA USA NantOmics, Santa Cruz, CA USA National Cancer Institute, Bethesda, MD USA National Cancer Institute, Bethesda, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Personal Genome Diagnostics, Baltimore, MD USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Fordham University, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA New York Presbyterian/Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR USA Earle A. Chile Research Institute, Portland, OR USA Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR USA Providence Portland Medical Center, Portland, OR USA Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR USA Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR USA Earle A. Chile Research Institute, Portland, OR USA Earle A. Chile Research Institute, Portland, OR USA Georgia State University, Atlanta, GA USA Georgia State University, Atlanta, GA USA Georgia State University, Atlanta, GA USA University of Chicago, Chicago, IL USA Department of Medicine, University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA Committee on Immunology and Department of Medicine, University of Chicago, Chicago, IL USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA University of California, Davis, Sacramento, CA USA Dana-Farber Cancer Institute, Boston, MA USA Dana-Farber Cancer Institute, Boston, MA USA Evelo Biosciences, Cambridge, MA USA Dana-Farber Cancer Institute, Boston, MA USA Dana-Farber Cancer Institute, Boston, MA USA Dana-Farber Cancer Institute, Boston, MA USA Dana-Farber Cancer Institute, Boston, MA USA Harvard Medical School, Boston, MA USA Dana-Farber Cancer Institute, Boston, MA USA Receptome, LLC, La Jolla, CA USA Miller School of Medicine, University of Miami, Miami, FL USA Miller School of Medicine, University of Miami, Miami, FL USA Miller School of Medicine, University of Miami, Miami, FL USA Miller School of Medicine, University of Miami, Miami, FL USA EMD Serono, Billerica, MA USA Merck KGaA, Darmstadt, Hessen Germany Compass Therapeutics, Cambridge, MA USA Agenus Inc., Lexington, MA USA TCR2 Therapeutics, Cambridge, MA USA EMD Serono, Billerica, MA USA University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland SIB Swiss Institute of Bioinformatics, Lausanne, Vaud Switzerland SIB Swiss Institute of Bioinformatics, Lausanne, Vaud Switzerland University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland SIB Swiss Institute of Bioinformatics, Lausanne, Vaud Switzerland University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland University of Lausanne, Ludwig Cancer Research, Epalinges, Vaud Switzerland Thomas Jefferson University, Philadelphia, PA USA Thomas Jefferson University, Philadelphia, PA USA Thomas Jefferson University, Philadelphia, PA USA Thomas Jefferson University, Philadelphia, PA USA Thomas Jefferson University, Philadelphia, PA USA Department of Internal Medicine, University of Zielona Gora, Zielona Gora, Lubuskie Poland Department of Medical Biotechnology, Jagiellonian University, Krakow, Malopolskie Poland Department of Medical Analytics, Pomeranian Medical University, Szczecin, Zachodniopomorskie Poland Department of Medical Analytics, Pomeranian Medical University, Szczecin, Zachodniopomorskie Poland Department of Microbiology and Immune Diagnostics, Pomeranian Medical University, Szczecin, Zachodniopomorskie Poland Department of Gastroenterology, Pomeranian Medical University, Szczecin, Zachodniopomorskie Poland Nexcelom Bioscience, Lawrence, MA USA University of Texas MD Anderson Cancer Center, Houston, TX USA Nexcelom Bioscience, Lawrence, MA USA Nexcelom Bioscience, Houston, MA USA Universit√§tsklinikum Freiburg, Freiburg, Germany Massachusetts General Hospital Cancer Center, Boston, MA USA University of Virginia, Charlottesville, VA USA University of Birmingham, Birmingham, England UK University of Birmingham, Birmingham, England UK University of Birmingham, Birmingham, England UK Massachusetts General Hospital Cancer Center, Boston, MA USA University of Virginia, Charlottesville, VA USA University of Birmingham, Birmingham, England UK University of Birmingham, Birmingham, England UK Universit√§tsklinikum Freiburg, Freiburg, Germany University of Birmingham, Birmingham, England UK Massachusetts General Hospital Cancer Center, Boston, MA USA Qatar Biomedical Research Instititute (QBRI), Doha, Ar Rayyan Qatar Sidra Medical and Research Center, Doha, Ad Dawhah Qatar Qatar Biomedical Research Instititute (QBRI), Doha, Ar Rayyan Qatar Qatar Biomedical Research Instititute (QBRI), Doha, Ar Rayyan Qatar University of Texas MD Anderson Cancer Center, Houston, TX USA Duke University Medical Center, Durham, NC USA Beth Israel Deaconess Medical Center, Boston, MA USA Loyola University Medical Center, Maywood, IL USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA UC San Diego Moores Cancer Center, La Jolla, CA USA Prometheus Laboratories Inc., San Diego, CA USA Prometheus Laboratories Inc., San Diego, CA USA Cancer Research Foundation, Chappaqua, NY USA Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH USA Cleveland Clinic, Cleveland, OH USA Cleveland Clinic, Cleveland, OH USA Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh India King Abdulaziz University, Jeddah, Afghanistan Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh India University of California, San Francisco, San Francisco, CA USA University of California, San Francisco, San Francisco, CA USA La Jolla Institute for Allergy and Immunology, La Jolla, CA USA University of California, San Francisco, San Francisco, CA USA University of California, San Francisco, San Francisco, CA USA University of California, San Francisco, San Francisco, CA USA University of California, San Francisco, San Francisco, CA USA University of California, San Francisco, San Francisco, CA USA University of California, San Francisco, San Francisco, CA USA University of Pittsburgh, Pittsburgh, PA USA Hospital Sant Joan de D√©u Barcelona, Barcelona, Spain La Jolla Institute for Allergy and Immunology, La Jolla, CA USA University of California, San Francisco, San Francisco, CA USA University of California, San Francisco, San Francisco, CA USA Seattle Genetics, Inc., Bothell, WA USA Seattle Genetics, Inc., Bothell, WA USA Seattle Genetics, Inc., Bothell, WA USA Seattle Genetics, Inc., Bothell, WA USA Seattle Genetics, Inc., Bothell, WA USA Seattle Genetics, Inc., Bothell, WA USA Seattle Genetics, Inc., Bothell, WA USA University of Birmingham, Birmingham, England UK University of Virginia, Charlottesville, VA USA University of Birmingham, Birmingham, England UK Stanford University, Stanford, CA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Birmingham, Birmingham, England UK University of Virginia, Charlottesville, VA USA Massachusetts General Hospital Cancer Center, Boston, MA USA Cleveland Clinic, Cleveland, OH USA Cleveland Clinic, Cleveland, OH USA Cleveland Clinic, Cleveland, OH USA Cleveland Clinic, Cleveland, OH USA Mologen AG, Berlin, Germany Mologen AG, Berlin, Germany Mologen AG, Berlin, Germany Foundation Institute Molecular Biology and Bioinformatics, Freie Universitaet Berlin, Berlin, Germany Mologen AG, Berlin, Germany Roche Diagnostics GmbH, Penzberg, Bayern Germany Roche Diagnostics GmbH, Penzberg, Bayern Germany Roche Diagnostics GmbH, Penzberg, Bayern Germany Roche Diagnostics GmbH, Penzberg, Bayern Germany ImmunoGen, Inc., Waltham, MA USA ImmunoGen, Inc., Waltham, MA USA ImmunoGen, Inc., Waltham, MA USA ImmunoGen, Inc., Waltham, MA USA Centre L√©on B√©rard, Innovations in immunotherapy platform, Lyon, Rhone-Alpes France Centre L√©on B√©rard, Innovations in immunotherapy platform, Lyon, Rhone-Alpes France Covalab, Villeurbanne, Rhone-Alpes France Centre L√©on B√©rard, Innovations in immunotherapy platform, Lyon, Rhone-Alpes France IC2MP, Poitiers, Limousin France CRCL, Lyon, Rhone-Alpes France IONTAS, Cambridge, England UK IONTAS, Cambridge, England UK Covalab, Villeurbanne, Rhone-Alpes France Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh India Sam Higginbotham Institute of Agriculture, Technology & Sciences, Allahabad, Uttar Pradesh India Rutgers University, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers Robert Wood Johnson Medical School, Somerset, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Center for Cell and Gene Therapy, Texas Children‚Äôs Hospital, Houston Methodist, Baylor College of Medicine, Houston, TX USA Center for Cell and Gene Therapy, Texas Children‚Äôs Hospital, Houston Methodist, Baylor College of Medicine, Houston, TX USA Center for Cell and Gene Therapy, Texas Children‚Äôs Hospital, Houston Methodist, Baylor College of Medicine, Houston, TX USA Center for Cell and Gene Therapy, Texas Children‚Äôs Hospital, Houston Methodist, Baylor College of Medicine, Houston, TX USA Center for Cell and Gene Therapy, Texas Children‚Äôs Hospital, Houston Methodist, Baylor College of Medicine, Houston, TX USA PsiOxus Therapeutics Ltd, Abingdon, England UK PsiOxus Therapeutics Ltd, Abingdon, England UK PsiOxus Therapeutics Ltd, Abingdon, England UK PsiOxus Therapeutics Ltd, Abingdon, England UK Oxford University, Oxford, England UK PsiOxus Therapeutics Ltd, Abingdon, England UK Uppsala University, Uppsala, Sweden Uppsala University, Uppsala, Sweden Uppsala University, Uppsala, Sweden Uppsala University, Uppsala, Sweden Uppsala University, Lokon Pharma AB, Uppsala, Sweden Uppsala University, Uppsala, Sweden Uppsala University, Amsterdam, Netherlands Uppsala University, Uppsala, Sweden Uppsala University, Uppsala, Sweden Uppsala University, Immuneed AB, Uppsala, Sweden Uppsala University, Uppsala University Hospital, Uppsala, Sweden Uppsala University, Uppsala, Sweden Institut Catal√° d‚ÄôOncologia, Barcelona, Spain Institut Catal√° d‚ÄôOncologia, Barcelona, Spain Uppsala University, Lokon Pharma AB, Uppsala, Sweden Uppsala University, Uppsala, Sweden Uppsala University, Amsterdam, Netherlands Institut Catal√° d‚ÄôOncologia, Barcelona, Spain Institut Catal√° d‚ÄôOncologia, Barcelona, Spain Uppsala University, Lokon Pharma AB, Uppsala, Sweden Rutgers University, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers University, New Brunswick, NJ USA Rutgers Robert Wood Johnson Medical School, Somerset, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Gabrail Cancer Center, Canton, OH USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Viralytics Limited, Sydney, New South Wales Australia Viralytics Limited, Sydney, New South Wales Australia Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Tocagen Inc, San Diego, CA USA Tocagen Inc, San Diego, CA USA Tocagen Inc, San Diego, CA USA Tocagen Inc, San Diego, CA USA Tocagen Inc, San Diego, CA USA Tocagen Inc, San Diego, CA USA Tocagen Inc, San Diego, CA USA BeneVir Biopharm, Inc, Gaithersburg, MD USA BeneVir Biopharm, Inc, Gaithersburg, MD USA BeneVir Biopharm, Inc, Gaithersburg, MD USA New York University Langone School of Medicine, New York, NY USA New York University Langone School of Medicine, New York, NY USA New York University Langone School of Medicine, New York, NY USA BeneVir Biopharm, Inc, Gaithersburg, MD USA PeptiCRAd Oy, Helsinki, Uusimaa Finland PeptiCRAd Oy, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA Univesity of Texas MD Anderson Cancer Center, Houston, TX USA St. Luke‚Äôs Hospital, Easton, PA USA University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA Oregon Health & Science University, Portland, OR USA Knight Cancer Institute, Oregon Health and Science University, Portland, OR USA Pennsylvania State University, Hershey Cancer Institute, Hershey, PA USA UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA USA University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA University of Utah School of Medicine, Salt Lake City, UT USA Theradex, Princeton, NJ USA Theradex, Princeton, NJ USA Takara Bio, Inc, Otsu, Shiga Japan University of Utah, Salt Lake City, UT USA University of Utah, Huntsman Cancer Institute, Salt Lake City, UT USA Providence Cancer Center, Portland, OR USA Oncology Specialists, Chicago, IL USA Innate Pharma, Marseille, Provence-Alpes-Cote d‚ÄôAzur France Providence Cancer Center, Portland, OR USA Providence Cancer Center, Portland, OR USA Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR USA Viralytics Limited, Sydney, New South Wales Australia Viralytics Limited, Sydney, New South Wales Australia University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland University of Washington, Seattle, WA USA University of Washington, Seattle, WA USA University of Zurich, Zurich, Switzerland VU University Medical Center, Amsterdam, Netherlands University of Helsinki, Helsinki, Uusimaa Finland University of Helsinki, Helsinki, Uusimaa Finland Cellular Technology Ltd, Shaker Hts, OH USA Cellular Technology Ltd, Shaker Hts, OH USA Cellular Technology Ltd, Shaker Hts, OH USA Cellular Technology Ltd, Shaker Hts, OH USA National Cancer Institute, Bethesda, MD USA Intensity Therapeutics, Inc., Westport, CT USA Intensity Therapeutics, Inc., Westport, CT USA National Cancer Institute, Bethesda, MD USA National Cancer Institute, Bethesda, MD USA University of California, San Diego, La Jolla, CA USA University of California, San Francisco, San Francisco, CA USA University of California, San Diego, La Jolla, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Stanford University School of Medicine, Stanford, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Atreca, Redwood City, CA USA Department of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX USA Atreca, Redwood City, CA USA Johns Hopkins University Cancer Center, Baltimore, MD USA Yale School of Medicine, New Haven, CT USA Johns Hopkins University Cancer Center, Baltimore, MD USA Johns Hopkins University, Sidney Kimmel Cancer Center, Baltimore, MD USA Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women‚Äôs Hospital, Boston, MA USA Harvard Medical School, Dana-Farber Cancer Center, and Brigham and Women‚Äôs Hospital, Boston, MA USA Dendreon Pharmaceuticals, Inc, Seattle, WA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA University of California, San Francisco School of Medicine, San Francisco, CA USA Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Hellen Diller Family Comprehensive Cancer Center, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, USA Meharry Medical College, Nashville, TN USA Medical College of Georgia, Augusta, GA USA Meharry Medical College, Nashville, TN USA Meharry Medical College, Nashville, TN USA Meharry Medical College School of Medicine, Nashville, TN USA Meharry Medical College, Nashville, TN USA Medical College of Georgia, Augusta, GA USA Meharry Medical College School of Medicine, Nashville, TN USA National Cancer Institute-Frederick, Frederick, MD USA CIP, Center for Cancer Research, BSP, Leidos Biomed Research Inc, National Cancer Institute-Frederick, Frederick, MD USA Meharry Medical College School of Medicine, Nashville, TN USA Beckman Research Institute/City of Hope, Monrovia, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Immune Design, Seattle, WA USA Seppic, Puteaux, Ile-de-France France Seppic Inc., Fairfield, NJ USA University of Birmingham, Birmingham, England UK Stanford University, Stanford, CA USA University of Birmingham, Birmingham, England UK University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Massachusetts General Hospital Cancer Center, Boston, MA USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Department of Public Health Sciences, University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX USA Texas Heart Institute, Houston, TX USA Department of Molecular Cardiology, Texas Heart Institute, Houston, TX USA Department of Molecular Cardiology, Texas Heart Institute, Houston, TX USA Department of Molecular Cardiology, Texas Heart Institute, Houston, TX USA 7 Hills Pharma LLC, Houston, TX USA Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX USA KU Leuven, Leuven, Vlaams-Brabant Belgium KU Leuven, Leuven, Vlaams-Brabant Belgium KU Leuven, Leuven, Vlaams-Brabant Belgium Caprion Biosciences Inc., Montreal, PQ Canada Caprion Biosciences Inc., Montreal, PQ Canada Caprion Biosciences Inc., Montreal, PQ Canada Transplant Institute, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden Transplant Institute, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden Department of Clinical Immunology, Gothenburg University, Gothenburg, Sweden Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA Aduro Biotech, Inc., Berkeley, CA USA University of Michigan Cancer Center, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan, Ann Arbor, MI USA University of Michigan Cancer Center, Ann Arbor, MI USA The Third Affiliated Hospital of Anhui Medical University, Heifei, Anhui People‚Äôs Republic of China Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei People‚Äôs Republic of China Tianjin University Cancer Institute and Hospital, Tianjin, Hebei People‚Äôs Republic of China MedImmune Inc, Gaithersburg, MD USA MedImmune Inc, Gaithersburg, MD USA University of Michigan, Ann Arbor, MI USA University of Michigan Medical School, Ann Arbor, MI USA University of Michigan Medical Center, 1150 W. Medical Center Dr, Ann Arbor, MI USA University of Pennsylvania, Philadelphia, PA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA University of Pennsylvania, Philadelphia, PA USA Inovio Pharmaceuticals, Philadelphia, PA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA University of Pennsylvania, Philadelphia, PA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA Inovio Pharmaceuticals, San Diego, CA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA University of Michigan, Ann Arbor, MI USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA The Wistar Institute, Philadelphia, PA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA Inovio Pharmaceuticals, Plymouth Meeting, PA USA University of Wisconsin Carbone Cancer Center, Madison, WI USA University of Wisconsin, Madison, WI USA University of Wisconsin, Madison, WI USA University of Wisconsin Carbone Cancer Center, Madison, WI USA University of Wisconsin Carbone Cancer Center, Madison, WI USA University of Wisconsin, Madison, WI USA University of Wisconsin Carbone Cancer Center, Madison, WI USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Department of Surgery, University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA Mary Crowley Cancer Research Centers, Texas Oncology, P.A, Dallas, TX USA Mary Crowley Cancer Research Centers, Texas Oncology, P.A, Dallas, TX USA Texas Oncology, P.A, Baylor University Medical Center, Dallas, TX USA Gradalis, Inc, Carrollton, TX USA Gradalis, Inc., Dallas, TX USA Mary Crowley Cancer Research Centers, Gradalis, Inc, Dallas, TX USA Mary Crowley Cancer Research Centers, Gradalis, Inc, Dallas, TX USA Sapporo Hokuyu Hospital, Sapporo, Hokkaido Japan Sapporo Hokuyu Hospital, Sapporo, Hokkaido Japan Brooke Army Medical Center, San Antonio, TX USA Brooke Army Medical Center, San Antonio, TX USA Womack Army Medical Center, Fayetteville, NC USA Brooke Army Medical Center, San Antonio, TX USA Department of Colon and Rectal Surgery, Washington University, St Louis, MO USA Brooke Army Medical Center, San Antonio, TX USA Brooke Army Medical Center, San Antonio, TX USA Brooke Army Medical Center, San Antonio, TX USA Madigan Army Medical Center, Tacoma, WA USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Cancer Vaccine Development Program, San Antonio, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Genocea Biosciences, Cambridge, MA USA Genocea Biosciences, Cambridge, MA USA Genocea Biosciences, Cambridge, MA USA Genocea Biosciences, Cambridge, MA USA Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Ludwig Collaborative Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY USA Memorial Sloan Kettering Cancer Center, New York, NY USA Genocea Biosciences, Cambridge, MA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA Nanobiotix, Paris, Ile-de-France France Nanobiotix, Paris, Ile-de-France France Nanobiotix, Paris, Ile-de-France France Thomas Jefferson University, Philadelphia, PA USA The Jenner Institute, University of Oxford, Oxford, England UK The Jenner Institute, University of Oxford, Oxford, England UK Nuffield Department of Surgical Sciences, University of Oxford, Oxford, England UK Nuffield Department of Surgical Sciences, University of Oxford, Oxford, England UK The Jenner Institute, University of Oxford, Oxford, England UK The Jenner Institute, University of Oxford, Oxford, England UK Augusta University, Georgia Cancer Center, Augusta, GA USA Augusta University, Georgia Cancer Center, Augusta, GA USA Augusta University, Georgia Cancer Center, Augusta, GA USA Augusta University, Georgia Cancer Center, Augusta, GA USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Etubics Corporation, Seattle, WA USA Etubics Corporation, Seattle, WA USA Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD USA Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA University of Pennsylvania, Philadelphia, PA USA Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan Taiho Pharmaceutical Co., Ltd, Tsukuba, Ibaraki Japan Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden ENT Department, Lund University Hospital, Lund, Skane Lan Sweden Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden ENT Department, Lund University Hospital, Lund, Skane Lan Sweden Department of Immunotechnology, Lund University, Lund, Skane Lan Sweden NextCure, Beltsville, MD USA University of New Mexico Comprehensive Cancer Center, Beltsville, MD USA University of New Mexico Comprehensive Cancer Center, Albuquerque, NM USA University of New Mexico, Albuquerque, NM USA University of New Mexico Comprehensive Cancer Center, Albuquerque, NM USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Department of Pathology, University of California, San Diego, La Jolla, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Stanford Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA USA Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA George Mason University, Manassas, VA USA Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA OracleBio, Newhouse, Scotland UK OracleBio, Newhouse, Scotland UK OracleBio, Newhouse, Scotland UK OracleBio, Newhouse, Scotland UK University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Yale Medical Oncology, New Haven, CT USA University of Texas MD Anderson Cancer Center, Houston, TX USA University of Texas MD Anderson Cancer Center, Houston, TX USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA Nektar Therapeutics, San Francisco, CA USA University of Texas MD Anderson Cancer Center, Houston, TX USA Yale Medical Oncology, New Haven, CT USA Yale Medical Oncology, New Haven, CT USA University of Texas MD Anderson Cancer Center, Houston, TX USA Johns Hopkins University, Baltimore, MD USA Johns Hopkins University, Baltimore, MD USA Johns Hopkins University, Baltimore, MD USA Johns Hopkins University, Baltimore, MD USA Johns Hopkins University, Baltimore, MD USA Johns Hopkins University, Baltimore, MD USA Johns Hopkins University, Baltimore, MD USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Texas Health Science Center at San Antonio, San Antonio, TX USA Roswell Park Cancer Institute, Buffalo, NY USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh, Pittsburgh, PA USA Department of Immunology, University of Pittsburgh, Pittsburgh, PA USA Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA Department of Cardiothoracic Surgery, University of Colorado, Aurora, CO USA Department of Pathology, University of Colorado, Aurora, CO USA Department of Pathology, University of Colorado, Aurora, CO USA Department of Surgery, University of Colorado, Aurora, CO USA Department of Medicine, University of Colorado, Aurora, CO USA National Jewish Health, Denver, CO USA University of Pittsburgh, Pittsburgh, PA USA Department of Immunology and Microbiology, University of Colorado, Aurora, CO USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA Biothera Pharmaceuticals Inc, Eagan, MN USA MedGenome Inc, Foster City, CA USA MedGenome Inc, Foster City, CA USA MedGenome Inc, Foster City, CA USA MedGenome Inc, Foster City, CA USA MedGenome Inc, Foster City, CA USA MedGenome Inc, Foster City, CA USA MedGenome Inc, Foster City, CA USA MedGenome Inc, Foster City, CA USA Fujian Provincial Cancer Hospital, Fuzhou, Fujian People‚Äôs Republic of China Fujian Provincial Cancer Hospital, Fuzhou, Fujian People‚Äôs Republic of China Fujian Provincial Cancer Hospital, Fuzhou, Fujian People‚Äôs Republic of China Fujian Provincial Cancer Hospital, Fuzhou, Fujian People‚Äôs Republic of China Fujian Provincial Cancer Hospital, Fuzhou, Fujian People‚Äôs Republic of China Fujian Provincial Cancer Hospital, Fuzhou, Fujian People‚Äôs Republic of China Cellecta, Inc, Mountain View, CA USA Cellecta, Inc, Mountain View, CA USA Cellecta, Inc, Mountain View, CA USA Cellecta, Inc, Mountain View, CA USA PerkinElmer, Hopkinton, MA USA PerkinElmer, Hopkinton, MA USA PerkinElmer, Hopkinton, MA USA PerkinElmer, Hopkinton, MA USA PerkinElmer, Hopkinton, MA USA PerkinElmer, Hopkinton, MA USA PerkinElmer, Hopkinton, MA USA PerkinElmer, Hopkinton, MA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA Massachusetts General Hospital, Harvard Medical, Boston, MA USA Massachusetts General Hospital, Harvard Medical, Boston, MA USA Massachusetts General Hospital, Harvard Medical, Boston, MA USA Massachusetts General Hospital, Harvard Medical, Boston, MA USA Massachusetts General Hospital, Harvard Medical, Boston, MA USA Massachusetts General Hospital, Harvard Medical, Boston, MA USA Columbia University Medical Center, New York, NY USA Perkin Elmer, Hopkinton, MA USA Columbia University Medical Center, New York, NY USA Columbia University, New York, NY USA Columbia University College of Physicians and Surgeons, New York, NY USA Columbia University College of Physicians and Surgeons, New York, NY USA Columbia University College of Physicians and Surgeons, New York, NY USA Columbia University College of Physicians and Surgeons, New York, NY USA Columbia University College of Physicians and Surgeons, New York, NY USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Columbia University Medical Center, New York, NY USA Columbia University Medical Center, New York, NY USA New York Presbyterian, Columbia University Medical Center, New York, NY USA Aduro Biotech, Berkeley, CA USA Aduro Biotech, Berkeley, CA USA Aduro Biotech, Berkeley, CA USA Aduro Biotech, Berkeley, CA USA Johns Hopkins University School of Medicine, Baltimore, MD USA Aduro Biotech, Berkeley, CA USA The University of Chicago, Chicago, IL USA Aduro Biotech, Berkeley, CA USA Aduro Biotech, Berkeley, CA USA Aduro Biotech, Berkeley, CA USA Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA Novartis Institutes for BioMedical Research, Inc., Cambridge, MA USA Genomics Institute of the Novartis Research Foundation (GNF), San Diego, CA USA Aduro Biotech, Berkeley, CA USA Aduro Biotech, Berkeley, CA USA Johns Hopkins University Cancer Center, Baltimore, MD USA University of Chicago Medical Center, Chicago, IL USA Aduro Biotech, Berkeley, CA USA Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA Murray Edwards College and School of Clinical Medicine, University of Cambridge,  Cambridge, England UK Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA Tish Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY USA Duke University Medical Center, Durham, NC USA Duke University Medical Center, Durham, NC USA Duke University Medical Center, Durham, NC USA Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC USA Duke University Medical Center, Durham, NC USA Stanford Research Institute, Menlo Park, CA USA Stanford Research Institute, Menlo Park, CA USA Rijksuniversiteit Groningen, Amsterdam, Groningen Netherlands University of Pennsylvania, Philadelphia, PA USA Acerta Pharma, Bellevue, WA USA Acerta Pharma, Bellevue, WA USA University of Washington, Seattle, WA USA Cynosure Clinical Research LLC, North Bend, WA USA Stanford Research Institute, Menlo Park, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA West Virginia University, Morgantown, WV USA West Virginia University, Morgantown, WV USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University Wexner Medical Center, Columbus, OH USA The Ohio State University Wexner Medical Center, Columbus, OH USA The Ohio State University Wexner Medical Center, Columbus, OH USA The Ohio State University Wexner Medical Center, Columbus, OH USA The Ohio State University, Columbus, OH USA The Ohio State University, Columbus, OH USA Queen‚Äôs University, Kingston, ON Canada Queen‚Äôs University, Kingston, ON Canada Queen‚Äôs University, Kingston, ON Canada Queen‚Äôs University, Kingston, ON Canada Queen‚Äôs University, Kingston, ON Canada Queen‚Äôs University, Kingston, ON Canada Queen‚Äôs University, Kingston, ON Canada Queen‚Äôs University, Kingston, ON Canada National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary National Institute of Oncology, Budapest, Hungary BioIncept, Cherry Hill, NJ USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA University of California, San Francisco School of Medicine, San Francisco, CA USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Brigham and Women‚Äôs Hospital, Boston, MA USA Baylor Clinic, Houston, TX USA UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA USA University of California, San Francisco School of Medicine, San Francisco, CA USA Plexxikon Inc., Berkeley, CA USA Oregon Health & Science University, Portland, OR USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Department of Public Health Sciences, University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA Dana Farber Cancer Institute, Harvard University, Boston, MA USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Janssen Pharmaceutical R&D, Spring House, PA USA Janssen Pharmaceutical R&D, Spring House, PA USA Janssen Pharmaceutical R&D, Spring House, PA USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Knight Cancer Institute, Howard Hughes Medical Institute, Portland, OR USA Oregon Health & Science University, Portland, OR USA University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA USA University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA USA Department of Immunology, University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA USA University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA USA University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA Oregon Health & Science University, Portland, OR USA University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Division of Surgical Oncology, University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Medical University of South Carolina, Charleston, SC USA Medical University of South Carolina, Charleston, SC USA Medical University of South Carolina, Charleston, SC USA Medical University of South Carolina, Charleston, SC USA Medical University of South Carolina, Charleston, SC USA Medical University of South Carolina, Charleston, SC USA Medical University of South Carolina, Charleston, SC USA Medical University of South Carolina, Charleston, SC USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA Provenance Biopharmaceuticals Corp., Carlisle, MA USA Bristol-Myers Squibb, Princeton, NJ USA Apeiron Biologics, Vienna, Austria University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA University of Wisconsin School of Medicine and Public Health, Madison, WI USA Rutgers University, New Brunswick, NJ USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Rush University, Chicago, IL USA Rush University, Chicago, IL USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ USA Helmholtz Zentrum M√ºnchen, Immunoanalytics- Tissue Control of Immunocytes, Munich, Bayern Germany Bioinformatics Core Unit, Biomedical Center, Ludwig-Maximilians-University, Planegg-Martinsried Munich, Munich, Bayern Germany Helmholtz Zentrum M√ºnchen, Institute of Experimental Genetics, Neuherberg, Bayern Germany Helmholtz Zentrum M√ºnchen, Institute of Experimental Genetics, Neuherberg, Bayern Germany Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Baden-Wurttemberg Germany Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Baden-Wurttemberg Germany Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, University of Tuebingen, Stuttgart, Baden-Wurttemberg Germany Helmholtz Zentrum M√ºnchen, Immunoanalytics-Tissue Control of Immunocytes, Munich, Bayern Germany Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Pulse Biosciences, Burlingame, CA USA Syndax Pharmaceuticals, Inc, Waltham, MA USA UCB Biopharma, Slough, England UK UCB Biopharma, Braine-l‚ÄôAlleud, Brabant Wallon Belgium UCB Biopharma, Slough, England UK UCB Biopharma, Slough, England UK UCB Biopharma, Braine-l‚ÄôAlleud, Brabant Wallon Belgium UCB Biopharma, Slough, England UK UCB Biopharma, Braine-l‚ÄôAlleud, Brabant Wallon Belgium UCB Biopharma, Slough, England UK Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Surface Oncology, Cambridge, MA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Arcus Biosciences, Hayward, CA USA Georgetown Lombardi Comprehensive Cancer Center, Washington, DC USA Washington Hospital Center, Washington, DC USA Lombardi Comprehensive Cancer Center, Washington, DC USA Lombardi Comprehensive Cancer Center, Washington, DC USA Lombardi Comprehensive Cancer Center, Washington, DC USA Washington University School of Medicine in St. Louis, St. Louis, MO USA Washington University School of Medicine in St. Louis, St. Louis, MO USA Washington University School of Medicine in St. Louis, St. Louis, MO USA Washington University School of Medicine in St. Louis, St. Louis, MO USA The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX USA Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA Department of Microbiology, University of Iowa, Iowa City, IA USA Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Pittsburgh, Pittsburgh, PA USA University of Alabama, Birmingham, AL USA Sidra Medical and Research Center, Doha, Ad Dawhah Qatar University of Virginia, Charlottesville, VA USA University of Virginia, Charlottesville, VA USA Hunter Holmes McGuire Veterans Administration Medical Center, Richmond, VA USA Dorevitch Pathology, Heidelberg West, Victoria Australia Department of Surgery, University of Virginia, Charlottesville, VA USA Ludwig Institute for Cancer Research, Epalinges, Vaud Switzerland Sidra Medical and Research Center, Doha, Ad Dawhah Qatar The University of Chicago, Chicago, IL USA Sidra Medical and Research Center, Doha, Ad Dawhah Qatar University of Virginia, Charlottesville, VA USA Department of Pathology, The University of Chicago, Chicago, IL USA Department of Pathology, The University of Chicago, Chicago, IL USA University of Chicago Medical Center, Chicago, IL USA Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD USA Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD USA Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD USA Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD USA University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA University of Chicago, Chicago, IL USA University of Chicago Medical Center, Chicago, IL USA University of Pittsburgh, Pittsburgh, PA USA Magee-Womens Research Institute, Ovarian Cancer Center of Excellence, and Peritoneal/Ovarian Cancer Specialty Care Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA USA Magee-Womens Research Institute, Ovarian Cancer Center of Excellence, and Peritoneal/Ovarian Cancer Specialty Care Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA USA Department of Surgery, University of Pittsburgh Cancer Institute, Pittsburgh, PA  USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA City of Hope, Duarte, CA USA},
note  = {doi:10.1186/s40425-016-0173-6.}
}

@Article{2009191,
author  = {Thompson, J. and Ritenbaugh, C. and Nichter, M.},
title  = {Reconsidering the Placebo Response from a Broad Anthropological Perspective.},
journal  = {Culture, medicine and psychiatry},
volume  = {33},
number  = {1},
pages  = {112-52},
year  = {2009},
abstract  = {This paper considers how the full range of human experience may catalyze a placebo response. The placebo effect has been characterized as something to control in clinical research, something to cultivate in clinical practice, and something present in all healing encounters. We examine domains in which the term ‚Äòplacebo‚Äô is used in discourse: clinical research, clinical practice, media representations of treatment efficacy, and lay interpretations of placebo‚Äîan under-researched topic. We briefly review major theoretical frameworks proposed to explain the placebo effect: classical conditioning, expectancy, the therapeutic relationship, and sociocultural ‚Äòmeaning.‚Äô As a corrective to what we see as an over-emphasis on conscious cognitive approaches to understanding placebo, we reorient the discussion to argue that direct embodied experience may  take precedence over meaning-making in the healing encounter. As an example, we examine the neurobiology of rehearsing or visualizing wellness as a mode of directly (performatively) producing an outcome often dismissed as a ‚Äòplacebo response.‚Äô Given body/mind/emotional resonance, we suggest that the placebo response is an evolutionarily adaptive trait and part of healing mechanisms operating across many levels‚Äîfrom genetic and cellular to social and cultural.},
address  = {Department of Anthropology, University of Arizona Department of Family and Community Medicine and Department of Anthropology, University of Arizona Department of Anthropology and Department of Family and Community Medicine, University of Arizona},
note  = {Cult Med Psychiatry. 2009 Mar;33(1):112-52. doi:10.1007/s11013-008-9122-2.}
}

@Article{2014192,
author  = {Aregueta-Robles, U. and Woolley, A. and Poole-Warren, L. and Lovell, N. and Green, R.},
title  = {Organic electrode coatings for next-generation neural interfaces.},
journal  = {Frontiers in Neuroengineering},
volume  = {7},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Traditional neuronal interfaces utilize metallic electrodes which in recent years have reached a plateau in terms of the ability to provide safe stimulation at high resolution or rather with high densities of microelectrodes with improved spatial selectivity. To achieve higher resolution it has become clear that reducing the size of electrodes is required to enable higher electrode counts from the implant device. The limitations of interfacing electrodes including low  charge injection limits, mechanical mismatch and foreign body response can be addressed through the use of organic electrode coatings which typically provide a softer, more roughened surface to enable both improved charge transfer and lower  mechanical mismatch with neural tissue. Coating electrodes with conductive polymers or carbon nanotubes offers a substantial increase in charge transfer area compared to conventional platinum electrodes. These organic conductors provide safe electrical stimulation of tissue while avoiding undesirable chemical reactions and cell damage. However, the mechanical properties of conductive polymers are not ideal, as they are quite brittle. Hydrogel polymers present a versatile coating option for electrodes as they can be chemically modified to provide a soft and conductive scaffold. However, the in vivo chronic inflammatory response of these conductive hydrogels remains unknown. A more recent approach proposes tissue engineering the electrode interface through the use of encapsulated neurons within hydrogel coatings. This approach may provide a method for activating tissue at the cellular scale, however, several technological challenges must be addressed to demonstrate feasibility of this innovative idea.  The review focuses on the various organic coatings which have been investigated to improve neural interface electrodes.},
address  = {Graduate School of Biomedical Engineering, University of New South WalesSydney, NSW, Australia Graduate School of Biomedical Engineering, University of New South WalesSydney, NSW, Australia Graduate School of Biomedical Engineering, University of New South WalesSydney, NSW, Australia Graduate School of Biomedical Engineering, University of New South WalesSydney, NSW, Australia Graduate School of Biomedical Engineering, University of New South WalesSydney, NSW, Australia},
note  = {Front Neuroeng. 2014 May 27;7:. doi:10.3389/fneng.2014.00015.}
}

@Article{2016193,
author  = {Ahn, S. and Nguyen, T. and Jang, H. and Kim, J. and Jun, S.},
title  = {Sleep Deprivation Using Simultaneous EEG, ECG, and fNIRS Data.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Investigations of the neuro-physiological correlates of mental loads, or states,  have attracted significant attention recently, as it is particularly important to evaluate mental fatigue in drivers operating a motor vehicle. In this research, we collected multimodal EEG/ECG/EOG and fNIRS data simultaneously to develop algorithms to explore neuro-physiological correlates of drivers' mental states. Each subject performed simulated driving under two different conditions (well-rested and sleep-deprived) on different days. During the experiment, we used 68 electrodes for EEG/ECG/EOG and 8 channels for fNIRS recordings. We extracted the prominent features of each modality to distinguish between the well-rested and sleep-deprived conditions, and all multimodal features, except EOG, were combined to quantify mental fatigue during driving. Finally, a novel driving condition level (DCL) was proposed that distinguished clearly between the features of well-rested and sleep-deprived conditions. This proposed DCL measure  may be applicable to real-time monitoring of the mental states of vehicle drivers. Further, the combination of methods based on each classifier yielded substantial improvements in the classification accuracy between these two conditions.},
address  = {School of Electrical Engineering and Computer Science, Gwangju Institute of Science and TechnologyGwangju, South Korea Department of Biomedical Science and Engineering, Gwangju Institute of Science and TechnologyGwangju, South Korea School of Electrical Engineering and Computer Science, Gwangju Institute of Science and TechnologyGwangju, South Korea Department of Biomedical Science and Engineering, Gwangju Institute of Science and TechnologyGwangju, South Korea School of Electrical Engineering and Computer Science, Gwangju Institute of Science and TechnologyGwangju, South Korea},
note  = {Front Hum Neurosci. 2016 May 13;10:. doi:10.3389/fnhum.2016.00219.}
}

@Article{2017194,
author  = {Frontera, W. and Bean, J. and Damiano, D. and Ehrlich-Jones, L. and Fried-Oken, M. and Jette, A. and Jung, R. and Lieber, R. and Malec, J. and Mueller, M. and Ottenbacher, K. and Tansey, K. and Thompson, A.},
title  = {Forward (Executive Summary).},
journal  = {The American Journal of Occupational Therapy},
volume  = {71},
number  = {3},
pages  = {7103320010P1-7103320010P12},
year  = {2017},
abstract  = {The authors summarize the discussions and proposals from a recent NIH conference, Rehabilitation Research at NIH: Moving the Field Forward, that will help guide rehabilitation research at NIH in the near future},
address  = {Walter R. Frontera, MD, PhD, Department of Physical Medicine and Rehabilitation,  Vanderbilt University Medical Center, Nashville, TN, and Department of Physical Medicine, Rehabilitation and Sports Medicine, University of Puerto Rico School of Medicine, San Juan, PR. Address correspondence to Walter R. Frontera, MD, PhD, Vanderbilt University School of Medicine, Vanderbilt University Medical Center, 2201 Children‚Äôs Way, Suite 1318, Nashville, TN 37212; walter.frontera@vanderbilt.edu. Jonathan F. Bean, MD, MS, MPH, Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, and New England GRECC, VA Boston Healthcare System, Boston, MA Diane Damiano, PT, PhD, Department of Rehabilitation Medicine, Clinical Center, National Institutes of Health, Bethesda, MD Linda Ehrlich-Jones, PhD, RN, Department of Physical Medicine and Rehabilitation, Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago, Chicago, IL Melanie Fried-Oken, PhD, CCC/Sp, Departments of Neurology, Pediatrics, BME, ENT,  Oregon Health and Science University, Portland Alan Jette, PT, PhD, Health and Disability Research Institute, School of Public Health, Boston University, Boston, MA Ranu Jung, PhD, Department of Biomedical Engineering, Florida International University, Miami Rick L. Lieber, PhD, Department of Physical Medicine and Rehabilitation, Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago, Chicago, IL James F. Malec, PhD, ABPP-Cn, Rp, Department of Physical Medicine and Rehabilitation, Indiana University School of Medicine and Rehabilitation Hospital of Indiana, Indianapolis Michael J. Mueller, PT, PhD, Program in Physical Therapy and Department of Radiology, Washington University School of Medicine, St. Louis, MO Kenneth J. Ottenbacher, PhD, OTR, Division of Rehabilitation Sciences, School of  Health Professions, University of Texas Medical Branch, Galveston Keith E. Tansey, MD, PhD, Methodist Rehabilitation Center, University of Mississippi Medical Center, Jackson Veterans Administration Medical Center, Jackson, MS Aiko Thompson, PhD, Department of Health Science and Research, College of Health  Professions, Medical University of South Carolina, Charleston},
note  = {doi:10.5014/ajot.2017.713003.}
}

@Article{2016195,
author  = {},
title  = {Meeting 9‚Äì11 December 2015, City Hall, Cardiff, UK.},
journal  = {Ultrasound: Journal of the British Medical Ultrasound Society},
volume  = {24},
number  = {2},
pages  = {NP1-NP54},
year  = {2016},
abstract  = {},
address  = {},
note  = {doi:10.1177/1742271X16642108.}
}

@Article{2014196,
author  = {Van, B. and Asotra, S. and Balducci, C. and Basu, P. and DiDonato, G. and Dorantes, A. and Eickhoff, W. and Ghosh, T. and Gonz√°lez, M. and Henry, T. and Howard, M. and Kamm, J. and Laurenz, S. and MacKenzie, R. and Mannion, R. and Noonan, P. and Ocheltree, T. and Pai, U. and Poska, R. and Putnam, M. and Raghavan, R. and Ruegger, C. and S√°nchez, E. and Shah, V. and Shao, Z. and Somma, R. and Tammara, V. and Thombre, A. and Thompson, B. and Timko, R. and Upadrashta, S. and Vaithiyalingam, S.},
title  = {IR and MR Dosage Forms in the Current Quality-by-Design Paradigm.},
journal  = {AAPS PharmSciTech},
volume  = {15},
number  = {3},
pages  = {665-93},
year  = {2014},
abstract  = {In this whitepaper, the Manufacturing Technical Committee of the Product Quality  Research Institute provides information on the common, best practices in use today in the development of high-quality chemistry, manufacturing and controls documentation. Important topics reviewed include International Conference on Harmonization, in vitro‚Äìin vivo correlation considerations, quality-by-design approaches, process analytical technologies and current scale-up, and process control and validation practices. It is the hope and intent that this whitepaper  will engender expanded dialog on this important subject by the pharmaceutical industry and its regulatory bodies.},
address  = {Nonclinical Drug Development Consulting Services, LLC, Basking Ridge, New Jersey  07920 USA AHI Inc., Brampton, Ontario Canada L6W 4K4 Novartis Pharmaceuticals, East Hanover, New Jersey 07936 USA National Institute of Pharmaceutical Technology and Engineering (NIPTE), Prospect, Illinois 60056 USA Bristol-Myers Squibb Co., Pennington, New Jersey 08534 USA Food & Drug Administration, Silver Spring, Maryland 20993 USA Merck & Co., West Point, Pennsylvania 19486 USA Food & Drug Administration, Silver Spring, Maryland 20993 USA P‚ÄôKinetics International, Inc., Pembroke Pines, Florida 33027 USA Old Greenwich, Connecticut 06870 USA McNeil Consumer Healthcare, Ft. Washington, Pennsylvania USA Summit Pharma Solutions, LLC, South Windsor, Connecticut USA AbbVie, North Chicago, Illinois 60064 USA Janssen Research & Development, LLC, Spring House, Pennsylvania 19477 USA Purdue Pharma LP, Cranbury, New Jersey 08512 USA PK Noonan & Associates, LLC, Williamsburg, Virginia 23188 USA Food & Drug Administration, Silver Spring, Maryland 20993 USA Sun Pharma USA, Cranbury, New Jersey 08512 USA AbbVie, North Chicago, Illinois 60064 USA Boehringer-Ingelheim VetMedica, Inc., Saint Joseph, Missouri 64506 USA Genentech, South San Francisco, California 94080 USA Novartis Pharmaceuticals, East Hanover, New Jersey 07936 USA Janssen Ortho, LLC., Gurabo, 00778 Puerto Rico North Potomac, Maryland 20878 USA Arena Pharmaceuticals, San Diego, California 92121 USA Somma Tech Consulting, Somerset, New Jersey 08873 USA Nuron Biotech Inc., Exton, Pennsylvania 19341 USA Pfizer Inc., Groton, Connecticut 06340 USA Merck & Co., West Point, Pennsylvania 19486 USA AstraZeneca LP, Wilmington, Delaware 19850 USA Millennium Pharmaceuticals, Cambridge, Massachusetts 02139 USA Teva Pharmaceuticals, Pomona, New York 10970 USA},
note  = {AAPS PharmSciTech. 2014 Mar 1;15(3):665-93. doi:10.1208/s12249-014-0087-x.}
}

@Article{2016197,
author  = {Medford, N. and Sierra, M. and Stringaris, A. and Giampietro, V. and Brammer, M. and David, A.},
title  = {Depersonalization Disorder.},
journal  = {Frontiers in Psychology},
volume  = {7},
number  = {},
pages  = {},
year  = {2016},
abstract  = {This paper presents functional MRI work on emotional processing in depersonalization disorder (DPD). This relatively neglected disorder is hallmarked by a disturbing change in the quality of first-person experience, almost invariably encompassing a diminished sense of self and an alteration in emotional experience such that the sufferer feels less emotionally reactive, with emotions experienced as decreased or ‚Äúdamped down,‚Ä? so that emotional life seems  to lack spontaneity and subjective validity. Here we explored responses to emotive visual stimuli to examine the functional neuroanatomy of emotional processing in DPD before and after pharmacological treatment. We also employed concurrent skin conductance measurement as an index of autonomic arousal. In common with previous studies we demonstrated that in DPD, there is attenuated psychophysiological response to emotional material, reflected in altered patterns of (i) regional brain response, (ii) autonomic responses. By scanning participants before and after treatment we were able to build on previous findings by examining the changes in functional MRI response in patients whose symptoms had improved at time 2. The attenuation of emotional experience was associated with reduced activity of the insula, whereas clinical improvement in DPD symptoms was associated with increased insula activity. The insula is known to be implicated in interoceptive awareness and the generation of feeling states. In addition an area of right ventrolateral prefrontal cortex emerged as particularly implicated in what may be ‚Äútop-down‚Ä? inhibition of emotional responses. The relevance of these findings to the wider study of emotion, self-related processes, and interoception is discussed.},
address  = {Department of Psychiatry, Brighton and Sussex Medical SchoolBrighton, UK Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK Institute of Psychiatry, Psychology, and NeuroscienceLondon, UK},
note  = {Front Psychol. 2016 Jun 02;7:. doi:10.3389/fpsyg.2016.00432.}
}

@Article{2011198,
author  = {Acosta, A. and Dewald, H. and Dewald, J.},
title  = {stroke.},
journal  = {Journal of Rehabilitation Research and Development},
volume  = {48},
number  = {4},
pages  = {431-44},
year  = {2011},
abstract  = {Robotic systems currently used in upper-limb rehabilitation following stroke rely on some form of visual feedback as part of the intervention program. We evaluated the effect of a video game environment (air hockey) on reaching in stroke with various levels of arm support. We used the Arm Coordination Training 3D system to provide variable arm support and to control the hockey stick. We instructed seven subjects to reach to one of three targets covering the workspace of the impaired  arm during the reaching task and to reach as far as possible while playing the video game. The results from this study showed that across subjects, support levels, and targets, the reaching distances achieved with the reaching task were  greater than those covered with the video game. This held even after further restricting the mapped workspace of the arm to the area most affected by the flexion synergy (effectively forcing subjects to fight the synergy to reach the hockey puck). The results from this study highlight the importance of designing video games that include specific reaching targets in the workspace compromised by the expression of the flexion synergy. Such video games would also adapt the target location online as a subject‚Äôs success rate increases.},
address  = {Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL Illinois Mathematics and Science Academy, Aurora, IL Department of Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL},
note  = {J Rehabil Res Dev. 2011;48(4):431-44.}
}

@Article{2015199,
author  = {Weber, M. and Wu, T. and Hanson, J. and Alam, N. and Solanoy, H. and Ngu, H. and Lauffer, B. and Lin, H. and Dominguez, S. and Reeder, J. and Tom, J. and Steiner, P. and Foreman, O. and Prusky, G. and Scearce-Levie, K.},
title  = {Model of Normal Aging.},
journal  = {eNeuro},
volume  = {2},
number  = {5},
pages  = {},
year  = {2015},
abstract  = {Age is the main risk factor for sporadic Alzheimer‚Äôs disease. Yet, cognitive decline in aged rodents has been less well studied, possibly due to concomitant changes in sensory or locomotor function that can complicate cognitive tests. We  tested mice that were 3, 11, and 23 months old in cognitive, sensory, and motor measures, and postmortem measures of gliosis and neural activity (c-Fos). Hippocampal synaptic function was also examined. While age-related impairments were detectable in tests of spatial memory, greater age-dependent effects were observed in tests of associative learning [active avoidance (AA)]. Gross visual function was largely normal, but startle responses to acoustic stimuli decreased  with increased age, possibly due to hearing impairments. Therefore, a novel AA variant in which light alone served as the conditioning stimuli was used. Age-related deficits were again observed. Mild changes in vision, as measured by  optokinetic responses, were detected in 19- versus 4-month-old mice, but these were not correlated to AA performance. Thus, deficits in hearing or vision are unlikely to account for the observed deficits in cognitive measures. Increased gliosis was observed in the hippocampal formation at older ages. Age-related changes in neural function and plasticity were observed with decreased c-Fos in the dentate gyrus, and decreased synaptic strength and paired-pulse facilitation  in CA1 slices. This work, which carefully outlines age-dependent impairments in cognitive and synaptic function, c-Fos activity, and gliosis during normal aging  in the mouse, suggests robust translational measures that will facilitate further study of the biology of aging.},
address  = {Department of Neuroscience, Genentech, South San Francisco, California 94080 Department of Neuroscience, Genentech, South San Francisco, California 94080 Department of Neuroscience, Genentech, South San Francisco, California 94080 Burke Medical Research Institute, White Plains, New York, 10605 Department of Neuroscience, Genentech, South San Francisco, California 94080 Department of Pathology, Genentech, South San Francisco, California 94080 Department of Neuroscience, Genentech, South San Francisco, California 94080 Department of Neuroscience, Genentech, South San Francisco, California 94080 Department of Neuroscience, Genentech, South San Francisco, California 94080 Department of Bioinformatics, Genentech, South San Francisco, California 94080 Department of Bioinformatics, Genentech, South San Francisco, California 94080 Department of Neuroscience, Genentech, South San Francisco, California 94080 Department of Pathology, Genentech, South San Francisco, California 94080 Department of Physiology and Biophysics, Weill Cornell Medical College, Burke Medical Research Institute, White Plains, New York 10605 Department of Neuroscience, Genentech, South San Francisco, California 94080},
note  = {eNeuro. 2015 Oct 15;2(5):. doi:10.1523/ENEURO.0047-15.2015.}
}

@Article{2011200,
author  = {Gonzalez-Burgos, G. and Fish, K. and Lewis, D.},
title  = {Schizophrenia.},
journal  = {Neural Plasticity},
volume  = {2011},
number  = {},
pages  = {},
year  = {2011},
abstract  = {Schizophrenia is a brain disorder associated with cognitive deficits that severely affect the patients' capacity for daily functioning. Whereas our understanding of its pathophysiology is limited, postmortem studies suggest that  schizophrenia is associated with deficits of GABA-mediated synaptic transmission. A major role of GABA-mediated transmission may be producing synchronized network  oscillations which are currently hypothesized to be essential for normal cognitive function. Therefore, cognitive deficits in schizophrenia may result from a GABA synapse dysfunction that disturbs neural synchrony. Here, we highlight recent studies further suggesting alterations of GABA transmission and  network oscillations in schizophrenia. We also review current models for the mechanisms of GABA-mediated synchronization of neural activity, focusing on parvalbumin-positive GABA neurons, which are altered in schizophrenia and whose function has been strongly linked to the production of neural synchrony. Alterations of GABA signaling that impair gamma oscillations and, as a result, cognitive function suggest paths for novel therapeutic interventions.},
address  = {Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA Translational Neuroscience Program, Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA},
note  = {Neural Plast. 2011;2011:. Epub 2011 Sep 5 doi:10.1155/2011/723184.}
}

@Article{2017201,
author  = {Johnson-Glenberg, M. and Megowan-Romanowicz, C.},
title  = {education.},
journal  = {Cognitive Research},
volume  = {2},
number  = {1},
pages  = {},
year  = {2017},
abstract  = {A mixed design was created using text and game-like multimedia to instruct in the content of physics. The study assessed which variables predicted learning gains after a 1-h lesson on the electric field. The three manipulated variables were: (1) level of embodiment; (2) level of active generativity; and (3) presence of story narrative. Two types of tests were administered: (1) a traditional text-based physics test answered with a keyboard; and (2) a more embodied, transfer test using the Wacom large tablet where learners could use gestures (long swipes) to create vectors and answers. The 166 participants were randomly assigned to four conditions: (1) symbols and text; (2) low embodied; (3) high embodied/active; or (4) high embodied/active with narrative. The last two conditions were active because the on-screen content could be manipulated with gross body gestures gathered via the Kinect sensor. Results demonstrated that the three groups that included embodiment learned significantly more than the symbols and text group on the traditional keyboard post-test. When knowledge was assessed with the Wacom tablet format that facilitated gestures, the two active gesture-based groups scored significantly higher. In addition, engagement scores  were significantly higher for the two active embodied groups. The Wacom results suggest test sensitivity issues; the more embodied test revealed greater gains in learning for the more embodied conditions. We recommend that as more embodied learning comes to the fore, more sensitive tests that incorporate gesture be used to accurately assess learning. The predicted differences in engagement and learning for the condition with the graphically rich story narrative were not supported. We hypothesize that a narrative effect for motivation and learning may be difficult to uncover in a lab experiment where participants are primarily motivated by course credit. Several design principles for mediated and embodied science education are proposed.Electronic supplementary material: The online version of this article (doi:10.1186/s41235-017-0060-9) contains supplementary material, which is available to authorized users.},
address  = {0000 0001 2151 2636grid.215654.1Department of Psychology, Arizona State University, Tempe, AZ USA Modeling Instruction Institute, Sacramento, CA USA},
note  = {doi:10.1186/s41235-017-0060-9.}
}

@Article{2016202,
author  = {Schoeppe, S. and Alley, S. and Van, L. and Bray, N. and Williams, S. and Duncan, M. and Vandelanotte, C.},
title  = {sedentary behaviour: a systematic review.},
journal  = {The International Journal of Behavioral Nutrition and Physical Activity},
volume  = {13},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Health and fitness applications (apps) have gained popularity in interventions to improve diet, physical activity and sedentary behaviours but their efficacy is unclear. This systematic review examined the efficacy of interventions that use apps to improve diet, physical activity and sedentary behaviour in children and adults. Methods: Systematic literature searches were conducted in five databases to identify papers published between 2006 and 2016. Studies were included if they used a smartphone app in an intervention to improve diet, physical activity and/or sedentary behaviour for prevention. Interventions  could be stand-alone interventions using an app only, or multi-component interventions including an app as one of several intervention components. Outcomes measured were changes in the health behaviours and related health outcomes (i.e., fitness, body weight, blood pressure, glucose, cholesterol, quality of life). Study inclusion and methodological quality were independently assessed by two reviewers. Results: Twenty-seven studies were included, most were randomised controlled trials (n‚Äâ=‚Äâ19; 70%). Twenty-three studies targeted adults  (17 showed significant health improvements) and four studies targeted children (two demonstrated significant health improvements). Twenty-one studies targeted physical activity (14 showed significant health improvements), 13 studies targeted diet (seven showed significant health improvements) and five studies targeted sedentary behaviour (two showed significant health improvements). More studies (n‚Äâ=‚Äâ12; 63%) of those reporting significant effects detected between-group improvements in the health behaviour or related health outcomes, whilst fewer studies (n‚Äâ=‚Äâ8; 42%) reported significant within-group improvements. A larger proportion of multi-component interventions (8 out of 13; 62%) showed significant between-group improvements compared to stand-alone app interventions  (5 out of 14; 36%). Eleven studies reported app usage statistics, and three of them demonstrated that higher app usage was associated with improved health outcomes. Conclusions: This review provided modest evidence that app-based interventions to improve diet, physical activity and sedentary behaviours can be  effective. Multi-component interventions appear to be more effective than stand-alone app interventions, however, this remains to be confirmed in controlled trials. Future research is needed on the optimal number and combination of app features, behaviour change techniques, and level of participant contact needed to maximise user engagement and intervention efficacy. Electronic supplementary material: The online version of this article (doi:10.1186/s12966-016-0454-y) contains supplementary material, which is available to authorized users.},
address  = {Central Queensland University, School of Health, Medical and Applied Sciences, Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD 4702 Australia Central Queensland University, School of Health, Medical and Applied Sciences, Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD 4702 Australia Ghent University, Department of Public Health, De Pintelaan 185-4 K3 room 036, 9000 Ghent, Belgium Central Queensland University, School of Health, Medical and Applied Sciences, Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD 4702 Australia Central Queensland University, School of Health, Medical and Applied Sciences, Building 6, Bruce Highway, Rockhampton, QLD 4702 Australia The University of Newcastle, School of Medicine & Public Health, Priority Research Centre for Physical Activity and Nutrition, University Drive, Callaghan, NSW 2308 Australia Central Queensland University, School of Health, Medical and Applied Sciences, Physical Activity Research Group, Building 77, Bruce Highway, Rockhampton, QLD 4702 Australia},
note  = {Int J Behav Nutr Phys Act. 2016 Dec 7;13:. doi:10.1186/s12966-016-0454-y.}
}

@Article{2017203,
author  = {Ahmetovic, D. and Manduchi, R. and Coughlan, J. and Mascetti, S.},
title  = {Mind your crossings: Mining GIS imagery for crosswalk localization.},
journal  = {ACM transactions on accessible computing},
volume  = {9},
number  = {4},
pages  = {},
year  = {2017},
abstract  = {For blind travelers, finding crosswalks and remaining within their borders while  traversing them is a crucial part of any trip involving street crossings. While standard Orientation & Mobility (O&M) techniques allow blind travelers to safely  negotiate street crossings, additional information about crosswalks and other important features at intersections would be helpful in many situations, resulting in greater safety and/or comfort during independent travel. For instance, in planning a trip a blind pedestrian may wish to be informed of the presence of all marked crossings near a desired route.We have conducted a survey  of several O&M experts from the United States and Italy to determine the role that crosswalks play in travel by blind pedestrians. The results show stark differences between survey respondents from the U.S. compared with Italy: the former group emphasized the importance of following standard O&M techniques at all legal crossings (marked or unmarked), while the latter group strongly recommended crossing at marked crossings whenever possible. These contrasting opinions reflect differences in the traffic regulations of the two countries and  highlight the diversity of needs that travelers in different regions may have.To  address the challenges faced by blind pedestrians in negotiating street crossings, we devised a computer vision-based technique that mines existing spatial image databases for discovery of zebra crosswalks in urban settings. Our  algorithm first searches for zebra crosswalks in satellite images; all candidates thus found are validated against spatially registered Google Street View images.  This cascaded approach enables fast and reliable discovery and localization of zebra crosswalks in large image datasets. While fully automatic, our algorithm can be improved by a final crowdsourcing validation. To this end, we developed a  Pedestrian Crossing Human Validation (PCHV) web service, which supports crowdsourcing to rule out false positives and identify false negatives.},
address  = {Carnegie Mellon University University of California Santa Cruz The Smith-Kettlewell Eye Research Institute Universit√† degli Studi di Milano},
note  = {ACM Trans Access Comput. 2017 Apr;9(4):. doi:10.1145/3046790.}
}

@Article{2004204,
author  = {Helmhout, P. and Harts, C. and Staal, J. and Candel, M. and de, B.},
title  = {program as minimal intervention treatment in low back pain: a randomized trial.},
journal  = {European Spine Journal},
volume  = {13},
number  = {6},
pages  = {537-47},
year  = {2004},
abstract  = {In a randomized, observer-blinded trial, the effectiveness of 3-month high-intensity training (HIT) of the isolated lumbar extensors was compared to low-intensity training (LIT). Eighty-one workers with nonspecific low back pain longer than 12 weeks were randomly assigned to either of the two training programs.Training sessions were performed on a modified training device that isolated the lower back extensors. Total intervention time was limited to 5‚Äì10 min (one or two training sessions) per week. Training effects were assessed  in terms of changes in self-rated degree of back complaints, functional disability, and general, physical and mental health. Secondary outcomes in this study were muscle strength and fear of moving the back (kinesiophobia). Outcomes  were evaluated at 1,2, 3, 6, and 9 months after randomization.The results showed  that the two treatment programs led to comparable improvements in all outcome measures, except for mean isometric strength at 1, 2, 3, 6, and 9 months and kinesiophobia score at 2 and 9 months of follow-up. The high-intensity training group showed a higher strength gain (24 to 48 Nm) but a smaller decline in kinesiophobia (2.5 and 3.4 points, respectively), compared to the low-intensity training group.It can be concluded that high-intensity training of the isolated back extensors was not superior to a non-progressive, low-intensity variant in restoring back function in nonspecific (chronic) low back pain. In further research, emphasis should be put on identifying subgroups of patients that will have the highest success rate with either of these training approaches.},
address  = {Department of Training Medicine and Training Physiology, Occupational Health and  Safety Service Royal Netherlands Army, LGen Knoopkazerne, Mineurslaan 500, 3521 AG Utrecht, The Netherlands Department of Training Medicine and Training Physiology, Occupational Health and  Safety Service Royal Netherlands Army, LGen Knoopkazerne, Mineurslaan 500, 3521 AG Utrecht, The Netherlands Department of Epidemiology, Maastricht University, Maastricht, The Netherlands Department of Methodology and Statistics, Maastricht University, Maastricht, The  Netherlands Department of Epidemiology, Maastricht University, Maastricht, The Netherlands},
note  = {doi:10.1007/s00586-004-0671-y.}
}

@Article{2009205,
author  = {Silvoni, S. and Volpato, C. and Cavinato, M. and Marchetti, M. and Priftis, K. and Merico, A. and Tonin, P. and Koutsikos, K. and Beverina, F. and Piccione, F.},
title  = {Amyotrophic Lateral Sclerosis.},
journal  = {Frontiers in Neuroscience},
volume  = {3},
number  = {},
pages  = {},
year  = {2009},
abstract  = {To describe results of training and 1-year follow-up of brain-communication in a  larger group of early and middle stage amyotrophic lateral sclerosis (ALS) patients using a P300-based brain‚Äìcomputer interface (BCI), and to investigate the relationship between clinical status, age and BCI performance. A group of 21  ALS patients were tested with a BCI-system using two-dimensional cursor movements. A four choice visual paradigm was employed to training and test the brain-communication abilities. The task consisted of reaching with the cursor one out of four icons representing four basic needs. Five patients performed a follow-up test 1‚Äâyear later. The clinical severity in all patients were assessed  with a battery of clinical tests. A comparable control group of nine healthy subjects was employed to investigate performance differences. Nineteen patients and nine healthy subjects were able to achieve good and excellent cursor movements' control, acquiring at least communication abilities above chance level; during follow-up the patients maintained their BCI-skill. We found mild cognitive impairments in the ALS group which may be attributed to motor deficiencies, while no relevant correlation has been found between clinical data  and BCI performance. A positive correlation between age and the BCI-skill in patients was found. Time since training acquisition and clinical status did not affect the patients brain-communication skill at early and middle stage of the disease. A brain-communication tool can be used in most ALS patients at early and middle stage of the disease before entering the locked-in stage.},
address  = {I.R.C.C.S. San Camillo HospitalVenice, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy Department of General Psychology, University of PaduaPadua, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy I.R.C.C.S. San Camillo HospitalVenice, Italy},
note  = {Front Neurosci. 2009 Jun 19;3:. doi:10.3389/neuro.20.001.2009.}
}

@Article{2015206,
author  = {Brondino, N. and Fusar-Poli, L. and Rocchetti, M. and Provenzani, U. and Barale, F. and Politi, P.},
title  = {Complementary and Alternative Therapies for Autism Spectrum Disorder.},
journal  = {Evidence-based Complementary and Alternative Medicine : eCAM},
volume  = {2015},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Background. Complementary and alternative medicine (CAM) represents a popular therapeutic option for patients with autism spectrum disorder (ASD). Unfortunately, there is a paucity of data regarding the efficacy of CAM in ASD. The aim of the present systematic review is to investigate trials of CAM in ASD.  Material and Methods. We searched the following databases: MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, CINAHL, Psychology and Behavioral Sciences Collection, Agricola, and Food Science Source. Results. Our literature search identified 2687 clinical publications. After the title/abstract screening, 139 publications were obtained for detailed evaluation. After detailed evaluation 67 studies were included, from hand search of references we retrieved 13 additional studies for a total of 80. Conclusion. There is no conclusive evidence supporting the efficacy of CAM therapies in ASD. Promising results are reported for music therapy, sensory integration therapy, acupuncture, and massage.},
address  = {Department of Brain and Behavioral Sciences, Section of Psychiatry, University of Pavia, Via Bassi 21, 27100 Pavia, Italy Department of Brain and Behavioral Sciences, Section of Psychiatry, University of Pavia, Via Bassi 21, 27100 Pavia, Italy Department of Brain and Behavioral Sciences, Section of Psychiatry, University of Pavia, Via Bassi 21, 27100 Pavia, Italy Department of Brain and Behavioral Sciences, Section of Psychiatry, University of Pavia, Via Bassi 21, 27100 Pavia, Italy Department of Brain and Behavioral Sciences, Section of Psychiatry, University of Pavia, Via Bassi 21, 27100 Pavia, Italy Department of Brain and Behavioral Sciences, Section of Psychiatry, University of Pavia, Via Bassi 21, 27100 Pavia, Italy},
note  = {doi:10.1155/2015/258589.}
}

@Article{2006207,
author  = {Airaksinen, O. and Brox, J. and Cedraschi, C. and Hildebrandt, J. and Klaber-Moffett, J. and Kovacs, F. and Mannion, A. and Reis, S. and Staal, J. and Ursin, H. and Zanoli, G.},
title  = {pain.},
journal  = {European Spine Journal},
volume  = {15},
number  = {Suppl 2},
pages  = {s192-300},
year  = {2006},
abstract  = {},
address  = {},
note  = {Eur Spine J. 2006 Mar;15(Suppl 2): s192-300. doi:10.1007/s00586-006-1072-1.}
}

@Article{2010208,
author  = {Barham, P. and Skibsted, L. and Bredie, W. and Bom, F. and M√∏ller, P. and Risbo, J. and Snitkj√¶r, P. and Mortensen, L.},
title  = {Molecular Gastronomy: A New Emerging Scientific Discipline.},
journal  = {Chemical Reviews},
volume  = {110},
number  = {4},
pages  = {2313-65},
year  = {2010},
abstract  = {},
address  = {},
note  = {Chem Rev. 2010 Apr 14;110(4):2313-65. Epub 2010 Feb 19 doi:10.1021/cr900105w.}
}

@Article{2015209,
author  = {Wyczesany, M. and Ligeza, T. and Grzybowski, S.},
title  = {Effective connectivity during visual processing is affected by emotional state.},
journal  = {Brain Imaging and Behavior},
volume  = {9},
number  = {4},
pages  = {717-28},
year  = {2015},
abstract  = {The limitations of our cognitive resources necessitate the selection of relevant  information from the incoming visual stream. This selection and prioritizing of stimuli allows the organism to adapt to the current conditions. However, the characteristics of this process vary with time and depend on numerous external and internal factors. The present study was aimed at determining how the emotional state affects effective connectivity between visual, attentional and control brain areas during the perception of affective visual stimuli. The Directed Transfer Function was applied on a 32-electrode EEG recording to quantify the direction and intensity of the information flow during two sessions: positive and negative. These data were correlated with a self-report of the emotional state. We demonstrated that the current mood, as measured by self-report, is a factor which affects the patterns of effective cortical connectivity. An increase in prefrontal top-down control over the visual and attentional areas was revealed in a state of tension. It was accompanied by increased outflow within and from the areas recognized as the ventral attentional network. By contrast, a positive emotional state was associated with heightened flow from the parietal to the occipital area. The functional significance of the  revealed effects is discussed.},
address  = {Psychophysiology Laboratory, Institute of Psychology, Jagiellonian University, Ingardena 6, PL-30060 Krak√≥w, Poland Psychophysiology Laboratory, Institute of Psychology, Jagiellonian University, Ingardena 6, PL-30060 Krak√≥w, Poland Psychophysiology Laboratory, Institute of Psychology, Jagiellonian University, Ingardena 6, PL-30060 Krak√≥w, Poland},
note  = {doi:10.1007/s11682-014-9326-8.}
}

@Article{2015210,
author  = {Nickel, F. and Brzoska, J. and Gondan, M. and Rangnick, H. and Chu, J. and Kenngott, H. and Linke, G. and Kadmon, M. and Fischer, L. and M√ºller-Stich, B.},
title  = {A Randomized Controlled Trial With Laparoscopic Novices.},
journal  = {Medicine},
volume  = {94},
number  = {20},
pages  = {},
year  = {2015},
abstract  = {This study compared virtual reality (VR) training with low cost-blended learning  (BL) in a structured training program.Training of laparoscopic skills outside the operating room is mandatory to reduce operative times and risks.Laparoscopy-na√Øve medical students were randomized in 2 groups stratified for sex. The BL group (n‚Ää=‚Ää42) used E-learning for laparoscopic cholecystectomy (LC) and practiced basic skills with box trainers. The VR group (n‚Ää=‚Ää42) trained basic skills and LC on the LAP Mentor II (Simbionix, Cleveland, OH). Each group trained 3‚Ää√ó‚Ää4‚Äähours followed by a knowledge test concerning LC. Blinded raters assessed the operative performance of cadaveric porcine LC using the Objective Structured Assessment of  Technical Skills (OSATS). The LC was discontinued when it was not completed within 80‚Äämin. Students evaluated their training modality with questionnaires.The VR group completed the LC significantly faster and more often within 80‚Äämin than  BL (45% v 21%, P‚Ää=‚Ää.02). The BL group scored higher than the VR group in the knowledge test (13.3‚Ää¬±‚Ää1.3 vs 11.0‚Ää¬±‚Ää1.7, P‚Ää<‚Ää0.001). Both groups showed equal operative performance of LC in the OSATS score (49.4‚Ää¬±‚Ää10.5 vs 49.7‚Ää¬±‚Ää12.0, P‚Ää=‚Ää0.90). Students generally liked training and felt well prepared for assisting in laparoscopic surgery. The efficiency of the training was judged higher by the  VR group than by the BL group.VR and BL can both be applied for training the basics of LC. Multimodality training programs should be developed that combine the advantages of both approaches.},
address  = {},
note  = {Medicine (Baltimore). 2015 May 22;94(20):. doi:10.1097/MD.0000000000000764.}
}

@Article{2017211,
author  = {Alia, C. and Spalletti, C. and Lai, S. and Panarese, A. and Lamola, G. and Bertolucci, F. and Vallone, F. and Di, G. and Chisari, C. and Micera, S. and Caleo, M.},
title  = {Recovery: Novel Approaches in Neurorehabilitation.},
journal  = {Frontiers in Cellular Neuroscience},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Ischemic damage to the brain triggers substantial reorganization of spared areas  and pathways, which is associated with limited, spontaneous restoration of function. A better understanding of this plastic remodeling is crucial to develop more effective strategies for stroke rehabilitation. In this review article, we discuss advances in the comprehension of post-stroke network reorganization in patients and animal models. We first focus on rodent studies that have shed light on the mechanisms underlying neuronal remodeling in the perilesional area and contralesional hemisphere after motor cortex infarcts. Analysis of electrophysiological data has demonstrated brain-wide alterations in functional connectivity in both hemispheres, well beyond the infarcted area. We then illustrate the potential use of non-invasive brain stimulation (NIBS) techniques  to boost recovery. We finally discuss rehabilitative protocols based on robotic devices as a tool to promote endogenous plasticity and functional restoration.},
address  = {CNR Neuroscience Institute, National Research Council (CNR)Pisa, Italy CNR Neuroscience Institute, National Research Council (CNR)Pisa, Italy Translational Neural Engineering Area, The BioRobotics Institute, Scuola Superiore Sant‚ÄôAnnaPontedera, Italy Translational Neural Engineering Area, The BioRobotics Institute, Scuola Superiore Sant‚ÄôAnnaPontedera, Italy Department of Neuroscience, Unit of Neurorehabilitation‚ÄîUniversity Hospital of PisaPisa, Italy Department of Neuroscience, Unit of Neurorehabilitation‚ÄîUniversity Hospital of PisaPisa, Italy Translational Neural Engineering Area, The BioRobotics Institute, Scuola Superiore Sant‚ÄôAnnaPontedera, Italy CNR Biophysics Institute, National Research Council (CNR)Pisa, Italy Department of Neuroscience, Unit of Neurorehabilitation‚ÄîUniversity Hospital of PisaPisa, Italy Translational Neural Engineering Area, The BioRobotics Institute, Scuola Superiore Sant‚ÄôAnnaPontedera, Italy CNR Neuroscience Institute, National Research Council (CNR)Pisa, Italy},
note  = {Front Cell Neurosci. 2017 Mar 16;11:. doi:10.3389/fncel.2017.00076.}
}

@Article{2011212,
author  = {Belda-Lois, J. and Mena-del, H. and Bermejo-Bosch, I. and Moreno, J. and Pons, J. and Farina, D. and Iosa, M. and Molinari, M. and Tamburella, F. and Ramos, A. and Caria, A. and Solis-Escalante, T. and Brunner, C. and Rea, M.},
title  = {Rehabilitation of gait after stroke: a review towards a top-down approach.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {8},
number  = {},
pages  = {66},
year  = {2011},
abstract  = {This document provides a review of the techniques and therapies used in gait rehabilitation after stroke. It also examines the possible benefits of including  assistive robotic devices and brain-computer interfaces in this field, according  to a top-down approach, in which rehabilitation is driven by neural plasticity.The methods reviewed comprise classical gait rehabilitation techniques (neurophysiological and motor learning approaches), functional electrical stimulation (FES), robotic devices, and brain-computer interfaces (BCI).From the  analysis of these approaches, we can draw the following conclusions. Regarding classical rehabilitation techniques, there is insufficient evidence to state that a particular approach is more effective in promoting gait recovery than other. Combination of different rehabilitation strategies seems to be more effective than over-ground gait training alone. Robotic devices need further research to show their suitability for walking training and their effects on over-ground gait. The use of FES combined with different walking retraining strategies has shown to result in improvements in hemiplegic gait. Reports on non-invasive BCIs  for stroke recovery are limited to the rehabilitation of upper limbs; however, some works suggest that there might be a common mechanism which influences upper  and lower limb recovery simultaneously, independently of the limb chosen for the  rehabilitation therapy. Functional near infrared spectroscopy (fNIRS) enables researchers to detect signals from specific regions of the cortex during performance of motor activities for the development of future BCIs. Future research would make possible to analyze the impact of rehabilitation on brain plasticity, in order to adapt treatment resources to meet the needs of each patient and to optimize the recovery process.},
address  = {Instituto de Biomec√°nica de Valencia, Universitat Polit√©cnica de Valencia, Camino de Vera, s/n ed. 9C, E46022 Valencia, Spain Instituto de Biomec√°nica de Valencia, Universitat Polit√©cnica de Valencia, Camino de Vera, s/n ed. 9C, E46022 Valencia, Spain Instituto de Biomec√°nica de Valencia, Universitat Polit√©cnica de Valencia, Camino de Vera, s/n ed. 9C, E46022 Valencia, Spain Bioengineering Group, Center for Automation and Robotics, Spanish National Research Council (CSIC). Madrid, Spain Bioengineering Group, Center for Automation and Robotics, Spanish National Research Council (CSIC). Madrid, Spain Department of Neurorehabilitation Engineering, Bernstein Center for Computational Neuroscience University Medical Center G√∂ttingen Georg-August University. G√∂ttingen, Germany Fondazione Santa Lucia. Roma, Italy Fondazione Santa Lucia. Roma, Italy Fondazione Santa Lucia. Roma, Italy University of T√ºbingen. T√ºbingen, Germany University of T√ºbingen. T√ºbingen, Germany Graz University of Technology. Austria Graz University of Technology. Austria University of T√ºbingen. T√ºbingen, Germany},
note  = {J Neuroeng Rehabil. 2011 Dec 13;8:66. doi:10.1186/1743-0003-8-66.}
}

@Article{2014213,
author  = {Motto, R. and Dante, V. and Mesin, L. and Petetti, E. and Del, G. and Pasero, E.},
title  = {tests.},
journal  = {Frontiers in Neuroengineering},
volume  = {7},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Different tactile interfaces have been proposed to represent either text (braille) or, in a few cases, tactile large-area screens as replacements for visual displays. None of the implementations so far can be customized to match users' preferences, perceptual differences and skills. Optimal choices in these respects are still debated; we approach a solution by designing a flexible device allowing the user to choose key parameters of tactile transduction. We present here a new dynamic tactile display, a 8 √ó 8 matrix of plastic pins based on well-established and reliable piezoelectric technology to offer high resolution (pin gap 0.7mm) as well as tunable strength of the pins displacement, and refresh rate up to 50s‚àí1. It can reproduce arbitrary patterns, allowing it to serve the dual purpose of providing, depending on contingent user needs, tactile rendering  of non-character information, and reconfigurable braille rendering. Given the relevance of the latter functionality for the expected average user, we considered testing braille encoding by volunteers a benchmark of primary importance. Tests were performed to assess the acceptance and usability with minimal training, and to check whether the offered flexibility was indeed perceived by the subject as an added value compared to conventional braille devices. Different mappings between braille dots and actual tactile pins were implemented to match user needs. Performances of eight experienced braille readers were defined as the fraction of correct identifications of rendered content. Different information contents were tested (median performance on random strings, words, sentences identification was about 75%, 85%, 98%, respectively, with a significant increase, p < 0.01), obtaining statistically significant improvements in performance during the tests (p < 0.05). Experimental results, together with qualitative ratings provided by the subjects, show a good acceptance and the effectiveness of the proposed solution.},
address  = {Center for Space Human Robotic, Istituto Italiano di Tecnologia (IIT@PoliTO), with Dipartimento di Elettronica e Telecomunicazioni of Politecnico di Torino, and with Istituto Nazionale Fisica Nuclearesezione di Torino, Torino, Italy Istituto Superiore di Sanit√† di Roma and with Istituto Nazionale Fisica NucleareSezione di Roma, Italy Dipartimento di Elettronica e Telecomunicazioni of Politecnico di TorinoTorino, Italy Istituto Superiore di Sanit√† di Roma and with Istituto Nazionale Fisica NucleareSezione di Roma, Italy Istituto Superiore di Sanit√† di Roma and with Istituto Nazionale Fisica NucleareSezione di Roma, Italy Dipartimento di Elettronica e Telecomunicazioni of Politecnico di Torino and with Istituto Nazionale Fisica NucleareSezione di Torino, Torino, Italy},
note  = {Front Neuroeng. 2014 Apr 08;7:. doi:10.3389/fneng.2014.00006.}
}

@Article{2008214,
author  = {Zeng, F. and Rebscher, S. and Harrison, W. and Sun, X. and Feng, H.},
title  = {Cochlear Implants:System Design, Integration and Evaluation.},
journal  = {IEEE reviews in biomedical engineering},
volume  = {1},
number  = {},
pages  = {115-42},
year  = {2008},
abstract  = {As the most successful neural prosthesis, cochlear implants have provided partial hearing to more than 120,000 persons worldwide; half of which being pediatric users who are able to develop nearly normal language. Biomedical engineers have played a central role in the design, integration and evaluation of the cochlear implant system, but the overall success is a result of collaborative work with physiologists, psychologists, physicians, educators, and entrepreneurs. This review presents broad yet in-depth academic and industrial perspectives on the underlying research and ongoing development of cochlear implants. The introduction accounts for major events and advances in cochlear implants, including dynamic interplays among engineers, scientists, physicians, and policy  makers. The review takes a system approach to address critical issues from design and specifications to integration and evaluation. First, the cochlear implant system design and specifications are laid out. Second, the design goals, principles, and methods of the subsystem components are identified from the external speech processor and radio frequency transmission link to the internal receiver, stimulator and electrode arrays. Third, system integration and functional evaluation are presented with respect to safety, reliability, and challenges facing the present and future cochlear implant designers and users. Finally, issues beyond cochlear implants are discussed to address treatment options for the entire spectrum of hearing impairment as well as to use the cochlear implant as a model to design and evaluate other similar neural prostheses such as vestibular and retinal implants.},
address  = {Departments of Anatomy and Neurobiology, Biomedical Engineering, Cognitive Sciences and Otolaryngology - Head and Neck Surgery, University of California, 364 Med Surg II, Irvine, CA 92697, USA (fzeng@uci.edu) Department of Otolaryngology - Head and Neck Surgery, University of California, San Francisco, CA 94143, USA Silere Medical Technology, Inc., Kirkland, WA 98034, USA Nurotron Biotechnology Inc., Irvine, CA 92618, USA Institute of Acoustics, Academia Sinica, Beijing 100190, China},
note  = {IEEE Rev Biomed Eng. 2008 Jan 1;1:115-42. doi:10.1109/RBME.2008.2008250.}
}

@Article{2014215,
author  = {Wang, Y. and Huang, K. and Wei, C. and Huang, T. and Ko, L. and Lin, C. and Cheng, C. and Jung, T.},
title  = {system.},
journal  = {Frontiers in Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {In America, 60% of adults reported that they have driven a motor vehicle while feeling drowsy, and at least 15‚Äì20% of fatal car accidents are fatigue-related. This study translates previous laboratory-oriented neurophysiological research to design, develop, and test an On-line Closed-loop Lapse Detection and Mitigation (OCLDM) System featuring a mobile wireless dry-sensor EEG headgear and a cell-phone based real-time EEG processing platform. Eleven subjects participated  in an event-related lane-keeping task, in which they were instructed to manipulate a randomly deviated, fixed-speed cruising car on a 4-lane highway. This was simulated in a 1st person view with an 8-screen and 8-projector immersive virtual-reality environment. When the subjects experienced lapses or failed to respond to events during the experiment, auditory warning was delivered to rectify the performance decrements. However, the arousing auditory signals were not always effective. The EEG spectra exhibited statistically significant differences between effective and ineffective arousing signals, suggesting that EEG spectra could be used as a countermeasure of the efficacy of arousing signals. In this on-line pilot study, the proposed OCLDM System was able to continuously detect EEG signatures of fatigue, deliver arousing warning to subjects suffering momentary cognitive lapses, and assess the efficacy of the warning in near real-time to rectify cognitive lapses. The on-line testing results of the OCLDM System validated the efficacy of the arousing signals in improving subjects' response times to the subsequent lane-departure events. This  study may lead to a practical on-line lapse detection and mitigation system in real-world environments.},
address  = {Department of Computer Science and Engineering, Jacobs School of Engineering, University of California San DiegoLa Jolla, CA, USA Department of Electrical Engineering, National Chiao-Tung UniversityHsinchu, Taiwan Swartz Center for Computational Neuroscience, Institute for Neural Computation, University of California San DiegoLa Jolla, CA, USA Department of Electrical Engineering, National Chiao-Tung UniversityHsinchu, Taiwan Department of Biological Science and Technology, National Chiao-Tung UniversityHsinchu, Taiwan Department of Electrical Engineering, National Chiao-Tung UniversityHsinchu, Taiwan Department of Computer Science and Engineering, Jacobs School of Engineering, University of California San DiegoLa Jolla, CA, USA Swartz Center for Computational Neuroscience, Institute for Neural Computation, University of California San DiegoLa Jolla, CA, USA},
note  = {Front Neurosci. 2014 Oct 13;8:. doi:10.3389/fnins.2014.00321.}
}

@Article{2015216,
author  = {},
title  = {D.C., USA, 23-26 April 2015.},
journal  = {Journal of Extracellular Vesicles},
volume  = {4},
number  = {},
pages  = {},
year  = {2015},
abstract  = {},
address  = {},
note  = {J Extracell Vesicles. 2015 Apr 21;4:. doi:10.3402/jev.v4.27783.}
}

@Article{2015217,
author  = {Strahler, R. and Herrera, N. and Uehara, P. and Amodeo, B.},
title  = {Guidelines of the Current Findings and the Associated Risk of Bias.},
journal  = {Frontiers in Psychiatry},
volume  = {6},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Empirical research studies have highlighted the need to investigate whether video game can be useful as a tool within a neuropsychological rehabilitation program for attention deficit hyperactivity disorder (ADHD) patients. However, little is  known about the possible gains that this kind of video game-based interventions can produce and even if these gains can be transferred to real life abilities. The present paper aims to uncover key information related to the use of video game in ADHD neuropsychological rehabilitation/intervention by focusing on its gains and its capability to transfer/generalize these gains to real life situation via a systematic review of the empirical literature. The PRISMA guidelines were adopted. Internet-based bibliographic searches were conducted via seven major electronic databases (i.e., PsycARTICLES, PsycINFO, Web of Science, Core Collection BIOSIS Citation Index, MEDLINE, SciELO Citation Index, and PubMed) to access studies examining the association between video game interventions in ADHD patients and behavioral and cognitive outcomes. A total of  14 empirical studies meeting the inclusion criteria were identified. The studies  reported the attention, working memory, and the behavioral aspects as the main target of the intervention. Cognitive and behavioral gains were reported after the video game training (VGT). However, many bias related to the choice of outcome instruments, sampling and blindness of assessors, weaken the results power. Additional researches are important to clarify the effects and stability of the VGT programs, and an important effort should be made to construct better methods to assess improvements on everyday cognitive abilities and real world functioning.},
address  = {Grupo de Investiga√ß√£o em Mem√≥ria Humana, Departamento de Psicobiologia, Universidade Federal de S√£o Paulo, S√£o Paulo, Brazil Departamento de Psicologia, Universidad Libre, Cali, Colombia Departamento de Psicologia, Universidade Federal Rural do Rio de Janeiro, Serop√©dica, Brazil Grupo de Investiga√ß√£o em Mem√≥ria Humana, Departamento de Psicobiologia, Universidade Federal de S√£o Paulo, S√£o Paulo, Brazil},
note  = {Front Psychiatry. 2015 Oct 22;6:. doi:10.3389/fpsyt.2015.00151.}
}

@Article{2010218,
author  = {Fox, S. and Levitt, P. and Nelson, C.},
title  = {Brain Architecture.},
journal  = {Child development},
volume  = {81},
number  = {1},
pages  = {28-40},
year  = {2010},
abstract  = {Early life events can exert a powerful influence on both the pattern of brain architecture and behavioral development. In this paper a conceptual framework is  provided for considering how the structure of early experience gets ‚Äúunder the skin.‚Ä? The paper begins with a description of the genetic framework that lays the foundation for brain development, and then to the ways experience interacts with  and modifies the structures and functions of the developing brain. Much of the attention is focused on early experience and sensitive periods, although it is made clear that later experience also plays an important role in maintaining and  elaborating this early wiring diagram, which is critical to establishing a solid  footing for development beyond the early years.},
address  = {Harvard-MIT Division of Health Sciences and Technology Vanderbilt University Children‚Äôs Hospital Boston, Harvard Medical School},
note  = {Child Dev. 2010 Jan-Feb;81(1):28-40. doi:10.1111/j.1467-8624.2009.01380.x.}
}

@Article{2006219,
author  = {},
title  = {Invited Lectures: Overviews Purinergic signalling: past, present and future.},
journal  = {Purinergic Signalling},
volume  = {2},
number  = {1},
pages  = {1-324},
year  = {2006},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11302-006-9006-2.}
}

@Article{2015220,
author  = {Gustafson, D. and McTavish, F. and Gustafson, D. and Mahoney, J. and Johnson, R. and Lee, J. and Quanbeck, A. and Atwood, A. and Isham, A. and Veeramani, R. and Clemson, L. and Shah, D.},
title  = {quality of life: study protocol for a randomized control trial.},
journal  = {Trials},
volume  = {16},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Background: This study investigates the use of an information and communication technology (Elder Tree) designed for older adults and their informal caregivers to improve older adult quality of life and address challenges older adults face in maintaining their independence (for example, loneliness and isolation, falling, managing medications, driving and transportation). Methods/Design: This  study, an unblinded randomized controlled trial, will evaluate the effectiveness  and cost of Elder Tree. Older adults who are at risk for losing their independence - along with their informal caregivers, if they name them - are randomized to two groups. The intervention group has access to their usual sources of information and communication as well as to Elder Tree for 18 months while the control group uses only their usual sources of information and communication. The primary outcome of the study is older adult quality of life. Secondary outcomes are cost per Quality-Adjusted Life Year and the impact of the  technology on independence, loneliness, falls, medication management, driving and transportation, and caregiver appraisal and mastery. We will also examine the mediating effect of self-determination theory. We will evaluate the effectiveness of Elder Tree by comparing intervention- and control-group participants at baseline and months 6, 12, and 18. We will use mixed-effect models to evaluate the primary and secondary outcomes, where pretest score functions as a covariate, treatment condition is a between-subjects factor, and the multivariate outcome reflects scores for a given assessment at the three time points. Separate analyses will be conducted for each outcome. Cost per Quality-Adjusted Life Year  will be compared between the intervention and control groups. Additional analyses will examine the mediating effect of self-determination theory on each outcome. Discussion: Elder Tree is a multifaceted intervention, making it a challenge to assess which services or combinations of services account for outcomes in which subsets of older adults. If Elder Tree can improve quality of life and reduce healthcare costs among older adults, it could suggest a promising way to ease the burden that advancing age can place on older adults, their families, and the healthcare system. Trial registration: ClinicalTrials.govNCT02128789. Registered  on 26 March 2014. Electronic supplementary material: The online version of this article (doi:10.1186/s13063-015-0713-2) contains supplementary material, which is available to authorized users.},
address  = {Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI 53706 USA Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI 53706 USA Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI 53706 USA Division of Geriatrics, Department of Medicine, University of Wisconsin School of Medicine and Public Health and Executive Director, Wisconsin Institute for Health Aging, Madison, WI 53792 USA Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI 53706 USA Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI 53705 USA Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI 53706 USA Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI 53706 USA Center for Health Enhancement Systems Studies, University of Wisconsin-Madison, Madison, WI 53706 USA College of Engineering and School of Business and Executive Director, University  of Wisconsin E-Business Institute, University of Wisconsin-Madison, Madison, WI 53706 USA Aging, Work & Health Research Group, Faculty of Health Sciences, University of Sydney, Sydney, Australia Mass Communication Research Center, School of Journalism and Mass Communication,  University of Wisconsin-Madison, Madison, WI 53706 USA},
note  = {Trials. 2015 Apr 25;16:. doi:10.1186/s13063-015-0713-2.}
}

@Article{2015221,
author  = {Paulraj, M. and Subramaniam, K. and Yaccob, S. and Adom, A. and Hema, C.},
title  = {Auditory Evoked Potential Response and Hearing Loss: A Review.},
journal  = {The Open Biomedical Engineering Journal},
volume  = {9},
number  = {},
pages  = {17-24},
year  = {2015},
abstract  = {Hypoacusis is the most prevalent sensory disability in the world and consequently, it can lead to impede speech in human beings. One best approach to  tackle this issue is to conduct early and effective hearing screening test using  Electroencephalogram (EEG). EEG based hearing threshold level determination is most suitable for persons who lack verbal communication and behavioral response to sound stimulation. Auditory evoked potential (AEP) is a type of EEG signal emanated from the brain scalp by an acoustical stimulus. The goal of this review  is to assess the current state of knowledge in estimating the hearing threshold levels based on AEP response. AEP response reflects the auditory ability level of an individual. An intelligent hearing perception level system enables to examine  and determine the functional integrity of the auditory system. Systematic evaluation of EEG based hearing perception level system predicting the hearing loss in newborns, infants and multiple handicaps will be a priority of interest for future research.},
address  = {Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia Department of Mechatronic Engineering, Universiti Malaysia Perlis, Malaysia Faculty of Engineering, Karpagam University, India},
note  = {Open Biomed Eng J. 2015 Feb 27 ;9:17-24. doi:10.2174/1874120701509010017.}
}

@Article{2014222,
author  = {},
title  = {2014 Joint ACTRIMS-ECTRIMS Meeting (MSBoston 2014): Oral Presentations.},
journal  = {Multiple Sclerosis (Houndmills, Basingstoke, England)},
volume  = {20},
number  = {1 Suppl},
pages  = {14-66},
year  = {2014},
abstract  = {},
address  = {},
note  = {Mult Scler. 2014 Sep;20(1 Suppl):14-66. doi:10.1177/1352458514546076.}
}

@Article{2013223,
author  = {Lai, X. and Liu, Q. and Wei, X. and Wang, W. and Zhou, G. and Han, G.},
title  = {A Survey of Body Sensor Networks.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {13},
number  = {5},
pages  = {5406-47},
year  = {2013},
abstract  = {The technology of sensor, pervasive computing, and intelligent information processing is widely used in Body Sensor Networks (BSNs), which are a branch of wireless sensor networks (WSNs). BSNs are playing an increasingly important role  in the fields of medical treatment, social welfare and sports, and are changing the way humans use computers. Existing surveys have placed emphasis on the concept and architecture of BSNs, signal acquisition, context-aware sensing, and  system technology, while this paper will focus on sensor, data fusion, and network communication. And we will introduce the research status of BSNs, the analysis of hotspots, and future development trends, the discussion of major challenges and technical problems facing currently. The typical research projects and practical application of BSNs are introduced as well. BSNs are progressing along the direction of multi-technology integration and intelligence. Although there are still many problems, the future of BSNs is fundamentally promising, profoundly changing the human-machine relationships and improving the quality of  people's lives.},
address  = {Faculty of Electronic Information and Electrical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China; E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.) Faculty of Electronic Information and Electrical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China; E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.) Faculty of Electronic Information and Electrical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China; E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.) Faculty of Electronic Information and Electrical Engineering, Dalian University of Technology, No. 2 Linggong Road, Ganjingzi District, Dalian 116024, China; E-Mails: weixin@mail.dlut.edu.cn (X.W.); wangwei@dlut.edu.cn (W.W.) School of Software, Dalian University of Technology, Economy and Technology Development Area, Dalian 116620, China; E-Mails: zhou.guo.qiao@mail.dlut.edu.cn (G.Z.); hanguangyi@mail.dlut.edu.cn (G.H.) School of Software, Dalian University of Technology, Economy and Technology Development Area, Dalian 116620, China; E-Mails: zhou.guo.qiao@mail.dlut.edu.cn (G.Z.); hanguangyi@mail.dlut.edu.cn (G.H.)},
note  = {Sensors (Basel). 2013 Apr 24;13(5):5406-47. doi:10.3390/s130505406.}
}

@Article{2016224,
author  = {Griebel, G. and Pichat, P. and Boulay, D. and Naimoli, V. and Potestio, L. and Featherstone, R. and Sahni, S. and Defex, H. and Desvignes, C. and Slowinski, F. and Vig√©, X. and Bergis, O. and Sher, R. and Kosley, R. and Kongsamut, S. and Black, M. and Varty, G.},
title  = {schizophrenia.},
journal  = {Scientific Reports},
volume  = {6},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Normalization of altered glutamate neurotransmission through activation of the mGluR2 has emerged as a new approach to treat schizophrenia. These studies describe a potent brain penetrant mGluR2 positive allosteric modulator (PAM), SAR218645. The compound behaves as a selective PAM of mGluR2 in recombinant and native receptor expression systems, increasing the affinity of glutamate at mGluR2 as inferred by competition and GTPŒ≥35S binding assays. SAR218645 augmented the mGluR2-mediated response to glutamate in a rat recombinant mGluR2 forced-coupled Ca2+ mobilization assay. SAR218645 potentiated mGluR2 agonist-induced contralateral turning. When SAR218645 was tested in models of the positive symptoms of schizophrenia, it reduced head twitch behavior induced by DOI, but it failed to inhibit conditioned avoidance and hyperactivity using pharmacological and transgenic models. Results from experiments in models of the  cognitive symptoms associated with schizophrenia showed that SAR218645 improved MK-801-induced episodic memory deficits in rats and attenuated working memory impairment in NMDA Nr1neo‚àí/‚àí mice. The drug reversed disrupted latent inhibition  and auditory-evoked potential in mice and rats, respectively, two endophenotypes  of schizophrenia. This profile positions SAR218645 as a promising candidate for the treatment of cognitive symptoms of patients with schizophrenia, in particular those with abnormal attention and sensory gating abilities.},
address  = {Sanofi R&D, Strategy, Science Policy & External Innovation, Chilly-Mazarin, France Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, Analytical Sciences, Montpellier, France Sanofi R&D, Lead Generation, Chilly-Mazarin, France Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France Sanofi R&D, Translational Sciences Unit, Chilly-Mazarin, France Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA Sanofi R&D, 1041 Route 202/206, Bridgewater, NJ, USA},
note  = {Sci Rep. 2016 Oct 13;6:. doi:10.1038/srep35320.}
}

@Article{2007225,
author  = {},
title  = {},
journal  = {Thorax},
volume  = {62},
number  = {Suppl 3},
pages  = {A64-A149},
year  = {2007},
abstract  = {},
address  = {},
note  = {Thorax. 2007 Dec;62(Suppl 3):A64-A149.}
}

@Article{2017226,
author  = {Partridge, E. and Davey, M. and Hornick, M. and McGovern, P. and Mejaddam, A. and Vrecenak, J. and Mesas-Burgos, C. and Olive, A. and Caskey, R. and Weiland, T. and Han, J. and Schupper, A. and Connelly, J. and Dysart, K. and Rychik, J. and Hedrick, H. and Peranteau, W. and Flake, A.},
title  = {An extra-uterine system to physiologically support the extreme premature lamb.},
journal  = {Nature Communications},
volume  = {8},
number  = {},
pages  = {},
year  = {2017},
abstract  = {In the developed world, extreme prematurity is the leading cause of neonatal mortality and morbidity due to a combination of organ immaturity and iatrogenic injury. Until now, efforts to extend gestation using extracorporeal systems have  achieved limited success. Here we report the development of a system that incorporates a pumpless oxygenator circuit connected to the fetus of a lamb via an umbilical cord interface that is maintained within a closed ‚Äòamniotic fluid' circuit that closely reproduces the environment of the womb. We show that fetal lambs that are developmentally equivalent to the extreme premature human infant can be physiologically supported in this extra-uterine device for up to 4 weeks.  Lambs on support maintain stable haemodynamics, have normal blood gas and oxygenation parameters and maintain patency of the fetal circulation. With appropriate nutritional support, lambs on the system demonstrate normal somatic growth, lung maturation and brain growth and myelination.},
address  = {Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Division of Neonatology, Department of Pediatrics, The Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Division of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA Center for Fetal Research, Department of Surgery, The Children's Hospital of Philadelphia Research Institute, Room 1116B, 3615 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA},
note  = {Nat Commun. 2017 Apr 25;8:. doi:10.1038/ncomms15112.}
}

@Article{2013227,
author  = {Marblestone, A. and Zamft, B. and Maguire, Y. and Shapiro, M. and Cybulski, T. and Glaser, J. and Amodei, D. and Stranges, P. and Kalhor, R. and Dalrymple, D. and Seo, D. and Alon, E. and Maharbiz, M. and Carmena, J. and Rabaey, J. and Boyden, E. and Church, G. and Kording, K.},
title  = {Physical principles for scalable neural recording.},
journal  = {Frontiers in Computational Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Simultaneously measuring the activities of all neurons in a mammalian brain at millisecond resolution is a challenge beyond the limits of existing techniques in neuroscience. Entirely new approaches may be required, motivating an analysis of  the fundamental physical constraints on the problem. We outline the physical principles governing brain activity mapping using optical, electrical, magnetic resonance, and molecular modalities of neural recording. Focusing on the mouse brain, we analyze the scalability of each method, concentrating on the limitations imposed by spatiotemporal resolution, energy dissipation, and volume  displacement. Based on this analysis, all existing approaches require orders of magnitude improvement in key parameters. Electrical recording is limited by the low multiplexing capacity of electrodes and their lack of intrinsic spatial resolution, optical methods are constrained by the scattering of visible light in brain tissue, magnetic resonance is hindered by the diffusion and relaxation timescales of water protons, and the implementation of molecular recording is complicated by the stochastic kinetics of enzymes. Understanding the physical limits of brain activity mapping may provide insight into opportunities for novel solutions. For example, unconventional methods for delivering electrodes may enable unprecedented numbers of recording sites, embedded optical devices could allow optical detectors to be placed within a few scattering lengths of the measured neurons, and new classes of molecularly engineered sensors might obviate cumbersome hardware architectures. We also study the physics of powering and communicating with microscale devices embedded in brain tissue and find that, while radio-frequency electromagnetic data transmission suffers from a severe power‚Äìbandwidth tradeoff, communication via infrared light or ultrasound may allow high data rates due to the possibility of spatial multiplexing. The use of  embedded local recording and wireless data transmission would only be viable, however, given major improvements to the power efficiency of microelectronic devices.},
address  = {Biophysics Program, Harvard UniversityBoston, MA, USA Department of Genetics, Harvard Medical SchoolBoston, MA, USA Department of Genetics, Harvard Medical SchoolBoston, MA, USA Division of Chemistry and Chemical Engineering, California Institute of TechnologyPasadena, CA, USA Interdepartmental Neuroscience Program, Northwestern UniversityChicago, IL, USA Interdepartmental Neuroscience Program, Northwestern UniversityChicago, IL, USA Department of Radiology, Stanford UniversityPalo Alto, CA, USA Department of Genetics, Harvard Medical SchoolBoston, MA, USA Department of Genetics, Harvard Medical SchoolBoston, MA, USA Biophysics Program, Harvard UniversityBoston, MA, USA Department of Electrical Engineering and Computer Sciences, University of California at BerkeleyBerkeley, CA, USA Department of Electrical Engineering and Computer Sciences, University of California at BerkeleyBerkeley, CA, USA Department of Electrical Engineering and Computer Sciences, University of California at BerkeleyBerkeley, CA, USA Department of Electrical Engineering and Computer Sciences, University of California at BerkeleyBerkeley, CA, USA Department of Electrical Engineering and Computer Sciences, University of California at BerkeleyBerkeley, CA, USA Media Laboratory, Massachusetts Institute of TechnologyCambridge, MA, USA Biophysics Program, Harvard UniversityBoston, MA, USA Departments of Physical Medicine and Rehabilitation and of Physiology, Northwestern University Feinberg School of MedicineChicago, IL, USA},
note  = {Front Comput Neurosci. 2013 Oct 21;7:. doi:10.3389/fncom.2013.00137.}
}

@Article{2016228,
author  = {},
title  = {2016 ACVIM Forum Research Report Program.},
journal  = {Journal of Veterinary Internal Medicine},
volume  = {30},
number  = {4},
pages  = {1520-51},
year  = {2016},
abstract  = {},
address  = {},
note  = {doi:10.1111/jvim.13963.}
}

@Article{2015229,
author  = {Singewald, N. and Schmuckermair, C. and Whittle, N. and Holmes, A. and Ressler, K.},
title  = {and trauma-related disorders.},
journal  = {Pharmacology & therapeutics},
volume  = {149},
number  = {},
pages  = {150-90},
year  = {2015},
abstract  = {Pathological fear and anxiety are highly debilitating and, despite considerable advances in psychotherapy and pharmacotherapy they remain insufficiently treated  in many patients with PTSD, phobias, panic and other anxiety disorders. Increasing preclinical and clinical evidence indicates that pharmacological treatments including cognitive enhancers, when given as adjuncts to psychotherapeutic approaches [cognitive behavioral therapy including extinction-based exposure therapy] enhance treatment efficacy, while using anxiolytics such as benzodiazepines as adjuncts can undermine long-term treatment success. The purpose of this review is to outline the literature showing how pharmacological interventions targeting neurotransmitter systems including serotonin, dopamine, noradrenaline, histamine, glutamate, GABA, cannabinoids, neuropeptides (oxytocin, neuropeptides Y and S, opioids) and other targets (neurotrophins BDNF and FGF2, glucocorticoids, L-type-calcium channels, epigenetic modifications) as well as their downstream signaling pathways, can augment fear extinction and strengthen extinction memory persistently in preclinical models. Particularly promising approaches are discussed in regard to  their effects on specific aspects of fear extinction namely, acquisition, consolidation and retrieval, including long-term protection from return of fear (relapse) phenomena like spontaneous recovery, reinstatement and renewal of fear. We also highlight the promising translational value of the preclinial research and the clinical potential of targeting certain neurochemical systems with, for example d-cycloserine, yohimbine, cortisol, and L-DOPA. The current body of research reveals important new insights into the neurobiology and neurochemistry  of fear extinction and holds significant promise for pharmacologically-augmented  psychotherapy as an improved approach to treat trauma and anxiety-related disorders in a more efficient and persistent way promoting enhanced symptom remission and recovery.},
address  = {Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI, Leopold-Franzens University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI, Leopold-Franzens University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria Department of Pharmacology and Toxicology, Institute of Pharmacy and CMBI, Leopold-Franzens University of Innsbruck, Innrain 80-82, A-6020 Innsbruck, Austria Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol  Abuse and Alcoholism, NIH, Bethesda, MD, USA Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA},
note  = {doi:10.1016/j.pharmthera.2014.12.004.}
}

@Article{2013230,
author  = {Zikopoulos, B. and Barbas, H.},
title  = {autism.},
journal  = {Frontiers in Human Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Converging evidence from diverse studies suggests that atypical brain connectivity in autism affects in distinct ways short- and long-range cortical pathways, disrupting neural communication and the balance of excitation and inhibition. This hypothesis is based mostly on functional non-invasive studies that show atypical synchronization and connectivity patterns between cortical areas in children and adults with autism. Indirect methods to study the course and integrity of major brain pathways at low resolution show changes in fractional anisotropy (FA) or diffusivity of the white matter in autism. Findings in post-mortem brains of adults with autism provide evidence of changes in the fine structure of axons below prefrontal cortices, which communicate over short-  or long-range pathways with other cortices and subcortical structures. Here we focus on evidence of cellular and axon features that likely underlie the changes  in short- and long-range communication in autism. We review recent findings of changes in the shape, thickness, and volume of brain areas, cytoarchitecture, neuronal morphology, cellular elements, and structural and neurochemical features of individual axons in the white matter, where pathology is evident even in gross images. We relate cellular and molecular features to imaging and genetic studies  that highlight a variety of polymorphisms and epigenetic factors that primarily affect neurite growth and synapse formation and function in autism. We report preliminary findings of changes in autism in the ratio of distinct types of inhibitory neurons in prefrontal cortex, known to shape network dynamics and the  balance of excitation and inhibition. Finally we present a model that synthesizes diverse findings by relating them to developmental events, with a goal to identify common processes that perturb development in autism and affect neural communication, reflected in altered patterns of attention, social interactions, and language.},
address  = {},
note  = {Front Hum Neurosci. 2013 Sep 27;7:. doi:10.3389/fnhum.2013.00609.}
}

@Article{2015231,
author  = {Herring, J. and Thut, G. and Jensen, O. and Bergmann, T.},
title  = {Attention Modulates TMS-Locked Alpha Oscillations in the Visual Cortex.},
journal  = {The Journal of Neuroscience},
volume  = {35},
number  = {43},
pages  = {14435-47},
year  = {2015},
abstract  = {Cortical oscillations, such as 8‚Äì12 Hz alpha-band activity, are thought to subserve gating of information processing in the human brain. While most of the supporting evidence is correlational, causal evidence comes from attempts to externally drive (‚Äúentrain‚Ä?) these oscillations by transcranial magnetic stimulation (TMS). Indeed, the frequency profile of TMS-evoked potentials (TEPs)  closely resembles that of oscillations spontaneously emerging in the same brain region. However, it is unclear whether TMS-locked and spontaneous oscillations are produced by the same neuronal mechanisms. If so, they should react in a similar manner to top-down modulation by endogenous attention. To test this prediction, we assessed the alpha-like EEG response to TMS of the visual cortex during periods of high and low visual attention while participants attended to either the visual or auditory modality in a cross-modal attention task. We observed a TMS-locked local oscillatory alpha response lasting several cycles after TMS (but not after sham stimulation). Importantly, TMS-locked alpha power was suppressed during deployment of visual relative to auditory attention, mirroring spontaneous alpha amplitudes. In addition, the early N40 TEP component, located at the stimulation site, was amplified by visual attention. The extent of attentional modulation for both TMS-locked alpha power and N40 amplitude did depend, with opposite sign, on the individual ability to modulate spontaneous alpha power at the stimulation site. We therefore argue that TMS-locked and spontaneous oscillations are of common neurophysiological origin, whereas the N40 TEP component may serve as an index of current cortical excitability at the time  of stimulation.SIGNIFICANCE STATEMENT Rhythmic transcranial magnetic stimulation  (TMS) is a promising tool to experimentally ‚Äúentrain‚Ä? cortical activity. If TMS-locked oscillatory responses actually recruit the same neuronal mechanisms as spontaneous cortical oscillations, they qualify as a valid tool to study the causal role of neuronal oscillations in cognition but also to enable new treatments targeting aberrant oscillatory activity in, for example, neurological  conditions. Here, we provide first-time evidence that TMS-locked and spontaneous  oscillations are indeed tightly related and are likely to rely on the same neuronal generators. In addition, we demonstrate that an early local component of the TMS-evoked potential (the N40) may serve as a new objective and noninvasive probe of visual cortex excitability, which so far was only accessible via subjective phosphene reports.},
address  = {Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 EN Nijmegen, The Netherlands, Centre for Cognitive Neuroimaging, Institute of Neuroscience and Psychology, University of Glasgow, Glasgow G12 8QQ, United Kingdom Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 EN Nijmegen, The Netherlands, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, 6525 EN Nijmegen, The Netherlands,},
note  = {J Neurosci. 2015 Oct 28;35(43):14435-47. doi:10.1523/JNEUROSCI.1833-15.2015.}
}

@Article{2013232,
author  = {},
title  = {Oral, June 9.},
journal  = {European Journal of Psychotraumatology},
volume  = {4},
number  = {},
pages  = {},
year  = {2013},
abstract  = {},
address  = {},
note  = {Eur J Psychotraumatol. 2013 Jun 04;4:. doi:10.3402/ejpt.v4i0.21227.}
}

@Article{2010233,
author  = {Chang, Y. and Peng, S. and Wang, T. and Chen, S. and Chen, Y. and Chen, H.},
title  = {Autonomous indoor wayfinding for individuals with cognitive impairments.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {7},
number  = {},
pages  = {45},
year  = {2010},
abstract  = {Background: A challenge to individuals with cognitive impairments in wayfinding is how to remain oriented, recall routines, and travel in unfamiliar areas in a way relying on limited cognitive capacity. While people without disabilities often use maps or written directions as navigation tools or for remaining oriented, this cognitively-impaired population is very sensitive to issues of abstraction (e.g. icons on maps or signage) and presents the designer with a challenge to tailor navigation information specific to each user and context. Methods: This paper describes an approach to providing distributed cognition support of travel guidance for persons with cognitive disabilities. A solution is proposed based on passive near-field RFID tags and scanning PDAs. A prototype is  built and tested in field experiments with real subjects. The unique strength of  the system is the ability to provide unique-to-the-user prompts that are triggered by context. The key to the approach is to spread the context awareness  across the system, with the context being flagged by the RFID tags and the appropriate response being evoked by displaying the appropriate path guidance images indexed by the intersection of specific end-user and context ID embedded in RFID tags. Results: We found that passive RFIDs generally served as good context for triggering navigation prompts, although individual differences in effectiveness varied. The results of controlled experiments provided more evidence with regard to applicabilities of the proposed autonomous indoor wayfinding method. Conclusions: Our findings suggest that the ability to adapt indoor wayfinding devices for appropriate timing of directions and standing orientation will be particularly important.},
address  = {Department of Electronic Engineering, Chung Yuan Christian University, Taiwan Department of Electronic Engineering, Chung Yuan Christian University, Taiwan Institute of Health and Welfare Policy, National Yang Ming University, Taiwan Center for Occupational Therapy, Taipei Municipal Hospital, Taiwan Department of Electronic Engineering, Chung Yuan Christian University, Taiwan Department of Electronic Engineering, Chung Yuan Christian University, Taiwan},
note  = {J Neuroeng Rehabil. 2010 Sep 14;7:45. doi:10.1186/1743-0003-7-45.}
}

@Article{2009234,
author  = {Romoser, M. and Fisher, D.},
title  = {Drivers‚Äô Scanning in Intersections.},
journal  = {Human factors},
volume  = {51},
number  = {5},
pages  = {652-68},
year  = {2009},
abstract  = {Objective: This study aimed (a) to determine whether older drivers looked less often for potential threats while turning than younger drivers and (b) to compare the effectiveness of active and passive training on older drivers‚Äô performance and evaluation of their driving skills in intersections. Background: Age-related  declines in vision, physical abilities, psychomotor coordination, and cognition combine to make it less likely that older drivers will look for potential threats during a turn. Research suggests that active training should be an effective means of improving older drivers‚Äô performance and self-awareness. Method: In Experiment 1, younger and older participants drove a series of virtual intersection scenarios, were shown video replays, and were provided feedback. In  Experiment 2, older drivers were assigned to one of three cohorts: active simulator training, passive classroom training, or no training. Pre- and posttraining simulator and field drives assessed training effectiveness. Results: In Experiment 1, older drivers looked less often during turns than younger drivers. Customized feedback was successful in altering drivers‚Äô perception of their abilities. In Experiment 2, active training increased a driver‚Äôs probability of looking for a threat during a turn by nearly 100% in both posttraining simulator and field drives. Those receiving passive training or no training showed no improvement. Conclusion: Compared with passive training, active training is a more effective strategy for increasing older drivers‚Äô likelihood of looking for threats during a turn. Application: The results of this research can guide the development of programs that could reduce intersection crashes among older drivers.},
address  = {},
note  = {Hum Factors. 2009 Oct;51(5):652-68.}
}

@Article{2011235,
author  = {Bekinschtein, T. and Manes, F. and Villarreal, M. and Owen, A. and Della-Maggiore, V.},
title  = {Functional Imaging Reveals Movement Preparatory Activity in the Vegetative State.},
journal  = {Frontiers in Human Neuroscience},
volume  = {5},
number  = {},
pages  = {},
year  = {2011},
abstract  = {The vegetative state (VS) is characterized by the absence of awareness of self or the environment and preserved autonomic functions. The diagnosis relies critically on the lack of consistent signs of purposeful behavior in response to  external stimulation. Yet, given that patients with disorders of consciousness often exhibit fragmented movement patterns, voluntary actions may go unnoticed. Here we designed a simple motor paradigm that could potentially detect signs of purposeful behavior in VS patients with mild to severe brain damage by examining  the neural correlates of motor preparation in response to verbal commands. Twenty-four patients who met the diagnostic criteria for VS were recruited for this study. Eleven of these patients showing preserved auditory evoked potentials underwent functional magnetic resonance imaging (fMRI) to test for basic speech processing. Five of these patients, who showed word related activity, were included in a second fMRI study aimed at detecting functional changes in premotor cortex elicited by specific verbal instructions to move either their left or their right hand. Despite the lack of overt muscle activity, two patients out of  five activated the dorsal premotor cortex contralateral to the instructed hand, consistent with movement preparation. Our results may reflect residual voluntary  processing in these two patients. We believe that the identification of positive  results with fMRI using this simple task, may complement the clinical assessment  by helping attain a more precise diagnosis in patients with disorders of consciousness.},
address  = {Institute of Cognitive NeurologyBuenos Aires, Argentina Institute of Cognitive NeurologyBuenos Aires, Argentina Ra√∫l Carrea Institute for Neurological ResearchBuenos Aires, Argentina Impaired Consciousness Research Group, Addenbrooke's Hospital, University of CambridgeCambridge, UK Department of Physiology, School of Medicine, University of Buenos AiresBuenos Aires, Argentina},
note  = {Front Hum Neurosci. 2011 Jan 27;5:. doi:10.3389/fnhum.2011.00005.}
}

@Article{2008236,
author  = {},
title  = {21st ESICM Annual Congress.},
journal  = {Intensive Care Medicine},
volume  = {34},
number  = {Suppl 1},
pages  = {5-92},
year  = {2008},
abstract  = {},
address  = {},
note  = {doi:10.1007/s00134-008-1239-9.}
}

@Article{2016237,
author  = {Eby, D. and Molnar, L. and Zhang, L. and St., L. and Zanier, N. and Kostyniuk, L. and Stanciu, S.},
title  = {Use, perceptions, and benefits of automotive technologies among aging drivers.},
journal  = {Injury Epidemiology},
volume  = {3},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Advanced in-vehicle technologies have been proposed as a potential way to keep older adults driving for as long as they can safely do so, by taking into account the common declines in functional abilities experienced by older adults. The purpose of this report was to synthesize the knowledge about older drivers and advanced in-vehicle technologies, focusing on three areas: use (how older drivers use these technologies), perception (what they think about the technologies), and outcomes (the safety and/or comfort benefits of the technologies). Twelve technologies were selected for review and grouped into three categories: crash avoidance systems (lane departure warning, curve speed warning, forward collision warning, blind spot warning, parking assistance); in-vehicle information systems  (navigation assistance, intelligent speed adaptation); and other systems (adaptive cruise control, automatic crash notification, night vision enhancement, adaptive headlight, voice activated control). A comprehensive and systematic search was conducted for each technology to collect related publications. 271 articles were included into the final review. Research findings for each of the 12 technologies are synthesized in relation to how older adults use and think about the technologies as well as potential benefits. These results are presented separately for each technology. Can advanced in-vehicle technologies help extend  the period over which an older adult can drive safely? This report answers this question with an optimistic ‚Äúyes.‚Ä? Some of the technologies reviewed in this report have been shown to help older drivers avoid crashes, improve the ease and  comfort of driving, and travel to places and at times that they might normally avoid.},
address  = {University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter Rd., Ann Arbor, MI 48109 USA University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter Rd., Ann Arbor, MI 48109 USA University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter Rd., Ann Arbor, MI 48109 USA University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter Rd., Ann Arbor, MI 48109 USA University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter Rd., Ann Arbor, MI 48109 USA University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter Rd., Ann Arbor, MI 48109 USA University of Michigan Transportation Research Institute (UMTRI), 2901 Baxter Rd., Ann Arbor, MI 48109 USA},
note  = {Inj Epidemiol. 2016 Dec 19;3:. doi:10.1186/s40621-016-0093-4.}
}

@Article{2006238,
author  = {Holschneider, D. and Yang, J. and Sadler, T. and Nguyen, P. and Givrad, T. and Maarek, J.},
title  = {Nontethered, Nonrestrained Rat.},
journal  = {NeuroImage},
volume  = {29},
number  = {4},
pages  = {1344-58},
year  = {2006},
abstract  = {Conditioned fear (CF) is one of the most frequently used behavioral paradigms; however, little work has mapped changes in cerebral perfusion during CF in the rat‚Äîthe species which has dominated CF research. Adult rats carrying an implanted minipump were exposed to a tone (controls, n = 8) or a tone conditioned in association with footshocks (CS group, n = 9). During reexposure to the tone 24 h later, animals were injected intravenously by remote activation with [14C]-iodoantipyrine using the pump. Significant group differences in regional CBF-related tissue radioactivity (CBF-TR) were determined by region-of-interest analysis of brain autoradiographs, as well as in the reconstructed, three-dimensional brain by statistical parametric mapping (SPM). CS animals demonstrated significantly greater, fear-enhanced increases in CBF-TR in auditory cortex than controls. The lateral amygdala was activated, whereas the basolateral/basomedial and central amygdala were deactivated. In the hippocampus  and medial prefrontal cortex, CBF-TR increased significantly ventrally but not dorsally. Significant activations were noted in medial striatum and the thalamic  midline and intralaminar nuclei. However, the ventrolateral/dorsolateral striatum and its afferents from motor and somatosensory cortex were deactivated, consistent with the behavioral immobility seen during CF. Significant activations were also noted in the lateral septum, periaqueductal gray, and deep mesencephalic nucleus/tegmental tract. Our results show that auditory stimuli endowed with aversive properties through conditioning result in significant redistribution of cerebral perfusion. SPM is a useful tool in the brain mapping of complex rodent behaviors, in particular the changes in activation patterns in  limbic, thalamic, motor, and cortical circuits during CF.},
address  = {Department of Psychiatry and the Behavioral Sciences, University of Southern California, Keck School of Medicine, Los Angeles, CA 90089-9112, USA Department of Psychiatry and the Behavioral Sciences, University of Southern California, Keck School of Medicine, Los Angeles, CA 90089-9112, USA Department of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, CA 90089-9112, USA Department of Psychiatry and the Behavioral Sciences, University of Southern California, Keck School of Medicine, Los Angeles, CA 90089-9112, USA Department of Biomedical Engineering, University of Southern California School of Engineering, Los Angeles, CA 90089-9112, USA Department of Biomedical Engineering, University of Southern California School of Engineering, Los Angeles, CA 90089-9112, USA},
note  = {doi:10.1016/j.neuroimage.2005.08.038.}
}

@Article{2012239,
author  = {Saggar, M. and King, B. and Zanesco, A. and MacLean, K. and Aichele, S. and Jacobs, T. and Bridwell, D. and Shaver, P. and Rosenberg, E. and Sahdra, B. and Ferrer, E. and Tang, A. and Mangun, G. and Wallace, B. and Miikkulainen, R. and Saron, C.},
title  = {oscillatory activity.},
journal  = {Frontiers in Human Neuroscience},
volume  = {6},
number  = {},
pages  = {},
year  = {2012},
abstract  = {The capacity to focus one's attention for an extended period of time can be increased through training in contemplative practices. However, the cognitive processes engaged during meditation that support trait changes in cognition are not well characterized. We conducted a longitudinal wait-list controlled study of intensive meditation training. Retreat participants practiced focused attention (FA) meditation techniques for three months during an initial retreat. Wait-list  participants later undertook formally identical training during a second retreat. Dense-array scalp-recorded electroencephalogram (EEG) data were collected during  6 min of mindfulness of breathing meditation at three assessment points during each retreat. Second-order blind source separation, along with a novel semi-automatic artifact removal tool (SMART), was used for data preprocessing. We observed replicable reductions in meditative state-related beta-band power bilaterally over anteriocentral and posterior scalp regions. In addition, individual alpha frequency (IAF) decreased across both retreats and in direct relation to the amount of meditative practice. These findings provide evidence for replicable longitudinal changes in brain oscillatory activity during meditation and increase our understanding of the cortical processes engaged during meditation that may support long-term improvements in cognition.},
address  = {Department of Psychiatry and Behavioral Sciences, Stanford UniversityStanford, CA, USA Department of Psychology, University of CaliforniaDavis, CA, USA Department of Psychology, University of CaliforniaDavis, CA, USA Department of Psychiatry and Behavioral Sciences, Johns Hopkins UniversityBaltimore, MD, USA Department of Psychology, University of CaliforniaDavis, CA, USA Center for Mind and Brain, University of CaliforniaDavis, CA, USA Mind Research NetworkAlbuquerque, NM, USA Department of Psychology, University of CaliforniaDavis, CA, USA Center for Mind and Brain, University of CaliforniaDavis, CA, USA School of Social Sciences and Psychology, University of Western SydneySydney, NSW, Australia Department of Psychology, University of CaliforniaDavis, CA, USA Department of Psychology, University of New MexicoAlbuquerque, NM, USA Department of Psychology, University of CaliforniaDavis, CA, USA Santa Barbara Institute for Consciousness StudiesSanta Barbara, CA, USA Department of Computer Science, University of Texas at AustinTX, USA Center for Mind and Brain, University of CaliforniaDavis, CA, USA},
note  = {Front Hum Neurosci. 2012 Sep 10;6:. doi:10.3389/fnhum.2012.00256.}
}

@Article{2011240,
author  = {Nioka, S. and Chen, Y.},
title  = {Optical Tecnology Developments in Biomedicine: History, Current and Future.},
journal  = {Translational Medicine @ UniSa},
volume  = {1},
number  = {},
pages  = {51-150},
year  = {2011},
abstract  = {Biomedical optics is a rapidly emerging field for medical imaging and diagnostics. This paper reviews several biomedical optical technologies that have been developed and translated for either clinical or pre-clinical applications. Specifically, we focus on the following technologies: 1) near-infrared spectroscopy and tomography, 2) optical coherence tomography, 3) fluorescence spectroscopy and imaging, and 4) optical molecular imaging. There representative  biomedical applications are also discussed here.},
address  = {Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104 USA - shoko@nioka.net Fischell Department of Bioengineering, University of Maryland, College Park, MD 20742 USA - yuchen@umd.edu},
note  = {Transl Med UniSa. 2011 Oct 17;1:51-150.}
}

@Article{2012241,
author  = {Arthur, J. and Philbeck, J. and Kleene, N. and Chichka, D.},
title  = {Path Integration.},
journal  = {Acta psychologica},
volume  = {141},
number  = {1},
pages  = {112-21},
year  = {2012},
abstract  = {Angular path integration refers to the ability to maintain an estimate of self-location after a rotational displacement by integrating internally-generated (idiothetic) self-motion signals over time. Previous work has found that non-sensory inputs, namely spatial memory, can play a powerful role in angular path integration (Arthur et al., 2007, 2009). Here we investigated the conditions under which spatial memory facilitates angular path integration. We hypothesized  that the benefit of spatial memory is particularly likely in spatial updating tasks in which one‚Äôs self-location estimate is referenced to external space. To test this idea, we administered passive, nonvisual body rotations (ranging 40¬∞ ‚Äì  140¬∞) about the yaw axis and asked participants to use verbal reports or open-loop manual pointing to indicate the magnitude of the rotation. Prior to some trials, previews of the surrounding environment were given. We found that when participants adopted an egocentric frame of reference, the previously-observed benefit of previews on within-subject response precision was  not manifested, regardless of whether remembered spatial frameworks were derived  from vision or spatial language. We conclude that the powerful effect of spatial  memory is dependent on one‚Äôs frame of reference during self-motion updating.},
address  = {Department of Psychology, The George Washington University, Department of Psychology, Washington, DC 20052 Department of Psychology, The George Washington University, Department of Psychology, Washington, DC 20052 Department of Psychology, The George Washington University, Department of Psychology, Washington, DC 20052 Department of Mechanical and Aerospace Engineering, The George Washington University, Department of Psychology, Washington, DC 20052},
note  = {doi:10.1016/j.actpsy.2012.07.003.}
}

@Article{2013242,
author  = {Halder, S. and Ruf, C. and Furdea, A. and Pasqualotto, E. and De, M. and van, d. and Bogdan, M. and Rosenstiel, W. and Birbaumer, N. and K√ºbler, A. and Matuz, T.},
title  = {Prediction of P300 BCI Aptitude in Severe Motor Impairment.},
journal  = {PLoS ONE},
volume  = {8},
number  = {10},
pages  = {},
year  = {2013},
abstract  = {Brain-computer interfaces (BCIs) provide a non-muscular communication channel for persons with severe motor impairments. Previous studies have shown that the aptitude with which a BCI can be controlled varies from person to person. A reliable predictor of performance could facilitate selection of a suitable BCI paradigm. Eleven severely motor impaired participants performed three sessions of a P300 BCI web browsing task. Before each session auditory oddball data were collected to predict the BCI aptitude of the participants exhibited in the current session. We found a strong relationship of early positive and negative potentials around 200 ms (elicited with the auditory oddball task) with performance. The amplitude of the P2 (r ‚Ää=‚Ää ‚àí0.77) and of the N2 (r ‚Ää=‚Ää ‚àí0.86) had the strongest correlations. Aptitude prediction using an auditory oddball was successful. The finding that the N2 amplitude is a stronger predictor of performance than P3 amplitude was reproduced after initially showing this effect  with a healthy sample of BCI users. This will reduce strain on the end-users by minimizing the time needed to find suitable paradigms and inspire new approaches  to improve performance.},
address  = {Institute of Psychology, University of W√ºrzburg, W√ºrzburg, Germany Institute of Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, T√ºbingen, Germany Institute of Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, T√ºbingen, Germany Psychological Sciences Research Institute, Universit√© catholique de Louvain, Louvain-la-neuve, Belgium Institute of Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, T√ºbingen, Germany Institute of Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, T√ºbingen, Germany Department of Computer Engineering, University of T√ºbingen, T√ºbingen, Germany Department of Computer Engineering, University of T√ºbingen, T√ºbingen, Germany Institute of Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, T√ºbingen, Germany Institute of Psychology, University of W√ºrzburg, W√ºrzburg, Germany Institute of Medical Psychology and Behavioral Neurobiology, University of T√ºbingen, T√ºbingen, Germany},
note  = {PLoS One. 2013 Oct 18;8(10):. doi:10.1371/journal.pone.0076148.}
}

@Article{2008243,
author  = {Hendricks, J. and Chikar, J. and Crumling, M. and Raphael, Y. and Martin, D.},
title  = {Localized Cell and Drug Delivery for Auditory Prostheses.},
journal  = {Hearing research},
volume  = {242},
number  = {1-2},
pages  = {117-31},
year  = {2008},
abstract  = {Localized cell and drug delivery to the cochlea and central auditory pathway can  improve the safety and performance of implanted auditory prostheses (APs). While  generally successful, these devices have a number of limitations and adverse effects including limited tonal and dynamic ranges, channel interactions, unwanted stimulation of non-auditory nerves, immune rejection, and infections including meningitis. Many of these limitations are associated with the tissue reactions to implanted auditory prosthetic devices and the gradual degeneration of the auditory system following deafness. Strategies to reduce the insertion trauma, degeneration of target neurons, fibrous and bony tissue encapsulation, and immune activation can improve the viability of tissue required for AP function as well as improve the resolution of stimulation for reduced channel interaction and improved place-pitch and level discrimination. Many pharmaceutical compounds have been identified that promote the viability of auditory tissue and prevent inflammation and infection. Cell delivery and gene therapy have provided promising results for treating hearing loss and reversing degeneration. Currently, many clinical and experimental methods can produce extremely localized and sustained drug delivery to address AP limitations. These  methods provide better control over drug concentrations while eliminating the adverse effects of systemic delivery. Many of these drug delivery techniques can  be integrated into modern auditory prosthetic devices to optimize the tissue response to the implanted device and reduce the risk of infection or rejection. Together, these methods and pharmaceutical agents can be used to optimize the tissue-device interface for improved AP safety and effectiveness.},
address  = {Department of Biomedical Engineering, The University of Michigan, 1107 Gerstacker Bldg., 2200 Bonisteel Blvd., Ann Arbor, MI, 48109-2099 USA Neuroscience Program, The University of Michigan, 4137 Undergraduate Research Bldg., 204 Washtenaw Ave., Ann Arbor, MI, 48109-2215 USA Department of Otolaryngology, Kresge Hearing Research Institute, The University of Michigan Medical School, MSRB-3 Rm. 9301, Ann Arbor, MI, 48109-5648 USA Neuroscience Program, The University of Michigan, 4137 Undergraduate Research Bldg., 204 Washtenaw Ave., Ann Arbor, MI, 48109-2215 USA Department of Biomedical Engineering, The University of Michigan, 1107 Gerstacker Bldg., 2200 Bonisteel Blvd., Ann Arbor, MI, 48109-2099 USA},
note  = {doi:10.1016/j.heares.2008.06.003.}
}

@Article{2016244,
author  = {Deeb, W. and Giordano, J. and Rossi, P. and Mogilner, A. and Gunduz, A. and Judy, J. and Klassen, B. and Butson, C. and Van, H. and Deny, D. and Dougherty, D. and Rowell, D. and Gerhardt, G. and Smith, G. and Ponce, F. and Walker, H. and Bronte-Stewart, H. and Mayberg, H. and Chizeck, H. and Langevin, J. and Volkmann, J. and Ostrem, J. and Shute, J. and Jimenez-Shahed, J. and Foote, K. and Wagle, S. and Rossi, M. and Oh, M. and Pourfar, M. and Rosenberg, P. and Silburn, P. and de, H. and Starr, P. and Denison, T. and Akbar, U. and Grill, W. and Okun, M.},
title  = {Emerging Issues and Technologies.},
journal  = {Frontiers in Integrative Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {This paper provides an overview of current progress in the technological advances and the use of deep brain stimulation (DBS) to treat neurological and neuropsychiatric disorders, as presented by participants of the Fourth Annual DBS Think Tank, which was convened in March 2016 in conjunction with the Center for Movement Disorders and Neurorestoration at the University of Florida, Gainesveille FL, USA. The Think Tank discussions first focused on policy and advocacy in DBS research and clinical practice, formation of registries, and issues involving the use of DBS in the treatment of Tourette Syndrome. Next, advances in the use of neuroimaging and electrochemical markers to enhance DBS specificity were addressed. Updates on ongoing use and developments of DBS for the treatment of Parkinson's disease, essential tremor, Alzheimer's disease, depression, post-traumatic stress disorder, obesity, addiction were presented, and progress toward innovation(s) in closed-loop applications were discussed. Each section of these proceedings provides updates and highlights of new information as presented at this year's international Think Tank, with a view toward current and near future advancement of the field.},
address  = {Department of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA Department of Neurology, and Neuroethics Studies Program, Pellegrino Center for Clinical Bioethics, Georgetown University Medical CenterWashington, DC, USA Department of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA Department of Neurosurgery, Center for Neuromodulation, New York University Langone Medical CenterNew York, NY, USA Department of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA Department of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA Department of Neurology, Mayo ClinicRochester, MN, USA Department of Bioengineering, Scientific Computing and Imaging Institute, University of UtahSalt Lake City, UT, USA Department of Neurosurgery, University of Kentucky Chandler Medical CenterLexington, KY, USA Department of Psychiatry, Academic Medical Center, University of AmsterdamAmsterdam, Netherlands Department of Psychiatry, Massachusetts General HospitalBoston, MA, USA Asia Pacific Centre for Neuromodulation, Queensland Brain Institute, The University of QueenslandBrisbane, QLD, Australia Department of Anatomy and Neurobiology, University of Kentucky Chandler Medical CenterLexington, KY, USA Departments of Psychiatry and Behavioral Sciences and Radiology and Radiological  Sciences, Johns Hopkins University School of MedicineBaltimore, MD, USA Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center PhoenixArizona, AZ, USA Department of Neurology and Department of Biomedical Engineering, University of Alabama at BirminghamBirmingham, AL, USA Departments of Neurology and Neurological Sciences and Neurosurgery, Stanford UniversityStanford, CA, USA Department of Psychiatry, Emory University School of MedicineAtlanta, GA, USA Electrical Engineering Department, University of WashingtonSeattle, WA, USA Department of Neurosurgery, VA Greater Los Angeles Healthcare SystemLos Angeles,  CA, USA Department of Neurology, University Clinic of W√ºrzburgW√ºrzburg, Germany Department of Neurology, University of California San FranciscoSan Francisco, CA, USA J. Crayton Pruitt Family Department of Biomedical Engineering, University of FloridaGainesville, FL, USA Department of Neurology, Baylor College of MedicineHouston, TX, USA Department of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA Department of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA Departments of Neurological Sciences, Diagnostic Radiology, and Nuclear Medicine, Rush University Medical CenterChicago, IL, USA Division of Functional Neurosurgery, Department of Neurosurgery, Allegheny General HospitalPittsburgh, PA, USA Department of Neurology, New York University Langone Medical CenterNew York, NY,  USA Psychiatry and Behavioral Sciences, Johns Hopkins Bayview Medical Center, Johns Hopkins School of MedicineBaltimore, MD, USA Asia Pacific Centre for Neuromodulation, Queensland Brain Institute, The University of QueenslandBrisbane, QLD, Australia Graduate Program in Neuroscience, Department of Neurological Surgery, Kavli Institute for Fundamental Neuroscience, University of California, San FranciscoSan Francisco, CA, USA Graduate Program in Neuroscience, Department of Neurological Surgery, Kavli Institute for Fundamental Neuroscience, University of California, San FranciscoSan Francisco, CA, USA Medtronic ModulationMinneapolis, MN, USA Movement Disorders Program, Department of Neurology, Alpert Medical School, Rhode Island Hospital, Brown UniversityProvidence, RI, USA Department of Biomedical Engineering, Duke UniversityDurham, NC, USA Department of Neurology, Center for Movement Disorders and Neurorestoration, University of FloridaGainesville, FL, USA},
note  = {Front Integr Neurosci. 2016 Nov 22;10:. doi:10.3389/fnint.2016.00038.}
}

@Article{2010245,
author  = {Lee, J. and Fowler, R. and Rodney, D. and Cherney, L. and Small, S.},
title  = {observation and imitation.},
journal  = {Aphasiology},
volume  = {24},
number  = {4},
pages  = {449-65},
year  = {2010},
abstract  = {Background: Neurophysiological evidence from primates has demonstrated the presence of mirror neurons, with visual and motor properties, that discharge both when an action is performed and during observation of the same action. A similar  system for observation-execution matching may also exist in humans. We postulate  that behavioral stimulation of this parietal-frontal system may play an important role in motor learning for speech and thereby aid language recovery after stroke. Aims: The purpose of this article is to describe the development of IMITATE, a computer-assisted system for aphasia therapy based on action observation and imitation. We also describe briefly the randomized controlled clinical trial that is currently underway to evaluate its efficacy and mechanism of action. Methods and Procedures: IMITATE therapy consists of silent observation of audio-visually  presented words and phrases spoken aloud by six different speakers, followed by a period during which the participant orally repeats the stimuli. We describe the rationale for the therapeutic features, stimulus selection, and delineation of treatment levels.The clinical trial is a randomized single blind controlled trial in which participants receive two pre-treatment baseline assessments, six weeks apart, followed by either IMITATE or a control therapy. Both treatments are provided intensively (90 minutes per day). Treatment is followed by a post-treatment assessment, and a six-week follow-up assessment. Outcomes & Results: Thus far, five participants have completed IMITATE. We expect the results of the randomized controlled trial to be available by late 2010. Conclusions: IMITATE is a novel computer-assisted treatment for aphasia that is supported by theoretical rationales and previous human and primate data from neurobiology. The treatment is feasible, and preliminary behavioral data are emerging. However, the results will not be known until the clinical trial data are available to evaluate fully the efficacy of IMITATE and to inform theoretically about the mechanism of action and the role of a human mirror system in aphasia treatment.},
address  = {Center for Aphasia Research and Treatment, Rehabilitation Institute of Chicago Department of Neurology, The University of Chicago Department of Neurology, The University of Chicago Center for Aphasia Research and Treatment, Rehabilitation Institute of Chicago Department of Neurology, The University of Chicago},
note  = {Aphasiology. 2010;24(4):449-65. doi:10.1080/02687030802714157.}
}

@Article{2017246,
author  = {B√©gel, V. and Di, L. and Seilles, A. and Dalla, B.},
title  = {Music Games: Potential Application and Considerations for Rhythmic Training.},
journal  = {Frontiers in Human Neuroscience},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Rhythmic skills are natural and widespread in the general population. The majority can track the beat of music and move along with it. These abilities are  meaningful from a cognitive standpoint given their tight links with prominent motor and cognitive functions such as language and memory. When rhythmic skills are challenged by brain damage or neurodevelopmental disorders, remediation strategies based on rhythm can be considered. For example, rhythmic training can  be used to improve motor performance (e.g., gait) as well as cognitive and language skills. Here, we review the games readily available in the market and assess whether they are well-suited for rhythmic training. Games that train rhythm skills may serve as useful tools for retraining motor and cognitive functions in patients with motor or neurodevelopmental disorders (e.g., Parkinson‚Äôs disease, dyslexia, or ADHD). Our criteria were the peripheral used to capture and record the response, the type of response and the output measure. None of the existing games provides sufficient temporal precision in stimulus presentation and/or data acquisition. In addition, games do not train selectively rhythmic skills. Hence, the available music games, in their present form, are not satisfying for training rhythmic skills. Yet, some features such as the device used, the interface or the game scenario provide good indications for devising efficient training protocols. Guidelines are provided for devising serious music  games targeting rhythmic training in the future.},
address  = {Euromov Laboratory, University of MontpellierMontpellier, France Homme, Environnement et Technologies de l‚ÄôInformation, Universit√© de Technologie  de TroyesTroyes, France NaturalPadMontpellier, France Euromov Laboratory, University of MontpellierMontpellier, France},
note  = {Front Hum Neurosci. 2017 May 29;11:. doi:10.3389/fnhum.2017.00273.}
}

@Article{2015247,
author  = {Sun, M. and Burke, L. and Baranowski, T. and Fernstrom, J. and Zhang, H. and Chen, H. and Bai, Y. and Li, Y. and Li, C. and Yue, Y. and Li, Z. and Nie, J. and Sclabassi, R. and Mao, Z. and Jia, W.},
title  = {Activity and Lifestyle.},
journal  = {Journal of healthcare engineering},
volume  = {6},
number  = {1},
pages  = {1-22},
year  = {2015},
abstract  = {Recently, wearable computers have become new members in the family of mobile electronic devices, adding new functions to those provided by smartphones and tablets. As ‚Äúalways-on‚Ä? miniature computers in the personal space, they will play increasing roles in the field of healthcare. In this work, we present our development of eButton, a wearable computer designed as a personalized, attractive, and convenient chest pin in a circular shape. It contains a powerful  microprocessor, numerous electronic sensors, and wireless communication links. We describe its design concepts, electronic hardware, data processing algorithms, and its applications to the evaluation of diet, physical activity and lifestyle in the study of obesity and other chronic diseases.},
address  = {Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA Department of Health and Community Systems, University of Pittsburgh, Pittsburgh, PA, USA Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA Center for Image Processing, Beihang University, Beijing, China Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA Department of Electrical and Computer Engineering, University of Pittsburgh, Pittsburgh, PA, USA Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA Department of Electrical and Computer Engineering, University of Pittsburgh, Pittsburgh, PA, USA Department of Electrical and Computer Engineering, University of Pittsburgh, Pittsburgh, PA, USA Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA Computational Diagnostics, Inc., Pittsburgh, PA, USA Department of Electrical and Computer Engineering, University of Pittsburgh, Pittsburgh, PA, USA Department of Neurosurgery, University of Pittsburgh, Pittsburgh, PA, USA},
note  = {J Healthc Eng. 2015;6(1):1-22. doi:10.1260/2040-2295.6.1.1.}
}

@Article{2013248,
author  = {Ritter, P. and Schirner, M. and McIntosh, A. and Jirsa, V.},
title  = {The Virtual Brain Integrates Computational Modeling and Multimodal Neuroimaging.},
journal  = {Brain Connectivity},
volume  = {3},
number  = {2},
pages  = {121-45},
year  = {2013},
abstract  = {Brain function is thought to emerge from the interactions among neuronal populations. Apart from traditional efforts to reproduce brain dynamics from the  micro- to macroscopic scales, complementary approaches develop phenomenological models of lower complexity. Such macroscopic models typically generate only a few selected‚Äîideally functionally relevant‚Äîaspects of the brain dynamics. Importantly, they often allow an understanding of the underlying mechanisms beyond computational reproduction. Adding detail to these models will widen their ability to reproduce a broader range of dynamic features of the brain. For instance, such models allow for the exploration of consequences of focal and distributed pathological changes in the system, enabling us to identify and develop approaches to counteract those unfavorable processes. Toward this end, The Virtual Brain (TVB) (www.thevirtualbrain.org), a neuroinformatics platform with a brain simulator that incorporates a range of neuronal models and dynamics  at its core, has been developed. This integrated framework allows the model-based simulation, analysis, and inference of neurophysiological mechanisms over several brain scales that underlie the generation of macroscopic neuroimaging signals. In this article, we describe how TVB works, and we present the first proof of concept.},
address  = {Minerva Research Group Brain Modes, Max Planck Institute for Human Cognitive and  Brain Sciences, Leipzig, Germany. Bernstein Focus State Dependencies of Learning & Bernstein Center for Computational Neuroscience, Berlin, Germany. Rotman Research Institute of Baycrest Centre, University of Toronto, Toronto, Canada. Institut de Neurosciences des Syst√®mes UMR INSERM 1106, Aix-Marseille Universit√©  Facult√© de M√©decine, Marseille, France.},
note  = {Brain Connect. 2013 Apr;3(2):121-45. doi:10.1089/brain.2012.0120.}
}

@Article{2004249,
author  = {},
title  = {November 18‚Äì21, 2004.},
journal  = {Neuro-Oncology},
volume  = {6},
number  = {4},
pages  = {307-87},
year  = {2004},
abstract  = {},
address  = {},
note  = {Neuro-oncol. 2004 Oct;6(4):307-87. doi:10.1215/S1152851704100148.}
}

@Article{2016250,
author  = {Otis, M. and Ayena, J. and Tremblay, L. and Fortin, P. and M√©n√©las, B.},
title  = {Soil Using Vibrotactile Cueing for the Elderly.},
journal  = {PLoS ONE},
volume  = {11},
number  = {9},
pages  = {},
year  = {2016},
abstract  = {Background: Our daily activities imply displacements on various types of soil. For persons with gait disorder or losing functional autonomy, walking on some types of soil could be challenging because of the risk of falling it represents.  Methods: In this paper, we present, in a first part, the use of an enactive shoe  for an automatic differentiation of several types of soil. In a second part, using a second improved prototype (an enactive insole), twelve participants with  Parkinson‚Äôs disease (PD) and nine age-matched controls have performed the Timed Up and Go (TUG) test on six types of soil with and without cueing. The frequency  of the cueing was set at 10% above the cadence computed at the lower risk of falling (walking over the concrete). Depending on the cadence computed at the lower risk, the enactive insole activates a vibrotactile cueing aiming to improve gait and balance control. Finally, a risk index is computed using gait parameters in relation to given type of soil. Results: The frequency analysis of the heel strike vibration allows the differentiation of various types of soil. The risk computed is associated to an appropriate rhythmic cueing in order to improve balance and gait impairment. The results show that a vibrotactile cueing could help to reduce the risk of falling. Conclusions: Firstly, this paper demonstrates the feasibility of reducing the risk of falling while walking on different types  of soil using vibrotactile cueing. We found a significant difference and a significant decrease in the computed risks of falling for most of types of soil especially for deformable soils which can lead to fall. Secondly, heel strike provides an approximation of the impulse response of the soil that can be analyzed with time and frequency-domain modeling. From these analyses, an index is computed enabling differentiation the types of soil.},
address  = {Department of Applied Sciences, University of Quebec at Chicoutimi (UQAC), REPARTI centre, Chicoutimi, Quebec, Canada Department of Applied Sciences, University of Quebec at Chicoutimi (UQAC), REPARTI centre, Chicoutimi, Quebec, Canada Department of Health Sciences, University of Quebec at Chicoutimi, Chicoutimi, Quebec, Canada Department of Electrical Engineering and Computer at the Center for intelligent machine, McGill University, Montreal, Quebec, Canada Department of Mathematics and Computer Sciences, University of Quebec at Chicoutimi, Chicoutimi, Quebec, Canada},
note  = {PLoS One. 2016 Sep 7;11(9):. doi:10.1371/journal.pone.0162107.}
}

@Article{2017251,
author  = {Frontera, W. and Bean, J. and Damiano, D. and Ehrlich-Jones, L. and Fried-Oken, M. and Jette, A. and Jung, R. and Lieber, R. and Malec, J. and Mueller, M. and Ottenbacher, K. and Tansey, K. and Thompson, A.},
title  = {Forward (Executive Summary).},
journal  = {Neurorehabilitation and Neural Repair},
volume  = {31},
number  = {4},
pages  = {304-14},
year  = {2017},
abstract  = {},
address  = {Department of Physical Medicine and Rehabilitation, Vanderbilt University Medical Center, Nashville, TN, USA Harvard Medical School, Boston, MA, USA National Institutes of Health, Bethesda, MD, USA Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago, IL, USA Oregon Health & Science University, Portland, OR, USA Boston University, MA, USA Florida International University, Miami, FL, USA Northwestern Feinberg Medical School and Rehabilitation Institute of Chicago, IL, USA Indiana University School of Medicine and Rehabilitation Hospital of Indiana, Indianapolis, IN, USA Washington University School of Medicine, St Louis, MO, USA University of Texas Medical Branch, Galveston, TX, USA Jackson Veteran‚Äôs Administration Medical Center, MS, USA Medical University of South Carolina, Charleston, SC, USA},
note  = {doi:10.1177/1545968317698875.}
}

@Article{2016252,
author  = {Nelson, J. and McKinley, R. and Phillips, C. and McIntire, L. and Goodyear, C. and Kreiner, A. and Monforton, L.},
title  = {Throughput Capacity.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Multitasking has become an integral attribute associated with military operations within the past several decades. As the amount of information that needs to be processed during these high level multitasking environments exceeds the human operators' capabilities, the information throughput capacity reaches an asymptotic limit. At this point, the human operator can no longer effectively process and respond to the incoming information resulting in a plateau or decline in performance. The objective of the study was to evaluate the efficacy of a non-invasive brain stimulation technique known as transcranial direct current stimulation (tDCS) applied to a scalp location over the left dorsolateral prefrontal cortex (lDLPFC) to improve information processing capabilities during a multitasking environment.Methods: The study consisted of 20 participants from Wright-Patterson Air Force Base (16 male and 4 female) with an  average age of 31.1 (SD = 4.5). Participants were randomly assigned into two groups, each consisting of eight males and two females. Group one received 2 mA of anodal tDCS and group two received sham tDCS over the lDLPFC on their testing  day.Results: The findings indicate that anodal tDCS significantly improves the participants' information processing capability resulting in improved performance compared to sham tDCS. For example, the multitasking throughput capacity for the  sham tDCS group plateaued near 1.0 bits/s at the higher baud input (2.0 bits/s) whereas the anodal tDCS group plateaued near 1.3 bits/s.Conclusion: The findings  provided new evidence that tDCS has the ability to augment and enhance multitasking capability in a human operator. Future research should be conducted  to determine the longevity of the enhancement of transcranial direct current stimulation on multitasking performance, which has yet to be accomplished.},
address  = {Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA Department of Biomedical, Industrial, and Human Factors Engineering, Wright State UniversityDayton, OH, USA Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA Air Force Research Laboratory, Wright-Patterson Air Force BaseOH, USA Department of Biomedical, Industrial, and Human Factors Engineering, Wright State UniversityDayton, OH, USA},
note  = {Front Hum Neurosci. 2016 Nov 29;10:. doi:10.3389/fnhum.2016.00589.}
}

@Article{2014253,
author  = {Kok, G. and Bouwsma, E. and Anema, J. and Vonk, N. and Knol, D. and Bosmans, J. and Schraffordt, K. and van, K. and van, B. and Lips, J. and Emanuel, M. and Scholten, P. and Mozes, A. and Adriaanse, A. and Br√∂lmann, H. and Huirne, J.},
title  = {Protocol of a Stepped Wedge Cluster Randomized Controlled Trial.},
journal  = {JMIR Research Protocols},
volume  = {3},
number  = {2},
pages  = {},
year  = {2014},
abstract  = {Background: The length of recovery after benign gynecological surgery and return  to work frequently exceeds the period that is recommended or expected by specialists. A prolonged recovery is associated with a poorer quality of life. In addition, costs due to prolonged sick leave following gynecological surgery cause a significant financial burden on society. Objective: The objective of our study  was to present the protocol of a stepped wedge cluster randomized controlled trial to evaluate the cost effectiveness of a new care program for patients undergoing hysterectomy and/or adnexal surgery for benign disease, compared to the usual care. Methods: The care program under study, designed to improve convalescence and to prevent delayed return to work, targets two levels. At the hospital level, guidelines will be distributed among clinical staff in order to stimulate evidence-based patient education. At the patient level, additional perioperative guidance is provided by means of an eHealth intervention, equipping patients with tailored convalescence advice, and an occupational intervention is  available for those patients at risk of prolonged sick leave. Due to the stepped  wedge design of the trial, the care program will be sequentially rolled out among the 9 participating hospitals, from which the patients are recruited. Eligible for this study are employed women, 18-65 years of age, who are scheduled for hysterectomy and/or laparoscopic adnexal surgery. The primary outcome is full sustainable return to work. The secondary outcomes include general recovery, quality of life, self-efficacy, coping, and pain. The data will be collected by means of self-reported electronic questionnaires before surgery and at 2, 6, 12,  26, and 52 weeks after surgery. Sick leave and cost data are measured by monthly  sick leave calendars, and cost diaries during the 12 month follow-up period. The  economic evaluation will be performed from the societal perspective. All statistical analyses will be conducted according to the intention-to-treat principle. Results: The enrollment of the patients started October 2011. The follow-up period will be completed in August 2014. Data cleaning or analysis has  not begun as of this article‚Äôs submission. Conclusions: We hypothesize the care program to be effective by means of improving convalescence and reducing costs associated with productivity losses following gynecological surgery. The results  of this study will enable health care policy makers to decide about future implementation of this care program on a broad scale. Trial Registration: Netherlands Trial Register: NTR2933; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2933 (Archived by WebCite at http://www.webcitation.org/6Q7exPG84).},
address  = {Department of Obstetrics and GynecologyVU University Medical CenterAmsterdamNetherlands Department of Public and Occupational HealthVU University Medical CenterAmsterdamNetherlands Department of Obstetrics and GynecologyVU University Medical CenterAmsterdamNetherlands Department of Epidemiology and StatisticsVU University Medical CenterAmsterdamNetherlands EMGO Institute for Health and Care ResearchAmsterdamNetherlands Department of Obstetrics and GynecologyMeander Medical CenterAmersfoortNetherlands Department of Obstetrics and GynecologyOnze Lieve Vrouwe GasthuisAmsterdamNetherlands Department of Obstetrics and GynecologyFlevo HospitalAlmereNetherlands Department of Obstetrics and GynecologyKennemer GasthuisHaarlemNetherlands Department of Obstetrics and GynaecologySpaarne HospitalHoofddorpNetherlands Department of Obstetrics and GynaecologyDiakonessenhuisUtrechtNetherlands Department of Obstetrics and GynecologyAmstelland HospitalAmstelveenNetherlands Department of Obstetrics and GynecologyMedical Center AlkmaarAlkmaarNetherlands Department of Obstetrics and GynecologyVU University Medical CenterAmsterdamNetherlands Department of Obstetrics and GynecologyVU University Medical CenterAmsterdamNetherlands},
note  = {JMIR Res Protoc. 2014 Jun 18;3(2):. doi:10.2196/resprot.3236.}
}

@Article{2013254,
author  = {Hasanuzzaman, F. and Yang, X. and Tian, Y. and Liu, Q. and Capezuti, E.},
title  = {Monitoring Activity of Taking Medicine by Incorporating RFID and Video Analysis.},
journal  = {Network modeling and analysis in health informatics and bioinformatics},
volume  = {2},
number  = {2},
pages  = {61-70},
year  = {2013},
abstract  = {In this paper, we present a new framework to monitor medication intake for elderly individuals by incorporating a video camera and Radio Frequency Identification (RFID) sensors. The proposed framework can provide a key function  for monitoring activities of daily living (ADLs) of elderly people at their own home. In an assistive environment, RFID tags are applied on medicine bottles located in a medicine cabinet so that each medicine bottle will have a unique ID. The description of the medicine data for each tag is manually input to a database. RFID readers will detect if any of these bottles are taken away from the medicine cabinet and identify the tag attached on the medicine bottle. A video camera is installed to continue monitoring the activity of taking medicine  by integrating face detection and tracking, mouth detection, background subtraction, and activity detection. The preliminary results demonstrate that 100% detection accuracy for identifying medicine bottles and promising results for monitoring activity of taking medicine.},
address  = {School of Information & Control Engineering, Nanjing University of Information Science and Technology, China qsliu@nuist.edu.cn College of Nursing, New York University, New York, NY USA ec65@nyu.edu},
note  = {7 doi:10.1007/s13721-013-0025-y.}
}

@Article{2014255,
author  = {Chen, F. and Qi, Z. and Luo, Y. and Hinchliffe, T. and Ding, G. and Xia, Y. and Ji, X.},
title  = {Non-pharmaceutical therapies for stroke: Mechanisms and clinical implications.},
journal  = {Progress in neurobiology},
volume  = {0},
number  = {},
pages  = {246-69},
year  = {2014},
abstract  = {Stroke is deemed a worldwide leading cause of neurological disability and death,  however, there is currently no promising pharmacotherapy for acute ischemic stroke aside from intravenous or intra-arterial thrombolysis. Yet because of the  narrow therapeutic time window involved, thrombolytic application is very restricted in clinical settings. Accumulating data suggest that non-pharmaceutical therapies for stroke might provide new opportunities for stroke treatment. Here we review recent research progress in the mechanisms and clinical implications of non-pharmaceutical therapies, mainly including neuroprotective approaches such as hypothermia, ischemic/hypoxic conditioning, acupuncture, medical gases, transcranial laser therapy, etc. In addition, we briefly summarize mechanical endovascular recanalization devices and recovery devices for the treatment of the chronic phase of stroke and discuss the relative merits of these devices.},
address  = {Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, Beijing 100053, China Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, Beijing 100053, China Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, Beijing 100053, China The Vivian L Smith Department of Neurosurgery, The University of Texas Medical School at Houston, Houston, TX 77030, USA Shanghai research center for Acupuncture and Meridiam, Shanghai 201203, China The Vivian L Smith Department of Neurosurgery, The University of Texas Medical School at Houston, Houston, TX 77030, USA Cerebrovascular Diseases Research Institute, Xuanwu Hospital of Capital Medical University, Beijing, Beijing 100053, China},
note  = {doi:10.1016/j.pneurobio.2013.12.007.}
}

@Article{2004256,
author  = {},
title  = {June 13‚Äì16.},
journal  = {Neuro-Oncology},
volume  = {6},
number  = {4},
pages  = {401-70},
year  = {2004},
abstract  = {},
address  = {},
note  = {Neuro-oncol. 2004 Oct;6(4):401-70. doi:10.1215/S115285170410015X.}
}

@Article{2013257,
author  = {Quercia, P. and Feiss, L. and Michel, C.},
title  = {Developmental dyslexia and vision.},
journal  = {Clinical Ophthalmology (Auckland, N.Z.)},
volume  = {7},
number  = {},
pages  = {869-81},
year  = {2013},
abstract  = {Developmental dyslexia affects almost 10% of school-aged children and represents  a significant public health problem. Its etiology is unknown. The consistent presence of phonological difficulties combined with an inability to manipulate language sounds and the grapheme‚Äìphoneme conversion is widely acknowledged. Numerous scientific studies have also documented the presence of eye movement anomalies and deficits of perception of low contrast, low spatial frequency, and  high frequency temporal visual information in dyslexics. Anomalies of visual attention with short visual attention spans have also been demonstrated in a large number of cases. Spatial orientation is also affected in dyslexics who manifest a preference for spatial attention to the right. This asymmetry may be so pronounced that it leads to a veritable neglect of space on the left side. The evaluation of treatments proposed to dyslexics whether speech or oriented towards the visual anomalies remains fragmentary. The advent of new explanatory theories, notably cerebellar, magnocellular, or proprioceptive, is an incentive for ophthalmologists to enter the world of multimodal cognition given the importance  of the eye‚Äôs visual input.},
address  = {Department of Ophthalmology, University Hospital, Dijon, France Office of Ophthalmology, Beaune, France University of Burgundy, Dijon, INSERM U1093, Cognition, Action et Plasticit√© Sensorimotrice, Dijon, France},
note  = {Clin Ophthalmol. 2013;7:869-81. Epub 2013 May 14 doi:10.2147/OPTH.S41607.}
}

@Article{2010258,
author  = {Anderson, B. and Rizzo, M. and Block, R. and Pearlson, G. and O'Leary, D.},
title  = {Sex Differences in the Effects of Marijuana on Simulated Driving Performance‚Ä†.},
journal  = {Journal of psychoactive drugs},
volume  = {42},
number  = {1},
pages  = {19-30},
year  = {2010},
abstract  = {In the United States, one in six teenagers has driven under the influence of marijuana. Driving under the influence of marijuana and alcohol is equally prevalent, despite the fact that marijuana use is less common than alcohol use. Much of the research examining the effects of marijuana on driving performance was conducted in the 1970s and led to equivocal findings. During that time, few studies included women and driving simulators were rudimentary. Further, the potency of marijuana commonly used recreationally has increased. This study examined sex differences in the acute effects of marijuana on driving performance using a realistic, validated driving simulator. Eighty-five subjects (n = 50 males, 35 females) participated in this between-subjects, double-blind, placebo controlled study. In addition to an uneventful, baseline segment of driving, participants were challenged with collision avoidance and distracted driving scenarios. Under the influence of marijuana, participants decreased their speed and failed to show expected practice effects during a distracted drive. No differences were found during the baseline driving segment or collision avoidance scenarios. No differences attributable to sex were observed. This study enhances  the current literature by identifying distracted driving and the integration of prior experience as particularly problematic under the influence of marijuana.},
address  = {Postdoctoral Fellow Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, CT Professor University of Iowa Carver College of Medicine, Iowa City, IA Professor University of Iowa Carver College of Medicine, Iowa City, IA Director Olin Neuropsychiatry Research Center, Hartford Hospital, Hartford, CT; Professor Yale University, New Haven, CT Professor University of Iowa Carver College of Medicine, Iowa City, IA},
note  = {J Psychoactive Drugs. 2010 Mar;42(1):19-30.}
}

@Article{2017259,
author  = {Mu√±oz, I. and Garatea, J. and Garatea, J. and Mu√±oz, I. and Ala, S. and Cardoso, F. and Paredes, H. and Gelautz, M. and Seitner, F. and Kapeller, C. and Brosch, N. and Frydrychova, Z. and Buresova, I. and Bartosova, K. and Huteckova, S. and Huteckova, S. and Buresov√°, I. and Bartosova, K. and Frydrychova, Z. and Pires, M. and Santos, V. and Almeida, L. and Santos, V. and Neiva, H. and Marques, M. and Travassos, B. and Marinho, D. and Gil, M. and Marques, M. and Neiva, H. and Sousa, A. and Marinho, D. and Sousa, A. and Travassos, B. and Gil, M. and Neiva, H. and Marinho, D. and Marques, M. and Rocha, T. and Reis, A. and Paredes, H. and Barroso, J. and Saffoury, R. and Blank, P. and Sessner, J. and Groh, B. and Martindale, C. and Dorschky, E. and Franke, J. and Eskofier, B. and Barros, G. and Melo, F. and Oliveira, R. and Borges, J. and Reis, A. and Santos, V. and Barroso, J. and Reis, A. and Paulino, D. and Paredes, H. and Filipe, V. and Barroso, J. and Reis, A. and Santos, V. and Paredes, H. and Filipe, V. and Barroso, J. and Ribeiro, J. and Reis, A. and Justino, E. and Santos, V. and Reis, A. and Barroso, J. and Amorim, V. and Filipe, V. and Paulino, D. and Reis, A. and Paredes, H. and Barroso, J.},
title  = {Wellbeing (TISHW): Vila Real, Portugal. 01-03 December 2016.},
journal  = {BMC Sports Science, Medicine and Rehabilitation},
volume  = {9},
number  = {Suppl 1},
pages  = {},
year  = {2017},
abstract  = {},
address  = {GAIA, Association of Electronic and Information Technologies in the Basque Country, Bilbao, Spain GAIA, Association of Electronic and Information Technologies in the Basque Country, Bilbao, Spain GAIA, Association of Electronic and Information Technologies in the Basque Country, Bilbao, Spain GAIA, Association of Electronic and Information Technologies in the Basque Country, Bilbao, Spain 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and Universidade de Tr√°s-os-Montes e Alto  Douro, Vila Real, Portugal 0000 0001 2348 4034grid.5329.dVienna University of Technology, Vienna, Austria emotion3D GmbH, Vienna, Austria 0000 0001 2348 4034grid.5329.dVienna University of Technology, Vienna, Austria 0000 0001 2348 4034grid.5329.dVienna University of Technology, Vienna, Austria 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000 0001 2194 0956grid.10267.32Department of Psychology, Masaryk University, Faculty of Arts, Brno, Czech Republic 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa, Portugal 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa, Portugal NOVA IMS, Lisboa, Portugal NOVA IMS, Lisboa, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University of Beira Interior, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University of Beira Interior, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University of Beira Interior, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences and CIDESD, University of Beira Interior, Covilh√£, Portugal Department of Sport Sciences, University of Beira Interior and Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal Department of Sport Sciences, University of Beira Interior and Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal Department of Sport Sciences, University of Beira Interior and Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal Department of Sport Sciences, University of Beira Interior and Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal Department of Sport Sciences, University of Beira Interior and Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira Interior, Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira Interior, Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira Interior, Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira Interior, Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira Interior, Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal 0000 0001 2220 7094grid.7427.6Department of Sport Sciences, University of Beira Interior, Research Centre in Sports Sciences, Health Sciences and Human Development, Covilh√£, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes and Alto  Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes and Alto  Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes and Alto  Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes and Alto  Douro, Vila Real, Portugal 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany 0000 0001 2107 3311grid.5330.5Institute for Factory Automation and Production Systems, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany 0000 0001 2107 3311grid.5330.5Institute for Factory Automation and Production Systems, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany 0000 0001 2107 3311grid.5330.5Digital Sports Group, Pattern Recognition Lab, Department of Computer Science, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany Fisio L√≥gic Centro de Fisioterapia, Lisboa, Portugal Faculdade de Motricidade Humana, Universidade de Lisboa, Laborat√≥rio de Comportamento Motor, Estrada da Costa, 1499-002 Cruz Quebrada, Portugal Faculdade de Motricidade Humana, Universidade de Lisboa, Laborat√≥rio de Comportamento Motor, Estrada da Costa, 1499-002 Cruz Quebrada, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD),  Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD),  Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD) and Instituto de Engenharia de Sistemas e Computadores, Tecnologia e Ci√™ncia (INESC TEC), Vila Real, Portugal 0000000121821287grid.12341.35Universidade de Tr√°s-os-Montes e Alto Douro (UTAD),  Vila Real, Portugal 0000000121511713grid.10772.33Universidade Nova de Lisboa, NOVA IMS, Lisboa, Portugal 0000000121821287grid.12341.35INESC TEC and Universidade de Tr√°s-os-Montes e Alto  Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and Universidade de Tr√°s-os-Montes e Alto  Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal 0000000121821287grid.12341.35INESC TEC and University of Tr√°s-os-Montes e Alto Douro, Vila Real, Portugal},
note  = {doi:10.1186/s13102-017-0068-y.}
}

@Article{2016260,
author  = {De, M. and Hawkins, R. and Aalbers, T. and Qin, L. and Baars, M. and de, L. and Kessels, R. and Olde, R.},
title  = {Life Using a Self-Motivated eHealth Intervention in Dutch Adults.},
journal  = {Journal of Medical Internet Research},
volume  = {18},
number  = {6},
pages  = {},
year  = {2016},
abstract  = {Background: Our labor force is aging, but aged workers are not yet coached on how to stay cognitively fit for the job. Objective: In this study, we tested whether  a self-motivated, complex eHealth intervention could improve multiple health-related behaviors that are associated with cognitive aging among working Dutch adults. Methods: This quasi-experimental prospective study with a pre-post  design was conducted with employees of Dutch medium to large companies. All employees with Internet access, a good understanding of the Dutch language, and who provided digital informed consent were eligible to participate. In total, 2972 participants (2110/2972, 71.11% females) with a mean (standard deviation, SD) age of 51.8 (SD 12.9) years were recruited; 2305 became active users of the intervention, and 173 completed the 1-year follow-up. This self-motivated eHealth lifestyle intervention stimulates participants to set personally relevant, monthly health behavior change goals using Goal Attainment Scaling and to realize these goals by implementing behavior change techniques grounded in behavior change theory. The primary outcomes were the goal-setting success rate and the change in overall lifestyle score from baseline to the 1-year follow-up; the score was based on physical activity, diet, smoking, alcohol, sleep, and stress scores. The secondary outcomes were the changes in body weight, body mass index,  specific lifestyle characteristics, and website usage. Results: A total of 1212 participants set 2620 behavior change goals; 392 participants assessed 1089 (1089/2288, 47.59%) goals and successfully achieved 422 (422/1089, 38.75%) of these goals. Among the goal-setting participants in follow-up, this led to a +0.81-point improvement (95% CI 0.49-1.13, P<.001) in overall lifestyle (d=0.32)  and weight loss of 0.62 kg (95% CI ‚àí1.16 to ‚àí0.07, P=.03). These participants also showed significant improvement in 8 out of 11 specific lifestyle components. Conclusions: Among an adult Dutch population, this eHealth intervention resulted  in lifestyle changes in behavioral risk factors associated with cognitive decline, and these improvements lasted over the period of 1 year. Given the general aging of our workforce, this eHealth intervention opens new avenues for the widespread use of cost-effective self-motivated prevention programs aimed at  prevention of early-stage cognitive decline and more self-management of their risk factors. Trial Registration: Nederlands Trial Register: NTR4144; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=4144 (Archived by WebCite at http://www.webcitation.org/6cZzwZSg3).},
address  = {Radboud University Medical CenterDepartment of Geriatric MedicineNijmegenNetherlands Radboud University Medical CenterDepartment of Geriatric MedicineNijmegenNetherlands HAN University of Applied SciencesInstitute of Social SciencesNijmegenNetherlands HAN University of Applied SciencesFaculty of Human Resource ManagementNijmegenNetherlands Radboud University NijmegenDonders Institute for Brain, Cognition and BehaviourNijmegenNetherlands Radboud University Medical CenterDepartment of Geriatric MedicineNijmegenNetherlands},
note  = {J Med Internet Res. 2016 Jun 17;18(6):. doi:10.2196/jmir.5269.}
}

@Article{2015261,
author  = {Chae, M. and Rozen, W. and McMenamin, P. and Findlay, M. and Spychal, R. and Hunter-Smith, D.},
title  = {Emerging Applications of Bedside 3D Printing in Plastic Surgery.},
journal  = {Frontiers in Surgery},
volume  = {2},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Modern imaging techniques are an essential component of preoperative planning in  plastic and reconstructive surgery. However, conventional modalities, including three-dimensional (3D) reconstructions, are limited by their representation on 2D workstations. 3D printing, also known as rapid prototyping or additive manufacturing, was once the province of industry to fabricate models from a computer-aided design (CAD) in a layer-by-layer manner. The early adopters in clinical practice have embraced the medical imaging-guided 3D-printed biomodels for their ability to provide tactile feedback and a superior appreciation of visuospatial relationship between anatomical structures. With increasing accessibility, investigators are able to convert standard imaging data into a CAD file using various 3D reconstruction softwares and ultimately fabricate 3D models using 3D printing techniques, such as stereolithography, multijet modeling, selective laser sintering, binder jet technique, and fused deposition modeling. However, many clinicians have questioned whether the cost-to-benefit ratio justifies its ongoing use. The cost and size of 3D printers have rapidly decreased over the past decade in parallel with the expiration of key 3D printing patents. Significant improvements in clinical imaging and user-friendly 3D software have permitted computer-aided 3D modeling of anatomical structures and implants without outsourcing in many cases. These developments offer immense potential for the application of 3D printing at the bedside for a variety of clinical applications. In this review, existing uses of 3D printing in plastic surgery practice spanning the spectrum from templates for facial transplantation  surgery through to the formation of bespoke craniofacial implants to optimize post-operative esthetics are described. Furthermore, we discuss the potential of  3D printing to become an essential office-based tool in plastic surgery to assist in preoperative planning, developing intraoperative guidance tools, teaching patients and surgical trainees, and producing patient-specific prosthetics in everyday surgical practice.},
address  = {3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC, Australia 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC, Australia Department of Anatomy and Developmental Biology, Centre for Human Anatomy Education, School of Biomedical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, VIC, Australia 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC, Australia 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC, Australia 3D PRINT Laboratory, Department of Surgery, Peninsula Health, Frankston, VIC, Australia},
note  = {Front Surg. 2015 Jun 16;2:. doi:10.3389/fsurg.2015.00025.}
}

@Article{2004262,
author  = {Plontke, S. and Zenner, H.},
title  = {Current aspects of hearing loss from occupational and leisure noise.},
journal  = {GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery},
volume  = {3},
number  = {},
pages  = {},
year  = {2004},
abstract  = {Hearing loss from occupational and leisure noise numbers amongst the most frequent causes of an acquired sensorineural hearing loss. Here we present a review of up-to-date findings on the pathophysiology of acoustic injury to the inner ear, with special attention being paid to its molecular-biological and genetic aspects. Epidemiological aspects shall also be dealt with, as shall the roles of lacking recovery from occupational noise due to additional exposure by leisure noise and the combined exposure of noise and chemicals. Based on the epidemiological and pathophysiological findings and against the background of published animal-experimental, pre-clinical and clinical findings, the various approaches for prevention, protection and therapeutic intervention with acoustic  trauma are discussed. Pharmacological strategies involving anti-oxidative, anti-excitotoxic and anti-apoptotic substances as well as non-pharmacological strategies like "sound conditioning" are given attention. Furthermore, systemic and local substance application as well as the therapy of acute acoustic trauma and chronic hearing problems (including modern therapy forms for comorbidities such as tinnitus) shall be delved into.},
address  = {Department of Otorhinolaryngology, Head and Neck Surgery, University of T√ºbingen, Germany T√ºbingen Hearing Research Centre (THRC), Germany},
note  = {GMS Curr Top Otorhinolaryngol Head Neck Surg. 2004 Dec 28;3:.}
}

@Article{2013263,
author  = {Samia, H. and Khan, S. and Lawrence, J. and Delaney, C.},
title  = {Simulation and Its Role in Training.},
journal  = {Clinics in Colon and Rectal Surgery},
volume  = {26},
number  = {1},
pages  = {47-55},
year  = {2013},
abstract  = {Despite its short history, surgical simulation has been successfully introduced into surgical residency programs in an effort to augment training. A wide range of simulator types and levels of complexity have proven an effective teaching method for surgical trainees. They have been used for training in areas such as general surgery, urology, gynecology, and ophthalmology among others. Coincident  with the introduction of simulators is the need for objective evaluation of skills learned on them, which has led to the development and validation of multiple evaluation tools. This article evaluates the drivers for simulation, types of simulators, training, and evaluation of them especially as it pertains to laparoscopic colorectal surgery.},
address  = {Division of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, Ohio Division of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, Ohio Division of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, Ohio Division of Colorectal Surgery, University Hospitals Case Medical Center, Cleveland, Ohio},
note  = {Clin Colon Rectal Surg. 2013 Mar;26(1):47-55. doi:10.1055/s-0033-1333661.}
}

@Article{2016264,
author  = {Yudi, M. and Clark, D. and Tsang, D. and Jelinek, M. and Kalten, K. and Joshi, S. and Phan, K. and Nasis, A. and Amerena, J. and Arunothayaraj, S. and Reid, C. and Farouque, O.},
title  = {syndromes [SMART-REHAB Trial]: a randomized controlled trial protocol.},
journal  = {BMC Cardiovascular Disorders},
volume  = {16},
number  = {1},
pages  = {},
year  = {2016},
abstract  = {Background: There are well-documented treatment gaps in secondary prevention of coronary heart disease and no clear guidelines to assist early physical activity  after acute coronary syndromes (ACS). Smartphone technology may provide an innovative platform to close these gaps. This paper describes the study design of a randomized controlled trial assessing whether a smartphone-based secondary prevention program can facilitate early physical activity and improve cardiovascular health in patients with ACS. Methods: We have developed a multi-faceted, patient-centred smartphone-based secondary prevention program emphasizing early physical activity with a graduated walking program initiated on discharge from ACS admission. The program incorporates; physical activity tracking through the smartphone‚Äôs accelerometer with interactive feedback and goal setting; a dynamic dashboard to review and optimize cardiovascular risk factors; educational messages delivered twice weekly; a photographic food diary;  pharmacotherapy review; and support through a short message service. The primary  endpoint of the trial is change in exercise capacity, as measured by the change in six-minute walk test distance at 8-weeks when compared to baseline. Secondary  endpoints include improvements in cardiovascular risk factor status, psychological well-being and quality of life, medication adherence, uptake of cardiac rehabilitation and re-hospitalizations. Discussion: This randomized controlled trial will use a smartphone-phone based secondary prevention program to emphasize early physical activity post-ACS. It will provide evidence regarding the feasibility and utility of this innovative platform in closing the treatment  gaps in secondary prevention. Trial registration: The trial was retrospectively registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) on April 4, 2016. The registration number is ACTRN12616000426482.},
address  = {Department of Cardiology, Austin Health, Melbourne, Australia Department of Cardiology, Austin Health, Melbourne, Australia Department of Cardiology, Western Health, Melbourne, Australia Department of Medicine, University of Melbourne, Melbourne, Australia Department of Cardiology, Austin Health, Melbourne, Australia Monash Heart, Monash Health, Melbourne, Australia Monash Heart, Monash Health, Melbourne, Australia Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia Department of Cardiology, Barwon Health, Geelong, Australia Department of Cardiology, St Vincent‚Äôs Hospital, Melbourne, Australia School of Public Health, Curtin University, Perth, Western Australia Australia Department of Cardiology, Austin Health, Melbourne, Australia},
note  = {BMC Cardiovasc Disord. 2016 Sep 5;16(1):. doi:10.1186/s12872-016-0356-6.}
}

@Article{2008265,
author  = {Yoo, S. and Lee, J. and O‚ÄôLeary, H. and Panych, L. and Jolesz, F.},
title  = {activation during motor imagery.},
journal  = {International journal of imaging systems and technology},
volume  = {18},
number  = {1},
pages  = {69-78},
year  = {2008},
abstract  = {We report the long-term effect of real-time functional MRI (rtfMRI) training on voluntary regulation of the level of activation from a hand motor area. During the performance of a motor imagery task of a right hand, blood-oxygenation-level-dependent (BOLD) signal originating from a primary motor  area was presented back to the subject in real-time. Demographically matched individuals also received the same procedure without valid feedback information.  Followed by the initial rtfMRI sessions, both groups underwent two-week long, daily-practice of the task. Off-line data analysis revealed that the individuals  in the experimental group were able to increase the level of BOLD signal from the regulatory target to a greater degree compared to the control group. Furthermore, the learned level of activation was maintained after the two-week period, with the recruitment of additional neural circuitries such as the hippocampus and the  limbo-thalamo-cortical pathway. The activation obtained from the control group, in the absence of proper feedback, was indifferent across the training conditions. The level of BOLD activity from the target regulatory region was positively correlated with a self evaluative score within the experimental group, while the majority of control subjects had difficulty adopting a strategy to attain the desired level of functional regulation. Our results suggest that rtfMRI helped individuals learn how to increase region-specific cortical activity associated with a motor imagery task, and the level of increased activation in motor areas was consolidated after the two-week self-practice period, with the involvement of neural circuitries implicated in motor skill learning.},
address  = {},
note  = {Int J Imaging Syst Technol. 2008 Jun 13;18(1):69-78. doi:10.1002/ima.20139.}
}

@Article{2016266,
author  = {Ko, B. and Lee, H. and Song, W.},
title  = {on gait in chronic hemiplegic stroke patients.},
journal  = {Journal of Physical Therapy Science},
volume  = {28},
number  = {5},
pages  = {1538-43},
year  = {2016},
abstract  = {[Purpose] The effects of various rhythmic auditory stimulation tempos on stroke gait pattern changes when training patients with a smartphone-based rhythmic auditory stimulation application were investigated. [Subjects and Methods] Fifteen patients with chronic stroke were included. Cadence during comfortable walking was measured (baseline). After the baseline findings were recorded, rhythmic auditory stimulation with five different tempos (i.e., ‚àí10%, ‚àí5%, 0%, +5%, and +10% change from baseline) was randomly applied. Finally, comfortable walking without rhythmic auditory stimulation was initiated to evaluate gait pattern changes. [Results] As the tempo increased, the spatiotemporal gait parameters of the stroke patients changed significantly. Gait speed, cadence, and gait cycle duration showed the greatest improvement in the +10% rhythmic auditory stimulation condition compared to baseline. After gait training with rhythmic auditory stimulation, gait speed, cadence, stride length, gait cycle duration, and step length of the affected and unaffected sides improved significantly compared to baseline. [Conclusion] Significant changes in the gait pattern of stroke patients were noted for various tempos after training with rhythmic auditory stimulation. These findings could be used to customize rehabilitative gait training for patients who experience stroke with hemiplegia.},
address  = {Department of Rehabilitation and Assistive Technology, National Rehabilitation Research Institute, National Rehabilitation Center, Republic of Korea Department of Rehabilitation and Assistive Technology, National Rehabilitation Research Institute, National Rehabilitation Center, Republic of Korea Department of Rehabilitation and Assistive Technology, National Rehabilitation Research Institute, National Rehabilitation Center, Republic of Korea},
note  = {doi:10.1589/jpts.28.1538.}
}

@Article{2012267,
author  = {Beebe, D.},
title  = {A Brief Primer on Sleep for Pediatric and Child Clinical Neuropsychologists.},
journal  = {and adolescence},
volume  = {18},
number  = {4},
pages  = {313-38},
year  = {2012},
abstract  = {Sleep problems are common in the children seen by pediatric and child clinical neuropsychologists, and these problems have the potential to significantly impact the child and his or her family. All are treatable to some degree, and some respond extremely well to existing treatments. This paper provides a brief overview of the impact, nature, screening, and treatment for childhood sleep problems, with a particular emphasis on issues relevant to practicing neuropsychologists.},
address  = {Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, Ohio. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Ohio},
note  = {doi:10.1080/09297049.2011.602014.}
}

@Article{2008268,
author  = {Mercer, J. and Nielsen, S. and Hoffmann, G.},
title  = {infrared thermography.},
journal  = {GMS German Medical Science},
volume  = {6},
number  = {},
pages  = {},
year  = {2008},
abstract  = {Background: Water-filtered infrared-A (wIRA) is a special form of heat radiation  with a high tissue-penetration and with a low thermal burden to the surface of the skin. wIRA is able to improve essential and energetically meaningful factors  of wound healing by thermal and non-thermal effects. Aim of the study: prospective study (primarily planned randomised, controlled, blinded, de facto with one exception only one cohort possible) using wIRA in the treatment of patients with recalcitrant chronic venous stasis ulcers of the lower legs with thermographic follow-up. Methods: 10 patients (5 males, 5 females, median age 62  years) with 11 recalcitrant chronic venous stasis ulcers of the lower legs were treated with water-filtered infrared-A and visible light irradiation (wIRA(+VIS), Hydrosun¬Æ radiator type 501, 10 mm water cuvette, water-filtered spectrum 550‚Äì1400 nm) or visible light irradiation (VIS; only possible in one patient). The uncovered wounds of the patients were irradiated two to five times per week for 30 minutes at a standard distance of 25 cm (approximately 140 mW/cm2 wIRA and approximately 45 mW/cm2 VIS). Treatment continued for a period of up to 2 months  (typically until closure or nearly closure of the ulcer). The main variable of interest was ‚Äúpercent change of ulcer size over time‚Ä? including complete wound closure. Additional variables of interest were thermographic image analysis, patient‚Äôs feeling of pain in the wound, amount of pain medication, assessment of  the effect of the irradiation (by patient and by clinical investigator), assessment of feeling of the wound area (by patient), assessment of wound healing (by clinical investigator) and assessment of the cosmetic state (by patient and by clinical investigator). For these assessments visual analogue scales (VAS) were used. Results: The study showed a complete or nearly complete healing of lower leg ulcers in 7 patients and a clear reduction of ulcer size in another 2 of 10 patients, a clear reduction of pain and pain medication consumption (e.g. from 15 to 0 pain tablets per day), and a normalization of the thermographic image (before the beginning of the therapy typically hyperthermic rim of the ulcer with relative hypothermic ulcer base, up to 4.5¬∞C temperature difference).  In one patient the therapy of an ulcer of one leg was performed with the fully active radiator (wIRA(+VIS)), while the therapy of an ulcer of the other leg was  made with a control group radiator (only VIS without wIRA), showing a clear difference in favour of the wIRA treatment. All mentioned VAS ratings improved remarkably during the period of irradiation treatment, representing an increased  quality of life. Failures of complete or nearly complete wound healing were seen  only in patients with arterial insufficiency, in smokers or in patients who did not have venous compression garment therapy. Discussion and conclusions: wIRA can alleviate pain considerably (with an impressive decrease of the consumption of analgesics) and accelerate wound healing or improve a stagnating wound healing process and diminish an elevated wound exudation and inflammation both in acute and in chronic wounds (in this study shown in chronic venous stasis ulcers of the lower legs) and in problem wounds including infected wounds. In chronic recalcitrant wounds complete healing is achieved, which was not reached before. Other studies have shown that even without a disturbance of wound healing an acute wound healing process can be improved (e.g. reduced pain) by wIRA. wIRA is  a contact-free, easily used and pleasantly felt procedure without consumption of  material with a good penetration effect, which is similar to solar heat radiation on the surface of the earth in moderate climatic zones. Wound healing and infection defence (e.g. granulocyte function including antibacterial oxygen radical formation of the granulocytes) are critically dependent on a sufficient energy supply (and on sufficient oxygen). The good clinical effect of wIRA on wounds and also on problem wounds and wound infections can be explained by the improvement of both the energy supply and the oxygen supply (e.g. for the granulocyte function). wIRA causes as a thermal effect in the tissue an improvement in three decisive factors: tissue oxygen partial pressure, tissue temperature and tissue blood flow. Besides this non-thermal effects of infrared-A by direct stimulation of cells and cellular structures with reactions of the cells have also been described. It is concluded that wIRA can be used to improve  wound healing, to reduce pain, exudation, and inflammation and to increase quality of life.},
address  = {Department of Medical Physiology, Faculty of Medicine, University of Troms√∏, Norway Department of Clinical Physiology, Hiller√∏d Hospital, Hiller√∏d, Denmark Institute of Sports Sciences, Johann Wolfgang Goethe University, Frankfurt/Main,  Germany},
note  = {Ger Med Sci. 2008 Oct 21;6:.}
}

@Article{2016269,
author  = {Banks, S. and Sreenivasan, K. and Weintraub, D. and Baldock, D. and Noback, M. and Pierce, M. and Frasnelli, J. and James, J. and Beall, E. and Zhuang, X. and Cordes, D. and Leger, G.},
title  = {Expertise in the Brain.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Our experiences, even as adults, shape our brains. Regional differences have been found in experts, with the regions associated with their particular skill-set. Functional differences have also been noted in brain activation patterns in some  experts. This study uses multimodal techniques to assess structural and functional patterns that differ between experts and non-experts. Sommeliers are experts in wine and thus in olfaction. We assessed differences in Master Sommeliers‚Äô brains, compared with controls, in structure and also in functional response to olfactory and visual judgment tasks. MRI data were analyzed using voxel-based morphometry as well as automated parcellation to assess structural properties, and group differences between tasks were calculated. Results indicate enhanced volume in the right insula and entorhinal cortex, with the cortical thickness of the entorhinal correlating with experience. There were regional activation differences in a large area involving the right olfactory and memory regions, with heightened activation specifically for sommeliers during an olfactory task. Our results indicate that sommeliers‚Äô brains show specialization  in the expected regions of the olfactory and memory networks, and also in regions important in integration of internal sensory stimuli and external cues. Overall,  these differences suggest that specialized expertise and training might result in enhancements in the brain well into adulthood. This is particularly important given the regions involved, which are the first to be impacted by many neurodegenerative diseases.},
address  = {Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Universit√© du Qu√©bec √† Trois-Rivi√®res, Trois-Rivi√®resQC, Canada Chappellet Vineyard, NapaCA, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA Cleveland Clinic Lou Ruvo Center for Brain Health, Las VegasNV, USA},
note  = {Front Hum Neurosci. 2016 Aug 22;10:. doi:10.3389/fnhum.2016.00414.}
}

@Article{2015270,
author  = {Takeuchi, N. and Izumi, S.},
title  = {perspectives on Hebbian plasticity and homeostatic metaplasticity.},
journal  = {Frontiers in Human Neuroscience},
volume  = {9},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Motor recovery after stroke involves developing new neural connections, acquiring new functions, and compensating for impairments. These processes are related to neural plasticity. Various novel stroke rehabilitation techniques based on basic  science and clinical studies of neural plasticity have been developed to aid motor recovery. Current research aims to determine whether using combinations of  these techniques can synergistically improve motor recovery. When different stroke neurorehabilitation therapies are combined, the timing of each therapeutic program must be considered to enable optimal neural plasticity. Synchronizing stroke rehabilitation with voluntary neural and/or muscle activity can lead to motor recovery by targeting Hebbian plasticity. This reinforces the neural connections between paretic muscles and the residual motor area. Homeostatic metaplasticity, which stabilizes the activity of neurons and neural circuits, can either augment or reduce the synergic effect depending on the timing of combination therapy and types of neurorehabilitation that are used. Moreover, the possibility that the threshold and degree of induced plasticity can be altered after stroke should be noted. This review focuses on the mechanisms underlying combinations of neurorehabilitation approaches and their future clinical applications. We suggest therapeutic approaches for cortical reorganization and maximal functional gain in patients with stroke, based on the processes of Hebbian plasticity and homeostatic metaplasticity. Few of the possible combinations of stroke neurorehabilitation have been tested experimentally; therefore, further studies are required to determine the appropriate combination  for motor recovery.},
address  = {},
note  = {Front Hum Neurosci. 2015 Jun 23;9:. doi:10.3389/fnhum.2015.00349.}
}

@Article{2010271,
author  = {Germain, D.},
title  = {Fabry disease.},
journal  = {Orphanet Journal of Rare Diseases},
volume  = {5},
number  = {},
pages  = {30},
year  = {2010},
abstract  = {Fabry disease (FD) is a progressive, X-linked inherited disorder of glycosphingolipid metabolism due to deficient or absent lysosomal Œ±-galactosidase A activity. FD is pan-ethnic and the reported annual incidence of 1 in 100,000 may underestimate the true prevalence of the disease. Classically affected hemizygous males, with no residual Œ±-galactosidase A activity may display all the characteristic neurological (pain), cutaneous (angiokeratoma), renal (proteinuria, kidney failure), cardiovascular (cardiomyopathy, arrhythmia), cochleo-vestibular and cerebrovascular (transient ischemic attacks, strokes) signs of the disease while heterozygous females have symptoms ranging from very mild to severe. Deficient activity of lysosomal Œ±-galactosidase A results in progressive accumulation of globotriaosylceramide within lysosomes, believed to trigger a cascade of cellular events. Demonstration of marked Œ±-galactosidase A deficiency is the definitive method for the diagnosis of hemizygous males. Enzyme analysis may occasionnally help to detect heterozygotes but is often inconclusive due to random X-chromosomal inactivation so that molecular testing (genotyping) of females is mandatory. In childhood, other possible causes of pain such as rheumatoid arthritis and 'growing pains' must be ruled out. In adulthood, multiple sclerosis is sometimes considered. Prenatal diagnosis, available by determination of enzyme activity or DNA testing in chorionic villi or cultured amniotic cells is, for ethical reasons, only considered in male fetuses. Pre-implantation diagnosis is possible. The existence of atypical variants and the availability of a specific therapy singularly complicate genetic counseling.  A disease-specific therapeutic option - enzyme replacement therapy using recombinant human Œ±-galactosidase A - has been recently introduced and its long term outcome is currently still being investigated. Conventional management consists of pain relief with analgesic drugs, nephroprotection (angiotensin converting enzyme inhibitors and angiotensin receptors blockers) and antiarrhythmic agents, whereas dialysis or renal transplantation are available for patients experiencing end-stage renal failure. With age, progressive damage to vital organ systems develops and at some point, organs may start to fail in functioning. End-stage renal disease and life-threatening cardiovascular or cerebrovascular complications limit life-expectancy of untreated males and females with reductions of 20 and 10 years, respectively, as compared to the general population. While there is increasing evidence that long-term enzyme therapy can halt disease progression, the importance of adjunctive therapies should be emphasized and the possibility of developing an oral therapy drives research forward into active site specific chaperones.},
address  = {University of Versailles - St Quentin en Yvelines (UVSQ), Facult√© de M√©decine Paris - Ile de France Ouest (PIFO), 78035 Versailles, France},
note  = {Orphanet J Rare Dis. 2010 Nov 22;5:30. doi:10.1186/1750-1172-5-30.}
}

@Article{2017272,
author  = {Tippett, D. and Hillis, A.},
title  = {Where are aphasia theory and management ‚Äúheaded‚Ä??},
journal  = {F1000Research},
volume  = {6},
number  = {},
pages  = {},
year  = {2017},
abstract  = {The sequelae of post-stroke aphasia are considerable, necessitating an understanding of the functional neuroanatomy of language, cognitive processes underlying various language tasks, and the mechanisms of recovery after stroke. This knowledge is vital in providing optimal care of individuals with aphasia and counseling to their families and caregivers. The standard of care in the rehabilitation of aphasia dictates that treatment be evidence-based and person-centered. Promising techniques, such as cortical stimulation as an adjunct to behavioral therapy, are just beginning to be explored. These topics are discussed in this review.},
address  = {Department of Neurology, Johns Hopkins University School of Medicine, Phipps 446, 600 N. Wolfe Street, Baltimore, MD, 21287, USA Department of Neurology, Johns Hopkins University School of Medicine, Phipps 446, 600 N. Wolfe Street, Baltimore, MD, 21287, USA},
note  = {F1000Res. 2017 Jul 3;6:. doi:10.12688/f1000research.11122.1.}
}

@Article{2014273,
author  = {Reisinger, K. and Ripat, J.},
title  = {Perceptions.},
journal  = {Qualitative Health Research},
volume  = {24},
number  = {11},
pages  = {1501-17},
year  = {2014},
abstract  = {In this study we explored the factors that affect assistive technology (AT) provision within the Navajo Nation using a qualitative approach to inquiry. Focus groups were held in which AT users discussed their awareness of AT and their need for, use of, and satisfaction with AT devices and services. Twenty-eight individuals who used wheelchairs, orthotics or prosthetics, hearing aids, communication aids, vision aids, and other AT participated in one of seven focus  groups. Seven AT providers discussed the facilitators and barriers that affect AT provision. The findings revealed six themes common to both stakeholder groups and two additional themes for AT users. The central theme for AT users centered on (not) feeling understood; the central theme for AT providers revolved around the  processes, activities, and roles the providers engaged in at times for different  clients. Activities to increase awareness and to promote successful AT provision  and satisfaction with AT devices were proposed.},
address  = {San Francisco State University, San Francisco, California, USA University of Manitoba, Winnipeg, Manitoba, Canada},
note  = {Qual Health Res. 2014 Nov;24(11):1501-17. doi:10.1177/1049732314546755.}
}

@Article{2017274,
author  = {Pinault, D.},
title  = {Using Transcranial Electric Stimulation of the Corticothalamic Pathway.},
journal  = {Brain Sciences},
volume  = {7},
number  = {4},
pages  = {},
year  = {2017},
abstract  = {Schizophrenia patients are waiting for a treatment free of detrimental effects. Psychotic disorders are devastating mental illnesses associated with dysfunctional brain networks. Ongoing brain network gamma frequency (30‚Äì80 Hz) oscillations, naturally implicated in integrative function, are excessively amplified during hallucinations, in at-risk mental states for psychosis and first-episode psychosis. So, gamma oscillations represent a bioelectrical marker  for cerebral network disorders with prognostic and therapeutic potential. They accompany sensorimotor and cognitive deficits already present in prodromal schizophrenia. Abnormally amplified gamma oscillations are reproduced in the corticothalamic systems of healthy humans and rodents after a single systemic administration, at a psychotomimetic dose, of the glutamate N-methyl-d-aspartate  receptor antagonist ketamine. These translational ketamine models of prodromal schizophrenia are thus promising to work out a preventive noninvasive treatment against first-episode psychosis and chronic schizophrenia. In the present essay,  transcranial electric stimulation (TES) is considered an appropriate preventive therapeutic modality because it can influence cognitive performance and neural oscillations. Here, I highlight clinical and experimental findings showing that,  together, the corticothalamic pathway, the thalamus, and the glutamatergic synaptic transmission form an etiopathophysiological backbone for schizophrenia and represent a potential therapeutic target for preventive TES of dysfunctional  brain networks in at-risk mental state patients against psychotic disorders.},
address  = {INSERM U1114, Neuropsychologie Cognitive et Physiopathologie de la Schizophr√©nie, Strasbourg F-67085, France; pinault@unistra.fr; Tel.: +33-(0)3-6885-3245},
note  = {Brain Sci. 2017 Mar 28;7(4):. doi:10.3390/brainsci7040034.}
}

@Article{2016275,
author  = {Farzan, F. and Vernet, M. and Shafi, M. and Rotenberg, A. and Daskalakis, Z. and Pascual-Leone, A.},
title  = {Stimulation Combined with Electroencephalography.},
journal  = {Frontiers in Neural Circuits},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {The concurrent combination of transcranial magnetic stimulation (TMS) with electroencephalography (TMS-EEG) is a powerful technology for characterizing and  modulating brain networks across developmental, behavioral, and disease states. Given the global initiatives in mapping the human brain, recognition of the utility of this technique is growing across neuroscience disciplines. Importantly, TMS-EEG offers translational biomarkers that can be applied in health and disease, across the lifespan, and in humans and animals, bridging the  gap between animal models and human studies. However, to utilize the full potential of TMS-EEG methodology, standardization of TMS-EEG study protocols is needed. In this article, we review the principles of TMS-EEG methodology, factors impacting TMS-EEG outcome measures, and the techniques for preventing and correcting artifacts in TMS-EEG data. To promote the standardization of this technique, we provide comprehensive guides for designing TMS-EEG studies and conducting TMS-EEG experiments. We conclude by reviewing the application of TMS-EEG in basic, cognitive and clinical neurosciences, and evaluate the potential of this emerging technology in brain research.},
address  = {Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, University of TorontoToronto, ON, Canada Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, MA, USA Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, MA, USA Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, MA, USA Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, University of TorontoToronto, ON, Canada Berenson-Allen Center for Non-invasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical SchoolBoston, MA, USA},
note  = {Front Neural Circuits. 2016 Sep 22;10:. doi:10.3389/fncir.2016.00073.}
}

@Article{2016276,
author  = {Henry, L. and Elbin, R. and Collins, M. and Marchetti, G. and Kontos, A.},
title  = {Multi-Modal Clinical Assessment Approach.},
journal  = {Neurosurgery},
volume  = {78},
number  = {2},
pages  = {232-41},
year  = {2016},
abstract  = {Background: Previous research estimates that the majority of athletes with sport-related concussion (SRC) will recover between 7‚Äì10 days following injury. This short, temporal window of recovery is predominately based on symptom resolution and cognitive improvement, and does not accurately reflect recent advances to the clinical assessment model. Objective: To characterize SRC recovery at 1-week post-injury time intervals on symptom, neurocognitive, and vestibular-oculomotor outcomes, and examine gender differences on SRC recovery time. Methods: A prospective, repeated measures design was used to examine the temporal resolution of neurocognitive, symptom, and vestibular-oculomotor impairment in 66 subjects (16.5 ¬± 1.9 years, range 14‚Äì23, 64% male) with SRC. Results: Recovery time across all outcomes was between 21‚Äì28 days post SRC for most athletes. Symptoms demonstrated the greatest improvement in the first 2 weeks, while neurocognitive impairment lingered across various domains up to 28 days post SRC. Vestibular-oculomotor decrements also resolved between one to three weeks post injury. There were no gender differences in neurocognitive recovery. Males were more likely to be asymptomatic by the fourth week and reported less vestibular-oculomotor impairment than females at weeks 1 and 2. Conclusion: When utilizing the recommended ‚Äúcomprehensive‚Ä? approach for concussion assessment, recovery time for SRC is approximately three to four weeks, which is longer than the commonly reported 7‚Äì14 days. Sports medicine clinicians should use a variety of complementing assessment tools to capture the  heterogeneity of SRC.},
address  = {Department of Orthopaedic Surgery/UPMC Sports Medicine Concussion Program- University of Pittsburgh Department of Health, Human Performance and Recreation/Office for Sport Concussion Research- University of Arkansas Department of Orthopaedic Surgery/UPMC Sports Medicine Concussion Program- University of Pittsburgh Department of Physical Therapy, Rangos School of Health Sciences- Duquesne University Department of Orthopaedic Surgery/UPMC Sports Medicine Concussion Program- University of Pittsburgh},
note  = {Neurosurgery. 2016 Feb;78(2):232-41. doi:10.1227/NEU.0000000000001041.}
}

@Article{2016277,
author  = {Mendes, J. and Vieira, M. and Pires, M. and Stevan, S.},
title  = {Sensor Fusion and Smart Sensor in Sports and Biomedical Applications.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {10},
pages  = {},
year  = {2016},
abstract  = {The following work presents an overview of smart sensors and sensor fusion targeted at biomedical applications and sports areas. In this work, the integration of these areas is demonstrated, promoting a reflection about techniques and applications to collect, quantify and qualify some physical variables associated with the human body. These techniques are presented in various biomedical and sports applications, which cover areas related to diagnostics, rehabilitation, physical monitoring, and the development of performance in athletes, among others. Although some applications are described in only one of two fields of study (biomedicine and sports), it is very likely that the same application fits in both, with small peculiarities or adaptations.  To illustrate the contemporaneity of applications, an analysis of specialized papers published in the last six years has been made. In this context, the main characteristic of this review is to present the largest quantity of relevant examples of sensor fusion and smart sensors focusing on their utilization and proposals, without deeply addressing one specific system or technique, to the detriment of the others.},
address  = {Department of Electronic Engineering, Federal University of Technology of Parana  (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.); mpires@alunos.utfpr.edu.br (M.B.P.) Department of Electronic Engineering, Federal University of Technology of Parana  (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.); mpires@alunos.utfpr.edu.br (M.B.P.) Department of Electronic Engineering, Federal University of Technology of Parana  (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.); mpires@alunos.utfpr.edu.br (M.B.P.) Department of Electronic Engineering, Federal University of Technology of Parana  (UTFPR), Ponta Grossa (PR) 84016-210, Brazil; josej@alunos.utfpr.edu.br (J.J.A.M.J.); mariovieira@alunos.utfpr.edu.br (M.E.M.V.); mpires@alunos.utfpr.edu.br (M.B.P.)},
note  = {Sensors (Basel). 2016 Sep 23;16(10):. doi:10.3390/s16101569.}
}

@Article{2016278,
author  = {Wexler, B. and Iseli, M. and Leon, S. and Zaggle, W. and Rush, C. and Goodman, A. and Esat, I. and Bo, E.},
title  = {Skills in Children.},
journal  = {Scientific Reports},
volume  = {6},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Cognitive operations are supported by dynamically reconfiguring neural systems that integrate processing components widely distributed throughout the brain. The inter-neuronal connections that constitute these systems are powerfully shaped by environmental input. We evaluated the ability of computer-presented brain training games done in school to harness this neuroplastic potential and improve  learning in an overall study sample of 583‚Äâsecond-grade children. Doing a 5-minute brain-training game immediately before math or reading curricular content games increased performance on the curricular content games. Doing three  20-minute brain training sessions per week for four months increased gains on school-administered math and reading achievement tests compared to control classes tested at the same times without intervening brain training. These results provide evidence of cognitive priming with immediate effects on learning, and longer-term brain training with far-transfer or generalized effects on academic achievement.},
address  = {Department of Psychiatry Yale University School of Medicine, 34 Park St, New Haven, CT 05619, USA National Center for Research on Evaluation, Standards, and Student Testing, CRESST/UCLA, 300 Charles E. Young Drive North, Los Angeles, CA, 90095USA National Center for Research on Evaluation, Standards, and Student Testing, CRESST/UCLA, 300 Charles E. Young Drive North, Los Angeles, CA, 90095USA C8 Sciences, 5 Science Park, New Haven, CT 06511, 970-371-1795, USA Department of Statistics, Yale University, 24 Hilhouse Ave, New Haven CT, 06511,  USA. New Initiatives, 6 Cedar Lane, Cedarhurst, NY 11516, 917-584-0137, USA. Department of Psychiatry Yale University School of Medicine, 34 Park St, New Haven, CT 05619, USA National Center for Research on Evaluation, Standards, and Student Testing, CRESST/UCLA, 300 Charles E. Young Drive North, Los Angeles, CA, 90095USA},
note  = {Sci Rep. 2016 Sep 12;6:. doi:10.1038/srep32859.}
}

@Article{2013279,
author  = {Goetz, G. and Mandel, Y. and Manivanh, R. and Palanker, D. and ƒåi≈æm√°r, T.},
title  = {Holographic display system for restoration of sight to the blind.},
journal  = {Journal of neural engineering},
volume  = {10},
number  = {5},
pages  = {056021},
year  = {2013},
abstract  = {Objective: We present a holographic near-the-eye display system enabling optical  approaches for sight restoration to the blind, such as photovoltaic retinal prosthesis, optogenetic and other photoactivation techniques. We compare it with  conventional LCD or DLP-based displays in terms of image quality, field of view,  optical efficiency and safety. Approach: We detail the optical configuration of the holographic display system and its characterization using a phase-only spatial light modulator. Main results: We describe approaches to controlling the  zero diffraction order and speckle related issues in holographic display systems  and assess the image quality of such systems. We show that holographic techniques offer significant advantages in terms of peak irradiance and power efficiency, and enable designs that are inherently safer than LCD or DLP-based systems. We demonstrate the performance of our holographic display system in the assessment of cortical response to alternating gratings projected onto the retinas of rats.  Significance: We address the issues associated with the design of high brightness, near-the-eye display systems and propose solutions to the efficiency  and safety challenges with an optical design which could be miniaturized and mounted onto goggles.},
address  = {Hansen Experimental Physics Laboratory, Stanford University, Stanford, CA 94305,  USA Hansen Experimental Physics Laboratory, Stanford University, Stanford, CA 94305,  USA Department of Ophthalmology, Stanford University, Stanford, CA 94305, USA Hansen Experimental Physics Laboratory, Stanford University, Stanford, CA 94305,  USA School of Medicine, University of St Andrews, North Haugh, KY16 9TF, UK},
note  = {doi:10.1088/1741-2560/10/5/056021.}
}

@Article{2002280,
author  = {},
title  = {Poster presentations.},
journal  = {Thorax},
volume  = {57},
number  = {Suppl 3},
pages  = {iii48-94},
year  = {2002},
abstract  = {},
address  = {},
note  = {Thorax. 2002 Dec;57(Suppl 3):iii48-94. doi:10.1136/thorax.57.suppl_3.iii48.}
}

@Article{2012281,
author  = {Pearce, A. and Adair, B. and Miller, K. and Ozanne, E. and Said, C. and Santamaria, N. and Morris, M.},
title  = {Robotics to Enable Older Adults to Remain Living at Home.},
journal  = {Journal of Aging Research},
volume  = {2012},
number  = {},
pages  = {},
year  = {2012},
abstract  = {Given the rapidly ageing population, interest is growing in robots to enable older people to remain living at home. We conducted a systematic review and critical evaluation of the scientific literature, from 1990 to the present, on the use of robots in aged care. The key research questions were as follows: (1) what is the range of robotic devices available to enable older people to remain mobile, independent, and safe? and, (2) what is the evidence demonstrating that robotic devices are effective in enabling independent living in community dwelling older people? Following database searches for relevant literature an initial yield of 161 articles was obtained. Titles and abstracts of articles were then reviewed by 2 independent people to determine suitability for inclusion. Forty-two articles met the criteria for question 1. Of these, 4 articles met the  criteria for question 2. Results showed that robotics is currently available to assist older healthy people and people with disabilities to remain independent and to monitor their safety and social connectedness. Most studies were conducted in laboratories and hospital clinics. Currently limited evidence demonstrates that robots can be used to enable people to remain living at home, although this  is an emerging smart technology that is rapidly evolving.},
address  = {Cognitive and Exercise Neuroscience Unit, School of Psychology, Deakin University, Melbourne, VIC, Australia Department of Physiotherapy, The University of Melbourne, Melbourne, VIC, Australia Department of Physiotherapy, The University of Melbourne, Melbourne, VIC, Australia Department of Social Work, The University of Melbourne, Melbourne, VIC, Australia Department of Physiotherapy, The University of Melbourne, Melbourne, VIC, Australia Department of Nursing, The University of Melbourne and Royal Melbourne Hospital,  Melbourne, VIC, Australia Department of Physiotherapy, The University of Melbourne, Melbourne, VIC, Australia},
note  = {J Aging Res. 2012;2012:. Epub 2012 Dec 4 doi:10.1155/2012/538169.}
}

@Article{2017282,
author  = {Al-Shargie, F. and Tang, T. and Kiguchi, M.},
title  = {canonical correlation analysis: an fNIRS-EEG study.},
journal  = {Biomedical Optics Express},
volume  = {8},
number  = {5},
pages  = {2583-98},
year  = {2017},
abstract  = {This paper presents an investigation about the effects of mental stress on prefrontal cortex (PFC) subregions using simultaneous measurement of functional Near-Infrared Spectroscopy (fNIRS) and Electroencephalography (EEG) signals. The  aim is to explore canonical correlation analysis (CCA) technique to study the relationship among the bi-modality signals in mental stress assessment, and how we could fuse the signals for better accuracy in stress detection. Twenty-five male healthy subjects participated in the study while performing mental arithmetic task under control and stress (under time pressure with negative feedback) conditions. The fusion of brain signals acquired by fNIRS-EEG was performed at feature-level using CCA by maximizing the inter-subject covariance across modalities. The CCA result discovered the associations across the modalities and estimated the components responsible for these associations. The experiment results showed that mental stress experienced by this cohort of subjects is subregion specific and localized to the right ventrolateral PFC subregion. These suggest the right ventrolateral PFC as a suitable candidate region to extract biomarkers as performance indicators of neurofeedback training  in stress coping.},
address  = {Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research, Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar,  Perak, Malaysia Universiti Teknologi PETRONAS, Centre of Intelligent Signal and Imaging Research, Department of Electrical and Electronic Engineering, 32610 Bandar Seri Iskandar,  Perak, Malaysia Hitachi, Ltd., Research & Development Group, 350-0395, Japan},
note  = {Biomed Opt Express. 2017 Apr 19;8(5):2583-98. doi:10.1364/BOE.8.002583.}
}

@Article{2015283,
author  = {Garc√≠a, C. and Quesada-Arencibia, A. and Crist√≥bal, T. and Padr√≥n, G. and P√©rez, R. and Alay√≥n, F.},
title  = {Public Transit by Highway.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {15},
number  = {8},
pages  = {20279-304},
year  = {2015},
abstract  = {The development of public transit systems that are accessible and safe for everyone, including people with special needs, is an objective that is justified  from the civic and economic points of view. Unfortunately, public transit services are conceived for people who do not have reduced physical or cognitive abilities. In this paper, we present an intelligent public transit system by highway with the goal of facilitating access and improving the safety of public transit for persons with special needs. The system is deployed using components that are commonly available in transport infrastructure, e.g., sensors, mobile communications systems, and positioning systems. In addition, the system can operate in non-urban transport contexts, e.g., isolated rural areas, where the availability of basic infrastructure, such as electricity and communications infrastructures, is not always guaranteed. To construct the system, the principles and techniques of Ubiquitous Computing and Ambient Intelligence have been employed. To illustrate the utility of the system, two cases of services rendered by the system are described: the first case involves a surveillance system to guarantee accessibility at bus stops; the second case involves a route  assistant for blind people.},
address  = {},
note  = {Sensors (Basel). 2015 Aug 18;15(8):20279-304. doi:10.3390/s150820279.}
}

@Article{2015284,
author  = {McCoy, S. and Jirikowic, T. and Price, R. and Ciol, M. and Hsu, L. and Dellon, B. and Kartin, D.},
title  = {Disorders: Feasibility Study.},
journal  = {Physical Therapy},
volume  = {95},
number  = {11},
pages  = {1569-81},
year  = {2015},
abstract  = {Background: Diminished sensory adaptation has been associated with poor balance control for children with fetal alcohol spectrum disorders (FASD). A virtual reality system, Sensorimotor Training to Affect Balance, Engagement and Learning  (STABEL), was developed to train sensory control for balance. Objectives: The purpose of this study was to examine the STABEL system in children with FASD and  children with typical development (TD) to (1) determine the feasibility of the STABEL system and (2) explore the immediate effects of the STABEL system on sensory attention and postural control. Design: This is a technical report with observational study data. Methods: Eleven children with FASD and 11 children with TD, aged 8 to 16 years, completed 30 minutes of STABEL training. The children answered questions about their experience using STABEL. Sensory attention and postural control were measured pre- and post-STABEL training with the Multimodal  Balance Entrainment Response system and compared using repeated-measures analysis of variance. Results: All children engaged in game play and tolerated controlled  sensory input during the STABEL protocol. Immediate effects post-STABEL training  in both groups were increased postural sway velocity and some changes in entrainment gain. Children with FASD showed higher entrainment gain to vestibular stimuli. There were no significant changes in sensory attention fractions. Limitations: The small sample size, dose of STABEL training, and exploratory statistical analyses are study limitations, but findings warrant larger systematic study to examine therapeutic effects. Conclusions: Children completed  the training protocol, demonstrating the feasibility of the STABEL system. Differences in postural sway velocity post-STABEL training may have been affected by fatigue, warranting further investigation. Limited immediate effects suggest more practice is needed to affect sensory attention; however, entrainment gain changes suggest the STABEL system provoked vestibular responses during balance practice.},
address  = {S.W. McCoy, PT, PhD, FAPTA, Department of Rehabilitation Medicine, University of  Washington, Box 356490, Seattle, WA 98195 (USA). T. Jirikowic, PhD, OTR/L, FAOTA, Department of Rehabilitation Medicine, University of Washington. R. Price, MSME, Department of Rehabilitation Medicine, University of Washington. M.A. Ciol, PhD, Department of Rehabilitation Medicine, University of Washington. L-Y. Hsu, PT, PhD, Department of Rehabilitation Medicine, University of Washington. B. Dellon, PhD, MSME, Boston Dynamics, Waltham, Massachusetts. D. Kartin, PT, PhD, Department of Rehabilitation Medicine, University of Washington.},
note  = {Phys Ther. 2015 Nov;95(11):1569-81. Epub 2015 Jun 25 doi:10.2522/ptj.20150124.}
}

@Article{2017285,
author  = {Xiao, M. and Xu, D. and Craig, M. and Pelkey, K. and Chien, C. and Shi, Y. and Zhang, J. and Resnick, S. and Pletnikova, O. and Salmon, D. and Brewer, J. and Edland, S. and Wegiel, J. and Tycko, B. and Savonenko, A. and Reeves, R. and Troncoso, J. and McBain, C. and Galasko, D. and Worley, P.},
title  = {NPTX2 and cognitive dysfunction in Alzheimer‚Äôs Disease.},
journal  = {eLife},
volume  = {6},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Memory loss in Alzheimer‚Äôs disease (AD) is attributed to pervasive weakening and  loss of synapses. Here, we present findings supporting a special role for excitatory synapses connecting pyramidal neurons of the hippocampus and cortex with fast-spiking parvalbumin (PV) interneurons that control network excitability and rhythmicity. Excitatory synapses on PV interneurons are dependent on the AMPA receptor subunit GluA4, which is regulated by presynaptic expression of the synaptogenic immediate early gene NPTX2 by pyramidal neurons. In a mouse model of AD amyloidosis, Nptx2-/- results in reduced GluA4 expression, disrupted rhythmicity, and increased pyramidal neuron excitability. Postmortem human AD cortex shows profound reductions of NPTX2 and coordinate reductions of GluA4. NPTX2 in human CSF is reduced in subjects with AD and shows robust correlations with cognitive performance and hippocampal volume. These findings implicate failure of adaptive control of pyramidal neuron-PV circuits as a pathophysiological mechanism contributing to cognitive failure in AD.DOI:http://dx.doi.org/10.7554/eLife.23798.001},
address  = {Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of  Medicine, Baltimore, United States Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of  Medicine, Baltimore, United States Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute  of Child Health and Human Development, Bethesda, United States Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute  of Child Health and Human Development, Bethesda, United States Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of  Medicine, Baltimore, United States Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of  Medicine, Baltimore, United States Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of  Medicine, Baltimore, United States Laboratory of Behavioral Neuroscience, National Institute on Aging, Intramural Research Program, Baltimore, United States Department of Pathology, Johns Hopkins University School of Medicine, Baltimore,  United States Department of Neurosciences, University of California San Diego Medical Center, San Diego, United States Department of Neurosciences, University of California San Diego Medical Center, San Diego, United States Shiley-Marcos Alzheimer's Disease Research Center, University of California San Diego Medical Center, San Diego, United States Institute for Basic Research, New York City, United States Taub Institute for Research on Alzheimer‚Äôs disease and the Aging Brain, Columbia  University, New York City, United States Department of Pathology, Johns Hopkins University School of Medicine, Baltimore,  United States Department of Physiology, Johns Hopkins University School of Medicine, Baltimore, United States Department of Pathology, Johns Hopkins University School of Medicine, Baltimore,  United States Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute  of Child Health and Human Development, Bethesda, United States Department of Neurosciences, University of California San Diego Medical Center, San Diego, United States Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of  Medicine, Baltimore, United States},
note  = {eLife. 2017;6:. doi:10.7554/eLife.23798.}
}

@Article{2014286,
author  = {Song, J. and Young, B. and Nigogosyan, Z. and Walton, L. and Nair, V. and Grogan, S. and Tyler, M. and Farrar-Edwards, D. and Caldera, K. and Sattin, J. and Williams, J. and Prabhakaran, V.},
title  = {rehabilitation utilizing brain-computer interface technology.},
journal  = {Frontiers in Neuroengineering},
volume  = {7},
number  = {},
pages  = {},
year  = {2014},
abstract  = {The relationship of the structural integrity of white matter tracts and cortical  activity to motor functional outcomes in stroke patients is of particular interest in understanding mechanisms of brain structural and functional changes while recovering from stroke. This study aims to probe these underlying mechanisms using diffusion tensor imaging (DTI) and fMRI measures. We examined the structural integrity of the posterior limb of the internal capsule (PLIC) using DTI and corticomotor activity using motor-task fMRI in stroke patients who  completed up to 15 sessions of rehabilitation therapy using Brain-Computer Interface (BCI) technology. We hypothesized that (1) the structural integrity of  PLIC and corticomotor activity are affected by stroke; (2) changes in structural  integrity and corticomotor activity following BCI intervention are related to motor recovery; (3) there is a potential relationship between structural integrity and corticomotor activity. We found that (1) the ipsilesional PLIC showed significantly decreased fractional anisotropy (FA) values when compared to the contralesional PLIC; (2) lower ipsilesional PLIC-FA values were significantly associated with worse motor outcomes (i.e., ipsilesional PLIC-FA and motor outcomes were positively correlated.); (3) lower ipsilesional PLIC-FA values were significantly associated with greater ipsilesional corticomotor activity during impaired-finger-tapping-task fMRI (i.e., ipsilesional PLIC-FA and ipsilesional corticomotor activity were negatively correlated), with an overall bilateral pattern of corticomotor activity observed; and (4) baseline FA values predicted motor recovery assessed after BCI intervention. These findings suggest that (1) greater vs. lesser microstructural integrity of the ipsilesional PLIC may contribute toward better vs. poor motor recovery respectively in the stroke-affected limb and demand lesser vs. greater cortical activity respectively from the ipsilesional motor cortex; and that (2) PLIC-FA is a promising biomarker in tracking and predicting motor functional recovery in stroke patients receiving BCI intervention.},
address  = {Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA Department of Biomedical Engineering, University of Wisconsin - MadisonMadison, WI, USA Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA Department of Biomedical Engineering, University of Wisconsin - MadisonMadison, WI, USA Department of Kinesiology, University of Wisconsin - MadisonMadison, WI, USA Departments of Orthopedics and Rehabilitation, University of Wisconsin - MadisonMadison, WI, USA Department of Neurology, University of Wisconsin - MadisonMadison, WI, USA Department of Biomedical Engineering, University of Wisconsin - MadisonMadison, WI, USA Department of Radiology, University of Wisconsin - MadisonMadison, WI, USA},
note  = {Front Neuroeng. 2014 Jul 29;7:. doi:10.3389/fneng.2014.00031.}
}

@Article{2017287,
author  = {Finn, S. and Shafie, F. and Cleary, E. and Patton, A. and Wu, H. and Xie, A. and Stubblefield, J. and Mass, W. and Grinstein, G. and Koch-Weser, S. and Brugge, D. and Wong, C.},
title  = {Making Air Pollution Visible: A Tool for Promoting Environmental Health Literacy.},
journal  = {JMIR Public Health and Surveillance},
volume  = {3},
number  = {2},
pages  = {},
year  = {2017},
abstract  = {Background: Digital maps are instrumental in conveying information about environmental hazards geographically. For laypersons, computer-based maps can serve as tools to promote environmental health literacy about invisible traffic-related air pollution and ultrafine particles. Concentrations of these pollutants are higher near major roadways and increasingly linked to adverse health effects. Interactive computer maps provide visualizations that can allow users to build mental models of the spatial distribution of ultrafine particles in a community and learn about the risk of exposure in a geographic context. Objective: The objective of this work was to develop a new software tool appropriate for educating members of the Boston Chinatown community (Boston, MA,  USA) about the nature and potential health risks of traffic-related air pollution. The tool, the Interactive Map of Chinatown Traffic Pollution (‚ÄúAir Pollution Map‚Ä? hereafter), is a prototype that can be adapted for the purpose of  educating community members across a range of socioeconomic contexts. Methods: We built the educational visualization tool on the open source Weave software platform. We designed the tool as the centerpiece of a multimodal and intergenerational educational intervention about the health risk of traffic-related air pollution. We used a previously published fine resolution (20 m) hourly land-use regression model of ultrafine particles as the algorithm for predicting pollution levels and applied it to one neighborhood, Boston Chinatown. In designing the map, we consulted community experts to help customize the user interface to communication styles prevalent in the target community. Results: The product is a map that displays ultrafine particulate concentrations averaged across census blocks using a color gradation from white to dark red. The interactive features allow users to explore and learn how changing meteorological conditions and traffic volume influence ultrafine particle concentrations. Users  can also select from multiple map layers, such as a street map or satellite view. The map legends and labels are available in both Chinese and English, and are thus accessible to immigrants and residents with proficiency in either language.  The map can be either Web or desktop based. Conclusions: The Air Pollution Map incorporates relevant language and landmarks to make complex scientific information about ultrafine particles accessible to members of the Boston Chinatown community. In future work, we will test the map in an educational intervention that features intergenerational colearning and the use of supplementary multimedia presentations.},
address  = {Center for Integration of Science and IndustryBentley UniversityWaltham, MAUnited States Environmental and Occupational Health Sciences InstituteRutgers UniversityPiscataway, NJUnited States Department of Public Policy and Public AffairsUniversity of Massachusetts BostonBoston, MAUnited States Institute for Asian American StudiesUniversity of Massachusetts BostonBoston, MAUnited States Computer Science DepartmentUniversity of Massachusetts LowellLowell, MAUnited States Computer Science DepartmentUniversity of Massachusetts LowellLowell, MAUnited States Computer Science DepartmentUniversity of Massachusetts LowellLowell, MAUnited States Department of Public Health and Community MedicineTufts University School of MedicineBoston, MAUnited States Department of Public Health and Community MedicineTufts University School of MedicineBoston, MAUnited States Institute for Asian American StudiesUniversity of Massachusetts BostonBoston, MAUnited States},
note  = {JMIR Public Health Surveill. 2017 Apr 12;3(2):. doi:10.2196/publichealth.7492.}
}

@Article{2008288,
author  = {},
title  = {Abstracts.},
journal  = {Association},
volume  = {10},
number  = {Suppl 1},
pages  = {7-228},
year  = {2008},
abstract  = {},
address  = {},
note  = {HPB (Oxford). 2008;10(Suppl 1):7-228. doi:10.1080/13651820701867935.}
}

@Article{2015289,
author  = {Woods, A. and Velasco, C. and Levitan, C. and Wan, X. and Spence, C.},
title  = {Conducting perception research over the internet: a tutorial review.},
journal  = {PeerJ},
volume  = {3},
number  = {},
pages  = {},
year  = {2015},
abstract  = {This article provides an overview of the recent literature on the use of internet-based testing to address important questions in perception research. Our goal is to provide a starting point for the perception researcher who is keen on  assessing this tool for their own research goals. Internet-based testing has several advantages over in-lab research, including the ability to reach a relatively broad set of participants and to quickly and inexpensively collect large amounts of empirical data, via services such as Amazon‚Äôs Mechanical Turk or Prolific Academic. In many cases, the quality of online data appears to match that collected in lab research. Generally-speaking, online participants tend to be more representative of the population at large than those recruited for lab based research. There are, though, some important caveats, when it comes to collecting data online. It is obviously much more difficult to control the exact  parameters of stimulus presentation (such as display characteristics) with online research. There are also some thorny ethical elements that need to be considered  by experimenters. Strengths and weaknesses of the online approach, relative to others, are highlighted, and recommendations made for those researchers who might be thinking about conducting their own studies using this increasingly-popular approach to research in the psychological sciences.},
address  = {Crossmodal Research Laboratory, Department of Experimental Psychology, University of Oxford, United Kingdom Crossmodal Research Laboratory, Department of Experimental Psychology, University of Oxford, United Kingdom Department of Cognitive Science, Occidental College, Los Angeles, USA Tsinghua University, Beijing, China Crossmodal Research Laboratory, Department of Experimental Psychology, University of Oxford, United Kingdom},
note  = {PeerJ. 2015 Jul 23;3:. doi:10.7717/peerj.1058.}
}

@Article{2017290,
author  = {Moulton, S. and T√ºrkay, S. and Kosslyn, S.},
title  = {presentations.},
journal  = {PLoS ONE},
volume  = {12},
number  = {7},
pages  = {},
year  = {2017},
abstract  = {Despite the prevalence of PowerPoint in professional and educational presentations, surprisingly little is known about how effective such presentations are. All else being equal, are PowerPoint presentations better than purely oral presentations or those that use alternative software tools? To address this question we recreated a real-world business scenario in which individuals presented to a corporate board. Participants (playing the role of the presenter) were randomly assigned to create PowerPoint, Prezi, or oral presentations, and then actually delivered the presentation live to other participants (playing the role of corporate executives). Across two experiments and on a variety of dimensions, participants evaluated PowerPoint presentations comparably to oral presentations, but evaluated Prezi presentations more favorably than both PowerPoint and oral presentations. There was some evidence that participants who viewed different types of presentations came to different conclusions about the business scenario, but no evidence that they remembered or  comprehended the scenario differently. We conclude that the observed effects of presentation format are not merely the result of novelty, bias, experimenter-, or software-specific characteristics, but instead reveal a communication preference  for using the panning-and-zooming animations that characterize Prezi presentations.},
address  = {Department of Psychology, Harvard University, Cambridge, Massachusetts, United States of America Harvard Initiative for Learning and Teaching, Harvard University, Cambridge, Massachusetts, United States of America Minerva Schools at the Keck Graduate Institute, San Francisco, California, United States of America},
note  = {PLoS One. 2017 Jul 5;12(7):. doi:10.1371/journal.pone.0178774.}
}

@Article{2013291,
author  = {Risacher, S. and Saykin, A.},
title  = {Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia.},
journal  = {Seminars in neurology},
volume  = {33},
number  = {4},
pages  = {386-416},
year  = {2013},
abstract  = {Neurodegenerative disorders leading to dementia are common diseases that affect many older and some young adults. Neuroimaging methods are important tools for assessing and monitoring pathological brain changes associated with progressive neurodegenerative conditions. In this review, the authors describe key findings from neuroimaging studies (magnetic resonance imaging and radionucleotide imaging) in neurodegenerative disorders, including Alzheimer‚Äôs disease (AD) and prodromal stages, familial and atypical AD syndromes, frontotemporal dementia, amyotrophic lateral sclerosis with and without dementia, Parkinson‚Äôs disease with and without dementia, dementia with Lewy bodies, Huntington‚Äôs disease, multiple sclerosis, HIV-associated neurocognitive disorder, and prion protein associated diseases (i.e., Creutzfeldt-Jakob disease). The authors focus on neuroimaging findings of in vivo pathology in these disorders, as well as the potential for neuroimaging to provide useful information for differential diagnosis of neurodegenerative disorders.},
address  = {Center for Neuroimaging, Department of Radiology and Imaging Sciences, and Indiana Alzheimer Disease Center Indiana University School of Medicine, Indianapolis, Indiana Center for Neuroimaging, Department of Radiology and Imaging Sciences, and Indiana Alzheimer Disease Center Indiana University School of Medicine, Indianapolis, Indiana},
note  = {doi:10.1055/s-0033-1359312.}
}

@Article{2015292,
author  = {Casilari, E. and Luque, R. and Mor√≥n, M.},
title  = {Analysis of Android Device-Based Solutions for Fall Detection.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {15},
number  = {8},
pages  = {17827-94},
year  = {2015},
abstract  = {Falls are a major cause of health and psychological problems as well as hospitalization costs among older adults. Thus, the investigation on automatic Fall Detection Systems (FDSs) has received special attention from the research community during the last decade. In this area, the widespread popularity, decreasing price, computing capabilities, built-in sensors and multiplicity of wireless interfaces of Android-based devices (especially smartphones) have fostered the adoption of this technology to deploy wearable and inexpensive architectures for fall detection. This paper presents a critical and thorough analysis of those existing fall detection systems that are based on Android devices. The review systematically classifies and compares the proposals of the literature taking into account different criteria such as the system architecture, the employed sensors, the detection algorithm or the response in case of a fall alarms. The study emphasizes the analysis of the evaluation methods that are employed to assess the effectiveness of the detection process. The review reveals the complete lack of a reference framework to validate and compare the proposals. In addition, the study also shows that most research works do not evaluate the actual applicability of the Android devices (with limited battery and computing resources) to fall detection solutions.},
address  = {},
note  = {Sensors (Basel). 2015 Jul 23;15(8):17827-94. doi:10.3390/s150817827.}
}

@Article{2015293,
author  = {Zheng, Z. and Zhu, X. and Yin, S. and Wang, B. and Niu, Y. and Huang, X. and Li, R. and Li, J.},
title  = {Intrinsic Functional Brain Architecture in Older Adults.},
journal  = {Neural Plasticity},
volume  = {2015},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Mounting evidence suggests that enriched mental, physical, and socially stimulating activities are beneficial for counteracting age-related decreases in  brain function and cognition in older adults. Here, we used functional magnetic resonance imaging (fMRI) to demonstrate the functional plasticity of brain activity in response to a combined cognitive-psychological-physical intervention  and investigated the contribution of the intervention-related brain changes to individual performance in healthy older adults. The intervention was composed of  a 6-week program of combined activities including cognitive training, Tai Chi exercise, and group counseling. The results showed improved cognitive performance and reorganized regional homogeneity of spontaneous fluctuations in the blood oxygen level-dependent (BOLD) signals in the superior and middle temporal gyri, and the posterior lobe of the cerebellum, in the participants who attended the intervention. Intriguingly, the intervention-induced changes in the coherence of  local spontaneous activity correlated with the improvements in individual cognitive performance. Taken together with our previous findings of enhanced resting-state functional connectivity between the medial prefrontal cortex and medial temporal lobe regions following a combined intervention program in older adults, we conclude that the functional plasticity of the aging brain is a rather complex process, and an effective cognitive-psychological-physical intervention is helpful for maintaining a healthy brain and comprehensive cognition during old age.},
address  = {Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China Center on Aging Psychology, Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences, Beijing 100101, China},
note  = {Neural Plast. 2015;2015:. Epub 2015 Feb 24 doi:10.1155/2015/713104.}
}

@Article{2015294,
author  = {Ritter, P. and Born, J. and Brecht, M. and Dinse, H. and Heinemann, U. and Pleger, B. and Schmitz, D. and Schreiber, S. and Villringer, A. and Kempter, R.},
title  = {State-dependencies of learning across brain scales.},
journal  = {Frontiers in Computational Neuroscience},
volume  = {9},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Learning is a complex brain function operating on different time scales, from milliseconds to years, which induces enduring changes in brain dynamics. The brain also undergoes continuous ‚Äúspontaneous‚Ä? shifts in states, which, amongst others, are characterized by rhythmic activity of various frequencies. Besides the most obvious distinct modes of waking and sleep, wake-associated brain states comprise modulations of vigilance and attention. Recent findings show that certain brain states, particularly during sleep, are essential for learning and memory consolidation. Oscillatory activity plays a crucial role on several spatial scales, for example in plasticity at a synaptic level or in communication across brain areas. However, the underlying mechanisms and computational rules linking brain states and rhythms to learning, though relevant for our understanding of brain function and therapeutic approaches in brain disease, have not yet been elucidated. Here we review known mechanisms of how brain states mediate and modulate learning by their characteristic rhythmic signatures. To understand the critical interplay between brain states, brain rhythms, and learning processes, a wide range of experimental and theoretical work in animal models and human subjects from the single synapse to the large-scale cortical level needs to be integrated. By discussing results from experiments and theoretical approaches, we illuminate new avenues for utilizing neuronal learning mechanisms in developing tools and therapies, e.g., for stroke patients and to devise memory enhancement strategies for the elderly.},
address  = {Minerva Research Group BrainModes, Max Planck Institute for Human Cognitive and Brain SciencesLeipzig, Germany Department of Medical Psychology and Behavioral Neurobiology & Center for Integrative Neuroscience (CIN), University of T√ºbingenT√ºbingen, Germany Bernstein Center for Computational Neuroscience, Humboldt-Universit√§t zu BerlinBerlin, Germany Neural Plasticity Lab, Institute for Neuroinformatics, Ruhr-University BochumBochum, Germany Bernstein Center for Computational Neuroscience, Humboldt-Universit√§t zu BerlinBerlin, Germany Clinic for Cognitive Neurology, University Hospital LeipzigLeipzig, Germany Bernstein Center for Computational Neuroscience, Humboldt-Universit√§t zu BerlinBerlin, Germany Bernstein Center for Computational Neuroscience, Humboldt-Universit√§t zu BerlinBerlin, Germany Berlin School of Mind and Brain & Mind and Brain Institute, Humboldt-Universit√§t  zu BerlinBerlin, Germany Bernstein Center for Computational Neuroscience, Humboldt-Universit√§t zu BerlinBerlin, Germany},
note  = {Front Comput Neurosci. 2015 Feb 26;9:. doi:10.3389/fncom.2015.00001.}
}

@Article{2014295,
author  = {G√≥mez-Nieto, R. and Horta-J√∫nior, J. and Castellano, O. and Millian-Morell, L. and Rubio, M. and L√≥pez, D.},
title  = {the acoustic startle reflex.},
journal  = {Frontiers in Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {The acoustic startle reflex (ASR) is a survival mechanism of alarm, which rapidly alerts the organism to a sudden loud auditory stimulus. In rats, the primary ASR  circuit encompasses three serially connected structures: cochlear root neurons (CRNs), neurons in the caudal pontine reticular nucleus (PnC), and motoneurons in the medulla and spinal cord. It is well-established that both CRNs and PnC neurons receive short-latency auditory inputs to mediate the ASR. Here, we investigated the anatomical origin and functional role of these inputs using a multidisciplinary approach that combines morphological, electrophysiological and  behavioral techniques. Anterograde tracer injections into the cochlea suggest that CRNs somata and dendrites receive inputs depending, respectively, on their basal or apical cochlear origin. Confocal colocalization experiments demonstrated that these cochlear inputs are immunopositive for the vesicular glutamate transporter 1 (VGLUT1). Using extracellular recordings in vivo followed by subsequent tracer injections, we investigated the response of PnC neurons after contra-, ipsi-, and bilateral acoustic stimulation and identified the source of their auditory afferents. Our results showed that the binaural firing rate of PnC neurons was higher than the monaural, exhibiting higher spike discharges with contralateral than ipsilateral acoustic stimulations. Our histological analysis confirmed the CRNs as the principal source of short-latency acoustic inputs, and  indicated that other areas of the cochlear nucleus complex are not likely to innervate PnC. Behaviorally, we observed a strong reduction of ASR amplitude in monaural earplugged rats that corresponds with the binaural summation process shown in our electrophysiological findings. Our study contributes to understand better the role of neuronal mechanisms in auditory alerting behaviors and provides strong evidence that the CRNs-PnC pathway mediates fast neurotransmission and binaural summation of the ASR.},
address  = {Neuroscience Institute of Castilla y Le√≥n, University of SalamancaSalamanca, Spain Neuroscience Institute of Castilla y Le√≥n, University of SalamancaSalamanca, Spain Neuroscience Institute of Castilla y Le√≥n, University of SalamancaSalamanca, Spain Neuroscience Institute of Castilla y Le√≥n, University of SalamancaSalamanca, Spain Department of Otolaryngology, University of PittsburghPittsburgh, PA, USA Neuroscience Institute of Castilla y Le√≥n, University of SalamancaSalamanca, Spain},
note  = {Front Neurosci. 2014 Jul 25;8:. doi:10.3389/fnins.2014.00216.}
}

@Article{2016296,
author  = {Middleton, E. and Latty, T.},
title  = {Resilience in social insect infrastructure systems.},
journal  = {Journal of the Royal Society Interface},
volume  = {13},
number  = {116},
pages  = {},
year  = {2016},
abstract  = {Both human and insect societies depend on complex and highly coordinated infrastructure systems, such as communication networks, supply chains and transportation networks. Like human-designed infrastructure systems, those of social insects are regularly subject to disruptions such as natural disasters, blockages or breaks in the transportation network, fluctuations in supply and/or  demand, outbreaks of disease and loss of individuals. Unlike human-designed systems, there is no deliberate planning or centralized control system; rather, individual insects make simple decisions based on local information. How do these highly decentralized, leaderless systems deal with disruption? What factors make  a social insect system resilient, and which factors lead to its collapse? In this review, we bring together literature on resilience in three key social insect infrastructure systems: transportation networks, supply chains and communication  networks. We describe how systems differentially invest in three pathways to resilience: resistance, redirection or reconstruction. We suggest that investment in particular resistance pathways is related to the severity and frequency of disturbance. In the final section, we lay out a prospectus for future research. Human infrastructure networks are rapidly becoming decentralized and interconnected; indeed, more like social insect infrastructures. Human infrastructure management might therefore learn from social insect researchers, who can in turn make use of the mature analytical and simulation tools developed  for the study of human infrastructure resilience.},
address  = {},
note  = {J R Soc Interface. 2016 Mar;13(116):. doi:10.1098/rsif.2015.1022.}
}

@Article{2016297,
author  = {Otal, B. and Dutta, A. and Foerster, √. and Ripolles, O. and Kuceyeski, A. and Miranda, P. and Edwards, D. and Iliƒá, T. and Nitsche, M. and Ruffini, G.},
title  = {Stimulation in Poststroke Rehabilitation.},
journal  = {Frontiers in Neurology},
volume  = {7},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Stroke is a leading cause of serious long-term disability worldwide. Functional outcome depends on stroke location, severity, and early intervention. Conventional rehabilitation strategies have limited effectiveness, and new treatments still fail to keep pace, in part due to a lack of understanding of the different stages in brain recovery and the vast heterogeneity in the poststroke population. Innovative methodologies for restorative neurorehabilitation are required to reduce long-term disability and socioeconomic burden. Neuroplasticity is involved in poststroke functional disturbances and also during rehabilitation. Tackling poststroke neuroplasticity by non-invasive brain stimulation is regarded as promising, but efficacy might be limited because of rather uniform application across patients despite individual heterogeneity of lesions, symptoms, and other  factors. Transcranial direct current stimulation (tDCS) induces and modulates neuroplasticity, and has been shown to be able to improve motor and cognitive functions. tDCS is suited to improve poststroke rehabilitation outcomes, but effect sizes are often moderate and suffer from variability. Indeed, the location, extent, and pattern of functional network connectivity disruption should be considered when determining the optimal location sites for tDCS therapies. Here, we present potential opportunities for neuroimaging-guided tDCS-based rehabilitation strategies after stroke that could be personalized. We  introduce innovative multimodal intervention protocols based on multichannel tDCS montages, neuroimaging methods, and real-time closed-loop systems to guide therapy. This might help to overcome current treatment limitations in poststroke  rehabilitation and increase our general understanding of adaptive neuroplasticity leading to neural reorganization after stroke.},
address  = {Neuroelectrics Barcelona, Barcelona, Spain INRIA (Sophia Antipolis), Universit√© Montpellier, Montpellier, France University of Medicine G√∂ttingen, G√∂ttingen, Germany Neuroelectrics Barcelona, Barcelona, Spain Department of Radiology, Brain and Mind Research Institute, Weill Cornell Medical College, New York, NY, USA Institute of Biophysics and Biomedical Engineering (IBEB), Faculdade de Ci√™ncias, Universidade de Lisboa, Lisboa, Portugal Non-Invasive Brain Stimulation and Human Motor Control Laboratory, Burke-Cornell  Medical Research Institute, White Plains, NY, USA Department of Clinical Neurophysiology, Medical Faculty of Military Medical Academy, University of Defense, Belgrade, Serbia Leibniz Research Centre for Working Environment and Human Factors, Technical University of Dortmund, Dortmund, Germany Neuroelectrics Barcelona, Barcelona, Spain},
note  = {Front Neurol. 2016 Feb 24;7:. doi:10.3389/fneur.2016.00021.}
}

@Article{2014298,
author  = {Maltais, F. and Decramer, M. and Casaburi, R. and Barreiro, E. and Burelle, Y. and Debigar√©, R. and Dekhuijzen, P. and Franssen, F. and Gayan-Ramirez, G. and Gea, J. and Gosker, H. and Gosselink, R. and Hayot, M. and Hussain, S. and Janssens, W. and Polkey, M. and Roca, J. and Saey, D. and Schols, A. and Spruit, M. and Steiner, M. and Taivassalo, T. and Troosters, T. and Vogiatzis, I. and Wagner, P.},
title  = {Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease.},
journal  = {American Journal of Respiratory and Critical Care Medicine},
volume  = {189},
number  = {9},
pages  = {e15-62},
year  = {2014},
abstract  = {Background: Limb muscle dysfunction is prevalent in chronic obstructive pulmonary disease (COPD) and it has important clinical implications, such as reduced exercise tolerance, quality of life, and even survival. Since the previous American Thoracic Society/European Respiratory Society (ATS/ERS) statement on limb muscle dysfunction, important progress has been made on the characterization of this problem and on our understanding of its pathophysiology and clinical implications.Purpose: The purpose of this document is to update the 1999 ATS/ERS  statement on limb muscle dysfunction in COPD.Methods: An interdisciplinary committee of experts from the ATS and ERS Pulmonary Rehabilitation and Clinical Problems assemblies determined that the scope of this document should be limited  to limb muscles. Committee members conducted focused reviews of the literature on several topics. A librarian also performed a literature search. An ATS methodologist provided advice to the committee, ensuring that the methodological  approach was consistent with ATS standards.Results: We identified important advances in our understanding of the extent and nature of the structural alterations in limb muscles in patients with COPD. Since the last update, landmark studies were published on the mechanisms of development of limb muscle dysfunction in COPD and on the treatment of this condition. We now have a better  understanding of the clinical implications of limb muscle dysfunction. Although exercise training is the most potent intervention to address this condition, other therapies, such as neuromuscular electrical stimulation, are emerging. Assessment of limb muscle function can identify patients who are at increased risk of poor clinical outcomes, such as exercise intolerance and premature mortality.Conclusions: Limb muscle dysfunction is a key systemic consequence of COPD. However, there are still important gaps in our knowledge about the mechanisms of development of this problem. Strategies for early detection and specific treatments for this condition are also needed.},
address  = {},
note  = {doi:10.1164/rccm.201402-0373ST.}
}

@Article{2012299,
author  = {Kharrazi, H. and Lu, A. and Gharghabi, F. and Coleman, W.},
title  = {A Scoping Review of Health Game Research: Past, Present, and Future.},
journal  = {Games For Health Journal},
volume  = {1},
number  = {2},
pages  = {153-64},
year  = {2012},
abstract  = {Health game research has flourished over the last decade. The number of peer-reviewed scientific publications has surged as the clinical application of health games has diversified. In response to this growth, several past literature reviews have assessed the effectiveness of health games in specific clinical subdomains. The past literature reviews, however, have not provided a general scope of health games independent of clinical context. The present systematic review identified 149 publications. All sources were published before 2011 in a peer-reviewed venue. To be included in this review, publications were required (1) to be an original research, (2) to focus on health, (3) to utilize a sound research design, (4) to report quantitative health outcomes, and (5) to target healthcare receivers. Initial findings showed certain trends in health game publications: Focus on younger male demographics, relatively low number of study  participants, increased number of controlled trials, short duration of intervention periods, short duration and frequency of user‚Äìgame interaction, dominance of exercise and rehab games, lack of underlying theoretical frameworks, and concentration on clinical contexts such as physical activity and nutrition. The review concludes that future research should (1) widen the demographics to include females and elderly, (2) increase the number of participants in controlled trials, (3) lengthen both the intervention period and user‚Äìgame interaction duration, and (4) expand the application of health games in new clinical contexts.},
address  = {},
note  = {Games Health J. 2012 Apr;1(2):153-64. doi:10.1089/g4h.2012.0011.}
}

@Article{2017300,
author  = {Yun, S. and Kwok, S.},
title  = {Light in diagnosis, therapy and surgery.},
journal  = {Nature biomedical engineering},
volume  = {1},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Light and optical techniques have made profound impacts on modern medicine, with  numerous lasers and optical devices being currently used in clinical practice to  assess health and treat disease. Recent advances in biomedical optics have enabled increasingly sophisticated technologies ‚Äî in particular those that integrate photonics with nanotechnology, biomaterials and genetic engineering. In this Review, we revisit the fundamentals of light‚Äìmatter interactions, describe the applications of light in imaging, diagnosis, therapy and surgery, overview their clinical use, and discuss the promise of emerging light-based technologies.},
address  = {Wellman Center for Photomedicine, Massachusetts General Hospital, 65 Landsdowne Street, Cambridge, MA 02139, USA Wellman Center for Photomedicine, Massachusetts General Hospital, 65 Landsdowne Street, Cambridge, MA 02139, USA},
note  = {Nat Biomed Eng. 2017;1:. Epub 2017 Jan 10 doi:10.1038/s41551-016-0008.}
}

@Article{2012301,
author  = {Moriyama, T. and Polanczyk, G. and Caye, A. and Banaschewski, T. and Brandeis, D. and Rohde, L.},
title  = {Evidence-Based Information on the Clinical Use of Neurofeedback for ADHD.},
journal  = {Neurotherapeutics},
volume  = {9},
number  = {3},
pages  = {588-98},
year  = {2012},
abstract  = {Neurofeedback (NF) is a training to enhance self-regulatory capacity over brain activity patterns and consequently over brain mental states. Recent findings suggest that NF is a promising alternative for the treatment of attention-deficit/hyperactivity disorder (ADHD). We comprehensively reviewed literature searching for studies on the effectiveness and specificity of NF for the treatment of ADHD. In addition, clinically informative evidence-based data are discussed. We found 3 systematic review on the use of NF for ADHD and 6 randomized controlled trials that have not been included in these reviews. Most nonrandomized controlled trials found positive results with medium-to-large effect sizes, but the evidence for effectiveness are less robust when only randomized controlled studies are considered. The direct comparison of NF and sham-NF in 3 published studies have found no group differences, nevertheless methodological caveats, such as the quality of the training protocol used, sample size, and sample selection may have contributed to the negative results. Further  data on specificity comes from electrophysiological studies reporting that NF effectively changes brain activity patterns. No safety issues have emerged from clinical trials and NF seems to be well tolerated and accepted. Follow-up studies support long-term effects of NF. Currently there is no available data to guide clinicians on the predictors of response to NF and on optimal treatment protocol. In conclusion, NF is a valid option for the treatment for ADHD, but further evidence is required to guide its use.Electronic supplementary material: The online version of this article (doi:10.1007/s13311-012-0136-7) contains supplementary material, which is available to authorized users.},
address  = {National Institute of Developmental Psychiatry for Children and Adolescents, (INCT-CNPq), S√£o Paulo, Brazil National Institute of Developmental Psychiatry for Children and Adolescents, (INCT-CNPq), S√£o Paulo, Brazil Child Psychiatric Division, Hospital de Cl√≠nicas de Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University, Mannheim, Germany National Institute of Developmental Psychiatry for Children and Adolescents, (INCT-CNPq), S√£o Paulo, Brazil},
note  = {doi:10.1007/s13311-012-0136-7.}
}

@Article{2015302,
author  = {Jung, J. and Aloni, D. and Yitzhaky, Y. and Peli, E.},
title  = {Active confocal imaging for visual prostheses.},
journal  = {Vision research},
volume  = {111},
number  = {0 0},
pages  = {182-96},
year  = {2015},
abstract  = {There are encouraging advances in prosthetic vision for the blind, including retinal and cortical implants, and other ‚Äúsensory substitution devices‚Ä? that use  tactile or electrical stimulation. However, they all have low resolution, limited visual field, and can display only few gray levels (limited dynamic range), severely restricting their utility. To overcome these limitations, image processing or the imaging system could emphasize objects of interest and suppress the background clutter. We propose an active confocal imaging system based on light-field technology that will enable a blind user of any visual prosthesis to  efficiently scan, focus on, and ‚Äúsee‚Ä? only an object of interest while suppressing interference from background clutter. The system captures three-dimensional scene information using a light-field sensor and displays only  an in-focused plane with objects in it. After capturing a confocal image, a de-cluttering process removes the clutter based on blur difference. In preliminary experiments we verified the positive impact of confocal-based background clutter removal on recognition of objects in low resolution and limited dynamic range simulated phosphene images. Using a custom-made multiple-camera system, we confirmed that the concept of a confocal de-cluttered  image can be realized effectively using light field imaging.},
address  = {Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA Department of Electro-Optics Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel Department of Electro-Optics Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA},
note  = {doi:10.1016/j.visres.2014.10.023.}
}

@Article{2016303,
author  = {Paggiaro, A. and Birbaumer, N. and Cavinato, M. and Turco, C. and Formaggio, E. and Del, F. and Masiero, S. and Piccione, F.},
title  = {Magnetoencephalography in Stroke Recovery and Rehabilitation.},
journal  = {Frontiers in Neurology},
volume  = {7},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Magnetoencephalography (MEG) is a non-invasive neurophysiological technique used  to study the cerebral cortex. Currently, MEG is mainly used clinically to localize epileptic foci and eloquent brain areas in order to avoid damage during  neurosurgery. MEG might, however, also be of help in monitoring stroke recovery and rehabilitation. This review focuses on experimental use of MEG in neurorehabilitation. MEG has been employed to detect early modifications in neuroplasticity and connectivity, but there is insufficient evidence as to whether these methods are sensitive enough to be used as a clinical diagnostic test. MEG has also been exploited to derive the relationship between brain activity and movement kinematics for a motor-based brain‚Äìcomputer interface. In the current body of experimental research, MEG appears to be a powerful tool in neurorehabilitation, but it is necessary to produce new data to confirm its clinical utility.},
address  = {Laboratory of Neurophysiology and Magnetoencephalography, Department of Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation, Venice, Italy Laboratory of Neurophysiology and Magnetoencephalography, Department of Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation, Venice, Italy Laboratory of Neurophysiology and Magnetoencephalography, Department of Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation, Venice, Italy Laboratory of Neurophysiology and Magnetoencephalography, Department of Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation, Venice, Italy Laboratory of Neurophysiology and Magnetoencephalography, Department of Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation, Venice, Italy Section of Rehabilitation, Department of Neuroscience, University of Padova, Padova, Italy Section of Rehabilitation, Department of Neuroscience, University of Padova, Padova, Italy Laboratory of Neurophysiology and Magnetoencephalography, Department of Neurophysiology, Institute of Care and Research, S.Camillo Hospital Foundation, Venice, Italy},
note  = {Front Neurol. 2016 Mar 31;7:. doi:10.3389/fneur.2016.00035.}
}

@Article{2007304,
author  = {Brabyn, J. and Schneck, M. and Haegerstrom-Portnoy, G. and Lott, L.},
title  = {Dual Sensory Loss: Overview of Problems, Visual Assessment, and Rehabilitation.},
journal  = {Trends in Amplification},
volume  = {11},
number  = {4},
pages  = {219-26},
year  = {2007},
abstract  = {This article provides an overview of some of the problems and possible solutions  surrounding the neglected issue of combined vision and hearing deficits. The subject is treated by considering each subpopulation, ranging from those who have no residual vision or hearing to those with mild coexisting vision and hearing losses. An attempt is made to relate the different types of visual deficit to the likely problems encountered in real-life activities, such as communication and travel, among individuals who also have a hearing impairment. The assessment and  appropriate referral of patients with these combined deficits is discussed, including the interpretation of visual test results and the importance of factors other than standard visual acuity. Speculation is offered on potential strategies and solutions for rehabilitation as well as the need for future research and improvements in service delivery.},
address  = {From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB, MES, GH-P, LAL) and School of Optometry, University of California, Berkeley, California (GH-P). From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB, MES, GH-P, LAL) and School of Optometry, University of California, Berkeley, California (GH-P). From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB, MES, GH-P, LAL) and School of Optometry, University of California, Berkeley, California (GH-P). From The Smith-Kettlewell Eye Research Institute, San Francisco, California (JAB, MES, GH-P, LAL) and School of Optometry, University of California, Berkeley, California (GH-P).},
note  = {Trends Amplif. 2007 Dec;11(4):219-26. doi:10.1177/1084713807307410.}
}

@Article{2013305,
author  = {Verboschi, F. and Domanico, D. and Nebbioso, M. and Corradetti, G. and Scalinci, S. and Vingolo, E.},
title  = {neural dysfunction.},
journal  = {Functional Neurology},
volume  = {28},
number  = {4},
pages  = {285-91},
year  = {2013},
abstract  = {The aim of this study was to evaluate the efficacy of visual rehabilitation with  MP-1 microperimeter biofeedback in advanced optic neural dysfunction due to glaucoma, and to precisely characterize fixation stability and location in affected patients. Ten patients (18 eyes) with advanced glaucoma were submitted to a rehabilitation protocol that consisted of: a 25-item questionnaire (National Eye Institute Visual Functioning Que stionnaire); measurement of visual acuity; a reading speed test; microperimetry with fixation study, retinal sensitivity and the bivariate contour ellipse area (BCEA). The rehabilitation program consisted of 10 training sessions of 10 minutes per eye performed over a period of one week and was repeated at four months, eight months, and one year. Statistical analysis was performed using the Student‚Äôs t-test and Spearman correlation; p values less  than 0.05 were considered statistically significant. In 13 eyes fixation changed  from unstable to relatively unstable while its location changed from predominantly eccentric to predominantly central. In five eyes, fixation changed  from relatively unstable to stable with a change of location from poor central fixation to predominantly central fixation. Mean retinal sensitivity changed from 7.43¬±8.28 dB to 8.33¬±9.04 dB (p<0.05); the mean best corrected visual acuity was  0.98¬±0.66 logMAR at the baseline assessment, and 0.75¬±0.6 logMAR at the end of rehabilitation (p>0.05); reading speed improved from a mean value of 31.4¬±4.3 words/minute to 55.6¬±3.2 words/minute at the end of the training (p<0.05). The BCEA changed from 0.94¬±0.39 deg2 to 0.86¬±0.46 deg2 (p=0.76). Rehabilitation with  MP-1 biofeedback in patients with advanced glaucoma is a useful means of improving these patients‚Äô fixation stability, reading speed and quality of life.},
address  = {Department of Ophthalmology, A. Fiorini Hospital, Terracina (LT), Italy Department of Ophthalmology, S.M. Goretti Hospital, Latina, Italy Sapienza University of Rome, Rome, Italy San Raffaele Scientific Institute Hospital, Milan, Italy Department of Medical and Surgical Sciences, University of Bologna, Italy Department of Ophthalmology, A. Fiorini Hospital, Terracina (LT), Italy},
note  = {Funct Neurol. 2014 Mar 5;28(4):285-91.}
}

@Article{2016306,
author  = {Ciancio, A. and Cordella, F. and Barone, R. and Romeo, R. and Bellingegni, A. and Sacchetti, R. and Davalli, A. and Di, P. and Ranieri, F. and Di, L. and Guglielmelli, E. and Zollo, L.},
title  = {Control of Prosthetic Hands via the Peripheral Nervous System.},
journal  = {Frontiers in Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {This paper intends to provide a critical review of the literature on the technological issues on control and sensorization of hand prostheses interfacing  with the Peripheral Nervous System (i.e., PNS), and their experimental validation on amputees. The study opens with an in-depth analysis of control solutions and sensorization features of research and commercially available prosthetic hands. Pros and cons of adopted technologies, signal processing techniques and motion control solutions are investigated. Special emphasis is then dedicated to the recent studies on the restoration of tactile perception in amputees through neural interfaces. The paper finally proposes a number of suggestions for designing the prosthetic system able to re-establish a bidirectional communication with the PNS and foster the prosthesis natural control.},
address  = {Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering, Universit√† Campus Bio-Medico di RomaRoma, Italy Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering, Universit√† Campus Bio-Medico di RomaRoma, Italy Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering, Universit√† Campus Bio-Medico di RomaRoma, Italy Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering, Universit√† Campus Bio-Medico di RomaRoma, Italy Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering, Universit√† Campus Bio-Medico di RomaRoma, Italy INAIL Centro ProtesiVigorso di Budrio, Italy INAIL Centro ProtesiVigorso di Budrio, Italy Institute of Neurology, Universit√† Campus Bio-Medico di RomaRoma, Italy Institute of Neurology, Universit√† Campus Bio-Medico di RomaRoma, Italy Institute of Neurology, Universit√† Campus Bio-Medico di RomaRoma, Italy Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering, Universit√† Campus Bio-Medico di RomaRoma, Italy Unit of Biomedical Robotics and Biomicrosystems, Department of Engineering, Universit√† Campus Bio-Medico di RomaRoma, Italy},
note  = {Front Neurosci. 2016 Apr 08;10:. doi:10.3389/fnins.2016.00116.}
}

@Article{2012307,
author  = {Adur, J. and Pelegati, V. and de, T. and Baratti, M. and Almeida, D. and Andrade, L. and Bottcher-Luiz, F. and Carvalho, H. and Cesar, C.},
title  = {Nonlinear Optics Microscopies.},
journal  = {PLoS ONE},
volume  = {7},
number  = {10},
pages  = {},
year  = {2012},
abstract  = {Background: Nonlinear optical (NLO) microscopy techniques have potential to improve the early detection of epithelial ovarian cancer. In this study we showed that multimodal NLO microscopies, including two-photon excitation fluorescence (TPEF), second-harmonic generation (SHG), third-harmonic generation (THG) and fluorescence lifetime imaging microscopy (FLIM) can detect morphological and metabolic changes associated with ovarian cancer progression. Methodology/Principal Findings: We obtained strong TPEF + SHG + THG signals from  fixed samples stained with Hematoxylin & Eosin (H&E) and robust FLIM signal from  fixed unstained samples. Particularly, we imaged 34 ovarian biopsies from different patients (median age, 49 years) including 5 normal ovarian tissue, 18 serous tumors and 11 mucinous tumors with the multimodal NLO platform developed in our laboratory. We have been able to distinguish adenomas, borderline, and adenocarcinomas specimens. Using a complete set of scoring methods we found significant differences in the content, distribution and organization of collagen fibrils in the stroma as well as in the morphology and fluorescence lifetime from epithelial ovarian cells. Conclusions/Significance: NLO microscopes provide complementary information about tissue microstructure, showing distinctive patterns for serous and mucinous ovarian tumors. The results provide a basis to interpret future NLO images of ovarian tissue and lay the foundation for future in vivo optical evaluation of premature ovarian lesions.},
address  = {Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of Physics ‚ÄúGleb Wataghin‚Ä?, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of Physics ‚ÄúGleb Wataghin‚Ä?, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of Physics ‚ÄúGleb Wataghin‚Ä?, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil INFABiC - National Institute of Science and Technology on Photonics Applied to Cell Biology, Campinas, S√£o Paulo, Brazil Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of Physics ‚ÄúGleb Wataghin‚Ä?, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil Department of Pathological Anatomy, Faculty of Medical Sciences, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil Department of Obstetrics and Gynecology, Faculty of Medical Sciences, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil Department of Anatomy, Cell Biology, Physiology and Biophysics, Institute of Biology, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil Biophotonic Group, Optics and Photonics Research Center (CEPOF), Institute of Physics ‚ÄúGleb Wataghin‚Ä?, State University of Campinas ‚Äì UNICAMP, Campinas, S√£o Paulo, Brazil},
note  = {PLoS One. 2012 Oct 8;7(10):. doi:10.1371/journal.pone.0047007.}
}

@Article{2014308,
author  = {Hasselmann, H.},
title  = {Ketamine as Antidepressant? Current State and Future Perspectives.},
journal  = {Current Neuropharmacology},
volume  = {12},
number  = {1},
pages  = {57-70},
year  = {2014},
abstract  = {Major depressive disorder (MDD) is a serious mental disorder that ranks among the major causes of disease burden. Standard medical treatment targeting cerebral monoamines often provides only insufficient symptom relief and fails in approximately every fifth patient. The complexity of MDD therefore, reflects more than monoaminergic dysregulation. Initial research argues the case for excessive  glutamate levels, suggesting that antiglutamatergic drugs might be useful in treating MDD. Ketamine is a non-selective, high-affinity N-methyl-D-aspartate receptor (NMDAR) antagonist most commonly used in pediatric and animal surgery. In the past, ketamine has gained popularity because of its ability to rapidly elevate mood, even in treatment-resistant and bipolar depression. However, there  are still many obstacles before widespread clinical approval of ketamine treatment could become reality. In this review, ketamine‚Äôs powerful antidepressant effects are discussed and further research necessary for therapeutic application is outlined. NMDAR antagonists provide an entirely new way of treating the manifold appearances of depression that should not be left unused.},
address  = {},
note  = {doi:10.2174/1570159X113119990043.}
}

@Article{2014309,
author  = {Bittner, A. and Wykstra, S. and Yoshinaga, P. and Li, T.},
title  = {Telerehabilitation for people with low vision.},
journal  = {The Cochrane database of systematic reviews},
volume  = {2014},
number  = {},
pages  = {},
year  = {2014},
abstract  = {This is the protocol for a review and there is no abstract. The objectives are as follows:Our goal is to systematically review the literature on telerehabilitation‚Äôs effectiveness for improving vision-related quality of life and/ or reading speed compared to face-to-face (e.g., in-office or inpatient) low vision rehabilitation services in patients with low vision or visual function loss due to any ocular condition. Secondary objectives are to evaluate compliance with scheduled rehabilitation sessions, VAE device abandonment rates, and/or patient satisfaction ratings in the same studies.},
address  = {Nova Southeastern University, College of Optometry, Ft. Lauderdale, Florida, USA New York, USA Southern California College of Optometry, Marshall B. Ketchum University, Fullerton, California, USA Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA},
note  = {Cochrane Database Syst Rev. 2014 Mar 10;2014:. doi:10.1002/14651858.CD011019.}
}

@Article{2014310,
author  = {Howes, P. and Wongsriruksa, S. and Laughlin, Z. and Witchel, H. and Miodownik, M.},
title  = {The Perception of Materials through Oral Sensation.},
journal  = {PLoS ONE},
volume  = {9},
number  = {8},
pages  = {},
year  = {2014},
abstract  = {This paper presents the results of a multimodal study of oral perception conducted with a set of material samples made from metals, polymers and woods, in which both the somatosensory and taste factors were examined. A multidimensional  scaling analysis coupled with subjective attribute ratings was performed to assess these factors both qualitatively and quantitatively. The perceptual somatosensory factors of warmth, hardness and roughness dominated over the basic  taste factors, and roughness was observed to be a less significant sensation compared to touch-only experiments. The perceptual somatosensory ratings were compared directly with physical property data in order to assess the correlation  between the perceived properties and measured physical properties. In each case,  a strong correlation was observed, suggesting that physical properties may be useful in industrial design for predicting oral perception.},
address  = {Materials Department, Imperial College London, London, United Kingdom Physics Department, King's College London, London, United Kingdom Institute of Making, University College London, London, United Kingdom Brighton and Sussex Medical School, University of Sussex Campus, Brighton, United Kingdom Institute of Making, University College London, London, United Kingdom},
note  = {PLoS One. 2014 Aug 19;9(8):. doi:10.1371/journal.pone.0105035.}
}

@Article{2014311,
author  = {Godlove, J. and O‚ÄôBrien, E. and Batista, A.},
title  = {motor control.},
journal  = {Journal of neural engineering},
volume  = {11},
number  = {4},
pages  = {046025},
year  = {2014},
abstract  = {Objectives: Current brain-computer interfaces (BCIs) rely on visual feedback, requiring sustained visual attention to use the device. Improvements to BCIs may  stem from the development of an effective way to provide quick feedback independent of vision. Tactile stimuli, either delivered on the skin surface, or  directly to the brain via microstimulation in somatosensory cortex, could serve that purpose. We examined the effectiveness of vibrotactile stimuli and microstimulation as a means of non-visual feedback by using a fundamental element of feedback: the ability to react to a stimulus while already in motion. Approach: Human and monkey subjects performed a center-out reach task which was,  on occasion, interrupted with a stimulus cue that instructed a change in reach target. Main results: Subjects generally responded faster to tactile cues than to visual cues. However, when we delivered cues via microstimuation in a monkey, its average response was slower than that for both tactile and visual cues. Significance: Tactile and microstimulation feedback can be used to rapidly adjust movements mid-flight. The relatively slow speed of microstimulation raises some interesting questions and warrants further investigation. Overall, these results  highlight the importance of considering temporal aspects of feedback when designing alternative forms of feedback for brain-computer interfaces.},
address  = {},
note  = {doi:10.1088/1741-2560/11/4/046025.}
}

@Article{2016312,
author  = {Lin, M. and Lin, K.},
title  = {Hemodynamic Activations and Gait Kinematics.},
journal  = {Frontiers in Behavioral Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Increasing evidence suggests that walking while performing a concurrent task negatively influences gait performance. However, it remains unclear how higher-level cognitive processes and coordination of limb movements are altered in challenging walking environments. This study investigated the influence of cognitive task complexity and walking road condition on the neutral  correlates of executive function and postural control in dual-task walking.Methods: Twenty-four healthy young adults completed a series of overground walks with three walking road conditions (wide, narrow, with obstacles) with and without the concurrent n-back working memory tasks of two complexity levels (1-back and 3-back). Prefrontal brain activation was assessed by functional near-infrared spectroscopy. A three-dimensional motion analysis system was used simultaneously to measure gait performance and lower-extremity kinematics. Repeated measures analysis of variance were performed to examine the  differences between the conditions.Results: In comparison with standing still, participants showed lower n-back task accuracy while walking, with the worst performance from the road with obstacles. Spatiotemporal gait parameters, lower-extremity joint movements, and the relative changes in oxygenated hemoglobin (HbO) concentration levels were all significantly different across the task complexity and walking path conditions. While dual-tasking participants were found to flex their hips and knees less, leading to a slower gait speed, longer stride time, shorter step length, and greater gait variability than during normal walking. For narrow-road walking, smaller ankle dorsiflexion and larger hip flexion were observed, along with a reduced gait speed. Obstacle negotiation was  mainly characterized by increased gait variability than other conditions. HbO levels appeared to be lower during dual-task walking than normal walking. Compared to wide and obstacle conditions, walking on the narrow road was found to elicit a smaller decrement in HbO levels.Conclusion: The current study provided direct evidence that, in young adults, neural correlates of executive function and dynamic postural control tend to be altered in response to the cognitive load imposed by the walking environment and the concurrent task during ambulation. A shift of brain activation patterns between functionally connected networks may occur when facing challenging cognitive‚Äìmotor interaction.},
address  = {},
note  = {Front Behav Neurosci. 2016 May 18;10:. doi:10.3389/fnbeh.2016.00092.}
}

@Article{2007313,
author  = {Amirabdollahian, F. and Loureiro, R. and Gradwell, E. and Collin, C. and Harwin, W. and Johnson, G.},
title  = {effectiveness of GENTLE/S robot-mediated stroke therapy.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {4},
number  = {},
pages  = {4},
year  = {2007},
abstract  = {Background: Robot-mediated therapies offer entirely new approaches to neurorehabilitation. In this paper we present the results obtained from trialling the GENTLE/S neurorehabilitation system assessed using the upper limb section of  the Fugl-Meyer (FM) outcome measure. Methods: We demonstrate the design of our clinical trial and its results analysed using a novel statistical approach based  on a multivariate analytical model. This paper provides the rational for using multivariate models in robot-mediated clinical trials and draws conclusions from  the clinical data gathered during the GENTLE/S study. Results: The FM outcome measures recorded during the baseline (8 sessions), robot-mediated therapy (9 sessions) and sling-suspension (9 sessions) was analysed using a multiple regression model. The results indicate positive but modest recovery trends favouring both interventions used in GENTLE/S clinical trial. The modest recovery shown occurred at a time late after stroke when changes are not clinically anticipated. Conclusion: This study has applied a new method for analysing clinical data obtained from rehabilitation robotics studies. While the data obtained during the clinical trial is of multivariate nature, having multipoint and progressive nature, the multiple regression model used showed great potential for drawing conclusions from this study.An important conclusion to draw from this paper is that this study has shown that the intervention and control phase both caused changes over a period of 9 sessions in comparison to the baseline. This might indicate that use of new challenging and motivational therapies can influence the outcome of therapies at a point when clinical changes are not expected.Further work is required to investigate the effects arising from early intervention, longer exposure and intensity of the therapies. Finally, more function-oriented robot-mediated therapies or sling-suspension therapies are needed to clarify the effects resulting from each intervention for stroke recovery.},
address  = {Think Lab, The University of Salford, Maxwell Building, Salford, M5 4WT, UK Department of Cybernetics, University of Reading, Reading, RG6 6AY, UK Community Therapy Team Florence Desmond Day Hospital, Royal Surrey County Hospital, Guildford, Surrey, GU2 7XX, UK Department of Neurorehabilitation, South Block Annexe, Royal Berkshire Hospital,  London Road, Reading, RG1 5AN, UK Department of Cybernetics, University of Reading, Reading, RG6 6AY, UK Centre for Rehabilitation and Engineering Studies, School of Mechanical and Systems Engineering, University of Newcastle upon Tyne, Newcastle, NE1 7RU, UK},
note  = {J Neuroengineering Rehabil. 2007 Feb 19;4:4. doi:10.1186/1743-0003-4-4.}
}

@Article{2007314,
author  = {Ward, T. and Soraghan, C. and Matthews, F. and Markham, C.},
title  = {through Motor Cortex Activity Feedback Using a Neural Prosthesis.},
journal  = {Computational Intelligence and Neuroscience},
volume  = {2007},
number  = {},
pages  = {},
year  = {2007},
abstract  = {This paper describes a concept for the extension of constraint-induced movement therapy (CIMT) through the use of feedback of primary motor cortex activity. CIMT requires residual movement to act as a source of feedback to the patient, thus preventing its application to those with no perceptible movement. It is proposed  in this paper that it is possible to provide feedback of the motor cortex effort  to the patient by measurement with near infrared spectroscopy (NIRS). Significant changes in such effort may be used to drive rehabilitative robotic actuators, for example. This may provide a possible avenue for extending CIMT to patients hitherto excluded as a result of severity of condition. In support of such a paradigm, this paper details the current status of CIMT and related attempts to extend rehabilitation therapy through the application of technology. An introduction to the relevant haemodynamics is given including a description of the basic technology behind a suitable NIRS system. An illustration of the proposed therapy is described using a simple NIRS system driving a robotic arm during simple upper-limb unilateral isometric contraction exercises with healthy  subjects.},
address  = {Department of Electronic Engineering, National University of Ireland, Maynooth, County Kildare, Ireland Department of Computer Science and Department of Experimental Physics, National University of Ireland, Maynooth, County Kildare, Ireland Hamilton Institute, National University of Ireland, Maynooth, County Kildare, Ireland Department of Computer Science, National University of Ireland, Maynooth, County  Kildare, Ireland},
note  = {Comput Intell Neurosci. 2007;2007:. Epub 2007 Sep 23 doi:10.1155/2007/51363.}
}

@Article{2016315,
author  = {Ross, A. and Rahmani, S. and Prieskorn, D. and Dishman, A. and Miller, J. and Lahann, J. and Altschuler, R.},
title  = {Cochlear Health following In Vivo Infusion3*.},
journal  = {Journal of biomedical materials research. Part A},
volume  = {104},
number  = {6},
pages  = {1510-22},
year  = {2016},
abstract  = {Delivery of pharmaceuticals to the cochleae of patients with auditory dysfunction could potentially have many benefits from enhancing auditory nerve survival to protecting remaining sensory cells and their neuronal connections. Treatment would require platforms to enable drug delivery directly to the cochlea and increase the potential efficacy of intervention. Cochlear implant recipients are  a specific patient subset that could benefit from local drug delivery as more candidates have residual hearing; and since residual hearing directly contributes to post-implantation hearing outcomes, it requires protection from implant insertion-induced trauma. This study assessed the feasibility of utilizing microparticles for drug delivery into cochlear fluids, testing persistence, distribution, biocompatibility, and drug release characteristics. To allow for delivery of multiple therapeutics, particles were composed of two distinct compartments; one containing polylactide-co-glycolide (PLGA), and one composed of acetal-modified dextran and PLGA. Following in vivo infusion, image analysis revealed microparticle persistence in the cochlea for at least 7 days post-infusion, primarily in the first and second turns. The majority of subjects  maintained or had only slight elevation in auditory brainstem response thresholds at 7 days post-infusion compared to pre-infusion baselines. There was only minor  to limited loss of cochlear hair cells and negligible immune response based on CD45+ immunolabling. When Piribedil-loaded microparticles were infused, Piribedil was detectable within the cochlear fluids at 7 days post-infusion. These results  indicate that segmented microparticles are relatively inert, can persist, release their contents, and be functionally and biologically compatible with cochlear function and therefore are promising vehicles for cochlear drug delivery.},
address  = {Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109, USA Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109, USA Kresge Hearing Research Institute, University of Michigan, Ann Arbor 48109, USA Department of Biophysics, University of Michigan, Ann Arbor 48109, USA Kresge Hearing Research Institute, University of Michigan, Ann Arbor 48109, USA Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109, USA Kresge Hearing Research Institute, University of Michigan, Ann Arbor 48109, USA},
note  = {doi:10.1002/jbm.a.35675.}
}

@Article{2012316,
author  = {Iosa, M. and Morone, G. and Fusco, A. and Bragoni, M. and Coiro, P. and Multari, M. and Venturiero, V. and De, A. and Pratesi, L. and Paolucci, S.},
title  = {Seven Capital Devices for the Future of Stroke Rehabilitation.},
journal  = {Stroke Research and Treatment},
volume  = {2012},
number  = {},
pages  = {},
year  = {2012},
abstract  = {Stroke is the leading cause of long-term disability for adults in industrialized  societies. Rehabilitation's efforts are tended to avoid long-term impairments, but, actually, the rehabilitative outcomes are still poor. Novel tools based on new technologies have been developed to improve the motor recovery. In this paper, we have taken into account seven promising technologies that can improve rehabilitation of patients with stroke in the early future: (1) robotic devices for lower and upper limb recovery, (2) brain computer interfaces, (3) noninvasive brain stimulators, (4) neuroprostheses, (5) wearable devices for quantitative human movement analysis, (6) virtual reality, and (7) tablet-pc used for neurorehabilitation.},
address  = {Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Operative Unit F, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy Clinical Laboratory of Experimental Neurorehabilitation, Santa Lucia Foundation I.R.C.C.S., Via Ardeatina 306, 00179 Rome, Italy},
note  = {Stroke Res Treat. 2012;2012:. Epub 2012 Dec 13 doi:10.1155/2012/187965.}
}

@Article{2001317,
author  = {Humayun, M.},
title  = {Intraocular retinal prosthesis.},
journal  = {Transactions of the American Ophthalmological Society},
volume  = {99},
number  = {},
pages  = {271-300},
year  = {2001},
abstract  = {PURPOSE: An electronic implant that can bypass the damaged photoreceptors and electrically stimulate the remaining retinal neurons to restore useful vision has been proposed. A number of key questions remain to make this approach feasible. The goal of this thesis is to address the following 2 specific null hypotheses: (1) Stimulus parameters make no difference in the electrically elicited retinal responses. (2) Just as we have millions of photoreceptors, so it will take a device that can generate millions of pixels/light points to create useful vision. METHODS: For electrophysiologic experiments, 2 different setups were used. In the first setup, charge-balanced pulses were delivered to the retinal surface via electrodes inserted through an open sky approach in normal or blind retinal degenerate (rd) mice. In the second setup, the rabbit retina was removed under red light conditions from an enucleated eye and then maintained in a chamber while being superfused with oxygenated, heated Ames media. In both setups, stimulating electrodes and recording electrodes were positioned on the retinal surface to evaluate the effect of varying stimulation parameters on the orthodromic retinal responses (i.e., recording electrode placed between stimulating electrodes and optic nerve head). For psychophysical experiments, visual images were divided into pixels of light that could be projected in a pattern on the retina in up to 8 sighted volunteers. Subjects were asked to perform various tasks ranging from reading and face recognition to various activities of daily living. RESULTS: Electrophysiologic experiments: In a normal  mouse, a single cycle of a 1-kHz sine wave was significantly more efficient than  a 1-kHz square wave (P < .05), but no such difference was noted in either of the  8- or 16-week-old rd mouse groups (8-week-old, P = .426; 16-week-old, P = .078).  Charge threshold was significantly higher in 16-week-old rd mouse versus both 8-week-old rd and normal mouse for every stimulus duration (P < .05). In all groups, short duration pulses (40, 80, and 120 microseconds) were more efficient  in terms of total charge (the product of pulse amplitude and pulse duration) than longer (500 and 1,000 microseconds) pulses (P < .05). In all groups, applying a pulse train did not lead to more efficient charge usage (P < .05). Psychophysical experiments: In high-contrast tests, facial recognition rates of over 75% were achieved for all subjects with dot sizes of up to 31.5 minutes of arc when using  a 25 x 25 grid with 4.5 arc minute gaps, a 30% dropout rate, and 6 gray levels. Even with a 4 x 4 array of pixels, some subjects were able to accurately describe 2 of the objects. Subjects who were able to read the 4-pixel letter height sentences (on the 6 x 10 and 16 x 16 array) seemed to have a good scanning technique. Scanning at the proper velocity tends to bring out more contrast in the lettering. The reading speed for the 72-point font is a bit slower than for the next smaller font. This may be due to the limited number of letters (3) visible in the window with this large font. CONCLUSIONS: Specific parameters needed to stimulate the retina were identified. Delineating the optimum parameters will decrease the current requirements. Psychophysical tests show that with limited pixels and image processing, useful vision is possible. Both these findings should greatly simplify the engineering of an electronic retinal prosthesis.},
address  = {},
note  = {Trans Am Ophthalmol Soc. 2001;99:271-300.}
}

@Article{2006318,
author  = {PACHER, P. and B√?TKAI, S. and KUNOS, G.},
title  = {The Endocannabinoid System as an Emerging Target of Pharmacotherapy.},
journal  = {Pharmacological reviews},
volume  = {58},
number  = {3},
pages  = {389-462},
year  = {2006},
abstract  = {The recent identification of cannabinoid receptors and their endogenous lipid ligands has triggered an exponential growth of studies exploring the endocannabinoid system and its regulatory functions in health and disease. Such studies have been greatly facilitated by the introduction of selective cannabinoid receptor antagonists and inhibitors of endocannabinoid metabolism and transport, as well as mice deficient in cannabinoid receptors or the endocannabinoid-degrading enzyme fatty acid amidohydrolase. In the past decade, the endocannabinoid system has been implicated in a growing number of physiological functions, both in the central and peripheral nervous systems and in peripheral organs. More importantly, modulating the activity of the endocannabinoid system turned out to hold therapeutic promise in a wide range of  disparate diseases and pathological conditions, ranging from mood and anxiety disorders, movement disorders such as Parkinson‚Äôs and Huntington‚Äôs disease, neuropathic pain, multiple sclerosis and spinal cord injury, to cancer, atherosclerosis, myocardial infarction, stroke, hypertension, glaucoma, obesity/metabolic syndrome, and osteoporosis, to name just a few. An impediment to the development of cannabinoid medications has been the socially unacceptable  psychoactive properties of plant-derived or synthetic agonists, mediated by CB1 receptors. However, this problem does not arise when the therapeutic aim is achieved by treatment with a CB1 receptor antagonist, such as in obesity, and may also be absent when the action of endocannabinoids is enhanced indirectly through blocking their metabolism or transport. The use of selective CB2 receptor agonists, which lack psychoactive properties, could represent another promising avenue for certain conditions. The abuse potential of plant-derived cannabinoids  may also be limited through the use of preparations with controlled composition and the careful selection of dose and route of administration. The growing number of preclinical studies and clinical trials with compounds that modulate the endocannabinoid system will probably result in novel therapeutic approaches in a  number of diseases for which current treatments do not fully address the patients‚Äô need. Here, we provide a comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy.},
address  = {},
note  = {Pharmacol Rev. 2006 Sep;58(3):389-462. doi:10.1124/pr.58.3.2.}
}

@Article{2010319,
author  = {},
title  = {Purines 2010: Adenine Nucleosides and Nucleotides in Biomedicine.},
journal  = {Purinergic Signalling},
volume  = {6},
number  = {Suppl 1},
pages  = {1-162},
year  = {2010},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11302-010-9187-6.}
}

@Article{2015320,
author  = {Murphy, M. and Guggenmos, D. and Bundy, D. and Nudo, R.},
title  = {Preclinical Trials to Use in Human Patients.},
journal  = {Frontiers in Cellular Neuroscience},
volume  = {9},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Current research in brain computer interface (BCI) technology is advancing beyond preclinical studies, with trials beginning in human patients. To date, these trials have been carried out with several different types of recording interfaces. The success of these devices has varied widely, but different factors such as the level of invasiveness, timescale of recorded information, and ability to maintain stable functionality of the device over a long period of time all must be considered in addition to accuracy in decoding intent when assessing the  most practical type of device moving forward. Here, we discuss various approaches to BCIs, distinguishing between devices focusing on control of operations extrinsic to the subject (e.g., prosthetic limbs, computer cursors) and those focusing on control of operations intrinsic to the brain (e.g., using stimulation or external feedback), including closed-loop or adaptive devices. In this discussion, we consider the current challenges facing the translation of various  types of BCI technology to eventual human application.},
address  = {Bioengineering Graduate Program, University of KansasLawrence, KS, USA Department of Rehabilitation Medicine, University of Kansas Medical CenterKansas  City, KS, USA Department of Rehabilitation Medicine, University of Kansas Medical CenterKansas  City, KS, USA Department of Rehabilitation Medicine, University of Kansas Medical CenterKansas  City, KS, USA},
note  = {Front Cell Neurosci. 2016 Jan 06;9:. doi:10.3389/fncel.2015.00497.}
}

@Article{2016321,
author  = {Brocklehurst, P.},
title  = {labour using the cardiotocograph ‚Äì the INFANT study protocol.},
journal  = {BMC Pregnancy and Childbirth},
volume  = {16},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Continuous electronic fetal heart rate monitoring in labour is widely used but its potential for improving fetal and neonatal outcomes has not been realised. The most likely reason is the difficulty of interpreting the fetal heart rate trace correctly during labour. Computerised interpretation of the fetal heart rate and intelligent decision-support has the potential to deliver this improvement in care.This trial will test whether the addition of decision support software to aid the interpretation of the cardiotocogram (CTG) during labour will reduce the number of ‚Äòpoor neonatal outcomes‚Äô in those women judged to require continuous electronic fetal heart rate monitoring. Methods and design: An individually randomised controlled trial of 46,000 women who are judged to require continuous electronic fetal monitoring in labour.Eligibility criteria: Women admitted to a participating labour ward who are judged to require continuous electronic fetal monitoring, have a singleton or twin pregnancy, are‚Äâ‚â•‚Äâ35 weeks‚Äô gestation, have no known gross fetal abnormality and are‚Äâ‚â•‚Äâ16 years of age.Exclusion criteria: Triplets or higher order pregnancy, elective caesarean section prior to the onset of labour, planned admission to NICU.Trial interventions: Computerised interpretation of the CTG with decision-support.Primary outcomes: Short term: A composite of ‚Äòpoor neonatal outcome‚Äô including stillbirth after trial entry, early neonatal death except deaths due to congenital anomalies, significant morbidity: neonatal encephalopathy, admissions to the neonatal unit with 48 h for‚Äâ>‚Äâ48 h with evidence of feeding difficulties, respiratory illness or encephalopathy where there is evidence of compromise at birth. Long term: Developmental assessment at  the age of 2 years in a subset of 7000 surviving babies.Data Collection: For all  participating women and babies, labour variables and outcomes will be stored automatically and contemporaneously onto the Guardian¬Æ system. Discussion: The results of this trial will have importance for pregnant women and for health professionals who provide care for them. Trial registration: Current Controlled Trials ISRCTN98680152 assigned 30.09.2008},
address  = {UCL EGA Institute for Women‚Äôs Health, 74 Huntley Street, WC1E 6 AU London, UK},
note  = {BMC Pregnancy Childbirth. 2016 Jan 20;16:. doi:10.1186/s12884-015-0780-0.}
}

@Article{2017322,
author  = {Mina, F. and Attina, V. and Duroc, Y. and Veuillet, E. and Truy, E. and Thai-Van, H.},
title  = {artifact-response mixture in the perspective of denoising.},
journal  = {PLoS ONE},
volume  = {12},
number  = {3},
pages  = {},
year  = {2017},
abstract  = {Auditory steady state responses (ASSRs) in cochlear implant (CI) patients are contaminated by the spread of a continuous CI electrical stimulation artifact. The aim of this work was to model the electrophysiological mixture of the CI artifact and the corresponding evoked potentials on scalp electrodes in order to  evaluate the performance of denoising algorithms in eliminating the CI artifact in a controlled environment. The basis of the proposed computational framework is a neural mass model representing the nodes of the auditory pathways. Six main contributors to auditory evoked potentials from the cochlear level and up to the  auditory cortex were taken into consideration. The simulated dynamics were then projected into a 3-layer realistic head model. 32-channel scalp recordings of the CI artifact-response were then generated by solving the electromagnetic forward problem. As an application, the framework‚Äôs simulated 32-channel datasets were used to compare the performance of 4 commonly used Independent Component Analysis (ICA) algorithms: infomax, extended infomax, jade and fastICA in eliminating the  CI artifact. As expected, two major components were detectable in the simulated datasets, a low frequency component at the modulation frequency and a pulsatile high frequency component related to the stimulation frequency. The first can be attributed to the phase-locked ASSR and the second to the stimulation artifact. Among the ICA algorithms tested, simulations showed that infomax was the most efficient and reliable in denoising the CI artifact-response mixture. Denoising algorithms can induce undesirable deformation of the signal of interest in real CI patient recordings. The proposed framework is a valuable tool for evaluating these algorithms in a controllable environment ahead of experimental or clinical  applications.},
address  = {Claude Bernard Lyon 1 University, Lyon, France Claude Bernard Lyon 1 University, Lyon, France Claude Bernard Lyon 1 University, Lyon, France Claude Bernard Lyon 1 University, Lyon, France Claude Bernard Lyon 1 University, Lyon, France Claude Bernard Lyon 1 University, Lyon, France},
note  = {PLoS One. 2017 Mar 28;12(3):. doi:10.1371/journal.pone.0174462.}
}

@Article{2009323,
author  = {Kell, D.},
title  = {diseases.},
journal  = {BMC Medical Genomics},
volume  = {2},
number  = {},
pages  = {2},
year  = {2009},
abstract  = {Background: The production of peroxide and superoxide is an inevitable consequence of aerobic metabolism, and while these particular 'reactive oxygen species' (ROSs) can exhibit a number of biological effects, they are not of themselves excessively reactive and thus they are not especially damaging at physiological concentrations. However, their reactions with poorly liganded iron  species can lead to the catalytic production of the very reactive and dangerous hydroxyl radical, which is exceptionally damaging, and a major cause of chronic inflammation. Review: We review the considerable and wide-ranging evidence for the involvement of this combination of (su)peroxide and poorly liganded iron in a large number of physiological and indeed pathological processes and inflammatory  disorders, especially those involving the progressive degradation of cellular and organismal performance. These diseases share a great many similarities and thus might be considered to have a common cause (i.e. iron-catalysed free radical and  especially hydroxyl radical generation).The studies reviewed include those focused on a series of cardiovascular, metabolic and neurological diseases, where iron can be found at the sites of plaques and lesions, as well as studies showing the significance of iron to aging and longevity. The effective chelation of iron  by natural or synthetic ligands is thus of major physiological (and potentially therapeutic) importance. As systems properties, we need to recognise that physiological observables have multiple molecular causes, and studying them in isolation leads to inconsistent patterns of apparent causality when it is the simultaneous combination of multiple factors that is responsible.This explains, for instance, the decidedly mixed effects of antioxidants that have been observed, since in some circumstances (especially the presence of poorly liganded iron) molecules that are nominally antioxidants can actually act as pro-oxidants. The reduction of redox stress thus requires suitable levels of both antioxidants  and effective iron chelators. Some polyphenolic antioxidants may serve both roles.Understanding the exact speciation and liganding of iron in all its states  is thus crucial to separating its various pro- and anti-inflammatory activities.  Redox stress, innate immunity and pro- (and some anti-)inflammatory cytokines are linked in particular via signalling pathways involving NF-kappaB and p38, with the oxidative roles of iron here seemingly involved upstream of the IkappaB kinase (IKK) reaction. In a number of cases it is possible to identify mechanisms by which ROSs and poorly liganded iron act synergistically and autocatalytically, leading to 'runaway' reactions that are hard to control unless one tackles multiple sites of action simultaneously. Some molecules such as statins and erythropoietin, not traditionally associated with anti-inflammatory activity, do  indeed have 'pleiotropic' anti-inflammatory effects that may be of benefit here.  Conclusion: Overall we argue, by synthesising a widely dispersed literature, that the role of poorly liganded iron has been rather underappreciated in the past, and that in combination with peroxide and superoxide its activity underpins the behaviour of a great many physiological processes that degrade over time. Understanding these requires an integrative, systems-level approach that may lead to novel therapeutic targets.},
address  = {School of Chemistry and Manchester Interdisciplinary Biocentre, The University of Manchester, 131 Princess St, Manchester, M1 7DN, UK},
note  = {BMC Med Genomics. 2009 Jan 8;2:2. doi:10.1186/1755-8794-2-2.}
}

@Article{2017324,
author  = {Wiesmann, M. and Zinnhardt, B. and Reinhardt, D. and Eligehausen, S. and Wachsmuth, L. and Hermann, S. and Dederen, P. and Hellwich, M. and Kuhlmann, M. and Broersen, L. and Heerschap, A. and Jacobs, A. and Kiliaan, A.},
title  = {ischemic stroke.},
journal  = {Theranostics},
volume  = {7},
number  = {2},
pages  = {493-512},
year  = {2017},
abstract  = {Occlusion of the middle cerebral artery (MCAo) is among the most common causes of ischemic stroke in humans. Cerebral ischemia leads to brain lesions existing of an irreversibly injured core and an ischemic boundary zone, the penumbra, containing damaged but potentially salvageable tissue. Using a transient occlusion (30 min) of the middle cerebral artery (tMCAo) mouse model in this cross-institutional study we investigated the neurorestorative efficacy of a dietary approach (Fortasyn) comprising docosahexaenoic acid, eicosapentaenoic acid, uridine, choline, phospholipids, folic acid, vitamins B12, B6, C, and E, and selenium as therapeutic approach to counteract neuroinflammation and impairments of cerebral (structural+functional) connectivity, cerebral blood flow (CBF), and motor function. Male adult C57BL/6j mice were subjected to right tMCAo using the intraluminal filament model. Following tMCAo, animals were either maintained on Control diet or switched to the multicomponent Fortasyn diet. At several time points after tMCAo, behavioral tests, and MRI and PET scanning were  conducted to identify the impact of the multicomponent diet on the elicited neuroinflammatory response, loss of cerebral connectivity, and the resulting impairment of motor function after experimental stroke. Mice on the multicomponent diet showed decreased neuroinflammation, improved functional and structural connectivity, beneficial effect on CBF, and also improved motor function after tMCAo. Our present data show that this specific dietary intervention may have beneficial effects on structural and functional recovery and therefore therapeutic potential after ischemic stroke.},
address  = {Department of Anatomy, Radboud university medical center, Donders Institute for Brain, Cognition & Behaviour, Nijmegen, The Netherlands European Institute for Molecular Imaging (EIMI), Westf√§lische Wilhelms University M√ºnster, M√ºnster, Germany European Institute for Molecular Imaging (EIMI), Westf√§lische Wilhelms University M√ºnster, M√ºnster, Germany European Institute for Molecular Imaging (EIMI), Westf√§lische Wilhelms University M√ºnster, M√ºnster, Germany Department of Clinical Radiology of the University Hospital, Westf√§lische Wilhelms University M√ºnster, M√ºnster, Germany European Institute for Molecular Imaging (EIMI), Westf√§lische Wilhelms University M√ºnster, M√ºnster, Germany Department of Anatomy, Radboud university medical center, Donders Institute for Brain, Cognition & Behaviour, Nijmegen, The Netherlands Department of Anatomy, Radboud university medical center, Donders Institute for Brain, Cognition & Behaviour, Nijmegen, The Netherlands European Institute for Molecular Imaging (EIMI), Westf√§lische Wilhelms University M√ºnster, M√ºnster, Germany Advanced Medical Nutrition, Nutricia Research, Utrecht, The Netherlands Department of Radiology & Nuclear Medicine, Radboud university medical center, Nijmegen, The Netherlands European Institute for Molecular Imaging (EIMI), Westf√§lische Wilhelms University M√ºnster, M√ºnster, Germany Department of Anatomy, Radboud university medical center, Donders Institute for Brain, Cognition & Behaviour, Nijmegen, The Netherlands},
note  = {Theranostics. 2017 Jan 6;7(2):493-512. doi:10.7150/thno.17559.}
}

@Article{2017325,
author  = {Ballesta, A. and Innominato, P. and Dallmann, R. and Rand, D. and L√©vi, F.},
title  = {Systems Chronotherapeutics.},
journal  = {Pharmacological Reviews},
volume  = {69},
number  = {2},
pages  = {161-99},
year  = {2017},
abstract  = {Chronotherapeutics aim at treating illnesses according to the endogenous biologic rhythms, which moderate xenobiotic metabolism and cellular drug response. The molecular clocks present in individual cells involve approximately fifteen clock  genes interconnected in regulatory feedback loops. They are coordinated by the suprachiasmatic nuclei, a hypothalamic pacemaker, which also adjusts the circadian rhythms to environmental cycles. As a result, many mechanisms of diseases and drug effects are controlled by the circadian timing system. Thus, the tolerability of nearly 500 medications varies by up to fivefold according to  circadian scheduling, both in experimental models and/or patients. Moreover, treatment itself disrupted, maintained, or improved the circadian timing system as a function of drug timing. Improved patient outcomes on circadian-based treatments (chronotherapy) have been demonstrated in randomized clinical trials,  especially for cancer and inflammatory diseases. However, recent technological advances have highlighted large interpatient differences in circadian functions resulting in significant variability in chronotherapy response. Such findings advocate for the advancement of personalized chronotherapeutics through interdisciplinary systems approaches. Thus, the combination of mathematical, statistical, technological, experimental, and clinical expertise is now shaping the development of dedicated devices and diagnostic and delivery algorithms enabling treatment individualization. In particular, multiscale systems chronopharmacology approaches currently combine mathematical modeling based on cellular and whole-body physiology to preclinical and clinical investigations toward the design of patient-tailored chronotherapies. We review recent systems research works aiming to the individualization of disease treatment, with emphasis on both cancer management and circadian timing system‚Äìresetting strategies for improving chronic disease control and patient outcomes.},
address  = {},
note  = {Pharmacol Rev. 2017 Apr;69(2):161-99. Epub 2017 Apr doi:10.1124/pr.116.013441.}
}

@Article{2005326,
author  = {},
title  = {Practice Guideline for Health-Care Professionals.},
journal  = {The Journal of Spinal Cord Medicine},
volume  = {28},
number  = {5},
pages  = {434-70},
year  = {2005},
abstract  = {},
address  = {},
note  = {J Spinal Cord Med. 2005;28(5):434-70.}
}

@Article{2017327,
author  = {Fountoulakis, K. and Young, A. and Yatham, L. and Grunze, H. and Vieta, E. and Blier, P. and Moeller, H. and Kasper, S.},
title  = {the Development of Guidelines.},
journal  = {International Journal of Neuropsychopharmacology},
volume  = {20},
number  = {2},
pages  = {98-120},
year  = {2017},
abstract  = {Background:: This paper includes a short description of the important clinical aspects of Bipolar Disorder with emphasis on issues that are important for the therapeutic considerations, including mixed and psychotic features, predominant polarity, and rapid cycling as well as comorbidity. Methods:: The workgroup performed a review and critical analysis of the literature concerning grading methods and methods for the development of guidelines. Results:: The workgroup arrived at a consensus to base the development of the guideline on randomized controlled trials and related meta-analyses alone in order to follow a strict evidence-based approach. A critical analysis of the existing methods for the grading of treatment options was followed by the development of a new grading method to arrive at efficacy and recommendation levels after the analysis of 32 distinct scenarios of available data for a given treatment option. Conclusion:: The current paper reports details on the design, method, and process for the development of CINP guidelines for the treatment of Bipolar Disorder. The rationale and the method with which all data and opinions are combined in order to produce an evidence-based operationalized but also user-friendly guideline and a specific algorithm are described in detail in this paper.},
address  = {3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper). 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper). 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper). 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper). 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper). 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper). 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper). 3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece (Dr Fountoulakis); Centre for Affective Disorders, Institute of Psychiatry, Psychology and Neuroscience, King‚Äôs College,  London, UK (Dr Young); Department of Psychiatry, University of British Columbia,  Mood Disorders Centre of Excellence, Djavad Mowafaghian Centre for Brain Health,  Vancouver, Canada (Dr Yatham); Paracelsus Medical University, Salzburg, Austria (Dr Grunze); Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain (Dr Vieta); The Royal Institute of Mental Health Research, Department of Psychiatry, University of Ottawa, Ottawa, Canada (Dr Blier); Psychiatric Department, Ludwig Maximilians University, Munich, Germany (Dr Moeller); Department of Psychiatry and Psychotherapy, Medical University Vienna, MUV, AKH, Vienna, Austria (Dr Kasper).},
note  = {Int J Neuropsychopharmacol. 2016 Nov 04;20(2):98-120. doi:10.1093/ijnp/pyw091.}
}

@Article{2014328,
author  = {Hebb, A. and Zhang, J. and Mahoor, M. and Tsiokos, C. and Matlack, C. and Chizeck, H. and Pouratian, N.},
title  = {Creating the feedback loop: Closed Loop Neurostimulation.},
journal  = {Neurosurgery clinics of North America},
volume  = {25},
number  = {1},
pages  = {187-204},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.1016/j.nec.2013.08.006.}
}

@Article{2006329,
author  = {Koren, D. and Seidman, L. and Goldsmith, M. and Harvey, P.},
title  = {Approach for Measuring (and Remediating) More ‚ÄúRight Stuff‚Ä?.},
journal  = {Schizophrenia Bulletin},
volume  = {32},
number  = {2},
pages  = {310-26},
year  = {2006},
abstract  = {While the role of impaired cognition in accounting for functional outcome in schizophrenia is generally established by now, the overlap is far from complete.  Moreover, little is known about the potential mechanisms that bridge between cognition and functional outcome. The aim of this article is to aid in closing this gap by presenting a novel, more ecologically valid approach for neuropsychological assessment. The new approach is motivated by the view that metacognitive processes of self-monitoring and self-regulation are fundamental determinants of competent functioning in the real world. The new approach incorporates experimental psychological concepts and paradigms used to study metacognition into current standard neuropsychological assessment procedures. Preliminary empirical data that support and demonstrate the utility of the new approach for assessment, as well as remediation efforts, in schizophrenia are presented and discussed.},
address  = {Department of Psychiatry, Harvard Medical School, Boston, MA Department of Psychology, University of Haifa, Haifa, Israel Department of Psychiatry, Mt. Sinai School of Medicine, New York, NY},
note  = {Schizophr Bull. 2006 Apr;32(2):310-26. Epub 2006 Jan 5 doi:10.1093/schbul/sbj035.}
}

@Article{2012330,
author  = {Singh, M. and Chang, K.},
title  = {The Neural Effects of Psychotropic Medications in Children and Adolescents.},
journal  = {Child and adolescent psychiatric clinics of North America},
volume  = {21},
number  = {4},
pages  = {753-71},
year  = {2012},
abstract  = {},
address  = {},
note  = {doi:10.1016/j.chc.2012.07.010.}
}

@Article{2016331,
author  = {Taylor, Z. and Hui, E. and Watson, A. and Nie, X. and Deardorff, R. and Jensen, J. and Helpern, J. and Shih, A.},
title  = {penetrating arterioles in mouse cortex.},
journal  = {Journal of Cerebral Blood Flow & Metabolism},
volume  = {36},
number  = {8},
pages  = {1357-73},
year  = {2016},
abstract  = {Small cerebral infarcts, i.e. microinfarcts, are common in the aging brain and linked to vascular cognitive impairment. However, little is known about the acute growth of these minute lesions and their effect on blood flow in surrounding tissues. We modeled microinfarcts in the mouse cortex by inducing photothrombotic clots in single penetrating arterioles. The resultant hemodynamic changes in tissues surrounding the occluded vessel were then studied using in vivo two-photon microscopy. We were able to generate a spectrum of infarct volumes by  occluding arterioles that carried a range of blood fluxes. Those resulting from occlusion of high-flux penetrating arterioles (flux of 2 nL/s or higher) exhibited a radial outgrowth that encompassed unusually large tissue volumes. The gradual expansion of these infarcts was propagated by an evolving insufficiency in capillary flow that encroached on territories of neighboring penetrating arterioles, leading to the stagnation and recruitment of their perfusion domains  into the final infarct volume. Our results suggest that local collapse of microvascular function contributes to tissue damage incurred by single penetrating arteriole occlusions in mice, and that a similar mechanism may add to pathophysiology induced by microinfarcts of the human brain.},
address  = {Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA Department of Diagnostic Radiology, The University of Hong Kong, Hong Kong Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA Department of Neurosciences, Medical University of South Carolina, Charleston, SC, USA},
note  = {doi:10.1177/0271678X15608388.}
}

@Article{2014332,
author  = {Horschig, J. and Zumer, J. and Bahramisharif, A.},
title  = {oscillations.},
journal  = {Frontiers in Systems Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Cortical oscillations have been shown to represent fundamental functions of a working brain, e.g., communication, stimulus binding, error monitoring, and inhibition, and are directly linked to behavior. Recent studies intervening with  these oscillations have demonstrated effective modulation of both the oscillations and behavior. In this review, we collect evidence in favor of how hypothesis-driven methods can be used to augment cognition by optimizing cortical oscillations. We elaborate their potential usefulness for three target groups: healthy elderly, patients with attention deficit/hyperactivity disorder, and healthy young adults. We discuss the relevance of neuronal oscillations in each group and show how each of them can benefit from the manipulation of functionally-related oscillations. Further, we describe methods for manipulation  of neuronal oscillations including direct brain stimulation as well as indirect task alterations. We also discuss practical considerations about the proposed techniques. In conclusion, we propose that insights from neuroscience should guide techniques to augment human cognition, which in turn can provide a better understanding of how the human brain works.},
address  = {Radboud University Nijmegen, Donders Institute for Brain, Behaviour and CognitionNijmegen, Netherlands Radboud University Nijmegen, Donders Institute for Brain, Behaviour and CognitionNijmegen, Netherlands Radboud University Nijmegen, Donders Institute for Brain, Behaviour and CognitionNijmegen, Netherlands},
note  = {Front Syst Neurosci. 2014 Jun 26;8:. doi:10.3389/fnsys.2014.00119.}
}

@Article{2013333,
author  = {Takeuchi, N. and Izumi, S.},
title  = {Plasticity.},
journal  = {Stroke Research and Treatment},
volume  = {2013},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Motor recovery after stroke is related to neural plasticity, which involves developing new neuronal interconnections, acquiring new functions, and compensating for impairment. However, neural plasticity is impaired in the stroke-affected hemisphere. Therefore, it is important that motor recovery therapies facilitate neural plasticity to compensate for functional loss. Stroke  rehabilitation programs should include meaningful, repetitive, intensive, and task-specific movement training in an enriched environment to promote neural plasticity and motor recovery. Various novel stroke rehabilitation techniques for motor recovery have been developed based on basic science and clinical studies of neural plasticity. However, the effectiveness of rehabilitative interventions among patients with stroke varies widely because the mechanisms underlying motor  recovery are heterogeneous. Neurophysiological and neuroimaging studies have been developed to evaluate the heterogeneity of mechanisms underlying motor recovery for effective rehabilitation interventions after stroke. Here, we review novel stroke rehabilitation techniques associated with neural plasticity and discuss individualized strategies to identify appropriate therapeutic goals, prevent maladaptive plasticity, and maximize functional gain in patients with stroke.},
address  = {Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan Department of Physical Medicine and Rehabilitation, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan},
note  = {Stroke Res Treat. 2013;2013:. Epub 2013 Apr 30 doi:10.1155/2013/128641.}
}

@Article{2016334,
author  = {Shin, J. and Kim, M. and Lee, J. and Jeon, Y. and Kim, S. and Lee, S. and Seo, B. and Choi, Y.},
title  = {controlled trial.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {13},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Virtual reality (VR)-based rehabilitation has been reported to have beneficial effects on upper extremity function in stroke survivors; however, there is limited information about its effects on distal upper extremity function and health-related quality of life (HRQoL). The purpose of the present study was  to examine the effects of VR-based rehabilitation combined with standard occupational therapy on distal upper extremity function and HRQoL, and compare the findings to those of amount-matched conventional rehabilitation in stroke survivors. Methods: The present study was a single-blinded, randomized controlled trial. The study included 46 stroke survivors who were randomized to a Smart Glove (SG) group or a conventional intervention (CON) group. In both groups, the  interventions were targeted to the distal upper extremity and standard occupational therapy was administered. The primary outcome was the change in the  Fugl‚ÄìMeyer assessment (FM) scores, and the secondary outcomes were the changes in the Jebsen‚ÄìTaylor hand function test (JTT), Purdue pegboard test, and Stroke Impact Scale (SIS) version 3.0 scores. The outcomes were assessed before the intervention, in the middle of the intervention, immediately after the intervention, and 1 month after the intervention. Results: The improvements in the FM (FM-total, FM-prox, and FM-dist), JTT (JTT-total and JTT-gross), and SIS (composite and overall SIS, SIS-social participation, and SIS-mobility) scores were significantly greater in the SG group than in the CON group. Conclusions: VR-based rehabilitation combined with standard occupational therapy might be more effective than amount-matched conventional rehabilitation for improving distal upper extremity function and HRQoL. Trial registration: This study is registered  under the title ‚ÄúEffects of Novel Game Rehabilitation System on Upper Extremity Function of Patients With Stroke‚Ä? and can be located in https://clinicaltrials.gov with the study identifier NCT02029651.},
address  = {National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea National Rehabilitation Center, Ministry of Health and Welfare, Seoul, Korea Department of Law, Hanyang University, Seoul, Korea Neofect, Yong-in, Korea School of Games, Hongik University, Seoul, Korea Neofect, Yong-in, Korea},
note  = {J Neuroeng Rehabil. 2016 Feb 24;13:. doi:10.1186/s12984-016-0125-x.}
}

@Article{2015335,
author  = {McGuire, B. and Fiorillo, B. and Ryugo, D. and Lauer, A.},
title  = {acoustic input in mice with early-onset progressive hearing loss.},
journal  = {Brain research},
volume  = {1605},
number  = {},
pages  = {22-30},
year  = {2015},
abstract  = {Perceptual performance in persons with hearing loss, especially those using devices to restore hearing, is not fully predicted by traditional audiometric measurements designed to evaluate the status of peripheral function. The integrity of auditory brainstem synapses may vary with different forms of hearing loss, and differential effects on the auditory nerve-brain interface may have particularly profound consequences for the transfer of sound from ear to brain. Loss of auditory nerve synapses in ventral cochlear nucleus (VCN) has been reported after acoustic trauma, ablation of the organ of Corti, and administration of ototoxic compounds. The effects of gradually acquired forms deafness on these synapses are less well understood. We investigated VCN gross morphology and auditory nerve synapse integrity in DBA/2J mice with early-onset progressive sensorineural hearing loss. Hearing status was confirmed using auditory brainstem response audiometry and acoustic startle responses. We found no change in VCN volume, number of macroneurons, or number of VGLUT1-positive auditory nerve terminals between young adult and older, deaf DBA/2J. Cell-type specific analysis revealed no difference in the number of VGLUT1 puncta contacting bushy and multipolar cell body profiles, but the terminals were smaller in deaf DBA/2J mice. Transmission electron microscopy confirmed the presence of numerous healthy, vesicle-filled auditory nerve synapses in older, deaf DBA/2J mice. The present results suggest that synapses can be preserved over a relatively long time-course in gradually acquired deafness. Elucidating the mechanisms supporting survival of central auditory nerve synapses in models of acquired deafness may reveal new opportunities for therapeutic intervention.},
address  = {Center for Hearing and Balance and Department of Otolaryngology-HNS, Johns Hopkins University, Baltimore, MD, 21205 USA Center for Hearing and Balance and Department of Otolaryngology-HNS, Johns Hopkins University, Baltimore, MD, 21205 USA Hearing Research Unit, Garvan Institute of Medical Research, Darlinghurst, New South Wales, 2010 Australia Center for Hearing and Balance and Department of Otolaryngology-HNS, Johns Hopkins University, Baltimore, MD, 21205 USA},
note  = {doi:10.1016/j.brainres.2015.02.012.}
}

@Article{2013336,
author  = {Balkenhol, T. and Wallh√§usser-Franke, E. and Delb, W.},
title  = {Associations with Oscillatory Brain Activity.},
journal  = {PLoS ONE},
volume  = {8},
number  = {1},
pages  = {},
year  = {2013},
abstract  = {Background: The phantom auditory perception of subjective tinnitus is associated  with aberrant brain activity as evidenced by magneto- and electroencephalographic studies. We tested the hypotheses (1) that psychoacoustically measured tinnitus loudness is related to gamma oscillatory band power, and (2) that tinnitus loudness and tinnitus-related distress are related to distinct brain activity patterns as suggested by the distinction between loudness and distress experienced by tinnitus patients. Furthermore, we explored (3) how hearing impairment, minimum masking level, and (4) psychological comorbidities are related to spontaneous oscillatory brain activity in tinnitus patients. Methods and Findings: Resting state oscillatory brain activity recorded electroencephalographically from 46 male tinnitus patients showed a positive correlation between gamma band oscillations and psychoacoustic tinnitus loudness  determined with the reconstructed tinnitus sound, but not with the other psychoacoustic loudness measures that were used. Tinnitus-related distress did also correlate with delta band activity, but at electrode positions different from those associated with tinnitus loudness. Furthermore, highly distressed tinnitus patients exhibited a higher level of theta band activity. Moreover, mean hearing loss between 0.125 kHz and 16 kHz was associated with a decrease in gamma activity, whereas minimum masking levels correlated positively with delta band power. In contrast, psychological comorbidities did not express significant correlations with oscillatory brain activity. Conclusion: Different clinically relevant tinnitus characteristics show distinctive associations with spontaneous  brain oscillatory power. Results support hypothesis (1), but exclusively for the  tinnitus loudness derived from matching to the reconstructed tinnitus sound. This suggests to preferably use the reconstructed tinnitus spectrum to determine psychoacoustic tinnitus loudness. Results also support hypothesis (2). Moreover,  hearing loss and minimum masking level correlate with oscillatory power in distinctive frequency bands. The lack of an association between psychological comorbidities and oscillatory power may be attributed to the overall low level of mental health problems in the present sample.},
address  = {Department of Phoniatrics and Audiology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Department of Phoniatrics and Audiology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany Department of Phoniatrics and Audiology, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany},
note  = {PLoS One. 2013 Jan 10;8(1):. doi:10.1371/journal.pone.0053180.}
}

@Article{337,
author  = {Todd, T. and Mehlman, M. and Keene, C. and DeAngeli, N. and Bucci, D.},
title  = {cues.},
journal  = {Learning & Memory},
volume  = {23},
number  = {6},
pages  = {278-88},
year  = {},
abstract  = {The restrosplenial cortex (RSC) has a well-established role in contextual and spatial learning and memory, consistent with its known connectivity with visuo-spatial association areas. In contrast, RSC appears to have little involvement with delay fear conditioning to an auditory cue. However, all previous studies have examined the contribution of the RSC to recently acquired auditory fear memories. Since neocortical regions have been implicated in the permanent storage of remote memories, we examined the contribution of the RSC to  remotely acquired auditory fear memories. In Experiment 1, retrieval of a remotely acquired auditory fear memory was impaired when permanent lesions (either electrolytic or neurotoxic) were made several weeks after initial conditioning. In Experiment 2, using a chemogenetic approach, we observed impairments in the retrieval of remote memory for an auditory cue when the RSC was temporarily inactivated during testing. In Experiment 3, after injection of a retrograde tracer into the RSC, we observed labeled cells in primary and secondary auditory cortices, as well as the claustrum, indicating that the RSC receives direct projections from auditory regions. Overall our results indicate the RSC has a critical role in the retrieval of remotely acquired auditory fear memories, and we suggest this is related to the quality of the memory, with less  precise memories being RSC dependent.},
address  = {Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New Hampshire 03755, USA Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New Hampshire 03755, USA Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New Hampshire 03755, USA Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New Hampshire 03755, USA Department of Psychological and Brain Sciences, Dartmouth College, Hanover, New Hampshire 03755, USA},
note  = {Learn Mem. ;23(6):278-88. doi:10.1101/lm.041822.116.}
}

@Article{2013338,
author  = {Carpenter, C. and Platts-Mills, T.},
title  = {Geriatric Emergencies.},
journal  = {Clinics in geriatric medicine},
volume  = {29},
number  = {1},
pages  = {},
year  = {2013},
abstract  = {Alternative management methods are essential to ensure high quality and efficient emergency care for the growing number of geriatric adults worldwide. Protocols for case-finding and rapid diagnosis to support early condition-specific treatment for older adults with acute severe illness and injury are needed. Improved emergency department care for older adults will require providers to look beyond the diagnosis to address the influence of other factors on the patient's health: isolation and depression; finances and transportation; and chronic medical conditions and polypharmacy. This review article describes recent and ongoing efforts to enhance the quality of emergency care for older adults using alternative management approaches spanning the spectrum from prehospital care, through the emergency department, and into evolving inpatient or outpatient processes of care.},
address  = {},
note  = {Clin Geriatr Med. 2013 Feb;29(1):. doi:10.1016/j.cger.2012.09.003.}
}

@Article{2012339,
author  = {Pitcher, J. and Schneider, L. and Burns, N. and Drysdale, J. and Higgins, R. and Ridding, M. and Nettelbeck, T. and Haslam, R. and Robinson, J.},
title  = {preterm.},
journal  = {The Journal of Physiology},
volume  = {590},
number  = {Pt 22},
pages  = {5827-44},
year  = {2012},
abstract  = {The mechanisms underlying the altered neurodevelopment commonly experienced by children born preterm, but without brain lesions, remain unknown. While individuals born the earliest are at most risk, late preterm children also experience significant motor, cognitive and behavioural dysfunction from school age, and reduced income and educational attainment in adulthood. We used transcranial magnetic stimulation and functional assessments to examine corticomotor development in 151 children without cerebral palsy, aged 10‚Äì13 years and born after gestations of 25‚Äì41 completed weeks. We hypothesized that motor cortex and corticospinal development are altered in preterm children, which underpins at least some of their motor dysfunction. We report for the first time  that every week of reduced gestation is associated with a reduction in corticomotor excitability that remains evident in late childhood. This reduced excitability was associated with poorer motor skill development, particularly manual dexterity. However, child adiposity, sex and socio-economic factors regarding the child's home environment soon after birth were also powerful influences on development of motor skills. Preterm birth was also associated with reduced left hemisphere lateralization, but without increasing the likelihood of  being left handed per se. These corticomotor findings have implications for normal motor development, but also raise questions regarding possible longer term consequences of preterm birth on motor function.},
address  = {Research Centre for Early Origins of Health and Disease, Robinson Institute, School of Paediatrics & Reproductive Health, University of AdelaideSA 5005, Australia Research Centre for Early Origins of Health and Disease, Robinson Institute, School of Paediatrics & Reproductive Health, University of AdelaideSA 5005, Australia School of Psychology, University of AdelaideSA 5005, Australia Research Centre for Early Origins of Health and Disease, Robinson Institute, School of Paediatrics & Reproductive Health, University of AdelaideSA 5005, Australia Research Centre for Early Origins of Health and Disease, Robinson Institute, School of Paediatrics & Reproductive Health, University of AdelaideSA 5005, Australia Research Centre for Early Origins of Health and Disease, Robinson Institute, School of Paediatrics & Reproductive Health, University of AdelaideSA 5005, Australia School of Psychology, University of AdelaideSA 5005, Australia Department of Perinatal Medicine, Women's and Children's HospitalNorth Adelaide,  SA 5006, Australia Research Centre for Early Origins of Health and Disease, Robinson Institute, School of Paediatrics & Reproductive Health, University of AdelaideSA 5005, Australia},
note  = {doi:10.1113/jphysiol.2012.239269.}
}

@Article{2012340,
author  = {Arias, P. and Robles-Garc√≠a, V. and Sanmart√≠n, G. and Flores, J. and Cudeiro, J.},
title  = {Elderly and Parkinson's Disease Patients.},
journal  = {PLoS ONE},
volume  = {7},
number  = {1},
pages  = {},
year  = {2012},
abstract  = {This work presents an immersive Virtual Reality (VR) system to evaluate, and potentially treat, the alterations in rhythmic hand movements seen in Parkinson's disease (PD) and the elderly (EC), by comparison with healthy young controls (YC). The system integrates the subjects into a VR environment by means of a Head Mounted Display, such that subjects perceive themselves in a virtual world consisting of a table within a room. In this experiment, subjects are presented in 1st person perspective, so that the avatar reproduces finger tapping movements performed by the subjects. The task, known as the finger tapping test (FT), was performed by all three subject groups, PD, EC and YC. FT was carried out by each  subject on two different days (sessions), one week apart. In each FT session all  subjects performed FT in the real world (FTREAL) and in the VR (FTVR); each mode  was repeated three times in randomized order. During FT both the tapping frequency and the coefficient of variation of inter-tap interval were registered. FTVR was a valid test to detect differences in rhythm formation between the three groups. Intra-class correlation coefficients (ICC) and mean difference between days for FTVR (for each group) showed reliable results. Finally, the analysis of  ICC and mean difference between FTVR vs FTREAL, for each variable and group, also showed high reliability. This shows that FT evaluation in VR environments is valid as real world alternative, as VR evaluation did not distort movement execution and detects alteration in rhythm formation. These results support the use of VR as a promising tool to study alterations and the control of movement in different subject groups in unusual environments, such as during fMRI or other imaging studies.},
address  = {Neuroscience and Motor Control Group (NEUROcom), Department of Medicine-INEF Galicia, University of A Coru√±a, A Coru√±a, Spain Neuroscience and Motor Control Group (NEUROcom), Department of Medicine-INEF Galicia, University of A Coru√±a, A Coru√±a, Spain Instituto de Investigaci√≥ns Tecnol√≥xicas, University of Santiago de Compostela, Santiago de Compostela, Spain Instituto de Investigaci√≥ns Tecnol√≥xicas, University of Santiago de Compostela, Santiago de Compostela, Spain Neuroscience and Motor Control Group (NEUROcom), Department of Medicine-INEF Galicia, University of A Coru√±a, A Coru√±a, Spain},
note  = {PLoS One. 2012 Jan 18;7(1):. doi:10.1371/journal.pone.0030021.}
}

@Article{2017341,
author  = {Ringler, M. and Szipl, G. and H√∂dl, W. and Khil, L. and Kofler, B. and Lonauer, M. and Provin, C. and Ringler, E.},
title  = {Acoustic ranging in poison frogs‚Äîit is not about signal amplitude alone.},
journal  = {Behavioral Ecology and Sociobiology},
volume  = {71},
number  = {8},
pages  = {},
year  = {2017},
abstract  = {Abstract: Acoustic ranging allows identifying the distance of a sound source and  mediates inter-individual spacing and aggression in territorial species. Birds and mammals are known to use more complex cues than only sound pressure level (SPL), which can be influenced by the signaller and signal transmission in non-predictable ways and thus is not reliable by itself. For frogs, only SPL is currently known to mediate inter-individual distances, but we hypothesise that the strong territoriality of Dendrobatids could make the use of complex cues for  ranging highly beneficial for this family. Therefore, we tested the ranging abilities of territorial males of Allobates femoralis (Dendrobatidae, Aromobatinae) in playback trials, using amplitude-normalized signals that were naturally degraded over distance, and synthetic signals that were masked with different levels of noise. Frogs responded significantly less to signals recorded from larger distances, regardless of SPL and signal-to-noise ratio (SNR), but showed no differential response to natural minimum and maximum SNRs across the typical communication range in wild populations. This indicates that frogs used signal amplitude and SNR only as ancillary cues when assessing the distance of sound sources and relied instead mainly on more complex cues, such as spectral degradation or reverberation. We suggest that this ability mediates territorial spacing and mate choice in A. femoralis. Good ranging abilities might also play a role in the remarkable orientation performance of this species, probably by enabling the establishment of a mental acoustic map of the habitat. Significance  statement: Acoustic ranging allows the distance of vocalizing competitors and mates to be identified. While birds and mammals are known to use complex cues such as temporal degradation, frequency-dependent attenuation and reverberation for ranging, previous research indicated that frogs rely only on signal amplitude (sound pressure level) to assess the distance of other callers. The present study shows for the first time that also poison frogs can make use of more complex cues, an ability which is likely to be highly beneficial in their territorial social organization and probably can also be used for orientation. Electronic supplementary material: The online version of this article (doi:10.1007/s00265-017-2340-2) contains supplementary material, which is available to authorized users.},
address  = {0000 0000 9632 6718grid.19006.3eDepartment of Ecology and Evolutionary Biology, University of California Los Angeles, 621 Charles E. Young Drive South, Los Angeles, CA 90095-1606 USA 0000 0001 2286 1424grid.10420.37Department of Cognitive Biology, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of  Vienna, Althanstrasse 14, 1090 Vienna, Austria 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of  Vienna, Althanstrasse 14, 1090 Vienna, Austria 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of  Vienna, Althanstrasse 14, 1090 Vienna, Austria 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of  Vienna, Althanstrasse 14, 1090 Vienna, Austria 0000 0001 2286 1424grid.10420.37Department of Integrative Zoology, University of  Vienna, Althanstrasse 14, 1090 Vienna, Austria 0000 0000 9632 6718grid.19006.3eDepartment of Ecology and Evolutionary Biology, University of California Los Angeles, 621 Charles E. Young Drive South, Los Angeles, CA 90095-1606 USA},
note  = {doi:10.1007/s00265-017-2340-2.}
}

@Article{2017342,
author  = {Majumder, S. and Mondal, T. and Deen, M.},
title  = {Wearable Sensors for Remote Health Monitoring.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {17},
number  = {1},
pages  = {},
year  = {2017},
abstract  = {Life expectancy in most countries has been increasing continually over the several few decades thanks to significant improvements in medicine, public health, as well as personal and environmental hygiene. However, increased life expectancy combined with falling birth rates are expected to engender a large aging demographic in the near future that would impose significant  burdens on the socio-economic structure of these countries. Therefore, it is essential to develop cost-effective, easy-to-use systems for the sake of elderly healthcare and well-being. Remote health monitoring, based on non-invasive and wearable sensors, actuators and modern communication and information technologies offers an efficient and cost-effective solution that allows the elderly to continue to live in their comfortable home environment instead of expensive healthcare facilities. These systems will also allow healthcare personnel to monitor important physiological signs of their patients in real time, assess health conditions and provide feedback from distant facilities. In this paper, we have presented and compared several low-cost and non-invasive health and activity monitoring systems that were reported in recent years. A survey on textile-based  sensors that can potentially be used in wearable systems is also presented. Finally, compatibility of several communication technologies as well as future perspectives and research challenges in remote monitoring systems will be discussed.},
address  = {Department of Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4L8, Canada; majums3@mcmaster.ca Department of Pediatrics, McMaster University, Hamilton, ON L8S 4L8, Canada; mondalt@mcmaster.ca Department of Electrical and Computer Engineering, McMaster University, Hamilton, ON L8S 4L8, Canada; majums3@mcmaster.ca},
note  = {Sensors (Basel). 2017 Jan 12;17(1):. doi:10.3390/s17010130.}
}

@Article{2014343,
author  = {Bacigalupe, G. and Fernandez-Luque, L. and Mira, J. and Navarro, I. and Botella, F. and Borr√°s, F. and Nu√±o-Solin√≠s, R. and Orozco, D. and Iglesias-Alonso, F. and P√©rez-P√©rez, P. and Lorenzo, S. and Toro, N.},
title  = {Randomized Controlled Trial.},
journal  = {Journal of Medical Internet Research},
volume  = {16},
number  = {4},
pages  = {},
year  = {2014},
abstract  = {Background: Nonadherence and medication errors are common among patients with complex drug regimens. Apps for smartphones and tablets are effective for improving adherence, but they have not been tested in elderly patients with complex chronic conditions and who typically have less experience with this type  of technology. Objective: The objective of this study was to design, implement, and evaluate a medication self-management app (called ALICE) for elderly patients taking multiple medications with the intention of improving adherence and safe medication use. Methods: A single-blind randomized controlled trial was conducted with a control and an experimental group (N=99) in Spain in 2013. The characteristics of ALICE were specified based on the suggestions of 3 nominal groups with a total of 23 patients and a focus group with 7 professionals. ALICE  was designed for Android and iOS to allow for the personalization of prescriptions and medical advice, showing images of each of the medications (the  packaging and the medication itself) together with alerts and multiple reminders  for each alert. The randomly assigned patients in the control group received oral and written information on the safe use of their medications and the patients in  the experimental group used ALICE for 3 months. Pre and post measures included rate of missed doses and medication errors reported by patients, scores from the  4-item Morisky Medication Adherence Scale (MMAS-4), level of independence, self-perceived health status, and biochemical test results. In the experimental group, data were collected on their previous experience with information and communication technologies, their rating of ALICE, and their perception of the level of independence they had achieved. The intergroup intervention effects were calculated by univariate linear models and ANOVA, with the pre to post intervention differences as the dependent variables. Results: Data were obtained  from 99 patients (48 and 51 in the control and experimental groups, respectively). Patients in the experimental group obtained better MMAS-4 scores (P<.001) and reported fewer missed doses of medication (P=.02). ALICE only helped to significantly reduce medication errors in patients with an initially higher rate of errors (P<.001). Patients with no experience with information and communication technologies reported better adherence (P<.001), fewer missed doses (P<.001), and fewer medication errors (P=.02). The mean satisfaction score for ALICE was 8.5 out of 10. In all, 45 of 51 patients (88%) felt that ALICE improved their independence in managing their medications. Conclusions: The ALICE app improves adherence, helps reduce rates of forgetting and of medication errors, and increases perceived independence in managing medication. Elderly patients with no previous experience with information and communication technologies are capable of effectively using an app designed to help them take their medicine more safely. Trial Registration: Clinicaltrials.gov NCT02071498; http://clinicaltrials.gov/ct2/show/NCT02071498 (Archived by WebCite at http://www.webcitation.org/6OJjdHVhD).},
address  = {Sant Joan-Alicante Health DistrictConseller√≠a SanidadAlicanteSpain Health Psychology DepartmentMiguel Hern√°ndez UniversityElcheSpain Center of Operations Research University InstituteMiguel Hern√°ndez UniversityElcheSpain Statistics, Mathematics and Informatics DepartmentMiguel Hern√°ndez UniversityElcheSpain Basque Institute for Healthcare Innovation (O+berri)BarakaldoSpain Department of Family MedicineFaculty of MedicineMiguel Hern√°ndez UniversityAlicanteSpain Castilla La Mancha Health Service (SESCAM)ToledoSpain Andalusian Patient Safety ObservatoryAndalusian Agency for Health Care QualitySevilleSpain Hospital Universitario Fundaci√≥n Alcorc√≥nMadridSpain Basque Institute for Healthcare Innovation (O+berri)BarakaldoSpain},
note  = {J Med Internet Res. 2014 Apr 04;16(4):. doi:10.2196/jmir.3269.}
}

@Article{2013344,
author  = {Tillman, G. and Calley, C. and Green, T. and Buhl, V. and Biggs, M. and Spence, J. and Briggs, R. and Haley, R. and Kraut, M. and Hart, J.},
title  = {evidence against a stress-related etiology.},
journal  = {Psychiatry research},
volume  = {211},
number  = {3},
pages  = {257-67},
year  = {2013},
abstract  = {An exaggerated response to emotional stimuli is among the many symptoms widely reported by veterans of the 1991 Persian Gulf War. These symptomologies have been attributed to damage and dysfunction associated with deployment-related exposures. We collected event-related potential data from 22 veterans meeting Haley criteria for Gulf War (GW) Syndromes 1-3 and from 8 matched GW veteran controls, who were deployed but not symptomatic, while they performed a visual three-condition oddball task where images authenticated to be associated with the 1991 Persian Gulf War were the distractor stimuli. Hyperarousal reported by ill veterans was significantly greater than that by control veterans, but this was not paralleled by higher amplitude P3a in their ERP responses to GW-related distractor stimuli. Whereas previous studies of PTSD patients have shown higher amplitude P3b responses to target stimuli that are placed amid trauma-related nontarget stimuli, ill veterans in this study showed P3b amplitudes to target stimuli‚Äîplaced amid GW-related nontarget stimuli‚Äîthat were significantly lower than those of the control group. Hyperarousal scores reliably predicted P3b, but  not P3a, amplitudes. Although many factors may contribute to P3b amplitude differences‚Äîmost notably depression and poor sleep quality, symptoms that are prevalent in the GW syndrome groups‚Äîour findings in context of previous studies on this population are consistent with the contention that dysfunction in cholinergic and dopaminergic neurotransmitter systems, and in white matter and basal ganglia may be contributing to impairments in GW veterans.},
address  = {Center for BrainHealth, The University of Texas at Dallas, Dallas, TX Center for BrainHealth, The University of Texas at Dallas, Dallas, TX Center for BrainHealth, The University of Texas at Dallas, Dallas, TX Center for BrainHealth, The University of Texas at Dallas, Dallas, TX VA North Texas Health Care System, Dallas, TX Department of Internal Medicine, University of Texas Southwestern Medical Center  Dallas, TX, USA Department of Radiology, University of Texas Southwestern Medical Center Dallas,  TX, USA Department of Internal Medicine, University of Texas Southwestern Medical Center  Dallas, TX, USA Center for BrainHealth, The University of Texas at Dallas, Dallas, TX Center for BrainHealth, The University of Texas at Dallas, Dallas, TX},
note  = {doi:10.1016/j.pscychresns.2012.08.004.}
}

@Article{2016345,
author  = {Azad, T. and Veeravagu, A. and Steinberg, G.},
title  = {Neurorestoration after stroke.},
journal  = {Neurosurgical focus},
volume  = {40},
number  = {5},
pages  = {E2},
year  = {2016},
abstract  = {Recent advancements in stem cell biology and neuromodulation have ushered in a battery of new neurorestorative therapies for ischemic stroke. While the understanding of stroke pathophysiology has matured, the ability to restore patients‚Äô quality of life remains inadequate. New therapeutic approaches, including cell transplantation and neurostimulation, focus on reestablishing the  circuits disrupted by ischemia through multidimensional mechanisms to improve neuroplasticity and remodeling. The authors provide a broad overview of stroke pathophysiology and existing therapies to highlight the scientifc and clinical implications of neurorestorative therapies for stroke.},
address  = {},
note  = {Neurosurg Focus. 2016 May;40(5):E2. doi:10.3171/2016.2.FOCUS15637.}
}

@Article{2014346,
author  = {Castermans, T. and Duvinage, M. and Cheron, G. and Dutoit, T.},
title  = {Rehabilitation Systems.},
journal  = {Brain Sciences},
volume  = {4},
number  = {1},
pages  = {1-48},
year  = {2014},
abstract  = {In the last few years, significant progress has been made in the field of walk rehabilitation. Motor cortex signals in bipedal monkeys have been interpreted to  predict walk kinematics. Epidural electrical stimulation in rats and in one young paraplegic has been realized to partially restore motor control after spinal cord injury. However, these experimental trials are far from being applicable to all patients suffering from motor impairments. Therefore, it is thought that more simple rehabilitation systems are desirable in the meanwhile. The goal of this review is to describe and summarize the progress made in the development of non-invasive brain-computer interfaces dedicated to motor rehabilitation systems. In the first part, the main principles of human locomotion control are presented. The paper then focuses on the mechanisms of supra-spinal centers active during gait, including results from electroencephalography, functional brain imaging technologies [near-infrared spectroscopy (NIRS), functional magnetic resonance imaging (fMRI), positron-emission tomography (PET), single-photon emission-computed tomography (SPECT)] and invasive studies. The first brain-computer interface (BCI) applications to gait rehabilitation are then presented, with a discussion about the different strategies developed in the field. The challenges to raise for future systems are identified and discussed. Finally, we present some proposals to address these challenges, in order to contribute to the improvement of BCI for gait rehabilitation.},
address  = {TCTS lab, Universit√© de Mons, Place du Parc 20, Mons 7000, Belgium; E-Mails: matthieu.duvinage@gmail.com (M.D.); Thierry.Dutoit@umons.ac.be (T.D.) TCTS lab, Universit√© de Mons, Place du Parc 20, Mons 7000, Belgium; E-Mails: matthieu.duvinage@gmail.com (M.D.); Thierry.Dutoit@umons.ac.be (T.D.) LNMB lab, Universit√© Libre de Bruxelles, Avenue Franklin Roosevelt 50, Bruxelles  1050, Belgium; E-Mail: gcheron@ulb.ac.be TCTS lab, Universit√© de Mons, Place du Parc 20, Mons 7000, Belgium; E-Mails: matthieu.duvinage@gmail.com (M.D.); Thierry.Dutoit@umons.ac.be (T.D.)},
note  = {Brain Sci. 2013 Dec 31;4(1):1-48. doi:10.3390/brainsci4010001.}
}

@Article{2016347,
author  = {Friesen, C. and Bardouille, T. and Neyedli, H. and Boe, S.},
title  = {Brain Activity.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Motor imagery (MI) and action observation have proven to be efficacious adjuncts  to traditional physiotherapy for enhancing motor recovery following stroke. Recently, researchers have used a combined approach called imagined imitation (II), where an individual watches a motor task being performed, while simultaneously imagining they are performing the movement. While neurofeedback (NFB) has been used extensively with MI to improve patients' ability to modulate  sensorimotor activity and enhance motor recovery, the effectiveness of using NFB  with II to modulate brain activity is unknown. This project tested the ability of participants to modulate sensorimotor activity during electroencephalography-based II-NFB of a complex, multi-part unilateral handshake, and whether this ability transferred to a subsequent bout of MI. Moreover, given the goal of translating findings from NFB research into practical applications, such as rehabilitation, the II-NFB system was designed with several user interface and user experience features, in an attempt to both drive user engagement and match the level of challenge to the abilities of the subjects. In  particular, at easy difficulty levels the II-NFB system incentivized contralateral sensorimotor up-regulation (via event related desynchronization of  the mu rhythm), while at higher difficulty levels the II-NFB system incentivized  sensorimotor lateralization (i.e., both contralateral up-regulation and ipsilateral down-regulation). Thirty-two subjects, receiving real or sham NFB attended four sessions where they engaged in II-NFB training and subsequent MI. Results showed the NFB group demonstrated more bilateral sensorimotor activity during sessions 2‚Äì4 during II-NFB and subsequent MI, indicating mixed success for the implementation of this particular II-NFB system. Here we discuss our findings in the context of the design features included in the II-NFB system, highlighting limitations that should be considered in future designs.},
address  = {Laboratory for Brain Recovery and Function, Dalhousie UniversityHalifax, NS, Canada Department of Psychology and Neuroscience, Dalhousie UniversityHalifax, NS, Canada Department of Psychology and Neuroscience, Dalhousie UniversityHalifax, NS, Canada Laboratory for Brain Recovery and Function, Dalhousie UniversityHalifax, NS, Canada},
note  = {Front Hum Neurosci. 2017 Jan 10;10:. doi:10.3389/fnhum.2016.00692.}
}

@Article{2017348,
author  = {Karlsson, D. and DeLuca, S. and Kanitkar, A. and Szturm, T. and Parmar, S. and Gandhi, D. and Rempel, G. and Restall, G. and Sharma, M. and Narayan, A. and Pandian, J. and Naik, N. and Savadatti, R. and Kamate, M.},
title  = {With Cerebral Palsy: Protocol for a Randomized Clinical Trial.},
journal  = {JMIR Research Protocols},
volume  = {6},
number  = {5},
pages  = {},
year  = {2017},
abstract  = {Background: It is difficult to engage young children with cerebral palsy (CP) in  repetitive, tedious therapy. As such, there is a need for innovative approaches and tools to motivate these children. We developed the low-cost, computer game-based rehabilitation platform CGR that combines fine manipulation and gross  movement exercises with attention and planning game activities appropriate for young children with CP. Objective: The objective of this study is to provide evidence of the therapeutic value of CGR to improve upper extremity (UE) motor function for children with CP. Methods: This randomized controlled, single-blind, clinical trial with an active control arm will be conducted at 4 sites. Children  diagnosed with CP between the ages of 4 and 10 years old with moderate UE impairments and fine motor control abnormalities will be recruited. Results: We will test the difference between experimental and control groups using the Quality of Upper Extremity Skills Test (QUEST) and Peabody Developmental Motor Scales, Second Edition (PDMS-2) outcome measures. The parents of the children and the therapist experiences with the interventions and tools will be explored using semi-structured interviews using the qualitative description approach. Conclusions: This research protocol, if effective, will provide evidence for the  therapeutic value and feasibility of CGR in the pediatric rehabilitation of UE function. Trial Registration: Clinicaltrials.gov NCT02728375; http:https://clinicaltrials.gov/ct2/show/NCT02728375 (Archived by WebCite at http://www.webcitation.org/6qDjvszvh)},
address  = {Applied Health SciencesUniversity of ManitobaWinnipeg, MBCanada College of Rehabilitation SciencesUniversity of ManitobaWinnipeg, MBCanada SDM College of Medical Sciences and HospitalRajiv Gandhi University of Health SciencesDharwadIndia Christian Medical College and HospitalDepartment of NeurologyBaba Farid University of Health SciencesLudhianaIndia Max Rady College of Medicine, Rady Faculty of Health SciencesDepartment of Pediatrics and Child HealthUniversity of ManitobaWinnipeg, MBCanada College of Rehabilitation SciencesUniversity of ManitobaWinnipeg, MBCanada Christian Medical College and HospitalDepartment of PediatricsBaba Farid University of Health SciencesLudhianaIndia Kasturba Medical CollegeDepartment of PhysiotherapyManipal UniversityMangaloreIndia Christian Medical College and HospitalDepartment of NeurologyBaba Farid University of Health SciencesLudhianaIndia Department of PhysiotherapyUshas School for Exceptional ChildrenHubliIndia SDM College of PhysiotherapyRajiv Gandhi University of Health SciencesDharwadIndia JN Medical College and HospitalDepartment of PediatricsKLE UniversityBelgaumIndia},
note  = {JMIR Res Protoc. 2017 May 18;6(5):. doi:10.2196/resprot.6846.}
}

@Article{2012349,
author  = {Woods, R. and Vallero, R. and Golub, M. and Suarez, J. and Ta, T. and Yasui, D. and Chi, L. and Kostyniak, P. and Pessah, I. and Berman, R. and LaSalle, J.},
title  = {mutation.},
journal  = {Human Molecular Genetics},
volume  = {21},
number  = {11},
pages  = {2399-411},
year  = {2012},
abstract  = {The widespread use of persistent organic polybrominated diphenyl ethers (PBDEs) as commercial flame retardants has raised concern about potential long-lived effects on human health. Epigenetic mechanisms, such as DNA methylation, are responsive to environmental influences and have long-lasting consequences. Autism spectrum disorders (ASDs) have complex neurodevelopmental origins whereby both genetic and environmental factors are implicated. Rett syndrome is an X-linked ASD caused by mutations in the epigenetic factor methyl-CpG binding protein 2 (MECP2). In this study, an Mecp2 truncation mutant mouse (Mecp2308) with social behavioral defects was used to explore the long-lasting effects of PBDE exposure  in a genetically and epigenetically susceptible model. Mecp2308/+ dams were perinatally exposed daily to 2,2‚Ä≤,4,4‚Ä≤-tetrabromodiphenyl ether 47 (BDE-47) and bred to wild-type C57BL/6J males, and the offspring of each sex and genotype were examined for developmental, behavioral and epigenetic outcomes. Perinatal BDE-47  exposure negatively impacted fertility of Mecp2308/+ dams and preweaning weights  of females. Global hypomethylation of adult brain DNA was observed specifically in female offspring perinatally exposed to BDE-47 and it coincided with reduced sociability in a genotype-independent manner. A reversing interaction of Mecp2 genotype on BDE-47 exposure was observed in a short-term memory test of social novelty that corresponded to increased Dnmt3a levels specifically in BDE-47-exposed Mecp2308/+ offspring. In contrast, learning and long-term memory in the Morris water maze was impaired by BDE-47 exposure in female Mecp2308/+ offspring. These results demonstrate that a genetic and environmental interaction relevant to social and cognitive behaviors shows sexual dimorphism, epigenetic dysregulation, compensatory molecular mechanisms and specific behavioral deficits.},
address  = {Medical Microbiology and Immunology and Rowe Program in Human Genetics, Medical Microbiology and Immunology and Rowe Program in Human Genetics, Environmental Toxicology, Medical Microbiology and Immunology and Rowe Program in Human Genetics, Center for Children's Environmental Health, Medical Microbiology and Immunology and Rowe Program in Human Genetics, Toxicology Research Center, University at Buffalo, The State University of New York, Buffalo, NY 14214-3015, USA Toxicology Research Center, University at Buffalo, The State University of New York, Buffalo, NY 14214-3015, USA M.I.N.D. Institute, M.I.N.D. Institute, Medical Microbiology and Immunology and Rowe Program in Human Genetics,},
note  = {doi:10.1093/hmg/dds046.}
}

@Article{2015350,
author  = {Muehsam, D. and Chevalier, G. and Barsotti, T. and Gurfein, B.},
title  = {An Overview of Biofield Devices.},
journal  = {Global Advances in Health and Medicine},
volume  = {4},
number  = {Suppl},
pages  = {42-51},
year  = {2015},
abstract  = {Advances in biophysics, biology, functional genomics, neuroscience, psychology, psychoneuroimmunology, and other fields suggest the existence of a subtle system  of ‚Äúbiofield‚Ä? interactions that organize biological processes from the subatomic, atomic, molecular, cellular, and organismic to the interpersonal and cosmic levels. Biofield interactions may bring about regulation of biochemical, cellular, and neurological processes through means related to electromagnetism, quantum fields, and perhaps other means of modulating biological activity and information flow. The biofield paradigm, in contrast to a reductionist, chemistry-centered viewpoint, emphasizes the informational content of biological  processes; biofield interactions are thought to operate in part via low-energy or ‚Äúsubtle‚Ä? processes such as weak, nonthermal electromagnetic fields (EMFs) or processes potentially related to consciousness and nonlocality. Biofield interactions may also operate through or be reflected in more well-understood informational processes found in electroencephalographic (EEG) and electrocardiographic (ECG) data. Recent advances have led to the development of a wide variety of therapeutic and diagnostic biofield devices, defined as physical  instruments best understood from the viewpoint of a biofield paradigm. Here, we provide a broad overview of biofield devices, with emphasis on those devices for  which solid, peer-reviewed evidence exists. A subset of these devices, such as those based upon EEG- and ECG-based heart rate variability, function via mechanisms that are well understood and are widely employed in clinical settings. Other device modalities, such a gas discharge visualization and biophoton emission, appear to operate through incompletely understood mechanisms and have unclear clinical significance. Device modes of operation include EMF-light, EMF-heat, EMF-nonthermal, electrical current, vibration and sound, physical and mechanical, intentionality and nonlocality, gas and plasma, and other (mode of operation not well-understood). Methodological issues in device development and interfaces for future interdisciplinary research are discussed. Devices play prominent cultural and scientific roles in our society, and it is likely that device technologies will be one of the most influential access points for the furthering of biofield research and the dissemination of biofield concepts. This  developing field of study presents new areas of research that have many important implications for both basic science and clinical medicine.},
address  = {Visual Institute of Developmental Arts and Sciences, National Institute of Biostructures and Biosystems, Bologna, Italy; and Consciousness and Healing Initiative, San Diego, California (Dr Muehsam) Developmental and Cell Biology Department, University of California Irvine, Irvine (Dr Chevalier) California Institute for Human Science, Encinitas, California (Ms Barsotti) Osher Center for Integrative Medicine, University of California, San Francisco, (Dr Gurfein)},
note  = {doi:10.7453/gahmj.2015.022.suppl.}
}

@Article{2010351,
author  = {Seeber, B. and Kerber, S. and Hafter, E.},
title  = {Research.},
journal  = {Hearing research},
volume  = {260},
number  = {1-2},
pages  = {1-10},
year  = {2010},
abstract  = {The article reports the experience gained from two implementations of the ‚ÄúSimulated Open-Field Environment‚Ä? (SOFE), a setup that allows sounds to be played at calibrated levels over a wide frequency range from multiple loudspeakers in an anechoic chamber. Playing sounds from loudspeakers in the free-field has the advantage that each participant listens with their own ears, and individual characteristics of the ears are captured in the sound they hear. This makes an easy and accurate comparison between various listeners with and without hearing devices possible. The SOFE uses custom calibration software to assure individual equalization of each loudspeaker. Room simulation software creates the spatio-temporal reflection pattern of sound sources in rooms which is played via the SOFE loudspeakers. The sound playback system is complemented by a  video projection facility which can be used to collect or give feedback or to study auditory-visual interaction. The article discusses acoustical and technical requirements for accurate sound playback against the specific needs in hearing research. An introduction to software concepts is given which allow easy, high-level control of the setup and thus fast experimental development, turning the SOFE into a ‚ÄúSwiss army knife‚Ä? tool for auditory, spatial hearing and audio-visual research.},
address  = {Audiory Perception Lab, Department of Psychology, University of California at Berkeley, Berkeley, CA 94530-1650, USA MRC Institute of Hearing Research, University Park, Nottingham, NG7 2RD, United Kingdom Audiory Perception Lab, Department of Psychology, University of California at Berkeley, Berkeley, CA 94530-1650, USA},
note  = {doi:10.1016/j.heares.2009.11.004.}
}

@Article{2009352,
author  = {Mayer, E. and Aziz, Q. and Coen, S. and Kern, M. and Labus, J. and Lane, R. and Kuo, B. and Naliboff, B. and Tracey, I.},
title  = {Team Report.},
journal  = {Gastrointestinal Motility Society},
volume  = {21},
number  = {6},
pages  = {},
year  = {2009},
abstract  = {},
address  = {Center for Neurobiology of Stress, Departments of Medicine, Physiology and Psychiatry, UCLA, CURE Digestive Diseases Research Center, UCLA Division of Digestive Diseases, Los Angeles, CA Wingate Institute for Neurogastroenterology, Neurogastroenterology Group, School  of Medicine and Dentistry, Queen Mary University of London, UK Wingate Institute for Neurogastroenterology, Neurogastroenterology Group, School  of Medicine and Dentistry, Queen Mary University of London, UK Department of Medicine, Division of Gastroenterology and Hepatology, Medical College of Wisconsin Milwaukee, WI Center for Neurobiology of Stress, Departments of Medicine, Physiology and Psychiatry, UCLA, CURE Digestive Diseases Research Center, UCLA Division of Digestive Diseases, Los Angeles, CA Departments of Psychiatry, Psychology and Neuroscience, University of Arizona, AZ Gastro Intestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA Center for Neurobiology of Stress, Departments of Medicine, Physiology and Psychiatry, UCLA, CURE Digestive Diseases Research Center, UCLA Division of Digestive Diseases, Los Angeles, CA Oxford Centre for Functional Magnetic Resonance Imaging of the Brain, FMRIB Centre, Oxford University Department of Clinical Neurology, John Radcliffe Hospital Oxford, UK},
note  = {Neurogastroenterol Motil. 2009 Jun;21(6):. doi:10.1111/j.1365-2982.2009.01304.x.}
}

@Article{2013353,
author  = {Casarotto, S. and Canali, P. and Rosanova, M. and Pigorini, A. and Fecchio, M. and Mariotti, M. and Lucca, A. and Colombo, C. and Benedetti, F. and Massimini, M.},
title  = {Means of Transcranial Magnetic Stimulation and Electroencephalography.},
journal  = {Brain Topography},
volume  = {26},
number  = {2},
pages  = {326-37},
year  = {2013},
abstract  = {Electroconvulsive therapy (ECT) has significant short-term antidepressant effects on drug-resistant patients with severe major depression. Animal studies have demonstrated that electroconvulsive seizures produce potentiation-like synaptic remodeling in both sub-cortical and frontal cortical circuits. However, the electrophysiological effects of ECT in the human brain are not known. In this work, we evaluated whether ECT induces a measurable change in the excitability of frontal cortical circuits in humans. Electroencephalographic (EEG) potentials evoked by transcranial magnetic stimulation (TMS) were collected before and after a course of ECT in eight patients with severe major depression. Cortical excitability was measured from the early and local EEG response to TMS. Clinical  assessment confirmed the beneficial effects of ECT on depressive symptoms at the  group level. TMS/EEG measurements revealed a clear-cut increase of frontal cortical excitability after ECT as compared to baseline, that was significant in  each and every patient. The present findings corroborate in humans the idea that  ECT may produce synaptic potentiation, as previously observed in animal studies.  Moreover, results suggest that TMS/EEG may be employed in depressed patients to monitor longitudinally the electrophysiological effects of different therapeutic  neuromodulators, e.g. ECT, repetitive TMS, and sleep deprivation. To the extent that depression involves an alteration of frontal cortical excitability, these measurements may be used to guide and evaluate treatment progression over time at the single-patient level.Electronic supplementary material: The online version of this article (doi:10.1007/s10548-012-0256-8) contains supplementary material, which is available to authorized users.},
address  = {Department of Biomedical and Clinical Sciences ‚ÄúL. Sacco‚Ä?, Universit√† degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy Department of Biomedical and Clinical Sciences ‚ÄúL. Sacco‚Ä?, Universit√† degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy Department of Biomedical and Clinical Sciences ‚ÄúL. Sacco‚Ä?, Universit√† degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy Department of Biomedical and Clinical Sciences ‚ÄúL. Sacco‚Ä?, Universit√† degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy Department of Biomedical and Clinical Sciences ‚ÄúL. Sacco‚Ä?, Universit√† degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy Department of Clinical Neurosciences, Scientific Institute and University Vita-Salute San Raffaele, Milan, Italy Department of Biomedical and Clinical Sciences ‚ÄúL. Sacco‚Ä?, Universit√† degli Studi di Milano, Via G.B. Grassi, 74, 20157 Milan, Italy},
note  = {Brain Topogr. 2013;26(2):326-37. Epub 2012 Oct 9 doi:10.1007/s10548-012-0256-8.}
}

@Article{2015354,
author  = {Hosemann, W. and Schroeder, H.},
title  = {Comprehensive review on rhino-neurosurgery.},
journal  = {GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery},
volume  = {14},
number  = {},
pages  = {},
year  = {2015},
abstract  = {In the past 2 decades, an innovative and active field of surgical collaboration has been evolved and established combining the expertise of neurosurgery and rhinosurgery in the endonasal treatment of different lesions affecting the anterior skull base together with the adjacent intranasal and intradural areas. Important prerequisites for this development were improvements of technical devices, definitions of transnasal surgical corridors, and approvements in endonasal reconstructions, e.g. by use of pedicled nasal mucosal flaps. Due to these improvements, the rate of perioperative infectious complications remained acceptable. Interdisciplinary surgical teams (4-hands-2-minds) have been established constituting specialized centers of ‚Äúrhino-neurosurgery‚Ä?. With growing expertise of these groups, it could be shown that oncological results and perioperative complications were comparable to traditional surgery while at the same time the patients‚Äô morbidity could be reduced.The present review encompasses the recent literature focusing on the development, technical details, results, and complications of ‚Äúrhino-neurosurgery‚Ä?.},
address  = {Department of Otolaryngology, Head & Neck Surgery, University Medicine Greifswald, Germany Department of Neurosurgery, University Medicine Greifswald, Germany},
note  = {doi:10.3205/cto000116.}
}

@Article{2012355,
author  = {Krieger, M. and Both, M. and Kranig, S. and Pitzer, C. and Klugmann, M. and Vogt, G. and Draguhn, A. and Schneider, A.},
title  = {important for cognitive functions.},
journal  = {Scientific Reports},
volume  = {2},
number  = {},
pages  = {},
year  = {2012},
abstract  = {We recently reported expression of hematopoietic growth factor GM-CSF and its receptor (GM-CSFR) in CNS neurons. Here we evaluated this system in learning and  memory formation using GM-CSF deficient mice. In complementation, GM-CSF signalling was manipulated specifically in adult murine hippocampus by adeno-associated virus (AAV)-mediated GM-CSFR alpha overexpression or knock-down. GM-CSF ablation caused various hippocampus and amygdala-dependent deficits in spatial and fear memory while rendering intact basic parameters like motor function, inherent anxiety, and pain threshold levels. Corroborating these data,  spatial memory of AAV-injected mice was positively correlated with GM-CSFRŒ± expression levels. Hippocampal neurons of knock-out mice showed markedly pruned dendritic trees, reduced spine densities, and lower percentages of mature spines. Despite such morphological alterations, long-term potentiation (LTP) was unimpaired in the knock-out hippocampus. Collectively, these results suggest that GM-CSF signalling plays a major role in structural plasticity relevant to learning and memory.},
address  = {SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany Institute for Physiology, University of Heidelberg, Im Neuenheimer Feld 346, 69120 Heidelberg, Germany Institute for Physiology, University of Heidelberg, Im Neuenheimer Feld 346, 69120 Heidelberg, Germany SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany Translational Neuroscience Facility, Department of Physiology, School of Medical  Sciences, University of New South Wales, UNSW Kensington Campus, Sydney, NSW, 2052, Australia SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany Institute for Physiology, University of Heidelberg, Im Neuenheimer Feld 346, 69120 Heidelberg, Germany SYGNIS Bioscience, Im Neuenheimer Feld 515, 69120 Heidelberg, Germany},
note  = {Sci Rep. 2012 Sep 26;2:. doi:10.1038/srep00697.}
}

@Article{2011356,
author  = {Fitzcharles, M. and Shir, Y.},
title  = {Clinician.},
journal  = {Therapeutic Advances in Musculoskeletal Disease},
volume  = {3},
number  = {4},
pages  = {179-90},
year  = {2011},
abstract  = {Pain that accompanies musculoskeletal conditions should be regarded as an illness entity in its own right and deserves treatment in parallel with the management of the underlying condition. Recent understanding of the pathophysiology of rheumatic pain invokes interplay of the nociceptive mechanisms driven by local tissue factors and the neurogenic responses that sustain chronic pain. In line with other pain conditions, ideal treatment of rheumatic pain should be through a multimodal approach, integrating nonpharmacologic as well as pharmacologic treatments. In the light of this new concept of pain mechanisms, future pharmacologic treatment options may encompass a wider scope than the use of traditional analgesics and nonsteroidal anti-inflammatory drugs. There is currently limited experience for use of pharmacologic treatments that act primarily on neurogenic mechanisms in rheumatic conditions. Drug combination studies are lacking, but this strategy seems clinically reasonable to allow for an approach to treating pain from different mechanistic perspectives. An added advantage would be the opportunity to use lower doses of individual drugs and thereby reduce the side effect profile. Ideal pain management must also include attention to the important co-associates of pain such as effects on sleep, mood and energy, which all have an impact on the global burden of suffering. Although  complete relief of pain is still an unrealistic objective, reasonable outcome goals for symptom relief should be accompanied with an improvement in function.},
address  = {Montreal General Hospital Pain Centre, Montreal General Hospital, McGill University, Montreal, Quebec, Canada},
note  = {Ther Adv Musculoskelet Dis. 2011 Aug;3(4):179-90. doi:10.1177/1759720X11408999.}
}

@Article{2010357,
author  = {Wall, C.},
title  = {individuals with imbalance.},
journal  = {Journal of neurologic physical therapy : JNPT},
volume  = {34},
number  = {2},
pages  = {98-104},
year  = {2010},
abstract  = {Background and Purpose: Balance rehabilitation and vestibular/balance prostheses  are both emerging fields that have a potential for synergistic interaction. This  paper reviews vibrotactile prosthetic devices that have been developed to date and ongoing work related to the application of vibrotactile feedback for enhanced postural control. A vibrotactile feedback device developed in the author‚Äôs laboratory is described. Methods: Twelve subjects with vestibular hypofunction were tested on a platform that moved randomly in a plane, while receiving vibrotactile feedback in the anterio-posterior direction. The feedback allowed subjects to significantly decrease their anterio-posterior body tilt, but did not change mediolateral tilt. A tandem walking task using subjects with vestibulopathies demonstrated a reduction in their medio-lateral sway due to vibrotactile feedback of medio-lateral body tilt, after controlling for the effects of task learning. The findings from two additional experiments conducted  in the laboratories of collaborating physical therapists are summarized. Results: The Dynamic Gait Index scores in community-dwelling elderly individuals who were  prone-to-fall were significantly improved with the use of medio-lateral body tilt feedback. Discussion and Conclusions: While more work is needed, these results suggest that vibrotactile tilt feedback of subjects‚Äô body motion can be used effectively by physical therapists for balance rehabilitation. A preliminary description of the 3rd generation device that has been reduced from a vest format to a belt format is described to demonstrate the progressive evolution from research to clinical application.},
address  = {Professor of Otolology and Laryngology, Harvard Medical School Director, Jenks Vestibular Diagnostic Laboratory, Massachusetts Eye & Ear Infirmary},
note  = {J Neurol Phys Ther. 2010 Jun;34(2):98-104. doi:10.1097/NPT.0b013e3181dde6f0.}
}

@Article{2014358,
author  = {Gierut, J. and Morrisette, M.},
title  = {How to Meet the Neighbors: Modality Effects on Phonological Generalization.},
journal  = {Clinical linguistics & phonetics},
volume  = {28},
number  = {0},
pages  = {477-92},
year  = {2014},
abstract  = {Long-term auditory priming of words from dense neighborhoods has been posited as  a learning mechanism that affects change in the phonological structure of children‚Äôs lexical representations. An apparent confound associated with the modality of priming responsible for structural change has been introduced in the  literature, which challenges this proposal. Thus, our purpose was to evaluate prime modality in treatment of children with phonological delay. Nine children were assigned to auditory-visual, auditory or visual priming of words from dense  neighborhoods prior to treatment of production as the independent variable. The dependent variable was phonological generalization. Results showed that auditory  priming (with or without visual input) promoted greater generalization on an order of magnitude of 3:1. Findings support the theoretical significance of auditory priming for phonological learning and demonstrate the applied utility of priming in clinical treatment.},
address  = {},
note  = {Clin Linguist Phon. 2014 Jul-Aug;28(0):477-92. doi:10.3109/02699206.2014.926992.}
}

@Article{2010359,
author  = {Sakamoto, J. and van, d. and Godin, B. and Blanco, E. and Serda, R. and Grattoni, A. and Ziemys, A. and Bouamrani, A. and Hu, T. and Ranganathan, S. and De, R. and Martinez, J. and Smid, C. and Buchanan, R. and Lee, S. and Srinivasan, S. and Landry, M. and Meyn, A. and Tasciotti, E. and Liu, X. and Decuzzi, P. and Ferrari, M.},
title  = {Enabling individualized therapy through nanotechnology.},
journal  = {Society},
volume  = {62},
number  = {2},
pages  = {57-89},
year  = {2010},
abstract  = {Individualized medicine is the healthcare strategy that rebukes the idiomatic dogma of ‚Äòlosing sight of the forest for the trees‚Äô. We are entering a new era of healthcare where it is no longer acceptable to develop and market a drug that is  effective for only 80% of the patient population. The emergence of ‚Äú-omic‚Ä? technologies (e.g. genomics, transcriptomics, proteomics, metabolomics) and advances in systems biology are magnifying the deficiencies of standardized therapy, which often provide little treatment latitude for accommodating patient  physiologic idiosyncrasies. A personalized approach to medicine is not a novel concept. Ever since the scientific community began unraveling the mysteries of the genome, the promise of discarding generic treatment regimens in favor of patient-specific therapies became more feasible and realistic. One of the major scientific impediments of this movement towards personalized medicine has been the need for technological enablement. Nanotechnology is projected to play a critical role in patient-specific therapy; however, this transition will depend heavily upon the evolutionary development of a systems biology approach to clinical medicine based upon ‚Äú-omic‚Ä? technology analysis and integration. This manuscript provides a forward looking assessment of the promise of nanomedicine as it pertains to individualized medicine and establishes a technology ‚Äúsnapshot‚Ä? of the current state of nano-based products over a vast array of clinical indications and range of patient specificity. Other issues such as market driven  hurdles and regulatory compliance reform are anticipated to ‚Äúself-correct‚Ä? in accordance to scientific advancement and healthcare demand. These peripheral, non-scientific concerns are not addressed at length in this manuscript; however they do exist, and their impact to the paradigm shifting healthcare transformation towards individualized medicine will be critical for its success.},
address  = {The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA The University of Texas Health Science Center, Department of Nanomedicine and Biomedical Engineering, 1825 Pressler Street, Suite 537A, Houston, TX 77030, USA},
note  = {doi:10.1016/j.phrs.2009.12.011.}
}

@Article{2007360,
author  = {Castelo-Branco, M. and Mendes, M. and Sebasti√£o, A. and Reis, A. and Soares, M. and Saraiva, J. and Bernardes, R. and Flores, R. and P√©rez-Jurado, L. and Silva, E.},
title  = {explaining human neurodevelopmental visual cortical disorders.},
journal  = {The Journal of Clinical Investigation},
volume  = {117},
number  = {12},
pages  = {3720-9},
year  = {2007},
abstract  = {Williams-Beuren syndrome (WBS), a neurodevelopmental genetic disorder whose manifestations include visuospatial impairment, provides a unique model to link genetically determined loss of neural cell populations at different levels of the nervous system with neural circuits and visual behavior. Given that several of the genes deleted in WBS are also involved in eye development and the differentiation of retinal layers, we examined the retinal phenotype in WBS patients and its functional relation to global motion perception. We discovered a low-level visual phenotype characterized by decreased retinal thickness, abnormal optic disk concavity, and impaired visual responses in WBS patients compared with age-matched controls by using electrophysiology, confocal and coherence in vivo imaging with cellular resolution, and psychophysics. These mechanisms of impairment are related to the magnocellular pathway, which is involved in the detection of temporal changes in the visual scene. Low-level magnocellular performance did not predict high-level deficits in the integration of motion and  3D information at higher levels, thereby demonstrating independent mechanisms of  dysfunction in WBS that will require remediation strategies different from those  used in other visuospatial disorders. These findings challenge neurodevelopmental theories that explain cortical deficits based on low-level magnocellular impairment, such as regarding dyslexia.},
address  = {Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal. Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, Coimbra, Portugal. CNTM, AIBILI, Azinhaga Sta. Comba, Coimbra, Portugal. Children‚Äôs Hospital, Coimbra, Portugal. Genetics Unit and CIBERER, Universitat Pompeu Fabra, Barcelona, Spain. Program in Molecular Medicine and Genetics, Hospital Universitari Vall d‚ÄôHebron, Barcelona, Spain. Centre for Hereditary Eye Diseases, Department of Ophthalmology, University Hospital of Coimbra, Coimbra, Portugal.},
note  = {J Clin Invest. 2007 Dec 3;117(12):3720-9. Epub 2007 Nov 21 doi:10.1172/JCI32556.}
}

@Article{2016361,
author  = {Akram, S. and Presacco, A. and Simon, J. and Shamma, S. and Babadi, B.},
title  = {environment via state-space modeling‚ú©.},
journal  = {NeuroImage},
volume  = {124},
number  = {0 0},
pages  = {906-17},
year  = {2016},
abstract  = {The underlying mechanism of how the human brain solves the cocktail party problem is largely unknown. Recent neuroimaging studies, however, suggest salient temporal correlations between the auditory neural response and the attended auditory object. Using magnetoencephalography (MEG) recordings of the neural responses of human subjects, we propose a decoding approach for tracking the attentional state while subjects are selectively listening to one of the two speech streams embedded in a competing-speaker environment. We develop a biophysically-inspired state-space model to account for the modulation of the neural response with respect to the attentional state of the listener. The constructed decoder is based on a maximum a posteriori (MAP) estimate of the state parameters via the Expectation Maximization (EM) algorithm. Using only the  envelope of the two speech streams as covariates, the proposed decoder enables us to track the attentional state of the listener with a temporal resolution of the  order of seconds, together with statistical confidence intervals. We evaluate the performance of the proposed model using numerical simulations and experimentally  measured evoked MEG responses from the human brain. Our analysis reveals considerable performance gains provided by the state-space model in terms of temporal resolution, computational complexity and decoding accuracy.},
address  = {Department of Electrical and Computer Engineering, University of Maryland, College Park, MD 20742, USA Department of Hearing and Speech Science, University of Maryland, College Park MD 20742, USA Department of Electrical and Computer Engineering, University of Maryland, College Park, MD 20742, USA Department of Electrical and Computer Engineering, University of Maryland, College Park, MD 20742, USA Department of Electrical and Computer Engineering, University of Maryland, College Park, MD 20742, USA},
note  = {doi:10.1016/j.neuroimage.2015.09.048.}
}

@Article{2016362,
author  = {Bernstein, P. and Li, B. and Vachali, P. and Gorusupudi, A. and Shyam, R. and Henriksen, B. and Nolan, J.},
title  = {Underlying Carotenoid-based Nutritional Interventions against Ocular Disease.},
journal  = {Progress in retinal and eye research},
volume  = {50},
number  = {},
pages  = {34-66},
year  = {2016},
abstract  = {The human macula uniquely concentrates three carotenoids: lutein, zeaxanthin, and meso-zeaxanthin. Lutein and zeaxanthin must be obtained from dietary sources such as green leafy vegetables and orange and yellow fruits and vegetables, while meso-zeaxanthin is rarely found in diet and is believed to be formed at the macula by metabolic transformations of ingested carotenoids. Epidemiological studies and large-scale clinical trials such as AREDS2 have brought attention to  the potential ocular health and functional benefits of these three xanthophyll carotenoids consumed through the diet or supplements, but the basic science and clinical research underlying recommendations for nutritional interventions against age-related macular degeneration and other eye diseases are underappreciated by clinicians and vision researchers alike. In this review article, we first examine the chemistry, biophysics, and physiology of these yellow pigments that are specifically concentrated in the macula lutea through the means of high-affinity binding proteins and specialized transport and metabolic proteins where they play important roles as short-wavelength (blue) light-absorbers and localized, efficient antioxidants in a region at high risk for light-induced oxidative stress. Next, we turn to clinical evidence supporting functional benefits of these carotenoids in normal eyes and for their potential protective actions against ocular disease from infancy to old age.},
address  = {Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of  Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132, USA Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of  Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132, USA Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of  Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132, USA Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of  Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132, USA Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of  Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132, USA Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of  Utah School of Medicine, 65 Mario Capecchi Drive, Salt Lake City, Utah, 84132, USA Macular Pigment Research Group, Vision Research Centre, Carriganore House, Waterford Institute of Technology, West Campus, Carriganore, Waterford, Ireland},
note  = {doi:10.1016/j.preteyeres.2015.10.003.}
}

@Article{2012363,
author  = {Liu, S. and Chow, H. and Xu, Y. and Erkkinen, M. and Swett, K. and Eagle, M. and Rizik-Baer, D. and Braun, A.},
title  = {Neural Correlates of Lyrical Improvisation: An fMRI Study of Freestyle Rap.},
journal  = {Scientific Reports},
volume  = {2},
number  = {},
pages  = {},
year  = {2012},
abstract  = {The neural correlates of creativity are poorly understood. Freestyle rap provides a unique opportunity to study spontaneous lyrical improvisation, a multidimensional form of creativity at the interface of music and language. Here  we use functional magnetic resonance imaging to characterize this process. Task contrast analyses indicate that improvised performance is characterized by dissociated activity in medial and dorsolateral prefrontal cortices, providing a  context in which stimulus-independent behaviors may unfold in the absence of conscious monitoring and volitional control. Connectivity analyses reveal widespread improvisation-related correlations between medial prefrontal, cingulate motor, perisylvian cortices and amygdala, suggesting the emergence of a network linking motivation, language, affect and movement. Lyrical improvisation  appears to be characterized by altered relationships between regions coupling intention and action, in which conventional executive control may be bypassed and motor control directed by cingulate motor mechanisms. These functional reorganizations may facilitate the initial improvisatory phase of creative behavior.},
address  = {National Institute on Deafness and Other Communication Disorders, National Institutes of Health National Institute on Deafness and Other Communication Disorders, National Institutes of Health National Institute on Deafness and Other Communication Disorders, National Institutes of Health National Institute on Deafness and Other Communication Disorders, National Institutes of Health National Institute on Deafness and Other Communication Disorders, National Institutes of Health Justice by Uniting Creative Energy Justice by Uniting Creative Energy National Institute on Deafness and Other Communication Disorders, National Institutes of Health},
note  = {Sci Rep. 2012 Nov 15;2:. doi:10.1038/srep00834.}
}

@Article{2016364,
author  = {Cerruela, G. and Luque, R. and G√≥mez-Nieto, M.},
title  = {Communication and Visible Light Communication in the Development of Smart Cities.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {11},
pages  = {},
year  = {2016},
abstract  = {The current social impact of new technologies has produced major changes in all areas of society, creating the concept of a smart city supported by an electronic infrastructure, telecommunications and information technology. This paper presents a review of Bluetooth Low Energy (BLE), Near Field Communication (NFC) and Visible Light Communication (VLC) and their use and influence within different areas of the development of the smart city. The document also presents  a review of Big Data Solutions for the management of information and the extraction of knowledge in an environment where things are connected by an ‚ÄúInternet of Things‚Ä? (IoT) network. Lastly, we present how these technologies can be combined together to benefit the development of the smart city.},
address  = {},
note  = {Sensors (Basel). 2016 Nov 23;16(11):. doi:10.3390/s16111968.}
}

@Article{2008365,
author  = {Fatourechi, M. and Ward, R. and Birch, G.},
title  = {Eye-Movement Artifacts and on Data Recorded in a Subsequent Session.},
journal  = {Computational Intelligence and Neuroscience},
volume  = {2008},
number  = {},
pages  = {},
year  = {2008},
abstract  = {The performance of a specific self-paced BCI (SBCI) is investigated using two different datasets to determine its suitability for using online: (1) data contaminated with large-amplitude eye movements, and (2) data recorded in a session subsequent to the original sessions used to design the system. No part of the data was rejected in the subsequent session. Therefore, this dataset can be regarded as a ‚Äúpseudo-online‚Ä? test set. The SBCI under investigation uses features extracted from three specific neurological phenomena. Each of these neurological phenomena belongs to a different frequency band. Since many prominent artifacts are either of mostly low-frequency (e.g., eye movements) or mostly high-frequency nature (e.g., muscle movements), it is expected that the system shows a fairly robust performance over artifact-contaminated data. Analysis of the data of four participants using epochs contaminated with large-amplitude eye-movement artifacts shows that the system's performance deteriorates only slightly. Furthermore, the system's performance during the session subsequent to the original sessions remained largely the same as in the original sessions for three out of the four participants. This moderate drop in performance can be considered tolerable, since allowing artifact-contaminated data to be used as inputs makes the system available for users at ALL times.},
address  = {Image and Signal Processing Laboratory, Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada V6T 1Z4 Image and Signal Processing Laboratory, Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada V6T 1Z4 Image and Signal Processing Laboratory, Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, Canada V6T 1Z4},
note  = {Comput Intell Neurosci. 2008;2008:. Epub 2008 May 11 doi:10.1155/2008/749204.}
}

@Article{2014366,
author  = {Li, W. and Li, M. and Zhao, J.},
title  = {Control of humanoid robot via motion-onset visual evoked potentials.},
journal  = {Frontiers in Systems Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {This paper investigates controlling humanoid robot behavior via motion-onset specific N200 potentials. In this study, N200 potentials are induced by moving a  blue bar through robot images intuitively representing robot behaviors to be controlled with mind. We present the individual impact of each subject on N200 potentials and discuss how to deal with individuality to obtain a high accuracy.  The study results document the off-line average accuracy of 93% for hitting targets across over five subjects, so we use this major component of the motion-onset visual evoked potential (mVEP) to code people's mental activities and to perform two types of on-line operation tasks: navigating a humanoid robot  in an office environment with an obstacle and picking-up an object. We discuss the factors that affect the on-line control success rate and the total time for completing an on-line operation task.},
address  = {Department of Computer and Electrical Engineering and Computer Science, California State UniversityBakersfield, CA, USA School of Electrical Engineering and Automation, Tianjin UniversityTianjin, China School of Electrical Engineering and Automation, Tianjin UniversityTianjin, China},
note  = {Front Syst Neurosci. 2015 Jan 09;8:. doi:10.3389/fnsys.2014.00247.}
}

@Article{2016367,
author  = {Serra-Sala, M. and Timoneda-Gallart, C. and P√©rez-√?lvarez, F.},
title  = {Clinical usefulness of hemoencephalography beyond the neurofeedback.},
journal  = {Neuropsychiatric Disease and Treatment},
volume  = {12},
number  = {},
pages  = {1173-80},
year  = {2016},
abstract  = {Aim: Hemoencephalography (HEG) is an emerging procedure for clinical application  in attention-deficit hyperactivity disorder and other disorders, regardless of age. It is available to any research group for its relative simplicity and low cost and is a useful tool for assessing prefrontal-dependent functions. Older teenagers pose peculiarities in the prefrontal maturation, and we aim to establish HEG patterns that might have clinical applicability. Methods: The HEG patterns of 70 university students (56 women and 14 men, 21‚Äì48 years old, mean 31.84, SD 10.65, standard error of mean 0.31) were compared with those of 59 adolescents ‚Äì 13‚Äì14-year-old secondary education students, 28 females and 31 males. The HEG patterns were obtained in response to the observation of shocking, unpleasant, and pleasant pictures. We use one-way and two-way analysis of variance to disentangle the differences between groups. All effects were analyzed with F-tests. Results: In all cases, university students and adolescents showed a decrease in prefrontal activity, indicative of differences in the emotional inner networks between groups, which are responsible for security‚Äìinsecurity processing. Compared with university students, adolescents showed statistically significant differences in decreased activity in very unpleasant (shocking) tests that demand increased security‚Äìinsecurity processing. Adolescents showed lower decrease. In addition, adolescents, compared with university subjects, did not show statistically significantly decreased HEG activity compared with the baseline in very unpleasant tests. Conclusion: Teens showed distinguishable patterns of HEG, which were consistent with the cognitive emotional dysregulation in cognition and emotion interaction, that is, exterior network versus internal network interactions. Disability in regulation (modulation) of emotional response to negative emotional stimuli (fear of insecurity) in adolescence is an indicator of possible future clinical and psychiatric disorders such as depression and anxiety with high incidence of onset at this critical age and frequent comorbidity in attention-deficit hyperactivity disorder. HEG pattern might be a useful marker to define maturation and future possible mental dysfunctions.},
address  = {Fundaci√≥ Carme Vidal NeuroPsicoPedagogia, Spain Fundaci√≥ Carme Vidal NeuroPsicoPedagogia, Spain Fundaci√≥ Carme Vidal NeuroPsicoPedagogia, Spain},
note  = {Neuropsychiatr Dis Treat. 2016 May 11;12:1173-80. doi:10.2147/NDT.S105476.}
}

@Article{2012368,
author  = {Hoch, D. and Watson, A. and Linton, D. and Bello, H. and Senelly, M. and Milik, M. and Baim, M. and Jethwani, K. and Fricchione, G. and Benson, H. and Kvedar, J.},
title  = {World.},
journal  = {PLoS ONE},
volume  = {7},
number  = {3},
pages  = {},
year  = {2012},
abstract  = {Introduction: Mind-body medical approaches may ameliorate chronic disease. Stress reduction is particularly helpful, but face-to-face delivery systems cannot reach all those who might benefit. An online, 3-dimensional virtual world may be able to support the rich interpersonal interactions required of this approach. In this pilot study, we explore the feasibility of translating a face-to-face stress reduction program into an online virtual setting and estimate the effect size of  the intervention. Methods and Findings: Domain experts in virtual world technology joined with mind body practitioners to translate an existing 8 week relaxation response-based resiliency program into an 8-week virtual world-based program in Second Life‚Ñ¢ (SL). Twenty-four healthy volunteers with at least one month's experience in SL completed the program. Each subject filled out the Perceived Stress Scale (PSS) and the Symptom Checklist 90- Revised (SCL-90-R) before and after taking part. Participants took part in one of 3 groups of about  10 subjects. The participants found the program to be helpful and enjoyable. Many reported that the virtual environment was an excellent substitute for the preferred face-to-face approach. On quantitative measures, there was a general trend toward decreased perceived stress, (15.7 to 15.0), symptoms of depression,  (57.6 to 57.0) and anxiety (56.8 to 54.8). There was a significant decrease of 2.8 points on the SCL-90-R Global Severity Index (p<0.05). Conclusions: This pilot project showed that it is feasible to deliver a typical mind-body medical intervention through a virtual environment and that it is well received. Moreover, the small reduction in psychological distress suggests further research is warranted. Based on the data collected for this project, a randomized trial with less than 50 subjects would be appropriately powered if perceived stress is  the primary outcome.},
address  = {The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United  States of America Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States of America Health 2.0, San Francisco, California, United States of America Harvard School of Public Health, Massachusetts, United States of America OneVision Solutions Inc., Austin, Texas, United States of America The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United  States of America The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United  States of America Center for Connected Health, Partners Healthcare, Boston, Massachusetts, United States of America The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United  States of America The Benson-Henry Institute for Mind Body Medicine, Boston, Massachusetts, United  States of America Center for Connected Health, Partners Healthcare, Boston, Massachusetts, United States of America},
note  = {PLoS One. 2012 Mar 28;7(3):. doi:10.1371/journal.pone.0033843.}
}

@Article{2016369,
author  = {Wiesmann, M. and Zerbi, V. and Jansen, D. and Haast, R. and L√ºtjohann, D. and Broersen, L. and Heerschap, A. and Kiliaan, A.},
title  = {apoE4 Mice.},
journal  = {Neural Plasticity},
volume  = {2016},
number  = {},
pages  = {},
year  = {2016},
abstract  = {APOE Œµ4 (apoE4) polymorphism is the main genetic determinant of sporadic Alzheimer's disease (AD). A dietary approach (Fortasyn) including docosahexaenoic acid, eicosapentaenoic acid, uridine, choline, phospholipids, folic acid, vitamins B12, B6, C, and E, and selenium has been proposed for dietary management of AD. We hypothesize that the diet could inhibit AD-like pathologies in apoE4 mice, specifically cerebrovascular and connectivity impairment. Moreover, we evaluated the diet effect on cerebral blood flow (CBF), functional connectivity (FC), gray/white matter integrity, and postsynaptic density in aging apoE4 mice.  At 10‚Äì12 months, apoE4 mice did not display prominent pathological differences compared to wild-type (WT) mice. However, 16‚Äì18-month-old apoE4 mice revealed reduced CBF and accelerated synaptic loss. The diet increased cortical CBF and amount of synapses and improved white matter integrity and FC in both aging apoE4 and WT mice. We demonstrated that protective mechanisms on vascular and synapse health are enhanced by Fortasyn, independent of apoE genotype. We further showed  the efficacy of a multimodal translational approach, including advanced MR neuroimaging, to study dietary intervention on brain structure and function in aging.},
address  = {Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour, Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour, Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour, Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour, Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands Institute for Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany Nutricia Research, Advanced Medical Nutrition, Utrecht, Netherlands Department of Radiology and Nuclear Medicine, Radboud University Medical Center,  6525 EZ Nijmegen, Netherlands Department of Anatomy, Donders Institute for Brain, Cognition & Behaviour, Radboud University Medical Center, 6525 EZ Nijmegen, Netherlands},
note  = {Neural Plast. 2016;2016:. Epub 2016 Mar 10 doi:10.1155/2016/6846721.}
}

@Article{2016370,
author  = {Ash, J. and Lu, H. and Taxier, L. and Long, J. and Yang, Y. and Stein, E. and Rapp, P.},
title  = {rats.},
journal  = {Proceedings of the National Academy of Sciences of the United States of America},
volume  = {113},
number  = {43},
pages  = {12286-91},
year  = {2016},
abstract  = {Neural network dynamics thought to play a key role in cognition are substantially disrupted in both normal and pathological aging. Using a rat model, here we aimed to define the effects of aging on the integrity of cortical resting state functional connectivity distinct from the potential contribution of neurodegenerative disease. The findings highlight that disrupted circuit connectivity with the retrosplenial/posterior cingulate cortex is coupled with variability in memory function during aging, and that adaptive plasticity in the  aged brain appears to contribute to successful cognitive aging. The development of interventions that promote neuroadaptive network plasticity is a potentially valuable alternative to strategies currently under investigation, toward bending  the trajectory of aging away from neurodegeneration.},
address  = {Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical Research Center, National Institutes of Health (NIH), Baltimore, MD 21224; Neuroimaging Research Branch, National Institute on Drug Abuse, Biomedical Research Center, NIH, Baltimore, MD 21224 Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical Research Center, National Institutes of Health (NIH), Baltimore, MD 21224; Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical Research Center, National Institutes of Health (NIH), Baltimore, MD 21224; Neuroimaging Research Branch, National Institute on Drug Abuse, Biomedical Research Center, NIH, Baltimore, MD 21224 Neuroimaging Research Branch, National Institute on Drug Abuse, Biomedical Research Center, NIH, Baltimore, MD 21224 Laboratory of Behavioral Neuroscience, National Institute on Aging, Biomedical Research Center, National Institutes of Health (NIH), Baltimore, MD 21224;},
note  = {doi:10.1073/pnas.1525309113.}
}

@Article{2013371,
author  = {Faralli, A. and Bigoni, M. and Mauro, A. and Rossi, F. and Carulli, D.},
title  = {Noninvasive Strategies to Promote Functional Recovery after Stroke.},
journal  = {Neural Plasticity},
volume  = {2013},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Stroke is a common and disabling global health-care problem, which is the third most common cause of death and one of the main causes of acquired adult disability in many countries. Rehabilitation interventions are a major component  of patient care. In the last few years, brain stimulation, mirror therapy, action observation, or mental practice with motor imagery has emerged as interesting options as add-on interventions to standard physical therapies. The neural bases  for poststroke recovery rely on the concept of plasticity, namely, the ability of central nervous system cells to modify their structure and function in response to external stimuli. In this review, we will discuss recent noninvasive strategies employed to enhance functional recovery in stroke patients and we will provide an overview of neural plastic events associated with rehabilitation in preclinical models of stroke.},
address  = {Department of Neuroscience, Neuroscience Institute of Turin, University of Turin, Regione Gonzole 10, 10043 Orbassano (Turin), Italy IRCCS Istituto Auxologico Italiano, Corso Goffredo Mameli 197, 28921 Verbania, Italy IRCCS Istituto Auxologico Italiano, Corso Goffredo Mameli 197, 28921 Verbania, Italy Department of Neuroscience, Neuroscience Institute of Turin, University of Turin, Regione Gonzole 10, 10043 Orbassano (Turin), Italy Department of Neuroscience, Neuroscience Institute of Turin, University of Turin, Regione Gonzole 10, 10043 Orbassano (Turin), Italy},
note  = {Neural Plast. 2013;2013:. Epub 2013 Jun 24 doi:10.1155/2013/854597.}
}

@Article{2015372,
author  = {Xiao, B. and Imel, Z. and Georgiou, P. and Atkins, D. and Narayanan, S.},
title  = {Counseling via Speech and Language Processing.},
journal  = {PLoS ONE},
volume  = {10},
number  = {12},
pages  = {},
year  = {2015},
abstract  = {The technology for evaluating patient-provider interactions in psychotherapy‚Äìobservational coding‚Äìhas not changed in 70 years. It is labor-intensive, error prone, and expensive, limiting its use in evaluating psychotherapy in the real world. Engineering solutions from speech and language processing provide new methods for the automatic evaluation of provider ratings from session recordings. The primary data are 200 Motivational Interviewing (MI)  sessions from a study on MI training methods with observer ratings of counselor empathy. Automatic Speech Recognition (ASR) was used to transcribe sessions, and  the resulting words were used in a text-based predictive model of empathy. Two supporting datasets trained the speech processing tasks including ASR (1200 transcripts from heterogeneous psychotherapy sessions and 153 transcripts and session recordings from 5 MI clinical trials). The accuracy of computationally-derived empathy ratings were evaluated against human ratings for  each provider. Computationally-derived empathy scores and classifications (high vs. low) were highly accurate against human-based codes and classifications, with a correlation of 0.65 and F-score (a weighted average of sensitivity and specificity) of 0.86, respectively. Empathy prediction using human transcription  as input (as opposed to ASR) resulted in a slight increase in prediction accuracies, suggesting that the fully automatic system with ASR is relatively robust. Using speech and language processing methods, it is possible to generate  accurate predictions of provider performance in psychotherapy from audio recordings alone. This technology can support large-scale evaluation of psychotherapy for dissemination and process studies.},
address  = {Department of Electrical Engineering, University of Southern California, Los Angeles, United States of America Department of Educational Psychology, University of Utah, Salt Lake City, United  States of America Department of Electrical Engineering, University of Southern California, Los Angeles, United States of America Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, United States of America Department of Electrical Engineering, University of Southern California, Los Angeles, United States of America},
note  = {PLoS One. 2015 Dec 2;10(12):. doi:10.1371/journal.pone.0143055.}
}

@Article{2007373,
author  = {Edwards, B.},
title  = {The Future of Hearing Aid Technology.},
journal  = {Trends in Amplification},
volume  = {11},
number  = {1},
pages  = {31-45},
year  = {2007},
abstract  = {Hearing aids have advanced significantly over the past decade, primarily due to the maturing of digital technology. The next decade should see an even greater number of innovations to hearing aid technology, and this article attempts to predict in which areas the new developments will occur. Both incremental and radical innovations in digital hearing aids will be driven by research advances in the following fields: (1) wireless technology, (2) digital chip technology, (3) hearing science, and (4) cognitive science. The opportunities and limitations for each of these areas will be discussed. Additionally, emerging trends such as  connectivity and individualization will also drive new technology, and these are  discussed within the context of the areas given here.},
address  = {From Starkey Hearing Research Center, Berkeley, California.},
note  = {Trends Amplif. 2007 Mar;11(1):31-45. doi:10.1177/1084713806298004.}
}

@Article{2012374,
author  = {Mitseva, A. and Peterson, C. and Karamberi, C. and Oikonomou, L. and Ballis, A. and Giannakakos, C. and Dafoulas, G.},
title  = {Acceptance of Informal Caregivers.},
journal  = {Current Gerontology and Geriatrics Research},
volume  = {2012},
number  = {},
pages  = {},
year  = {2012},
abstract  = {The incidence of cognitive impairment in older age is increasing, as is the number of cognitively impaired older adults living in their own homes. Due to lack of social care resources for these adults and their desires to remain in their own homes and live as independently as possible, research shows that the current standard care provisions are inadequate. Promising opportunities exist in using home assistive technology services to foster healthy aging and to realize the unmet needs of these groups of citizens in a user-centered manner. ISISEMD project has designed, implemented, verified, and assessed an assistive technology platform of personalized home care (telecare) for the elderly with cognitive impairments and their caregivers by offering intelligent home support services. Regions from four European countries have carried out long-term pilot-controlled  study in real-life conditions. This paper presents the outcomes from intermediate evaluations pertaining to user satisfaction with the system, acceptance of the technology and the services, and quality of life outcomes as a result of utilizing the services.},
address  = {North Denmark EU-Office, Aalborg Municipality, Boulevarden 13, 9000 Aalborg, Denmark Center for TeleInFrastruktur (CTiF), Aalborg University, Niels Jernes Vej 12, 9220 Aalborg, Denmark Municipal Enterprise for Social Development (DEKA) of Trikala, European Projects  Department, Valkanou 6, 42100 Trikala, Greece Municipal Enterprise for Social Development (DEKA) of Trikala, European Projects  Department, Valkanou 6, 42100 Trikala, Greece e-Trikala SA, e-Health Department and R&D Department, Street Sarafi 44, 42100 Trikala, Greece Hellenic Statistical Authority, Census Department, Piraeus 46 & Eponiton, 18510 Piraeus, Greece e-Trikala SA, e-Health Department and R&D Department, Street Sarafi 44, 42100 Trikala, Greece},
note  = {Curr Gerontol Geriatr Res. 2012;2012:. Epub 2012 Mar 22 doi:10.1155/2012/401705.}
}

@Article{2013375,
author  = {Ninaus, M. and Kober, S. and Witte, M. and Koschutnig, K. and Stangl, M. and Neuper, C. and Wood, G.},
title  = {training.},
journal  = {Frontiers in Human Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Learning to modulate one's own brain activity is the fundament of neurofeedback (NF) applications. Besides the neural networks directly involved in the generation and modulation of the neurophysiological parameter being specifically  trained, more general determinants of NF efficacy such as self-referential processes and cognitive control have been frequently disregarded. Nonetheless, deeper insight into these cognitive mechanisms and their neuronal underpinnings sheds light on various open NF related questions concerning individual differences, brain-computer interface (BCI) illiteracy as well as a more general  model of NF learning. In this context, we investigated the neuronal substrate of  these more general regulatory mechanisms that are engaged when participants believe that they are receiving NF. Twenty healthy participants (40‚Äì63 years, 10  female) performed a sham NF paradigm during fMRI scanning. All participants were  novices to NF-experiments and were instructed to voluntarily modulate their own brain activity based on a visual display of moving color bars. However, the bar depicted a recording and not the actual brain activity of participants. Reports collected at the end of the experiment indicate that participants were unaware of the sham feedback. In comparison to a passive watching condition, bilateral insula, anterior cingulate cortex and supplementary motor and dorsomedial and lateral prefrontal areas were activated when participants actively tried to control the bar. In contrast, when merely watching moving bars, increased activation in the left angular gyrus was observed. These results show that the intention to control a moving bar is sufficient to engage a broad frontoparietal  and cingulo-opercular network involved in cognitive control. The results of the present study indicate that tasks such as those generally employed in NF training recruit the neuronal correlates of cognitive control even when only sham NF is presented.},
address  = {Department of Psychology, University of GrazGraz, Austria Department of Psychology, University of GrazGraz, Austria Department of Psychology, University of GrazGraz, Austria Department of Psychology, University of GrazGraz, Austria Aging and Cognition Research Group, German Center for Neurodegenerative Diseases  (DZNE)Magdeburg, Germany Department of Psychology, University of GrazGraz, Austria Department of Psychology, University of GrazGraz, Austria},
note  = {Front Hum Neurosci. 2013 Dec 26;7:. doi:10.3389/fnhum.2013.00914.}
}

@Article{2017376,
author  = {Carrasco-Zevallos, O. and Viehland, C. and Keller, B. and Draelos, M. and Kuo, A. and Toth, C. and Izatt, J.},
title  = {applications [Invited].},
journal  = {Biomedical Optics Express},
volume  = {8},
number  = {3},
pages  = {1607-37},
year  = {2017},
abstract  = {During microsurgery, en face imaging of the surgical field through the operating  microscope limits the surgeon‚Äôs depth perception and visualization of instruments and sub-surface anatomy. Surgical procedures outside microsurgery, such as breast tumor resections, may also benefit from visualization of the sub-surface tissue structures. The widespread clinical adoption of optical coherence tomography (OCT) in ophthalmology and its growing prominence in other fields, such as cancer imaging, has motivated the development of intraoperative OCT for real-time tomographic visualization of surgical interventions. This article reviews key technological developments in intraoperative OCT and their applications in human  surgery. We focus on handheld OCT probes, microscope-integrated OCT systems, and  OCT-guided laser treatment platforms designed for intraoperative use. Moreover, we discuss intraoperative OCT adjuncts and processing techniques currently under  development to optimize the surgical feedback derivable from OCT data. Lastly, we survey salient clinical studies of intraoperative OCT for human surgery.},
address  = {Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA Department of Ophthalmology, Duke University Medical Center, NC 27710, USA Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA},
note  = {Biomed Opt Express. 2017 Feb 21;8(3):1607-37. doi:10.1364/BOE.8.001607.}
}

@Article{2014377,
author  = {Bareket-Keren, L. and Hanein, Y.},
title  = {challenges.},
journal  = {International Journal of Nanomedicine},
volume  = {9},
number  = {Suppl 1},
pages  = {65-83},
year  = {2014},
abstract  = {Light activation of neurons is a growing field with applications ranging from basic investigation of neuronal systems to the development of new therapeutic methods such as artificial retina. Many recent studies currently explore novel methods for optical stimulation with temporal and spatial precision. Novel materials in particular provide an opportunity to enhance contemporary approaches. Here we review recent advances towards light directed interfaces for  neuronal stimulation, focusing on state-of-the-art nanoengineered devices. In particular, we highlight challenges and prospects towards improved retinal prostheses.},
address  = {School of Electrical Engineering, Tel-Aviv University, Tel-Aviv University, Tel-Aviv, Israel School of Electrical Engineering, Tel-Aviv University, Tel-Aviv University, Tel-Aviv, Israel},
note  = {Int J Nanomedicine. 2014 May 06;9(Suppl 1):65-83. doi:10.2147/IJN.S51193.}
}

@Article{2012378,
author  = {Conesa-Mu√±oz, J. and Ribeiro, A.},
title  = {Strategic Installations.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {12},
number  = {3},
pages  = {3281-301},
year  = {2012},
abstract  = {Due to the sensitive international situation caused by still-recent terrorist attacks, there is a common need to protect the safety of large spaces such as government buildings, airports and power stations. To address this problem, developments in several research fields, such as video and cognitive audio, decision support systems, human interface, computer architecture, communications  networks and communications security, should be integrated with the goal of achieving advanced security systems capable of checking all of the specified requirements and spanning the gap that presently exists in the current market. This paper describes the implementation of a decision system for crisis management in infrastructural building security. Specifically, it describes the implementation of a decision system in the management of building intrusions. The positions of the unidentified persons are reported with the help of a Wireless Sensor Network (WSN). The goal is to achieve an intelligent system capable of making the best decision in real time in order to quickly neutralise one or more  intruders who threaten strategic installations. It is assumed that the intruders‚Äô behaviour is inferred through sequences of sensors‚Äô activations and their fusion. This article presents a general approach to selecting the optimum operation from  the available neutralisation strategies based on a Minimax algorithm. The distances among different scenario elements will be used to measure the risk of the scene, so a path planning technique will be integrated in order to attain a good performance. Different actions to be executed over the elements of the scene such as moving a guard, blocking a door or turning on an alarm will be used to neutralise the crisis. This set of actions executed to stop the crisis is known as the neutralisation strategy. Finally, the system has been tested in simulations of real situations, and the results have been evaluated according to  the final state of the intruders. In 86.5% of the cases, the system achieved the  capture of the intruders, and in 59.25% of the cases, they were intercepted before they reached their objective.},
address  = {},
note  = {Sensors (Basel). 2012 Mar 7;12(3):3281-301. doi:10.3390/s120303281.}
}

@Article{2015379,
author  = {E., F. and C., M. and Shepherd, S. and Cabot, J. and Hopkins, N.},
title  = {controlled trial.},
journal  = {BMC Public Health},
volume  = {15},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Background: Excessive sitting time is a risk factor for cardiovascular disease mortality and morbidity independent of physical activity. This aim of this study  was to evaluate the impact of a sit-stand workstation on sitting time, and vascular, metabolic and musculoskeletal outcomes in office workers, and to investigate workstation acceptability and feasibility. Methods: A two-arm, parallel-group, individually randomised controlled trial was conducted in one organisation. Participants were asymptomatic full-time office workers aged ‚â•18 years. Each participant in the intervention arm had a sit-stand workstation installed on their workplace desk for 8 weeks. Participants in the control arm received no intervention. The primary outcome was workplace sitting time, assessed at 0, 4 and 8 weeks by an ecological momentary assessment diary. Secondary behavioural, cardiometabolic and musculoskeletal outcomes were assessed. Acceptability and feasibility were assessed via questionnaire and interview. ANCOVA and magnitude-based inferences examined intervention effects relative to controls at 4 and 8 weeks. Participants and researchers were not blind to group allocation. Results: Forty-seven participants were randomised (intervention n‚Äâ=‚Äâ26; control n‚Äâ=‚Äâ21). Relative to the control group at 8 weeks,  the intervention group had a beneficial decrease in sitting time (‚àí80.2 min/8-h workday (95 % CI‚Äâ=‚Äâ‚àí129.0, ‚àí31.4); p‚Äâ=‚Äâ0.002), increase in standing time (72.9 min/8-h workday (21.2, 124.6); p‚Äâ=‚Äâ0.007) and decrease in total cholesterol (‚àí0.40 mmol/L  (‚àí0.79, ‚àí0.003); p‚Äâ=‚Äâ0.049). No harmful changes in musculoskeletal discomfort/pain were observed relative to controls, and beneficial changes in flow-mediated dilation and diastolic blood pressure were observed. Most participants self-reported that the workstation was easy to use and their work-related productivity did not decrease when using the device. Factors that negatively influenced workstation use were workstation design, the social environment, work tasks and habits. Conclusion: Short-term use of a feasible sit-stand workstation reduced daily sitting time and led to beneficial improvements in cardiometabolic risk parameters in asymptomatic office workers. These findings imply that if the observed use of the sit-stand workstations continued over a longer duration, sit-stand workstations may have important ramifications for the prevention and reduction of cardiometabolic risk in a large proportion of the working population. Trial registration: ClinicalTrials.gov NCT02496507.},
address  = {Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UK Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UK Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UK Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UK Research Institute for Sport and Exercise Science, Liverpool John Moores University, Liverpool, UK},
note  = {BMC Public Health. 2015 Nov 19;15:. doi:10.1186/s12889-015-2469-8.}
}

@Article{2010380,
author  = {Mabrey, J. and Reinig, K. and Cannon, W.},
title  = {Virtual Reality in Orthopaedics: Is It a Reality?},
journal  = {Clinical Orthopaedics and Related Research},
volume  = {468},
number  = {10},
pages  = {2586-91},
year  = {2010},
abstract  = {Background: Virtual reality (VR) simulation has been a requirement for airline and military pilots for decades and is only now being integrated into surgical training programs. Thus far, orthopaedic training programs have been slow to adopt VR training. Questions/purposes: We therefore asked (1) how VR has worked for other surgical specialties; (2) what VR solutions are available for orthopaedics; and (3) should VR simulation become part of the orthopaedic curriculum? Methods: An informal literature review was performed, searching for orthopaedically-oriented VR surgical simulators and comparing this to the number  of programs available for general surgery teaching programs. An in-depth review of a VR simulator for knee arthroscopy is also presented. Where are we now?The number of papers specific to orthopaedics and VR is limited. VR is used effectively in other specialties, especially general surgery. VR simulators are readily available for shoulder and knee arthroscopy but not as well incorporated  into training curricula. Where do we need to go?VR technology is available today  for training programs. Integration of VR into the orthopaedic curriculum will save time in the OR, reduce operative errors, and improve the resident‚Äôs overall  educational experience. The public will expect their surgeons to train on these simulators. How do we get there?Orthopaedic training programs should take advantage of the commercially available VR simulators for orthopaedic procedures  and incorporate them into their training curricula. This effort could be led by the American Academy of Orthopaedic Surgeons (AAOS) and the American Board of Orthopaedic Surgery (ABOS), two of the primary sponsors of a major study in the effectiveness of VR simulators for knee arthroscopy.},
address  = {Department of Orthopaedics, Baylor University Medical Center, 3500 Gaston Ave., 6 Hoblitzelle, Dallas, TX 75246 USA Touch of Life Technologies, Aurora, CO USA Department of Orthopaedics, University of California, San Francisco, CA USA},
note  = {doi:10.1007/s11999-010-1426-1.}
}

@Article{2017381,
author  = {Febo, M. and Blum, K. and Badgaiyan, R. and Perez, P. and Colon-Perez, L. and Thanos, P. and Ferris, C. and Kulkarni, P. and Giordano, J. and Baron, D. and Gold, M.},
title  = {of na√Øve rodent brain produced by pro-dopaminergic agent KB220Z.},
journal  = {PLoS ONE},
volume  = {12},
number  = {4},
pages  = {},
year  = {2017},
abstract  = {Dopaminergic reward dysfunction in addictive behaviors is well supported in the literature. There is evidence that alterations in synchronous neural activity between brain regions subserving reward and various cognitive functions may significantly contribute to substance-related disorders. This study presents the  first evidence showing that a pro-dopaminergic nutraceutical (KB220Z) significantly enhances, above placebo, functional connectivity between reward and cognitive brain areas in the rat. These include the nucleus accumbens, anterior cingulate gyrus, anterior thalamic nuclei, hippocampus, prelimbic and infralimbic loci. Significant functional connectivity, increased brain connectivity volume recruitment (potentially neuroplasticity), and dopaminergic functionality were found across the brain reward circuitry. Increases in functional connectivity were specific to these regions and were not broadly distributed across the brain. While these initial findings have been observed in drug na√Øve rodents, this robust, yet selective response implies clinical relevance for addicted individuals at risk for relapse, who show reductions in functional connectivity after protracted withdrawal. Future studies will evaluate KB220Z in animal models of addiction.},
address  = {Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, United States of America Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, United States of America Department of Psychiatry, Wright State University, Boonshoft School of Medicine,  Dayton, Ohio, United States of America Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, United States of America Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, United States of America Research Institute on Addictions, University at Buffalo, Buffalo, New York, United States of America Center for Translational Neuroimaging, Department of Psychology and Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America Center for Translational Neuroimaging, Department of Psychology and Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America Department of Holistic Medicine, National Institute for Holistic Addiction Studies, North Miami Beach, Florida, United States of America Department of Psychiatry, Keck Medicine University of Southern California, Los Angeles, California, United States of America Department of Psychiatry & McKnight Brain Institute, University of Florida College of Medicine, Gainesville, Florida, United States of America},
note  = {PLoS One. 2017 Apr 26;12(4):. doi:10.1371/journal.pone.0174774.}
}

@Article{2016382,
author  = {Ayhan, Y. and McFarland, R. and Pletnikov, M.},
title  = {perspective.},
journal  = {Progress in neurobiology},
volume  = {136},
number  = {},
pages  = {1-27},
year  = {2016},
abstract  = {Schizophrenia has long been considered as a disorder with multifactorial origins. Recent discoveries have advanced our understanding of the genetic architecture of the disease. However, even with the increase of identified risk variants, heritability estimates suggest an important contribution of non-genetic factors.  Various environmental risk factors have been proposed to play a role in the etiopathogenesis of schizophrenia. These include season of birth, maternal infections, obstetric complications, adverse events at early childhood, and drug  abuse. Despite the progress in identification of genetic and environmental risk factors, we still have a limited understanding of the mechanisms whereby gene-environment interactions (GxE) operate in schizophrenia and psychoses at large. In this review we provide a critical analysis of current animal models of  GxE relevant to psychotic disorders and propose that dimensional perspective will advance our understanding of the complex mechanisms of these disorders.},
address  = {Departmant of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine Departmant of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine Departmant of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine},
note  = {doi:10.1016/j.pneurobio.2015.10.002.}
}

@Article{2013383,
author  = {Parpura, V. and Silva, G. and Tass, P. and Bennet, K. and Meyyappan, M. and Koehne, J. and Lee, K. and Andrews, R.},
title  = {Neuromodulation: Selected approaches and challenges.},
journal  = {Journal of neurochemistry},
volume  = {124},
number  = {4},
pages  = {436-53},
year  = {2013},
abstract  = {The brain operates through complex interactions in the flow of information and signal processing within neural networks. The ‚Äúwiring‚Ä? of such networks, being neuronal or glial, can physically and/or functionally go rogue in various pathological states. Neuromodulation, as a multidisciplinary venture, attempts to correct such faulty nets. In this review, selected approaches and challenges in neuromoduation are discussed. The use of water-dispersible carbon nanotubes have  proven effective in modulation of neurite outgrowth in culture as well as in aiding regeneration after spinal cord injury in vivo. Studying neural circuits using computational biology and analytical engineering approaches brings to light geometrical mapping of dynamics within neural networks, much needed information for stimulation interventions in medical practice. Indeed, sophisticated desynchronization approaches used for brain stimulation have been successful in coaxing ‚Äúmisfiring‚Ä? neuronal circuits to resume productive firing patterns in various human disorders. Devices have been developed for the real time measurement of various neurotransmitters as well as electrical activity in the human brain during electrical deep brain stimulation. Such devices can establish  the dynamics of electrochemical changes in the brain during stimulation. With increasing application of nanomaterials in devices for electrical and chemical recording and stimulating in the brain, the era of cellular, and even intracellular, precision neuromodulation will soon be upon us.},
address  = {Department of Neurobiology, Center for Glial Biology in Medicine, Atomic Force Microscopy and Nanotechnology Laboratories, Civitan International Research Center, Evelyn F. McKnight Brain Institute, University of Alabama, Birmingham, Alabama, USA Department of Bioengineering, Department of Ophthalmology, and Neurosciences Program, University of California, San Diego, USA Institute of Neuroscience and Medicine ‚Äì Neuromodulation, Research Center J√ºlich, J√ºlich, Germany Divison of Engineering, Mayo Clinic Rochester, Rochester, MN, USA Center for Nanotechnology, NASA Ames Research Center, Moffett Field, CA, USA Center for Nanotechnology, NASA Ames Research Center, Moffett Field, CA, USA Department of Neurosurgery, Mayo Clinic Rochester, Rochester, MN, USA Center for Nanotechnology, NASA Ames Research Center, Moffett Field, CA, USA},
note  = {J Neurochem. 2013 Feb;124(4):436-53. Epub 2012 Dec 26 doi:10.1111/jnc.12105.}
}

@Article{2016384,
author  = {Gouty-Colomer, L. and Hosseini, B. and Marcelo, I. and Schreiber, J. and Slump, D. and Yamaguchi, S. and Houweling, A. and Jaarsma, D. and Elgersma, Y. and Kushner, S.},
title  = {Arc expression identifies the lateral amygdala fear memory trace.},
journal  = {Molecular Psychiatry},
volume  = {21},
number  = {3},
pages  = {364-75},
year  = {2016},
abstract  = {Memories are encoded within sparsely distributed neuronal ensembles. However, the defining cellular properties of neurons within a memory trace remain incompletely understood. Using a fluorescence-based Arc reporter, we were able to visually identify the distinct subset of lateral amygdala (LA) neurons activated during auditory fear conditioning. We found that Arc-expressing neurons have enhanced intrinsic excitability and are preferentially recruited into newly encoded memory traces. Furthermore, synaptic potentiation of thalamic inputs to the LA during fear conditioning is learning-specific, postsynaptically mediated and highly localized to Arc-expressing neurons. Taken together, our findings validate the immediate-early gene Arc as a molecular marker for the LA neuronal ensemble recruited during fear learning. Moreover, these results establish a model of fear memory formation in which intrinsic excitability determines neuronal selection, whereas learning-related encoding is governed by synaptic plasticity.},
address  = {Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands Division of Morphological Neuroscience, Gifu University Graduate School of Medicine, Gifu, Japan Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands Department of Neuroscience, Erasmus Medical Centre, Rotterdam, The Netherlands Department of Psychiatry, Erasmus University Medical Center, Rotterdam, The Netherlands},
note  = {Mol Psychiatry. 2016 Mar;21(3):364-75. Epub 2015 Mar 24 doi:10.1038/mp.2015.18.}
}

@Article{2014385,
author  = {Thielbar, K. and Lord, T. and Fischer, H. and Lazzaro, E. and Barth, K. and Stoykov, M. and Triandafilou, K. and Kamper, D.},
title  = {improved fine motor control post-stroke.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {11},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Background: Dexterous manipulation of the hand, one of the features of human motor control, is often compromised after stroke, to the detriment of basic functions. Despite the importance of independent movement of the digits to activities of daily living, relatively few studies have assessed the impact of specifically targeting individuated movements of the digits on hand rehabilitation. The purpose of this study was to investigate the impact of such finger individuation training, by means of a novel mechatronic-virtual reality system, on fine motor control after stroke. Methods: An actuated virtual keypad (AVK) system was developed in which the impaired hand controls a virtual hand playing a set of keys. Creation of individuated digit movements is assisted by a  pneumatically actuated glove, the PneuGlove. A study examining efficacy of the AVK system was subsequently performed. Participants had chronic, moderate hand impairment resulting from a single stroke incurred at least 6 months prior. Each  subject underwent 18 hour-long sessions of extensive therapy (3x per week for 6 weeks) targeted at finger individuation. Subjects were randomly divided into two groups: the first group (Keypad: N‚Äâ=‚Äâ7) utilized the AVK system while the other group (OT: N‚Äâ=‚Äâ7) received a similarly intensive dose of occupational therapy; both groups worked directly with a licensed occupational therapist. Outcome measures such as the Jebsen-Taylor Hand Function Test (JTHFT), Action research Arm Test (ARAT), Fugl-Meyer Upper Extremity Motor Assessment/Hand subcomponent (FMUE/FMH), grip and pinch strengths were collected at baseline, post-treatment and one-month post-treatment. Results: While both groups exhibited some signs of change after the training sessions, only the Keypad group displayed statistically significant improvement both for measures of impairment (FMH: p‚Äâ=‚Äâ0.048) and measures of task performance (JTHFT: p‚Äâ=‚Äâ0.021). Additionally, the finger individuation index ‚Äì a measure of finger independence ‚Äì improved only for the Keypad group after training (p‚Äâ=‚Äâ0.05) in the subset (Keypad: N‚Äâ=‚Äâ4; OT: N‚Äâ=‚Äâ5) of these participants for which it was measured. Conclusions: Actively assisted individuation therapy comprised of non task-specific modalities, such as can be achieved with virtual platforms like the AVK described here, may prove to  be valuable clinical tools for increasing the effectiveness and efficiency of therapy following stroke. Electronic supplementary material: The online version of this article (doi:10.1186/1743-0003-11-171) contains supplementary material, which is available to authorized users.},
address  = {Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E Superior Street,Suite 1406, Chicago, IL 60611 USA Department of Biomedical Engineering, Illinois Institute of Technology, Chicago,  IL 60616 USA Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E Superior Street,Suite 1406, Chicago, IL 60611 USA Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E Superior Street,Suite 1406, Chicago, IL 60611 USA Department of Biomedical Engineering, Vanderbilt University, Nashville, TN 37235  USA Occupational Therapy College of Health Sciences, Rush University, Chicago, IL 60612 USA Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E Superior Street,Suite 1406, Chicago, IL 60611 USA Sensory Motor Performance Program, Rehabilitation Institute of Chicago, 345 E Superior Street,Suite 1406, Chicago, IL 60611 USA},
note  = {J Neuroeng Rehabil. 2014 Dec 26;11:. doi:10.1186/1743-0003-11-171.}
}

@Article{2012386,
author  = {Shih, A. and Driscoll, J. and Drew, P. and Nishimura, N. and Schaffer, C. and Kleinfeld, D.},
title  = {the rodent brain.},
journal  = {Journal of Cerebral Blood Flow & Metabolism},
volume  = {32},
number  = {7},
pages  = {1277-309},
year  = {2012},
abstract  = {The cerebral vascular system services the constant demand for energy during neuronal activity in the brain. Attempts to delineate the logic of neurovascular  coupling have been greatly aided by the advent of two-photon laser scanning microscopy to image both blood flow and the activity of individual cells below the surface of the brain. Here we provide a technical guide to imaging cerebral blood flow in rodents. We describe in detail the surgical procedures required to  generate cranial windows for optical access to the cortex of both rats and mice and the use of two-photon microscopy to accurately measure blood flow in individual cortical vessels concurrent with local cellular activity. We further provide examples on how these techniques can be applied to the study of local blood flow regulation and vascular pathologies such as small-scale stroke.},
address  = {Department of Physics, University of California at San Diego, La Jolla, California, USA Department of Physics, University of California at San Diego, La Jolla, California, USA Department of Engineering Science and Mechanics, Pennsylvania State University, University Park, Pennsylvania, USA Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA Department of Biomedical Engineering, Cornell University, Ithaca, New York, USA Department of Physics, University of California at San Diego, La Jolla, California, USA},
note  = {doi:10.1038/jcbfm.2011.196.}
}

@Article{2011387,
author  = {Mahmoudi, M. and Sahraian, M. and Shokrgozar, M. and Laurent, S.},
title  = {of Multiple Sclerosis.},
journal  = {ACS Chemical Neuroscience},
volume  = {2},
number  = {3},
pages  = {118-40},
year  = {2011},
abstract  = {Smart superparamagnetic iron oxide nanoparticles (SPIONs) are the most promising  candidate for theragnosis (i.e., diagnosis and treatment) of multiple sclerosis.  A deep understanding of the dynamics of the in vivo neuropathology of multiple sclerosis can be achieved by improving the efficiency of various medical techniques (e.g., positron emission tomography and magnetic resonance imaging) using multimodal SPIONs. In this Review, recent advances and challenges in the development of smart SPIONs for theragnostic applications are comprehensively described. In addition, critical outlines of emerging developments are provided from the points of view of both clinicians and nanotechnologists.},
address  = {National Cell Bank, Pasteur Institute of Iran, Tehran, 11365-8639, Iran Department of Neurology National Cell Bank, Pasteur Institute of Iran, Tehran, 11365-8639, Iran Department of General, Organic, and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons, Avenue Maistriau, 19, B-7000 Mons, Belgium},
note  = {ACS Chem Neurosci. 2011 Feb 04;2(3):118-40. doi:10.1021/cn100100e.}
}

@Article{2014388,
author  = {Young, B. and Nigogosyan, Z. and Nair, V. and Walton, L. and Song, J. and Tyler, M. and Edwards, D. and Caldera, K. and Sattin, J. and Williams, J. and Prabhakaran, V.},
title  = {preexisting sensorineural disability.},
journal  = {Frontiers in Neuroengineering},
volume  = {7},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Therapies involving new technologies such as brain-computer interfaces (BCI) are  being studied to determine their potential for interventional rehabilitation after acute events such as stroke produce lasting impairments. While studies have examined the use of BCI devices by individuals with disabilities, many such devices are intended to address a specific limitation and have been studied when  this limitation or disability is present in isolation. Little is known about the  therapeutic potential of these devices for individuals with multiple disabilities with an acquired impairment overlaid on a secondary long-standing disability. We  describe a case in which a male patient with congenital deafness suffered a right pontine ischemic stroke, resulting in persistent weakness of his left hand and arm. This patient volunteer completed four baseline assessments beginning at 4 months after stroke onset and subsequently underwent 6 weeks of interventional rehabilitation therapy using a closed-loop neurofeedback BCI device with visual,  functional electrical stimulation, and tongue stimulation feedback modalities. Additional assessments were conducted at the midpoint of therapy, upon completion of therapy, and 1 month after completing all BCI therapy. Anatomical and functional MRI scans were obtained at each assessment, along with behavioral measures including the Stroke Impact Scale (SIS) and the Action Research Arm Test (ARAT). Clinically significant improvements in behavioral measures were noted over the course of BCI therapy, with more than 10 point gains in both the ARAT scores and scores for the SIS hand function domain. Neuroimaging during finger tapping of the impaired hand also showed changes in brain activation patterns associated with BCI therapy. This case study demonstrates the potential for individuals who have preexisting disability or possible atypical brain organization to learn to use a BCI system that may confer some rehabilitative benefit.},
address  = {Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA Department of Biomedical Engineering, University of Wisconsin-MadisonMadison, WI, USA Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA Department of Biomedical Engineering, University of Wisconsin-MadisonMadison, WI, USA Departments of Kinesiology and Medicine, University of Wisconsin-MadisonMadison,  WI, USA Department of Orthopedics and Rehabilitation, University of Wisconsin-MadisonMadison, WI, USA Department of Neurology, University of Wisconsin-MadisonMadison, WI, USA Neuroscience Training Program, University of Wisconsin-MadisonMadison, WI, USA Department of Radiology, University of Wisconsin-MadisonMadison, WI, USA},
note  = {Front Neuroeng. 2014 Jun 24;7:. doi:10.3389/fneng.2014.00018.}
}

@Article{2014389,
author  = {Yang, B. and Roys, S. and Tan, U. and Philip, M. and Richard, H. and Gullapalli, R. and Desai, J.},
title  = {Biopsy under Continuous MRI*.},
journal  = {The International journal of robotics research},
volume  = {33},
number  = {4},
pages  = {616-30},
year  = {2014},
abstract  = {Magnetic Resonance Imaging (MRI) provides superior soft-tissue contrast in cancer diagnosis compared to other imaging modalities. However, the strong magnetic field inside the MRI bore along with limited scanner bore size poses significant  challenges. Since current approaches in breast biopsy using MR images is primarily a blind targeting approach, it is necessary to develop a MRI-compatible robot that can avoid multiple needle insertions into the breast tissue. This MRI-compatible robotic system could potentially lead to improvement in the targeting accuracy and reduce sampling errors. A master-slave surgical system has been developed comprising of a MRI-compatible slave robot which consists of one piezo motor and five pneumatic cylinders connected by long pneumatic transmission lines. The slave robot follows the configuration of the master robot, which provides an intuitive manipulation interface for the physician and operates inside the MRI bore to adjust the needle position and orientation and perform needle insertion task. Based on the MRI experiments using the slave robot, there  was no significant distortion in the images and hence the slave robot can be safely operated inside the MRI with minimal loss in signal-to-noise ratio (SNR).  Ex vivo and in vivo experiments have been conducted to evaluate the performance of the master-slave surgical system.},
address  = {Robotics, Automation, and Medical Systems (RAMS) Laboratory, Maryland Robotics Center, Institute for System Research, University of Maryland, College Park, MD,  USA University of Maryland School of Medicine, Baltimore, MD, USA Singapore University of Technology and Design, Singapore University of Maryland School of Medicine, Baltimore, MD, USA University of Maryland School of Medicine, Baltimore, MD, USA University of Maryland School of Medicine, Baltimore, MD, USA Robotics, Automation, and Medical Systems (RAMS) Laboratory, Maryland Robotics Center, Institute for System Research, University of Maryland, College Park, MD,  USA},
note  = {Int J Rob Res. 2014 Apr;33(4):616-30. doi:10.1177/0278364913500365.}
}

@Article{2011390,
author  = {Ritaccio, A. and Boatman-Reich, D. and Brunner, P. and Cervenka, M. and Cole, A. and Crone, N. and Duckrow, R. and Korzeniewska, A. and Litt, B. and Miller, K. and Moran, D. and Parvizi, J. and Viventi, J. and Williams, J. and Schalk, G.},
title  = {Electrocorticography.},
journal  = {Epilepsy & behavior : E&B},
volume  = {22},
number  = {4},
pages  = {},
year  = {2011},
abstract  = {The Second International Workshop on Advances in Electrocorticography (ECoG) was  convened in San Diego, CA, USA, on November 11‚Äì12, 2010. Between this meeting and the inaugural 2009 event, a much clearer picture has been emerging of cortical ECoG physiology and its relationship to local field potentials and single-cell recordings. Innovations in material engineering are advancing the goal of a stable long-term recording interface. Continued evolution of ECoG-driven brain‚Äìcomputer interface technology is determining innovation in neuroprosthetics. Improvements in instrumentation and statistical methodologies continue to elucidate ECoG correlates of normal human function as well as the ictal state. This proceedings document summarizes the current status of this rapidly evolving field.},
address  = {Albany Medical College, Albany, NY, USA The Johns Hopkins Hospital, Baltimore, MD, USA Albany Medical College, Albany, NY, USA The Johns Hopkins Hospital, Baltimore, MD, USA Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA The Johns Hopkins Hospital, Baltimore, MD, USA Yale University, New Haven, CT, USA The Johns Hopkins Hospital, Baltimore, MD, USA University of Pennsylvania, Pittsburgh, PA, USA Stanford University, Stanford, CA, USA Washington University, St. Louis, MO, USA Stanford University, Stanford, CA, USA Polytechnic Institute of New York University, Brooklyn, NY, USA University of Wisconsin‚ÄîMadison, Madison, WI, USA Albany Medical College, Albany, NY, USA},
note  = {doi:10.1016/j.yebeh.2011.09.028.}
}

@Article{2012391,
author  = {Bewernitz, M. and Derendorf, H.},
title  = {Electroencephalogram-based pharmacodynamic measures: a review .},
journal  = {International Journal of Clinical Pharmacology and Therapeutics},
volume  = {50},
number  = {3},
pages  = {162-84},
year  = {2012},
abstract  = {Pharmacokinetics and pharmacodynamics can provide a useful modeling framework for predicting drug activity and can serve as a basis for dose optimization. Determining a suitable biomarker or surrogate measure of drug effect for pharmacodynamic models can be challenging. The electroencephalograph is a widely-available and non-invasive tool for recording brain-wave activity simultaneously from multiple brain regions. Certain drug classes (such as drugs that act on the central nervous system) also generate a reproducible electroencephalogram (EEG) effect. Characterization of such a drug-induced EEG effect can produce pharmacokinetic/pharmacodynamic models useful for titrating drug levels and expediting development of chemically-similar drug analogs. This paper reviews the relevant concepts involved in pharmacokinetic/pharmacodynamic modeling using EEG-based pharmacodynamic measures. In addition, examples of such  models for various drugs are organized by drug activity as well as chemical structure and presented.},
address  = {},
note  = {doi:10.5414/CP201484.}
}

@Article{2016392,
author  = {Muller, C. and Anacker, A. and Veenstra-VanderWeele, J.},
title  = {models.},
journal  = {Neuroscience},
volume  = {321},
number  = {},
pages  = {24-41},
year  = {2016},
abstract  = {Elevated whole blood serotonin, or hyperserotonemia, was the first biomarker identified in autism spectrum disorder (ASD) and is present in more than 25% of affected children. The serotonin system is a logical candidate for involvement in ASD due to its pleiotropic role across multiple brain systems both dynamically and across development. Tantalizing clues connect this peripheral biomarker with  changes in brain and behavior in ASD, but the contribution of the serotonin system to ASD pathophysiology remains incompletely understood. Studies of whole blood serotonin levels in ASD and in a large founder population indicate greater  heritability than for the disorder itself and suggest an association with recurrence risk. Emerging data from both neuroimaging and postmortem samples also indicate changes in the brain serotonin system in ASD. Genetic linkage and association studies of both whole blood serotonin levels and of ASD risk point to the chromosomal region containing the serotonin transporter (SERT) gene in males  but not in females. In ASD families with evidence of linkage to this region, multiple rare SERT amino acid variants lead to a convergent increase in serotonin uptake in cell models. A knock-in mouse model of one of these variants, SERT Gly56Ala, recapitulates the hyperserotonemia biomarker and shows increased brain  serotonin clearance, increased serotonin receptor sensitivity, and altered social, communication, and repetitive behaviors. Data from other rodent models also suggest an important role for the serotonin system in social behavior, in cognitive flexibility, and in sensory development. Recent work indicates that reciprocal interactions between serotonin and other systems, such as oxytocin, may be particularly important for social behavior. Collectively, these data point to the serotonin system as a prime candidate for treatment development in a subgroup of children defined by a robust, heritable biomarker.},
address  = {Vanderbilt Brain Institute, Vanderbilt University, 465 21 Ave S, Nashville, TN, 37232, USA Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, 1051 Riverside Drive, Mail Unit 78, New York, NY, 10032, USA Department of Psychiatry, Columbia University, and New York State Psychiatric Institute, 1051 Riverside Drive, Mail Unit 78, New York, NY, 10032, USA},
note  = {doi:10.1016/j.neuroscience.2015.11.010.}
}

@Article{2015393,
author  = {Aldaz, G. and Shluzas, L. and Pickham, D. and Eris, O. and Sadler, J. and Joshi, S. and Leifer, L.},
title  = {Study for Improved Wound Care Management.},
journal  = {PLoS ONE},
volume  = {10},
number  = {4},
pages  = {},
year  = {2015},
abstract  = {Chronic wounds, including pressure ulcers, compromise the health of 6.5 million Americans and pose an annual estimated burden of $25 billion to the U.S. health care system. When treating chronic wounds, clinicians must use meticulous documentation to determine wound severity and to monitor healing progress over time. Yet, current wound documentation practices using digital photography are often cumbersome and labor intensive. The process of transferring photos into Electronic Medical Records (EMRs) requires many steps and can take several days.  Newer smartphone and tablet-based solutions, such as Epic Haiku, have reduced EMR upload time. However, issues still exist involving patient positioning, image-capture technique, and patient identification. In this paper, we present the development and assessment of the SnapCap System for chronic wound photography. Through leveraging the sensor capabilities of Google Glass, SnapCap  enables hands-free digital image capture, and the tagging and transfer of images  to a patient‚Äôs EMR. In a pilot study with wound care nurses at Stanford Hospital  (n=16), we (i) examined feature preferences for hands-free digital image capture  and documentation, and (ii) compared SnapCap to the state of the art in digital wound care photography, the Epic Haiku application. We used the Wilcoxon Signed-ranks test to evaluate differences in mean ranks between preference options. Preferred hands-free navigation features include barcode scanning for patient identification, Z(15) = -3.873, p < 0.001, r = 0.71, and double-blinking  to take photographs, Z(13) = -3.606, p < 0.001, r = 0.71. In the comparison between SnapCap and Epic Haiku, the SnapCap System was preferred for sterile image-capture technique, Z(16) = -3.873, p < 0.001, r = 0.68. Responses were divided with respect to image quality and overall ease of use. The study‚Äôs results have contributed to the future implementation of new features aimed at enhancing mobile hands-free digital photography for chronic wound care.},
address  = {Center for Design Research, Stanford University, Stanford, CA, United States of America Center for Design Research, Stanford University, Stanford, CA, United States of America Stanford Health Care, Stanford, CA, United States of America Delft University of Technology, Delft, The Netherlands Center for Design Research, Stanford University, Stanford, CA, United States of America Center for Design Research, Stanford University, Stanford, CA, United States of America Center for Design Research, Stanford University, Stanford, CA, United States of America},
note  = {PLoS One. 2015 Apr 22;10(4):. doi:10.1371/journal.pone.0121179.}
}

@Article{2016394,
author  = {Lee, S. and Fallegger, F. and Casse, B. and Fried, S.},
title  = {Implantable microcoils for intracortical magnetic stimulation.},
journal  = {Science Advances},
volume  = {2},
number  = {12},
pages  = {},
year  = {2016},
abstract  = {Magnetic stimulation from cortically implantable microcoils can activate neuronal circuits with high selectivity and reliability.},
address  = {Boston Veterans Affairs Healthcare System, Boston, MA 02130, USA. Palo Alto Research Center, a Xerox company, Palo Alto, CA 94304, USA. Palo Alto Research Center, a Xerox company, Palo Alto, CA 94304, USA. Boston Veterans Affairs Healthcare System, Boston, MA 02130, USA.},
note  = {Sci Adv. 2016 Dec 09;2(12):. doi:10.1126/sciadv.1600889.}
}

@Article{2014395,
author  = {Tateno, T. and Nishikawa, J.},
title  = {neural preparations in vitro.},
journal  = {Frontiers in Neuroengineering},
volume  = {7},
number  = {},
pages  = {},
year  = {2014},
abstract  = {In this report, we describe the system integration of a complementary metal oxide semiconductor (CMOS) integrated circuit (IC) chip, capable of both stimulation and recording of neurons or neural tissues, to investigate electrical signal propagation within cellular networks in vitro. The overall system consisted of three major subunits: a 5.0 √ó 5.0 mm CMOS IC chip, a reconfigurable logic device  (field-programmable gate array, FPGA), and a PC. To test the system, microelectrode arrays (MEAs) were used to extracellularly measure the activity of cultured rat cortical neurons and mouse cortical slices. The MEA had 64 bidirectional (stimulation and recording) electrodes. In addition, the CMOS IC chip was equipped with dedicated analog filters, amplification stages, and a stimulation buffer. Signals from the electrodes were sampled at 15.6 kHz with 16-bit resolution. The measured input-referred circuitry noise was 10.1 Œº V root  mean square (10 Hz to 100 kHz), which allowed reliable detection of neural signals ranging from several millivolts down to approximately 33 Œº Vpp. Experiments were performed involving the stimulation of neurons with several spatiotemporal patterns and the recording of the triggered activity. An advantage over current MEAs, as demonstrated by our experiments, includes the ability to stimulate (voltage stimulation, 5-bit resolution) spatiotemporal patterns in arbitrary subsets of electrodes. Furthermore, the fast stimulation reset mechanism allowed us to record neuronal signals from a stimulating electrode around 3 ms after stimulation. We demonstrate that the system can be directly applied to, for example, auditory neural prostheses in conjunction with an acoustic sensor and a sound processing system.},
address  = {Special Research Promotion Group, Graduate School of Frontier Biosciences, Osaka  UniversityOsaka, Japan Bioengineering and Bioinformatics, Graduate School of Information Science and Technology, Hokkaido UniversitySapporo, Japan},
note  = {Front Neuroeng. 2014 Oct 10;7:. doi:10.3389/fneng.2014.00039.}
}

@Article{2016396,
author  = {Piersma, D. and Fuermaier, A. and de, W. and Davidse, R. and de, G. and Doumen, M. and Bredewoud, R. and Claesen, R. and Lemstra, A. and Vermeeren, A. and Ponds, R. and Verhey, F. and Brouwer, W. and Tucha, O.},
title  = {Prediction of Fitness to Drive in Patients with Alzheimer's Dementia.},
journal  = {PLoS ONE},
volume  = {11},
number  = {2},
pages  = {},
year  = {2016},
abstract  = {The number of patients with Alzheimer‚Äôs disease (AD) is increasing and so is the  number of patients driving a car. To enable patients to retain their mobility while at the same time not endangering public safety, each patient should be assessed for fitness to drive. The aim of this study is to develop a method to assess fitness to drive in a clinical setting, using three types of assessments,  i.e. clinical interviews, neuropsychological assessment and driving simulator rides. The goals are (1) to determine for each type of assessment which combination of measures is most predictive for on-road driving performance, (2) to compare the predictive value of clinical interviews, neuropsychological assessment and driving simulator evaluation and (3) to determine which combination of these assessments provides the best prediction of fitness to drive. Eighty-one patients with AD and 45 healthy individuals participated. All participated in a clinical interview, and were administered a neuropsychological  test battery and a driving simulator ride (predictors). The criterion fitness to  drive was determined in an on-road driving assessment by experts of the CBR Dutch driving test organisation according to their official protocol. The validity of the predictors to determine fitness to drive was explored by means of logistic regression analyses, discriminant function analyses, as well as receiver operating curve analyses. We found that all three types of assessments are predictive of on-road driving performance. Neuropsychological assessment had the  highest classification accuracy followed by driving simulator rides and clinical  interviews. However, combining all three types of assessments yielded the best prediction for fitness to drive in patients with AD with an overall accuracy of 92.7%, which makes this method highly valid for assessing fitness to drive in AD. This method may be used to advise patients with AD and their family members about fitness to drive.},
address  = {Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, the Netherlands Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, the Netherlands Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, the Netherlands SWOV Institute for Road Safety Research, The Hague, the Netherlands SWOV Institute for Road Safety Research, The Hague, the Netherlands Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, the Netherlands CBR Dutch driving test organisation, Rijswijk, the Netherlands CBR Dutch driving test organisation, Rijswijk, the Netherlands Department of Neurology, Alzheimer Center, VU University Medical Center, Amsterdam, the Netherlands Department of Neuropsychology & Psychopharmacology, Maastricht University, Maastricht, the Netherlands Department of Psychiatry and Neuropsychology, School of Mental Health and Neurosciences (MHeNS), Maastricht University, Maastricht, the Netherlands Department of Psychiatry and Neuropsychology, School of Mental Health and Neurosciences (MHeNS), Maastricht University, Maastricht, the Netherlands Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, the Netherlands Department of Clinical and Developmental Neuropsychology, University of Groningen, Groningen, the Netherlands},
note  = {PLoS One. 2016 Feb 24;11(2):. doi:10.1371/journal.pone.0149566.}
}

@Article{2016397,
author  = {Bigdely-Shamlo, N. and Makeig, S. and Robbins, K.},
title  = {Containerized Approach.},
journal  = {Frontiers in Neuroinformatics},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Large-scale analysis of EEG and other physiological measures promises new insights into brain processes and more accurate and robust brain‚Äìcomputer interface models. However, the absence of standardized vocabularies for annotating events in a machine understandable manner, the welter of collection-specific data organizations, the difficulty in moving data across processing platforms, and the unavailability of agreed-upon standards for preprocessing have prevented large-scale analyses of EEG. Here we describe a ‚Äúcontainerized‚Ä? approach and freely available tools we have developed to facilitate the process of annotating, packaging, and preprocessing EEG data collections to enable data sharing, archiving, large-scale machine learning/data  mining and (meta-)analysis. The EEG Study Schema (ESS) comprises three data ‚ÄúLevels,‚Ä? each with its own XML-document schema and file/folder convention, plus  a standardized (PREP) pipeline to move raw (Data Level 1) data to a basic preprocessed state (Data Level 2) suitable for application of a large class of EEG analysis methods. Researchers can ship a study as a single unit and operate on its data using a standardized interface. ESS does not require a central database and provides all the metadata data necessary to execute a wide variety of EEG processing pipelines. The primary focus of ESS is automated in-depth analysis and meta-analysis EEG studies. However, ESS can also encapsulate meta-information for the other modalities such as eye tracking, that are increasingly used in both laboratory and real-world neuroimaging. ESS schema and  tools are freely available at www.eegstudy.org and a central catalog of over 850  GB of existing data in ESS format is available at studycatalog.org. These tools and resources are part of a larger effort to enable data sharing at sufficient scale for researchers to engage in truly large-scale EEG analysis and data mining (BigEEG.org).},
address  = {Qusp Labs, Qusp, San DiegoCA, USA Swartz Center for Computational Neuroscience, University of California, San Diego, San DiegoCA, USA Department of Computer Science, University of Texas at San Antonio, San AntonioTX, USA},
note  = {Front Neuroinform. 2016 Mar 08;10:. doi:10.3389/fninf.2016.00007.}
}

@Article{2017398,
author  = {Assenza, G. and Capone, F. and di, B. and Ferreri, F. and Florio, L. and Guerra, A. and Marano, M. and Paolucci, M. and Ranieri, F. and Salomone, G. and Tombini, M. and Thut, G. and Di, L.},
title  = {for Neuromodulation.},
journal  = {Frontiers in Aging Neuroscience},
volume  = {9},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Non-invasive brain stimulation (NIBS) has been under investigation as adjunct treatment of various neurological disorders with variable success. One challenge  is the limited knowledge on what would be effective neuronal targets for an intervention, combined with limited knowledge on the neuronal mechanisms of NIBS. Motivated on the one hand by recent evidence that oscillatory activities in neural systems play a role in orchestrating brain functions and dysfunctions, in  particular those of neurological disorders specific of elderly patients, and on the other hand that NIBS techniques may be used to interact with these brain oscillations in a controlled way, we here explore the potential of modulating brain oscillations as an effective strategy for clinical NIBS interventions. We first review the evidence for abnormal oscillatory profiles to be associated with a range of neurological disorders of elderly (e.g., Parkinson‚Äôs disease (PD), Alzheimer‚Äôs disease (AD), stroke, epilepsy), and for these signals of abnormal network activity to normalize with treatment, and/or to be predictive of disease  progression or recovery. We then ask the question to what extent existing NIBS protocols have been tailored to interact with these oscillations and possibly associated dysfunctions. Our review shows that, despite evidence for both reliable neurophysiological markers of specific oscillatory dis-functionalities in neurological disorders and NIBS protocols potentially able to interact with them, there are few applications of NIBS aiming to explore clinical outcomes of this interaction. Our review article aims to point out oscillatory markers of neurological, which are also suitable targets for modification by NIBS, in order  to facilitate in future studies the matching of technical application to clinical targets.},
address  = {Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Clinical Neurology, Campus Biomedico University of RomeRome, Italy Centre for Cognitive Neuroimaging (CCNi), Institute of Neuroscience and Psychology, University of GlasgowGlasgow, United Kingdom Clinical Neurology, Campus Biomedico University of RomeRome, Italy},
note  = {Front Aging Neurosci. 2017 Jun 13;9:. doi:10.3389/fnagi.2017.00189.}
}

@Article{2009399,
author  = {Cheeran, M. and Lokensgard, J. and Schleiss, M.},
title  = {Prospects for Intervention.},
journal  = {Clinical Microbiology Reviews},
volume  = {22},
number  = {1},
pages  = {99-126},
year  = {2009},
abstract  = {Congenital cytomegalovirus (CMV) infection is the leading infectious cause of mental retardation and hearing loss in the developed world. In recent years, there has been an improved understanding of the epidemiology, pathogenesis, and long-term disabilities associated with CMV infection. In this review, current concepts regarding the pathogenesis of neurological injury caused by CMV infections acquired by the developing fetus are summarized. The pathogenesis of CMV-induced disabilities is considered in the context of the epidemiology of CMV  infection in pregnant women and newborn infants, and the clinical manifestations  of brain injury are reviewed. The prospects for intervention, including antiviral therapies and vaccines, are summarized. Priorities for future research are suggested to improve the understanding of this common and disabling illness of infancy.},
address  = {Center for Infectious Diseases and Microbiology Translational Research, Departments of Medicine, Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota Center for Infectious Diseases and Microbiology Translational Research, Departments of Medicine, Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota Center for Infectious Diseases and Microbiology Translational Research, Departments of Medicine, Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota},
note  = {Clin Microbiol Rev. 2009 Jan;22(1):99-126. doi:10.1128/CMR.00023-08.}
}

@Article{2015400,
author  = {Mawjee, K. and Woltering, S. and Tannock, R.},
title  = {Controlled Study.},
journal  = {PLoS ONE},
volume  = {10},
number  = {9},
pages  = {},
year  = {2015},
abstract  = {Objectives: To determine whether standard-length computerized training enhances working memory (WM), transfers to other cognitive domains and shows sustained effects, when controlling for motivation, engagement, and expectancy. Methods: 97 post-secondary students (59.8% female) aged 18‚Äì35 years with Attention-Deficit/Hyperactivity Disorder, were randomized into standard-length adaptive Cogmed WM training (CWMT; 45-min/session), a shortened-length adaptive version of CWMT (15 min/session) that controlled for motivation, engagement and expectancy of change, or into a no training group (waitlist-control group). All three groups received weekly telephone calls from trained coaches, who supervised the CWMT and were independent from the research team. All were evaluated before and 3 weeks post-training; those in the two CWMT groups were also assessed 3 months post-training. Untrained outcome measures of WM included the WAIS-IV Digit Span (auditory-verbal WM), CANTAB Spatial Span (visual-spatial WM) and WRAML Finger Windows (visual-spatial WM). Transfer-of-training effects included measures of short-term memory, cognitive speed, math and reading fluency, complex reasoning, and ADHD symptoms. Results: Performance on 5/7 criterion measures indicated that shortened-length CWMT conferred as much benefit on WM performance  as did standard-length training, with both CWMT groups improving more than the waitlist-control group. Only 2 of these findings remained robust after correcting for multiple comparisons. Follow-up analyses revealed that post-training improvements on WM performance were maintained for at least three months. There was no evidence of any transfer effects but the standard-length group showed improvement in task-specific strategy use. Conclusions: This study failed to find robust evidence of benefits of standard-length CWMT for improving WM in college students with ADHD and the overall pattern of findings raise questions about the  specificity of training effects. Trial Registration: ClinicalTrials.gov NCT01657721},
address  = {University of Toronto, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada University of Toronto, Toronto, Ontario, Canada},
note  = {PLoS One. 2015 Sep 23;10(9):. doi:10.1371/journal.pone.0137173.}
}

@Article{2009401,
author  = {Walker, J. and Cassidy, J. and Sharpe, M.},
title  = {patients.},
journal  = {Trials},
volume  = {10},
number  = {},
pages  = {18},
year  = {2009},
abstract  = {Background: Depression Care for People with Cancer is a complex intervention delivered by specially trained cancer nurses, under the supervision of a psychiatrist. It is given as a supplement to the usual care for depression, which patients receive from their general practitioner and cancer service. In a 'proof  of concept' trial (Symptom Management Research Trials in Oncology-1) Depression Care for People with Cancer improved depression more than usual care alone. The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2 Trial) will test its effectiveness and cost-effectiveness in a 'real world' setting. Design: A two arm parallel group multi-centre randomised controlled trial. Trial  Procedures: 500 patients will be recruited through established systematic Symptom Monitoring Services, which screen patients for depression. Patients will have: a  diagnosis of cancer (of various types); an estimated life expectancy of twelve months or more and a diagnosis of Major Depressive Disorder. Patients will be randomised to usual care or usual care plus Depression Care for People with Cancer. Randomisation will be carried out by telephoning a secure computerised central randomisation system or by using a secure web interface. The primary outcome measure is 'treatment response' measured at 24 week outcome data collection. 'Treatment response' will be defined as a reduction of 50% or more in the patient's baseline depression score, measured using the 20-item Symptom Checklist (SCL-20D). Secondary outcomes include remission of major depressive disorder, depression severity and patients' self-rated improvement of depression. Trial Registration: Current controlled trials ISRCTN40568538 Trial Hypotheses: (1) Depression Care for People with Cancer as a supplement to usual care will be  more effective than usual care alone in achieving a 50% reduction in baseline SCL-20D score at 24 weeks. (2) Depression Care for People with Cancer as a supplement to usual care will cost more than usual care alone but will be more cost effective in achieving improvements in patients' depression and quality of life.},
address  = {Cancer Research UK Clinical Research Training Fellow, University of Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road, Edinburgh, EH4 2XR, Scotland Professor of Oncology, Cancer Research UK, Department of Medical Oncology, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1BD, Scotland Professor of Psychological Medicine Psychological Medicine Research School of Molecular and Clinical Medicine, University of Edinburgh, Kennedy Tower, Royal Edinburgh Hospital, Morningside Park, Edinburgh, EH10 5HF, Scotland},
note  = {Trials. 2009 Mar 30;10:18. doi:10.1186/1745-6215-10-18.}
}

@Article{2015402,
author  = {Doyle, K. and Quach, L. and Sol√©, M. and Axtell, R. and Nguyen, T. and Soler-Llavina, G. and Jurado, S. and Han, J. and Steinman, L. and Longo, F. and Schneider, J. and Malenka, R. and Buckwalter, M.},
title  = {B-Lymphocyte-Mediated Delayed Cognitive Impairment following Stroke.},
journal  = {The Journal of Neuroscience},
volume  = {35},
number  = {5},
pages  = {2133-45},
year  = {2015},
abstract  = {Each year, 10 million people worldwide survive the neurologic injury associated with a stroke. Importantly, stroke survivors have more than twice the risk of subsequently developing dementia compared with people who have never had a stroke. The link between stroke and the later development of dementia is not understood. There are reports of oligoclonal bands in the CSF of stroke patients, suggesting that in some people a B-lymphocyte response to stroke may occur in the CNS. Therefore, we tested the hypothesis that a B-lymphocyte response to stroke could contribute to the onset of dementia. We discovered that, in mouse models, activated B-lymphocytes infiltrate infarcted tissue in the weeks after stroke. B-lymphocytes undergo isotype switching, and IgM, IgG, and IgA antibodies are found in the neuropil adjacent to the lesion. Concurrently, mice develop delayed  deficits in LTP and cognition. Genetic deficiency, and the pharmacologic ablation of B-lymphocytes using an anti-CD20 antibody, prevents the appearance of delayed  cognitive deficits. Furthermore, immunostaining of human postmortem tissue revealed that a B-lymphocyte response to stroke also occurs in the brain of some  people with stroke and dementia. These data suggest that some stroke patients may develop a B-lymphocyte response to stroke that contributes to dementia, and is potentially treatable with FDA-approved drugs that target B cells.},
address  = {Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305, Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305, Department of Pathology and Neurological Sciences, Rush Alzheimer's Disease Center Rush University Medical Center, Chicago, Illinois 60612, and Nancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305, Department of Neurology and Neurological Sciences, Stanford University School of  Medicine, Stanford, California 94305,},
note  = {J Neurosci. 2015 Feb 4;35(5):2133-45. doi:10.1523/JNEUROSCI.4098-14.2015.}
}

@Article{2005403,
author  = {Br√©zin, A. and Lafuma, A. and Fagnani, F. and Mesbah, M. and Berdeaux, G.},
title  = {living in institutions: a nationwide survey.},
journal  = {Health and Quality of Life Outcomes},
volume  = {3},
number  = {},
pages  = {27},
year  = {2005},
abstract  = {Background: The prevalence of self-reported low vision (LV) and blindness, and their associated disabilities, handicaps and socio-economic consequences for individuals living in institutions are poorly documented. Methods: 2,075 institutions were selected at random and eight individuals were picked at random  from the list of residents. Three groups of individuals were defined: blind, LV,  and a control group (CG). These were compared after adjustment for age and co-morbidities. Of the 15,403 individuals, 14,603 interviews (94.9%) were completed. Results: The prevalence of blindness was 1.6% and the LV 13.4%. Blind  individuals needed assistance more often (OR: 2.65 to 11.35) than CG members while the assistance required by LV individuals was similar to that for the CG. Blind individuals required institution adaptation (building and furniture changes) more often than the CG. Blind (57.9%) and LV individuals (35.4%) were more often registered for social allowances. Monthly social allowances were EUR 86 higher for blind than LV individuals. Monthly family incomes were found to be  similar between the three groups (from EUR 782 to 797). Social and demographic data, institution description, income, handicaps, disabilities, social allowances and details of daily activities were collected interviews Conclusion: The results demonstrate the impact of self-reported blindness and LV on daily life for patients living in institutions.},
address  = {H√¥pital Cochin ‚Äì Service d'ophtalmologie ‚Äì Universit√© Paris 5 ‚Äì 27 rue du Faubourg Saint-Jacques F-75679 Paris cedex 14, France Cemka, 43, Boulevard du Mar√©chal Joffre, F-92340 Bourg-la-Reine, France Cemka, 43, Boulevard du Mar√©chal Joffre, F-92340 Bourg-la-Reine, France Universit√© Pierre et marie Curie, 175, rue du Chevaleret, F-75013 Paris France Gilles Berdeaux, Alcon France, 4 Rue Henri Sainte Claire Deville, F-92563 Rueil-Malmaison Cedex, France},
note  = {Health Qual Life Outcomes. 2005 Apr 25;3:27. doi:10.1186/1477-7525-3-27.}
}

@Article{2017404,
author  = {Karkar, R. and Schroeder, J. and Epstein, D. and Pina, L. and Scofield, J. and Fogarty, J. and Kientz, J. and Munson, S. and Vilardaga, R. and Zia, J.},
title  = {Individualized Food Triggers.},
journal  = {Conference},
volume  = {2017},
number  = {},
pages  = {6850-63},
year  = {2017},
abstract  = {Diagnostic self-tracking, the recording of personal information to diagnose or manage a health condition, is a common practice, especially for people with chronic conditions. Unfortunately, many who attempt diagnostic self-tracking have trouble accomplishing their goals. People often lack knowledge and skills needed  to design and conduct scientifically rigorous experiments, and current tools provide little support. To address these shortcomings and explore opportunities for diagnostic self-tracking, we designed, developed, and evaluated a mobile app  that applies a self-experimentation framework to support patients suffering from  irritable bowel syndrome (IBS) in identifying their personal food triggers. TummyTrials aids a person in designing, executing, and analyzing self-experiments to evaluate whether a specific food triggers their symptoms. We examined the feasibility of this approach in a field study with 15 IBS patients, finding that  participants could use the tool to reliably undergo a self-experiment. However, we also discovered an underlying tension between scientific validity and the lived experience of self-experimentation. We discuss challenges of applying clinical research methods in everyday life, motivating a need for the design of self-experimentation systems to balance rigor with the uncertainties of everyday  life.},
address  = {Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA, United States Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA, United States Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA, United States Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA, United States Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA, United States Computer Science & Engineering, DUB Group, University of Washington, Seattle, WA, United States Human Centered Design & Engineering, DUB Group, University of Washington, Seattle, WA, United States Human Centered Design & Engineering, DUB Group, University of Washington, Seattle, WA, United States Center for Addiction Science and Technology, Duke University, Durham, NC, United  States Division of Gastroenterology, DUB Group, University of Washington, Seattle, WA, United States},
note  = {doi:10.1145/3025453.3025480.}
}

@Article{2009405,
author  = {Wolinsky, F. and Mahncke, H. and Weg, M. and Martin, R. and Unverzagt, F. and Ball, K. and Jones, R. and Tennstedt, S.},
title  = {Suspected Clinical Depression.},
journal  = {The Journals of Gerontology Series B: Psychological Sciences and Social Sciences},
volume  = {64B},
number  = {5},
pages  = {577-85},
year  = {2009},
abstract  = {We evaluated the effects of the 3 cognitive interventions fielded in the Advanced Cognitive Training for Independent and Vital Elderly study on 2 subsets of participants‚Äî1,606 without and 424 with suspected clinical depression at baseline. In the former group, only the speed of processing (vs. no-contact control) intervention had a significant effect, with its participants being 38% less likely to develop suspected clinical depression at 1 year (adjusted odds ratio = 0.62; p < .01). None of the interventions had a significant effect on recovery from suspected clinical depression in the latter group. Although the etiological mechanism of the speed of processing‚Äôs protective effect was not isolated, it may result from successful adaptation to age-related changes through selective optimization with compensation.},
address  = {Center for Research in the Implementation of Innovative Strategies into Practice, Iowa City VAMC, Iowa Department of Research and Outcomes, Posit Science Corporation, San Francisco, California Center for Research in the Implementation of Innovative Strategies into Practice, Iowa City VAMC, Iowa Center for Research in the Implementation of Innovative Strategies into Practice, Iowa City VAMC, Iowa Department of Psychiatry, Indiana University School of Medicine, Indianapolis Department of Psychology, University of Alabama at Birmingham Institute for Aging Research, Hebrew Senior-Life, Boston, Massachusetts Department of Behavioral and Social Science Research, New England Research Institutes, Boston, Massachusetts},
note  = {doi:10.1093/geronb/gbp061.}
}

@Article{2016406,
author  = {Antic, S. and Empson, R. and Kn√∂pfel, T.},
title  = {Voltage imaging to understand connections and functions of neuronal circuits.},
journal  = {Journal of Neurophysiology},
volume  = {116},
number  = {1},
pages  = {135-52},
year  = {2016},
abstract  = {Understanding of the cellular mechanisms underlying brain functions such as cognition and emotions requires monitoring of membrane voltage at the cellular, circuit, and system levels. Seminal voltage-sensitive dye and calcium-sensitive dye imaging studies have demonstrated parallel detection of electrical activity across populations of interconnected neurons in a variety of preparations. A game-changing advance made in recent years has been the conceptualization and development of optogenetic tools, including genetically encoded indicators of voltage (GEVIs) or calcium (GECIs) and genetically encoded light-gated ion channels (actuators, e.g., channelrhodopsin2). Compared with low-molecular-weight calcium and voltage indicators (dyes), the optogenetic imaging approaches are 1)  cell type specific, 2) less invasive, 3) able to relate activity and anatomy, and 4) facilitate long-term recordings of individual cells' activities over weeks, thereby allowing direct monitoring of the emergence of learned behaviors and underlying circuit mechanisms. We highlight the potential of novel approaches based on GEVIs and compare those to calcium imaging approaches. We also discuss how novel approaches based on GEVIs (and GECIs) coupled with genetically encoded  actuators will promote progress in our knowledge of brain circuits and systems.},
address  = {Stem Cell Institute, Institute for Systems Genomics, UConn Health, Farmington, Connecticut; Department of Physiology, Brain Research New Zealand, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand; and Division of Brain Sciences, Department of Medicine and Centre for Neurotechnology, Institute of Biomedical Engineering, Imperial College London, London, United Kingdom},
note  = {doi:10.1152/jn.00226.2016.}
}

@Article{2013407,
author  = {Dougherty, J. and Maloney, S. and Wozniak, D. and Rieger, M. and Sonnenblick, L. and Coppola, G. and Mahieu, N. and Zhang, J. and Cai, J. and Patti, G. and Abrahams, B. and Geschwind, D. and Heintz, N.},
title  = {Serotonergic Neurons, Results in Autism-Related Behaviors.},
journal  = {Neuroscience},
volume  = {33},
number  = {7},
pages  = {2732-53},
year  = {2013},
abstract  = {The immense molecular diversity of neurons challenges our ability to understand the genetic and cellular etiology of neuropsychiatric disorders. Leveraging knowledge from neurobiology may help parse the genetic complexity: identifying genes important for a circuit that mediates a particular symptom of a disease may help identify polymorphisms that contribute to risk for the disease as a whole. The serotonergic system has long been suspected in disorders that have symptoms of repetitive behaviors and resistance to change, including autism. We generated  a bacTRAP mouse line to permit translational profiling of serotonergic neurons. From this, we identified several thousand serotonergic-cell expressed transcripts, of which 174 were highly enriched, including all known markers of these cells. Analysis of common variants near the corresponding genes in the AGRE collection implicated the RNA binding protein CELF6 in autism risk. Screening for rare variants in CELF6 identified an inherited premature stop codon in one of the probands. Subsequent disruption of Celf6 in mice resulted in animals exhibiting resistance to change and decreased ultrasonic vocalization as well as abnormal levels of serotonin in the brain. This work provides a reproducible and accurate  method to profile serotonergic neurons under a variety of conditions and suggests a novel paradigm for gaining information on the etiology of psychiatric disorders.},
address  = {Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110 Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110 Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110 Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110 UCLA Center for Autism Research and Treatment, Semel Institute for Neuroscience and Behavior, Los Angeles, California 90095 Program in Neurogenetics, Department of Neurology, Los Angeles, California 90095 Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110 Laboratory of Molecular Biology, Howard Hughes Medical Institute, New York, New York 10065 Departments of Genetics and Neuroscience, Albert Einstein College of Medicine, New York, New York 10461 Department of Genetics, Washington University School of Medicine, St. Louis, Missouri 63110 Departments of Genetics and Neuroscience, Albert Einstein College of Medicine, New York, New York 10461 UCLA Center for Autism Research and Treatment, Semel Institute for Neuroscience and Behavior, Los Angeles, California 90095 Laboratory of Molecular Biology, Howard Hughes Medical Institute, New York, New York 10065},
note  = {J Neurosci. 2013 Feb 13;33(7):2732-53. doi:10.1523/JNEUROSCI.4762-12.2013.}
}

@Article{2012408,
author  = {Cartreine, J. and Chang, T. and Seville, J. and Sandoval, L. and Moore, J. and Xu, S. and Hegel, M.},
title  = {Problem-Solving Treatment for Depression.},
journal  = {Depression Research and Treatment},
volume  = {2012},
number  = {},
pages  = {},
year  = {2012},
abstract  = {Problem-solving treatment (PST) offers a promising approach to the depression care; however, few PST training opportunities exist. A computer-guided, interactive media program has been developed to deliver PST electronically (ePST), directly to patients. The program is a six-session, weekly intervention modeled on an evidence-based PST protocol. Users are guided through each session  by a clinician who is presented via hundreds of branching audio and video clips.  Because expert clinician behaviors are modeled in the program, not only does the  ePST program have the potential to deliver PST to patients but it may also serve  as a training tool to teach clinicians how to deliver PST. Thirteen social workers and trainees used ePST self-instructionally and subsequently attended a day-long workshop on PST. Participants' PST knowledge level increased significantly from baseline to post-ePST (P = .001) and did not increase significantly further after attending the subsequent workshop. Additionally, attending the workshop did not significantly increase the participants' skill at  performing PST beyond the use of the ePST program. Using the ePST program appears to train novices to a sufficient level of competence to begin practicing PST under supervision. This self-instructional training method could enable PST for depression to be widely disseminated, although follow-up supervision is still required.},
address  = {Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, 1249 Boylston Avenue 3rd floor, Boston, MA 02215, USA Harvard Medical School, Boston, MA 02215, USA Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03756, USA Department of Educational Psychology, University of Texas at Austin, Austin, TX 72705, USA Harvard Medical School, Boston, MA 02215, USA Harvard Medical School, Boston, MA 02215, USA Department of Psychiatry, Dartmouth-Hitchcock Medical Center, Dartmouth Medical School, Lebanon, NH 03756, USA},
note  = {Depress Res Treat. 2012;2012:. Epub 2012 Nov 14 doi:10.1155/2012/309094.}
}

@Article{2009409,
author  = {Pezaris, J. and Eskandar, E.},
title  = {microstimulation.},
journal  = {Neurosurgical focus},
volume  = {27},
number  = {1},
pages  = {E6},
year  = {2009},
abstract  = {Common causes of blindness are diseases that affect the ocular structures, such as glaucoma, retinitis pigmentosa, and macular degeneration, rendering the eyes no longer sensitive to light. The visual pathway, however, as a predominantly central structure, is largely spared in these cases. It is thus widely thought that a device-based prosthetic approach to restoration of visual function will be effective and will enjoy similar success as cochlear implants have for restoration of auditory function. In this article the authors review the potential locations for stimulation electrode placement for visual prostheses, assessing the anatomical and functional advantages and disadvantages of each. Of  particular interest to the neurosurgical community is placement of deep brain stimulating electrodes in thalamic structures that has shown substantial promise  in an animal model. The theory of operation of visual prostheses is discussed, along with a review of the current state of knowledge. Finally, the visual prosthesis is proposed as a model for a general high-fidelity machine-brain interface.},
address  = {},
note  = {Neurosurg Focus. 2009 Jul;27(1):E6. doi:10.3171/2009.4.FOCUS0986.}
}

@Article{2005410,
author  = {},
title  = {Abstracts.},
journal  = {Gut},
volume  = {54},
number  = {Suppl 2},
pages  = {a1-a117},
year  = {2005},
abstract  = {},
address  = {},
note  = {Gut. 2005 Apr;54(Suppl 2):a1-a117.}
}

@Article{2012411,
author  = {MacLachlan, R. and Becker, B. and Tabar√©s, J. and Podnar, G. and Lobes, L. and Riviere, C.},
title  = {Micron: an Actively Stabilized Handheld Tool for Microsurgery.},
journal  = {Society},
volume  = {28},
number  = {1},
pages  = {195-212},
year  = {2012},
abstract  = {We describe the design and performance of a hand-held actively stabilized tool to increase accuracy in micro-surgery or other precision manipulation. It removes involuntary motion such as tremor by actuating the tip to counteract the effect of the undesired handle motion. The key components are a three-degree-of-freedom  piezoelectric manipulator that has 400 Œºm range of motion, 1 N force capability,  and bandwidth over 100 Hz, and an optical position measurement subsystem that acquires the tool pose with 4 Œºm resolution at 2000 samples/s. A control system using these components attenuates hand motion by at least 15 dB (a fivefold reduction). By considering the effect of the frequency response of Micron on the  human visual feedback loop, we have developed a filter that reduces unintentional motion, yet preserves intuitive eye-hand coordination. We evaluated the effectiveness of Micron by measuring the accuracy of the human/machine system in  three simple manipulation tasks. Handheld testing by three eye surgeons and three non-surgeons showed a reduction in position error of between 32% and 52%, depending on the error metric.},
address  = {Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA University of Valladolid, Spain Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA Dept. of Ophthalmology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213 USA Robotics Institute, Carnegie Mellon University, Pittsburgh, PA 15213 USA},
note  = {doi:10.1109/TRO.2011.2169634.}
}

@Article{2014412,
author  = {Stevens, J. and Prince, J. and Prager, L. and Stern, T.},
title  = {Evaluation and Management.},
journal  = {The Primary Care Companion for CNS Disorders},
volume  = {16},
number  = {2},
pages  = {},
year  = {2014},
abstract  = {},
address  = {},
note  = {doi:10.4088/PCC.13f01514.}
}

@Article{2009413,
author  = {Maki, P. and Rubin, L. and Fornelli, D. and Drogos, L. and Banuvar, S. and Shulman, L. and Geller, S.},
title  = {Women.},
journal  = {Menopause (New York, N.Y.)},
volume  = {16},
number  = {6},
pages  = {1167-77},
year  = {2009},
abstract  = {Objective: To characterize the effects of red clover, black cohosh, and combined  hormone therapy on cognitive function in comparison to placebo in women with moderate to severe vasomotor symptoms. Design: In a Phase II randomized, double-blind, placebo-controlled study, 66 midlife women (out of 89 from a parent study; mean age=53 y) with ‚â• 35 weekly hot flashes were randomized to receive red clover (120 mg), black cohosh (128 mg), CEE/MPA (0.625 mg conjugated equine estrogens plus 2.5 mg medroxyprogesterone acetate), or placebo. Participants completed measures of verbal memory (primary outcome) and other cognitive measures (secondary outcomes) before and during the 12th treatment month. A subset of 19 women completed objective, physiological measures of hot flashes using ambulatory skin conductance monitors. Results: There was no impact of either of the botanical treatments on any cognitive measure. Compared to placebo, CEE/MPA led to greater decline in verbal learning (one of five verbal memory measures). This effect just missed statistical significance (p=0.057) in unadjusted analyses, but reached significance (p=.02) after adjusting for vasomotor symptoms. Neither botanical treatment group showed a change in verbal memory that differed from the placebo group (ps>0.28), even after controlling for improvements in hot flashes. In secondary outcomes, CEE/MPA led to a decrease in  immediate digit recall and an improvement in letter fluency. Only CEE/MPA significantly reduced objective hot flashes. Conclusions: Results indicate no effects of a red clover (phytoestrogen) supplement or black cohosh on cognitive function. CEE/MPA reduces objective hot flashes but worsens some aspects of verbal memory.},
address  = {Department of Psychiatry, University of Illinois at Chicago Department of Psychiatry, University of Illinois at Chicago Department of Psychiatry, University of Illinois at Chicago Department of Psychiatry, University of Illinois at Chicago Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University Department of Obstetrics and Gynecology, Feinberg School of Medicine, Northwestern University Department of Obstetrics and Gynecology, University of Illinois at Chicago},
note  = {Menopause. 2009 Nov‚ÄìDec;16(6):1167-77. doi:10.1097/gme.0b013e3181ace484.}
}

@Article{2008414,
author  = {Sharar, S. and Miller, W. and Teeley, A. and Soltani, M. and Hoffman, H. and Jensen, M. and Patterson, D.},
title  = {Applications of virtual reality for pain management in burn-injured patients.},
journal  = {Expert review of neurotherapeutics},
volume  = {8},
number  = {11},
pages  = {1667-74},
year  = {2008},
abstract  = {The pain associated with burn injuries is intense, unremitting and often exacerbated by anxiety, depression and other complicating patient factors. On top of this, modern burn care involves the repetitive performance ‚Äì often on a daily  basis for weeks to months ‚Äì of painful and anxiety-provoking procedures that create additional treatment-related pain, such as wound care, dressing changes and rehabilitation activities. Pain management in burn patients is primarily achieved by potent pharmacologic analgesics (e.g., opioids), but is necessarily complemented by nonpharmacologic techniques, including distraction or hypnosis. Immersive virtual reality provides a particularly intense form of cognitive distraction during such brief, painful procedures, and has undergone preliminary  study by several research groups treating burn patients over the past decade. Initial reports from these groups are consistent in suggesting that immersive virtual reality is logistically feasible, safe and effective in ameliorating the  pain and anxiety experienced in various settings of post-burn pain. Furthermore,  the technique appears applicable to a wide age range of patients and may be particularly well-adapted for use in children, one of the most challenging populations of burn victims to treat. However, confirmation and extension of these results in larger numbers of patients in various types of burn-related pain is necessary to more clearly define the specific benefits and limitations of virtual reality analgesia in the burn care setting.},
address  = {Professor, Department of Anesthesiology, Harborview Medical Center, #359724, 325  Ninth Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744 5765, Fax: +1 206 744 8090, sharar@u.washington.edu Research Assistant, Department of, Rehabilitation Medicine, Harborview, Medical Center, #359796, 325 Ninth, Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744 4811, Fax: +1 206 744 8580, ano327@u.washington.edu Research Coordinator, Department of, Rehabilitation Medicine, Harborview, Medical Center, #359796, 325 Ninth, Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744 4811, Fax: +1 206 744 8580, aubriana@u.washington.edu Research Coordinator, Department of, Rehabilitation Medicine, Harborview, Medical Center, #359796, 325 Ninth, Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744 2172, Fax: +1 206 744 8580, soltani@u.washington.edu Research Scientist, Human Interface, Technology Laboratory, University of Washington, #352142, Seattle, WA 98195, USA Tel.: +1 206 616 1496 Fax: +1 206 543 5380 hunter@hitl.washington.edu Professor, Department of Rehabilitation, Medicine, University of Washington, #356490, Seattle, WA 98195, USA, Tel.: +1 206 543 3185, Fax: +1 206 685 3244, mjensen@u.washington.edu Professor, Department of Rehabilitation, Medicine, Harborview Medical Center, #359740, 325 Ninth Avenue, Seattle, WA 98104, USA, Tel.: +1 206 744 3418, Fax: +1 206 744 8580, davepatt@u.washington.edu},
note  = {Expert Rev Neurother. 2008 Nov;8(11):1667-74. doi:10.1586/14737175.8.11.1667.}
}

@Article{2009415,
author  = {Mettler, L. and Dewan, P.},
title  = {Virtual Reality Simulators in Gynecological Endoscopy: a Surging New Wave.},
journal  = {JSLS : Journal of the Society of Laparoendoscopic Surgeons},
volume  = {13},
number  = {3},
pages  = {279-86},
year  = {2009},
abstract  = {},
address  = {Department of Obstetrics and Gynecology, University Hospitals Schleswig-Holstein, Campus Kiel, Germany.},
note  = {JSLS. 2009 Jul-Sep;13(3):279-86.}
}

@Article{2012416,
author  = {Sch√ºck, A. and Labruy√®re, R. and Vallery, H. and Riener, R. and Duschau-Wicke, A.},
title  = {in a 4-week pilot trial.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {9},
number  = {},
pages  = {31},
year  = {2012},
abstract  = {Background: Functional training is becoming the state-of-the-art therapy approach for rehabilitation of individuals after stroke and spinal cord injury. Robot-aided treadmill training reduces personnel effort, especially when treating severely affected patients. Improving rehabilitation robots towards more patient-cooperative behavior may further increase the effects of robot-aided training. This pilot study aims at investigating the feasibility of applying patient-cooperative robot-aided gait rehabilitation to stroke and incomplete spinal cord injury during a therapy period of four weeks. Short-term effects within one training session as well as the effects of the training on walking function are evaluated. Methods: Two individuals with chronic incomplete spinal cord injury and two with chronic stroke trained with the Lokomat gait rehabilitation robot which was operated in a new, patient-cooperative mode for a  period of four weeks with four training sessions of 45 min per week. At baseline, after two and after four weeks, walking function was assessed with the ten meter  walking test. Additionally, muscle activity of the major leg muscles, heart rate  and the Borg scale were measured under different walking conditions including a non-cooperative position control mode to investigate the short-term effects of patient-cooperative versus non-cooperative robot-aided gait training. Results: Patient-cooperative robot-aided gait training was tolerated well by all subjects  and performed without difficulties. The subjects trained more actively and with more physiological muscle activity than in a non-cooperative position-control mode. One subject showed a significant and relevant increase of gait speed after  the therapy, the three remaining subjects did not show significant changes. Conclusions: Patient-cooperative robot-aided gait training is feasible in clinical practice and overcomes the main points of criticism against robot-aided  gait training: It enables patients to train in an active, variable and more natural way. The limited number of subjects in this pilot trial does not permit valid conclusions on the effect of patient-cooperative robot-aided gait training  on walking function. A large, possibly multi-center randomized controlled clinical trial is required to shed more light on this question.},
address  = {Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland Spinal Cord Injury Center, University Hospital Balgrist, University of Zurich, Zurich, Switzerland Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems, Department of Mechanical and Process Engineering,, ETH Zurich, Zurich, Switzerland Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems, Department of Mechanical and Process Engineering,, ETH Zurich, Zurich, Switzerland Sensory-Motor Systems Lab, Institute of Robotics and Intelligent Systems, Department of Mechanical and Process Engineering,, ETH Zurich, Zurich, Switzerland},
note  = {J Neuroeng Rehabil. 2012 May 31;9:31. doi:10.1186/1743-0003-9-31.}
}

@Article{2008417,
author  = {},
title  = {Traumatology.},
journal  = {Society of Orthopaedics and Traumatology},
volume  = {9},
number  = {Suppl 1},
pages  = {1-94},
year  = {2008},
abstract  = {},
address  = {},
note  = {doi:10.1007/s10195-008-0030-6.}
}

@Article{2011418,
author  = {Cantor, S. and Yamal, J. and Guillaud, M. and Cox, D. and Atkinson, E. and Benedet, J. and Miller, D. and Ehlen, T. and Matisic, J. and van, N. and Bertrand, M. and Milbourne, A. and Rhodes, H. and Malpica, A. and Staerkel, G. and Nader-Eftekhari, S. and Adler-Storthz, K. and Scheurer, M. and Basen-Engquist, K. and Shinn, E. and West, L. and Vlastos, A. and Tao, X. and Beck, J. and MacAulay, C. and Follen, M.},
title  = {neoplasia: testing a device as an adjunct to colposcopy.},
journal  = {International journal of cancer. Journal international du cancer},
volume  = {128},
number  = {5},
pages  = {1151-68},
year  = {2011},
abstract  = {Testing emerging technologies involves the evaluation of biologic plausibility, technical efficacy, clinical effectiveness, patient satisfaction, and cost-effectiveness. The objective of this study was to select an effective classification algorithm for optical spectroscopy as an adjunct to colposcopy and obtain preliminary estimates of its accuracy for the detection of CIN 2 or worse. We recruited 1000 patients from screening and prevention clinics and 850 patients from colposcopy clinics at two comprehensive cancer centers and a community hospital. Optical spectroscopy was performed and 4864 biopsies were obtained from the sites measured, including abnormal and normal colposcopic areas. The gold standard was the histologic report of biopsies, read 2‚Äì3 times by histopathologists blinded to the cytologic, histopathologic, and spectroscopic results. We calculated sensitivities, specificities, receiver operating characteristic (ROC) curves, and areas under the ROC curves. We identified a cutpoint for an algorithm based on optical spectroscopy that yielded an estimated sensitivity of 1.00 [95% confidence interval (CI) = 0.92 ‚Äì 1.00] and an estimated specificity of 0.71 [95% CI = 0.62 ‚Äì 0.79] in a combined screening and diagnostic population. The positive and negative predictive values were 0.58 and 1.00, respectively. The area under the ROC curve was 0.85 (95% CI 0.81 ‚Äì 0.89). The per-patient and per-site performance were similar in the diagnostic and poorer in the screening settings. Like colposcopy, the device performs best in a diagnostic population. Alternative statistical approaches demonstrate that the analysis is robust and that spectroscopy works as well as or slightly better than colposcopy  for the detection of CIN 2 to cancer.},
address  = {Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas Division of Biostatistics, The University of Texas School of Public Health, Houston, Texas Department of Cancer Imaging, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada Department of Statistics, Rice University, Houston, Texas Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Cancer Imaging, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Obstetrics, Gynecology, and Reproductive Sciences, The University of Texas Health Science Center at Houston, Houston, Texas The University of Texas Health Science Center at Houston Dental Branch, Houston,  Texas Department of Pediatrics and Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas Fox Chase Cancer Center, Philadelphia, Pennsylvania Department of Cancer Imaging, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas},
note  = {Int J Cancer. 2011 Mar 1;128(5):1151-68. Epub 2010 Nov 9 doi:10.1002/ijc.25667.}
}

@Article{2013419,
author  = {Burke, E. and Cramer, S.},
title  = {Biomarkers and predictors of restorative therapy effects after stroke.},
journal  = {Current neurology and neuroscience reports},
volume  = {13},
number  = {2},
pages  = {329},
year  = {2013},
abstract  = {Many restorative therapies that promote brain repair are under development. Stroke is very heterogeneous, highlighting the need to identify target populations and to understand inter-subject differences in treatment response. Several neuroimaging measures have shown promise as biomarkers and predictors, including measures of structure and function, in gray matter and white matter. Choice of biomarker and predictor can vary with the content of therapy and with the population under study, for example, contralesional hemisphere measures may be of particular importance in patients with more severe injury. Studies of training effects in healthy subjects provide insights useful to brain repair. Limitations of published studies include a focus on chronic stroke, however the brain is most galvanized to respond to restorative therapies in the early days post-stroke. Multimodal approaches might be the most robust approach for stratifying patients and so for optimizing prescription of restorative therapies  after stroke.},
address  = {Department of Anatomy & Neurobiology, University of California, Irvine Department of Anatomy & Neurobiology, University of California, Irvine},
note  = {Curr Neurol Neurosci Rep. 2013 Feb;13(2):329. doi:10.1007/s11910-012-0329-9.}
}

@Article{2016420,
author  = {Elmer, S. and K√ºhnis, J.},
title  = {Language Translation: An EEG Study.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Cortical speech processing is dependent on the mutual interdependence of two distinctive processing streams supporting sound-to-meaning (i.e., ventral stream) and sound-to-articulation (i.e., dorsal stream) mapping. Here, we compared the strengths of intracranial functional connectivity between two main hubs of the dorsal stream, namely the left auditory-related cortex (ARC) and Broca‚Äôs region,  in a sample of simultaneous interpreters (SIs) and multilingual control subjects  while the participants performed a mixed and unmixed auditory semantic decision task. Under normal listening conditions such kind of tasks are known to initiate  a spread of activation along the ventral stream. However, due to extensive and specific training, here we predicted that SIs will more strongly recruit the dorsal pathway in order to pre-activate the speech codes of the corresponding translation. In line with this reasoning, EEG results demonstrate increased left-hemispheric theta phase synchronization in SLI compared to multilingual control participants during early task-related processing stages. In addition, within the SI group functional connectivity strength in the left dorsal pathway was positively related to the cumulative number of training hours across lifespan, and inversely correlated with the age of training commencement. Hence,  we propose that the alignment of neuronal oscillations between brain regions involved in ‚Äúhearing‚Ä? and ‚Äúspeaking‚Ä? results from an intertwining of training, sensitive period, and predisposition.},
address  = {Auditory Research Group Zurich (ARGZ), Division Neuropsychology, Institute of Psychology, University of ZurichZurich, Switzerland Auditory Research Group Zurich (ARGZ), Division Neuropsychology, Institute of Psychology, University of ZurichZurich, Switzerland},
note  = {Front Hum Neurosci. 2016 Feb 19;10:. doi:10.3389/fnhum.2016.00060.}
}

@Article{2016421,
author  = {Muldoon, S. and Pasqualetti, F. and Gu, S. and Cieslak, M. and Grafton, S. and Vettel, J. and Bassett, D.},
title  = {Stimulation-Based Control of Dynamic Brain Networks.},
journal  = {PLoS Computational Biology},
volume  = {12},
number  = {9},
pages  = {},
year  = {2016},
abstract  = {The ability to modulate brain states using targeted stimulation is increasingly being employed to treat neurological disorders and to enhance human performance.  Despite the growing interest in brain stimulation as a form of neuromodulation, much remains unknown about the network-level impact of these focal perturbations. To study the system wide impact of regional stimulation, we employ a data-driven  computational model of nonlinear brain dynamics to systematically explore the effects of targeted stimulation. Validating predictions from network control theory, we uncover the relationship between regional controllability and the focal versus global impact of stimulation, and we relate these findings to differences in the underlying network architecture. Finally, by mapping brain regions to cognitive systems, we observe that the default mode system imparts large global change despite being highly constrained by structural connectivity.  This work forms an important step towards the development of personalized stimulation protocols for medical treatment or performance enhancement.},
address  = {Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America Department of Mechanical Engineering, University of California, Riverside, Riverside, California, United States of America Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America Department of Psychological and Brain Sciences, University of California, Santa Barbara, Santa Barbara, California, United States of America Department of Psychological and Brain Sciences, University of California, Santa Barbara, Santa Barbara, California, United States of America US Army Research Laboratory, Aberdeen Proving Ground, Maryland, United States of  America Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America},
note  = {PLoS Comput Biol. 2016 Sep 9;12(9):. doi:10.1371/journal.pcbi.1005076.}
}

@Article{2015422,
author  = {Kozai, T. and Jaquins-Gerstl, A. and Vazquez, A. and Michael, A. and Cui, X.},
title  = {Intervention Strategies.},
journal  = {ACS Chemical Neuroscience},
volume  = {6},
number  = {1},
pages  = {48-67},
year  = {2015},
abstract  = {Implantable biosensors are valuable scientific tools for basic neuroscience research and clinical applications. Neurotechnologies provide direct readouts of  neurological signal and neurochemical processes. These tools are generally most valuable when performance capacities extend over months and years to facilitate the study of memory, plasticity, and behavior or to monitor patients‚Äô conditions. These needs have generated a variety of device designs from microelectrodes for fast scan cyclic voltammetry (FSCV) and electrophysiology to microdialysis probes for sampling and detecting various neurochemicals. Regardless of the technology used, the breaching of the blood‚Äìbrain barrier (BBB) to insert devices triggers a cascade of biochemical pathways resulting in complex molecular and cellular responses to implanted devices. Molecular and cellular changes in the microenvironment surrounding an implant include the introduction of mechanical strain, activation of glial cells, loss of perfusion, secondary metabolic injury, and neuronal degeneration. Changes to the tissue microenvironment surrounding the device can dramatically impact electrochemical and electrophysiological signal sensitivity and stability over time. This review summarizes the magnitude, variability, and time course of the dynamic molecular and cellular level neural tissue responses induced by state-of-the-art implantable devices. Studies show that insertion injuries and foreign body response can impact signal quality across all implanted central nervous system (CNS) sensors to varying degrees over both acute (seconds to minutes) and chronic periods (weeks to months). Understanding the underlying biological processes behind the brain tissue response to the devices at the cellular and molecular level leads to a variety of intervention strategies for improving signal sensitivity and longevity.},
address  = {Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan Institute for Regenerative Medicine, Department of Chemistry, and Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan Institute for Regenerative Medicine, Department of Chemistry, and Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan Institute for Regenerative Medicine, Department of Chemistry, and Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan Institute for Regenerative Medicine, Department of Chemistry, and Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States Department of Bioengineering, Center for the Neural Basis of Cognition, McGowan Institute for Regenerative Medicine, Department of Chemistry, and Department of Radiology, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States},
note  = {ACS Chem Neurosci. 2014 Dec 29;6(1):48-67. doi:10.1021/cn500256e.}
}

@Article{2009423,
author  = {Freudenmann, R. and Lepping, P.},
title  = {Delusional Infestation.},
journal  = {Clinical Microbiology Reviews},
volume  = {22},
number  = {4},
pages  = {690-732},
year  = {2009},
abstract  = {Summary: This papers aims at familiarizing psychiatric and nonpsychiatric readers with delusional infestation (DI), also known as delusional parasitosis. It is characterized by the fixed belief of being infested with pathogens against all medical evidence. DI is no single disorder but can occur as a delusional disorder of the somatic type (primary DI) or secondary to numerous other conditions. A set of minimal diagnostic criteria and a classification are provided. Patients with DI pose a truly interdisciplinary problem to the medical system. They avoid psychiatrists and consult dermatologists, microbiologists, or general practitioners but often lose faith in professional medicine. Epidemiology and history suggest that the imaginary pathogens change constantly, while the delusional theme ‚Äúinfestation‚Ä? is stable and ubiquitous. Patients with self-diagnosed ‚ÄúMorgellons disease‚Ä? can be seen as a variation of this delusional theme. For clinicians, clinical pathways for efficient diagnostics and etiology-specific treatment are provided. Specialized outpatient clinics in dermatology with a liaison psychiatrist are theoretically best placed to provide  care. The most intricate problem is to engage patients in psychiatric therapy. In primary DI, antipsychotics are the treatment of choice, according to limited but  sufficient evidence. Pimozide is no longer the treatment of choice for reasons of drug safety. Future research should focus on pathophysiology and the neural basis of DI, as well as on conclusive clinical trials, which are widely lacking. Innovative approaches will be needed, since otherwise patients are unlikely to adhere to any study protocol.},
address  = {Department of Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany, North Wales NHS Trust, Wrexham Academic Unit, Wrexham, Wales, United Kingdom Department of Psychiatry and Psychotherapy, University of Ulm, Ulm, Germany, North Wales NHS Trust, Wrexham Academic Unit, Wrexham, Wales, United Kingdom},
note  = {Clin Microbiol Rev. 2009 Oct;22(4):690-732. doi:10.1128/CMR.00018-09.}
}

@Article{2009424,
author  = {Albuquerque, E. and Pereira, E. and Alkondon, M. and Rogers, S.},
title  = {Mammalian Nicotinic Acetylcholine Receptors: From Structure to Function.},
journal  = {Physiological reviews},
volume  = {89},
number  = {1},
pages  = {73-120},
year  = {2009},
abstract  = {The classical studies of nicotine by Langley at the turn of the 20th century introduced the concept of a ‚Äúreceptive substance,‚Ä? from which the idea of a ‚Äúreceptor‚Ä? came to light. Subsequent studies aided by the Torpedo electric organ, a rich source of muscle-type nicotinic receptors (nAChRs), and the discovery of Œ±-bungarotoxin, a snake toxin that binds pseudo-irreversibly to the muscle nAChR, resulted in the muscle nAChR being the best characterized ligand-gated ion channel hitherto. With the advancement of functional and genetic studies in the late 1980s, the existence of nAChRs in the mammalian brain was confirmed and the  realization that the numerous nAChR subtypes contribute to the psychoactive properties of nicotine and other drugs of abuse and to the neuropathology of various diseases, including Alzheimer‚Äôs, Parkinson‚Äôs, and schizophrenia, has since emerged. This review provides a comprehensive overview of these findings and the more recent revelations of the impact that the rich diversity in function and expression of this receptor family has on neuronal and nonneuronal cells throughout the body. Despite these numerous developments, our understanding of the contributions of specific neuronal nAChR subtypes to the many facets of physiology throughout the body remains in its infancy.},
address  = {},
note  = {Physiol Rev. 2009 Jan;89(1):73-120. doi:10.1152/physrev.00015.2008.}
}

@Article{2008425,
author  = {Bentley, P. and Driver, J. and Dolan, R.},
title  = {disease and in health.},
journal  = {Brain : a journal of neurology},
volume  = {131},
number  = {Pt 2},
pages  = {409-24},
year  = {2008},
abstract  = {Visuo-attentional deficits occur early in Alzheimer's disease (AD) and are considered more responsive to pro-cholinergic therapy than characteristic memory  disturbances. We hypothesised that neural responses in AD during visual attentional processing would be impaired relative to controls, yet partially susceptible to improvement with cholinesterase inhibition. We studied 16 mild AD  patients and 17 age-matched healthy controls, using fMRI-scanning to enable within-subject placebo-controlled comparisons of the effects of physostigmine on  stimulus- and attention-related brain activations, and to allow between-group comparisons for these. Subjects viewed stimuli comprising faces or buildings while performing a shallow judgement (colour of image) or a deep judgement (young/old age of depicted face or building). Behaviourally, AD subjects performed poorer than controls in both tasks, while physostigmine benefited AD patients for the more demanding age-judgement task. Stimulus-selective (face minus building, and vice versa) BOLD signals in precuneus and posterior parahippocampal cortex were attenuated in AD relative to controls but increased following physostigmine. By contrast, face-selective responses in fusiform cortex were not impaired in AD and showed decreases following physostigmine for both groups. Task-dependent responses in right parietal and prefrontal cortices were diminished in AD but improved following physostigmine. A similar pattern of group and treatment effects was observed in two extrastriate cortical regions that showed enhanced stimulus-selectivity for the deep versus shallow task. Finally, for the healthy group, physostigmine decreased task-dependent effects, partly due to an exaggeration of selectivity during the shallow relative to deep task. Our results demonstrate cholinergic-mediated improvements for both stimulus- and attention-dependent responses in functionally affected extrastriate and frontoparietal regions for AD. We also show that normal stimulus- and task-dependent activity patterns can be perturbed in the healthy brain by cholinergic stimulation.},
address  = {Wellcome Centre for Neuroimaging at UCL, 12 Queen Square, London WC1N 3BG, UK Wellcome Centre for Neuroimaging at UCL, 12 Queen Square, London WC1N 3BG, UK Wellcome Centre for Neuroimaging at UCL, 12 Queen Square, London WC1N 3BG, UK},
note  = {Brain. 2008 Feb;131(Pt 2):409-24. Epub 2007 Dec 12 doi:10.1093/brain/awm299.}
}

@Article{2006426,
author  = {},
title  = {Diego, California, July 9‚Äì12.},
journal  = {American Journal of Pharmaceutical Education},
volume  = {70},
number  = {3},
pages  = {},
year  = {2006},
abstract  = {},
address  = {},
note  = {Am J Pharm Educ. 2006 Jun 15;70(3):.}
}

@Article{2007427,
author  = {Symvoulakis, E. and Clark, L. and Dowson, A. and Jones, R. and Ridsdale, L.},
title  = {Headache: a ‚Äòsuitable case‚Äô for behavioural treatment in primary care?},
journal  = {The British Journal of General Practice},
volume  = {57},
number  = {536},
pages  = {231-7},
year  = {2007},
abstract  = {Headache is a health problem with considerable impact at personal, social, and financial levels in terms of distress, disability, and cost. In the past, many studies have investigated the use of various behavioural treatment modalities for headache. Literature reviews consistently support the effectiveness of behavioural therapeutic approaches for the treatment of the most common primary headaches, namely migraine and tension-type headache. This article recommends that behavioural headache therapies should be developed, tested, and integrated into primary care practice, where most patients with headache are seen and treated. The large population seen in general practice, most of whom have uncomplicated primary headaches, could represent the ideal target for testing behavioural therapies.},
address  = {},
note  = {Br J Gen Pract. 2007 Mar 01;57(536):231-7.}
}

@Article{2016428,
author  = {Roux, S. and Matonti, F. and Dupont, F. and Hoffart, L. and Takerkart, S. and Picaud, S. and Pham, P. and Chavane, F.},
title  = {Probing the functional impact of sub-retinal prosthesis.},
journal  = {eLife},
volume  = {5},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Retinal prostheses are promising tools for recovering visual functions in blind patients but, unfortunately, with still poor gains in visual acuity. Improving their resolution is thus a key challenge that warrants understanding its origin through appropriate animal models. Here, we provide a systematic comparison between visual and prosthetic activations of the rat primary visual cortex (V1).  We established a precise V1 mapping as a functional benchmark to demonstrate that sub-retinal implants activate V1 at the appropriate position, scalable to a wide  range of visual luminance, but with an aspect-ratio and an extent much larger than expected. Such distorted activation profile can be accounted for by the existence of two sources of diffusion, passive diffusion and activation of ganglion cells‚Äô axons en passant. Reverse-engineered electrical pulses based on impedance spectroscopy is the only solution we tested that decreases the extent and aspect-ratio, providing a promising solution for clinical applications.DOI:http://dx.doi.org/10.7554/eLife.12687.001},
address  = {Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Universit√©, Marseille, France Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Universit√©, Marseille, France CEA-LETI, Grenoble, France Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Universit√©, Marseille, France Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Universit√©, Marseille, France Inserm, UMRS-986, Institut de la vision, Paris, France CEA-LETI, Grenoble, France Institut de Neurosciences de la Timone, CNRS, Aix-Marseille Universit√©, Marseille, France},
note  = {eLife. 2016;5:. doi:10.7554/eLife.12687.}
}

@Article{2012429,
author  = {Demirtas-Tatlidede, A. and Vahabzadeh-Hagh, A. and Bernabeu, M. and Tormos, J. and Pascual-Leone, A.},
title  = {NONINVASIVE BRAIN STIMULATION IN TRAUMATIC BRAIN INJURY.},
journal  = {The Journal of Head Trauma Rehabilitation},
volume  = {27},
number  = {4},
pages  = {274-92},
year  = {2012},
abstract  = {Brain stimulation techniques have evolved in the last few decades with more novel methods capable of painless, noninvasive brain stimulation. While the number of clinical trials employing noninvasive brain stimulation continues to increase in  a variety of medication-resistant neurological and psychiatric diseases, studies  evaluating their diagnostic and therapeutic potential in traumatic brain injury (TBI) are largely lacking. This review introduces different techniques of noninvasive brain stimulation, which may find potential use in TBI. We cover transcranial magnetic stimulation (TMS), transcranial direct current stimulation  (tDCS), low-level laser therapy (LLLT) and transcranial doppler sonography (TCD)  techniques. We provide a brief overview of studies to date, discuss possible mechanisms of action, and raise a number of considerations when thinking about translating these methods to clinical use.},
address  = {Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA Guttmann University Institute for Neurorehabilitation, Universitat Autonoma de Barcelona, Badalona, Spain Guttmann University Institute for Neurorehabilitation, Universitat Autonoma de Barcelona, Badalona, Spain Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA},
note  = {J Head Trauma Rehabil. 2012 Jul;27(4):274-92. doi:10.1097/HTR.0b013e318217df55.}
}

@Article{2015430,
author  = {Yadav, K. and Chamberlain, J. and Lewis, V. and Abts, N. and Chawla, S. and Hernandez, A. and Johnson, J. and Tuveson, G. and Burd, R.},
title  = {Designing Real-time Decision Support for Trauma Resuscitations.},
journal  = {Emergency Medicine},
volume  = {22},
number  = {9},
pages  = {1076-84},
year  = {2015},
abstract  = {Background: Use of electronic clinical decision support (eCDS) has been recommended to improve implementation of clinical decision rules. Many eCDS tools, however, are designed and implemented without taking into account the context in which clinical work is performed. Implementation of the pediatric traumatic brain injury (TBI) clinical decision rule at one Level I pediatric emergency department includes an electronic questionnaire triggered when ordering a head computed tomography using computerized physician order entry (CPOE). Providers use this CPOE tool in less than 20% of trauma resuscitation cases. A human factors engineering approach could identify the implementation barriers that are limiting the use of this tool. Objectives: The objective was to design a pediatric TBI eCDS tool for trauma resuscitation using a human factors approach.  The hypothesis was that clinical experts will rate a usability-enhanced eCDS tool better than the existing CPOE tool for user interface design and suitability for  clinical use. Methods: This mixed-methods study followed usability evaluation principles. Pediatric emergency physicians were surveyed to identify barriers to  using the existing eCDS tool. Using standard trauma resuscitation protocols, a hierarchical task analysis of pediatric TBI evaluation was developed. Five clinical experts, all board-certified pediatric emergency medicine faculty members, then iteratively modified the hierarchical task analysis until reaching  consensus. The software team developed a prototype eCDS display using the hierarchical task analysis. Three human factors engineers provided feedback on the prototype through a heuristic evaluation, and the software team refined the eCDS tool using a rapid prototyping process. The eCDS tool then underwent iterative usability evaluations by the five clinical experts using video review of 50 trauma resuscitation cases. A final eCDS tool was created based on their feedback, with content analysis of the evaluations performed to ensure all concerns were identified and addressed. Results: Among 26 EPs (76% response rate), the main barriers to using the existing tool were that the information displayed is redundant and does not fit clinical workflow. After the prototype eCDS tool was developed based on the trauma resuscitation hierarchical task analysis, the human factors engineers rated it to be better than the CPOE tool for nine of 10 standard user interface design heuristics on a three-point scale.  The eCDS tool was also rated better for clinical use on the same scale, in 84% of 50 expert‚Äìvideo pairs, and was rated equivalent in the remainder. Clinical experts also rated barriers to use of the eCDS tool as being low. Conclusions: An eCDS tool for diagnostic imaging designed using human factors engineering methods has improved perceived usability among pediatric emergency physicians.},
address  = {},
note  = {Acad Emerg Med. 2015 Sep;22(9):1076-84. Epub 2015 Aug 24 doi:10.1111/acem.12747.}
}

@Article{2016431,
author  = {Sykes, E. and Dai, Q. and Sarsons, C. and Chen, J. and Rocheleau, J. and Hwang, D. and Zheng, G. and Cramb, D. and Rinker, K. and Chan, W.},
title  = {Tailoring nanoparticle designs to target cancer based on tumor pathophysiology.},
journal  = {Proceedings of the National Academy of Sciences of the United States of America},
volume  = {113},
number  = {9},
pages  = {E1142-51},
year  = {2016},
abstract  = {Nanotechnology is a promising approach for improving cancer diagnosis and treatment with reduced side effects. A key question that has emerged is: What is  the ideal nanoparticle size, shape, or surface chemistry for targeting tumors? Here, we show that tumor pathophysiology and volume can significantly impact nanoparticle targeting. This finding presents a paradigm shift in nanomedicine away from identifying and using a universal nanoparticle design for cancer detection and treatment. Rather, our results suggest that future clinicians will  be capable of tailoring nanoparticle designs according to the patient's tumor characteristics. This concept of ‚Äúpersonalized nanomedicine‚Ä? was tested for detection of prostate tumors and was successfully demonstrated to improve nanoparticle targeting by over 50%.},
address  = {Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada M5S 3G9; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada M5S 3G9; Biomedical Engineering, University of Calgary, Calgary, AB, Canada T2N 1N4; Department of Medical Biophysics, Princess Margaret Cancer Centre, University of  Toronto, Toronto, ON, Canada M5G 1L7; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada M5S 3G9; Department of Pathology, University Health Network, Toronto, ON, Canada M5G 2C4; Department of Medical Biophysics, Princess Margaret Cancer Centre, University of  Toronto, Toronto, ON, Canada M5G 1L7; Department of Chemistry, University of Calgary, Calgary, AB, Canada T2N 1N4; Biomedical Engineering, University of Calgary, Calgary, AB, Canada T2N 1N4; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada M5S 3G9;},
note  = {doi:10.1073/pnas.1521265113.}
}

@Article{2016432,
author  = {Tao, D. and Or, C. and Veinot, T. and Vandenberg, N. and Chaet, A. and Morshedi, B. and Wells, K. and Barnes, L. and Valdez, R.},
title  = {Systematic Review.},
journal  = {Journal of Medical Internet Research},
volume  = {18},
number  = {8},
pages  = {},
year  = {2016},
abstract  = {Background: As consumer health information technology (IT) becomes more thoroughly integrated into patient care, it is critical that these tools are appropriate for the diverse patient populations whom they are intended to serve.  Cultural differences associated with ethnicity are one aspect of diversity that may play a role in user-technology interactions. Objective: Our aim was to evaluate the current scope of consumer health IT interventions targeted to the US Spanish-speaking Latino population and to characterize these interventions in terms of technological attributes, health domains, cultural tailoring, and evaluation metrics. Methods: A narrative synthesis was conducted of existing Spanish-language consumer health IT interventions indexed within health and computer science databases. Database searches were limited to English-language articles published between January 1990 and September 2015. Studies were included if they detailed an assessment of a patient-centered electronic technology intervention targeting health within the US Spanish-speaking Latino population. Included studies were required to have a majority Latino population sample. The following were extracted from articles: first author‚Äôs last name, publication year, population characteristics, journal domain, health domain, technology platform and functionality, available languages of intervention, US region, cultural tailoring, intervention delivery location, study design, and evaluation  metrics. Results: We included 42 studies in the review. Most of the studies were  published between 2009 and 2015 and had a majority percentage of female study participants. The mean age of participants ranged from 15 to 68. Interventions most commonly focused on urban population centers and within the western region of the United States. Of articles specifying a technology domain, computer was found to be most common; however, a fairly even distribution across all technologies was noted. Cancer, diabetes, and child, infant, or maternal health were the most common health domains targeted by consumer health IT interventions. More than half of the interventions were culturally tailored. The most frequently used evaluation metric was behavior/attitude change, followed by usability and knowledge retention. Conclusions: This study characterizes the existing body of research exploring consumer health IT interventions for the US Spanish-speaking Latino population. In doing so, it reveals three primary needs within the field.  First, while the increase in studies targeting the Latino population in the last  decade is a promising advancement, future research is needed that focuses on Latino subpopulations previously overlooked. Second, preliminary steps have been  taken to culturally tailor consumer health IT interventions for the US Spanish-speaking Latino population; however, focus must expand beyond intervention content. Finally, the field should work to promote long-term evaluation of technology efficacy, moving beyond intermediary measures toward measures of health outcomes.},
address  = {Department of Public Health SciencesUniversity of VirginiaCharlottesville, VAUnited States Department of Public Health SciencesUniversity of VirginiaCharlottesville, VAUnited States Department of PsychologySan Diego State UniversitySan Diego, CAUnited States Department of Systems and Information EngineeringUniversity of VirginiaCharlottesville, VAUnited States Department of Public Health SciencesUniversity of VirginiaCharlottesville, VAUnited States},
note  = {J Med Internet Res. 2016 Aug 10;18(8):. doi:10.2196/jmir.5794.}
}

@Article{2013433,
author  = {Nikolaou, K. and Critchley, H. and Duka, T.},
title  = {Processing of Stimuli Signalling a Stop Response.},
journal  = {PLoS ONE},
volume  = {8},
number  = {9},
pages  = {},
year  = {2013},
abstract  = {Alcohol impairs inhibitory control, including the ability to terminate an initiated action. While there is increasing knowledge about neural mechanisms involved in response inhibition, the level at which alcohol impairs such mechanisms remains poorly understood. Thirty-nine healthy social drinkers received either 0.4g/kg or 0.8g/kg of alcohol, or placebo, and performed two variants of a Visual Stop-signal task during acquisition of functional magnetic resonance imaging (fMRI) data. The two task variants differed only in their instructions: in the classic variant (VSST), participants inhibited their response to a ‚ÄúGo-stimulus‚Ä? when it was followed by a ‚ÄúStop-stimulus‚Ä?. In the control variant (VSST_C), participants responded to the ‚ÄúGo-stimulus‚Ä? even if it  was followed by a ‚ÄúStop-stimulus‚Ä?. Comparison of successful Stop-trials (Sstop)>Go, and unsuccessful Stop-trials (Ustop)>Sstop between the three beverage groups enabled the identification of alcohol effects on functional neural circuits supporting inhibitory behaviour and error processing. Alcohol impaired inhibitory control as measured by the Stop-signal reaction time, but did not affect other aspects of VSST performance, nor performance on the VSST_C. The low  alcohol dose evoked changes in neural activity within prefrontal, temporal, occipital and motor cortices. The high alcohol dose evoked changes in activity in areas affected by the low dose but importantly induced changes in activity within subcortical centres including the globus pallidus and thalamus. Alcohol did not affect neural correlates of perceptual processing of infrequent cues, as revealed by conjunction analyses of VSST and VSST_C tasks. Alcohol ingestion compromises the inhibitory control of action by modulating cortical regions supporting attentional, sensorimotor and action-planning processes. At higher doses the impact of alcohol also extends to affect subcortical nodes of fronto-basal ganglia- thalamo-cortical motor circuits. In contrast, alcohol appears to have little impact on the early visual processing of infrequent perceptual cues. These observations clarify clinically-important effects of alcohol on behaviour.},
address  = {Behavioural and Clinical Neuroscience, School of Psychology, University of Sussex, Brighton, United Kingdom Behavioural and Clinical Neuroscience, School of Psychology, University of Sussex, Brighton, United Kingdom Behavioural and Clinical Neuroscience, School of Psychology, University of Sussex, Brighton, United Kingdom},
note  = {PLoS One. 2013 Sep 25;8(9):. doi:10.1371/journal.pone.0076649.}
}

@Article{2015434,
author  = {Li, S. and Zaninotto, A. and Neville, I. and Paiva, W. and Nunn, D. and Fregni, F.},
title  = {injury: current evidence.},
journal  = {Neuropsychiatric Disease and Treatment},
volume  = {11},
number  = {},
pages  = {1573-86},
year  = {2015},
abstract  = {Traumatic brain injury (TBI) remains the main cause of disability and a major public health problem worldwide. This review focuses on the neurophysiology of TBI, and the rationale and current state of evidence of clinical application of brain stimulation to promote TBI recovery, particularly on consciousness, cognitive function, motor impairments, and psychiatric conditions. We discuss the mechanisms of different brain stimulation techniques including major noninvasive  and invasive stimulations. Thus far, most noninvasive brain stimulation interventions have been nontargeted and focused on the chronic phase of recovery  after TBI. In the acute stages, there is limited available evidence of the efficacy and safety of brain stimulation to improve functional outcomes. Comparing the studies across different techniques, transcranial direct current stimulation is the intervention that currently has the higher number of properly  designed clinical trials, though total number is still small. We recognize the need for larger studies with target neuroplasticity modulation to fully explore the benefits of brain stimulation to effect TBI recovery during different stages  of recovery.},
address  = {Department of Rehabilitation Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People‚Äôs Republic of China Spaulding Neuromodulation Center, Harvard Medical School, Boston, MA, USA Division of Neurosurgery, University of S√£o Paulo Medical School, S√£o Paulo, S√£o  Paulo, Brazil Division of Neurosurgery, University of S√£o Paulo Medical School, S√£o Paulo, S√£o  Paulo, Brazil Spaulding Neuromodulation Center, Harvard Medical School, Boston, MA, USA Spaulding Neuromodulation Center, Harvard Medical School, Boston, MA, USA},
note  = {Neuropsychiatr Dis Treat. 2015 Jun 30;11:1573-86. doi:10.2147/NDT.S65816.}
}

@Article{2013435,
author  = {Parks, N.},
title  = {considerations and potential artifacts.},
journal  = {Frontiers in Human Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {The simultaneous application of transcranial magnetic stimulation (TMS) with non-invasive neuroimaging provides a powerful method for investigating functional connectivity in the human brain and the causal relationships between areas in distributed brain networks. TMS has been combined with numerous neuroimaging techniques including, electroencephalography (EEG), functional magnetic resonance imaging (fMRI), and positron emission tomography (PET). Recent work has also demonstrated the feasibility and utility of combining TMS with non-invasive near-infrared optical imaging techniques, functional near-infrared spectroscopy (fNIRS) and the event-related optical signal (EROS). Simultaneous TMS and optical imaging affords a number of advantages over other neuroimaging methods but also involves a unique set of methodological challenges and considerations. This paper describes the methodology of concurrently performing optical imaging during the administration of TMS, focusing on experimental design, potential artifacts, and  approaches to controlling for these artifacts.},
address  = {},
note  = {Front Hum Neurosci. 2013 Sep 19;7:. doi:10.3389/fnhum.2013.00592.}
}

@Article{2015436,
author  = {Meiring, G. and Myburgh, H.},
title  = {Intelligence Algorithms.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {15},
number  = {12},
pages  = {30653-82},
year  = {2015},
abstract  = {In this paper the various driving style analysis solutions are investigated. An in-depth investigation is performed to identify the relevant machine learning and artificial intelligence algorithms utilised in current driver behaviour and driving style analysis systems. This review therefore serves as a trove of information, and will inform the specialist and the student regarding the current state of the art in driver style analysis systems, the application of these systems and the underlying artificial intelligence algorithms applied to these applications. The aim of the investigation is to evaluate the possibilities for unique driver identification utilizing the approaches identified in other driver  behaviour studies. It was found that Fuzzy Logic inference systems, Hidden Markov Models and Support Vector Machines consist of promising capabilities to address unique driver identification algorithms if model complexity can be reduced.},
address  = {},
note  = {Sensors (Basel). 2015 Dec 04;15(12):30653-82. doi:10.3390/s151229822.}
}

@Article{2017437,
author  = {Shin, K. and Choi, J. and Ko, G. and Baik, S. and Kim, D. and Park, O. and Lee, K. and Cho, H. and Han, S. and Lee, S. and Lee, D. and Lee, N. and Kim, H. and Hyeon, T.},
title  = {image-guided procedures.},
journal  = {Nature Communications},
volume  = {8},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Tissue adhesives have emerged as an alternative to sutures and staples for wound  closure and reconnection of injured tissues after surgery or trauma. Owing to their convenience and effectiveness, these adhesives have received growing attention particularly in minimally invasive procedures. For safe and accurate applications, tissue adhesives should be detectable via clinical imaging modalities and be highly biocompatible for intracorporeal procedures. However, few adhesives meet all these requirements. Herein, we show that biocompatible tantalum oxide/silica core/shell nanoparticles (TSNs) exhibit not only high contrast effects for real-time imaging but also strong adhesive properties. Furthermore, the biocompatible TSNs cause much less cellular toxicity and less inflammation than a clinically used, imageable tissue adhesive (that is, a mixture of cyanoacrylate and Lipiodol). Because of their multifunctional imaging  and adhesive property, the TSNs are successfully applied as a hemostatic adhesive for minimally invasive procedures and as an immobilized marker for image-guided procedures.},
address  = {Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea Department of Pathology, Seoul National University Hospital, Seoul 03080, Republic of Korea Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea School of Advanced Materials Engineering, Kookmin University, Seoul 02707, Republic of Korea Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 08826, Republic of Korea},
note  = {Nat Commun. 2017 Jul 19;8:. doi:10.1038/ncomms15807.}
}

@Article{2012438,
author  = {Prasov, L. and Masud, T. and Khaliq, S. and Mehdi, S. and Abid, A. and Oliver, E. and Silva, E. and Lewanda, A. and Brodsky, M. and Borchert, M. and Kelberman, D. and Sowden, J. and Dattani, M. and Glaser, T.},
title  = {vitreous.},
journal  = {Human Molecular Genetics},
volume  = {21},
number  = {16},
pages  = {3681-94},
year  = {2012},
abstract  = {The vertebrate basic helix‚Äìloop‚Äìhelix (bHLH) transcription factor ATOH7 (Math5) is specifically expressed in the embryonic neural retina and is required for the  genesis of retinal ganglion cells (RGCs) and optic nerves. In Atoh7 mutant mice,  the absence of trophic factors secreted by RGCs prevents the development of the intrinsic retinal vasculature and the regression of fetal blood vessels, causing  persistent hyperplasia of the primary vitreous (PHPV). We therefore screened patients with hereditary PHPV, as well as bilateral optic nerve aplasia (ONA) or  hypoplasia (ONH), for mutations in ATOH7. We identified a homozygous ATOH7 mutation (N46H) in a large family with an autosomal recessive PHPV disease trait  linked to 10q21, and a heterozygous variant (R65G, p.Arg65Gly) in one of five sporadic ONA patients. High-density single-nucleotide polymorphism analysis also  revealed a CNTN4 duplication and an OTX2 deletion in the ONA cohort. Functional analysis of ATOH7 bHLH domain substitutions, by electrophoretic mobility shift and luciferase cotransfection assays, revealed that the N46H variant cannot bind  DNA or activate transcription, consistent with structural modeling. The N46H variant also failed to rescue RGC development in mouse Atoh7‚àí/‚àí retinal explants. The R65G variant retains all of these activities, similar to wild-type human ATOH7. Our results strongly suggest that autosomal recessive persistent hyperplastic primary vitreous is caused by N46H and is etiologically related to nonsyndromic congenital retinal nonattachment. The R65G allele, however, cannot explain the ONA phenotype. Our study firmly establishes ATOH7 as a retinal disease gene and provides a functional basis to analyze new coding variants.},
address  = {Department of Human Genetics and Department of Human Genetics and Department of Human Genetics and Molecular Biology, University of Health Sciences, Lahore, Pakistan, Centre for Human Genetics, Sindh Institute of Urology and Transplantation, Karachi 74200, Pakistan, Centre for Human Genetics, Sindh Institute of Urology and Transplantation, Karachi 74200, Pakistan, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA, Visual Neuroscience Laboratory, IBILI, Faculty of Medicine, University of Coimbra, Portugal, Department of Pediatrics, Inova Fairfax Hospital for Children, Falls Church, VA,  22031, USA, Department of Ophthalmology and Neurology, Mayo Clinic, Rochester, MN 55905, USA, The Vision Center, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA, Ulverscroft Vision Research Group, Developmental Biology Unit, UCL Institute of Child Health, London, UK and Ulverscroft Vision Research Group, Developmental Biology Unit, UCL Institute of Child Health, London, UK and Developmental Endocrine Research Unit, UCL Institute of Child Health and Great Ormond Street Hospital for Children, London, UK Department of Human Genetics and},
note  = {doi:10.1093/hmg/dds197.}
}

@Article{2016439,
author  = {Braun, N. and Emkes, R. and Thorne, J. and Debener, S.},
title  = {Embodied neurofeedback with an anthropomorphic robotic hand.},
journal  = {Scientific Reports},
volume  = {6},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Neurofeedback-guided motor imagery training (NF-MIT) has been suggested as a promising therapy for stroke-induced motor impairment. Whereas much NF-MIT research has aimed at signal processing optimization, the type of sensory feedback given to the participant has received less attention. Often the feedback signal is highly abstract and not inherently coupled to the mental act performed. In this study, we asked whether an embodied feedback signal is more efficient for neurofeedback operation than a non-embodiable feedback signal. Inspired by the rubber hand illusion, demonstrating that an artificial hand can be incorporated into one‚Äôs own body scheme, we used an anthropomorphic robotic hand to visually guide the participants‚Äô motor imagery act and to deliver neurofeedback. Using two experimental manipulations, we investigated how a participant‚Äôs neurofeedback performance and subjective experience were influenced by the embodiability of the robotic hand, and by the neurofeedback signal‚Äôs validity. As pertains to embodiment, we found a promoting effect of robotic-hand embodiment in subjective, behavioral, electrophysiological and electrodermal measures. Regarding neurofeedback signal validity, we found some differences between real and sham neurofeedback in terms of subjective and electrodermal measures, but not in terms of behavioral and electrophysiological measures. This study motivates the further development of embodied feedback signals for NF-MIT.},
address  = {Neuropsychology Lab, Department of Psychology, University of Oldenburg, Oldenburg, Germany Neuropsychology Lab, Department of Psychology, University of Oldenburg, Oldenburg, Germany Neuropsychology Lab, Department of Psychology, University of Oldenburg, Oldenburg, Germany Neuropsychology Lab, Department of Psychology, University of Oldenburg, Oldenburg, Germany},
note  = {Sci Rep. 2016 Nov 21;6:. doi:10.1038/srep37696.}
}

@Article{2014440,
author  = {Menter, D. and Patterson, S. and Logsdon, C. and Kopetz, S. and Sood, A. and Hawk, E.},
title  = {Convergence of Nanotechnology and Cancer Prevention: Are We There Yet?},
journal  = {Cancer prevention research (Philadelphia, Pa.)},
volume  = {7},
number  = {10},
pages  = {973-92},
year  = {2014},
abstract  = {Nanotechnology is emerging as a promising modality for cancer treatment; however, in the realm of cancer prevention, its full utility has yet to be determined. Here, we discuss the potential of integrating nanotechnology in cancer prevention to augment early diagnosis, precision targeting and controlled release of chemopreventive agents, reduced toxicity, risk/response assessment, and personalized point-of-care monitoring. Cancer is a multistep, progressive disease; the functional and acquired characteristics of the early precancer phenotype are intrinsically different from those of a more advanced anaplastic or invasive malignancy. Therefore, applying nanotechnology to precancers is likely to be far more challenging than applying it to established disease. Frank cancers are more readily identifiable through imaging and biomarker and histopathologic assessment than their precancerous precursors. In addition, prevention subjects routinely have more rigorous intervention criteria than therapy subjects. Any nanopreventive agent developed to prevent sporadic cancers found in the general population must exhibit a very low risk of serious side effects. In contrast, a greater risk of side effects might be more acceptable in subjects at high risk for cancer. Using nanotechnology to prevent cancer is an aspirational goal, but clearly identifying the intermediate objectives and potential barriers is an essential first step in this exciting journey.},
address  = {Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 Department of Cancer Biology, The University of Texas MD Anderson Cancer Center,  Houston, Texas 77030 Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030 Division of Cancer Prevention & Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030},
note  = {doi:10.1158/1940-6207.CAPR-14-0079.}
}

@Article{2016441,
author  = {Maximova, T. and Moffatt, R. and Ma, B. and Nussinov, R. and Shehu, A.},
title  = {and Dynamics.},
journal  = {PLoS Computational Biology},
volume  = {12},
number  = {4},
pages  = {},
year  = {2016},
abstract  = {Investigation of macromolecular structure and dynamics is fundamental to understanding how macromolecules carry out their functions in the cell. Significant advances have been made toward this end in silico, with a growing number of computational methods proposed yearly to study and simulate various aspects of macromolecular structure and dynamics. This review aims to provide an  overview of recent advances, focusing primarily on methods proposed for exploring the structure space of macromolecules in isolation and in assemblies for the purpose of characterizing equilibrium structure and dynamics. In addition to surveying recent applications that showcase current capabilities of computational methods, this review highlights state-of-the-art algorithmic techniques proposed  to overcome challenges posed in silico by the disparate spatial and time scales accessed by dynamic macromolecules. This review is not meant to be exhaustive, as such an endeavor is impossible, but rather aims to balance breadth and depth of strategies for modeling macromolecular structure and dynamics for a broad audience of novices and experts.},
address  = {Department of Computer Science, George Mason University, Fairfax, Virginia, United States of America Department of Computer Science, George Mason University, Fairfax, Virginia, United States of America Basic Science Program, Leidos Biomedical Research, Inc. Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland, United States of America Basic Science Program, Leidos Biomedical Research, Inc. Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland, United States of America Department of Computer Science, George Mason University, Fairfax, Virginia, United States of America},
note  = {PLoS Comput Biol. 2016 Apr 28;12(4):. doi:10.1371/journal.pcbi.1004619.}
}

@Article{2017442,
author  = {List, A. and Rosenberg, M. and Sherman, A. and Esterman, M.},
title  = {Pattern classification of EEG signals reveals perceptual and attentional states.},
journal  = {PLoS ONE},
volume  = {12},
number  = {4},
pages  = {},
year  = {2017},
abstract  = {Pattern classification techniques have been widely used to differentiate neural activity associated with different perceptual, attentional, or other cognitive states, often using fMRI, but more recently with EEG as well. Although these methods have identified EEG patterns (i.e., scalp topographies of EEG signals occurring at certain latencies) that decode perceptual and attentional states on  a trial-by-trial basis, they have yet to be applied to the spatial scope of attention toward global or local features of the display. Here, we initially used pattern classification to replicate and extend the findings that perceptual states could be reliably decoded from EEG. We found that visual perceptual states, including stimulus location and object category, could be decoded with high accuracy peaking between 125‚Äì250 ms, and that the discriminative spatiotemporal patterns mirrored and extended our (and other well-established) ERP results. Next, we used pattern classification to investigate whether spatiotemporal EEG signals could reliably predict attentional states, and particularly, the scope of attention. The EEG data were reliably differentiated for local versus global attention on a trial-by-trial basis, emerging as a specific spatiotemporal activation pattern over posterior electrode sites during  the 250‚Äì750 ms interval after stimulus onset. In sum, we demonstrate that multivariate pattern analysis of EEG, which reveals unique spatiotemporal patterns of neural activity distinguishing between behavioral states, is a sensitive tool for characterizing the neural correlates of perception and attention.},
address  = {Department of Psychology and Neuroscience Program, Hamilton College, Clinton, New York, United States of America Department of Psychology, Yale University, New Haven, Connecticut, United States  of America Department of Cognitive Science, Occidental College, Los Angeles, California, United States of America Research Service, VA Boston Healthcare System, Boston, Massachusetts, United States of America},
note  = {PLoS One. 2017 Apr 26;12(4):. doi:10.1371/journal.pone.0176349.}
}

@Article{2007443,
author  = {},
title  = {Abstracts.},
journal  = {Association},
volume  = {9},
number  = {Suppl 1},
pages  = {36-110},
year  = {2007},
abstract  = {},
address  = {},
note  = {HPB (Oxford). 2007;9(Suppl 1):36-110. doi:10.1080/16515320701258846.}
}

@Article{1999444,
author  = {Kandel, E. and Pittenger, C.},
title  = {The past, the future and the biology of memory storage.},
journal  = {Philosophical Transactions of the Royal Society B: Biological Sciences},
volume  = {354},
number  = {1392},
pages  = {2027-52},
year  = {1999},
abstract  = {We here briefly review a century of accomplishments in studying memory storage and delineate the two major questions that have dominated thinking in this area:  the systems question of memory, which concerns where in the brain storage occurs; and the molecular question of memory, which concerns the mechanisms whereby memories are stored and maintained. We go on to consider the themes that memory research may be able to address in the 21st century. Finally, we reflect on the clinical and societal import of our increasing understanding of the mechanisms of memory, discussing possible therapeutic approaches to diseases that manifest with disruptions of learning and possible ethical implication of the ability, which is on the horizon, to ameliorate or even enhance human memory.},
address  = {},
note  = {Philos Trans R Soc Lond B Biol Sci. 1999 Dec 29;354(1392):2027-52.}
}

@Article{2013445,
author  = {Abdollahi, F. and Kenyon, R. and Patton, J.},
title  = {Mirror versus parallel bimanual reaching.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {10},
number  = {},
pages  = {71},
year  = {2013},
abstract  = {Background: In spite of their importance to everyday function, tasks that require both hands to work together such as lifting and carrying large objects have not been well studied and the full potential of how new technology might facilitate recovery remains unknown. Methods: To help identify the best modes for self-teleoperated bimanual training, we used an advanced haptic/graphic environment to compare several modes of practice. In a 2-by-2 study, we compared  mirror vs. parallel reaching movements, and also compared veridical display to one that transforms the right hand‚Äôs cursor to the opposite side, reducing the area that the visual system has to monitor. Twenty healthy, right-handed subjects (5 in each group) practiced 200 movements. We hypothesized that parallel reaching movements would be the best performing, and attending to one visual area would reduce the task difficulty. Results: The two-way comparison revealed that mirror  movement times took an average 1.24 s longer to complete than parallel. Surprisingly, subjects‚Äô movement times moving to one target (attending to one visual area) also took an average of 1.66 s longer than subjects moving to two targets. For both hands, there was also a significant interaction effect, revealing the lowest errors for parallel movements moving to two targets (p‚Äâ<‚Äâ0.001). This was the only group that began and maintained low errors throughout training. Conclusion: Combined with other evidence, these results suggest that the most intuitive reaching performance can be observed with parallel movements with a veridical display (moving to two separate targets). These results point to the expected levels of challenge for these bimanual training modes, which could be used to advise therapy choices in self-neurorehabilitation.},
address  = {Rehabilitation Institute of Chicago, Sensory Motor Performance Program (SMPP), Suite: 1406, 345 E. Superior Street, Chicago, IL 60611, USA Rehabilitation Institute of Chicago, Sensory Motor Performance Program (SMPP), Suite: 1406, 345 E. Superior Street, Chicago, IL 60611, USA Rehabilitation Institute of Chicago, Sensory Motor Performance Program (SMPP), Suite: 1406, 345 E. Superior Street, Chicago, IL 60611, USA},
note  = {J Neuroeng Rehabil. 2013 Jul 9;10:71. doi:10.1186/1743-0003-10-71.}
}

@Article{2016446,
author  = {Potter, S. and Conroy, E. and Williamson, P. and Thrush, S. and Whisker, L. and Skillman, J. and Barnes, N. and Cutress, R. and Teasdale, E. and Mills, N. and Mylvaganam, S. and Branford, O. and McEvoy, K. and Jain, A. and Gardiner, M. and Blazeby, J. and Holcombe, C.},
title  = {implant-based breast reconstruction.},
journal  = {Pilot and Feasibility Studies},
volume  = {2},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Background: Implant-based breast reconstruction (IBBR) is the most commonly performed reconstructive procedure in the UK. The introduction of techniques to augment the subpectoral pocket has revolutionised the procedure, but there is a lack of high-quality outcome data to describe the safety or effectiveness of these techniques. Randomised controlled trials (RCTs) are the best way of comparing treatments, but surgical RCTs are challenging. The iBRA (implant breast reconstruction evaluation) study aims to determine the feasibility, design and conduct of a pragmatic RCT to examine the effectiveness of approaches to IBBR. Methods/design: The iBRA study is a trainee-led research collaborative project with four phases:Phase 1 ‚Äì a national practice questionnaire (NPQ) to survey current practicePhase 2 ‚Äì a multi-centre prospective cohort study of patients undergoing IBBR to evaluate the clinical and patient-reported outcomesPhase 3‚Äì an IBBR-RCT acceptability survey and qualitative work to explore patients‚Äô and surgeons‚Äô views of proposed trial designs and candidate outcomes.Phase 4 ‚Äì phases 1 to 3 will inform the design and conduct of the future RCTAll centres offering IBBR will be encouraged to participate by the breast and plastic surgical professional associations (Association of Breast Surgery and British Association  of Plastic Reconstructive and Aesthetic Surgeons).Data collected will inform the  feasibility of undertaking an RCT by defining current practice and exploring issues surrounding recruitment, selection of comparator arms, choice of primary outcome, sample size, selection criteria, trial conduct, methods of data collection and feasibility of using the trainee collaborative model to recruit patients and collect data. Discussion: The preliminary work undertaken within the iBRA study will determine the feasibility, design and conduct of a definitive RCT in IBBR. It will work with the trainee collaborative to build capacity by creating an infrastructure of research-active breast and plastic surgeons which will facilitate future high-quality research that will ultimately improve outcomes for all women seeking reconstructive surgery. Trial registration: ISRCTN37664281},
address  = {Bristol Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, Room 3.12 Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS  UK MRC North West Hub for Trials Methodology Research, Department of Biostatistics,  Clinical Trials Research Centre, University of Liverpool, Liverpool, L69 3GS UK MRC North West Hub for Trials Methodology Research, Department of Biostatistics,  Clinical Trials Research Centre, University of Liverpool, Liverpool, L69 3GS UK Breast Unit, Worcester Royal Hospital. Charles Hastings Way, Worcester, WR5 1DD UK Breast Institute, Nottingham University Hospitals NHS Trust, Hucknall Road, Nottingham, NG5 1PB UK Department of Plastic Surgery, University Hospitals Coventry and Warwickshire NHS Trust, Clifford Bridge Road, Coventry, CV2 2DX UK The Nightingale Centre Breast Unit, University Hospital of South Manchester NHS Foundation Trust, Southmoor Road, Manchester, M23 9LT UK Breast Unit, University Hospital Southampton, Tremona Road, Southampton, Hampshire SO16 6YD UK Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital, Prescot Street, Liverpool, L7 8XP UK Bristol Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, Room 3.12 Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS  UK New Cross Hospital, Royal Wolverhampton Hospitals NHS Trust, Wednesfield Way, Wolverhampton, WV10 0QP UK Department of Plastic Surgery, The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ UK City Hospital, Dudley Road, West Midlands, B18 7QH UK Imperial College London NHS Trust, London, SW7 2AZ UK Imperial College London NHS Trust, London, SW7 2AZ UK Bristol Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, Room 3.12 Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS  UK Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospital, Prescot Street, Liverpool, L7 8XP UK},
note  = {Pilot Feasibility Stud. 2016 Aug 4;2:. doi:10.1186/s40814-016-0085-8.}
}

@Article{2014447,
author  = {McEvoy, M. and Hand, W. and Stoll, W. and Furse, C. and Nietert, P.},
title  = {Is Improved by an Electronic Decision Support Tool and Designated ‚ÄòReader‚Äô.},
journal  = {Regional anesthesia and pain medicine},
volume  = {39},
number  = {4},
pages  = {299-305},
year  = {2014},
abstract  = {Background and Objectives: A hardcopy or paper cognitive aid has been shown to improve performance during the management of simulated local anesthetic systemic  toxicity (LAST) when given to the team leader. However, there remains room for improvement in order to ensure a system that can achieve perfect adherence to the published guidelines for LAST management. Recent research has shown that implementing a checklist via a designated reader may be of benefit. Accordingly,  we sought to investigate the effect of an electronic decision support tool (DST)  and designated ‚ÄòReader‚Äô role on team performance during an in-situ simulation of  LAST. Methods: Participants were randomized to Reader+DST (N = 16, rDST) and Control (N = 15, memory alone). The rDST group received the assistance of a dedicated Reader on the response team who was equipped with an electronic DST. The primary outcome measure was adherence to guidelines. Results: For overall and critical percent correct scores, the rDST group scored higher than Control (99.3% vs 72.2%, P < 0.0001; 99.5% vs 70%, P < 0.0001, respectively). In the LAST scenario, 0 of 15 (0%) in the control group performed 100% of critical management steps, while 15 of 16 (93.8%) in the rDST group did so (P < 0.0001). Conclusions: In a prospective, randomized single-blinded study, a designated Reader with an electronic DST improved adherence to guidelines in the management of an in-situ simulation of LAST. Such tools are promising in the future of medicine, but further research is needed to ensure the best methods for implementing them in the clinical arena.},
address  = {Department of Anesthesiology, Vanderbilt University School of Medicine, Nashville, TN Department of Anesthesia and Perioperative Medicine, and ‚Ä°Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC Department of Anesthesia and Perioperative Medicine, and ‚Ä°Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC Department of Anesthesia and Perioperative Medicine, and ‚Ä°Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC Department of Anesthesia and Perioperative Medicine, and ‚Ä°Department of Medicine, Division of Biostatistics and Epidemiology, Medical University of South Carolina, Charleston, SC},
note  = {doi:10.1097/AAP.0000000000000097.}
}

@Article{2013448,
author  = {Al-Kadi, M. and Reaz, M. and Ali, M.},
title  = {Evolution of Electroencephalogram Signal Analysis Techniques during Anesthesia.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {13},
number  = {5},
pages  = {6605-35},
year  = {2013},
abstract  = {Biosignal analysis is one of the most important topics that researchers have tried to develop during the last century to understand numerous human diseases. Electroencephalograms (EEGs) are one of the techniques which provides an electrical representation of biosignals that reflect changes in the activity of the human brain. Monitoring the levels of anesthesia is a very important subject, which has been proposed to avoid both patient awareness caused by inadequate dosage of anesthetic drugs and excessive use of anesthesia during surgery. This article reviews the bases of these techniques and their development within the last decades and provides a synopsis of the relevant methodologies and algorithms that are used to analyze EEG signals. In addition, it aims to present some of the physiological background of the EEG signal, developments in EEG signal processing, and the effective methods used to remove various types of noise. This review will hopefully increase efforts to develop methods that use EEG signals for determining and classifying the depth of anesthesia with a high data rate to  produce a flexible and reliable detection device.},
address  = {Department of Electrical, Electronic & Systems Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia, UKM Bangi Selangor 43600, Malaysia; E-Mails: mamun.reaz@gmail.com (M.B.I.R.); mama@eng.ukm.my (M.A.M.A.) Department of Electrical, Electronic & Systems Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia, UKM Bangi Selangor 43600, Malaysia; E-Mails: mamun.reaz@gmail.com (M.B.I.R.); mama@eng.ukm.my (M.A.M.A.) Department of Electrical, Electronic & Systems Engineering, Faculty of Engineering and Built Environment, Universiti Kebangsaan Malaysia, UKM Bangi Selangor 43600, Malaysia; E-Mails: mamun.reaz@gmail.com (M.B.I.R.); mama@eng.ukm.my (M.A.M.A.)},
note  = {Sensors (Basel). 2013 May 17;13(5):6605-35. doi:10.3390/s130506605.}
}

@Article{2014449,
author  = {Magnuson, M. and Thompson, G. and Pan, W. and Keilholz, S.},
title  = {Connectivity and Spontaneous Dynamic Activity in the Rat Brain.},
journal  = {Brain Connectivity},
volume  = {4},
number  = {1},
pages  = {15-29},
year  = {2014},
abstract  = {Functional networks, defined by synchronous spontaneous blood oxygenation level-dependent (BOLD) oscillations between spatially distinct brain regions, appear to be essential to brain function and have been implicated in disease states, cognitive capacity, and sensing and motor processes. While the topographical extent and behavioral function of these networks has been extensively investigated, the neural functions that create and maintain these synchronizations remain mysterious. In this work callosotomized rodents are examined, providing a unique platform for evaluating the influence of structural  connectivity via the corpus callosum on bilateral resting state functional connectivity. Two experimental groups were assessed, a full callosotomy group, in which the corpus callosum was completely sectioned, and a sham callosotomy group, in which the gray matter was sectioned but the corpus callosum remained intact. Results indicated a significant reduction in interhemispheric connectivity in the full callosotomy group as compared with the sham group in primary somatosensory cortex and caudate-putamen regions. Similarly, electrophysiology revealed significantly reduced bilateral correlation in band limited power. Bilateral gamma Band-limited power connectivity was most strongly affected by the full callosotomy procedure. This work represents a robust finding indicating the corpus callosum's influence on maintaining integrity in bilateral functional networks; further, functional magnetic resonance imaging (fMRI) and electrophysiological connectivity share a similar decrease in connectivity as a result of the callosotomy, suggesting that fMRI-measured functional connectivity  reflects underlying changes in large-scale coordinated electrical activity. Finally, spatiotemporal dynamic patterns were evaluated in both groups; the full  callosotomy rodents displayed a striking loss of bilaterally synchronous propagating waves of cortical activity.},
address  = {},
note  = {Brain Connect. 2014 Feb 01;4(1):15-29. doi:10.1089/brain.2013.0167.}
}

@Article{2016450,
author  = {Teplitzky, B. and Zitella, L. and Xiao, Y. and Johnson, M.},
title  = {Number of Radial Electrodes and Machine Learning Feature Sets.},
journal  = {Frontiers in Computational Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Deep brain stimulation (DBS) leads with radially distributed electrodes have potential to improve clinical outcomes through more selective targeting of pathways and networks within the brain. However, increasing the number of electrodes on clinical DBS leads by replacing conventional cylindrical shell electrodes with radially distributed electrodes raises practical design and stimulation programming challenges. We used computational modeling to investigate: (1) how the number of radial electrodes impact the ability to steer, shift, and sculpt a region of neural activation (RoA), and (2) which RoA features are best used in combination with machine learning classifiers to predict programming settings to target a particular area near the lead. Stimulation configurations were modeled using 27 lead designs with one to nine radially distributed electrodes. The computational modeling framework consisted of a three-dimensional finite element tissue conductance model in combination with a multi-compartment biophysical axon model. For each lead design, two-dimensional threshold-dependent RoAs were calculated from the computational modeling results. The models showed more radial electrodes enabled finer resolution RoA steering; however, stimulation amplitude, and therefore spatial extent of the RoA, was limited by charge injection and charge storage capacity constraints due to the small electrode surface area for leads with more than four radially distributed electrodes. RoA shifting resolution was improved by the addition of radial electrodes when using uniform multi-cathode stimulation, but non-uniform multi-cathode stimulation produced equivalent or better resolution shifting without increasing the number of radial electrodes. Robust machine learning classification of 15 monopolar stimulation configurations was achieved using as few as three geometric features describing a RoA. The results of this study indicate that, for a clinical-scale DBS lead, more than four radial electrodes minimally improved in the ability to steer, shift, and sculpt axonal activation around a DBS lead and a simple feature set consisting of the RoA center of mass and orientation enabled robust machine learning classification. These results provide important design constraints for future development of high-density DBS arrays.},
address  = {Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA Department of Biomedical Engineering, University of MinnesotaMinneapolis, MN, USA},
note  = {Front Comput Neurosci. 2016 Jun 10;10:. doi:10.3389/fncom.2016.00058.}
}

@Article{2004451,
author  = {Aman, M. and Novotny, S. and Samango-Sprouse, C. and Lecavalier, L. and Leonard, E. and Gadow, K. and King, B. and Pearson, D. and Gernsbacher, M. and Chez, M.},
title  = {Outcome Measures for Clinical Drug Trials in Autism.},
journal  = {CNS spectrums},
volume  = {9},
number  = {1},
pages  = {36-47},
year  = {2004},
abstract  = {This paper identifies instruments and measures that may be appropriate for randomized clinical trials in participants with autism spectrum disorders (ASDs). The Clinical Global Impressions scale was recommended for all randomized clinical trials. At this point, however, there is no ‚Äúperfect‚Ä? choice of outcome measure for core features of autism, although we will discuss five measures of potential  utility. Several communication instruments are recommended, based in part on suitability across the age range. In trials where the intention is to alter core  features of ASDs, adaptive behavior scales are also worthy of consideration. Several ‚Äúbehavior complexes‚Ä? common to ASDs are identified, and instruments are recommended for assessment of these. Given the prevalence of cognitive impairment in ASDs, it is important to assess any cognitive effects, although cognitive data from ASD randomized clinical trials, thus far, are minimal. Guidance from trials  in related pharmacologic areas and behavioral pharmacology may be helpful. We recommend routine elicitation of side effects, height and weight, vital signs, and (in the case of antipsychotics) extrapyramidal side-effects assessment. It is often appropriate to include laboratory tests and assessments for continence and  sleep pattern.},
address  = {professor of psychology and psychiatry in the Departments of Psychology and Psychiatry at the Nisonger Center at Ohio University in Columbus assistant professor of psychiatry in the Department of Psychiatry at the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Campus associate clinical professor in the Department of Pediatrics at the George Washington University in Washington, D.C assistant professor of psychology in the Department of Psychology at Ohio State University lecturer on psychology in the Department of Psychiatry at Harvard Medical School  in Boston, Massachusetts professor of psychiatry in the Department of Psychiatry at the State University of New York at Stony Brook the director of Child and Adolescent Psychiatry in the Department of Psychiatry at Dartmouth Medical School in Hanover, New Hampshire associate professor of psychiatry and behavioral sciences in the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School in Houston Sir Frederic C. Bartlett Professor of Psychology in the Department of Psychology  at the University of Wisconsin, Madison assistant professor of Neurology and Pediatrics at the Rush Medical School and Lecturer at the Chicago Medical School, both in Chicago, IL},
note  = {CNS Spectr. 2004 Jan;9(1):36-47.}
}

@Article{2015452,
author  = {Krishnan, C. and Santos, L. and Peterson, M. and Ehinger, M.},
title  = {Safety of Noninvasive Brain Stimulation in Children and Adolescents.},
journal  = {Brain stimulation},
volume  = {8},
number  = {1},
pages  = {76-87},
year  = {2015},
abstract  = {Background: Noninvasive brain stimulation (NIBS) techniques such as transcranial  magnetic stimulation (TMS) and transcranial current stimulation (tCS) have the potential to mitigate a variety of symptoms associated with neurological and psychiatric conditions, including stroke, cerebral palsy, autism, depression, and Tourette syndrome. While the safety of these modalities has been established in adults, there is a paucity of research assessing the safety of NIBS among children. Objective: To examine the existing literature regarding the safety of NIBS techniques in children and adolescents with neurologic and neuropsychiatric  disorders. Methods: An electronic search was performed on online databases for studies using NIBS in individuals less than 18 years of age. Non-English publications, diagnostic studies, electroconvulsive therapy, single/dual pulse TMS studies, and reviews were excluded. Adverse events reported in the studies were carefully examined and synthesized to understand the safety and tolerability of NIBS among children and adolescents. Results: The data from 48 studies involving more than 513 children/adolescents (2.5‚Äì17.8 years of age) indicate that the side-effects of NIBS were, in general, mild and transient [TMS: headache (11.5%), scalp discomfort (2.5%), twitching (1.2%), mood changes (1.2%), fatigue  (0.9%), tinnitus (0.6%); tCS: tingling (11.5%), itching (5.8%), redness (4.7%), scalp discomfort (3.1%)] with relatively few serious adverse events. Conclusion:  Our findings indicate that both repetitive TMS and tCS are safe modalities in children and adolescents with various neurological conditions, especially when safety guidelines are followed. The incidence of adverse events appears to be similar to that observed in adults; however, further studies with longer treatment and follow-up periods are needed to better understand the benefits and  tolerance of long-term use of NIBS in children.},
address  = {Department of Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, USA Department of Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, USA Department of Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, USA Department of Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, USA},
note  = {doi:10.1016/j.brs.2014.10.012.}
}

@Article{2010453,
author  = {Hodge, S. and Makris, N. and Kennedy, D. and Caviness, V. and Howard, J. and McGrath, L. and Steele, S. and Frazier, J. and Tager-Flusberg, H. and Harris, G.},
title  = {Cerebellum, Language, and Cognition in Autism and Specific Language Impairment.},
journal  = {Journal of autism and developmental disorders},
volume  = {40},
number  = {3},
pages  = {300-16},
year  = {2010},
abstract  = {We performed cerebellum segmentation and parcellation on magnetic resonance images from right-handed boys, aged 6‚Äì13 years, including 22 boys with autism (16 with language impairment (ALI)), 9 boys with Specific Language Impairment (SLI),  and 11 normal controls. Language-impaired groups had reversed asymmetry relative  to unimpaired groups in posterior-lateral cerebellar lobule VIIIA (right side larger in unimpaired groups, left side larger in ALI and SLI), contralateral to previous findings in inferior frontal cortex language areas. Lobule VIIA Crus I was smaller in SLI than in ALI. Vermis volume, particularly anterior I-V, was decreased in language-impaired groups. Language performance test scores correlated with lobule VIIIA asymmetry and with anterior vermis volume. These findings suggest ALI and SLI subjects show abnormalities in neurodevelopment of fronto-corticocerebellar circuits that manage motor control and the processing of language, cognition, working memory, and attention.},
address  = {Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA Center for Morphometric Analysis, Massachusetts General Hospital, Boston, MA Boston University School of Medicine, Lab of Cognitive Neuroscience, Boston, MA Boston University School of Medicine, Lab of Cognitive Neuroscience, Boston, MA Department of Psychiatry, Harvard Medical School, Boston, MA Boston University School of Medicine, Lab of Cognitive Neuroscience, Boston, MA Radiology Computer Aided Diagnostics Laboratory, Massachusetts General Hospital,  Boston, MA},
note  = {J Autism Dev Disord. 2010 Mar;40(3):300-16. doi:10.1007/s10803-009-0872-7.}
}

@Article{2014454,
author  = {Ayton, L. and Blamey, P. and Guymer, R. and Luu, C. and Nayagam, D. and Sinclair, N. and Shivdasani, M. and Yeoh, J. and McCombe, M. and Briggs, R. and Opie, N. and Villalobos, J. and Dimitrov, P. and Varsamidis, M. and Petoe, M. and McCarthy, C. and Walker, J. and Barnes, N. and Burkitt, A. and Williams, C. and Shepherd, R. and Allen, P.},
title  = {First-in-Human Trial of a Novel Suprachoroidal Retinal Prosthesis.},
journal  = {PLoS ONE},
volume  = {9},
number  = {12},
pages  = {},
year  = {2014},
abstract  = {: Retinal visual prostheses (‚Äúbionic eyes‚Ä?) have the potential to restore vision  to blind or profoundly vision-impaired patients. The medical bionic technology used to design, manufacture and implant such prostheses is still in its relative  infancy, with various technologies and surgical approaches being evaluated. We hypothesised that a suprachoroidal implant location (between the sclera and choroid of the eye) would provide significant surgical and safety benefits for patients, allowing them to maintain preoperative residual vision as well as gaining prosthetic vision input from the device. This report details the first-in-human Phase 1 trial to investigate the use of retinal implants in the suprachoroidal space in three human subjects with end-stage retinitis pigmentosa. The success of the suprachoroidal surgical approach and its associated safety benefits, coupled with twelve-month post-operative efficacy data, holds promise for the field of vision restoration. Trial Registration: Clinicaltrials.gov NCT01603576},
address  = {Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Bionics Institute, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Bionics Institute, East Melbourne, Australia Bionics Institute, East Melbourne, Australia Bionics Institute, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Bionics Institute, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia Bionics Institute, East Melbourne, Australia NICTA, Computer Vision Research Group, Canberra, Australia NICTA, Computer Vision Research Group, Canberra, Australia NICTA, Computer Vision Research Group, Canberra, Australia Bionics Institute, East Melbourne, Australia Bionics Institute, East Melbourne, Australia Bionics Institute, East Melbourne, Australia Centre for Eye Research Australia, University of Melbourne, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia},
note  = {PLoS One. 2014 Dec 18;9(12):. doi:10.1371/journal.pone.0115239.}
}

@Article{2014455,
author  = {Ward, P. and Herrity, A. and Smith, R. and Willhite, A. and Harrison, B. and Petruska, J. and Harkema, S. and Hubscher, C.},
title  = {Injured Male Rats.},
journal  = {Journal of Neurotrauma},
volume  = {31},
number  = {9},
pages  = {819-33},
year  = {2014},
abstract  = {Locomotor training (LT) after spinal cord injury (SCI) is a rehabilitative therapy used to enhance locomotor recovery. There is evidence, primarily anecdotal, also associating LT with improvements in bladder function and reduction in some types of SCI-related pain. In the present study, we determined  if a step training paradigm could improve outcome measures of locomotion, bladder function, and pain/allodynia. After a T10 contusive SCI trained animals (adult male Wistar rats), trained animals began quadrupedal step training beginning 2 weeks post-SCI for 1‚Äâh/day. End of study experiments (3 months of training) revealed significant changes in limb kinematics, gait, and hindlimb flexor-extensor bursting patterns relative to non-trained controls. Importantly,  micturition function, evaluated with terminal transvesical cystometry, was significantly improved in the step trained group (increased voiding efficiency, intercontraction interval, and contraction amplitude). Because both SCI and LT affect neurotrophin signaling, and neurotrophins are involved with post-SCI plasticity in micturition pathways, we measured bladder neurotrophin mRNA. Training regulated the expression of nerve growth factor (NGF) but not BDNF or NT3. Bladder NGF mRNA levels were inversely related to bladder function in the trained group. Monitoring of overground locomotion and neuropathic pain throughout the study revealed significant improvements, beginning after 3 weeks of training, which in both cases remained consistent for the study duration. These novel findings, improving non-locomotor in addition to locomotor functions, demonstrate that step training post-SCI could contribute to multiple quality of life gains, targeting patient-centered high priority deficits.},
address  = {Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, Kentucky Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, Kentucky Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, Kentucky Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, Kentucky Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, Kentucky Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, Kentucky Kentucky Spinal Cord Injury Research Center, University of Louisville, Louisville, Kentucky Department of Anatomical Sciences and Neurobiology, University of Louisville, Louisville, Kentucky},
note  = {J Neurotrauma. 2014 May 01;31(9):819-33. doi:10.1089/neu.2013.3082.}
}

@Article{2017456,
author  = {Frullo, J. and Elinger, J. and Pehlivan, A. and Fitle, K. and Nedley, K. and Francisco, G. and Sergi, F. and O‚ÄôMalley, M.},
title  = {Spinal Cord Injury: A Parallel-Group Controlled Trial.},
journal  = {Frontiers in Neurorobotics},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Background: Robotic rehabilitation of the upper limb following neurological injury has been supported through several large clinical studies for individuals  with chronic stroke. The application of robotic rehabilitation to the treatment of other neurological injuries is less developed, despite indications that strategies successful for restoration of motor capability following stroke may benefit individuals with incomplete spinal cord injury (SCI) as well. Although recent studies suggest that robot-aided rehabilitation might be beneficial after  incomplete SCI, it is still unclear what type of robot-aided intervention contributes to motor recovery. Methods: We developed a novel assist-as-needed (AAN) robotic controller to adjust challenge and robotic assistance continuously  during rehabilitation therapy delivered via an upper extremity exoskeleton, the MAHI Exo-II, to train independent elbow and wrist joint movements. We further enrolled seventeen patients with incomplete spinal cord injury (AIS C and D levels) in a parallel-group balanced controlled trial to test the efficacy of the AAN controller, compared to a subject-triggered (ST) controller that does not adjust assistance or challenge levels continuously during therapy. The conducted  study is a stage two, development-of-concept pilot study. Results: We validated the AAN controller in its capability of modulating assistance and challenge during therapy via analysis of longitudinal robotic metrics. For the selected primary outcome measure, the pre‚Äìpost difference in ARAT score, no statistically  significant change was measured in either group of subjects. Ancillary analysis of secondary outcome measures obtained via robotic testing indicates gradual improvement in movement quality during the therapy program in both groups, with the AAN controller affording greater increases in movement quality over the ST controller. Conclusion: The present study demonstrates feasibility of subject-adaptive robotic therapy after incomplete spinal cord injury, but does not demonstrate gains in arm function occurring as a result of the robot-assisted rehabilitation program, nor differential gains obtained as a result of the developed AAN controller. Further research is warranted to better quantify the recovery potential provided by AAN control strategies for robotic rehabilitation  of the upper limb following incomplete SCI.ClinicalTrials.gov registration number: NCT02803255.},
address  = {Department of Mechanical Engineering, Rice University, Houston, TX, United States Department of Mechanical Engineering, Rice University, Houston, TX, United States Department of Mechanical Engineering, Rice University, Houston, TX, United States Department of Mechanical Engineering, Rice University, Houston, TX, United States TIRR Memorial Hermann, Houston, TX, United States TIRR Memorial Hermann, Houston, TX, United States Department of Biomedical Engineering, University of Delaware, Newark, DE, United  States Department of Mechanical Engineering, Rice University, Houston, TX, United States},
note  = {Front Neurorobot. 2017 Jun 13;11:. doi:10.3389/fnbot.2017.00026.}
}

@Article{2014457,
author  = {Perruchoud, D. and Murray, M. and Lefebvre, J. and Ionta, S.},
title  = {Focal dystonia and the Sensory-Motor Integrative Loop for Enacting (SMILE).},
journal  = {Frontiers in Human Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Performing accurate movements requires preparation, execution, and monitoring mechanisms. The first two are coded by the motor system, the latter by the sensory system. To provide an adaptive neural basis to overt behaviors, motor and sensory information has to be properly integrated in a reciprocal feedback loop.  Abnormalities in this sensory-motor loop are involved in movement disorders such  as focal dystonia, a hyperkinetic alteration affecting only a specific body part  and characterized by sensory and motor deficits in the absence of basic motor impairments. Despite the fundamental impact of sensory-motor integration mechanisms on daily life, the general principles of healthy and pathological anatomic‚Äìfunctional organization of sensory-motor integration remain to be clarified. Based on the available data from experimental psychology, neurophysiology, and neuroimaging, we propose a bio-computational model of sensory-motor integration: the Sensory-Motor Integrative Loop for Enacting (SMILE). Aiming at direct therapeutic implementations and with the final target of implementing novel intervention protocols for motor rehabilitation, our main goal is to provide the information necessary for further validating the SMILE model. By translating neuroscientific hypotheses into empirical investigations and clinically relevant questions, the prediction based on the SMILE model can be further extended to other pathological conditions characterized by impaired sensory-motor integration.},
address  = {Laboratory for Investigative Neurophysiology, Department of Radiology and Department of Clinical Neurosciences, University Hospital Center and University of LausanneLausanne, Switzerland Laboratory for Investigative Neurophysiology, Department of Radiology and Department of Clinical Neurosciences, University Hospital Center and University of LausanneLausanne, Switzerland Laboratory for Investigative Neurophysiology, Department of Radiology and Department of Clinical Neurosciences, University Hospital Center and University of LausanneLausanne, Switzerland Laboratory for Investigative Neurophysiology, Department of Radiology and Department of Clinical Neurosciences, University Hospital Center and University of LausanneLausanne, Switzerland},
note  = {Front Hum Neurosci. 2014 Jun 20;8:. doi:10.3389/fnhum.2014.00458.}
}

@Article{2015458,
author  = {Song, Y. and Totz, J. and Thompson, S. and Johnsen, S. and Barratt, D. and Schneider, C. and Gurusamy, K. and Davidson, B. and Ourselin, S. and Hawkes, D. and Clarkson, M.},
title  = {Locally rigid, vessel-based registration for laparoscopic liver surgery.},
journal  = {International Journal of Computer Assisted Radiology and Surgery},
volume  = {10},
number  = {12},
pages  = {1951-61},
year  = {2015},
abstract  = {Purpose: Laparoscopic liver resection has significant advantages over open surgery due to less patient trauma and faster recovery times, yet is difficult for most lesions due to the restricted field of view and lack of haptic feedback. Image guidance provides a potential solution but is challenging in a soft deforming organ such as the liver. In this paper, we therefore propose a laparoscopic ultrasound (LUS) image guidance system and study the feasibility of  a locally rigid registration for laparoscopic liver surgery. Methods: We developed a real-time segmentation method to extract vessel centre points from calibrated, freehand, electromagnetically tracked, 2D LUS images. Using landmark-based initial registration and an optional iterative closest point (ICP) point-to-line registration, a vessel centre-line model extracted from preoperative computed tomography (CT) is registered to the ultrasound data during surgery. Results: Using the locally rigid ICP method, the RMS residual error when registering to a phantom was 0.7 mm, and the mean target registration error (TRE) for two in vivo porcine studies was 3.58 and 2.99 mm, respectively. Using the locally rigid landmark-based registration method gave a mean TRE of 4.23 mm using vessel centre lines derived from CT scans taken with pneumoperitoneum and 6.57 mm without pneumoperitoneum. Conclusion: In this paper we propose a practical image-guided surgery system based on locally rigid registration of a CT-derived model to vascular structures located with LUS. In a physical phantom and during porcine laparoscopic liver resection, we demonstrate accuracy of target location  commensurate with surgical requirements. We conclude that locally rigid registration could be sufficient for practically useful image guidance in the near future.},
address  = {Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK Royal Free Campus, 9th Floor, Royal Free Hospital, UCL Medical School, Rowland Hill Street, London, UK Royal Free Campus, 9th Floor, Royal Free Hospital, UCL Medical School, Rowland Hill Street, London, UK Royal Free Campus, 9th Floor, Royal Free Hospital, UCL Medical School, Rowland Hill Street, London, UK Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK Centre For Medical Image Computing, Engineering Front Building, University College London, Malet Place, London, UK},
note  = {doi:10.1007/s11548-015-1236-8.}
}

@Article{2013459,
author  = {Pahs, G. and Rankin, P. and Helen, C. and Croft, L. and Northam, G. and Liegeois, F. and Greenway, S. and Harrison, S. and Vargha-Khadem, F. and Baldeweg, T.},
title  = {children with focal epilepsy.},
journal  = {Brain},
volume  = {136},
number  = {10},
pages  = {3163-75},
year  = {2013},
abstract  = {Reorganization of eloquent cortex enables rescue of language functions in patients who sustain brain injury. Individuals with left-sided, early-onset focal epilepsy often show atypical (i.e. bilateral or right-sided) language dominance.  Surprisingly, many patients fail to show such interhemispheric shift of language  despite having major epileptogenic lesions in close proximity to eloquent cortex. Although a number of epilepsy-related factors may promote interhemispheric plasticity, it has remained unexplored if neuroanatomical asymmetries linked to human language dominance modify the likelihood of atypical lateralization. Here we examined the asymmetry of the planum temporale, one of the most striking asymmetries in the human brain, in relation to language lateralization in children with left-sided focal epilepsy. Language functional magnetic resonance imaging was performed in 51 children with focal epilepsy and left-sided lesions and 36 healthy control subjects. We examined the association of language laterality with a range of potential clinical predictors and the asymmetry of the length of the planum temporale. Using voxel-based methods, we sought to determine the effect of lesion location (in the affected left hemisphere) and grey matter density (in the unaffected right hemisphere) on language laterality. Atypical language lateralization was observed in 19 patients (38%) and in four controls (11%). Language laterality was increasingly right-sided in patients who showed atypical handedness, a left perisylvian ictal electroencephalographic focus, and  a lesion in left anterior superior temporal or inferior frontal regions. Most striking was the relationship between rightward asymmetry of the planum temporale and atypical language (R = 0.70, P < 0.0001); patients with a longer planum temporale in the right (unaffected) hemisphere were more likely to have atypical  language dominance. Voxel-based regression analysis confirmed that increased grey matter density in the right temporo-parietal junction was correlated with right hemisphere lateralization of language. The length of the planum temporale in the  right hemisphere was the main predictor of language lateralization in the epilepsy group, accounting for 48% of variance, with handedness accounting for only a further 5%. There was no correlation between language lateralization and planum temporale asymmetry in the control group. We conclude that asymmetry of the planum temporale may be unrelated to language lateralization in healthy individuals, but the size of the right, contra-lesional planum temporale region may reflect a ‚Äòreserve capacity‚Äô for interhemispheric language reorganization in  the presence of a seizure focus and lesions within left perisylvian regions.},
address  = {1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 2 Neurosciences Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK 1 Developmental Cognitive Neuroscience Unit, Institute of Child Health, University College London, London, WC1N 1EH, UK},
note  = {Brain. 2013 Oct;136(10):3163-75. doi:10.1093/brain/awt225.}
}

@Article{2014460,
author  = {Hjelm, R. and Calhoun, V. and Salakhutdinov, R. and Allen, E. and Adali, T. and Plis, S.},
title  = {Intrinsic Networks.},
journal  = {NeuroImage},
volume  = {96},
number  = {},
pages  = {245-60},
year  = {2014},
abstract  = {Matrix factorization models are the current dominant approach for resolving meaningful data-driven features in neuroimaging data. Among them, independent component analysis (ICA) is arguably the most widely used for identifying functional networks, and its success has led to a number of versatile extensions  to group and multimodal data. However there are indications that ICA may have reached a limit in flexibility and representational capacity, as the majority of  such extensions are case-driven, custom-made solutions that are still contained within the class of mixture models. In this work, we seek out a principled and naturally extensible approach and consider a probabilistic model known as a restricted Boltzmann machine (RBM). An RBM separates linear factors from functional brain imaging data by fitting a probability distribution model to the  data. Importantly, the solution can be used as a building block for more complex  (deep) models, making it naturally suitable for hierarchical and multimodal extensions that are not easily captured when using linear factorizations alone. We investigate the capability of RBMs to identify intrinsic networks and compare  its performance to that of well-known linear mixture models, in particular ICA. Using synthetic and real task fMRI data, we show that RBMs can be used to identify networks and their temporal activations with accuracy that is equal or greater than that of factorization models. The demonstrated effectiveness of RBMs supports its use as a building block for deeper models, a significant prospect for future neuroimaging research.},
address  = {Department of Computer Science, University of New Mexico, Albuquerque, New Mexico 87131, USA Department of Computer Science, University of New Mexico, Albuquerque, New Mexico 87131, USA Department of Computer Science, University of Toronto, Toronto, Ontario M5S 2J7,  Canada Mind Research Network, Albuquerque, New Mexico 87106, USA University of Maryland Baltimore County, Baltimore, Maryland 21250, USA Mind Research Network, Albuquerque, New Mexico 87106, USA},
note  = {doi:10.1016/j.neuroimage.2014.03.048.}
}

@Article{2015461,
author  = {Lin, S. and Demuth, K.},
title  = {Children's Acquisition of English Onset and Coda /l/: Articulatory Evidence.},
journal  = {Journal of Speech, Language, and Hearing Research : JSLHR},
volume  = {58},
number  = {1},
pages  = {13-27},
year  = {2015},
abstract  = {Purpose: The goal of this study was to better understand how and when onset /l/ (leap) and coda /l/ (peel) are acquired by children by examining both the articulations involved and adults' perceptions of the produced segments. Method:  Twenty-five typically developing Australian English‚Äìspeaking children aged 3;0 (years;months) to 7;11 participated in an elicited imitation task, during which audio, video, and lingual ultrasound images were collected. Transcribers perceptually rated audio, whereas video and ultrasound images were visually examined for the presence of adult-like articulations. Results: Data from this study establish that for Australian English‚Äìlearning children, coda /l/s are acquired later than onset /l/s, and older children produce greater proportions of adultlike /l/s in both onset and coda positions, roughly following established norms for American English‚Äìspeaking children. However, although perceptibility of coda /l/s was correlated with their articulations, onset /l/s were nearly uniformly perceived as adultlike despite substantial variation in the articulations used to produce them. Conclusions: The disparity in the production  and perception of children's singleton onset /l/s is linked to both physiological and phonological development. Suggestions are made for future research to tease these factors apart.},
address  = {University of California, Berkeley ARC Centre of Excellence in Cognition and Its Disorders, Macquarie University, Sydney, New South Wales, Australia},
note  = {J Speech Lang Hear Res. 2015 Feb;58(1):13-27. doi:10.1044/2014_JSLHR-S-14-0041.}
}

@Article{2014462,
author  = {Lee, C. and Mirman, D. and Buxbaum, L.},
title  = {from eyetracking.},
journal  = {Neuropsychologia},
volume  = {59},
number  = {},
pages  = {13-26},
year  = {2014},
abstract  = {Action representations associated with object use may be incidentally activated during visual object processing, and the time course of such activations may be influenced by lexical-semantic context (e.g., Lee, Middleton, Mirman, Kal√©nine, & Buxbaum, 2012). In this study we used the ‚Äúvisual world‚Ä? eye-tracking paradigm to examine whether a deficit in producing skilled object-use actions (apraxia) is associated with abnormalities in incidental activation of action information, and assessed the neuroanatomical substrates of any such deficits. Twenty left hemisphere stroke patients, ten of whom were apraxic, performed a task requiring  identification of a named object in a visual display containing manipulation-related and unrelated distractor objects. Manipulation relationships among objects were not relevant to the identification task. Objects were cued with neutral (‚ÄúS/he saw the‚Ä¶.‚Ä?), or action-relevant (‚ÄúS/he used the‚Ä¶.‚Ä?) sentences. Non-apraxic participants looked at use-related non-target objects significantly more than at unrelated non-target objects when cued both by neutral and action-relevant sentences, indicating that action information is incidentally activated. In contrast, apraxic participants showed delayed activation of manipulation-based action information during object identification when cued by neutral sentences. The magnitude of delayed activation in the neutral sentence condition was reliably predicted by lower scores on a test of gesture production  to viewed objects, as well as by lesion loci in the inferior parietal and posterior temporal lobes. However, when cued by a sentence containing an action verb, apraxic participants showed fixation patterns that were statistically indistinguishable from non-apraxic controls. In support of grounded theories of cognition, these results suggest that apraxia and temporal-parietal lesions may be associated with abnormalities in incidental activation of action information from objects. Further, they suggest that the previously-observed facilitative role of action verbs in the retrieval of object-related action information extends to participants with apraxia.},
address  = {Graduate Institute of Linguistics, Department of Psychology, Graduate Institute of Brain and Mind Sciences, and Neurobiology and Cognitive Neuroscience Center, National Taiwan University, Taipei, Taiwan Moss Rehabilitation Research Institute, Philadelphia, Pennsylvania, USA Moss Rehabilitation Research Institute, Philadelphia, Pennsylvania, USA},
note  = {doi:10.1016/j.neuropsychologia.2014.04.004.}
}

@Article{2013463,
author  = {McDougald, S. and Jackson, G. and Ho, Y. and Yan, Z. and Davison, C. and Rosenbloom, S.},
title  = {and Providers through a Patient Portal.},
journal  = {AMIA Annual Symposium Proceedings},
volume  = {2013},
number  = {},
pages  = {959-68},
year  = {2013},
abstract  = {Despite increases in the scientific evidence for a variety of medical treatments, a gap remains in the adoption of best medical practices. This manuscript describes a process for adapting published summary guides from comparative effectiveness research to render them concise, targeted to audience, and easily actionable; and a strategy for disseminating such evidence to patients and their  physicians through a web-based portal and linked electronic health record. This project adapted summary guides about oral medications for adults with type 2 diabetes to a fifth-grade literacy level and modified the resulting materials based on evaluations with the Suitability Assessment of Materials instrument. Focus groups and individual interviews with patients, diabetes providers, and health literacy experts were employed to evaluate and enhance the adapted summary guide. We present the lessons learned as general guidelines for the creation of concise, targeted, and actionable evidence and its delivery to both patients and  providers through increasingly prevalent health information technologies.},
address  = {},
note  = {AMIA Annu Symp Proc. 2013 Nov 16;2013:959-68.}
}

@Article{2014464,
author  = {Patki, G. and Solanki, N. and Atrooz, F. and Ansari, A. and Allam, F. and Jannise, B. and Maturi, J. and Salim, S.},
title  = {defeat-induced anxiety-like behavior and memory impairment in rats.},
journal  = {Physiology & behavior},
volume  = {130},
number  = {},
pages  = {135-44},
year  = {2014},
abstract  = {Social defeat (SD) induced stress causes physiological and behavioral deficits in rodents, including depression and anxiety-like behaviors, as well as memory impairment. Anxiolytic and mood elevating effects of physical exercise are also known. However, rescue effect of physical exercise in social defeat-induced anxiety, depression or memory impairment has not been addressed. Role of epigenetic mechanisms that potentially contribute to these rescue or protective effects are also not known. Present study investigated the effect of moderate treadmill exercise on anxiety-like behavior and memory function in rats subjected to SD using a modified version of the resident-intruder model for social stress (defeat). Changes in histone acetylation and histone-modifying enzymes were examined in hippocampus, amygdala and frontal cortex which are considered critical for anxiety, depression and cognition. Sprague Dawley rats were randomly assigned in four groups; control, exercised, social defeat, social defeat and exercise. At the end of the SD or control exposure lasting 30 min daily for 7 days, one group of SD rats was subjected to treadmill exercise for 2 weeks, whereas the other SD group was handled without exercise. Anxiety-like behavior tests and radial arm water maze test suggested that moderate treadmill exercise rescued social defeat induced anxiety-like behavior and memory impairment. Moreover, exercise normalized SD-induced increase in oxidative stress, most likely by adjusting antioxidant response. Our data suggests involvement of epigenetic mechanisms including histone acetylation of H3 and modulation of methyl-CpG-binding in the hippocampus that might contribute to the rescue effects of exercise in SD-induced behavioral deficits in rats.},
address  = {Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Texas, USA},
note  = {doi:10.1016/j.physbeh.2014.04.011.}
}

@Article{2016465,
author  = {Gagnon, L. and Smith, A. and Boas, D. and Devor, A. and Secomb, T. and Sakad≈æiƒá, S.},
title  = {Microvascular Network Structure, Blood Flow, and Oxygenation.},
journal  = {Frontiers in Computational Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Oxygen is delivered to brain tissue by a dense network of microvessels, which actively control cerebral blood flow (CBF) through vasodilation and contraction in response to changing levels of neural activity. Understanding these network-level processes is immediately relevant for (1) interpretation of functional Magnetic Resonance Imaging (fMRI) signals, and (2) investigation of neurological diseases in which a deterioration of neurovascular and neuro-metabolic physiology contributes to motor and cognitive decline. Experimental data on the structure, flow and oxygen levels of microvascular networks are needed, together with theoretical methods to integrate this information and predict physiologically relevant properties that are not directly measurable. Recent progress in optical imaging technologies for high-resolution in vivo measurement of the cerebral microvascular architecture, blood flow, and oxygenation enables construction of detailed computational models of cerebral hemodynamics and oxygen transport based on realistic three-dimensional microvascular networks. In this article, we review state-of-the-art optical microscopy technologies for quantitative in vivo imaging of cerebral microvascular structure, blood flow and oxygenation, and theoretical methods that utilize such data to generate spatially resolved models for blood flow and oxygen transport. These ‚Äúbottom-up‚Ä? models are essential for the understanding of the processes governing brain oxygenation in normal and disease states and for eventual translation of the lessons learned from animal studies to humans.},
address  = {Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical SchoolCharlestown, MA, USA Institut de M√©canique des Fluides de ToulouseToulouse, France Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical SchoolCharlestown, MA, USA Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical SchoolCharlestown, MA, USA Department of Physiology, University of ArizonaTucson, AZ, USA Optics Division, Department of Radiology, MHG/MIT/HMS Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical SchoolCharlestown, MA, USA},
note  = {Front Comput Neurosci. 2016 Aug 31;10:. doi:10.3389/fncom.2016.00082.}
}

@Article{2013466,
author  = {Bhattacharya, D. and Cheng, J.},
title  = {CASP10.},
journal  = {PLoS ONE},
volume  = {8},
number  = {7},
pages  = {},
year  = {2013},
abstract  = {Protein structure refinement refers to the process of improving the qualities of  protein structures during structure modeling processes to bring them closer to their native states. Structure refinement has been drawing increasing attention in the community-wide Critical Assessment of techniques for Protein Structure prediction (CASP) experiments since its addition in 8th CASP experiment. During the 9th and recently concluded 10th CASP experiments, a consistent growth in number of refinement targets and participating groups has been witnessed. Yet, protein structure refinement still remains a largely unsolved problem with majority of participating groups in CASP refinement category failed to consistently improve the quality of structures issued for refinement. In order to alleviate this need, we developed a completely automated and computationally efficient protein 3D structure refinement method, i3Drefine, based on an iterative and highly convergent energy minimization algorithm with a powerful all-atom composite physics and knowledge-based force fields and hydrogen bonding  (HB) network optimization technique. In the recent community-wide blind experiment, CASP10, i3Drefine (as ‚ÄòMULTICOM-CONSTRUCT‚Äô) was ranked as the best method in the server section as per the official assessment of CASP10 experiment. Here we provide the community with free access to i3Drefine software and systematically analyse the performance of i3Drefine in strict blind mode on the refinement targets issued in CASP10 refinement category and compare with other state-of-the-art refinement methods participating in CASP10. Our analysis demonstrates that i3Drefine is only fully-automated server participating in CASP10 exhibiting consistent improvement over the initial structures in both global and local structural quality metrics. Executable version of i3Drefine is freely available at http://protein.rnet.missouri.edu/i3drefine/.},
address  = {Department of Computer Science, University of Missouri, Columbia, Missouri, United States of America Department of Computer Science, Informatics Institute, Bond Life Science Center,  University of Missouri, Columbia, Missouri, United States of America},
note  = {PLoS One. 2013 Jul 19;8(7):. doi:10.1371/journal.pone.0069648.}
}

@Article{2012467,
author  = {Calhoun, V. and Pearlson, G.},
title  = {Hybrid Paradigms, Analysis Approaches, and Future Directions.},
journal  = {NeuroImage},
volume  = {59},
number  = {1},
pages  = {25-35},
year  = {2012},
abstract  = {Naturalistic paradigms such as movie watching or simulated driving that mimic closely real-world complex activities are becoming more widely used in functional magnetic resonance imaging (fMRI) studies both because of their ability to robustly stimulate brain connectivity and the availability of analysis methods which are able to capitalize on connectivity within and among intrinsic brain networks identified both during a task and in resting fMRI data. In this paper we review over a decade of work from our group and others on the use of simulated driving paradigms to study both the healthy brain as well as the effects of acute alcohol administration on functional connectivity during such paradigms. We briefly review our initial work focused on the configuration of the driving simulator and the analysis strategies. We then describe in more detail several recent studies from our group including a hybrid study examining distracted driving and compare resulting data with those from a separate visual oddball task.The analysis of these data were performed primarily using a combination of group independent component analysis (ICA) and the general linear model (GLM) and in the various studies we highlight novel findings which result from an analysis  of either 1) within-network connectivity, 2) inter-network connectivity, also called functional network connectivity, or 3) the degree to which the modulation  of the various intrinsic networks were associated with the alcohol administration and the task context.Despite the fact that the behavioral effects of alcohol intoxication are relatively well known, there is still much to discover on how acute alcohol exposure modulates brain function in a selective manner, associated with behavioral alterations. Through the above studies, we have learned more regarding the impact of acute alcohol intoxication on organization of the brain‚Äôs intrinsic connectivity networks during performance of a complex, real-world cognitive operation. Lessons learned from the above studies have broader applicability to designing ecologically valid, complex, functional MRI cognitive  paradigms and incorporating pharmacologic challenges into such studies. Overall,  the use of hybrid driving studies is a particularly promising area of neuroscience investigation.},
address  = {The Mind Research Network, Albuquerque, NM 87106 Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT 06106},
note  = {doi:10.1016/j.neuroimage.2011.06.037.}
}

@Article{2017468,
author  = {Bleichner, M. and Debener, S.},
title  = {EEG.},
journal  = {Frontiers in Human Neuroscience},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Electroencephalography (EEG) is an important clinical tool and frequently used to study the brain-behavior relationship in humans noninvasively. Traditionally, EEG signals are recorded by positioning electrodes on the scalp and keeping them in place with glue, rubber bands, or elastic caps. This setup provides good coverage of the head, but is impractical for EEG acquisition in natural daily-life situations. Here, we propose the transparent EEG concept. Transparent EEG aims for motion tolerant, highly portable, unobtrusive, and near invisible data acquisition with minimum disturbance of a user's daily activities. In recent years several ear-centered EEG solutions that are compatible with the transparent EEG concept have been presented. We discuss work showing that miniature electrodes placed in and around the human ear are a feasible solution, as they are sensitive enough to pick up electrical signals stemming from various brain and non-brain sources. We also describe the cEEGrid flex-printed sensor array, which enables unobtrusive multi-channel EEG acquisition from around the ear. In a number of validation studies we found that the cEEGrid enables the recording of meaningful continuous EEG, event-related potentials and neural oscillations. Here, we explain the rationale underlying the cEEGrid ear-EEG solution, present possible use cases and identify open issues that need to be solved on the way toward transparent EEG.},
address  = {Neuropsychology Lab, Department of Psychology, European Medical School, University of OldenburgOldenburg, Germany Neuropsychology Lab, Department of Psychology, European Medical School, University of OldenburgOldenburg, Germany},
note  = {Front Hum Neurosci. 2017 Apr 07;11:. doi:10.3389/fnhum.2017.00163.}
}

@Article{2017469,
author  = {Tendler, A. and Roth, Y. and Barnea-Ygael, N. and Zangen, A.},
title  = {Other than Depression.},
journal  = {Journal of Visualized Experiments : JoVE},
volume  = {},
number  = {119},
pages  = {},
year  = {2017},
abstract  = {Deep transcranial magnetic stimulation (dTMS) is a relatively new technique that  uses different coils for the treatment of different neuropathologies. The coils are made of soft copper windings in multiple planes that lie adjacent to the skull. They are located within a special helmet so that their magnetic fields combine and improve depth penetration. The H1 dTMS coil is designed to stimulate  bilateral prefrontal cortices with greater effective stimulation over the left than the right. By positioning the left side of the coil close to the left dorsolateral prefrontal cortex (DLPFC), the H1 coil was used in a multisite study, leading to FDA approval for treatment-resistant depression. In this same position, the H1 coil was also explored as a possible treatment for negative symptoms of schizophrenia, bipolar depression, and migraine. When moved to different positions over the subject's skull, the H1 coil was also explored as a  possible treatment for other conditions. Such manipulation of the H1 coil was demonstrated for PTSD and alcohol dependence by positioning it over the medial prefrontal cortex (mPFC), for anxiety by positioning it over the right prefrontal cortex (rPFC), for auditory hallucinations and tinnitus by positioning it over the temporoparietal junction (TPJ), and for Parkinson's and fatigue from multiple sclerosis (MS) by positioning it over the motor cortex (MC) and PFC. Corresponding electrical field diagrams measured with an oscilloscope through a saline-filled head are included.},
address  = {Brainsway LTD Brainsway LTD Department of Life Sciences, Ben Gurion University of the Negev Department of Life Sciences, Ben Gurion University of the Negev},
note  = {J Vis Exp. 2017 Jan 23;(119):. doi:10.3791/55100.}
}

@Article{2016470,
author  = {Khanassov, V. and Pluye, P. and Descoteaux, S. and Haggerty, J. and Russell, G. and Gunn, J. and Levesque, J.},
title  = {care for vulnerable populations: a scoping review.},
journal  = {International Journal for Equity in Health},
volume  = {15},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Access to community-based primary health care (hereafter, ‚Äòprimary care‚Äô) is a priority in many countries. Health care systems have emphasized policies that help the community ‚Äòget the right service in the right place at the right time‚Äô.  However, little is known about organizational interventions in primary care that  are aimed to improve access for populations in situations of vulnerability (e.g., socioeconomically disadvantaged) and how successful they are. The purpose of this scoping review was to map the existing evidence on organizational interventions that improve access to primary care services for vulnerable populations. Scoping  review followed an iterative process. Eligibility criteria: organizational interventions in Organisation for Economic Cooperation and Development (OECD) countries; aiming to improve access to primary care for vulnerable populations; all study designs; published from 2000 in English or French; reporting at least one outcome (avoidable hospitalization, emergency department admission, or unmet  health care needs). Sources: Main bibliographic databases (Medline, Embase, CINAHL) and team members‚Äô personal files. Study selection: One researcher selected relevant abstracts and full text papers. Theory-driven synthesis: The researcher classified included studies using (i) the ‚ÄòPatient Centered Access to  Healthcare‚Äô conceptual framework (dimensions and outcomes of access to primary care), and (ii) the classification of interventions of the Cochrane Effective Practice and Organization of Care. Using pattern analysis, interventions were mapped in accordance with the presence/absence of ‚Äòdimension-outcome‚Äô patterns. Out of 8,694 records (title/abstract), 39 studies with varying designs were included. The analysis revealed the following pattern. Results of 10 studies on interventions classified as ‚ÄòFormal integration of services‚Äô suggested that these interventions were associated with three dimensions of access (approachability, availability and affordability) and reduction of hospitalizations (four/four studies), emergency department admissions (six/six studies), and unmet healthcare needs (five/six studies). These 10 studies included seven non-randomized studies, one randomized controlled trial, one quantitative descriptive study, and one mixed methods study. Our results suggest the limited breadth of research in this  area, and that it will be feasible to conduct a full systematic review of studies on the effectiveness of the formal integration of services to improve access to primary care services for vulnerable populations.},
address  = {Department of Family Medicine, McGill University, 5858 C√¥te-des-neiges, 3rd Floor, Suite 300, Montreal, QC H3S 1Z1 Canada Department of Family Medicine, McGill University, 5858 C√¥te-des-neiges, 3rd Floor, Suite 300, Montreal, QC H3S 1Z1 Canada St. Mary‚Äôs Hospital Research Centre, 3830 Lacombe Ave, Montr√©al, QC H3T1M5 Canada Department of Family Medicine, McGill University, St. Mary‚Äôs Hospital Research Centre, 3830 Lacombe Ave, Montr√©al, QC H3T1M5 Canada Southern Academic Primary Care Research Unit, Department of General Practice, School of Primary Health Care, Monash University, Building 1, 270 Ferntree Gully  Rd, Notting Hill, VIC 3168 Australia University of Melbourne, 200 Berkeley Street, Melbourne, VIC 3053 Australia Centre for Primary Health Care and Equity, University of New South Wales, Bureau  of Health Information, 67 Albert Avenue, Chatswood, Sydney, NSW 2067 Australia},
note  = {Int J Equity Health. 2016 Oct 10;15:. doi:10.1186/s12939-016-0459-9.}
}

@Article{2010471,
author  = {Bowers, A. and Mandel, A. and Goldstein, R. and Peli, E.},
title  = {Driving with Hemianopia, II: Lane Position and Steering in a Driving Simulator.},
journal  = {Investigative Ophthalmology & Visual Science},
volume  = {51},
number  = {12},
pages  = {6605-13},
year  = {2010},
abstract  = {Drivers with hemianopia took a lane position that increased their safety margin on the blind side. Although their steering control appeared commensurate with safe driving, their poor blind-side detection did not seem compatible with safe driving.},
address  = {From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts. From The Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.},
note  = {Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6605-13. doi:10.1167/iovs.10-5310.}
}

@Article{2011472,
author  = {Quik, M. and Wonnacott, S.},
title  = {Disease.},
journal  = {Pharmacological Reviews},
volume  = {63},
number  = {4},
pages  = {938-66},
year  = {2011},
abstract  = {Parkinson's disease is a debilitating movement disorder characterized by a generalized dysfunction of the nervous system, with a particularly prominent decline in the nigrostriatal dopaminergic pathway. Although there is currently no cure, drugs targeting the dopaminergic system provide major symptomatic relief. As well, agents directed to other neurotransmitter systems are of therapeutic benefit. Such drugs may act by directly improving functional deficits in these other systems, or they may restore aberrant motor activity that arises as a result of a dopaminergic imbalance. Recent research attention has focused on a role for drugs targeting the nicotinic cholinergic systems. The rationale for such work stems from basic research findings that there is an extensive overlap in the organization and function of the nicotinic cholinergic and dopaminergic systems in the basal ganglia. In addition, nicotinic acetylcholine receptor (nAChR) drugs could have clinical potential for Parkinson's disease. Evidence for this proposition stems from studies with experimental animal models showing that  nicotine protects against neurotoxin-induced nigrostriatal damage and improves motor complications associated with l-DOPA, the ‚Äúgold standard‚Ä? for Parkinson's disease treatment. Nicotine interacts with multiple central nervous system receptors to generate therapeutic responses but also produces side effects. It is important therefore to identify the nAChR subtypes most beneficial for treating Parkinson's disease. Here we review nAChRs with particular emphasis on the subtypes that contribute to basal ganglia function. Accumulating evidence suggests that drugs targeting Œ±6Œ≤2* and Œ±4Œ≤2* nAChR may prove useful in the management of Parkinson's disease.},
address  = {},
note  = {Pharmacol Rev. 2011 Dec;63(4):938-66. doi:10.1124/pr.110.003269.}
}

@Article{2014473,
author  = {Arehart, K. and Croghan, N. and Muralimanohar, R.},
title  = {and Cochlear-Implant Hearing.},
journal  = {Ear and hearing},
volume  = {35},
number  = {2},
pages  = {195-202},
year  = {2014},
abstract  = {Objectives: Recent evidence suggests that age might affect the ability of listeners to process fundamental frequency cues in speech, and that this difficulty might impact the ability of older listeners to use and combine envelope and fine structure cues available in simulations of electro-acoustic and cochlear-implant hearing. The purpose of this paper is to examine whether this difficulty extends to music. Specially, this study focuses on whether older listeners have a decreased ability to utilize and combine different types of cues in the perception of melody and timbre. Design: A group of older listeners with normal to near-normal hearing and a group of younger listeners with normal hearing participated in the melody and timbre recognition tasks of the University of Washington Clinical Assessment of Music Perception (CAMP) test. The recognition tasks were completed for five different processing conditions: 1) an  unprocessed condition; 2) an eight-channel vocoding condition that simulated a traditional cochlear implant and contained temporal envelope cues; 3) a simulation of electro-acoustic stimulation (sEAS) that included a low-pass acoustic component and high-pass vocoded portion, and which provided fine structure and envelope cues; 4) a condition that included only the low-pass acoustic portion of the sEAS and 5) a condition that included only the high-frequency vocoded portion of the sEAS stimulus. Results: Melody recognition  was excellent for both younger and older listeners in the conditions containing the unprocessed stimuli, the full sEAS stimuli, and the low-pass sEAS stimuli. Melody recognition was significantly worse in the cochlear-implant simulation condition, especially for the older group of listeners. Performance on the timbre task was highest for the unprocessed condition, and progressively decreased for the sEAS and cochlear-implant simulation conditions. Compared to younger listeners, older listeners had significantly poorer timbre recognition for all processing conditions. For melody recognition, the unprocessed low-frequency portion of the sEAS stimulus was the primary factor determining improved performance in the sEAS condition compared to the cochlear-implant simulation. For timbre recognition, both the unprocessed low-frequency and high-frequency vocoded portions of the sEAS stimulus contributed to sEAS improvement in the younger group. In contrast, most listeners in the older group were not able to take advantage of the high-frequency vocoded portion of the sEAS stimulus for timbre recognition. Conclusions: The results of this simulation study support the idea that older listeners will have diminished timbre and melody perception in traditional cochlear-implant listening due to degraded envelope processing. The findings also suggest that music perception by older listeners with cochlear implants will be improved with the addition of low-frequency residual hearing. However, these improvements might not be comparable for all dimensions of music perception. That is, more improvement might be evident for tasks that rely primarily on the low-frequency portion of the electro-acoustic stimulus (e.g., melody recognition) and less improvement might be evident in situations that require across-frequency integration of cues (e.g., timbre perception).},
address  = {Department of Speech, Language, Hearing Sciences, University of Colorado Department of Speech, Language, Hearing Sciences, University of Colorado Department of Speech, Language, Hearing Sciences, University of Colorado},
note  = {Ear Hear. 2014 Mar-Apr;35(2):195-202. doi:10.1097/AUD.0b013e3182a69a5c.}
}

@Article{2002474,
author  = {},
title  = {Bone Anchored Hearing Aid: An Evidence-Based Analysis.},
journal  = {Ontario Health Technology Assessment Series},
volume  = {2},
number  = {3},
pages  = {1-47},
year  = {2002},
abstract  = {Objective: The objective of this health technology policy assessment was to determine the effectiveness and cost-effectiveness of bone-anchored hearing aid (BAHA) in improving the hearing of people with conduction or mixed hearing loss.The Technology: The (BAHA) is a bone conduction hearing device that includes a titanium fixture permanently implanted into the mastoid bone of the skull and an external percutaneous sound processor. The sound processor is attached to the  fixture by means of a skin penetrating abutment. Because the device bypasses the  middle ear and directly stimulates the cochlea, it has been recommended for individuals with conduction hearing loss or discharging middle ear infection.The  titanium implant is expected to last a lifetime while the external sound processor is expected to last 5 years. The total initial device cost is approximately $5,300 and the external sound processor costs approximately $3,500. Review of BAHA by the Medical Advisory Secretariat: The Medical Advisory Secretariat‚Äôs review is a descriptive synthesis of findings from 36 research articles published between January 1990 and May 2002.Summary of Findings: No randomized controlled studies were found. The evidence was derived from level 4 case series with relative small sample sizes (ranging from 30-188). The majority  of the studies have follow-up periods of eight years or longer. All except one study were based on monaural BAHA implant on the side with the best bone conduction threshold. Safety: Level 4 evidence showed that BAHA has been be implanted safely in adults and children with success rates of 90% or higher in most studies. No mortality or life threatening morbidity has been reported. Revision rates for tissue reduction or resiting were generally under 10% for adults but have been reported to be as high as 25% in pediatric studies.Adverse skin reaction around the skin penetration site was the most common complication reported. Most of these conditions were successfully treated with antibiotics, and only 1% to 2% required surgical revision. Less than 1% required removal of the fixture.Other complications included failure to osseointegrate and loss of fixture and/or abutment due to trauma or infection. Effectiveness: Studies showed that BAHAs were implanted in people who have conduction or mixed hearing loss, congenital atresia or suppurative otitis media who were not candidates for surgical repair, and who cannot use conventional bone conduction hearing aids. The need for BAHA is not age- related. Objective audiometric measures and subjective patient satisfaction surveys showed that BAHA significantly improved the unaided and aided free field and sound field thresholds as well as speech discrimination in quiet and in noise for former users of conventional bone conduction hearing aids. The outcomes were ambiguous for former users of air conduction hearing aids.BAHA has been shown to reduce the frequency of ear infection and reduce the discharge particularly among patients with suppurative otitis media.Patients have reported that BAHA improved their quality of life. Reported benefits were improved speech intelligibility, better sound comfort, less pressure on the head, less skin irritation, greater cosmetic acceptance and  increase in confidence. Main reported shortcomings were wind noise, feedback and  difficulty in using the telephone.Experts and the BAHA manufacturer recommended that recipients of a BAHA implant be at least 5 years old. Challenges associated  with the implantation of BAHA in pediatric patients include thin bone, soft bone, higher rates of fixture loss due to trauma, psychological problems, and higher revision rates due to rapid bone growth. The overall outcomes are comparable to adult BAHA. The benefits of pediatric BAHA (e.g. on speech development) appear to outweigh the disadvantages.Screening according to strict eligibility criteria, preoperative counselling, close monitoring by a physician with BAHA expertise and on-going follow-up were identified as critical factors for long-term implant survival. Examples of eligibility criteria were provided. Cost-effectiveness: No  literature on cost-effectiveness of BAHA was found.},
address  = {},
note  = {Ont Health Technol Assess Ser. 2002 Sep 1;2(3):1-47.}
}

@Article{2009475,
author  = {Hunt, R. and Zavalin, A. and Bhatnagar, A. and Chinnasamy, S. and Das, K.},
title  = {Bioenergy Applications.},
journal  = {International Journal of Molecular Sciences},
volume  = {10},
number  = {10},
pages  = {4515-58},
year  = {2009},
abstract  = {The surge of interest in bioenergy has been marked with increasing efforts in research and development to identify new sources of biomass and to incorporate cutting-edge biotechnology to improve efficiency and increase yields. It is evident that various microorganisms will play an integral role in the development of this newly emerging industry, such as yeast for ethanol and Escherichia coli for fine chemical fermentation. However, it appears that microalgae have become the most promising prospect for biomass production due to their ability to grow fast, produce large quantities of lipids, carbohydrates and proteins, thrive in poor quality waters, sequester and recycle carbon dioxide from industrial flue gases and remove pollutants from industrial, agricultural and municipal wastewaters. In an attempt to better understand and manipulate microorganisms for optimum production capacity, many researchers have investigated alternative methods for stimulating their growth and metabolic behavior. One such novel approach is the use of electromagnetic fields for the stimulation of growth and metabolic cascades and controlling biochemical pathways. An effort has been made  in this review to consolidate the information on the current status of biostimulation research to enhance microbial growth and metabolism using electromagnetic fields. It summarizes information on the biostimulatory effects on growth and other biological processes to obtain insight regarding factors and  dosages that lead to the stimulation and also what kind of processes have been reportedly affected. Diverse mechanistic theories and explanations for biological effects of electromagnetic fields on intra and extracellular environment have been discussed. The foundations of biophysical interactions such as bioelectromagnetic and biophotonic communication and organization within living systems are expounded with special consideration for spatiotemporal aspects of electromagnetic topology, leading to the potential of multipolar electromagnetic  systems. The future direction for the use of biostimulation using bioelectromagnetic, biophotonic and electrochemical methods have been proposed for biotechnology industries in general with emphasis on an holistic biofuel system encompassing production of algal biomass, its processing and conversion to biofuel.},
address  = {Department of Biological and Agricultural Engineering, The University of Georgia, Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.); csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.) Mass Spectrometry Research Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA; E-Mail: andrey.zavalin@vanderbilt.edu (A.Z.) Department of Biological and Agricultural Engineering, The University of Georgia, Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.); csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.) Department of Biological and Agricultural Engineering, The University of Georgia, Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.); csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.) Department of Biological and Agricultural Engineering, The University of Georgia, Athens, GA 30602, USA; E-Mails: bhatnagarashis@gmail.com (A.B.); csenthil@engr.uga.edu (S.C.); kdas@engr.uga.edu (K.C.D.)},
note  = {Int J Mol Sci. 2009 Nov 20;10(10):4515-58. doi:10.3390/ijms10104515.}
}

@Article{2009476,
author  = {Qiu, R. and Guo, N. and Li, H. and Wu, Z. and Chakravarthy, V. and Song, Y. and Hu, Z. and Zhang, P. and Chen, Z.},
title  = {and Multi-GHz Wideband Testbed.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {9},
number  = {8},
pages  = {6530-603},
year  = {2009},
abstract  = {Dynamic spectrum access is a must-have ingredient for future sensors that are ideally cognitive. The goal of this paper is a tutorial treatment of wideband cognitive radio and radar‚Äîa convergence of (1) algorithms survey, (2) hardware platforms survey, (3) challenges for multi-function (radar/communications) multi-GHz front end, (4) compressed sensing for multi-GHz waveforms‚Äîrevolutionary A/D, (5) machine learning for cognitive radio/radar, (6) quickest detection, and  (7) overlay/underlay cognitive radio waveforms. One focus of this paper is to address the multi-GHz front end, which is the challenge for the next-generation cognitive sensors. The unifying theme of this paper is to spell out the convergence for cognitive radio, radar, and anti-jamming. Moore‚Äôs law drives the  system functions into digital parts. From a system viewpoint, this paper gives the first comprehensive treatment for the functions and the challenges of this multi-function (wideband) system. This paper brings together the inter-disciplinary knowledge.},
address  = {Department of Electrical and Computer Engineering, Center for Manufacturing Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails: nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu (Z.C.) Department of Electrical and Computer Engineering, Center for Manufacturing Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails: nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu (Z.C.) Department of Electrical Engineering and Computer Science, The University of Tennessee Knoxville, TN 37996-2100, USA; E-Mail: husheng@eecs.utk.edu Department of Electrical Engineering, Wright State University, 3640 Colonel Glenn Highway, Dayton, OH 45435-0001, USA; E-Mail: zhiqiang.wu@wright.edu Department of Electrical and Computer Engineering, Center for Manufacturing Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails: nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu (Z.C.) Department of Electrical and Computer Engineering, Center for Manufacturing Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails: nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu (Z.C.) Department of Electrical and Computer Engineering, Center for Manufacturing Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails: nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu (Z.C.) Department of Electrical and Computer Engineering, Center for Manufacturing Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails: nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu (Z.C.) Department of Electrical and Computer Engineering, Center for Manufacturing Research, Tennessee Technological University, Cookeville, TN 38505, USA; E-Mails: nguo@tntech.edu (N.G.); ysong21@tntech.edu (Y.S.); Vasu.Chakravarthy@wpafb.af.mil (V.C.); zhu21@tntech.edu (Z.H.); pzhang21@tntech.edu (P.Z.); zchen42@tntech.edu (Z.C.)},
note  = {Sensors (Basel). 2009 Aug 21;9(8):6530-603. doi:10.3390/s90806530.}
}

@Article{477,
author  = {Dastjerdi, M. and Ozker, M. and Foster, B. and Rangarajan, V. and Parvizi, J.},
title  = {conditions.},
journal  = {Nature Communications},
volume  = {4},
number  = {},
pages  = {},
year  = {},
abstract  = {Human cognition is traditionally studied in experimental conditions wherein confounding complexities of the natural environment are intentionally eliminated. Thus, it remains unknown how a brain region involved in a particular experimental condition is engaged in natural conditions. Here we use electrocorticography to address this uncertainty in three participants implanted with intracranial electrodes and identify activations of neuronal populations within the intraparietal sulcus region during an experimental arithmetic condition. In a subsequent analysis, we report that the same intraparietal sulcus neural populations are activated when participants, engaged in social conversations, refer to objects with numerical content. Our prototype approach provides a means  for both exploring human brain dynamics as they unfold in complex social settings and reconstructing natural experiences from recorded brain signals.},
address  = {Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology  and Neurological Sciences, Stanford Human Intracranial Cognitive Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room  A343, Stanford, California 94305, USA Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology  and Neurological Sciences, Stanford Human Intracranial Cognitive Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room  A343, Stanford, California 94305, USA Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology  and Neurological Sciences, Stanford Human Intracranial Cognitive Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room  A343, Stanford, California 94305, USA Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology  and Neurological Sciences, Stanford Human Intracranial Cognitive Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room  A343, Stanford, California 94305, USA Laboratory of Behavioral and Cognitive Neurology (LBCN), Department of Neurology  and Neurological Sciences, Stanford Human Intracranial Cognitive Electrophysiology Program (SHICEP), Stanford University, 300 Pasteur Drive, Room  A343, Stanford, California 94305, USA},
note  = {Nat Commun. ;4:. doi:10.1038/ncomms3528.}
}

@Article{2014478,
author  = {Williams, I. and Constandinou, T.},
title  = {for prostheses: a simulation study.},
journal  = {Frontiers in Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Accurate models of proprioceptive neural patterns could 1 day play an important role in the creation of an intuitive proprioceptive neural prosthesis for amputees. This paper looks at combining efficient implementations of biomechanical and proprioceptor models in order to generate signals that mimic human muscular proprioceptive patterns for future experimental work in prosthesis feedback. A neuro-musculoskeletal model of the upper limb with 7 degrees of freedom and 17 muscles is presented and generates real time estimates of muscle spindle and Golgi Tendon Organ neural firing patterns. Unlike previous neuro-musculoskeletal models, muscle activation and excitation levels are unknowns in this application and an inverse dynamics tool (static optimization) is integrated to estimate these variables. A proprioceptive prosthesis will need  to be portable and this is incompatible with the computationally demanding nature of standard biomechanical and proprioceptor modeling. This paper uses and proposes a number of approximations and optimizations to make real time operation on portable hardware feasible. Finally technical obstacles to mimicking natural feedback for an intuitive proprioceptive prosthesis, as well as issues and limitations with existing models, are identified and discussed.},
address  = {Department of Electrical and Electronic Engineering, Imperial College LondonLondon, UK Department of Electrical and Electronic Engineering, Imperial College LondonLondon, UK},
note  = {Front Neurosci. 2014 Jun 25;8:. doi:10.3389/fnins.2014.00181.}
}

@Article{2012479,
author  = {Kleinberg, L.},
title  = {evidence for role in era of standard adjuvant temozolomide.},
journal  = {Core Evidence},
volume  = {7},
number  = {},
pages  = {115-30},
year  = {2012},
abstract  = {The Polifeprosan 20 with carmustine (BCNU, bis-chloroethylnitrosourea, Gliadel¬Æ)  polymer implant wafer is a biodegradable compound containing 3.85% carmustine which slowly degrades to release carmustine and protects it from exposure to water with resultant hydrolysis until the time of release. The carmustine implant wafer was demonstrated to improve survival in blinded placebo-controlled trials in selected patients with newly diagnosed or recurrent malignant glioma, with little increased risk of adverse events. Based on these trials and other supporting data, US and European regulatory authorities granted approval for its  use in recurrent and newly diagnosed malignant glioma, and it remains the only approved local treatment. The preclinical and clinical data suggest that it is optimally utilized primarily in the proportion of patients who may have total or  near total removal of gross tumor. The aim of this work was to review the evidence for the use of carmustine implants in the management of malignant astrocytoma (World Health Organization grades III and IV), including newly diagnosed and recurrent disease, especially in the setting of a standard of care  that has changed since the randomized trials were completed. Therapy has evolved  such that patients now generally receive temozolomide chemotherapy during and after radiotherapy treatment. For patients undergoing repeat resection for malignant glioma, a randomized, blinded, placebo-controlled trial demonstrated a  median survival for 110 patients who received carmustine polymers of 31 weeks compared with 23 weeks for 122 patients who only received placebo polymers. The benefit achieved statistical significance only on analysis adjusting for prognostic factors rather than for the randomized groups as a whole (hazard ratio = 0.67, P = 0.006). A blinded, placebo-controlled trial has also been performed for carmustine implant placement in newly diagnosed patients prior to standard radiotherapy. Median survival was improved from 11.6 to 13.9 months (P = 0.03), with a 29% reduction in the risk of death. When patients with glioblastoma multiforme alone were analyzed, the median survival improved from 11.4 to 13.5 months, but this improvement was not statistically significant. When a Cox‚Äôs proportional hazard model was utilized to account for other potential prognostic  factors, there was a significant 31% reduction in the risk of death (P = 0.04) in this subgroup. Data from other small reports support these results and confirm that the incidence of adverse events does not appear to be increased meaningfully. Given the poor prognosis without possibility of cure, these benefits from a treatment with a favorable safety profile were considered meaningful. There is randomized evidence to support the use of carmustine wafers  placed during resection of recurrent disease. Therefore, although there is limited specific evidence, this treatment is likely to be efficacious in an environment when nearly all patients receive temozolomide as part of initial management. Given that half of the patients in the randomized trial assessing the value of carmustine implants in recurrent disease had received prior chemotherapy, it is likely that this remains a valuable treatment at the time of  repeat resection, even after temozolomide. There are data from multiple reports to support safety. Although there is randomized evidence to support the use of this therapy in newly diagnosed patients who will receive radiotherapy alone, it  is now standard to administer both adjuvant temozolomide and radiotherapy. There  are survival outcome reports for small cohorts of patients receiving temozolomide with radiotherapy, but this information is not sufficient to support firm recommendations. Based on the rationale and evidence of safety, this approach appears to be a reasonable option as more information is acquired. Available data support the safety of using carmustine wafers in this circumstance, although special attention to surgical guidelines for implanting the wafers is warranted.},
address  = {},
note  = {Core Evid. 2012;7:115-30. Epub 2012 Oct 26 doi:10.2147/CE.S23244.}
}

@Article{2015480,
author  = {Nagaraj, V. and Lee, S. and Krook-Magnuson, E. and Soltesz, I. and Benquet, P. and Irazoqui, P. and Netoff, T.},
title  = {The Future of Seizure Prediction and Intervention: Closing the loop.},
journal  = {Electroencephalographic Society},
volume  = {32},
number  = {3},
pages  = {194-206},
year  = {2015},
abstract  = {The ultimate goal of epilepsy therapies is to provide seizure control for all patients while eliminating side effects. Improved specificity of intervention through on-demand approaches may overcome many of the limitations of current intervention strategies. This article reviews progress in seizure prediction and  detection, potential new therapies to provide improved specificity, and devices to achieve these ends. Specifically, we discuss 1) potential signal modalities and algorithms for seizure detection and prediction, 2) closed-loop intervention  approaches, and 3) hardware for implementing these algorithms and interventions.  Seizure prediction and therapies maximize efficacy while minimizing side-effects  through improved specificity may represent the future of epilepsy treatments.},
address  = {Graduate Program in Neuroscience, University of Minnesota Weldon School of Biomedical Engineering, Purdue University Department of Anatomy & Neurobiology, University of California, Irvine Department of Anatomy & Neurobiology, University of California, Irvine INSERM U1099 LTSI University of Rennes 1, France Weldon School of Biomedical Engineering, Purdue University Graduate Program in Neuroscience, University of Minnesota},
note  = {J Clin Neurophysiol. 2015 Jun;32(3):194-206. doi:10.1097/WNP.0000000000000139.}
}

@Article{2016481,
author  = {Beversdorf, D.},
title  = {Autism Spectrum Disorders.},
journal  = {Journal of Developmental and Behavioral Pediatrics},
volume  = {37},
number  = {8},
pages  = {659-73},
year  = {2016},
abstract  = {Despite the progress made in understanding the biology of autism spectrum disorder (ASD), effective biological interventions for the core symptoms remain elusive. Because of the etiological heterogeneity of ASD, identification of a ‚Äúone-size-fits-all‚Ä? treatment approach will likely continue to be challenging. A  meeting was convened at the University of Missouri and the Thompson Center to discuss strategies for stratifying patients with ASD for the purpose of moving toward precision medicine. The ‚Äúwhite paper‚Ä? presented here articulates the challenges involved and provides suggestions for future solutions.},
address  = {},
note  = {doi:10.1097/DBP.0000000000000351.}
}

@Article{2012482,
author  = {Bridges, R. and Lutgen, V. and Lobner, D. and Baker, D.},
title  = {Glutamatergic Signaling.},
journal  = {Pharmacological Reviews},
volume  = {64},
number  = {3},
pages  = {780-802},
year  = {2012},
abstract  = {System xc‚àí represents an intriguing target in attempts to understand the pathological states of the central nervous system. Also called a cystine-glutamate antiporter, system xc‚àí typically functions by exchanging one molecule of extracellular cystine for one molecule of intracellular glutamate. Nonvesicular glutamate released during cystine-glutamate exchange activates extrasynaptic glutamate receptors in a manner that shapes synaptic activity and plasticity. These findings contribute to the intriguing possibility that extracellular glutamate is regulated by a complex network of release and reuptake mechanisms, many of which are unique to glutamate and rarely depicted in models of excitatory signaling. Because system xc‚àí is often expressed on non-neuronal cells, the study of cystine-glutamate exchange may advance the emerging viewpoint that glia are active contributors to information processing in the brain. It is noteworthy that system xc‚àí is at the interface between excitatory signaling and oxidative stress, because the uptake of cystine that results from cystine-glutamate exchange is critical in maintaining the levels of glutathione,  a critical antioxidant. As a result of these dual functions, system xc‚àí has been  implicated in a wide array of central nervous system diseases ranging from addiction to neurodegenerative disorders to schizophrenia. In the current review, we briefly discuss the major cellular components that regulate glutamate homeostasis, including glutamate release by system xc‚àí. This is followed by an in-depth discussion of system xc‚àí as it relates to glutamate release, cystine transport, and glutathione synthesis. Finally, the role of system xc‚àí is surveyed across a number of psychiatric and neurodegenerative disorders.},
address  = {},
note  = {Pharmacol Rev. 2012 Jul;64(3):780-802. doi:10.1124/pr.110.003889.}
}

@Article{2011483,
author  = {Wang, D. and Kriegstein, A.},
title  = {Alterations in Cortical Circuits and Sensorimotor Gating Deficits.},
journal  = {Cerebral Cortex (New York, NY)},
volume  = {21},
number  = {3},
pages  = {574-87},
year  = {2011},
abstract  = {A high incidence of seizures occurs during the neonatal period when immature networks are hyperexcitable and susceptible to hypersyncrhonous activity. During  development, Œ≥-aminobutyric acid (GABA), the primary inhibitory neurotransmitter  in adults, typically excites neurons due to high expression of the Na+-K+-2Cl‚àí cotransporter (NKCC1). NKCC1 facilitates seizures because it renders GABA activity excitatory through intracellular Cl‚àí accumulation, while blocking NKCC1  with bumetanide suppresses seizures. Bumetanide is currently being tested in clinical trials for treatment of neonatal seizures. By blocking NKCC1 with bumetanide during cortical development, we found a critical period for the development of Œ±-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate synapses. Disruption of GABA signaling during this window resulted in permanent decreases in excitatory synaptic transmission and sensorimotor gating deficits, a common feature in schizophrenia. Our study identifies an essential role for GABA-mediated depolarization in regulating the balance between cortical excitation and inhibition during a critical period and suggests a cautionary approach for using bumetanide in treating neonatal seizures.},
address  = {Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco CA 94143, USA Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco CA 94143, USA},
note  = {Cereb Cortex. 2011 Mar;21(3):574-87. Epub 2010 Jul 12 doi:10.1093/cercor/bhq124.}
}

@Article{2016484,
author  = {Accomasso, L. and Gallina, C. and Turinetto, V. and Giachino, C.},
title  = {Overview.},
journal  = {Stem Cells International},
volume  = {2016},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Accurate and noninvasive stem cell tracking is one of the most important needs in regenerative medicine to determine both stem cell destinations and final differentiation fates, thus allowing a more detailed picture of the mechanisms involved in these therapies. Given the great importance and advances in the field of nanotechnology for stem cell imaging, currently, several nanoparticles have become standardized products and have been undergoing fast commercialization. This review has been intended to summarize the current use of different engineered nanoparticles in stem cell tracking for regenerative medicine purposes, in particular by detailing their main features and exploring their biosafety aspects, the first step for clinical application. Moreover, this review has summarized the advantages and applications of stem cell tracking with nanoparticles in experimental and preclinical studies and investigated present limitations for their employment in the clinical setting.},
address  = {Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, Orbassano, 10043 Turin, Italy Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, Orbassano, 10043 Turin, Italy Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, Orbassano, 10043 Turin, Italy Department of Clinical and Biological Sciences, University of Turin, Regione Gonzole 10, Orbassano, 10043 Turin, Italy},
note  = {Stem Cells Int. 2016;2016:. Epub 2015 Dec 29 doi:10.1155/2016/7920358.}
}

@Article{2015485,
author  = {Montgomery, K. and Yeh, A. and Ho, J. and Tsao, V. and Iyer, S. and Grosenick, L. and Ferenczi, E. and Tanabe, Y. and Deisseroth, K. and Delp, S. and Poon, A.},
title  = {circuits in mice.},
journal  = {Nature methods},
volume  = {12},
number  = {10},
pages  = {969-74},
year  = {2015},
abstract  = {To enable sophisticated optogenetic manipulation of neural circuits throughout the nervous system with limited disruption of animal behavior, light-delivery systems beyond fiber optic tethering and large, head-mounted wireless receivers are desirable. We report the development of an easy-to-construct, implantable wireless optogenetic device. Our smallest version (20 mg, 10 mm3) is two orders of magnitude smaller than previously reported wireless optogenetic systems, allowing the entire device to be implanted subcutaneously. With a radio-frequency (RF) power source and controller, this implant produces sufficient light power for optogenetic stimulation with minimal tissue heating (<1 ¬∞C). We show how three adaptations of the implant allow for untethered optogenetic control throughout the nervous system (brain, spinal cord and peripheral nerve endings) of behaving mice. This technology opens the door for optogenetic experiments in which animals are able to behave naturally with optogenetic manipulation of both  central and peripheral targets.},
address  = {Department of Bioengineering, Stanford University, Stanford, California, USA Department of Electrical Engineering, Stanford University, Stanford, California,  USA Department of Electrical Engineering, Stanford University, Stanford, California,  USA Department of Electrical Engineering, Stanford University, Stanford, California,  USA Department of Bioengineering, Stanford University, Stanford, California, USA Department of Bioengineering, Stanford University, Stanford, California, USA Department of Bioengineering, Stanford University, Stanford, California, USA Department of Electrical Engineering, Stanford University, Stanford, California,  USA Department of Bioengineering, Stanford University, Stanford, California, USA Department of Bioengineering, Stanford University, Stanford, California, USA Department of Electrical Engineering, Stanford University, Stanford, California,  USA},
note  = {Nat Methods. 2015 Oct;12(10):969-74. Epub 2015 Aug 17 doi:10.1038/nmeth.3536.}
}

@Article{2001486,
author  = {REVESZ, T.},
title  = {Normal and pathologic development of the human brain and spinal cord.},
journal  = {Journal of Neurology, Neurosurgery, and Psychiatry},
volume  = {70},
number  = {5},
pages  = {709},
year  = {2001},
abstract  = {},
address  = {},
note  = {J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709a.}
}

@Article{2009487,
author  = {Reichman, J.},
title  = {LEAD OR FOLLOW?},
journal  = {Houston law review / University of Houston},
volume  = {46},
number  = {4},
pages  = {1115-85},
year  = {2009},
abstract  = {Developing countries, particularly the BRIC countries of Brazil, Russia, India, and China, should accommodate their national systems of innovation to the worldwide intellectual property (IP) regime emerging after the adoption of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) in a way that maximizes global economic welfare in the foreseeable future. As many developed countries‚Äô experience demonstrates, badly configured, over-protectionist IP regimes stifle innovation by making inputs to future innovation too costly and too cumbersome to sustain over time. More carefully considered IP regimes, however, are an important way to protect innovative small- and medium-sized firms from predatory, larger competitors. The challenge is for emerging economies to capture the benefits of IP without importing the serious problems that developed countries have themselves failed to solve. Emerging economies can attain this balance by pursuing a policy of counter-harmonization in which they take advantage of existing exemptions in international agreements governing IP to establish regional, local, and international practices that promote more innovative, flexible uses of IP. Such practices include a research exemption for experimental uses of IP, government imposed nonexclusive licensing, anti-blocking provisions, an essential facilities doctrine, and compulsory licenses. Additional tools include an ex ante regime of compensatory liability rules for small scale innovation and sensible exceptions, particularly for science as well as general fair use provisions, to the exclusive rights of domestic copyright laws. Emerging economies will have to overcome strong economic pressure to accept more restrictive IP regimes as part of free trade agreements as well as a lack of technical expertise and internal government coordination. However, emerging economies have already accrued enough experience to be aware of the strengths and weaknesses of various IP schemes and their own ability to tailor IP to local needs. Developing countries will need to take advantage of that experience and defend innovative practices at international dispute resolution forums. Through creative, determined efforts, the developing countries can avoid other countries‚Äô IP excesses while establishing the kind of IP norms that address the real conditions of creativity and innovation in today‚Äôs digitally empowered universe of scientific discourse.},
address  = {Bunyan S. Womble Professor of Law, Duke University School of Law, Durham, N.C},
note  = {Houst Law Rev. 2009 Jan 31;46(4):1115-85.}
}

@Article{2015488,
author  = {Sato, S. and Bergmann, T. and Borich, M.},
title  = {electroencephalography to characterize cortical activity in stroke.},
journal  = {Frontiers in Human Neuroscience},
volume  = {9},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Stroke is the leading cause of disability in the United States. Despite the high  incidence and mortality of stroke, sensitive and specific brain-based biomarkers  predicting persisting disabilities are lacking. Both neuroimaging techniques like electroencephalography (EEG) and non-invasive brain stimulation (NIBS) techniques such as transcranial magnetic stimulation (TMS) have proven useful in predicting  prognosis, recovery trajectories and response to rehabilitation in individuals with stroke. We propose, however, that additional synergetic effects can be achieved by simultaneously combining both approaches. Combined TMS-EEG is able to activate discrete cortical regions and directly assess local cortical reactivity  and effective connectivity within the network independent of the integrity of descending fiber pathways and also outside the motor system. Studying cortical reactivity and connectivity in patients with stroke TMS-EEG may identify salient  neural mechanisms underlying motor disabilities and lead to novel biomarkers of stroke pathophysiology which can then be used to assess, monitor, and refine rehabilitation approaches for individuals with significant disability to improve  outcomes and quality of life after stroke.},
address  = {Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of MedicineAtlanta, GA, USA Institute of Psychology, Christian-Albrechts University KielKiel, Germany Division of Physical Therapy, Department of Rehabilitation Medicine, Emory University School of MedicineAtlanta, GA, USA},
note  = {Front Hum Neurosci. 2015 May 05;9:. doi:10.3389/fnhum.2015.00250.}
}

@Article{2016489,
author  = {Nagy, D. and Stoiljkovic, M. and Menniti, F. and Haj√≥s, M.},
title  = {Gamma Synchrony: Relevance to Rapid-Onset Antidepressant Efficacy.},
journal  = {Neuropsychopharmacology},
volume  = {41},
number  = {6},
pages  = {1486-94},
year  = {2016},
abstract  = {Ketamine, a pan-NMDA receptor channel blocker, and CP-101,606, an NR2B-selective  negative allosteric modulator, have antidepressant effects in humans that develop rapidly after the drugs are cleared from the body. It has been proposed that the  antidepressant effect of ketamine results from delayed synaptic potentiation. To  further investigate this hypothesis and potential mechanistic underpinnings we compared the effects of ketamine and CP-101,606 on neurophysiological biomarkers  in rats immediately after drug administration and after the drugs had been eliminated. Local field and auditory-evoked potentials (AEPs) were recorded from  primary auditory cortex and hippocampus in freely moving rats. Effects of different doses of ketamine or CP-101,606 were evaluated on amplitude of AEPs, auditory gating, and absolute power of delta and gamma oscillations 5‚Äì30‚Äâmin (drug-on) and 5‚Äì6‚Äâh (drug-off) after systemic administration. Both ketamine and CP-101,606 significantly enhanced AEPs in cortex and hippocampus in the drug-off  phase. In contrast, ketamine but not CP-101,606 disrupted auditory gating and increased gamma-band power during the drug-on period. Although both drugs affected delta power, these changes did not correlate with increase in AEPs in the drug-off phase. Our findings show that both ketamine and CP-101,606 augment AEPs after drug elimination, consistent with synaptic potentiation as a mechanism for antidepressant efficacy. However, these drugs had different acute effects on  neurophysiological parameters. These results have implications for understanding  the underlying mechanisms for the rapid-onset antidepressant effects of NMDA receptor inhibition and for the use of electrophysiological measures as translatable biomarkers.},
address  = {Laboratory of Translational Neuropharmacology, Section of Comparative Medicine, Yale School of Medicine, New Haven, CT, USA Laboratory of Translational Neuropharmacology, Section of Comparative Medicine, Yale School of Medicine, New Haven, CT, USA Mnemosyne Pharmaceuticals Inc., Providence, RI, USA Laboratory of Translational Neuropharmacology, Section of Comparative Medicine, Yale School of Medicine, New Haven, CT, USA},
note  = {doi:10.1038/npp.2015.298.}
}

@Article{2014490,
author  = {Gray, R. and Ho, C. and Spence, C.},
title  = {Does the Warning Need to Be Linked to the Collision Event?},
journal  = {PLoS ONE},
volume  = {9},
number  = {1},
pages  = {},
year  = {2014},
abstract  = {Recent research demonstrates that auditory and vibrotactile forward collision warnings presenting a motion signal (e.g., looming or apparent motion across the  body surface) can facilitate speeded braking reaction times (BRTs). The purpose of the present study was to expand on this work by directly comparing warning signals in which the motion conveyed was constant across all collision events with signals in which the speed of motion was dependent on the closing velocity (CV). Two experiments were conducted using a simulated car-following task and BRTs were measured. In Experiment 1, increasing intensity (looming) vibrotactile  signals were presented from a single tactor attached to the driver's waist. When  the increase in intensity was CV-linked, BRTs were significantly faster as compared to a no-warning condition, however, they were not significantly different from constant intensity and CV-independent looming warnings. In Experiment 2, a vertical array of three tactors was used to create motion either  towards (upwards) or away (downwards) from the driver's head. When the warning signal presented upwards motion that was CV-linked, BRTs were significantly faster than all other warning types. Downwards warnings led to a significantly higher number of brake activations in false alarm situations as compared to upwards moving warnings. The effectiveness of dynamic tactile collision warnings  would therefore appear to depend on both the link between the warning and collision event and on the directionality of the warning signal.},
address  = {School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham,  Birmingham, United Kingdom Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom Department of Experimental Psychology, University of Oxford, Oxford, United Kingdom},
note  = {PLoS One. 2014 Jan 27;9(1):. doi:10.1371/journal.pone.0087070.}
}

@Article{2015491,
author  = {Depp, C. and Ceglowski, J. and Wang, V. and Yaghouti, F. and Mausbach, B. and Thompson, W. and Granholm, E.},
title  = {Randomized Controlled Trial.},
journal  = {Journal of affective disorders},
volume  = {174},
number  = {},
pages  = {23-30},
year  = {2015},
abstract  = {Background: Psychosocial interventions for bipolar disorder are frequently unavailable and resource intensive. Mobile technology may improve access to evidence-based interventions and may increase their efficacy. We evaluated the feasibility, acceptability and efficacy of an augmentative mobile ecological momentary intervention targeting self-management of mood symptoms. Methods: This  was a randomized single-blind controlled trial with 82 consumers diagnosed with bipolar disorder who completed a four-session psychoeducational intervention and  were assigned to 10 weeks of either: 1) mobile device delivered interactive intervention linking patient-reported mood states with personalized self-management strategies, or 2) paper-and-pencil mood monitoring. Participants  were assessed at baseline, 6 weeks (mid-point), 12 weeks (post-treatment), and 24 weeks (follow up) with clinician-rated depression and mania scales and self-reported functioning. Results: Retention at 12 weeks was 93% and both conditions were associated with high satisfaction. Compared to the paper-and-pencil condition, participants in the augmented mobile intervention condition showed significantly greater reductions in depressive symptoms at 6 and 12 weeks (Cohen's d for both were d=0.48). However, these effects were not maintained at 24-week follow up. Conditions did not differ significantly in the impact on manic symptoms or functional impairment. Limitations: This was not a definitive trial and was not powered to detect moderators and mediators. Conclusions: Automated mobile-phone intervention is feasible, acceptable, and may enhance the impact of brief psychoeducation on depressive symptoms in bipolar disorder. However, sustainment of gains from symptom self-management mobile interventions, once stopped, may be limited.},
address  = {Department of Psychiatry, UC San Diego Department of Psychiatry, UC San Diego Department of Psychiatry, UC San Diego Department of Psychiatry, UC San Diego Department of Psychiatry, UC San Diego Department of Psychiatry, UC San Diego Department of Psychiatry, UC San Diego},
note  = {doi:10.1016/j.jad.2014.10.053.}
}

@Article{2017492,
author  = {Wang, H. and Trocm√©-Thibierge, C. and Stucky, A. and Shah, S. and Kvasic, J. and Khan, A. and Morain, P. and Guignot, I. and Bouguen, E. and Deschet, K. and Pueyo, M. and Mocaer, E. and Ousset, P. and Vellas, B. and Kiyasova, V.},
title  = {pathogenesis.},
journal  = {Alzheimer's Research & Therapy},
volume  = {9},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Background: The apolipoprotein E Œµ4 (APOE4) genotype is a prominent late-onset Alzheimer‚Äôs disease (AD) risk factor. ApoE4 disrupts memory function in rodents and may contribute to both plaque and tangle formation. Methods: Coimmunoprecipitation and Western blot detection were used to determine: 1) the effects of select fragments from the apoE low-density lipoprotein (LDL) binding domain and recombinant apoE subtypes on amyloid beta (AŒ≤)42-Œ±7 nicotinic acetylcholine receptor (Œ±7nAChR) interaction and tau phosphorylation in rodent brain synaptosomes; and 2) the level of AŒ≤42-Œ±7nAChR complexes in matched controls and patients with mild cognitive impairment (MCI) and dementia due to AD with known APOE genotypes. Results: In an ex vivo study using rodent synaptosomes, apoE141‚Äì148 of the apoE promotes AŒ≤42-Œ±7nAChR association and AŒ≤42-induced Œ±7nAChR-dependent tau phosphorylation. In a single-blind study, we examined lymphocytes isolated from control subjects, patients with MCI and dementia due to AD with known APOE genotypes, sampled at two time points (1 year  apart). APOE Œµ4 genotype was closely correlated with heightened AŒ≤42-Œ±7nAChR complex levels and with blunted exogenous AŒ≤42 effects in lymphocytes derived from AD and MCI due to AD cases. Similarly, plasma from APOE Œµ4 carriers enhanced the AŒ≤42-induced AŒ≤42-Œ±7nAChR association in rat cortical synaptosomes. The progression of cognitive decline in APOE Œµ4 carriers correlated with higher levels of AŒ≤42-Œ±7nAChR complexes in lymphocytes and greater enhancement by their  plasma of AŒ≤42-induced AŒ≤42-Œ±7nAChR association in rat cortical synaptosomes. Conclusions: Our data suggest that increased lymphocyte AŒ≤42-Œ±7nAChR-like complexes may indicate the presence of AD pathology especially in APOE Œµ4 carriers. We show that apoE, especially apoE4, promotes AŒ≤42-Œ±7nAChR interaction  and AŒ≤42-induced Œ±7nAChR-dependent tau phosphorylation via its apoE141‚Äì148 domain. These apoE-mediated effects may contribute to the APOE Œµ4-driven neurodysfunction and AD pathologies.},
address  = {0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA 0000 0004 1936 8753grid.137628.9Department of Physiology, Pharmacology and Neuroscience, CUNY School of Medicine, 160 Convent Avenue, New York, NY 10031 USA 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France 0000 0001 1457 2980grid.411175.7Alzheimer‚Äôs Disease Research and Clinical Center, Inserm U1027, Toulouse University Hospital, Toulouse, France 0000 0001 1457 2980grid.411175.7Alzheimer‚Äôs Disease Research and Clinical Center, Inserm U1027, Toulouse University Hospital, Toulouse, France 0000 0001 2163 3905grid.418301.fInstitut de Recherches Internationales Servier, 50 Rue Carnot, 92284 Suresnes, France},
note  = {Alzheimers Res Ther. 2017 Jul 27;9:. doi:10.1186/s13195-017-0280-8.}
}

@Article{2016493,
author  = {Bove, G. and Harris, M. and Zhao, H. and Barbe, M.},
title  = {extremity overuse injury.},
journal  = {Journal of the neurological sciences},
volume  = {361},
number  = {},
pages  = {168-80},
year  = {2016},
abstract  = {Key clinical features of carpal tunnel syndrome and other types of cumulative trauma disorders of the hand and wrist include pain and functional disabilities.  Mechanistic details remain under investigation but may involve tissue inflammation and/or fibrosis. We examined the effectiveness of modeled manual therapy (MMT) as a treatment for sensorimotor behavior declines and increased fibrogenic processes occurring in forearm tissues of rats performing an high repetition high force (HRHF) reaching and grasping task for 12 weeks. Young adult, female rats were examined: food restricted control rats (FRC, n=12); rats  that were trained for 6 weeks before performing the HRHF task for 12 weeks with no treatment (HRHF-CON, n=11); and HRHF task rats received modeled manual therapy (HRHF-MMT, n=5) for 5 days/week for the duration of the 12-week of task. Rats receiving the MMT expressed fewer discomfort-related behaviors, and performed progressively better in the HRHF task. Grip strength, while decreased after training, improved following MMT. Fibrotic nerve and connective tissue changes (increased collagen and TGF-Œ≤1 deposition) present in 12-week HRHF-CON rats were  significantly decreased in 12-week HRHF-MMT rats. These observations support the  investigation of manual therapy as a preventative for repetitive motion disorders.},
address  = {Department of Biomedical Sciences, University of New England College of Osteopathic Medicine, 11 Hills Beach Rd, Biddeford, ME 04005 Department of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA, USA Department of Clinical Sciences and Biostatistical Consulting Center, Temple University School of Medicine, Philadelphia, PA, USA Department of Anatomy and Cell Biology, Temple University School of Medicine, Philadelphia, PA, USA},
note  = {doi:10.1016/j.jns.2015.12.029.}
}

@Article{2013494,
author  = {Collinger, J. and Foldes, S. and Bruns, T. and Wodlinger, B. and Gaunt, R. and Weber, D.},
title  = {Neuroprosthetic technology for individuals with spinal cord injury.},
journal  = {The Journal of Spinal Cord Medicine},
volume  = {36},
number  = {4},
pages  = {258-72},
year  = {2013},
abstract  = {Context: Spinal cord injury (SCI) results in a loss of function and sensation below the level of the lesion. Neuroprosthetic technology has been developed to help restore motor and autonomic functions as well as to provide sensory feedback. Findings: This paper provides an overview of neuroprosthetic technology that aims to address the priorities for functional restoration as defined by individuals with SCI. We describe neuroprostheses that are in various stages of preclinical development, clinical testing, and commercialization including functional electrical stimulators, epidural and intraspinal microstimulation, bladder neuroprosthesis, and cortical stimulation for restoring sensation. We also discuss neural recording technologies that may provide command or feedback signals for neuroprosthetic devices. Conclusion/clinical relevance: Neuroprostheses have begun to address the priorities of individuals with SCI, although there remains room for improvement. In addition to continued technological improvements, closing the loop between the technology and the user  may help provide intuitive device control with high levels of performance.},
address  = {Department of Veterans Affairs, Pittsburgh, PA, USA; Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; and Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA Department of Veterans Affairs, Pittsburgh, PA, USA; Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; and Center for the Neural Basis of Cognition, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; and Center for the Neural Basis of Cognition, Pittsburgh, PA, USA Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; and Department of Bioengineering, University of Pittsburgh,  Pittsburgh, PA, USA Department of Veterans Affairs, Pittsburgh, PA, USA; Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA, USA; Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA; and  Center for the Neural Basis of Cognition, Pittsburgh, PA, USA},
note  = {J Spinal Cord Med. 2013 Jul;36(4):258-72. doi:10.1179/2045772313Y.0000000128.}
}

@Article{2012495,
author  = {Schenk, D. and Basi, G. and Pangalos, M.},
title  = {Treatment Strategies Targeting Amyloid Œ≤-Protein.},
journal  = {Cold Spring Harbor Perspectives in Medicine},
volume  = {2},
number  = {9},
pages  = {},
year  = {2012},
abstract  = {With the advent of the key discovery in the mid-1980s that the amyloid Œ≤-protein  (AŒ≤) is the core constituent of the amyloid plaque pathology found in Alzheimer disease (AD), an intensive effort has been underway to attempt to mitigate its role in the hope of treating the disease. This effort fully matured when it was clarified that the AŒ≤ is a normal product of cleavage of the amyloid precursor protein, and well-defined proteases for this process were identified. Further therapeutic options have been developed around the concept of anti-AŒ≤ aggregation inhibitors and the surprising finding that immunization with AŒ≤ itself leads to reduction of pathology in animal models of the disease. Here we review the progress in this field toward the goal of targeting AŒ≤ for treatment and prevention of AD and identify some of the major challenges for the future of this area of medicine.},
address  = {Netotope Biosciences Inc., San Francisco, California 94080 Netotope Biosciences Inc., San Francisco, California 94080 AstraZeneca, Mereside, Alderley Park SK10 4TG, United Kingdom},
note  = {Cold Spring Harb Perspect Med. 2012 Sep;2(9):. doi:10.1101/cshperspect.a006387.}
}

@Article{2014496,
author  = {Martin, C.},
title  = {understanding of human neuroimaging signals.},
journal  = {Frontiers in Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Many of the major advances in our understanding of how functional brain imaging signals relate to neuronal activity over the previous two decades have arisen from physiological research studies involving experimental animal models. This approach has been successful partly because it provides opportunities to measure  both the hemodynamic changes that underpin many human functional brain imaging techniques and the neuronal activity about which we wish to make inferences. Although research into the coupling of neuronal and hemodynamic responses using animal models has provided a general validation of the correspondence of neuroimaging signals to specific types of neuronal activity, it is also highlighting the key complexities and uncertainties in estimating neural signals  from hemodynamic markers. This review will detail how research in animal models is contributing to our rapidly evolving understanding of what human neuroimaging  techniques tell us about neuronal activity. It will highlight emerging issues in  the interpretation of neuroimaging data that arise from in vivo research studies, for example spatial and temporal constraints to neuroimaging signal interpretation, or the effects of disease and modulatory neurotransmitters upon neurovascular coupling. We will also give critical consideration to the limitations and possible complexities of translating data acquired in the typical animals models used in this area to the arena of human fMRI. These include the commonplace use of anesthesia in animal research studies and the fact that many neuropsychological questions that are being actively explored in humans have limited homologs within current animal models for neuroimaging research. Finally  we will highlighting approaches, both in experimental animals models (e.g. imaging in conscious, behaving animals) and human studies (e.g. combined fMRI-EEG), that mitigate against these challenges.},
address  = {},
note  = {Front Neurosci. 2014 Aug 19;8:. doi:10.3389/fnins.2014.00211.}
}

@Article{2008497,
author  = {},
title  = {Purines 2008 Meeting 29 June ‚Äì 2 July 2008, Copenhagen, Denmark.},
journal  = {Purinergic Signalling},
volume  = {4},
number  = {Suppl 1},
pages  = {1-210},
year  = {2008},
abstract  = {},
address  = {},
note  = {doi:10.1007/s11302-008-9116-0.}
}

@Article{2015498,
author  = {Harrington, I. and Grisham, W. and Brasier, D. and Gallagher, S. and Gizerian, S. and Gordon, R. and Hagenauer, M. and Linden, M. and Lom, B. and Olivo, R. and Sandstrom, N. and Stough, S. and Vilinsky, I. and Wiest, M.},
title  = {An Instructor‚Äôs Guide to (Some of) the Most Amazing Papers in Neuroscience.},
journal  = {Journal of Undergraduate Neuroscience Education},
volume  = {14},
number  = {1},
pages  = {R3-R14},
year  = {2015},
abstract  = {Although textbooks are still assigned in many undergraduate science courses, it is now not uncommon, even in some of the earliest courses in the curriculum, to supplement texts with primary source readings from the scientific literature. Not only does reading these articles help students develop an understanding of specific course content, it also helps foster an ability to engage with the discipline the way its practitioners do. One challenge with this approach, however, is that it can be difficult for instructors to select appropriate readings on topics outside of their areas of expertise as would be required in a  survey course, for example. Here we present a subset of the papers that were offered in response to a request for the ‚Äúmost amazing papers in neuroscience‚Ä? that appeared on the listserv of the Faculty for Undergraduate Neuroscience (FUN). Each contributor was subsequently asked to describe briefly the content of their recommended papers, their pedagogical value, and the audiences for which these papers are best suited. Our goal is to provide readers with sufficient information to decide whether such articles might be useful in their own classes. It is not our intention that any article within this collection will provide the  final word on an area of investigation, nor that this collection will provide the final word for the discipline as a whole. Rather, this article is a collection of papers that have proven themselves valuable in the hands of these particular educators. Indeed, it is our hope that this collection represents the inaugural offering of what will become a regular feature in this journal, so that we can continue to benefit from the diverse expertise of the FUN community.},
address  = {Augustana College, Rock Island, IL 61201; University of California, Los Angeles, Los Angeles CA 90095; Carnegie Mellon University, Pittsburgh, PA 15213; Millersville University, Millersville, PA 17551; Washington State University, Pullman, WA 99164; Augustana College, Rock Island, IL 61201; University of Michigan, Ann Arbor, MI 48106; Brown University, Providence, RI 02912; Davidson College, Davidson, NC 28035; Smith College, Northampton, MA 01063; Williams College, Williamstown, MA 01267; Augustana College, Rock Island, IL 61201; University of Cincinnati, Cincinnati, OH 45221; Wellesley College, Wellesley, MA 02481.},
note  = {J Undergrad Neurosci Educ. 2015 Oct 15;14(1):R3-R14.}
}

@Article{2015499,
author  = {D‚ÄôSouza, S.},
title  = {Aneurysmal Subarachnoid Hemorrhage.},
journal  = {Journal of Neurosurgical Anesthesiology},
volume  = {27},
number  = {3},
pages  = {222-40},
year  = {2015},
abstract  = {Aneurysmal subarachnoid hemorrhage (SAH) is a worldwide health burden with high fatality and permanent disability rates. The overall prognosis depends on the volume of the initial bleed, rebleeding, and degree of delayed cerebral ischemia  (DCI). Cardiac manifestations and neurogenic pulmonary edema indicate the severity of SAH. The International Subarachnoid Aneurysm Trial (ISAT) reported a  favorable neurological outcome with the endovascular coiling procedure compared with surgical clipping at the end of 1 year. The ISAT trial recruits were primarily neurologically good grade patients with smaller anterior circulation aneurysms, and therefore the results cannot be reliably extrapolated to larger aneurysms, posterior circulation aneurysms, patients presenting with complex aneurysm morphology, and poor neurological grades. The role of hypothermia is not proven to be neuroprotective according to a large randomized controlled trial, Intraoperative Hypothermia for Aneurysms Surgery Trial (IHAST II), which recruited patients with good neurological grades. Patients in this trial were subjected to slow cooling and inadequate cooling time and were rewarmed rapidly.  This methodology would have reduced the beneficial effects of hypothermia. Adenosine is found to be beneficial for transient induced hypotension in 2 retrospective analyses, without increasing the risk for cardiac and neurological  morbidity. The neurological benefit of pharmacological neuroprotection and neuromonitoring is not proven in patients undergoing clipping of aneurysms. DCI is an important cause of morbidity and mortality following SAH, and the pathophysiology is likely multifactorial and not yet understood. At present, oral nimodipine has an established role in the management of DCI, along with maintenance of euvolemia and induced hypertension. Following SAH, hypernatremia,  although less common than hyponatremia, is a predictor of poor neurological outcome.},
address  = {},
note  = {doi:10.1097/ANA.0000000000000130.}
}

@Article{2012500,
author  = {Blatt, G.},
title  = {The Neuropathology of Autism.},
journal  = {Scientifica},
volume  = {2012},
number  = {},
pages  = {},
year  = {2012},
abstract  = {Autism is a behaviorally defined neurodevelopmental disorder that affects over 1% of new births in the United States and about 2% of boys. The etiologies are unknown and they are genetically complex. There may be epigenetic effects, environmental influences, and other factors that contribute to the mechanisms and affected neural pathway(s). The underlying neuropathology of the disorder has been evolving in the literature to include specific brain areas in the cerebellum, limbic system, and cortex. Part(s) of structures appear to be affected most rather than the entire structure, for example, select nuclei of the amygdala, the fusiform face area, and so forth. Altered cortical organization characterized by more frequent and narrower minicolumns and early overgrowth of the frontal portion of the brain, affects connectivity. Abnormalities include cytoarchitectonic laminar differences, excess white matter neurons, decreased numbers of GABAergic cerebellar Purkinje cells, and other events that can be traced developmentally and cause anomalies in circuitry. Problems with neurotransmission are evident by recent receptor and binding site studies especially in the inhibitory GABA system likely contributing to an imbalance of excitatory/inhibitory transmission. As postmortem findings are related to core behavior symptoms, and technology improves, researchers are gaining a much better perspective of contributing factors to the disorder.},
address  = {Department of Anatomy & Neurobiology, School of Medicine, Boston University, 72 East Concord Street L 1004, Boston, MA 02118, USA},
note  = {Scientifica (Cairo). 2012;2012:. Epub 2012 Dec 19 doi:10.6064/2012/703675.}
}

@Article{2002501,
author  = {Kantarci, K. and Smith, G. and Ivnik, R. and Petersen, R. and Boeve, B. and Knopman, D. and Tangalos, E. and Jack, C.},
title  = {Genotype in Normal Aging, Mild Cognitive Impairment and Alzheimer‚Äôs Disease.},
journal  = {Journal of the International Neuropsychological Society : JINS},
volume  = {8},
number  = {7},
pages  = {934-42},
year  = {2002},
abstract  = {The aim of this study was to examine the associations of Apolipoprotein E (APOE)  genotype, metabolic changes in the posterior cingulate detected by 1H magnetic resonance spectroscopy (MRS), and neuropsychologic measures of memory and cognition both in normally aging elderly, and in patients with mild cognitive impairment (MCI) and AD. We studied 67 controls, 18 MCI and 33 AD patients. We used the Dementia Rating Scale total score (DRSTOT) as a measure of general cognitive function and the total learning from the Auditory Verbal Learning Test  (AVTOT) as a measure of memory performance. No differences were noted on 1H MRS metabolite ratios or cognitive measures across APOE genotype within control and patient groups.. In controls, age was a significant predictor of both cognitive test scores, and NAA/Cr was a univariate associate of DRSTOT. All three 1H MRS metabolite ratios, N-acetylaspartate (NAA)/Creatine (Cr), myoinositol (MI)/Cr, and NAA/MI, were univariate associates of AVTOT and DRSTOT scores in the combined MCI and AD group. In stepwise regression analyses in the combined patient group only NAA/MI entered the model. These data suggest NAA/Cr could be a modest predictor of general cognitive function in both healthy elderly and impaired patients, while MI/Cr is a more specific marker for neuropsychologic dysfunction  associated with neurodegenerative disease. Among 1H MRS measurements, the NAA/MI  ratio maybe the most efficient predictor of memory and cognitive function in patients with MCI and AD.},
address  = {Department of Diagnostic Radiology Department of Psychiatry and Psychology Department of Psychiatry and Psychology Alzheimer‚Äôs Disease Research Center Alzheimer‚Äôs Disease Research Center Alzheimer‚Äôs Disease Research Center Alzheimer‚Äôs Disease Research Center Department of Diagnostic Radiology},
note  = {J Int Neuropsychol Soc. 2002 Nov;8(7):934-42.}
}

@Article{2015502,
author  = {Sayin, U. and Hutchinson, E. and Meyerand, M. and Sutula, T.},
title  = {evidence for a hippocampal critical period influencing plasticity in adulthood.},
journal  = {Neuroscience},
volume  = {288},
number  = {},
pages  = {120-34},
year  = {2015},
abstract  = {Neural activity promotes circuit formation in developing systems and during critical periods permanently modifies circuit organization and functional properties. These observations suggest that excessive neural activity, as occurs  during seizures, might influence developing neural circuitry with long-term outcomes that depend on age at the time of seizures. We systematically examined long-term structural and functional consequences of seizures induced in rats by kainic acid, pentylenetetrazol, and hyperthermia across postnatal ages from birth through postnatal day 90 in adulthood (P90). Magnetic resonance imaging (MRI), diffusion tensor imaging (DTI), and electrophysiological methods at ‚â•P95 following seizures induced from P1 to P90 demonstrated consistent patterns of gross atrophy, microstructural abnormalities in the corpus callosum and hippocampus, and functional alterations in hippocampal circuitry at ‚â•P95 that were independent of the method of seizure induction and varied systematically as  a function of age at the time of seizures. Three distinct epochs were observed in which seizures resulted in distinct long-term structural and functional outcomes  at ‚â•P95. Seizures prior to P20 resulted in DTI abnormalities in corpus callosum and hippocampus in the absence of gross cerebral atrophy, and increased paired pulse inhibition (PPI) in the dentate gyrus at ‚â•P95. Seizures after P30 induced a different pattern of DTI abnormalities in the fimbria and hippocampus accompanied by gross cerebral atrophy with increases in lateral ventricular volume, as well as increased PPI in the dentate gyrus at ‚â•P95. In contrast, seizures between P20-P30 did not result in cerebral atrophy or significant imaging abnormalities in the hippocampus or white matter, but irreversibly decreased PPI in the dentate gyrus compared to normal adult controls. These age-specific long-term structural  and functional outcomes identify P20-P30 as a potential critical period in hippocampal development defined by distinctive long-term structural and functional properties in adult hippocampal circuitry, including loss of capacity  for seizure-induced plasticity in adulthood that could influence epileptogenesis  and other hippocampal ‚Äì dependent behaviors and functional properties.},
address  = {Department of Neurology, University of Wisconsin UW Medical Foundation Centennial Building 1685 Highland Ave Madison, WI 53705, USA Department of Neurology, University of Wisconsin UW Medical Foundation Centennial Building 1685 Highland Ave Madison, WI 53705, USA Department of Medical Physics, University of Wisconsin Wisconsin Institutes Medical Research 1111 Highland Avenue Madison, WI 53705, USA Department of Neurology, University of Wisconsin UW Medical Foundation Centennial Building 1685 Highland Ave Madison, WI 53705, USA},
note  = {doi:10.1016/j.neuroscience.2014.12.017.}
}

@Article{2014503,
author  = {Elfar, J. and Stanbury, S. and Menorca, R. and Reed, J.},
title  = {Composite Bone Models in Orthopaedic Surgery Research and Education.},
journal  = {The Journal of the American Academy of Orthopaedic Surgeons},
volume  = {22},
number  = {2},
pages  = {111-20},
year  = {2014},
abstract  = {Composite bone models are increasingly used in orthopaedic biomechanics research  and surgical education‚Äîapplications that traditionally relied on cadavers. Cadaver bones are suboptimal for myriad reasons, including issues of cost, availability, preservation, and inconsistency between specimens. Further, cadaver samples disproportionately represent the elderly, whose bone quality may not be representative of the greater orthopaedic population. The current fourth-generation composite bone models provide an accurate reproduction of the biomechanical properties of human bone when placed under bending, axial, and torsional loads. The combination of glass fiber and epoxy resin components into a single phase has enabled manufacturing by injection molding. The high anatomic fidelity of the cadaver-based molds and negligible shrinkage properties of the epoxy resin results in a process that allows for excellent definition of anatomic detail in the cortical wall and optimized consistency of features between models. Recent biomechanical studies of composites have validated their use as a suitable substitute for cadaver specimens.},
address  = {},
note  = {J Am Acad Orthop Surg. 2014 Feb;22(2):111-20. doi:10.5435/JAAOS-22-02-111.}
}

@Article{2014504,
author  = {Vurro, M. and Crowell, A. and Pezaris, J.},
title  = {sighted humans.},
journal  = {Frontiers in Human Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {The psychophysics of reading with artificial sight has received increasing attention as visual prostheses are becoming a real possibility to restore useful  function to the blind through the coarse, pseudo-pixelized vision they generate.  Studies to date have focused on simulating retinal and cortical prostheses; here  we extend that work to report on thalamic designs. This study examined the reading performance of normally sighted human subjects using a simulation of three thalamic visual prostheses that varied in phosphene count, to help understand the level of functional ability afforded by thalamic designs in a task of daily living. Reading accuracy, reading speed, and reading acuity of 20 subjects were measured as a function of letter size, using a task based on the MNREAD chart. Results showed that fluid reading was feasible with appropriate combinations of letter size and phosphene count, and performance degraded smoothly as font size was decreased, with an approximate doubling of phosphene count resulting in an increase of 0.2 logMAR in acuity. Results here were consistent with previous results from our laboratory. Results were also consistent with those from the literature, despite using naive subjects who were  not trained on the simulator, in contrast to other reports.},
address  = {},
note  = {Front Hum Neurosci. 2014 Nov 04;8:. doi:10.3389/fnhum.2014.00816.}
}

@Article{2015505,
author  = {Parker, J. and Angarita-Jaimes, N. and Abe, M. and Towers, C. and Towers, D. and McCall, P.},
title  = {reveals rapid decisive impact after brief localised net contact.},
journal  = {Scientific Reports},
volume  = {5},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Long-lasting insecticidal bed nets (LLINs) protect humans from malaria transmission and are fundamental to malaria control worldwide, but little is known of how mosquitoes interact with nets. Elucidating LLIN mode of action is essential to maintain or improve efficacy, an urgent need as emerging insecticide resistance threatens their future. Tracking multiple free-flying Anopheles gambiae responding to human-occupied bed nets in a novel large-scale system, we characterised key behaviours and events. Four behavioural modes with different levels of net contact were defined: swooping, visiting, bouncing and resting. Approximately 75% of all activity occurred at the bed net roof where multiple brief contacts were focussed above the occupant‚Äôs torso. Total flight and net contact times were lower at LLINs than untreated nets but the essential character of the response was unaltered. LLINs did not repel mosquitoes but impacted rapidly: LLIN contact of less than 1‚Äâminute per mosquito during the first ten minutes reduced subsequent activity; after thirty minutes, activity at LLINs was  negligible. Velocity measurements showed that mosquitoes detected nets, including unbaited untreated nets, prior to contact. This is the most complete characterisation of mosquito-LLIN interactions to date, and reveals many aspects  of LLIN mode of action, important for developing the next generation of LLINs.},
address  = {Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK Optical Engineering Group, School of Engineering, University of Warwick, Coventry, CV4 7AL, UK Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK Optical Engineering Group, School of Engineering, University of Warwick, Coventry, CV4 7AL, UK Optical Engineering Group, School of Engineering, University of Warwick, Coventry, CV4 7AL, UK Vector Biology Department, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, UK},
note  = {Sci Rep. 2015 Sep 01;5:. doi:10.1038/srep13392.}
}

@Article{2016506,
author  = {McNamee, J. and Bellier, P. and Konkle, A. and Thomas, R. and Wasoontarajaroen, S. and Lemay, E. and Gajda, G.},
title  = {radiofrequency fields.},
journal  = {International Journal of Radiation Biology},
volume  = {92},
number  = {6},
pages  = {338-50},
year  = {2016},
abstract  = {Purpose: To assess 1.9‚ÄâGHz radiofrequency (RF) field exposure on gene expression  within a variety of discrete mouse brain regions using whole genome microarray analysis. Materials and methods: Adult male C57BL/6 mice were exposed to 1.9‚ÄâGHz  pulse-modulated or continuous-wave RF fields for 4‚Äâh/day for 5 consecutive days at whole body average (WBA) specific absorption rates of 0 (sham), ‚àº0.2 W/kg and  ‚àº1.4 W/kg. Total RNA was isolated from the auditory cortex, amygdala, caudate, cerebellum, hippocampus, hypothalamus, and medial prefrontal cortex and differential gene expression was assessed using Illumina MouseWG-6 (v2) BeadChip  arrays. Validation of potentially responding genes was conducted by RT-PCR. Results: When analysis of gene expression was conducted within individual brain regions when controlling the false discovery rate (FDR), no differentially expressed genes were identified relative to the sham control. However, it must be noted that most fold changes among groups were observed to be less than 1.5-fold  and this study had limited ability to detect such small changes. While some genes were differentially expressed without correction for multiple-comparisons testing, no consistent pattern of response was observed among different RF-exposure levels or among different RF-modulations. Conclusions: The current study provides the most comprehensive analysis of potential gene expression changes in the rodent brain in response to RF field exposure conducted to date. Within the exposure conditions and limitations of this study, no convincing evidence of consistent changes in gene expression was found in response to 1.9‚ÄâGHz RF field exposure.},
address  = {Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer  and Clinical Radiation Protection Bureau, Ottawa Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer  and Clinical Radiation Protection Bureau, Ottawa Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada Gladstone Institutes, San Francisco, CA, USA Faculty of Engineering, Rajamangala University of Technology, Isan, Khon Kaen, Thailand Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer  and Clinical Radiation Protection Bureau, Ottawa Health Canada, Environmental and Radiation Health Sciences Directorate, Consumer  and Clinical Radiation Protection Bureau, Ottawa},
note  = {doi:10.3109/09553002.2016.1159353.}
}

@Article{2015507,
author  = {Iso, N. and Moriuchi, T. and Sagari, A. and Kitajima, E. and Iso, F. and Tanaka, K. and Kikuchi, Y. and Tabira, T. and Higashi, T.},
title  = {Motor Imagery Using Near-Infrared Spectroscopy.},
journal  = {Frontiers in Physiology},
volume  = {6},
number  = {},
pages  = {},
year  = {2015},
abstract  = {The aim of this study was to clarify the topographical localization of motor-related regional hemodynamic signal changes during motor execution (ME) and motor imagery (MI) by using near-infrared spectroscopy (NIRS), as this technique  is more clinically expedient than established methods (e.g., fMRI). Twenty right-handed healthy subjects participated in this study. The experimental protocol was a blocked design consisting of 3 cycles of 20 s of task performance  and 30 s of rest. The tapping sequence task was performed with their fingers under 4 conditions: ME and MI with the right or left hand. Hemodynamic brain activity was measured with NIRS to monitor changes in oxygenated hemoglobin (oxy-Hb) concentration. Oxy-Hb in the somatosensory motor cortex (SMC) increased  significantly only during contralateral ME and showed a significant interaction between task and hand. There was a main effect of hand in the left SMC. Although  there were no significant main effects or interactions in the supplemental motor  area (SMA) and premotor area (PMA), oxy-Hb increased substantially under all conditions. These results clarified the topographical localization by motor-related regional hemodynamic signal changes during ME and MI by using NIRS.},
address  = {Unit of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical SciencesNagasaki, Japan Unit of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical SciencesNagasaki, Japan Unit of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical SciencesNagasaki, Japan Center for Industry, University and Government Cooperation, Nagasaki UniversityNagasaki, Japan Unit of Physical and Occupational Therapy, Nagasaki University Graduate School of Biomedical SciencesNagasaki, Japan Unit of Physical and Occupational Therapy, Nagasaki University Graduate School of Biomedical SciencesNagasaki, Japan Unit of Physical and Occupational Therapy, Nagasaki University Graduate School of Biomedical SciencesNagasaki, Japan Department of Occupational Therapy, Faculty of Rehabilitation Sciences, Nishikyushu UniversitySaga, Japan Unit of Rehabilitation Sciences, Nagasaki University Graduate School of Biomedical SciencesNagasaki, Japan},
note  = {Front Physiol. 2016 Jan 11;6:. doi:10.3389/fphys.2015.00416.}
}

@Article{2014508,
author  = {Ajdaharian, J. and Dadkhah, M. and Sabokpey, S. and Biren-Fetz, J. and Chung, N. and Wink, C. and Wilder-Smith, P.},
title  = {Multimodality Imaging of the Effects of a Novel Dentifrice on Oral Biofilm.},
journal  = {Lasers in surgery and medicine},
volume  = {46},
number  = {7},
pages  = {546-52},
year  = {2014},
abstract  = {Objective: Oral biofilm formation and progression on the surface of the tooth can lead to advanced oral disease such as gingivitis. The purpose of this randomized, controlled, double-blinded study was to evaluate the effects of a novel dental gel on oral plaque biofilm using multimodal imaging techniques. Materials and Methods: Twenty-five subjects with moderate gingival inflammation (L√∂e and Silness Gingival Index ‚â• 2) and pocket depths <4 were randomly assigned to brush  twice daily for 21 days with the test or the control dental gel. In vivo multimodality in situ imaging was performed over a 3-week period using in vivo Optical Coherence Tomography (OCT) and Non-Linear Optical microscopy (NLOM). Plaque levels, gingival inflammation and gingival bleeding were also charted on days 0, 7, 14, and 21 using standard clinical indices. Results: After 3 weeks, OCT and NLOM images showed a macroscopic break-up of the plaque layer and smaller, fragmented residual deposits in the test group with no apparent changes  in the pellicle. Biofilm was also reduced in the control group, but to a lesser degree with regard to thickness, continuity and surface area. Paralleling these imaging results, clinical indices were significantly improved in both groups (P <0.05) and significantly lower in the test group (P <0.05). Conclusion: Both dental gels reduced oral biofilm with the test gel showing greater efficacy (P <0.05) as determined by clinical and imaging parameters.},
address  = {Beckman Laser Institute, University of California, Irvine, California 92612 Beckman Laser Institute, University of California, Irvine, California 92612 Beckman Laser Institute, University of California, Irvine, California 92612 Beckman Laser Institute, University of California, Irvine, California 92612 Beckman Laser Institute, University of California, Irvine, California 92612 Beckman Laser Institute, University of California, Irvine, California 92612 Beckman Laser Institute, University of California, Irvine, California 92612},
note  = {Lasers Surg Med. 2014 Sep;46(7):546-52. Epub 2014 Jun 10 doi:10.1002/lsm.22265.}
}

@Article{2015509,
author  = {Kose, S. and Steinberg, J. and Moeller, F. and Gowin, J. and Zuniga, E. and Kamdar, Z. and Schmitz, J. and Lane, S.},
title  = {Alcohol Dependence.},
journal  = {Behavioral neuroscience},
volume  = {129},
number  = {2},
pages  = {183-96},
year  = {2015},
abstract  = {Alcohol-related aggression is a complex and problematic phenomenon with profound  public health consequences. We examined neural correlates potentially moderating  the relationship between human aggressive behavior and chronic alcohol use. Thirteen subjects meeting DSM‚ÄìIV criteria for past alcohol-dependence in remission (AD) and 13 matched healthy controls (CONT) participated in an fMRI study adapted from a laboratory model of human aggressive behavior (Point Subtraction Aggression Paradigm, or PSAP). Blood oxygen level dependent (BOLD) activation was measured during bouts of operationally defined aggressive behavior, during postprovocation periods, and during monetary-reinforced behavior. Whole brain voxelwise random-effects analyses found group differences in brain regions relevant to chronic alcohol use and aggressive behavior (e.g., emotional and behavioral control). Behaviorally, AD subjects responded on both the aggressive response and monetary response options at significantly higher rates than CONT. Whole brain voxelwise random-effects analyses revealed significant group differences in response to provocation (monetary subtractions), with CONT subjects showing greater activation in frontal and prefrontal cortex, thalamus, and hippocampus. Collapsing data across all subjects, regression analyses of postprovocation brain activation on aggressive response rate revealed significant positive regression slopes in precentral gyrus and parietal cortex; and significant negative regression slopes in orbitofrontal cortex, prefrontal cortex, caudate, thalamus, and middle temporal gyrus. In these collapsed analyses, response to provocation and aggressive behavior were associated with activation in brain regions subserving inhibitory and emotional control, sensorimotor integration, and goal directed motor activity.},
address  = {University of Texas Medical School at Houston and Center for Neurobehavioral Research on Addictions (CNRA), Houston, Texas Virginia Commonwealth University School of Medicine Virginia Commonwealth University School of Medicine National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland Virginia Commonwealth University School of Medicine Center for Neurobehavioral Research on Addictions (CNRA), Houston, Texas University of Texas Medical School at Houston and Center for Neurobehavioral Research on Addictions (CNRA), Houston, Texas University of Texas Medical School at Houston and Center for Neurobehavioral Research on Addictions (CNRA), Houston, Texas},
note  = {Behav Neurosci. 2015 Apr;129(2):183-96. Epub 2015 Feb 09 doi:10.1037/bne0000038.}
}

@Article{2015510,
author  = {Schulze, A. and Gomez-Marin, A. and Rajendran, V. and Lott, G. and Musy, M. and Ahammad, P. and Deogade, A. and Sharpe, J. and Riedl, J. and Jarriault, D. and Trautman, E. and Werner, C. and Venkadesan, M. and Druckmann, S. and Jayaraman, V. and Louis, M.},
title  = {Dynamical feature extraction at the sensory periphery guides chemotaxis.},
journal  = {eLife},
volume  = {4},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Behavioral strategies employed for chemotaxis have been described across phyla, but the sensorimotor basis of this phenomenon has seldom been studied in naturalistic contexts. Here, we examine how signals experienced during free olfactory behaviors are processed by first-order olfactory sensory neurons (OSNs) of the Drosophila larva. We find that OSNs can act as differentiators that transiently normalize stimulus intensity‚Äîa property potentially derived from a combination of integral feedback and feed-forward regulation of olfactory transduction. In olfactory virtual reality experiments, we report that high activity levels of the OSN suppress turning, whereas low activity levels facilitate turning. Using a generalized linear model, we explain how peripheral encoding of olfactory stimuli modulates the probability of switching from a run to a turn. Our work clarifies the link between computations carried out at the sensory periphery and action selection underlying navigation in odor gradients.DOI:http://dx.doi.org/10.7554/eLife.06694.001},
address  = {EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States Department of Mechanical Engineering and Materials Science, Yale University, New  Haven, United States Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain},
note  = {eLife. 2015;4:. doi:10.7554/eLife.06694.}
}

@Article{2009511,
author  = {Gaisler-Salomon, I. and Miller, G. and Chuhma, N. and Lee, S. and Zhang, H. and Ghoddoussi, F. and Lewandowski, N. and Fairhurst, S. and Wang, Y. and Conjard-Duplany, A. and Masson, J. and Balsam, P. and Hen, R. and Arancio, O. and Galloway, M. and Moore, H. and Small, S. and Rayport, S.},
title  = {Schizophrenia.},
journal  = {Neuropsychopharmacology},
volume  = {34},
number  = {10},
pages  = {2305-22},
year  = {2009},
abstract  = {Dysregulated glutamatergic neurotransmission has been strongly implicated in the  pathophysiology of schizophrenia (SCZ). Recently, presynaptic modulation of glutamate transmission has been shown to have therapeutic promise. We asked whether genetic knockdown of glutaminase (gene GLS1) to reduce glutamatergic transmission presynaptically by slowing the recycling of glutamine to glutamate,  would produce a phenotype relevant to SCZ and its treatment. GLS1 heterozygous (GLS1 het) mice showed about a 50% global reduction in glutaminase activity, and  a modest reduction in glutamate levels in brain regions relevant to SCZ pathophysiology, but displayed neither general behavioral abnormalities nor SCZ-associated phenotypes. Functional imaging, measuring regional cerebral blood  volume, showed hippocampal hypometabolism mainly in the CA1 subregion and subiculum, the inverse of recent clinical imaging findings in prodromal and SCZ patients. GLS1 het mice were less sensitive to the behavioral stimulating effects of amphetamine, showed a reduction in amphetamine-induced striatal dopamine release and in ketamine-induced frontal cortical activation, suggesting that GLS1 het mice are resistant to the effects of these pro-psychotic challenges. Moreover, GLS1 het mice showed clozapine-like potentiation of latent inhibition,  suggesting that reduction in glutaminase has antipsychotic-like properties. These observations provide further support for the pivotal role of altered glutamatergic synaptic transmission in the pathophysiology of SCZ, and suggest that presynaptic modulation of the glutamine‚Äìglutamate pathway through glutaminase inhibition may provide a new direction for the pharmacotherapy of SCZ.},
address  = {Department of Psychiatry, Columbia University, New York, NY, USA Department of Psychiatry, Columbia University, New York, NY, USA Department of Psychiatry, Columbia University, New York, NY, USA Department of Psychiatry, Columbia University, New York, NY, USA Department of Pathology, Columbia University, New York, NY, USA Departments of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne  State University School of Medicine, Detroit, MI, USA Department of Neurology, Columbia University, New York, NY, USA Department of Cognitive Neuroscience, New York State Psychiatric Institute, New York, NY, USA Department of Psychiatry, Columbia University, New York, NY, USA INSERM U820, Centre de M√©tabolomique et Maladies M√©taboliques, Facult√© de M√©decine Laennec, Lyon, France INSERM U894, Centre de Psychiatrie et Neuroscience, Facult√© de M√©decine, Universit√© Paris Descartes‚ÄîParis 5, Paris, France Department of Psychiatry, Columbia University, New York, NY, USA Department of Pharmacology, Columbia University, New York, NY, USA Department of Pathology, Columbia University, New York, NY, USA Departments of Psychiatry and Behavioral Neurosciences and Anesthesiology, Wayne  State University School of Medicine, Detroit, MI, USA Department of Psychiatry, Columbia University, New York, NY, USA Department of Neurology, Columbia University, New York, NY, USA Department of Psychiatry, Columbia University, New York, NY, USA},
note  = {doi:10.1038/npp.2009.58.}
}

@Article{2005512,
author  = {Leuwer, R. and M√ºller, J.},
title  = {hearing aids ‚Äì cochlear implants ‚Äì auditory brainstem implants.},
journal  = {GMS Current Topics in Otorhinolaryngology, Head and Neck Surgery},
volume  = {4},
number  = {},
pages  = {},
year  = {2005},
abstract  = {Aim of this report is to explain the current concept of hearing restoration using hearing aids. At present the main issues of conventional hearing aids are the relative benefits of analogue versus digital devices and different strategies for the improvement of hearing in noise. Implantable hearing aids provide a better sound quality and less distortion. The lack of directional microphones is the major disadvantage of the partially implantable hearing aids commercially available. Two different clinical studies about fully implantable hearing aids have been started in 2004. One of the most-promising developments seems to be the electric-acoustic stimulation.},
address  = {Klinik und Poliklinik f√ºr Hals-, Nasen- und Ohrenheilkunde, Universit√§tsklinikum  Hamburg-Eppendorf Klinik und Poliklinik f√ºr Hals-, Nasen- und Ohrenkranke, Universit√§t W√ºrzburg},
note  = {GMS Curr Top Otorhinolaryngol Head Neck Surg. 2005 Sep 28;4:.}
}

@Article{2003513,
author  = {},
title  = {Symposium of the EMSOS Nurse Group, 7‚Äì9 May 2003, Budapest: Abstracts.},
journal  = {Sarcoma},
volume  = {7},
number  = {2},
pages  = {93-129},
year  = {2003},
abstract  = {},
address  = {},
note  = {Sarcoma. 2003 Jun;7(2):93-129. doi:10.1080/13577140310001607338.}
}

@Article{2013514,
author  = {Kok, R. and Allen, N. and Nolan, R. and Green, B. and Thiboutot, J. and Sciamanna, C. and Falkner, B. and Kephart, D. and Stuckey, H. and Adelman, A. and Curry, W. and Lehman, E.},
title  = {Inertia on Blood Pressure Control: Cluster Randomized Controlled Trial.},
journal  = {Journal of Medical Internet Research},
volume  = {15},
number  = {9},
pages  = {},
year  = {2013},
abstract  = {Background: Only approximately half of patients with hypertension have their blood pressure controlled, due in large part to the tendency of primary care providers (PCPs) not to intensify treatment when blood pressure values are elevated. Objective: This study tested the effect of an intervention designed to  help patients ask questions at the point of care to encourage PCPs to appropriately intensify blood pressure treatment. Methods: PCPs and their patients with hypertension (N=500) were recruited by letter and randomized into 2 study groups: (1) intervention condition in which patients used a fully automated website each month to receive tailored messages suggesting questions to ask their PCP to improve blood pressure control, and (2) control condition in which a similar tool suggested questions to ask about preventive services (eg, cancer screening). The Web-based tool was designed to be used during each of the 12 study months and before scheduled visits with PCPs. The primary outcome was the percentage of patients in both conditions with controlled blood pressure. Results: Of 500 enrolled patients (intervention condition: n=282; control condition: n=218), 418 (83.6%) completed the 12-month follow-up visit. At baseline, 289 (61.5%) of participants had controlled blood pressure. Most (411/500, 82.2%) participants used the intervention during at least 6 of 12 months and 222 (62.5%) reported asking questions directly from the Web-based tool. There were no group differences in asking about medication intensification  and there were no differences in blood pressure control after 12 months between the intervention condition (201/282, 71.3%) and control condition (143/218, 65.6%; P=.27) groups. More intervention condition participants discussed having a creatinine test (92, 52.6% vs 49, 35.5%; P=.02) and urine protein test (81, 44.8% vs 21, 14.6%; P<.001), but no group differences were observed in the rate of testing. The control condition participants reported more frequent discussions about tetanus and pneumonia vaccines and reported more tetanus (30, 13.8% vs 15,  5.3%; P=.02) and pneumonia (25, 11.5% vs 16, 5.7%; P=.02) vaccinations after 12 months. Conclusions: The use of an interactive website designed to overcome clinical inertia for hypertension care did not lead to improvements in blood pressure control. Participant adherence to the intervention was high. The control intervention led to positive changes in the use of preventive services (eg, tetanus immunization) and the intervention condition led to more discussions of hypertension-relevant tests (eg, serum creatinine and urine protein). By providing patients with individually tailored questions to ask during PCP visits, this study demonstrated that participants were likely to discuss the questions with PCPs. These discussions did not, however, lead to improvements in blood pressure control. Trial Registration: ClinicalTrials.gov NCT00377208; http://clinicaltrials.gov/ct2/show/NCT00377208 (Archived by WebCite at http://www.webcitation.org/6IqWiPLon).},
address  = {Mount Sinai School of MedicineNew York, NYUnited States Pennsylvania State University College of MedicineMS Hershey Medical CenterHershey, PAUnited States Jefferson Medical CollegeThomas Jefferson UniversityPhiladelphia, PAUnited States Pennsylvania State University College of MedicineMS Hershey Medical CenterHershey, PAUnited States Pennsylvania State University College of MedicineMS Hershey Medical CenterHershey, PAUnited States Pennsylvania State University College of MedicineMS Hershey Medical CenterHershey, PAUnited States Pennsylvania State University College of MedicineMS Hershey Medical CenterHershey, PAUnited States Pennsylvania State University College of MedicineMS Hershey Medical CenterHershey, PAUnited States},
note  = {J Med Internet Res. 2013 Sep 04;15(9):. doi:10.2196/jmir.2298.}
}

@Article{2012515,
author  = {Rettig, G. and Behlke, M.},
title  = {Progress Toward In Vivo Use of siRNAs-II.},
journal  = {Molecular Therapy},
volume  = {20},
number  = {3},
pages  = {483-512},
year  = {2012},
abstract  = {RNA interference (RNAi) has been extensively employed for in vivo research since  its use was first demonstrated in mammalian cells 10 years ago. Design rules have improved, and it is now routinely possible to obtain reagents that suppress expression of any gene desired. At the same time, increased understanding of the  molecular basis of unwanted side effects has led to the development of chemical modification strategies that mitigate these concerns. Delivery remains the single greatest hurdle to widespread adoption of in vivo RNAi methods. However, exciting advances have been made and new delivery systems under development may help to overcome these barriers. This review discusses advances in RNAi biochemistry and  biology that impact in vivo use and provides an overview of select publications that demonstrate interesting applications of these principles. Emphasis is placed on work with synthetic, small interfering RNAs (siRNAs) published since the first installment of this review which appeared in 2006.},
address  = {Integrated DNA Technologies, Inc., Coralville, Iowa, USA Integrated DNA Technologies, Inc., Coralville, Iowa, USA},
note  = {Mol Ther. 2012 Mar;20(3):483-512. Epub 2011 Dec 20 doi:10.1038/mt.2011.263.}
}

@Article{2015516,
author  = {Meldrum, D. and Deutsch, J. and Turolla, A. and Tatla, S. and Shirzad, N. and Lohse, K. and Virji-Babul, N. and Hoens, A. and Holsti, L. and Li, L. and Miller, K. and Lam, M. and Van, d.},
title  = {Rehabilitation.},
journal  = {JMIR Serious Games},
volume  = {3},
number  = {1},
pages  = {},
year  = {2015},
abstract  = {Background: The application of technologies, such as video gaming and social media for rehabilitation, is garnering interest in the medical field. However, little research has examined clinicians‚Äô perspectives regarding technology adoption by their clients. Objective: The objective of our study was to explore therapists‚Äô perceptions of how young people and adults with hemiplegia use gaming and social media technologies in daily life and in rehabilitation, and to identify barriers to using these technologies in rehabilitation. Methods: We conducted two focus groups comprised of ten occupational therapists/physiotherapists who provide neurorehabilitation to individuals with hemiplegia secondary to stroke or cerebral palsy. Data was analyzed using inductive thematic analysis. The diffusion of innovations theory provided a framework to interpret emerging themes. Results: Therapists were using technology in a limited capacity. They identified barriers to using social media and gaming  technology with their clients, including a lack of age appropriateness, privacy issues with social media, limited transfer of training, and a lack of accessibility of current systems. Therapists also questioned their role in the context of technology-based interventions. The opportunity for social interaction was perceived as a major benefit of integrated gaming and social media. Conclusions: This study reveals the complexities associated with adopting new technologies in clinical practice, including the need to consider both client and clinician factors. Despite reporting several challenges with applying gaming and  social media technology with clinical populations, therapists identified opportunities for increased social interactions and were willing to help shape the development of an upper limb training system that could more readily meet the needs of clients with hemiplegia. By considering the needs of both therapists and clients, technology developers may increase the likelihood that clinicians will adopt innovative technologies.},
address  = {Sunny Hill Health Centre for ChildrenVancouver, BCCanada Biomedical Engineering Graduate ProgramUniversity of British ColumbiaVancouver, BCCanada School of KinesiologyAuburn UniversityAuburn, ALUnited States Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada The Department of Occupational Science and Occupational TherapyUniversity of British ColumbiaVancouver, BCCanada Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada Department of Physical TherapyUniversity of British ColumbiaVancouver, BCCanada Department of Human KineticsSt Francis Xavier UniversityAntigonish, NSCanada Department of Mechanical EngineeringUniversity of British ColumbiaVancouver, BCCanada},
note  = {JMIR Serious Games. 2015 Mar 10;3(1):. doi:10.2196/games.3401.}
}

@Article{2011517,
author  = {Eisner, A. and Luoh, S.},
title  = {Disease.},
journal  = {Current Eye Research},
volume  = {36},
number  = {10},
pages  = {867-85},
year  = {2011},
abstract  = {This review concerns the effects on vision and the eye of medications prescribed  at three phases of treatment for women with early-stage breast cancer (BC): (1) adjuvant cytotoxic chemotherapy, (2) adjuvant endocrine therapy, and (3) symptomatic relief. The most common side effects of cytotoxic chemotherapy are epiphora and ocular surface irritation, which can be caused by any of several different regimens. Most notably, the taxane docetaxel can lead to epiphora by inducing canalicular stenosis. The selective-estrogen-receptor-modulator (SERM) tamoxifen, long the gold-standard adjuvant-endocrine-therapy for women with hormone-receptor-positive BC, increases the risk of posterior subcapsular cataract. Tamoxifen also affects the optic nerve head more often than previously  thought, apparently by causing subclinical swelling within the first 2 years of use for women older than ‚àº50 years. Tamoxifen retinopathy is rare, but it can cause foveal cystoid spaces that are revealed with spectral-domain optical coherence tomography (OCT) and that may increase the risk for macular holes. Tamoxifen often alters the perceived color of flashed lights detected via short-wavelength-sensitive (SWS) cone response isolated psychophysically; these altered perceptions may reflect a neural-response sluggishness that becomes evident at ‚àº2 years of use. The aromatase inhibitor (AI) anastrozole affects perception similarly, but in an age-dependent manner suggesting that the change of estrogen activity towards lower levels is more important than the low estrogen activity itself. Based on analysis of OCT retinal thickness data, it is likely that anastrozole increases the tractional force between the vitreous and retina.  Consequently, AI users, myopic AI users particularly, might be at increased risk  for traction-related vision loss. Because bisphosphonates are sometimes prescribed to redress AI-induced bone loss, clinicians should be aware of their potential to cause scleritis and uveitis occasionally. We conclude by suggesting  some avenues for future research into the visual and ocular effects of AIs, particularly as relates to assessment of cognitive function.},
address  = {Women's Health Research Unit, Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon, USA Division of Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, USA},
note  = {doi:10.3109/02713683.2011.594202.}
}

@Article{2017518,
author  = {Rebhan, M.},
title  = {Towards a systems approach for chronic diseases, based on health state modeling.},
journal  = {F1000Research},
volume  = {6},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Rising pressure from chronic diseases means that we need to learn how to deal with challenges at a different level, including the use of systems approaches that better connect across fragments, such as disciplines, stakeholders, institutions, and technologies. By learning from progress in leading areas of health innovation (including oncology and AIDS), as well as complementary indications (Alzheimer‚Äôs disease), I try to extract the most enabling innovation  paradigms, and discuss their extension to additional areas of application within  a systems approach. To facilitate such work, a Precision, P4 or Systems Medicine  platform is proposed, which is centered on the representation of health states that enable the definition of time in the vision to provide the right intervention for the right patient at the right time and dose. Modeling of such health states should allow iterative optimization, as longitudinal human data accumulate. This platform is designed to facilitate the discovery of links between opportunities related to a) the modernization of diagnosis, including the increased use of omics profiling, b) patient-centric approaches enabled by technology convergence, including digital health and connected devices, c) increasing understanding of the pathobiological, clinical and health economic aspects of disease progression stages, d) design of new interventions, including  therapies as well as preventive measures, including sequential intervention approaches. Probabilistic Markov models of health states, e.g. those used for health economic analysis, are discussed as a simple starting point for the platform. A path towards extension into other indications, data types and uses is discussed, with a focus on regenerative medicine and relevant pathobiology.},
address  = {Novartis Institutes for Biomedical Research, Basel, 4056, Switzerland},
note  = {F1000Res. 2017 Mar 23;6:. doi:10.12688/f1000research.11085.1.}
}

@Article{2017519,
author  = {Alegria, A. and Wulff, M. and Brinson, H. and Barker, G. and Norman, L. and Brandeis, D. and Stahl, D. and David, A. and Taylor, E. and Giampietro, V. and Rubia, K.},
title  = {disorder.},
journal  = {Human Brain Mapping},
volume  = {38},
number  = {6},
pages  = {3190-209},
year  = {2017},
abstract  = {Attention Deficit Hyperactivity Disorder (ADHD) is associated with poor self‚Ä?control, underpinned by inferior fronto‚Ä?striatal deficits. Real‚Ä?time functional magnetic resonance neurofeedback (rtfMRI‚Ä?NF) allows participants to gain self‚Ä?control over dysregulated brain regions. Despite evidence for beneficial effects of electrophysiological‚Ä?NF on ADHD symptoms, no study has applied the spatially superior rtfMRI‚Ä?NF neurotherapy to ADHD. A randomized controlled trial tested the efficacy of rtfMRI‚Ä?NF of right inferior prefrontal cortex (rIFG), a key region that is compromised in ADHD and upregulated with psychostimulants, on improvement of ADHD symptoms, cognition, and inhibitory fMRI activation. To control for region‚Ä?specificity, an active control group received rtfMRI‚Ä?NF of the left parahippocampal gyrus (lPHG). Thirty‚Ä?one ADHD boys were randomly allocated and had to learn to upregulate their target brain region in an average of 11 rtfMRI‚Ä?NF runs over 2 weeks. Feedback was provided through a video‚Ä?clip of a rocket that had to be moved up into space. A transfer session without feedback tested learning retention as a proximal measure of transfer to everyday life. Both NF groups showed significant linear activation increases with increasing number of runs in their respective target regions and significant reduction in ADHD symptoms after neurotherapy and at 11‚Ä?month follow‚Ä?up. Only the group targeting rIFG, however, showed a transfer effect, which correlated with ADHD symptom reductions, improved at trend level in sustained attention, and showed increased IFG activation during an inhibitory fMRI task. This proof‚Ä?of‚Ä?concept study demonstrates for the first time feasibility, safety, and shorter‚Ä? and longer‚Ä?term efficacy of rtfMRI‚Ä?NF of rIFG in adolescents with ADHD.  Hum Brain Mapp 38:3190‚Äì3209, 2017. ¬© 2017 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc.},
address  = {Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology  and Neuroscience, King's College LondonLondonUnited Kingdom Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology  and Neuroscience, King's College LondonLondonUnited Kingdom Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology  and Neuroscience, King's College LondonLondonUnited Kingdom Centre for Neuroimaging Science, Institute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology  and Neuroscience, King's College LondonLondonUnited Kingdom Department of Child and Adolescent Psychiatry and PsychotherapyCentral Institute  of Mental Health, Medical Faculty Mannheim/Heidelberg UniversityMannheimGermany Department of BiostatisticsKing's College LondonLondonUnited Kingdom Department of Psychosis StudiesInstitute of Psychiatry, Psychology and Neuroscience King's College LondonLondonUnited Kingdom Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology  and Neuroscience, King's College LondonLondonUnited Kingdom Centre for Neuroimaging Science, Institute of Psychiatry, Psychology and Neuroscience, King's College LondonLondonUnited Kingdom Department of Child and Adolescent PsychiatryInstitute of Psychiatry, Psychology  and Neuroscience, King's College LondonLondonUnited Kingdom},
note  = {Hum Brain Mapp. 2017 Jun;38(6):3190-209. Epub 2017 Mar 25 doi:10.1002/hbm.23584.}
}

@Article{2015520,
author  = {Kim, J. and Brown, W. and Maher, J. and Levinson, H. and Wax, A.},
title  = {Functional Optical Coherence Tomography: Principles and Progress.},
journal  = {Physics in medicine and biology},
volume  = {60},
number  = {10},
pages  = {R211-37},
year  = {2015},
abstract  = {In the past decade, several functional extensions of optical coherence tomography (OCT) have emerged, and this review highlights key advances in instrumentation, theoretical analysis, signal processing and clinical application of these extensions. We review five principal extensions: Doppler OCT (DOCT), polarization-sensitive OCT (PS-OCT), optical coherence elastography (OCE), spectroscopic OCT (SOCT), and molecular imaging OCT. The former three have been further developed with studies in both ex vivo and in vivo human tissues. This review emphasizes the newer techniques of SOCT and molecular imaging OCT, which show excellent potential for clinical application but have yet to be well reviewed in the literature. SOCT elucidates tissue characteristics, such as oxygenation and carcinogenesis, by detecting wavelength-dependent absorption and  scattering of light in tissues. While SOCT measures endogenous biochemical distributions, molecular imaging OCT detects exogenous molecular contrast agents. These newer advances in functional OCT broaden the potential clinical application of OCT by providing novel ways to understand tissue activity that cannot be accomplished by other current imaging methodologies.},
address  = {Department of Surgery, Duke University, Durham, NC 27710 Department of Biomedical Engineering, Duke University, Durham, NC 27708 Department of Biomedical Engineering, Duke University, Durham, NC 27708 Department of Surgery, Duke University, Durham, NC 27710 Department of Biomedical Engineering, Duke University, Durham, NC 27708},
note  = {doi:10.1088/0031-9155/60/10/R211.}
}

@Article{2001521,
author  = {STONE, J.},
title  = {The Volitional Brain: towards a neuroscience of free will.},
journal  = {Journal of Neurology, Neurosurgery, and Psychiatry},
volume  = {70},
number  = {5},
pages  = {709},
year  = {2001},
abstract  = {},
address  = {},
note  = {J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709c.}
}

@Article{2001522,
author  = {SCHOTT, G.},
title  = {Botulinum toxin type A in pain management.},
journal  = {Journal of Neurology, Neurosurgery, and Psychiatry},
volume  = {70},
number  = {5},
pages  = {709},
year  = {2001},
abstract  = {},
address  = {},
note  = {J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709e.}
}

@Article{2008523,
author  = {},
title  = {A Brief Report.},
journal  = {Journal of acquired immune deficiency syndromes (1999)},
volume  = {49},
number  = {Suppl 1},
pages  = {S52-8},
year  = {2008},
abstract  = {Objective: To describe the advantages and limitations of an ACASI system in a multisite trial with African American couples and to present the steps in designing, testing, and implementing a system. Methods: The ACASI system evolved  from a paper and pencil interview (PAPI) that was pilot tested. Based on this initial work, the PAPI was translated into story boards that were the basis of the development of ACASI system. Story Boards consisted of one page per question  and provided the programmers with the test of the question, valid responses, and  any instructions that were to be read to the participants. Story boards were further translated into flow diagrams representing each module of the survey and  illustrating the skip patterns used to navigate a participant through the survey. Provisions were also made to insert a face-to-face interview, into the ACASI assessment process, to elicit sexual abuse history data which typically requires  specially trained data collectors with active listening skills in order to help participants reframe and coordinate times, places and emotionally difficult memories. Results: The ACASI was successfully developed and implemented in the main trial. During an exit interview, respondents indicated that they liked using the ACASI and indicating that they favored it as the method to answer questions.  Conclusions: It is feasible to implement an ACASI system in a multisite study in  a timely and efficient way.},
address  = {NIMH Multisite HIV/STD Prevention Trial for African American Couples, Center for  Mental Health Research on AIDS, Division of AIDS and Health and Behavior Research, National Institiutes of Mental Health, National Institutes of Health, 6001 Executive Boulevard, Room 6219B, Bethesda, MD 20892 (wpequegn@mail.nih.gov).},
note  = {doi:10.1097/QAI.0b013e318184481a.}
}

@Article{2016524,
author  = {Gordon, P. and Hoedemaker, R.},
title  = {Effective Scheduling of Looking and Talking During Rapid Automatized Naming.},
journal  = {Journal of experimental psychology. Human perception and performance},
volume  = {42},
number  = {5},
pages  = {742-60},
year  = {2016},
abstract  = {Rapid Automatized Naming (RAN) is strongly related to literacy gains in developing readers, reading disabilities and reading ability in children and adults. Because successful RAN performance depends on the close coordination of a number of abilities, it is unclear what specific skills drive this RAN-reading relationship. The current study used concurrent recordings of young adult participants‚Äô vocalizations and eye movements during the RAN task to assess how individual variation in RAN performance depends on the coordination of visual and vocal processes. Results showed that fast RAN times are facilitated by having the eyes one or more items ahead of the current vocalization, as long as the eyes do  not get so far ahead of the voice as to require a regressive eye movement to an earlier item. These data suggest that optimizing RAN performance is a problem of  scheduling eye movements and vocalization given memory constraints and the efficiency of encoding and articulatory control. Both RAN completion time (conventionally used to indicate RAN performance) and eye-voice relations predicted some aspects of participants‚Äô eye movements on a separate sentence reading task. However, eye-voice relations predicted additional features of first-pass reading that were not predicted by RAN completion time. This shows that measurement of eye-voice patterns can identify important aspects of individual variation in reading that are not identified by the standard measure of RAN performance. We argue that RAN performance predicts reading ability because both tasks entail challenges of scheduling cognitive and linguistic processes that operate simultaneously on multiple linguistic inputs.},
address  = {},
note  = {doi:10.1037/xhp0000171.}
}

@Article{2001525,
author  = {HAWKINS, C.},
title  = {Multiple sclerosis.},
journal  = {Journal of Neurology, Neurosurgery, and Psychiatry},
volume  = {70},
number  = {5},
pages  = {709},
year  = {2001},
abstract  = {},
address  = {},
note  = {J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709b.}
}

@Article{2001526,
author  = {HANNA, M.},
title  = {in clinical neurosciences. Volume 18.},
journal  = {Journal of Neurology, Neurosurgery, and Psychiatry},
volume  = {70},
number  = {5},
pages  = {709},
year  = {2001},
abstract  = {},
address  = {},
note  = {J Neurol Neurosurg Psychiatry. 2001 May;70(5):709. doi:10.1136/jnnp.70.5.709d.}
}

@Article{2015527,
author  = {Elliott, J. and Dsouza, A. and Davis, S. and Olson, J. and Paulsen, K. and Roberts, D. and Pogue, B.},
title  = {Review of fluorescence guided surgery visualization and overlay techniques.},
journal  = {Biomedical Optics Express},
volume  = {6},
number  = {10},
pages  = {3765-82},
year  = {2015},
abstract  = {In fluorescence guided surgery, data visualization represents a critical step between signal capture and display needed for clinical decisions informed by that signal. The diversity of methods for displaying surgical images are reviewed, and a particular focus is placed on electronically detected and visualized signals, as required for near-infrared or low concentration tracers. Factors driving the choices such as human perception, the need for rapid decision making in a surgical environment, and biases induced by display choices are outlined. Five practical suggestions are outlined for optimal display orientation, color map, transparency/alpha function, dynamic range compression, and color perception check.},
address  = {Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA Neurosurgery Section, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03766, USA Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA Neurosurgery Section, Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, NH 03766, USA Thayer School of Engineering, Dartmouth College, 14 Engineering Drive, Hanover, NH 03755, USA},
note  = {Biomed Opt Express. 2015 Sep 03;6(10):3765-82. doi:10.1364/BOE.6.003765.}
}

@Article{2014528,
author  = {Jha, R. and Jha, P. and Chaudhury, K. and Rana, S. and Guha, S.},
title  = {prospects of reproductive healthcare aided by nano-biotechnology.},
journal  = {Nano Reviews},
volume  = {5},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Among the various applications of nano-biotechnology, healthcare is considered one of the most significant domains. For that possibility to synthesize various kind of nanoparticles (NPs) and the ever-increasing ability to control their size as well as structure, to improve surface characteristics and binding NPs with other desired curing agents has played an important role. In this paper, a brief  sketch of various kinds of nanomaterials and their biomedical applications is given. Despite claims of bio-nanotechnology about to touch all areas of medical science, information pertaining to the role of nanotechnology for the betterment  of reproductive healthcare is indeed limited. Therefore, the various achievements of nano-biotechnology for healthcare in general have been illustrated while giving special insight into the role of nano-biotechnology for the future of reproductive healthcare betterment as well as current achievements of nanoscience and nanotechnology in this arena.},
address  = {School of Medical Science and Technology, Indian Institute of Technology Kharagpur, India School of Medical Science and Technology, Indian Institute of Technology Kharagpur, India School of Medical Science and Technology, Indian Institute of Technology Kharagpur, India Toxicology Laboratory, CCS University, Meerut, India School of Medical Science and Technology, Indian Institute of Technology Kharagpur, India},
note  = {Nano Rev. 2014 Feb 26;5:. doi:10.3402/nano.v5.22762.}
}

@Article{2003529,
author  = {},
title  = {Free Papers.},
journal  = {Association},
volume  = {5},
number  = {Suppl 1},
pages  = {23-87},
year  = {2003},
abstract  = {},
address  = {},
note  = {HPB (Oxford). 2003;5(Suppl 1):23-87.}
}

@Article{2015530,
author  = {Mastanduno, M. and Xu, J. and El-Ghussein, F. and Jiang, S. and Yin, H. and Zhao, Y. and Wang, K. and Ren, F. and Gui, J. and Pogue, B. and Paulsen, K.},
title  = {Breast MRI.},
journal  = {Cancer Research},
volume  = {21},
number  = {17},
pages  = {3906-12},
year  = {2015},
abstract  = {Purpose: The purpose of this study was to determine the diagnostically most important molecular biomarkers quantified by magnetic resonance-guided (MR) near-infrared spectral tomography (NIRST) that distinguish malignant breast lesions from benign abnormalities when combined with outcomes from clinical breast MRI. Experimental Design: The study was HIPAA compliant and approved by the Dartmouth Institutional Review Board, the NIH, the United States State Department, and Xijing Hospital. MR-guided NIRST evaluated hemoglobin, water, and lipid content in regions of interest defined by concurrent dynamic contrast-enhanced MRI (DCE-MRI) in the breast. MRI plus NIRST was performed in 44 subjects (median age, 46, age range, 20‚Äì81 years), 28 of whom had subsequent malignant pathologic diagnoses, and 16 had benign conditions. A subset of 30 subject examinations yielded optical data that met minimum sensitivity requirements to the suspicious lesion and were included in the analyses of diagnostic performance. Results: In the subset of 30 subject examinations meeting minimum optical data sensitivity criterion, the MR-guided NIRST separated malignant from benign lesions using total hemoglobin (HbT; P < 0.01) and tissue optical index (TOI; P < 0.001). Combined MRI plus TOI data caused one false positive and 1 false negative, and produced the best diagnostic performance, yielding an AUC of 0.95, sensitivity of 95%, specificity of 89%, positive predictive value of 95%, and negative predictive value of 89%, respectively. Conclusions: MRI plus NIRST results correlated well with histopathologic diagnoses and could provide additional information to reduce the number of MRI-directed biopsies.},
address  = {Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire Department of Radiology, Xijing Hospital, Xi‚Äôan, China Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire Department of Radiology, Xijing Hospital, Xi‚Äôan, China Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire Department of Radiology, Xijing Hospital, Xi‚Äôan, China Department of Radiology, Xijing Hospital, Xi‚Äôan, China Department of Community and Family Medicine, Geisel School of Medicine, Dartmouth College, Hanover, New Hampshire Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire},
note  = {doi:10.1158/1078-0432.CCR-14-2546.}
}

@Article{2015531,
author  = {Kim, S. and Callier, T. and Tabot, G. and Gaunt, R. and Tenore, F. and Bensmaia, S.},
title  = {somatosensory cortex.},
journal  = {Proceedings of the National Academy of Sciences of the United States of America},
volume  = {112},
number  = {49},
pages  = {15202-7},
year  = {2015},
abstract  = {Electrical stimulation of sensory structures in the brain is a powerful tool to investigate neural circuits and may provide a means to restore sensation for patients for whom stimulation of the nerve is not an option. For both purposes, however, it is critical to understand how the design of the stimulation shapes the evoked sensory experience. With this in mind, we investigate the ability of monkeys to detect and discriminate trains of electrical pulses delivered to their somatosensory cortex through chronically implanted electrode arrays. We show that artificial touch is highly dependent on various features of the electrical stimuli and discuss the implications of our results for the use of electrical stimulation in neuroscience and neural engineering.},
address  = {Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL  60637; Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL  60637; Committee on Computational Neuroscience, University of Chicago, Chicago, IL 60637; Department of Physical Medicine and Rehabilitation, University of Pittsburgh, Pittsburgh, PA 15213; Research and Exploratory Development Department, Applied Physics Laboratory, Johns Hopkins University, Laurel, MD 20723 Department of Organismal Biology and Anatomy, University of Chicago, Chicago, IL  60637;},
note  = {doi:10.1073/pnas.1509265112.}
}

@Article{2015532,
author  = {Wu, Y. and Stangl, E. and Zhang, X. and Bentler, R.},
title  = {Construct Validity of the Ecological Momentary Assessment in Audiology Research.},
journal  = {Journal of the American Academy of Audiology},
volume  = {26},
number  = {10},
pages  = {872-84},
year  = {2015},
abstract  = {Background: Ecological momentary assessment (EMA) is a methodology involving repeated assessments/surveys to collect data describing respondents‚Äô current or very recent experiences and related contexts in their natural environments. The use of EMA in audiology research is growing. Purpose: This study examined the construct validity (i.e., the degree to which a measurement reflects what it is intended to measure) of EMA in terms of measuring speech understanding and related listening context. Experiment 1 investigated the extent to which individuals can accurately report their speech recognition performance and characterize the listening context in controlled environments. Experiment 2 investigated whether the data aggregated across multiple EMA surveys conducted in uncontrolled, real-world environments would reveal a valid pattern that was consistent with the established relationships between speech understanding, hearing aid use, listening context, and lifestyle. Research Design: This is an observational study. Study Sample: Twelve and twenty-seven adults with hearing impairment participated in Experiments 1 and 2, respectively. Data Collection and Analysis: In the laboratory testing of Experiment 1, participants estimated their speech recognition performance in settings wherein the signal-to-noise ratio was  fixed or constantly varied across sentences. In the field testing the participants reported the listening context (e.g., noisiness level) of several semicontrolled real-world conversations. Their reports were compared to (1) the context described by normal-hearing observers and (2) the background noise level  measured using a sound level meter. In Experiment 2, participants repeatedly reported the degree of speech understanding, hearing aid use, and listening context using paper-and-pencil journals in their natural environments for 1 week. They also carried noise dosimeters to measure the sound level. The associations between (1) speech understanding, hearing aid use, and listening context, (2) dosimeter sound level and self-reported noisiness level, and (3) dosimeter data and lifestyle quantified using the journals were examined. Results: For Experiment 1, the reported and measured speech recognition scores were highly correlated across all test conditions (r = 0.94 to 0.97). The field testing results revealed that most listening context properties reported by the participants were highly consistent with those described by the observers (74‚Äì95% consistency), except for noisiness rating (58%). Nevertheless, higher noisiness rating was associated with higher background noise level. For Experiment 2, the EMA results revealed several associations: better speech understanding was associated with the use of hearing aids, front-located speech, and lower dosimeter sound level; higher noisiness rating was associated with higher dosimeter sound level; listeners with more diverse lifestyles tended to have higher dosimeter sound levels. Conclusions: Adults with hearing impairment were able to report their listening experiences, such as speech understanding, and characterize listening context in controlled environments with reasonable accuracy. The pattern of the data aggregated across multiple EMA surveys conducted in a wide range of uncontrolled real-world environment was consistent with the established knowledge in audiology. The two experiments suggested that,  regarding speech understanding and related listening contexts, EMA reflects what  it is intended to measure, supporting its construct validity in audiology research.},
address  = {Department of Communication Sciences and Disorders, The University of Iowa, Iowa  City, IA 52242 Department of Communication Sciences and Disorders, The University of Iowa, Iowa  City, IA 52242 Department of Communication Sciences and Disorders, The University of Iowa, Iowa  City, IA 52242 Department of Communication Sciences and Disorders, The University of Iowa, Iowa  City, IA 52242},
note  = {J Am Acad Audiol. 2015 Nov-Dec;26(10):872-84. doi:10.3766/jaaa.15034.}
}

@Article{2001533,
author  = {},
title  = {Poster presentations.},
journal  = {British Journal of Cancer},
volume  = {85},
number  = {Suppl 1},
pages  = {33-109},
year  = {2001},
abstract  = {},
address  = {},
note  = {Br J Cancer. 2001;85(Suppl 1):33-109. doi:10.1054/bjoc.2001.1918.}
}

@Article{2004534,
author  = {},
title  = {IHPBA World Congress abstracts ‚Äì Free Papers and Videos.},
journal  = {Association},
volume  = {6},
number  = {Suppl 1},
pages  = {1-64},
year  = {2004},
abstract  = {},
address  = {},
note  = {HPB (Oxford). 2004;6(Suppl 1):1-64. doi:10.1080/16515320410032700.}
}

@Article{2014535,
author  = {Hernandez, C. and Mallow, J. and Narsavage, G.},
title  = {Delivering telemedicine interventions in chronic respiratory disease.},
journal  = {Breathe (Sheffield, England)},
volume  = {10},
number  = {3},
pages  = {198-212},
year  = {2014},
abstract  = {},
address  = {Integrated Care Unit, Hospital Clinic, Barcelona Spain School of Nursing and West Virginia Clinical Translational Science Institute (WVCTSI), West Virginia University (WVU), Morgantown, WV, USA Robert C. Byrd Health Sciences Center, Mary Babb Randolph Cancer Center, and WVCTSI, West Virginia University, Morgantown, WV, USA},
note  = {Breathe (Sheff). 2014 Sep;10(3):198-212. doi:10.1183/20734735.008314.}
}

@Article{2014536,
author  = {Mishra, J. and Gazzaley, A.},
title  = {cognitive rehabilitation.},
journal  = {Frontiers in Human Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {},
address  = {},
note  = {Front Hum Neurosci. 2014 Apr 11;8:. doi:10.3389/fnhum.2014.00218.}
}

@Article{537,
author  = {Lobatto, M. and Fuster, V. and Fayad, Z. and Mulder, W.},
title  = {atherosclerosis.},
journal  = {Nature reviews. Drug discovery},
volume  = {10},
number  = {11},
pages  = {835-52},
year  = {},
abstract  = {The use of nanotechnology for medical purposes ‚Äî nanomedicine ‚Äî has grown exponentially over the past few decades. This is exemplified by the US Food and Drug Administration‚Äôs approval of several nanotherapies for various conditions, as well as the funding of nanomedical programmes worldwide. Although originally the domain of anticancer therapy, recent advances have illustrated the considerable potential of nanomedicine in the diagnosis and treatment of atherosclerosis. This Review elaborates on nanoparticle-targeting concepts in atherosclerotic disease, provides an overview of the use of nanomedicine in atherosclerosis, and discusses potential future applications and clinical benefits.},
address  = {Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, BOX 1234, New York 10029, USA. Department of Cardiology, Zena and Michael A. Weiner Cardiovascular Institute and Marie-Jos√©e and Henry R. Kravis Cardiovascular Health Center, Mount Sinai School  of Medicine, One Gustave L. Levy Place, New York 10029, USA. Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, BOX 1234, New York 10029, USA. Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, BOX 1234, New York 10029, USA.},
note  = {Nat Rev Drug Discov. ;10(11):835-52. doi:10.1038/nrd3578.}
}

@Article{2015538,
author  = {Ziegelwanger, H. and Majdak, P. and Kreuzer, W.},
title  = {sound localization: Microphone model and mesh discretization.},
journal  = {The Journal of the Acoustical Society of America},
volume  = {138},
number  = {1},
pages  = {208},
year  = {2015},
abstract  = {Head-related transfer functions (HRTFs) can be numerically calculated by applying the boundary element method on the geometry of a listener‚Äôs head and pinnae. The  calculation results are defined by geometrical, numerical, and acoustical parameters like the microphone used in acoustic measurements. The scope of this study was to estimate requirements on the size and position of the microphone model and on the discretization of the boundary geometry as triangular polygon mesh for accurate sound localization. The evaluation involved the analysis of localization errors predicted by a sagittal-plane localization model, the comparison of equivalent head radii estimated by a time-of-arrival model, and the analysis of actual localization errors obtained in a sound-localization experiment. While the average edge length (AEL) of the mesh had a negligible effect on localization performance in the lateral dimension, the localization performance in sagittal planes, however, degraded for larger AELs with the geometrical error as dominant factor. A microphone position at an arbitrary position at the entrance of the ear canal, a microphone size of 1 mm radius, and  a mesh with 1 mm AEL yielded a localization performance similar to or better than observed with acoustically measured HRTFs.},
address  = {},
note  = {J Acoust Soc Am. 2015 Jul;138(1):208. doi:10.1121/1.4922518.}
}

@Article{2016539,
author  = {Bor, R. and F√°bi√°n, A. and Szepes, Z.},
title  = {Role of ultrasound in colorectal diseases.},
journal  = {World Journal of Gastroenterology},
volume  = {22},
number  = {43},
pages  = {9477-87},
year  = {2016},
abstract  = {Ultrasound is an undervalued non-invasive examination in the diagnosis of colonic diseases. It has been replaced by the considerably more expensive magnetic resonance imaging and computed tomography, despite the fact that, as first examination, it can usefully supplement the diagnostic process. Transabdominal ultrasound can provide quick information about bowel status and help in the choice of adequate further examinations and treatment. Ultrasonography, as a screening imaging modality in asymptomatic patients can identify several colonic  diseases such as diverticulosis, inflammatory bowel disease or cancer. In addition, it is widely available, cheap, non-invasive technique without the use of ionizing radiation, therefore it is safe to use in childhood or during pregnancy, and can be repeated at any time. New ultrasound techniques such as elastography, contrast enhanced and Doppler ultrasound, mini-probes rectal and transperineal ultrasonography have broadened the indication. It gives an overview of the methodology of various ultrasound examinations, presents the morphology of normal bowel wall and the typical changes in different colonic diseases. We will  pay particular attention to rectal and transperineal ultrasound because of their  outstanding significance in the diagnosis of rectal and perineal disorders. This  article seeks to overview the diagnostic impact and correct indications of bowel  ultrasound.},
address  = {},
note  = {doi:10.3748/wjg.v22.i43.9477.}
}

@Article{2015540,
author  = {Byun, T. and Halpin, P. and Szeredi, D.},
title  = {Online crowdsourcing for efficient rating of speech: A validation study.},
journal  = {Journal of communication disorders},
volume  = {53},
number  = {},
pages  = {70-83},
year  = {2015},
abstract  = {Blinded listener ratings are essential for valid assessment of interventions for  speech disorders, but collecting these ratings can be time-intensive and costly.  This study evaluated the validity of speech ratings obtained through online crowdsourcing, a potentially more efficient approach. 100 words from children with /r/ misarticulation were electronically presented for binary rating by 35 phonetically trained listeners and 205 na√Øve listeners recruited through the Amazon Mechanical Turk (AMT) crowdsourcing platform. Bootstrapping was used to compare different-sized samples of AMT listeners against a ‚Äúgold standard‚Ä? (mode  across all trained listeners) and an ‚Äúindustry standard‚Ä? (mode across bootstrapped samples of 3 trained listeners). There was strong overall agreement  between trained and AMT listeners. The ‚Äúindustry standard‚Ä? level of performance was matched by bootstrapped samples with n = 9 AMT listeners. These results support the hypothesis that valid ratings of speech data can be obtained in an efficient manner through AMT. Researchers in communication disorders could benefit from increased awareness of this method.},
address  = {},
note  = {doi:10.1016/j.jcomdis.2014.11.003.}
}

@Article{2013541,
author  = {Sokoloff, P. and Leriche, L. and Diaz, J. and Louvel, J. and Pumain, R.},
title  = {pathways: implications for the treatment of schizophrenia.},
journal  = {Naunyn-Schmiedeberg's Archives of Pharmacology},
volume  = {386},
number  = {2},
pages  = {107-24},
year  = {2013},
abstract  = {This article, based on original data as well as on previously reported preclinical and clinical data that are reviewed, describes direct and indirect interactions of the D3 receptor with N-methyl-d-aspartate receptor (NMDA) signaling and their functional consequences and therapeutic implications for schizophrenia. D3 receptor immunoreactivity at ultrastructural level with electron microscopy was identified at presumably glutamatergic, asymmetric synapses of the medium-sized spiny neurons of the nucleus accumbens. This finding supports the existence of a direct interaction of the D3 receptor with glutamate, in line with previously described interactions with NMDA signaling involving Ca2+/calmodulin-dependent protein kinase II at post-synaptic densities (Liu et al. 2009). Indirect interactions of the D3 receptor with glutamate could involve  a negative control exerted by the D3 receptor on mesocortical dopamine neurons and the complex regulation of the glutamatergic pyramidal cells by dopamine in the prefrontal cortex. This could be exemplified here by the regulation of pyramidal cell activity in conditions of chronic NMDA receptor blockade with dizocilpine (MK-801). BP897, a D3 receptor-selective partial agonist, reversed the dysregulation of cortical c-fos mRNA expression and pyramidal cell hyperexcitability, as measured by paired-pulse electrophysiology. At the behavioral level, blockade of the D3 receptor, by known D3 receptor antagonists or the novel D3 receptor-selective antagonist F17141, produces antipsychotic-like effects in reversing hyperactivity and social interaction deficits induced by NMDA receptor blockade by MK-801 in mice. The glutamate‚ÄìD3 receptor interactions  described here offer a conceptual framework for developing new D3 receptor-selective drugs, which may appear as an original, efficacious, and safe  way to potentially indirectly target glutamate in schizophrenia.},
address  = {Pierre Fabre Research Center, Castres, 81100 France Pierre Fabre Research Center, Castres, 81100 France Neurobiology and Pharmacology (INSERM U573), Paris, 74014 France Neurobiology and Pharmacology (INSERM U573), Paris, 74014 France Neurobiology and Pharmacology (INSERM U573), Paris, 74014 France},
note  = {doi:10.1007/s00210-012-0797-0.}
}

@Article{2010542,
author  = {Derado, G. and Bowman, F. and Ely, T. and Kilts, C.},
title  = {Processing Networks*.},
journal  = {Statistics and its interface},
volume  = {3},
number  = {1},
pages  = {45-58},
year  = {2010},
abstract  = {Data-driven statistical approaches, such as cluster analysis or independent component analysis, applied to in vivo functional neuroimaging data help to identify neural processing networks that exhibit similar task-related or restingstate patterns of activity. Ideally, the measured brain activity for voxels within such networks should exhibit high autocorrelation. An important limitation is that the algorithms do not typically quantify or statistically test the strength or nature of the within-network relatedness between voxels. To extend the results given by such data-driven analyses, we propose the use of Moran‚Äôs I statistic to measure the degree of functional autocorrelation within identified neural processing networks and to evaluate the statistical significance of the observed associations. We adapt the conventional definition of Moran‚Äôs I, for applicability to neuroimaging analyses, by defining the global  autocorrelation index using network-based neighborhoods. Also, we compute network-specific contributions to the overall autocorrelation. We present results from a bootstrap analysis that provide empirical support for the use of our hypothesis testing framework. We illustrate our methodology using positron emission tomography (PET) data from a study that examines the neural representation of working memory among individuals with schizophrenia and functional magnetic resonance imaging (fMRI) data from a study of depression.},
address  = {Department of Biostatistics and Bioinformatics, The Rollins School of Public Health, Emory University, gderado@emory.edu Department of Biostatistics and Bioinformatics, The Rollins School of Public Health, Emory University, dbowma3@sph.emory.edu Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, tely01@emory.edu Department of Psychiatry and Behavioral Sciences, School of Medicine, Emory University, sdpcdk@emory.edu},
note  = {Stat Interface. 2010;3(1):45-58.}
}

@Article{543,
author  = {Loo, S. and Lenartowicz, A. and Makeig, S.},
title  = {directions.},
journal  = {Journal of child psychology and psychiatry, and allied disciplines},
volume  = {},
number  = {},
pages  = {},
year  = {},
abstract  = {Background: Electroencephalography (EEG) and related measures have a long and productive history in child psychopathology research and are currently experiencing a renaissance in interest, particularly for use as putative biomarkers. Method and Scope: First, the recent history leading to the use of EEG measures as endophenotypes and biomarkers for disease and treatment response are  reviewed. Two key controversies within the area of non-invasive human electrophysiology research are discussed, and problems that currently either function as barriers or provide gateways to progress. First, the differences between the main types of EEG measurements (event related potentials, quantitative EEG, and time-frequency measures) and how they can contribute collectively to better understanding of cortical dynamics underlying cognition and behavior are highlighted. Second, we focus on the ongoing shift in analytic focus to specific cortical sources and source networks whose dynamics are relevant to the clinical and experimental focus of the study, and the effective increase in source signal-to-noise ratio (SNR) that may be obtained in the process. Conclusions: Understanding of these issues informs any discussion of current trends in EEG research. We highlight possible ways to evolve our understanding of brain dynamics beyond the apparent contradictions in understanding and modeling EEG activity highlighted by these controversies. Finally, we summarize some promising future directions of EEG biomarker research  in child psychopathology.},
address  = {Semel Neuropsychiatric Institute, David Geffen School of Medicine, UCLA, CA, USA Semel Neuropsychiatric Institute, David Geffen School of Medicine, UCLA, CA, USA Swartz Center for Computational Neuroscience, UCSD, CA, USA},
note  = {J Child Psychol Psychiatry. ;:. doi:10.1111/jcpp.12435.}
}

@Article{2009544,
author  = {Gatto, C. and Broadie, K.},
title  = {Consolidation.},
journal  = {Molecular neurobiology},
volume  = {39},
number  = {2},
pages  = {},
year  = {2009},
abstract  = {The control of new protein synthesis provides a means to locally regulate the availability of synaptic components necessary for dynamic neuronal processes. The Fragile X Mental Retardation Protein (FMRP), an RNA-binding translational regulator, is a key player mediating appropriate synaptic protein synthesis in response to neuronal activity levels. Loss of FMRP causes Fragile X Syndrome (FraX), the most commonly inherited form of mental retardation and autism spectrum disorders. FraX-associated translational dysregulation causes wide-ranging neurological deficits including severe impairments of biological rhythms, learning processes and memory consolidation. Dysfunction in cytoskeletal regulation and synaptic scaffolding disrupts neuronal architecture and functional synaptic connectivity. The understanding of this devastating disease and the implementation of meaningful treatment strategies require a thorough exploration  of the temporal and spatial requirements for FMRP in establishing and maintaining neural circuit function.},
address  = {},
note  = {Mol Neurobiol. 2009 Apr;39(2):. Epub 2009 Feb 12 doi:10.1007/s12035-009-8057-0.}
}

@Article{2013545,
author  = {Nam, H. and Park, E. and Heo, J.},
title  = {Facilitating Stroke Management using Modern Information Technology.},
journal  = {Journal of Stroke},
volume  = {15},
number  = {3},
pages  = {135-43},
year  = {2013},
abstract  = {Background and Purpose: Information technology and mobile devices may be beneficial and useful in many aspects of stroke management, including recognition of stroke, transport and triage of patients, emergent stroke evaluation at the hospital, and rehabilitation. In this review, we address the contributions of information technology and mobile health to stroke management. Summary of Issues: Rapid detection and triage are essential for effective thrombolytic treatment. Awareness of stroke warning signs and responses to stroke could be enhanced by using mobile applications. Furthermore, prehospital assessment and notification could be streamlined for use in telemedicine and teleradiology. A mobile telemedicine system for assessing the National Institutes of Health Stroke Scale  scores has shown higher correlation and fast assessment comparing with face-to-face method. Because the benefits of thrombolytic treatment are time-dependent, treatment should be initiated as quickly as possible. In-hospital communication between multidisciplinary team members can be enhanced using information technology. A computerized in-hospital alert system using computerized physician-order entry was shown to be effective in reducing the time intervals from hospital arrival to medical evaluations and thrombolytic treatment. Mobile devices can also be used as supplementary tools for neurologic  examination and clinical decision-making. In post-stroke rehabilitation, virtual  reality and telerehabilitation are helpful. Mobile applications might be useful for public awareness, lifestyle modification, and education/training of healthcare professionals. Conclusions: Information technology and mobile health are useful tools for management of stroke patients from the acute period to rehabilitation. Further improvement of technology will change and enhance stroke  prevention and treatment.},
address  = {Department of Neurology, Yonsei University College of Medicine, Seoul, Korea. Wireless Health Institute, University of California Los Angeles (UCLA), Los Angeles, United States. Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.},
note  = {J Stroke. 2013 Sep;15(3):135-43. Epub 2013 Sep 27 doi:10.5853/jos.2013.15.3.135.}
}

@Article{2012546,
author  = {Li, Z. and Chadalapaka, G. and Ramesh, A. and Khoshbouei, H. and Maguire, M. and Safe, S. and Rhoades, R. and Clark, R. and Jules, G. and McCallister, M. and Aschner, M. and Hood, D.},
title  = {In Utero Exposure to Inhaled Benzo(a)pyrene.},
journal  = {Toxicological Sciences},
volume  = {125},
number  = {1},
pages  = {233-47},
year  = {2012},
abstract  = {The wild-type (WT) Cprlox/lox (cytochrome P450 oxidoreductase, Cpr) mouse is an ideal model to assess the contribution of P450 enzymes to the metabolic activation and disposition of environmental xenobiotics. In the present study, we examined the effect of in utero exposure to benzo(a)pyrene [B(a)P] aerosol on Sp4 and N-methyl-D-aspartate (NMDA)‚Äìdependent systems as well as a resulting behavioral phenotype (object discrimination) in Cpr offspring. Results from in utero exposure of WT Cprlox/lox mice were compared with in utero exposed brain-Cpr-null offspring mice. Null mice were used as they do not express brain cytochrome P4501B1‚Äìassociated NADPH oxidoreductase (CYP1B1-associated NADPH oxidoreductase), thus reducing their capacity to produce neural B(a)P metabolites. Subsequent to in utero (E14‚ÄìE17) exposure to B(a)P (100 Œºg/m3), Cprlox/lox offspring exhibited: (1) elevated B(a)P metabolite and F2-isoprostane  neocortical tissue burdens, (2) elevated concentrations of cortical glutamate, (3) premature developmental expression of Sp4, (4) decreased subunit ratios of NR2B:NR2A, and (5) deficits in a novelty discrimination phenotype monitored to in utero exposed brain-Cpr-null offspring. Collectively, these findings suggest that in situ generation of metabolites by CYP1B1-associated NADPH oxidoreductase promotes negative effects on NMDA-mediated signaling processes during the period  when synapses are first forming as well as effects on a subsequent behavioral phenotype.},
address  = {Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral  Neuroscience, Meharry Medical College, Nashville, Tennessee 37208 Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843-4466 Department of Biochemistry and Cancer Biology Department of Physiology, Meharry Medical College, Nashville, Tennessee 37208 Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral  Neuroscience, Meharry Medical College, Nashville, Tennessee 37208 Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843-4466 Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral  Neuroscience, Meharry Medical College, Nashville, Tennessee 37208 Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral  Neuroscience, Meharry Medical College, Nashville, Tennessee 37208 Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral  Neuroscience, Meharry Medical College, Nashville, Tennessee 37208 Department of Pediatrics Department of Neuroscience and Pharmacology, Center for Molecular and Behavioral  Neuroscience, Meharry Medical College, Nashville, Tennessee 37208},
note  = {Toxicol Sci. 2012 Jan;125(1):233-47. Epub 2011 Oct 10 doi:10.1093/toxsci/kfr261.}
}

@Article{2012547,
author  = {Freeman, W. and Barrett, K. and Vatz, K. and Demaerschalk, B.},
title  = {Future Neurohospitalist: Teleneurohospitalist.},
journal  = {The Neurohospitalist},
volume  = {2},
number  = {4},
pages  = {132-43},
year  = {2012},
abstract  = {Despite the growing demand for emergency neurological evaluations and neurohospitalists, the supply of neurologists remains relatively fixed over time.  Telemedicine is a unique tool that has the ability to put a medical specialist like a neurologist in 2 places in a relatively short period of time, expanding expertise in many rural and in some underserved urban facilities that would ordinarily be devoid of such expertise. Teleneurology is a branch of telemedicine that consults and practices through remote neurological evaluation.  Telestroke is defined as remote stroke evaluation. The demand for timely neurological evaluation, especially acute stroke evaluation and treatment with intravenous recombinant tissue plasminogen activator (IV rtPA), continues to fuel the growth of neurohospitalists, telestroke, and teleneurology services.  Remote, rural, or underserved urban emergency departments and hospitals which are unable  to successfully recruit a neurologist or neurohospitalist to provide this service are uniquely suited to a teleneurology option.  The number of private practices and academic centers providing telestroke services has grown significantly in the past decade with continued growth expected.  We describe the benefits and drawbacks of teleneurology/telestroke, as well as other practical aspects for the teleneurohospitalist.},
address  = {Department of Neurology, Mayo Clinic, Jacksonville, FL, USA Department of Neurology, Mayo Clinic, Jacksonville, FL, USA CommunityHealth, Chicago, IL, USA Department of Neurology, Mayo Clinic, Phoenix, AZ, USA},
note  = {Neurohospitalist. 2012 Oct;2(4):132-43. doi:10.1177/1941874412450714.}
}

@Article{2014548,
author  = {Meyer, T. and Peters, J. and Zander, T. and Sch√∂lkopf, B. and Grosse-Wentrup, M.},
title  = {Predicting motor learning performance from Electroencephalographic data.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {11},
number  = {},
pages  = {24},
year  = {2014},
abstract  = {Background: Research on the neurophysiological correlates of visuomotor integration and learning (VMIL) has largely focused on identifying learning-induced activity changes in cortical areas during motor execution. While such studies have generated valuable insights into the neural basis of VMIL, little is known about the processes that represent the current state of VMIL independently of motor execution. Here, we present empirical evidence that a subject‚Äôs performance in a 3D reaching task can be predicted on a trial-to-trial  basis from pre-trial electroencephalographic (EEG) data. This evidence provides novel insights into the brain states that support successful VMIL. Methods: Six healthy subjects, attached to a seven degrees-of-freedom (DoF) robot with their right arm, practiced 3D reaching movements in a virtual space, while an EEG recorded their brain‚Äôs electromagnetic field. A random forest ensemble classifier was used to predict the next trial‚Äôs performance, as measured by the time needed  to reach the goal, from pre-trial data using a leave-one-subject-out cross-validation procedure. Results: The learned models successfully generalized  to novel subjects. An analysis of the brain regions, on which the models based their predictions, revealed areas matching prevalent motor learning models. In these brain areas, the Œ±/Œº frequency band (8‚Äì14 Hz) was found to be most relevant for performance prediction. Conclusions: VMIL induces changes in cortical processes that extend beyond motor execution, indicating a more complex role of these processes than previously assumed. Our results further suggest that the capability of subjects to modulate their Œ±/Œº bandpower in brain regions associated with motor learning may be related to performance in VMIL. Accordingly, training subjects in Œ±/Œº-modulation, e.g., by means of a brain-computer interface (BCI), may have a beneficial impact on VMIL.},
address  = {Department Empirical Inference, Max Planck Institute for Intelligent Systems, T√ºbingen, Germany Department Empirical Inference, Max Planck Institute for Intelligent Systems, T√ºbingen, Germany Department Empirical Inference, Max Planck Institute for Intelligent Systems, T√ºbingen, Germany Department Empirical Inference, Max Planck Institute for Intelligent Systems, T√ºbingen, Germany Department Empirical Inference, Max Planck Institute for Intelligent Systems, T√ºbingen, Germany},
note  = {J Neuroeng Rehabil. 2014 Mar 4;11:24. doi:10.1186/1743-0003-11-24.}
}

@Article{2011549,
author  = {Cox, T. and Erler, J.},
title  = {diseases and cancer.},
journal  = {Disease Models & Mechanisms},
volume  = {4},
number  = {2},
pages  = {165-78},
year  = {2011},
abstract  = {Dynamic remodeling of the extracellular matrix (ECM) is essential for development, wound healing and normal organ homeostasis. Life-threatening pathological conditions arise when ECM remodeling becomes excessive or uncontrolled. In this Perspective, we focus on how ECM remodeling contributes to  fibrotic diseases and cancer, which both present challenging obstacles with respect to clinical treatment, to illustrate the importance and complexity of cell-ECM interactions in the pathogenesis of these conditions. Fibrotic diseases, which include pulmonary fibrosis, systemic sclerosis, liver cirrhosis and cardiovascular disease, account for over 45% of deaths in the developed world. ECM remodeling is also crucial for tumor malignancy and metastatic progression, which ultimately cause over 90% of deaths from cancer. Here, we discuss current methodologies and models for understanding and quantifying the impact of environmental cues provided by the ECM on disease progression, and how improving  our understanding of ECM remodeling in these pathological conditions is crucial for uncovering novel therapeutic targets and treatment strategies. This can only  be achieved through the use of appropriate in vitro and in vivo models to mimic disease, and with technologies that enable accurate monitoring, imaging and quantification of the ECM.},
address  = {Cancer Research UK Tumour Cell Signalling Unit, Section of Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK Cancer Research UK Tumour Cell Signalling Unit, Section of Cell and Molecular Biology, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK},
note  = {Dis Model Mech. 2011 Mar;4(2):165-78. doi:10.1242/dmm.004077.}
}

@Article{2016550,
author  = {Cogan, S. and Ludwig, K. and Welle, C. and Takmakov, P.},
title  = {Tissue damage thresholds during therapeutic electrical stimulation.},
journal  = {Journal of neural engineering},
volume  = {13},
number  = {2},
pages  = {021001},
year  = {2016},
abstract  = {Objective: Recent initiatives in bioelectronic modulation of the nervous system by the NIH (SPARC), DARPA (ElectRx, SUBNETS) and the GlaxoSmithKline Bioelectronic Medicines effort are ushering in a new era of therapeutic electrical stimulation. These novel therapies are prompting a re-evaluation of established electrical thresholds for stimulation-induced tissue damage. Approach: In this review, we explore what is known and unknown in published literature regarding tissue damage from electrical stimulation. Main results: For macroelectrodes, the potential for tissue damage is often assessed by comparing the intensity of stimulation, characterized by the charge density and charge per  phase of a stimulus pulse, with a damage threshold identified through histological evidence from in vivo experiments as described by the Shannon equation. While the Shannon equation has proved useful in assessing the likely occurrence of tissue damage, the analysis is limited by the experimental parameters of the original studies. Tissue damage is influenced by factors not explicitly incorporated into the Shannon equation, including pulse frequency, duty cycle, current density, and electrode size. Microelectrodes in particular do not follow the charge per phase and charge density co-dependence reflected in the Shannon equation. The relevance of these factors to tissue damage is framed in the context of available reports from modeling and in vivo studies. Significance: It is apparent that emerging applications, especially with microelectrodes, will  require clinical charge densities that exceed traditional damage thresholds. Experimental data show that stimulation at higher charge densities can be achieved without causing tissue damage, suggesting that safety parameters for microelectrodes might be distinct from those defined for macroelectrodes. However, these increased charge densities may need to be justified by bench, non-clinical or clinical testing to provide evidence of device safety.},
address  = {The Department of Bioengineering, The University of Texas at Dallas, Richardson,  TX, USA Department of Neurological Surgery, Mayo Clinic, Rochester, MD, USA FDA/CDRH/OSEL/DBP, Silver Spring, MD, USA FDA/CDRH/OSEL/DBCMS, Silver Spring, MD, USA},
note  = {doi:10.1088/1741-2560/13/2/021001.}
}

@Article{2015551,
author  = {Hicks, J. and Uchida, T. and Seth, A. and Rajagopal, A. and Delp, S.},
title  = {Musculoskeletal Models and Simulations of Movement.},
journal  = {Journal of Biomechanical Engineering},
volume  = {137},
number  = {2},
pages  = {0209051-02090524},
year  = {2015},
abstract  = {Computational modeling and simulation of neuromusculoskeletal (NMS) systems enables researchers and clinicians to study the complex dynamics underlying human and animal movement. NMS models use equations derived from physical laws and biology to help solve challenging real-world problems, from designing prosthetics that maximize running speed to developing exoskeletal devices that enable walking after a stroke. NMS modeling and simulation has proliferated in the biomechanics  research community over the past 25 years, but the lack of verification and validation standards remains a major barrier to wider adoption and impact. The goal of this paper is to establish practical guidelines for verification and validation of NMS models and simulations that researchers, clinicians, reviewers, and others can adopt to evaluate the accuracy and credibility of modeling studies. In particular, we review a general process for verification and validation applied to NMS models and simulations, including careful formulation of a research question and methods, traditional verification and validation steps, and documentation and sharing of results for use and testing by other researchers. Modeling the NMS system and simulating its motion involves methods to represent neural control, musculoskeletal geometry, muscle‚Äìtendon dynamics, contact forces, and multibody dynamics. For each of these components, we review modeling choices and software verification guidelines; discuss variability, errors, uncertainty, and sensitivity relationships; and provide recommendations for verification and validation by comparing experimental data and testing robustness. We present a series of case studies to illustrate key principles. In  closing, we discuss challenges the community must overcome to ensure that modeling and simulation are successfully used to solve the broad spectrum of problems that limit human mobility.},
address  = {Department of Bioengineering, Stanford University, Stanford, CA 94305e-mail:‚ÄÇjenhicks@stanford.edu Department of Bioengineering, Stanford University, Stanford, CA 94305 Department of Bioengineering, Stanford University, Stanford, CA 94305 Department of Mechanical Engineering, Stanford University, Stanford, CA 94305 Department of Bioengineering and the Department of Mechanical Engineering, Stanford University, Stanford, CA 94305},
note  = {J Biomech Eng. 2015 Feb;137(2):0209051-02090524. doi:10.1115/1.4029304.}
}

@Article{2011552,
author  = {Bliss, T. and Cooke, S.},
title  = {Long-term potentiation and long-term depression: a clinical perspective.},
journal  = {Clinics},
volume  = {66},
number  = {Suppl 1},
pages  = {3-17},
year  = {2011},
abstract  = {Long-term potentiation and long-term depression are enduring changes in synaptic  strength, induced by specific patterns of synaptic activity, that have received much attention as cellular models of information storage in the central nervous system. Work in a number of brain regions, from the spinal cord to the cerebral cortex, and in many animal species, ranging from invertebrates to humans, has demonstrated a reliable capacity for chemical synapses to undergo lasting changes in efficacy in response to a variety of induction protocols. In addition to their physiological relevance, long-term potentiation and depression may have important clinical applications. A growing insight into the molecular mechanisms underlying these processes, and technological advances in non-invasive manipulation of brain activity, now puts us at the threshold of harnessing long-term potentiation and depression and other forms of synaptic, cellular and circuit plasticity to manipulate synaptic strength in the human nervous system. Drugs may be used to erase or treat pathological synaptic states and non-invasive stimulation devices  may be used to artificially induce synaptic plasticity to ameliorate conditions arising from disrupted synaptic drive. These approaches hold promise for the treatment of a variety of neurological conditions, including neuropathic pain, epilepsy, depression, amblyopia, tinnitus and stroke.},
address  = {National Institute for Medical Research, Ridgeway, Mill Hill, London, U.K. Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, Massachusetts, U.S.},
note  = {doi:10.1590/S1807-59322011001300002.}
}

@Article{2008553,
author  = {Medvedev, A. and Kainerstorfer, J. and Borisov, S. and Barbour, R. and VanMeter, J.},
title  = {detection by the Independent Component Analysis.},
journal  = {Brain research},
volume  = {1236},
number  = {},
pages  = {145-58},
year  = {2008},
abstract  = {Noninvasive recording of fast optical signals presumably reflecting neuronal activity is a challenging task because of a relatively low signal-to-noise ratio. To improve detection of those signals in rapid object recognition tasks, we used  the Independent Component Analysis (ICA) to reduce ‚Äúglobal interference‚Ä? (heartbeat and contribution of superficial layers). We recorded optical signals from the left prefrontal cortex in 10 right-handed participants with a continuous-wave instrument (DYNOT, NIRx, Brooklyn, NY). Visual stimuli were pictures of urban, landscape and seashore scenes with various vehicles as targets (target-to-non-target ratio 1:6) presented at ISI = 166 ms or 250 ms. Subjects mentally counted targets. Data were filtered at 2‚Äì30 Hz and artifactual components were identified visually (for heartbeat) and using the ICA weight matrix (for superficial layers). Optical signals were restored from the ICA components with artifactual components removed and then averaged over target and  non-target epochs. After ICA processing, the event-related response was detected  in 70‚Äì100% of subjects. The refined signal showed a significant decrease from baseline within 200‚Äì300 ms after targets and a slight increase after non-targets. The temporal profile of the optical signal corresponded well to the profile of a  ‚Äúdifferential ERP response‚Ä?, the difference between targets and non-targets which peaks at 200 ms in similar object detection tasks. These results demonstrate that the detection of fast optical responses with continuous-wave instruments can be improved through the ICA method capable to remove noise, global interference and  the activity of superficial layers. Fast optical signals may provide further information on brain processing during higher-order cognitive tasks such as rapid categorization of objects.},
address  = {Center for Functional and Molecular Imaging, Department of Neurology, Georgetown  University Medical Center, Washington, DC 20057, USA Department of Physics, University of Vienna, Vienna, Austria Center for Functional and Molecular Imaging, Department of Neurology, Georgetown  University Medical Center, Washington, DC 20057, USA Department of Pathology, State University of New York Downstate Medical Center, New York 11203, USA Center for Functional and Molecular Imaging, Department of Neurology, Georgetown  University Medical Center, Washington, DC 20057, USA},
note  = {doi:10.1016/j.brainres.2008.07.122.}
}

@Article{2013554,
author  = {Ortiz-Catalan, M. and Marin-Millan, J. and Delbeke, J. and H√•kansson, B. and Br√•nemark, R.},
title  = {electrodes into smaller recording areas.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {10},
number  = {},
pages  = {22},
year  = {2013},
abstract  = {Background: Cuff electrodes have been widely used chronically in different clinical applications. This neural interface has been dominantly used for nerve stimulation while interfering noise is the major issue when employed for recording purposes. Advancements have been made in rejecting extra-neural interference by using continuous ring contacts in tripolar topologies. Ring contacts provide an average of the neural activity, and thus reduce the information retrieved. Splitting these contacts into smaller recording areas could potentially increase the information content. In this study, we investigate the impact of such discretization on the Signal-to-Noise Ratio (SNR). The effect  of contacts positioning and an additional short circuited pair of electrodes were also addressed. Methods: Different recording configurations using ring, dot, and  a mixed of both contacts were studied in vitro in a frog model. An interfering signal was induced in the medium to simulate myoelectric noise. The experimental  setup was design in such a way that the only difference between recordings was the configuration used. The inter-session experimental differences were taken care of by a common configuration that allowed normalization between electrode designs. Results: It was found that splitting all contacts into small recording areas had negative effects on noise rejection. However, if this is only applied to the central contact creating a mixed tripole configuration, a considerable and statistically significant improvement was observed. Moreover, the signal to noise ratio was equal or larger than what can be achieved with the best known configuration, namely the short circuited tripole. This suggests that for recording purposes, any tripole topology would benefit from splitting the central contact into one or more discrete contacts. Conclusions: Our results showed that  a mixed tripole configuration performs better than the configuration including only ring contacts. Therefore, splitting the central ring contact of a cuff electrode into a number of dot contacts not only provides additional information  but also an improved SNR. In addition, the effect of an additional pair of short  circuited electrodes and the ‚Äúend effect‚Ä? observed with the presented method are  in line with previous findings by other authors.},
address  = {Department of Signals and Systems, Biomedical Engineering Division, Chalmers, University of Technology, Gothenburg, Sweden School of Medicine (MD), Institute of Neuroscience (SSS/IoNS/COSY), Universit√© Catholique de Louvain, Brussels, Belgium School of Medicine (MD), Institute of Neuroscience (SSS/IoNS/COSY), Universit√© Catholique de Louvain, Brussels, Belgium Department of Signals and Systems, Biomedical Engineering Division, Chalmers, University of Technology, Gothenburg, Sweden Centre of Orthopaedic Osseointegration, Department of Orthopaedics, Sahlgrenska University Hospital, Gothenburg, Sweden},
note  = {J Neuroeng Rehabil. 2013 Feb 21;10:22. doi:10.1186/1743-0003-10-22.}
}

@Article{2011555,
author  = {Christianson, J. and Jennings, J. and Ragole, T. and Flyer, J. and Benison, A. and Barth, D. and Watkins, L. and Maier, S.},
title  = {involving the sensory insular cortex and bed nucleus of the stria terminalis.},
journal  = {Biological psychiatry},
volume  = {70},
number  = {5},
pages  = {458-64},
year  = {2011},
abstract  = {BACKGROUND: Safety signals exert a powerful buffering effect when provided during exposure to uncontrollable stressors. We evaluated the role of the sensory insular cortex (Si) and the extend amygdala in this ‚Äúsafety signal effect.‚Ä? METHODS: Rats were implanted with microinjection cannula, exposed to inescapable  tailshocks either with or without a safety signal and later tested for anxiety-like behavior or neuronal Fos expression. RESULTS: Exposure to the uncontrollable stressor reduced later social exploration, but not when safety signals were present. Temporary inhibition of Si during stressor exposure, but not during later behavioral testing, blocked the safety signal effect on social exploration. The stressor induced Fos in all regions of the amygdala, but safety  signals significantly reduced the number of Fos immunoreactive cells in the basolateral amygdala and ventrolateral region of the bed nucleus of the stria terminalis (BNSTlv). Inhibition of BNSTlv neuronal activity during uncontrollable stressor exposure prevented the later reduction in social exploration. Finally, safety signals reduced the time spent freezing during uncontrollable stress. CONCLUSIONS: These data suggest that safety signals inhibit the neural fear or anxiety response that normally occurs during uncontrollable stressors and that inhibition of the BNSTlv is sufficient to prevent later anxiety. These data lend  support to a growing body of evidence that chronic fear is mediated in the basolateral amygdala and BNSTlv and that environmental factors that modulate fear during stress will alter the long-term consequences of the stressor.},
address  = {},
note  = {Biol Psychiatry. 2011 Sep 1;70(5):458-64. doi:10.1016/j.biopsych.2011.04.004.}
}

@Article{2009556,
author  = {Mor√≠n, M. and Bryan, K. and Mayo-Merino, F. and Goodyear, R. and Menc√≠a, √. and Modamio-H√∏ybj√∏r, S. and del, C. and Cabalka, J. and Richardson, G. and Moreno, F. and Rubenstein, P. and Moreno-Pelayo, M.},
title  = {cause DFNA20/26 hearing impairment.},
journal  = {Human Molecular Genetics},
volume  = {18},
number  = {16},
pages  = {3075-89},
year  = {2009},
abstract  = {Here we report the functional assessment of two novel deafness-associated Œ≥-actin mutants, K118N and E241K, in a spectrum of different situations with increasing biological complexity by combining biochemical and cell biological analysis in yeast and mammalian cells. Our in vivo experiments showed that while the K118N had a very mild effect on yeast behaviour, the phenotype caused by the E241K mutation was very severe and characterized by a highly compromised ability to grow on glycerol as a carbon source, an aberrant multi-vacuolar pattern and the deposition of thick F-actin bundles randomly in the cell. The latter feature is consistent with the highly unusual spontaneous tendency of the E241K mutant to form bundles in vitro, although this propensity to bundle was neutralized by tropomyosin and the E241K filament bundles were hypersensitive to severing in the presence of cofilin. In transiently transfected NIH3T3 cells both mutant actins were normally incorporated into cytoskeleton structures, although cytoplasmic aggregates were also observed indicating an element of abnormality caused by the  mutations in vivo. Interestingly, gene-gun mediated expression of these mutants in cochlear hair cells results in no gross alteration in cytoskeletal structures  or the morphology of stereocilia. Our results provide a more complete picture of  the biological consequences of deafness-associated Œ≥-actin mutants and support the hypothesis that the post-lingual and progressive nature of the DFNA20/26 hearing loss is the result of a progressive deterioration of the hair cell cytoskeleton over time.},
address  = {Unidad de Gen√©tica Molecular, Hospital Ram√≥n y Cajal, 28034 Madrid, Spain Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA Unidad de Gen√©tica Molecular, Hospital Ram√≥n y Cajal, 28034 Madrid, Spain School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QG, UK Unidad de Gen√©tica Molecular, Hospital Ram√≥n y Cajal, 28034 Madrid, Spain Unidad de Gen√©tica Molecular, Hospital Ram√≥n y Cajal, 28034 Madrid, Spain Unidad de Gen√©tica Molecular, Hospital Ram√≥n y Cajal, 28034 Madrid, Spain Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA School of Life Sciences, University of Sussex, Falmer, Brighton BN1 9QG, UK Unidad de Gen√©tica Molecular, Hospital Ram√≥n y Cajal, 28034 Madrid, Spain Department of Biochemistry, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA Unidad de Gen√©tica Molecular, Hospital Ram√≥n y Cajal, 28034 Madrid, Spain},
note  = {doi:10.1093/hmg/ddp249.}
}

@Article{2009557,
author  = {Lozano, C. and Kaczmarek, K. and Santello, M.},
title  = {and cross-modality estimation.},
journal  = {Somatosensory & motor research},
volume  = {26},
number  = {2},
pages  = {50-63},
year  = {2009},
abstract  = {Due to its high sensitivity and conductivity, electrotactile stimulation (ETS) on the tongue has proven to be a useful and technically convenient tool to substitute and/or augment sensory capabilities. However, most of its applications have only provided spatial attributes and little is known about (a) the ability of the tongue's sensory system to process electrical stimuli of varying magnitudes and (b) how modulation of ETS intensity affects subjects' ability to decode stimulus intensity. We addressed these questions by quantifying: (1) the magnitude of the dynamic range (DR; maximal comfortable intensity/perception threshold) and its sensitivity to prolonged exposure; (2) subjects' ability to perceive intensity changes; and (3) subjects' ability to associate intensity with angular excursions of a protractor's handle. We found that the average DR (17 dB) was generally large in comparison with other tactile loci and of a relatively constant magnitude among subjects, even after prolonged exposure, despite a slight but significant upward drift (P < 0.001). Additionally, our results showed that as stimulus intensity increased, subjects' ability to discriminate ETS stimuli of different intensities improved (P < 0.05) while estimation accuracy, in general, slightly decreased (increasing underestimation). These results suggest that higher ETS intensity may increase recruitment of rapidly adapting mechanoreceptor fibers, as these are specialized for coding stimulus differences  rather than absolute intensities. Furthermore, our study revealed that the tongue's sensory system can effectively convey electrical stimuli despite minimal practice and when information transfer is limited by memory and DR drift.},
address  = {Department of Kinesiology, Arizona State University, Tempe, AZ 85287. USA Department of Orthopedics and Rehabilitation Medicine and Department of Biomedical Engineering, University of Wisconsin, Madison, WI 53706, USA Department of Kinesiology, Arizona State University, Tempe, AZ 85287. USA},
note  = {Somatosens Mot Res. 2009 Jun;26(2):50-63. doi:10.1080/08990220903158797.}
}

@Article{2009558,
author  = {Walker, J. and Cassidy, J. and Sharpe, M.},
title  = {care, compared to usual care alone in patients with lung cancer.},
journal  = {Trials},
volume  = {10},
number  = {},
pages  = {92},
year  = {2009},
abstract  = {Background: Depression Care for People with Lung Cancer is a complex intervention delivered by specially trained cancer nurses, under the supervision of a psychiatrist. It is given as a supplement to the usual care for depression, which patients receive from their general practitioner and cancer service. The third Symptom Management Research Trial in Oncology (SMaRT Oncology-3 Trial) will test  its efficacy when compared to usual care alone. Design: A two arm parallel group  multi-centre randomised controlled trial. 200 patients will be recruited through  established systematic Symptom Monitoring Services, which screen patients for depression. Patients will have: a diagnosis of lung cancer; an estimated life expectancy of three months or more and a diagnosis of Major Depressive Disorder.  Patients will be randomised to usual care or usual care plus Depression Care for  People with Lung Cancer. Randomisation will be carried out by telephoning a secure computerised central randomisation system or by using a secure web interface. The primary outcome measure is average depression severity. This will  be assessed using scores on the 20-item Symptom Hopkins Checklist (SCL-20D), collected every four weeks over 32 weeks. Secondary outcomes include severity of  anxiety, pain and fatigue; self-rated improvement of depression; quality of life  and satisfaction with depression care. Trial Registration: Current controlled trials ISRCTN75905964},
address  = {Cancer Research UK, The University of Edinburgh Cancer Research Centre, Western General Hospital, Crewe Road, Edinburgh, UK Cancer Research UK, Department of Medical Oncology, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, UK Psychological Medicine Research, School of Molecular and Clinical Medicine, the University of Edinburgh, Kennedy Tower, Royal Edinburgh Hospital, Morningside Park, Edinburgh, UK},
note  = {Trials. 2009 Sep 30;10:92. doi:10.1186/1745-6215-10-92.}
}

@Article{2017559,
author  = {Ketelaar, M. and Van, D. and Dijk, F. and Klaassen, E. and Grotenboer, N. and Nawijn, M. and Dompeling, E. and Koppelman, G. and Murray, C. and Foden, P. and Lowe, L. and Durrington, H. and Custovic, A. and Simpson, A. and Simpson, A. and Shaw, D. and Sousa, A. and Fleming, L. and Roberts, G. and Pandis, I. and Bansal, A. and Corfield, J. and Wagers, S. and Djukanovic, R. and Chung, K. and Sterk, P. and Vestbo, J. and Fowler, S. and Tebbutt, S. and Singh, A. and Shannon, C. and Kim, Y. and Yang, C. and Gauvreau, G. and Fitzgerald, J. and Boulet, L. and O‚ÄôByrne, P. and Begley, N. and Loudon, A. and Ray, D. and Baos, S. and Cremades, L. and Calzada, D. and Lahoz, C. and C√°rdaba, B. and Asosingh, K. and Lauruschkat, C. and Queisser, K. and Wanner, N. and Weiss, K. and Xu, W. and Erzurum, S. and Sokolowska, M. and Chen, L. and Liu, Y. and Martinez-Anton, A. and Logun, C. and Alsaaty, S. and Cuento, R. and Cai, R. and Sun, J. and Quehenberger, O. and Armando, A. and Dennis, E. and Levine, S. and Shelhamer, J. and Choi, K. and Lazova, S. and Perenovska, P. and Miteva, D. and Priftis, S. and Petrova, G. and Yablanski, V. and Vlaev, E. and Rafailova, H. and Kumae, T. and Holmes, L. and Yorke, J. and Ryan, D. and Chinratanapisit, S. and Matchimmadamrong, K. and Deerojanawong, J. and Karoonboonyanan, W. and Sritipsukho, P. and Youroukova, V. and Dimitrova, D. and Slavova, Y. and Lesichkova, S. and Tzocheva, I. and Parina, S. and Angelova, S. and Korsun, N. and Craiu, M. and Stan, I. and Deliu, M. and Yavuz, T. and Sperrin, M. and Sahiner, U. and Belgrave, D. and Sackesen, C. and Kalayci, √. and Velikov, P. and Velikova, T. and Ivanova-Todorova, E. and Tumangelova-Yuzeir, K. and Kyurkchiev, D. and Megremis, S. and Constantinides, B. and Sotiropoulos, A. and Xepapadaki, P. and Robertson, D. and Papadopoulos, N. and Wilkinson, M. and Portsmouth, C. and Ray, D. and Goodacre, R. and Valerieva, A. and Bobolea, I. and Vera, D. and Gonzalez-Salazar, G. and Moreno, C. and Rodriguez, C. and De, L. and Wang, R. and Satia, I. and Niven, R. and Smith, J. and Southworth, T. and Plumb, J. and Gupta, V. and Pearson, J. and Ramis, I. and Lehner, M. and Miralpeix, M. and Singh, D. and Satia, I. and Woodhead, M. and O‚ÄôByrne, P. and Smith, J. and Forss, C. and Cook, P. and Brown, S. and Svedberg, F. and Stephenson, K. and Bertuzzi, M. and Bignell, E. and Enerb√§ck, M. and Cunoosamy, D. and Macdonald, A. and Liu, C. and Zhu, L. and Fukuda, K. and Zhang, C. and Ouyang, S. and Chen, X. and Qin, L. and Rachakonda, S. and Aronica, M. and Qin, J. and Li, X. and Larose, M. and Archambault, A. and Provost, V. and Chakir, J. and Laviolette, M. and Flamand, N. and Logan, N. and Ruckerl, D. and Allen, J. and Sutherland, T. and Hamelmann, E. and Vogelberg, C. and Goldstein, S. and Azzi, G. and Engel, M. and Sigmund, R. and Szefler, S. and Mesquita, R. and Coentr√£o, L. and Veiga, R. and Paiva, J. and Roncon-Albuquerque, R. and Porras, W. and Moreno, A. and Iglesias, J. and Ramos, G. and Acevedo, Y. and Alonso, M. and Del, M. and Krcmova, I. and Novosad, J. and Hanania, N. and Massanari, M. and Hecker, H. and Kassel, E. and Laforce, C. and Rickard, K. and Snelder, S. and Braunstahl, G. and Jones, T. and Neville, D. and Heiden, E. and Lanning, E. and Brown, T. and Rupani, H. and Babu, K. and Chauhan, A. and Eldegeir, M. and Chapman, A. and Ferwana, M. and Caldron, M.},
title  = {Abstracts from the 3rd International Severe Asthma Forum (ISAF).},
journal  = {Clinical and Translational Allergy},
volume  = {7},
number  = {Suppl 2},
pages  = {},
year  = {2017},
abstract  = {},
address  = {0000 0000 9558 4598grid.4494.dBeatrix Children‚Äôs Hospital, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands grid.412966.eDepartment of Pediatric Pulmonology, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht,  The Netherlands 0000 0000 9558 4598grid.4494.dBeatrix Children‚Äôs Hospital, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands grid.412966.eDepartment of General Practice, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands 0000 0000 9558 4598grid.4494.dDepartment of Pathology and Medical Biology, Laboratory of Experimental Pulmonology and Inflammation Research (EXPIRE), Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands 0000 0000 9558 4598grid.4494.dDepartment of Pathology and Medical Biology, Laboratory of Experimental Pulmonology and Inflammation Research (EXPIRE), Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands grid.412966.eDepartment of Pediatric Pulmonology, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht,  The Netherlands 0000 0000 9558 4598grid.4494.dBeatrix Children‚Äôs Hospital, Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, Groningen, The Netherlands 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000 0001 2113 8111grid.7445.2Imperial College, London, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000 0004 0430 9363grid.5465.2Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester and University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK 0000 0004 1936 8868grid.4563.4Respiratory Research Unit, University of Nottingham, Nottingham, UK 0000 0001 2162 0389grid.418236.aRespiratory Therapeutic Unit, GSK, Stockley Park, London, UK 0000 0001 2113 8111grid.7445.2National Heart and Lung Institute, Imperial College, London, UK grid.454385.bBiomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, NIHR Southampton Respiratory, Southampton, UK 0000 0001 2113 8111grid.7445.2Data Science Institute, South Kensington Campus, Imperial College London, London, UK 0000000121885934grid.5335.0Acclarogen Ltd, St John‚Äôs Innovation Centre, Cambridge, UK 0000 0001 1519 6403grid.418151.8AstraZeneca R&D, M√∂lndal, Sweden BioSci Consulting, Maasmechelen, Belgium grid.454385.bBiomedical Research Unit, Clinical and Experimental Sciences and Human Development and Health, NIHR Southampton Respiratory, Southampton, UK 0000 0001 2113 8111grid.7445.2National Heart and Lung Institute, Imperial College, London, UK 0000000084992262grid.7177.6Dept of Respiratory Medicine, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands 0000 0004 0430 9363grid.5465.2Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester and University Hospital of South Manchester, NHS Foundation Trust, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada grid.460559.bPROOF Centre of Excellence, Vancouver, Canada 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada 0000 0004 1936 8227grid.25073.33McMaster University, Hamilton, Canada 0000 0001 2288 9830grid.17091.3eUniversity of British Columbia, Vancouver, Canada 0000 0004 1936 8390grid.23856.3aUniversit√© Laval, Qu√©bec City, Canada 0000 0004 1936 8227grid.25073.33McMaster University, Hamilton, Canada 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK grid.419651.eIIS-Fundaci√≥n Jim√©nez D√≠az-UAM, Madrid, Spain grid.419651.eIIS-Fundaci√≥n Jim√©nez D√≠az-UAM, Madrid, Spain grid.419651.eIIS-Fundaci√≥n Jim√©nez D√≠az-UAM, Madrid, Spain grid.419651.eIIS-Fundaci√≥n Jim√©nez D√≠az-UAM, Madrid, Spain grid.419651.eIIS-Fundaci√≥n Jim√©nez D√≠az-UAM, Madrid, Spain 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dLaboratory of Asthma and Lung Inflammation, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA Department of Medicine, Department of Pharmacology, San Diego, CA USA 0000 0001 2107 4242grid.266100.3Department of Chemistry and Biochemistry, San Diego, CA USA 0000 0001 2107 4242grid.266100.3Department of Chemistry and Biochemistry, San Diego, CA USA 0000 0001 2297 5165grid.94365.3dLaboratory of Asthma and Lung Inflammation, Cardiovascular and Pulmonary Branch, National Heart, Lung and Blood Institute, NIH, Bethesda, MD USA 0000 0001 2297 5165grid.94365.3dCritical Care Medicine Department, Clinical Center, NIH, Bethesda, MD USA 0000 0004 0642 340Xgrid.415520.7Seoul Medical Center, Seoul, South Korea 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT Alexandrovska, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT Alexandrovska, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT Alexandrovska, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Medical University, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT Alexandrovska, Sofia, Bulgaria grid.479663.9Orthopedics Department, Tokuda Hospital, Sofia, Bulgaria grid.479663.9Orthopedics Department, Tokuda Hospital, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Medical University, Pediatric Clinic, UMHAT Alexandrovska, Sofia, Bulgaria grid.410772.7Research Institute, Tokyo University of Agriculture, Tokyo, Japan 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester & University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester, Manchester, UK 0000 0004 0617 6015grid.414501.5Division of Allergy and Immunology, Department of Pediatrics, Bhumibol Adulyadej Hospital, Bangkok, Thailand Saraburi Hospital, Saraburi, Thailand 0000 0001 0244 7875grid.7922.eDivision of Respiratory Disease and Intensive Care, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand 0000 0004 0617 6015grid.414501.5Department of Pediatrics, Bhumibol Adulyadej Hospital, Bangkok, Thailand 0000 0004 1937 1127grid.412434.4Center of Excellence in Applied Epidemiology, Thammasat University, Bangkok, Thailand 0000 0004 0621 0092grid.410563.5Clinical Center of Pulmonary Diseases; SHATPD ‚ÄúSt. Sofia‚Ä?, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Clinical Center of Pulmonary Diseases; SHATPD ‚ÄúSt. Sofia‚Ä?, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Clinical Center of Pulmonary Diseases; SHATPD ‚ÄúSt. Sofia‚Ä?, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria grid.107984.3Department of Clinical Immunology, Medical Faculty of Medical University of Sofia, University Hospital Alexandrovska, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Pediatric Clinic, University Hospital Alexandrovska, Medical University, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Pediatric Clinic, University Hospital Alexandrovska, Medical University, Sofia, Bulgaria National Centre of Infectious and Parasitic Diseases, National Laboratory Influenza and ARD, Sofia, Bulgaria National Centre of Infectious and Parasitic Diseases, National Laboratory Influenza and ARD, Sofia, Bulgaria INSMC Alessandrescu-Rusescu, Bucharest, Romania INSMC Alessandrescu-Rusescu, Bucharest, Romania 0000000121662407grid.5379.8Institute of Population Health, Health e-Research Centre, University of Manchester, Manchester, UK 0000000109409118grid.7256.6Division of Pediatric Allergy, GATA Military School of Medicine, Ankara, Turkey 0000000121662407grid.5379.8Centre for Health Informatics, Institute of Population Health, University of Manchester, Manchester, UK 0000 0001 2342 7339grid.14442.37Division of Pediatric Allergy, Hacettepe University School of Medicine, Ankara, Turkey 0000 0001 2113 8111grid.7445.2Faculty of Medicine, Department of Medicine, Imperial College London, London, UK 0000000106887552grid.15876.3dKo√ß University Hospital, Istanbul, Turkey 0000 0001 2342 7339grid.14442.37Pediatric Allergy and Asthma Unit, Hacettepe University School of Medicine, Ankara, Turkey 0000 0004 0621 0092grid.410563.5Medical University, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria 0000 0004 0621 0092grid.410563.5Laboratory of Clinical Immunology, University Hospital St. Ivan Rilski, Medical University, Sofia, Bulgaria 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000 0001 2155 0800grid.5216.0University of Athens, Athens, Greece 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK 0000000121662407grid.5379.8Division of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK 0000000121662407grid.5379.8Division of Metabolism and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK 0000000121662407grid.5379.8School of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, UK 0000 0004 0621 0092grid.410563.5Clinic of Allergy and Asthma, University Hospital Alexandrovska, Medical Faculty of Medical University of Sofia, Sofia, Bulgaria 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute,  Madrid, Spain 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute,  Madrid, Spain 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute,  Madrid, Spain 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute,  Madrid, Spain 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute,  Madrid, Spain 0000 0001 1945 5329grid.144756.5Hospital 12 de octubre, i+12 Research Institute,  Madrid, Spain 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester, Manchester, UK 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester, Manchester, UK 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester, Manchester, UK 0000 0004 0430 9363grid.5465.2University Hospital of South Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK grid.474012.4Almirall S. A., Barcelona, Spain grid.474012.4Almirall S. A., Barcelona, Spain grid.474012.4Almirall S. A., Barcelona, Spain 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000000121662407grid.5379.8University of Manchester, Manchester, UK 0000 0004 1936 8227grid.25073.33McMaster University, Hamilton, Canada 0000000121662407grid.5379.8University of Manchester, Manchester, UK Manchester Collaborative Centre for Inflammation Research, Manchester, UK Manchester Collaborative Centre for Inflammation Research, Manchester, UK Manchester Collaborative Centre for Inflammation Research, Manchester, UK Manchester Collaborative Centre for Inflammation Research, Manchester, UK Manchester Collaborative Centre for Inflammation Research, Manchester, UK Manchester Fungal Infection Group, Manchester, UK Manchester Fungal Infection Group, Manchester, UK 0000 0001 1519 6403grid.418151.8AstraZeneca R&D, M√∂lndal, Sweden 0000 0001 1519 6403grid.418151.8AstraZeneca R&D, M√∂lndal, Sweden Manchester Collaborative Centre for Inflammation Research, Manchester, UK 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA 0000 0001 0675 4725grid.239578.2Cleveland Clinic, Cleveland, OH USA CRIUCPQ, Qu√©bec, Canada CRIUCPQ, Qu√©bec, Canada CRIUCPQ, Qu√©bec, Canada CRIUCPQ, Qu√©bec, Canada CRIUCPQ, Qu√©bec, Canada CRIUCPQ, Qu√©bec, Canada 0000 0004 1936 7988grid.4305.2Institute of Immunology and Infection Research, University of Edinburgh, Edinburgh, UK 0000000121662407grid.5379.8Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK 0000000121662407grid.5379.8Faculty of Biology, Medicine & Health, University of Manchester, Manchester, UK 0000000121662407grid.5379.8Manchester Collaborative Centre for Inflammation Research, University of Manchester, Manchester, UK 0000 0004 0490 981Xgrid.5570.7Children‚Äôs Center, Evangelisches Krankenhaus Bielefeld, and Allergy Center, Ruhr University, Bochum, Germany 0000 0001 2111 7257grid.4488.0University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany Island Medical Research, Rockville Centre, New York City, NY USA 0000 0001 2171 7500grid.420061.1Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany 0000 0001 2171 7500grid.420061.1Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim Am Rhein, Germany 0000 0001 2171 7500grid.420061.1Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach An Der Riss, Germany Children‚Äôs Hospital of Colorado, University of Colorado School of Medicine, Aurora City, CO USA 0000 0000 9375 4688grid.414556.7Internal Medicine Department, Centro Hospitalar de S√£o Jo√£o, Porto, Portugal 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department, Centro Hospitalar de S√£o Jo√£o, Porto, Portugal 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department, Centro Hospitalar de S√£o Jo√£o, Porto, Portugal 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department, Centro Hospitalar de S√£o Jo√£o, Porto, Portugal 0000 0000 9375 4688grid.414556.7Emergency and Intensive Care Medicine Department, Centro Hospitalar de S√£o Jo√£o, Porto, Portugal 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorc√≥n, Madrid,  Spain 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorc√≥n, Madrid,  Spain 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorc√≥n, Madrid,  Spain 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorc√≥n, Madrid,  Spain 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorc√≥n, Madrid,  Spain 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorc√≥n, Madrid,  Spain 0000 0004 0425 3881grid.411171.3University Hospital Foundation Alcorc√≥n, Madrid,  Spain 0000 0004 0609 2284grid.412539.8Institute of Clinical Immunology and Allergy, University Hospital, Hradec Kralove, Czechia 0000 0004 0609 2284grid.412539.8Institute of Clinical Immunology and Allergy, University Hospital, Hradec Kralove, Czechia 0000 0001 2160 926Xgrid.39382.33Baylor College of Medicine, Houston, TX USA Circassia, Raleigh, NC USA Circassia, Raleigh, NC USA Circassia, Raleigh, NC USA grid.477632.3North Carolina Clinical Research, Raleigh, NC USA Circassia, Raleigh, NC USA 0000 0004 0459 9858grid.461048.fSint Franciscus Gasthuis, Rotterdam, The Netherlands 0000 0004 0459 9858grid.461048.fSint Franciscus Gasthuis, Rotterdam, The Netherlands 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK 0000 0004 0456 1761grid.418709.3Portsmouth Hospitals NHS Trust, Portsmouth, UK National Guard Hospital, Dammam, Saudi Arabia 0000 0001 2113 8111grid.7445.2Imperial College, London, UK 0000 0004 1773 5396grid.56302.32King Saud University, Riyadh, Saudi Arabia 0000 0001 2113 8111grid.7445.2Imperial College, London, UK},
note  = {Clin Transl Allergy. 2017 May 24;7(Suppl 2):. doi:10.1186/s13601-017-0149-8.}
}

@Article{2010560,
author  = {Coleman, J. and Nahmani, M. and Gavornik, J. and Haslinger, R. and Heynen, A. and Erisir, A. and Bear, M.},
title  = {Experience-Dependent Functional Plasticity in Mouse Primary Visual Cortex.},
journal  = {Neuroscience},
volume  = {30},
number  = {29},
pages  = {9670-82},
year  = {2010},
abstract  = {Monocular lid closure (MC) causes a profound shift in the ocular dominance (OD) of neurons in primary visual cortex (V1). Anatomical studies in both cat and mouse V1 suggest that large-scale structural rearrangements of eye-specific thalamocortical (TC) axons in response to MC occur much more slowly than the shift in OD. Consequently, there has been considerable debate as to whether the plasticity of TC synapses, which transmit competing visual information from each  eye to V1, contributes to the early functional consequences of MC or is simply a  feature of long-term deprivation. Here, we used quantitative immuno-electron microscopy to examine the possibility that alterations of TC synapses occur rapidly enough to impact OD after brief MC. The effect of short-term deprivation  on TC synaptic structure was examined in male C57BL/6 mice that underwent 3 and 7 d of MC or monocular retinal inactivation (MI) with tetrodotoxin. The data show that 3 d of MC is sufficient to induce substantial remodeling of TC synapses. In  contrast, 3 d of MI, which alters TC activity but does not shift OD, does not significantly affect the structure of TC synapses. Our results support the hypothesis that the rapid plasticity of TC synapses is a key step in the sequence of events that shift OD in visual cortex.},
address  = {Howard Hughes Medical Institute, The Picower Institute for Learning and Memory, Cambridge, Massachusetts 02142 Department of Psychology, University of Virginia, Charlottesville, Virginia 22904-4400 Howard Hughes Medical Institute, The Picower Institute for Learning and Memory, Cambridge, Massachusetts 02142 Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142 Howard Hughes Medical Institute, The Picower Institute for Learning and Memory, Cambridge, Massachusetts 02142 Department of Psychology, University of Virginia, Charlottesville, Virginia 22904-4400 Howard Hughes Medical Institute, The Picower Institute for Learning and Memory, Cambridge, Massachusetts 02142},
note  = {J Neurosci. 2010 Jul 21;30(29):9670-82. doi:10.1523/JNEUROSCI.1248-10.2010.}
}

@Article{2013561,
author  = {Snider, J. and Plank, M. and Lynch, G. and Halgren, E. and Poizner, H.},
title  = {Memory.},
journal  = {The Journal of Neuroscience},
volume  = {33},
number  = {38},
pages  = {15056-68},
year  = {2013},
abstract  = {Spatial representations and walking speed in rodents are consistently related to  the phase, frequency, and/or amplitude of Œ∏ rhythms in hippocampal local field potentials. However, neuropsychological studies in humans have emphasized the importance of parietal cortex for spatial navigation, and efforts to identify the electrophysiological signs of spatial navigation in humans have been stymied by the difficulty of recording during free exploration of complex environments. We resolved the recording problem and experimentally probed brain activity of human  participants who were fully ambulant. On each of 2 d, electroencephalography was  synchronized with head and body movement in 13 subjects freely navigating an extended virtual environment containing numerous unique objects. Œ∏ phase and amplitude recorded over parietal cortex were consistent when subjects walked through a particular spatial separation at widely separated times. This spatial displacement Œ∏ autocorrelation (STAcc) was quantified and found to be significant from 2 to 8 Hz within the environment. Similar autocorrelation analyses performed on an electrooculographic channel, used to measure eye movements, showed no significant spatial autocorrelations, ruling out eye movements as the source of STAcc. Strikingly, the strength of an individual's STAcc maps from day 1 significantly predicted object location recall success on day 2. Œ∏ was also significantly correlated with walking speed; however, this correlation appeared unrelated to STAcc and did not predict memory performance. This is the first demonstration of memory-related, spatial maps in humans generated during active spatial exploration.},
address  = {Institute for Neural Computation, University of California, San Diego, La Jolla,  California 92093, Institute for Neural Computation, University of California, San Diego, La Jolla,  California 92093, Departments of Psychiatry and Human Behavior and Anatomy and Neurobiology, University of California, Irvine, Irvine, California 92697, Departments of Radiology, Neuroscience, and Psychiatry, University of California, San Diego, La Jolla, California 92093, and Institute for Neural Computation, University of California, San Diego, La Jolla,  California 92093,},
note  = {J Neurosci. 2013 Sep 18;33(38):15056-68. doi:10.1523/JNEUROSCI.0268-13.2013.}
}

@Article{2010562,
author  = {Ben-Pazi, H. and Ishihara, A. and Kukke, S. and Sanger, T.},
title  = {handwriting in children.},
journal  = {Journal of child neurology},
volume  = {25},
number  = {6},
pages  = {674-80},
year  = {2010},
abstract  = {The aim of this study was to determine the effect of mechanical properties of the pen on the quality of handwriting in children.Twenty two school aged children, ages 8‚Äì14 years wrote in cursive using a pen attached to a robot. The robot was programmed to increase the effective weight (inertia) and stiffness (viscosity) of the pen. Speed, frequency, variability, and quality of the two handwriting samples were compared.Increased inertia and viscosity improved handwriting quality in 85% of children (p<0.05). Handwriting quality did not correlate with changes in speed, suggesting that improvement was not due to reduced speed. Measures of movement variability remained unchanged, suggesting that improvement  was not due to mechanical smoothing of pen movement by the robot. Since improvement was not explained by reduced speed or mechanical smoothing, we conclude that children alter handwriting movements in response to pen mechanics.  Altered movement could be caused by changes in proprioceptive sensory feedback.},
address  = {Neuropediatric Unit, Shaare Zedek Medical Center, Jerusalem, Israel and Department of Child Neurology, Stanford Medical Center, Stanford CA, USA Department of Child Neurology, Stanford Medical Center, Stanford CA, USA Department of Child Neurology, Stanford Medical Center, Stanford CA, USA Department of Child Neurology, Stanford Medical Center, Stanford CA, USA},
note  = {doi:10.1177/0883073809342592.}
}

@Article{2010563,
author  = {Leckman, J. and Bloch, M. and Smith, M. and Larabi, D. and Hampson, M.},
title  = {Neurobiological Substrates of Tourette's Disorder.},
journal  = {Journal of Child and Adolescent Psychopharmacology},
volume  = {20},
number  = {4},
pages  = {237-47},
year  = {2010},
abstract  = {Objective: This article reviews the available scientific literature concerning the neurobiological substrates of Tourette's disorder (TD). Methods: The electronic databases of PubMed, ScienceDirect, and PsycINFO were searched for relevant studies using relevant search terms. Results: Neuropathological as well  as structural and functional neuroimaging studies of TD implicate not only the sensorimotor corticostriatal circuit, but also the limbic and associative circuits as well. Preliminary evidence also points to abnormalities in the frontoparietal network that is thought to maintain adaptive online control. Evidence supporting abnormalities in dopaminergic and noradrenergic neurotransmission remains strong, although the precise mechanisms remain the subject of speculation. Conclusion: Structural and functional abnormalities in multiple parallel corticostriatal circuits may underlie the behavioral manifestations of TD and related neuropsychiatric disorders over the course of development. Further longitudinal research is needed to elucidate these neurobiological substrates.},
address  = {Child Study Center, Yale University, New Haven, Connecticut. Child Study Center, Yale University, New Haven, Connecticut. Child Study Center, Yale University, New Haven, Connecticut. University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Department of Diagnostic Radiology, Yale University, New Haven, Connecticut.},
note  = {doi:10.1089/cap.2009.0118.}
}

@Article{2016564,
author  = {Banerjee, A. and Rikhye, R. and Breton-Provencher, V. and Tang, X. and Li, C. and Li, K. and Runyan, C. and Fu, Z. and Jaenisch, R. and Sur, M.},
title  = {cortical processing in Rett syndrome.},
journal  = {Proceedings of the National Academy of Sciences of the United States of America},
volume  = {113},
number  = {46},
pages  = {E7287-96},
year  = {2016},
abstract  = {Understanding neurophysiological correlates of neurodevelopmental disorders is one of the pressing challenges of neuroscience. By analyzing a mouse model of Rett syndrome (RTT), we show that cortical pyramidal neurons in methyl-CpG binding protein 2 (MeCP2) mutant mice have reduced excitatory as well as inhibitory synaptic drive. Thus, neuronal response reliability and selectivity, features that arise from excitatory/inhibitory processing circuits within cortex, are reduced. MeCP2 deletion crucially regulates inhibition via two complementary  mechanisms: reducing responses of parvalbumin-expressing (PV+) inhibitory neurons and altering the polarity of GABAergic inhibition in pyramidal neurons. Treating  mutant mice with recombinant human insulin-like growth factor-1 (rhIGF1) restores GABAergic polarity along with PV+ and pyramidal neuron responses, thus providing  a mechanistic basis of action of rhIGF1 in RTT.},
address  = {The Picower Institute for Learning and Memory, Department of Brain and Cognitive  Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; The Picower Institute for Learning and Memory, Department of Brain and Cognitive  Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; The Picower Institute for Learning and Memory, Department of Brain and Cognitive  Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; The Whitehead Institute for Biomedical Research, Cambridge, MA 02142; Broad Institute of MIT and Harvard, Cambridge, MA 02142 The Picower Institute for Learning and Memory, Department of Brain and Cognitive  Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; The Picower Institute for Learning and Memory, Department of Brain and Cognitive  Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; Broad Institute of MIT and Harvard, Cambridge, MA 02142 The Whitehead Institute for Biomedical Research, Cambridge, MA 02142; The Picower Institute for Learning and Memory, Department of Brain and Cognitive  Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139;},
note  = {doi:10.1073/pnas.1615330113.}
}

@Article{2013565,
author  = {Freeman, J. and Emond, J. and Gillespie, B. and Appelbaum, P. and Weinrieb, R. and Hill-Callahan, P. and Gordon, E. and Terrault, N. and Trotter, J. and Ashworth, A. and Dew, M. and Pruett, T.},
title  = {The Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL).},
journal  = {Clinical transplantation},
volume  = {27},
number  = {4},
pages  = {633-45},
year  = {2013},
abstract  = {Background: Despite its importance, determination of competence to consent to organ donation varies widely based on local standards. We piloted a new tool to aid transplant centers in donor assessment. Methods: We assessed competence-related abilities among potential living liver donors (LDs) in the 9-center A2ALL study. Prospective LDs viewed an educational video, and were queried to assess Understanding, Appreciation, Reasoning, and ability to express  a Final Choice using the MacArthur Competence Assessment Tool for Clinical Research, adapted for computerized administration in LDs (‚ÄúMacLiver‚Ä?). Videotaped responses were scored by a clinical neuropsychologist (JF). Results: Ninety-three LDs were assessed. Mean (standard deviation; domain maximum) scores were: Understanding: 18.1 (2.6; max=22), Appreciation: 5.1 (1.0; max=6), Reasoning: 3.1 (0.8; max=4), and Final Choice: 3.8 (0.5; max=4). Scores did not differ by demographics, relationship to the recipient, eligibility to donate, or eventual donation (p>0.4). Higher education was associated with greater Understanding (p=0.004) and Reasoning (p=0.03). Conclusion: Standardized, computerized education with independent ratings of responses may (1) alert the clinical staff  to potential donors who may not be competent to donate, and (2) highlight areas needing further assessment and education, leading to better informed decision-making.},
address  = {Department of Psychiatry and Neurobehavioral Sciences, University of Virginia, Charlottesville, VA Department of Surgery, Columbia University Medical Center, New York, NY Department of Biostatistics, University of Michigan, Ann Arbor, MI Department of Psychiatry, Columbia University Medical Center, New York, NY Department of Psychiatry, University of Pennsylvania, Philadelphia, PA Arbor Research Collaborative for Health, Ann Arbor, MI Center for Healthcare Studies and Comprehensive Transplant Center, Northwestern University, Chicago, IL Department of Medicine, University of California at San Francisco, San Francisco, CA Department of Surgery, University of Colorado, Aurora, CO (Current affiliation =  Department of Medicine, Baylor University Medical Center, Dallas, TX) Department of Transplant Surgery, Virginia Commonwealth University Medical Center, Richmond, VA Department of Psychiatry, Univ. of Pittsburgh School of Medicine and Medical Center, Pittsburgh, PA Department of Transplant Surgery, University of Minnesota, Minneapolis, MN},
note  = {doi:10.1111/ctr.12184.}
}

@Article{2000566,
author  = {Anagnostaras, S. and Josselyn, S. and Frankland, P. and Silva, A.},
title  = {Computer-Assisted Behavioral Assessment of Pavlovian Fear Conditioning in Mice.},
journal  = {Learning & Memory},
volume  = {7},
number  = {1},
pages  = {58-72},
year  = {2000},
abstract  = {In Pavlovian fear conditioning, a conditional stimulus (CS, usually a tone) is paired with an aversive unconditional stimulus (US, usually a foot shock) in a novel context. After even a single pairing, the animal comes to exhibit a long-lasting fear to the CS and the conditioning context, which can be measured as freezing, an adaptive defense reaction in mice. Both context and tone conditioning depend on the integrity of the amygdala, and context conditioning further depends on the hippocampus. The reliability and efficiency of the fear conditioning assay makes it an excellent candidate for the screening of learning  and memory deficits in mutant mice. One obstacle is that freezing in mice has been accurately quantified only by human observers, using a tedious method that can be subject to bias. In the present study we generated a simple, high-speed, and highly accurate algorithm that scores freezing of four mice simultaneously using NIH Image on an ordinary Macintosh computer. The algorithm yielded a high correlation and excellent linear fit between computer and human scores across a broad range of conditions. This included the ability to score low pretraining baseline scores and accurately mimic the effects of two independent variables (shock intensity and test modality) on fear. Because we used a computer and digital video, we were able to acquire a secondary index of fear, activity suppression, as well as baseline activity scores. Moreover, we measured the unconditional response to shock. These additional measures can enhance the sensitivity of the assay to detect interesting memory phenotypes and control for  possible confounds. Thus, this computer-assisted system for measuring behavior during fear conditioning allows for the standardized and carefully controlled assessment of multiple aspects of the fear conditioning experience.},
address  = {},
note  = {Learn Mem. 2000 Jan;7(1):58-72.}
}

@Article{2017567,
author  = {McAlearney, A. and Hefner, J. and Sieck, C. and Walker, D. and Aldrich, A. and Sova, L. and Gaughan, A. and Slevin, C. and Hebert, C. and Hade, E. and Buck, J. and Grove, M. and Huerta, T.},
title  = {protocol.},
journal  = {Implementation Science : IS},
volume  = {12},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Background: Healthcare-associated infections (HAIs) impact patients‚Äô lives through prolonged hospitalization, morbidity, and death, resulting in significant costs to both health systems and society. Central line-associated bloodstream infections (CLABSIs) and catheter-associated urinary tract infections (CAUTIs) are two of the most preventable HAIs. As a result, these HAIs have been the focus of significant efforts to identify evidence-based clinical strategies to reduce infection rates. The Comprehensive Unit-based Safety Program (CUSP) provides a formal model for translating CLABSI-reduction evidence into practice. Yet, a national demonstration project found organizations experienced variable levels of success using CUSP to reduce CLABSIs. In addition, in Fiscal year 2019, Medicare  will expand use of CLABSI and CAUTI metrics beyond ICUs to the entire hospital for reimbursement purposes. As a result, hospitals need guidance about how to successfully translate HAI-reduction efforts such as CUSP to non-ICU settings (clinical practice), and how to shape context (management practice)‚Äîincluding culture and management strategies‚Äîto proactively support clinical teams. Methods: Using a mixed-methods approach to evaluate the contribution of management factors to successful HAI-reduction efforts, our study aims to: (1) Develop valid and reliable measures of structural management practices associated with the recommended CLABSI Management Strategies for use as a survey (HAI Management Practice Guideline Survey) to support HAI-reduction efforts in both medical/surgical units and ICUs; (2) Develop, validate, and then deploy the HAI Management Practice Guideline Survey, first across Ohio hospitals, then nationwide, to determine the positive predictive value of the measurement instrument as it relates to CLABSI- and CAUTI-prevention; and (3) Integrate findings into a Management Practices Toolkit for HAI reduction that includes an organization-specific data dashboard for monitoring progress and an implementation program for toolkit use, and disseminate that Toolkit nationwide.  Discussion: Providing hospitals with the tools they need to successfully measure  management structures that support clinical care provides a powerful approach that can be leveraged to reduce the incidence of HAIs experienced by patients. This study is critical to providing the information necessary to successfully ‚Äúmake health care safer‚Ä? by providing guidance on how contextual factors within a healthcare setting can improve patient safety across hospitals.},
address  = {0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Division of Health Services Management and Policy, College of Public Health, The Ohio State University, Columbus, OH 43201 USA 0000 0001 2285 7943grid.261331.4Center for Biostatistics, College of Medicine, The Ohio State University, 320G Lincoln Tower, 1800 Cannon Drive, Columbus, OH 43201 USA 0000 0001 1545 0811grid.412332.5The Ohio State University Wexner Medical Center,  134 Doan Hall, 410 W. 10th Ave, Columbus, OH 43210 USA 0000 0001 1545 0811grid.412332.5The Ohio State University Wexner Medical Center,  134 Doan Hall, 410 W. 10th Ave, Columbus, OH 43210 USA 0000 0001 2285 7943grid.261331.4Department of Family Medicine, College of Medicine, The Ohio State University, 2231 North High Street, Suite 273, Columbus, OH 43201 USA},
note  = {Implement Sci. 2017 Jun 28;12:. doi:10.1186/s13012-017-0610-z.}
}

@Article{2014568,
author  = {Luque, R. and Casilari, E. and Mor√≥n, M. and Redondo, G.},
title  = {Comparison and Characterization of Android-Based Fall Detection Systems.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {14},
number  = {10},
pages  = {18543-74},
year  = {2014},
abstract  = {Falls are a foremost source of injuries and hospitalization for seniors. The adoption of automatic fall detection mechanisms can noticeably reduce the response time of the medical staff or caregivers when a fall takes place. Smartphones are being increasingly proposed as wearable, cost-effective and not-intrusive systems for fall detection. The exploitation of smartphones' potential (and in particular, the Android Operating System) can benefit from the  wide implantation, the growing computational capabilities and the diversity of communication interfaces and embedded sensors of these personal devices. After revising the state-of-the-art on this matter, this study develops an experimental testbed to assess the performance of different fall detection algorithms that ground their decisions on the analysis of the inertial data registered by the accelerometer of the smartphone. Results obtained in a real testbed with diverse  individuals indicate that the accuracy of the accelerometry-based techniques to identify the falls depends strongly on the fall pattern. The performed tests also show the difficulty to set detection acceleration thresholds that allow achieving a good trade-off between false negatives (falls that remain unnoticed) and false  positives (conventional movements that are erroneously classified as falls). In any case, the study of the evolution of the battery drain reveals that the extra  power consumption introduced by the Android monitoring applications cannot be neglected when evaluating the autonomy and even the viability of fall detection systems.},
address  = {},
note  = {Sensors (Basel). 2014 Oct 08;14(10):18543-74. doi:10.3390/s141018543.}
}

@Article{2012569,
author  = {Hoffmann, A. and Gill, H.},
title  = {effectiveness in an in-vitro model of acute coronary thrombosis.},
journal  = {Thrombosis Journal},
volume  = {10},
number  = {},
pages  = {23},
year  = {2012},
abstract  = {Background: Low Frequency Vibro-Percussion (LFVP) assists clearance of thrombi in catheter systems and when applied to the heart and timed to diastole is known to  enhance coronary flow. However LFVP on a clotted coronary like vessel given engagement over a chest wall sized barrier (to resemble non-invasive heart attack therapy) requires study. Methods: One hour old clots (n=16) were dispensed within a flexible segment of Soft-Flo catheter (4 mm lumen), weighted, interfaced with Heparinized Saline (HS), secured atop a curved dampening base, and photographed.  A ~4 cm meat slab was placed over the segment and randomized to receive intermittent LFVP (engaged, - disengaged at 1 second intervals), or no LFVP for 20 minutes. HS was pulsed (~120/80 mmHg), with the diastolic phase coordinated to match LFVP delivery. The segment was then re-photographed and aspirated of fluid  to determine post clot weight. The trial was then repeated with 0.5 mls of Streptokinase (15,000 IU/100 microlitre) delivered ~ 2 cm upstream from the clot. Results: LFVP - HS only samples (vs. controls) showed; a) development of clot length fluid channels absent in the control group (p < 0.0002); b) enhanced dissolved clot mixing scores ( 5.0 vs. 0.8, p < 2.8 E ‚Äì 6); and c) increased percent clot dissolution (23.0% vs. 1.8% respectively, p < 8.5 E-6). LFVP - SK samples had a similar comparative clot disruptive profile, however fluid channels developed faster and percent clot dissolution more than doubled (51.0% vs. 3.0%,  p< 9.8 E- 6). Conclusion: Diastolic timed LFVP (50 Hz) engaged across a chest wall sized barrier enhances clot disruptive effects to an underlying coronary like system.},
address  = {Ahof Biophysical Systems Inc, 3858 Regent St, Burnaby, BC, Canada , V5C4G8 In-Vitro Labs, 5407 Canada Way, Burnaby, BC, Canada , V5E 3N5},
note  = {Thromb J. 2012 Nov 12;10:23. doi:10.1186/1477-9560-10-23.}
}

@Article{2009570,
author  = {Arbab, A. and Janic, B. and Haller, J. and Pawelczyk, E. and Liu, W. and Frank, J.},
title  = {In Vivo Cellular Imaging for Translational Medical Research.},
journal  = {Current medical imaging reviews},
volume  = {5},
number  = {1},
pages  = {19-38},
year  = {2009},
abstract  = {Personalized treatment using stem, modified or genetically engineered, cells is becoming a reality in the field of medicine, in which allogenic or autologous cells can be used for treatment and possibly for early diagnosis of diseases. Hematopoietic, stromal and organ specific stem cells are under evaluation for cell-based therapies for cardiac, neurological, autoimmune and other disorders. Cytotoxic or genetically altered T-cells are under clinical trial for the treatment of hematopoietic or other malignant diseases. Before using stem cells in clinical trials, translational research in experimental animal models are essential, with a critical emphasis on developing noninvasive methods for tracking the temporal and spatial homing of these cells to target tissues. Moreover, it is necessary to determine the transplanted cell‚Äôs engraftment efficiency and functional capability. Various in vivo imaging modalities are in use to track the movement and incorporation of administered cells. Tagging cells  with reporter genes, fluorescent dyes or different contrast agents transforms them into cellular probes or imaging agents. Recent reports have shown that magnetically labeled cells can be used as cellular magnetic resonance imaging (MRI) probes, demonstrating the cell trafficking to target tissues. In this review, we will discuss the methods to transform cells into probes for in vivo imaging, along with their advantages and disadvantages as well as the future clinical applicability of cellular imaging method and corresponding imaging modality.},
address  = {Cellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford Hospital, Detroit, MI Cellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford Hospital, Detroit, MI Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD Frank Laboratory, Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD},
note  = {Curr Med Imaging Rev. 2009 Feb 1;5(1):19-38. doi:10.2174/157340509787354697.}
}

@Article{2011571,
author  = {Kerr, C. and Shaw, J. and Conboy, L. and Kelley, J. and Jacobson, E. and Kaptchuk, T.},
title  = {model.},
journal  = {Consciousness and cognition},
volume  = {20},
number  = {3},
pages  = {784-91},
year  = {2011},
abstract  = {Evidence that placebo acupuncture is an effective treatment for chronic pain presents a puzzle: how do placebo needles appearing to patients to penetrate the  body, but instead sitting on the skin‚Äôs surface in the manner of a tactile stimulus, evoke a healing response? Previous accounts of ritual touch healing in  which patients often described enhanced touch sensations (including warmth, tingling or flowing sensations) suggest an embodied healing mechanism. In this qualitative study, we asked a subset of patients in a randomized trial in irritable bowel syndrome to describe treatment experiences. Analysis focused on patients‚Äô unprompted descriptions of any enhanced touch sensations (e.g., warmth, tingling) and any significance patients assigned to the sensations. We found in 5/6 cases, patients associated sensations including ‚Äúwarmth‚Ä? and ‚Äútingling‚Ä? with  treatment efficacy. The conclusion offers a ‚Äúneurophenomenological‚Ä? account of the placebo effect by considering dynamic effects of attentional filtering on early sensory cortices, possibly underlying the phenomenology of placebo acupuncture.},
address  = {Osher Research Center, Harvard Medical School, Boston, MA Osher Research Center, Harvard Medical School, Boston, MA Osher Research Center, Harvard Medical School, Boston, MA Endicott College, Beverly, MA Osher Research Center, Harvard Medical School, Boston, MA Osher Research Center, Harvard Medical School, Boston, MA},
note  = {doi:10.1016/j.concog.2010.12.009.}
}

@Article{2010572,
author  = {Conner, J. and Kulczycki, M. and Tuszynski, M.},
title  = {Plasticity and Learning.},
journal  = {Cerebral Cortex (New York, NY)},
volume  = {20},
number  = {11},
pages  = {2739-48},
year  = {2010},
abstract  = {The cholinergic basal forebrain projects throughout the neocortex, exerting a critical role in modulating plasticity associated with normal learning. Cholinergic modulation of cortical plasticity could arise from 3 distinct mechanisms by 1) ‚Äúdirect‚Ä? modulation via cholinergic inputs to regions undergoing plasticity, 2) ‚Äúindirect‚Ä? modulation via cholinergic projections to anterior, prefrontal attentional systems, or 3) modulating more global aspects of processing via distributed inputs throughout the cortex. To segregate these potential mechanisms, we investigated cholinergic-dependent reorganization of cortical motor representations in rats undergoing skilled motor learning. Behavioral and electrophysiological consequences of depleting cholinergic inputs  to either motor cortex, prefrontal cortex, or globally, were compared. We find that local depletion of cholinergic afferents to motor cortex significantly disrupts map plasticity and skilled motor behavior, whereas prefrontal cholinergic depletion has no effect on these measures. Global cholinergic depletion perturbs map plasticity comparable with motor cortex depletions but results in significantly greater impairments in skilled motor acquisition. These  findings indicate that local cholinergic activation within motor cortex, as opposed to indirect regulation of prefrontal systems, modulate cortical map plasticity and motor learning. More globally acting cholinergic mechanisms provide additional support for the acquisition of skilled motor behaviors, beyond those associated with cortical map reorganization.},
address  = {Department of Neurosciences, University of California-San Diego, La Jolla, CA 92093-0626, USA Department of Neurosciences, University of California-San Diego, La Jolla, CA 92093-0626, USA Department of Neurosciences, University of California-San Diego, La Jolla, CA 92093-0626, USA},
note  = {doi:10.1093/cercor/bhq022.}
}

@Article{2010573,
author  = {Wise, A. and Hume, C. and Flynn, B. and Jeelall, Y. and Suhr, C. and Sgro, B. and O'Leary, S. and Shepherd, R. and Richardson, R.},
title  = {Resprouting in the Deafened Cochlea.},
journal  = {Molecular Therapy},
volume  = {18},
number  = {6},
pages  = {1111-22},
year  = {2010},
abstract  = {A cochlear implant may be used to electrically stimulate spiral ganglion neurons  (SGNs) in people with severe sensorineural hearing loss (SNHL). However, these neurons progressively degenerate after SNHL due to loss of neurotrophins normally supplied by sensory hair cells (HCs). Experimentally, exogenous neurotrophin administration prevents SGN degeneration but can also result in abnormal resprouting of their peripheral fibers. This study aimed to create a target-derived neurotrophin source to increase neuron survival and redirect fiber resprouting following SNHL. Adenoviral (Ad) vectors expressing green fluorescent  protein (GFP) alone or in combination with brain-derived neurotrophic factor (BDNF) or neurotrophin-3 (NT3) were injected into the cochlear scala tympani or scala media of guinea-pigs (GPs) deafened via aminoglycosides for 1 week. After 3 weeks, cochleae were examined for gene expression, neuron survival, and the projection of peripheral fibers in response to gene expression. Injection of vectors into the scala media resulted in more localized gene expression than scala tympani injection with gene expression consistently observed within the partially degenerated organ of Corti. There was also greater neuron survival and  evidence of localized fiber responses to neurotrophin-expressing cells within the organ of Corti from scala media injections (P < 0.05), a first step in promoting  organized resprouting of auditory peripheral fibers via gene therapy.},
address  = {Bionic Ear Institute East Melbourne, Victoria, Australia Department of Otolaryngology‚ÄìHead and Neck Surgery, University of Washington Seattle, Washington, USA Bionic Ear Institute East Melbourne, Victoria, Australia Bionic Ear Institute East Melbourne, Victoria, Australia Bionic Ear Institute East Melbourne, Victoria, Australia Bionic Ear Institute East Melbourne, Victoria, Australia Bionic Ear Institute East Melbourne, Victoria, Australia Bionic Ear Institute East Melbourne, Victoria, Australia Bionic Ear Institute East Melbourne, Victoria, Australia},
note  = {Mol Ther. 2010 Jun;18(6):1111-22. Epub 2010 Mar 09 doi:10.1038/mt.2010.28.}
}

@Article{2010574,
author  = {Ronsse, R. and Wei, K. and Sternad, D.},
title  = {Optimal Control of a Hybrid Rhythmic-Discrete Task: The Bouncing Ball Revisited.},
journal  = {Journal of Neurophysiology},
volume  = {103},
number  = {5},
pages  = {2482-93},
year  = {2010},
abstract  = {Rhythmically bouncing a ball with a racket is a hybrid task that combines continuous rhythmic actuation of the racket with the control of discrete impact events between racket and ball. This study presents experimental data and a two-layered modeling framework that explicitly addresses the hybrid nature of control: a first discrete layer calculates the state to reach at impact and the second continuous layer smoothly drives the racket to this desired state, based on optimality principles. The testbed for this hybrid model is task performance at a range of increasingly slower tempos. When slowing the rhythm of the bouncing actions, the continuous cycles become separated into a sequence of discrete movements interspersed by dwell times and directed to achieve the desired impact. Analyses of human performance show increasing variability of performance measures with slower tempi, associated with a change in racket trajectories from approximately sinusoidal to less symmetrical velocity profiles. Matching results  of model simulations give support to a hybrid control model based on optimality,  and therefore suggest that optimality principles are applicable to the sensorimotor control of complex movements such as ball bouncing.},
address  = {Department of Electrical Engineering and Computer Science, Montefiore Institute,  Universit√© de Li√®ge, Li√®ge, Belgium; Rehabilitation Institute of Chicago, Northwestern University, Chicago, Illinois; Departments of Biology, Electrical and Computer Engineering, and Physics, Northeastern University, Boston, Massachusetts},
note  = {doi:10.1152/jn.00600.2009.}
}

@Article{2011575,
author  = {Wise, A. and Fallon, J. and Neil, A. and Pettingill, L. and Geaney, M. and Skinner, S. and Shepherd, R.},
title  = {Combining Cell-Based Therapies and Neural Prostheses to Promote Neural Survival.},
journal  = {Neurotherapeutics},
volume  = {8},
number  = {4},
pages  = {774-87},
year  = {2011},
abstract  = {Cochlear implants provide partial restoration of hearing for profoundly deaf patients by electrically stimulating spiral ganglion neurons (SGNs); however, these neurons gradually degenerate following the onset of deafness. Although the  exogenous application of neurotrophins (NTs) can prevent SGN loss, current techniques to administer NTs for long periods of time have limited clinical applicability. We have used encapsulated choroid plexus cells (NTCells; Living Cell Technologies, Auckland, New Zealand) to provide NTs in a clinically viable manner that can be combined with a cochlear implant. Neonatal cats were deafened  and unilaterally implanted with NTCells and a cochlear implant. Animals received  chronic electrical stimulation (ES) alone, NTs alone, or combined NTs and ES (ES  + NT) for a period of as much as 8 months. The opposite ear served as a deafened  unimplanted control. Chronic ES alone did not result in increased survival of SGNs or their peripheral processes. NT treatment alone resulted in greater SGN survival restricted to the upper basal cochlear region and an increased density of SGN peripheral processes. Importantly, chronic ES in combination with NTs provided significant SGN survival throughout a wider extent of the cochlea, in addition to an increased peripheral process density. Re-sprouting peripheral processes were observed in the scala media and scala tympani, raising the possibility of direct contact between peripheral processes and a cochlear implant electrode array. We conclude that cell-based therapy is clinically viable and effective in promoting SGN survival for extended durations of cochlear implant use. These findings have important implications for the safe delivery of therapeutic drugs to the cochlea.Electronic supplementary material: The online version of this article (doi:10.1007/s13311-011-0070-0) contains supplementary material, which is available to authorized users.},
address  = {The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia Living Cell Technologies Limited, Manukau, 2025 New Zealand Living Cell Technologies Limited, Manukau, 2025 New Zealand The Bionics Institute, 384-388 Albert Street, East Melbourne, 3002 Australia},
note  = {doi:10.1007/s13311-011-0070-0.}
}

@Article{2013576,
author  = {Parker, M. and Boron, W.},
title  = {Transporters.},
journal  = {Physiological Reviews},
volume  = {93},
number  = {2},
pages  = {803-959},
year  = {2013},
abstract  = {The mammalian Slc4 (Solute carrier 4) family of transporters is a functionally diverse group of 10 multi-spanning membrane proteins that includes three Cl-HCO3  exchangers (AE1‚Äì3), five Na+-coupled HCO3‚àí transporters (NCBTs), and two other unusual members (AE4, BTR1). In this review, we mainly focus on the five mammalian NCBTs-NBCe1, NBCe2, NBCn1, NDCBE, and NBCn2. Each plays a specialized role in maintaining intracellular pH and, by contributing to the movement of HCO3‚àí across epithelia, in maintaining whole-body pH and otherwise contributing to epithelial transport. Disruptions involving NCBT genes are linked to blindness, deafness, proximal renal tubular acidosis, mental retardation, and epilepsy. We also review AE1‚Äì3, AE4, and BTR1, addressing their relevance to the  study of NCBTs. This review draws together recent advances in our understanding of the phylogenetic origins and physiological relevance of NCBTs and their progenitors. Underlying these advances is progress in such diverse disciplines as physiology, molecular biology, genetics, immunocytochemistry, proteomics, and structural biology. This review highlights the key similarities and differences between individual NCBTs and the genes that encode them and also clarifies the sometimes confusing NCBT nomenclature.},
address  = {},
note  = {Physiol Rev. 2013 Apr;93(2):803-959. doi:10.1152/physrev.00023.2012.}
}

@Article{2016577,
author  = {Iraji, A. and Chen, H. and Wiseman, N. and Zhang, T. and Welch, R. and O'Neil, B. and Kulek, A. and Ayaz, S. and Wang, X. and Zuk, C. and Haacke, E. and Liu, T. and Kou, Z.},
title  = {traumatic brain injury at the acute stage.},
journal  = {NeuroImage : Clinical},
volume  = {12},
number  = {},
pages  = {100-15},
year  = {2016},
abstract  = {Mild traumatic brain injury (mTBI) accounts for over one million emergency visits each year in the United States. The large-scale structural and functional network connectivity changes of mTBI are still unknown. This study was designed to determine the connectome-scale brain network connectivity changes in mTBI at both structural and functional levels. 40 mTBI patients at the acute stage and 50 healthy controls were recruited. A novel approach called Dense Individualized and Common Connectivity-based Cortical Landmarks (DICCCOLs) was applied for connectome-scale analysis of both diffusion tensor imaging and resting state functional MRI data. Among 358 networks identified on DICCCOL analysis, 41 networks were identified as structurally discrepant between patient and control groups. The involved major white matter tracts include the corpus callosum, and superior and inferior longitudinal fasciculi. Functional connectivity analysis identified 60 connectomic signatures that differentiate patients from controls with 93.75% sensitivity and 100% specificity. Analysis of functional domains showed decreased intra-network connectivity within the emotion network and among  emotion-cognition interactions, and increased interactions among action-emotion and action-cognition as well as within perception networks. This work suggests that mTBI may result in changes of structural and functional connectivity on a connectome scale at the acute stage.},
address  = {Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA Department of Computer Science, University of Georgia, Athens, GA, USA Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Detroit, MI, USA Department of Computer Science, University of Georgia, Athens, GA, USA Department of Emergency Medicine, Wayne State University, Detroit, MI, USA Department of Emergency Medicine, Wayne State University, Detroit, MI, USA Department of Emergency Medicine, Wayne State University, Detroit, MI, USA Department of Emergency Medicine, Wayne State University, Detroit, MI, USA Department of Radiology, Wayne State University, Detroit, MI, USA Department of Radiology, Wayne State University, Detroit, MI, USA Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA Department of Computer Science, University of Georgia, Athens, GA, USA Department of Biomedical Engineering, Wayne State University, Detroit, MI, USA},
note  = {Neuroimage Clin. 2016 Jun 16;12:100-15. doi:10.1016/j.nicl.2016.06.012.}
}

@Article{2013578,
author  = {Hu, C. and Dillon, J. and Kearn, J. and Murray, C. and O‚ÄôConnor, V. and Holden-Dye, L. and Morgan, H.},
title  = {Biology Screening of Caenorhabditis elegans Adult and Larvae.},
journal  = {PLoS ONE},
volume  = {8},
number  = {5},
pages  = {},
year  = {2013},
abstract  = {Genetic and chemical biology screens of C. elegans have been of enormous benefit  in providing fundamental insight into neural function and neuroactive drugs. Recently the exploitation of microfluidic devices has added greater power to this experimental approach providing more discrete and higher throughput phenotypic analysis of neural systems. Here we make a significant addition to this repertoire through the design of a semi-automated microfluidic device, NeuroChip, which has been optimised for selecting worms based on the electrophysiological features of the pharyngeal neural network. We demonstrate this device has the capability to sort mutant from wild-type worms based on high definition extracellular electrophysiological recordings. NeuroChip resolves discrete differences in excitatory, inhibitory and neuromodulatory components of the neural network from individual animals. Worms may be fed into the device consecutively from a reservoir and recovered unharmed. It combines microfluidics  with integrated electrode recording for sequential trapping, restraining, recording, releasing and recovering of C. elegans. Thus mutant worms may be selected, recovered and propagated enabling mutagenesis screens based on an electrophysiological phenotype. Drugs may be rapidly applied during the recording thus permitting compound screening. For toxicology, this analysis can provide a precise description of sub-lethal effects on neural function. The chamber has been modified to accommodate L2 larval stages showing applicability for small size nematodes including parasitic species which otherwise are not tractable to this experimental approach. We also combine NeuroChip with optogenetics for targeted interrogation of the function of the neural circuit. NeuroChip thus adds a new tool for exploitation of C. elegans and has applications in neurogenetics,  drug discovery and neurotoxicology.},
address  = {Hybrid Biodevices Group, Electronics and Computer Science, University of Southampton, Southampton, United Kingdom Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom Centre for Biological Sciences, Institute for Life Sciences, University of Southampton, Southampton, United Kingdom Hybrid Biodevices Group, Electronics and Computer Science, University of Southampton, Southampton, United Kingdom},
note  = {PLoS One. 2013 May 22;8(5):. doi:10.1371/journal.pone.0064297.}
}

@Article{2016579,
author  = {Lee, S. and Holly, K. and Voziyanov, V. and Villalba, S. and Tong, R. and Grigsby, H. and Glasscock, E. and Szele, F. and Vlachos, I. and Murray, T.},
title  = {Behavioral Test Performance over Time.},
journal  = {PLoS ONE},
volume  = {11},
number  = {1},
pages  = {},
year  = {2016},
abstract  = {Implanted gradient index lenses have extended the reach of standard multiphoton microscopy from the upper layers of the mouse cortex to the lower cortical layers and even subcortical regions. These lenses have the clarity to visualize dynamic  activities, such as calcium transients, with subcellular and millisecond resolution and the stability to facilitate repeated imaging over weeks and months. In addition, behavioral tests can be used to correlate performance with observed changes in network function and structure that occur over time. Yet, this raises the questions, does an implanted microlens have an effect on behavioral tests, and if so, what is the extent of the effect? To answer these questions, we compared the performance of three groups of mice in three common behavioral tests. A gradient index lens was implanted in the prefrontal cortex of experimental mice. We compared their performance with mice that had either a cranial window or a sham surgery. Three presurgical and five postsurgical sets of behavioral tests were performed over seven weeks. Behavioral tests included rotarod, foot fault, and Morris water maze. No significant differences were found between the three groups, suggesting that microlens implantation did not affect performance. The results for the current study clear the way for combining behavioral studies with gradient index lens imaging in the prefrontal cortex, and potentially other regions of the mouse brain, to study structural, functional, and behavioral relationships in the brain.},
address  = {Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech University, Ruston, Louisiana, United States of America Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech University, Ruston, Louisiana, United States of America Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech University, Ruston, Louisiana, United States of America Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech University, Ruston, Louisiana, United States of America Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech University, Ruston, Louisiana, United States of America Center for Biomedical Research and Rehabilitation Sciences, Louisiana Tech University, Ruston, Louisiana, United States of America},
note  = {PLoS One. 2016 Jan 22;11(1):. doi:10.1371/journal.pone.0146533.}
}

@Article{2014580,
author  = {Tiete, J. and Dom√≠nguez, F. and da, S. and Segers, L. and Steenhaut, K. and Touhafi, A.},
title  = {Localization.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {14},
number  = {2},
pages  = {1918-49},
year  = {2014},
abstract  = {Sound source localization is a well-researched subject with applications ranging  from localizing sniper fire in urban battlefields to cataloging wildlife in rural areas. One critical application is the localization of noise pollution sources in urban environments, due to an increasing body of evidence linking noise pollution to adverse effects on human health. Current noise mapping techniques often fail to accurately identify noise pollution sources, because they rely on the interpolation of a limited number of scattered sound sensors. Aiming to produce accurate noise pollution maps, we developed the SoundCompass, a low-cost sound sensor capable of measuring local noise levels and sound field directionality. Our first prototype is composed of a sensor array of 52 Microelectromechanical systems (MEMS) microphones, an inertial measuring unit and a low-power field-programmable gate array (FPGA). This article presents the SoundCompass‚Äôs hardware and firmware design together with a data fusion technique that exploits  the sensing capabilities of the SoundCompass in a wireless sensor network to localize noise pollution sources. Live tests produced a sound source localization accuracy of a few centimeters in a 25-m2 anechoic chamber, while simulation results accurately located up to five broadband sound sources in a 10,000-m2 open field.},
address  = {Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.); ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.) Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.); ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.) Department of Industrial Sciences and Technology (INDI), Vrije Universiteit Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails: BrunoTiago.Da.Silva.Gomes@ehb.be (B.S.); lasegers@vub.ac.be (L.S.) Department of Industrial Sciences and Technology (INDI), Vrije Universiteit Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails: BrunoTiago.Da.Silva.Gomes@ehb.be (B.S.); lasegers@vub.ac.be (L.S.) Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.); ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.) Department of Electronics and Informatics (ETRO), Vrije Universiteit Brussel, Pleinlaan 2, Elsene 1050, Belgium; E-Mails: fedoming@vub.ac.be (F.D.); ksteenha@etro.vub.ac.be (K.S.); abdellah.touhafi@vub.ac.be (A.T.)},
note  = {Sensors (Basel). 2014 Jan 23;14(2):1918-49. doi:10.3390/s140201918.}
}

@Article{2015581,
author  = {Kenealy, T. and Parsons, M. and Rouse, A. and Doughty, R. and Sheridan, N. and Hindmarsh, J. and Masson, S. and Rea, H.},
title  = {Costs. A Randomised Controlled Trial and Qualitative Evaluation.},
journal  = {PLoS ONE},
volume  = {10},
number  = {3},
pages  = {},
year  = {2015},
abstract  = {Objectives: To assess the effect of telecare on health related quality of life, self-care, hospital use, costs and the experiences of patients, informal carers and health care professionals. Methods: Patients were randomly assigned either to usual care or to additionally entering their data into a commercially-available electronic device that uploaded data once a day to a nurse-led monitoring station. Patients had congestive heart failure (Site A), chronic obstructive pulmonary disease (Site B), or any long-term condition, mostly diabetes (Site C). Site C contributed only intervention patients ‚Äì they considered a usual care option to be unethical. The study took place in New Zealand between September 2010 and February 2012, and lasted 3 to 6 months for each patient. The primary outcome was health-related quality of life (SF36). Data on experiences were collected by individual and group interviews and by questionnaire. Results: There were 171 patients (98 intervention, 73 control). Quality of life, self-efficacy and disease-specific measures did not change significantly, while anxiety and depression both decreased significantly with the intervention. Hospital admissions, days in hospital, emergency department visits, outpatient visits and  costs did not differ significantly between the groups. Patients at all sites were universally positive. Many felt safer and more cared-for, and said that they and  their family had learned more about managing their condition. Staff could all see potential benefits of telecare, and, after some initial technical problems, many  staff felt that telecare enabled them to effectively monitor more patients. Conclusions: Strongly positive patient and staff experiences and attitudes complement and contrast with small or non-significant quantitative changes. Telecare led to patients and families taking a more active role in self-management. It is likely that subgroups of patients benefitted in ways that  were not measured or visible within the quantitative data, especially feelings of safety and being cared-for. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN12610000269033},
address  = {Department of General Practice and Primary Health Care, University of Auckland, Auckland, New Zealand Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand, in partnership with Waikato District Health Board, Waikato, New Zealand Department of Accounting and Finance, The University of Auckland Business School, The University of Auckland, Auckland, New Zealand Department of Medicine, University of Auckland and Greenlane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand School of Nursing, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand Ngati Porou Hauora Charitable Trust, Te Puia Springs, Tairawhiti/East Coast, New  Zealand School of Nursing, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand Department of Medicine, University of Auckland, Auckland, New Zealand},
note  = {PLoS One. 2015 Mar 13;10(3):. doi:10.1371/journal.pone.0116188.}
}

@Article{2008582,
author  = {Kamel, B. and Ramloll, R. and Jones, R. and Toth-Cohen, S.},
title  = {Second Life¬Æ.},
journal  = {International Journal of Environmental Research and Public Health},
volume  = {5},
number  = {4},
pages  = {290-317},
year  = {2008},
abstract  = {Over the past three years (2006‚Äì2008), the medical/health and public health communities have shown a growing interest in using online 3D virtual worlds like  Second Life¬Æ (http://secondlife.com/) for health education, community outreach, training and simulations purposes. 3D virtual worlds are seen as the precursors of ‚ÄòWeb 3D‚Äô, the next major iteration of the Internet that will follow in the coming years. This paper provides a tour of several flagship Web 3D experiences in Second Life¬Æ, including Play2Train Islands (emergency preparedness training),  the US Centers for Disease Control and Prevention‚ÄîCDC Island (public health), Karuna Island (AIDS support and information), Tox Town at Virtual NLM Island (US  National Library of Medicine - environmental health), and Jefferson‚Äôs Occupational Therapy Center. We also discuss the potential and future of Web 3D.  These are still early days of 3D virtual worlds, and there are still many more untapped potentials and affordances of 3D virtual worlds that are yet to be explored, as the technology matures further and improves over the coming months and years.},
address  = {Faculty of Health and Social Work, University of Plymouth, Drake Circus, Plymouth, Devon, PL4 8AA, UK; E-Mails: mnkamelboulos@plymouth.ac.uk (M. N. K. B.); ray.jones@plymouth.ac.uk (R. J.) Idaho State University, Pocatello, USA; E-Mail: r.ramloll@gmail.com (R. R.) Faculty of Health and Social Work, University of Plymouth, Drake Circus, Plymouth, Devon, PL4 8AA, UK; E-Mails: mnkamelboulos@plymouth.ac.uk (M. N. K. B.); ray.jones@plymouth.ac.uk (R. J.) Department of Occupational Therapy, Jefferson College of Health Professions, Thomas Jefferson University, USA; E-Mail: Susan.Toth-Cohen@jefferson.edu (S. T. C.)},
note  = {doi:10.3390/ijerph5040290.}
}

@Article{2013583,
author  = {Park, S. and Parwani, A. and Aller, R. and Banach, L. and Becich, M. and Borkenfeld, S. and Carter, A. and Friedman, B. and Rojo, M. and Georgiou, A. and Kayser, G. and Kayser, K. and Legg, M. and Naugler, C. and Sawai, T. and Weiner, H. and Winsten, D. and Pantanowitz, L.},
title  = {The history of pathology informatics: A global perspective.},
journal  = {Journal of Pathology Informatics},
volume  = {4},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Pathology informatics has evolved to varying levels around the world. The history of pathology informatics in different countries is a tale with many dimensions. At first glance, it is the familiar story of individuals solving problems that arise in their clinical practice to enhance efficiency, better manage (e.g., digitize) laboratory information, as well as exploit emerging information technologies. Under the surface, however, lie powerful resource, regulatory, and  societal forces that helped shape our discipline into what it is today. In this monograph, for the first time in the history of our discipline, we collectively perform a global review of the field of pathology informatics. In doing so, we illustrate how general far-reaching trends such as the advent of computers, the Internet and digital imaging have affected pathology informatics in the world at  large. Major drivers in the field included the need for pathologists to comply with national standards for health information technology and telepathology applications to meet the scarcity of pathology services and trained people in certain countries. Following trials by a multitude of investigators, not all of them successful, it is apparent that innovation alone did not assure the success  of many informatics tools and solutions. Common, ongoing barriers to the widespread adoption of informatics devices include poor information technology infrastructure in undeveloped areas, the cost of technology, and regulatory issues. This review offers a deeper understanding of how pathology informatics historically developed and provides insights into what the promising future might hold.},
address  = {Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA Department of Anatomical Pathology, and National Health Laboratory Service (NHLS), Walter Sisulu University, Mthatha, South Africa Department of Biomedical Informatics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA International Academy of Telepathology, Heidelberg, Germany Department of Pathology and Laboratory Medicine, Biomedical Informatics, Emory University School of Medicine, Atlanta, GA, USA Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, USA Hospital General de Ciudad Real, Ciudad Real, Spain Centre for Health Systems and Safety Research, Australian Institute of Health Innovation, Faculty of Medicine, University of New South Wales, NSW, Australia Institute of Pathology, University Freiburg, Freiburg, Germany Institute of Pathology, Charite, Berlin, Germany Centre for Health Informatics and e-Health Research, University of Wollongong, Wollongong, NSW, Australia Department of Pathology and Laboratory Medicine, University of Calgary, and Calgary Laboratory Services, Calgary, Alberta, Canada Department of Pathology, School of Medicine, Iwate Medical University, Iwate Prefecture, Japan Weiner Consulting Services, Florence, OR, USA Dennis Winsten and Associates, Inc., Healthcare Systems Consultants, Tucson, AZ,  USA Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA},
note  = {J Pathol Inform. 2013 May 30;4:. doi:10.4103/2153-3539.112689.}
}

@Article{2015584,
author  = {Bol, G. and Vesuna, F. and Xie, M. and Zeng, J. and Aziz, K. and Gandhi, N. and Levine, A. and Irving, A. and Korz, D. and Tantravedi, S. and Heerma, v. and Gabrielson, K. and Bordt, E. and Polster, B. and Cope, L. and van, d. and Kondaskar, A. and Rudek, M. and Hosmane, R. and van, d. and van, D. and Tran, P. and Raman, V.},
title  = {Targeting DDX3 with a small molecule inhibitor for lung cancer therapy.},
journal  = {EMBO Molecular Medicine},
volume  = {7},
number  = {5},
pages  = {648-69},
year  = {2015},
abstract  = {Lung cancer is the most common malignancy worldwide and is a focus for developing targeted therapies due to its refractory nature to current treatment. We identified a RNA helicase, DDX3, which is overexpressed in many cancer types including lung cancer and is associated with lower survival in lung cancer patients. We designed a first-in-class small molecule inhibitor, RK-33, which binds to DDX3 and abrogates its activity. Inhibition of DDX3 by RK-33 caused G1 cell cycle arrest, induced apoptosis, and promoted radiation sensitization in DDX3-overexpressing cells. Importantly, RK-33 in combination with radiation induced tumor regression in multiple mouse models of lung cancer. Mechanistically, loss of DDX3 function either by shRNA or by RK-33 impaired Wnt signaling through disruption of the DDX3‚ÄìŒ≤-catenin axis and inhibited non-homologous end joining‚Äîthe major DNA repair pathway in mammalian somatic cells. Overall, inhibition of DDX3 by RK-33 promotes tumor regression, thus providing a compelling argument to develop DDX3 inhibitors for lung cancer therapy.},
address  = {Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiation Oncology, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiation Oncology, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiation Oncology, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Molecular and Comparative Pathobiology, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Anesthesiology, University of Maryland School of MedicineBaltimore, MD, USA Department of Anesthesiology, University of Maryland School of MedicineBaltimore, MD, USA Department of Oncology, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Pathology, University Medical Center UtrechtUtrecht, The Netherlands Department of Chemistry & Biochemistry, University of MarylandBaltimore County, MD, USA Department of Oncology, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Chemistry & Biochemistry, University of MarylandBaltimore County, MD, USA Department of Internal Medicine, University Medical Center UtrechtUtrecht, The Netherlands Department of Pathology, University Medical Center UtrechtUtrecht, The Netherlands Department of Radiation Oncology, Johns Hopkins University School of MedicineBaltimore, MD, USA Department of Radiology and Radiological Science, Johns Hopkins University School of MedicineBaltimore, MD, USA},
note  = {EMBO Mol Med. 2015 May;7(5):648-69. Epub 2015 Mar 27 doi:10.15252/emmm.201404368.}
}

@Article{2013585,
author  = {Zaaimi, B. and Ruiz-Torres, R. and Solla, S. and Miller, L.},
title  = {detection.},
journal  = {Journal of neural engineering},
volume  = {10},
number  = {5},
pages  = {},
year  = {2013},
abstract  = {Brain machine interfaces (BMIs) that decode control signals from motor cortex have developed tremendously in the past decade, but virtually all rely exclusively on vision to provide feedback. There is now increasing interest in developing an afferent interface to replace natural somatosensation, much as the  cochlear implant has done for the sense of hearing. Preliminary experiments toward a somatosensory neuroprosthesis have mostly addressed the sense of touch,  but proprioception, the sense of limb position and movement, is also critical for the control of movement. However, proprioceptive areas of cortex lack the precise somatotopy of tactile areas. We showed previously that there is only a weak tendency for neighboring neurons in area 2 to signal similar directions of hand movement. Consequently, stimulation with the relatively large currents used in many studies is likely to activate a rather heterogeneous set of neurons. Here, we have compared the effect of single-electrode stimulation at sub-threshold levels to the effect of stimulating as many as seven electrodes in combination. We found a mean enhancement in the sensitivity to the stimulus (d‚Ä≤) of 0.17 for pairs compared to individual electrodes (an increase of roughly 30%), and an increase of 2.5 for groups of seven electrodes (260%). We propose that a proprioceptive interface made up of several hundred electrodes may yield safer, more effective sensation than a BMI using fewer electrodes and larger currents.},
address  = {Department of Physiology, Northwestern University, Chicago, IL, 60611, USA Department of Physiology, Northwestern University, Chicago, IL, 60611, USA Department of Physiology, Northwestern University, Chicago, IL, 60611, USA Department of Physiology, Northwestern University, Chicago, IL, 60611, USA},
note  = {doi:10.1088/1741-2560/10/5/056013.}
}

@Article{2008586,
author  = {Maher, T. and Gat, M. and Allen, D. and Devaraj, A. and Wells, A. and Geddes, D.},
title  = {individuals.},
journal  = {Thorax},
volume  = {63},
number  = {6},
pages  = {542-8},
year  = {2008},
abstract  = {Background and aim:: Acoustic lung imaging offers a unique method for visualising the lung. This study was designed to demonstrate reproducibility of acoustic lung images recorded from healthy individuals at different time points and to assess intra- and inter-rater agreement in the assessment of dynamically represented acoustic lung images. Methods:: Recordings from 29 healthy volunteers were made on three separate occasions using vibration response imaging. Reproducibility was measured using quantitative, computerised assessment of vibration energy. Dynamically represented acoustic lung images were scored by six blinded raters. Results:: Quantitative measurement of acoustic recordings was highly reproducible with an intraclass correlation score of 0.86 (very good agreement). Intraclass correlations for inter-rater agreement and reproducibility were 0.61 (good agreement) and 0.86 (very good agreement), respectively. There was no significant difference found between the six raters at any time point. Raters ranged from 88% to 95% in their ability to identically evaluate the different features of the same image presented to them blinded on two separate occasions. Conclusion:: Acoustic lung imaging is reproducible in healthy individuals. Graphic representation of lung images can be interpreted with a high degree of accuracy by the same and by different reviewers.},
address  = {Department of Respiratory Medicine, The Royal Brompton Hospital, London, UK Deep Breeze Ltd, North Industrial Park, Or Akiva, Israel Department of Radiology, The Royal Brompton Hospital, London, UK Department of Radiology, The Royal Brompton Hospital, London, UK Department of Respiratory Medicine, The Royal Brompton Hospital, London, UK Department of Respiratory Medicine, The Royal Brompton Hospital, London, UK},
note  = {Thorax. 2008 Jun;63(6):542-8. Epub 2007 Nov 16 doi:10.1136/thx.2007.086405.}
}

@Article{2014587,
author  = {Malek, G. and Lad, E.},
title  = {degeneration.},
journal  = {Cellular and molecular life sciences : CMLS},
volume  = {71},
number  = {23},
pages  = {4617-36},
year  = {2014},
abstract  = {Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly in the Western world. Over the last 30 years, our understanding of the pathogenesis of the disease has grown exponentially thanks to the results of countless epidemiology, genetic, histo-logical, and biochemical studies. This information, in turn, has led to the identification of multiple biologic pathways potentially involved in development and progression of AMD, including but not limited to inflammation, lipid and extracellular matrix dysregulation, and angiogenesis. Nuclear receptors are a superfamily of transcription factors that have been shown to regulate many of the pathogenic pathways linked with AMD and as such they are emerging as promising targets for therapeutic intervention. In this review, we will present the fundamental phenotypic features of AMD and discuss our current understanding of the pathobiological disease mechanisms. We will introduce the nuclear receptor superfamily and discuss the current literature on their effects on AMD-related pathophysiology.},
address  = {Department of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road, AERI Room 4006, Durham, NC 27710, USA Department of Pathology, Duke University School of Medicine, Durham, NC, USA Department of Ophthalmology, Duke University School of Medicine, 2351 Erwin Road, AERI Room 4006, Durham, NC 27710, USA},
note  = {doi:10.1007/s00018-014-1709-x.}
}

@Article{2011588,
author  = {Kaczmarek, K.},
title  = {presentation.},
journal  = {engineering},
volume  = {18},
number  = {6},
pages  = {1476-85},
year  = {2011},
abstract  = {The Tongue Display Unit (TDU) is a 144-channel programmable pulse generator that  delivers dc-balanced voltage pulses suitable for electrotactile (electrocutaneous) stimulation of the anterior-dorsal tongue, through a matrix of surface electrodes. This article reviews the theory of operation and a design overview of the TDU, as well as selected applications. These include sensory substitution, tactile information display and neurorehabilitation via induced neuroplasticity.},
address  = {Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, 1300 University Ave., Madison, WI 53711, USA},
note  = {doi:10.1016/j.scient.2011.08.020.}
}

@Article{2012589,
author  = {Psaltis, P. and Simari, R. and Rodriguez-Porcel, M.},
title  = {therapeutics: a clinical perspective.},
journal  = {European Journal of Nuclear Medicine and Molecular Imaging},
volume  = {39},
number  = {1},
pages  = {165-81},
year  = {2012},
abstract  = {Despite preclinical promise, the progress of cell-based therapy to clinical cardiovascular practice has been slowed by several challenges and uncertainties that have been highlighted by the conflicting results of human trials. Most telling has been the revelation that current strategies fall short of achieving sufficient retention and engraftment of cells to meet the ambitious objective of  myocardial regeneration. This has sparked novel research into the refinement of cell biology and delivery to overcome these shortcomings. Within this context, molecular imaging has emerged as a valuable tool for providing noninvasive surveillance of cell fate in vivo. Direct and indirect labelling of cells can be  coupled with clinically relevant imaging modalities, such as radionuclide single  photon emission computed tomography and positron emission tomography, and magnetic resonance imaging, to assess their short- and long-term distributions, along with their viability, proliferation and functional interaction with the host myocardium. This review details the strengths and limitations of the different cell labelling and imaging techniques and their potential application to the clinical realm. We also consider the broader, multifaceted utility of imaging throughout the cell therapy process, providing a discussion of its considerable value during cell delivery and its importance during the evaluation  of cardiac outcomes in clinical studies.},
address  = {},
note  = {doi:10.1007/s00259-011-1925-7.}
}

@Article{2012590,
author  = {ASTRAKAS, L. and NAQVI, S. and KATEB, B. and TZIKA, A.},
title  = {from chronic stroke in the molecular medicine era (Review).},
journal  = {International Journal of Molecular Medicine},
volume  = {29},
number  = {6},
pages  = {963-73},
year  = {2012},
abstract  = {The number of individuals suffering from stroke is increasing daily, and its consequences are a major contributor to invalidity in today‚Äôs society. Stroke rehabilitation is relatively new, having been hampered from the longstanding view that lost functions were not recoverable. Nowadays, robotic devices, which aid by stimulating brain plasticity, can assist in restoring movement compromised by stroke-induced pathological changes in the brain which can be monitored by MRI. Multiparametric magnetic resonance imaging (MRI) of stroke patients participating in a training program with a novel Magnetic Resonance Compatible Hand-Induced Robotic Device (MR_CHIROD) could yield a promising biomarker that, ultimately, will enhance our ability to advance hand motor recovery following chronic stroke. Using state-of-the art MRI in conjunction with MR_CHIROD-assisted therapy can provide novel biomarkers for stroke patient rehabilitation extracted by a meta-analysis of data. Successful completion of such studies may provide a ground breaking method for the future evaluation of stroke rehabilitation therapies. Their results will attest to the effectiveness of using MR-compatible hand devices with MRI to provide accurate monitoring during rehabilitative therapy. Furthermore, such results may identify biomarkers of brain plasticity that can be monitored during stroke patient rehabilitation. The potential benefit for chronic stroke patients is that rehabilitation may become possible for a longer period of time after stroke than previously thought, unveiling motor skill improvements possible even after six months due to retained brain plasticity.},
address  = {Department of Surgery, NMR Surgical Laboratory, Massachusetts General Hospital and Shriners Burn Institute, Harvard Medical School, Boston, MA 02114, USA Department of Surgery, NMR Surgical Laboratory, Massachusetts General Hospital and Shriners Burn Institute, Harvard Medical School, Boston, MA 02114, USA Brain Mapping Foundation, West Hollywood, CA 90046, USA Department of Surgery, NMR Surgical Laboratory, Massachusetts General Hospital and Shriners Burn Institute, Harvard Medical School, Boston, MA 02114, USA},
note  = {Int J Mol Med. 2012 Jun;29(6):963-73. Epub 2012 Mar 15 doi:10.3892/ijmm.2012.942.}
}

@Article{2012591,
author  = {Lau, T. and Gwin, J. and McDowell, K. and Ferris, D.},
title  = {cognitive EEG activity during locomotion.},
journal  = {Journal of NeuroEngineering and Rehabilitation},
volume  = {9},
number  = {},
pages  = {47},
year  = {2012},
abstract  = {Background: High-density electroencephalography (EEG) with active electrodes allows for monitoring of electrocortical dynamics during human walking but movement artifacts have the potential to dominate the signal. One potential method for recovering cognitive brain dynamics in the presence of gait-related artifact is the Weighted Phase Lag Index. Methods: We tested the ability of Weighted Phase Lag Index to recover event-related potentials during locomotion. Weighted Phase Lag Index is a functional connectivity measure that quantified how consistently 90¬∞ (or 270¬∞) phase ‚Äòlagging‚Äô one EEG signal was compared to another. 248-channel EEG was recorded as eight subjects performed a visual oddball discrimination and response task during standing and walking (0.8 or 1.2‚Äâm/s) on a treadmill. Results: Applying Weighted Phase Lag Index across channels we were able to recover a p300-like cognitive response during walking. This response was similar to the classic amplitude-based p300 we also recovered during standing. We also showed that the Weighted Phase Lag Index detects more complex and variable activity patterns than traditional voltage-amplitude measures. This variability makes it challenging to compare brain activity over time and across subjects. In contrast, a statistical metric of the index‚Äôs variability, calculated over a moving time window, provided a more generalized measure of behavior. Weighted Phase Lag Index Stability returned a peak change of 1.8%‚Äâ+‚Äâ‚àí0.5% from baseline for the walking case and 3.9%‚Äâ+‚Äâ‚àí1.3% for the standing case. Conclusions: These findings suggest that both Weighted Phase Lag Index and  Weighted Phase Lag Index Stability have potential for the on-line analysis of cognitive dynamics within EEG during human movement. The latter may be more useful from extracting general principles of neural behavior across subjects and  conditions.},
address  = {Human Neuromechanics Laboratory, School of Kinesiology, University of Michigan, Ann Arbor, MI 48109-2214, USA Human Neuromechanics Laboratory, School of Kinesiology, University of Michigan, Ann Arbor, MI 48109-2214, USA US Army Research Laboratory, Human Research and Engineering Directorate, Translational Neuroscience Branch, Aberdeen Proving Ground, Aberdeen, MD 21005, USA Human Neuromechanics Laboratory, School of Kinesiology, University of Michigan, Ann Arbor, MI 48109-2214, USA},
note  = {J Neuroeng Rehabil. 2012 Jul 24;9:47. doi:10.1186/1743-0003-9-47.}
}

@Article{2016592,
author  = {Mohammadi-Abdar, H. and Ridgel, A. and Discenzo, F. and Loparo, K.},
title  = {Individuals with Parkinson‚Äôs Disease.},
journal  = {Industrial Electronics Society and the ASME Dynamic Systems and Control Division},
volume  = {21},
number  = {3},
pages  = {1650-8},
year  = {2016},
abstract  = {Recent studies in rehabilitation of Parkinson‚Äôs disease (PD) have shown that cycling on a tandem bike at a high pedaling rate can reduce the symptoms of the disease. In this research, a smart motorized bicycle has been designed and built  for assisting Parkinson‚Äôs patients with exercise to improve motor function. The exercise bike can accurately control the rider‚Äôs experience at an accelerated pedaling rate while capturing real-time test data. Here, the design and development of the electronics and hardware as well as the software and control algorithms are presented. Two control algorithms have been developed for the bike; one that implements an inertia load (static mode) and one that implements a speed reference (dynamic mode). In static mode the bike operates as a regular exercise bike with programmable resistance (load) that captures and records the required signals such as heart rate, cadence and power. In dynamic mode the bike  operates at a user-selected speed (cadence) with programmable variability in speed that has been shown to be essential to achieving the desired motor performance benefits for PD patients. In addition, the flexible and extensible design of the bike permits readily changing the control algorithm and incorporating additional I/O as needed to provide a wide range of riding experiences. Furthermore, the network-enabled controller provides remote access to bike data during a riding session.},
address  = {EECS Department, Case Western Reserve University, Cleveland, Ohio, 44106, USA (hmabdar@case.edu) Department of Exercise Science, Kent State University, Kent, OH, USA (aridgel@kent.edu) Advanced Technology Laboratory, Rockwell Automation, Mayfield Heights, OH, USA (fmdiscenzo@ra.rockwell.com) EECS Department Case Western Reserve University, Cleveland, Ohio, 44106, USA (kal4@case.edu)},
note  = {doi:10.1109/TMECH.2015.2508030.}
}

@Article{2012593,
author  = {Delorme, A. and Palmer, J. and Onton, J. and Oostenveld, R. and Makeig, S.},
title  = {Independent EEG Sources Are Dipolar.},
journal  = {PLoS ONE},
volume  = {7},
number  = {2},
pages  = {},
year  = {2012},
abstract  = {Independent component analysis (ICA) and blind source separation (BSS) methods are increasingly used to separate individual brain and non-brain source signals mixed by volume conduction in electroencephalographic (EEG) and other electrophysiological recordings. We compared results of decomposing thirteen 71-channel human scalp EEG datasets by 22 ICA and BSS algorithms, assessing the pairwise mutual information (PMI) in scalp channel pairs, the remaining PMI in component pairs, the overall mutual information reduction (MIR) effected by each  decomposition, and decomposition ‚Äòdipolarity‚Äô defined as the number of component  scalp maps matching the projection of a single equivalent dipole with less than a given residual variance. The least well-performing algorithm was principal component analysis (PCA); best performing were AMICA and other likelihood/mutual  information based ICA methods. Though these and other commonly-used decomposition methods returned many similar components, across 18 ICA/BSS algorithms mean dipolarity varied linearly with both MIR and with PMI remaining between the resulting component time courses, a result compatible with an interpretation of many maximally independent EEG components as being volume-conducted projections of partially-synchronous local cortical field activity within single compact cortical domains. To encourage further method comparisons, the data and software  used to prepare the results have been made available (http://sccn.ucsd.edu/wiki/BSSComparison).},
address  = {Swartz Center for Computational Neuroscience, University of California San Diego, La Jolla, California, United States of America Swartz Center for Computational Neuroscience, University of California San Diego, La Jolla, California, United States of America Swartz Center for Computational Neuroscience, University of California San Diego, La Jolla, California, United States of America Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands Swartz Center for Computational Neuroscience, University of California San Diego, La Jolla, California, United States of America},
note  = {PLoS One. 2012 Feb 15;7(2):. doi:10.1371/journal.pone.0030135.}
}

@Article{2010594,
author  = {Braun, C. and Coombs, S.},
title  = {of specific stimulation channels using multiple behavioral approaches.},
journal  = {Journal of experimental psychology. Animal behavior processes},
volume  = {36},
number  = {2},
pages  = {243-57},
year  = {2010},
abstract  = {An underwater vibratory source simultaneously presents acoustic and hydrodynamic  disturbances. Because vibratory dipole sources are poor sonic projectors, most researchers have assumed that such sources are of greatest relevance to the lateral line system (LL). Both hydroacoustic principles and empirical studies have shown that vibratory dipole sources are also a potent stimulus to the inner  ear of fishes. Responses to vibratory sources in mottled sculpin (Cottus bairdi)  were assessed using unconditioned orienting, differential and non-differential-classical conditioning. Orienting responses are dominated by LL  inputs and eliminated by LL pharmacological inactivation. Simple conditioning depends on inputs from other systems and was not affected by LL inactivation. Differential conditioning alters behavioral control, and sculpin could be conditioned to ignore substrate borne vibrations and respond only to hydroacoustic stimulation of the ear. The lateral line and inner ear of mottled sculpin do not necessarily exhibit range fractionation, as both systems operate over a similar distance from the animal (within 1.5 body lengths) and respond to  many of the same sources. Vibratory dipole sources generate compound stimuli that simultaneously activate multiple octavolateralis systems, and animals make use of the channels differentially under different behavioral tasks.},
address  = {Department of Psychology, Hunter College; & Psychology, The Graduate Center, City University of New York, 695 Park Ave, New York, NY 10021 Department of Biological Sciences, JP Scott Center for Neuroscience, Mind and Behavior, Bowling Green State University, Bowling Green, Oh 43402},
note  = {J Exp Psychol Anim Behav Process. 2010 Apr;36(2):243-57. doi:10.1037/a0016747.}
}

@Article{2010595,
author  = {Rahman, M. and Ingole, N. and Roblyer, D. and Stepanek, V. and Richards-Kortum, R. and Gillenwater, A. and Shastri, S. and Chaturvedi, P.},
title  = {cancer.},
journal  = {Head & Neck Oncology},
volume  = {2},
number  = {},
pages  = {10},
year  = {2010},
abstract  = {Background: There is an important global need to improve early detection of oral  cancer. Recent reports suggest that optical imaging technologies can aid in the identification of neoplastic lesions in the oral cavity; however, there is little data evaluating the use of optical imaging modalities in resource limited settings where oral cancer impacts patients disproportionately. In this article,  we evaluate a simple, low-cost optical imaging system that is designed for early  detection of oral cancer in resource limited settings. We report results of a clinical study conducted at Tata Memorial Hospital (TMH) in Mumbai, India using this system as a tool to improve detection of oral cancer and its precursors. Methods: Reflectance images with white light illumination and fluorescence images with 455 nm excitation were obtained from 261 sites in the oral cavity from 76 patients and 90 sites in the oral cavity from 33 normal volunteers. Quantitative  image features were used to develop classification algorithms to identify neoplastic tissue, using clinical diagnosis of expert observers as the gold standard. Results: Using the ratio of red to green autofluorescence, the algorithm identified tissues judged clinically to be cancer or clinically suspicious for neoplasia with a sensitivity of 90% and a specificity of 87%. Conclusions: Results suggest that the performance of this simple, objective low-cost system has potential to improve oral screening efforts, especially in low-resource settings.},
address  = {Department of Bioengineering, Rice University, Houston, 77005, USA Head and Neck Surgery, Tata Memorial Hospital, Mumbai, 400012, India Department of Bioengineering, Rice University, Houston, 77005, USA Department of Bioengineering, Rice University, Houston, 77005, USA Department of Bioengineering, Rice University, Houston, 77005, USA Department of Bioengineering, Rice University, Houston, 77005, USA Head and Neck Surgery, Tata Memorial Hospital, Mumbai, 400012, India Head and Neck Surgery, Tata Memorial Hospital, Mumbai, 400012, India},
note  = {Head Neck Oncol. 2010 Apr 22;2:10. doi:10.1186/1758-3284-2-10.}
}

@Article{2016596,
author  = {Linden, D. and Turner, D.},
title  = {neurorehabilitation.},
journal  = {Current Opinion in Neurology},
volume  = {29},
number  = {4},
pages  = {412-8},
year  = {2016},
abstract  = {Purpose of review: Recent developments in functional magnetic resonance imaging (fMRI) have catalyzed a new field of translational neuroscience. Using fMRI to monitor the aspects of task-related changes in neural activation or brain connectivity, investigators can offer feedback of simple or complex neural signals/patterns back to the participant on a quasireal-time basis [real-time-fMRI-based neurofeedback (rt-fMRI-NF)]. Here, we introduce some background methodology of the new developments in this field and give a perspective on how they may be used in neurorehabilitation in the future. Recent  findings: The development of rt-fMRI-NF has been used to promote self-regulation  of activity in several brain regions and networks. In addition, and unlike other  noninvasive techniques, rt-fMRI-NF can access specific subcortical regions and in principle any region that can be monitored using fMRI including the cerebellum, brainstem and spinal cord. In Parkinson's disease and stroke, rt-fMRI-NF has been demonstrated to alter neural activity after the self-regulation training was completed and to modify specific behaviours. Summary: Future exploitation of rt-fMRI-NF could be used to induce neuroplasticity in brain networks that are involved in certain neurological conditions. However, currently, the use of rt-fMRI-NF in randomized, controlled clinical trials is in its infancy.},
address  = {MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University School  of Medicine, and Cardiff University Brain Imaging Centre, Cardiff Neurorehabilitation Unit, School of Health, Sport and Bioscience, University of East London, London, UK},
note  = {doi:10.1097/WCO.0000000000000340.}
}

@Article{2013597,
author  = {Andersson, N. and Cockcroft, A. and Thabane, L. and Marokoane, N. and Laetsang, D. and Masisi, M.},
title  = {protocol for a randomised controlled trial.},
journal  = {Trials},
volume  = {14},
number  = {},
pages  = {274},
year  = {2013},
abstract  = {Background: Most HIV prevention strategies assume beneficiaries can act on their  prevention decisions. But some people are unable to do so. They are ‚Äòchoice-disabled‚Äô. Economic and educational interventions can reduce sexual violence, but there is less evidence that they can reduce HIV. There is little research on complex interventions in HIV prevention, yet all countries in southern Africa implement combination prevention programmes. Methods/Design: The  primary objective is to reduce HIV infections among women aged 15 to 29 years. Secondary objectives are reduction in gender violence and improvement in HIV-related knowledge, attitudes and practices among youth aged 15 to 29 years.A  random sample of 77 census enumeration areas in three countries (Botswana, Namibia and Swaziland) was allocated randomly to three interventions, alone or in combination, in a factorial design stratified by country, HIV rates (above or below average for country), and urban/rural location. A baseline survey of youth  aged 15 to 29 years provided cluster specific rates of HIV. All clusters continue existing prevention efforts and have a baseline and follow-up survey. Cluster is  the unit of allocation, intervention and analysis, using generalised estimating equations, on an intention-to-treat basis.One intervention discusses evidence about choice disability with local HIV prevention services, to help them to serve the choice-disabled. Another discusses an eight-episode audio-docudrama with community groups, of all ages and both sexes, to generate endogenous strategies to reduce gender violence and develop an enabling environment. A third supports groups of women aged 18 to 25 years to build self-esteem and life skills and to set up small enterprises to generate income.A survey in all clusters after 3 years will measure outcomes, with interviewers unaware of group assignment of the clusters. The primary outcome is HIV infection in women aged 15 to 29 years. Secondary outcomes in youth aged 15 to 29 years are gender violence and protective knowledge, attitudes, subjective norms, intention to change, agency, discussion of prevention and practices related to HIV and gender violence. Trial  registration: Trial registration number: ISRCTN28557578},
address  = {Centro de Investigaci√≥n de Enfermedades Tropicales (CIET), Universidad Aut√≥noma de Guerrero, Calle Pino, El Roble, Acapulco, Mexico CIET Trust Botswana, P.O. Box 1240, Gaborone, Botswana McMaster University, Hamilton, ON, Canada CIET Trust, 71 Oxford Road, Johannesburg 2196, South Africa CIET Trust Botswana, P.O. Box 1240, Gaborone, Botswana Minister for Presidential Affairs and Public Administration, Office of the President, Private Bag 001, Gaborone, Botswana},
note  = {Trials. 2013 Aug 29;14:274. doi:10.1186/1745-6215-14-274.}
}

@Article{2016598,
author  = {Dettmer, M. and Pourmoghaddam, A. and Lee, B. and Layne, C.},
title  = {Translations in Healthy Adults?},
journal  = {Current Gerontology and Geriatrics Research},
volume  = {2016},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Appropriate neuromuscular responses to support surface perturbations are crucial  to prevent falls, but aging-related anatomical and physiological changes affect the appropriateness and efficiency of such responses. Low-level noise application to sensory receptors has shown to be effective for postural improvement in a variety of different balance tasks, but it is unknown whether this intervention may have value for improvement of corrective postural responses. Ten healthy younger and ten healthy older adults were exposed to sudden backward translations of the support surface. Low-level noise (mechanical vibration) to the foot soles  was added during random trials and temporal (response latency) and spatial characteristics (maximum center-of-pressure excursion and anterior-posterior path length) of postural responses were assessed. Mixed-model ANOVA was applied for analysis of postural response differences based on age and vibration condition. Age affected postural response characteristics, but older adults were well able to maintain balance when exposed to a postural perturbation. Low-level noise application did not affect any postural outcomes. Healthy aging affects some specific measures of postural stability, and in high-functioning older individuals, a low-level noise intervention may not be valuable. More research is needed to investigate if recurring fallers and neuropathy patients could benefit  from the intervention in postural perturbation tasks.},
address  = {Memorial Bone & Joint Research Foundation, 1140 Business Center Drive Suite 101,  Houston, TX 77043, USA Memorial Bone & Joint Research Foundation, 1140 Business Center Drive Suite 101,  Houston, TX 77043, USA Health and Human Performance Department, University of Houston, 3855 Holman Street, Houston, TX 77204-6015, USA Health and Human Performance Department, University of Houston, 3855 Holman Street, Houston, TX 77204-6015, USA},
note  = {Curr Gerontol Geriatr Res. 2016;2016:. Epub 2016 Apr 19 doi:10.1155/2016/2941964.}
}

@Article{2011599,
author  = {Abbs, B. and Liang, L. and Makris, N. and Tsuang, M. and Seidman, L. and Goldstein, J.},
title  = {Sex Differences are Critical.},
journal  = {NeuroImage},
volume  = {56},
number  = {4},
pages  = {1865-74},
year  = {2011},
abstract  = {Women have consistently demonstrated better verbal memory on tests that evaluate  immediate and delayed free recall. In patients with schizophrenia, these verbal memory processes are relatively more preserved in women than men. However an understanding of the brain anatomy of the female advantage for verbal memory is still unclear.29 females and 59 males with schizophrenia made comparable to 21 female and 27 male healthy volunteers were scanned using structural magnetic resonance imaging (sMRI) in order to assess volumes of regions across the entire  brain. Sex differences within and between groups in the covariance structure of memory circuitry regions were evaluated using a novel approach to covariance analysis (the Box M Test). Brain areas of interest included prefrontal cortex (PFC), inferior parietal lobule (iPAR), anterior cingulate gyrus (ACG), parahippocampus, and hippocampus (HIPP).Results showed significant differences in the covariance matrices of females and males with schizophrenia compared with their healthy counterparts, in particular the relationships between iPAR-PFC, iPAR-ACG, and HIPP-PFC. Sex differences in the iPAR-PFC relationship were significantly associated with sex differences in verbal memory performance. In control women, but not in men ACG volume correlated strongly with memory performance. In schizophrenia, ACG volume was reduced in females, but not in men, relative to controls.Findings suggest that the relationship between iPAR and PFC  is particularly important for understanding the relative preservation of verbal memory processing in females with schizophrenia and may compensate for ACG volume reductions. These results illustrate the utility of a unique covariance structure modeling approach that yields important new knowledge for understanding the nature of schizophrenia.},
address  = {Harvard Medical School (HMS), Departments of Psychiatry and Medicine Brigham and  Women's Hospital, Connors Center for Women's Health and Gender Biology 1620 Tremont St. BC 3-34, Boston, MA 02120 USA Department of Neurology, Massachusetts General Hospital (MGH) 149 13 St., Charlestown, MA 02129 USA Department of Neurology, Massachusetts General Hospital (MGH) 149 13 St., Charlestown, MA 02129 USA Center for Behavioral Genomics, Institute for Genomic Medicine, Department of Psychiatry, University of California, San Diego MGH & MIT Athinoula Martinos Center for Biomedical Imaging & MGH Center for Morphometric Analysis 149 13 St., Charlestown, MA 02129 USA Harvard Medical School (HMS), Departments of Psychiatry and Medicine Brigham and  Women's Hospital, Connors Center for Women's Health and Gender Biology 1620 Tremont St. BC 3-34, Boston, MA 02120 USA},
note  = {doi:10.1016/j.neuroimage.2011.03.079.}
}

@Article{2012600,
author  = {Hoey, H. and Mlinac, A. and Tran, C. and Schlaeger, C.},
title  = {Beyond, May 3‚Äì5, 2012, Dublin, Ireland.},
journal  = {Diabetes Technology & Therapeutics},
volume  = {14},
number  = {12},
pages  = {1155-73},
year  = {2012},
abstract  = {},
address  = {Diabetes Ireland, Dublin, Ireland. Adecco Human Resources GmbH, Mannheim, Germany. Roche Diagnostics GmbH, Mannheim, Germany. Roche Diagnostics GmbH, Mannheim, Germany.},
note  = {Diabetes Technol Ther. 2012 Dec;14(12):1155-73. doi:10.1089/dia.2012.0230.}
}

@Article{601,
author  = {Sehgal, M. and Ehlers, V. and Moyer, J.},
title  = {Learning enhances intrinsic excitability in a subset of lateral amygdala neurons.},
journal  = {Learning & Memory},
volume  = {21},
number  = {3},
pages  = {161-70},
year  = {},
abstract  = {Learning-induced modulation of neuronal intrinsic excitability is a metaplasticity mechanism that can impact the acquisition of new memories. Although the amygdala is important for emotional learning and other behaviors, including fear and anxiety, whether learning alters intrinsic excitability within the amygdala has received very little attention. Fear conditioning was combined with intracellular recordings to investigate the effects of learning on the intrinsic excitability of lateral amygdala (LA) neurons. To assess time-dependent changes, brain slices were prepared either immediately or 24-h post-conditioning. Fear conditioning significantly enhanced excitability of LA neurons, as evidenced by both decreased afterhyperpolarization (AHP) and increased neuronal firing. These changes were time-dependent such that reduced AHPs were evident at both time points whereas increased neuronal firing was only observed at the later (24-h) time point. Moreover, these changes occurred within a subset (32%) of LA neurons. Previous work also demonstrated that learning-related changes in synaptic plasticity are also evident in less than one-third of amygdala neurons,  suggesting that the neurons undergoing intrinsic plasticity may be critical for fear memory. These data may be clinically relevant as enhanced LA excitability following fear learning could influence future amygdala-dependent behaviors.},
address  = {Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201, USA Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201, USA Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201, USA},
note  = {Learn Mem. ;21(3):161-70. doi:10.1101/lm.032730.113.}
}

@Article{2013602,
author  = {Gomez, P. and Faraji, J. and Metz, G. and Tatsuno, M. and Luczak, A.},
title  = {Recent Advancements.},
journal  = {Stroke Research and Treatment},
volume  = {2013},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Transcranial direct current stimulation (tDCS) is a promising technique to treat  a wide range of neurological conditions including stroke. The pathological processes following stroke may provide an exemplary system to investigate how tDCS promotes neuronal plasticity and functional recovery. Changes in synaptic function after stroke, such as reduced excitability, formation of aberrant connections, and deregulated plastic modifications, have been postulated to impede recovery from stroke. However, if tDCS could counteract these negative changes by influencing the system's neurophysiology, it would contribute to the formation of functionally meaningful connections and the maintenance of existing  pathways. This paper is aimed at providing a review of underlying mechanisms of tDCS and its application to stroke. In addition, to maximize the effectiveness of tDCS in stroke rehabilitation, future research needs to determine the optimal stimulation protocols and parameters. We discuss how stimulation parameters could be optimized based on electrophysiological activity. In particular, we propose that cortical synchrony may represent a biomarker of tDCS efficacy to indicate communication between affected areas. Understanding the mechanisms by which tDCS  affects the neural substrate after stroke and finding ways to optimize tDCS for each patient are key to effective rehabilitation approaches.},
address  = {},
note  = {Stroke Res Treat. 2013;2013:. Epub 2013 Feb 27 doi:10.1155/2013/170256.}
}

@Article{2013603,
author  = {Enriquez-Geppert, S. and Huster, R. and Scharfenort, R. and Mokom, Z. and Vosskuhl, J. and Figge, C. and Zimmermann, J. and Herrmann, C.},
title  = {neurofeedback success.},
journal  = {Frontiers in Human Neuroscience},
volume  = {7},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Humans differ in their ability to learn how to control their own brain activity by neurofeedback. However, neural mechanisms underlying these inter-individual differences, which may determine training success and associated cognitive enhancement, are not well-understood. Here, it is asked whether neurofeedback success of frontal-midline (fm) theta, an oscillation related to higher cognitive functions, could be predicted by the morphology of brain structures known to be critically involved in fm-theta generation. Nineteen young, right-handed participants underwent magnetic resonance imaging of T1-weighted brain images, and took part in an individualized, eight-session neurofeedback training in order to learn how to enhance activity in their fm-theta frequency band. Initial training success, measured at the second training session, was correlated with the final outcome measure. We found that the inferior, superior, and middle frontal cortices were not associated with training success. However, volume of the midcingulate cortex as well as volume and concentration of the underlying white matter structures act as predictor variables for the general responsiveness to training. These findings suggest a neuroanatomical foundation for the ability  to learn to control one's own brain activity.},
address  = {Department of Psychology, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany Department of Psychology, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany Department of Psychology, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany Department of Psychology, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany Department of Psychology, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany Karl-Jaspers Clinic, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany Karl-Jaspers Clinic, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany Department of Psychology, European Medical School, Carl von Ossietzky UniversityOldenburg, Germany},
note  = {Front Hum Neurosci. 2013 Aug 09;7:. doi:10.3389/fnhum.2013.00453.}
}

@Article{2014604,
author  = {Song, D. and Jegatheesan, P. and Weiss, S. and Govindaswami, B. and Wang, J. and Lee, J. and Oder, A. and Barlow, S.},
title  = {stimulation in preterm infants.},
journal  = {Pediatric research},
volume  = {75},
number  = {0},
pages  = {85-92},
year  = {2014},
abstract  = {Background: Stimulation of the nervous system plays a central role in brain development and neurodevelopmental outcome. Thalamocortical and corticocortical development is diminished in premature infants and correlated to electroencephalography (EEG) progression. The purpose of this study was to determine the effects of orocutaneous stimulation on the modulation of spectral edge frequency, fc=90% (SEF-90) derived from EEG recordings in preterm infants. Methods: Twenty two preterm infants were randomized to experimental and control conditions. Pulsed orocutaneous stimulation was presented during gavage feedings  begun at around 32 weeks postmenstrual age (PMA). The SEF-90 was derived from 2-channel EEG recordings. Results: Compared to the control condition, the pulsed  orocutaneous stimulation produced a significant reorganization of SEF-90 in the left (p = 0.005) and right (p < 0.0001) hemispheres. Notably, the left and right  hemisphere showed a reversal in the polarity of frequency shift, demonstrating hemispheric asymmetry in the frequency domain. Pulsed orocutaneous stimulation also produced a significant pattern of short term cortical adaptation and a long  term neural adaptation manifest as a 0.5 Hz elevation in SEF-90 after repeated stimulation sessions. Conclusion: This is the first study to demonstrate the modulating effects of a servo-controlled oral somatosensory input on the spectral features of EEG activity in preterm infants.},
address  = {Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical Center, San Jose, California Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical Center, San Jose, California Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical Center, San Jose, California Division of Neonatology, Department of Pediatrics, Santa Clara Valley Medical Center, San Jose, California Department of Speech-Language-Hearing: Sciences and Disorders, Neuroscience and Bioengineering, University of Kansas, Lawrence, Kansas Center for Research Methods and Data Analysis, University of Kansas, Lawrence, Kansas Department of Speech-Language-Hearing: Sciences and Disorders, Neuroscience and Bioengineering, University of Kansas, Lawrence, Kansas Department of Speech-Language-Hearing: Sciences and Disorders, Neuroscience and Bioengineering, University of Kansas, Lawrence, Kansas},
note  = {Pediatr Res. 2014 Jan;75(0):85-92. Epub 2013 Oct 15 doi:10.1038/pr.2013.179.}
}

@Article{2010605,
author  = {Pollay, M.},
title  = {The function and structure of the cerebrospinal fluid outflow system.},
journal  = {Cerebrospinal Fluid Research},
volume  = {7},
number  = {},
pages  = {9},
year  = {2010},
abstract  = {This review traces the development of our understanding of the anatomy and physiological properties of the two systems responsible for the drainage of cerebrospinal fluid (CSF) into the systemic circulation. The roles of the cranial and spinal arachnoid villi (AV) and the lymphatic outflow systems are evaluated as to the dominance of one over the other in various species and degree of animal maturation. The functional capabilities of the total CSF drainage system are presented, with evidence that the duality of the system is supported by the changes in fluid outflow dynamics in human and sub-human primates in hydrocephalus. The review also reconciles the relative importance and alterations of each of the outflow systems in a variety of clinical pathological conditions.},
address  = {14205 W Via Tercero, Sun City West, AZ 85375, USA},
note  = {Cerebrospinal Fluid Res. 2010 Jun 21;7:9. doi:10.1186/1743-8454-7-9.}
}

@Article{2008606,
author  = {Hamid, S. and Hayek, R.},
title  = {cord injury: an overview.},
journal  = {European Spine Journal},
volume  = {17},
number  = {9},
pages  = {1256-69},
year  = {2008},
abstract  = {Structural discontinuity in the spinal cord after injury results in a disruption  in the impulse conduction resulting in loss of various bodily functions depending upon the level of injury. This article presents a summary of the scientific research employing electrical stimulation as a means for anatomical or functional recovery for patients suffering from spinal cord injury. Electrical stimulation in the form of functional electrical stimulation (FES) can help facilitate and improve upper/lower limb mobility along with other body functions lost due to injury e.g. respiratory, sexual, bladder or bowel functions by applying a controlled electrical stimulus to generate contractions and functional movement in the paralysed muscles. The available rehabilitative techniques based on FES technology and various Food and Drug Administration, USA approved neuroprosthetic devices that are in use are discussed. The second part of the article summarises  the experimental work done in the past 2 decades to study the effects of weakly applied direct current fields in promoting regeneration of neurites towards the cathode and the new emerging technique of oscillating field stimulation which has shown to promote bidirectional regeneration in the injured nerve fibres. The present article is not intended to be an exhaustive review but rather a summary aiming to highlight these two applications of electrical stimulation and the degree of anatomical/functional recovery associated with these in the field of spinal cord injury research.},
address  = {Environmental and Life Sciences, Macquarie University, Sydney, NSW Australia Environmental and Life Sciences, Macquarie University, Sydney, NSW Australia},
note  = {doi:10.1007/s00586-008-0729-3.}
}

@Article{2012607,
author  = {Rapoport, B. and Turicchia, L. and Wattanapanitch, W. and Davidson, T. and Sarpeshkar, R.},
title  = {Efficient Universal Computing Architectures for Decoding Neural Activity.},
journal  = {PLoS ONE},
volume  = {7},
number  = {9},
pages  = {},
year  = {2012},
abstract  = {The ability to decode neural activity into meaningful control signals for prosthetic devices is critical to the development of clinically useful brain‚Äì machine interfaces (BMIs). Such systems require input from tens to hundreds of brain-implanted recording electrodes in order to deliver robust and accurate performance; in serving that primary function they should also minimize power dissipation in order to avoid damaging neural tissue; and they should transmit data wirelessly in order to minimize the risk of infection associated with chronic, transcutaneous implants. Electronic architectures for brain‚Äì machine interfaces must therefore minimize size and power consumption, while maximizing the ability to compress data to be transmitted over limited-bandwidth wireless channels. Here we present a system of extremely low computational complexity, designed for real-time decoding of neural signals, and suited for highly scalable implantable systems. Our programmable architecture is an explicit implementation  of a universal computing machine emulating the dynamics of a network of integrate-and-fire neurons; it requires no arithmetic operations except for counting, and decodes neural signals using only computationally inexpensive logic operations. The simplicity of this architecture does not compromise its ability to compress raw neural data by factors greater than . We describe a set of decoding algorithms based on this computational architecture, one designed to operate within an implanted system, minimizing its power consumption and data transmission bandwidth; and a complementary set of algorithms for learning, programming the decoder, and postprocessing the decoded output, designed to operate in an external, nonimplanted unit. The implementation of the implantable  portion is estimated to require fewer than 5000 operations per second. A proof-of-concept, 32-channel field-programmable gate array (FPGA) implementation  of this portion is consequently energy efficient. We validate the performance of  our overall system by decoding electrophysiologic data from a behaving rodent.},
address  = {M.D.‚ÄìPh.D. Program, Harvard Medical School, Boston, Massachusetts, United States  of America Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America Department of Bioengineering, Stanford University School of Medicine, Stanford, California, United States of America Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America},
note  = {PLoS One. 2012 Sep 12;7(9):. doi:10.1371/journal.pone.0042492.}
}

@Article{2012608,
author  = {Ehrhardt, D. and Frommer, W.},
title  = {New Technologies for 21st Century Plant Science.},
journal  = {The Plant Cell},
volume  = {24},
number  = {2},
pages  = {374-94},
year  = {2012},
abstract  = {Plants are one of the most fascinating and important groups of organisms living on Earth. They serve as the conduit of energy into the biosphere, provide food, and shape our environment. If we want to make headway in understanding how these  essential organisms function and build the foundation for a more sustainable future, then we need to apply the most advanced technologies available to the study of plant life. In 2009, a committee of the National Academy highlighted the ‚Äúunderstanding of plant growth‚Ä? as one of the big challenges for society and part of a new era which they termed ‚Äúnew biology.‚Ä? The aim of this article is to identify how new technologies can and will transform plant science to address the challenges of new biology. We assess where we stand today regarding current technologies, with an emphasis on molecular and imaging technologies, and we try  to address questions about where we may go in the future and whether we can get an idea of what is at and beyond the horizon.},
address  = {},
note  = {Plant Cell. 2012 Feb;24(2):374-94. Epub 2012 Feb 24 doi:10.1105/tpc.111.093302.}
}

@Article{2015609,
author  = {Fiscella, K. and Boyd, M. and Brown, J. and Carroll, J. and Cassells, A. and Corales, R. and Cross, W. and El‚ÄôDaher, N. and Farah, S. and Fine, S. and Fowler, R. and Hann, A. and Luque, A. and Rodriquez, J. and Sanders, M. and Tobin, J.},
title  = {Activation of persons living with HIV for treatment, the great study.},
journal  = {BMC Public Health},
volume  = {15},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Background: Patient empowerment represents a potent tool for addressing racial, ethnic and socioeconomic disparities in health care, particularly for chronic conditions such as HIV infection that require active patient engagement. This multimodal intervention, developed in concert with HIV patients and clinicians, aims to provide HIV patients with the knowledge, skills, attitudes and tools to become more activated patients. Methods/Design: Randomized controlled trial of a  multimodal intervention designed to activate persons living with HIV. The intervention includes four components: 1) use of a web-enabled hand-held device (Apple iPod Touch) loaded with a Personal Health Record (ePHR) customized for HIV patients; 2) six 90-minute group-based training sessions in use of the device, internet and the ePHR; 3) a pre-visit coaching session; and 4) clinician education regarding how they can support activated patients. Outcome measures include pre- post changes in patient activation measure score (primary outcome),  eHealth literacy, patient involvement in decision-making and care, medication adherence, preventive care, and HIV Viral Load. Discussion: We hypothesize that participants receiving the intervention will show greater improvement in empowerment and the intervention will reduce disparities in study outcomes. Disparities in these measures will be smaller than those in the usual care group. Findings have implications for activating persons living with HIV and for other marginalized groups living with chronic illness. Trial registration: ClinicalTrials.gov Identifier: NCT02165735, 6/13/2014.},
address  = {Public Health Sciences and Community Health, Department of Family Medicine, University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA Public Health Sciences and Community Health, Department of Family Medicine, University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA Trillium Health, Rochester, USA Department of Family Medicine, University of Colorado, Denver, USA Clinical Directors Network, New York, USA Trillium Health, Rochester, USA Department of Psychiatry, University of Rochester Medical Center, Rochester, USA Rochester Regional Health System, Unity Family Medicine at St. Mary‚Äôs and Unity Infectious Disease, Rochester, USA Public Health Sciences and Community Health, Department of Family Medicine, University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA Department of Medicine, Infectious Diseases (SMD), University of Rochester, Rochester, USA Trillium Health, Rochester, USA Rochester Regional Health System, Unity Family Medicine at St. Mary‚Äôs and Unity Infectious Disease, Rochester, USA Department of Medicine, Infectious Diseases (SMD), University of Rochester, Rochester, USA Clinical Directors Network, New York, USA Public Health Sciences and Community Health, Department of Family Medicine, University of Rochester Medical Center, 1381 South Ave, Rochester, NY 14620 USA Clinical Directors Network, New York, USA},
note  = {BMC Public Health. 2015 Oct 16;15:. doi:10.1186/s12889-015-2382-1.}
}

@Article{2017610,
author  = {Greggor, A. and Thornton, A. and Clayton, N.},
title  = {conservation.},
journal  = {Behavioral Ecology and Sociobiology},
volume  = {71},
number  = {1},
pages  = {},
year  = {2017},
abstract  = {Social learning can influence how animals respond to anthropogenic changes in the environment, determining whether animals survive novel threats and exploit novel  resources or produce maladaptive behaviour and contribute to human-wildlife conflict. Predicting where social learning will occur and manipulating its use are, therefore, important in conservation, but doing so is not straightforward. Learning is an inherently biased process that has been shaped by natural selection to prioritize important information and facilitate its efficient uptake. In this regard, social learning is no different from other learning processes because it too is shaped by perceptual filters, attentional biases and  learning constraints that can differ between habitats, species, individuals and contexts. The biases that constrain social learning are not understood well enough to accurately predict whether or not social learning will occur in many situations, which limits the effective use of social learning in conservation practice. Nevertheless, we argue that by tapping into the biases that guide the social transmission of information, the conservation applications of social learning could be improved. We explore the conservation areas where social learning is highly relevant and link them to biases in the cues and contexts that shape social information use. The resulting synthesis highlights many promising areas for collaboration between the fields and stresses the importance of systematic reviews of the evidence surrounding social learning practices.},
address  = {0000000121885934grid.5335.0Department of Psychology, University of Cambridge, Cambridge, UK 0000 0004 1936 8024grid.8391.3Centre for Ecology and Conservation, University of  Exeter, Penryn, UK 0000000121885934grid.5335.0Department of Psychology, University of Cambridge, Cambridge, UK},
note  = {Behav Ecol Sociobiol. 2017;71(1):. Epub 2016 Dec 7 doi:10.1007/s00265-016-2238-4.}
}

@Article{2016611,
author  = {Ying, H. and Dey, P. and Yao, W. and Kimmelman, A. and Draetta, G. and Maitra, A. and DePinho, R.},
title  = {Genetics and biology of pancreatic ductal adenocarcinoma.},
journal  = {Genes & Development},
volume  = {30},
number  = {4},
pages  = {355-85},
year  = {2016},
abstract  = {Ying et al. review pancreatic ductal adenocarcinoma (PDAC) genetics and biology,  particularly altered cancer cell metabolism, the complexity of immune regulation  in the tumor microenvironment, and impaired DNA repair processes.},
address  = {Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Division of Genomic Stability and DNA Repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA; Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Department of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA; Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA;},
note  = {Genes Dev. 2016 Feb 15;30(4):355-85. doi:10.1101/gad.275776.115.}
}

@Article{2011612,
author  = {Deng, Z. and Lisanby, S. and Peterchev, A.},
title  = {seizure therapy: A finite element simulation study.},
journal  = {Journal of neural engineering},
volume  = {8},
number  = {1},
pages  = {016007},
year  = {2011},
abstract  = {We present the first computational study comparing the electric field induced by  various electroconvulsive therapy (ECT) and magnetic seizure therapy (MST) paradigms. Four ECT electrode configurations (bilateral, bifrontal, right unilateral, and focal electrically administered seizure therapy) and three MST coil configurations (circular, cap, and double cone) were modeled. The model incorporated a modality-specific neural activation threshold. ECT (0.3 ms pulse width) and MST induced maximum electric field in the brain of 2.1‚Äì2.5 V/cm and 1.1‚Äì2.2 V/cm, corresponding to 6.2‚Äì7.2 times and 1.2‚Äì2.3 times the neural activation threshold, respectively. The MST electric field is more confined to the superficial cortex compared to ECT. The brain volume stimulated was much higher with ECT (up to 100%) than MST (up to 8.2%). MST with the double cone coil was the most focal and bilateral ECT was the least focal. Our results suggest a possible biophysical explanation of the reduced side effects of MST compared to ECT. Our results also indicate that the conventional ECT pulse amplitude (800‚Äì900 mA) is much higher than necessary for seizure induction. Reducing the ECT pulse amplitude should be explored as a potential means of diminishing side effects.},
address  = {Division of Brain Stimulation and Therapeutic Modulation, Department of Psychiatry, ColumbiaUniversity/New York State Psychiatric Institute, 1051 Riverside Drive, Unit 21, New York, NY 10032, USA Department of Psychiatry and Behavioral Sciences, Duke University, Box 3950 DUMC, Durham, NC27710, USA Division of Brain Stimulation and Therapeutic Modulation, Department of Psychiatry, ColumbiaUniversity/New York State Psychiatric Institute, 1051 Riverside Drive, Unit 21, New York, NY 10032, USA},
note  = {doi:10.1088/1741-2560/8/1/016007.}
}

@Article{2017613,
author  = {Dall√©rac, G. and Graupner, M. and Knippenberg, J. and Martinez, R. and Tavares, T. and Tallot, L. and El, M. and Verschueren, A. and H√∂hn, S. and Bertolus, J. and Reyes, A. and LeDoux, J. and Schafe, G. and Diaz-Mataix, L. and Doy√®re, V.},
title  = {under amygdala control.},
journal  = {Nature Communications},
volume  = {8},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Pavlovian aversive conditioning requires learning of the association between a conditioned stimulus (CS) and an unconditioned, aversive stimulus (US) but also involves encoding the time interval between the two stimuli. The neurobiological  bases of this time interval learning are unknown. Here, we show that in rats, the dorsal striatum and basal amygdala belong to a common functional network underlying temporal expectancy and learning of a CS‚ÄìUS interval. Importantly, changes in coherence between striatum and amygdala local field potentials (LFPs)  were found to couple these structures during interval estimation within the lower range of the theta rhythm (3‚Äì6‚ÄâHz). Strikingly, we also show that a change to the CS‚ÄìUS time interval results in long-term changes in cortico-striatal synaptic efficacy under the control of the amygdala. Collectively, this study reveals physiological correlates of plasticity mechanisms of interval timing that take place in the striatum and are regulated by the amygdala.},
address  = {Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Center for Neural Science, New York University, New York, New York 10003, USA Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Laboratory of Neuromodulation, Teaching and Research Institute, Hospital Sirio Libanes, Rua Professor Daher Cutait, 69, Sao Paulo 01308-060, Brazil Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France Center for Neural Science, New York University, New York, New York 10003, USA Center for Neural Science, New York University, New York, New York 10003, USA Department of Psychology, Hunter College, New York, New York 10065, USA Center for Neural Science, New York University, New York, New York 10003, USA Institut des Neurosciences Paris-Saclay (Neuro-PSI), Cognition and Behaviour Department, UMR 9197, Universit√© Paris Sud, CNRS, Universit√© Paris Saclay, Orsay  F-91405, France},
note  = {Nat Commun. 2017 Jan 09;8:. doi:10.1038/ncomms13920.}
}

@Article{2015614,
author  = {Bispo, P. and Haas, W. and Gilmore, M.},
title  = {Biofilms in Infections of the Eye.},
journal  = {Pathogens},
volume  = {4},
number  = {1},
pages  = {111-36},
year  = {2015},
abstract  = {The ability to form biofilms in a variety of environments is a common trait of bacteria, and may represent one of the earliest defenses against predation. Biofilms are multicellular communities usually held together by a polymeric matrix, ranging from capsular material to cell lysate. In a structure that imposes diffusion limits, environmental microgradients arise to which individual  bacteria adapt their physiologies, resulting in the gamut of physiological diversity. Additionally, the proximity of cells within the biofilm creates the opportunity for coordinated behaviors through cell‚Äìcell communication using diffusible signals, the most well documented being quorum sensing. Biofilms form  on abiotic or biotic surfaces, and because of that are associated with a large proportion of human infections. Biofilm formation imposes a limitation on the uses and design of ocular devices, such as intraocular lenses, posterior contact  lenses, scleral buckles, conjunctival plugs, lacrimal intubation devices and orbital implants. In the absence of abiotic materials, biofilms have been observed on the capsule, and in the corneal stroma. As the evidence for the involvement of microbial biofilms in many ocular infections has become compelling, developing new strategies to prevent their formation or to eradicate  them at the site of infection, has become a priority.},
address  = {},
note  = {Pathogens. 2015 Mar 23;4(1):111-36. doi:10.3390/pathogens4010111.}
}

@Article{2013615,
author  = {Whittaker, R. and Furberg, R. and McKinley, M. and Buis, L. and Hirzel, L. and Turske, S. and Des, J. and Yarandi, H. and Bondurant, P.},
title  = {Health Behavior Change (Part I): Assessment of Participant Reach and Adoption.},
journal  = {Journal of Medical Internet Research},
volume  = {15},
number  = {12},
pages  = {},
year  = {2013},
abstract  = {Background: There are an estimated 25.8 million American children and adults, equivalent to 8.3% of the US population, living with diabetes. Diabetes is particularly burdensome on minority populations. The use of mobile technologies for reaching broad populations is a promising approach, given its wide footprint  and ability to deliver inexpensive personalized messages, to increase awareness of type 2 diabetes and promote behavior changes targeting risk factors associated with type 2 diabetes. As a part of the Beacon Community Cooperative Agreement Program, txt4health, a public-facing mobile health information service, was launched in 3 Beacon Communities: the Southeast Michigan Beacon Community in Detroit, MI, the Greater Cincinnati Beacon Community in Cincinnati, OH, and the Crescent City Beacon Community in New Orleans, LA. Txt4health is a mobile health  information service designed to help people understand their risk for type 2 diabetes and become more informed about the steps they can take to lead healthy lives. Objective: The purpose of this investigation was to use the RE-AIM framework to document txt4health reach and adoption by focusing on enrollment and participant engagement in program pilots in Southeast Michigan and Greater Cincinnati. Methods: We conducted a retrospective records analysis of individual-level txt4health system data from participants in Southeast Michigan and Greater Cincinnati to determine participant usage of txt4health and engagement with the program. Results: Results from the retrospective records analysis revealed that 5570 participants initiated the 2-step enrollment process  via 1 of 3 enrollment strategies: text message, website, or directly with Beacon  staff who signed participants up via the website. In total, 33.00% (1838/5570) of participants completed the 2-step enrollment process and were fully enrolled in the program. All participants (100.00%, 1620/1620) who enrolled via text message  completed the entire 2-step enrollment process versus 5.52% (218/3950) of participants who enrolled via website or a Beacon staff member. Of those who fully enrolled, 71.00% (1305/1838) completed the diabetes risk assessment and 74.27% (1365/1838) set an initial weight loss goal. Overall, 39.06% (718/1838) of participants completed all 14 weeks of the program and 56.26% (1034/1838) dropped out before completing all 14 weeks, with the bulk of dropouts occurring in the first 4 weeks. Length of participation varied greatly, ranging from 0-48.7 weeks  (median 8.6, mean 15.8, SD 15.8). Wide variability of participant engagement in regards to weekly weight and physical activity was documented. Conclusions: Although broadly focused public health text message interventions may have the potential to reach large populations and show high levels of engagement among some users, the level of individual engagement among participants varies widely,  suggesting that this type of approach may not be appropriate for all.},
address  = {University of MichiganDepartment of Family MedicineAnn Arbor, MIUnited States Wayne State UniversityCollege of NursingDetroit, MIUnited States Southeast Michigan Beacon CommunityDetroit, MIUnited States Southeast Michigan Beacon CommunityDetroit, MIUnited States Wayne State UniversityCollege of NursingDetroit, MIUnited States Greater Cincinnati Beacon CollaborativeCincinnati, OHUnited States},
note  = {J Med Internet Res. 2013 Dec 19;15(12):. doi:10.2196/jmir.2928.}
}

@Article{2017616,
author  = {Tortiglione, C. and Antognazza, M. and Tino, A. and Bossio, C. and Marchesano, V. and Bauduin, A. and Zangoli, M. and Morata, S. and Lanzani, G.},
title  = {Semiconducting polymers are light nanotransducers in eyeless animals.},
journal  = {Science Advances},
volume  = {3},
number  = {1},
pages  = {},
year  = {2017},
abstract  = {Light polymer nanotransducers control cell functions in vivo.},
address  = {Istituto di Scienze Applicate e Sistemi Intelligenti ‚ÄúEduardo Caianiello,‚Ä? Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy. Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia,  Via Pascoli 70/3, 20133 Milano, Italy. Istituto di Scienze Applicate e Sistemi Intelligenti ‚ÄúEduardo Caianiello,‚Ä? Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy. Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia,  Via Pascoli 70/3, 20133 Milano, Italy. Istituto di Scienze Applicate e Sistemi Intelligenti ‚ÄúEduardo Caianiello,‚Ä? Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy. Istituto di Scienze Applicate e Sistemi Intelligenti ‚ÄúEduardo Caianiello,‚Ä? Consiglio Nazionale delle Ricerche, Via Campi Flegrei 34, 80078 Pozzuoli, Italy. Istituto per la Sintesi Organica e la Fotoreattivit√†, Consiglio Nazionale delle Ricerche, Via P. Gobetti 101, 40129 Bologna, Italy. Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia,  Via Pascoli 70/3, 20133 Milano, Italy. Center for Nano Science and Technology @PoliMi, Istituto Italiano di Tecnologia,  Via Pascoli 70/3, 20133 Milano, Italy.},
note  = {Sci Adv. 2017 Jan 25;3(1):. doi:10.1126/sciadv.1601699.}
}

@Article{2010617,
author  = {Della, S. and Migliaccio, A. and Hayden, R. and Melvin, T. and Fridman, G. and Chiang, B. and Davidovics, N. and Dai, C. and Carey, J. and Minor, L. and Anderson, I. and Park, H. and Lyford-Pike, S. and Tang, S.},
title  = {update on the Johns Hopkins Multichannel Vestibular Prosthesis Project.},
journal  = {Cochlear Implants International},
volume  = {11},
number  = {Suppl 2},
pages  = {2-11},
year  = {2010},
abstract  = {Bilateral loss of vestibular sensation can disable individuals whose vestibular hair cells are injured by ototoxic medications, infection, M√©ni√®re‚Äôs disease or other insults to the labyrinth including surgical trauma during cochlear implantation. Without input to vestibulo-ocular and vestibulo-spinal reflexes that normally stabilize the eyes and body, affected patients suffer blurred vision during head movement, postural instability, and chronic disequilibrium. While individuals with some residual sensation often compensate for their loss through rehabilitation exercises, those who fail to do so are left with no adequate treatment options. An implantable neuroelectronic vestibular prosthesis  that emulates the normal labyrinth by sensing head movement and modulating activity on appropriate branches of the vestibular nerve could significantly improve quality of life for these otherwise chronically dizzy patients.This brief review describes the impact and current management of bilateral loss of vestibular sensation, animal studies supporting the feasibility of prosthetic vestibular stimulation, and a vestibular prosthesis designed to restore sensation of head rotation in all directions. Similar to a cochlear implant in concept and  size, the Johns Hopkins Multichannel Vestibular Prosthesis (MVP) includes miniature gyroscopes to sense head rotation, a microcontroller to process inputs  and control stimulus timing, and current sources switched between pairs of electrodes implanted within the vestibular labyrinth. In rodents and rhesus monkeys rendered bilaterally vestibular-deficient via treatment with gentamicin and/or plugging of semicircular canals, the MVP partially restores the vestibulo-ocular reflex for head rotations about any axis of rotation in 3-dimensional space. Our efforts now focus on addressing issues prerequisite to human implantation, including refinement of electrode designs and surgical technique to enhance stimulus selectivity and preserve cochlear function, optimization of stimulus protocols, and reduction of device size and power consumption.},
address  = {},
note  = {doi:10.1179/146701010X12726366068454.}
}

@Article{2011618,
author  = {Raghavendran, K. and Willson, D. and Notter, R.},
title  = {Surfactant Therapy of ALI and ARDS.},
journal  = {Critical care clinics},
volume  = {27},
number  = {3},
pages  = {525-59},
year  = {2011},
abstract  = {This article examines exogenous lung surfactant replacement therapy and its utility in mitigating clinical acute lung injury (ALI) and the acute respiratory  distress syndrome (ARDS). Biophysical research has documented that lung surfactant dysfunction can be reversed or mitigated by increasing surfactant concentration, and multiple studies in animals with ALI/ARDS have shown that respiratory function and pulmonary mechanics in vivo can be improved by exogenous surfactant administration. Exogenous surfactant therapy is a routine intervention in neonatal intensive care, and is life-saving in preventing or treating the neonatal respiratory distress syndrome (NRDS) in premature infants. In applications relevant for lung injury-related respiratory failure and ALI/ARDS, surfactant therapy has been shown to be beneficial in term infants with pneumonia and meconium aspiration lung injury, and in children up to age 21 with direct pulmonary forms of ALI/ARDS. However, extension of exogenous surfactant therapy to adults with respiratory failure and clinical ALI/ARDS remains a challenge. Coverage here reviews clinical studies of surfactant therapy in pediatric and adult patients with ALI/ARDS, particularly focusing on its potential advantages in patients with direct pulmonary forms of these syndromes. Also discussed is the rationale for mechanism-based therapies utilizing exogenous surfactant in combination with agents targeting other aspects of the multifaceted pathophysiology of inflammatory lung injury. Additional factors affecting the efficacy of exogenous surfactant therapy in ALI/ARDS are also described, including the difficulty of effectively delivering surfactants to injured lungs and the existence of activity differences between clinical surfactant drugs.},
address  = {Department of Surgery, University of Michigan, Ann Arbor, MI Department of Pediatrics and Anesthesiology, University of Virginia, Charlottesville, VA Department of Pediatrics, University of Rochester, Rochester, NY},
note  = {Crit Care Clin. 2011 Jul 1;27(3):525-59. doi:10.1016/j.ccc.2011.04.005.}
}

@Article{2010619,
author  = {Kissil, J. and Blakeley, J. and Ferner, R. and Huson, S. and Kalamarides, M. and Mautner, V. and McCormick, F. and Morrison, H. and Packer, R. and Ramesh, V. and Ratner, N. and Rauen, K. and Stevenson, D. and Hunter-Schaedle, K. and North, K.},
title  = {Frontiers.},
journal  = {American journal of medical genetics. Part A},
volume  = {152A},
number  = {2},
pages  = {269-83},
year  = {2010},
abstract  = {The NF Conference is the largest annual gathering of researchers and clinicians focused on neurofibromatosis and has been convened by the Children‚Äôs Tumor Foundation for over 20 years. The 2009 NF Conference was held in Portland, Oregon from June 13th ‚Äì June 16th, 2009 and co-chaired by Kathryn North from the University of Sydney and The Children‚Äôs Hospital at Westmead, Sydney, Australia;  and Joseph Kissil from the Wistar Institute, Philadelphia. The Conference included 80 platform presentations in 9 sessions over 4 days; over 100 abstracts  presented as posters; and three Keynote presentations. To date, there have been tremendous advances in basic research in the pathogenesis of neurofibromatosis, and more recently in progress toward identifying effective drug therapies and the commencement of neurofibromatosis clinical trials. The NF Conference attendees have significantly increased (doubling from 140 in 2005 to 280 attending in 2009) with a significant increase in attendance of physicians and clinical researchers. Correspondingly the NF Conference scope has expanded to include translational research, clinical trials and clinical management issues while retaining a core of basic research. These themes are reflected in the highlights from the 2009 NF  Conference presented here.},
address  = {The Wistar Institute, Philadelphia, PA Johns Hopkins University Guy‚Äôs and St Thomas‚Äô NHS Trust, London, United Kingdom St. Mary‚Äôs Hospital, University of Manchester, United Kingdom Hopital Beaujon, Clichy, France University Eppendorf, Hamburg, Germany University of California, San Francisco Leibniz Institute for Age Research, Germany Children‚Äôs National Medical Center, Washington, DC Massachusetts General Hospital, Harvard Medical School, Boston, MA Cincinnati Children‚Äôs Hospital Medical Center, Cincinnati, OH University of California, San Francisco University of Utah, Salt Lake City, UT Children‚Äôs Tumor Foundation, New York, NY University of Sydney and The Children‚Äôs Hospital at Westmead, Sydney, Australia},
note  = {Am J Med Genet A. 2010 Feb;152A(2):269-83. doi:10.1002/ajmg.a.33189.}
}

@Article{2016620,
author  = {Holly, K. and Orndorff, C. and Murray, T.},
title  = {experiments.},
journal  = {Scientific Reports},
volume  = {6},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Stretch-attend posture (SAP) occurs during risk assessment and is prevalent in common rodent behavioral tests. Measuring this behavior can enhance behavioral tests. For example, stretch-attend posture is a more sensitive measure of the effects of anxiolytics than traditional spatiotemporal indices. However, quantifying stretch-attend posture using human observers is time consuming, somewhat subjective, and prone to errors. We have developed MATLAB-based software, MATSAP, which is a quick, consistent, and open source program that provides objective automated analysis of stretch-attend posture in rodent behavioral experiments. Unlike human observers, MATSAP is not susceptible to fatigue or subjectivity. We assessed MATSAP performance with videos of male Swiss mice moving in an open field box and in an elevated plus maze. MATSAP reliably detected stretch-attend posture on par with human observers. This freely-available program can be broadly used by biologists and psychologists to accelerate neurological, pharmacological, and behavioral studies.},
address  = {Department of Biomedical Engineering, Louisiana Tech University, Ruston, Louisiana, United States of America Department of Mathematics and Statistics, Louisiana Tech University, Ruston, Louisiana, United States of America Department of Biomedical Engineering, Louisiana Tech University, Ruston, Louisiana, United States of America},
note  = {Sci Rep. 2016 Aug 09;6:. doi:10.1038/srep31286.}
}

@Article{2016621,
author  = {Goodyear, K. and Parasuraman, R. and Chernyak, S. and Madhavan, P. and Deshpande, G. and Krueger, F.},
title  = {Advice Taking from Humans and Machines: An fMRI and Effective Connectivity Study.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {With new technological advances, advice can come from different sources such as machines or humans, but how individuals respond to such advice and the neural correlates involved need to be better understood. We combined functional MRI and  multivariate Granger causality analysis with an X-ray luggage-screening task to investigate the neural basis and corresponding effective connectivity involved with advice utilization from agents framed as experts. Participants were asked to accept or reject good or bad advice from a human or machine agent with low reliability (high false alarm rate). We showed that unreliable advice decreased performance overall and participants interacting with the human agent had a greater depreciation of advice utilization during bad advice compared to the machine agent. These differences in advice utilization can be perceivably due to  reevaluation of expectations arising from association of dispositional credibility for each agent. We demonstrated that differences in advice utilization engaged brain regions that may be associated with evaluation of personal characteristics and traits (precuneus, posterior cingulate cortex, temporoparietal junction) and interoception (posterior insula). We found that the right posterior insula and left precuneus were the drivers of the advice utilization network that were reciprocally connected to each other and also projected to all other regions. Our behavioral and neuroimaging results have significant implications for society because of progressions in technology and increased interactions with machines.},
address  = {Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, ProvidenceRI, USA Department of Psychology, George Mason University, FairfaxVA, USA Molecular Neuroscience Department, George Mason University, FairfaxVA, USA Institute for Defense Analyses, AlexandriaVA, USA Auburn University MRI Research Center, Department of Electrical & Computer Engineering, Auburn University, AuburnAL, USA Department of Psychology, George Mason University, FairfaxVA, USA},
note  = {Front Hum Neurosci. 2016 Nov 04;10:. doi:10.3389/fnhum.2016.00542.}
}

@Article{1998622,
author  = {},
title  = {The Back Pages.},
journal  = {The British Journal of General Practice},
volume  = {48},
number  = {428},
pages  = {1105-22},
year  = {1998},
abstract  = {Images: p1108-ap1109-a},
address  = {},
note  = {Br J Gen Pract. 1998 Mar;48(428):1105-22.}
}

@Article{2012623,
author  = {Santangelo, R. and Acker, T. and Zimmerman, S. and Katzman, B. and Strong, K. and Traynelis, S. and Liotta, D.},
title  = {Novel NMDA Receptor Modulators: An Update.},
journal  = {Expert opinion on therapeutic patents},
volume  = {22},
number  = {11},
pages  = {1337-52},
year  = {2012},
abstract  = {Introduction: The NMDA receptor is a ligand-gated ion channel that plays a critical role in higher level brain processes and has been implicated in a range  of neurological and psychiatric conditions. Although initial studies for the use  of NMDA receptor antagonists in neuroprotection were unsuccessful, more recently, NMDA receptor antagonists have shown clinical promise in other indications such as Alzheimer‚Äôs disease, Parkinson‚Äôs disease, pain and depression. Based on the clinical observations and more recent insights into receptor pharmacology, new modulatory approaches are beginning to emerge, with potential therapeutic benefit. Areas Covered: The article covers the known pharmacology and important features regarding NMDA receptors and their function. A discussion of pre-clinical and clinical relevance is included, as well. The subsequent patent literature review highlights the current state of the art targeting the receptor  since the last review in 2010. Expert Opinion: The complex nature of the NMDA receptor structure and function is becoming better understood. As knowledge about this receptor increases, it opens up new opportunities for targeting the receptor for many therapeutic indications. New strategies and advances in older technologies will need to be further developed before clinical success can be achieved. First-in-class potentiators and subunit-selective agents form the basis for most new strategies, complemented by efforts to limit off-target liability and fine-tune on-target properties.},
address  = {Department of Chemistry, Emory University, Atlanta, GA 30322 Department of Chemistry, Emory University, Atlanta, GA 30322 Department of Chemistry, Emory University, Atlanta, GA 30322 Department of Chemistry, Emory University, Atlanta, GA 30322 Department of Chemistry, Emory University, Atlanta, GA 30322 Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 30322 Department of Chemistry, Emory University, Atlanta, GA 30322},
note  = {doi:10.1517/13543776.2012.728587.}
}

@Article{2015624,
author  = {Moynihan, V. and Chen, J. and Aicken, C. and Abroms, L. and Whittaker, R. and Free, C. and Mendel, V. and Schindler-Ruwisch, J.},
title  = {Recommended Steps.},
journal  = {JMIR mHealth and uHealth},
volume  = {3},
number  = {4},
pages  = {},
year  = {2015},
abstract  = {Background: A growing body of evidence demonstrates that text messaging-based programs (short message service [SMS]) on mobile phones can help people modify health behaviors. Most of these programs have consisted of automated and sometimes interactive text messages that guide a person through the process of behavior change. Objective: This paper provides guidance on how to develop text messaging programs aimed at changing health behaviors. Methods: Based on their collective experience in designing, developing, and evaluating text messaging programs and a review of the literature, the authors drafted the guide. One author initially drafted the guide and the others provided input and review. Results: Steps for developing a text messaging program include conducting formative research for insights into the target audience and health behavior, designing the text messaging program, pretesting the text messaging program concept and messages, and revising the text messaging program. Conclusions: The steps outlined in this guide may help in the development of SMS-based behavior change programs.},
address  = {The Milken Institute School of Public HealthThe George Washington UniversityWashington, DCUnited States National Institute for Health InnovationThe University of AucklandAucklandNew Zealand Clinical Trials Research UnitLondon School of Hygiene and Tropical MedicineLondonUnited Kingdom The Milken Institute School of Public HealthThe George Washington UniversityWashington, DCUnited States The Milken Institute School of Public HealthThe George Washington UniversityWashington, DCUnited States},
note  = {JMIR Mhealth Uhealth. 2015 Dec 21;3(4):. doi:10.2196/mhealth.4917.}
}

@Article{2016625,
author  = {Kleinberg, L.},
title  = {selection and perspectives on a low-burden therapy.},
journal  = {Patient preference and adherence},
volume  = {10},
number  = {},
pages  = {2397-406},
year  = {2016},
abstract  = {Polifeprosan 20 with carmustine (GLIADEL¬Æ) polymer implant wafer is a biodegradable compound containing 3.85% carmustine (BCNU, bischloroethylnitrosourea) implanted in the brain at the time of planned tumor surgery, which then slowly degrades to release the BCNU chemotherapy directly into the brain thereby bypassing the blood‚Äìbrain barrier. Carmustine implant wafers were demonstrated to improve survival in randomized placebo-controlled trials in patients undergoing a near total resection of newly diagnosed or recurrent malignant glioma. Based on these trials and other supporting data, carmustine wafer therapy was approved for use for newly diagnosed and recurrent malignant glioma in the United States and the European Union. Adverse events are  uncommon, and as this therapy is placed at the time of surgery, it does not add to patient treatment burden. Nevertheless, this therapy appears to be underutilized. This article reviews the evidence for a favorable therapeutic ratio for the patient and the potential barriers. Consideration of these issues is important for optimal use of this therapeutic approach and may be important as this technology and other local therapies are further developed in the future.},
address  = {Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins  University, Baltimore, MD, USA},
note  = {Patient Prefer Adherence. 2016 Nov 24;10:2397-406. doi:10.2147/PPA.S93020.}
}

@Article{2017626,
author  = {Zielinski, D. and Sorensen, P.},
title  = {a complex sound.},
journal  = {PLoS ONE},
volume  = {12},
number  = {6},
pages  = {},
year  = {2017},
abstract  = {Behavioral responses of silver carp (Hypopthalmichthys molitrix), bighead carp (H. nobilis), and common carp (Cyprinus carpio) to a complex, broadband sound were tested in the absence of visual cues to determine whether these species are  negatively phonotaxic and the roles that sound pressure and particle motion might play mediating this response. In a dark featureless square enclosure, groups of 3 fish were tracked and the distance of each fish from speakers and their swimming  trajectories relative to sound pressure and particle acceleration were analyzed before, and then while an outboard motor sound was played. All three species exhibited negative phonotaxis during the first two exposures after which they ceased responding. The median percent time fish spent near the active speaker for the first two trials decreased from 7.0% to 1.3% for silver carp, 7.9% to 1.1% for bighead carp, and 9.5% to 3% for common carp. Notably, when close to the active speaker fish swam away from the source and maintained a nearly perfect 0¬∞  orientation to the axes of particle acceleration. Fish did not enter sound fields greater than 140 dB (ref. 1 ŒºPa). These results demonstrate that carp avoid complex sounds in darkness and while initial responses may be informed by sound pressure, sustained oriented avoidance behavior is likely mediated by particle motion. This understanding of how invasive carp use particle motion to guide avoidance could be used to design new acoustic deterrents to divert them in dark, turbid river waters.},
address  = {Department of Fisheries, Wildlife, and Conservation Biology, University of Minnesota, St. Paul, Minnesota, United States of America Department of Fisheries, Wildlife, and Conservation Biology, University of Minnesota, St. Paul, Minnesota, United States of America},
note  = {PLoS One. 2017 Jun 27;12(6):. doi:10.1371/journal.pone.0180110.}
}

@Article{2015627,
author  = {Dudik, J. and Coyle, J. and Sejdiƒá, E.},
title  = {Signal-Processing Techniques.},
journal  = {IEEE transactions on human-machine systems},
volume  = {45},
number  = {4},
pages  = {465-77},
year  = {2015},
abstract  = {Cervical auscultation is the recording of sounds and vibrations caused by the human body from the throat during swallowing. While traditionally done by a trained clinician with a stethoscope, much work has been put towards developing more sensitive and clinically useful methods to characterize the data obtained with this technique. The eventual goal of the field is to improve the effectiveness of screening algorithms designed to predict the risk that swallowing disorders pose to individual patients‚Äô health and safety. This paper provides an overview of these signal processing techniques and summarizes recent  advances made with digital transducers in hopes of organizing the highly varied research on cervical auscultation. It investigates where on the body these transducers are placed in order to record a signal as well as the collection of analog and digital filtering techniques used to further improve the signal quality. It also presents the wide array of methods and features used to characterize these signals, ranging from simply counting the number of swallows that occur over a period of time to calculating various descriptive features in the time, frequency, and phase space domains. Finally, this paper presents the algorithms that have been used to classify this data into ‚Äònormal‚Äô and ‚Äòabnormal‚Äô categories. Both linear as well as non-linear techniques are presented in this regard.},
address  = {Department of Electrical and Computer Engineering, Swanson School of Enginering,  University of Pittsburgh, Pittsburgh, PA, USA Department of Communication Science and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA, USA Department of Electrical and Computer Engineering, Swanson School of Enginering,  University of Pittsburgh, Pittsburgh, PA, USA},
note  = {IEEE Trans Hum Mach Syst. 2015 Aug;45(4):465-77. doi:10.1109/THMS.2015.2408615.}
}

@Article{2014628,
author  = {Adur, J. and Carvalho, H. and Cesar, C. and Casco, V.},
title  = {Nonlinear Optical Microscopy Signal Processing Strategies in Cancer.},
journal  = {Cancer Informatics},
volume  = {13},
number  = {},
pages  = {67-76},
year  = {2014},
abstract  = {This work reviews the most relevant present-day processing methods used to improve the accuracy of multimodal nonlinear images in the detection of epithelial cancer and the supporting stroma. Special emphasis has been placed on  methods of non linear optical (NLO) microscopy image processing such as: second harmonic to autofluorescence ageing index of dermis (SAAID), tumor-associated collagen signatures (TACS), fast Fourier transform (FFT) analysis, and gray level co-occurrence matrix (GLCM)-based methods. These strategies are presented as a set of potential valuable diagnostic tools for early cancer detection. It may be  proposed that the combination of NLO microscopy and informatics based image analysis approaches described in this review (all carried out on free software) may represent a powerful tool to investigate collagen organization and remodeling of extracellular matrix in carcinogenesis processes.},
address  = {Microscopy Laboratory Applied to Molecular and Cellular Studies, Bioengineering School, National University of Entre Rios, Oro Verde, Entre Rios, Argentina. INFABiC‚ÄîNational Institute of Science and Technology on Photonics Applied to Cell Biology, Campinas, S√£o Paulo, Brazil. INFABiC‚ÄîNational Institute of Science and Technology on Photonics Applied to Cell Biology, Campinas, S√£o Paulo, Brazil. Microscopy Laboratory Applied to Molecular and Cellular Studies, Bioengineering School, National University of Entre Rios, Oro Verde, Entre Rios, Argentina.},
note  = {Cancer Inform. 2014 Apr 02;13:67-76. doi:10.4137/CIN.S12419.}
}

@Article{2013629,
author  = {Bastawrous, A. and Armstrong, M.},
title  = {peer-reviewed literature.},
journal  = {Journal of the Royal Society of Medicine},
volume  = {106},
number  = {4},
pages  = {130-42},
year  = {2013},
abstract  = {The evolution of mobile phone technology has introduced new possibilities to the  field of medicine. Combining technological advances with medical expertise has led to the use of mobile phones in all healthcare areas including diagnostics, telemedicine, research, reference libraries and interventions. This article provides an overview of the peer-reviewed literature, published between 1 August  2006 and 1 August 2011, for the application of mobile/cell phones (from basic text-messaging systems to smartphones) in healthcare in both resource-poor and high-income countries. Smartphone use is paving the way in high-income countries, while basic text-messaging systems of standard mobile phones are proving to be of value in low- and middle-income countries. Ranging from infection outbreak reporting, anti-HIV therapy adherence to gait analysis, resuscitation training and radiological imaging, the current uses and future possibilities of mobile phone technology in healthcare are endless. Multiple mobile phone based applications are available for healthcare workers and healthcare consumers; however, the absolute majority lack an evidence base. Therefore, more rigorous research is required to ensure that healthcare is not flooded with non-evidence based applications and is maximized for patient benefit.},
address  = {International Centre for Eye Health, Clinical Research Department, London School  of Hygiene & Tropical Medicine, London WC1E 7HT, UK Centre for Liver Research and NIHR Liver Biomedical Research Unit, University of  Birmingham, Birmingham B15 2TT, UK},
note  = {J R Soc Med. 2013 Apr;106(4):130-42. doi:10.1177/0141076812472620.}
}

@Article{2015630,
author  = {Lee, S. and Yoo, J. and Han, G.},
title  = {Access.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {15},
number  = {6},
pages  = {14679-700},
year  = {2015},
abstract  = {Despite the remarkable improvement of hardware and network technology, the inevitable delay from a user's command action to a system response is still one of the most crucial influence factors in user experiences (UXs). Especially for a web video service, an initial delay from click action to video start has significant influences on the quality of experience (QoE). The initial delay of a system can be minimized by preparing execution based on predicted user's intention prior to actual command action. The introduction of the sequential and  concurrent flow of resources in human cognition and behavior can significantly improve the accuracy and preparation time for intention prediction. This paper introduces a threaded interaction model and applies it to user intention prediction for initial delay reduction in web video access. The proposed technique consists of a candidate selection module, a decision module and a preparation module that prefetches and preloads the web video data before a user's click action. The candidate selection module selects candidates in the web page using proximity calculation around a cursor. Meanwhile, the decision module  computes the possibility of actual click action based on the cursor-gaze relationship. The preparation activates the prefetching for the selected candidates when the click possibility exceeds a certain limit in the decision module. Experimental results show a 92% hit-ratio, 0.5-s initial delay on average and 1.5-s worst initial delay, which is much less than a user's tolerable limit in web video access, demonstrating significant improvement of accuracy and advance time in intention prediction by introducing the proposed threaded interaction model.},
address  = {School of Integrated Technology, Yonsei University, Incheon 406-840, Korea; E-Mails: youb007@yonsei.ac.kr (S.L.); j.y@yonsei.ac.kr (J.Y.) School of Integrated Technology, Yonsei University, Incheon 406-840, Korea; E-Mails: youb007@yonsei.ac.kr (S.L.); j.y@yonsei.ac.kr (J.Y.) School of Integrated Technology, Yonsei University, Incheon 406-840, Korea; E-Mails: youb007@yonsei.ac.kr (S.L.); j.y@yonsei.ac.kr (J.Y.)},
note  = {Sensors (Basel). 2015 Jun 19;15(6):14679-700. doi:10.3390/s150614679.}
}

@Article{2015631,
author  = {Robbins, R. and Mellins, C. and Leu, C. and Rowe, J. and Warne, P. and Abrams, E. and Witte, S. and Stein, D. and Remien, R.},
title  = {Technology.},
journal  = {AIDS and behavior},
volume  = {19},
number  = {0 2},
pages  = {163-76},
year  = {2015},
abstract  = {Multimedia technologies offer powerful tools to increase capacity of health workers to deliver standardized, effective, and engaging antiretroviral medication adherence counseling. Masivukeni is an innovative multimedia-based, computer-driven, lay counselor-delivered intervention designed to help people living with HIV in resource-limited settings achieve optimal adherence. This pilot study examined medication adherence and key psychosocial outcomes among 55  non-adherent South African HIV+ patients, on ART for at least 6 months, who were  randomized to receive either Masivukeni or standard of care (SOC) counseling for  ART non-adherence. At baseline, there were no significant differences between the SOC and Masivukeni groups on any outcome variables. At post-intervention (approximately 5‚Äì6 weeks after baseline), clinic-based pill count adherence data  available for 20 participants (10 per intervention arm) showed a 10% improvement  for Masivukeni participants and a decrease of 8% for SOC participants. Masivukeni participants reported significantly more positive attitudes towards disclosure and medication social support, less social rejection, and better clinic-patient relationships than did SOC participants. Masivukeni shows promise to promote optimal adherence and provides preliminary evidence that multimedia, computer-based technology can help lay counselors offer better adherence counseling than standard approaches.},
address  = {HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, New York HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, New York HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, New York The Columbia Center for New Media Teaching and Learning, Columbia University, New York, New York HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, New York ICAP, Mailman School of Public Health and College of Physicians & Surgeons, Columbia University, New York, New York Social Intervention Group, School of Social Work, Columbia University, New York,  New York Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa HIV Center for Clinical and Behavioral Studies, New York State Psychiatric Institute and Columbia University, New York, New York},
note  = {AIDS Behav. 2015 Jun;19(0 2):163-76. doi:10.1007/s10461-014-0988-4.}
}

@Article{2013632,
author  = {Asaad, W. and Santhanam, N. and McClellan, S. and Freedman, D.},
title  = {MATLAB.},
journal  = {Journal of Neurophysiology},
volume  = {109},
number  = {1},
pages  = {249-60},
year  = {2013},
abstract  = {Behavioral, psychological, and physiological experiments often require the ability to present sensory stimuli, monitor and record subjects' responses, interface with a wide range of devices, and precisely control the timing of events within a behavioral task. Here, we describe our recent progress developing an accessible and full-featured software system for controlling such studies using the MATLAB environment. Compared with earlier reports on this software, key new features have been implemented to allow the presentation of more complex visual stimuli, increase temporal precision, and enhance user interaction. These  features greatly improve the performance of the system and broaden its applicability to a wider range of possible experiments. This report describes these new features and improvements, current limitations, and quantifies the performance of the system in a real-world experimental setting.},
address  = {Brown Institute for Brain Science, Norman Prince Neurosciences Institute and the  Department of Neurosurgery, Alpert Medical School, Brown University and Rhode Island Hospital, Providence, Rhode Island Department of Neurobiology, The University of Chicago, Chicago, Illinois; and Department of Neurobiology, The University of Chicago, Chicago, Illinois; and Department of Neurobiology, The University of Chicago, Chicago, Illinois; and},
note  = {doi:10.1152/jn.00527.2012.}
}

@Article{2013633,
author  = {Whittaker, R. and Furberg, R. and McKinley, M. and Abebe, N. and Capozza, K. and Des, J. and Kulick, D. and Rein, A. and Schachter, A. and Turske, S.},
title  = {Beacon Communities.},
journal  = {Journal of Medical Internet Research},
volume  = {15},
number  = {10},
pages  = {},
year  = {2013},
abstract  = {Mobile health (mHealth) is gaining widespread attention for its potential to engage patients in their health and health care in their daily lives. Emerging evidence suggests that mHealth interventions can be used effectively to support behavior change, but numerous challenges remain when implementing these programs  at the community level. This paper provides an overview of considerations when implementing community-based mHealth initiatives, based on the experiences of three Beacon Communities across the United States that have launched text messaging (short message service, SMS) pilot programs aimed at diabetes risk reduction and disease management. The paper addresses lessons learned and suggests strategies to overcome challenges related to developing text message content, conducting marketing and outreach, enrolling participants, engaging providers, evaluating program effectiveness, and sustaining and scaling the programs.},
address  = {Louisiana Public Health InstituteCrescent City Beacon CommunityNew Orleans, LAUnited States HealthInsightUtah Beacon CommunitySalt Lake City, UTUnited States Southeast Michigan Beacon CommunityDetroit, MIUnited States Louisiana Public Health InstituteCrescent City Beacon CommunityNew Orleans, LAUnited States AcademyHealthWashington, DCUnited States AcademyHealthWashington, DCUnited States Southeast Michigan Beacon CommunityDetroit, MIUnited States},
note  = {J Med Internet Res. 2013 Oct 15;15(10):. doi:10.2196/jmir.2803.}
}

@Article{2016634,
author  = {Meinel, A. and Casta√±o-Candamil, S. and Reis, J. and Tangermann, M.},
title  = {Neuroergonomics for a Hand Force Task.},
journal  = {Frontiers in Human Neuroscience},
volume  = {10},
number  = {},
pages  = {},
year  = {2016},
abstract  = {We propose a framework for building electrophysiological predictors of single-trial motor performance variations, exemplified for SVIPT, a sequential isometric force control task suitable for hand motor rehabilitation after stroke. Electroencephalogram (EEG) data of 20 subjects with mean age of 53 years was recorded prior to and during 400 trials of SVIPT. They were executed within a single session with the non-dominant left hand, while receiving continuous visual feedback of the produced force trajectories. The behavioral data showed strong trial-by-trial performance variations for five clinically relevant metrics, which accounted for reaction time as well as for the smoothness and precision of the produced force trajectory. 18 out of 20 tested subjects remained after preprocessing and entered offline analysis. Source Power Comodulation (SPoC) was  applied on EEG data of a short time interval prior to the start of each SVIPT trial. For 11 subjects, SPoC revealed robust oscillatory EEG subspace components, whose bandpower activity are predictive for the performance of the upcoming trial. Since SPoC may overfit to non-informative subspaces, we propose to apply three selection criteria accounting for the meaningfulness of the features. Across all subjects, the obtained components were spread along the frequency spectrum and showed a variety of spatial activity patterns. Those containing the  highest level of predictive information resided in and close to the alpha band. Their spatial patterns resemble topologies reported for visual attention processes as well as those of imagined or executed hand motor tasks. In summary,  we identified subject-specific single predictors that explain up to 36% of the performance fluctuations and may serve for enhancing neuroergonomics of motor rehabilitation scenarios.},
address  = {Brain State Decoding Lab, Cluster of Excellence BrainLinks-BrainTools, Department of Computer Science, Albert-Ludwigs-UniversityFreiburg, Germany Brain State Decoding Lab, Cluster of Excellence BrainLinks-BrainTools, Department of Computer Science, Albert-Ludwigs-UniversityFreiburg, Germany Department of Neurology, Albert-Ludwigs-UniversityFreiburg, Germany Brain State Decoding Lab, Cluster of Excellence BrainLinks-BrainTools, Department of Computer Science, Albert-Ludwigs-UniversityFreiburg, Germany},
note  = {Front Hum Neurosci. 2016 Apr 25;10:. doi:10.3389/fnhum.2016.00170.}
}

@Article{2007635,
author  = {Swerdlow, N. and Sprock, J. and Light, G. and Cadenhead, K. and Calkins, M. and Dobie, D. and Freedman, R. and Green, M. and Greenwood, T. and Gur, R. and Mintz, J. and Olincy, A. and Nuechterlein, K. and Radant, A. and Schork, N. and Seidman, L. and Siever, L. and Silverman, J. and Stone, W. and Tsuang, D. and Tsuang, M. and Turetsky, B. and Braff, D.},
title  = {on the Genetics of Schizophrenia.},
journal  = {Schizophrenia research},
volume  = {92},
number  = {1-3},
pages  = {237-51},
year  = {2007},
abstract  = {Background:: Startle and its inhibition by weak lead stimuli (‚Äúprepulse inhibition‚Ä?: PPI) are studied to understand the neurobiology of information processing in patients and community comparison subjects (CCS). PPI has a strong  genetic basis in infrahumans, and there is evidence for its heritability, stability and reliability in humans. PPI has gained increasing use as an endophenotype to identify vulnerability genes for brain disorders, including schizophrenia. Genetic studies now often employ multiple, geographically dispersed test sites to accommodate the need for large and complex study samples. Here, we assessed the feasibility of using PPI in multi-site studies. Methods:: Within a 7-site investigation with multiple measures, the Consortium on the Genetics of Schizophrenia conducted a methodological study of acoustic startle and PPI in CCS. Methods were manualized, videotaped and standardized across sites with intensive in-person training sessions. Equipment was acquired and programmed at the ‚ÄúPPI site‚Ä? (UCSD), and stringent quality assurance (QA) procedures were used. Testing was completed on 196 CCS over 2.5 years, with 5 primary startle dependent measures: eyeblink startle magnitude, habituation, peak latency, latency facilitation and PPI. Results:: Analyses identified significant variability across sites in some but not all primary measures, and determined factors both within the testing process and subject characteristics that influenced a number of test measures. QA procedures also identified non-standardized practices with respect to testing methods and procedural ‚Äúdrift‚Ä?, which may be particularly relevant to multi-site studies using these measures. Conclusion:: With thorough oversight and QA procedures, measures of acoustic startle PPI can be acquired reliably across multiple testing sites. Nonetheless, even among sites with substantial expertise in utilizing psychophysiological measures, multi-site studies using startle and PPI as dependent measures require careful attention to methodological procedures.},
address  = {Department of Psychiatry, University of California San Diego, San Diego, California, USA. Department of Psychiatry, University of California San Diego, San Diego, California, USA. Department of Psychiatry, University of California San Diego, San Diego, California, USA. Department of Psychiatry, University of California San Diego, San Diego, California, USA. Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, and VA Puget Sound Health Care System, Seattle, Washington,  USA, and VISN20 MIRECC. Department of Psychiatry, University of Colorado Health Sciences Center, Denver,  Colorado, USA. Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA. Department of Psychiatry, University of California San Diego, San Diego, California, USA. Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA. Department of Psychiatry, University of Colorado Health Sciences Center, Denver,  Colorado, USA. Department of Psychiatry and Biobehavioral Sciences, Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, USA. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, and VA Puget Sound Health Care System, Seattle, Washington,  USA, and VISN20 MIRECC. Department of Psychiatry, University of California San Diego, San Diego, California, USA. Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel  Deaconess Medical Center, Harvard Medical School Department of Psychiatry, Boston, Massachusetts, and Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, Massachusetts, USA. Department of Psychiatry, The Mount Sinai School of Medicine, New York, New York, USA, and James J. Peters VA Medical Center and VISN3 MIRECC. Department of Psychiatry, The Mount Sinai School of Medicine, New York, New York, USA, and James J. Peters VA Medical Center and VISN3 MIRECC. Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel  Deaconess Medical Center, Harvard Medical School Department of Psychiatry, Boston, Massachusetts, and Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, Massachusetts, USA. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, Washington, and VA Puget Sound Health Care System, Seattle, Washington,  USA, and VISN20 MIRECC. Department of Psychiatry, University of California San Diego, San Diego, California, USA. Department of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Department of Psychiatry, University of California San Diego, San Diego, California, USA.},
note  = {doi:10.1016/j.schres.2007.01.012.}
}

@Article{2011636,
author  = {Hillman, E. and Amoozegar, C. and Wang, T. and McCaslin, A. and Bouchard, M. and Mansfield, J. and Levenson, R.},
title  = {In vivo optical imaging and dynamic contrast methods for biomedical research.},
journal  = {sciences},
volume  = {369},
number  = {1955},
pages  = {4620-43},
year  = {2011},
abstract  = {This paper provides an overview of optical imaging methods commonly applied to basic research applications. Optical imaging is well suited for non-clinical use, since it can exploit an enormous range of endogenous and exogenous forms of contrast that provide information about the structure and function of tissues ranging from single cells to entire organisms. An additional benefit of optical imaging that is often under-exploited is its ability to acquire data at high speeds; a feature that enables it to not only observe static distributions of contrast, but to probe and characterize dynamic events related to physiology, disease progression and acute interventions in real time. The benefits and limitations of in vivo optical imaging for biomedical research applications are described, followed by a perspective on future applications of optical imaging for basic research centred on a recently introduced real-time imaging technique called dynamic contrast-enhanced small animal molecular imaging (DyCE).},
address  = {Laboratory for Functional Optical Imaging, Department of Biomedical Engineering,  and Columbia University in the City of New York, New York, NY 10027, USA Laboratory for Functional Optical Imaging, Department of Biomedical Engineering,  and Columbia University in the City of New York, New York, NY 10027, USA Laboratory for Functional Optical Imaging, Department of Biomedical Engineering,  and Columbia University in the City of New York, New York, NY 10027, USA Laboratory for Functional Optical Imaging, Department of Biomedical Engineering,  and Columbia University in the City of New York, New York, NY 10027, USA Laboratory for Functional Optical Imaging, Department of Biomedical Engineering,  and Columbia University in the City of New York, New York, NY 10027, USA Caliper Life Sciences Inc., Hopkinton, MA 01748, USA Brighton Consulting Group, Brighton, MA 02135, USA},
note  = {doi:10.1098/rsta.2011.0264.}
}

@Article{2009637,
author  = {Brown, G. and McCarthy, G. and Bischoff-Grethe, A. and Ozyurt, B. and Greve, D. and Potkin, S. and Turner, J. and Notestine, R. and Calhoun, V. and Ford, J. and Mathalon, D. and Manoach, D. and Gadde, S. and Glover, G. and Wible, C. and Belger, A. and Gollub, R. and Lauriello, J. and O'Leary, D. and Lim, K.},
title  = {Cognitive Modeling Approach.},
journal  = {Schizophrenia Bulletin},
volume  = {35},
number  = {1},
pages  = {32-46},
year  = {2009},
abstract  = {Correlations of cognitive functioning with brain activation during a sternberg item recognition paradigm (SIRP) were investigated in patients with schizophrenia and in healthy controls studied at 8 sites. To measure memory scanning times, 4 response time models were fit to SIRP data. The best fitting model assumed exhaustive serial memory scanning followed by self-terminating memory search and  involved one intercept parameter to represent SIRP processes not contributing directly to memory scanning. Patients displayed significantly longer response times with increasing memory load and differed on the memory scanning, memory search, and intercept parameters of the best fitting probability model. Groups differed in the correlation between the memory scanning parameter and linear brain response to increasing memory load within left inferior and left middle frontal gyrus, bilateral caudate, and right precuneus. The pattern of findings in these regions indicated that high scanning capacity was associated with high neural capacity among healthy subjects but that scanning speed was uncoupled from brain response to increasing memory load among schizophrenia patients. Group differences in correlation of the best fitting model's scanning parameter with a  quadratic trend in brain response to increasing memory load suggested inefficient or disordered patterns of neural inhibition among individuals with schizophrenia, especially in the left perirhinal and entorhinal cortices. The results show at both cognitive and neural levels that disordered memory scanning contributes to deficient SIRP performance among schizophrenia patients.},
address  = {Department of Psychiatry, University of California San Diego; Psychology Service, VA San Diego Healthcare System Department of Psychiatry, Yale University Department of Psychiatry, University of California San Diego Department of Psychiatry, University of California San Diego Department of Psychiatry, Massachusetts General Hospital Department of Psychiatry, University of California Irvine Department of Psychiatry, University of California Irvine Department of Psychiatry, University of California San Diego Electrical and Computer Engineering; The Mind Research Network, University of New Mexico, Albuquerque, NM 87131 Department of Psychiatry, University of California San Francisco Department of Psychiatry, University of California San Francisco Department of Psychiatry, Massachusetts General Hospital Department of Psychiatry, Duke University Radiological Sciences Laboratory, Stanford University Department of Psychiatry, Harward Medical School and Brockton VAMC Department of Psychiatry, University of North Carolina‚ÄîChapel Hill Department of Psychiatry, Massachusetts General Hospital Department of Psychiatry, University of New Mexico Department of Psychiatry, University of Iowa},
note  = {Schizophr Bull. 2009 Jan;35(1):32-46. Epub 2008 Nov 20 doi:10.1093/schbul/sbn149.}
}

@Article{2014638,
author  = {Mouƒ?ek, R. and Je≈æek, P. and Va≈ôeka, L. and ≈òond√≠k, T. and Br≈Øha, P. and Pape≈æ, V. and Mautner, P. and Novotn√Ω, J. and Prokop, T. and ≈†tƒõbet√°k, J.},
title  = {Software and hardware infrastructure for research in electrophysiology.},
journal  = {Frontiers in Neuroinformatics},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {As in other areas of experimental science, operation of electrophysiological laboratory, design and performance of electrophysiological experiments, collection, storage and sharing of experimental data and metadata, analysis and interpretation of these data, and publication of results are time consuming activities. If these activities are well organized and supported by a suitable infrastructure, work efficiency of researchers increases significantly. This article deals with the main concepts, design, and development of software and hardware infrastructure for research in electrophysiology. The described infrastructure has been primarily developed for the needs of neuroinformatics laboratory at the University of West Bohemia, the Czech Republic. However, from the beginning it has been also designed and developed to be open and applicable in laboratories that do similar research. After introducing the laboratory and the whole architectural concept the individual parts of the infrastructure are described. The central element of the software infrastructure is a web-based portal that enables community researchers to store, share, download and search data and metadata from electrophysiological experiments. The data model, domain ontology and usage of semantic web languages and technologies are described. Current data publication policy used in the portal is briefly introduced. The registration of the portal within Neuroscience Information Framework is described. Then the methods used for processing of electrophysiological signals are presented. The specific modifications of these methods introduced by laboratory researches are summarized; the methods are organized into a laboratory workflow. Other parts of the software infrastructure include mobile and offline solutions for data/metadata storing and a hardware stimulator communicating with  an EEG amplifier and recording software.},
address  = {Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic Department of Computer Science and Engineering, Faculty of Applied Sciences, University of West BohemiaPlze≈à, Czech Republic},
note  = {Front Neuroinform. 2014 Mar 07;8:. doi:10.3389/fninf.2014.00020.}
}

@Article{2009639,
author  = {Yoon, H. and Lowe, V. and Cassivi, S. and Romero, Y.},
title  = {Cancer of the Esophagus or Gastroesophageal Junction.},
journal  = {Gastroenterology clinics of North America},
volume  = {38},
number  = {1},
pages  = {105-ix},
year  = {2009},
abstract  = {},
address  = {Division of Medical Oncology, Department of Oncology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN 55906, USA Division of General Thoracic Surgery, Department of Surgery, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA},
note  = {doi:10.1016/j.gtc.2009.01.007.}
}

@Article{2016640,
author  = {Plow, E. and Sankarasubramanian, V. and Cunningham, D. and Potter-Baker, K. and Varnerin, N. and Cohen, L. and Sterr, A. and Conforto, A. and Machado, A.},
title  = {Models to Tailor Brain Stimulation Therapies in Stroke.},
journal  = {Neural Plasticity},
volume  = {2016},
number  = {},
pages  = {},
year  = {2016},
abstract  = {A great challenge facing stroke rehabilitation is the lack of information on how  to derive targeted therapies. As such, techniques once considered promising, such as brain stimulation, have demonstrated mixed efficacy across heterogeneous samples in clinical studies. Here, we explain reasons, citing its one-type-suits-all approach as the primary cause of variable efficacy. We present evidence supporting the role of alternate substrates, which can be targeted instead in patients with greater damage and deficit. Building on this groundwork, this review will also discuss different frameworks on how to tailor brain stimulation therapies. To the best of our knowledge, our report is the first instance that enumerates and compares across theoretical models from upper limb recovery and conditions like aphasia and depression. Here, we explain how different models capture heterogeneity across patients and how they can be used to predict which patients would best respond to what treatments to develop targeted, individualized brain stimulation therapies. Our intent is to weigh pros and cons of testing each type of model so brain stimulation is successfully tailored to maximize upper limb recovery in stroke.},
address  = {Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA Department of Biomedical Engineering, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA Human Cortical Physiology and Stroke Neurorehabilitation Section, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA University of Surrey, Guildford, Surrey GU2 7XH, UK Neurology Clinical Division, Neurology Department, Hospital das Clinicas, Sao Paulo University, 05508-090 Sao Paulo, SP, Brazil Center for Neurological Restoration, Neurosurgery, Neurological Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH 44195, USA},
note  = {Neural Plast. 2016;2016:. Epub 2016 Feb 23 doi:10.1155/2016/4071620.}
}

@Article{2014641,
author  = {Shulman, R. and Hyder, F. and Rothman, D.},
title  = {an alternative empirical model for studying the brain's support of behavior.},
journal  = {Journal of Cerebral Blood Flow & Metabolism},
volume  = {34},
number  = {11},
pages  = {1721-35},
year  = {2014},
abstract  = {Functional neuroimaging measures quantitative changes in neurophysiological parameters coupled to neuronal activity during observable behavior. These results have usually been interpreted by assuming that mental causation of behavior arises from the simultaneous actions of distinct psychological mechanisms or modules. However, reproducible localization of these modules in the brain using functional magnetic resonance imaging (MRI) and positron emission tomography (PET) imaging has been elusive other than for sensory systems. In this paper, we  show that neuroenergetic studies using PET, calibrated functional magnetic resonance imaging (fMRI), 13C magnetic resonance spectroscopy, and electrical recordings do not support the standard approach, which identifies the location of mental modules from changes in brain activity. Of importance in reaching this conclusion is that changes in neuronal activities underlying the fMRI signal are  many times smaller than the high ubiquitous, baseline neuronal activity, or energy in resting, awake humans. Furthermore, the incremental signal depends on the baseline activity contradicting theoretical assumptions about linearity and insertion of mental modules. To avoid these problems, while making use of these valuable results, we propose that neuroimaging should be used to identify observable brain activities that are necessary for a person's observable behavior rather than being used to seek hypothesized mental processes.},
address  = {Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA Magnetic Resonance Research Center, Yale University, New Haven, Connecticut, USA},
note  = {doi:10.1038/jcbfm.2014.145.}
}

@Article{2013642,
author  = {Blackiston, D. and Levin, M.},
title  = {light-mediated learning.},
journal  = {The Journal of Experimental Biology},
volume  = {216},
number  = {6},
pages  = {1031-40},
year  = {2013},
abstract  = {A major roadblock in the biomedical treatment of human sensory disorders, including blindness, has been an incomplete understanding of the nervous system and its ability to adapt to changes in sensory modality. Likewise, fundamental insight into the evolvability of complex functional anatomies requires understanding brain plasticity and the interaction between the nervous system and body architecture. While advances have been made in the generation of artificial  and biological replacement components, the brain's ability to interpret sensory information arising from ectopic locations is not well understood. We report the  use of eye primordia grafts to create ectopic eyes along the body axis of Xenopus tadpoles. These eyes are morphologically identical to native eyes and can be induced at caudal locations. Cell labeling studies reveal that eyes created in the tail send projections to the stomach and trunk. To assess function we performed light-mediated learning assays using an automated machine vision and environmental control system. The results demonstrate that ectopic eyes in the tail of Xenopus tadpoles could confer vision to the host. Thus ectopic visual organs were functional even when present at posterior locations. These data and protocols demonstrate the ability of vertebrate brains to interpret sensory input from ectopic structures and incorporate them into adaptive behavioral programs. This tractable new model for understanding the robust plasticity of the central nervous system has significant implications for regenerative medicine and sensory augmentation technology.},
address  = {},
note  = {J Exp Biol. 2013 Mar 15;216(6):1031-40. doi:10.1242/jeb.074963.}
}

@Article{2009643,
author  = {Hasan, M. and Reaz, M. and Ibrahimy, M. and Hussain, M. and Uddin, J.},
title  = {Detection and Processing Techniques of FECG Signal for Fetal Monitoring.},
journal  = {Biological Procedures Online},
volume  = {11},
number  = {},
pages  = {263-95},
year  = {2009},
abstract  = {Fetal electrocardiogram (FECG) signal contains potentially precise information that could assist clinicians in making more appropriate and timely decisions during labor. The ultimate reason for the interest in FECG signal analysis is in  clinical diagnosis and biomedical applications. The extraction and detection of the FECG signal from composite abdominal signals with powerful and advance methodologies are becoming very important requirements in fetal monitoring. The purpose of this review paper is to illustrate the various methodologies and developed algorithms on FECG signal detection and analysis to provide efficient and effective ways of understanding the FECG signal and its nature for fetal monitoring. A comparative study has been carried out to show the performance and  accuracy of various methods of FECG signal analysis for fetal monitoring. Finally, this paper further focused some of the hardware implementations using electrical signals for monitoring the fetal heart rate. This paper opens up a passage for researchers, physicians, and end users to advocate an excellent understanding of FECG signal and its analysis procedures for fetal heart rate monitoring system.},
address  = {Department of Electrical and Computer Engineering, International Islamic University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia Department of Electrical, Electronic and Systems Engineering, Universiti Kebangsaan Malaysia, 43600 UKM, Bangi, Selangor, Malaysia Department of Electrical and Computer Engineering, International Islamic University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia Department of Electrical and Computer Engineering, International Islamic University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia Department of Electrical and Computer Engineering, International Islamic University Malaysia, Gombak, 53100, Kuala Lumpur, Malaysia},
note  = {Biol Proced Online. 2009 Mar 27;11:263-95. doi:10.1007/s12575-009-9006-z.}
}

@Article{2014644,
author  = {Herreros, I. and Giovannucci, A. and Taub, A. and Hogri, R. and Magal, A. and Bamford, S. and Prueckl, R. and Verschure, P.},
title  = {A Cerebellar Neuroprosthetic System: Computational Architecture and in vivo Test.},
journal  = {Frontiers in Bioengineering and Biotechnology},
volume  = {2},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Emulating the input‚Äìoutput functions performed by a brain structure opens the possibility for developing neuroprosthetic systems that replace damaged neuronal  circuits. Here, we demonstrate the feasibility of this approach by replacing the  cerebellar circuit responsible for the acquisition and extinction of motor memories. Specifically, we show that a rat can undergo acquisition, retention, and extinction of the eye-blink reflex even though the biological circuit responsible for this task has been chemically inactivated via anesthesia. This is achieved by first developing a computational model of the cerebellar microcircuit involved in the acquisition of conditioned reflexes and training it with synthetic data generated based on physiological recordings. Secondly, the cerebellar model is interfaced with the brain of an anesthetized rat, connecting  the model‚Äôs inputs and outputs to afferent and efferent cerebellar structures. As a result, we show that the anesthetized rat, equipped with our neuroprosthetic system, can be classically conditioned to the acquisition of an eye-blink response. However, non-stationarities in the recorded biological signals limit the performance of the cerebellar model. Thus, we introduce an updated cerebellar model and validate it with physiological recordings showing that learning becomes stable and reliable. The resulting system represents an important step toward replacing lost functions of the central nervous system via neuroprosthetics, obtained by integrating a synthetic circuit with the afferent and efferent pathways of a damaged brain region. These results also embody an early example of science-based medicine, where on the one hand the neuroprosthetic system directly validates a theory of cerebellar learning that informed the design of the system, and on the other one it takes a step toward the development of neuro-prostheses that could recover lost learning functions in animals and, in the longer term, humans.},
address  = {Synthetic Perceptive, Emotive and Cognitive Systems group (SPECS), Universitat Pompeu Fabra, Barcelona, Spain Synthetic Perceptive, Emotive and Cognitive Systems group (SPECS), Universitat Pompeu Fabra, Barcelona, Spain Psychobiology Research Unit, Tel Aviv University, Tel Aviv, Israel Psychobiology Research Unit, Tel Aviv University, Tel Aviv, Israel Psychobiology Research Unit, Tel Aviv University, Tel Aviv, Israel Physics Laboratory, Istituto Superiore di Sanit√†, Rome, Italy Guger Technologies OG, Graz, Austria Synthetic Perceptive, Emotive and Cognitive Systems group (SPECS), Universitat Pompeu Fabra, Barcelona, Spain},
note  = {Front Bioeng Biotechnol. 2014 May 21;2:. doi:10.3389/fbioe.2014.00014.}
}

@Article{2016645,
author  = {Jin, Y. and Bouyer, J. and Shumsky, J. and Haas, C. and Fischer, I.},
title  = {TRANSPLANTATION OF NEURAL PROGENITOR CELLS IN CHRONIC SPINAL CORD INJURY.},
journal  = {Neuroscience},
volume  = {320},
number  = {},
pages  = {69-82},
year  = {2016},
abstract  = {Previous studies demonstrated that neural progenitor cells (NPCs) transplanted into a subacute contusion injury improve motor, sensory, and bladder function. In this study we tested whether transplanted NPCs can also improve functional recovery after chronic spinal cord injury (SCI) alone or in combination with the  reduction of glial scar and neurotrophic support. Adult rats received a T10 moderate contusion. Thirteen weeks after the injury they were divided into four groups and received either: 1. Medium (control), 2. NPC transplants, 3. NPC + lentivirus vector expressing chondroitinase, or 4. NPC + lentivirus vectors expressing chondroitinase and neurotrophic factors. During the 8 weeks post-transplantation the animals were tested for functional recovery and eventually analyzed by anatomical and immunohistochemical assays. The behavioral  tests for motor and sensory function were performed before and after injury, and  weekly after transplantation, with some animals also tested for bladder function  at the end of the experiment. Transplant survival in the chronic injury model was variable and showed NPCs at the injury site in 60% of the animals in all transplantation groups. The NPC transplants comprised less than 40% of the injury site, without significant anatomical or histological differences among the groups. All groups also showed similar patterns of functional deficits and recovery in the 12 weeks after injury and in the 8 weeks after transplantation using the Basso, Beattie, and Bresnahan rating score, the grid test, and the Von  Frey test for mechanical allodynia. A notable exception was group 4 (NPC together with chondroitinase and neurotrophins), which showed a significant improvement in bladder function. This study underscores the therapeutic challenges facing transplantation strategies in a chronic SCI in which even the inclusion of treatments designed to reduce scarring and increase neurotrophic support produce  only modest functional improvements. Further studies will have to identify the combination of acute and chronic interventions that will augment the survival and efficacy of neural cell transplants.},
address  = {},
note  = {doi:10.1016/j.neuroscience.2016.01.066.}
}

@Article{2012646,
author  = {Wolinsky, J. and Colson, Y. and Grinstaff, M.},
title  = {Polymeric Films, Rods, and Wafers.},
journal  = {Society},
volume  = {159},
number  = {1},
pages  = {},
year  = {2012},
abstract  = {},
address  = {Departments of Biomedical Engineering and Chemistry, Boston University, Boston, Massachusetts Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts Departments of Biomedical Engineering and Chemistry, Boston University, Boston, Massachusetts},
note  = {doi:10.1016/j.jconrel.2011.11.031.}
}

@Article{2011647,
author  = {Schiller, P. and Slocum, W. and Kwak, M. and Kendall, G. and Tehovnik, E.},
title  = {striate cortex (area V1) is electrically stimulated.},
journal  = {Proceedings of the National Academy of Sciences of the United States of America},
volume  = {108},
number  = {43},
pages  = {17809-14},
year  = {2011},
abstract  = {Creating a prosthetic device for the blind is a central future task. Our research examines the feasibility of producing a prosthetic device based on electrical stimulation of primary visual cortex (area V1), an area that remains intact for many years after loss of vision attributable to damage to the eyes. As an initial step in this effort, we believe that the research should be carried out in animals, as it has been in the creation of the highly successful cochlear implant. We chose the rhesus monkey, whose visual system is similar to that of man. We trained monkeys on two tasks to assess the size, contrast, and color of the percepts created when single sites in area V1 are stimulated through microelectrodes. Here, we report that electrical stimulation within the central 5¬∞ of the visual field representation creates a small spot that is between 9 and  26 min of arc in diameter and has a contrast ranging between 2.6% and 10%. The dot generated by the stimulation in the majority of cases was darker than the background viewed by the animal and was composed of a variety of low-contrast colors. These findings can be used as inputs to models of electrical stimulation  in area V1. On the basis of these findings, we derive what kinds of images would  be expected when implanted arrays of electrodes are stimulated through a camera attached to the head whose images are converted into electrical stimulation using appropriate algorithms.},
address  = {Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139; and The Edmond and Lily Safra International Institute of Neuroscience of Natal (ELS-IINN), Macaiba, 59280, Rio Grande do Norte, Brazil},
note  = {doi:10.1073/pnas.1108337108.}
}

@Article{2014648,
author  = {Schain, A. and Hill, R. and Grutzendler, J.},
title  = {spectral confocal reflectance microscopy.},
journal  = {Nature medicine},
volume  = {20},
number  = {4},
pages  = {443-9},
year  = {2014},
abstract  = {We report a new technique for high-resolution in vivo imaging of myelinated axons in the brain, spinal cord and peripheral nerve that requires no fluorescent labeling. This method, based on spectral confocal reflectance microscopy (SCoRe), uses a conventional laser scanning confocal system to generate images by merging  the simultaneously reflected signals from multiple lasers of different wavelengths. Striking color patterns unique to individual myelinated fibers are generated that facilitate their tracing in dense axonal areas. These patterns highlight nodes of Ranvier and Schmidt-Lanterman incisures and can be used to detect various myelin pathologies. Using SCoRe we performed chronic brain imaging up to 400 Œºm deep, capturing for the first time de novo myelination of mouse cortical axons in vivo. We also established the feasibility of imaging myelinated axons in the human cerebral cortex. SCoRe adds a powerful component to the evolving toolbox for imaging myelination in living animals and potentially in humans.},
address  = {Yale University School of Medicine, Department of Neurology, 300 George St. Suite 8201, New Haven, CT 06511 Yale University School of Medicine, Department of Neurology, 300 George St. Suite 8201, New Haven, CT 06511 Yale University School of Medicine, Department of Neurology, 300 George St. Suite 8201, New Haven, CT 06511},
note  = {Nat Med. 2014 Apr;20(4):443-9. Epub 2014 Mar 30 doi:10.1038/nm.3495.}
}

@Article{2012649,
author  = {Martinez, Y. and Dubois-Dauphin, M. and Krause, K.},
title  = {Lineages and Neural Tissues.},
journal  = {Frontiers in Physiology},
volume  = {3},
number  = {},
pages  = {},
year  = {2012},
abstract  = {Human pluripotent stem cells (hPSCs) represent a new and exciting field in modern medicine, now the focus of many researchers and media outlets. The hype is well-earned because of the potential of stem cells to contribute to disease modeling, drug screening, and even therapeutic approaches. In this review, we focus first on neural differentiation of these cells. In a second part we compare the various cell types available and their advantages for in vitro modeling. Then we provide a ‚Äústate-of-the-art‚Ä? report about two major biomedical applications: (1) the drug and toxicity screening and (2) the neural tissue replacement. Finally, we made an overview about current biomedical research using differentiated hPSCs.},
address  = {Department of Pathology and Immunology, Faculty of Medicine, University of GenevaGeneva, Switzerland Department of Pathology and Immunology, Faculty of Medicine, University of GenevaGeneva, Switzerland},
note  = {Front Physiol. 2012 Mar 19;3:. doi:10.3389/fphys.2012.00047.}
}

@Article{2010650,
author  = {Hampson, M. and Hoffman, R.},
title  = {the Neural Bases of Brain Disorders.},
journal  = {Frontiers in Systems Neuroscience},
volume  = {4},
number  = {},
pages  = {},
year  = {2010},
abstract  = {There has been an increasing emphasis on characterizing pathophysiology underlying psychiatric and neurological disorders in terms of altered neural connectivity and network dynamics. Transcranial magnetic stimulation (TMS) provides a unique opportunity for investigating connectivity in the human brain.  TMS allows researchers and clinicians to directly stimulate cortical regions accessible to electromagnetic coils positioned on the scalp. The induced activation can then propagate through long-range connections to other brain areas. Thus, by identifying distal regions activated during TMS, researchers can  infer connectivity patterns in the healthy human brain and can examine how those  patterns may be disrupted in patients with different brain disorders. Conversely, connectivity maps derived using neuroimaging methods can identify components of a dysfunctional network. Nodes in this dysfunctional network accessible as targets  for TMS by virtue of their proximity to the scalp may then permit TMS-induced alterations of components of the network not directly accessible to TMS via propagated effects. Thus TMS can provide a portal for accessing and altering neural dynamics in networks that are widely distributed anatomically. Finally, when long-term modulation of network dynamics is induced by trains of repetitive  TMS, changes in functional connectivity patterns can be studied in parallel with  changes in patient symptoms. These correlational data can elucidate neural mechanisms underlying illness and recovery. In this review, we focus on the application of these approaches to the study of psychiatric and neurological illnesses.},
address  = {Department of Diagnostic Radiology, Yale University School of MedicineNew Haven,  CT, USA Department of Psychiatry, Yale University School of MedicineNew Haven, CT, USA},
note  = {Front Syst Neurosci. 2010 Aug 12;4:. doi:10.3389/fnsys.2010.00040.}
}

@Article{2011651,
author  = {Reeder, B. and Turner, A.},
title  = {public health operations and emergency management.},
journal  = {Journal of biomedical informatics},
volume  = {44},
number  = {6},
pages  = {978-88},
year  = {2011},
abstract  = {Responding to public health emergencies requires rapid and accurate assessment of workforce availability under adverse and changing circumstances. However, public  health information systems to support resource management during both routine and emergency operations are currently lacking. We applied scenario-based design as an approach to engage public health practitioners in the creation and validation  of an information design to support routine and emergency public health activities. Methods: Using semi-structured interviews we identified the information needs and activities of senior public health managers of a large municipal health department during routine and emergency operations. Results: Interview analysis identified twenty-five information needs for public health operations management. The identified information needs were used in conjunction  with scenario-based design to create twenty-five scenarios of use and a public health manager persona. Scenarios of use and persona were validated and modified  based on follow-up surveys with study participants. Scenarios were used to test and gain feedback on a pilot information system. Conclusion: The method of scenario-based design was applied to represent the resource management needs of senior-level public health managers under routine and disaster settings. Scenario-based design can be a useful tool for engaging public health practitioners in the design process and to validate an information system design.},
address  = {Biobehavioral Nursing and Health Systems, School of Nursing, Box 359442, University of Washington, Seattle, WA 98195, USA Department of Health Services, School of Public Health, Box 354943, University of Washington, Seattle, WA 98195, USA},
note  = {doi:10.1016/j.jbi.2011.07.004.}
}

@Article{2015652,
author  = {Jones, T. and Adkins, D.},
title  = {Perfection.},
journal  = {Physiology},
volume  = {30},
number  = {5},
pages  = {358-70},
year  = {2015},
abstract  = {Stroke instigates regenerative responses that reorganize connectivity patterns among surviving neurons. The new connectivity patterns can be suboptimal for behavioral function. This review summarizes current knowledge on post-stroke motor system reorganization and emerging strategies for shaping it with manipulations of behavior and cortical activity to improve functional outcome.},
address  = {Psychology Department, Neuroscience Institute, University of Texas at Austin, Austin, Texas; and Neurosciences Department, and Health Sciences & Research Department, Colleges of  Medicine & Health Professions, Medical University of South Carolina, Charleston,  South Carolina},
note  = {Physiology (Bethesda). 2015 Sep;30(5):358-70. doi:10.1152/physiol.00014.2015.}
}

@Article{2015653,
author  = {Shoaib, M. and Bosch, S. and Incel, O. and Scholten, H. and Havinga, P.},
title  = {A Survey of Online Activity Recognition Using Mobile Phones.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {15},
number  = {1},
pages  = {2059-85},
year  = {2015},
abstract  = {Physical activity recognition using embedded sensors has enabled many context-aware applications in different areas, such as healthcare. Initially, one or more dedicated wearable sensors were used for such applications. However, recently, many researchers started using mobile phones for this purpose, since these ubiquitous devices are equipped with various sensors, ranging from accelerometers to magnetic field sensors. In most of the current studies, sensor  data collected for activity recognition are analyzed offline using machine learning tools. However, there is now a trend towards implementing activity recognition systems on these devices in an online manner, since modern mobile phones have become more powerful in terms of available resources, such as CPU, memory and battery. The research on offline activity recognition has been reviewed in several earlier studies in detail. However, work done on online activity recognition is still in its infancy and is yet to be reviewed. In this paper, we review the studies done so far that implement activity recognition systems on mobile phones and use only their on-board sensors. We discuss various  aspects of these studies. Moreover, we discuss their limitations and present various recommendations for future research.},
address  = {Pervasive Systems Group, Department of Computer Science, Zilverling Building, PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails: stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.); p.j.m.havinga@utwente.nl (P.J.M.H.) Pervasive Systems Group, Department of Computer Science, Zilverling Building, PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails: stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.); p.j.m.havinga@utwente.nl (P.J.M.H.) Department of Computer Engineering, Galatasaray University, Ortakoy, Istanbul 34349, Turkey; E-Mail: odincel@gsu.edu.tr Pervasive Systems Group, Department of Computer Science, Zilverling Building, PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails: stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.); p.j.m.havinga@utwente.nl (P.J.M.H.) Pervasive Systems Group, Department of Computer Science, Zilverling Building, PO-Box 217, 7500 AE Enschede, The Netherlands; E-Mails: stephan@inertia-technology.com (S.B.); hans.scholten@utwente.nl (H.S.); p.j.m.havinga@utwente.nl (P.J.M.H.)},
note  = {Sensors (Basel). 2015 Jan 19;15(1):2059-85. doi:10.3390/s150102059.}
}

@Article{2015654,
author  = {Collman, F. and Buchanan, J. and Phend, K. and Micheva, K. and Weinberg, R. and Smith, S.},
title  = {Mapping Synapses by Conjugate Light-Electron Array Tomography.},
journal  = {The Journal of Neuroscience},
volume  = {35},
number  = {14},
pages  = {5792-807},
year  = {2015},
abstract  = {Synapses of the mammalian CNS are diverse in size, structure, molecular composition, and function. Synapses in their myriad variations are fundamental to neural circuit development, homeostasis, plasticity, and memory storage. Unfortunately, quantitative analysis and mapping of the brain's heterogeneous synapse populations has been limited by the lack of adequate single-synapse measurement methods. Electron microscopy (EM) is the definitive means to recognize and measure individual synaptic contacts, but EM has only limited abilities to measure the molecular composition of synapses. This report describes conjugate array tomography (AT), a volumetric imaging method that integrates immunofluorescence and EM imaging modalities in voxel-conjugate fashion. We illustrate the use of conjugate AT to advance the proteometric measurement of EM-validated single-synapse analysis in a study of mouse cortex.},
address  = {Department of Molecular and Cellular Physiology, Stanford School of Medicine, Stanford University, Stanford California 94305, Department of Molecular and Cellular Physiology, Stanford School of Medicine, Stanford University, Stanford California 94305, Department of Cell Biology and Physiology, University of North Carolina School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, Department of Molecular and Cellular Physiology, Stanford School of Medicine, Stanford University, Stanford California 94305, Department of Cell Biology and Physiology, University of North Carolina School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599, Department of Molecular and Cellular Physiology, Stanford School of Medicine, Stanford University, Stanford California 94305,},
note  = {J Neurosci. 2015 Apr 8;35(14):5792-807. doi:10.1523/JNEUROSCI.4274-14.2015.}
}

@Article{2015655,
author  = {Connolly, A. and Muralidharan, A. and Hendrix, C. and Johnson, L. and Gupta, R. and Stanslaski, S. and Denison, T. and Baker, K. and Vitek, J. and Johnson, M.},
title  = {disease using the Activa PC + S neurostimulator.},
journal  = {Journal of neural engineering},
volume  = {12},
number  = {6},
pages  = {066012},
year  = {2015},
abstract  = {Objective: Using the Medtronic Activa¬Æ PC + S system, this study investigated how passive joint manipulation, reaching behavior, and deep brain stimulation (DBS) modulate local field potential (LFP) activity in the subthalamic nucleus (STN) and globus pallidus (GP). Approach: Five non-human primates were implanted unilaterally with one or more DBS leads. LFPs were collected in montage recordings during resting state conditions and during motor tasks that facilitate the expression of parkinsonian motor signs. These recordings were made in the na√Øve state in one subject, in the parkinsonian state in two subjects, and in both na√Øve and parkinsonian states in two subjects. Main results: LFPs measured at rest were consistent over time for a given recording location and parkinsonian state in a given subject; however, LFPs were highly variable between subjects, between and within recording locations, and across parkinsonian states. LFPs in both na√Øve and parkinsonian states across all recorded nuclei contained a spectral peak in the beta band (10‚Äì30 Hz). Moreover, the spectral content of recorded LFPs was modulated by passive and active movement of the subjects‚Äô limbs. LFPs recorded during a cued-reaching task displayed task-related beta desynchronization in STN and GP. The bidirectional capabilities of the Activa¬Æ PC + S also allowed for recording LFPs while delivering DBS. The therapeutic effect  of STN DBS on parkinsonian rigidity outlasted stimulation for 30‚Äì60 s, but there  was no correlation with beta band power. Significance: This study emphasizes (1)  the variability in spontaneous LFPs amongst subjects and (2) the value of using the Activa¬Æ PC + S system to record neural data in the context of behavioral tasks that allow one to evaluate a subject‚Äôs symptomatology.},
address  = {Department of Biomedical Engineering, University of Minnesota, USA Department of Neurology, University of Minnesota, USA Department of Neurology, University of Minnesota, USA Department of Neurology, University of Minnesota, USA Global Research, Medtronic Neuromodulation, USA Core Technologies, Medtronic Neuromodulation, USA Core Technologies, Medtronic Neuromodulation, USA Department of Neurology, University of Minnesota, USA Department of Neurology, University of Minnesota, USA Department of Biomedical Engineering, University of Minnesota, USA},
note  = {doi:10.1088/1741-2560/12/6/066012.}
}

@Article{2007656,
author  = {Hysong, S. and Best, R. and Pugh, J.},
title  = {Primary Care Clinics.},
journal  = {Health Services Research},
volume  = {42},
number  = {1 Pt 1},
pages  = {84-103},
year  = {2007},
abstract  = {Background: The Department of Veterans Affairs (VA) mandated the system-wide implementation of clinical practice guidelines (CPGs) in the mid-1990s, arming all facilities with basic resources to facilitate implementation; despite this resource allocation, significant variability still exists across VA facilities in implementation success. Objective: This study compares CPG implementation strategy patterns used by high and low performing primary care clinics in the VA. Research Design: Descriptive, cross-sectional study of a purposeful sample of six Veterans Affairs Medical Centers (VAMCs) with high and low performance on six CPGs. Subjects: One hundred and two employees (management, quality improvement, clinic personnel) involved with guideline implementation at each VAMC primary care clinic. Measures: Participants reported specific strategies used by their facility to implement guidelines in 1-hour semi-structured interviews. Facilities were classified as high or low performers based on their guideline adherence scores calculated through independently conducted chart reviews. Findings: High performing facilities (HPFs) (a) invested significantly in the implementation of  the electronic medical record and locally adapting it to provider needs, (b) invested dedicated resources to guideline-related initiatives, and (c) exhibited  a clear direction in their strategy choices. Low performing facilities exhibited  (a) earlier stages of development for their electronic medical record, (b) reliance on preexisting resources for guideline implementation, with little local adaptation, and (c) no clear direction in their strategy choices. Conclusion: A multifaceted, yet targeted, strategic approach to guideline implementation emphasizing dedicated resources and local adaptation may result in more successful implementation and higher guideline adherence than relying on standardized resources and taxing preexisting channels.},
address  = {},
note  = {doi:10.1111/j.1475-6773.2006.00610.x.}
}

@Article{2014657,
author  = {Bedo, N. and Ribary, U. and Ward, L.},
title  = {Reading.},
journal  = {PLoS ONE},
volume  = {9},
number  = {2},
pages  = {},
year  = {2014},
abstract  = {We describe for the first time the fast dynamics of functional and effective (causal) connectivity during word reading. Independent component analysis of high-density EEG recorded during a word reading task recovered multiple sources of electrical brain activity previously identified by fMRI and PET. Results confirmed the ventral occipito-temporal cortex (vOT) as a central hub for word reading, showing a progression of theta-band (3‚Äì7 Hz) and gamma-band (30‚Äì50 Hz) phase synchronization and directed theta-band and gamma-band information flow with both early visual areas and high-level language-processing areas. These results highlight the interplay between local and long-distance neural dynamics involved at each stage of the reading process. Moreover, these measures of functional and causal connectivity dynamics may be used as a benchmark for comparison with clinical populations (e.g. individuals with developmental dyslexia), such that disturbances in connectivity dynamics may provide insight as to underlying neurological problems with language processing, and their potential remediation.},
address  = {Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada Behavioral and Cognitive Neuroscience Institute, Simon Fraser University, Burnaby, British Columbia, Canada Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada},
note  = {PLoS One. 2014 Feb 14;9(2):. doi:10.1371/journal.pone.0088940.}
}

@Article{2016658,
author  = {Vetter, P. and Dayer, J. and Schibler, M. and Allegranzi, B. and Brown, D. and Calmy, A. and Christie, D. and Eremin, S. and Hagon, O. and Henderson, D. and Iten, A. and Kelley, E. and Marais, F. and Ndoye, B. and Pugin, J. and Robert-Nicoud, H. and Sterk, E. and Tapper, M. and Siegrist, C. and Kaiser, L. and Pittet, D.},
title  = {The 2014‚Äì2015 Ebola outbreak in West Africa: Hands On.},
journal  = {Antimicrobial Resistance and Infection Control},
volume  = {5},
number  = {},
pages  = {},
year  = {2016},
abstract  = {The International Consortium for Prevention and Infection Control (ICPIC) organises a biannual conference (ICPIC) on various subjects related to infection  prevention, treatment and control. During ICPIC 2015, held in Geneva in June 2015, a full one-day session focused on the 2014‚Äì2015 Ebola virus disease (EVD) outbreak in West Africa. This article is a non-exhaustive compilation of these discussions. It concentrates on lessons learned and imagining a way forward for the communities most affected by the epidemic. The reader can access video recordings of all lectures delivered during this one-day session, as referenced.  Topics include the timeline of the international response, linkages between the dynamics of the epidemic and infection prevention and control, the importance of  community engagement, and updates on virology, diagnosis, treatment and vaccination issues. The paper also includes discussions from public health, infectious diseases, critical care and infection control experts who cared for patients with EVD in Africa, in Europe, and in the United Sates and were involved in Ebola preparedness in both high- and low-resource settings and countries. This review concludes that too little is known about the pathogenesis and treatment of EVD, therefore basic and applied research in this area are urgently required. Furthermore, it is clear that epidemic preparedness needs to improve globally, in particular through the strengthening of health systems at local and national levels. There is a strong need for culturally sensitive approaches to public health which could be designed and delivered by social scientists and medical professionals working together. As of December 2015, this epidemic killed more than 11,000 people and infected more than 28,000; it has also generated more than 17,000 survivors and orphans, many of whom face somatic and psychological complications. The continued treatment and rehabilitation of these people is a public health priority, which also requires an integration of specific medical and social science approaches, not always available in West Africa.},
address  = {Infection Control Programme and WHO Collaborating Centre on Patient Safety, University Hospitals and University of Geneva Medical School, Geneva, Switzerland Division of Infectious Diseases, Laboratory of Virology and Swiss Reference Centre for Emerging Viral Diseases, University of Geneva Hospitals, Geneva, Switzerland Division of Infectious Diseases, Laboratory of Virology and Swiss Reference Centre for Emerging Viral Diseases, University of Geneva Hospitals, Geneva, Switzerland World Health Organization, Geneva, Switzerland UK Department for International Development, London, UK HIV unit, Division of Infectious Diseases, University of Geneva Hospitals, Geneva, Switzerland Institute of Global Health, University of Geneva, Geneva, Switzerland World Health Organization, Geneva, Switzerland Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland National Institutes of Health (NIH) Clinical Center, Washington DC, USA Infection Control Programme and WHO Collaborating Centre on Patient Safety, University Hospitals and University of Geneva Medical School, Geneva, Switzerland World Health Organization, Geneva, Switzerland Western Cape Government and Stellenbosch University, Cape Town, South Africa Expert-consultant and trainer in hospital hygiene, infection control and patient  safety for WHO and UNDP, Dakar, Senegal Intensive Care Unit, University of Geneva Hospitals, Geneva, Switzerland M√©decins sans Fronti√®res, Geneva Operational Centre, Geneva, Switzerland M√©decins sans Fronti√®res, Geneva Operational Centre, Geneva, Switzerland Division of Infectious Diseases, Lenox Hill Hospital, New York, USA Departments of Pathology, Immunology and Paediatrics, WHO Collaborating Centre for Vaccine Immunology, University of Geneva Hospitals, Geneva, Switzerland Division of Infectious Diseases, Laboratory of Virology and Swiss Reference Centre for Emerging Viral Diseases, University of Geneva Hospitals, Geneva, Switzerland Infection Control Programme and WHO Collaborating Centre on Patient Safety, University Hospitals and University of Geneva Medical School, Geneva, Switzerland},
note  = {Antimicrob Resist Infect Control. 2016 May 5;5:. doi:10.1186/s13756-016-0112-9.}
}

@Article{2017659,
author  = {Maurer, A. and Johnson, S. and Hernandez, A. and Reasor, J. and Cossio, D. and Fertal, K. and Mizell, J. and Lubke, K. and Clark, B. and Burke, S.},
title  = {Performance on Object Discrimination.},
journal  = {Frontiers in Systems Neuroscience},
volume  = {11},
number  = {},
pages  = {},
year  = {2017},
abstract  = {Age-related memory deficits correlate with dysfunction in the CA3 subregion of the hippocampus, which includes both hyperactivity and overly rigid activity patterns. While changes in intrinsic membrane currents and interneuron alterations are involved in this process, it is not known whether alterations in  afferent input to CA3 also contribute. Neurons in layer II of the lateral entorhinal cortex (LEC) project directly to CA3 through the perforant path, but no data are available regarding the effects of advanced age on LEC activity and whether these activity patterns update in response to environmental change. Furthermore, it is not known the extent to which age-related deficits in sensory  discrimination relate to the inability of aged CA3 neurons to update in response  to new environments. Young and aged rats were pre-characterized on a LEGO¬© object discrimination task, comparable to behavioral tests in humans in which CA3 hyperactivity has been linked to impairments. The cellular compartment analysis of temporal activity with fluorescence in situ hybridization for the immediate-early gene Arc was then used to identify the principal cell populations that were active during two distinct epochs of random foraging in different environments. This approach enabled the extent to which rats could discriminate two similar objects to be related to the ability of CA3 neurons to update across  different environments. In both young and aged rats, there were animals that performed poorly on the LEGO object discrimination task. In the aged rats only, however, the poor performers had a higher percent of CA3 neurons that were active during random foraging in a novel environment, but this is not related to the ability of CA3 neurons to remap when the environment changed. Afferent neurons to CA3 in LEC, as identified with the retrograde tracer choleratoxin B (CTB), also showed a higher percentage of cells that were positive for Arc mRNA in aged poor  performing rats. This suggests that LEC contributes to the hyperactivity seen in  CA3 of aged animals with object discrimination deficits and age-related cognitive decline may be the consequence of dysfunction endemic to the larger network.},
address  = {Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States Department of Psychology, University of New MexicoAlburquerque, NM, United States Department of Neuroscience, McKnight Brain Institute, University of FloridaGainesville, FL, United States},
note  = {Front Syst Neurosci. 2017 Jun 30;11:. doi:10.3389/fnsys.2017.00049.}
}

@Article{2016660,
author  = {Zhao, H. and Winter, S.},
title  = {A Time-Aware Routing Map for Indoor Evacuation ‚Ä†.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {16},
number  = {1},
pages  = {},
year  = {2016},
abstract  = {Knowledge of dynamic environments expires over time. Thus, using static maps of the environment for decision making is problematic, especially in emergency situations, such as evacuations. This paper suggests a fading memory model for mapping dynamic environments: a mechanism to put less trust on older knowledge in decision making. The model has been assessed by simulating indoor evacuations, adopting and comparing various strategies in decision making. Results suggest that fading memory generally improves this decision making.},
address  = {},
note  = {Sensors (Basel). 2016 Jan 18;16(1):. doi:10.3390/s16010112.}
}

@Article{2006661,
author  = {Johnson, C.},
title  = {healthcare systems.},
journal  = {Quality & Safety in Health Care},
volume  = {15},
number  = {Suppl 1},
pages  = {i76-81},
year  = {2006},
abstract  = {Clinicians and support staff are faced with increasingly complex computer applications. This complexity stems partly from the integration of heterogeneous  systems ranging from computerized patient records to theatre management and dosage planning applications, and also from the increased functionality offered by the new generation of IT systems. Many members of clinical staff are bewildered by the vast array of configuration options and operating modes supported by computer based systems, while manufacturers often feel compelled to  offer more and more software features to retain market position. These factors combine to create ‚Äúusability‚Ä? problems that have had a direct impact on patient outcomes as well as a number of indirect effects‚Äîfor example, the costs of replacing and upgrading inadequate computer systems carry significant opportunity costs in terms of services that might otherwise have been funded. In the future we need to educate staff to reject substandard computer interfaces early in the acquisition process; encourage the use of human computer interaction techniques in health care; and train staff to recognize the dangers of ‚Äúworking around‚Ä? poor interface design.},
address  = {},
note  = {Qual Saf Health Care. 2006 Dec;15(Suppl 1):i76-81. doi:10.1136/qshc.2005.016105.}
}

@Article{2012662,
author  = {Holland, R. and Crinion, J.},
title  = {Can tDCS enhance treatment of aphasia after stroke?},
journal  = {Aphasiology},
volume  = {26},
number  = {9},
pages  = {1169-91},
year  = {2012},
abstract  = {Background: Recent advances in the application of transcranial direct current stimulation (tDCS) in healthy populations have led to the exploration of the technique as an adjuvant method to traditional speech therapies in patients with  post-stroke aphasia. Aims: The purpose of the review is: (i) to review the features of tDCS that make it an attractive tool for research and potential future use in clinical contexts; (ii) to describe recent studies exploring the facilitation of language performance using tDCS in post-stroke aphasia; (iii) to  explore methodological considerations of tDCS that may be key to understanding tDCS in treatment of aphasia post stroke; and (iv) to highlight several caveats and outstanding questions that need to be addressed in future work. Main Contribution: This review aims to highlight our current understanding of the methodological and theoretical issues surrounding the use of tDCS as an adjuvant  tool in the treatment of language difficulties after stroke. Conclusions: Preliminary evidence shows that tDCS may be a useful tool to complement treatment of aphasia, particularly for speech production in chronic stroke patients. To build on this exciting work, further systematic research is needed to understand  the mechanisms of tDCS-induced effects, its application to current models of aphasia recovery, and the complex interactions between different stimulation parameters and language rehabilitation techniques. The potential of tDCS is to optimise language rehabilitation techniques and promote long-term recovery of language. A stimulating future for aphasia rehabilitation!},
address  = {Institute of Cognitive Neuroscience, University College London, London, UK Institute of Cognitive Neuroscience, University College London, London, UK},
note  = {doi:10.1080/02687038.2011.616925.}
}

@Article{2015663,
author  = {Chandra, P. and Lee, S.},
title  = {Synthetic Extracellular Microenvironment for Modulating Stem Cell Behaviors.},
journal  = {Biomarker Insights},
volume  = {10},
number  = {Suppl 1},
pages  = {105-16},
year  = {2015},
abstract  = {The innate ability of stem cells to self-renew and differentiate into multiple cell types makes them a promising source for tissue engineering and regenerative  medicine applications. Their capacity for self-renewal and differentiation is largely influenced by the combination of physical, chemical, and biological signals found in the stem cell niche, both temporally and spatially. Embryonic and adult stem cells are potentially useful for cell-based approaches; however, regulating stem cell behavior remains a major challenge in their clinical use. Most of the current approaches for controlling stem cell fate do not fully address all of the complex signaling pathways that drive stem cell behaviors in their natural microenvironments. To overcome this limitation, a new generation of biomaterials is being developed for use as three-dimensional synthetic microenvironments that can mimic the regulatory characteristics of natural extracellular matrix (ECM) proteins and ECM-bound growth factors. These synthetic microenvironments are currently being investigated as a substrate with surface immobilization and controlled release of bioactive molecules to direct the stem cell fate in vitro, as a tissue template to guide and improve the neo-tissue formation both in vitro and in vivo, and as a delivery vehicle for cell therapy in vivo. The continued advancement of such an intelligent biomaterial system as the synthetic extracellular microenvironment holds the promise of improved therapies for numerous debilitating medical conditions for which no satisfactory  cure exists today.},
address  = {},
note  = {Biomark Insights. 2015 Jun 17;10(Suppl 1):105-16. doi:10.4137/BMI.S20057.}
}

@Article{2016664,
author  = {Guerra, A. and Pogosyan, A. and Nowak, M. and Tan, H. and Ferreri, F. and Di, L. and Brown, P.},
title  = {Cancelation During Beta tACS.},
journal  = {Cerebral Cortex (New York, NY)},
volume  = {26},
number  = {10},
pages  = {3977-90},
year  = {2016},
abstract  = {The human motor cortex has a tendency to resonant activity at about 20 Hz so stimulation should more readily entrain neuronal populations at this frequency. We investigated whether and how different interneuronal circuits contribute to such resonance by using transcranial magnetic stimulation (TMS) during transcranial alternating current stimulation (tACS) at motor (20 Hz) and a nonmotor resonance frequency (7 Hz). We tested different TMS interneuronal protocols and triggered TMS pulses at different tACS phases. The effect of cholinergic short-latency afferent inhibition (SAI) was abolished by 20 Hz tACS,  linking cortical beta activity to sensorimotor integration. However, this effect  occurred regardless of the tACS phase. In contrast, 20 Hz tACS selectively modulated MEP size according to the phase of tACS during single pulse, GABAAergic short-interval intracortical inhibition (SICI) and glutamatergic intracortical facilitation (ICF). For SICI this phase effect was more marked during 20 Hz stimulation. Phase modulation of SICI also depended on whether or not spontaneous beta activity occurred at ~20 Hz, supporting an interaction effect between tACS and underlying circuit resonances. The present study provides in vivo evidence linking cortical beta activity to sensorimotor integration, and for beta oscillations in motor cortex being promoted by resonance in GABAAergic interneuronal circuits.},
address  = {Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, University Campus Bio-Medico, 00128 Rome, Italy Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, University Campus Bio-Medico, 00128 Rome, Italy Unit of Neurology, Neurophysiology, Neurobiology, Department of Medicine, University Campus Bio-Medico, 00128 Rome, Italy Medical Research Council Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DU, UK},
note  = {doi:10.1093/cercor/bhw245.}
}

@Article{2010665,
author  = {Rose, J. and Salley, A. and Behm, F. and Bates, J. and Westman, E.},
title  = {REINFORCING EFFECTS OF NICOTINE AND NON-NICOTINE COMPONENTS OF CIGARETTE SMOKE.},
journal  = {Psychopharmacology},
volume  = {210},
number  = {1},
pages  = {1-12},
year  = {2010},
abstract  = {We assessed the reinforcing effects of nicotine and non-nicotine components of cigarette smoke, by presenting a concurrent choice paradigm in which participants had access to intravenous (IV) nicotine infusions vs. saline (placebo) infusions  and puffs from denicotinized (‚Äúdenic‚Ä?) cigarettes vs. air (sham puffs). We also measured the effects on self-administration of prior satiation with each component. Sixteen smokers participated in 7 sessions, consisting of: 1) a baseline smoking assessment, which was used to tailor the nicotine dose per infusion to that of puffs from subjects‚Äô preferred brands of cigarettes; 2) two sessions in which participants were trained to discriminate IV nicotine vs. saline infusions and denic smoke vs. sham (air) puffs; and 3) four sessions assessing choice behavior after different satiation conditions. Results showed that subjects self-administered more puffs of denic smoke than any other alternative, including IV nicotine. IV nicotine, however, was preferred over IV saline and sham puffs. Preference for denic smoke vs. IV nicotine was highly correlated with subjective ratings of ‚Äúcomfort‚Ä? associated with the two alternatives. Satiation with smoke diminished the number of denic puffs taken during choice periods, while prior administration of nicotine did not affect the  number of puffs taken. Smoking withdrawal symptoms were alleviated both by nicotine administration and by denic smoke. These results show that in established smokers, non-nicotine aspects of cigarette smoking have potent reinforcing effects. While current smoking cessation pharmacotherapies primarily  address the nicotine component of cigarette addiction, future cessation strategies should also be designed to target non-nicotine factors.},
address  = {Department of Psychiatry, Duke University Medical Center, Durham, NC USA Department of Psychiatry, Duke University Medical Center, Durham, NC USA Department of Psychiatry, Duke University Medical Center, Durham, NC USA Department of Psychiatry, Duke University Medical Center, Durham, NC USA Department of Medicine, Duke University Medical Center, Durham, NC USA},
note  = {doi:10.1007/s00213-010-1810-2.}
}

@Article{2010666,
author  = {Kelly, R. and Alexopoulos, G. and Wang, Z. and Gunning, F. and Murphy, C. and Morimoto, S. and Kanellopoulos, D. and Jia, Z. and Lim, K. and Hoptman, M.},
title  = {removal from fMRI data.},
journal  = {Journal of Neuroscience Methods},
volume  = {189},
number  = {2},
pages  = {233-45},
year  = {2010},
abstract  = {Artifacts in fMRI data, primarily those related to motion and physiological sources, negatively impact the functional signal-to-noise ratio in fMRI studies,  even after conventional fMRI preprocessing. Independent component analysis‚Äô demonstrated capacity to separate sources of neural signal, structured noise, and random noise into separate components might be utilized in improved procedures to remove artifacts from fMRI data. Such procedures require a method for labeling independent components (ICs) as representing artifacts to be removed or neural signals of interest to be spared. Visual inspection is often considered an accurate method for such labeling as well as a standard to which automated labeling methods are compared. However, detailed descriptions of methods for visual inspection of ICs are lacking in the literature. Here we describe the details of, and the rationale for, an operationalized fMRI data denoising procedure that involves visual inspection of ICs (96% inter-rater agreement). We  estimate that dozens of subjects/sessions can be processed within a few hours using the described method of visual inspection. Our hope is that continued scientific discussion of and testing of visual inspection methods will lead to the development of improved, cost-effective fMRI denoising procedures.},
address  = {Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College The MRI Unit and The Division of Child and Adolescent Psychiatry, Columbia University and New York State Psychiatric Institute (NYSPI), New York, New York Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College Department of Psychiatry, University of Minnesota Division of Clinical Research, Nathan S. Kline Institute for Psychiatric Research},
note  = {doi:10.1016/j.jneumeth.2010.03.028.}
}

@Article{2016667,
author  = {Torabi, E. and Froehle, C. and Lindsell, C. and Moomaw, C. and Kanter, D. and Kleindorfer, D. and Adeoye, O.},
title  = {Monte Carlo Simulation Modeling of a Regional Stroke Team‚Äôs Use of Telemedicine.},
journal  = {Emergency Medicine},
volume  = {23},
number  = {1},
pages  = {55-62},
year  = {2016},
abstract  = {Objectives: The objective of this study was to evaluate operational policies that may improve the proportion of eligible stroke patients within a population who would receive intravenous recombinant tissue plasminogen activator (rt-PA), and minimize time to treatment in eligible patients. Methods: In the context of a regional stroke team, the authors examined the effects of staff location and telemedicine deployment policies on the timeliness of thrombolytic treatment, and estimated the efficacy and cost-effectiveness of six different policies. A process map comprising the steps from recognition of stroke symptoms to intravenous administration of rt-PA was constructed using data from published literature combined with expert opinion. Six scenarios were investigated: telemedicine deployment (none, all, or outer-ring hospitals only); and, staff location (center of region or anywhere in region). Physician locations were randomly generated based on their zip codes of residence and work. The outcomes of interest were onset-to-treatment (OTT) time, door-to-needle (DTN) time, and the proportion of patients treated within three hours. A Monte Carlo simulation of the stroke team care-delivery system was constructed based on a primary dataset of 121 ischemic stroke patients who were potentially eligible for treatment with rt-PA. Results: With the physician located randomly in the region, deploying telemedicine at all hospitals in the region (compared with partial or no telemedicine) would result in the highest rates of treatment within three hours (80% vs. 75% vs. 70%) and the shortest OTT (148 vs. 164 vs. 176 minutes), and DTN (45 vs. 61 vs. 73 minutes) times. However, locating the on-call physician centrally coupled with partial telemedicine deployment (five of the 17 hospitals) would be most cost-effective with comparable eligibility and treatment times. Conclusions: Given the potential societal benefits, continued efforts to deploy telemedicine appear warranted. Aligning the incentives between those who would have to fund the up-front technology investments and those who will benefit over  time from reduced ongoing health care expenses will be necessary to fully realize the benefits of telemedicine for stroke care.},
address  = {},
note  = {Acad Emerg Med. 2016 Jan;23(1):55-62. Epub 2015 Dec 31 doi:10.1111/acem.12839.}
}

@Article{2016668,
author  = {Wagner, T. and Burstin, H. and Frakt, A. and Krein, S. and Lorenz, K. and Maciejewski, M. and Pizer, S. and Weiner, M. and Yoon, J. and Zulman, D. and Asch, S.},
title  = {Veterans Affairs.},
journal  = {Journal of General Internal Medicine},
volume  = {31},
number  = {Suppl 1},
pages  = {78-83},
year  = {2016},
abstract  = {},
address  = {Health Economics Resource Center, VA Palo Alto, 795 Willow Rd, 152-MPD, Menlo Park, CA 94025 USA grid.422331.50000000094192138National Quality Forum, Washington, DC USA grid.410370.10000000446571992Health Care Financing & Economics, VA Boston Health  Care System, Boston, MA USA VA Ann Arbor Center for Clinical Management Research, Ann Arbor, MI USA Center for Innovation to Implementation, Palo Alto VA, Menlo Park, CA USA grid.410332.70000000404199846Center for Innovation, Durham VA Medical Center, Durham, NC USA grid.410370.10000000446571992Health Care Financing & Economics, VA Boston Health  Care System, Boston, MA USA VA Center for Health Information and Communication, Indianapolis, IN USA Health Economics Resource Center, VA Palo Alto, 795 Willow Rd, 152-MPD, Menlo Park, CA 94025 USA Center for Innovation to Implementation, Palo Alto VA, Menlo Park, CA USA Center for Innovation to Implementation, Palo Alto VA, Menlo Park, CA USA},
note  = {doi:10.1007/s11606-015-3538-5.}
}

@Article{2013669,
author  = {Leise, T. and Harrington, M. and Molyneux, P. and Song, I. and Queenan, H. and Zimmerman, E. and Lall, G. and Biello, S.},
title  = {Voluntary exercise can strengthen the circadian system in aged mice.},
journal  = {Age},
volume  = {35},
number  = {6},
pages  = {2137-52},
year  = {2013},
abstract  = {Consistent daily rhythms are important to healthy aging according to studies linking disrupted circadian rhythms with negative health impacts. We studied the  effects of age and exercise on baseline circadian rhythms and on the circadian system's ability to respond to the perturbation induced by an 8 h advance of the  light:dark (LD) cycle as a test of the system's robustness. Mice (male, mPer2luc/C57BL/6) were studied at one of two ages: 3.5 months (n‚Äâ=‚Äâ39) and >18 months (n‚Äâ=‚Äâ72). We examined activity records of these mice under entrained and shifted conditions as well as mPER2::LUC measures ex vivo to assess circadian function in the suprachiasmatic nuclei (SCN) and important target organs. Age was associated with reduced running wheel use, fragmentation of activity, and slowed  resetting in both behavioral and molecular measures. Furthermore, we observed that for aged mice, the presence of a running wheel altered the amplitude of the  spontaneous firing rate rhythm in the SCN in vitro. Following a shift of the LD cycle, both young and aged mice showed a change in rhythmicity properties of the  mPER2::LUC oscillation of the SCN in vitro, and aged mice exhibited longer lasting internal desynchrony. Access to a running wheel alleviated some age-related changes in the circadian system. In an additional experiment, we replicated the effect of the running wheel, comparing behavioral and in vitro results from aged mice housed with or without a running wheel (>21 months, n‚Äâ=‚Äâ8  per group, all examined 4 days after the shift). The impact of voluntary exercise on circadian rhythm properties in an aged animal is a novel finding and has implications for the health of older people living with environmentally induced circadian disruption.Electronic supplementary material: The online version of this article (doi:10.1007/s11357-012-9502-y) contains supplementary material, which is available to authorized users.},
address  = {Mathematics Department, Amherst College, Amherst, MA 01002 USA Neuroscience Program, Smith College, Northampton, MA 01063 USA Neuroscience Program, Smith College, Northampton, MA 01063 USA Neuroscience Program, Smith College, Northampton, MA 01063 USA Neuroscience Program, Smith College, Northampton, MA 01063 USA Neuroscience Program, Smith College, Northampton, MA 01063 USA Medway School of Pharmacy, University of Kent, Central Avenue, Chatham, Kent, ME4 4TB UK School of Psychology, University of Glasgow, Glasgow, G12 8QB Scotland UK},
note  = {doi:10.1007/s11357-012-9502-y.}
}

@Article{2016670,
author  = {LaRiviere, M. and Gross, R.},
title  = {Generation of Minimally Invasive Epilepsy Surgery.},
journal  = {Frontiers in Surgery},
volume  = {3},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Epilepsy is a common, disabling illness that is refractory to medical treatment in approximately one-third of patients, particularly among those with mesial temporal lobe epilepsy. While standard open mesial temporal resection is effective, achieving seizure freedom in most patients, efforts to develop safer,  minimally invasive techniques have been underway for over half a century. Stereotactic ablative techniques, in particular, radiofrequency (RF) ablation, were first developed in the 1960s, with refinements in the 1990s with the advent  of modern computed tomography and magnetic resonance-based imaging. In the past 5‚Äâyears, the most recent techniques have used MRI-guided laser interstitial thermotherapy (LITT), the development of which began in the 1980s, saw refinements in MRI thermal imaging through the 1990s, and was initially used primarily for the treatment of intracranial and extracranial tumors. The present  review describes the original stereotactic ablation trials, followed by modern imaging-guided RF ablation series for mesial temporal lobe epilepsy. The developments of LITT and MRI thermometry are then discussed. Finally, the two currently available MRI-guided LITT systems are reviewed for their role in the treatment of mesial temporal lobe and other medically refractory epilepsies.},
address  = {Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA Departments of Neurosurgery and Neurology, Emory University School of Medicine, Atlanta, GA, USA},
note  = {Front Surg. 2016 Dec 05;3:. doi:10.3389/fsurg.2016.00064.}
}

@Article{2011671,
author  = {Pradhan, A. and Divekar, G. and Masserang, K. and Romoser, M. and Zafian, T. and Blomberg, R. and Thomas, F. and Reagan, I. and Knodler, M. and Pollatsek, A. and Fisher, D.},
title  = {drivers' glances inside the vehicle.},
journal  = {Ergonomics},
volume  = {54},
number  = {10},
pages  = {917-31},
year  = {2011},
abstract  = {Several studies have documented that the failure of drivers to attend to the forward roadway for a period lasting longer than 2-3 seconds is a major cause of  highway crashes. Moreover, several studies have demonstrated that novice drivers  are more likely to glance away from the roadway than experienced drivers for extended periods when attempting to do a task inside the vehicle. The present study examines the efficacy of a PC-based training program (FOCAL) designed to teach novice drivers not to glance away for these extended periods of time. A FOCAL-trained group was compared to a placebo-trained group in an on-road test, and the FOCAL-trained group made significantly fewer glances away from the roadway that were more than 2 seconds than the placebo-trained group. Other measures indicated an advantage for the FOCAL-trained group as well.},
address  = {Department of Mechanical and Industrial Engineering, University of Massachusetts, Elab 110, Amherst MA 01003, USA Department of Mechanical and Industrial Engineering, University of Massachusetts, Elab 110, Amherst MA 01003, USA Department of Psychology, University of Massachusetts, Tobin Hall, Amherst MA 01003, USA Department of Mechanical and Industrial Engineering, University of Massachusetts, Elab 110, Amherst MA 01003, USA Department of Mechanical and Industrial Engineering, University of Massachusetts, Elab 110, Amherst MA 01003, USA Dunlap and Associates, Inc, Stamford, CT 06906, USA Dunlap and Associates, Inc, Stamford, CT 06906, USA National Highway Traffic Safety Administration, 1200 New Jersey Ave., SE. Washington, DC., 20590 Department of Civil and Environmental Engineering, University of Massachusetts, 216 Marston Hall, Amherst MA 01003, USA Department of Psychology, University of Massachusetts, Tobin Hall, Amherst MA 01003, USA Department of Mechanical and Industrial Engineering, University of Massachusetts, 210D Marston Hall, Amherst MA 01003, USA},
note  = {Ergonomics. 2011 Oct;54(10):917-31. doi:10.1080/00140139.2011.607245.}
}

@Article{2017672,
author  = {Dirks, P. and Roberts, E. and Hilbert-Wolf, H. and Kramers, J. and Hawks, J. and Dosseto, A. and Duval, M. and Elliott, M. and Evans, M. and Gr√ºn, R. and Hellstrom, J. and Herries, A. and Joannes-Boyau, R. and Makhubela, T. and Placzek, C. and Robbins, J. and Spandler, C. and Wiersma, J. and Woodhead, J. and Berger, L.},
title  = {South Africa.},
journal  = {eLife},
volume  = {6},
number  = {},
pages  = {},
year  = {2017},
abstract  = {New ages for flowstone, sediments and fossil bones from the Dinaledi Chamber are  presented. We combined optically stimulated luminescence dating of sediments with U-Th and palaeomagnetic analyses of flowstones to establish that all sediments containing Homo naledi fossils can be allocated to a single stratigraphic entity  (sub-unit 3b), interpreted to be deposited between 236 ka and 414 ka. This result has been confirmed independently by dating three H. naledi teeth with combined U-series and electron spin resonance (US-ESR) dating. Two dating scenarios for the fossils were tested by varying the assumed levels of 222Rn loss in the encasing sediments: a maximum age scenario provides an average age for the two least altered fossil teeth of 253 +82/‚Äì70 ka, whilst a minimum age scenario yields an average age of 200 +70/‚Äì61 ka. We consider the maximum age scenario to  more closely reflect conditions in the cave, and therefore, the true age of the fossils. By combining the US-ESR maximum age estimate obtained from the teeth, with the U-Th age for the oldest flowstone overlying Homo naledi fossils, we have constrained the depositional age of Homo naledi to a period between 236 ka and 335 ka. These age results demonstrate that a morphologically primitive hominin, Homo naledi, survived into the later parts of the Pleistocene in Africa, and indicate a much younger age for the Homo naledi fossils than have previously been hypothesized based on their morphology.DOI:http://dx.doi.org/10.7554/eLife.24231.001},
address  = {Department of Geoscience, James Cook University, Townsville, Australia Department of Geoscience, James Cook University, Townsville, Australia Department of Geoscience, James Cook University, Townsville, Australia Department of Geology, University of Johannesburg, Johannesburg, South Africa Evolutionary Studies Institute and the National Centre for Excellence in PalaeoSciences, University of the Witwatersrand, Wits, South Africa School of Earth and Environmental Sciences, University of Wollongong, Wollongong, Australia Australian Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Nathan, Australia Evolutionary Studies Institute and the National Centre for Excellence in PalaeoSciences, University of the Witwatersrand, Wits, South Africa School of Geosciences, University of the Witwatersrand, Wits, South Africa Australian Research Centre for Human Evolution, Environmental Futures Research Institute, Griffith University, Nathan, Australia School of Earth Sciences, The University of Melbourne, Parkville, Australia The Australian Archaeomagnetism Laboratory, Department of Archaeology and History, La Trobe University, Melbourne, Australia Geoarchaeology and Archaeometry Research Group, Department of GeoScience, Southern Cross University, Lismore, Australia Department of Geology, University of Johannesburg, Johannesburg, South Africa Department of Geoscience, James Cook University, Townsville, Australia Department of Geoscience, James Cook University, Townsville, Australia Department of Geoscience, James Cook University, Townsville, Australia Department of Geoscience, James Cook University, Townsville, Australia School of Earth Sciences, The University of Melbourne, Parkville, Australia Evolutionary Studies Institute and the National Centre for Excellence in PalaeoSciences, University of the Witwatersrand, Wits, South Africa},
note  = {eLife. 2017;6:. doi:10.7554/eLife.24231.}
}

@Article{2015673,
author  = {W√∂hr, M. and Orduz, D. and Gregory, P. and Moreno, H. and Khan, U. and V√∂rckel, K. and Wolfer, D. and Welzl, H. and Gall, D. and Schiffmann, S. and Schwaller, B.},
title  = {autism core symptoms and related neural morphofunctional abnormalities.},
journal  = {Translational Psychiatry},
volume  = {5},
number  = {3},
pages  = {e525-},
year  = {2015},
abstract  = {Gene mutations and gene copy number variants are associated with autism spectrum  disorders (ASDs). Affected gene products are often part of signaling networks implicated in synapse formation and/or function leading to alterations in the excitation/inhibition (E/I) balance. Although the network of parvalbumin (PV)-expressing interneurons has gained particular attention in ASD, little is known on PV's putative role with respect to ASD. Genetic mouse models represent powerful translational tools for studying the role of genetic and neurobiological factors underlying ASD. Here, we report that PV knockout mice (PV‚àí/‚àí) display behavioral phenotypes with relevance to all three core symptoms present in human  ASD patients: abnormal reciprocal social interactions, impairments in communication and repetitive and stereotyped patterns of behavior. PV-depleted mice also showed several signs of ASD-associated comorbidities, such as reduced pain sensitivity and startle responses yet increased seizure susceptibility, whereas no evidence for behavioral phenotypes with relevance to anxiety, depression and schizophrenia was obtained. Reduced social interactions and communication were also observed in heterozygous (PV+/‚àí) mice characterized by lower PV expression levels, indicating that merely a decrease in PV levels might  be sufficient to elicit core ASD-like deficits. Structural magnetic resonance imaging measurements in PV‚àí/‚àí and PV+/‚àí mice further revealed ASD-associated developmental neuroanatomical changes, including transient cortical hypertrophy and cerebellar hypoplasia. Electrophysiological experiments finally demonstrated  that the E/I balance in these mice is altered by modification of both inhibitory  and excitatory synaptic transmission. On the basis of the reported changes in PV  expression patterns in several, mostly genetic rodent models of ASD, we propose that in these models downregulation of PV might represent one of the points of convergence, thus providing a common link between apparently unrelated ASD-associated synapse structure/function phenotypes.},
address  = {Department of Behavioral Neuroscience, Faculty of Psychology, Philipps-University of Marburg, Marburg, Germany Laboratory of Neurophysiology, ULB Neuroscience Institute (UNI), Universit√© Libre de Bruxelles (ULB), Brussels, Belgium Anatomy Unit, Department of Medicine, University of Fribourg, Fribourg, Switzerland Department of Neurology, SUNY Downstate Medical Center, The Robert F Furchgott Center for Neural and Behavioral Science, Brooklyn, NY, USA Department of Neurology, SUNY Downstate Medical Center, The Robert F Furchgott Center for Neural and Behavioral Science, Brooklyn, NY, USA Department of Behavioral Neuroscience, Faculty of Psychology, Philipps-University of Marburg, Marburg, Germany Institute of Anatomy, Faculty of Medicine, University of Z√ºrich, Z√ºrich, Switzerland Institute of Anatomy, Faculty of Medicine, University of Z√ºrich, Z√ºrich, Switzerland Laboratory of Neurophysiology, ULB Neuroscience Institute (UNI), Universit√© Libre de Bruxelles (ULB), Brussels, Belgium Laboratory of Neurophysiology, ULB Neuroscience Institute (UNI), Universit√© Libre de Bruxelles (ULB), Brussels, Belgium Anatomy Unit, Department of Medicine, University of Fribourg, Fribourg, Switzerland},
note  = {Transl Psychiatry. 2015 Mar;5(3):e525-. Epub 2015 Mar 10 doi:10.1038/tp.2015.19.}
}

@Article{2012674,
author  = {Kim, Y. and Park, J. and Prausnitz, M.},
title  = {Microneedles for drug and vaccine delivery.},
journal  = {Advanced drug delivery reviews},
volume  = {64},
number  = {14},
pages  = {1547-68},
year  = {2012},
abstract  = {Microneedles were first conceptualized for drug delivery many decades ago, but only became the subject of significant research starting in the mid-1990‚Äôs when microfabrication technology enabled their manufacture as (i) solid microneedles for skin pretreatment to increase skin permeability, (ii) microneedles coated with drug that dissolves off in the skin, (iii) polymer microneedles that encapsulate drug and fully dissolve in the skin and (iv) hollow microneedles for  drug infusion into the skin. As shown in more than 350 papers now published in the field, microneedles have been used to deliver a broad range of different low  molecular weight drugs, biotherapeutics and vaccines, including published human studies with a number of small-molecule and protein drugs and vaccines. Influenza vaccination using a hollow microneedle is in widespread clinical use and a number of solid microneedle products are sold for cosmetic purposes. In addition to applications in the skin, microneedles have also been adapted for delivery of bioactives into the eye and into cells. Successful application of microneedles depends on device function that facilitates microneedle insertion and possible infusion into skin, skin recovery after microneedle removal, and drug stability during manufacturing, storage and delivery, and on patient outcomes, including lack of pain, skin irritation and skin infection, in addition to drug efficacy and safety. Building off a strong technology base and multiple demonstrations of  successful drug delivery, microneedles are poised to advance further into clinical practice to enable better pharmaceutical therapies, vaccination and other applications.},
address  = {Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of  Science and Technology (KAIST), Daejeon, Republic of Korea Department of BioNano Technology and Gachon BioNano Research Institute, Gachon University, Seongnam, Gyeonggi-Do, Republic of Korea School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, GA 30332 USA},
note  = {doi:10.1016/j.addr.2012.04.005.}
}

@Article{2012675,
author  = {Brookes, J. and Horsfield, A. and Stoneham, A.},
title  = {The Swipe Card Model of Odorant Recognition.},
journal  = {Sensors (Basel, Switzerland)},
volume  = {12},
number  = {11},
pages  = {15709-49},
year  = {2012},
abstract  = {Just how we discriminate between the different odours we encounter is not completely understood yet. While obviously a matter involving biology, the core issue is a matter for physics: what microscopic interactions enable the receptors in our noses-small protein switches‚Äîto distinguish scent molecules? We survey what is and is not known about the physical processes that take place when we smell things, highlighting the difficulties in developing a full understanding of the mechanics of odorant recognition. The main current theories, discussed here,  fall into two major groups. One class emphasises the scent molecule's shape, and  is described informally as a ‚Äúlock and key‚Ä? mechanism. But there is another category, which we focus on and which we call ‚Äúswipe card‚Ä? theories: the molecular shape must be good enough, but the information that identifies the smell involves other factors. One clearly-defined ‚Äúswipe card‚Ä? mechanism that we  discuss here is Turin's theory, in which inelastic electron tunnelling is used to discern olfactant vibration frequencies. This theory is explicitly quantal, since it requires the molecular vibrations to take in or give out energy only in discrete quanta. These ideas lead to obvious experimental tests and challenges. We describe the current theory in a form that takes into account molecular shape  as well as olfactant vibrations. It emerges that this theory can explain many observations hard to reconcile in other ways. There are still some important gaps in a comprehensive physics-based description of the central steps in odorant recognition. We also discuss how far these ideas carry over to analogous processes involving other small biomolecules, like hormones, steroids and neurotransmitters. We conclude with a discussion of possible quantum behaviours in biology more generally, the case of olfaction being just one example. This paper is presented in honour of Prof. Marshall Stoneham who passed away unexpectedly during its writing.},
address  = {Department of Chemistry and Chemical Biology, Harvard University, Oxford Street,  Cambridge, MA 02138, USA Department of Materials, Imperial College London, South Kensington Campus, London SW7 2AZ, UK London Centre for Nanotechnology, 17-19 Gordon Street, London WC1H 0AH, UK; E-Mail: a.stoneham@ucl.ac.uk},
note  = {Sensors (Basel). 2012 Nov 12;12(11):15709-49. doi:10.3390/s121115709.}
}

@Article{2008676,
author  = {Green, M. and George, S. and Schilsky, R.},
title  = {Group B.},
journal  = {Seminars in oncology},
volume  = {35},
number  = {5},
pages  = {},
year  = {2008},
abstract  = {Members of the Cancer and Leukemia Group B have been striving to improve cancer therapies for more than 50 years. The organization began in the mid 1950s as a multi-institutional collaboration between investigators at the National Cancer Institute, Roswell Park Memorial Institute, and the Children‚Äôs Hospital in Buffalo New York. In 1956 it was officially designated as the Acute Leukemia Group B (ALGB) and for most of its first decade focused largely on leukemia research. Reflecting an expansion of its research portfolio during the 1960s and  70s, the name was changed in 1976 to Cancer and Leukemia Group B (CALGB). Currently the organization has hundreds of members including nurses, clinical research associates, statisticians, physicians, translational scientists, and an  administrative staff from a nationwide network of academic and community based organizations and medical practices. Disease areas within the scope of CALGB research include hematologic malignancies, as well as breast, gastro-intestinal,  genito-urinary, and respiratory cancers. Modality expertise includes quality of life, medical oncology, surgery, radiation oncology, pathology, imaging, oncology nursing, health outcomes, geriatrics, biostatistics, data management, and an extensive array of correlative sciences. Some of the major accomplishments of CALGB investigators and the patients participating in CALGB research as critical  and committed partners will be reviewed in this manuscript.},
address  = {Medical University of South Carolina, Charleston, South Carolina CALGB Statistical Center, Duke University Medical Center, Durham, North Carolina Cancer and Leukemia Group B, Central Office of the Chairman and University of Chicago, Chicago, Illinois},
note  = {Semin Oncol. 2008 Oct;35(5):. doi:10.1053/j.seminoncol.2008.07.002.}
}

@Article{2014677,
author  = {Liu, J. and Kou, Z. and Tian, Y.},
title  = {imaging techniques.},
journal  = {Neural Regeneration Research},
volume  = {9},
number  = {12},
pages  = {1222-30},
year  = {2014},
abstract  = {Previous neuropathological studies regarding traumatic brain injury have primarily focused on changes in large structures, for example, the clinical prognosis after cerebral contusion, intracerebral hematoma, and epidural and subdural hematoma. In fact, many smaller injuries can also lead to severe neurological disorders. For example, cerebral microbleeds result in the dysfunction of adjacent neurons and the disassociation between cortex and subcortical structures. These tiny changes cannot be adequately visualized on CT  or conventional MRI. In contrast, gradient echo sequence-based susceptibility-weighted imaging is very sensitive to blood metabolites and microbleeds, and can be used to evaluate traumatic cerebral microbleeds with high sensitivity and accuracy. Cerebral microbleed can be considered as an important imaging marker for diffuse axonal injury with potential relevance for prognosis.  For this reason, based on experimental and clinical studies, this study reviews the role of imaging data showing traumatic cerebral microbleeds in the evaluation of cerebral neuronal injury and neurofunctional loss.},
address  = {Department of Radiology, Second Xiangya Hospital, Central South University, Changsha, Hunan Province, China Department of Biomedical Engineering and Radiology, School of Medicine, Wayne State University, 3990 John R St, Detroit, MI, USA School of Public Administration, Central South University, Changsha, Hunan Province, China},
note  = {Neural Regen Res. 2014 Jun 15;9(12):1222-30. doi:10.4103/1673-5374.135330.}
}

@Article{2008678,
author  = {Asaad, W. and Eskandar, E.},
title  = {A flexible software tool for temporally-precise behavioral control in Matlab.},
journal  = {Journal of neuroscience methods},
volume  = {174},
number  = {2},
pages  = {245-58},
year  = {2008},
abstract  = {Systems and cognitive neuroscience depend on carefully designed and precisely implemented behavioral tasks to elicit the neural phenomena of interest. To facilitate this process, we have developed a software system that allows for the  straightforward coding and temporally-reliable execution of these tasks in Matlab. We find that, in most cases, millisecond accuracy is attainable, and those instances in which it is not are usually related to predictable, programmed events. In this report, we describe the design of our system, benchmark its performance in a real-world setting, and describe some key features.},
address  = {Department of Neurosurgery, Massachusetts General Hospital, Boston, MA, 02114, USA Program in Neuroscience, Harvard Medical School, Boston, MA, 02115, USA},
note  = {doi:10.1016/j.jneumeth.2008.07.014.}
}

@Article{2015679,
author  = {Chalah, M. and Lefaucheur, J. and Ayache, S.},
title  = {Non-invasive Central and Peripheral Stimulation: New Hope for Essential Tremor?},
journal  = {Frontiers in Neuroscience},
volume  = {9},
number  = {},
pages  = {},
year  = {2015},
abstract  = {Essential tremor (ET) is among the most frequent movement disorders. It usually manifests as a postural and kinematic tremor of the arms, but may also involve the head, voice, lower limbs, and trunk. An oscillatory network has been proposed as a neural correlate of ET, and is mainly composed of the olivocerebellar system, thalamus, and motor cortex. Since pharmacological agents have limited benefits, surgical interventions like deep brain stimulation are the last-line treatment options for the most severe cases. Non-invasive brain stimulation techniques, particularly transcranial magnetic or direct current stimulation, are used to ameliorate ET. Their non-invasiveness, along with their side effects profile, makes them an appealing treatment option. In addition, peripheral stimulation has been applied in the same perspective. Hence, the aim of the present review is to shed light on the emergent use of non-invasive central and peripheral stimulation techniques in this interesting context.},
address  = {EA 4391, Excitabilit√© Nerveuse et Th√©rapeutique, Universit√© Paris-Est-Cr√©teilCr√©teil, France EA 4391, Excitabilit√© Nerveuse et Th√©rapeutique, Universit√© Paris-Est-Cr√©teilCr√©teil, France EA 4391, Excitabilit√© Nerveuse et Th√©rapeutique, Universit√© Paris-Est-Cr√©teilCr√©teil, France},
note  = {Front Neurosci. 2015 Nov 18;9:. doi:10.3389/fnins.2015.00440.}
}

@Article{2016680,
author  = {Sapoznik, E. and Niu, G. and Zhou, Y. and Murphy, S. and Soker, S.},
title  = {Fluorescent Cell Imaging in Regenerative Medicine.},
journal  = {Biomedical Engineering and Computational Biology},
volume  = {7},
number  = {Suppl 1},
pages  = {29-33},
year  = {2016},
abstract  = {Fluorescent protein imaging, a promising tool in biological research, incorporates numerous applications that can be of specific use in the field of regenerative medicine. To enhance tissue regeneration efforts, scientists have been developing new ways to monitor tissue development and maturation in vitro and in vivo. To that end, new imaging tools and novel fluorescent proteins have been developed for the purpose of performing deep-tissue high-resolution imaging. These new methods, such as intra-vital microscopy and F√∂rster resonance energy transfer, are providing new insights into cellular behavior, including cell migration, morphology, and phenotypic changes in a dynamic environment. Such applications, combined with multimodal imaging, significantly expand the utility  of fluorescent protein imaging in research and clinical applications of regenerative medicine.},
address  = {Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA. Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA. Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA. Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA. Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC, USA.},
note  = {Biomed Eng Comput Biol. 2016 May 02;7(Suppl 1):29-33. doi:10.4137/BECB.S39045.}
}

@Article{2013681,
author  = {Chemali, J. and Ching, S. and Purdon, P. and Solt, K. and Brown, E.},
title  = {burst suppression.},
journal  = {Journal of neural engineering},
volume  = {10},
number  = {5},
pages  = {056017},
year  = {2013},
abstract  = {Objective: Burst suppression is an electroencephalogram pattern in which bursts of electrical activity alternate with an isoelectric state. This pattern is commonly seen in states of severely reduced brain activity such as profound general anesthesia, anoxic brain injuries, hypothermia and certain developmental  disorders. Devising accurate, reliable ways to quantify burst suppression is an important clinical and research problem. Although thresholding and segmentation algorithms readily identify burst suppression periods, analysis algorithms require long intervals of data to characterize burst suppression at a given time  and provide no framework for statistical inference. Approach: We introduce the concept of the burst suppression probability (BSP) to define the brain‚Äôs instantaneous propensity of being in the suppressed state. To conduct dynamic analyses of burst suppression we propose a state-space model in which the observation process is a binomial model and the state equation is a Gaussian random walk. We estimate the model using an approximate expectation maximization  algorithm and illustrate its application in the analysis of rodent burst suppression recordings under general anesthesia and a patient during induction of controlled hypothermia. Main result: The BSP algorithms track burst suppression on a second-to-second time scale, and make possible formal statistical comparisons of burst suppression at different times. Significance: The state-space approach suggests a principled and informative way to analyze burst suppression that can be used to monitor, and eventually to control, the brain states of patients in the operating room and in the intensive care unit.},
address  = {Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General  Hospital, Boston, MA, USA Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General  Hospital, Boston, MA, USA Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General  Hospital, Boston, MA, USA Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General  Hospital, Boston, MA, USA Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General  Hospital, Boston, MA, USA},
note  = {doi:10.1088/1741-2560/10/5/056017.}
}

@Article{2013682,
author  = {Young, C. and van, d. and Lewis, N. and Brooks, K. and Buchan, A. and Szele, F.},
title  = {Subventricular Zone after Stroke.},
journal  = {Cerebral Cortex (New York, NY)},
volume  = {23},
number  = {3},
pages  = {647-59},
year  = {2013},
abstract  = {Subventricular zone (SVZ) astrocytes and ependymal cells are both derived from radial glia and may have similar gliotic reactions after stroke. Diminishing SVZ  neurogenesis worsens outcomes in mice, yet the effects of stroke on SVZ astrocytes and ependymal cells are poorly understood. We used mouse experimental  stroke to determine if SVZ astrocytes and ependymal cells assume similar phenotypes and if stroke impacts their functions. Using lateral ventricular wall  whole mount preparations, we show that stroke caused SVZ reactive astrocytosis, disrupting the neuroblast migratory scaffold. Also, SVZ vascular density and neural proliferation increased but apoptosis did not. In contrast to other reports, ependymal denudation and cell division was never observed. Remarkably, however, ependymal cells assumed features of reactive astrocytes post stroke, robustly expressing de novo glial fibrillary acidic protein, enlargening and extending long processes. Unexpectedly, stroke disrupted motile cilia planar cell polarity in ependymal cells. This suggested ciliary function was affected and indeed ventricular surface flow was slower and more turbulent post stroke. Together, these results demonstrate that in response to stroke there is significant SVZ reorganization with implications for both pathophysiology and therapeutic strategies.},
address  = {Department of Physiology, Anatomy and Genetics Department of Physiology, Anatomy and Genetics Department of Physiology, Anatomy and Genetics Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX13QX, UK Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX13QX, UK Department of Physiology, Anatomy and Genetics},
note  = {Cereb Cortex. 2013 Mar;23(3):647-59. Epub 2012 Mar 13 doi:10.1093/cercor/bhs049.}
}

@Article{2008683,
author  = {Ratnayaka, K. and Faranesh, A. and Guttman, M. and Kocaturk, O. and Saikus, C. and Lederman, R.},
title  = {Interventional cardiovascular magnetic resonance: still tantalizing.},
journal  = {Journal of Cardiovascular Magnetic Resonance},
volume  = {10},
number  = {1},
pages  = {62},
year  = {2008},
abstract  = {The often touted advantages of MR guidance remain largely unrealized for cardiovascular interventional procedures in patients. Many procedures have been simulated in animal models. We argue these opportunities for clinical interventional MR will be met in the near future. This paper reviews technical and clinical considerations and offers advice on how to implement a clinical-grade interventional cardiovascular MR (iCMR) laboratory. We caution that this reflects our personal view of the "state of the art."},
address  = {Translational Medicine Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA Translational Medicine Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA Translational Medicine Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA Translational Medicine Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA Translational Medicine Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA Translational Medicine Branch, Division of Intramural Research, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA},
note  = {J Cardiovasc Magn Reson. 2008 Dec 29;10(1):62. doi:10.1186/1532-429X-10-62.}
}

@Article{2015684,
author  = {Porambo, M. and Phillips, A. and Marx, J. and Ternes, K. and Arauz, E. and Pletnikov, M. and Wilson, M. and Rothstein, J. and Johnston, M. and Fatemi, A.},
title  = {Despite Limited Cell Survival.},
journal  = {Glia},
volume  = {63},
number  = {3},
pages  = {452-65},
year  = {2015},
abstract  = {Objective: Neonatal White Matter Injury (NWMI) is the leading cause of cerebral palsy and other neurocognitive deficits in prematurely-born children, and no restorative therapies exist. Our objective was to determine the fate and effect of glial restricted precursor cell (GRP) transplantation in an ischemic mouse model of NWMI. Methods: Neonatal CD-1 mice underwent unilateral carotid artery ligation on postnatal-day 5 (P5). At P22, intracallosal injections of either eGFP+ GRPs or saline were performed in control and ligated mice. Neurobehavioral  and postmortem studies were performed at four and eight weeks post-transplantation. Results: GRP survival was comparable at one month but significantly lower at two months post-transplantation in NWMI mice compared to unligated controls. Surviving cells showed better migration capability in controls; however, the differentiation capacity of transplanted cells was similar in control and NWMI. Saline-treated NWMI mice showed significantly altered response in startle amplitude and pre-pulse inhibition paradigms compared to unligated controls, while these behavioral tests were completely normal in GRP-transplanted animals. Similarly, there was significant increase in hemispheric myelin basic protein density, along with significant decrease in pathologic axonal staining in cell-treated NWMI mice compared to saline-treated NWMI animals. Interpretation: The Reduced long-term survival and migration of transplanted GRPs in an ischemia-induced NWMI model suggests that neonatal ischemia leads to long-lasting detrimental effects on oligodendroglia even months after the initial insult. Despite limited GRP-survival, behavioral and neuropathological outcomes were improved after GRP-transplantation. Our results suggest that exogenous GRPs improve myelination through trophic effects in addition to differentiation into mature oligodendrocytes.},
address  = {Kennedy Krieger Institute, Johns Hopkins University Kennedy Krieger Institute, Johns Hopkins University Kennedy Krieger Institute, Johns Hopkins University Kennedy Krieger Institute, Johns Hopkins University Department of Psychiatry, Johns Hopkins University Kennedy Krieger Institute, Johns Hopkins University Department of Neurology, Johns Hopkins University Kennedy Krieger Institute, Johns Hopkins University Kennedy Krieger Institute, Johns Hopkins University},
note  = {Glia. 2015 Mar;63(3):452-65. Epub 2014 Nov 06 doi:10.1002/glia.22764.}
}

@Article{2005685,
author  = {Wolkoff, P. and Nojgaard, J. and Troiano, P. and Piccoli, B.},
title  = {influenced by eye blinking efficiency.},
journal  = {Occupational and Environmental Medicine},
volume  = {62},
number  = {1},
pages  = {4-12},
year  = {2005},
abstract  = {To achieve a common base for understanding work related eye complaints in the office environment, it is necessary to merge approaches from indoor air science,  occupational health, and ophthalmology. Based on database searches, it is concluded that precorneal tear film (PTF) alteration leads to eye complaints that may be caused by: (1) thermal factors (low relative humidity; high room temperature); (2) demanding task content (attention decreases blinking and widens the exposed ocular surface area); and (3) individual characteristics (for example, tear film alterations, blinking anomalies, gland dysfunctions, and use of contact lenses). These factors and conditions are able to progressively increase water evaporation and faster thinning of the PTF, which causes dryness and dry spot formation on the cornea, possibly followed by corneal and conjunctiva epithelial alterations and eye complaints. Another possible cause of  eye complaints is certain irritating chemical compounds, in addition to oxidation mixtures that are formed in reactions between ozone and unsaturated organic compounds (alkenes). The effect may be exacerbated by low relative humidity.},
address  = {},
note  = {Occup Environ Med. 2005 Jan;62(1):4-12. doi:10.1136/oem.2004.016030.}
}

@Article{2016686,
author  = {Reid, L. and Cunnington, R. and Boyd, R. and Rose, S.},
title  = {Brain Pathology: A Study Linking Structure and Function in Cerebral Palsy.},
journal  = {PLoS ONE},
volume  = {11},
number  = {8},
pages  = {},
year  = {2016},
abstract  = {Diffusion MRI (dMRI) tractography analyses are difficult to perform in the presence of brain pathology. Automated methods that rely on cortical parcellation for structural connectivity studies often fail, while manually defining regions is extremely time consuming and can introduce human error. Both methods also make assumptions about structure-function relationships that may not hold after cortical reorganisation. Seeding tractography with functional-MRI (fMRI) activation is an emerging method that reduces these confounds, but inherent smoothing of fMRI signal may result in the inclusion of irrelevant pathways. This paper describes a novel fMRI-seeded dMRI-analysis pipeline based on surface-meshes that reduces these issues and utilises machine-learning to generate task specific white matter pathways, minimising the requirement for manually-drawn ROIs. We directly compared this new strategy to a standard voxelwise fMRI-dMRI approach, by investigating correlations between clinical scores and dMRI metrics of thalamocortical and corticomotor tracts in 31 children with unilateral cerebral palsy. The surface-based approach successfully processed more participants (87%) than the voxel-based approach (65%), and provided significantly more-coherent tractography. Significant correlations between dMRI metrics and five clinical scores of function were found for the more superior regions of these tracts. These significant correlations were stronger and more frequently found with the surface-based method (15/20 investigated were significant; R2 = 0.43‚Äì0.73) than the voxelwise analysis (2 sig. correlations; 0.38 & 0.49). More restricted fMRI signal, better-constrained tractography, and the novel track-classification method all appeared to contribute toward these differences.},
address  = {The Australian e-Health Research Centre, CSIRO, Brisbane, Australia School of Psychology and Queensland Brain Institute, The University of Queensland, St Lucia, Brisbane, Australia Level 6, Queensland Cerebral Palsy and Rehabilitation Research Centre, Children‚Äôs Health Research Centre, School of Medicine, The University of Queensland, Brisbane, Australia The Australian e-Health Research Centre, CSIRO, Brisbane, Australia},
note  = {PLoS One. 2016 Aug 3;11(8):. doi:10.1371/journal.pone.0159540.}
}

@Article{2014687,
author  = {Preter, M. and Klein, D.},
title  = {extension of the false suffocation alarm theory of panic disorder.},
journal  = {Neuroscience and biobehavioral reviews},
volume  = {46 Pt 3},
number  = {},
pages  = {345-51},
year  = {2014},
abstract  = {},
address  = {Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, Department of Child and Adolescent Psychiatry, New York University Langone Medical Center 550 1st Ave, New York, NY 10016, USA. donaldk737@aol.com},
note  = {doi:10.1016/j.neubiorev.2014.03.025.}
}

@Article{2012688,
author  = {Berquist, R. and Gledhill, K. and Peterson, M. and Doan, A. and Baxter, G. and Yopak, K. and Kang, N. and Walker, H. and Hastings, P. and Frank, L.},
title  = {Morphological Diversity of Fish.},
journal  = {PLoS ONE},
volume  = {7},
number  = {4},
pages  = {},
year  = {2012},
abstract  = {Museum fish collections possess a wealth of anatomical and morphological data that are essential for documenting and understanding biodiversity. Obtaining access to specimens for research, however, is not always practical and frequently conflicts with the need to maintain the physical integrity of specimens and the collection as a whole. Non-invasive three-dimensional (3D) digital imaging therefore serves a critical role in facilitating the digitization of these specimens for anatomical and morphological analysis as well as facilitating an efficient method for online storage and sharing of this imaging data. Here we describe the development of the Digital Fish Library (DFL, http://www.digitalfishlibrary.org), an online digital archive of high-resolution, high-contrast, magnetic resonance imaging (MRI) scans of the soft tissue anatomy  of an array of fishes preserved in the Marine Vertebrate Collection of Scripps Institution of Oceanography. We have imaged and uploaded MRI data for over 300 marine and freshwater species, developed a data archival and retrieval system with a web-based image analysis and visualization tool, and integrated these into the public DFL website to disseminate data and associated metadata freely over the web. We show that MRI is a rapid and powerful method for accurately depicting the in-situ soft-tissue anatomy of preserved fishes in sufficient detail for large-scale comparative digital morphology. However these 3D volumetric data require a sophisticated computational and archival infrastructure in order to be  broadly accessible to researchers and educators.},
address  = {Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America Marine Vertebrate Collection and Marine Biology Research Division, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California, United States of America Marine Vertebrate Collection and Marine Biology Research Division, Scripps Institution of Oceanography, University of California San Diego, La Jolla, California, United States of America Center for Scientific Computation in Imaging, University of California San Diego, La Jolla, California, United States of America},
note  = {PLoS One. 2012 Apr 6;7(4):. doi:10.1371/journal.pone.0034499.}
}

@Article{2013689,
author  = {Schmunk, G. and Gargus, J.},
title  = {Channelopathy pathogenesis in autism spectrum disorders.},
journal  = {Frontiers in Genetics},
volume  = {4},
number  = {},
pages  = {},
year  = {2013},
abstract  = {Autism spectrum disorder (ASD) is a syndrome that affects normal brain development and is characterized by impaired social interaction as well as verbal and non-verbal communication and by repetitive, stereotypic behavior. ASD is a complex disorder arising from a combination of multiple genetic and environmental factors that are independent from racial, ethnic and socioeconomical status. The  high heritability of ASD suggests a strong genetic basis for the disorder. Furthermore, a mounting body of evidence implies a role of various ion channel gene defects (channelopathies) in the pathogenesis of autism. Indeed, recent genome-wide association, and whole exome- and whole-genome resequencing studies linked polymorphisms and rare variants in calcium, sodium and potassium channels  and their subunits with susceptibility to ASD, much as they do with bipolar disorder, schizophrenia and other neuropsychiatric disorders. Moreover, animal models with these genetic variations recapitulate endophenotypes considered to be correlates of autistic behavior seen in patients. An ion flux across the membrane regulates a variety of cell functions, from generation of action potentials to gene expression and cell morphology, thus it is not surprising that channelopathies have profound effects on brain functions. In the present work, we summarize existing evidence for the role of ion channel gene defects in the pathogenesis of autism with a focus on calcium signaling and its downstream effects.},
address  = {Department of Physiology and Biophysics, University of CaliforniaIrvine, CA, USA Department of Physiology and Biophysics, University of CaliforniaIrvine, CA, USA},
note  = {Front Genet. 2013 Nov 05;4:. doi:10.3389/fgene.2013.00222.}
}

@Article{2014690,
author  = {Uversky, V.},
title  = {pathogenicity of deregulated regulators.},
journal  = {Frontiers in Molecular Biosciences},
volume  = {1},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Biologically active proteins without stable tertiary structure are common in all  known proteomes. Functions of these intrinsically disordered proteins (IDPs) are  typically related to regulation, signaling, and control. Cellular levels of these important regulators are tightly regulated by a variety mechanisms ranging from firmly controlled expression to precisely targeted degradation. Functions of IDPs are controlled by binding to specific partners, alternative splicing, and posttranslational modifications among other means. In the norm, right amounts of  precisely activated IDPs have to be present in right time at right places. Wrecked regulation brings havoc to the ordered world of disordered proteins, leading to protein misfolding, misidentification, and missignaling that give rise to numerous human diseases, such as cancer, cardiovascular disease, neurodegenerative diseases, and diabetes. Among factors inducing pathogenic transformations of IDPs are various cellular mechanisms, such as chromosomal translocations, damaged splicing, altered expression, frustrated posttranslational modifications, aberrant proteolytic degradation, and defective  trafficking. This review presents some of the aspects of deregulated regulation of IDPs leading to human diseases.},
address  = {Department of Molecular Medicine and USF Health Byrd Alzheimer's Research Institute, Morsani College of Medicine, University of South FloridaTampa, FL, USA},
note  = {Front Mol Biosci. 2014 Jul 25;1:. doi:10.3389/fmolb.2014.00006.}
}

@Article{2008691,
author  = {Martelle, J. and Nader, M.},
title  = {Effects of the Dopamine D2-Like Receptor Antagonist Eticlopride.},
journal  = {CNS neuroscience & therapeutics},
volume  = {14},
number  = {3},
pages  = {248-62},
year  = {2008},
abstract  = {Eticlopride is a substituted benzamide analog with high affinity and selectivity  for dopamine (DA) D2-like receptors that was initially developed as a potential antipsychotic agent. A great deal of research has utilized this drug to better understand central DA receptor function, the role of D2-like receptors in behavior, and the influence of blockade of these receptors on several preclinical animal models. This review highlights research utilizing this drug and compares it to typical and atypical antipsychotics used clinically. First, we describe structure‚Äìactivity relationships as it relates to binding at DA receptors and the consequences on behavior. This is followed by a discussion of several imaging strategies including the use of eticlopride for in vivo, in vitro, and ex vivo examination of DA D2-like receptor densities and function. Finally, we discuss the use of eticlopride in several behavioral models predictive of antipsychotic activity, extrapyramidal side effects (EPS), and learning and memory. While eticlopride is not used clinically, it remains a viable research tool for understanding DA receptor function and behavior.},
address  = {},
note  = {CNS Neurosci Ther. 2008 Fall;14(3):248-62. doi:10.1111/j.1755-5949.2008.00047.x.}
}

@Article{2015692,
author  = {Otero-Millan, J. and Roberts, D. and Lasker, A. and Zee, D. and Kheradmand, A.},
title  = {sensitive, accurate, and low-noise technique for measuring ocular torsion.},
journal  = {Journal of Vision},
volume  = {15},
number  = {14},
pages  = {},
year  = {2015},
abstract  = {Torsional eye movements are rotations of the eye around the line of sight. Measuring torsion is essential to understanding how the brain controls eye position and how it creates a veridical perception of object orientation in three dimensions. Torsion is also important for diagnosis of many vestibular, neurological, and ophthalmological disorders. Currently, there are multiple devices and methods that produce reliable measurements of horizontal and vertical eye movements. Measuring torsion, however, noninvasively and reliably has been a  longstanding challenge, with previous methods lacking real-time capabilities or suffering from intrusive artifacts. We propose a novel method for measuring eye movements in three dimensions using modern computer vision software (OpenCV) and  concepts of iris recognition. To measure torsion, we use template matching of the entire iris and automatically account for occlusion of the iris and pupil by the  eyelids. The current setup operates binocularly at 100 Hz with noise <0.1¬∞ and is accurate within 20¬∞ of gaze to the left, to the right, and up and 10¬∞ of gaze down. This new method can be widely applicable and fill a gap in many scientific  and clinical disciplines.},
address  = {jotero@jhu.edu Department of Neurology The Johns Hopkins University, Baltimore, MD, US, dale.roberts@jhu.edu Department of Neurology The Johns Hopkins University, Baltimore, MD, US, alasker@jhu.edu Department of Neurology The Johns Hopkins University, Baltimore, MD, US, dzee@jhu.edu Department of Neurology The Johns Hopkins University, Baltimore, MD, US, akherad@jhu.edu Department of Neurology The Johns Hopkins University, Baltimore, MD, US,},
note  = {J Vis. 2015 Oct 22;15(14):. doi:10.1167/15.14.11.}
}

@Article{2017693,
author  = {Wang, Y. and Yu, L. and Kong, X. and Sun, L.},
title  = {Application of nanodiagnostics in point-of-care tests for infectious diseases.},
journal  = {International Journal of Nanomedicine},
volume  = {12},
number  = {},
pages  = {4789-803},
year  = {2017},
abstract  = {Although tremendous efforts have been put into the treatment of infectious diseases to prevent epidemics and mortality, it is still one of the major health  care issues that have a profound impact on humankind. Therefore, the development  of specific, sensitive, accurate, rapid, low-cost, and easy-to-use diagnostic tools is still in urgent demand. Nanodiagnostics, defined as the application of nanotechnology to medical diagnostics, can offer many unique opportunities for more successful and efficient diagnosis and treatment for infectious diseases. In this review, we provide an overview of the nanodiagnostics for infectious diseases from nanoparticle-based, nanodevice-based, and point-of-care test (POCT) platforms. Most importantly, emphasis focused on the recent trends in the nanotechnology-based POCT system. The current state-of-the-art and most promising point-of-care nanodiagnostic technologies, including miniaturized diagnostic magnetic resonance platform, magnetic barcode assay system, cell phone-based polarized light microscopy platform, cell phone-based dongle platform, and paper-based POCT platform, for infectious diseases were fully examined. The limitations, challenges, and future trends of the nanodiagnostics in POCTs for infectious diseases are also discussed.},
address  = {Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, Hefei, Anhui, People‚Äôs Republic of China Department of Microbiology and Parasitology, Anhui Provincial Laboratory of Microbiology and Parasitology, Anhui Key Laboratory of Zoonoses, Anhui Medical University, Hefei, Anhui, People‚Äôs Republic of China Anhui Key Laboratory of Modern Biomanufacturing, School of Life Sciences, Anhui University, Hefei, Anhui, People‚Äôs Republic of China Department of Biomedical Engineering, The Ohio State University, Columbus, OH, USA},
note  = {Int J Nanomedicine. 2017 Jul 04;12:4789-803. doi:10.2147/IJN.S137338.}
}

@Article{2014694,
author  = {Wander, J. and Rao, R.},
title  = {Brain-computer interfaces: a powerful tool for scientific inquiry.},
journal  = {Current opinion in neurobiology},
volume  = {0},
number  = {},
pages  = {70-5},
year  = {2014},
abstract  = {Brain-computer interfaces (BCIs) are devices that record from the nervous system, provide input directly to the nervous system, or do both. Sensory BCIs such as cochlear implants have already had notable clinical success and motor BCIs have shown great promise for helping patients with severe motor deficits. Clinical and engineering outcomes aside, BCIs can also be tremendously powerful tools for scientific inquiry into the workings of the nervous system. They allow researchers to inject and record information at various stages of the system, permitting investigation of the brain in vivo and facilitating the reverse engineering of brain function. Most notably, BCIs are emerging as a novel experimental tool for investigating the tremendous adaptive capacity of the nervous system.},
address  = {Center for Sensorimotor Neural Engineering and Department of Bioengineering, University of Washington, William H. Foege Building, Box 355061, 4000 15 Ave NE,  Seattle, WA 98195 Center for Sensorimotor Neural Engineering and Department of Computer Science and Engineering, University of Washington, AC101 Paul G. Allen Center, Box 352350, 185 Stevens Way, Seattle, WA 98195},
note  = {doi:10.1016/j.conb.2013.11.013.}
}

@Article{2010695,
author  = {Yang, Z. and Carter, E. and Torbey, M. and Martin, L. and Koehler, R.},
title  = {against neonatal ischemic degeneration of striatal neurons.},
journal  = {Experimental neurology},
volume  = {221},
number  = {1},
pages  = {166-74},
year  = {2010},
abstract  = {In adult stroke models, 4-phenyl-1-(4-phenylbutyl) piperidine (PPBP), a sigma receptor agonist, attenuates activity of neuronal nitric oxide synthase (nNOS), blunts ischemia-induced nitric oxide production, and provides neuroprotection. Here, we tested the hypothesis that PPBP attenuates neuronal damage in a model of global hypoxia-ischemia (H‚ÄìI) in newborn piglets. Piglets subjected to hypoxia followed by asphyxic cardiac arrest were treated with saline or two dosing regimens of PPBP after resuscitation. Sigma-1 receptors were found in striatal neurons. PPBP dose-dependently protected neurons in putamen at 4 days of recovery from H‚ÄìI. Immunoblots of putamen extracts at 3 h of recovery showed that PPBP decreased H‚ÄìI-induced recruitment of nNOS in the membrane fraction and reduced the association of nNOS with NMDA receptor NR2 subunit. The latter effect was associated with changes in the coupling of nNOS to postsynaptic density-95 (PSD-95), but not NR2-PSD-95 interactions. Moreover, PPBP suppressed NOS activity in the membrane fraction and reduced H‚ÄìI‚Äìinduced nitrative and oxidative damage to proteins and nucleic acids. These findings indicate that PPBP protects striatal neurons in a large animal model of neonatal H‚ÄìI and that the protection  is associated with decreased coupling of nNOS to PSD-95.},
address  = {Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA Division of Neuropathology, Department of Pathology, Johns Hopkins University, Baltimore, Maryland, USA Department of Anesthesiology/Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland, USA},
note  = {doi:10.1016/j.expneurol.2009.10.019.}
}

@Article{2011696,
author  = {Marquez, d. and Garces, J. and Kojori, E. and Grinnan, J. and Krishnan, K. and Pidikiti, R. and Spence, J. and Devous, M. and Moore, C. and McColl, R. and Madden, C. and Diaz-Arrastia, R.},
title  = {after Traumatic Axonal Injury.},
journal  = {Archives of neurology},
volume  = {68},
number  = {1},
pages  = {74-84},
year  = {2011},
abstract  = {Objective: To examine the functional connectivity (fc) of hippocampal and selected frontal lobe circuits among patients with traumatic axonal injury (TAI). Design: Echo-planar and high-resolution T1-weighted images were acquired using 3  Tesla scanners. Regions of interest (ROI) were drawn bilaterally for the hippocampus, anterior cingulate cortex (ACC), and dorsolateral prefrontal cortex  (DLPFC), and were used to extract time series data. BOLD data from each ROI were  used as reference functions for correlating with all other brain voxels. Interhermispheric fc was assessed for each participant by correlating homologous  regions using a Pearson correlation coefficient. Patient functional and neurocognitive outcomes were assessed approximately 6 months post-injury. Setting: Patients were recruited within days of their injury while in an inpatient traumatic brain injury unit. Imaging and neurocognitive assessments were conducted in an outpatient research facility. Participants: 25 consecutive patients with brain injuries consistent with TAI and acute subcortical white matter abnormalities were studied. Sixteen healthy volunteers of similar age and  gender were recruited. Main Outcome Measures: Interhemispheric fc for each ROI was compared between patients and controls. Spatial patterns of fc were examined  for each of the three ROIs. Connectivity measures were examined for associations  with functional and neurocognitive outcomes. Results: Patients showed significantly lower interhemispheric fc for the hippocampus and ACC. Healthy controls demonstrate stronger and more focused fc for hippocampi and ACC, and a more focused recruitment of the default mode network for the DLPFC ROI. The interhemispheric fc for the hippocampus was correlated to delayed recall of verbal information. Conclusions: Our findings suggest that traumatic axonal injury impacts interhemispheric neural activity, as patients with TAI show disrupted interhemipsheric fc. These results suggest more careful investigation of interhemisheric connectivity is warranted, as it demonstrated a modest association with outcome in chronic TBI.},
address  = {Center for Brain Health, The University of Texas at Dallas, Richardson, TX, USA Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Radiology (Neuroradiology), University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Radiology (Neuroradiology), University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Neurological Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, USA},
note  = {Arch Neurol. 2011 Jan;68(1):74-84. doi:10.1001/archneurol.2010.342.}
}

@Article{2014697,
author  = {Litjens, G. and Toth, R. and van, d. and Hoeks, C. and Kerkstra, S. and van, G. and Vincent, G. and Guillard, G. and Birbeck, N. and Zhang, J. and Strand, R. and Malmberg, F. and Ou, Y. and Davatzikos, C. and Kirschner, M. and Jung, F. and Yuan, J. and Qiu, W. and Gao, Q. and Edwards, P. and Maan, B. and van, d. and Ghose, S. and Mitra, J. and Dowling, J. and Barratt, D. and Huisman, H. and Madabhushi, A.},
title  = {Evaluation of prostate segmentation algorithms for MRI: the PROMISE12 challenge.},
journal  = {Medical image analysis},
volume  = {18},
number  = {2},
pages  = {359-73},
year  = {2014},
abstract  = {Prostate MRI image segmentation has been an area of intense research due to the increased use of MRI as a modality for the clinical workup of prostate cancer. Segmentation is useful for various tasks, e.g. to accurately localize prostate boundaries for radiotherapy or to initialize multi-modal registration algorithms. In the past, it has been difficult for research groups to evaluate prostate segmentation algorithms on multi-center, multi-vendor and multi-protocol data. Especially because we are dealing with MR images, image appearance, resolution and the presence of artifacts are affected by differences in scanners and/or protocols, which in turn can have a large influence on algorithm accuracy. The Prostate MR Image Segmentation (PROMISE12) challenge was setup to allow a fair and meaningful comparison of segmentation methods on the basis of performance and robustness. In this work we will discuss the initial results of the online PROMISE12 challenge, and the results obtained in the live challenge workshop hosted by the MICCAI2012 conference. In the challenge, 100 prostate MR cases from 4 different centers were included, with differences in scanner manufacturer, field strength and protocol. A total of 11 teams from academic research groups and industry participated. Algorithms showed a wide variety in methods and implementation, including active appearance models, atlas registration and level  sets. Evaluation was performed using boundary and volume based metrics which were combined into a single score relating the metrics to human expert performance. The winners of the challenge where the algorithms by teams Imorphics and ScrAutoProstate, with scores of 85.72 and 84.29 overall. Both algorithms where significantly better than all other algorithms in the challenge (p < 0.05) and had an efficient implementation with a run time of 8 minutes and 3 second per case respectively. Overall, active appearance model based approaches seemed to outperform other approaches like multi-atlas registration, both on accuracy and computation time. Although average algorithm performance was good to excellent and the Imorphics algorithm outperformed the second observer on average, we showed that algorithm combination might lead to further improvement, indicating that optimal performance for prostate segmentation is not yet obtained. All results are available online at http://promise12.grand-challenge.org/.},
address  = {Radboud University Nijmegen Medical Centre, The Netherlands Case Western Reserve University, USA Radboud University Nijmegen Medical Centre, The Netherlands Radboud University Nijmegen Medical Centre, The Netherlands Radboud University Nijmegen Medical Centre, The Netherlands Radboud University Nijmegen Medical Centre, The Netherlands Imorphics, England Imorphics, England Siemens Corporate Research, USA Siemens Corporate Research, USA Uppsala University, Sweden Uppsala University, Sweden University of Pennsylvania, USA University of Pennsylvania, USA Technische Universitat Darmstadt, Germany Technische Universitat Darmstadt, Germany Robarts Research Institute, Canada Robarts Research Institute, Canada Imperial College London, England Imperial College London, England University of Twente, The Netherlands University of Twente, The Netherlands Commonwealth Scientific and Industrial Research Organisation, Australia Commonwealth Scientific and Industrial Research Organisation, Australia Commonwealth Scientific and Industrial Research Organisation, Australia University College London, England Radboud University Nijmegen Medical Centre, The Netherlands Case Western Reserve University, USA},
note  = {doi:10.1016/j.media.2013.12.002.}
}

@Article{2014698,
author  = {Wang, H. and Wang, B. and Normoyle, K. and Jackson, K. and Spitler, K. and Sharrock, M. and Miller, C. and Best, C. and Llano, D. and Du, R.},
title  = {neuroscientists.},
journal  = {Frontiers in Neuroscience},
volume  = {8},
number  = {},
pages  = {},
year  = {2014},
abstract  = {Brain temperature, as an independent therapeutic target variable, has received increasingly intense clinical attention. To date, brain hypothermia represents the most potent neuroprotectant in laboratory studies. Although the impact of brain temperature is prevalent in a number of common human diseases including: head trauma, stroke, multiple sclerosis, epilepsy, mood disorders, headaches, and neurodegenerative disorders, it is evident and well recognized that the therapeutic application of induced hypothermia is limited to a few highly selected clinical conditions such as cardiac arrest and hypoxic ischemic neonatal encephalopathy. Efforts to understand the fundamental aspects of brain temperature regulation are therefore critical for the development of safe, effective, and pragmatic clinical treatments for patients with brain injuries. Although centrally-mediated mechanisms to maintain a stable body temperature are  relatively well established, very little is clinically known about brain temperature's spatial and temporal distribution, its physiological and pathological fluctuations, and the mechanism underlying brain thermal homeostasis. The human brain, a metabolically ‚Äúexpensive‚Ä? organ with intense heat production, is sensitive to fluctuations in temperature with regards to its functional activity and energy efficiency. In this review, we discuss several critical aspects concerning the fundamental properties of brain temperature from  a clinical perspective.},
address  = {Department of Neurosurgery, Carle Foundation Hospital, University of Illinois College of Medicine at Urbana-ChampaignUrbana, IL, USA Department of Internal Medicine, Carle Foundation Hospital, University of Illinois College of Medicine at Urbana-ChampaignUrbana, IL, USA Department of Internal Medicine, College of Medicine at Urbana-Champaign, University of IllinoisChampaign, Urbana, IL, USA Thermal Neuroscience Laboratory, Beckman Institute, University of Illinois at Urbana-ChampaignUrbana, IL, USA Department of Internal Medicine, Carle Foundation Hospital, University of Illinois College of Medicine at Urbana-ChampaignUrbana, IL, USA Department of Internal Medicine, College of Medicine at Urbana-Champaign, University of IllinoisChampaign, Urbana, IL, USA Department of Internal Medicine, College of Medicine at Urbana-Champaign, University of IllinoisChampaign, Urbana, IL, USA Molecular and Cellular Biology, University of Illinois at Urbana-ChampaignUrbana, IL, USA Thermal Neuroscience Laboratory, Beckman Institute, University of Illinois at Urbana-ChampaignUrbana, IL, USA Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical SchoolBoston, MA, USA},
note  = {Front Neurosci. 2014 Oct 08;8:. doi:10.3389/fnins.2014.00307.}
}

@Article{2016699,
author  = {Rajendran, P. and Nakamura, K. and Ajijola, O. and Vaseghi, M. and Armour, J. and Ardell, J. and Shivkumar, K.},
title  = {intrinsic cardiac nervous system.},
journal  = {The Journal of Physiology},
volume  = {594},
number  = {2},
pages  = {321-41},
year  = {2016},
abstract  = {Key points: Intrinsic cardiac (IC) neurons undergo differential morphological and phenotypic remodelling that reflects the site of myocardial infarction (MI).Afferent neural signals from the infarcted region to IC neurons are attenuated, while those from border and remote regions are preserved post‚Ä?MI, giving rise to a ‚Äòneural sensory border zone‚Äô.Convergent IC local circuit (processing) neurons have enhanced transduction capacity following MI.Functional  network connectivity within the intrinsic cardiac nervous system is reduced post‚Ä?MI.MI reduces the response and alters the characteristics of IC neurons to ventricular pacing. Abstract: Autonomic dysregulation following myocardial infarction (MI) is an important pathogenic event. The intrinsic cardiac nervous system (ICNS) is a neural network located on the heart that is critically involved in autonomic regulation. The aims of this study were to characterize structural and functional remodelling of the ICNS post‚Ä?MI in a porcine model (control (n = 16) vs. healed anteroapical MI (n = 16)). In vivo microelectrode recordings of basal activity, as well as responses to afferent and efferent stimuli, were recorded from intrinsic cardiac neurons. From control 118 neurons and from MI animals 102 neurons were functionally classified as afferent, efferent, or convergent (receiving both afferent and efferent inputs). In control and MI, convergent neurons represented the largest subpopulation (47% and 48%, respectively) and had enhanced transduction capacity following MI. Efferent inputs to neurons were maintained post‚Ä?MI. Afferent inputs were attenuated from the infarcted region (19% in control vs. 7% in MI; P = 0.03), creating a ‚Äòneural  sensory border zone‚Äô, or heterogeneity in afferent information. MI reduced transduction of changes in preload (54% in control vs. 41% in MI; P = 0.05). The  overall functional network connectivity, or the ability of neurons to respond to  independent pairs of stimuli, within the ICNS was reduced following MI. The neuronal response was differentially decreased to ventricular vs. atrial pacing post‚Ä?MI (63% in control vs. 44% in MI to ventricular pacing; P < 0.01). MI induced morphological and phenotypic changes within the ICNS. The alteration of afferent neural signals, and remodelling of convergent neurons, represents a ‚Äòneural signature‚Äô of ischaemic heart disease.},
address  = {University of California ‚Äì Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid Geffen School of MedicineLos AngelesCAUSA University of California ‚Äì Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid Geffen School of MedicineLos AngelesCAUSA University of California ‚Äì Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid Geffen School of MedicineLos AngelesCAUSA University of California ‚Äì Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid Geffen School of MedicineLos AngelesCAUSA University of California ‚Äì Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid Geffen School of MedicineLos AngelesCAUSA University of California ‚Äì Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid Geffen School of MedicineLos AngelesCAUSA University of California ‚Äì Los Angeles (UCLA) Cardiac Arrhythmia CenterDavid Geffen School of MedicineLos AngelesCAUSA},
note  = {J Physiol. 2016 Jan 15;594(2):321-41. Epub 2015 Dec 15 doi:10.1113/JP271165.}
}

@Article{2016700,
author  = {Liu, B. and Huberman, A. and Scanziani, M.},
title  = {behaviour.},
journal  = {Nature},
volume  = {538},
number  = {7625},
pages  = {383-7},
year  = {2016},
abstract  = {The mammalian visual cortex massively innervates the brainstem, a phylogenetically older structure, via cortico-fugal axonal projections1. Many cortico-fugal projections target brainstem nuclei that mediate innate motor behaviours, but the function of these projections remains poorly understood1‚Äì4. A prime example of such behaviours is the optokinetic reflex (OKR), an innate eye movement mediated by the brainstem accessory optic system3,5,6, that stabilizes images on the retina as the animal moves through the environment and is thus crucial for vision5. The OKR is plastic, allowing the amplitude of this reflex to be adaptively adjusted relative to other oculomotor reflexes and thereby ensuring image stability throughout life7‚Äì11. Although the plasticity of the OKR is thought to involve subcortical structures such as the cerebellum and vestibular nuclei10‚Äì13, cortical lesions have suggested that the visual cortex might also be involved9,14,15. Here we show that projections from the mouse visual cortex to the accessory optic system promote the adaptive plasticity of the OKR. OKR potentiation, a compensatory plastic increase in the amplitude of the OKR in response to vestibular impairment11,16‚Äì18, is diminished by silencing visual cortex. Furthermore, targeted ablation of a sparse population of cortico-fugal neurons that specifically project to the accessory optic system severely impairs  OKR potentiation. Finally, OKR potentiation results from an enhanced drive exerted by the visual cortex onto the accessory optic system. Thus, cortico-fugal projections to the brainstem enable the visual cortex, an area that has been principally studied for its sensory processing function19, to plastically adapt the execution of innate motor behaviours.},
address  = {Howard Hughes Medical Institute and Center for Neural Circuits and Behavior, University of California San Diego, La Jolla, California 92093-0634, USA Department of Neurobiology, Stanford University School of Medicine, Palo Alto, California 94305, USA Howard Hughes Medical Institute and Center for Neural Circuits and Behavior, University of California San Diego, La Jolla, California 92093-0634, USA},
note  = {Nature. 2016 Oct 20;538(7625):383-7. Epub 2016 Oct 12 doi:10.1038/nature19818.}
}

@Article{2011701,
author  = {Lynn, L. and Curry, J.},
title  = {Patterns of unexpected in-hospital deaths: a root cause analysis.},
journal  = {Patient Safety in Surgery},
volume  = {5},
number  = {},
pages  = {3},
year  = {2011},
abstract  = {Background: Respiratory alarm monitoring and rapid response team alerts on hospital general floors are based on detection of simple numeric threshold breaches. Although some uncontrolled observation trials in select patient populations have been encouraging, randomized controlled trials suggest that this simplistic approach may not reduce the unexpected death rate in this complex environment. The purpose of this review is to examine the history and scientific  basis for threshold alarms and to compare thresholds with the actual pathophysiologic patterns of evolving death which must be timely detected. Methods: The Pubmed database was searched for articles relating to methods for triggering rapid response teams and respiratory alarms and these were contrasted  with the fundamental timed pathophysiologic patterns of death which evolve due to sepsis, congestive heart failure, pulmonary embolism, hypoventilation, narcotic overdose, and sleep apnea. Results: In contrast to the simplicity of the numeric  threshold breach method of generating alerts, the actual patterns of evolving death are complex and do not share common features until near death. On hospital  general floors, unexpected clinical instability leading to death often progresses along three distinct patterns which can be designated as Types I, II and III. Type I is a pattern comprised of hyperventilation compensated respiratory failure typical of congestive heart failure and sepsis. Here, early hyperventilation and  respiratory alkalosis can conceal the onset of instability. Type II is the pattern of classic CO2 narcosis. Type III occurs only during sleep and is a pattern of ventilation and SPO2 cycling caused by instability of ventilation and/or upper airway control followed by precipitous and fatal oxygen desaturation if arousal failure is induced by narcotics and/or sedation. Conclusion: The traditional threshold breach method of detecting instability on hospital wards was not scientifically derived; explaining the failure of threshold based monitoring and rapid response team activation in randomized trials. Furthermore,  the thresholds themselves are arbitrary and capricious. There are three common fundamental pathophysiologic patterns of unexpected hospital death. These patterns are too complex for early detection by any unifying numeric threshold. New methods and technologies which detect and identify the actual patterns of evolving death should be investigated.},
address  = {The Sleep and Breathing Research Institute, Columbus, Ohio USA Department of Anesthesiology and Perioperative Care, Hoag Memorial Hospital Presbyterian, Newport Beach, CA 92658 USA},
note  = {Patient Saf Surg. 2011 Feb 11;5:3. doi:10.1186/1754-9493-5-3.}
}

@Article{2012702,
author  = {Maffeo, C. and Bhattacharya, S. and Yoo, J. and Wells, D. and Aksimentiev, A.},
title  = {Modeling and Simulation of Ion Channels.},
journal  = {Chemical reviews},
volume  = {112},
number  = {12},
pages  = {6250-84},
year  = {2012},
abstract  = {},
address  = {},
note  = {Chem Rev. 2012 Dec 12;112(12):6250-84. Epub 2012 Oct 04 doi:10.1021/cr3002609.}
}

@Article{2015703,
author  = {Segawa, J. and Tourville, J. and Beal, D. and Guenther, F.},
title  = {The neural correlates of speech motor sequence learning.},
journal  = {Journal of cognitive neuroscience},
volume  = {27},
number  = {4},
pages  = {819-31},
year  = {2015},
abstract  = {Speech is perhaps the most sophisticated example of a species-wide movement capability in the animal kingdom, requiring split-second sequencing of approximately 100 muscles in the respiratory, laryngeal, and oral movement systems. Despite the unique role speech plays in human interaction and the debilitating impact of its disruption, little is known about the neural mechanisms underlying speech motor learning. Here, we studied the behavioral and  neural correlates of learning new speech motor sequences. Subjects repeatedly produced novel, meaningless syllables comprising illegal consonant clusters (e.g. GVAZF) over two days of practice. Following practice, subjects produced the sequences with fewer errors and shorter durations, indicative of motor learning.  Using functional magnetic resonance imaging, we compared brain activity during production of the learned illegal sequences and novel illegal sequences. Greater  activity was noted during production of novel sequences in brain regions linked to non-speech motor sequence learning, including the basal ganglia and pre-supplementary motor area. Activity during novel sequence production was also  greater in brain regions associated with learning and maintaining speech motor programs, including lateral premotor cortex, frontal operculum, and posterior superior temporal cortex. Measures of learning success correlated positively with activity in left frontal operculum and white matter integrity under left posterior superior temporal sulcus. These findings indicate speech motor sequence learning relies not only on brain areas involved generally in motor sequencing learning but also those associated with feedback-based speech motor learning. Furthermore, learning success is modulated by the integrity of structural connectivity between these motor and sensory brain regions.},
address  = {Boston University, Department of Speech, Language and Hearing Sciences, Boston, MA 02215 Boston University, Department of Speech, Language and Hearing Sciences, Boston, MA 02215 Boston University, Department of Speech, Language and Hearing Sciences, Boston, MA 02215 Boston University, Department of Speech, Language and Hearing Sciences, Boston, MA 02215},
note  = {doi:10.1162/jocn_a_00737.}
}

@Article{2010704,
author  = {Wildenberg, J. and Tyler, M. and Danilov, Y. and Kaczmarek, K. and Meyerand, M.},
title  = {stimulation.},
journal  = {Brain imaging and behavior},
volume  = {4},
number  = {3-4},
pages  = {199-211},
year  = {2010},
abstract  = {This pilot study aimed to show that information-free stimulation of the tongue can improve behavioral measures and induce sustained neuromodulation of the balance-processing network in individuals with balance dysfunction. Twelve balance-impaired subjects received one week of cranial nerve non-invasive neuromodulation (CN-NINM). Before and after the week of stimulation, postural sway and fMRI activation were measured to monitor susceptibility to optic flow. Nine normal controls also underwent the postural sway and fMRI tests but did not  receive CN-NINM. Results showed that before CN-NINM balance-impaired subjects swayed more than normal controls as expected (p‚â§0.05), and that overall sway and  susceptibility to optic flow decreased after CN-NINM (p‚â§0.005 & p‚â§0.05). fMRI showed upregulation of visual sensitivity to optic flow in balance-impaired subjects that decreased after CN-NINM. A region of interest analysis indicated that CN-NINM may induce neuromodulation by increasing activity within the dorsal  pons (p‚â§0.01).},
address  = {Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI 53705, USA Medical Scientist Training Program, University of Wisconsin-Madison, Madison, WI  53705, USA 1122o Wisconsin Institutes for Medical Research, 1111 Highland Ave., Madison, WI  53705, USA Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, WI 53705, USA Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, WI 53705, USA Department of Orthopedics and Rehabilitation, University of Wisconsin-Madison, Madison, WI 53705, USA Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI 53705, USA Department of Medical Physics, University of Wisconsin-Madison, Madison, WI 53705, USA},
note  = {Brain Imaging Behav. 2010 Dec;4(3-4):199-211. doi:10.1007/s11682-010-9099-7.}
}

@Article{2013705,
author  = {Neymotin, S. and Chadderdon, G. and Kerr, C. and Francis, J. and Lytton, W.},
title  = {Sensorimotor Cortex.},
journal  = {Neural computation},
volume  = {25},
number  = {12},
pages  = {3263-93},
year  = {2013},
abstract  = {Neocortical mechanisms of learning sensorimotor control involve a complex series  of interactions at multiple levels, from synaptic mechanisms to cellular dynamics to network connectomics. We developed a model of sensory and motor neocortex consisting of 704 spiking model neurons. Sensory and motor populations included excitatory cells and two types of interneurons. Neurons were interconnected with  AMPA/NMDA and GABAA synapses. We trained our model using spike-timing-dependent reinforcement learning to control a two-joint virtual arm to reach to a fixed target. For each of 125 trained networks, we used 200 training sessions, each involving 15 s reaches to the target from 16 starting positions. Learning altered network dynamics, with enhancements to neuronal synchrony and behaviorally relevant information flow between neurons. After learning, networks demonstrated  retention of behaviorally relevant memories by using proprioceptive information to perform reach-to-target from multiple starting positions. Networks dynamically controlled which joint rotations to use to reach a target, depending on current arm position. Learning-dependent network reorganization was evident in both sensory and motor populations: learned synaptic weights showed target-specific patterning optimized for particular reach movements. Our model embodies an integrative hypothesis of sensorimotor cortical learning that could be used to interpret future electrophysiological data recorded in vivo from sensorimotor learning experiments. We used our model to make the following predictions: learning enhances synchrony in neuronal populations and behaviorally relevant information flow across neuronal populations, enhanced sensory processing aids task-relevant motor performance and the relative ease of a particular movement in vivo depends on the amount of sensory information required to complete the movement.},
address  = {samuel.neymotin@yale.edu, Department of Neurobiology, Yale University School of Medicine, New Haven, CT 06510, U.S.A., and Department of Physiology and Pharmacology, SUNY Downstate, Brooklyn, NY 11203, U.S.A. georgec@neurosim.downstate.edu, Department of Physiology and Pharmacology, SUNY Downstate, Brooklyn, NY 11203, U.S.A. cliffk@neurosim.downstate.edu, Department of Physiology and Pharmacology, SUNY Downstate, Brooklyn, NY 11203, U.S.A., and School of Physics, University of Sydney, Sydney 2050, Australia Joe.francis@downstate.edu, Department of Physiology and Pharmacology, Program in  Neural and Behavioral Science, and Robert F. Furchgott Center for Neural and Behavioral Science, SUNY Downstate, Brooklyn, NY 11203, U.S.A., and Joint Program in Biomedical Engineering, NYU Poly and SUNY Downstate, Brooklyn, NY 11203, U.S.A. billl@neurosim.downstate.edu, Department of Physiology and Pharmacology, Department of Neurology, Program in Neural and Behavioral Science, and Robert F.  Furchgott Center for Neural and Behavioral Science, SUNY Downstate, Brooklyn, NY  11203, U.S.A.; Joint Program in Biomedical Engineering, NYU Poly and SUNY Downstate, Brooklyn, NY 11203, U.S.A.; and Department of Neurology, Kings County  Hospital, Brooklyn, NY 11203, U.S.A.},
note  = {doi:10.1162/NECO_a_00521.}
}

@Article{2015706,
author  = {Wahnoun, R. and Benson, M. and Helms‚Ä?Tillery, S. and Adelson, P.},
title  = {study.},
journal  = {Brain and Behavior},
volume  = {5},
number  = {10},
pages  = {},
year  = {2015},
abstract  = {Background: In surgical planning for epileptic focus resection, functional mapping of eloquent cortex is attained through direct electrical stimulation of the brain. This procedure is uncomfortable, can trigger seizures or nausea, and relies on subjective evaluation. We hypothesize that a method combining vibrotactile stimulation and statistical clustering may provide improved somatosensory mapping. Methods: Seven pediatric candidates for surgical resection underwent a task in which their fingers were independently stimulated using a custom designed finger pad, during electrocorticographic monitoring. A cluster‚Ä?based statistical analysis was then performed to localize the elicited activity on the recording grids. Results: Mid‚Ä?Gamma clusters (65‚Äì115 Hz) arose in areas consistent with anatomical predictions as well as clinical findings, with five subjects presenting a somatotopic organization of the fingers. This process  allowed us to delineate finger representation even in patients who were sleeping, with strong interictal activity, or when electrical stimulation did not successfully locate eloquent areas. Conclusions: We suggest that this scheme, relying on the endogenous neural response rather than exogenous electrical activation, could eventually be extended to map other sensory areas and provide a faster and more objective map to better anticipate outcomes of surgical resection.},
address  = {Barrow Neurological Institute at Phoenix Children's HospitalChildren's Neuroscience ResearchPhoenixArizona Barrow Neurological Institute at Phoenix Children's HospitalChildren's Neuroscience ResearchPhoenixArizona School of Biological and Health Systems EngineeringArizona State UniversityTempeArizona Barrow Neurological Institute at Phoenix Children's HospitalChildren's Neuroscience ResearchPhoenixArizona},
note  = {Brain Behav. 2015 Sep 20;5(10):. doi:10.1002/brb3.369.}
}

@Article{2013707,
author  = {Lin, K. and Wang, G. and Herreros, J. and Chomutare, T. and Gao, J. and Mart√≠nez-P√©rez, B. and de, l. and L√≥pez-Coronado, M.},
title  = {Organization: Review and Analysis.},
journal  = {Journal of Medical Internet Research},
volume  = {15},
number  = {6},
pages  = {},
year  = {2013},
abstract  = {Background: New possibilities for mHealth have arisen by means of the latest advances in mobile communications and technologies. With more than 1 billion smartphones and 100 million tablets around the world, these devices can be a valuable tool in health care management. Every aid for health care is welcome and necessary as shown by the more than 50 million estimated deaths caused by illnesses or health conditions in 2008. Some of these conditions have additional  importance depending on their prevalence. Objective: To study the existing applications for mobile devices exclusively dedicated to the eight most prevalent health conditions by the latest update (2004) of the Global Burden of Disease (GBD) of the World Health Organization (WHO): iron-deficiency anemia, hearing loss, migraine, low vision, asthma, diabetes mellitus, osteoarthritis (OA), and unipolar depressive disorders. Methods: Two reviews have been carried out. The first one is a review of mobile applications in published articles retrieved from the following systems: IEEE Xplore, Scopus, ScienceDirect, Web of Knowledge, and  PubMed. The second review is carried out by searching the most important commercial app stores: Google play, iTunes, BlackBerry World, Windows Phone Apps+Games, and Nokia's Ovi store. Finally, two applications for each condition,  one for each review, were selected for an in-depth analysis. Results: Search queries up to April 2013 located 247 papers and more than 3673 apps related to the most prevalent conditions. The conditions in descending order by the number of applications found in literature are diabetes, asthma, depression, hearing loss, low vision, OA, anemia, and migraine. However when ordered by the number of commercial apps found, the list is diabetes, depression, migraine, asthma, low vision, hearing loss, OA, and anemia. Excluding OA from the former list, the four most prevalent conditions have fewer apps and research than the final four. Several results are extracted from the in-depth analysis: most of the apps are designed for monitoring, assisting, or informing about the condition. Typically an Internet connection is not required, and most of the apps are aimed for the general public and for nonclinical use. The preferred type of data visualization  is text followed by charts and pictures. Assistive and monitoring apps are shown  to be frequently used, whereas informative and educational apps are only occasionally used. Conclusions: Distribution of work on mobile applications is not equal for the eight most prevalent conditions. Whereas some conditions such as diabetes and depression have an overwhelming number of apps and research, there is a lack of apps related to other conditions, such as anemia, hearing loss, or low vision, which must be filled.},
address  = {University of ValladolidDepartment of Signal Theory and Communications, and Telematics Engineering.University of ValladolidValladolidSpain University of ValladolidDepartment of Signal Theory and Communications, and Telematics Engineering.University of ValladolidValladolidSpain University of ValladolidDepartment of Signal Theory and Communications, and Telematics Engineering.University of ValladolidValladolidSpain},
note  = {J Med Internet Res. 2013 Jun 14;15(6):. doi:10.2196/jmir.2600.}
}

@Article{2016708,
author  = {Mohammed, A. and Gritton, H. and Tseng, H. and Bucklin, M. and Yao, Z. and Han, X.},
title  = {using wide-field calcium imaging.},
journal  = {Scientific Reports},
volume  = {6},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Advances in neurotechnology have been integral to the investigation of neural circuit function in systems neuroscience. Recent improvements in high performance fluorescent sensors and scientific CMOS cameras enables optical imaging of neural networks at a much larger scale. While exciting technical advances demonstrate the potential of this technique, further improvement in data acquisition and analysis, especially those that allow effective processing of increasingly larger datasets, would greatly promote the application of optical imaging in systems neuroscience. Here we demonstrate the ability of wide-field imaging to capture the concurrent dynamic activity from hundreds to thousands of neurons over millimeters of brain tissue in behaving mice. This system allows the visualization of morphological details at a higher spatial resolution than has been previously achieved using similar functional imaging modalities. To analyze  the expansive data sets, we developed software to facilitate rapid downstream data processing. Using this system, we show that a large fraction of anatomically distinct hippocampal neurons respond to discrete environmental stimuli associated with classical conditioning, and that the observed temporal dynamics of transient calcium signals are sufficient for exploring certain spatiotemporal features of large neural networks.},
address  = {Boston University, Department of Biomedical Engineering, Boston, MA 02215. Boston University, Department of Biomedical Engineering, Boston, MA 02215. Boston University, Department of Biomedical Engineering, Boston, MA 02215. Boston University, Department of Biomedical Engineering, Boston, MA 02215. Boston University, Department of Biomedical Engineering, Boston, MA 02215. Boston University, Department of Biomedical Engineering, Boston, MA 02215.},
note  = {Sci Rep. 2016 Feb 08;6:. doi:10.1038/srep20986.}
}

@Article{2016709,
author  = {Horn, U. and Grothe, M. and Lotze, M.},
title  = {Stroke.},
journal  = {Neural Plasticity},
volume  = {2016},
number  = {},
pages  = {},
year  = {2016},
abstract  = {Several biomarkers have been identified which enable a considerable prediction of hand-motor outcome after cerebral damage already in the subacute stage after stroke. We here review the value of MRI biomarkers in the evaluation of corticospinal integrity and functional recruitment of motor resources. Many of the functional imaging parameters are not feasible early after stroke or for patients with high impairment and low compliance. Whereas functional connectivity parameters have demonstrated varying results on their predictive value for hand-motor outcome, corticospinal integrity evaluation using structural imaging showed robust and high predictive power for patients with different levels of impairment. Although this is indicative of an overall higher value of structural  imaging for prediction, we suggest that this variation be explained by structure  and function relationships. To gain more insight into the recovering brain, not only one biomarker is needed. We rather argue for a combination of different measures in an algorithm to classify fine-graded subgroups of patients. Approaches to determining biomarkers have to take into account the established markers to provide further information on certain subgroups. Assessing the best therapy approaches for individual patients will become more feasible as these subgroups become specified in more detail. This procedure will help to considerably save resources and optimize neurorehabilitative therapy.},
address  = {Functional Imaging Unit, Department of Diagnostic Radiology and Neuroradiology, University Medicine, University of Greifswald, Greifswald, Germany Department of Neurology, University Medicine, University of Greifswald, Greifswald, Germany Functional Imaging Unit, Department of Diagnostic Radiology and Neuroradiology, University Medicine, University of Greifswald, Greifswald, Germany},
note  = {Neural Plast. 2016;2016:. Epub 2016 Sep 26 doi:10.1155/2016/9265621.}
}

@Article{2013710,
author  = {McGregor, K. and Licandro, U. and Arenas, R. and Eden, N. and Stiles, D. and Bean, A. and Walker, E.},
title  = {Why Words are Hard for Adults with Developmental Language Impairments.},
journal  = {Journal of speech, language, and hearing research : JSLHR},
volume  = {56},
number  = {6},
pages  = {1845-56},
year  = {2013},
abstract  = {PURPOSE:: To determine whether word learning problems associated with developmental language impairment (LI) reflect deficits in encoding or subsequent remembering of forms and meanings. METHOD:: Sixty-nine 18-25-year-olds with LI or without (ND) took tests to measure learning of 16 word forms and meanings immediately after training (encoding) and 12-hours, 24-hours, and 1-week later (remembering). Half of the participants trained in the morning and half in the evening. RESULTS:: At immediate posttest, those with LI performed more poorly on  form and meaning than those with ND. Poor performance was more likely among those with more severe LI. The LI and ND groups demonstrated no difference in remembering word meanings over one week. In both groups, participants who trained in the evening, and therefore slept shortly after training, demonstrated greater  gains in meaning recall than those who trained in the morning. In contrast, the LI-ND gap for word form recall widened over the week. CONCLUSIONS:: Some adults with LI have encoding deficits that limit the addition of word forms and meanings to the lexicon. Similarities and differences in patterns of remembering in the LI and ND groups motivate the hypothesis that consolidation of declarative memory is a strength for adults with LI.},
address  = {},
note  = {doi:10.1044/1092-4388(2013/12-0233).}
}

@Article{2016711,
author  = {Ruchi, M. and Ann, D. and Komal, P. and Connor, B. and Daniel, J.},
title  = {neurons along the longitudinal hippocampal axis.},
journal  = {Hippocampus},
volume  = {26},
number  = {3},
pages  = {341-61},
year  = {2016},
abstract  = {Differences in behavioral roles, anatomical connectivity and gene expression patterns in the dorsal, intermediate and ventral regions of the hippocampus are well characterized. Relatively fewer studies have, however, focused on comparing  the physiological properties of neurons located at different dorsoventral extents of the hippocampus. Recently we reported that dorsal CA1 neurons are less excitable than ventral neurons. There is little or no information for how neurons in the intermediate hippocampus compare to those from the dorsal and ventral ends. Also, it is not known whether the transition of properties along the dorsoventral axis is gradual or segmented. In this study, we developed a statistical model to predict the dorsoventral position of transverse hippocampal  slices. Using current clamp recordings combined with this model, we found that CA1 neurons in dorsal, intermediate and ventral hippocampus have distinct electrophysiological and morphological properties and that the transition in most (but not all) of these properties from the ventral to dorsal end is gradual. Using linear and segmented regression analyses, we found that input resistance and resting membrane potential changed linearly along the V‚ÄìD axis. Interestingly, the transition in resonance frequency, rebound slope, dendritic branching in stratum radiatum and action potential properties was segmented along the V‚ÄìD axis. Together, the findings from this study highlight the heterogeneity  in CA1 neuronal properties along the entire longitudinal axis of hippocampus.},
address  = {Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St, Austin, TX 78712 Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St, Austin, TX 78712 Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St, Austin, TX 78712 Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St, Austin, TX 78712 Center for Learning and Memory, The University of Texas at Austin, 100 E 24 St, Austin, TX 78712},
note  = {Hippocampus. 2016 Mar;26(3):341-61. Epub 2015 Oct 10 doi:10.1002/hipo.22526.}
}

@Article{2012712,
author  = {Wohlleben, W.},
title  = {classification to as-tested coronas.},
journal  = {Journal of Nanoparticle Research},
volume  = {14},
number  = {12},
pages  = {},
year  = {2012},
abstract  = {Granulometry is the regulatory category where the differences between traditional materials and nanomaterials culminate. Reported herein is a careful validation of methods for the quantification of dispersability and size distribution in relevant media, and for the classification according to the EC nanodefinition recommendation. Suspension-based techniques can assess the nanodefinition only if the material in question is reasonably well dispersed. Using dispersed material of several chemical compositions (organic, metal, metal-oxide) as test cases we benchmark analytical ultracentrifugation (AUC), dynamic light scattering (DLS), hydrodynamic chromatography, nanoparticle tracking analysis (NTA) against the known content of bimodal suspensions in the commercially relevant range between 20 nm and a few microns. The results validate fractionating techniques, especially AUC, which successfully identifies any dispersed nanoparticle content  from 14 to 99.9 nb% with less than 5 nb% deviation. In contrast, our screening casts severe doubt over the reliability of ensemble (scattering) techniques and highlights the potential of NTA to develop into a counting upgrade of DLS. The unique asset of centrifuges with interference, X-ray or absorption detectors‚Äîto quantify the dispersed solid content for each size interval from proteins over individualized nanoparticles up to agglomerates, while accounting for their loose packing‚Äîaddresses also the adsorption/depletion of proteins and (de-)agglomeration of nanomaterials under cell culture conditions as tested for toxicological endpoints.},
address  = {BASF SE, Material Physics GMC/R, 67056 Ludwigshafen, Germany},
note  = {J Nanopart Res. 2012 Dec;14(12):. Epub 2012 Nov 24 doi:10.1007/s11051-012-1300-z.}
}

@Article{2005713,
author  = {McCurdy, N. and Griswold, W. and Lenert, L.},
title  = {Disasters Using Ubiquitous Video.},
journal  = {AMIA Annual Symposium Proceedings},
volume  = {2005},
number  = {},
pages  = {510-4},
year  = {2005},
abstract  = {The first moments at a disater scene are chaotic. The command center initially operates with little knowledge of hazards, geography and casualties, building up  knowledge of the event slowly as information trickles in by voice radio channels. RealityFlythrough is a tele-presence system that stitches together live video feeds in real-time, using the principle of visual closure, to give command center personnel the illusion of being able to explore the scene interactively by moving smoothly between the video feeds. Using RealityFlythrough, medical, fire, law enforcement, hazardous materials, and engineering experts may be able to achieve  situational awareness earlier, and better manage scarce resources. The RealityFlythrough system is composed of camera units with off-the-shelf GPS and orientation systems and a server/viewing station that offers access to images collected by the camera units in real time by position/orientation. In initial field testing using an experimental mesh 802.11 wireless network, two camera unit operators were able to create an interactive image of a simulated disaster scene  in about five minutes.},
address  = {California Institute for Telecommunications and Information Technology, University of California, San Diego, La Jolla, CA California Institute for Telecommunications and Information Technology, University of California, San Diego, La Jolla, CA},
note  = {AMIA Annu Symp Proc. 2005;2005:510-4.}
}

@Article{2012714,
author  = {Kussrow, A. and Enders, C. and Bornhop, D.},
title  = {Interferometric Methods for Label-Free Molecular Interaction Studies.},
journal  = {Analytical chemistry},
volume  = {84},
number  = {2},
pages  = {779-92},
year  = {2012},
abstract  = {},
address  = {},
note  = {Anal Chem. 2012 Jan 17;84(2):779-92. Epub 2011 Nov 07 doi:10.1021/ac202812h.}
}

@Article{2002715,
author  = {Palya, W. and Walter, D. and Kessel, R. and Lucke, R.},
title  = {Linear modeling of steady-state behavioral dynamics.},
journal  = {Journal of the Experimental Analysis of Behavior},
volume  = {77},
number  = {1},
pages  = {3-27},
year  = {2002},
abstract  = {The observed steady-state behavioral dynamics supported by unsignaled periods of  reinforcement within repeating 2,000-s trials were modeled with a linear transfer function. These experiments employed improved schedule forms and analytical methods to improve the precision of the measured transfer function, compared to previous work. The refinements include both the use of multiple reinforcement periods that improve spectral coverage and averaging of independently determined  transfer functions. A linear analysis was then used to predict behavior observed  for three different test schedules. The fidelity of these predictions was determined.},
address  = {},
note  = {J Exp Anal Behav. 2002 Jan;77(1):3-27. doi:10.1901/jeab.2002.77-3.}
}

@Article{2014716,
author  = {Azene, N. and Fu, Y. and Maurer, J. and Kraitchman, D.},
title  = {Tracking of stem cells in vivo for cardiovascular applications.},
journal  = {Journal of Cardiovascular Magnetic Resonance},
volume  = {16},
number  = {1},
pages  = {7},
year  = {2014},
abstract  = {In the past ten years, the concept of injecting stem and progenitor cells to assist with rebuilding damaged blood vessels and myocardial tissue after injury in the heart and peripheral vasculature has moved from bench to bedside. Non-invasive imaging can not only provide a means to assess cardiac repair and, thereby, cellular therapy efficacy but also a means to confirm cell delivery and  engraftment after administration. In this first of a two-part review, we will review the different types of cellular labeling techniques and the application of these techniques in cardiovascular magnetic resonance and ultrasound. In addition, we provide a synopsis of the cardiac cellular clinical trials that have been performed to-date.},
address  = {Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, Baltimore, MD, USA Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, Baltimore, MD, USA Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, Baltimore, MD, USA Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University, Baltimore, MD, USA},
note  = {J Cardiovasc Magn Reson. 2014 Jan 10;16(1):7. doi:10.1186/1532-429X-16-7.}
}

@Article{2015717,
author  = {Zhou, H. and Hernandez, C. and Goss, M. and Gawlik, A. and Exner, A.},
title  = {Biomedical Imaging in Implantable Drug Delivery Systems.},
journal  = {Current drug targets},
volume  = {16},
number  = {6},
pages  = {672-82},
year  = {2015},
abstract  = {Implantable drug delivery systems (DDS) provide a platform for sustained release  of therapeutic agents over a period of weeks to months and sometimes years. Such  strategies are typically used clinically to increase patient compliance by replacing frequent administration of drugs such as contraceptives and hormones to maintain plasma concentration within the therapeutic window. Implantable or injectable systems have also been investigated as a means of local drug administration which favors high drug concentration at a site of interest, such as a tumor, while reducing systemic drug exposure to minimize unwanted side effects. Significant advances in the field of local DDS have led to increasingly  sophisticated technology with new challenges including quantification of local and systemic pharmacokinetics and implant-body interactions. Because many of these sought-after parameters are highly dependent on the tissue properties at the implantation site, and rarely represented adequately with in vitro models, new nondestructive techniques that can be used to study implants in situ are highly desirable. Versatile imaging tools can meet this need and provide quantitative data on morphological and functional aspects of implantable systems. The focus of this review article is an overview of current biomedical imaging techniques, including magnetic resonance imaging (MRI), ultrasound imaging, optical imaging, X-ray and computed tomography (CT), and their application in evaluation of implantable DDS.},
address  = {Department of Biomedical Engineering, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA Department of Biomedical Engineering, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA Department of Biomedical Engineering, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA Department of Biomedical Engineering, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA Department of Biomedical Engineering, Case Western Reserve University, 11100 Euclid Ave, Cleveland, OH, 44106, USA},
note  = {Curr Drug Targets. 2015;16(6):672-82.}
}

@Article{2009718,
author  = {Midgley, K. and Holcomb, P. and Grainger, J.},
title  = {investigated with event-related potentials‚òÜ.},
journal  = {Journal of neurolinguistics},
volume  = {22},
number  = {3},
pages  = {281-300},
year  = {2009},
abstract  = {The present study examines language effects in second language learners. In three experiments participants monitored a stream of words for occasional probes from one semantic category and ERPs were recorded to non-probe critical items. In Experiment 1 L1 English participants who were university learners of French saw two lists of words blocked by language, one in French and one in English. We observed a large effect of language that mostly affected amplitudes of the N400 component, but starting as early as 150 ms post-stimulus onset. A similar pattern was found in Experiment 2 with L1 French and L2 English, showing that the effect  is due to language dominance and not language per se. Experiment 3 found that proficient French/English bilinguals exhibited a different pattern of language effects showing that these effects are modulated by proficiency. These results lend further support to the hypothesis that word recognition during the early phases of L2 acquisition in late learners of L2 involves a specific set of mechanisms compared with recognition of L1 words.},
address  = {Department of Psychology, Tufts University, Medford, MA, USA Department of Psychology, Tufts University, Medford, MA, USA CNRS, Marseille, France},
note  = {J Neurolinguistics. 2009 May;22(3):281-300. doi:10.1016/j.jneuroling.2008.08.001.}
}

@Article{2014719,
author  = {Ruffini, G. and Fox, M. and Ripolles, O. and Miranda, P. and Pascual-Leone, A.},
title  = {pattern targeting from realistic modeling of electric fields.},
journal  = {NeuroImage},
volume  = {89},
number  = {},
pages  = {216-25},
year  = {2014},
abstract  = {Recently, multifocal transcranial current stimulation (tCS) devices using several relatively small electrodes have been used to achieve more focal stimulation of specific cortical targets. However, it is becoming increasingly recognized that many behavioral manifestations of neurological and psychiatric disease are not solely the result of abnormality in one isolated brain region but represent alterations in brain networks. In this paper we describe a method for optimizing  the configuration of multifocal tCS for stimulation of brain networks, represented by spatially extended cortical targets. We show how, based on fMRI, PET, EEG or other data specifying a target map on the cortical surface for excitatory, inhibitory or neutral stimulation and a constraint of the maximal number of electrodes, a solution can be produced with the optimal currents and locations of the electrodes. The method described here relies on a fast calculation of multifocal tCS electric fields (including components normal and tangential to the cortical boundaries) using a five layer finite element model of a realistic head. Based on the hypothesis that the effects of current stimulation are to first order due to the interaction of electric fields with populations of  elongated cortical neurons, it is argued that the optimization problem for tCS stimulation can be defined in terms of the component of the electric field normal to the cortical surface. Solutions are found using constrained least squares to optimize current intensities, while electrode number and their locations are selected using a genetic algorithm. For direct current tCS (tDCS) applications, we provide some examples of this technique using an available tCS system providing 8 small Ag/AgCl stimulation electrodes. We demonstrate the approach both for localized and spatially extended targets defined using rs-fcMRI and PET  data, with clinical applications in stroke and depression. Finally, we extend these ideas to more general stimulation protocols, such as alternating current tCS (tACS).},
address  = {Starlab Barcelona, C. Teodor Roviralta 45, 08022 Barcelona, Spain Massachusetts General Hospital, Brigham and Women‚Äôs Hospital, Harvard Medical School, Boston, MA, USA Neuroelectrics Barcelona, C. Teodor Roviralta 45, 08022 Barcelona, Spain Neuroelectrics Barcelona, C. Teodor Roviralta 45, 08022 Barcelona, Spain Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA},
note  = {doi:10.1016/j.neuroimage.2013.12.002.}
}

